PDF File - Mahidol University
PDF File - Mahidol University
PDF File - Mahidol University
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Brain & Development 24 (2002) 345–649<br />
www.elsevier.com/locate/braindev<br />
KN<br />
Human genome project and its medical implications<br />
Y. Sakaki<br />
Human Genome Center, The Institute of Medical Science,<br />
The <strong>University</strong> of Tokyo, Tokyo, Japan<br />
Human genome project (HGP) started on 1990 under an<br />
international cooperation, and has made remarkable<br />
progress such as the first generation genetic linkage map<br />
of the human genome on 1994, and the draft sequence of<br />
the entire genome on 2000. These great achievements<br />
opened a new field of medicine and biology. Discovery of<br />
genetic variations, particularly large amounts of single<br />
nucleotide polymorphisms enabled us to genetically analyze<br />
not only typical Mendelian disorders but also complex<br />
diseases. Discovery of disease related genes opened a gate<br />
to the medical, clinical applications of genomics such as<br />
genetic diagnosis, gene therapy and drug discovery, and<br />
the progress of such applied genomics will eventually establish<br />
new types of medicine; that is, genome-based preventive<br />
medicine and personalized medicine. The progress of<br />
HGP, together with the development of new technologies<br />
such as DNA chip/micro array, and yeast two hybrid system,<br />
also allow us to explore the molecular mechanisms of<br />
complex biological process such as development and differentiation,<br />
immune system and neural system. I will summarize<br />
such progress of genomics and discuss its impact on<br />
medicine.<br />
PLENARY LECTURE/TOPIC UPDATE<br />
PL-1/TU-1<br />
Developmental Neuroscience<br />
PL-1<br />
Clinical disorders of brain plasticity<br />
M.V. Johnston<br />
Kennedy Krieger Institute and Johns Hopkins <strong>University</strong><br />
School of Medicine, Baltimore, MD, USA<br />
The child’s brain is far more plastic than the adult’s as<br />
judged by its greater ability to reorganize and recover after<br />
injury and its capacity for learning and memory. Several<br />
cellular and molecular events have been correlated with<br />
the enhanced plasticity of the developing brain, including<br />
the proliferation and pruning of synapses in cerebral cortex<br />
and the enhanced activity of excitatory neurotransmitter<br />
receptors in the neonatal period. The N-methyl-d-aspartate<br />
(NMDA)-type glutamate receptor is one of several cell<br />
surface receptors involved in neuronal plasticity, and its<br />
activity regulates neuronal survival. Over-stimulation of<br />
the NMDA receptor by perinatal hypoxic ischemia can trigger<br />
apoptosis or necrosis while blockade of NMDA receptors<br />
can also trigger apoptosis. Physiologic stimulation of<br />
the NMDA receptor as well as receptors linked to the Ras-<br />
MAP kinase pathway can activate transcription factors such<br />
as cAMP-response element-binding protein (CREB), stimulating<br />
expression of genes involved in learning and memory.<br />
An expanding group of pediatric neurologic disorders can<br />
be linked to disorders in these signaling pathways. In Coffin-<br />
Lowry syndrome, the degree of mental retardation can be<br />
correlated with the ability of the protein kinase C agonist<br />
PMA to stimulate CREB phosphorylation by the mutated<br />
kinase RSK2 in lymphoblasts (Harum et al., Neurology<br />
2001;56:207). Genetic disorders in similar signaling<br />
cascades have been detected in Rubinstein-Taybi syndrome,<br />
neurofibromatosis one, tuberous sclerosis two, and Huntington’s<br />
disease. Encephalopathies associated with congenital<br />
hypothyroidism, non-ketotic hyperglycinemia and lead<br />
poisoning also appear to involve abnormalities in these<br />
pathways. Clinical disorders of neuronal plasticity may be<br />
amenable to treatment as their pathogenesis is understood.<br />
TU-1A<br />
Disease gene hunting in China<br />
Y. Shen<br />
Chinese national human genome research center, national<br />
laboratory of medical molecular biology, IBMS, CAMS and<br />
PUMC, Beijing, China<br />
Public release of human genome sequence has ensured a<br />
level playing field worldwide for clinicians and researchers<br />
tracking the genes mutated in inherited diseases. Studies of<br />
samples taken from Chinese populations are yielding<br />
advances. The first success came in 1998, when a team<br />
led by Jia-hui Xia of the National Laboratory of Medical<br />
Genetics of China in Changsha, Hunan province, identified<br />
a gene for a form of neurological deafness. Last year, my<br />
group revealed the genetic basis of another disease, dentinogenesis<br />
imperfecta Shields type II, in which the teeth are<br />
discoloured and chip easily. We showed that a mutation in a<br />
gene called dentin sialophosphoprotein (DSSP) is responsible.<br />
Alongside our paper, researchers led by Xiangyin Kong<br />
of the Shanghai Research Center of Biotechnology reported<br />
that mutations in DSPP can also cause hearing loss.<br />
Researchers led by Lin He mapped the gene for brachydactyly<br />
type A-1, a disease in which joints of the figures are<br />
missing, misplaced or disfigured, to a small region of chro-<br />
0387-7604/02/$ - see front matter q 2002 Elsevier Science B.V. All rights reserved.<br />
PII: S0387-7604(02)00091-8
346<br />
Abstracts<br />
mosome 2 and found that mutations in Indian hedgehog<br />
(IHH) cause brachydactyly type A-1, beating competition<br />
from several groups around the world.<br />
TU-1B<br />
The central nerve system synaptic junction: evolution,<br />
architecture and plasticity of an adhesive device<br />
D.R. Colman<br />
The Montreal Neurological Institute, Canada<br />
The central nervous system (CNS) synaptic junction is<br />
likely to have evolved from the adherens junction of primitive<br />
epithelia. Both junctional types are held together by<br />
classic cadherins, and we have proposed that these bona<br />
fide adhesion molecules are involve in establishing specific<br />
connectivity patterns and in functioning as synaptic glue.<br />
Data supporting this notion will be presented. In other<br />
studies, we have been pursuing a biochemical dissection<br />
of CNS synaptic junction, and now report the key structural<br />
features of the presynaptic compartment may be solubilized<br />
and then reconstituted in vitro. This is a first step in generating<br />
a ‘synthetic’ synapse, using a minimum of functional<br />
elements.<br />
PL-2/TU-2<br />
Neonatal Neurology<br />
PL-2<br />
Brain injury in the premature infant – recent advances<br />
J. Volpe<br />
Harvard Medical School and Children’s Hospital, USA<br />
Brain injury in the premature infant is a problem of<br />
enormous importance. Periventricular leukomalacia<br />
(PVL) is the major neuropathological form of this brain<br />
injury and underlies most of the neurologic morbidity<br />
encountered in survivors of premature birth. Prevention<br />
of PVL now seems ultimately achievable because of recent<br />
neurobiologic insights into pathogenesis. The pathogenesis<br />
of this lesion relates to three major interacting factors. The<br />
first two of these, an incomplete state of development of<br />
the vascular supply to the cerebral white matter, and a<br />
maturation- dependent impairment in regulation of cerebral<br />
blood flow underlie a propensity for ischemic injury to<br />
cerebral white matter. The third major pathogenetic factor<br />
is the maturation-dependent vulnerability of the oligodendroglial<br />
(OL) precursor cell that represents the major cellular<br />
target in PVL. Recent neurobiologic studies show that<br />
these cells are exquisitely vulnerable to attack by free radicals,<br />
known to be generated in abundance with ischemiareperfusion.<br />
This vulnerability of OLs is maturation-dependent,<br />
with the OL precursor cell highly vulnerable and the<br />
mature OL resistant, and appears to relate to a developmental<br />
window characterized by a combination of deficient<br />
antioxidant defenses and active acquisition of iron during<br />
OL differentiation. The result is generation of deadly reactive<br />
oxygen species and apoptotic OL death. Important<br />
contributory factors in pathogenesis interact with this<br />
central theme of vulnerability to free radical attack. Thus,<br />
the increased likelihood of PVL in the presence of intraventricular<br />
hemorrhage could relate to increases in local<br />
iron concentrations derived from the hemorrhage. The<br />
important contributory role of maternal/fetal infection or<br />
inflammation and cytokines in the pathogenesis of PVL<br />
could be related to effects on the cerebral vasculature<br />
and cerebral hemodynamics, to generation of reactive<br />
oxygen species, or to direct toxic effects on vulnerable<br />
OL precursors. A key role for elevations in extracellular<br />
glutamate, caused by ischemia-reperfusion, is suggested by<br />
demonstrations that glutamate causes toxicity to OL<br />
precursors by both non-receptor- and receptor-mediated<br />
mechanisms. The former involves an exacerbation of the<br />
impairment in antioxidant defenses, and the latter, an<br />
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid<br />
(AMPA)/kainate receptor-mediated cell death. Most<br />
importantly, these new insights into the pathogenesis of<br />
PVL suggest potential preventative interventions. The<br />
latter include avoidance of cerebral ischemia by detection<br />
of infants with impaired cerebrovascular autoregulation,<br />
e.g. through the use of in vivo near-infrared spectroscopy,<br />
the use of free radical scavengers to prevent toxicity by<br />
reactive oxygen species, the administration of AMPA/<br />
kanaite receptor antagonists to prevent glutamate-mediated<br />
injury, or the use of maternal antibiotics or anticytokine<br />
agents to prevent toxicity from maternal/fetal infection or<br />
inflammation and cytokines.<br />
TU-2A<br />
Neuropathological studies on neonatal hypoxic-ischemic<br />
brain damage in experimental animals<br />
H. Yoshioka<br />
Department of Pediatrics, Kyoto Prefectural <strong>University</strong> of<br />
Medicine, Kyoto, Japan<br />
Biochemical and physiological experiments on neonatal<br />
hypoxic-ischemic brain damage may demonstrate many<br />
biochemical or physiological derangements in the brain,<br />
but it cannot be known without pathological verification<br />
whether such a derangement may result in permanent brain<br />
damage or not. Neuropathological approach has advantage<br />
as follows. (1) It can distinguish irreversible damage from<br />
reversible ones. Therefore, we can find which therapy<br />
protects or reduces permanent brain damage. (2) It can<br />
demonstrate regional difference in the response of the<br />
brain. Here I present some results of neuropathological<br />
studies on neonatal hypoxic-ischemic brain damage<br />
obtained in our laboratory. Since our earlier studies<br />
using neonatal mice suggested that hypoxia alone does<br />
not lead to apparent brain damage, but ischemia with or
Abstracts 347<br />
without hypoxia causes unequivocal brain lesions, we<br />
produced a new model of global ischemia by 3-vesselocclusion<br />
in 10-day-old rats. Using this model, we investigated<br />
pathogenic mechanisms and effective treatments of<br />
ischemic brain damage. (1) One-hour-ischemia reduced<br />
cerebral blood flow (CBF) to about 10% of control level<br />
and caused exhaustion of brain adenosine-5 0 -triphosphate<br />
(ATP) within 20 min. (2) Although ATP was exhausted for<br />
more than 30 min, 24 h later the brains revealed that only<br />
10% of cortical neurons had ischemic changes. (3) Twohour-ischemia<br />
caused diffuse brain infarct: More than 70%<br />
of cortical neurons showed ischemic changes. (4) Most<br />
ischemic neurons were TUNEL positive and electrophoresis<br />
of the brain tissues showed ladder formation, but electron<br />
microscopic study revealed only necrotic changes and<br />
no evidence of apoptosis. (5) Post-ischemic administration<br />
of polyethylene glycol-superoide dismutase (PEG-SOD)<br />
reduced ischemic damage to about 10%. (6) Pre- and<br />
post-ischemic administration of magnesium sulfate<br />
reduced ischemic brain damage to about 20%. Intraventricular<br />
administration of synaptotagmine antisense DNA 3<br />
days before ischemic event prevented ischemic brain<br />
damage.<br />
TU-2B<br />
Neuroimaging characteristics of neonatal brain injury<br />
P.S. Hüppi<br />
Department of Pediatrics, <strong>University</strong> of Geneva, Switzerland<br />
and Department of Neurology, Harvard Medical<br />
School, Boston, USA<br />
Despite marked improvements in perinatal practice, perinatal<br />
brain injury remains one of the most common complications<br />
causing chronic handicapping conditions. Many of<br />
the cellular and vascular mechanisms of perinatal brain<br />
damage have been studied and show a correlation between<br />
the nature of the injury and the maturation of the brain. In<br />
vivo diagnostic tools are therefore needed to assess brain<br />
development, to detect and to localize early brain injury<br />
and monitor interventions aimed at minimizing or preventing<br />
irreversible brain injury. Magnetic resonance (MR)<br />
techniques have in recent years become the imaging<br />
modality of choice for a more detailed structural as well<br />
as metabolic and functional assessment of the developing<br />
brain. Conventional MR imaging (MRI) has widely proven<br />
its potential to identify normal and pathologic brain<br />
morphology giving objective information about the structure<br />
of the neonatal brain during development. The sensitivity<br />
of MR imaging to delineate gray matter from white<br />
matter, myelinated and unmyelinated, renders it suitable<br />
for the quantitative measurement of the cerebrum, with<br />
further application to the study of brain maturation in<br />
vivo. Volumetric analysis of 3D-MR imaging data sets is<br />
achieved by segmentation of the imaged volume into the<br />
different tissue types. Quantitative 3D-MRI at term in<br />
preterm infants with perinatal white matter injury shows<br />
significantly decreased cortical gray matter (GM) volume<br />
and a reduced amount of myelinated white matter (WM) as<br />
an expression of structural alteration of brain development<br />
after perinatal brain injury. Functional MR imaging such as<br />
diffusion- weighted imaging (DWI) and perfusion and<br />
blood-oxygenation-dependent BOLD imaging are new<br />
imaging methods providing insights into brain physiology.<br />
DWI in preterm and full term newborns have shown a<br />
reduction of apparent diffusion coefficient (ADC) with<br />
increasing age but also acutely reduced ADC in regions<br />
of early ischemic injury, making this technique ideal for<br />
the early assessment of hypoxic-ischemic injury. Magnetic<br />
resonance spectroscopy represents the unique modality to<br />
study brain metabolism and has become an important addition<br />
to MRI. This review will therefore focus mainly on<br />
recent advances in the application of magnetic resonance<br />
techniques in pre- and postnatal neuroimaging of perinatal<br />
brain injury.<br />
PL-3/TU-3<br />
Seizure Disorders<br />
PL-3<br />
Epilepsy and the developing brain<br />
K. Watanabe<br />
Department of Pediatrics, Nagoya <strong>University</strong> Postgraduate<br />
School of Medicine, Nagoya, Japan<br />
Age-related onset is a characteristic feature of childhood<br />
epilepsy, and different epileptic syndromes occur at different<br />
ages. Epileptic seizures and syndromes undergo evolutionary<br />
changes with development, and one epileptic<br />
syndrome may evolve into another as in age-dependent<br />
epileptic encephalopathy. These features of childhood<br />
epilepsy are related to the maturation of the brain as well<br />
as the plasticity of the developing brain. Epileptic<br />
syndromes of the newborn undergo evolutionary changes<br />
with development. A common evolution in symptomatic<br />
epilepsies of neonatal onset was partial epilepsy with transient<br />
West syndrome during infancy. In symptomatic West<br />
syndrome, focal and then multifocal discharges were<br />
followed by the appearance of hypsarrhythmia. In symptomatic<br />
generalized epilepsies, discrepancies between electroencephalogram<br />
(EEG) and seizure types are common:<br />
epileptic spasms may persist even if interictal paroxysmal<br />
discharges tend to show localized discharges with age.<br />
Localization-related epilepsies may demonstrate transient<br />
generalization of paroxysmal discharges with various<br />
degrees of clinical deterioration during a certain stage of<br />
development. Severe myoclonic epilepsy never evolves<br />
into Lennox-Gastaut syndrome.
348<br />
Abstracts<br />
TU-3A<br />
Pediatric epilepsy: clinical update<br />
O. Dulac<br />
Service de Neuropediatrie Hopital Saint-Vincent de Paul,<br />
France<br />
One of the major challenges in paediatric epilepsy is to<br />
prevent psychomotor and behavioural deterioration. It may<br />
result from long lasting or frequent seizures, or from major<br />
activation of so-called interictal paroxysmal activity. Early<br />
identification of at risk conditions and risk factors are necessary<br />
conditions to prevent such deterioration. Risk factors for<br />
hypothalamic harmatoma (HH) syndrome are Sturge-Weber<br />
disease, tuberous sclerosis and callosal agenesis that are<br />
disclosed from birth with neuroradiology. For Dravet<br />
syndrome, the identification of abnormal genetic background<br />
will permit optimising new antiepileptic drug treatment and<br />
prevent the use of worsening compounds, to prevent status<br />
epilepticus. West and Lennox-Gastaut syndromes may be<br />
precipitated by inappropriate medication administered for<br />
other types of seizures. For myoclonic-astatic epilepsy, the<br />
early diagnosis of this syndrome, presently based on the clinical/EEG<br />
features could benefit from the ongoing progress in<br />
molecular genetics, permitting early adequate treatment to<br />
prevent the occurrence of myoclonic status. Symptomatic<br />
continuous spikes and waves during slow sleep (CSWS)<br />
may complicate pre-, peri- or early postnatal ischaemic<br />
brain lesions. As for cryptogenic CSWS, some medications<br />
may precipitate the generalisation and the continuous spikewave<br />
activity.<br />
TU-3B<br />
Genetics of epilepsy<br />
I.E. Scheffer<br />
Epilepsy Research Institute, <strong>University</strong> of Melbourne, Austin<br />
and Repatriation Medical Centre, Monash Medical Centre<br />
and Royal Children’s Hospital, Melbourne, Australia<br />
Revolutionary insights have been gained from the discovery<br />
of epilepsy genes over the last 7 years. Although only ten<br />
idiopathic epilepsy genes have been identified to date, many<br />
encode subunits of ligand-gated and voltage-gated ion channels<br />
which are associated with specific epilepsy syndromes.<br />
For example, ligand-gated ion channels with mutations<br />
include neuronal nicotinic acetylcholine receptors in Autosomal<br />
dominant nocturnal frontal lobe epilepsy and gamma<br />
amino butyric acid A (GABA A ) receptors in generalized<br />
epilepsy with febrile seizures plus (GEFS 1 ) and childhood<br />
absence epilepsy. Similarly, potassium channel genes are<br />
mutated in benign familial neonatal convulsions and sodium<br />
channel genes in GEFS 1 . In vitro functional studies of<br />
sodium channel and GABA mutations show loss of function.<br />
Two recently identified epilepsy genes suggest different<br />
pathways. In autosomal dominant partial epilepsy with auditory<br />
features, a gene encoding the leucine-rich, glioma-inactivated<br />
1 gene has defects. X-linked infantile spasms are<br />
associated with mutations in Aristaless related homeobox<br />
gene (ARX), a homeobox gene involved in gene transcription.<br />
All genes identified thus far are associated with the rare<br />
group of monogenic epilepsies. These genes may not be relevant<br />
to the common idiopathic epilepsies following complex<br />
inheritance where several genes interact and environmental<br />
factors play a role. The challenge is to determine the genes<br />
involved in the common epilepsies and how they interact to<br />
produce specific epilepsy syndromes. A range of strategies<br />
such as sib pair analysis and association studies is being<br />
adopted to solve the genetics of the common epilepsies but<br />
it is unclear which will bear fruit. Unravelling the genetics of<br />
the idiopathic epilepsies holds the promise of refining diagnosis<br />
and treatment in the future.<br />
PL-4/TU-4<br />
Infectious Disease and Immunology<br />
PL-4<br />
Neurological manifestations of falciparum malaria in<br />
children<br />
C.R.J.C. Newton<br />
Neuroscience’s Unit, Institute of Child Health, London, UK<br />
Plasmodium falciparum remains one of the most common<br />
causes of central nervous system infection world-wide, with<br />
children living in sub-Saharan Africa bearing the brunt of the<br />
disease. In comparison to other forms of human malaria, P.<br />
falciparum appears to have a propensity for the brain. The<br />
manifestations of severe falciparum malaria depend upon the<br />
age of the patient, the immune status and there appear to be<br />
differences in the clinical presentation between children<br />
living in Africa and those in Asia. In African children,<br />
seizures and cerebral malaria are the most common acute<br />
manifestations. About 11% of these children with cerebral<br />
malaria develop neurological deficits, of which half appear to<br />
be transient. However other children develop neuro-cognitive<br />
deficits, particularly language impairment and epilepsy.<br />
Epilepsy is associated with complicated seizures during<br />
admission. In Asia, cerebellar ataxia and other post-malaria<br />
neurological syndromes occur, although the aetiology is<br />
unclear. The impact of parasitisation and the long-term<br />
consequences have received little attention, and may have<br />
profound influence on children growing up in endemic areas.<br />
TU-4A<br />
Bacterial meningitis<br />
V. Kalra<br />
Pediatrics, All India Institute of Medial Sciences, New<br />
Delhi, India<br />
Bacterial meningitis, is a catastrophic childhood illness
Abstracts 349<br />
despite advent of potent antibiotics. Bacterial meningitis may<br />
be acute, recurrent orchronic andmay occur sporadically orin<br />
epidemics. Acute bacterial meningitis is etiologically diverse<br />
in the neonatal period, from later years. Geographic differences<br />
in etiology, prevalence patterns, are common. Lumbar<br />
puncture remains the single most important investigation.<br />
Ideally blood sugar estimation – 20–30 min before a L.P.,<br />
staining of csf cells, counting cells within 30 min, gram’s<br />
stain of csf centrifugate and immediate plating for cultures<br />
should be performed. Newer antigen detection methods like<br />
CIE, LPA, Elisaand PCRare usefulduetohighspecificity and<br />
sensitivity (in increasing order), but are not always available.<br />
Evolution of empiric antibiotic regime from penicillin/ampicillin<br />
and chloramphenicolto ceftrixone or cefotaxime will be<br />
discussed. The status of I.V. corticosteroids, preceding initiationantibioticstherapyandourdataregardingoutcomewillbe<br />
discussed. Partially treated acute bacterial meningitis<br />
frequently poses a diagnostic dilemma making therapy decisions<br />
difficult. The algorithm followed in this situation will be<br />
presented. Chronic bacterial meningitis in children most<br />
commonly is tubercular. Fungal, parasitic, risickettsial,<br />
neoplastic or immune deficiency need to be excluded. TBM<br />
merits early diagnosis by high index of suspicion, csf, chest<br />
skiagram Mantoux, family screening, and cranial imaging.<br />
The low diagnostic yield of these tests and current status of<br />
AFB detection techniques will be reviewed. A five drug<br />
regimeincluding streptomycin is recommended. Dexamethasone<br />
probably reduces morbidity related to raised ICP, focal<br />
deficits and inflammatory consequences. Long term ATT<br />
regime is still recommended. Appearance of tuberculomas<br />
post therapy, BCG modification of the clinical profile and<br />
prevalence of TBM will be addressed.<br />
TU-4B<br />
Immune mechanisms in multiple sclerosis<br />
H. Wekerle<br />
Max-Planck-Institute of Neurobiology, Martinsried,<br />
Germany<br />
Multiple sclerosis is more than just one particular disease.<br />
It encompasses a broad spectrum of inflammatory demyelinating<br />
diseases, which are remarkably distinct in distribution<br />
and cellular composition of lesions. This diversity may be<br />
explained by an immune pathogenesis, which is by far more<br />
complex than traditionally assumed. It now turns out that<br />
individual MS lesions are generated in sequential steps involving<br />
close interaction between the auto aggressive lymphocytes<br />
and non-lymphoid target cells. In a first step,<br />
autoimmune T lymphocytes, which are components of the<br />
healthy immune repertoire, are activated, presumably by<br />
microbial factors. The activated T cells then migrate through<br />
immune organs, and undergo profound functional changes<br />
before they break through the endothelial blood–brain<br />
barrier. Within the brain parenchyme, the T cells act on<br />
local glia cells to become efficient presenters of myelin autoantigens.<br />
Glial cell activation is under the tight control of<br />
neurons, which critically determine immune responsiveness<br />
in the brain microenvironment. Active neurons suppress<br />
immune reactivity, while areas with compromised neuronal<br />
activity become preferred sites of immune reactions. Neurotrophins<br />
are involved in neuronal suppression of brain<br />
immune reactivity. Local antigen presentation leads to<br />
fresh activation of the autoimmune T cells, and thus sets<br />
the stage for the recruitment of inflammatory macrophages,<br />
and myelin specific B lymphocytes, processes which can be<br />
studied using transgenic knock-in mice. Myelin binding auto<br />
antibodies cause destruction of myelin sheaths and myelin<br />
forming oligodendrocytes. Axonal processes crossing a<br />
demyelinating inflammatory area degenerate either following<br />
removal of myelin, or after to direct cytotoxic T cell<br />
attacks. Each of the pathogenic steps qualifies as a potential<br />
target of specific immune therapies.<br />
PL-5/TU-5<br />
Autistic Spectrum Disorders<br />
PL-5<br />
Screening, diagnosis and treatment of autistic spectrum<br />
disorders<br />
P. Filipek<br />
<strong>University</strong> of California Irvine, Irvine, CA, USA<br />
The appropriate diagnosis of autism requires a two-tiered<br />
approach: (1) routine developmental surveillance by all<br />
primary care medical providers; and (2) a diagnostic evaluation<br />
specific to autism. Practice parameters for the diagnosis<br />
and evaluation of autism were formulated by the Child<br />
Neurology Society and the American Academy of Neurology<br />
in 2000, in conjunction with nine professional and four parent<br />
organizations, with liaisons from the National Institutes of<br />
Health. The National Academy of Science later developed<br />
specific recommendations for the treatment of young children<br />
with autism in 2001. This plenary lecture will focus on<br />
the specific detailed recommendations that were established<br />
for each level of diagnosis, and the appropriate intervention<br />
for young children with autism. These consensus statements<br />
are intended to improve the rate of early suspicion and diagnosis<br />
of autism, and therefore early appropriate intervention.<br />
TU-5A<br />
Neuroimaging in autism<br />
T. Hashimoto<br />
Department of Education for Disabled, Naruto <strong>University</strong> of<br />
Education Nakashima, Takashima, Naruto, Tokushima,<br />
Japan<br />
Autism is a behavioral disorder defined by specific qualitative<br />
impairment of reciprocal social interaction and<br />
communication, as well as restricted interest and stereotyped
350<br />
Abstracts<br />
patterns of behavior, interests, and activities. MRI studies in<br />
autism have found a variety of alterations including a<br />
decrease of size of various brain structures. In functional<br />
neuroimaging studies such as functional MRI (fMRI),<br />
magnetic resonance spectroscopy (MRS), positron emission<br />
spectroscopy (PET) and single photon emission computed<br />
tomography (SPECT), various abnormalities have been<br />
reported. SPECT has found a decrease of regional cerebral<br />
blood flow (rCBF) in the frontal and temporal regions and the<br />
left cerebral hemisphere, and has shown the relationship<br />
between rCBF and symptoms. PET has found metabolic<br />
abnormalities in frontal monoaminergic neuron systems,<br />
and a decrease of glucose metabolic activity in anterior<br />
cingulate gyrus. MRS has found energy metabolism abnormality<br />
in the frontal lobe using 31P-MRS, and abnormality in<br />
medial temporal and lateral frontal regions using 1 H-MRS.<br />
fMRI has found a lower activity in the amygdala during face<br />
recognition test and in the right fusiform gyrus during face<br />
discrimination test. These structural and functional imaging<br />
findings suggest that the anatomic abnormalities are multiple<br />
and not located, and are more likely to be the results of<br />
abnormal development of connections of undefined<br />
disturbed neural networks for complex information processing<br />
involving the frontal cerebral cortex, limbic system, and<br />
posterior fosse brain structures. In this presentation,<br />
previously reported findings will be discussed in relations<br />
with possible mechanism of symptom occurrence in autism.<br />
TU-5B<br />
ADHD: current concepts and neurobiology<br />
M. Denckla<br />
The Kennedy Krieger Institute, Baltimore, MD, USA<br />
Aided by advances in cognitive neuroscience and neuroimaging,<br />
the emerging current concept of ADHD is that it<br />
represents a group of deficits in self-control; affected in<br />
some combination are motor control, cognitive control, and<br />
emotional control. So frequent is the comorbidity with<br />
ADHD of Developmental Motor Coordination Disorder<br />
that this combination mirrors Gillberg’s DAMP syndrome.<br />
Neuroimaging implicates parallel underlying circuits<br />
comprised of frontal, striatal, and cerebellar regions, with<br />
consensus based on MRI measurements that somewhat smaller<br />
total brain volumes (3–5% reductions) are of multifocal<br />
(not diffuse) origin, mostly small frontal and striatal hypoplasia.<br />
This topic update on ADHD will also review diagnosis,<br />
behavioral genetics, prognosis (especially genderdiscrepant),<br />
neurotransmitters (with implications for genetics<br />
and pharmacotherapeutics) and non-pharmacological<br />
therapies. The emphasis, however, will be on the following:<br />
implications of motor localization clues; neurocognitive<br />
elucidation that attention allocation (not attention per se) is<br />
deficient; and evidence from in vivo MR neuroimaging, both<br />
anatomic MRI and fMRI, that frontal-striatal-cerebellar<br />
circuits deserve scrutiny in relation to ADHD.<br />
SYMPOSIUM<br />
SY-1<br />
Pathogenesis and Prevention of Prenatal and Perinatal<br />
Brain Damage<br />
SY-01-1<br />
Structural and functional studies on cadherins, synaptic<br />
adhesion molecules<br />
W. Shan, D.R. Colman<br />
Fishberg Research Center for Neurobiology, The Mount<br />
Sinai School of Medicine, New York, New York, USA<br />
The ability of the mammalian CNS to perform complex<br />
informative processes and highly cognitive functions is<br />
based on the precise and specifically determined connectivity<br />
of different neuronal cell types at synapses. Recently studies<br />
implicate that cadherins, calcium-dependent cell adhesion<br />
molecules, are involved in synaptic formation, specifying<br />
connections among different synapses and functional modulation<br />
during early development. The molecular mechanisms<br />
by which the classic cadherin mediate adhesion are beginning<br />
to be elucidated. We have identified certain key residues<br />
at the interface of N-cadherin molecules that participate in<br />
cell-cell adhesion formation. In addition, two different, but<br />
conserved cadherins are highly likely to form hetero-interaction<br />
at adherent junction sites, which may increase the<br />
diversity of synaptic connections. Furthermore, synaptic<br />
modulation could be activated in either physiological or<br />
pathological conditions, indicating a role for cadherins in<br />
synaptic plasticity. Taken together, our data provide insights<br />
into the mechanisms of formation of adherens junctions,<br />
synaptic targeting, and modulation of synaptic activity.<br />
SY-01-2<br />
Basic mechanisms and prevention of prenatal brain<br />
damage<br />
P. Evrard<br />
Service de Neurologie Pediatrique et des Maladies Metaboliques,<br />
Faculte de Medicine Xavier-Bichat, Hospital<br />
Robert-Debre, Paris, France<br />
Abstract not submitted<br />
SY-01-3<br />
Neurophysilogical analysis of periventricular<br />
leukomalacia in preterm infants<br />
A. Okumura, K. Watanabe, F. Hayakawa, T. Kato<br />
Department of Pediatrics, Nagoya <strong>University</strong> Graduate<br />
School of Medicine, Nagoya, Japan<br />
PVL is an important cause of cerebral palsy in preterm<br />
infants. Serial EEG recordings are not only of great prognostic<br />
value but also useful to determine the timing of brain
Abstracts 351<br />
injuries in preterm infants with PVL. Flash visual evoked<br />
potentials (FVEP) are also useful for the diagnosis of PVL<br />
and the analysis of its pathogenesis. EEG abnormalities can<br />
be divided into two categories; acute and chronic stage<br />
abnormalities. Acute stage abnormalities mainly consist of<br />
changes in continuity, frequency and voltage. Acute stage<br />
abnormalities appear immediately after acute brain insults.<br />
Chronic stage abnormalities consist of dysmature and disorganized<br />
patterns. Disorganized pattern refers to abnormal<br />
deformed background activities without findings of acute<br />
depression. They are usually recognized in infants with<br />
PVL and indicate irreversible brain damages. As to FVEP,<br />
we paid attention to the waveform of the negative peak with<br />
a mean latency of 300 ms (N300). Abnormal FVEP findings<br />
were categorized into three patterns; absent VEP, abnormal<br />
wave form, and delayed latencies. Our recent studies<br />
revealed that acute stage abnormalities were seen in 60%<br />
of infants with cystic PVL, chronic stage abnormalities in<br />
90%, and FVEP abnormalities in 80%. These abnormalities<br />
were always recognized before cystic changes appeared on<br />
ultrasonography. Evolutional EEG changes suggested that<br />
the timing of injury was antenatal or perinatal. It is remarkable<br />
that EEG abnormalities usually preceded FVEP<br />
abnormalities. This suggested that the interval of several<br />
days will exist from a brain insult to irreversible brain<br />
damages in infants with PVL.<br />
SY-01-4<br />
Pathogenesis, plasticity and prevention of perinatal<br />
brain damage<br />
A. Oka, A. Hirayama, S. Takashima<br />
Division of Child Neurology, Institute of Neurological<br />
Sciences Tottori <strong>University</strong> School of Medicine, Japan<br />
Infants born as prematures are highly susceptible to<br />
ischemic white matter damage, i.e. PVL. Currently, PVL<br />
is regarded as a main type of white matter injury, causing<br />
cerebral palsy and intellectual deficits. In the pathogenesis<br />
of PVL, the development of vasculature in deep white<br />
matter as well as the vulnerability of differentiating glial<br />
progenitor cells is an important predisposing factor, and the<br />
cerebral hypoperfusion associated with inflammatory<br />
factors is causally related to PVL. We have evaluated<br />
neuropathology of PVL. While cystic lesions in periventricular<br />
areas are characteristic, the lesions are often widelyspread,<br />
reaching to deeper white matter in extremely lowbirth-weight<br />
infants. Immunohistochemical studies have<br />
revealed the early stage of axonal injury is accompanied<br />
by accumulation of amyloid precursor protein, which is<br />
carried by axonal transport. Axons at PVL lesions also<br />
express adhesion molecules, such as L1 or HNK-1,<br />
which are up-regulated by axonal growth during fetal<br />
period, or GAP-43, a marker of axonal re-growth. Later,<br />
focal or diffuse accumulation of neurofilament in swollen<br />
axons persists, indicating axonal damage in PVL. These<br />
changes indicate early axonal damage, followed by reactive<br />
or repair mechanisms. In terms of glial cells, we found<br />
increased immunoreactivity of nestin and myelin transcription<br />
factor (MyT1) in PVL brains of later stage. Nestin is<br />
expressed by multipotential stem cells, and intense labeling<br />
is seen in early fetal white matter. Surrounding PVL<br />
lesions of chronic stage, nestin-immunoreactive astrocytes<br />
as well as axons are present, suggesting tissue repair.<br />
MyT1 is a zinc-dependent DNA-binding protein, and<br />
expressed in early progenitors of oligodendrocyte cell lineage.<br />
In the chronic stage, there is an increase in MyT1-<br />
immunoreactive cells, which are distributed around necrotic<br />
foci. The increase in immature oligodendrocytes near<br />
PVL lesions also indicates compensatory mechanism,<br />
probably leading to plasticity.<br />
SY-2<br />
Neuromuscular Disorders<br />
SY-02-1<br />
The molecular genetics of spinal muscular atrophy:<br />
recent progress and therapeutic implication<br />
C.H. Wang<br />
Department of Child Health, <strong>University</strong> of Missouri, One<br />
Hospital Drive, Columbia, MO, USA<br />
Spinal muscular atrophy (SMA) is a neuromuscular<br />
disorder characterized by degeneration of the spinal cord<br />
motor neurons. SMA is phenotypically heterogeneous and<br />
has been classified into three subtypes. The gene for the<br />
three types of autosomal recessive SMA was mapped to<br />
chromosome 5q13 in 1990. Further progress in the field has<br />
led to the identification of the survival of motor neuron<br />
(SMN) gene in 1995. The SMN gene is presented in two<br />
highly homologous copies: the telomeric copy SMN1, and<br />
the centromeric copy SMN2. Over 95% of the SMA<br />
patients harbor a homozygous deletion or mutation of the<br />
SMN1 gene but retain at least one copy of the SMN2 gene.<br />
The SMA severity is correlated with the copy number of<br />
the SMN2 gene and its ability to produce intact SMN<br />
messenger RNA (mRNA) and protein within the SMA<br />
patients. The SMN gene plays a crucial role in the cellular<br />
mRNA metabolism. A mouse model of SMA has been<br />
generated that exhibits both clinical and pathological<br />
resemblance of human SMA. The therapeutic application<br />
of these findings includes identifying ways to augment the<br />
production of intact SMN protein by SMN2 gene in order<br />
to ameliorate the clinical symptoms of SMA. Several transcription<br />
factors have been shown to induce the production<br />
of intact SMN protein by interacting with crucial<br />
sequences on the exon 7 of SMN2 gene. Large scale<br />
drug screen has been started in an attempt to identify pharmacological<br />
compounds which can stimulate in vivo<br />
production of SMN protein. Progress in this area will be<br />
reported.
352<br />
Abstracts<br />
SY-02-2<br />
Recent advances in congenital muscular dystrophies<br />
I. Nonaka, Y.K. Hayashi, H. Ishikawa, K. Sugie, F.<br />
Uematsu, I. Nishino<br />
National Center of Neurology and Psychiatry, Tokyo, Japan<br />
Congenital muscular dystrophy (CMD) has been classified<br />
into two major groups: Fukuyama type CMD (FCMD)<br />
and classical CMD (non-FCMD). FCMD is prevalent in the<br />
Japanese, comprising 1–2/100 000 population and characterized<br />
clinically by muscle hypotonia and weakness from<br />
early infancy and central nervous system abnormalities. The<br />
gene for FCMD has been mapped to 9q31 and the gene<br />
product, fukutin, consists of 461 amino acids, but its function<br />
is unknown. Since immunoreactivity to alpha-dystroglycan<br />
was deficient, the fukutin gene mutation is probably<br />
related to altered glycosylation, which may lead to disruption<br />
of the transmembranous molecular linkage. The classical<br />
form of non-FCMD has been further subdivided into<br />
several distinct forms, including merosin deficiency,<br />
muscle-eye-brain (MEB) disease and congenital atonicsclerotic<br />
muscular dystrophy (Ullrich’s disease). We have<br />
studied nine patients with Ullrich’s disease clinically and<br />
pathologically. From early infancy, all patients had proximal<br />
joint contractures, including limited neck flexion and<br />
kyphoscoliosis, and distal joint hyperlaxity. Although four<br />
patients learned to walk, the disease is slowly progressive.<br />
One patient had a complete collagen VI deficiency immunohistochemically<br />
and compound heterozygous mutation in<br />
the COL6 gene. The other eight had partial collagen VI<br />
deficiency immunohistochemically.<br />
SY-02-3<br />
Mitochondrial myopathies<br />
S. DiMauro<br />
Columbia <strong>University</strong> College of Physicians and Surgeons,<br />
New York, NY, USA<br />
The ‘molecular era’ of mitochondrial myopathies started<br />
in 1988 with the discovery of the first mutations in mitochondrial<br />
DNA (mtDNA). The small circular molecule of<br />
mtDNA turned out to be a Pandora’s box of pathogenic<br />
mutations, which have been associated with a bewildering<br />
variety of clinical syndromes. From a genetic point of<br />
view, mtDNA mutations can be divided into two groups:<br />
those affecting mitochondrial protein synthesis in toto; and<br />
those affecting specific proteins of the respiratory chain. In<br />
recent years, interest has shifted towards Mendelian genetics,<br />
a shift justified by the fact that most proteins of the<br />
respiratory chain are encoded by nuclear DNA (nDNA). In<br />
addition, proper assembly and function of respiratory chain<br />
complexes requires numerous nDNA-encoded ancillary<br />
proteins, whose mutations cause mitochondrial encephalomyopathies<br />
(‘murder by proxy’). Because mtDNA is the<br />
slave of nDNA, numerous nuclear factors are needed to<br />
insure mtDNA replication and to preserve mtDNA integrity.<br />
Mutations in these factors impair intergenomic<br />
communication and result in syndromes characterized by<br />
mtDNA multiple deletions, mtDNA depletion, or both<br />
together. Within the past year, mutations in four genes<br />
have been associated with autosomal dominant or recessive<br />
forms of progressive external ophthalmoplegia and multiple<br />
mtDNA deletions, and mutations in two genes have<br />
been associated with mtDNA depletion syndromes. Finally,<br />
new pathogenetic concepts are being introduced. For<br />
example, alterations of the respiratory chain may be due<br />
to altered composition of the inner mitochondrial<br />
membrane (IMM) lipid milieu. This is the case of Barth<br />
syndrome, an X-linked recessive mitochondrial myopathy/<br />
cardiopathy characterized by severe deficiency of cardiolipin,<br />
the major phospholipid of the IMM.<br />
SY-02-4<br />
Lipid storage myopathies<br />
I. Tein<br />
Division of Pediatric Neurology, Hospital for Sick Children,<br />
Canada<br />
Genetic defects in fatty acid oxidation (FAO) are an<br />
important group of infancy- or childhood-onset disorders<br />
because they are potentially rapidly fatal and a source of<br />
major morbidity. FAO defects encompass a spectrum of clinical<br />
disorders including progressive lipid storage myopathy,<br />
episodic myoglobinuria, neuropathy, pigmentary retinopathy,<br />
progressive cardiomyopathy and recurrent hypoglycemic,<br />
hypoketotic encephalopathy or Reye-like syndrome<br />
with secondary seizures and potential developmental delay.<br />
Recurrent myoglobinuria may be seen in carnitine palmitoyltransferase<br />
II, carnitine acylcarnitine translocase, long- and<br />
very long-chain acyl-CoA dehydrogenase, short-chain l-3-<br />
hydroxyacyl-CoA dehydrogenase and long-chain l-3-hydroxyacyl-CoA<br />
dehydrogenase or trifunctional protein deficiencies.<br />
As all of the known FAO defects are inherited as<br />
autosomal recessive diseases, there is oftentimes a family<br />
history of sudden unexpected death or sudden infant death<br />
syndrome (SIDS) in siblings. Early recognition and prompt<br />
initiation of therapy, as well as institution of appropriate<br />
preventive measures, may be lifesaving and significantly<br />
decrease long-term morbidity, particularly with respect to<br />
neurological sequelae. There are now at least 17 recognized<br />
defects in FAO, most of which have been diagnosed in the<br />
last 15 years. With significant biomedical advances and<br />
increased index of clinical suspicion, there has been a rapid<br />
increase in the number of diagnosed cases. In a recent survey<br />
from the Pennsylvania newborn screening program, the incidence<br />
of medium-chain acyl-coenzyme A dehydrogenase<br />
deficiency was found to be as high as 1 in 8930 live births.<br />
In order to provide the background for understanding these<br />
disorders, an overview will be given of the pathway of FAO
Abstracts 353<br />
and the central role of carnitine. This will be followed by a<br />
description of the hallmark clinical, biochemical and pathological<br />
features of specific genetic defects in FAO,<br />
approaches to diagnosis, and current treatment methodologies.<br />
SY-3<br />
Molecular Basis of Neurological Diseases in Children<br />
SY-03-1<br />
Identification and characterization of novel mutations of<br />
the aspartoacylase gene in non-Jewish patients with<br />
Canavan disease<br />
E.H. Kolodny a , B. Zeng a , Z.-H. Wang a , L.A. Ribeiro a ,P.<br />
Leone b , S.-J. Kim a , G.M. Pastores a , S. Raghavan a , E. Ong a<br />
a Department of Neurology, New York <strong>University</strong> School of<br />
Medicine, New York, NY;<br />
b Division of Neurosurgery,<br />
Department of Surgery, <strong>University</strong> of Medicine and Dentistry<br />
of New Jersey, Camden, NJ, USA<br />
Canavan disease (CD) is a severe progressive autosomal<br />
recessive neurodegenerative disorder, caused by mutations<br />
in the aspartoacylase (ASPA) gene. While two predominant<br />
mutations account for approximately 97% of the<br />
mutant alleles in Ashkenazi Jewish individuals with higher<br />
prevalence of CD, this disease has also been diagnosed in<br />
other diverse ethnic groups. However, mutations in the<br />
ASPA gene among non-Jewish patients are different and<br />
more diverse. In the present study, the ASPA gene was<br />
analyzed in 22 unrelated non-Jewish patients with CD, and<br />
24 different mutations were found. Of these, 14 novel<br />
mutations were identified, including five missense mutations<br />
(E24G, D68A, D249V, C152W, H244R), two<br />
nonsense mutations (Q184X, E214X), three deletions<br />
(923delT, 33del13, 244delA), one insertion mutation<br />
(698insC), two sequence variations in one allele<br />
([10T ! G; 11insG]), an elimination of the stop codon<br />
(941A ! G, TAG ! TGG, X314W), and one splice acceptor<br />
site mutation (IVS1-2A ! T). The E24G mutation<br />
resulted in substitution of an invariable amino acid residue<br />
(Glu) in the first esterase catalytic domain consensus<br />
sequence. The IVS1-2A ! T mutation caused the retention<br />
of 40 nucleotides of intron 1 upstream of exon 2. The<br />
results of transient expression of the mutant ASPA<br />
complementary DNA (cDNA) containing these mutations<br />
in COS-7 cells and assay for ASPA activity of patient<br />
fibroblasts indicated that these mutations were responsible<br />
for the enzyme deficiency. Our studies expand the spectrum<br />
of novel mutations in non-Jewish patients with CD,<br />
and are useful for the accurate diagnosis of CD in these<br />
patient populations, for prenatal diagnosis of CD in informative<br />
families, and for detection of carriers in affected<br />
families.<br />
SY-03-2<br />
Facioscapulohumeral muscular dystrophy (FSHD)<br />
N. Raksadawan<br />
Siriraj Hospital, <strong>Mahidol</strong> <strong>University</strong>, Bangkok, Thailand<br />
Facioscapulohumeral muscular dystrophy (FSHD), one<br />
of the common muscular dystrophy, is transmitted as an<br />
autosomal dominant in majority of cases while few show<br />
a de novo mutation. It has a characteristic and distinctive<br />
distribution of weakness. Symptoms usually begin in childhood<br />
with weakness, which affects predominantly facescapular<br />
stabilizer-humeral muscles and rarely in early<br />
infantile onset associated with generalized hypotonia.<br />
Retinal and cochlear diseases are occasionally associated<br />
defects. Its molecular pathogenesis is still unknown, though.<br />
FSHD locus is known on the subtelomeric region of human<br />
chromosome 4q. Mutation is the result of a deletion of<br />
multiple copies of 3.3-kb tandem repeats (D4Z4) which<br />
cause a position variegation effect on more proximal<br />
DNA. The molecular diagnosis based upon the detection<br />
of the short fragment of the tandem repeats, using p13E11<br />
probe after EcoRI, EcoRI/BlnI digestion, is possible in<br />
majorities of cases. Because of unknown underlying muscle<br />
injury mechanism, curative therapy is not yet available.<br />
However, few clinical trials of symptomatic treatments<br />
have been tried.<br />
SY-03-3<br />
Duchenne muscular dystrophy: from gene diagnosis to<br />
molecular therapy<br />
M. Matsuo<br />
Division of Molecular Medicine, Kobe <strong>University</strong> Graduate<br />
School of Medicine, Hyogo, Japan<br />
Duchenne and Becker muscular dystrophies (DMD/BMD)<br />
are X-linked muscular dystrophies. The isolation of the<br />
defective gene in DMD/BMD has led to a better understanding<br />
of the disease process and has promoted studies regarding<br />
the application of molecular therapy. Due to frame-shifting<br />
mutations in the DMD gene that cause dystrophin deficiency,<br />
DMD patients suffer from lethal muscle degeneration. In<br />
contrast, mutations in the allelic Becker muscular dystrophy<br />
(BMD) do not disrupt the translational reading frame,<br />
thereby resulting in a less severe phenotype. The purpose<br />
of this report is to present the recent progress made in this<br />
area of research, with particular reference to dystrophin<br />
Kobe, which is caused by exon skipping during splicing<br />
due to the presence of an intra-exon deletion. On the basis<br />
of results from the molecular analysis of dystrophin Kobe, we<br />
proposed a novel way of molecular therapy for DMD wherein<br />
antisense oligonucleotides transform DMD into a milder<br />
phenotype by inducing exon skipping. We explored a genetic<br />
therapy aimed at restoring the reading frame in muscle cells<br />
from a DMD patient through targeted modulation of dystro-
354<br />
Abstracts<br />
phin pre-mRNA splicing. In myotube cultures from a DMD<br />
patient carrying an exon 20 deletion, the induced skipping of<br />
exon 19 in mRNA led to the production of in-frame dystrophin<br />
mRNA and internally deleted dystrophin in myotubes.<br />
Our results provide evidence of restoration of dystrophin<br />
expression from the endogenous gene in DMD patientderived<br />
muscle cells. In addition, current proposals of other<br />
molecular therapies for DMD are discussed.<br />
SY-03-4<br />
Signal transduction defects: an emerging family of<br />
genetic encephalopathies<br />
J. Jaeken a , K. Freson b , N. Goemans a , P. De Cock a , C. Van<br />
Geet a,b<br />
a Department of Pediatrics and b Center for Molecular and<br />
Vascular Biology, <strong>University</strong> Hospital Gasthuisberg,<br />
<strong>University</strong> of Leuven, Leuven, Belgium<br />
Mutations in the alpha subunit of the Gs proteins<br />
(encoded by GNAS1 located in an imprinted region on<br />
chromosome 20q13.12–13) cause rare endocrine disorders.<br />
The GNAS1 gene also encodes XL-GNAS1, which is<br />
paternally expressed and maternally methylated. Using a<br />
modified platelet aggregation test (Freson et al., Thromb<br />
Haemost 2001;86:733–738) to evaluate Gs function we<br />
identified six patients (from four families) with an internal<br />
repeat extension of the XL-GNAS1 exon 1 on the paternal<br />
allele. These patients had mainly a neurological syndrome<br />
(psychomotor retardation, hypotonia, behaviour disturbances,<br />
movement disorders) as well as variable dysmorphy<br />
(mainly of face and hands) and, in only one, a<br />
clinically important bleeding tendency. This defect was<br />
associated with over expression of GNAS1 and increased<br />
cAMP levels in platelets and fibroblasts upon stimulation.<br />
In four patients this defect was combined with a polymorphism<br />
in G-b 3 . (Jaeken et al., J Inherit Metab Dis<br />
2000;23(Suppl. 1):205). In two other patients (sisters)<br />
with severe psychomotor retardation, axial hypotonia,<br />
hyporeflexia, overgrowth, thrombocytosis and hypercholesterolemia<br />
a maternally inherited G-b 3 null-allele associated<br />
with the same G-b 3 polymorphism on the paternal allele,<br />
was identified. One of them died at the age of 4 years.<br />
Conclusion: G protein defects can be associated with<br />
neurological syndromes. Platelet function analysis is a<br />
valuable tool in the identification of these (and other)<br />
signal transduction defects.<br />
SY-03-5<br />
Gene therapy/cell therapy for genetic neurological<br />
disorders<br />
Y. Eto, T. Ohashi<br />
Department of Pediatrics/Department of Gene Therapy,<br />
Institute of DNA Medicine, Tokyo Jikei <strong>University</strong> School<br />
of Medicine, Tokyo, Japan<br />
Among various genetic diseases, we focused to lysosomal<br />
storage diseases (LSD) which are caused by a genetic<br />
deficiency of lysosomal enzyme and accumulates various<br />
compounds in lysosomes. Recently, LSD patients can be<br />
treated by: (1) enzyme replacement therapy for Gaucher<br />
disease, Fabry disease, Hunter syndrome, Pompe disease<br />
and Hurler syndrome. The enzyme replacement therapy is<br />
limited to treat in non-neurological form of LSD. (2) Bone<br />
marrow transplantation (BMT) is also potentially important<br />
therapy to treat LSD since BMT may treat neurological<br />
involvement of LSD, if treated in early period. (3) Cell<br />
therapy/gene therapy are most promising treatment in<br />
future. We are trying to treat LSD using mucopolysaccharidoses<br />
(MPS) VII model mice and twitcher mice (model<br />
for human Krabbe disease). Using these model mice, we<br />
tried to treat these mice with adenovirus vector by intravenous<br />
administration or intraventricular administration.<br />
Visceral involvement in MPS VII mice was successfully<br />
treated by adenovirus administration at least for 1 month.<br />
In twitcher mice, intraventricular administration of adenovirus<br />
showed reduced number of globoid cells in CNS,<br />
which indicated that the CNS involvement could be treated<br />
with gene therapy. Many LSD patients show neurological<br />
disorders, since these cells can be converted into neuronal<br />
cells in a certain condition. These results suggest that<br />
mesenchymal cells can be used fro the treatment of CNS<br />
involvement in LSD.<br />
SY-4<br />
Epilepsies and Related Disorders in Infancy, Childhood<br />
and Adolescence<br />
SY-04-1<br />
Epileptogenic malformations of the cerebral cortex:<br />
classification and genetic mechanisms<br />
R. Guerinni<br />
Department of Child Neuropsychiatry, <strong>University</strong> of Pisa,<br />
Italy<br />
Abstract not submitted<br />
SY-04-2<br />
Seizure induced brain injury in immature rat: short<br />
term and long term<br />
Y.-W. Jiang, G.-J. Zhang, H.-Y. Cao, X.-R. Wu<br />
Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />
Beijing, China<br />
Objective: To study seizure induced brain injury and its<br />
mechanism in immature rats. Method: We established two<br />
seizure models: flurothyl inhalation induced seizure (Postnatal<br />
day 15) (in vivo model) and magnesium-free culture<br />
induced epileptiform discharge in cultured rats embryo<br />
cortical neurons (in vitro model). The apoptosis and cellu-
Abstracts 355<br />
lar MTT uptake were investigated as the indices of shortterm<br />
brain injury, while the mossy fiber sprouting, behavior<br />
and learning ability, and susceptibility to seizure-induced<br />
brain injury in adulthood were observed as the indices of<br />
long-term brain injury. We also investigated the neuron<br />
NMDA receptor (NR) expression and intracellular calcium<br />
after recurrent seizures, in order to find some clue of the<br />
mechanism of the seizure-induced brain injury. Results:<br />
From short time observation after seizure, we found that<br />
the expression of NR subunits-NR1, NR2A protein upregulated<br />
in hippocampus and cerebral cortex in vivo;<br />
meanwhile, the cellular MTT uptake decrease, intracellular<br />
calcium increase and were observed in cultured cortical<br />
neurons. However, we had not found the obvious neuron<br />
apoptosis increase. In long-term study, we found that the<br />
susceptibility to seizure-induced brain injury, such as apoptosis,<br />
mossy fiber sprouting, and learning and memory<br />
defect after the second seizure in adulthood, were increased<br />
in rats that had seizure experience during development,<br />
either febrile convulsion or the kainite-induced convulsion.<br />
Conclusions: The seizure induced brain seizure in developmental<br />
brain were relatively less serious and lethal, but it<br />
will influence the brain for a long time, which will made<br />
the brain more susceptible to new pathogenic stimulus in<br />
the adulthood.<br />
SY-04-3<br />
Idiopathic focal epilepsies in infancy<br />
F. Vigevano<br />
Ospedale Pediatrico Bambino Gesù, IRCCS, Roma, Italy<br />
The 1989 classification of epilepsies and epileptic<br />
syndromes (Commission, 1989) includes among the idiopathic<br />
localization-related epilepsies the occipital form and<br />
that with centrotemporal spikes, both with onset during<br />
childhood, and among generalized epilepsies familial and<br />
non-familial neonatal convulsions and benign myoclonic<br />
epilepsy of infancy. In recent years, numerous publications<br />
have reported localization-related epilepsy with onset<br />
during early infancy, idiopathic aetiology and favorable<br />
outcome. In 1963, Fukuyama reported cases occurring in<br />
the first 2 years of life that were characterized by partial<br />
seizures, absence of a etiologic factors and benign<br />
outcome. Later, other reports of this clinical entity studied<br />
the localization and semiology of seizures (Watanabe et al.,<br />
1987, 1990, 1993), the prognosis (Sugiura et al., 1983), and<br />
the presence or absence of familial occurrence (Vigevano<br />
et al., 1990; Vigevano et al., 1992; Vigevano et al., 1994).<br />
In particular, Watanabe and coworkers on several occasions<br />
described cases with partial seizures of a different<br />
type, proposing the term benign partial epilepsy of infancy<br />
with complex partial seizures (BPE with CPS) and benign<br />
partial epilepsy of infancy with secondarily generalized<br />
seizures (BPE with SGS). Most of these cases were not<br />
familial. Vigevano and coworkers directed attention to<br />
the presence of cases with a family history of convulsions<br />
with benign outcome during infancy, with autosomal dominant<br />
inheritance, suggesting the term benign infantile<br />
familial convulsions (BIFC). Benign infantile convulsions<br />
are divided now into familial and non-familial forms, even<br />
though the two forms can overlap. Genetic studies in familial<br />
forms led to the identification of a marker on chromosome<br />
19 (Guipponi et al., 1997). This was not confirmed by<br />
later studies, therefore genetic heterogeneity was hypothesized<br />
(Gennaro et al., 1999). Recently Malacarne (Malacarne<br />
et al., 2001) studying eight Italian families with<br />
BIFC mapped a novel locus on chromosome 2. In 1997,<br />
Szepetowski (1997) described the association between<br />
BIFC and variably expressed paroxysmal choreoathetosis.<br />
Following the identification of a specific marker on chromosome<br />
16, this entity constitutes a variant of the familial<br />
forms, called infantile convulsions and choreoathetosis.<br />
However, the chromosome 16 marker may account for<br />
more than this particular phenotype (Caraballo et al.,<br />
2001). Bureau and Maton (1998), Bureau et al. (1998)<br />
and Capovilla and Beccaria (2000) described another<br />
form of benign epilepsy with partial seizures, onset in<br />
infancy or early childhood and benign outcome. In these<br />
children, seizures did not present in clusters; rather they<br />
were quite sporadic with prevalently complex partial type<br />
semiology, and without automatisms. The EEG findings<br />
showed peculiar interictal anomalies characterized by<br />
central and vertex spikes or spikes and waves only evident<br />
during sleep.<br />
SY-04-4<br />
Benign focal epilepsies in childhood and adolescence<br />
N. Fejerman<br />
Hospital de Pediatria ‘J.P. Garrahan’, Department of<br />
Neurology, Combate de los Pozos 1881, 1245 Buenos<br />
Aires, Argentina<br />
Abstract not submitted<br />
SY-04-5<br />
Lafora’s progressive myoclonus epilepsy: clinical and<br />
genetic advances<br />
A.V. Delgado-Escueta b , S. Ganesh a , T. Suzuki a ,S.<br />
Francheschetti c , C. Riggio c , G. Avanzini c , A. Rabinowicz d ,<br />
S. Bohlega e , J. Bailey b , M.E. Alonso f , A. Rasmussen f , A.E.<br />
Thomson d , A. Ochoa f , A.J. Prado f , M.T. Medina g ,K.<br />
Yamakawa a<br />
a Laboratory for Neurogenetics, RIKEN Brain Science Institute,<br />
Wako-shi, Japan;<br />
b Epilepsy Genetics/Genomics<br />
Laboratories, Comprehensive Epilepsy Program, UCLA<br />
School of Medicine and VA GLAHS West Los Angeles Medical<br />
Center, Los Angeles, USA; c Instituto Nazionale Neurologico,<br />
Besta, Milano, Italy;<br />
d FLENI Medical Center,<br />
Buenos Aires, Argentina; e King Faisal Medical Center,
356<br />
Abstracts<br />
Riyahd, Saudi Arabia; f National Institute of Neurology and<br />
Neurosurgery, Mexico City, Mexico; g Direccion de Investigation<br />
Cientifica, Universidad National Autonoma de<br />
Honguras, Tegulcigalpa, Honduras<br />
Mutations in the EPM2A gene encoding a dual-specificity<br />
phosphatase (laforin) cause an autosomal recessive<br />
fatal disorder called Lafora’s disease (LD) classically<br />
described as an adolescent onset stimulus sensitive<br />
myoclonus, epilepsy and neurologic deterioration. We<br />
present correlation between mutations in EPM2A and<br />
phenotypes of 22 patients (14 families). In addition to<br />
classical LD associated mainly with mutations in exon 4<br />
(P ¼ 0:0007), we identified atypical LD with childhood<br />
onset dyslexia and learning disorder followed by epilepsy<br />
and neurologic deterioration associated mainly with mutations<br />
in exon 1 (P ¼ 0:0015). To understand the two<br />
subsyndromes better, we investigated the effect of five<br />
missense mutations in the carbohydrate binding domain<br />
(CBD-4; coded by exon 1) and three missense mutations<br />
in the dual phosphatase domain (DSPD; coded by exons 3<br />
and 4) on laforin’s intracellular localization in HeLa cells.<br />
Expression of three mutant proteins (T194I, G279S and<br />
Y294N) in DSPD formed ubiquitin positive cytoplasmic<br />
aggregates suggesting they were folding mutants set for<br />
degradation. In contrast, none of the three CBD-4 mutants<br />
showed cytoplasmic clumping. However, CBD-4 mutants<br />
W32G and R108C targeted both cytoplasm and nucleus<br />
suggesting that laforin had diminished its usual affinity<br />
for polysomes. Our data, thus, represents the first report<br />
of a novel childhood syndrome for LD. Our results also<br />
provide clues for distinct roles for the CBD-4 and DSP<br />
domains of laforin in the etiology of two subsyndromes<br />
of LD. To study the ontogenesis of LD pathology and<br />
laforin functions, we disrupted the Epm2a gene in mice.<br />
Supporting the concept of childhood onset or atypical<br />
human LD, homozygous null mutants developed widespread<br />
degeneration of neurons, most of which occurred<br />
in the absence of Lafora bodies, as early as 1–2 months<br />
of age. Dying neurons characteristically exhibited swelling<br />
in the endoplasmic reticulum, Golgi networks and mitochondria<br />
in the absence of apoptotic bodies or fragmentation<br />
of DNA. As Lafora bodies became more prominent at<br />
4–12 months, organelles and nuclei were disrupted. The<br />
Lafora bodies, present both in neuronal and non-neural<br />
tissues, were positive for ubiquitin and advanced glycation<br />
end products only in neurons, suggesting different pathological<br />
consequence for Lafora inclusions in neuronal<br />
tissues. Neuronal degeneration and Lafora inclusion bodies<br />
predate the onset of impaired behavioral responses, ataxia,<br />
spontaneous myoclonic seizures and EEG epileptiform<br />
activity. Our results suggest that LD is a primary neurodegenerative<br />
disorder that may utilize a non-apoptotic<br />
mechanism of cell death.<br />
SY-5<br />
Neuroimaging<br />
SY-05-1<br />
Introduction: focused on functional neuroimaging<br />
K. Iinuma<br />
Tohoku <strong>University</strong> School of Medicine, Sendai, Japan<br />
During the last two decades of the 20th century, various<br />
neuroimaging techniques have strikingly developed.<br />
Among various neuroimaging methods, functional imagings<br />
give us valuable information about the pathophysiological<br />
mechanisms and condition of neurological disorders. In this<br />
symposium, the several neuroimaging techniques and their<br />
applications will be explained. PET as relatively early<br />
developed imaging method is recently shifting to understand<br />
the receptor binding or brain metabolism. The functional<br />
MRI will give us more detailed mapping of the brain<br />
for fine functions by the development of various methods of<br />
tasks. Magnetic resonance spectroscopy can give us the<br />
information about characteristics of the tissues and/or cells<br />
of the brain, moreover is capable to give the information on,<br />
for example, GABA transmission, etc. Optical topography<br />
recently has been developed by means of near-infrared spectroscopy<br />
(NIRS). This method is multichannel NIRS that<br />
makes spacial expression, and has an advantage of excellent<br />
time resolution. This may have a possibility to analyze the<br />
various phenomena concerning of the brain function, such<br />
as epileptic seizures, motor and mental activity, etc.<br />
SY-05-2<br />
Applications of PET scanning in pediatric neurology<br />
H.T. Chugani<br />
Division of Pediatric Neurology, Positron Emission Tomography<br />
(PET) Center, Children’s Hospital of Michigan,<br />
Wayne State <strong>University</strong>, Detroit, MI, USA<br />
The clinical role of PET scanning is mainly in localization<br />
of epileptic foci for surgical treatment in refractory epilepsy.<br />
PET tracers used in epilepsy include 2-deoxy-2 ( 18 F) fluorod-glucose<br />
(FDG) and various ligands for evaluating neurotransmitter<br />
function. In temporal lobe epilepsy, interictal<br />
FDG-PET identifies areas of decreased glucose utilization<br />
that correspond to epileptogenic areas (sensitivity: 80–<br />
90%). In nonlesional extratemporal lobe epilepsy, FDG-<br />
PET provides useful lateralization and localization data to<br />
guide the placement of intracranial electrodes. Neurophysiological<br />
correlations based on coregistration of MRI, PET and<br />
subdural electrodes indicate that the seizure onset zone typically<br />
lies in the periphery or boundary of the cortical hypometabolism<br />
rather than within the hypometabolic zone. Our<br />
data also show that the size of the hypometabolic zone<br />
increases along the major propagation pathways as a function<br />
of duration of intractable epilepsy, thus supporting the
Abstracts 357<br />
concept of network growth and secondary epileptogenesis<br />
proposed by Morrell. In a number of childhood epilepsy<br />
syndromes characterized by generalized seizures, such as<br />
infantile spasms and Lennox-Gastaut syndrome, resection<br />
of focal PET abnormalities corresponding to focal ictal and<br />
interictal EEG abnormalities is associated with improved<br />
seizure and cognitive outcome. In PET studies on patients<br />
with infantile spasms, there is evidence of complex corticosubcortical<br />
interactions believed to be important in an agedependent<br />
secondary generalization of focal cortical<br />
discharges to result in the typical spasms. Only about 20%<br />
of patients with cryptogenic infantile spasms’ show a single<br />
PET focus amenable to resection. The other 80% of patients<br />
show more than one focus, and most of these will not be<br />
optimal surgical candidates. Some of these infants will benefit<br />
from the use of newer PET tracers (see below), which may<br />
reveal the primary seizure focus. The finding of bilateral<br />
symmetric hypometabolism suggests a nonlesional etiology<br />
for the spasms and is a useful indication to pursue further<br />
neurogenetic/neurometabolic evaluation rather than a surgical<br />
approach. In children with unilateral Sturge-Weber<br />
syndrome, we have shown that early and rapid loss of functional<br />
activity in the affected hemisphere is associated with a<br />
better cognitive outcome than slow progression, presumably<br />
because early demise of the affected hemisphere allows the<br />
intact hemisphere to undergo reorganizational changes early<br />
in the course of the disease. Recent studies using other PET<br />
tracers have attempted to provide a more specific and accurate<br />
assessment of seizure foci. 11 C-flumazenil labels central<br />
benzodiazepine receptors and is particularly useful in showing:<br />
decreased receptor binding in medial temporal sclerosis,<br />
dual pathology, perilesional epileptogenic zones, seizure<br />
onset zones, and potential secondary epileptic foci.<br />
11 C-<br />
alpha-methyl-l-tryptophan (AMT), an analogue of tryptophan,<br />
traces serotonin synthesis and kynurenine pathways<br />
in the brain. AMT-PET in patients with epilepsy demonstrate<br />
focally increased uptake in cortical regions of epileptogenesis<br />
interictally. In children with tuberous sclerosis and<br />
intractable epilepsy, focal increase in AMT uptake is seen<br />
in the region of epileptogenic tubers, but not in non-epileptogenic<br />
tubers. Other ligands, which label histamine, opioid<br />
and serotonin receptors have also been applied in patients<br />
with epilepsy. Ontogeny of brain glucose metabolism,<br />
GABA A receptors and serotonin synthesis has been studied<br />
in children using PET. These studies have shown characteristic<br />
developmental changes, which are disturbed in various<br />
disorders. For example, autistic children do not undergo the<br />
normal transient developmental increase of serotonin synthesis<br />
seen in normal children. Focal patterns of abnormal<br />
tryptophan uptake are also seen in autistic children. Glucose<br />
metabolism PET studies in newborns show the very early<br />
functional maturation of limbic structures believed to be<br />
involved in infant attachment. Children adopted from Romanian<br />
orphanages show disturbances of glucose metabolism in<br />
some of these same regions. The potential of PET scanning in<br />
the study of pediatric neurological disorders is enormous, but<br />
this technique remains under utilized in children for a variety<br />
of reasons.<br />
SY-05-3<br />
Functional MRI (fMRI) in children<br />
W.J. Logan<br />
Division of Neurology, Department of Pediatrics, The<br />
<strong>University</strong> of Toronto, The Hospital for Sick Children,<br />
Toronto, Canada<br />
It has been recognized for over a decade that function, in<br />
addition to structure, can be examined with MRI. The detection<br />
and localization of function with MRI depends on the<br />
hemodynamic changes that are known to accompany<br />
changes in neural activity. Most modern MR scanners<br />
have the capability for fMRI studies. The use of fMRI in<br />
children is appealing because it is non-invasive, has no<br />
radiation effects, is potentially widely available, can be<br />
repeated many times and provides high spatial resolution<br />
localization of brain function. Drawbacks such as need for<br />
patient restraint and confinement, susceptibility to movement<br />
induced artifact, need for a cooperative patient, extensive<br />
data analysis time required and poorer temporal<br />
resolution than electromagnetic techniques place some<br />
limits on the application of fMRI. With improvements in<br />
technique and greater experience, these limitations and<br />
other constraints are becoming less of a concern. fMRI activation<br />
does occur in children; in older children, this resembles<br />
that seen in adults. Children are very amenable to fMRI<br />
study. The major clinical application of fMRI in children is<br />
brain mapping of sensory, motor, language and possibly<br />
memory functions for pre-surgical planning. Other clinical<br />
applications include evaluation of the integrity of neurological<br />
pathways and cerebrovascular reactivity. Potential<br />
clinical applications include diagnosis of specific impairments<br />
such as dyslexia, predicting recovery of function<br />
after brain injury and localizing the epileptic focus. These<br />
are the subjects of current research studies. Other areas of<br />
research are determining the mechanisms of plasticity, the<br />
effect of rehabilitation and development on patterns of activation<br />
and development of new paradigms especially for<br />
younger children. There will be advances in the study of<br />
sedated patients, in combining electromagnetic and fMRI<br />
studies and in improving the techniques of investigation<br />
such as real time data analysis and improved motion control<br />
and correction. With advances in the above areas one can<br />
predict an increasing use of fMRI in children.<br />
SY-05-4<br />
Proton magnetic resonance spectroscopy in children<br />
with acute brain injury<br />
S. Ashwal<br />
Department of Pediatrics, Loma Linda <strong>University</strong> School of<br />
Medicine Loma Linda, CA, USA
358<br />
Abstracts<br />
Proton MRS is an emerging technology that allows for the<br />
quantitative non-invasive assessment of regional brain metabolic<br />
activity. MRS has been used to study a wide variety of<br />
pediatric neurometabolic disorders, tumors and demyelinating<br />
diseases. It has also been used to assess prognosis after<br />
acute brain injury (perinatal asphyxia, near drowning, etc.)<br />
and it is useful in localizing focal epilepsies. Brain metabolites<br />
assessed with MRS and often expressed as ratios<br />
include: (1) N-acetyl aspartate (NAA) found in neurons; (2)<br />
creatine and phosphocreatine (Cre) that reflect energy metabolism;<br />
(3) choline-containing compounds (Cho) released<br />
during membrane disruption; (4) presence of lactate indicating<br />
a disturbance in cerebral energy metabolism; and (5)<br />
glutamate/glutamine that is a reflection of asphyxial injury.<br />
Markedly reduced levels of NAA and increased lactate have<br />
been seen in patients who ultimately suffer severe long-term<br />
neurologic disability. Usually this can be seen 3–5 days after<br />
injury and is a diffuse phenomenon present in cerebral gray<br />
and white matter. Patients with malignant tumors are likely to<br />
have moderate to marked increases in choline and reduced<br />
NAA whereas patients with lower grade tumors may show<br />
milder abnormalities. MRS is also useful in evaluating children<br />
with traumatic brain injury (TBI) as is a new MR technique<br />
known as susceptibility weighted imaging which is<br />
more sensitive in detecting hemorrhagic lesions associated<br />
with diffuse axonal injury that also show very abnormal MRS<br />
patterns that correlate with outcome. Multivoxel MRS allows<br />
non-invasive sampling of many brain regions. It is likely that<br />
as MRS technology continues to improve, its use for the<br />
diagnosis of many nervous system disorders of children<br />
will increase.<br />
SY-05-5<br />
Diffusion tensor imaging<br />
A. Ohnuma<br />
Division of Pediatric neurology, Miyagi Prefectural Takutoh<br />
Rehabilitation Center for Children, Miyagi, Japan<br />
The recent development of diffusion tensor imaging<br />
(DTI) has made it possible to visualize anatomic details of<br />
the human brain and to provide quantitative measures of<br />
fiber tract integrity and orientation. The evidence of brain<br />
plasticity was confirmed via DTI and FMRI in the intellectually<br />
normal five subjects (aged 8–26 years) with unilateral<br />
extensive brain lesions, which developed in the prenatal<br />
(cortical dysplasia one and encephalo-clastic lesion two),<br />
perinatal (encephalo-clastic lesion 1) and neonatal (intracranial<br />
bleeding) stage. Fractional anisotropy (FA) images<br />
included whole brain axial images and coronal pyramidal<br />
tract images at the brainstem. FMRI during the motor task<br />
was performed by the affected hand grasping. DTI depicted<br />
markedly reduced FA of the pyramidal tract of the affected<br />
hemisphere in two cases, moderately reduced in two and<br />
bilateral normal in one. FMRI showed ipsilateral activations<br />
in two cases, bilateral in one and contralateral in one. The<br />
mode of the reorganization of the pyramidal tracts seemed<br />
to depend on the stage of the development of the hemispherical<br />
brain damages and the state of the residual brain tissues<br />
of the affected hemisphere. DTI was also examined in the<br />
cases with various kinds of white matter disorders, such as<br />
Pelizaeus-Merzbacher disease, X-linked adrenoleukodystrophy,<br />
metachromatic leukodystrophy, Cockayne<br />
syndrome and Fukuyama type congenital muscular dystrophy,<br />
in comparing with normal controls. Quantitative<br />
measures of diffusivity and FA were useful for evaluating<br />
the white matter status of these disorders.<br />
SY-6<br />
Channelopathies<br />
SY-06-1<br />
Mutations of sodium channels in GEFS 1 and SMEI<br />
K. Yamakawa<br />
Laboratory for Neurogenetics, RIKEN Brain Science Institute,<br />
Japan<br />
GEFS 1 , a clinical subset of febrile seizures (FS), is characterized<br />
by frequent episodes beyond 6 years of age (FS 1 )<br />
and various types of subsequent epilepsy. Recent evidences<br />
have indicated that the neuronal voltage-gated sodium channels<br />
(SCN1A, SCN2A, SCN1B) are responsible for GEFS 1 .<br />
Some of mutant channels showed slowed inactivation that<br />
may lead to the augment of sodium ion influx, cause hyperexcitability<br />
of neurons, and finally result in epileptic<br />
seizures. SCN1A has been also reported to be mutated in<br />
severe myoclonic epilepsy in infancy (SMEI). SMEI is an<br />
extremely intractable epilepsy; normal development before<br />
onset; seizures beginning during 1st year of life in the form<br />
of generalized or unilateral febrile clonic seizures; secondary<br />
appearance of myoclonic seizures, and associates with<br />
ataxia and mental decline. SCN1A mutations in SMEI were<br />
heterozygous and de novo, and most of them are frameshift<br />
or nonsense. Mutations in GEFS 1 are all missense mutations,<br />
and these suggest the distinct pathologies of GEFS 1<br />
and SMEI even if SCN1A is responsible for both diseases.<br />
In my talk, I will summarize the SCN1A mutations of<br />
GEFS 1 and SMEI and discuss the genotype-phenotype<br />
correlation as well as the predicted molecular pathology<br />
of these diseases.<br />
SY-06-2<br />
Benign familial neonatal convulsions<br />
S. Hirose, A. Mitsudome<br />
Department of Pediatrics, School of Medicine, Fukuoka<br />
<strong>University</strong>, Fukuoka, Japan<br />
Benign familial neonatal convulsions (BFNC) is monogenic<br />
epilepsy inherited via an autosomal dominant trait and<br />
characterized by clusters of generalized and partial seizures
Abstracts 359<br />
afflicting exclusively, if any, neonates, and remits spontaneously.<br />
However, the incidence of subsequent epilepsy<br />
later in life is also higher in individuals who suffer from<br />
BFNC. Mutations of two KQT-like K 1 -channel genes, the<br />
KCNQ2 and KCNQ3 genes, were identified as the underlying<br />
abnormalities of BFNC. To date, some ten mutations<br />
of KCNQ2 have been discovered while only two mutations<br />
including one found in a Japanese pedigree with BFNC have<br />
been identified in KCNQ3. All mutations were heterozygous.<br />
KCNQ2 and KCNQ3 synergistically contribute to<br />
the formation of the M-current, which controls the subthreshold<br />
electroexcitability of neurons. Dysfunction of<br />
either KCNQ2 or KCNQ3 can hence result in indistinguishable<br />
BFNC phenotype. The exact pathomechanisms of agedependency<br />
and propensity for future epilepsies in BFNC<br />
remain to be determined. We have recently shown that<br />
KCNQ K 1 -channels serve as a predominant inhibitory<br />
system in CNS during neonates, since GABAergic-transmission<br />
governs the inhibitory system afterwards. Thus,<br />
deficient KCNQ K 1 -channels cause convulsions during<br />
the neonatal period. We have recently suggested that<br />
abnormalities of KCNQ2 and KCNQ3 are not necessarily<br />
the only causes of BFNC phenotypes, but rather other<br />
genes are probably involved in the pathogenesis of the<br />
BFNC phenotype, i.e. further genetic heterogeneity underlies<br />
this familial epilepsy. Deficiency of other ion channels<br />
and their modulation may result in the BFNC phenotype as<br />
well.<br />
SY-06-3<br />
Single gene mutation, dual phenotype, and differential<br />
mechanisms in stargazer mutant<br />
X.-X. Qiao<br />
Department of Cellular Biology and Anatomy, Louisiana<br />
State <strong>University</strong> Health Sciences Center, Shreveport, LA,<br />
USA<br />
Voltage-dependent calcium channels (VDCC) play a<br />
key role in regulating a broad spectrum of cellular functions<br />
in both developing and mature central nervous<br />
system. While more neurological disorders have been<br />
linked to mutations of these genes in humans, several<br />
spontaneous mutant mouse strains have recently been<br />
found to harbor different VDCC subunit mutations. Interestingly,<br />
all of these mutants share a similar phenotype of<br />
characteristic spike-wave epilepsy and ataxia. Investigation<br />
of these mutants has furthered our understanding of<br />
the role of VDCC genes in neuronal function and provided<br />
more insights of the mechanisms underlying inherited<br />
neurological diseases. Studies from one such mutant, stargazer,<br />
which carries a defected VDCC g2 subunit, have<br />
revealed differential cellular processes involved in different<br />
brain regions. In the frontal brain, an autonomous<br />
increase in cortical network excitability in vitro has been<br />
correlated with the prolonged seizure activity in vivo.<br />
Aberrant mossy fiber sprouting and increased neuropeptide-Y<br />
expression in the hippocampus are subsequent to<br />
the epileptic discharges. In the cerebellum, the only area<br />
that is not invaded by the seizure activity, severe impairment<br />
of motor coordination and sensory-motor learning is<br />
correlated with regionally restricted molecular and cellular<br />
defects. The abnormalities include altered cerebellar granule<br />
cell migration, maturation, and synaptic transmission.<br />
The underlying molecules are linked to the selective failure<br />
of BDNF mRNA expression and AMPA receptor<br />
synaptic targeting. These results revealed significant regional<br />
specificity to the defects in stargazer brain. It provides<br />
clear evidence that calcium channelopathies initiate<br />
complex, region-specific, molecular defects in synaptic<br />
signaling during brain development.<br />
SY-06-4<br />
GABA gene mutations in human epilepsies symposium<br />
of channelopathies<br />
I.E. Scheffer<br />
Epilepsy Research Institute, <strong>University</strong> of Melbourne,<br />
Austin and Repatriation Medical Centre, Monash Medical<br />
Centre and Royal Children’s Hospital, Melbourne, Australia<br />
GABA is the major inhibitory neurotransmitter in the<br />
central nervous system. GABA receptors are heteropentameric<br />
ligand-gated chloride channels. GABA receptors in<br />
human brain most commonly comprise alpha subunits, beta<br />
subunits and a gamma subunit. The alpha and beta subunits<br />
can form a functional receptor alone. The gamma subunit<br />
contributes to the benzodiazepine binding site and is essential<br />
for benzodiazepine potentiation of action potentials.<br />
Three mutations of the gamma 2 subunit gene of the<br />
GABA A receptor (GABRG2) were identified in families<br />
with GEFS 1 , one also had childhood absence epilepsy<br />
(CAE). In vitro functional studies using two electrode<br />
voltage clamp recordings of the mutations expressed in<br />
functional GABA receptors showed marked attenuation<br />
of the GABA-mediated current with two mutations. In<br />
the third mutation, GABA current was not altered, however<br />
benzodiazepine potentiation was abolished. Recently, a<br />
family with Autosomal Dominant Juvenile Myoclonic<br />
Epilepsy with a mutation of the alpha 1 subunit gene of<br />
the GABA A receptor (GABRA1) was reported. In vitro<br />
studies also showed reduction of the GABA activated<br />
current. The range of mutations of GABA receptors in<br />
the idiopathic epilepsies still remains to be explored. It is<br />
likely that other subunit genes will be involved in the<br />
idiopathic generalized epilepsies, including GEFS 1 . Genotype-phenotype<br />
correlation will be essential to understanding<br />
the neurobiology of these disorders. Eventually the<br />
clinician may treat patients based on the rational understanding<br />
of the interaction of a number of ion channel<br />
mutations.
360<br />
Abstracts<br />
SY-06-5<br />
Epileptic channelopathies in man and mouse<br />
J. Noebels<br />
Department of Neurology, Baylor College of Medicine,<br />
Houston, TX, USA<br />
Inherited disorders of ion channels are now the single<br />
most common known cause of idiopathic generalized<br />
epilepsy. Despite this rapid progress in gene discovery,<br />
we are only beginning to understand their intriguing pathophysiology.<br />
Channelopathy phenotypes arise in both the<br />
developing and mature central nervous system, and show<br />
remarkable clinical diversity, including tonic/clonic,<br />
absence, and myoclonic epilepsy, as well as other episodic<br />
neurological disorders. The mutations target both voltageand<br />
ligand-gated channels, and produce disease by altering<br />
the biophysical properties of the pore subunit or by modifying<br />
auxiliary subunits that regulate membrane insertion,<br />
modulation, and localization of the channel complex. In<br />
almost all cases, the direct result is to prolong intrinsic<br />
membrane depolarisation or impair synaptic transmission.<br />
Recent studies in orthologous mouse models suggest that<br />
the mechanisms for age-dependent epileptogenesis in these<br />
inherited errors are more complex than initially realized.<br />
Despite widespread expression, only certain neural<br />
networks are vulnerable at various developmental stages,<br />
presumably accounting for phenotypic diversity. The selectivity<br />
is explained by the differential contributions of individual<br />
channels to the excitability and firing behavior, and<br />
by the presence of compensatory subunits. As one example,<br />
generalized spike-wave absence epilepsy is seen in a<br />
cluster of four mutant mouse models, each representing a<br />
subunit of the brain voltage-gated calcium channel. In two<br />
of these models (a1a and b4), the compensatory subunits<br />
have been identified, and their absence in thalamic neurons<br />
contributes to thalamocortical synchrony. We have recently<br />
identified further downstream cellular plasticity in thalamic<br />
low threshold calcium currents that may also directly<br />
contribute to the seizure phenotype.<br />
SY-7<br />
What Happens to a Child at Risk for Developmental<br />
Delay/Disability<br />
SY-07-1<br />
Introduction<br />
S. Harel<br />
Division of Pediatrics, The Institute For Child Development<br />
and Pediatrics Neurology, Tel Aviv, Israel<br />
Abstract not submitted<br />
SY-07-2<br />
School age outcomes of pre-school children diagnosed<br />
with either global developmental delay or specific<br />
language impairment<br />
M. Shevell, A. Majnemer, R. Platt<br />
Montreal Children’s Hospital-McGill <strong>University</strong>, Canada<br />
The objective of this study is to describe prospectively the<br />
school age (6–7 years) functional and developmental<br />
outcomes in a cohort of children diagnosed previously<br />
with either a global developmental delay or a specific<br />
language impairment. Two cohorts have been assembled:<br />
(a) global developmental delay (n ¼ 99); and (b) specific<br />
language impairment (n ¼ 72). These cohorts were initially<br />
assessed and diagnosed at a mean age of 37.6 and 43.3<br />
months, respectively. Functional, developmental and<br />
language outcomes were assessed in each cohort between<br />
the ages of 6–7 years using a variety of measures. These<br />
included the Battelle Developmental Inventory, Vineland<br />
Adaptive Behavior Scale, WeeFIM, Child Health Questionnaire,<br />
Parenting Stress Index, Child Behavior Checklist/4–<br />
18, Expressive One-Word Picture Vocabulary Test and the<br />
Peabody Picture Vocabulary Test-Revised. Outcomes on<br />
each of these measures for each cohort in this ongoing<br />
study will be described and co-related with factors identified<br />
at initial intake to establish the possibility and strength of<br />
prognostic variables.<br />
SY-07-3<br />
Cerebral visual disorders in children with brain lesions:<br />
outcome and correlation with neuroimaging<br />
G. Cioni, A. Guzzetta, F. Tinelli<br />
Division of Child Neurology and Psychiatry, Stella Maris<br />
Scientific Institute and <strong>University</strong> of Pisa, I Calambrone,<br />
Pisa, Italy<br />
Children with brain lesions of antenatal or perinatal<br />
onset are at high risk for early disturbances of their visual<br />
development, detectable since the first months of life by<br />
means of new behavioural and electrophysiological techniques.<br />
Several studies have reported that various aspects of<br />
visual function, such as visual acuity, visual fields, optokinetic<br />
nystagmus, fixation shift, and perception of movement<br />
are often impaired in these children. A strong<br />
correlation between the results of visual assessment, and<br />
cognitive and motor development also has been also<br />
reported, suggesting a crucial role for visual function in<br />
the early development. Long-term follow-up of these children<br />
have revealed subtle neuropsychological disorders.<br />
Neuroimaging techniques, and brain MRI in particular,<br />
are useful in predicting the occurrence and extent of visual<br />
impairment. However, the correlation between imaging<br />
findings and function is not always consistent. This is probably<br />
due to the involvement of the complex extra-striatal
Abstracts 361<br />
visual pathways and also to the plasticity of the developing<br />
brain. Children often show less severe visual impairments<br />
than adults with apparently similar brain lesions. Newer<br />
MR techniques, particularly fMRI, can provide other<br />
important contributions to this issue. These results are<br />
important for understanding the advantages but also the<br />
limitations, of plasticity and reorganization of the immature<br />
visual brain.<br />
SY-07-4<br />
The study investigates long-term effects of slight<br />
biological and slight socioeconomic risks on complex<br />
achievement variables using two different data sets<br />
G. Spie, C. Spiel, G. Sange, P. Wagner<br />
Department of Child Neurology/Psychiatry, and Special<br />
Education for Children and Adolescents-Hospital Klagenfurt,<br />
Klagenfurt, Australia<br />
On the one hand, observations collected in the Vienna<br />
developmental study (VDS), on the other hand, the same<br />
kind of data from the Viennese study ‘children at risk’<br />
(VCRS) were used. The sample of the VDS study consisted<br />
of 94 randomly selected children. The sample of the VCRS<br />
study consisted of 129 children who were selected for slight<br />
biological risks at birth. In addition a comparison sample<br />
without known biological risks was drawn from the general<br />
population. Needless to say that only compliant members of<br />
the study were followed in the long run. The following risk<br />
conditions were analyzed in both samples: biological risks,<br />
socio-economic status, hospitalizations, severe strains and<br />
life-events, and early occurring developmental variables. As<br />
outcome variables cognitive competence (fluid and crystallized<br />
intelligence) was collected at the age of 12 years, and<br />
school achievement from the first to the fourth grade(ages<br />
6–10) modeling the overall academic development during<br />
primary school. Multiple regression analyses were used in<br />
both studies to investigate the effects of risk conditions and<br />
earlier developmental parameters on outcome variables<br />
mentioned before.<br />
SY-07-5<br />
Neuropsychological outcome of children with<br />
intrauterine growth retardation (IUGR)<br />
Y. Leitner a , A. Fattal-Valevski a , R. Geva a , H. Bassan a ,H.<br />
Goez a , A.J. Jaffa b , S. Harel a<br />
a The Institute for Child Development and Pediatric Neurology<br />
Unit, Division of Pediatrics, b Department of Obstetrics<br />
and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky<br />
Medical Center, Sackler Faculty of Medicine, Tel Aviv<br />
<strong>University</strong>, Israel<br />
Intrauterine growth retardation (IUGR) occurs in 3–10%<br />
of all pregnancies, and is more prevalent in children with<br />
neurocognitive disabilities. Our study was conducted to<br />
characterize the neurodevelopmental and cognitive difficulties<br />
specific to IUGR children and identification of early<br />
risks and clinical predictors of these difficulties. Since<br />
1990, a group of 320 children with IUGR has been<br />
followed-up annually from pregnancy to school age, by<br />
neurodevelopmental and psychological evaluation, and<br />
data collected by socioeconomic, obstetric and neonatal<br />
risk questionnaires. The risk questionnaires and neurodevelopmental<br />
evaluations were all scored according to Prechtl’s<br />
‘optimality concept’. Psychological evaluation was<br />
performed by standard IQ tests. The data presented in this<br />
study demonstrates the changes observed in the IUGR<br />
group, versus the controls matched for gestational age and<br />
socioeconomic status at three points of the follow-up, i.e.<br />
age 3 (n ¼ 130), 6–7 years (n ¼ 110), and 9–10 years<br />
(n ¼ 56). Significant differences in growth parameters<br />
were found in all age groups. At all ages (3, 6–7 and 9–10<br />
years), the score of the IUGR children was significantly<br />
poorer (P , 0:005, P , 0:05, and P , 0:005, respectively)<br />
on the neurodevelopmental score, than the matched<br />
controls. At ages 6–7 and 9–10 years, the IUGR children<br />
had lower IQ scores (P , 0:05; P , 0:005). No differences<br />
were found in IQ scores at age 3. Statistically significant<br />
items on the 3-year neurodevelopmental test that differed<br />
IUGR children from controls were in the area of motor<br />
coordination. At age 6–7, a specific profile of difficulties<br />
in coordination, special maturation tasks and graphomotor<br />
skills is typical of the IUGR children. At 9–10 years of age,<br />
attention span, activity, coordination, timed coordination<br />
performance, visuomotor dysfunction, language verbal<br />
fluency and school achievements were typical for IUGR<br />
children. The clinical parameters that best predict neurodevelopmental<br />
outcome at 3 years were the cephalization<br />
index [CI]: (head circumference [HC]/birth weight based<br />
on the ‘brain sparing’ process expressing the severity of<br />
the IUGR process) (P , 0:005) and the HC (P , 0:005).<br />
At 6–7 years of age the best predictors were the neonatal<br />
risk score (P , 0:005) and weight (P , 0:005). At 9–10<br />
years, the best predictors were CI (P , 0:001) and weight<br />
(P , 0; 005). The best predictors for IQ at age 3 years were<br />
HC (P , 0:05) and maternal education (P , 0:005); at 6–7<br />
years neonatal risk score (P , 0:001); HC (P , 0:005), and<br />
maternal education (P , 0:001); and at 9–10 years the CI<br />
(P , 0:005); HC (P , 0:005) and maternal education<br />
(P , 0:005). At age 6–7 years neurodevelopmental<br />
outcome and IQ score were worse in IUGR children with<br />
neonatal complications than those without (P , 0:05;<br />
P , 0:005, respectively). Children with IUGR diagnosed<br />
prenatally had the same neuropsychological outcome as<br />
those diagnosed at birth, probably due to early delivery<br />
and careful perinatal and obstetric care. Preliminary conclusions<br />
of this long-term follow-up: children with IUGR lag<br />
behind in their somatic and neurocognitive development.<br />
The neuropsychological items that most clearly differentiated<br />
IUGR children from the controls were those requiring<br />
motor coordination, visuomotor skills, attention span,
362<br />
Abstracts<br />
language and school achievements, hinting at later learning<br />
disabilities. Clinical predictors of neurocognitive development:<br />
CI and the neonatal risk predict neurodevelopmental<br />
outcome. CI, neonatal risk score, HC, maternal education<br />
and paternal occupation predict cognitive ability. Neurodevelopmental<br />
outcome was worse in IUGR children with<br />
neonatal risk. IUGR children diagnosed prenatally, despite<br />
being at high risk, had the same outcome as the low-risk<br />
children diagnosed only at birth, probably reflecting careful<br />
obstetric and neonatal care. At a younger age, the biological<br />
parameters have a greater impact on neurodevelopment,<br />
while later environmental influences, such as maternal<br />
education, appear to gain importance in cognitive performance.<br />
SY-07-6<br />
The outcome of early intervention in<br />
neurodevelopmental disabilities<br />
T. Velickovic<br />
Ljubljana, Slovenia<br />
Abstract not submitted<br />
SY-8<br />
Neurometabolic Disorders Update<br />
SY-08-1<br />
Screening for neurometabolic disorders<br />
B. Wilcken<br />
The Children’s Hospital, Westmead, New South Wales,<br />
Australia<br />
Screening implies pre-symptomatic diagnosis. One classical<br />
criterion for screening in newborns is that there should be<br />
benefit to the baby from early diagnosis. Newborn screening<br />
began in the 1960s with a test for phenylketonuria, which had<br />
been found to account for 1% of institutionalized mentally<br />
retarded persons in western countries. Later, screening for<br />
primary congenital hypothyroidism detected another cause<br />
of mental retardation, and indicated iodine-deficiency areas<br />
where endemic cretinism occurred. The new newborn<br />
screening by tandem mass-spectrometry enormously<br />
increases the potential for early detection of genetic metabolic<br />
disorders, detecting amino acid, organic acid, and fatty<br />
acid disorders in a single test. Screening newborns for untreatable<br />
disorders is not favored, but as treatment becomes more<br />
available the classes of disorder, which are tested for, will<br />
expand. The more important neurometabolic disorders have<br />
been hard to screen for, as many do not have suitable<br />
biochemical markers in blood or urine, or common DNA<br />
mutations. There is promise of a newborn test for lysosomal<br />
storage disorders, and treatment by enzyme replacement<br />
therapy is currently available or developing for many of<br />
these. Some rare neurometabolic disorders that could likely<br />
be detected by screening using modifications to current technology<br />
include disorders of creatine deficiency, serine deficiency,<br />
purines and pyrimidines, cholesterol synthesis,<br />
carbohydrate deficient glycoprotein syndromes, and peroxisomal<br />
disorders. It is important that each potential screening<br />
initiative is carefully evaluated for evidence of benefit,<br />
before widespread adoption.<br />
SY-08-2<br />
Postnatal and prenatal diagnosis of lysosomal storage<br />
diseases<br />
H.-P. Shi a , W.-M. Zhang a , Y.-F. Guo a , S.-M. Zhao b , N.-H.<br />
Sun b<br />
a Institute of basic Medical Sciences, CAMS, School of Basic<br />
Medicine, PUMC, Beijing, China; b PUMC Hospital, Beijing,<br />
China<br />
Objective: LSD constitute a group of inherited metabolic<br />
diseases, in which lysosomal acid hydrolases are deficient,<br />
resulting in accumulation of the substrate of the affected<br />
hydrolase within lysosomes. Since there is no definitive<br />
treatment for LSD, except Gaucher disease, accurate prenatal<br />
diagnosis is the only way to prevent the birth of affected<br />
fetuses. Methods: Microanalysis of enzyme activity is<br />
adapted from the Department of clinical genetics, Erasmus<br />
<strong>University</strong>, Rotterdam, Netherlands. Fifteen kinds of methods<br />
for enzyme assays were set up. Results: Since 1991, 202<br />
index patients were diagnosed based on the characteristic<br />
clinical manifestation and specific enzyme assay. Prenatal<br />
diagnosis has been carried out in 43 pregnancies at risk of<br />
LSD (13 mucopolysaccharidoses, seven G M1 gangliosidosis,<br />
four G M2 gangliosidosis, seven metachromatic leukodystrophy,<br />
five Gaucher disease, four Niemann-Pick disease and<br />
three mucolipidosis) in early pregnancy, 11 affected fetuses<br />
were detected. Gaucher disease (GD) is the most prevalent<br />
LSD. We have performed gene analysis from 10 Chinese<br />
patients with GD. Mutation L444P is the most frequent and<br />
accounts for 40% of the alleles, which is associated with all<br />
types of GD. The genotype of one case is L444P/L444P. His<br />
mother had another pregnancy, the prenatal diagnosis was<br />
carried out by both enzyme assays and polymerase chain<br />
reaction (PCR)/restriction fragment length polymorphisms<br />
(RFLP). The result is that the fetus is a heterozygote of GD.<br />
Conclusion: Microanalysis of enzyme activity is a reliable<br />
method for postnatal and prenatal diagnosis of LSD.<br />
SY-08-3<br />
Biology and therapy of Niemann-Pick disease, type C<br />
M.C. Patterson<br />
Columbia <strong>University</strong>, New York, USA<br />
Niemann-Pick disease, type C (NPC), is an autosomal<br />
recessive, progressive neurodegenerative disorder resulting<br />
from mutations in NPC 1 (.95% of cases) or NPC2. The<br />
NPC1 gene product is an integral membrane protein with
Abstracts 363<br />
homology to the sterol-sensing domain of SREBP cleavage<br />
cleavage – activating protein (SCAP) and hemimegalencephaly<br />
(HMG) CoA reductase and to the Drosophila morphogen,<br />
patched, and is expressed in a late endosomal<br />
compartment. Cultured fibroblasts from NPC patients show<br />
impaired intracellular vesicular trafficking, of multiple<br />
macromolecular cargoes, leading to a net accumulation of<br />
free cholesterol and glycosphingolipids in membrane bound<br />
vesicles. The function of the NPC2 gene product (epididymal<br />
secretory protein E1 (hE1)) in the brain is under investigation.<br />
Clinical expression ranges from fetal/neonatal onset<br />
with predominant hepatic and pulmonary disease, through<br />
childhood presentations with multisystem neurologic<br />
disease, to psychiatric and cognitive adult disease. G M2 ganglioside<br />
accumulation in NPC correlates with meganeurite<br />
formation and ectopic dendritogenesis. Pharmacologic inhibition<br />
of glycosphingolipid synthesis by OGT 918 (that<br />
competitively inhibits glucosyltransferase synthase) leads<br />
to increased survival in the Balb/c murine model of NPC.<br />
A genetic model of glycosphingolipid synthesis in NPC,<br />
created by a cross between the Balb/c mutant and a GalNAc<br />
transferase knockout, shows no survival advantage over the<br />
untreated Balb/c mutant. These data suggest that lactosylceramide,<br />
glucosylceramide and ganglioside accumulation<br />
must all be reduced to produce increased survival in murine<br />
NPC. A phase I/II clinical trial of OGT 918 in human NPC is<br />
in progress.<br />
SY-08-4<br />
Neuropathic Gaucher disease: diagnosis and<br />
management<br />
G.M. Pastores<br />
Neurogenetics Unit, Department of Neurology, New York<br />
<strong>University</strong> School of Medicine, New York, NY, USA<br />
GD is a defect glycosphingolipid metabolism due to a<br />
deficiency of lysosomal glucocerebrosidase. Most patients<br />
do not have primary CNS involvement (type 1 GD); some<br />
develop acute or chronic neurodegeneration. Presence of the<br />
N370S mutation precludes CNS disease, while homozygosity<br />
for L444P is often seen with severe disease and a relatively<br />
high (but not invariable) risk of neurologic<br />
involvement. Brainstem auditory evoked response (BAER)<br />
may show abnormal peak forms and inter-peak latencies, and<br />
short-latency somatosensory evoked potential (SSEP) testing<br />
may reveal giant cortical potentials, which correlate with<br />
development of cognitive impairment. Although brain<br />
imaging and neurophysiological studies provide prognostic<br />
information, absence of abnormal findings does not exclude<br />
the possibility of CNS involvement. Enzyme therapy safely<br />
reverses the extra-neuronal manifestations. Treatment does<br />
not appear to ultimately influence the neurologic disease<br />
course in acute Neuronopathic Gaucher disease (NGD).<br />
Treatment of chronic NGD patients has been reported to<br />
stabilize supranuclear palsy and cognitive function, although<br />
there are patients who have worsened and developed progressive<br />
myoclonic encephalopathy accompanied by cranial<br />
MRI and EEG. Assessment of therapeutic response for<br />
chronic NGD is complicated by wide heterogeneity in clinical<br />
expression. Novel therapeutic strategies, including direct<br />
delivery to local sites of pathology, may be necessary to<br />
achieve optimal responses. Substrate synthesis inhibitors<br />
(SSI) have recently been shown to effect a clinical response<br />
in patients with type 1 GD. The safety and effectiveness of<br />
SSI for NGD remains to be established.<br />
SY-08-5<br />
Chemical chaperone therapy for lysosomal diseases with<br />
central nerve system pathology<br />
Y. Suzuki a , E. Nanba b , K. Ohno b , J. Matsuda c , S. Ogawa d<br />
a International <strong>University</strong> of Health and Welfare, Otawara,<br />
Japan; b Tottori <strong>University</strong>, Yonago, Japan; c National Institute<br />
of Infectious Diseases, Tokyo, Japan; d Keio <strong>University</strong>,<br />
Yokohama, Japan<br />
Some mutant enzyme proteins are labile and rapidly<br />
degraded in somatic cells from patients with Fabry disease<br />
(Fan, Ishii, Asano, Suzuki: Nature Med, 1999). If an<br />
exogenous substrate analog compound of low molecular<br />
weight is added to the cell, association of these two molecules<br />
stabilizes the mutant enzyme protein, which is then<br />
safely transported to the lysosome and expresses the catalytic<br />
activity after spontaneous dissociation with the<br />
compound (chemical chaperone) in the lysosome. We<br />
further confirmed this paradoxical phenomenon for b-galactosidase<br />
deficiency (G M1 -gangliosidosis and Morquio B<br />
disease) and b-glucosidase deficiency (Gaucher disease).<br />
After screening of newly synthesized compounds, we<br />
found two potent competitive inhibitors: GalX for b-galactosidase<br />
and GlcX for b-glucosidase (tentative nomenclature).<br />
They are enzyme inhibitors in vitro, but induced<br />
expression of the mutant enzyme activity at low concentrations<br />
in cultured fibroblasts from some patients, respectively,<br />
with these two diseases. Mutant enzyme activities<br />
were remarkably elevated after several days of culture<br />
with one of these compounds. The mutations responsive<br />
to this procedure mainly represented late onset or atypical<br />
clinical phenotypes. Furthermore we produced a few mouse<br />
lines expressing phenotype-specific mutant human b-galactosidase,<br />
by introducing cDNA as transgene into the<br />
enzyme-deficient knockout mouse. This new disease<br />
model, knockout-transgenic mouse, serves for animal<br />
experiments of our therapeutic approach to human b-galactosidase<br />
deficiency disorders. One of the model mouse lines<br />
expressing the R201C mutation was fed with GalX solution<br />
for a week. All tissues including the brain showed 5–15-fold<br />
elevation of the b-galactosidase activity. This result indicates<br />
that the compound GalX passed through the blood–<br />
brain barrier to restore enzyme activity in the brain, which is<br />
sufficient for intracellular degradation of stored substrates.
364<br />
Abstracts<br />
This is the first achievement for developing a new therapeutic<br />
approach by oral medication to the brain pathology in<br />
lysosomal storage diseases.<br />
SY-9<br />
Child and Adolescent Epilepsy in the Framework of<br />
the ILAE/IBE/WHO Global Campaign against Epilepsy<br />
SY-09-1<br />
The ILAE/IBE/WHO global campaign against epilepsy:<br />
A progress report<br />
S. Jan<br />
India<br />
Abstract not submitted<br />
SY-09-2<br />
Epilepsy in infancy and childhood: Incidence,<br />
prevalence and clinical spectrum<br />
S. Ohtahara<br />
Department of Child Neurology, Okayama <strong>University</strong> Medical<br />
School, Okayama, Japan<br />
Onset of epilepsies is mostly in childhood; about 70% of<br />
epileptic patients have their initial attack within the first 3<br />
years of life. Response to the treatment is usually favorable<br />
in childhood epilepsy in comparison with that of adult<br />
epilepsy. This may suggest the possibility of remarkable<br />
reduction of epileptic patients by the proper treatment of<br />
childhood epilepsy. The real condition of childhood<br />
epilepsy will be outlined according to the epidemiological<br />
findings, particularly two extensive neuroepidemiological<br />
investigations of childhood epilepsy in Okayama Prefecture.<br />
Relating the intractable cases, cardinal epileptic<br />
syndromes are overviewed. Characteristics of childhood<br />
epilepsy are mentioned, referring to the conceptualization<br />
of the age-dependent epileptic encephalopathy and its<br />
developmental aspects.<br />
SY-09-3<br />
Development and disruption: long-term effects epileptic<br />
interference with early cognitive development<br />
S.J. Wallace<br />
<strong>University</strong> Hospital of Wales, Cardiff, UK<br />
Of the stages of development of the brain, neuronal<br />
migration and organisation; and, the formation of synapses,<br />
with their reinforcement or apoptosis, seem to be the most<br />
relevant. The peak period of migration is passed well before<br />
fetal viability, but organisation and synaptic formation<br />
continue into the early years. When epilepsy develops<br />
very early, poor later cognitive development may merely<br />
be a reflection of severe abnormalities in prenatal brain<br />
development: these would be impossible to correct. Epilepsies<br />
with onset after the neonatal period will be the main<br />
subject for discussion, since there could be some scope for<br />
amelioration of subsequent cognitive difficulties. Four main<br />
aspects will be considered. Biochemical/metabolic reasons<br />
for neuronal damage following epileptic seizures include<br />
the actions of excito-toxic amino acids; and during status<br />
epilepticus, additionally, hypoxia and metabolic acidosis.<br />
Disruption of learning can be secondary to the presence of<br />
the epilepsy of particular syndromes, such as those of West,<br />
Dravet and Lennox-Gastaut, and in epilepsies with specific<br />
cognitive symptomatology. Possible effects of treatment of<br />
epilepsy, such as drugs, which might interfere with, or<br />
enhance, cognition and educational progress, need consideration.<br />
Secondary effects on psychosocial functioning, e.g.<br />
alterations in parental management and expectations, and,<br />
reduced educational and social opportunities can be important.<br />
The less florid, but equally important, educational<br />
problems of children with benign focal epilepsies and<br />
absences will be addressed. Epilepsy is a further additional<br />
handicap in children with cerebral palsy, when it is associated<br />
with enhanced cognitive problems.<br />
SY-09-4<br />
The impact of epilepsy. The influence of epilepsy on the<br />
lives of the child, the parents and the siblings<br />
M. Endziniene<br />
Kaunas <strong>University</strong> of Medicine, Lithuania<br />
One of the most difficult aspects of having epilepsy is not<br />
the epilepsy itself, but the problem of adjusting to it. In early<br />
years, physical impact of epilepsy on the child is most<br />
prominent (injuries caused by seizures, medication side<br />
effects, unpleasant medical procedures). In later years,<br />
emotional and behavioral consequences as well as difficulties<br />
in psychological and social adjustment come to front.<br />
The unpredictability of seizures make the patients feel not as<br />
good as other people. Poor self-esteem, depression, anxiety;<br />
fear of being isolated by peers and of being unable to meet<br />
parental expectations; learning difficulties, multiple restrictions,<br />
uncertainty in the future and continuous striving to<br />
avoid overprotection are the key problems that that the teenagers<br />
have to deal daily. On the other hand, the burden of<br />
having a chronically ill child has great influence on the<br />
family relationships and social roles. It sometimes takes<br />
months to accept the diagnosis of epilepsy, to settle realistic<br />
expectations and to learn how to help the child in coping<br />
with its problems. The feelings of guilt, anxiety, helplessness<br />
and doubts lead to overprotection and excessive restrictions<br />
towards the disabled child. Loss of parental attention<br />
and care may cause emotional problems in healthy siblings.<br />
Parental inability to cope with personal emotions and to plan<br />
family life often lead to complete disruption of family relations<br />
or professional career, and to social isolation. Providing<br />
adequate knowledge and timely counseling for the
Abstracts 365<br />
family members and for the child, teaching them to take<br />
active part in dealing with epilepsy-related problems can<br />
prevent stigmatization and improve social adjustment.<br />
Education of healthcare professionals as well as of the<br />
public also plays a major role.<br />
SY-09-5<br />
Living with epilepsy – a patient with epilepsy from India<br />
R. Sehgal<br />
India<br />
Abstract not submitted<br />
SY-10<br />
Tourette Syndrome<br />
SY-10-1<br />
Phenomenology and natural history of tic disorders<br />
J.F. Leckman<br />
Child Study Center, South Frontage Road, Yale <strong>University</strong><br />
School of Medicine, New Haven, CT, USA<br />
Tics are isolated, disinhibited fragments of normal motor<br />
or vocal behaviors. Like habits, tics often arise from a<br />
heightened and selective sensitivity to cues from within<br />
the body or from the outside world. Many patients report<br />
being besieged by premonitory somatosensory urges (bodily<br />
cues) that are often localized to discrete anatomical areas.<br />
These urges and the internal struggle to control them can be<br />
as debilitating as the tics themselves. Motor tics usually<br />
begin between the ages of 3 and 8 years. Typically vocal<br />
tics follow the onset of motor tics by several yrs. In uncomplicated<br />
cases, motor and vocal tic severity peaks early in<br />
the second decade with many patients showing a marked<br />
reduction in tic severity by the age of 20 years. However, the<br />
most severe cases occur in adulthood. Motor and phonic tics<br />
occur in bouts over the course of a day and wax and wane in<br />
severity over the course of weeks to months. Less well<br />
known is the ‘self-similarity’ of these temporal patterns<br />
across different time scales. Knowledge of the temporal<br />
patterning of tics is fundamental for the practitioner as it<br />
informs decisions about when to initiate or change anti-tic<br />
medications, and when to be patient and simply provide<br />
close monitoring and support to the family. A deeper understanding<br />
of the multiplicative processes that govern these<br />
temporal patterns may clarify both microscopic neural<br />
events occurring in millisecond time scales as well as<br />
macroscopic features of the natural history of tic disorders<br />
that occur over decades. In addition to tics, many patients<br />
suffer with symptoms of attention deficit hyperactivity<br />
disorder and/or obsessive-compulsive disorder. When<br />
present, these coexisting conditions can add greatly to the<br />
morbidity associated with tic disorders and detract from the<br />
patient’s overall quality of life.<br />
SY-10-2<br />
Neurobiology of Tourette syndrome<br />
H.S. Singer<br />
Department of Pediatrics Division, The Johns Hopkins<br />
<strong>University</strong>, USA<br />
Neuroanatomy: Significant data, derived from volumetric<br />
MRI, area measurements of the corpus callosum, imaging of<br />
glucose metabolism and blood flow, coulometer paradigms,<br />
transcranial magnetic stimulation, and functional MRI,<br />
supports the proposal that Tourette syndrome (TS) is associated<br />
with changes in frontal-subcortical circuits. Volumetric<br />
MRI studies in subjects with TS have shown:<br />
significant differences in the symmetry of the putamen<br />
and lenticular region in boys and a reduction in the size of<br />
these structures in adults; larger volumes of a region that<br />
approximated dorsal prefrontal and smaller volumes of<br />
regions that approximated premotor and orbitofrontal cortex<br />
in boys; and a larger percentage of white matter in the right<br />
frontal lobe. fMRI studies of tic activity and suppression<br />
have implicated various cortical regions, basal ganglia,<br />
and thalamus. Neurochemistry: The distribution of classical<br />
neurotransmitters (e.g. dopamine, serotonin, GABA, glutamate,<br />
acetylcholine, norepinephrine, and opioids) within the<br />
basal ganglia and frontal-subcortical circuits raises the<br />
possibility that a variety of transmitters could be involved<br />
in the pathobiology of TS. In general, current hypotheses are<br />
based on extrapolations from clinical trials evaluating the<br />
response to specific medications; from studies of cerebrospinal<br />
fluid (CSF), blood, and urine; from neurochemical<br />
assays on a limited number of postmortem brain tissues;<br />
and from SPECT and PET investigations. Microarray analysis<br />
in TS and control postmortem putamen has identified<br />
several significant differences in gene expression. PET<br />
studies have primarily focused on the dopamine and serotonin<br />
systems. A recent report has shown that TS patients, as<br />
compared to controls, have an increased release of dopamine<br />
in the putamen following a pharmacologic challenge<br />
with amphetamine. Neuroimmunology: Although TS is a<br />
genetic disorder, environmental factors, especially infections,<br />
have been hypothesized to evoke or exacerbate tics.<br />
The existence of pediatric autoimmune neuropsychiatric<br />
disorders associated with streptococcal infection<br />
(PANDAS), however, remains controversial. Confirmatory<br />
studies, which seek to identify an immune-mediated<br />
mechanism involving molecular mimicry, to date, have<br />
only been partially successful. A small number of patients<br />
with PANDAS have responded to immunomodulatory therapy<br />
with either intravenous immunoglobulin (IVIG) or plasmapheresis.<br />
Antineuronal antibodies measured against three<br />
distinct fractions (supernatant, pellet, and synaptosomes)<br />
from adult postmortem caudate, putamen, and globus pallidus,<br />
however, showed no difference between PANDAS<br />
patients and controls. Additionally, the validity of studies<br />
suggesting that the microinfusion of TS or PANDAS sera
366<br />
Abstracts<br />
into rodent striatum caused significant increases in oral<br />
stereotypic behaviors and episodic utterances have been<br />
questioned.<br />
SY-10-3<br />
Recent advances in genetics on Toulette syndrome<br />
J. Walkup<br />
Department of Pediatrics Division, The Johns Hopkins<br />
<strong>University</strong>, USA<br />
Abstract not submitted<br />
SY-10-4<br />
Tourette syndrome in Taiwan<br />
H.-S. Wang<br />
Division of Pediatric Neurology, Chang Gung Children’s<br />
Hospital, College of Medicine, Chang Gung <strong>University</strong>,<br />
Taoyuan, Chinese Taipei<br />
The prevalence of TS in a primary elementary school here<br />
is around 0.6%. It is no more a rare or degenerative disorder;<br />
it is a model of neuropsychiatric disorder in children.<br />
Although the pathogenesis of TS is still uncertain, the high<br />
incidence offamilial cases up to 30% suggests a possibility of<br />
genetic origin. Pharmacological, electrophysiological, and<br />
neuroimaging evidences all implicate the hyper-responsiveness<br />
of dopamine influencing the cortical-striatal-thalamocortical<br />
circuits of patients with TS. Facing patients with tics,<br />
first of all we must exclude the possibilities of Tourettism<br />
with secondary etiologies. Ninety percent of patients with<br />
primary tics occur transiently and spontaneously subside<br />
within 1 year. Those patients with tics persisting longer<br />
than a year will be chronic tic disorder or TS depending on<br />
how many types of motor and/or vocal tics they have ever<br />
had. Tics are mild in 73% of patients with TS. For them,<br />
understanding and acceptance from family, teachers, and<br />
friends are the most important things. When tics are so severe<br />
that medication is necessary, haloperidol is no longer the first<br />
or only choice. Clonidine or atypical neuroleptics such as<br />
risperidone or olanzapine should be used first for their<br />
minor side effects. Many other medicines such as topiramate<br />
are still in trial. Some children visiting our Tourette Clinics<br />
were found to have high serum copper concentrations that are<br />
under our further evaluation.<br />
SY-10-5<br />
Toulette syndrome in Asian countries<br />
Y. Nomura<br />
Segawa Neurological Clinic for Children, Chiyoda-ku,<br />
Tokyo, Japan<br />
Abstract not submitted<br />
SY-11<br />
Neurocutaneous Syndromes<br />
SY-11-1<br />
Advances in understanding neurological and<br />
behavioural phenotypes in tuberous sclerosis<br />
P. Curatolo<br />
Pediatric Neurology, Tor Vergata <strong>University</strong> of Rome,<br />
Rome, Italy<br />
Tuberous sclerosis (TSC) is a disorder of cells migration,<br />
proliferation, and differentiation. Cell lineage and cell<br />
migration disorders in the developing cortex of TSC children<br />
produce very different neurological phenotypes including<br />
epilepsy, cognitive impairment and autism. Cortical<br />
tubers constitute the hallmark of the disease. At the moment<br />
about 400 different mutations in both TSC genes are known.<br />
Patients with TSC1 mutation have on average milder<br />
disease in comparison with patients with TSC2 mutations.<br />
They have a lower frequency of seizures and moderatesevere<br />
mental retardation, fewer cortical tubers, less severe<br />
kidney involvement and facial angiofibromas, and no retinal<br />
hamartoma. Epilepsy is the most common neurological<br />
feature. Seizures often begin in the first months of life and<br />
are frequently intractable. Selected drug resistant patients<br />
could be considered for surgical treatment. The finding of<br />
the multiple areas of cerebral involvement should not automatically<br />
preclude epilepsy surgery in a child with intractable<br />
seizures and well-defined seizures origin. Autism<br />
appears to be more common in infants with frontal and<br />
parieto-temporal tubers and may be due to an early dysfunction<br />
in the associative areas. Autism could be also considered<br />
a secondary effect of seizures and/or mental<br />
retardation. An alternative and more intriguing explanation<br />
is that this abnormal behavior may reflect a more direct<br />
effect of the abnormal genetic program. A couple of genome<br />
scans in autism suggested that a potential susceptibility gene<br />
may be located on chromosome 16p13. The genetic analysis<br />
of the short arm of the chromosome 16 will help to localise<br />
such candidate gene and clarify its position with respect to<br />
the TSC2 locus.<br />
SY-11-2<br />
Recent progress about mutational analysis of TSC1 and<br />
TSC2 genes and functions of the hamartin protein<br />
E. Nanba<br />
Gene Research Center, Tottori <strong>University</strong>, Yonago, Japan<br />
TSC is a neurocutaneous syndrome characterized by<br />
development of unusual tumor-like growths. Involvement<br />
of the brain is associated with the most problematic clinical<br />
manifestations of TSC, including intellectual retardation,<br />
epilepsy and abnormal behaviors. Until now, over 300<br />
mutations of TSC1 and TSC2 were reported. We have
Abstracts 367<br />
surveyed the mutations of TSC1 and TSC2 from 76 Japanese<br />
patients. We analyzed the all the exons of both genes<br />
by single strand conformation polymorphism method<br />
(SSCP) followed by sequencing. Nine TSC1 mutations<br />
and 20 TSC2 mutations were found. The mutations were<br />
not clustered on a particular exons in either of the genes.<br />
All mutations were could not be found in the family<br />
members. The nonsense mutations in TSC1 and missense<br />
mutations in TSC2 were relatively popular and no splicing<br />
mutation was found. The patients with TSC2 mutations tend<br />
to exhibit relatively severe mental retardation in comparison<br />
to those with TSC1 mutations. Our mutation detection rate<br />
was only 40% and there are several possibilities including<br />
other undiscovered gene for Japanese TSC patients for the<br />
rate. To analysis of the function of hamartin that is TSC1<br />
gene product, we have tried to screen the proteins binding to<br />
TSC1 gene product by yeast two-hybrid method. We found<br />
several genes and have continued further study.<br />
SY-11-3<br />
Typical and atypical non-neoplastic brain abnormalities<br />
on MRI in children and adolescents with<br />
neurofibromatosis type 1<br />
O. Eeg-Olofsson, R. Raininko, L. Thelin<br />
<strong>University</strong> Hospital, Uppsala, Sweden<br />
The occurrence, localization and longitudinal course of<br />
non-neoplastic MRI abnormalities in children and adolescents<br />
with neurofibromatosis type 1 (NF1) were studied.<br />
Thirty-five patients who satisfied the criteria for NF1 underwent<br />
114 MRI examinations. They were 9 months to 18<br />
years old at the time of their first examination, and 23<br />
were examined more than once (2–11 times). The followup<br />
time varied from 3 months to 10 years (mean: 4 years).<br />
High signal intensity lesions on T2-weighted images were<br />
seen in the cerebellum, brain stem, and deep cerebral gray<br />
matter and, less frequently, in the cerebral white matter in<br />
89% of the subjects. Proton density-weighted and T1-<br />
weighted images showed changes in 80 and 50%, respectively.<br />
During follow-up, some new lesions developed,<br />
some disappeared and some changed in size and appearance<br />
without correlation to the patient’s age. In four patients, all<br />
boys, one or two of the lesions with a high T2 intensity were<br />
expansive. They were located in the upper medulla oblongata,<br />
in the medulla oblongata expanding into the spinal<br />
cord, in the left cerebellar hemisphere, and in the wall of<br />
the left lateral ventricle. The last-mentioned lesion showed<br />
contrast enhancement that disappeared in 2 years. All those<br />
lesions had atypical features, commonly regarded as signs<br />
of a neoplasm, but they receded without specific treatment.<br />
There were no related clinical symptoms in any patients.<br />
Obviously, the border between neoplastic and non-neoplastic<br />
lesions is indistinct. High signal lesions on T2-weighted<br />
MR images should be included as another criterion for the<br />
diagnosis of NF1.<br />
SY-11-4<br />
Vascular malformations and neurocutaneous diseases<br />
I. Pascual-Castroviejo<br />
Pediatric Neurology Service, <strong>University</strong> Hospital La Paz,<br />
Madrid, Spain<br />
Neurocutaneous diseases (an old concept is phakomatoses)<br />
are frequently associated with vascular intra or extracranial<br />
malformations. Vascular anomalies mostly occurs in<br />
classical phakomatoses such as SWS and also in other disorders<br />
described more recently. However, a great part of the<br />
neurocutaneous diseases can develop some type of vascular<br />
anomalies. Arteriography and especially magnetic resonance<br />
arteriography (MRA) show a great variety of vascular<br />
malformations. Neurifibromatosis type1 (NF1): it can be<br />
occasionally associated with internal carotid asymmetry or<br />
with moyamoya disease. SWS: The presence of leptomeningeal<br />
angiomatosis ipsolateral to the facial nevus flammeus<br />
distributed over a partial or total zone innervated by the first<br />
sensory branch of the trigeminal nerve is a necessary criterion<br />
in the diagnosis of SWS. Furthermore, angiomas in the<br />
ocular choroids and absence of various images in the cortical<br />
region of the affected hemisphere can be seen. Cutaneous<br />
hemangioma-vascular complex syndrome: This is<br />
the most frequent neurocutaneous disease, surpassing the<br />
NF1. This disease was described in 1978. It is associated<br />
with persistence of the trigeminal artery and absence of<br />
carotid and/or vertebral arteries, mostly of the same side<br />
of the cutaneous hemangioma, in a great part of the patients.<br />
Angiomatous or mega-arterial intracranial anomalies can be<br />
seen as well. Increase and decrease in parallel with the<br />
cutaneous and the intracranial arteries are usually seen.<br />
Conclusion: During the last years new neurocutaneous<br />
diseases appeared and new vascular findings were discovered;<br />
MRA is the most recommended study.<br />
SY-11-5<br />
Vascular malformations and neurocutaneous diseases<br />
I. Pascual-Castroviejo<br />
Pediatric Neurology Service, <strong>University</strong> Hospiutal La Paz,<br />
Madrid, Spain<br />
Neurocutaneous diseases (an old concept is phakomatoses)<br />
are frequently associated with vascular intra- or extracranial<br />
malformations. Vascular anomalies mostly occur in<br />
classical phakomatoses such as Sturge-Weber syndrome<br />
(SWS) and also in other disorders described more recently<br />
(1, 2). However, a great part of the neurocutaneos diseases<br />
can develop some types of vascular anomalies. Arteriography<br />
and especially magnetic resonance arteriography (MRA)<br />
show great variety of vascular malformations. NF1: It can be<br />
occasionally associated with internal carotid asymmetry or<br />
with moyamoya disease. SWS: The presence of leptomeningeal<br />
angiomatosis ipsilateral to the facial nevus flammeus
368<br />
Abstracts<br />
distributed over a partial or total zone innervated by the first<br />
sensory branch of the trigeminal nerve is a necessary criterion<br />
in the diagnosis of SWS. Furthermore, angioma in the<br />
ocular choroid and absence of venous images in the cortical<br />
region of the affected hemisphere can be seen. Cutaneos<br />
hemangioma-vascular complex syndrome: This is the most<br />
frequent neurocutaneous disease, surpassing the NF1. This<br />
disease was described in 1978 (1). It is associated with persistence<br />
of the trigeminal artery and absence of carotid and/or<br />
vertebral arteries, mostly of the same side of the cutaneous<br />
hemangioma, in a great part of the patients. Angiomatous or<br />
mega-arterial intracranial anomalies can be seen as well.<br />
Increase and decrease in parallel of the cutaneous and the<br />
intracranial arteries are usually seen. Conclusion: During<br />
the last years new neurocutaneos diseases appeared and<br />
new vascular findings were discovered. MRA is the most<br />
recommended study.<br />
SY-12<br />
Education of Child Neurologists<br />
SY-12-1<br />
Overview of peripheral neuropathy in childhood 2002<br />
R. Ouvrier<br />
The Children’s Hospital at Westmead, Australia<br />
This presentation describes the findings in a biopsy<br />
series of 260 cases of polyneuropathy in children up to<br />
16 years of age. Conditions in which we have had a particular<br />
interest will be emphasised and illustrated with<br />
videotapes. Approximately 83% of cases were genetic in<br />
origin, and about 17% were acquired. Of the acquired<br />
neuropathies, acute and chronic inflammatory polyneuropathies<br />
are the most frequent (8% of the series) and the<br />
most important, since effective treatment is available.<br />
Chronic polyneuropathies are of two main pathological<br />
types-axonal degenerative and de- (and re-) myelinating.<br />
The axonal forms constituted some 137 cases (53%). Their<br />
molecular basis is, in most cases, poorly understood.<br />
Hereditary motor and sensory neuropathy (HMSN) of<br />
neuronal type commencing in early childhood and the<br />
newly described severe infantile axonal neuropathy with<br />
respiratory failure (SIANR or SMARD) will be discussed<br />
in detail. There were 103 cases of demyelinating neuropathies,<br />
most of which were due to inherited mutations of<br />
specific myelin proteins. In this paediatric series, there<br />
were five documented point mutations of the methyl<br />
prednisolone (MPZ) and three of the PMP22 genes, all of<br />
which presented with features of the Dejerine-Sottas<br />
syndrome. X-linked Charcot-Marie-Tooth disease is<br />
usually caused by mutations of connexin 32. There were<br />
five cases in the series. Most cases of chronic demyelinating<br />
neuropathy presenting in childhood can be precisely<br />
diagnosed to enable accurate genetic counselling. Unfortunately,<br />
specific treatment is not yet available for such cases<br />
but the expansion of the understanding of these conditions<br />
gives real hope for an eventual cure.<br />
SY-12-2<br />
Education of child neurologists in China<br />
X.-R. Wu<br />
Department of Pediatrics, First Hospital, Peking <strong>University</strong>,<br />
Beijing, China<br />
In early 1960s, several child neurology groups were<br />
established spontaneously in Beijing, Shanghai, and<br />
Guonzhou cities, they were the pioneers and founders of<br />
child neurology in China. In 1985, Chinese Pediatric<br />
Neurology Society was formally established as one of the<br />
subsocieties of Chinese Pediatric Society. Since late 1970s,<br />
the OPEN policy greatly promoted the training and international<br />
professional exchange in child neurology of<br />
China. (1) The national pediatric resident postgraduate<br />
education program started in 1986 organized by Ministry<br />
of Health of China, it included total 5 years training,<br />
divided into first 3 years and later 2 years. During the 5<br />
years, there were national doctor’s license exam and final<br />
resident postgraduate education training qualified exam.<br />
For child neurologists, in addition to pass the 5 years training,<br />
should be further trained in a domestic child neurology<br />
eligible center (1 year), or passed the master or Ph.D.<br />
training programs of child neurology, or in adult neurology<br />
(6 month–1 year), or in child neurology of foreign countries.<br />
The national specialist examination systems of China<br />
are still during working. (2) Child neurology training class:<br />
Since 1980–2001, total 95 classes in 25 cities of China<br />
were held, 4290 pediatricians have been trained. Four to<br />
8 weeks for each class. In addition to general child neurology<br />
class, also special topic classes such as seizure disorders,<br />
cerebral palsy, anticonvulsants pharmacology,<br />
neonatal screening, EEG, learning and behavior problems,<br />
etc. (3) International professional exchange in child neurology:<br />
Send pediatricians to be trained in child neurology<br />
training program in foreign countries as USA, Japan,<br />
Australia, etc., also in Hong Kong area. We invited child<br />
neurology experts or neuroscientists from foreign countries<br />
to visit and give lectures, to establish collaborated research<br />
projects, etc. We encourage young doctors to attend international<br />
child neurology meetings. (4) So far, more domestic<br />
child neurology textbooks or reference books have been<br />
published, also there are more international child neurology<br />
textbooks and journals can be seen in most big cities<br />
library in China. The young generation of Chinese child<br />
neurologists already have been grown up today in China.<br />
We express our heartfelt thanks to all of the friends in the<br />
world they have been so kindly supported us during the<br />
passed 20 years.
Abstracts 369<br />
SY-12-3<br />
Electroencephalographic photosensitivity among<br />
Zimbabwean youths<br />
J.B. Familusi, B. Adamolekun<br />
Departments of Pediatrics and Medicine <strong>University</strong> of<br />
Zimbabwe, Harare, Zimbabwe<br />
To clarify the factors associated with EEG photosensitivity,<br />
the records of patients who had EEG examinations in the<br />
city of Harare, Zimbabwe between 1968 and 1996 were<br />
studied. EEG photosensitivity was confirmed in 107 of a<br />
total of 9082 youths (age 0–25 years), giving an overall<br />
photosensitivity prevalence of 1.17% in the study population.<br />
Photosensitivity occurred more frequently in females<br />
than in males, and the peak age period for its occurrence was<br />
during adolescence. A significantly higher prevalence of<br />
photosensitivity was recorded among whites and Asians<br />
than among black, while the coloured population had an<br />
intermediate prevalence. The monthly and seasonal incidence<br />
of photosensitivity in the present study showed no<br />
correlation with the prevailing mean monthly or seasonal<br />
temperatures, sunshine duration and sunlight intensity in<br />
Harare during the period covered by the study. These findings<br />
indicate that sunshine-related factors do not play a<br />
dominant role in the occurrence of photosensitivity, thereby<br />
negating previous opinions which attributed the relative<br />
rarity of photosensitivity in black Africans to high levels<br />
of exposure to sunshine in tropical Africa. Our findings<br />
therefore corroborate the view that photosensitivity depends<br />
primarily on genetic rather than environmental factors.<br />
SY-12-4<br />
Education approach to metabolic abnormalities in<br />
childhood<br />
K. Swaiman<br />
Pediatric Neurology, St. Paul, MN, USA<br />
The education of trainees directed at metabolic disease<br />
must convey a sense of systematic evaluation. This evaluation<br />
begins with the likelihood of a metabolic disease based<br />
on history and examination. In all cases, the patterns of<br />
genetic transmission must be understood. Among the<br />
amino acidopathies, the prototypic disease is phenylketonuria.<br />
As has been the case for many amino acidopathies,<br />
a number of forms of phenylketouria have been associated<br />
with various intricacles of the involved metabolic pathways.<br />
Other common amino acidopathies are maple syrup urine<br />
disease which is the result usually of abnormalities in<br />
branched-chain ketoacid decarboxylase, homocystinuria<br />
(of which there are several types), and a number of other<br />
less common conditions. Many of these conditions, involving<br />
essential amino acids, are treated with special dietary<br />
preparations. In some cases, patients will respond to cofactor<br />
administration because the abnormal protein enzyme<br />
requires greater than normal concentrations of the cofactor.<br />
Hyperammonemia is extremely toxic to nervous tissue.<br />
Although hyperammonemia may be a secondary finding in<br />
a number of conditions, significant metabolic central<br />
nervous system disruption may result. When the enzyme<br />
deficiency in Krebs-Hensleit urea cycle pathway is proximal<br />
in the urea cycle pathway, as a rule, the more severe the<br />
clinical condition. Lysosomal disease such as the sphingolipidoses,<br />
mucopolysaccharidoses, mucolipidoses, glycogen<br />
storage disease, glycoproteinoses and some other storage<br />
disease are the result of abnormal accumulation of normal<br />
substrates and their catabolic products within lysosome.<br />
Research has resulted in a much better understanding of<br />
mechanisms common to these diseases, as well as mechanisms<br />
specific to each disease. The peroxisomal disorders, a<br />
group of disease entities that share structural and/or functional<br />
abnormalities of the peroxisomes, are inherited and<br />
may have profound neurologic and systemic effects. Some<br />
of the disorders lack peroxisomes in cells, while others have<br />
single or multiple peroxisomal enzymatic deficiencies in<br />
spite of the presence of normal peroxisomes. Abnormalities<br />
of energy metabolism are frequently accompanied by lactic<br />
acidosis. Hypoglycemia and hyperammonemia may be<br />
evident. Abnormalities may be present in pyruvate metabolism<br />
which are usually due to abnormalities in pyruvate<br />
carboxlase deficiency or variations thereof, pyruvate dehydrogenase<br />
complex deficiency, citric acid cycle abnormalities,<br />
and respiratory chain abnormalities. Brain and muscle<br />
are chiefly involved. For most cell type, when the oxygen<br />
supply is adequate, energy requirements are met in mitochondria<br />
by oxidation of pyruvate, fatty acids, or ketone<br />
bodies. These substances are converted into acetyl-CoA<br />
and enter the citric acid cycle and the respiratory chain.<br />
Impairment of oxidative metabolism may occur due to<br />
disorders of substrate transport, of substrate utilization, of<br />
citric acid cycle function, or of the respiratory chain.<br />
SY-12-5<br />
Intractable pediatric epilepsy syndromes in early<br />
infancy<br />
S. Ohtahara<br />
Department of Child Neurology, Okayama <strong>University</strong> Medical<br />
School, Okayama, Japan<br />
The new classification of epilepsy adopted the epiltptic<br />
encephalopathy, among which Ohtahara syndrome, early<br />
myoclonic encephalopathy, peculiar early-onset type of<br />
symptomatic partial epilepsy, and severe myclonic epilepsy<br />
in infancy (Dravet syndrome) have their onset in early<br />
infancy. The concept of the epileptic encephalopathy and<br />
these epileptic syndromes will be mentioned with their<br />
etiology, clinicoelectrical characteristics, diagnostic<br />
criteria, differential diagnosis, treatment, prognosis and<br />
mutual relationship. Ohtahara syndrome is delineated, particularly<br />
from the developmental viewpoint.
370<br />
SY-13<br />
Pervasive Developmental Disorders<br />
SY-13-1<br />
Earliest signs of autism in infants<br />
Abstracts<br />
in sarcastic sentences. The number of landmine was also<br />
significantly high in HFPDD. Conclusion: ADHD children<br />
were balanced in this test, however HFPDD children<br />
showed specific difficulty in sarcastic sentences. This<br />
might cause their social troubles.<br />
P. Filipek<br />
<strong>University</strong> of California Irvine, Irvine, CA, USA<br />
Infant siblings of autistic children are routinely followed<br />
by the author to document the earliest signs suspicious for<br />
autism or other developmental disorders. Longitudinal<br />
videotapes will be shown for several case studies, to demonstrate<br />
the wide variability of the early warning signs, and the<br />
effects of early intervention on these babies.<br />
SY-13-2<br />
Genetics<br />
J.T. McCracken<br />
Division of Child and Adolescent Psychiatry, UCLA Neurophychiatric<br />
Institute, Los Angeles, USA<br />
Abstract not submitted<br />
SY-13-3<br />
Pragmatic difficulties of figurative and sarcastic<br />
sentences in pervasive developmental disorders<br />
T. Koeda<br />
Department of Humanity Education, Faculty of Education<br />
and Regional Sciences, Tottori <strong>University</strong>, Tottori, Japan<br />
It is well known that the children with high function<br />
pervasive developmental disorders (HFPDD) fail the theory<br />
of mind tasks. These children often have the episode of<br />
social troubles. The causes of the troubles are not only the<br />
mind blindness but also the language impairments, i.e.<br />
comprehensive difficulties of figurative and/or sarcastic<br />
situations. We made a novel test using figurative and sarcastic<br />
sentences for HFPDD to know their pragmatic skills. The<br />
test is constructed from five of figurative and five of sarcastic<br />
sentences. The normative distribution of this test was<br />
studied. Normative distribution: Two hundred normative<br />
children, second grade to sixth of primary school (age 7–<br />
12 year-old), 96 boys, were carried out the test. The results<br />
are following; the number of correct answers in figurative<br />
sentences is increasing as grade. In sarcastic sentences, there<br />
is no significant difference except for between the second<br />
and sixth grade. Most serious incorrect answer, we called<br />
‘landmine’, is not so much in normative children. HFPDD<br />
and attention deficit and hyperactivity disorder (ADHD) 15<br />
of HFPDD and nine of ADHD children were nominated ion<br />
this study. There is no significant difference between<br />
HFPDD and ADHD in figurative sentences, however<br />
HFPDD children answered more incorrectly than ADHD<br />
SY-13-4<br />
The neurrophysiological aspect of pervasive<br />
developmental disorders<br />
M. Miyao<br />
Department of Developmental Neuropsychology, National<br />
children’s medical center National center for child health<br />
and development, Japan<br />
Childhood autism is now widely viewed as being of<br />
developmental neurobiological origin that is defined behaviorally<br />
by severe deficiencies in reciprocal social interaction,<br />
verbal and nonverbal communication, and restricted<br />
interests. Yet, localized structural and functional brain<br />
correlates of autism have to be established. Structural<br />
brain-imaging studies performed in autistic patients have<br />
reported abnormalities such as increased total brain volume<br />
and cerebellar abnormalities. However, none of these<br />
abnormalities fully account for the full range of autistic<br />
symptoms. A large number of investigation techniques are<br />
used to relationships between the clinical and neurophysiological<br />
data were necessary to analysis in the field of pervasive<br />
developmental disorder. The prevalence of epilepsy in<br />
the general population is 0.5%; the published figures on<br />
epilepsy in autism range 4–7%. One of the most difficult<br />
things to understand in the field of autism is the many papers<br />
describing brainstem auditory evoked potentials, cortical<br />
evoked potentials and event related potentials. Midlatency<br />
auditory evoked responses (P1), measuring the ascending<br />
reticular activation system and their thalamic target cells,<br />
have been reported as abnormal in children with autism.<br />
Event related potential P3 waves are smaller in children<br />
with autism compared to controls. Resting EEGs from the<br />
bilateral frontal, central, and occipital regions were examined<br />
though power spectrum. The frequency of the dominant<br />
peak in the occipital EEGs reached maximum at 12–20<br />
years. And development of sleep spindles was analyzed.<br />
Two spindle types, 11–13 Hz frontal lobe spindles and<br />
12–14 Hz centro-parietal lobe spindles were recorded. The<br />
frontal lobe spindles were frequently recorded at 8 years, the<br />
centro-parietal spindles were frequently recorded at 18<br />
years. Topographical maps of the EEG coherence demonstrated<br />
that a synchronous component at the anterior-occipital<br />
areas and right and left were higher in subjects with<br />
autism compared to controls. We think that neurophysiological<br />
research into childhood autism has a particular interest<br />
in the broader field of developmental neuropsychology<br />
because it could give some explanation of casual mechanisms<br />
that underlie autistic syndrome and other developmental<br />
syndromes.
Abstracts 371<br />
SY-14<br />
Neurosurgery<br />
SY-14-1<br />
Technological advances in pediatric neurosurgery<br />
S. Constantini<br />
Department of Pediatric Neurosurgery, Dana Children’s<br />
Hospital, Israel<br />
Several technological advances that occurred in the last<br />
10 years completely altered the setup in the pediatric<br />
neurosurgical operating room. These innovations have<br />
significantly changed our approach towards children with<br />
complex brain and spinal cord problems. Technological<br />
advances are not all positive and common sense has to<br />
be preserved. Economical issues, an enormous logistic<br />
burden, and the potential for errors are all reasons to<br />
review our new reality with respect to prioritization, decision-making,<br />
and optimal usage. The lecture will try and<br />
provide an overview on our modern operating room and<br />
cover areas such as neuro-navigation-intraoperative MRIneuroendoscopy,<br />
and real-time, intraoperative evoked<br />
potential monitoring. The new ‘gadgets’ and their ability<br />
will be presented together with day-to-day dilemmas that<br />
come along.<br />
SY-14-2<br />
Surgical concepts of fetal hydrocephalus and<br />
dysraphism with its specific plasticity<br />
S. Oi<br />
Department of Neurosurgery, The Jikei <strong>University</strong>, School<br />
of Medicine, Tokyo, Japan<br />
The specific plasticity of the immature brain and spinal<br />
cord is one of the most significant factors affecting the<br />
therapeutic outcomes in hydrocephalus and some forms<br />
of dysraphic state. In fetal hydrocephalus, the time of<br />
onset of the hydrocephalic state is various initially involving<br />
different stage of the neuronal maturation process. In<br />
order to analyze and anticipate the postnatal outcome, we<br />
proposed a new classification of congenital hydrocephalus,<br />
namely, the perspective classification of congenital hydrocephalus<br />
(PCCH) Stage I–V (J. Neurosurg. 88:685–694,<br />
1998). Our data clearly indicated that the time of the<br />
onset of hydrocephalic state is the key in different stages<br />
of the neuronal maturation process in the affected brain of<br />
the fetus. It may be indicated to perform the intrauterine<br />
decompressive procedure as the fetal surgery. Although we<br />
have performed the experimental fetal surgery on the<br />
animal models, the best operative technique is still debatable.<br />
On the other hand, regarding the fetal surgery for<br />
fetal dysraphism, especially to fetal spina bifida, there have<br />
been over 200 fetuses with myeloschisis operated during<br />
the fetal period in utero in the United States of America<br />
since April, 1997. The results suggested that the early<br />
repair of myeloschisis, such as in PCCH Stage II, may<br />
decrease the occurrence of Chiari malformation and hydrocephalus<br />
after birth. In order to clarify both embryological<br />
and surgicoanatomical concept of the dysraphic state, we<br />
have proposed a new classification, namely, embryo-pathogenetic<br />
surgico-anatomical classification of dysraphism<br />
(Nervous System in Children 27:213–222, 2002). In our<br />
prospective analysis of spina bifida in the last 10 years, it<br />
has been identified to be important to classify the morphological<br />
findings of the fetus MRI for the indication and goal<br />
of the treatment in fetal surgery in spina bifida/cranium<br />
bifidum. The current state of these surgical of the fetal<br />
CNS anomalies will be further discussed from the specific<br />
plasticity of the fetus brain in the process of neuronal<br />
maturation.<br />
SY-14-3<br />
Current status of craniofacial surgery<br />
A. Hockley<br />
Neurosurgeon, The Birmingham Children’s Hospital,<br />
Birmingham Great Britain<br />
Abstract not submitted<br />
SY-14-4<br />
Neurosurgical treatment of phacomatoses<br />
C. Di Rocco<br />
Institute of Neurosurgery, Catholic <strong>University</strong> medical<br />
School, Rome, Italy<br />
Phacomatoses constitute a heterogeneous group of<br />
conditions of a particular interest to the pediatric neurosurgeon.<br />
Children with neurofibromatosis 1 are at a higher risk<br />
of malignancy, mainly optic pathways tumors, than the<br />
general population. Though the criteria for diagnosis are<br />
generally met when the patients are 8 year old, optic pathways<br />
gliomas become often symptomatic by 3 years of age.<br />
The occurrence of these tumors, the evolution of which is<br />
particularly unpredictable, arises significant problems in<br />
terms of management. In aggressive lesions the combination<br />
of ‘conservative’ surgical treatment and chemotherapy<br />
seems at the moment to represent the best option. Patients<br />
with tuberous sclerosis need surgical operation generally<br />
before puberty in cases in whom a progressive subependymal<br />
giant cell astrocytoma in the region of the foramen of<br />
Monro exerts a mass effect on the adjacent neural structures<br />
and/or causes an obstructive hydrocephalus. The<br />
direct surgical excision of the tumor may be curative and<br />
also assures the best change to avoid the insertion of a CSF<br />
shunt device. More rarely, the surgical operation is<br />
required in the very young subject to remove a cortical<br />
tuber responsible for an epilepsy refractory to the medical<br />
treatment in order to reduce the number and the severity of
372<br />
Abstracts<br />
seizures and favoring psychomotor development. Drugresistant<br />
seizures are indeed the main reason for operative<br />
treatment in infants and children with Sturge-Weber<br />
disease and linear nevus syndrome with hemimegalencephaly.<br />
In nearly all the case, the operation is required in the<br />
very young age. While only a subgroup of patients with<br />
Sturge-Weber disease actually needs of hemispheric ablative<br />
or deafferentative surgical procedures, the large majority<br />
of subjects with hemimegalencephaly and epilepsy<br />
benefit of an early operation. Several types of deafferentation<br />
of the malformed cerebral hemisphere are available.<br />
On the grounds of his experience, the author will discuss<br />
the pros and the cons of the various techniques.<br />
SY-14-5<br />
Syringomyelia in children<br />
T. Abe, A. Isoshima, S. Tani, S. Oi<br />
Department of Neurosurgery, Jikei <strong>University</strong> School of<br />
Medicine, Japan<br />
We performed a retrospective study of 23 patients with<br />
syringomyelia under the age of 15 in whom the results of<br />
MRI and clinical course had been used to indicate the characteristic<br />
feature of syringomyelia in children. On the basis<br />
of MRI and intraoperative findings, cases of syringomyelia<br />
were classified into three types according to the associated<br />
lesions: Chiari malformation types 1 and 2, and based<br />
arachnoiditis. Pediatric patients accounted for 12% of all<br />
cases of syringomyelia in our series. Syringomyelia with<br />
Chiari type 1 malformation was most common type of syringomyelia<br />
in children, accounting for 91% of cases, and<br />
highly associated with pituitary dwarfism that accounted<br />
for 22%. The most common initial symptom was scoliosis<br />
in children and dissociated sensory disturbance in adults.<br />
We found that foramen magnum decompression (FMD)<br />
was the most appropriate treatment for syringomyelia with<br />
Chiari type 1 malformation. During FMD, dural plasty using<br />
Goatex should be done to prevent the post operative<br />
arachnoid adhesion around the foramen magnum, but C2<br />
laminectomy should not be done to prevent the postoperative<br />
swan neck deformity in children. FMD with 4th ventricle-subarachnoid<br />
shunt was done for the patients with Chiari<br />
Type 1 malformation, basilar impression, small posterior<br />
fossa and flat posterior fossa base. Our surgical treatment,<br />
which had been selected on the basis of the results of MRI,<br />
successfully collapsed the syrinx without complications in<br />
most patients. However, four patients needed to have<br />
reoperation because of syrinx reexpansion. The causes of<br />
syrinx reexpansion were scar formation around the foramen<br />
magnum and new bone formation at the site of posterior<br />
fossa craniectomy.<br />
SY-14-6<br />
Microsurgical treatment for hypothalamic hamartoma<br />
in children with precocious puberty<br />
S.-Q. Luo, C.-D. Li, Z.-Y. Ma, Y.-Q. Zhang, G. Jia<br />
Department of Neurosurgery, Tiantan Hospital, Beijing,<br />
China<br />
Objective: To study the surgical treatment of hypothalamic<br />
hamartoma causing precocious puberty. Methods:<br />
Twelve children (six girls and six boys) with precocious<br />
puberty secondary to hypothalamic hamartoma were<br />
recruited for our study. The mean age of the patients was<br />
45 months old (ranged from 13 months to 9 years), and the<br />
mean age of the onset of puberty was 9 months. All patients<br />
were treated by microsurgery. Results: All patients had a<br />
high percentile of stature, body weight, bone growth and<br />
serum levels of sexual hormones. MR scan revealed an<br />
isointense mass below the tuber cinereum extending into<br />
supersellar and interpeduncular cistern, ranging from 3 to<br />
25 mm in diameter, consistent with pedunculate hamartoma.<br />
Ten hamartoma that was less than 16 mm in diameter were<br />
removed completely and the other two hamartoma that were<br />
large than 21 mm in diameter were gross partially removed<br />
via a right pterional approach. The symptoms and signs of<br />
precocious puberty resolved completely and sexual<br />
hormone levels decreased to the pre-pubertal range without<br />
any postoperative complications in all ten patients whose<br />
hamartoma were totally removed, the other two patients<br />
whose hamartoma were gross partially removed also<br />
improved the symptom. Conclusion: Microsurgery is a<br />
good choice of treatment for pedunculate hypothalamic<br />
hamartoma if the hamartoma was totally removed.<br />
SY-15<br />
Oriental Medicine<br />
SY-15-1<br />
Tongue acupuncture in brain disorders in children<br />
V. Wong a , J.G. Sun b<br />
a Department of Paediatrics, The <strong>University</strong> of Hong Kong;<br />
b The Jockey Club MRI Engineering Centre, The <strong>University</strong><br />
of Hong Kong, Hong Kong, China<br />
Introduction: Tongue acupuncture (TAC) is an innovative<br />
acupuncture technique invented by Dr Sun. We<br />
launched a collaborative project of integrating traditional<br />
Chinese medicine (TCM) into our NeuroHabilitation<br />
Program for children with cerebral palsy, developmental<br />
delay/mental retardation, autistic spectrum disorder<br />
(ASD), ataxia, cortical visual impairment (CVI), stroke,<br />
and various neurological functional disabilities such as<br />
drooling. Objective: To study the efficacy and tolerability<br />
of TAC in children with neurological disorders. Patients<br />
and methods: Inclusion criteria: Children with neurological
Abstracts 373<br />
disabilities undergoing conventional interdisciplinary<br />
Neuro-Habilitation program. More than 500 children were<br />
enrolled into the study during 1999 Feb–2002 May with<br />
parental consent. TAC was given to specific tongue<br />
acupoints daily (5 days per week) for 4–8 weeks<br />
(Total ¼ 20–40 sessions). The acupoints chosen were determined<br />
by the functional disability of the neurological disorder.<br />
Objective outcome measures were used to document<br />
efficacy (Pre-TAC and Post-TAC), depending on the<br />
problems addressed. Randomized placebo control trials,<br />
some double blind, were conducted for autistic spectrum<br />
disorder, cerebral palsy and stroke. Results: Functional<br />
improvement of various degrees occurred depending on<br />
the age and severity of the disabilities. Some improvement<br />
was noticeable within a few TAC sessions, especially for<br />
drooling, gait pattern (scissoring or tiptoeing) and hyperactivity.<br />
The intermediate effect was sustained with repeated<br />
courses. Occasional pain and minor bleeding occurred in<br />
some. Conclusion: (1) There is a need for integration of<br />
TCM and Western medicine in NeuroHabilitation program.<br />
There are limitations in both disciplines as the basic philosophy<br />
and theories are different. Both are complementary to<br />
each other (TCM with .2000 years of clinical human<br />
experience and Western medicine with 100 years of scientific<br />
research basis). (2) Currently we are investigating the<br />
underlying mechanism of TAC in neurological plasticity<br />
with functional neuroimaging modalities (fMRI, PET scan<br />
of the brain). We hope to document brain regeneration with<br />
TAC and create a Tongue Acu-Map for linking 14 meridians<br />
and ‘Zung-Fu’ or organ systems.<br />
SY-15-2<br />
Neurotransmitters and acupuncture<br />
E.-Y. Shen<br />
Department of Pediatrics, Mackay Memorial Hospital,<br />
Chinese Taipei<br />
Neurotransmitters are released from their storage vesicles<br />
by exocytosis. Previous study showed the release of endorphin<br />
from periaqueductal grey matters after electric stimulation<br />
on some specific acupoint. It is obvious that the<br />
endogenous analgesic system may play an important role<br />
in analgesia and pain treatment by acupuncture therapy.<br />
Chinese scientist (Han et al.) reported that intraventricular<br />
or intrathecal injection in rats with scrotonin precursor<br />
resulted in an increase of analytic effect by acupuncture.<br />
Zhu et al. reported that excitatory neurotransmitter, glutamic<br />
acid and inhibitory neurotransmitters, GABA, also play<br />
important role on acupuncture analgesia. Clinically,<br />
acupuncture has been proved to be effective in treating<br />
many neurological disorders in Chinese as well as other<br />
parts of the world. From the TCM point of view, the circulation<br />
of Qi in the meridian is important in diagnosis and<br />
treatment of diseases. However, it will be worthwhile for the<br />
neurologist to understand the release of neurotransmitters in<br />
the brain during acupuncture stimulation.<br />
SY-15-3<br />
Studies of mechanism of ‘Kangxian’ capsule on<br />
convulsion in experimental epilepsy rats induced with<br />
metrazol<br />
P.-P. Zuo a , F.-L. Yao b , X.-K. Li a ,R.Ma b<br />
a Institute of Basic Medical Science, Chinese Academy of<br />
Medical Science, Beijing, China; b Attached Hospital, Tianjin<br />
<strong>University</strong> of Traditional Chinese Medicine, Tianjin,<br />
China<br />
‘Kangxian’ capsule is composed of 14 traditional Chinese<br />
medicine, such as Acorus gramineus soland, Ginseng, and<br />
Gastrodia alata Blume, etc. ‘Kangxian’ capsule had been<br />
used to treat difficult and complicated cases for many<br />
years in clinic and they have been restored to health. To<br />
elucidate its action mechanism, in this study we adopted<br />
the epilepsy rats induced with metrazol. The behavioral<br />
experiments showed that it effectively improved the<br />
epilepsy symptoms, increased the convulsion threshold<br />
and extended the latent period in epilepsy rats. ‘Kangxian’<br />
capsule could inhibit the decrease of GABA and regulate the<br />
balance between Glu and GABA. We particularly observed<br />
the critical enzyme, glutamate decarboxylase (GAD), which<br />
transferred excited transmitter Glu to inhibited transmitter<br />
GABA and played an important role. ‘Kangxian’ capsule<br />
might affect the brain function through regulating this metabolizing<br />
process. Compared to control group, it also significantly<br />
down regulated the expression of c-fos in cerebral<br />
cortex and hippocampus (P , 0:01). ‘Kangxian’ capsule<br />
also improved the cognitive function, which was related<br />
with NMDA receptor and Ach system in epilepsy rats.<br />
These results suggested that ‘Kangxian’ capsule was<br />
multi-targeting, and its action was through different<br />
mechanisms that need further research.<br />
SY-15-4<br />
Antiepileptic action and its immunological mechanisms<br />
of traditional Chinese medicine<br />
L. Wang, H. Zhang<br />
Pediatric Neurology, Peking <strong>University</strong> First Hospital,<br />
Beijing, China<br />
Objective: Traditional Chinese medicine is a great<br />
thesaurus against human disease upon the theory ‘fu zheng<br />
gu ben’. To investigate the effects of antiepileptic action,<br />
learning-memory and its immunological mechanisms of<br />
CaoGuo ZhiMu Tang (CGZMT), we have done a comprehensive<br />
study from gross, cellular to molecular levels, both<br />
in clinic and animal experiments. Methods: (1) Clinic effects<br />
of CGZMT were observed in 22 children with epilepsy by
374<br />
Abstracts<br />
open label. (2) Three animal seizure models (maximal electric<br />
shock-MES, pentylentetrazol seizure threshold-PST,<br />
audiogenic seizure-AGS) were randomly divided into six<br />
groups (n ¼ 10), i.p. NS10 ml/kg, CGZMT 10 g/kg,<br />
CGZMT 20 g/kg, phenobarbital 50 mg/kg, clonazepam<br />
(CZP) 0.1 mg/kg, CZP 1 mg/kg, respectively. Antiepileptic<br />
effects were measured at CGZMT peak time and 7–14 days<br />
afterwards. Three progresses (acquisition, consolidation and<br />
retrieval) of learning-memory were measured by step down<br />
test. The immunological functions effects of CGZMT were<br />
studied by using the colorimetry, spectrophotometry (QHS),<br />
quantitative hemolysis 3 H-TdR incorporation, and optical<br />
microscope. Results: (1) Seizures-controlled rate was<br />
64.6% in children with epilepsy. There were no relationships<br />
with patient’s age, gender, duration of disease,<br />
mono/polytherapy. (2) Seizures-free rate of CGZMT was<br />
75% in MES, 80% in AGS and 100% (CGZMT 5 g/kg<br />
was added CZP 0.1 mg/kg). CGZMT could prolong the<br />
latency of PST. There was no statistical significance<br />
compared with phenobarbital (PB). CGZMT had no adverse<br />
effects and could accelerate learning speed and learningmemory<br />
score. CGZMT could enhance the activity of<br />
macrophage (MV), biological activity of interleukin-2<br />
(IL-2), proliferation of T lymphocyte stimulated by concanavalin-A<br />
(ConA), RBC-C 3 bRR and RBC-ICR, lower<br />
proliferation of B lymphocyte stimulated by lipopolysaccharide<br />
(LPS), level of antibody forming cell and hemolysin<br />
antibody. Conclusion: CGZMT had antiepileptic efficacy<br />
with accelerating cognitive function by increasing the activity<br />
of MV, cell immune function and RBC adhesion function.<br />
The improving of body immune state, i.e. ‘fu zheng gu<br />
ben’.<br />
SY-16-1<br />
HIV-1/AIDS in children<br />
SY-16<br />
Infectious Diseases<br />
A.L. Belman<br />
School of Medicine, State <strong>University</strong> of New York, Stony<br />
Brook, NY, USA<br />
Since the initial descriptions of AIDS in children two<br />
decades ago, much has been learned about the biology of<br />
human immunodeficiency virus 1 (HIV-1) and the cells it<br />
infects. Much has also been learned about maternal-infant<br />
viral transmission and the natural history of HIV-1 infection.<br />
Key studies led to strategies to interrupt maternal-infant<br />
transmission resulting in a significant decline in neonatal<br />
HIV-1 infection. More proficient diagnostic techniques<br />
made possible early diagnosis of HIV-1 infected neonates<br />
and infants during asymptomatic or mildly symptomatic<br />
disease stages. Major treatment advances led to better control<br />
of viral replication and thereby altered the course of disease<br />
progression. HIV-1/AIDS associated neurological disorders<br />
declined in parallel. A dramatic decline in the numbers of<br />
infants born HIV-1 infected has been observed in countries<br />
where currently recommended therapies are readily available.<br />
Children with HIV-1/AIDS are living longer, many<br />
already surviving into adolescence and young adulthood.<br />
Unfortunately, worldwide, this is not the case; and it is worldwide<br />
where the epidemic predominates and where the<br />
complexity of medical care required and expensive drug<br />
therapies are limited. Many issues remain. Just how HIV-1<br />
affects the developing central nervous system (CNS) is still<br />
not clearly understood and is the focus of continuing<br />
research. The long-term effects of prenatal exposure to antiretroviral<br />
agents are not yet known and continue to be<br />
studied. Just exactly how HAART therapy may affect early<br />
signs of pediatric HIV-1/AIDS associated CNS disease,<br />
should it develop, is unclear. As new antiretroviral agents<br />
are developed, and new combination drug regimens instituted,<br />
the potential for neurological complications, toxicities,<br />
and adverse drug interactions (for example with AEDS)<br />
exists and will need to be identified and monitored.<br />
SY-16-2<br />
Viral encephalitis<br />
Hj.M.I. Hussain<br />
Penang, Malaysia<br />
Traditionally discussions on viral encephalitis have<br />
focused on Herpes viruses and Japanese Encephalitis.<br />
However in recent years new viruses have been recognized<br />
to cause outbreaks of viral encephalitis with a high case<br />
fatality rate. Dengue hemorrhagic fever is often associated<br />
with neurological manifestations especially headache,<br />
altered sensorium and convulsions. These were thought<br />
initially to arise from an encephalopathy secondary to circulatory<br />
changes, cerebral hemorrhage or hepatic derangement.<br />
Now the virus has been isolated from the cerebral<br />
spinal fluid of patients with encephalopathy proving dengue<br />
to be a neurotropic virus. In recent years outbreaks of Enterovirus<br />
71 in Bulgaria, Malaysia and Taiwan have resulted in<br />
many deaths among young children. Most of the children<br />
died from fulminant pulmonary edema secondary to brainstem<br />
encephalitis, similar to deaths from poliovirus in the<br />
late fifties. Other affected children developed acute flaccid<br />
paralysis. This raises concerns that Enterovirus 71 may<br />
replace polio as a cause of acquired paralysis in children.<br />
Most recently, a newly identified virus, the Nipah virus<br />
caused an outbreak of encephalitis involving 265 adults in<br />
Malaysia. There were 105 deaths with 12 relapses among<br />
the survivors. As in Japanese encephalitis, swine are thought<br />
to act as amplifying host for the Nipah virus. Spread to<br />
humans is via direct contact with secretions and blood<br />
products. Climatic and environmental changes are believed<br />
to have precipitated the outbreak of Nipah encephalitis.<br />
Continued global warming and deforestation may result in<br />
similar outbreaks in future.
Abstracts 375<br />
SY-16-3<br />
Tuberculosis of the central nervous system in children<br />
P. Visudhiphan, A. Visudtibhan, S. Chiemchanya<br />
Department of Pediatrics, Ramathibodi Hospital, Bangkok,<br />
Thailand<br />
Tuberculosis in developing countries remains a significant<br />
public health problems. The number of cases is increasing,<br />
partly due to wide spreading of HIV infection in these<br />
regions. Tuberculous meningitis (TBM) is one of the most<br />
common extrapulmonary manifestations of tuberculosis in<br />
children. Despite effective antituberculosis drugs, morbidity<br />
and mortality rate remain high. Early death and poor clinical<br />
response are usually caused by failure to recognize the<br />
disease and begin appropriate therapy in the early stage.<br />
The duration and combination of drugs therapy of TBM in<br />
children is still a controversial issue. Early study showed<br />
that treatment with isoniazid (INH) and rifampin (RIF) for<br />
12-months was generally effective in children with drugsusceptable<br />
TBM. Due to increasing incidence of drug resistant<br />
tuberculosis, the American Academy of Pediatrics<br />
recommends a 12-month regimen of antituberculosis<br />
drugs in children with TBM. But some experts have<br />
shown that regimen between 6 and 9 months are equally<br />
effective. We conducted, non-randomized, prospective<br />
open clinical investigation in non-compromized host of all<br />
cases of TBM tuberculomas, and spinal tuberculosis who<br />
were admitted at the Department of Pediatrics, Ramathibodi<br />
Hospital from January 1991 to December 2000. The combination<br />
of antituberculosis drug treatment including daily<br />
INH, RIF, pyrazinamide (PZA) and the fourth drug was<br />
streptomycin (SM) or ethambutol (EMB) for 2 months<br />
then followed with daily INH and RIF for 7 months.<br />
There were 31 patients enrolled in this prospective study,<br />
which include cases of TBM 23, TBM with tuberculomas<br />
four, and spinal tuberculosis with spinal cord compression<br />
in four patients. Of 23 TBM and four tuberculomas patients,<br />
four, 11 and 12 patients were admitted in the first, second<br />
and third stages of the disease respectively. Twenty-four of<br />
these patients and four of spinal tuberculosis received the<br />
initial treatment with INH, RIF, PZA and SM and the other<br />
three patients received EMB instead of SM as the initial<br />
treatment. Four patients required ventriculoperitoneal<br />
shunting in the early stage to relieve their severe hydrocephalus.<br />
Two patients who had tuberculomas needed craniotomy<br />
for partial removal of the mass and confirmation of the<br />
diagnosis. All cases of spinal tuberculosis with spinal cord<br />
compression had surgical decompression of the spinal cord.<br />
The outcome of these patients revealed no death. There was<br />
no significant neurological deficit of the patients who were<br />
admitted in stages I and II and also in cases of spinal tuberculosis.<br />
But eight out of 12 patients who were admitted in<br />
the third stage had mild to severe neurological sequel. The<br />
mycobacterium were identified from the CSF in six patients,<br />
and all susceptible to antituberculosis drugs given. No<br />
recurrent of tuberculous infection observed at the last<br />
followed up examination from 1 to 9 years.<br />
SY-16-4<br />
Treatment and prophylaxis of falciparum malaria<br />
S. Looareesuwan<br />
Hospital for Tropical Diseases, Faculty of Tropical Medicine,<br />
<strong>Mahidol</strong> <strong>University</strong>, Bangkok, Thailand<br />
The treatment for uncomplicated malaria is aimed at<br />
producing a radical cure using the combination of: artesunate<br />
(4 mg/kg per day) plus mefloquine (8 mg/kg per day)<br />
for 3 days; a fixed dose of artemether and lumefantrine (20/<br />
120 mg tablet) named Coartem w (four tablets twice a day<br />
for 3 days for adults weighing more than 35 kg); quinine 10<br />
mg/kg 8-h plus tetracycline 250 mg 6-h for 7 days (or<br />
doxycycline 200 mg once a day for 7 days as an alternative<br />
to tetracycline) in patients aged 8 years and over; a combination<br />
of atovaquone and proguanil called Malarone w (in<br />
adult, four tablets given daily £ 3 days). In treating severe<br />
malaria, early diagnosis and early treatment with a potent<br />
antimalarial drug is recommended to save the patient’s life.<br />
The antimalarial drugs of choice are: intravenous quinine<br />
or a parenteral form of an artemisinin derivative (artesunate<br />
i.v./i.m. 2.4 mg/kg followed by 1.2 mg/kg injection at<br />
12 and 24 h and then daily for 5 days; artemether i.m. 3.2<br />
mg/kg injection followed by 1.6 mg/kg at 12 and 24 h and<br />
then daily for 5 days; arteether i.m. (Artemotil w ) with the<br />
same dose of artemether; artesunate suppository (5 mg/kg)<br />
given rectally 12 h for 3 days). Oral artemisinin derivatives<br />
(artesunate, artemether, dihydroartemisinin with the dose 4<br />
mg/kg per day should replace parenteral forms when<br />
patients can tolerate oral medication. Oral mefloquine (25<br />
mg/kg divided into two doses 8 h apart) should be given at<br />
the end of the artemisinin treatment course to reduce recrudescence.<br />
Early recognition of malaria’s complications and<br />
their adequate treatment also play an important role as<br />
these complications (hypoglycemia, pulmonary oedema,<br />
acute renal failure, metabolic acidosis, convulsions) often<br />
increase the mortality rate. Other symptomatic and supportive<br />
treatments include the careful monitoring of fluid input<br />
and urine output, the provision of good nursing care and<br />
the avoidance of harmful adjuvant treatment. In spite of<br />
these efforts, mortality from severe malaria is still high.<br />
There is no absolutely guaranteed chemoprophylaxis of<br />
malaria. Therefore, personal protection (sleeping beneath<br />
treated mosquito nets, avoidance of exposure to mosquito<br />
bites) is recommended. In low-transmission areas, the use<br />
of repellents and an awareness of any fever in the 6 weeks<br />
after exposure in areas endemic for malaria should be<br />
encouraged. Most visitors to low transmission areas probably<br />
require no chemoprophylaxis. However, in high transmission<br />
areas or in high-risk groups chemoprophylaxis<br />
(malarone w , doxycycline, primaquine with food) is recommended.
376<br />
Abstracts<br />
SY-16-5<br />
New concepts in the immunopathogenesis of central<br />
nervous system (CNS) infections<br />
P.K. Peterson, S. Hu, G. Gekker, W.S. Sheng, M.C.-J.<br />
Cheeran, J.R. Lokensgard<br />
Neuroimmunology Laboratory, Minneapolis Medical<br />
Research Foundation, and the <strong>University</strong> of Minnesota<br />
Medical School, Minneapolis, MN, USA<br />
Despite the emergence of new etiologies and the serious<br />
nature of encephalitis, little is known about the cellular and<br />
molecular mechanisms involved in defense and neuropathogenesis<br />
of infections within the brain. To address<br />
this void in knowledge, research in our laboratory has<br />
focused on interactions between neurotropic agents and<br />
homogeneous populations of microglia, the resident macrophages<br />
of the brain, astrocytes, the predominant brain cell<br />
type, and highly enriched neurons. We have studied a variety<br />
of intracellular pathogens including HIV-1, the etiologic<br />
agent of AIDS dementia, cytomegalovirus, an<br />
important cause of congenital brain disease and of encephalitis<br />
in immunocompromised patients, and herpes<br />
simplex virus (HSV)-1 which causes a devastating encephalitis<br />
in immunocompetent individuals. Striking differences<br />
have been found in the growth characteristics and in<br />
the induction of cytokines and chemokines by these viruses<br />
in microglia, astrocytes, and neurons. While several proinflammatory<br />
cytokines can inhibit viral replication in glial<br />
cells and neurons, the inability of brain cells to produce<br />
interferon represents a major defect in host defense of the<br />
brain. To solve this deficiency, it appears that chemokines<br />
are used to attract CD4 1 and CD8 1 lymphocytes into the<br />
infected brain. While this strategy may lead to resolution of<br />
infection, in HSV-1 encephalitis it appears that ingress of<br />
activated T-cells contributes to immune-mediated brain<br />
damage. These concepts of the brain as an ‘immunologically<br />
underprivileged site’ and of microglia and T-cells as<br />
‘double-edged swords’ may guide development of new<br />
therapeutic approaches to CNS infections.<br />
MORNING SEMINAR<br />
MS-1<br />
Nutrition and Developing Brain<br />
MS-01<br />
Nutrition and the developing brain: the role of<br />
polyunsaturated fatty acids<br />
B. Koletzko<br />
<strong>University</strong> of Munich, Germany<br />
Intrauterine and early postnatal growth is characterised<br />
by a very rapid deposition of lipids. The brain, retina and<br />
other membrane rich tissues rapidly incorporate long-chain<br />
polyunsaturated fatty acids (LCPUFA), especially docosahexaenoic<br />
acid (DHA, C22:6n-3). In utero, the foetus is<br />
supplied with preformed LCPUFA by placental transfer.<br />
After birth, breast fed infants receive appreciable amounts<br />
of preformed LCPUFA that meet intrauterine accretion<br />
rates in membrane rich tissues. Stable isotope studies<br />
show that human milk LCPUFA contents are not primarily<br />
regulated by maternal tissues and not maternal diet. In<br />
contrast, infant formulas based on vegetable oils did not<br />
contain LCPUFA. Term infants fed formulas without<br />
LCPUFA show a LCPUFA depletion in blood and tissues,<br />
including the brain. Several studies have evaluated the<br />
supplementation of infant formulas with different sources<br />
of LCPUFA, which may normalise LCPUFA status relative<br />
to reference groups fed human milk. Double blind<br />
randomised trials demonstrated that LCPUFA induce<br />
significant improvements of visual acuity and a variety<br />
of measures of cognitive development (Bayley, Fagan,<br />
Brunet-Lezine, and others). Our recent studies in children<br />
with phenylketonuria indicate that DHA modulates brain<br />
function also during school age. From the available data<br />
we conclude that LCPUFA are conditionally essential<br />
substrates in infants and children that modulate visual<br />
and cognitive function.<br />
MS-2<br />
Peripheral Neuropathy<br />
MS-02-1<br />
Progressive understanding on the pathogenesis of<br />
Guillain-Barré syndrome<br />
F.-C. Cai<br />
Department of Neurology, Children’s Hospital, Chongqing<br />
<strong>University</strong> of Medical Sciences, Chongqing, China<br />
Guillain-Barré syndrome (GBS) is an acute autoimmune<br />
polyneuropathy and currently is recognized as a heterogeneous<br />
disorder with several different subtypes including<br />
acute inflammatory demyelinating polyneuropathy<br />
(AIDP), acute motor axonal neuropathy (AMAN),acute<br />
motor-sensory axonal neuropathy (AMSAN), and Miller-<br />
Fisher syndrome, etc. Patients usually have antecedent<br />
events (an illness of respiratory or gastrointestinal tract in<br />
most), however recently there are strong evidences<br />
supporting that at least 30–40% of GBS patients are<br />
infected with Campylobacter jejuni prior to the onset of<br />
the disorder in 2 weeks. Infection by C. jejuni or other<br />
organisms may trigger an antibody response in patients<br />
with GBS but not in those uncomplicated cases. Most<br />
current studies of pathogenesis are centered on the hypothesis<br />
of molecular mimicry between LPS of C. jejuni and<br />
epitopes of host’s nerve gangliosides. Antibodies to ganglioside<br />
GM 1 are present in 14–50% of GBS patients, but<br />
more common in cases with axonal degeneration associated<br />
with any subtype. Antibodies to ganglioside GQ1b<br />
are very closely associated with Fisher syndrome. However
Abstracts 377<br />
attempts to match the subtypes of GBS to the fine specificity<br />
of antiganglioside antibodies have not yet full<br />
explained the pathogenesis. It has been indicated that<br />
special properties of the infecting organism could be act<br />
an important role, since some strains such as Penner 0.19<br />
and 0.41 are particularly associated with GBS but not with<br />
enteritis. It is also to be important for the immunogenetic<br />
background of the patient because the risk of developing<br />
GBS after infection with type 0.19 is estimated only to be 1<br />
in 158. Exotoxin of C. jejuni could enhance the immunogenic<br />
pathogenicity of antibodies to GM 1 such as destroying<br />
blood-nerve barrier, but no similarly immunogenic<br />
consequence to nerves as ganglioside GM 1 in rats. T<br />
cells are also involved in the pathogenesis of most or<br />
even all forms of GBS. Response of T cells to any myelin<br />
proteins such PO, P2, or PMP22 could induce experimental<br />
autoimmune neuritis but the specificity of activated T cells<br />
in pathogenesis of GBS still not quite clear. On the basis of<br />
increased immunological understanding of GBS over the<br />
past 15 years, both of plasmapheresis and IVIG infusion<br />
have been shown as effective therapies to the disease.<br />
MS-02-2<br />
Advances in childhood neuropathy 2002<br />
R. Ouvrier<br />
The Children’s Hospital at Westmead, Australia<br />
In a biopsy series of 260 cases of polyneuropathy in<br />
children up to 16 years of age, approximately 83% of<br />
cases were genetic in origin, and about 17% were acquired.<br />
Of the acquired neuropathies, acute and chronic inflammatory<br />
polyneuropathies were the most frequent (8% of the<br />
series) and the most important, since effective treatment is<br />
available. Chronic polyneuropathies are of two main pathological<br />
types – axonal degenerative and de- (and re-)<br />
myelinating. The axonal forms constituted some 137<br />
cases (53%). Their molecular basis is, in most cases, poorly<br />
understood. HMSN of neuronal type commencing in early<br />
childhood and the newly described severe infantile axonal<br />
neuropathy with respiratory failure (SMARD) will be<br />
discussed in detail. The latter condition has been shown<br />
to be due to a mutation of the IGHMBP2 gene and prenatal<br />
diagnosis is now possible. There were 103 cases of demyelinating<br />
neuropathies, most of which were due to inherited<br />
mutations of specific myelin proteins. In this paediatric<br />
series, there were five documented point mutations of the<br />
MPZ and three of the PMP22 genes, all of which presented<br />
with features of the Dejerine-Sottas syndrome (DSS).<br />
Other causes of DSS will be reviewed. Most cases of<br />
chronic demyelinating neuropathy presenting in childhood<br />
can be precisely diagnosed to enable accurate genetic<br />
counselling. Unfortunately, specific treatment is not yet<br />
available for such cases but the expansion of the understanding<br />
of these conditions gives real hope for an eventual<br />
cure.<br />
MS-3<br />
Case Presentations<br />
MS-03<br />
Cerebral vascular malformations: intravascular<br />
interventional therapy<br />
Xiang Cai<br />
Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />
Beijing, China<br />
Abstract not submitted<br />
MS-4<br />
Ethical Decisions in Neurology of Early Life<br />
MS-04-1<br />
The minimally conscious state in children<br />
S. Ashwal<br />
Department of Pediatrics, Loma Linda <strong>University</strong> School of<br />
Medicine, Loma Linda, CA, USA<br />
The minimally conscious state is a condition of severely<br />
altered consciousness in which minimal but definite behavioral<br />
evidence of self or environmental awareness is<br />
demonstrated. To make the diagnosis of the minimally<br />
conscious state, evidence of limited but clearly discernible<br />
self or environmental awareness must be demonstrated on a<br />
reproducible or sustained basis by one or more of the four<br />
types of behaviors: (1) simple command-following; (2)<br />
gestural or verbal ‘yes/no’ responses (regardless of accuracy);<br />
(3) intelligible verbalization; and (4) purposeful<br />
behavior including movements or affective behaviors that<br />
occur in contingent relation to relevant environmental<br />
stimuli and are not due to reflexive activity. Minimally<br />
Conscious State (MCS) differs from the vegetative state<br />
(VS) in several ways. Patients in a vegetative state have<br />
no awareness of self or the environment whereas MCS<br />
patients have definite although limited awareness of self<br />
or the environment. VS patients have no evidence of<br />
language comprehension or expression whereas MCS<br />
patients may show a limited but reproducible form of<br />
simple communication. MCS patients are also more likely<br />
to experience pain and suffering in contrast to VS patients.<br />
MCS must be distinguished from the VS because the<br />
evaluation, care, medical decision-making and prognosis<br />
differ in these two conditions. MCS can occur in children<br />
with acute brain injuries, progressive neurometabolic disorders<br />
or nervous system developmental malformations.<br />
Additional research concerning prognosis, long-term<br />
outcome and treatment effectiveness will be needed to<br />
help clarify many of the medical, ethical and legal issues<br />
surrounding the care of these patients.
378<br />
Abstracts<br />
MS-04-2<br />
Ethical decisions in neurology of early life<br />
P. Evrard<br />
Service de Neurologie Pediatrique et des Maladies Metaboliques,<br />
Faculte de Medicine Xavier-Bichat, Hospital<br />
Robert-Debre, Paris, France<br />
Abstract not submitted<br />
MS-05<br />
Medical Informatics<br />
MS-5<br />
Medical Informatics<br />
D. Stumpf<br />
Department of Neurology, Northwestern <strong>University</strong> Medical<br />
School, Evanston, Illinois, USA<br />
Abstract not submitted<br />
MS-6<br />
Environmental Medicine<br />
MS-06-1<br />
Preventing lead neurotoxicity in Shanghai, China<br />
X.-M. Shen<br />
Child Development and Rehabilitation Center, Shanghai<br />
Children’s Medical Center, Shanghai, China<br />
Abstract not submitted<br />
MS-06-2<br />
Neurotoxic effects of lead in children<br />
M. Markowitz<br />
Henry and Lucy Moses Division, Montefiore Medical<br />
Center The <strong>University</strong> Hospital for the Albert Einstein<br />
College of Medicine, Bronx, NY, USA<br />
The recognition that lead induces central and peripheral<br />
nervous system disease dates back more than 2000 years.<br />
Over the last two millennia these effects were recognized<br />
only at the clinical level; the neurologic aspects of the<br />
disease were characterized by symptoms of encephalopathy<br />
and peripheral neuropathy. In the latter half of the 20th<br />
century an appreciation of the subclinical effects grew as<br />
cross-sectional and then longitudinal studies of children<br />
with low level lead exposure demonstrated detrimental<br />
effects on cognition and behavior. Laboratory studies elucidated<br />
some of the biochemical mechanisms responsible for<br />
these lead effects. Most recent studies raise the question of<br />
whether there is any threshold below which lead is safe in<br />
humans.<br />
MS-07<br />
Headache<br />
MS-7<br />
Headache<br />
D. Rothner<br />
Department of Neurology, Cleveland Clinic S-71, Cleveland,<br />
OH, USA<br />
Abstract not submitted<br />
MD-08-1<br />
Short introduction<br />
MS-8<br />
Rett Syndrome<br />
Y. Nomura<br />
Segawa Neurological Clinic for Children, Chiyoda-ku,<br />
Tokyo, Japan<br />
Abstract not submitted<br />
MS-08-2<br />
The autonomic problem in Rett disorder<br />
A.M. Kerr<br />
Academic Centre, Department of Psychological Medicine,<br />
Gartnavel Royal Hospital, Glasgow Scotland, UK<br />
The British Isles Survey data comes from clinical examination<br />
and postal health questionnaires, providing a longitudinal<br />
account of the natural history of the condition. 1094<br />
individuals aged 2–66 years are under continuing review<br />
(1982–2002). Indices of health and severity first developed<br />
in 1996 are now matched to MECP2 test results (300 cases),<br />
contributing to national and international projects linking<br />
MECP2 mutation type and site to clinical presentation.<br />
Non-invasive out-patient monitoring of autonomic function,<br />
using the NeuroScope e (MediFit Diagnostics Ltd, London,<br />
UK) developed by Drs Peter Julu and Stig Hansen, has<br />
helped to explain the non-epileptic vacant spells which are<br />
common in Rett and which seem to contribute to sudden<br />
deaths accounting for at least 20% of all (74) UK deaths.<br />
Detailed analysis of clinical events, electroencephalogram,<br />
breathing rhythm, vagal tone and baroreflex sensitivity in 47<br />
cases has revealed inadequate brainstem regulation of<br />
central autonomic cardio-respiratory function. Episodes<br />
have been documented of brainstem shut down and of inappropriate<br />
brainstem activation. Without accurate autonomic<br />
monitoring these potentially life-threatening events may<br />
appear to the clinician as shallow, apneustic, deep or interrupted<br />
breathing associated with brief periods of altered<br />
consciousness and pallor or cyanosis, readily confused<br />
with epilepsy. That the autonomic abnormality can be
Abstracts 379<br />
measured non-invasively and objectively will permit the<br />
development and evaluation of effective intervention.<br />
MS-08-3<br />
MECP2 and beyond: phenotype-genotype correlations<br />
in Rett Syndrome and related disorders<br />
J. Christodoulou<br />
Western Sydney Genetics Program, Children’s Hospital at<br />
Westmead, Department of Paediatrics and Child Health,<br />
<strong>University</strong> of Sydney, Sydney, NSW, Australia<br />
Rett syndrome [RTT; OMIM 312750] is a severe neurodevelopmental<br />
disorder primarily affecting females. The<br />
diagnosis is based on the presence of a constellation of<br />
clinical features associated with a specific developmental<br />
profile. However, there is marked clinical variability, even<br />
amongst classical RTT patients. The recent recognition that<br />
methyl CpG-binding protein 2 (MECP2) gene mutations<br />
cause RTT, has permitted definitive diagnosis in many<br />
cases, including atypical variants. Large cohort studies<br />
suggest that clinical severity can in part be predicted by<br />
the type of mutation (missense versus truncation), the<br />
affected region of the methyl-CpG binding protein-2<br />
(MeCP2) protein (main binding domains versus non-critical<br />
critical domains), and whether there is skewing of X-inactivation.<br />
More recently it has been recognised that MECP2<br />
mutations may be associated with other clinical phenotypes,<br />
including an Angelman syndrome-like phenotype, nonspecific<br />
mental retardation, with or without spasticity, and<br />
with or without an X-linked inheritance pattern, or neonatal<br />
encephalopathy in males. Moreover, the marked clinical<br />
variability even in patients with identical mutations,<br />
suggests that other currently unknown genetic and epigenetic<br />
factors also modulate the clinical phenotype. The<br />
development of an international database, with pooling of<br />
data from multiple sources, will hopefully increase numbers<br />
sufficiently to permit a more thorough examination of these<br />
interactions. Finally the development of in vitro assays of<br />
MeCP2 function and mouse models for RTT will help clarify<br />
the effects of loss of protein function on embryonic<br />
development and later neurodevelopmental progress, and<br />
pave the way for a better understanding of the reasons for<br />
the phenotypic variability seen in humans.<br />
MS-08-4<br />
Concluding remarks<br />
S. Naidu<br />
The Kennedy Krieger Research Institute, Baltimore, MD,<br />
USA<br />
Abstract not submitted<br />
MS-9<br />
Neuro-Oncology<br />
MS-09-1<br />
Childhood brain tumors: biologic breakthroughs,<br />
therapeutic advances, and 0ngoing challenges<br />
R.J. Packer<br />
Children’s National Medical Center, Department of Neurology,<br />
Washington DC, USA<br />
Childhood brain tumors are the leading cause of morbidity<br />
and mortality in children with cancer. Progress is being made<br />
in some forms of childhood brain tumors, especially medulloblastomas<br />
(MB). Although surgery and radiation therapy<br />
remain the mainstays of treatment, chemotherapy is playing<br />
an increasing role in the management of most forms of malignant<br />
childhood brain tumors and some benign tumors. Molecular<br />
genetic studies have recently suggested that children<br />
with MB can be more discretely stratified into risk groups<br />
using molecular genetic findings. In some subgroups of children<br />
with MB, after treatment with aggressive surgery,<br />
immediate postoperative radiotherapy coupled with<br />
chemotherapy during and after radiation therapy, survival<br />
rates as high as 85–90%, 5 years after diagnosis, can be<br />
expected. In other subsets of patients, similar treatment will<br />
result in disease control in less than one-third of patients. For<br />
other malignant childhood brain tumors, such as brain stem<br />
gliomas and high-grade cortical gliomas, alterations in therapy<br />
have not resulted in improved survival. A relatively<br />
newly-recognized subtype of primitive tumor, the atypical<br />
teratoid tumor, has recently been characterized and carries<br />
an horrendous prognosis. Low-grade glial tumors comprise<br />
nearly 50% of all childhood brain tumors and surgery remains<br />
the primary option for the majority of patients with such<br />
tumors. However, for very young children who harbor tumors<br />
in eloquent areas of brain, chemotherapy has been shown to be<br />
effective in delaying, if not obviating, the need for extensive<br />
surgery or radiotherapy. With the therapeutic advances seen,<br />
thereisneedtopaygreaterattentiontothelong-termqualityof<br />
lifeofsurvivorsofchildhoodbraintumors.Thereisincreasing<br />
evidence that survivors have significant neurologic, neurocognitive<br />
and psychosocial sequelae. The approaches being<br />
utilized must attempt to reach a better balance between survival<br />
and quality of life of survivors.<br />
MS-09-2<br />
Pediatric neuooncology-brainstem and spinal cord<br />
tumors<br />
S. Constantini<br />
Division of Pediatric Neurosurgery, Dana Children’s<br />
Hospital, Tel-Aviv-Sourasky Medical Center, Tel-Aviv,<br />
Israel<br />
Abstract not submitted
380<br />
Abstracts<br />
MS-10<br />
Therapeutic Drug Monitoring<br />
MS-10-1<br />
Therapeutic drug monitoring (TDM) of anti-epileptic<br />
drugs in children<br />
P. Walson<br />
Professor of Pediatrics, <strong>University</strong> of Cincinnati Director,<br />
Division of Clinical Pharmacology and Clinical Trials<br />
Office Children’s Hospital Medical Center, USA<br />
Accurate measurement and proper interpretation of drug<br />
concentrations (TDM) can greatly improve medical diagnosis<br />
and management. However, TDM requires much more<br />
than just measurement of drug concentrations. TDM is a<br />
process by which measurement of drug concentrations is<br />
combined with knowledge of the drug’s pharmacokinetics<br />
and pharmacodynamics, as well as with patient specific<br />
analytical and clinical data. TDM is useful for all drugs in<br />
some specific clinical situations. TDM is especially useful<br />
for drugs with: (a) a well-defined relationship between<br />
concentration and effects (either therapeutic or toxic); (b)<br />
wide inter- or intra-individual differences in drug clearance;<br />
and (c) where this is no readily available method to clinically<br />
assess therapeutic or toxic effects. Antiepileptic drugs<br />
(AEDs) are examples of drugs for which properly done<br />
TDM has been shown to improve efficacy while decreasing<br />
toxicity. A number of published studies done over the past<br />
20 years in our laboratory with older AEDs will be briefly<br />
reviewed. Some important general and specific principles of<br />
pediatric TDM will be discussed including some practical<br />
and theoretical differences between children and adults.<br />
Some examples will be discussed to illustrate how proper<br />
pediatric TDM differs from ‘numbers only’ reporting of<br />
concentrations. These studies illustrate how much can be<br />
learned about pediatric AED use from a review of properly<br />
collected, analyzed and interpreted AED TDM database.<br />
These data also demonstrate the wide intra-individual differences<br />
in AED clearance and illustrate why TDM is required<br />
to effectively individualize AED dosing to treat pediatric<br />
seizure patients. Finally, data on the usefulness of TDM<br />
of newer AEDs will be discussed.<br />
MS-10-2<br />
Developmental and therapeutic pharmacology of<br />
antiepileptic drugs<br />
H. Miura<br />
Department of Pediatrics, Kitasato <strong>University</strong> School of<br />
Medicine, Sagamihara, Kanagawa, Japan<br />
We investigated the clinical effects and plasma levels of<br />
zonisamide (ZNS) in children with cryptogenic localizationrelated<br />
epilepsies. ZNS is absorbed slowly and its biological<br />
half-life is long as compared with that of other antiepilepic<br />
drugs. The peak-to-trough plasma level ratios during a day<br />
were as small as 1.28 ^ 0.15 in children taking a daily dose of<br />
8 mg/kg of ZNS once a day as a single drug. The plasma level<br />
(mg/ml) to dose (mg/kg per day) ratios estimated by the<br />
trough and peak plasma levels both increased with advancing<br />
age, but the peak-to-trough plasma level ratios were maintained<br />
almost uniformly throughout the pediatric age period.<br />
A wide range of the plasma levels was associated with<br />
complete freedom from seizures. However, the clinical<br />
effects of ZNS were in agreement with the range of generally<br />
accepted therapeutic plasma levels of 15–40 mg/ml. Any<br />
patient who receives polytherapy is at risk to develop drug<br />
interactions. Concurrent administration of carbamazepine<br />
(CBZ) decreases plasma concentrations of ZNS. However,<br />
ZNS does not alter plasma concentrations of CBZ or its<br />
primary metabolite, carbamazepine-10,11-epoxide (CBZ-<br />
E). Drug-protein binding interactions are one source of side<br />
effects. A simultaneous administration of valproic acid<br />
increases the total plasma CBZ-E levels relative to the<br />
CBZ dose associated with the raised free fractions of CBZ<br />
and CBZ-E. The free plasma concentrations of CBZ-E above<br />
1.5 mg/ml may be responsible for the side effects.<br />
WORKSHOP<br />
WS-1<br />
Cerebral Palsy<br />
WS-1-1<br />
Etiology and risk factors for cerebral palsy<br />
V. Kalra<br />
Department of Pediatrics, All India Institute of Medial<br />
Sciences, Ansari Nagar, New Delhi, India<br />
Cerebral palsy (CP) implies a group of non-progressive<br />
neuromotor impairment syndromes due to an acute insult to<br />
the developing brain. Prenatal and perinatal period provides<br />
greatest vulnerability. The casual factors are complex, often<br />
multiple and the attributable risk from an individual factor is<br />
often difficult to define in a patient. Preterm, extreme low<br />
birth weight, multiple pregnancies, perinatal hypoxia, hypoglycemia,<br />
hypothermia, sepsis and jaundice remain<br />
commonly identifiable perinatal factors in our data. In<br />
developing countries with domiciliary deliveries, perinatal<br />
hypoxia still remains an important contributory factor.<br />
Prevention of perinatal hypoxia neonatal sepsis, hypothermia<br />
hypoglycemia are important in developing countries.<br />
Congenital intrauterine infections are important identifiable<br />
factors due to therapy issues. Malformations of the brain<br />
remain an important cause to identify. Maternal infections<br />
are assuming greater importance. Maternal socioeconomic<br />
status, anemia, systemic diseases, hypertension, iodine deficiencies<br />
unattended during pregnancy are not uncommon in<br />
developing countries. Neuroinfections and acquired neurological<br />
insults in early childhood are also more frequent than<br />
in developing countries. Risk factors for CP in developing
Abstracts 381<br />
countries may be multiple. Reduction implies a multipronged<br />
strategy by improved obstetric and perinatal care.<br />
WS-1-2<br />
Evaluation of the risk factors associated with cerebral<br />
palsy in children<br />
Y.-Y. Zhong<br />
Cheng Du Children Hospital, Cheng Du, China<br />
Objective: To evaluate the risk factors associated with the<br />
pathogenesis of childhood cerebral palsy (CP). Method: A<br />
cross-sectionalsurvey on the prevalence of CP was conducted<br />
in 1–6 years old children in Leshan area, Sichuan Province.<br />
Cluster sampling and 1: 2 case control study methods were<br />
used to investigate the risk factors of CP pathogenesis. Result:<br />
A total of 148 723 children were surveyed among which 308<br />
(2.07‰) were diagnosed as CP. Low birth weight, twins and<br />
premature birth were associated with significantly increased<br />
CP prevalence. The single factor analysis showed that the<br />
pathogenesis of CP were multifactorial. The multifactorial<br />
analysis revealed the significant risk factors which included<br />
delivery at home, low 5 min Apgar score, illness within the 1st<br />
monthoflife,maternal‘cold’withfeverinearlygestation,low<br />
protein intake (meat and egg) during pregnancy and poor<br />
education of the mother. Conclusion: The prevalence and<br />
clinical features of CP in Leshan Area is comparable to the<br />
advanced countries. The relevant risk factors can be seen<br />
primarily in the gestational and perinatal periods which may<br />
involve in the mother and the child, the environment and<br />
heredity, etc. Better recognition of and improvement in gestational<br />
and perinatal health care should be a critical way to<br />
reduce the occurrence of CP in children.<br />
WS-1-3<br />
Severe forms of cerebral palsy<br />
K. Kodama<br />
National Rehabilitation Center for Disabled Children in<br />
Japan, Japan<br />
In this presentation I will explain the prevalence and medical<br />
problems of very severely handicapped children and<br />
special care systems for them in Japan. They have severe<br />
motor problems combined with profound cognitive damages,<br />
often accompanied by various kinds of medical problems.<br />
We estimate there are about 35 000 such cases in Japan<br />
now. Though their diagnoses are not same, over 70% of<br />
them are seemed to be cerebral palsy. About two third of<br />
them need drug therapy against epilepsy or extreme hypertonus.<br />
In most severe group among them, nearly 50% have<br />
upper respiratory problems, swallowing difficulties and<br />
gastro-easophageal refluxes. Also hip joint dislocation,<br />
high degree of scoliosis or multiple deformities they have.<br />
Since mid of 1960s we have been developing care systems for<br />
them. The number of special institutions with the functions of<br />
medical hospital and life care home has been increasing up to<br />
100 and about 16 000 cases are now living in such institutions.<br />
Also we combined day care community centers, home<br />
visiting nursing services and respite day or night care systems<br />
and made special community networks. Furthermore, we are<br />
paying our efforts to prevent future disabilities from early<br />
stages of their lives. This time I will report how they changed<br />
their posture and motor conditions and other disabilities<br />
through over 20 years life, how we predict their future course<br />
from young period and how we prevent their wrong course.<br />
WS-1-4<br />
Risk factors for pathological long bone fractures in nonambulatory<br />
cerebral palsy children: a case control study<br />
C.H. Ko, V.S.K. Ho, E.C.C. Wong, E.C.P. So, M.K.Y. Koo,<br />
P.W.T. Tse<br />
Developmental Disabilities Unit (DDU), Department of<br />
Paediatrics, Caritas Medical Centre, Hong Kong, China<br />
Introduction: Pathological long bone fractures is a<br />
common problem in non-ambulatory spastic or dyskinetic<br />
CP children. This is a retrospective study to identify the<br />
risk factors for this problem. Methods: From June 1992 to<br />
June 2001, all the CP children residing in the DDU who had a<br />
history of pathological fracture were reviewed. The data<br />
collected included the demographic data, nutritional status,<br />
mode of feeding, contracture status, orthopedic surgery and<br />
postoperative immobilization within 12 months prior to fracture,<br />
anti-epileptic therapy, and general health status. The<br />
comparison group composed of concomitant CP residents<br />
who did not have a history of fracture. Multivariate analysis<br />
was utilized to identify the independent risk factors for pathological<br />
fracture. Results: The patients composed of 19 children<br />
with 25 fractures, including 21 in the femur, two in the<br />
tibia or fibula, one in the radius and one in the humerus. The<br />
comparison group composed of 108 children. The body mass<br />
index (BMI) (P ¼ 0:0127, odds ratio ¼ 0.74) and presence of<br />
contracture in any extremity (P ¼ 0:0457, odds ratio ¼ 2.72)<br />
were found to be significant independent risk factors for<br />
pathological fracture. Discussion: In non-ambulatory spastic<br />
or dyskinetic CP children, a low BMI and the presence of<br />
severe extremity contracture were found to be significant risk<br />
factors leading to pathological fracture. The habilitation<br />
goals should include intensive physiotherapy and anti-spasticity<br />
therapies to prevent contractures, as well as nutritional<br />
measures to augment the BMI.<br />
WS-1-5<br />
Cerebral palsy – therapeutic possibilities<br />
G. Cole<br />
The Robert Jones and Agnes Hunt Orthopaedic Hospital,<br />
Oswestry, Shropshire, UK<br />
In recent years an increasing choice of treatment modal-
382<br />
Abstracts<br />
ities have become available for treating the mobility<br />
problems associated with cerebral palsy. Although the benefits<br />
conferred by certain treatments are clear, other management<br />
options are more controversial. In addition to<br />
conventional orthopaedic surgery and physiotherapy,<br />
multi-level surgery, intramuscular botulinum injections,<br />
selective dorsal rhizotomy, intrathecal baclofen, targeted<br />
training and sophisticated orthoses all have their advocates.<br />
Less orthodox strategies too, such as hyperbaric oxygen,<br />
cranial osteopathy and lycra suits have been in vogue. Cerebral<br />
palsy is a heterogeneous condition and it might be legitimately<br />
argued that its management should be highly<br />
individualised. For professionals in the field however there<br />
is now a bewildering choice of treatment options available in<br />
many countries, with only scant guidelines about the criteria<br />
of choice. Our lack of full understanding of some of the basic<br />
concepts of neuromuscular function such as tone and spasticity<br />
has contributed to some of this confusion and this has<br />
been made worse by the lack of universally acceptable<br />
‘outcome measures’ for comparing different treatment techniques.<br />
Gait analysis has been shown to be useful in the child<br />
with hemiplegia, diplegia and mild quadriplegia (less so with<br />
ataxic and dyskinetic cerebral palsy), not only for determining<br />
intervention, but also in its use of measuring outcomes in<br />
a range of therapeutic options. It is however a very expensive<br />
academic outcome tool and other less technical procedures<br />
have been developed in recent years for determining<br />
outcome. Tools such as gross motor function measure<br />
(GMFM), paediatric evaluation of disability inventory<br />
(PEDI), etc., have the major advantage of being performed<br />
at home by trained therapists but all such tools lack some<br />
versatility. Individual treatment options will be discussed,<br />
including the criteria currently available, which help us to<br />
make individual decisions about individual children.<br />
WS-1-6<br />
Treatment of 140 cerebral palsied children based on<br />
combination of traditional Chinese medicine and<br />
Western medicine<br />
X.-J. Zhou, N.-X. Zhuang, S.-Q. Zheng, T. Chen, Y.-F. Luo<br />
The Children’s Hospital, Zhejiang <strong>University</strong> School of<br />
Medicine, Hang Zhou, China<br />
Objective: To investigate the effective approaches and<br />
practicable plan for the rehabilitation on childhood cerebral<br />
palsy. Methods: Cerebral palsied children received multiple<br />
therapy based on age, type and status of cerebral palsy,<br />
including preparation of traditional Chinese medicine,<br />
scalp acupuncture, body acupuncture, point-injection therapy,<br />
auricular-plaster therapy, massage and pressing points,<br />
manipulation, physiotherapy, occupational therapy, etc.<br />
And they not only were handled in hospital, but also at<br />
home. Results: The majority of cerebral palsied children<br />
got progress on motor and social adaptation capacity.<br />
There were highly significant differences on motor and<br />
adaptive capacity between before and after treatment by<br />
signed rank test (P , 0:01). Conclusion: It is a pattern of<br />
rehabilitation suitable for the Chinese children with cerebral<br />
palsy that is based on combination of traditional Chinese<br />
medicine and Western medicine, rehabilitation in hospital<br />
and at home. If the pattern of treatment can be better implement<br />
and carried out, the most of cerebral palsied children<br />
will be rehabilitated effectively.<br />
WS-2<br />
Epilepsy<br />
WS-2-1<br />
The clinically efficacy of midazolam on childhood status<br />
epilepticus<br />
Q.-K. Huang, M. Zhao, J.-C. Gu<br />
Department of Pediatrics, Shanxian Central Hospital,<br />
Shandong, China<br />
The purpose of this study was to explore the safety and<br />
efficacy of midazolam in the treatment of childhood status<br />
epilepticus. Forty-three patients with status epilepticus (41<br />
with convulsive status epilepticus and two with epilepsia<br />
partialis continua) were treated from June 1997 to June<br />
2001. The underly disease was idiopathic status epilepticus<br />
in 35 patients and symptomatic status epilepticus in eight<br />
patients. They were divided randomly into the treatment<br />
group and control group. During the study, the pulse, respiration,<br />
blood pressure were monitored. The treatment group<br />
included 22 cases (12 boys and ten girls) aged 8 months–12<br />
years. The midazolam was given in a dose of 0.05–0.2 mg/kg<br />
bolus for the patients with continuous seizures, and 3–15 mg/<br />
kg per min infusion for those who had frequent seizures. The<br />
seizure ceased 10 min to 4 h after the administration of midazolam,<br />
and no comp1ication occurred. The control group<br />
included 21 cases (11 boys and ten girls) aged 10 months–<br />
12 years diazepam, phenobarbital, lidocain and thiopentone<br />
was given sequentially. The seizure ceased 15 min–42 h after<br />
the first anticonvulsant administration. In control group, the<br />
case with seizure continuous for 42 h that died of underlying<br />
disease, three patients need intubating and assisted ventilation<br />
because of respiration suppresion. The time interval<br />
from midazolam administration to seizure ceased was significantly<br />
shorter than that of control group (Rank test<br />
P , 0:05). It is concluded that midazolam is safe and effective<br />
in treating the childhood status epilepticus.<br />
WS-2-2<br />
Five children with frontal lobe epilepsy<br />
J. Li, H.-B. Zhang<br />
Jinan Children Hospital, Jinan, China<br />
We report five children (four male and one female; age is<br />
22 days, 5, 6, 8 and 8 years, respectively) with frontal lobe
Abstracts 383<br />
epilepsy. Three children were misdiagnosed as dyssomnia,<br />
hysteria and tetany. Two children were diagnosed as undetermined<br />
epilepsy. Twenty-three seizures (duration range<br />
10–45 s) of the five children were evaluated with longterm<br />
(12–15 h) video-EEG monitoring; two children had<br />
seizures during sleep, two in the wake of or during sleep,<br />
and the other when awake. The same child suffered from<br />
similar symptoms at every onset. All five children presented<br />
with atypical tic seizures; one child suffered from panic and<br />
crying in sleep, one adversive seizures, two tonic postural<br />
seizures, the other paresthesia with both lower extremities<br />
tics. All of the five children became flushed with panic.<br />
Common EEGs of five children are negative. Typical spikes<br />
coming from frontal lobe can be found on video-EEG in<br />
both seizure term and interval and noted in sleep. Our<br />
cases show that the clinical manifestation of frontal lobe<br />
epilepsy varied, being characterized by high seizure<br />
frequencies, short duration, and nocturnal preponderance,<br />
with vegetative and psychiatric symptoms. Video-EEG is<br />
of value in diagnosis because of a high positive rate, and<br />
the relation between clinical manifestation and cerebral<br />
electrical activity can be synchronized on video-EEG.<br />
There is one child who had seizures in the neonatal period,<br />
which has never been reported before.<br />
WS-2-3<br />
Reappraisal of a peculiar form of acute encephalitis/<br />
encephalopathy presenting with catastrophic status<br />
Y. Awaya a,b , K. Hayashi b , Y. Fukuyama b,c , M. Osawa b<br />
a Department of Pediatrics, Seibo International Catholic<br />
Hospital, Tokyo, Japan; b Department of Pediatrics, Tokyo<br />
Women’s Medical <strong>University</strong>, Tokyo, Japan; c Child Neurology<br />
Institute, Tokyo, Japan<br />
Background: In 1986 and 1989, the authors described ‘a<br />
peculiar type of post-encephalitic epilepsy’ as a probable<br />
new clinical entity, the characteristics of which consisted<br />
of acute onset of encephalitis/encephalopathy with catastrophic<br />
status followed by an evolution into intractable<br />
chronic partial epilepsy. Since, similar cases have been<br />
reported sporadically in Japan, but no description exists in<br />
non-Japanese literature yet, except for Baxter’s abstract in<br />
1999. Methods: Medical records of five patients prospectively<br />
observed by the authors were reviewed. In addition,<br />
a review of Japanese literatures from 1988 to 2001 identified<br />
29 compatible cases in 18 papers. Based upon 34 cases thus<br />
gathered, clinical features of the syndrome were reassessed.<br />
Results: (1) Age of onset: 7 years old in average (range 1–15<br />
years). (2) Preceding fever in all, except one. (3) Cardinal<br />
symptoms in acute stage; seizures, consciousness disturbance<br />
and fever. (4) Catastrophic status epilepticus, necessitating<br />
general anesthesia and intubation for one to a few<br />
weeks. (5) Stabilizes one to several months later and evolves<br />
to intractable CPS and mental impairment. (6) Mild CSF<br />
pleocytosis in some, virological and other exams negative.<br />
Discussion and conclusion: Differential diagnosis includes<br />
acute/subacute encephalitides, intoxication, Reye syndrome,<br />
brain anomalies, metabolic and circulatory disturbances. No<br />
clues suggestive for etiology are available. This is a unique<br />
devastating status which requires urgent seizure control as<br />
well as life-supportive measures.<br />
WS-2-4<br />
Study of genotypes and phenotypes of severe myoclonic<br />
epilepsy in infancy<br />
T. Fujiwara a , T. Sugawara b , E. Mazaki-Miyazaki b ,K.<br />
Fukushima a , Y. Takahashi a , M. Watanabe a , K. Hara a ,T.<br />
Morikawa a , K. Yagi a , K. Yamakawa b , Y. Inoue a<br />
a National Epilepsy Center, Shizuoka Medical Institute of<br />
Neurological Disorders, Shizuoka, Japan; b Laboratory for<br />
Neurogenetics, RIKEN, Brain Science Institute, Saitama,<br />
Japan<br />
Purpose: Recent studies have demonstrated that frameshift<br />
mutation and nonsense mutation of the sodium ion<br />
channel a1 subunit (SCN1A) gene are responsible for<br />
SME in infancy (Class et al., 2001). We analyzed the<br />
SCN1A genotypes and phenotypes in a relatively large<br />
number of Japanese SME patients. Subjects and methods:<br />
Mutations of the SCN1A gene were studied in one pair of<br />
monozygotic twins (details of phenotypes have been<br />
reported, Fujiwara et al., 1990) and 29 single patients<br />
(total 31 cases) with SME. The methods of analysis were<br />
according to the previous report (Sugawara et al., 2001).<br />
This study was approved by the Ethical Committee of<br />
RIKEN, Brain Science Institute and of Shizuoka Medical<br />
Institute of Neurological Disorders. Informed consent was<br />
obtained from all the patients or parents. Results: Mutation<br />
of the SCN1A gene was found in 25 of 31 cases (81%),<br />
consisting of six cases of frameshift mutation, ten cases of<br />
non-sense mutation (including the monozygotic twins), and<br />
nine cases of missense mutation. No SCN1A gene mutation<br />
was detected in the remaining six cases. Genetic analyses of<br />
the parents of seven patients gave negative results. These<br />
mutations were therefore considered to be de novo mutations.<br />
Conclusion: Mutations of the SCN1A gene were<br />
detected at a high rate (81%) in Japanese SME patients.<br />
The mutations were diverse, ranging from frame shift,<br />
nonsense to missense mutations. The relationship between<br />
genotypes and phenotypes is under investigation.<br />
WS-2-5<br />
The effects of epilepsy-surgery on the quality-of-life of<br />
children<br />
M. Boonzaaijer, R. van Empelen, A. Jennekens-Schinkel, C.<br />
Volman, C.W.M. van Veelen, P.C. van Rijen, O. van<br />
Nieuwenhuizen<br />
UMCU/WKZ, Department of Paediatric Physical Therapy,<br />
Utrecht, Netherlands
384<br />
Abstracts<br />
Quality of life (QoL) is more and more considered an<br />
important indicator of the impact of medical treatment.<br />
With respect to epilepsy surgery in childhood, success of<br />
the operation is measured not only at the level of impairments<br />
(ICIDH 2000), but the child and his parents are also<br />
asked to evaluate postoperative changes in the child’s functioning<br />
in respect of participation. Quality of life, therefore,<br />
is a multidimensional construct that can hardly be understood<br />
solely by quantitative research (van Zuuren, 1999;<br />
Wallander, 2001). Objective: To identify the effects of<br />
epilepsy-surgery on QoL of children suffering from intractable<br />
epilepsy. Design: explorative, pre-post surgery,<br />
prospective, partly qualitative and partly quantitative<br />
research. Methods: ‘HAY’ (how are you) (Bruil, 1999), a<br />
Dutch health-related QoL-questionnaire with a generic and<br />
an epilepsy-specific part, for children between the ages of 7<br />
and 13 years. CBSK (Veerman, 1997), a Dutch adaptation<br />
of the Self-Perception Profile for children between the ages<br />
of 7 and 13 years (Harter, 1985). An open interview was<br />
held with nine children and their parent(s) to obtain an<br />
unrestrained idea of QoL before and after epilepsy surgery.<br />
The qualitative data have been analysed quantitatively.<br />
Results: Both parental and children’s perceptions changed<br />
on all subscales of the HAY. Children report positive<br />
changes in physical and cognitive activities and in feelings<br />
about these activities. Parents report that the children have<br />
become more active in social, physical and cognitive fields<br />
and more proficient in physical activities. Both parents and<br />
children report that, postoperatively, the frequencies of<br />
seizures and of treatment contacts have significantly<br />
decreased. On the CBSK the amelioration on the sub-scale<br />
‘physical appearance’ is significant (P , 0:05) and the<br />
amelioration on the sub-scales Social Acceptance,<br />
Romance, Global Self-worth and Friendship tend to significance<br />
(P , 0:1). The interview data amplify the questionnaire<br />
findings: post-operatively, the child initiates contacts<br />
with peers, the seizure-related necessity of intense one-toone<br />
accompaniment has disappeared, freedom to undertake<br />
social activities has increased accordingly, and – but not<br />
least – the child’s energy has increased. Conclusion: Both<br />
parents and children report a significant improvement in<br />
frequency of social activities, the self-perceptions of the<br />
children improve, some to a statistically significant degree,<br />
and the parents report a significant energy gain.<br />
WS-2-6<br />
Memory impairment in specific childhood epilepsy<br />
syndromes<br />
A.M. Nolan, A. Redoblado, S. Lah, M. Sabaz, J.A. Lawson,<br />
A.M. Cunningham, A. Bleasel, A.M.E. Bye<br />
Department of Neurology, Sydney Children’s Hospital and<br />
The Children’s Hospital; The Universities of New South<br />
Wales and Sydney, Sydney, Australia<br />
Aim: Memory impairment in children with epilepsy can<br />
be a severe disability. Its incidence according to specific<br />
childhood epilepsy syndromes is not well studied. We evaluated<br />
verbal and visual memory in generalised idiopathic<br />
epilepsy (GIE), frontal lobe epilepsy (FLE), temporal lobe<br />
epilepsy (TLE), central epilepsy (CE) and non-localised<br />
partial epilepsy (PE). Methods: From a population of 130<br />
children with epilepsy aged 6–18 years monitored with<br />
video-EEG telemetry, 107 were identified with GIE<br />
(n ¼ 16), FLE (n ¼ 25), TLE (n ¼ 34), CE (n ¼ 12) or<br />
PE (n ¼ 20). Syndrome identification was determined by<br />
International League Against Epilepsy criteria using clinical<br />
data, seizure semiology, interictal and ictal recordings. Each<br />
child had detailed memory evaluation using age-normed<br />
instruments. Memory impairment was defined as scores<br />
more than two standard deviations below the normed<br />
mean. Results: Memory impairment was found in 5% of<br />
GIE and CE, 8% of FLE, 18% of TLE and 20% of PE<br />
children. Four verbal and one visual subtest showed statistically<br />
significant differences in performance between<br />
syndrome groups. GIE had significantly better performance<br />
than TLE in two verbal and the visual subtest (P ¼ 0:019,<br />
P ¼ 0:024, P ¼ 0:055). In one verbal and the visual subtest<br />
GIE had significantly better performance than PE<br />
(P ¼ 0:011, P ¼ 0:019). A trend for better performance in<br />
FLE than TLE approached significance on one verbal subset<br />
(P ¼ 0:052). Discussion: In childhood epilepsy, memory<br />
impairment is a quantifiable problem. Children with GIE<br />
perform best, and significantly worse memory function<br />
can be demonstrated in TLE and PE compared to GIE.<br />
This information is invaluable in planning educational and<br />
therapeutic interventions.<br />
WS-2-7<br />
Genetic abnormalities underlying severe myoclonic<br />
epilepsy in infancy in Japanese<br />
G. Fukuma, S. Hirose, T. Inoue, S. Yasumoto, M. Ohfu, A.<br />
Watanachai, A. Mitsudome, Study Group on Epilepsy<br />
Genetics in Japan<br />
School of Medicine, Fukuoka <strong>University</strong>, Fukuoka, Japan<br />
Objective: To identify genetic abnormalities underlying<br />
SMEI in Japanese. Background: Recently, mutations of the<br />
neuronal voltage-gated Na 1 channel 1 subunit gene<br />
(SCN1A) have been identified as a cause of SMEI.<br />
SCN1A and genes encoding other components of Na 1 channels<br />
in the brain such as 2, one and two subunits (SCN2A,<br />
SCN1B and SCN2B, respectively) were candidate genes for<br />
SMEI. Methods: Our study recruited 54 unrelated individuals<br />
whose clinical manifestations were consistent with<br />
SMEI and 96 healthy volunteers. Each participant or a<br />
responsible person signed an informed consent form<br />
approved by the Ethics Review Committee of Fukuoka<br />
<strong>University</strong> or similar committees of the participating institutions.<br />
Genetic abnormalities of SCN1A, SCN2A, SCN1B<br />
and SCN2B were sought in genomic DNA using a direct
Abstracts 385<br />
sequencing method with an ABI 3700 sequencer. Results:In<br />
SCN1A, eight heterozygous nonsense, 23 missense and<br />
three frame-shift mutations resulting in a premature stop<br />
were found in 44 individuals with SMEI. The mutations<br />
identified in the patients were not found in 96 healthy volunteers<br />
and hence considered to be disease-causing mutations.<br />
No mutation was found within the examined region of<br />
SCN2A, SCN1B and SCN2B. Conclusions: In the first<br />
report made by a Belgian group, mutations of SCN1A<br />
were found in all patients they studied while only 44 of<br />
54 patients bore causative mutations in SCN1A in our<br />
subjects. The relations between phenotype and genotype<br />
of SMEI should be further delineated.<br />
WS-2-8<br />
Severe myoclonic epilepsy of infancy and SCN1A:<br />
phenotypical-genotypical correlation<br />
B. Ceulemans a,b , L. Claes c , L. Lagae a,d , D. Audenaert c ,J.<br />
Del-Favero c , M. Boel a,d , C. Van Broeckhoven c ,P.De<br />
Jonghe c , P. Evrard e , S. Raskin f , S. Ala-Mello g , L. Basel-<br />
Vanagaite h , N.I. Wolf i , B. Plecko j<br />
a Epilepsy Center for Children and Youth, Pulderbos,<br />
Belgium; b Neurology, <strong>University</strong> Hospital Antwerp; c Molecular<br />
Genetics, <strong>University</strong> Antwerp;<br />
d Child Neurology,<br />
Gasthuisberg, Leuven, Belgium; e Inserm, Paris, France;<br />
f Genetika, Parana, Brazil; g Medical Genetics, Helsinki,<br />
Finland; h Medical Genetics, Petah Tikva, Israel; i Paediatric<br />
Neurology, Heidelberg, Germany; j Neuropediatrics,<br />
Graz, Austria<br />
SMEI is a rare epileptic syndrome included in the International<br />
League Against Epilepsy (ILAE) classification as<br />
an epileptic encephalopathy. Although it has been<br />
mentioned that the family-history for febrile seizures and/<br />
or epilepsy is frequently positive in children with SMEI, we<br />
described, last year, herterozygotic de novo mutations in the<br />
alfa subunit of a neuronal voltage-gated sodium channel<br />
SCN1A in seven Belgian patients. We hypothesised that<br />
loss of function or at least severe damage of this protein<br />
causes the clinical picture of SMEI. A new group of ten,<br />
all well characterised, cases of SMEI and mutations in the<br />
same gene will be presented. Four are Belgians, five are<br />
other Europeans and one is Brazilian. In a few families<br />
with GEFS 1 SMEI occur as the most severe clinical phenotype.<br />
On behalf of our own results and the published cases<br />
with known mutations a phenotypical-genotypical correlation<br />
will be presented.<br />
WS-2-9<br />
Rotatory seizures in non-lesional frontal lobe epilepsy –<br />
ictal recordings with video-EEG, SPECT and MEG<br />
O. Kanazawa, J. Tohyama<br />
Department of Pediatrics, Epilepsy Center, National Nishi-<br />
Niigata Central Hospital, Niigata, Japan<br />
Rotatory seizures, during which patients turn around their<br />
axis one or more times are also known as circling seizures or<br />
gyratory seizures. Pure stereotypical rotatory seizures seem<br />
to be a rare epileptic manifestation, the mechanism of body<br />
turning still being obscure. We report on two girls, who had<br />
had daily rotatory seizures with normal brain MRI findings.<br />
Patient 1, who was 5 years 8 months of age, began to have<br />
brief episodes of body turning to the right. Maximal seizure<br />
frequency was over 20 times per day. Her interictal EEG<br />
showed left frontopolar spikes. Ictal SPECT showed left<br />
frontal hyperperfusion. Two months later, complete seizure<br />
control was obtained by medication with carbamazepine<br />
200 mg. Patient 2, who is 10 years 6 months of age at<br />
present, began to have brief episodes of body turning to<br />
the left at age 7 years 10 months. Maximal seizure<br />
frequency was around 80 times per day. She had two 1-<br />
year remission periods, but subsequently seizures relapsed<br />
at age 10 years 1 month. Her interictal EEG showed right<br />
frontal spikes. Ictal SPECT showed right frontal hyperperfusion.<br />
Ictal magnetoencephalography revealed right frontal<br />
dipole sources. Four months later, her seizures were<br />
controlled by medication with phenytion 300 mg and primidone<br />
250 mg. Because circling constitutes the only ictal<br />
behaviour observed, patients may be misdiagnosed as<br />
having a psychogenic reaction. Ictal SPECT findings in<br />
our patients may support that basal ganglia involvement is<br />
a necessary part of the mechanism of rotational seizures, as<br />
Vercueil et al. have suggested.<br />
WS-3<br />
Specific Learning Disabilities<br />
WS-3-1<br />
Dyslexia in the Chinese language<br />
C.K. Leong<br />
Professor Emeritus, <strong>University</strong> of Saskatchewan and<br />
Adjunct Professor, The Chinese <strong>University</strong> of Hong Kong,<br />
Hong Kong, China<br />
This paper discusses the nature of reading disabilities in<br />
Chinese. Recent data from children in Beijing and Hong<br />
Kong provide suggestive evidence to show the universality<br />
and specific constraints on phonological analysis in learning<br />
to read Chinese and to prevent reading difficulties.<br />
WS-3-2<br />
FMRI and reading<br />
L.-H. Tan<br />
Joint Laboratories for Language and Cognitive<br />
Neuroscience 3A, The <strong>University</strong> of Hong Kong, Hong<br />
Kong, China<br />
Functional MRI findings of neuroanatomical mechanisms<br />
underlying Chinese and English reading will be reviewed.
386<br />
Abstracts<br />
Our studies using several cognitive tasks have indicated that<br />
peak activation in the processing of Chinese characters was<br />
located in the left middle frontal cortex (BA 9 and 46),<br />
regions that previous investigations with English and other<br />
alphabetic languages have not commonly identified. Because<br />
the left middle frontal cortex is known to subserve visualspatial<br />
processing of objects and spatial working memory, we<br />
have hypothesized that its extremely strong activation in<br />
reading Chinese is associated with the unique square configuration<br />
of characters. We further found that when Chinese-<br />
English bilinguals process English words phonologically, the<br />
left middle frontal cortex is most strongly activated. This<br />
suggests that the processing of Chinese phonology (where<br />
logographic characters are pronounced monosyllabically and<br />
do not call for phonemic parsing) carries over to second<br />
language processing. Finally, in a study with Chinese<br />
dyslexics, we found less middle frontal and temporal activations<br />
for dyslexic children, suggesting that they were facing a<br />
great difficulty in phonological processing.<br />
WS-3-3<br />
Specific learning disabilities (SLD): advocacy<br />
C.-W. Chan<br />
Working Party on SLD, The Hong Kong Society of Child<br />
Neurology and Developmental Paediatrics (HKCNDP),<br />
Hong Kong, China<br />
With advancement in our understanding of the neurobiological<br />
bases, clinical features and evidence-supported<br />
interventions for SLD, it is imperative that services for<br />
and interests of affected individuals are safeguarded accordingly.<br />
These are rights embodied under the UN Charter for<br />
Children’s Rights. In order to achieve these we need alignment<br />
of definitions among professionals, accurate identification<br />
and diagnosis through powerful screening and<br />
assessment tools and integrated multidisciplinary teams, as<br />
well as specific and accountable management plans. In line<br />
with these, there must be parents who understand their children’s<br />
condition and needs, school teachers who have<br />
appropriate preparation and ongoing in-service training,<br />
enlightened education administrators, as well as wide spread<br />
public awareness and acceptance of the disabilities. Adverse<br />
complications associated with undiagnosed or improperly<br />
managed children with SLD include school failure and<br />
drop out, eroded self esteem, juvenile delinquency,<br />
substance abuse, and a future life of unemployment and<br />
underachievement. Effective legislation and government<br />
policies, plus close partnerships between professionals,<br />
stakeholders and the public are foundations for success.<br />
Given the range of information and services that address<br />
the full scope of SLD and appropriate measures to promote<br />
their talents and potentials, every individual with SLD will<br />
have the opportunity to lead a productive and fulfilling life,<br />
from which society will ultimately benefit.<br />
WS-3-4<br />
Clinical diagnosis and management<br />
C.C.C. LAM<br />
Central Kowloon Child Assessment Centre, Kowloon, Hong<br />
Kong, China<br />
Abstract not submitted<br />
FREE PAPERS-Oral Presentation<br />
FO-1<br />
Neuroscience<br />
FO-1-1<br />
Effects of developmental lead exposure on nitric oxide<br />
synthase activity in different brain regions of rat<br />
G.-J. Dong, Z.-Y. Zhao, Z.-W. Zhu<br />
The Affiliated Children’s Hospital of Zhejiang <strong>University</strong><br />
School of Medicine, Hangzhou, China<br />
Objective: To observe the influence of lead exposure on<br />
nitric oxide synthase (NOS) in different brain regions of rat.<br />
Methods: By establishing a series of rat models exposed to<br />
different low levels lead during developing period, (drinking<br />
water containing 0.025, 0.05 and 0.075% lead acetate) we<br />
studied NOS activity in hippocampus, cerebellum, cerebral<br />
cortical and brain stem. Results: For 0.025 and 0.05% groups,<br />
NOS activity in hippocampus was obviously inhibited, had<br />
significant difference with that in cerebral cortical and brain<br />
stem (P , 0:05). For 0.075% group, NOS activity in cerebral<br />
cortical was obviously lower than those in hippocampus and<br />
brain stem (P , 0:05). On the 21st and 28th day after birth,<br />
NOS activity in cerebellum of 0.025 and 0.05% groups was<br />
lower than those in hippocampus, cerebral cortical and brain<br />
stem (P , 0:05), while NOS activity in cerebellum of<br />
0.075% group was lower than those in hippocampus and<br />
brain stem (P , 0:05). On the 21st and 28th day after birth,<br />
NOS activity in hippocampus and cerebellum of each experiment<br />
group was obviously lower than that of control group<br />
(P , 0:01). On different time points, NOS activity in Cerebral<br />
cortical of 0.075% group was obviously lower than that<br />
of control, 0.025 and 0.05% groups (P , 0:05). Lead exposure<br />
had no influence on NOS activity in brain stem<br />
(P . 0:05). Conclusions: NOS activities in hippocampus,<br />
cerebral cortical and cerebella cortical of rat were inhibited<br />
by lead exposure and the degree of the effect was related to Pb<br />
exposure time and level of Pb.<br />
FO-1-2<br />
Developing cortical neurons injury following recurrent<br />
epileptiform discharges induced by magnesium-free<br />
culture<br />
H.-Y. Cao, Y.-W. Jiang, T. Bo, X.-R. Wu<br />
Division of neurology, Department of Pediatrics, Peking<br />
<strong>University</strong> First Hospital, Beijing, China
Abstracts 387<br />
Objective: To study developing cortical neurons injury<br />
following recurrent epileptiform discharges induced by<br />
magnesium-free culture. Methods: We cultured the cortical<br />
neurons from 16 days rat fetuses. Cultures were exposed to<br />
magnesium-free media for 3 h, returned to regular media<br />
containing normal level magnesium, and maintained for 72<br />
h. During and after the treatment, we used intracellular<br />
recording techniques to detect the epileptiform discharges,<br />
trypan blue staining and flow cytometry to present neuronal<br />
viability and apoptosis, and MTT assay plus lactate dedhydrogenase<br />
(LDH) activity to determine the cell function and<br />
viability. Results: (1) Epileptiform discharges were induced<br />
in all neurons sampled in the culture during the magnesiumfree<br />
treatment, and spontaneous recurrent seizure activity<br />
lasted 72 h in 77.8% of the sampled neurons. (2) At different<br />
time (6, 12 and 72 h) after returning to regular media from<br />
Mg 21 free media, no differences were found among neurons<br />
in different cultured days (6, 12 and 17 days) on the rates of<br />
cell death and apoptosis (P . 0:05). (3) Compared with<br />
control, MTT metabolic activity decrease occurred at 6 h<br />
after Mg 21 -free treatment (P , 0:05) in neurons cultured<br />
for 6 days (85.69%), but at 24 h in neurons cultured for<br />
12 (78.19%) and 17 days (64.00%). (4) LDH activity in<br />
the supernatant of the culture medium decreased not significantly<br />
at all time points after Mg 21 -free treatment<br />
(P . 0:05). Conclusions: Our findings demonstrated that<br />
the acute injury of neurons in this seizure cell model was<br />
mainly functional, long term prognosis is during studying.<br />
(This work is supported by National Natural Science Foundation<br />
of China).<br />
FO-1-3<br />
Barrel field sizes are reduced in Down syndrome mouse<br />
model and barrel plasticity is stunted in neonatally nBM<br />
lesioned mouse<br />
A. Nishimura a,b, *, M.E. Blue a,b , T.H. Moran d , C.F.<br />
Hohmann e , G.T. Capone a,b,c , M.V. Johnston a,b,c<br />
a Neuroscience Laboratory, Kennedy Krieger Institute,<br />
b Department of Neurol,<br />
c Pediatrics, and d Psychiatry,<br />
Johns Hopkins <strong>University</strong> School of Med, Baltimore, MD,<br />
USA,<br />
e Department of Biology, Morgan State <strong>University</strong>,<br />
Baltimore, MD, USA<br />
*Present address: Department of Pediatrics, Kyoto Pref<br />
<strong>University</strong> of Medicine, Kamigyo-Ku, Kyoto, Japan.<br />
Previous studies have shown that neonatal lesion of basal<br />
forebrain cholinergic projections (nBM) in mice leads to a<br />
transient cholinergic depletion of neocortex and to permanent<br />
alterations in cortical cytoarchitecture and in cognitive<br />
performance. The present study examined whether neonatal<br />
nBM lesions modify neocortical plasticity. The present<br />
study also investigated whether Ts65Dn mouse, one of<br />
Down syndrome models has an aberrant neocortical development.<br />
Using cytochrome oxidase histochemistry, we<br />
compared cross-sectional areas of individual barrels in<br />
rows A–E and the Straddlers in the somatosensory cortex<br />
of four groups of postnatal day 8 (P8) old mice that received<br />
(1) right nBM lesions; or (2) left C row 1–4 whisker follicle<br />
ablations; or (3) combined treatment on P1 (12–24 h after<br />
birth) and in (4) untreated controls. And using young adult<br />
Ts65Dn mice and control littermates, we compared crosssectional<br />
areas of individual barrels in rows A–E. The plastic<br />
response to whisker removal was stunted in nBM<br />
lesioned animals. The present findings correspond to those<br />
from a study of rats injected with the cholinergic immunotoxin,<br />
IgG-saporin. We also found that the barrel field sizes<br />
were reduced in Ts65Dn mouse whose nBM cholinergic<br />
neurons degenerate at 6 months of age (Holtzman et al.,<br />
PNAS 93 (23): 13333–8, 1996). These results suggest that<br />
cholinergic inputs play a role in mouse barrel cortex development<br />
and plasticity.<br />
FO-1-4<br />
Dioxin alters cell proliferation of neural progenitor cells<br />
in the developing cerebral wall<br />
T. Takahashi<br />
Keio <strong>University</strong> School of Medicine, Tokyo, Japan<br />
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most<br />
potent dioxin, is an artificial environmental pollutant<br />
known to disturb hormonal homeostasis and induce maldevelopment<br />
of immune and urogenital systems in mice. In the<br />
CNS, in utero and lactational exposure to TCDD causes<br />
deficits in spatial learning and memory in rats. Several<br />
reports in vitro indicate that TCDD may directly alter cell<br />
cycle kinetics: TCDD retards G1 phase progression by inducing<br />
p27Kip1 in a hepatoma cell line and in fetal thymocytes.<br />
We have previously shown that G1 phase regulation<br />
of proliferative neural progenitor cells plays a critical role in<br />
the course of cerebral histogenesis. Thus, it is possible that<br />
in utero TCDD exposure may affect cell cycle regulation,<br />
particularly during G1 phase, of neural progenitor cells and<br />
results in abnormal histogenesis of the neocortex. We investigated<br />
effects of TCDD on cell cycle kinetics in the developing<br />
mouse brain. Pregnant mice were given a single oral<br />
dose of TCDD (20 mg/kg body weight) on embryonic day<br />
(E) 7. On E14, after a continuous exposure to 5-bromodeoxyuridine<br />
(BUdR) for 2, 8, 12 and 16 h, the BUdR labeling<br />
index (LI; BUdR positive nuclei/all nuclei) was calculated<br />
for the neural progenitor cell population of the proliferative<br />
neuroepithelium in the developing cerebral wall. BUdR LI’s<br />
of the neural progenitor cells were reduced in the TCDD<br />
exposed embryos as compared to those in the control<br />
embryos. All of the mitotic figures were BUdR positive<br />
after 2 h exposure to BUdR both in the TCDD exposed<br />
and control embryos, indicating that the combined length<br />
of G2/M phases was not affected by TCDD. BUdR LI for 16<br />
h-BUdR exposure was 1.0 for TCDD exposed embryos as in<br />
control, indicating that all of the neural progenitor cells of<br />
the proliferative neuroepithelium retained proliferative
388<br />
Abstracts<br />
activity even after TCDD exposure. These observations<br />
taken together, the reduction in the LI’s after TCDD exposure<br />
indicates that TCDD exposure caused G1 phase prolongation<br />
in the neural progenitor cells. These results suggest<br />
that in utero exposure to dioxin may affect cell cycle regulation<br />
of the neural progenitor cells and thus, alter the process<br />
of neuron production and eventually result in abnormal<br />
development of the neocortex. Supported by Grant-in-Aid<br />
from the Ministry of Health and Welfare, Pharmacia Fund<br />
for Growth and Development Research, Science and Technology<br />
Agency and CREST Tohyama Team, JST.<br />
FO-2<br />
Cerebral Palsy (1)<br />
FO-2-1<br />
Botulinum toxin type A in prevention of hip luxation of<br />
bilateral cerebral palsy. Treatment of 65 patients<br />
P.P. Si, P. Castroviejoi<br />
Service of Pediatric Neurology, Hospital Infantile ‘La Paz’,<br />
Madrid, Spain<br />
Introduction: In bilateral CP, tetraplegic or diplegic, the<br />
spasticity of flexor and adductor muscles of the hip often<br />
produce hip dysplasia and/or progressive luxation. Objective:<br />
To study the effectiveness of botulinum toxin type A<br />
(BT-A) in prevention of external femoral head migration<br />
and hip luxation in CP. Material and methods: All CP<br />
patients treated with BT-A because pelvic girdle spasticity<br />
were revised. Ages at the first injection were two–7 years.<br />
The clinical and radiological evolution prior to BT-A treatment<br />
and after it is analyzed. The drug was infiltrated in<br />
adductors, medial hamstring muscles in every patient and<br />
also in iliac psoas muscles if required. Post-treatment<br />
follow-up ranged between 1 and 4 years. Results: Sixtyfive<br />
children, 22% of 295 patients treated in our hospital<br />
with BT-A because CP, suffered hip disorder. A total of 122<br />
hips were treated. Pre-treatment evolution was bad, progressive<br />
external femoral head migration out of Perkins’ line<br />
was seen (10% of mean migration at 1 year of age, 21%<br />
at 2, 26% at 3, 31% at 4 years of age). Nineteen/122 hip<br />
were already luxated (more than 50% of migration) at the<br />
onset of treatment, in spite of correct physiotherapy and<br />
other treatments. After BT-A treatment, the progressive<br />
impairment stopped. There was not statistical difference in<br />
radiograph migration in patients group analysis, 10% of<br />
femoral heads improved it position, 8% worsened and the<br />
rest did not change during follow-up). Only one hip resulted<br />
luxated after treatment. This is a very good result according<br />
to the negative natural evolution of the disorder. Motor<br />
function improved in every case whose hip was not luxated.<br />
Conclusion: It is necessary to study clinically and radiologically<br />
the hips of every child with bilateral CP before 3<br />
years old. BT-A allows us to treat all the muscles implicated<br />
in hip spasticity and avoids the progressive functional<br />
impairment of hip mobility, so negative for the future physical<br />
independence of CP patients.<br />
FO-2-2<br />
An epidemiological study of cerebral palsy in Henan<br />
Province, China<br />
L. Gao, Y. Meng, S.-Y. Zhao, C.-J. Zhou, C.-Z. Yuan, Y.-H.<br />
Wang, M. Zhao, S.-L. Ma<br />
Department of Pediatrics, Henan Provincial People’s<br />
Hospital, Zhengzhou City, China<br />
Objective: To investigate the prevalence, distribution of<br />
different types and correlative etiologic factors and complications<br />
of CP in Henan Province, China. Methods: From<br />
January to December 2001, a random cluster sampling of<br />
children aged 0 , 6 years were investigated in ten cities and<br />
counties, including three districts – JinShui, ErQi,<br />
MangShan in Zhengzhou City; JianXi district in Luoyang<br />
City; JiYuan City and counties as YuanYang, XinYie,<br />
TangHe, TaiKang, YuCheng, among others. The etiology,<br />
clinical types, computed tomography and magnetic resonance<br />
imaging of all cases were analyzed. Results: There<br />
were 582 CP patients among 434 920 children investigated;<br />
the total prevalence rate of CP was 1.58%, Of the 582 cases<br />
of CP, spastic type was 56.87%, hypotonic type 21.13%,<br />
mixture type 7.56%, tonic type 6.70%, ataxia type 5.33%,<br />
tremor type 1.38%, and athetosis type 1.03%. The causes of<br />
CP were perinatal asphyxia or hypoxic-ischemic encephalopathy<br />
(HIE) (38.32%); premature or low birth weight<br />
(16.84%); maternal infections during early pregnancy<br />
(11.86%); hyperbilirubinemia (10.14%); intraventricular<br />
hemorrhage (IVH) (8.25%). The incidence rate of complications<br />
was 68.38%, 47.08% related to mental retardation<br />
(MR). Conclusion: This investigation demonstrated the<br />
approximate prevalence of CP in Henan Province. The spastic<br />
type is the most common type of CP. Asphyxia and HIE,<br />
premature and low birth weight, maternal infections during<br />
early pregnancy and hyperbilirubinemia, among others were<br />
high-risk factors. The main complication was MR. Most of<br />
the causes could be prevented by health care in perinatal<br />
period.<br />
FO-2-3<br />
Neonatal periventricular/intraventricular hemorrhage:<br />
incidence and some risk factor<br />
T.S. Al-Karagully<br />
Department of Pediatrics, Saddam College of Medicine,<br />
Baghdad, Iraq<br />
Background: In a prospective study extending along an 8-<br />
month period (April–November 1998), 100 newborns at the<br />
<strong>University</strong> Hospital/Saddam College of Medicine, were<br />
randomly selected and examined by cranial ultrasound (U/<br />
S) to determine the incidence of periventricular hemorrhage/
Abstracts 389<br />
intraventricular homorrhage (PVH/IVH) and some risk<br />
factors. Methods: All sonograms were performed using<br />
Real-time sector scanner with a 5-megahertz (5-MHz) Phasedarry<br />
transducer. All examinations were performed by taking<br />
the baby to the ultrasound examination room. No sedation<br />
was used. Standard sonographic techniques, including axial<br />
and occipital views, were used to obtain sections in coronal<br />
and sagittal planes. The cranial U/S examination was<br />
performed by the same doctor for all the babies included in<br />
the study. Results: The incidence of PVH/IVH was 43.8% in<br />
babies less than 1500 gm birth weight, 14.3% in babies 1500–<br />
2500 g birth weight and no hemorrhage in babies more than<br />
2500 g birth weight. Asphyxia was significantly (P ¼ 0:02)<br />
related to PVH/IVH in babies less than 1500 g birth weight. A<br />
total of 44.4% of the babies were clinically silent and the<br />
most common presenting features were lethargy 55.5%,<br />
convulsion 27.8%, bulging fontanel 22.2% and apnea<br />
16.7%. Conclusions: (1) PVH/IVH is a major problem of<br />
infants with birth weight of 1500 g; or less. (2) Asphyxia is<br />
a major risk factor for the development of PVH/IVH in babies<br />
with birth weight 1500 gm. or less. (3) A clinically silent<br />
presentation may occur in the majority of cases of PVH/<br />
IVH. (4) Lethargy, although non-specific, is the most<br />
common presentation followed by convulsion, bulging<br />
fontanel and apnea. (5) Sonography has enabled us to have<br />
a better understanding of the morbid anatomy; and pathophysiology<br />
of intracranial hemorrhage with the least invasion<br />
and disturbance to the baby.<br />
FO-2-4<br />
DC-EEG unmasks very slow activity patterns during<br />
sleep in infants<br />
S. Vanhatalo a,b , P. Tallgren a , S. Andersson 3 , K. Sainio d ,J.<br />
Voipio a , K. Kaila a<br />
a Department of Biosciences, b Department of Child Neurology,<br />
c Department of Pediatrics,<br />
d Department of Clinical<br />
Neurophysiology, <strong>University</strong> of Helsinki, Finland<br />
Abundance of slow frequencies is the most prominent<br />
feature of neonatal EEG. We used direct current electroencephalography<br />
(DC-EEG) to test the hypothesis that the<br />
immature human brain exhibits slow electrical activity<br />
which is not detected by the conventional (i.e. high pass<br />
filtered) EEG method. We performed recordings with DC-<br />
EEG during sleep on 24 infants ranging from 32 to 46 weeks<br />
of conceptional age. At all ages, DC-EEG revealed a significant<br />
amount of oscillatory and other activity patterns that<br />
are not seen with regular filter settings. Spectral analysis of<br />
DC-EEG revealed prominent peaks at 0.01–0.2 Hz. Most<br />
surprisingly, the activity pattern resembling delta-frequency<br />
bursts in conventional EEG appeared to be, in fact, gigantic<br />
negative transients. They had occipital maximum with a<br />
very large amplitude (200–700 mV) and long duration (1–<br />
5 s). They were also associated with bursts of high<br />
frequency activity with intriguing similarity to the spontaneous,<br />
synchronous neuronal activity described in recent<br />
animal experiments. Our results demonstrate that neonatal<br />
EEG contain significant amount of activity patterns that are<br />
too slow to detect with a conventional EEG method. These<br />
EEG waveforms are both quantitatively and visually very<br />
prominent. We propose that their proper visualization with<br />
DC-EEG may open a new avenue for non-invasive assessment<br />
of physiological and pathological brain functions<br />
during the neonatal period.<br />
FO-3<br />
Seizure Disorders (1)<br />
FO-3-1<br />
Higher incidence of posterior slow synchrony in EEG of<br />
children with complex febrile seizures<br />
V. Komárek, D. Pavlová, Z. Hrncir, M. Palus, T. Procházka,<br />
P. Jiruska<br />
Department of Child Neurology, Charles <strong>University</strong> Hospital<br />
Motol, Prague, Czech Republic<br />
Objective: Febrile seizures (FS) affect 3–5% of all children.<br />
About 20% of FS are familial. The seizure type,<br />
whether ‘simplex’ or ‘complex’, is important since it relates<br />
to further prognosis. The role of EEG in differential diagnosis<br />
of FS is still controversial (Maytal, 2000). The aim of our<br />
study was to evaluate characteristic patterns in EEG of children<br />
with different FS subtypes. Methods: The clinical and<br />
EEG data were collected from 587 children suffering from<br />
FS. In addition to visual evaluation we used linear spectral<br />
(right-left coherence) and on-linear EEG analysis (phase<br />
synchronization). Results: The normal EEG was found in<br />
406 children. Specific epileptiform discharges were present<br />
in six records. The excessive posterior slow (2–5 Hz)<br />
synchrony (PSS) was found in 58 children (10%). The incidence<br />
of PSS was significantly higher in children with<br />
complex febrile seizures – 42 from 141 (27 %) than in<br />
simplex febrile seizures – 16/446 (3.5%). Comments:<br />
Doose (1997) reported PSS in 64% of FS with later epilepsy<br />
and in 20% of FS with good prognosis. Our data suggest that<br />
visual and mathematical evaluation of the EEG may be<br />
important not only for electroclinical subclassification of<br />
FS but also for further genotypical studies. Supported in<br />
part by grant IGAMZCR-6258.<br />
FO-3-2<br />
A first locus for common simple febrile seizures<br />
R. Nabbout a,b,c , J.F. Prud’Homme b , A. Herman a ,J.<br />
Feingold a,e , A. Brice a,d,e , O. Dulac c , E. LeGuern a,d,e<br />
a INSERM U289, Hôpital Pitié-Salpêtrière,<br />
b Généthon,<br />
Evry, c Service de Neuro-Pédiatrie, Hôpital Saint Vincent<br />
de Paul, Paris, d Fédération de Neurologie, Hôpital Pitié-<br />
Salpêtrière, e Departement de Génétique, Cytogénétique et<br />
Embryologie, Hôpital Pitié-Salpêtrière, Paris, France
390<br />
Abstracts<br />
We report a large multigenerational French family with a<br />
homogeneous phenotype consisting of isolated simple FS.<br />
The FS trait did not show any linkage with the reported loci<br />
for FS and GEFS 1 . After a genome scan, a new locus for FS<br />
was identified. Patients and methods: This family was<br />
obtained through a national campaign for familial epilepsy.<br />
It consisted of 166 individuals in five generations. Affected<br />
members presented a history of simple FS that segregates as<br />
an autosomosal dominant trait. After exclusion of reported<br />
loci for FS and GEFS 1 , a genome-wide search was<br />
performed with 380 markers. Results: The clinical data<br />
were obtained from the parents and/or medical files. In the<br />
oldest generation, the status of all members was considered<br />
as unknown since their parents were not alive at the time of<br />
the present study. All FS occurred after 10 months of age<br />
and ceased before 5 years. Only two affected patients had a<br />
transitory anti-epileptic treatment. None presented a febrile<br />
seizure or epilepsy and all family members have a normal<br />
cognitive development. The genome wide search allowed<br />
the identification of a new candidate region (Z max ¼ 3:31 at<br />
q ¼ 0:00). Multipoint analysis and haplotypes construction<br />
confirmed the genetic linkage of this region to simple FS<br />
trait. Conclusion: Our family presents a homogeneous<br />
phenotype consisting of isolated simple FS, the commonest<br />
form of FS. A new locus is identified in this family and the<br />
sequence analysis of potential candidate genes is in<br />
progress.<br />
FO-3-3<br />
Infantile primary generalized epilepsy: benign epileptic<br />
syndrome during infancy<br />
E. Shahar a , S. Barak a , J. Andraus a , U. Kramer b<br />
a Child Neurology Unit and Epilepsy Service, Rambam<br />
Medical Center; b Haifa, Epilepsy Service, Dana Children’s<br />
Hospital, Tel-Aviv, Israel<br />
The present study delineates a benign generalized epileptic<br />
disorder during infancy and early childhood, which we<br />
termed infantile primary generalized epilepsy (IPGE), similar<br />
to PGE. It includes infants under the age of 4 years<br />
presenting with generalized clonic non-febrile seizures<br />
associated with generalized epileptic EEG discharges,<br />
favorable response to anti-epileptic drugs, and preserved<br />
cognition and speech. Twenty-five infants who fulfilled<br />
the inclusion criteria for IPGE, presenting at age 4–36<br />
months (mean: 17) with recurrent generalized short-lived<br />
clonic seizures, two also had status epilepticus. Eighteen<br />
infants (72%) had accompanying recurrent, commonly<br />
preceding, febrile seizures. Family history of seizures was<br />
detected in eight (32%). EEG showed generalized 3–4 Hz<br />
epileptiform discharges and normal background activity in<br />
21 (84%), with a photosensitive response induced in three.<br />
The larger group of 18 infants, mainly treated with valproate,<br />
promptly responded to therapy terminated after 2 years,<br />
with EEG normalization and no recurrence of seizures. A<br />
smaller group of seven patients require prolonged therapy<br />
that maintains them seizure-free, the EEG remains paroxysmal<br />
and seizure may recur if treatment is discontinued.<br />
Cognition and speech are intact in all children, but twelve<br />
are irritable with a short attention span. The data presented<br />
here delineates a unique generalized epileptic syndrome<br />
during infancy with a benign course, rapid response to therapy<br />
and preservation of cognitive skills, similar to adolescent<br />
PGE.<br />
FO-3-4<br />
Non-convulsive status epilepticus (NCSE) in children<br />
R. Koul, S. Qaboos<br />
<strong>University</strong> Hospital, BW-1, Children ward one, Alkhod,<br />
Oman<br />
Non-convulsive status epilepticus is a condition characterized<br />
by a cognitive or behavioral change, which lasts for<br />
at least 30 min, with EEG evidence of seizures. NCSE is<br />
uncommon in children and often seen after 10 years age.<br />
This form of status epilepticus (SE) is often missed and is<br />
picked up in epilepsy clinics, EEG laboratories and neurointensive<br />
care units. One must keep this condition in mind in<br />
patients with epilepsy who develop recent change in behavior,<br />
memory, unexplained ataxia, prolonged speech loss<br />
and prolonged inattention. The EEG is diagnostic. Various<br />
types of NCSE are absence SE, complex partial SE,<br />
Lennox-Gastaut SE, Landau-Kleffner SE, myoclonic astatic<br />
epilepsy of Doose status and electrical epilepticus of slow<br />
wave sleep. Eighteen patients of NCSE (26.5%) were seen<br />
over last 8 years out of total 68 patients with SE. Complex<br />
partial SE and Lennox-Gastaut SE formed six and five<br />
patients, respectively, making 61% of cases. Majority of<br />
literature supports aggressive management like convulsive<br />
SE. Twelve children were treated with iv midazolam, nine<br />
with additional phenytoin sodium while rest on oral antiepileptic<br />
drugs. Outcome was good in six, poor in six and<br />
recurrent attacks of NCSE were seen in four. Two patients<br />
were lost to follow up. NCSE should be kept in mind in<br />
children with epilepsy who develop change in behavior, loss<br />
of speech, prolonged inattention or automatisms, or confusional<br />
state. The management should be effective and<br />
adequate.<br />
FO-4<br />
Neuroscience/Genetics<br />
FO-4-1<br />
Genotype-phenotype correlation of glucose transporter-<br />
1 (Glut-1) deficiency syndrome<br />
D. Wang, J.M. Pascual, P. Kranz-Eble, H. Yang, M.G.<br />
Alvarez, R.P. Sun, D.C. De Vivo<br />
Colleen Giblin Laboratories for Pediatric Neurology<br />
Research, Columbia <strong>University</strong>, New York, NY, USA
Abstracts 391<br />
Glut-1 deficiency syndrome (Glut-1 DS) was first<br />
described in 1991. Since then, about 80 patients have been<br />
diagnosed. Glut-1 DS is characterized by infantile seizures,<br />
developmental delay, hypotonia, ataxia, acquired microcephaly,<br />
and hypoglycorrhachia (30–35 mg/dl). The clinical<br />
diagnosis can be confirmed by decreased glucose uptake<br />
into erythrocytes (46.8%), fluorescence in situ hybridization<br />
studies and molecular analysis of the GLUT-1 gene. We<br />
have screened 36 patients and identified pathogenic mutations<br />
including three cases of hemizygosity, 13 missense<br />
mutations, four nonsense mutations, three insertions, six<br />
microdeletions and three splice site mutations. The mutations<br />
tend to be private with two exceptions. A missense<br />
mutation (R333W) has been seen in three unrelated patients,<br />
and several missense mutations have been seen in three<br />
families at the R126 amino acid residue. There is a spectrum<br />
of clinical severity in this patient population. Patients are<br />
from relatively minor to severely disabled neurologically.<br />
The phenotype-genotype correlations thus far have<br />
remained elusive, although there is an emerging impression<br />
that the patients with the milder phenotypes tend to have<br />
less pathogenic missense mutations whereas the patients<br />
with the more severe phenotypes tend to have more pathogenic<br />
nonsense mutations or frame shift mutations that<br />
produce a stop codon. These preliminary observations are<br />
preliminary and subject to future modifications as more<br />
patients are investigated.<br />
FO-4-2<br />
Fukutin protein expression in developing human<br />
brainstem<br />
Yoshiaki Saito a,b , Makio Kobayashi c , Kayoko Saito a ,<br />
Masashi Mizuguchi d , Masayuki Itoh e , Sachio Takashima e ,<br />
Makiko Osawa a<br />
a Department of Pediatrics, Tokyo Women’s Medical<br />
<strong>University</strong>, Tokyo Japan; b Division of Pediatric Neurology,<br />
Yokohama Ryo-iku En; c Department of Pathology, Tokyo<br />
Women’s Medical <strong>University</strong>; d Department of Pediatrics,<br />
Jichi Medical School; e National Institute of Neuroscience,<br />
National Center of Neurology and Psychiatry, Japan<br />
FCMD results from fukutin gene defects and is characterized<br />
pathologically by polymicrogyria of the cerebral and<br />
cerebellar cortex, as well as brainstem anomalies including<br />
the aberrant pyramidal tract. In accordance with its<br />
predicted role in the regulation of corticogenesis, fukutin<br />
is expressed in neurons of the developing cerebral and cerebellar<br />
cortices. This time we examined immunohistochemically<br />
its expression in the brainstem structures, which has<br />
not been scrutinized. Antisera were raised in rabbits against<br />
synthetic peptides that correspond to amino acid residues of<br />
fukutin protein. Brainstem tissues were obtained at necropsy<br />
from 14 control subjects aged 13 gestational weeks to 1 year<br />
7 months. In the pons (n ¼ 9), fukutin was immunoreactive<br />
in neurons of the facial, trigeminal and pontine nuclei as<br />
well as the tegmentum areas including the locus ceruleus. In<br />
medulla oblongata (n ¼ 9), positive labeling was noted in<br />
the neurons of the vestibular, hypoglossal, ambiguus, arcuate<br />
and inferior olivery nuclei. During the first trimester,<br />
immunoreactivity (IR) was also noted in the subependymal<br />
germinal cell layer and the roof attachment area of fourth<br />
ventricle in the medulla oblongata. The IR in the pontine<br />
nucleus was limited in the outer areas during this period. IR<br />
was preserved in many of the above structures during early<br />
childhood. The spatial and temporal pattern of fukutin<br />
expression in the brainstem structures may suggest its role<br />
in the morphogenesis of brainstem, as well as possible<br />
abnormalities in brainstem function of FCMD patients,<br />
including sleep state maintenance, respiration and deglutition.<br />
FO-4-3<br />
Effective international collaboration in rare disease<br />
research: DNA banking in the interest of the community<br />
P.F. Terry a,b , S.F. Terry a,c , M.E. Davidson c , C.T. Driscoll d ,<br />
E.W. Johnson e<br />
a PXE International, Inc., Sharon MA, USA; b Directory of<br />
Consumer Advocacy, Genomic Health, Inc., Palo Alto, CA,<br />
USA; c Genetic Alliance, Washington, DC, USA; d Technology<br />
Transfer Office, NHGRI, NIH, Bethesda, MD, USA;<br />
e Barrow Neurological Institute, Neurogenetics, Phoenix,<br />
AZ, USA<br />
Susceptibility to genetic disease crosses national borders.<br />
International rare disorder laid advocacy groups accelerate<br />
and focus research efforts. A diverse set of international<br />
advocacy organizations, including those falling under the<br />
umbrella of larger groups such as The Genetic Alliance in<br />
the United States, have created small, niche repositories of<br />
biological materials or ‘biobanks’. These biobanks provide<br />
an invaluable asset to the research community by streamlining<br />
what is perhaps the most logistically difficult aspects of<br />
searching for a gene: local ‘red tape’, including accessing<br />
and collecting appropriate DNA samples, protecting patient<br />
confidentiality, recontacting/redrawing patients as needed,<br />
and making sure the patient community is regularly<br />
informed about progress in the field, often needing to be<br />
done in an international context. It is also an exceptional<br />
opportunity to empower these groups and the communities<br />
that support them and foster the global effort to find the<br />
causes and cures for these diseases. Pseudoxanthoma elasticum<br />
(PXE) international is a lay advocacy group that has<br />
served as a major player in advancing research into the<br />
biology and genetics of a rare genetic disorder, PXE. PXE<br />
International has been able to encourage a number of<br />
productive international collaborations in 21 countries<br />
throughout the world that have rapidly accelerated the<br />
research on PXE. The organization is also uniquely able<br />
to safeguard confidentiality by acting as both a bridge and<br />
a ‘firewall’ between researchers, participants, and govern-
392<br />
Abstracts<br />
mental organizations. Lessons learned from biobanking<br />
efforts, all born of advocacy, for different diseases, using<br />
different models, will be discussed.<br />
FO-4-4<br />
MeCP2 expression in human neocortex<br />
W.E. Kaufman, M.H. Jarrar, S.M. MacDonald<br />
Departments of Pathology, Neurology, Pediatrics, Psychiatry,<br />
and Radiology, The Johns Hopkins <strong>University</strong> School of<br />
Medicine, and the Kennedy Krieger Institute, Baltimore,<br />
MD, USA<br />
MeCP2 is a member of the methyl-CpG-binding family<br />
of proteins, which is involved in transcriptional repression.<br />
Rett syndrome is a disorder characterized by mental retardation<br />
and autistic features, which is associated in a majority<br />
of cases with mutations within the coding region of the<br />
MeCP2 gene. Considering that MeCP2 mutations are<br />
mainly associated with neurologic disorders, we examined<br />
the pattern of expression of MeCP2 in normal human frontal<br />
neocortex by immunoblotting using a battery of antibodies<br />
targeting different domains of the protein. In<br />
addition to our recent demonstration of extra-nuclear,<br />
mainly postsynaptic, MeCP2 immunoreactivity, we found<br />
that MeCP2 is expressed as two distinctive bands of ,75<br />
and ,100 kd. Both bands are better defined under higher<br />
denaturing conditions, suggesting that MeCP2 has a<br />
complex conformation in brain. The most abundant 75<br />
kd MeCP2 band is the predominant one in nuclear fractions<br />
and in bovine whole cortex, our technical control<br />
mammalian sample, with 75:100 kd ratios of 2.59 and<br />
2.23, respectively. In contrast, in human whole homogenates<br />
the 100 kd is expressed in a higher proportion with<br />
respect to the 75 kd (75:100 kd ratio: 1.80). This suggests<br />
that the 100 kd MeCP2, at this point of uncertain origin<br />
(posttranslational modification versus different isoform), is<br />
a major component of MeCP2’s extra-nuclear pool. These<br />
findings further support the concept that MeCP2 may link<br />
synaptic activity and other signaling processes with transcriptional<br />
regulation in neurons, a base for the predominant<br />
neurologic involvement shown by individuals with<br />
MeCP2 mutations.<br />
FO-5<br />
Cerebral Palsy (2)<br />
FO-5-1<br />
The normal tissue distribution of the neuroglobin gene<br />
and its expression under hypoxic-ischemic brain damage<br />
H.-Y. Wang, M.-Y. Deng, C.-G. Zhang<br />
Department of Pediatrics the General Hospital of the PLA,<br />
Beijing, China<br />
The globins are proteins famous for their oxygen-carrying<br />
capacity. Two types are known in vertebrates: hemoglobin<br />
and myoglobin. Recently neuroglobin (NGB) has<br />
been identified, mainly in the brain, which is a monomer<br />
with a high oxygen affinity. The globin has a distinct function<br />
similar to myoglobin. To investigate its function to a<br />
greater degree, we initially studied the normal distribution<br />
of the NGB gene in the brain. Using the nucleic acid in situ<br />
hybridization (ISH) and immunohistochemistry method,<br />
we found that NGB mRNA and NGB protein were abundant<br />
in the brain of the normal adult rat. A large number of<br />
NGB mRNA and NGB-immunoreactive (NGB-IR) positive<br />
cells were distributed in the neurons of the rat brain. They<br />
were both distributed in the cytoplasm of neurons. Notably,<br />
the number of NGB mRNA and NGB-IR positive cells in<br />
the cerebral cortex was much higher than in the hippocampus<br />
and cerebellum, especially in the piriform cortex.<br />
Secondly, the dynamic change of expression of NGB<br />
mRNA in cerebral tissue was studied by using an adult<br />
rat ischemic brain damage model and reverse transcription<br />
(RT)-PCR technique. We discovered that the expression of<br />
NGB gene showed a time-dependent pattern. It increased<br />
rapidly at 1 min after ischemia, kept at a high level at 5<br />
min, then returned to normal at 15 min. It then increased<br />
again, but more slowly. Finally, we studied the expression<br />
of NGB mRNA in 13 different tissues of humans. The<br />
result showed that there was high expression in fetal<br />
kidneys and normal adult livers, apart from the brain.<br />
FO-5-2<br />
Types and complications of 1192 cases with cerebral<br />
palsy<br />
Y.-K. Li a ,Q.Li b , Y.-J. Liu b , X.-S. Wen a<br />
a Qingdao Children Hospital, Qingdao City, China; b Rehabilitation<br />
Center for Cerebral Palsy, Jiamusi <strong>University</strong>,<br />
China<br />
We analyzed types and complications of 1192 cases with<br />
CP, come around China and hospitalized in Rehabilitation<br />
Center for Cerebral palsy, Jiamusi <strong>University</strong> during 1986–<br />
1997. Ages of those patients varied from 5 months to 7<br />
years 3 months, averaged 3 years 2 months. Purpose: This<br />
report provides basic data for studies of cerebral palsy in<br />
China. Results: On types of CP, spastic was 715 cases<br />
(60.0%), athetosis 287 (24.1%), mixed types 113 (9.5%),<br />
atonic 58 (4.9%), ataxia nine (0.7%), unclassified ten<br />
(0.8%), similar to the investigation of Narabayashi. In the<br />
spastic CP, quadriplegia was most, 375 cases (52.5%),<br />
diplegia 135 (18.9%), hemiplegia 83 (11.6%), double<br />
hemiplegia 77 (10.8%), triplegia 21 (7.3%), paraplegia<br />
13 (1.8%) and monoplegia 11 (1.5%). In the athetosis,<br />
quadriplegia was predominant (284 cases, 99.0%), only<br />
three cases of hemiplegia (1.0%). Complications of CP<br />
chiefly were MR, 567 cases (47.6%), principally found in<br />
spastic quadriplegia (53.6%), triplegia (57.1%), double<br />
hemiplegia (46.8%), athetosis (48.1%) and mixed type
Abstracts 393<br />
(54.0%), caused almost always by anoxia or asphyxia. But<br />
rates of MR in spastic hemiplegia, diplegia and paraplegia<br />
were lower (respectively 31.3, 25.2 and 15.4%). Other<br />
complications were dysopsia (114 cases, 9.6%), microcephalia<br />
(77, 6.5%), epilepsy (53, 4.5%), dysphasia (51,<br />
4.3%) and dysacousis (6, 0.5%). Dysopsia mainly occurred<br />
in spastic diplegia and quadriplegia, then microcephalia<br />
and epilepsy chiefly in spastic quadriplegia, and dysphasia<br />
mostly in spastic quadriplegia and athetotic quadriplegia.<br />
In the dysopsias, internal strabismus was most (73 cases,<br />
6.1%), occurring mainly in spastic quadriplegia (21) and<br />
diplegia (14). Others were external strabismus (13, 1.1%),<br />
optic atrophy (7, 0.6%), nystagmus (7, 0.6%) and dislocate<br />
of the lens (one case).<br />
FO-5-3<br />
A model of combination of pediatric clinical<br />
rehabilitation and community rehabilitation<br />
J.-N. Mai<br />
Neurological and Rehabilitating Department, Guangzhou<br />
Children’s Hospital, China<br />
In the past 15 years, many pediatric hospitals have set<br />
up rehabilitation department. A majority of children with<br />
neurological disorders, such as cerebral palsy, have been<br />
treated in the pediatric hospitals in the means of ‘comprehensive<br />
rehabilitation service program on bed’. In some<br />
hospitals, the rehabilitation service programs were carried<br />
out by rehabilitation doctors and their multi-disciplinary<br />
teams. Therefore, children with neurological damages<br />
could enjoy the rehabilitation service from acute, chronic<br />
and periods on beds and under the clinical condition, for<br />
example, prevention of CP could start in neonatal stage<br />
and the treatment of CP could be infantile period. Clinical<br />
rehabilitation on bed plays an important role in the prevention<br />
of CP and decreases the severity of disability in the<br />
children with high risk factors. Since the rehabilitation of<br />
motor dysfunction and disability must be long term or for<br />
life time, only clinical rehabilitation on bed could not meet<br />
the needs of these disabled children. Community and home<br />
site rehabilitation can be an ideal model which disabled<br />
children could benefit for life. A community rehabilitation<br />
service and home rehabilitation program can be set up with<br />
the help and long term supervision of experts from pediatric<br />
hospital which is in the place of top level. Therefore, a<br />
network which includes pediatric hospital, community<br />
rehabilitation service and home rehabilitation program<br />
can provide effective and economical service to children<br />
with neurological disorders. the children with high risk<br />
factors and abnormal function can receive early intervention<br />
program and early rehabilitation service on the hospital<br />
base, disabled children can enjoy long term or lifetime<br />
service on the site of community and home. Neurological<br />
and rehabilitation department in Guangzhou children’s<br />
hospital which is a top level hospital in the south China<br />
has played a positive role in constructing the network of<br />
neurological rehabilitation service for disabled children in<br />
the communities, home and the rural areas.<br />
FO-5-4<br />
Interrater reliability of a visual function checklist for<br />
cerebral palsy children with severe grade mental<br />
retardation<br />
C.H. Ko a , C.Y. Ko b , L. Chia b , C.C.H. Lo a , P.W.T. Tse a<br />
a Department of Paediatrics, b Department of Ophthalmology,<br />
Caritas Medical Centre, China<br />
Introduction: The visual function checklist (VFC) is an<br />
innovative behavioral tool to assess visual function in children<br />
with severe visual impairment or poor cooperation. It<br />
assesses the child’s response to light perception, abilities of<br />
visual exploration, fixation, following, distance viewing,<br />
grabbing, orientation, and the presence of optokinetic<br />
nystagmus. Methods: The subjects included 15 children<br />
with cerebral palsy and severe to profound grade mental<br />
retardation residing in the Developmental Disabilities Unit<br />
of Caritas Medical Centre. Patients with underlying<br />
syndrome disorders, poorly controlled epilepsy, respiratory<br />
diseases requiring oxygen therapy, concurrent acute<br />
ophthalmic or systemic infections were excluded from<br />
the study. Each child received repeated independent assessments<br />
by an ophthalmologist, paediatric neurologist, and<br />
optometrist with the VFC. The assessment was conducted<br />
in standardized settings. The results were converted into a<br />
visual quotient (VQ), with a range from 0 to 1. Each rater<br />
was blinded to the others’ scores. Intraclass correlation<br />
coefficients (ICC) were computed to determine the interrater<br />
reliability. Results: The mean VQs measured by the<br />
ophthalmologist, paediatric neurologist, and optometrist<br />
were 0.592 ^ 0.397, 0.597 ^ 0.390, and 0.615 ^ 0.431,<br />
respectively. The overall ICC was 0.873 (95% C.I.<br />
0.695–0.961). The ICC between the ophthalmologist and<br />
optometrist was 0.954 (0.837–0.987). The ICC between the<br />
ophthalmologist and neurologist was 0.747 (0.378–0.911),<br />
and the ICC between the neurologist and the optometrist<br />
was 0.838 (0.506–0.954). Discussion: The VFC has a high<br />
degree of interrater reliability across different disciplines of<br />
health care professions. It is particularly useful for children<br />
with multiple disabilities precluding accurate determination<br />
of visual acuity. It is also a useful tool to monitor<br />
treatment outcomes in this group of patients. (Acknowledgement:<br />
This Project is supported by a grant from S.K.<br />
Yee Medical Foundation 2000).
394<br />
Abstracts<br />
FO-6<br />
Seizure Disorders (2)<br />
FO-6-1<br />
Efficacy of ketogenic diet on intractable epilepsy in<br />
children: a report of 215 cases<br />
M. Ghofrani<br />
Mofid Children Hospital, Tehran, Iran<br />
The ketogenic diet is a high fat, low protein, low carbohydrate<br />
diet. This study is conducted to determine the<br />
effectiveness of ketogenic diet in epileptic children refractory<br />
to medication. A total of 215 children, age 2–12 years,<br />
who continued to have more than two seizure attacks<br />
weekly despite adequate therapy with at least two anticonvulsant<br />
medications, were enrolled in this study and<br />
followed for 1 month to 3 years. Ketogenic diet’s effectiveness<br />
was studied at the first, second and third follow<br />
ups (1st, 6th and 12th month, respectively). Tolerance to<br />
diet and adverse events secondary to ketogenic diet<br />
consumption were recorded. Two hundred and fifteen children<br />
with mean age of 5.1 years, averaged 235 seizures per<br />
month before the diet, despite an exposure to a mean of 6.6<br />
antiepileptic medications were enrolled. At 1 month follow<br />
up after the initiation of diet, 68.8% were seizure-free and<br />
11.7% had .50% decrease in seizure frequency. A total of<br />
98.3% of the patients had adhered to the diet regimen and<br />
reported at 1-month follow up. At 6 months, 44.5% were<br />
seizure-free and 21.7% had .50% decrease in seizure<br />
frequency. A total of 89.3% had observed the diet till the<br />
6th month and reported for follow up. At 12 months, 14.8%<br />
were seizure-free and 12.9% had .50% decrease in seizure<br />
frequency. A total of 57.2% continued with the ketogenic<br />
diet for 1 year and were observed. In conclusion, the ketogenic<br />
diet should be considered as effective treatment for<br />
epileptic children whose seizures remain refractory to treatment.<br />
It seems that ketogenic diet is more effective and<br />
cheaper than many new antiepileptic medications.<br />
FO-6-2<br />
Low-dose synthetic ACTH therapy for West syndrome:<br />
initial effects and long-term outcome<br />
M. Ito<br />
Kyoto Multi-Institutional Study Group of Pediatric Neurology,<br />
Shiga Medical Center for Children, Moriyama, Japan<br />
Background: Most Japanese pediatric neurologists<br />
attempt other treatments before using adrenocorticotropic<br />
hormone (ACTH) therapy for West syndrome (WS), and<br />
even then, they use only a low-dose synthetic ACTH to<br />
avoid serious adverse effects. In this multi-institutional<br />
study, we analyzed the initial effects, adverse effects and<br />
long-term outcome in patients treated with low-dose<br />
synthetic ACTH in Japan. Methods: We analyzed the medical<br />
records of 138 patients with WS, who were treated with<br />
low-dose synthetic ACTH therapy for the first time at our<br />
institutions between 1989 and 1998. Results: At the end of<br />
ACTH therapy, excellent effect on seizures was noted in<br />
106 out of 138 (76%) patients, good effect in 23 (17%), and<br />
poor effect in nine (7%). Initial effects on EEG were excellent<br />
in 53 out of 138 (38%) patients, good in 76 (55%) and<br />
poor in nine (7%). As for seizure prognosis at the time of<br />
follow-up, 51 out of 99 (52%) patients were seizure-free,<br />
while 48 (48%) patients had seizures. Mental outcome was<br />
normal in six out of 98 (6%) patients, mild MR in 16<br />
(16%), moderate MR in 26 (27%) and severe MR in 50<br />
(51%). The initial effects of ACTH on seizures and longterm<br />
outcome were not dose-dependent (daily dosage;<br />
0.005–0.032 mg/kg, 0.2–1.28 IU/kg, total dosage; 0.1–<br />
0.87 mg/kg, 4–34.8 IU/kg). The severity of adverse effects<br />
correlated with total dosage of ACTH and the severity of<br />
brain volume loss due to ACTH correlated well with the<br />
daily dosage and total dosage of ACTH. Conclusion: Lowdose<br />
synthetic ACTH therapy is as effective for the treatment<br />
of WS as the higher doses used in previous studies.<br />
The dosage of synthetic ACTH used in the treatment of<br />
WS can be decreased as much as possible to avoid serious<br />
adverse effects.<br />
FO-6-3<br />
Neurophysiological responses to novel stimuli in infants<br />
with infantile spasms<br />
K.G. Werner, T. Baldeweg, R.C. Scott, S. Boyd, B.G.R.<br />
Neville<br />
Neurosciences Unit, Institute of Child Health, London,<br />
United Kingdom<br />
Objectives: Infantile spasms (IS) are strongly associated<br />
with cognitive and social impairment, possibly related to<br />
abnormalities in frontal/temporal neuronal networks. In<br />
adults and older children novel environmental sounds elicit<br />
prominent event-related potentials (ERPs) in temporal and<br />
frontal cortices. The aims of this study were to determine<br />
whether similarly robust novelty ERPs can be recorded in<br />
infants and if they are abnormal in infants with IS. Methods:<br />
Twenty-four full term infants (age range 3–10 months)<br />
and 13 infants with IS (range 3–10 months) were recruited.<br />
EEG was recorded continuously from 19 electrodes (10–20<br />
system). An oddball paradigm was used with frequent<br />
tones (80%, 1 kHz), deviant tones (10%, 1.5 kHz) and<br />
brief novel environmental sounds (10%, 200 ms long),<br />
delivered binaurally (interstimulus interval 700 ms) via<br />
speakers at a distance of 30 cm. Infants were either asleep<br />
in stages I to II or awake and feeding. Three blocks were<br />
recorded, with 180 deviants and 180 novels. Results:<br />
Robust and reproducible ERPs to novels were detected in<br />
all normal infants, with peak to peak amplitudes of up to 25<br />
mV. They consisted of two components over the temporal<br />
(latency 250 ms) and fronto-central scalp (500 ms), respec-
Abstracts 395<br />
tively. In all patients with IS the novelty-ERPs showed<br />
markedly reduced amplitudes or delayed latencies in<br />
comparison with controls. Conclusions: Novelty-ERPs<br />
can be recorded reliably from 3 months of age. ERPs are<br />
different in children with infantile spasms compared with<br />
controls. The preliminary results support the hypothesis<br />
that there is altered temporal lobe processing in children<br />
with infantile spasms.<br />
FO-6-4<br />
Practice parameter: evaluating a first non-febrile<br />
seizure in children<br />
D. Hirtz, S. Ashwal, A. Berg, D. Bettis, C. Camfield, P.<br />
Camfield, P. Crumrine, R. Elterman, S. Schneider, S.<br />
Shinnar<br />
National Institute of Neurological Disorders and Stroke,<br />
Bethesda, MD, USA<br />
Objective: The Quality Standard Subcommittee of the<br />
American Academy of Neurology and the Practice Committee<br />
of the Child Neurology Society develop practice parameters<br />
as strategies for patient management based on<br />
analysis of evidence. For this practice parameter, the authors<br />
reviewed available evidence concerning the value of diagnostic<br />
testing after a first non-febrile non-provoked seizure<br />
in a child. Neonatal seizures and seizures lasting more than<br />
30 min or more were excluded. Methods: Multiple searches<br />
revealed relevant literature and each article was reviewed,<br />
abstracted, and classified. Recommendations were based on<br />
a three-tiered scheme of classification of the evidence.<br />
Results: There was sufficient evidence to provide a recommendation<br />
that an EEG be obtained routinely as part of the<br />
diagnostic evaluation. Other studies were recommended as<br />
based on specific clinical circumstances. Conclusions:<br />
Further studies are needed using large, well-characterized<br />
samples and standardized data collection instruments.<br />
Collection of data regarding appropriate timing as well as<br />
the choice of evaluations would be important.<br />
FO-7<br />
Neuroimaging (1)<br />
FO-7-1<br />
Prognostic value of combined use of general movement<br />
assessment and proton magnetic resonance spectroscopy<br />
in term infants affected by hypoxic-ischemic<br />
encephalopathy<br />
G. Rapisardi a , M. Cappellini b , M. Luce Cioni a , C. Ernst a ,C.<br />
Fonda b<br />
a NICU, Department of Pediatrics; b Pediatric Radiology<br />
Unit, A. Meyer Hospital, Florence, Italy<br />
Objective: To evaluate the neurodevelopmental (ND)<br />
prognostic value of the early combined use of Prechtl’s<br />
method of qualitative assessment of general movements<br />
(GMs) and proton magnetic resonance spectroscopy (1H<br />
MRS) in term infants affected by hypoxic-ischemic encephalopathy<br />
(HIE). Subjects and methods: 24 infants born at<br />
term transferred to our NICU for suspected HIE. All the<br />
infants had a 1 H MRS within the 1st week after admission,<br />
repeated GM assessments before discharge and then<br />
between 9 and 16 weeks post-term ( fidgety age) and the<br />
neurological outcome assessed at 12 months of age. Results:<br />
The 11 infants with a poor ND outcome (death or CP) had a<br />
significantly higher mean Lac/Cr and lower NAA/Cr at 1 H<br />
MRS than the 13 infants with a normal ND outcome<br />
(P , 0:05). All infants with normal GMs at 9–16 weeks<br />
had a normal ND outcome. Within the 15 subjects with<br />
signs of moderate to severe hypoxic-ischemic insults at 1 H<br />
MRS, the four who had a normal ND outcome had normal<br />
GMs before the discharge. Within the 18 subjects with<br />
abnormal GMs in the 1st week after admission, the seven<br />
who had a normal ND outcome had lower Lac/Cr and higher<br />
NAA/Cr in the first week of life. Conclusion: In term infants<br />
affected by HIE the combined use of GMs and 1 H MRS<br />
increases their specific separate ND prognostic value.<br />
FO-7-2<br />
Non-invasive focus localization using dipole modeling<br />
and EEG-assisted functional MRI in benign childhood<br />
epilepsy with centrotemporal spikes<br />
R. Boor, G. Vucurevic, G. Kutschke, T. Bauermann, S. Boor<br />
<strong>University</strong> Children’s Hospital, Department of Child<br />
Neurology, Mainz, Germany<br />
The localization of epileptic foci is an important issue in<br />
children with extratemporal epilepsies. However, the value<br />
of non-invasive methods such as dipole modeling of EEG<br />
spikes, and the EEG-assisted fMRI has not been sufficiently<br />
investigated in children. As a model of extratemporal<br />
epilepsies, we studied nine patients aged 4–13 (median<br />
10) years with benign rolandic epilepsy. Interictal EEGs<br />
were recorded with 23 channels and included four lower<br />
temporal electrodes. The spikes were averaged and the<br />
dipoles were modeled with the BESA 2000 program, and<br />
then imported into the anatomical 3D-MRI (T1-weighted<br />
3D-MPRAGE). Additionally, interictal spikes were<br />
recorded during the fMRI acquisition (BOLD, 1.5 Tesla,<br />
EPI T2-sequence, TR 6000 ms, TE 66 ms, matrix<br />
128 £ 128, slice thickness 6 mm, 16 transversal slices) on<br />
a MR-compatible battery-powered digital EEG system with<br />
16 channels. The fMRI sequences were correlated off-line<br />
with the EEG spikes and analyzed with the SPM 99 software.<br />
EEG source analysis demonstrated the spike onset in<br />
the central region (face or hand area) in all patients. The<br />
fMRI results were consistent with the modeled dipoles in<br />
five patients; we could not demonstrate fMRI activation<br />
despite active spiking in two patients, and two patients did<br />
not produce sufficient spikes (under sultiame treatment) for
396<br />
Abstracts<br />
fMRI analysis. In conclusion, we localized the interictal<br />
spikes in the central region in patients with rolandic epilepsy<br />
and confirmed these results by EEG-assisted fMRI. These<br />
techniques appear to improve focus localization in children<br />
with extratemporal epilepsies<br />
FO-7-3<br />
Quantitative measurement of hippocampal volume in<br />
children with epilepsy and clinical analysis<br />
L.-M. Ye<br />
Department of Neurology, Tianjin Children’s Hospital,<br />
China<br />
Objective: We aim to measure normal hippocampal<br />
volume of Chinese children with an age of 6–14 and the<br />
hippocampal volume loss of patients with epilepsy, to<br />
compare the reliability of two assessment methods, and to<br />
study patients with hippocampal volume loss. Methods:We<br />
selected 30 members for experiment group and 40 members<br />
for comparison group. We used Marconi 1.5 T.MR scanner<br />
to get hippocampal images, measured the right/left hippocampal<br />
volume, and then performed P testament after differential<br />
analysis. We analysed the relation between eight<br />
clinical data and different treatment effects. We examined<br />
the therapeutic effect of Topamax, the newly developed<br />
medicine for epilepsy. Result: Normative hippocampal<br />
volume: right: 0.5530 ^ 0.0458 cm 3 , left:<br />
0.5500 ^ 0.0495 cm 3 . Right/left differential value:<br />
0.0033 ^ 0.0250 cm 3 . The P for self-differential value and<br />
self-differential ratio: 0.000.Visual estimation for hippocampal<br />
loss: left: 0.0895 ^ 0.0243 cm 3 ; right:<br />
0.07 ^ 0.0183cm 3 . Diagnosis limit: right .0.05, left<br />
,20.05 cm 3 . Only 24.4% of traditional medicines for<br />
epilepsy are effective. Topamax presents obvious effects<br />
for controlling the attack of epilepsy and reaching normal<br />
EEG. Conclusions: Selective performance of hippocamal<br />
volume measurement is conducive to the diagnosis, treatment<br />
and prevention of epilepsy.<br />
FO-7-4<br />
The utility of neuroimaging in the evaluation of pediatric<br />
migraine and migraine-like headache<br />
V. Farkas, A. Nyquist<br />
Semmelweis <strong>University</strong>, Children’s Hospital, Budapest,<br />
Hungary<br />
The aim of this study was to collect data about the<br />
usefulness of neuroimaging in the diagnosis of pediatric<br />
patients suffering from migraine with aura as well as<br />
migraine-like headache accompanied by neurological deficient<br />
symptoms. Children and adolescents (range 6–15<br />
years) with a complaint specifically of migraine with<br />
aura (130 patients) classified according to the International<br />
Headache Society (IHS) criteria and migrainous disorder<br />
not fulfilling the IHS criteria of migraine (80 patients) were<br />
investigated. They had attacks with severe neurological<br />
deficient symptoms like sensory disturbances, dysphasia,<br />
dysarthria, unilateral short lasting hemiparesis with<br />
decreased level of consciousness. All patients underwent<br />
at the diagnosis a skull CT scan with intravenous contrast<br />
agent. During the follow-up period (3–8 years) 59 patients<br />
had a further neuroimaging by using of MRI because of<br />
progressive worsening of headache symptoms (a); longlasting<br />
unilateral slowing of the EEG background activity<br />
(b); newly developed headache symptoms (c): basilar<br />
migraine, ophtalmoplegic migraine and thunderclap headache.<br />
At the diagnosis CT scans in both group of patients<br />
revealed various non-significant pathologies of the CNS,<br />
but three otherwise healthy young children had findings<br />
thought to be clinical significant: Arnold-Chiari malformation<br />
I–II (one patient), cerebral arteriovenous malformation<br />
(two patients). By using MRI techniques during the followup<br />
period in 53 patients findings were normal or irrelevant<br />
to the headache, but in two patients with long lasting<br />
ophthalmoplegia a swollen oculomotor nerve with contrast<br />
enhancement was present and in four additional patients<br />
deep venous abnormality was detected. According to our<br />
results the greater resolution and discrimination of MRI,<br />
appeared to be of little clinical importance in the evaluation<br />
of pediatric migraineurs. Although there are some rare,<br />
unique headache types like ophthalmoplegic migraine,<br />
non-aneurysmal thunderclap headache that remain a diagnosis<br />
only by exclusion.<br />
FO-7-5<br />
Clinical and MR imaging study in term children with<br />
spastic diplegia<br />
Y. Kobayashi, S. Tanaka, A. Onuma<br />
Division of Pediatric Neurology, Takutoh Rehabilitation<br />
Center for Children, Sendai, Miyagi Japan<br />
In preterm children with spastic diplegia (preterm SD),<br />
the brain lesions on MRI have predominantly shown periventricular<br />
leukomalasia (PVL). Lesions of SD in term birth<br />
children (term SD) are, however, heterogeneous on MRI<br />
and distinct from preterm SD, although both have clinically<br />
been categorized as SD. We studied MR images of the brain<br />
in 61 terms SD (57 singletons, four twins, 36 males, 25<br />
females, mean age 14.2 ^ 5.1 years). The mean birth weight<br />
was 3027 ^ 326 g. The correlation was examined between<br />
clinical profiles and MRI findings. Our results showed: (1)<br />
MRI findings in term SD showed various lesions, PVL in<br />
seven, posthemorrhagic porencephaly in five, dysmyelination<br />
in four, brain infarction in three, brain anomalies in one,<br />
and others. No lesions on MRI were seen in 32 of 61 term<br />
SD (52.5%). (2) Perinatal complications were not so<br />
common, asphyxia in 14, respiratory distress in 5, seizures<br />
in 5 and feeding difficulty in 15. (3) Mental retardation was<br />
found in 44 children with term SD (72.1%). (4) Seizures and
Abstracts 397<br />
EEG abnormalities were more often observed in children<br />
with various lesions on MRI. MRI findings in term children<br />
with SD were more heterogeneous. The most common finding<br />
was no lesion on MRI. A different approach may<br />
provide some answers in term SD with normal MRI finding.<br />
Term SD seems to be associated with more severe disability<br />
than preterm SD. The pathogenesis of term SD remains to<br />
be studied further.<br />
FO-7-6<br />
Magnetic resonance imaging patterns of immediate<br />
brain damage and their evolution following ‘Shaken<br />
Baby Syndrome’<br />
R.A. Minns a , T.-Y.M. Lo a , M. McPhillips b , R.J. Gibson b<br />
a Department of Child Life and Health, <strong>University</strong> of Edinburgh,<br />
Edinburgh UK; b Department of Paediatric Radiology,<br />
Royal Hospital for Sick Children, Edinburgh UK<br />
The pathological consequences of acute rotation-deceleration<br />
injury that occur in ‘shaken baby syndrome’ are<br />
most comprehensively seen on MRI (Barlow et al., 1999).<br />
As part of an ongoing prospective study, a total of 72 MRI<br />
scans were obtained from a cohort of children who were<br />
scanned during the acute encephalopathic phase (20 infants)<br />
and during the follow-up period (38 children). The acute<br />
phase scan evaluation was based on the frequency of the<br />
following observations: (1) subtemporal, suboccipital and<br />
interhemispheric subdural haematoma; (2) tearing of pericerebral<br />
veins; (3) compartmentalisation and varying signal<br />
intensity of the subdural haematoma; (4) contusion and<br />
lacerations; (5) petechiae of the corpus callosum and the<br />
grey-white interface; (6) cerebral oedema; (7) intraventricular<br />
and subarachnoid haemorrhages; and (8) asphyxial<br />
injury. Seventeen of the 38 patients with long-term<br />
follow-up scans had equential MR imagings (a mean of<br />
four scans per child). Microencephaly occurred in 94% of<br />
these children on follow-up and diffuse or focal white matter<br />
atrophy was responsible for more than 50% of these cases.<br />
FO-8<br />
Infection/Immunology<br />
FO-8-1<br />
Effect of dexamethasone on nitric oxide synthase gene<br />
expression in endotoxemia in neonate rats<br />
H. Wang, X.-H. Du, Y.-B. Wu, B.-M. Wu<br />
Department of Pediatrics, The Second Clinical College,<br />
China Medical <strong>University</strong> Shenyang, China<br />
NOS played a role in endotoxemic brain injury, which<br />
has been increasingly concerned. The expression of three<br />
types of NOS mRNA in the brain and effects of dexamethasone<br />
on NOS and caspase-3 mRNA expression<br />
were investigated by RT-PCR in postnatal 7-day Wistar<br />
rats with acute endotoxemia established by intraperitoneal<br />
administration of Escherichia coli LPS. The results showed<br />
neuronal nitric oxide synthase (nNOS) and caspase-3<br />
mRNA were faintly expressed in the brain of normal<br />
control rats, while iNOS and endothelial nitric oxide<br />
synthase (eNOS) mRNA could not detected. The expressions<br />
of three types of NOS mRNA were weak at 2 h after<br />
acute endotoxemia (LPS 5 mg/mg), peaked at 6 h, thereafter<br />
reducing gradually to 24 h. The intensity of expression<br />
was nNOS . iNOS . eNOS. It was found that<br />
expression of NOS mRNA was inhibited in rats when<br />
dexamethasone was administered together with LPS (5<br />
mg/mg) with intensity of iNOS . nNOS . eNOS.<br />
Caspase-3 mRNA expression was increased at 2, 4 and 6<br />
h after acute endotoxemia, peaked at 24 h, and inhibited<br />
partially by dexamethasone administration. The results<br />
suggest that LPS-induced NO production induces apoptotic<br />
death of neurons through mechanism involving the<br />
caspase-3 activation, which may play an important role<br />
in the pathogenesis of brain injury during endotoxemia,<br />
and neuro-protective effects of dexamethasone may be<br />
partially realized through inhibiting the expression of<br />
NOS mRNA.<br />
FO-8-2<br />
Dynamic changes of brain derived neurotrophic factor<br />
(BDNF) mRNA after experimental bacterial meningitis<br />
and antibiotic treatment<br />
L. Li, Q.-X. Shui<br />
Affiliated Children’s Hospital, Zhejiang <strong>University</strong> School<br />
of Medicine, Hangzhou, China<br />
To investigate why mortality and neurologic deficits still<br />
occur following bacterial meningitis (BM) in children with<br />
newer and more potent antibiotics, we used in situ hybridization<br />
to study the mRNA expression of BDNF in the brain<br />
during the course of experimental meningitis and after antibiotic<br />
treatment in the rats (n ¼ 42). We established the<br />
animal models by inoculating Streptococcus pneumoniae<br />
(SP) intracisternally, and inoculating the same volume of<br />
normal saline suspension in uninfected control rats. BDNF<br />
protein was also evaluated by immunohistochemistry in the<br />
brain of SP inoculated rats. BDNF mRNA expression was<br />
obviously up-regulated at 24 h post-inoculation (p.i.)<br />
(0.13320 ^ 0.0275) (P , 0:01), then declined and still<br />
stronger (0.09403 ^ 0.00383) than that of control rats<br />
(0.06495 ^ 0.01241) on 5 days p.i. (P , 0:05), but downregulated<br />
and nearly undetectable in the brain of rats on 5<br />
days by antibiotic treatment for 3 days (0.03814 ^ 0.0120)<br />
(P , 0:01). Immunochemistry showed similar changes to<br />
mRNA expression, but the differences from mRNA expression<br />
was that BDNF protein had declined to normal levels<br />
on 5 days p.i. The results of the study support the hypothesis<br />
that BDNF might play a neuroprotective role in brain<br />
damage process of bacterial meningitis in rats. The expres-
398<br />
Abstracts<br />
sion of BDNF mRNA expression might be inhibited after<br />
antibiotic treatment, and this may weaken the endogenous<br />
neuroprotective ability. It might be one of the mechanisms<br />
of mortality and neurologic deficits following BM. Supplementary<br />
BDNF might be a possible therapeutic strategies to<br />
prevent brain damage.<br />
FO-8-3<br />
Spectrum of movement disorders in children with<br />
Japanese encephalitis: a clinicoradiological correlation<br />
U.K. Misra, J. Kalita<br />
Department of Neurology, Sanjay Gandhi PGIMS, Lucknow,<br />
India<br />
Background: A systematic evaluation of movement disorders<br />
in children with Japanese encephalitis (JE) is lacking.<br />
Aim: To evaluate the spectrum of movement disorders in<br />
children with JE and correlate these with MRI findings.<br />
Methods: Consecutive children with JE admitted to our<br />
institute were included. The diagnosis of JE was based on<br />
clinical, radiological and serological criteria. CT and MRI<br />
were carried out. The movement disorders were documented<br />
and their severity was graded on a 0–IV scale. Outcome<br />
was defined at 3 months on the basis of the Barthel Index<br />
score. Movement disorders were correlated with radiological<br />
findings and outcome. Results: Thirty consecutive children<br />
(eight females) with JE whose mean age was 11.2 years<br />
were included. In the acute stage mean Glasgow coma scale<br />
(GCS) score was 7.4 and 13 had seizures. CT scan was<br />
abnormal in nine out of 26 revealing thalamic lesion in<br />
nine, basal ganglia, substantia nigra and pons in one each.<br />
Cranial MRI was abnormal in 22 out of 27 patients revealing<br />
thalamic lesions in 19, basal ganglia nine, substantia nigra<br />
16 and pons two. Movement disorders were noted in 25<br />
patients after 1–4 weeks of ictus. Parkinsonian features<br />
were present in all and dystonia in 18 patients. Dystonia<br />
involved trunk and limbs mainly but three patients had<br />
mouth open dystonia. Dyskinesia was present in nine<br />
patients. There was no statistical correlation of the various<br />
movement disorders with MRI changes (P . 0:05). Patients<br />
with movement disorders had poorer outcome at 3 months<br />
compared to those without (P , 0:01) and patients with<br />
dystonia had worse outcome compared to parkinsonian<br />
features only. Conclusion: A wide variety of movement<br />
disorders are common in children with JE. Presence of<br />
dystonia is associated with poor outcome.<br />
FO-8-4<br />
Acute necrotizing encephalopathy of childhood:<br />
radiologic and pathologic features of thalamic lesions<br />
M. Mizuguchi a , M. Hayashi b , Y. Nakai c , M. Itoh c ,S.<br />
Takashima c<br />
a Department of Pediatrics, Jichi Medical School, Minamikawachi,<br />
Tochigi; b Department of Clinical Neuroscience,<br />
Tokyo Metropolitan Institute for Neuroscience, Fuchu;<br />
c Department of Mental Retardation and Birth Defect<br />
Research, National Institute of Neuroscience, Kodaira,<br />
Japan<br />
Acute necrotizing encephalopathy of childhood (ANE), a<br />
fulminant parainfectious disorder prevalent in Japan and<br />
Taiwan, is characterized by multiple, symmetrical brain<br />
lesions affecting the bilateral thalami, putamina and cerebral<br />
white matter. To elucidate the pathomechanism of ANE, we<br />
studied cranial CT and MRI findings of 14 patients, and<br />
necropsy findings of four of them. In all the cases, CT<br />
demonstrated thalamic hypodensity as soon as coma developed.<br />
After the 3rd day of illness, the center of thalamic<br />
lesions of most cases became hyperdense, producing a<br />
concentric appearance which was further evident on MRI.<br />
Neuropathologic examination revealed laminar changes of<br />
vascular and parenchymal pathology. Excessive permeability<br />
of blood vessels and resultant vasogenic edema became<br />
more prominent with increasing depth from the cerebral<br />
surface. The deep portion of the lesions showed severe perivascular<br />
hemorrhage, accounting for the central high<br />
density on CT. These results indicate that brain lesions of<br />
ANE are caused by local breakdown of the blood–brain<br />
barrier.<br />
FO-8-5<br />
The outcome of severe pediatric Guillain-Barre<br />
syndrome seen in a tertiary hospital: supportive care<br />
alone vs. intravenous immunoglobulin treatment and<br />
supportive care<br />
A.L.F. Luat<br />
Child Neuroscience Division, Philippine Children’s Medical<br />
Center, Quezon City, Philippines<br />
Objective: To compare the outcome of the pediatric<br />
patients with severe Guillain-Barre syndrome (GBS) who<br />
received supportive care alone with the outcome of those<br />
who received intravenous immunoglobulins plus supportive<br />
care. Methods: This was a 6-year retrospective, descriptive,<br />
cross-sectional study. Among the 48 patients diagnosed to<br />
have GBS during the study period, 37 were included.<br />
Twenty four received supportive care alone, while 13<br />
received intravenous immunoglobulins in addition to<br />
supportive care. The main outcome criterion was the<br />
improvement by at least one functional grade within 28<br />
days after the onset of illness. The secondary outcome<br />
criterion was the ability walk unaided within 42 days of<br />
the onset of illness. Other outcome measures were the<br />
mean length of hospitalization, mean length of intensive<br />
care unit stay and mean duration of intubation. Results: A<br />
total of 69% of the patients in the IVIG group improved by<br />
one functional grade within 28 days after the onset of illness<br />
compared to 41% of the patients who received supportive<br />
care alone. Similarly, 69% of the patients in the IVIG group
Abstracts 399<br />
were able to walk unaided within 42 days, compared to 37%<br />
of the supportive care group. The results however did not<br />
reach statistically significant difference with p values of<br />
0.0873 and 0.0652, respectively. There was also no statistically<br />
significant difference in the duration of hospitalization<br />
between the two groups (IVIG-17 days, supportive care-19<br />
days; P-value ¼ 0.5569). Similarly, although there was a<br />
trend towards shorter days of intubation and ICU stay in<br />
the IVIG group, the results did not reach statistical significance.<br />
In the supportive care group, one had hypoxic<br />
ischemic encephalopathy and one died due to sepsis.<br />
Conclusions: This restropective study showed that though<br />
there was a trend towards benefits in favor of the IVIG group<br />
in all outcome measures, the difference did not reach statistical<br />
significance.<br />
FO-8-6<br />
Neuroradiological diagnostic and prognostic features of<br />
tuberculous meningitis in childhood<br />
S. Andronikou a , B. Smith a , R. van Toorn b , H. Douis a , J.M.<br />
Wilmshurst b<br />
a Department of Pediatric Radiology, and b Department of<br />
Pediatric Neurology, Red Cross Children’s Hospital,<br />
School of Child and Adolescent Health, <strong>University</strong> of<br />
Cape Town, Cape Town, South Africa<br />
We present our clinical experience of affected patients<br />
and correlating neuroradiological features. Methods: The<br />
study composed of a retrospective review of all CT scans,<br />
clinical and laboratory findings in children presenting with a<br />
provisional diagnosis of TBM between 1998 and 2001. CT<br />
scans were assessed with regard to the presence of imaging<br />
features such as basal meningeal enhancement, hydrocephalus,<br />
infarction and tuberculomata. Patients were defined as<br />
those with definite proof of TBM (TB CSF culture positive),<br />
those with circumstantial proof of TBM (clinical presentation<br />
and consistent CSF features) and those without<br />
evidence of TBM. Correlation was made between the<br />
presence and severity of meningeal enhancement with<br />
presentation, proof of TB and outcome, initially concentrating<br />
on the CSF culture positive group and then including the<br />
probable group. Results: Seventy-two patient records were<br />
reviewed, from the group 19 patients (seven M:12 F) were<br />
CSF culture positive and 40 (24 M:16 F) were clinically<br />
consistent with a diagnosis of TBM. The youngest patient<br />
was 3.3 months and the oldest was 12 years with a median of<br />
16 months for the culture positive group. The clinical<br />
features in the two groups were summarized and statistically<br />
compared with no significant difference found. The<br />
commonest positive CT finding of the affected patients<br />
was basal meningeal enhancement, followed by hydrocephalus,<br />
cisternal high-density exudate prior to IVI contrast,<br />
infarction and TB granulomas. Conclusion: From this an<br />
inclusion criterion has been devised, including the neuroradiology,<br />
to enhance the early confirmation of TBM.<br />
Current established guidelines are lacking this.<br />
FO-9<br />
Genetics/Molecular Pathology<br />
FO-9-1<br />
Docosahexaenoic acid induced opening of voltage-gated<br />
K channels prevents repetitive firing in neurons<br />
D. Erichsen a , X.-P. Xu b , F. Elinder a<br />
a Department of Neuroscience, and The Nobel Institute for<br />
Neurophysiology, Karolinska Institute, Stockholm, Sweden;<br />
b Department of Pediatrics, the First Hospital of Harbin<br />
Medical <strong>University</strong>, Harbin, China<br />
Epilepsy is a brain disorder characterized by recurrent<br />
seizures caused by the synchronous firing of large groups<br />
of neurons. About 25–30% of epileptic children are intractable<br />
to the conventional anti-epileptic drug treatment.<br />
However, the ketogenic diet (KD) could be an effective<br />
option for them. In order to investigate the mechanism of<br />
the KD anticonvulsant action from the effect of free fatty<br />
acids (FFAs) and ketone bodies on voltage-gated K channels,<br />
we carried out the study with the two-electrode voltage<br />
clamp technique on the Shaker K channel expressed in<br />
Xenopus oocytes and measured currents through channels<br />
with the concentrations changed from those before treatment<br />
to those during treatment. The results showed docosahexaenoic<br />
acid (DHA), eicosapentaenoic acid (EPA) and<br />
linoleic acid (LA) within clinically relevant concentrations<br />
for the KD open the K channel by shifting the G (V) in<br />
negative direction. A total of 30 mV DHA shifts the G (V)<br />
curve with 22.3 ^ 0.4 mV (n ¼ 3). In experiments with<br />
200 mg/l albumin, 100 mM DHA did not shift the G (V)<br />
curve. At the concentration of 100 mM, EPA and LA,<br />
respectively, shift the G (V) curve with 25.0 ^ 2.2<br />
(n ¼ 3) and 24.0 ^ 0.4 mV (n ¼ 3). In contrast, similar<br />
experiments performed for ketone bodies (b-hydroxybutyric<br />
acid and acetoacetate) showed no effect at all. Computer<br />
simulations of a simple excitable system showed that repetitive<br />
firing is completely abolished at all stimulating<br />
currents when the voltage dependence of the K channels<br />
in shifted as little as 22 mV. The present findings open<br />
up a new mechanism for anti-epileptic treatment.<br />
FO-9-2<br />
Glucose transporter (GLUT1) deficiency without<br />
epilepsy, an unusual cause for developmental delay<br />
W.C.G. Overweg-Plandsoen a , J.E.M. Groener b , O.F.<br />
Brouwer c , H.D. Bakker d , D.C. De Vivo e<br />
a Department of Pediatric Neurology,<br />
b Department of<br />
Pediatrics, Leiden <strong>University</strong> Medical Center, LEIDEN,<br />
The Netherlands; c Groningen <strong>University</strong> Center: Department<br />
of Pediatric Neurology; d Academic Medical Center
400<br />
Abstracts<br />
Amsterdam: Department of Pediatrics; e Columbia Presbyterian<br />
Medical Center New York: Department of Neurology,<br />
USA<br />
The case of a 7.5 year old boy will be presented. His<br />
psychomotor development was delayed and especially his<br />
ability to walk remained poor due to imbalance. His<br />
parents reported fluctuations during the day. He never<br />
had epileptic seizures. The neurological and psychological<br />
examinations showed a TIQ (WIPPSI-R) of 61, a cerebellar<br />
syndrome, signs of involvement of the pyramidal tract<br />
and dystonic posturing of the arms while walking. Examinations<br />
for detecting the cause of the retardation were<br />
performed. The EEG and MRI-brain were without abnormalities.<br />
The results of the metabolic screen showed a serum<br />
lactate of 2.3 mmol/l. Lactate in CSF was low (0.85 mmol/<br />
l). The CSF/plasma ratio of glucose was low twice (0.31<br />
and 0.34, normal value .0.6) indicating a deficiency of<br />
glucose transport across the blood–brain barrier. In De<br />
Vivo’s laboratory the GLUT1 deficiency was confirmed<br />
in erythrocytes, DNA analysis is underway. Although this<br />
patient does not have epilepsy he has been treated with a<br />
ketogenic diet to provide an alternative energy source and<br />
to try influencing his neurological symptoms. There seems<br />
to be amelioration of the neurological symptoms after 3<br />
months of using the diet. An overview will be presented<br />
of the symptoms of ‘De Vivo’ disease. Epilepsy is present<br />
in all patients except in this one. The disease is autosomal<br />
dominant, the gene is located on chromosome 1. This is the<br />
first case of GLUT1 deficiency without epilepsy.<br />
FO-9-3<br />
Immunological pathogenesis of the allergic neuropathy<br />
induced by lipopolysaccharide of Campylobacter jejuni<br />
Y.-X. Gao, F.-C. Cai<br />
Department of Neurology, Chongqing Children’s Hospital,<br />
Chongqing <strong>University</strong> of Medical Science, Chongqing,<br />
China<br />
Objective: To investigate the immunological pathogenesis<br />
of neuropathy induced by Campylobacter jejuni (CJ)<br />
LPS. Methods: (1) The specific anti-CJ LPS IgG antibody<br />
was purified from the sera of immunized rats by affinity<br />
chromatography; (2) pathologic examination of sciatic<br />
nerve was performed after perineural injection by specific<br />
anti-CJ LPS IgG antibody; (3) the affinity of the specific<br />
anti-CJ LPS IgG antibody to the sciatic nerves of normal<br />
rat or human was detected by immunohistochemistry<br />
(streptavidin-biotin-peroxidase complex (SABC) and fluorescein<br />
isothiocyanate (FITC)-immunofluorescent method);<br />
(4) expression of the specific CJ LPS IgG in the pathological<br />
nerves was detected by immunohistochemistry; and<br />
(5) Expression of tumor necrosis factor alpha (TNF-a)<br />
mRNA in damaged nerves was detected by in situ hybridization<br />
histochemistry. Results: (1) Significant lesion of<br />
sciatic nerves caused by the specific antibody of CJ LPS<br />
was observed. The incidence of pathologic fibers (20.7%)<br />
was much higher than that of control group (4.8%),<br />
P , 0:01; (2) strong conjugation of the specific anti-CJ<br />
LPS antibody with the sciatic nerves of normal rat or<br />
human was confirmed by immunohistochemistry; (3) the<br />
specific IgG was strongly deposited in nerves with axonal<br />
degeneration and mixed lesion. However there was sparse<br />
IgG deposition in 60% nerves with demyelination; (4) there<br />
was high expression of TNF-a mRNA in 84% of pathological<br />
nerves after repeated immunization by CJ LPS and no<br />
expression of TNF-a mRNA in that of control group.<br />
Conclusion: CJ LPS could induce peripheral neuropathy,<br />
result in more expression of specific antibody and TNF-a<br />
on pathological fibers. This might be an important factor in<br />
the pathogenesis of patients of CJ-associated GBS.<br />
FO-9-4<br />
Platelet-derived growth factor and its receptor in<br />
muscular dystrophies<br />
Y.-J. Zhao a,b , K. Haginoya a , K. Iinuma a<br />
a Department of Pediatrics, Tohoku <strong>University</strong> School of<br />
Medicine, Sendai, Japan;<br />
b Department of Pediatrics,<br />
Second Clinical College of China Medical <strong>University</strong>,<br />
Shenyang, China<br />
We examined the immunological localization of platelet-derived<br />
growth factor (PDGF)-A, PDGF-B, and PDGF<br />
receptor PDGFR alpha and beta to clarify their role in the<br />
progression of human muscular dystrophy. Biopsied<br />
frozen muscle from patients with DMD, BMD, and<br />
CMD were analyzed immunohistochemically using antibodies<br />
raised against PDGF-A, PDGF-B, PDGFR alpha<br />
and beta. In normal control muscle, neuromuscular junctions<br />
and vessels were positively stained with antibodies<br />
against PDGF-A, PDGF-B, PDGFR alpha and beta. In<br />
dystrophic muscle, PDGF-A, PDGF-B, PDGFR alpha<br />
and PDGFR beta were strongly immunolocalized in the<br />
regenerating muscle fibers and infiltrating macrophages.<br />
PDGFR alpha was also immunolocalized at the muscle<br />
fibers sarcolemma and endomysial connective tissue. The<br />
most significant finding in this study was a remarkable<br />
over-expression of PDGFR beta in the endomysium in<br />
DMD and CMD muscles. Double immunolabeling<br />
revealed that activated interstitial fibroblasts were clearly<br />
positive for PDGFR beta. These findings indicate that<br />
PDGF and its receptors have an important role in the<br />
proliferation of fibroblasts, which leads to muscle fibrosis<br />
in DMD and CMD. They also have role in muscle fiber<br />
regeneration and signaling at neuromuscular junctions in<br />
normal and diseased muscle.
Abstracts 401<br />
FO-9-5<br />
A novel autosomal dominant hereditary motor and<br />
sensory neuropathy with intermediate conduction<br />
velocities in six children<br />
Y. Pan a , F.P. Thomas a,b , F. Gondim a , L.J. Kinsella a , M. Al-<br />
Lozi c , J.A. Antenor a , T.J. Geller a , S.S. Scherer d ,P.De<br />
Jonghe e , V. Timmerman e<br />
a Department of Neurology, Saint Louis <strong>University</strong> School of<br />
Medicine, St. Louis, MO, USA; b St. Louis Veterans Administration<br />
Hospital, Institute for Molecular Virology, Department<br />
of Molecular Microbiology and Immunology, Saint<br />
Louis <strong>University</strong>; c Department of Neurology, Washington<br />
<strong>University</strong>, St. Louis, MO, USA; d Department of Neurology,<br />
<strong>University</strong> of Pennsylvania Medical Center, Philadelphia,<br />
PA, USA; e Peripheral Neurology Group, Department of<br />
Neurology and Molecular Genetics, <strong>University</strong> of Antwerpen,<br />
Antwerpen, Belgium<br />
Charcot-Marie-Tooth disease (CMT) encompasses multiple<br />
heterogeneous hereditary neuropathies linked to numerous<br />
genetic loci and genes. We diagnosed CMT in five girls<br />
and one boy, ages 5–14, among 20 children from a fourgeneration<br />
family with a novel genotype and phenotype.<br />
Walking age was normal; disease onset was in the 1st decade.<br />
The central and autonomic nervous systems and cranial<br />
nerves were uninvolved. Heel walking was impaired in<br />
five; otherwise strength was normal. Tremor was present in<br />
four, distal atrophy in one. Hyporeflexia was present in three.<br />
Sensation was impaired in five. Romberg sign, nerve enlargement<br />
and foot deformities were absent. Neurophysiologic<br />
studies were normal in two children (ages 5 and 9). One child<br />
(age 7) had borderline sural nerve conduction velocities<br />
(NCV, m/s) of 41; a 2nd (age 8) had abnormal NCVs of 42<br />
(peroneal), 39 (tibial) and 40 (sural); a 3rd (age 10) had a<br />
borderline motor peroneal amplitude; a 4th (age 14) had<br />
NCVs of 45 (median), 32 (peroneal) and 37 (tibial), low<br />
sensory nerve action potential amplitudes and distal muscle<br />
denervation. No peripheral myelin protein 22, myelin protein<br />
zero, connexin-32, early growth response gene 2, or neurofilament<br />
light chain gene mutations were found. Linkages to<br />
the CMT1A, CMT1B, CMT1D, CMT2A, CMT2D, CMT2E,<br />
CMT2F loci and the intermediate NCV loci on chromosomes<br />
19p12–p13.2 and 10q24.1–q25.1 were excluded. A genomewide<br />
search is in progress. This study describes the clinical,<br />
electrical and genetic features of a novel, axonal and demyelinating<br />
autosomal dominant polyneuropathy with intermediate<br />
NCV; a new gene locus is likely.<br />
FO-9-6<br />
The value of serum neuron specific enolase and SPECT<br />
rCBF imaging in children with status epilepticus<br />
Y. Ouyang, Q. Peng, F.-G. Mu<br />
Sichuan Provincial Hospital, No32, first ring road in<br />
western, Chengdu, China<br />
Objective: To explore the value of serum neuron specific<br />
enolase (NSE) and SPECT rCBF imaging in the evaluation<br />
of brain injury of SE in children. Methods: Serum NSE was<br />
detected through ABC-ELISA method. Serum NSE was<br />
performed in 28 status epilepticus within 24 h after seizure<br />
attacks, and in 40 normal controls. Ten of SE cases had<br />
serum NSE detection at 1, 3 and 7 days. SPECT rCBF<br />
imaging was performed in 15 of status epilepticus. Results:<br />
The mean serum NSE in SE patients was 15.13 ^ 6.22 mg/l,<br />
which was higher than that of normal controls(mean<br />
2.635 ^ 0.765 mg/l, P , 0:001); the serum NSE returned<br />
to normal at 7th day and these children’s long-term outcome<br />
was better. The SPECT rCBF imaging abnormal rate in 15<br />
SE was 73.4%. In SE patients with acute etiological factors,<br />
rCBF abnormal region was larger than those with chronic<br />
etological factors. Conclusion: Status epilepticus in children<br />
can cause brain injury. The serum NSE is a reliable marker<br />
of brain injury. Observation of serum NSE may predict<br />
long-term neurological outcome. SPECT rCBF imaging<br />
abnormalities in childhood status epilepticus might be of<br />
help in the evaluation of brain injury. Therefore, serum<br />
NSE and SPECT rCBF imaging in children with SE may<br />
be very useful to assess the degree brain injury and longterm<br />
outcome.<br />
FO-10<br />
Neuroimaging (2)<br />
FO-10-1<br />
Variability in clinical and neuroimaging presentation in<br />
congenital bilateral perisylvian polymicrogyria (CBPP)<br />
in pediatric patients<br />
R.M. Valério, F.N. Arita, S. Rosemberg<br />
Neuropediatrics Division, Department of Pediatrics, Santa<br />
Casa de Sao Paulo Medical School, Sao Paulo, Brazil<br />
CBPP refers to a clinicopathological syndrome characterized<br />
by a particular type of neuronal migratory disorder<br />
easily detected through MRI. The most frequent clinical<br />
signs include dysarthria, abnormal tongue movements,<br />
dysphagia, pyramidal signs, epilepsy and mental retardation.<br />
We report ten patients calling attention to the variability<br />
of clinical presentation and MRI findings in CBPP.<br />
There were five males and five females. There were no<br />
familial cases. The pregnancy was uneventful in eight.<br />
Toxoplasmosis was detected and treated during the 4th<br />
month of pregnancy in one case and in the remaining, the<br />
mother was drug addicted. Age at first consultation ranged<br />
from 7 months to 14 years (mean: 5.2 years). Eight patients<br />
were referred for developmental delay, one for seizures and<br />
one for speech disturbance. Four patients were microcephalic,<br />
and macrocephaly was observed in one. Three patients,<br />
all under 2 years of age were severely handycaped. Motor<br />
examination was normal in two patients. Pyramidal and/or<br />
extra-pyramidal signs were observed in the remaining five.
402<br />
Abstracts<br />
Pseudo-bulbar sings were detected in nine patients. Six<br />
patients had epilepsy whose onset varied between ages of<br />
10 months and 12 years (mean: 3.5 years). MRI revealed<br />
relatively symmetrical bilateral perisylvian polymicrogyria<br />
in nine patients and in one the alteration predominated on<br />
the right side. In addition, bifrontal periventricular nodular<br />
heterotopia, bifrontal schizencephaly, and biparietal schizencephaly<br />
were associated in three cases. In conclusion,<br />
CBPP is not a homogeneous cortical developmental malformation.<br />
It is worth mentionning that in this series of no<br />
familial cases, the incidence of intractable epilpsy was<br />
30% and CBPP may be accompanied by other disorders<br />
of cortical development.<br />
FO-10-2<br />
Attention deficit hyperactivity disorder: subtypes and<br />
1 H-magnetic resonance spectroscopic characteristics<br />
Z. Jin a , Y.-W. Zeng a , L. Sun b , G. Liu a , Y. Wang a , Y.-F.<br />
Wang b<br />
a fMRI Center, Hospital 306, Beijing, China; b Mental Institute,<br />
Peking <strong>University</strong>, Beijing, China<br />
Background: According to DSM-IV, the patients with<br />
ADHD could be divided into three clinical subtypes, those<br />
were different in demographic characteristics, functional<br />
impairment, and comorbidity with other disorders. Thus,<br />
we hypothesized that there would be different neurochemical<br />
status among the patients. Methods: Thirty-four<br />
untreated school children suffering from ADHD (inattentive<br />
subtype ADHD-IA, n ¼ 19; hyperactive/impulsive subtype<br />
ADHD-HI, n ¼ 4; combined subtype ADHD-C, n ¼ 11)<br />
were investigated by using 1 H-MRS. Spectra were acquired<br />
bilaterally in the globus pallidus. Peaks of NAA, Cho, myoinositol,<br />
glutamate and creatine (Cr) were measured and<br />
their ratios were calculated and compared with data from<br />
matched controls. Results: All three subtypes showed significant<br />
decreased NAA/Cr ratios comparing with normal<br />
controls. Among them the ADHD-C subtype had the lowest<br />
NAA/Cr value. ADHD-IA and ADHD-C subtypes appeared<br />
mild increased Cho/Cr ratios, while the value in ADHD-HI<br />
group was decreased. Conclusion: These findings suggested<br />
that striatal neuronal death or dysfunction exits in all the<br />
three ADHD subtypes. Among them ADHD-C subtype was<br />
the most severe one. There seemed to be a mild hyperactivity<br />
of the cholinergic system in ADHD-IA and ADHD-C<br />
subtypes, but not the ADHD-HI subtype.<br />
FO-10-3<br />
Single photon emission computed tomography (SPECT)<br />
in attention deficit hyperactivity disorder (ADHD) –<br />
baseline and post intervention<br />
S. Gulati a , V. Kalra a , C.S. Bal b , H. Zamir a<br />
a Departments of Pediatrics and Nuclear Medicine; b All<br />
India Institute of Medical Sciences, New Delhi, India<br />
Background: ADHD is a common childhood neurobehavioral<br />
disorder. Objective: To study the cerebral perfusion<br />
abnormalities in children with ADHD. Materials and methods:<br />
A randomized double blind placebo controlled trial to<br />
evaluate the efficacy of a polyherbal formulation, Mentat<br />
(Bacopa monnieri, Withania somnifera, Centella asiatica,<br />
Nardostachys jatamanasi) in 60 children with ADHD<br />
(DSM IV criteria). Subjects were randomised into Mentat<br />
(30) and placebo groups (30). Cerebral perfusion was evaluated<br />
using 99mTc ethyl cystine dimer brain SPECT in a<br />
subset of 37 children whose parents gave consent. SPECT<br />
images were acquired using a dual-headed gamma camera<br />
system with fan beam – collimator (Elscint varicans).<br />
SPECT scans were performed at baseline (37) and if abnormal<br />
(26), repeat at 6 months. Consent for post intervention<br />
repeat scan was obtained in 12/26 with abnormal SPECT.<br />
Results: Thirty-seven ADHD children age range 5–14<br />
years, boys predominated (30). Abnormal cerebral perfusion<br />
was seen in 26/37 (70.2%) (P ¼ 0:006). Twenty-four/<br />
37 (64.8%) had hypoperfusion in thalamus and/or basal<br />
ganglia. Two had temporal and basifrontal hypoperfusion<br />
respectively. Among 12 follow up scans, decoding at the<br />
end of the trial revealed six from either group. In Mentat<br />
group 3/6 (50%) showed post treatment normalization of<br />
perfusion abnormality versus 1/6 (16.6%) in placebo group<br />
(P ¼ 0:11). Conclusions: A statistically significant proportion<br />
of children with ADHD had thalamic and/or basal<br />
ganglia hypoperfusion. The area identified may help to<br />
understand the anatomic substrates in this entity. SPECT<br />
abnormalities may in future be used to evaluate and monitor<br />
therapy outcomes in ADHD.<br />
FO-10-4<br />
Correlation of long-term intellectual and<br />
neuropsychological effects of closed head injury in<br />
infants and children using proton MR spectroscopy<br />
S. Ashwal, B.A. Holshouser, T. Brenner, M.C. Freier, T.<br />
Burley<br />
Radiology and Psychology, Departments of Pediatrics,<br />
Loma Linda <strong>University</strong>, Loma Linda CA, USA<br />
The ability to predict long-term neurologic and neuropsychological<br />
outcome in 22 children, ages 1 week to 14<br />
years at the time of closed head injury (CHI), were investigated<br />
using proton magnetic resonance spectroscopy<br />
(MRS) acquired post injury and compared to standardized<br />
neurologic, intellectual, and neuropsychological testing<br />
done 1–7 years later. Clinical indicators of acute injury<br />
severity including age at injury, electroencephalography,<br />
MRS variables of NAA/Cho, Cho/Cre, and lactate presence<br />
accurately classified children as functioning above or<br />
below the average range for most outcome measures.<br />
Combined clinical and MRS variables accounted for<br />
approximately 50% of the variance in cognitive and<br />
neuropsychological outcome confirming the validity of
Abstracts 403<br />
their predictive use. Of the injury severity indictors,<br />
presence of lactate is a particularly important prognostic<br />
marker of poor long-term intellectual and neuropsychological<br />
functioning. Our findings indicate the potential for<br />
providing accurate estimates of long-term intellectual and<br />
neuropsychological functioning after CHI in infants and<br />
children using proton MRS in combination with clinical<br />
variables.<br />
FO-11<br />
Morphogenesis<br />
FO-11-1<br />
Partial trisomy 16 mice model for Down syndrome: an<br />
analysis of brain morphology and physiology<br />
P. Belichenko a , A. Kleschevnikov a , E. Masliah b ,W.<br />
Mobley a<br />
a Department Neurology and Neurological Science, Stanford<br />
<strong>University</strong> Medical Center, Stanford; b School of Medicine,<br />
UCSD, La Jolla, USA<br />
Partial trisomy 16 mice (Ts65Dn) are a genetic model<br />
for Down syndrome. The medial and lateral septum, fascia<br />
dentata (FD), CA1 area of hippocampus, motor and somatosensory<br />
cortices were studied. Sections for confocal<br />
microscopy were immunostained for synaptophysin (p38),<br />
or were examined after neuronal microinjection with Lucifer<br />
yellow. Electrophysiological experiments were<br />
performed on hippocampal slices. Relative to controls,<br />
the area of p38-IR was significantly increased in cortex,<br />
hippocampus, FD and medial septum of Ts65Dn mice at 21<br />
days, 3, 6 and 16 months of age. In granule cells of FD, the<br />
number of dendritic spines was decreased in Ts65Dn mice<br />
at 21 days, 3 and 6 months of age. In Ts65Dn mice, spine<br />
head area was significantly increased while the length of<br />
spine neck was decreased. In all areas investigated in<br />
Ts65Dn mice, EM showed enlarged and tortuous neurites<br />
with abundant electrodense, laminated bodies and occasional<br />
synaptic vesicles and spines were distended with<br />
vacuolization of the endomembrane system. There was a<br />
defect in induction of long-term potentiation (LTP) of the<br />
perforant path input to the FD in Ts65Dn mice: LTP was<br />
suppressed at 45–60 min after the first tetanus. Furthermore,<br />
paired-pulse depression of the population spike<br />
observed in FD was significantly stronger in the Ts65Dn<br />
mice, suggesting enhanced efficiency of the feed-back inhibitory<br />
system. Our data show dramatic changes in both<br />
morphology and function of synapses in Ts65Dn mice.<br />
The defects are seen in both developing and mature<br />
Ts65Dn mice. Further studies are required to show whether<br />
or not these abnormalities are also present in the brain of<br />
Down syndrome patients. Supported by NIH grants<br />
AG16999 and NS38869.<br />
FO-11-2<br />
Clinical spectrum of holoprosencephaly: a clinicalneuroradiologic<br />
analysis<br />
J.S. Hahn, L.L. Plawner, M. Delgado, V. Miller, E. Levey,<br />
S.L. Kinsman, A.J. Barkovich, E. Simon, N. Clegg, V.<br />
Sweet, E. Stashinko<br />
Stanford <strong>University</strong> School of Medicine, Department of<br />
Neurology, Stanford, Texas Scottish Rite Hospital, Dallas,<br />
Kennedy Krieger Institute, Baltimore, <strong>University</strong> of California<br />
San Francisco, San Francisco, Children’s Hospital of<br />
Philadelphia, PA, USA<br />
Holoprosencephaly (HPE) is a brain malformation that<br />
results from incomplete cleavage of the prosencephalon<br />
into two hemispheres. We evaluated 68 children with HPE<br />
with history, developmental assessment, and physical examination.<br />
Neuroimaging studies were assessed for the grade of<br />
HPE (from least to most severe: lobar, semilobar, and<br />
alobar), the degree of non-separation of the deep gray nuclei,<br />
and presence of dorsal cyst or cortical malformation. In<br />
general, the severity of clinical problems and neurological<br />
dysfunctions paralleled the grade of HPE. Dystonia was<br />
correlated with the degree on non-separation of the caudate<br />
and lentiform nuclei, as well as, the grade of HPE (P , 0:05).<br />
Hypotonia was correlated with the grade of HPE (P , 0:05).<br />
Mobility, upper extremity function, and language were all<br />
significantly correlated with the degree of non-separation of<br />
the caudate, lentiform, and thalamic nuclei and grade of HPE<br />
(P , 0:01). Seizures occurred in approximately half of the<br />
children with HPE. The presence of cortical malformation<br />
was associated with seizures that were difficult to control.<br />
Endocrinologic dysfunction was noted in 72% of the patients<br />
with all having at least diabetes insipidus. The severity of<br />
endocrine abnormality correlated with the degree of<br />
hypothalamic non-separation (P ¼ 0:029). There was a<br />
correlation between the severity of the facial malformation<br />
and the grade of HPE (P ¼ 0:032), but there were many<br />
exceptions. In conclusion, this study shows that by combining<br />
the detailed neuroradiologic features of HPE with clinical<br />
assessments, we were able to develop a more accurate classification<br />
scheme for predicting outcome and clinical<br />
problems.<br />
FO-11-3<br />
Role of intrauterine infection for the pathogenesis of<br />
epilepsy in children at the early stage of life<br />
S.A. Gulyaev, A.A. Ovchnnickova, S.E. Gulyaeva, I.V.<br />
Archipenko, L.V. Viborova<br />
Vladivostok State Medical <strong>University</strong>, Vladivostok, Russia<br />
Distinctive clinical signs of epilepsy in 79 children at the<br />
age up to 5 years born from mothers infected by sexual<br />
relations and having high percentage of miscarriages, stillborn<br />
fetus, pathology in pregnancy and delivery were
404<br />
Abstracts<br />
studied. It was found that among all examined children 71%<br />
of babies were carried to full term, 57% had signs possibly<br />
due to intrauterine hypoxia, or perinatal asphyxia, 73.4%<br />
had signs of intrauterine infection, and 16.5% had slight<br />
traumatic destruction (of the nervous system). At the early<br />
neonatal period incidence of epilepsy reached 27.5%.<br />
Among all kinds of epilepsy generalized form was prevalent<br />
(63.6%). Hemangioma was found in 45.5%, and subarachnoidal<br />
hemorrhage – in 41.4%. Central nervous system<br />
symptoms were observed only in 1/3 of all patients at this<br />
stage. No further information was obtained. The pathological<br />
lesion at the early years of life was most precisely<br />
recorded by neurosonography that was useful to see changes<br />
of brain structure (77.3%). The findings were characterized<br />
as a stable increase of echodensity in parenchyma in 17.6%,<br />
and as inborn defects of brain structure development in<br />
5.8%. This research demonstrated not only early clinical<br />
signs of epilepsy in children born to mothers infected by<br />
sexual relations but also severe pathology with changes in<br />
the brain structure caused by infectious agents, influencing<br />
the nervous tissue. We conclude that prevention of brain<br />
pathology in these prenatally affected children is an urgent<br />
issue in child neurology.<br />
FO-11-4<br />
Epileptic chromosomopathies: epileptic syndromes of<br />
childhood due to chromosomal disorders<br />
P.A. Hwang, L. Chen, J. Shaw, P. Wyatt<br />
Departments of Paediatrics and Genetics, North York<br />
General Hospital, Bloorview Epilepsy Research Program,<br />
<strong>University</strong> of Toronto, Toronto, Canada<br />
A retrospective review of over 1500 patients in a community-based<br />
practice revealed about 2% of children with chromosomal<br />
disorders, detected by karyotype, fluorescent in-situ<br />
hybidization (FISH), methylation studies or specific DNA<br />
probes. In addition to the usual trisomy 21 in Down syndrome,<br />
two had balanced Robertsonian translocation, 15 had Angelman<br />
Syndrome, with and without deletions at 15q11–12 loci,<br />
ten had Rett syndrome and one each had Smith-Magenis with<br />
17p and Wolff-Hirschorn with 4p deletions respectively. The<br />
clinical features were quite characteristic although not specific:<br />
dysmorphic features, developmental delay, and multiple<br />
seizure types: partial and generalized, often refractory to antiepileptic<br />
drugs. The EEGs were variable: disorganized background<br />
activity, multifocal epileptiform discharges, and<br />
characteristic features in certain syndromes: central spikes,<br />
pseudoperiodic discharges of Rett syndrome, and stimulussensitive<br />
central-parietal spikes of Angelman syndrome.<br />
Certain chromosomal disorders have a high risk of epileptic<br />
seizures: Angelman (but not Prader-Willi), Rett and Wolff-<br />
Hirschorn, but not Prader-Willi, Smith-Magenis or Down<br />
syndrome. Only in the Angelman syndrome does the deletion<br />
at 15q11–12 involve GABA-A receptor subunit loci and may<br />
be considered to constitute an epileptic chromosomopathy.<br />
FO-12<br />
Genopathies<br />
FO-12-1<br />
The frequency of common mutations among patients<br />
with mucopolysaccharidosis types I, II and IIIA<br />
diagnosed in Austria over the last 17 years<br />
Th. Kroepfl, K. Paul, B. Plecko, E. Paschke<br />
<strong>University</strong> of Graz, Department of Pediatrics, Graz, Austria<br />
The MPS are a hereditary, clinically heterogeneous group<br />
of 11 disorders caused by the deficiency of lysosomal<br />
enzymes involved in mucopolysaccharide catabolism.<br />
Their phenotypes include growth retardation, dysostosis,<br />
enlargement of visceral organs, progredient psychomental<br />
retardation and reduced life span. In populations originating<br />
from Northern European and Anglo-American countries,<br />
three enzyme defects comprise the majority of cases,<br />
namely a-l-iduronidase, MPS I, iduronate-2-sulphatase,<br />
MPS II, and heparan N-sulphatase, MPS IIIA. Several mutations<br />
have been shown to be common among European<br />
cases and genotyping has become essential for genetic counselling<br />
and possible prediction of clinical phenotype. Therefore,<br />
we started to define the genotype of all cases diagnosed<br />
enzymatically in Austria between the years 1983–2000.We<br />
initially tested 66 cases for common mutations in MPS I, II<br />
and IIIA. Similar to other European countries the majority<br />
of cases were MPS I (23), MPS II (21) and MPS IIIA (22).<br />
Taken together, the frequency of common mutations in<br />
MPS I and IIIA among patients diagnosed in Austria was<br />
found to be slightly below the average distribution found in<br />
other European countries with a reversed ratio of the<br />
frequency of the main common mutations Q70X and<br />
W402X in MPS I. Moreover, S66W, a mutation common<br />
in Italian populations, was found to be unexpectedly<br />
frequent in MPS IIIA. The methods for the discovery of<br />
these mutations are simple and reliable. We therefore<br />
suggest that W402X and Q70X in MPS I as well as R74C,<br />
R245H and S66W in MPS IIIA should be assayed routinely<br />
after identification of the enzyme defect. This would help to<br />
avoid time-consuming cell cultivation procedures and thus<br />
be helpful in situations of late amniocentesis.<br />
FO-12-2<br />
Spectrum of mutations and phenotype/genotype<br />
correlations in muscle-eye-brain (MEB), another defect<br />
of glycosylation<br />
H. Pihko, C. Diesen, J. Dieguez-Lucena, W. Dobyns, P.<br />
Santavuori, A.-E. Lehesjoki<br />
Hospital for Children and Adolescents, HUS, Helsinki, and<br />
Department of Medical Genetics, <strong>University</strong> of Helsinki,<br />
Finland<br />
MEB disease is a recessively inherited disorder charac-
Abstracts 405<br />
terized by a severe brain malformation, ocular abnormalities<br />
and muscular dystrophy. The disease was first described in<br />
Finland 20 years ago, but after the localization of the gene to<br />
1p32, we have been able to identify MEB-patients from<br />
several countries around the world. Although the clinical<br />
severity of MEB is more variable than previously thought,<br />
we were able to exclude patients with Walker-Warburg<br />
syndrome from the MEB locus, thus showing that these<br />
two disorders are caused by different genes. The defective<br />
gene, O-mannose b-1,2-N-acetylglucosaminyl transferase<br />
(POMGnT1), places the disease into the increasing group<br />
of inherited disorders of glycosylation. We have analyzed<br />
mutations of POMGnT1 in Finnish as well as in patients<br />
from different nationalities. So far, one mutation, G to A at<br />
position 5750, has been found in 18 Finnish patients studied.<br />
The results of this mutation analysis as well as genotypephenotype<br />
correlations will be presented.<br />
FO-12-3<br />
Septo-optic dysplasia: a new phenotype associated with a<br />
heteroplasmic mutation in the mitochondrial<br />
cytochrome B gene<br />
M. Schuelke a , H. Krude b , B. Finckh c , E. Mayatepek d ,J.<br />
Smeitink e<br />
a Department of Neuropediatrics, b Department of Pediatric<br />
Endocrinology, Charité <strong>University</strong> Hospital, Berlin,<br />
Germany; c Children’s Hospital, <strong>University</strong> of Hamburg,<br />
Germany; d Division of Metabolic and Endocrine Diseases,<br />
<strong>University</strong> Children’s Hospital, Heidelberg, Germany; e Nijmegen<br />
Center for Mitochondrial Disorders at the Department<br />
of Pediatrics, <strong>University</strong> Medical Center, Nijmegen,<br />
The Netherlands<br />
Septo-optic dysplasia (de Morsier syndrome, MIM<br />
182230) is characterized by hypoplasia of the optic nerve,<br />
agenesis of the septum pellucidum, and hypothalamic<br />
dysfunction. The most frequent endocrine defect is growth<br />
hormone deficiency. Most cases occur spontaneously and<br />
their genetic basis is unknown. Recently a missense mutation<br />
in the homeobox gene HESX1 was detected in one familial<br />
case. Here we present a patient in whom a mutation in HESX1<br />
was excluded but in whom we detected an isolated respiratory<br />
complex III-deficiency due to a new heteroplasmic<br />
mutation (14849T . C) in the mitochondrially encoded<br />
cytochrome b gene. The 25-year-old patient suffered from<br />
septo-optic dysplasia, retinitis pigmentosa, lactic acidosis,<br />
exercise intolerance, hypertrophic cardiomyopathy and<br />
rhabdomyolysis. The mutation causes a replacement of the<br />
serine35 by proline at the ubiquinone (Q i ) binding site. This<br />
interrupts the electron flow from complex II to cytochrome c.<br />
Lack of ATP due to malfunction of the respiratory chain<br />
could explain the exercise intolerance and lactic acidosis<br />
but not the septo-optic dysplasia or the retinitis pigmentosa.<br />
The latter condition hints to free oxygen radicals as putative<br />
pathogenic agents. A low a-tocopherol concentration in the<br />
muscle, a reduced total radical trapping parameter of the<br />
plasma and an increased excretion of leukotriene E 4 in the<br />
urine are compatible with increased reactive oxygen species<br />
(ROS)-generation. Morphogenesis of the brain demands a<br />
fine tuning between proliferation and apoptosis. We hypothesize<br />
that in our patient a disturbance of this balance due to<br />
increased ROS-concentration and a subsequent increase in<br />
apoptosis might have resulted in deranged fetal brain development<br />
such as seen in septo-optic dysplasia.<br />
FO-12-4<br />
Identification of the genetic defect in an Asian-Indian<br />
community with megalencephalic leukoencephalopathy<br />
and cysts<br />
B.S. Singhal a , E.P. Hoffman b , F.-F. Wu b , D. Stephan b ,S.<br />
Naidu c , R. Gorospe b<br />
a Bombay Hospital, Department of Neurology, Institute of<br />
Medical Science, Medical Research Center, Bombay,<br />
India;<br />
b Children’s National Medical Center, Research<br />
Center for Genetic Medicine, Washington, DC; c Kennedy<br />
Krieger Institute/Johns Hopkins Medical Institute, Division<br />
of Neurology and Pediatrics, Baltimore, MD, USA<br />
We screened the entire coding region of the MLC1 gene in<br />
a group of 23 unrelated Asian Indian patients from one ethnic<br />
group-Agarwals-who presented with a clinical syndrome<br />
characterized by early-onset megalencephaly, leukoencephalopathy<br />
with cysts, progressive spasticity, seizures, and<br />
learning problems. The majority of the patients (22/23, 96%)<br />
were homozygous for an insertion of cytosine in exon 2<br />
between nucleotides 250 and 251, indicative of a recessive<br />
disorder with a founder effect. One patient (1/23, 4%) was<br />
homozygous for C585A; however, he was adopted and<br />
parental details were unknown. Despite the commonality<br />
of the gene defect in this ethnic group, there was significant<br />
phenotypic variability indicative of possible environmental<br />
factors or individual genetic background as contributors.<br />
These novel mutations in MLC1 gene indicate that this clinical<br />
syndrome among Asian Indian Agarwals is the same as<br />
that among Turkish and European patients. Individuals from<br />
this Indian community live in various parts of the world.<br />
When a patient from this ethnic group presents with the<br />
above-mentioned clinical and neuroimaging features, mutations<br />
in the MLC1 gene should be sought.<br />
FO-13<br />
Higher Cortical Functions<br />
FO-13-1<br />
Reactus: a new cognitive function diagnostic device<br />
B. Scott, S. Freiger, J. Rehrmann<br />
Trifolium, ideas and solutions, Kassel, Germany<br />
The ‘Reactus’ consists of integrating medical test proce-
406<br />
Abstracts<br />
dures into a comprehensive system where visual reaction,<br />
audio reaction, psycho-motor abilities, visual-motor coordination,<br />
attentiveness and concentration are examined. The<br />
doctor will be able to analyze the cognitive function of<br />
children and adults in a 5-min test procedure and the results<br />
can be printed in an easy to understand graph. The Reactus<br />
evaluates various abilities of an individual including: *starting<br />
reflex, *surprise reactions, *visual and auditory reaction,<br />
*visual and auditory differentiation, *visual and auditory<br />
reliability, *constancy of reactions, *attentiveness,<br />
*concentration, *strategy, *psycho-motor abilities,<br />
*visual-motor coordination, *short-and long-term endurance.<br />
The user-friendly software can enable the doctor to<br />
perform further analysis using SPSS data. Researches in the<br />
field of ADHD, LD, Turner, diabetes mellitus, effects of<br />
medicine and very low birth weight (VLBW) had been<br />
performed in Japan (National Children’s Hospital Tokyo,<br />
Teikyo <strong>University</strong>, Saitama Municipal General Center,<br />
Tokyo Metropolitan <strong>University</strong> of Health Sciences, Jichi<br />
Medical <strong>University</strong> and Tokyo Gakugei <strong>University</strong>); in<br />
China (Hua Shan Hospital, Shanghai); in Germany (Leipzig<br />
<strong>University</strong>). All doctors are connected via the Internet and<br />
the research activities were printed in a bi-monthly email-<br />
Newsletter. The results of Reactus display a more specific<br />
picture about the abilities of children and adults.<br />
FO-13-2<br />
Environmental mercury exposure in children with<br />
autistic spectrum disorder (ASD): A case-control study<br />
P. Ip, H.K. Ho, J. Lee, W. Wong, V. Wong<br />
Division of Neurodevelopmental Paediatrics, Department<br />
of Paediatrics, Queen Mary Hospital, The <strong>University</strong> of<br />
Hong Kong, Hong Kong SAR, China<br />
Objective: To study whether there is any increased<br />
environmental mercury exposure in children with ASD.<br />
Methods: A cross-sectional study was performed from<br />
April to September, 2000. Simultaneous hair and blood<br />
mercury levels were analysed in 2 groups of children: (i)<br />
ASD; and (ii) control. A questionnaire on sociodemographic<br />
data, dietary habits and other risk factors for environmental<br />
mercury exposure was completed. Results:<br />
Altogether 82 autistic (aged 7.2 years) and 55 normal children<br />
(aged 7.8 years) were recruited. There was no difference<br />
in the mean hair mercury level of autistic group (2.3<br />
ppm) as compared with control group (mean 2.1 ppm)<br />
(P ¼ 0:79). The mean blood mercury level of autistic<br />
group (19.5nmol/l) compared to control group (14.7<br />
nmol/l) (P ¼ 0:056). The mean hair mercury level in<br />
both groups of children (n ¼ 137) was 2.2 ppm, even<br />
higher than the levels of adults in Europe (1.2 ppm) and<br />
U.S. (1.5 ppm). Hair mercury levels correlated well with<br />
blood mercury levels in our children (r ¼ 0:88). The<br />
frequency of fish consumption was the only independent<br />
variable correlated with hair (r ¼ 0:51) and blood<br />
(r ¼ 0:54) mercury levels. For those children who<br />
consumed fish more than three times per week, their hair<br />
and blood mercury levels were twice than those who<br />
consumed fish less than three times per week and three<br />
times of those who never consumed fish. Five autistic children<br />
had toxic blood mercury levels (.45 nmol/l). Their<br />
family members were screened and half of them also had<br />
toxic mercury levels. However, some had features of<br />
mercury poisoning. The mean blood mercury level of<br />
those with mercury intoxication dropped from 70.5 to<br />
26.8 nmol/l (P ¼ 0:0001) after reducing fish consumption<br />
for 3 months. Conclusions: There was no significant difference<br />
in the hair and blood mercury levels between autistic<br />
and normal children. All our children had high hair<br />
mercury levels which correlated well with blood mercury<br />
levels. Frequency of fish consumption correlated with hair<br />
and blood mercury levels in Hong Kong children. Thus<br />
there is an overall increased risk of environmental mercury<br />
exposure.<br />
FO-13-3<br />
A study to use modern IT device in facilitating written<br />
communication of children with developmental dyslexia<br />
C.W. Chan, K.Y. Cheng, C.C. Lam, T.F. Ho, C.K. Leong<br />
Working Party on Specific Learning Disabilities (SLD), The<br />
Hong Kong Society of Child Neurology and Developmental<br />
Paediatrics (HKCNDP), China<br />
The aim of this study was to explore the feasibility and<br />
effectiveness of using Cantonese speech-to-text input technology<br />
as a tool for dictating Chinese characters into word<br />
processing applications in facilitating written communication<br />
of children with dyslexia. Fourteen Hong Kong children<br />
with dyslexia, aged 9–14, and three without dyslexia,<br />
aged 10–15, were trained. In the six training sessions, participants<br />
were familiarized with the use of the input device<br />
and guided to personalize the associated speech template,<br />
input specially designed reading texts into the computer,<br />
and complete two oral pictorial composition exercises.<br />
These sessions were conducted with the help of parents<br />
and volunteer workers. Usefulness of the technology was<br />
evaluated with regard to both the written product and to<br />
process factors. Participants’ written output was analyzed<br />
for recognition accuracy rate for different types of writing<br />
tasks. Through analysis of structured feedback from helper<br />
observations, parent questionnaires, and interviews, difficulties<br />
encountered and factors noted to contribute to<br />
success in the training and trial processes were studied.<br />
Results indicated high individual variability in the effectiveness<br />
of using this tool. Implications for the improvement<br />
of this Cantonese speech-to-text technology as well<br />
as its potential application for facilitating the learning of<br />
children with dyslexia at home and school will be<br />
discussed.
Abstracts 407<br />
FO-13-4<br />
The ‘learning brain’ and environment: Pavlovian<br />
philosophy<br />
K.B. Kulkarni<br />
Sanjivani Nursing Home, Gwalior (M.P.), India<br />
The ‘learning brain’ and environment implies unity of<br />
organism and its social and ecological environment which<br />
becomes manifest during the early phase of neuropsychic<br />
development of a growing child. This has important applications<br />
in neonatology, developmental Pediatrics, disorders<br />
of affect, even environmental Pediatrics. Interrelationships<br />
between body and environment are realised through conditioned<br />
reflexes which by perseverence and practice can be<br />
transformed into instinctive, even herd reflexes (genetic<br />
transmission). Relationship between interoceptors from<br />
viscera and exteroceptors from environment is inseparable.<br />
We must appreciate the claims put on newborn CNS by<br />
adjustment to environmental influences. The newborn<br />
cortex is under protracted protective inhibition resulting in<br />
continuous sleep. Powerful stimuli for conditioned reflexes<br />
inducing sleep are fresh air or breeze, quiet environment,<br />
certain body positions, light clothing and even mother’s<br />
sweet song or words. Even the experimental model of cat<br />
newborn for studying the ontogenesis of breast feeding<br />
related behaviour draws parallels from Pavlovian ethos<br />
which has great bearing on the human situation of breast<br />
feeding. Principal Pavlovian idea is the process of ‘imprinting’<br />
which answers ‘No’ for the question: should parents<br />
prevent children from being exposed to life’s dangers and<br />
difficulties? Pavlov’s observations lay the ground work for<br />
this by observing behaviour of animal newborns under<br />
adverse circumstances. Birdies under comfortable environment<br />
loath to build nests later. Pavlov further thought that<br />
Nature has worked out detailed programme of behaviour for<br />
each animal species including Man but has consciously left<br />
numerous gaps to be filled by ‘imprinting’ –a form of<br />
conditioned reflex activity.<br />
FO-13-5<br />
Conversion disorder: under diagnosed? Over<br />
investigated?<br />
P.M. Leary<br />
Bristol Royal Hospital for Children, Bristol, United Kingdom<br />
The term ’conversion disorder’ (DSM-IV) is applied<br />
when symptoms and deficits involving voluntary motor<br />
and sensory function suggest a neurological or other physical<br />
condition, which in fact is not present. In Britain and<br />
almost certainly elsewhere as well such cases are regularly<br />
encountered by paediatric neurologists and place significant<br />
demand on consulting time and diagnostic resources. The<br />
widely diverse manner in which organic neurological disorder<br />
may present creates a dilemma in the diagnosis and<br />
management of conversion disorders. While there is real<br />
need to exclude organic disease the thoroughness with<br />
which this is often done may strengthen patient and parental<br />
conviction that there must be a physical explanation for the<br />
symptoms. Management may be further complicated by<br />
anxiety about litigation, parental refusal to accept an<br />
emotional cause for symptoms, ’Gillick competent’ patient<br />
refusal to accept intervention and a community shortage of<br />
resources for treating children and adolescents with<br />
emotional problems. In this study illustrative cases are<br />
presented, diagnostic procedures reviewed, management<br />
strategies discussed and guidelines suggested.<br />
FO-13-6<br />
Trial of risperidone in children with conduct disorders<br />
A. Dayan-Nahmad, S. Mann-Shvili, A. Gonzalez-<br />
Astiazaran, M.-A. Collado-Corona, C. Martínez-Wbaldo<br />
Centro Nacional de Rehabilitación, Instituto de la Comunicación<br />
Humana, México City, Mexico<br />
Objective: To study the use of Risperidone in children<br />
with behavior dysfunctions. Method: An open-labelled<br />
prospective trial was conducted for the use of risperidone<br />
from July 2000 to December 2001 in 220 subjects with<br />
conduct disorder. A total of 112 were excluded as they<br />
received another drug or abandoned the treatment. Thus,<br />
108 (80 boys, 28 girls) were enrolled in the study 95 had<br />
additional language problems and 30 also had hypoacusia.<br />
The ages were 2–13.11 years. Patients were seen monthly<br />
throughout the trial. Risperidone was increased at monthly<br />
intervals with an initial dose of 0.027 mg/kg per day,<br />
depending on symptom control. Results: Risperidone was<br />
associated with clinical improvement at a dose of 0.027–<br />
0.15 mg/kg per day. Almost all patients showed minor<br />
adverse effects, (initial drowsiness and weight gain).<br />
None-developed extrapyramidal side effects. Conclusions:<br />
These data provide preliminary evidence that risperidone<br />
efficacy in the treatment of conduct disorders in children.<br />
FO-14<br />
Treatment<br />
FO-14-1<br />
Effect of topiramate on body mass index and<br />
hyperphagic behaviour of morbid obese children, after<br />
brain tumour treatment<br />
C.E. Catsman-Berrevoets a , E.L.T. Van den Akker b , F.K.<br />
Aarsen a , S.L.S. Drop b<br />
a Departments of Child Neurology and 2 Child Endocrinology,<br />
<strong>University</strong> Hospital Rotterdam/Sophia Children’s<br />
Hospital, Rotterdam, The Netherlands<br />
Reduced appetite and weight loss were found in clinical
408<br />
Abstracts<br />
trials of topiramate for epilepsy. In children treated for brain<br />
tumour and especially craniopharyngioma hyperphagia and<br />
therapy resistant morbid obesity frequently occurs. In a pilot<br />
study we explored the effectiveness and the tolerability of<br />
topiramate in children with obesity, after treatment of brain<br />
tumour. We evaluated the response after 3, 6 and 12 months<br />
of treatment with topiramate up to 7 mg/kg per day. Eating<br />
behaviour, weight, effect on hypothalamic dependent<br />
hormones and neuropsychological side effects were evaluated.<br />
Two boys and four girls (aged 8.7–17.2 years) with a<br />
BMI 2.75–4.4 SD above the age related were included. Five<br />
had been treated for craniopharyngeoma, one for primitive<br />
neuroectodermal tumor (PNET). After starting topiramate<br />
treatment, at doses ranging from 2.7 to 3.7 mg/kg per day<br />
parents of all five children reported a marked reduction of<br />
the obsessive hyperphagia. On the child behavioural checklist<br />
they all scored better on items of self-esteem. BMI at 3<br />
months ranged from 10.15 to 3.78 (mean 21.38) in<br />
comparison to BMI at the start of the study. After 6 months<br />
BMI ranged from 11.44– 2 4.47 (mean 20.94) and after<br />
12 months from 11.36 to 24.38 (mean 20.3) with BMI at<br />
the start of the study. No important changes in blood parameters<br />
were detected. Neuropsychological evaluation in<br />
comparison to that at the start of the study mainly showed<br />
a decreased performance on tests of attention and concentration,<br />
verbal short memory, verbal sequential memory and<br />
a reduced verbal fluency. These problems started to occur<br />
with a dosage exceeding 4 mg/kg per day and were reversible.<br />
Results of this small pilot study suggest that topiramate<br />
stabilizes weight in children with morbid obesity,<br />
which have been treated for a brain tumour, but does not<br />
lead to important weight loss. Doses of topiramate exceeding<br />
4 mg/kg per day mainly have adverse, but reversible<br />
effects on performance on attention, concentration, verbal<br />
memory and verbal fluency tasks. Topiramate seems to have<br />
a positive effect on the obsessive, ‘craving’ behaviour of the<br />
child in respect to food and subsequently on feelings of selfesteem.<br />
FO-14-2<br />
Curative effect in cerebral palsy with acupoint injection<br />
of drug<br />
Q.-F. Yuan, W.-C. Nan, S.-S. Yun, H.-L. Rong<br />
Woman and Child Health Center, Shenyang, China<br />
Objective: To investigate the effect of acupoint injection of<br />
drug in children with cerebral palsy. Sixty children from 40<br />
days to 3 years were divided into two groups. Both groups<br />
adopted physical treatment, massage and other therapy. In<br />
the treatment group acupoint injection of drug was added,<br />
which included cerebral and body acupoint injection, 10-<br />
day-injection is a course. Then 10 days break, three courses<br />
consecutively. Drugs include Lizhusaile injection and<br />
dansen injection and vitamin B12, B1 and ATP. Injective<br />
acupoints on head area, feeling area and equilibrium area<br />
and so on. Clinic Curative rate in the treatment group was<br />
94.95%, clinic curative rate in the control group is 78.4%<br />
(P , 0:01). So comprehensive treatment is better than single<br />
motor treatment and reduces the treatment course.<br />
FO-14-3<br />
Effect of cerebroprotein hydrolysate injection and<br />
conductive education in children with cerebral palsy<br />
D. Wu, J.-L. Tang, D.-Y. Liu, J.-X. Wu<br />
Pediatric department, the first Hospital Affiliated to Anhui<br />
Medical <strong>University</strong>, Hefei City, China<br />
To find a new way to treat children with cerebral palsy.<br />
One hundred eighty three children with cerebral palsy, aged<br />
3 months to 5 years were divided into three groups: CHI<br />
group, conductive education (CD) group, CHI plus CD<br />
group and control group. They were followed-up for 5<br />
years. CHI was intravenously injected, 5 ml/day for 1-<br />
year-old children and 10 ml/day for children older than 1-<br />
year-old. We defined 3 months as a course of treatment. We<br />
regularly give a short course of CD for the children with<br />
cerebral palsy and their parents from May 1997. Children<br />
with cerebral palsy and their parents attended the course.<br />
Some simply training methods of CD were introduced to the<br />
parents – home conductors, and then the parents began to<br />
train the cerebral palsy children at home. The results are as<br />
follows: (1) CHI plus CD was most effective in all ways. (2)<br />
Both CHI group and CD method group were more effective<br />
than control group (P , 0:01). (3) CHI group and CD group<br />
were more effective than CD group (P , 0:05).<br />
FO-14-4<br />
Quantum neurodynamics and biofeedback efficiency in<br />
treating neurological disorders<br />
J. Pop-Jordanov a , N. Pop-Jordanova b , D. Dimitrovski a ,E.<br />
Solov’ev a , N. Markovska a<br />
a Research Center of Energy, Informatics and Materials,<br />
Macedonian Academy of Science and Arts, Skopje, Macedonia;<br />
b Department of Psychophysiology, Pediatric Clinic,<br />
Faculty of Medicine, Macedonia<br />
As a technique for learning self-control by back-reported<br />
biological signals, biofeedback is ultimately based on<br />
mental-neural information flow. All standard attempts to<br />
explain the mechanism of the subtle two-way interaction<br />
between non-material mental agencies and neural events<br />
were confronted with violation of the energy-matter conservation<br />
laws of physics. One non-classical hypothesis was<br />
defined by Eccles (Nobelist for Physiology and Medicine) in<br />
his paper with a provocative title: ‘do mental events cause<br />
neural events analogously to the probability fields of quantum<br />
mechanics?’ In this paper, the consecutive steps of<br />
biofeedback signal flow are investigated, in the light of<br />
the fundamental Eccles hypotheses. An advanced quantum
Abstracts 409<br />
mechanical modeling is performed, to calculate the probabilities<br />
for quantum transitions within neural molecules in<br />
cortical electric field. The results indicated the brain-wave<br />
frequency as a physical quantity associated with perception<br />
and memory processing. In addition, limiting the probability<br />
of transitions as to maximize the information entropy, the<br />
relevant number of molecules is calculated for the<br />
frequency of electric fields the cytoplasm is exposed to.<br />
Consequently, some basic rationales for biofeedback efficiency<br />
in treating neurological disorders, like seizure, attention<br />
deficit, as well as neuromuscular computer related ones,<br />
are deduced and discussed. In particular, the effects of brainwave<br />
frequency ‘filtering’ by neurofeedback are considered.<br />
FO-14-5<br />
Randomized treatment study of inosiplex versus<br />
combined inosiplex and intraventricular alpha<br />
interferon in subacute sclerosing panencephalitis (SSPE)<br />
G.G. Gascon, B.A. Anlar, M. Fojas, V. Udani<br />
The International Consortium on SSPE, and Devol E Brown<br />
<strong>University</strong>, Providence, RI, USA: Haceteppe <strong>University</strong>,<br />
Ankara, Turkey; Makati Medical Center, Manila, Philippines;<br />
Hinduja National Hospital and Research Center,<br />
Bombay, India, King Faisal Specialist Hospital and<br />
Research Centre, Riyadh, Saudi Arabia<br />
Methods: One hundred and twenty-one patients, mainly<br />
from Ankara, Manila and Bombay, who met diagnostic<br />
criteria for SSPE were randomized into oral inosiplex<br />
alone (Group A) and combined oral inosiplex and intraventricular<br />
alpha interferon (Group B), delivered through an<br />
Ommaya reservoir. Inclusion criteria were Stage II SSPE<br />
or better. The Stage, Neurological Disability Index (NDI),<br />
and Brief Assessment Exam (BAE) were used for clinical<br />
rating of neurological status. The principal laboratory value<br />
followed was the CSF IgG Synthesis Index (Tourtellotte).<br />
Dose of inosiplex (Isoprinosine, Newport Pharmaceuticals,<br />
Dublin) was 100 mg/kg per day in divided doses, for 6<br />
months. Alpha interferon 2b (Intron A, Schering Plough,<br />
NJ, USA) started with 100 000 units per meter squared<br />
and escalated to 1 000 000 units per meter squared over 5<br />
inpatient days, then 1 000 000 units/meter squared twice a<br />
week for 6 months. Baseline and follow-up data flow sheets<br />
were filled at 3, 6, 12, 18, 24 and 30 weeks, and at longer<br />
intervals till at least 2 years. Results: After excluding 35<br />
cases whose data sheets were not received and another 18<br />
disqualified for various reasons, mainly protocol noncompliance,<br />
68 cases remained for analysis, 40 in Group<br />
A and 28 in Group B). Survival analysis, carried out so<br />
far through 30 weeks, showed five observed deaths during<br />
treatment in Group A and one in Group B, total 6. There was<br />
82% survival at 30 weeks in Group A, 90% in Group B. The<br />
Log-Rank test between Groups A and B, showed a chisquare<br />
of 1.0134, with P ¼ 0:31. Conclusion: No evidence<br />
of difference in survival at 30 weeks between treatment with<br />
inosiplex alone, versus combined inosiplex-alpha interferon.<br />
Commentary: Survival analysis will be carried out<br />
further to 2 years post-institution of treatment. Morbidity<br />
over time will be analyzed similarly for NDI, BAE and<br />
Staging. Toxicity and complications will be analysed.<br />
FO-14-6<br />
Population pharmacokinetic model of valproate in<br />
children with epilepsy and prediction of valproate serum<br />
concentrations<br />
D.-C. Jiang, L. Wang<br />
Department of pediatrics of Peking <strong>University</strong> 1st Hospital,<br />
Beijing, China<br />
Objective: Using therapeutic drug monitoring data of<br />
valproate serum concentrations to set up the population<br />
pharmacokinetic model of valproate for pediatric patients<br />
with epilepsy in China and to predict serum concentrations<br />
for new patients by Bayesian approach. Method: We<br />
collected valproate serum concentrations of 50 pediatric<br />
patients with epilepsy who were taking valproate in monotherapy<br />
regimens, and had no hepatic or renal disease. They<br />
were divided into two groups (n ¼ 25). Each patient had at<br />
least two steady state concentration points. This study used<br />
the NPEM2 software to estimate valproate population pharmacokinetic<br />
parameter values and distributions in a first<br />
group of patients. On a second group, we used these parameters<br />
to predict valproate blood concentrations with Bayesian<br />
approach by the USC*PACK PC Program. Accuracy<br />
and precision were assessed by mean prediction error (ME)<br />
and mean squared prediction error (MSE). Results: We<br />
successfully set up the population pharmacokinetic model<br />
of valproate. Estimated population parameter values<br />
(mean ^ SD) were Kel, 0.0868 ^ 0.0507 h 21 ; Ka,<br />
0.143 ^ 0.120 h 21 ; and Vs 0.0419 ^ 0.025 L/kg.<br />
ME ¼ 22.18; MSE ¼ 16.82. Using these parameters, we<br />
can accurately predict valproate blood levels in new patients<br />
with epilepsy by Bayesian approach. Conclusion: The adoption<br />
of the previously mentioned population pharmacokinetic<br />
model of valproate and Bayesian approach can<br />
accurately predict steady state concentrations. It must be<br />
essential for a better use of valproate in clinical practice.<br />
FO-15<br />
Headache/Vasculopathy<br />
FO-15-1<br />
Idiopathic intracranial hypertension in childhood<br />
D.I. Zafeiriou a , C. Basiakos b , E. Maratou a , E. Vargiami a ,G.<br />
Katzos a , N. Gombakis a , E. Kontopoulos a<br />
a 1st Department of Pediatrics, Aristotle <strong>University</strong>,<br />
‘Hippokratio’ Hospital, Thessaloniki, Greece; b Department<br />
of Ophthalmology, ‘Hippokratio’ Hospital, Thessaloniki,<br />
Greece
410<br />
Abstracts<br />
Idiopathic intracranial hypertension (IIH) is an unusual,<br />
but important cause of headache, which can result in loss of<br />
vision. In a partly retrospective partly prospective study, the<br />
etiology, the presenting symptoms and the clinical course of<br />
24 patients with IIH (ten females, 14 males; age range 4–16<br />
years) who were admitted to our Department between 1991<br />
and 2001. Predisposing factors included acute otitis media<br />
(N ¼ 7 children), upper airway infection (N ¼ 3), obesity<br />
(N ¼ 2), frontal sinusitis (N ¼ 1), previous use of corticosteroids<br />
(N ¼ 1), growth hormone use (N ¼ 1), peptic ulcer<br />
(N ¼ 1), systemic hypertension (N ¼ 1), marfanoid habitus<br />
with mitral valve prolapse (N ¼ 1) and allergy (N ¼ 1),<br />
while in five patients no association could be found. Most<br />
frequent signs at presentation included headache (91.7%),<br />
vomiting (37.5%), nausea (29.2%), vision blurring (27.5%),<br />
abducens nerve palsy (20.8%), diplopia (16.6%) and photophobia<br />
(12.5%). Nineteen patients (79.2%) presented with<br />
the classical clinical picture with headache, papilledema and<br />
raised CSF pressure. Two patients had increased CSF pressure<br />
without papilledema and three patients had papilledema<br />
without increased CSF pressure. In 15 patients, IIH<br />
resolved with the use of acetazolamide, in two patients with<br />
corticosteroids, in four patients with acetazolamide and<br />
corticosteroids and in two patients with acetazolamide and<br />
furosemide. Only one patient was treated with repeated<br />
lumbar punctures, while in four of them, IIH relapsed<br />
(range 2–4 relapses). Other ophthalmologic findings<br />
included decreased visual acuity (6/24), abnormal visual<br />
field examination (4/20) and abnormal visual evoked potential<br />
testing (3/15); however, only one patient continues to<br />
have a mild decrease of his visual acuity to date (follow-up<br />
range 6 months–4 years). In none of the patients was either a<br />
lumboperitoneal shunting or an optic nerve sheath fenestration<br />
required. From our series, we conclude that acetazolamide<br />
alone or in combination seems to be the treatment of<br />
first choice for most patients with IIH, since it is associated<br />
with a relative low risk (4.2%) for long-term visual loss.<br />
However, careful and frequent ophthalmologic follow-up,<br />
as well as prospective multicenter randomized studies, is<br />
needed in order to establish evidence-based treatment protocols<br />
associated with minimal long term residuals.<br />
FO-15-2<br />
Changes in the visual crowding effect as a function of age<br />
E. Vandenbussche a , G. Van Hamme a , T. Reinehr a ,H.<br />
Maes a , L. Lagae b<br />
a Laboratory of Neuropsychology K.U. Leuven, Campus<br />
Gasthuisberg, Leuven, Belgium; b Department of Neuropediatrics,<br />
U.Z. Gasthuisberg, Leuven, Belgium<br />
Introduction: Visual crowding is a form of contour interaction<br />
due to spatial lateral masking. Originally, Flom et al.<br />
(1963) used Landolt-C and four surrounding bars to quantify<br />
thistypeofcontourinteraction.Theyvariedtheangularsizeof<br />
a single black four-position Landolt-C in a larger white field,<br />
so that the C was monocularly recognised in less than 100% of<br />
the time. Although the literature mentions that crowding<br />
decreased by age, no data are yet available. Aim of the study:<br />
To assess the visual crowding effect in binocular vision, in<br />
children of 60–146 month of age. Method: We used the procedureofFlom<br />
withaLandolt-Cat aspecific angularsize,sothat<br />
it was recognised in 70% of the time. The Landolt-C was<br />
presented 1 sec at maximal contrast. The distance of the four<br />
surrounding bars to the Landolt-C was varied in 5 steps (0.1,<br />
0.2, 0.4, 0.8, 1.6 times the size of the Landolt-C). During the<br />
crowding assessment the refraction of both eyes was optimally<br />
corrected Results: (1) The crowding effect is maximal<br />
at a distance 0.4 times the size of the Landolt-C. In children<br />
younger than 72 months there is even a tendency to reach the<br />
maximal crowding effect at a smaller distance. (2) The crowdingeffect<br />
decreases gradually with age. (3) The distance range<br />
withinwhichthecrowdingeffectoccurred,decreasedsymmetrically<br />
around the distance with optimal crowding.<br />
FO-15-3<br />
A clinical study on spontaneous intracranial<br />
hemorrhage in children<br />
J.-L. Cai a , K.-R. Bao a , J.-M. Yu b<br />
a Department of Pediatrics, b Department of radiology, The<br />
Xinhua Hospital of Shanghai Second Medical <strong>University</strong>,<br />
China<br />
Objective: To study the causes, clinical manifestations,<br />
neuroimaging features and prognosis in children with spontaneous<br />
intracranial hemorrhage. To seek for the methods to<br />
reduce the morbidity, mortality and sequelae. Methods: A<br />
retrospective study was performed on 49 cases with spontaneous<br />
intracranial hemorrhage confirmed by clinical manifestation<br />
combined with neuroimaging features and/or<br />
cerebrospinal fluid examination. Results: Delayed vitamin<br />
Kdeficiency (36.7%) and cerebral vascular malformation<br />
(22.4%) were the common causes of spontaneous intracranial<br />
hemorrhage in children. No risk factors were found in<br />
22.4% cases. The main clinical manifestations were headache<br />
and/or vomiting, seizure and disturbance of consciousness.<br />
Hemorrhages in cerebral parenchyma were commonly<br />
seen in children with spontaneous intracranial hemorrhages<br />
and had relatively better prognosis. Conclusion: Prevention<br />
of delayed vitamin K deficiency, hemorrhage relapse and<br />
ischemic damage of cerebral vascular malformation can<br />
effectively reduce the morbidity, mortality and sequelae of<br />
spontaneous intracranial hemorrhage in children.<br />
FO-15-4<br />
Stroke: outcome, risk factors and aetiology in Pakistani<br />
children<br />
Z. Habib, S. Ibrahim, S. Mithani, B.S. Hasan<br />
Department of Pediatrics, Aga Khan <strong>University</strong> Hospital,<br />
Karachi, Pakistan
Abstracts 411<br />
Objectives: This is the first descriptive study that addresses<br />
factors for stroke outcome, clinical features and etiology in<br />
Pakistani children. Aims of the study were to (a) describe age<br />
groups, gender and selected clinical variables in ischemic (I)<br />
and hemmorhagic (H) stroke; (b) classify causes of strokes;<br />
and (c) investigate poor prognostic indicators for stroke<br />
mortality within hospital and morbidity (length of hospital<br />
stay). Methods: Data from 138 children (ages 2 days–192<br />
months; 92 (67%) males, 46 (33%) females) was gleaned<br />
from chart reviews of the past ten years from the pediatric<br />
department of the Aga Khan <strong>University</strong> Hospital. Descriptive<br />
statistics, chi-square, odds ratios, 95% confidence intervals<br />
and multiple logistic regression analyses were used.<br />
Results and conclusions: The mortality was higher in hemorrhagic<br />
(64%) versus ischemic (36%) strokes at P ¼ 0:002.<br />
Overall, the percentage of strokes (I 1 H) was higher in the<br />
infant age group (40%). The percentage of (I) strokes was<br />
higher in the neonate (83%), preschool (74%) and toddler age<br />
groups (73%). The occurrence of seizure activity was higher<br />
in (I) stroke, odds ratio 2.45, P ¼ 0:01. Anemia occurred<br />
with higher frequency in (H) strokes with odds ratios of<br />
5.3, P ¼ 0:000. Presence of seizures dictated morbidity<br />
(bivariate analysis). However, morbidity was not affected<br />
by age at onset of stroke, gender, level of consciousness,<br />
seizure or stroke type at the multivariate level of analysis.<br />
The odds of the child dying from hemmorhagic stroke was<br />
three times higher than ischemic stroke. Plausible pathophysiological<br />
mechanism in the etiology of both (I) and<br />
(H) strokes were presented.<br />
FO-15-5<br />
Visual failure without headache in paediatric ‘Benign’<br />
intracranial hypertension<br />
M.J. Lim, A. Penn, D. Calver, J.P. Lin<br />
Paediatric Neurology and Ophthalmology Department,<br />
Guy’s Hospital, London, UK<br />
Background and objective: We have recently described a<br />
small group of children (n ¼ 7) with benign intracranial<br />
hypertension (BIH) with no headaches, presenting with<br />
focal neurological signs, visual problems and an increased<br />
risk of visual failure. We have continued to recruit more<br />
patients to further assess the differences between the headache<br />
and non-headache groups in BIH. Results: (Table 1)):<br />
A significant proportion present without headaches (31%),<br />
within the paediatric BIH group, In our current bigger<br />
sample size, the atypical presentation group continues to<br />
exhibit more visual abnormalities (blurred vision, diplopia,<br />
visual field defects, larger blind spots and poor visual<br />
acuity) and focal neurological signs (6th and 7th nerve<br />
palsy) when compared to the headache group. Four children<br />
in the non-headache group have marked visual impairment<br />
at follow up. The recognised risk factors for BIH (e.g.<br />
weight) are also less commonly seen within the non-headache<br />
group. Conclusion: These children without headaches<br />
represent a subgroup that have different characteristics to<br />
the headache group and are at risk of visual failure, warranting<br />
early recognition, aggressive management and very<br />
close follow up.<br />
FO-15-6<br />
Confusional migraine: revisited<br />
D. Ghosh, E. Varley, K. Busch, A.D. Rothner<br />
Division of Pediatric Neurology and Otolaryngology and<br />
Communication Disorders, The Cleveland Clinic Foundation,<br />
Cleveland, OH, USA<br />
Confusion is defined as disorientation with or without<br />
altered sensorium. It is the cardinal symptom in acute<br />
confusional migraine (ACM). Our experience and review<br />
of the literature suggest that: (a) confusion is seen in<br />
several migraine variants; and (b) may represent either a<br />
receptive or expressive aphasia. The charts of 20 patients<br />
with ‘confusional’ migraine were reviewed. Twelve were<br />
males. Ages were 5–20 years (14.25). Six had ACM, five<br />
basilar artery migraine, three hemiplegic migraine, three<br />
trauma triggered migraine, two ‘complicated’ migraine<br />
and 1 migraine with aura. One to four episodes per patient<br />
occurred lasting 20 min to 36 h (6.5 h). All had throbbing<br />
headache. Eleven had aphasia. Two were examined during<br />
the attack. One had an expressive aphasia (dysfluent speech<br />
with preserved comprehension), the other a receptive aphasia<br />
(with reading, writing and naming difficulties). EEG in<br />
both showed focal slowing over the dominant cortex. Focal<br />
slowing was seen in six of 11 cases. Interictal CT and/or<br />
MRI were normal. In one child the MRI showed middle<br />
cerebral artery spasm and cortical T2-hyper-intensity over<br />
the dominant cortex. In no patient was an underlying etiol-<br />
Table 1<br />
Headache group (n ¼ 24) Non-headache group (n ¼ 11)<br />
Age (95% CI) 9.8 (^3.3) 7.6 (^3.4)<br />
Sex M:F 7:5 4:7<br />
Associated risk factors (%) 62 27<br />
Visual failure (acuity worse than 6/36 in either eye) (%) 8 36<br />
Blind spot affected (%) 5 (n ¼ 20) 25 (n ¼ 8)<br />
Focal neurological signs (%) 12 45
412<br />
Abstracts<br />
ogy found. In conclusion, confusion can be a prominent<br />
feature of the different migraine variants. Awareness of this<br />
may help avoid invasive investigations. Aphasia as a<br />
component of ACM is common. A detailed language<br />
evaluation during the attack may be useful. Reversible<br />
vasospasm of intracranial vessels causing ischemia contributes<br />
to the mechanism for confusion and aphasia in<br />
migraine.<br />
FREE PAPERS-Poster Presentation<br />
FP-A<br />
Developmental/Basic Neuroscience<br />
FP-A-001<br />
Significance of Pavlov’s work on the physiology of<br />
neuropsychic behaviour of man<br />
K.B. Kulkarni<br />
Sanjivani Nursing Home, Gwalior (M.P.), India<br />
Pavlov’s epoch making observations and animal experiments<br />
provide the edifice for understanding neonatology,<br />
developmental pediatrics, psychology and overall higher<br />
nervous activity. His concept of integral nature of organism,<br />
nervism, unity of organism with social and ecological environs,<br />
the complex toxicosis involving CNS excitation and<br />
inhibition, his idea of multitudinous reflexes as basic reserve<br />
of higher nervous activity, the concept of sleep and internal<br />
inhibition as part of the same process of excitation are only a<br />
few examples. The Pavlovian thought underscores not just<br />
conditioned reflexes but also the instinctive reflexes of<br />
dynamic stereotypes, conditioned switching and reflex<br />
chains. Ukhstomsky’s dominance focus or the dominant<br />
and Pavlov’s conditioned reflex is the elementary functional<br />
unit of central organisation of behaviour. In fact, many<br />
mechanisms of mental activity are a part of the second<br />
and third signalling system of conditioned reflex activity:<br />
even speech, writing and developing communication skills<br />
in the era of information technology. According to him, by<br />
forming numerous two ways connections – forward and<br />
backward – we form mental images of the world around<br />
and likewise, respond reflexively or voluntarily. His observations<br />
on young birds and mammals provide the answer<br />
whether our children should be exposed to life’s dangers and<br />
difficulties. He therefore immensely valued the process of<br />
‘imprinting’. Pavlov stressed on ‘reinforcement’ mechanism<br />
on which elaboration, existence, discontinuation and<br />
extinction of conditioned reflex depends. He took pains to<br />
differentiate between a biologically significant stimulus<br />
from useless one, both in the laboratory and in real life.<br />
Without Pavlovian theory of emotions it would not have<br />
been possible to extricate psychology so early from physiology.<br />
FP-A-002<br />
Aminophylline aggravates long-term morphological and<br />
cognitive damages in status epilepticus in immature rats<br />
L.-T. Huang a , S.N. Yang a , M.-C. Lai b , P.-L. Hung a<br />
a Department of Pediatrics, Chang Gung Memorial Hospital,<br />
Kaohsiung, Chinese Taipei; b Department of Pediatrics,<br />
Chi Mei Foundation Hospital, Chinese Taipei<br />
The aim of this work was to investigate whether aminophylline,<br />
an adenosine receptor antagonist used usually as a<br />
treatment for premature apnea, had synergistic effects on<br />
status epilepticus in the developing brain. On the postnatal<br />
day 14 (P14), four groups of rats intraperitoneally received<br />
saline, aminophylline, lithium-pilocarpine (Li-PC), and Li-<br />
PC plus aminophylline, respectively. Subsequently, Morris<br />
water maze task was performed at P80. The brains were then<br />
analyzed with cresyl violet stain for histological lesions and<br />
evaluated for mossy fiber sprouting with the Timm stain. No<br />
seizures were elicited in the saline-treated or aminophyllinetreated<br />
rats. Both the Li-PC-treated and aminophylline plus<br />
Li-PC-treated rats exhibited seizures and there was no<br />
significant difference in mortality between the two groups.<br />
More interestingly, as in adulthood (P80), aminophylline<br />
aggravated the spatial deficits and histological damages in<br />
hippocampus seen in Li-PC-treated rats. In summary, this<br />
present study suggests that the use of adenosine receptor<br />
antagonists, such as aminophylline, exacerbates seizureinduced<br />
damage in the developing brain.<br />
FP-A-003<br />
Immunohistological evaluation of the diencephalon and<br />
basal ganglia in alobar holoprosencephaly<br />
M. Hayashi a , K. Hamano b , S. Araki c , T. Kohji a ,S.<br />
Kumada b , M. Itoh a , K. Tamagawa c , J. Satoh a ,Y.<br />
Morimatsu a<br />
a Department of Clinical Neuropathology, Tokyo Metropolitan<br />
Institute for Neuroscience, Tokyo, Japan; b Tokyo<br />
Metropolitan Medical Center for SIMDS, Tokyo, Japan;<br />
c Tokyo Metropolitan Neurological Hospital, Tokyo, Japan<br />
Holoprosencephaly (HPE) is caused by the impaired cleavage<br />
of the embryonic prosencephalon and in the severest<br />
type, alobar HPE, the bilateral diencephalon and basal ganglia<br />
are usually fused and tend to intermingle with the upper<br />
brainstem. Therefore, their detailed neuropathological<br />
features have not fully been investigated, although disturbed<br />
regulation in body temperature, electrolyte balance and/or<br />
muscle tonus is frequently observed in HPE patients. We<br />
immunohistologically examined the expression of hypothalamic<br />
markers such as vasopressin and orexin A, neurotransmitters,<br />
neuropeptides and calcium binding proteins in six<br />
female autopsy cases of alobar HPE, in addition to six agematched<br />
controls, who showed preserved immunoreactivities<br />
for these markers from the neonatal period. The HPE
Abstracts 413<br />
cases consisted of two preterm babies, two infants and two<br />
cases over 1 year in age. The neurons immunoreactive for<br />
either vasopressin and/or orexin A were found on both sides<br />
of the diencephalic midline cleft in five cases, with the<br />
exception of the preterm infant case of 35 weeks of gestational<br />
age. The tyrosine hydroxylase-immunoreactive fibers<br />
and neurons were observed in the mixture of diencephalon<br />
and basal ganglia and the mesencephalic substantia nigralike<br />
structure in all the HPE cases. The parvalbumin-immunoreactive<br />
structures mimicking the red nucleus was identified<br />
in one preterm infant case and two cases over 1 year,<br />
while the immunoreactivity for methionine-enkephalin was<br />
found only in cases over 1 year in the mixture of diencephalon<br />
and basal ganglia. These data suggest that the<br />
jumbled diencephalon and basal ganglia showed some<br />
degree of functional development in alobar HPE, and<br />
incomplete or delayed expression of the markers examined<br />
here may partly reflect the diencephalic and motor disturbances<br />
in HPE.<br />
FP-A-004<br />
Developmental changes in EEG multifractal<br />
characteristics of normal and abnormal brain<br />
E.L. Wasserman a , R.I. Polonnikov b , N.K. Kartashev b<br />
a V.M. Bekhterev Psychoneurological Research Institute,<br />
Saint-Petersburg, Russia;<br />
b Institute of Informatics and<br />
Automation of RAS, Russia<br />
One hundred-ten males and females (6.5–19.5 years old)<br />
were investigated (48 healthy persons, 51 ones with hemiplegic<br />
cerebral palsy and 11 ones with similar acquired<br />
cerebral defect). Monopolar 12-channel EEG were<br />
processed and then regarded as multifractal processes.<br />
Power spectrums of 30 successive 1-s fragments of background<br />
activity in each channel were approximated by k·f b<br />
model ( f-frequency in 2–30 Hz band, k and b-model parameters).<br />
Model parameters were averaged in all 30 fragments<br />
and 12 channels and then analysed. Stable<br />
correlations (accordant to Spearman, r s , P , 0:0001) of<br />
both parameters with the age of person were discovered:<br />
k (r s ¼ 20:63) and b (r s ¼ 20:58). These dependences<br />
were approximated well by exponential functions and<br />
observed in healthy persons (r s ¼ 20:55, r s ¼ 20:56) as<br />
well as in patients (r s ¼ 20:67, r s ¼ 20:64). It was<br />
concluded: (1) parameter b (which is an informational<br />
characteristic of EEG as multifractal) and parameter k<br />
(which is a power characteristic of EEG) demonstrate regular<br />
changes with age reflecting the process of cerebral<br />
maturation; and (2) this regularity takes place not only in<br />
the cases of normal development of brain but also in the<br />
cases of its abnormal development caused by early or later<br />
injury.<br />
FP-A-005<br />
The expression of PRL, GFAP and Fos in the cerebral<br />
cortex and amygdala of acute heat stress model of<br />
seizure in weanling rats<br />
H. Ni, Q.-X. Shui<br />
Department of Neurology, Children’s Hospital, College of<br />
Medicine, Zhejiang <strong>University</strong>, Hangzhou, China<br />
Many investigations have suggested the possibility that<br />
febrile convulsions (FC) in early childhood are an etiologic<br />
factor in human temporal lobe epilepsy. In order to explore<br />
the morphological basis of pathogenesis in FC, the expression<br />
of prolactin, glial fibrillary acidic protein (PRL, GFAP)<br />
and Fos immunoreactivity in cerebral cortex and amygdala<br />
of weanling rats was examined. We studied this by using the<br />
warm-water-immersion model and immunohistochemistry<br />
method. Thirty rats were randomly divided into two groups:<br />
normal control group (n ¼ 6) and hyperthermia-treated<br />
group (n ¼ 14). The latter was further divided into FC<br />
(n ¼ 6, score reaching Grade 5, two rats were abandoned<br />
for only reaching Grade 2) and hyperthemic (non-convulsion)<br />
groups according to the reaction to hyperthemia treatment.<br />
Our results demonstrated that there was a large<br />
number of positive cells with PRL, GFAP and Fos immunoreaction<br />
in both cerebral cortex and amygdala in<br />
hyperthermia-treated group (P , 0:01). Moreover, the<br />
expression of GFAP and Fos were markedly high in FC<br />
group than in hyperthemic (non-convulsion) group, meanwhile<br />
the expression of PRL did not change significantly<br />
between the hyperthemic and FC group (P . 0:05). These<br />
results indicated that the increased prolactin immunoreactivity<br />
is involved in the progress of heat stress activity, but<br />
may have no significant relationship with seizure activity.<br />
However, GFAP and Fos are not only involved in pathogenesis<br />
of heat stress progress, but may also associate with<br />
seizure activity.<br />
FP-A-006<br />
Different expression of c-Fos and prolactin in neonatal<br />
rat with hypoxic-ischemic encephalopathy<br />
H. Ni a , Q.-X. Shui a , Y.-C. Wang b , C.-C. Shi b<br />
a Department of Neurology, Children’s Hospital, College of<br />
Medicine, Zhejiang <strong>University</strong>, Hangzhou, China; b The<br />
Peoples’ Hospital of Jinhua, Zhejiang Provence, China<br />
Recent studies have showed that prolactin is not only<br />
synthesized in the pituitary gland, but also within the central<br />
nervous system to control a variety of behaviors. The<br />
expression of c-fos like protein is regarded as a marker for<br />
neuronal activity following noxious stimulation in the rat.<br />
The present study was to investigate the relationship<br />
between c-fos and prolactin expressions in neonatal rat<br />
with HIE. Twenty 7-day-old SD rats were randomized<br />
divided into two groups: normal control group (n ¼ 8, with-
414<br />
Abstracts<br />
out hypoxic-ischemic treatment) and hypoxic-ischemic<br />
treatment group (HIE, n ¼ 12). After ligation of the left<br />
common carotid artery, the rats of HIE group were exposed<br />
to 8% oxygen-92% nitrogen at 378C for 3 h. At the end of<br />
the hypoxic period, they were removed from the container<br />
and placed in room air for 60 min before being decapitated.<br />
Immunohistochemistry was used to detect the expression of<br />
PRL and Fos. Compared with controls, the number of Fos<br />
positive neurons elevated significantly in hypothalamus,<br />
supramammillary nucleus, suprachiasmatic nucleus, thalamic<br />
pavaventricular nucleus, the thalamic midline nucleus,<br />
and amygdala (P , 0:01). On the other hand, cortical and<br />
hippocampal PRL immunoreactive cells were significantly<br />
elevated compared with the control (P , 0:01). The<br />
increased expression of Fos and PRL might closely related<br />
to hypoxic-ischemic processes. The different expression<br />
region of Fos and PRL suggest differential role of them in<br />
HIE.<br />
FP-A-007<br />
Ontogenic expression of colony stimulating factor-1<br />
receptor on neurons<br />
S.-Q. Qu, Y.-Q. Wang, L. Zuo, X.-H. Hu<br />
Navy general hospital, Beijing, China<br />
The mice with different ages, from embryonic day 14, 18<br />
(E14, E18) to newborn and postnatal 7, 14, 21, 28 (P7, P14,<br />
P21, P28) were used in our experiment. Immunochemical<br />
staining and immunoblotting were used to examine the<br />
expression of CSF-1 receptor (CSF-1R) on neurons in<br />
CNS. The results showed that the expression of CSF-1R<br />
could be detected on brain neurons of mice from fetal age<br />
14 days and increased gradually along with the growing of<br />
fetal mice and reached the peak value in newborn mice.<br />
The expression decreased gradually after birth and reached<br />
plateau 4 weeks later showed by Western blot. The<br />
numbers of CSF-1R positive neurons also showed the<br />
same pattern as western blot in immunochemical study. It<br />
was indicated that there might be a close relationship<br />
between the level of CSF-1R expression and the ontogeny<br />
and development of neurons in CNS in mice. Ya-qi<br />
Wang’s work showed that expression of CSF-1R were<br />
only observed in a few of neurons in the brainstem in<br />
normal state, but up-regulated not only at the vicinity of<br />
the lesion but also in distant areas after the ischemic lesion.<br />
It was suggested that neurons have the potency of expressing<br />
CSF-1R during the development, which might be<br />
down-regulated somehow after birth and up-regulated in<br />
the lesion’s conditions in our experiment. We supposed<br />
that CSF-1R might play an important role in the development<br />
course of neural system in mice and was one of the<br />
factors in response to the stimulation.<br />
FP-A-008<br />
Effect of nerve growth factor on neuronal injury in<br />
strychnine-nitrate induced seizure rats<br />
M.-Y. Hu, Z.-M. Ren, M. Jiang<br />
Department of pediatric Second Affiliated Hospital of<br />
Harbin Medical <strong>University</strong> Harbin, China<br />
Objective: To probe whether exogenous nerve growth<br />
factor (NGF) might have an active effect on the encephalo-neuronal<br />
apoptosis induced by acute seizures. Methods:<br />
With the model of strychnine-nitrate-induced epilepsy,<br />
the morphological changes of brain cells were observed<br />
under the photomicroscrope with hematoxylin and eosin<br />
(HE) dying as well as the amount of apoptotic neurons<br />
and the effect of NGF on that were detected by the method<br />
of immuno-histochemistry with bax and bc1-2 protein.<br />
Result: Apoptotic neurons in CA1 of the hippocampus and<br />
the cortex were seen 24 h after epilepsy was induced, which<br />
increased significantly at 48 h and reached the peak at 72 h,<br />
then decreased toward 7 days to the valley. There are far<br />
fewer apoptotic neurons in brain cells of the rats injected<br />
with NGF into their abdomen than those without injection<br />
killed at the same time expectedly (P , 0:05). Conclusions:<br />
Exogenous NGF could inhibit the encephalo-neuronal apoptosis<br />
induced by acute seizures, which means that NGF may<br />
have a neuroprotective effect against brain damage owing to<br />
epilepsy.<br />
FP-A-009<br />
Levels of CSF neurotrophic factors in patients with Rett<br />
syndrome and children with autism<br />
R.S. Riikonen, R. Vanhala, U. Turpeinen<br />
Children’s Hospital, <strong>University</strong> of Kuopio, Kuopio, Finland<br />
Autism and Rett syndrome (RS) are both developmental<br />
disorders of unknown origin. Differentiation of RS from<br />
infantile autism in the very early stages is not always<br />
easy. The aim of the present study was to determine whether<br />
CSF NGF or CSF insulin-like growth factor-I (IGF-I). (1)<br />
Distinguish patients with RS from autism; and (2) could<br />
have a role in the pathogenesis of the syndromes. Method:<br />
We measured CSF NGF levels with two-site ELISA method<br />
and CSF IGF-1 levels with radioimmunoassay (RIA).<br />
Results: Patients with RS had low to negligible levels of<br />
CSF NGF. Patients with autism had normal CSF NGF<br />
levels. CSF IGF-I of patients with RS did not differ from<br />
controls. Patients with autism had low levels of CSF IGF-I<br />
compared to controls. NGF acts specifically on cholinergic<br />
neurons of the basal forebrain. In RS the frontal cortex is<br />
more severely affected than the other cortical areas. IGF-1 is<br />
important for cerebellar development. In autism, many<br />
studies show hippocampal or cerebellar pathology. Conclusions:<br />
Our findings are in agreement with the different<br />
morphological and neurochemical findings (brain growth,
Abstracts 415<br />
affected brain areas, neurotransmitter metabolism) in the<br />
two syndromes.<br />
FP-A-010<br />
Monoamines in brain tissues of newborn rabbits with<br />
cerebral palsy<br />
X.-J. Li, Y.-Q. Li, Z.-M. Jiang, L. Li<br />
Prevention, Treatment and Rehabilitation Center for Child<br />
Cerebral Palsy in Heilongjiang Province, Jiamusi, Heilongjiang,<br />
China<br />
To study the role of monoamines (DA, 5-hydroxytryplamine,<br />
5-HT, NE) in pathogenesis of CP by measuring the<br />
levels of dopamine (DA), 5-HT, nonepinephrine (NE) in CP<br />
rabbit models. Twenty newborn rabbits (2–3 days) were<br />
randomly divided into two groups: the control group (C<br />
n ¼ 10), the model group (M n ¼ 10). Rabbits in group M<br />
were administered intraperitoneal bilirubin 100 mg/kg, total<br />
dose was 300 mg/kg. Rabbits in group C were administered<br />
saline as the same dose as those in group M. Animals were<br />
killed after being fed naturally for 45 days, hippocampus,<br />
cerebral cortex, basal ganglia and brainstem were separated<br />
respectively. Each region was divided into two parts: one<br />
part was fixed and examined with light microscope. The<br />
levels of monoamines in the other part were determined.<br />
The levels of NE, 5-HT in basal ganglia and NE in brainstem<br />
in group M were significantly lower than those in<br />
group C (P , 0:05). There was positive correlation between<br />
DA, 5-HT in basal ganglia and NE in brainstem<br />
(r ¼ 0:8979, r ¼ 0:7112, P , 0:05), and between 5-HT<br />
and DA in basal ganglia (r ¼ 0:6178, P , 0:05). The results<br />
suggest that bilirubin may be responsible for the decreased<br />
DA, 5-HT, NE in brain tissues. DA, 5-HT may participate in<br />
the damage of basal ganglia induced by bilirubin. The levels<br />
of NE may be related to the symptoms of CP.<br />
FP-A-011<br />
Pilocarpine-induced status epilepticus produces<br />
neuronal death: implications for programmed cell death<br />
mechanisms<br />
R.-Z. An, Y.-R. Yin, C.-J. Jin, G.-H. Li<br />
Department of Pediatrics, College of Medicine, YanBian,<br />
<strong>University</strong>, Yanji, China; New Era Children Hospital,<br />
Yanji, China<br />
Purpose: Prolonged and continuous epileptic seizures<br />
(SE) induced by pilocarpine activate programmed cell<br />
death mechanisms. In order to test this hypothesis, we<br />
investigated the morphology of neuronal death (necrotic<br />
and apoptotic) from pilocarpine-induced SE, and the<br />
expression of proapoptotic and antiapoptotic protein bax<br />
and bcl-2, respectively. Methods: Pilocarpine induced<br />
status epilepticus lasting 2 h was induced in Sprague-<br />
Dawley adult male rats, which were allowed to recover<br />
for 24 or 72 h before perfusion-fixation. Neuronal death<br />
was assessed by light microscopy with the haematoxylinand<br />
-eosin stain and with in situ terminal deoxynucleotidyl<br />
transferase dUTP nick-end labelling (TUNEL stain). Bax<br />
and bcl-2 protein expression were examined by immunohistochemistry.<br />
Results: Twenty-four and 72 h after 2 h<br />
pilocarpine induced SE, neuronal death in hippocampus<br />
(CA1 and CA3) was morphologically necrotic, but there<br />
were TUNEL-positive and morphologically necrotic cells<br />
in the hippocampal CA1 and CA3 regions at 72 h, but not<br />
at 24 h, after SE. Bax protein expression was also increased<br />
in the hippocampal CA1 and CA3 regions at 72 h after SE.<br />
Bcl-2 protein expression was not detected. Conclusion: Our<br />
results suggest that programmed cell death promoting<br />
mechanisms are activated by SE in neurons that become<br />
necrotic and could contribute necrotic, as well as apoptotic,<br />
neuronal death.<br />
FP-A-012<br />
Expression of GABA A receptor a 1 subunit in rat<br />
hippocampus following kainic acid-induced temporal<br />
lobe epilepsy<br />
G.-F. Lei, R.-P. Sun, Y.-L. Wang, B.-M. Li, J.-W. Wang,<br />
R.-M. Hu, S.-H. Guo<br />
Pediatric Department, Shandong <strong>University</strong> Qilu Hospital,<br />
Shandong, China<br />
Intrahippocampus injection of kainic acid (KA) in the rat<br />
represents a widely used animal model of human TLE, the<br />
etiology of which is controversial. This study evaluated by<br />
immunohistochemistry for the expression of GABA A receptor<br />
a 1 subunit (major a subunit expressed in adult brain) in<br />
the contralateral hippocampus of rats 12, 24, 72 h, 7 and 30<br />
days after injection of KA into right hippocampus. At early<br />
intervals (within 24 h after KA injection) a 1 subunit expression<br />
on hippocampus was decreased. The decrease was<br />
followed by increase of a 1 subunit expression after 7–30<br />
days. The results indicate that the decreased GABA A receptor<br />
a 1 subunit expression on hippocampus at early interval<br />
may play an important role in the induction and maintenance<br />
of epilepsy, and the decrease in GABA A receptor a 1<br />
subunit expression may be compensated partly by increased<br />
expression at late interval. Thus the compensatory mechanism<br />
is operative in epileptic hippocampus.<br />
FP-A-013<br />
Effect of radix salviae miltiorrhizae on inducible nitric<br />
oxide synthase activity in rat astrocytes<br />
F. Gao, J.-F. Lu, Q.-X. Shui, Z.-Z. Xia, B.-L. Zhou<br />
Department of Neurology, Children’s Hospital, Zhejiang<br />
<strong>University</strong> Medical College, Hangzhou, China<br />
Objective: The present study was undertaken to examine<br />
the effect of radix salviae miltiorrhizae (RSM) on the indu-
416<br />
Abstracts<br />
cible nitric oxide synthase (iNOS) activity induced by endotoxin<br />
in cultured rat astrocytes. Method: We detected iNOS<br />
activity in normal astrocytes, LPS induced astrocytes, and<br />
RSM treated LPS induced astrocytes by Griess methods.<br />
Results: (1) The effect of LPS induced iNOS activity expression<br />
in astrocytes was significant among the different LPS<br />
concentrations within the range of 0.01–50 mg/ml, the maximum<br />
stimulation for iNOS activity was obtain with 10 mg/<br />
ml LPS (40.00 ^ 2.52 mM). (2) The effect of different incubation<br />
time on iNOS activity of astrocytes: the iNOS activity<br />
of astrocytes in the control group was no significant<br />
change from 0 to 48 h of incubation time. However, when<br />
it was stimulated with 5 mg/ml LPS, the iNOS activity<br />
increased to be 6.02 ^ 0.52, 6.93 ^ 0.52, 27.65 ^ 1.47,<br />
29.20 ^ 6.09, 29.40 ^ 1.60 mM with the time of incubation<br />
at 3, 12, 24, 36 and 48 h, respectively. The induction of<br />
iNOS activity by endotoxin was not influenced by RSM<br />
incubation within 12 h, otherwise RSM exhibited strong<br />
inhibition at 24, 36 and 48 h, respectively, as compared<br />
with that of LPS group. (3) The effect of various concentrations<br />
of RSM on 5 mg/ml LPS induced iNOS activity: iNOS<br />
activity attenuated gradually, with the increase of RSM<br />
concentrations. Conclusions: It was suggested that the<br />
iNOS of astrocytes might take part in the pathology of<br />
bacterial infection in central nervous system, and its role<br />
could be decreased by RSM.<br />
FP-A-014<br />
Gene therapy for rat hypoxic-ischemic encephalopathy<br />
by neurotrophin-4-engineered marrow stromal cell<br />
Y.-J. Jia, Y.-J. Yang, X.-R. Zheng, J.-B. Liu, J.-H. Song<br />
Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />
China<br />
Objective: Marrow stromal cells, which have many characteristics<br />
of stem cells, populate various non-hematopoietic<br />
tissues including the brain. In the present study, we explored<br />
the protocol of gene therapy for hypoxic-ischemic encephalopathy<br />
by neurotrophin-4(NT-4)-engineered marrow stromal<br />
cell. Methods: The recombinant pcDNA3.1(1) NT-4<br />
plasmids were constructed and transduced into marrow stromal<br />
cells by lipofectin. The newborn rat hypoxic-ischemic<br />
model was successfully established, and NT-4-engineered<br />
marrow stromal cells were transplanted into brain. Results:<br />
The plasmids could express active NT-4 protein and mRNA<br />
in marrow stromal cells presented by immunohistology and<br />
in situ hybridization. Four weeks after transplantation, more<br />
NT-4 immuno-reaction positive cells were observed in the<br />
transplanted group compared with the control group. In addition,<br />
significant difference in motor activity and histological<br />
changes were detected between the two groups. Conclusion:<br />
These results suggested that NT-4-engineered marrow stromal<br />
cells were effective in gene therapy for hypoxicischemic<br />
encephalopathy.<br />
FP-A-015<br />
Changes of nestin expression in marrow stromal cells<br />
differentiate to neuron and islet<br />
Y.-J. Jia, Y.-J. Yang, J.-B. Liu, X.-R. Zheng, J.-H. Song<br />
Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />
China<br />
Objective: Marrow stromal cells (MSCs) exhibited multiple<br />
traits of a stem cell population. In the present study, we<br />
explored changes of nestin expression during marrow stromal<br />
cells differentiating into neurons and islets. Methods:<br />
MSCs from adult rats were induced by baicalin in serumfree<br />
medium for 6 h, and post-induced by baicalin for neuron<br />
or by kinetics gain factor (KGF) for islet. After inducement,<br />
neuron and islet were evaluated by immunocytochemistry<br />
staining. And insulin released was measured by radioimmunoassay.<br />
The expression of nestin was measured by immunocytochemistry<br />
and RT-PCR. Results: After induction,<br />
MSCs expressed neuronal special proteins, such as NSE,<br />
NF and NeuN, and islet special proteins, such as insulin<br />
and glucagons. In addition, cumulative quantities of insulin<br />
with 24 h and the stimulation index maintained at high level.<br />
The expression of nestin was appeared in 6 h of differentiating<br />
into both neuron and islets. After 24 h, the expression was<br />
not detected. Conclusions: The results showed that nestin<br />
may play a role in MSCs differentiate into neuron and islets.<br />
They suggested that there may be a common path of neuron<br />
and islets differentiation.<br />
FP-A-016<br />
Effects of phenytoin on primary cortical neuron cultures<br />
Y.-J. Jia, Y. Zhou, Y.-J. Yang<br />
Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />
China<br />
Objective: By observing the effects of phenytoin (PHT)<br />
on cortical neuron, we tried to give an explanation of the<br />
mechanism of PHT-induced neurotoxicity. Methods: After<br />
established the method of primary rat cortical neuron<br />
culture, neuron membranous fluidity, percentage of surviving,<br />
LDH releasing ratio, and morphologic changes in the<br />
various doses of PHT (2.5, 5, 12.5, 25 mg/ml and control<br />
groups) were measured. Moreover, the conformation of<br />
membrane proteins was calculated by circular dichroism<br />
spectra. Results: There were no significant differences<br />
between the control group and low-dosed groups (2 and<br />
12.5 mg/ml). On the contrary, in the high-dosed groups<br />
(25 and 50 mg/ml), there were significant decrease of<br />
membranous fluidity and the percentage of neuron surviving,<br />
and increase of LDH releasing ratio (P , 0:05). a-helix<br />
content in the membrane proteins of control group was<br />
48.3%. After treated by high-dosed PHT, the content<br />
increased to 53.7 and 55.9%, respectively. Conclusions:<br />
The results showed that the high-dosed PHT may play a<br />
role in decrease of membranous fluidity, increase of LDH
Abstracts 417<br />
efflux and a-helix content in the membrane proteins. They<br />
suggested that there is a relationship between PHT-induced<br />
neurotoxicity and changes of membranous structure.<br />
FP-A-017<br />
Isolation and cultivation of neural stem cells from<br />
newborn rats<br />
Y.-J. Jia, Y.-J. Yang, J.-H. Song, J.-B. Liu, X.-R. Zheng<br />
Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />
China<br />
Objective: To study the isolation and cultivation of<br />
neural stem cells from newborn rats. Methods: Cell culture,<br />
indirect immunofluorescence cytochemistry and gene<br />
transfection techniques were used. Results: The neural<br />
stem cells isolated from newborn rats had the potential to<br />
form clones, express neuroepithelial stem cell protein<br />
(nestin) and differentiate into mature neurons and astrocytes.<br />
Moreover, green fluorescent protein vector could<br />
be efficiently transfected into this cell line. Conclusion:<br />
The results demonstrated that our neural stem cells can<br />
only be characterized on a critical functional basis in<br />
terms of their undifferentiated features, capacity for selfrenewal,<br />
proliferation, pluripotentiality, and ability to efficiently<br />
express ex vivo gene.<br />
FP-A-018<br />
The dose-dependents and time-dependents in induced<br />
brain heat shock protein 70 (HSP70) expression with<br />
curcumin<br />
R. Huang, F. Luo, Y.-J. Yang<br />
Department of pediatrics, XiangYa Hospital, Central South<br />
<strong>University</strong>, Changsha, China<br />
Objectives: To study the dose-dependents and timedependents<br />
in induced HSP70 expression with curcumin.<br />
Methods: I The dose-dependents. SD rats were randomly<br />
divided into seven groups: (1) blank group (B); (2) DMSO<br />
group (DMSO); (3) heat shock group (HS); (4) curcumin<br />
80 mg group (C80); (5) curcumin 40 mg group (C40); (6)<br />
curcumin 20 mg group (C20); (7) curcumin 10 mg group<br />
(C10); animals were killed 24 h after HS or injection<br />
DMSO or curcumin. Brain HSP70 were tested by Western<br />
blot analysis. II The time-dependents. SD rats were all<br />
injected with curcumin 40 mg/kg into peritoneal. Then<br />
randomly divided into eight groups according the killed<br />
time, 0, 2, 4, 6, 12 and 16, 24 and 48 h. Brain HSP70<br />
expression was detected by the Western blot analysis.<br />
Results: The Brain HSP70 expression of HS, C40, C80<br />
group were increased significantly, especially in C40<br />
group (P , 0:01). HSP70 expression was increased gradually<br />
with the time going, and the top in 16H group; then,<br />
there was a plateau in 24 and 48 h group. Conclusions:<br />
Brain HSP70 expression can be induced by pretreatment<br />
with curcumin, and there are dose-dependents and timedependents.<br />
FP-A-019<br />
Effects of developmental lead exposure on N-methyl-daspartate<br />
receptor mRNA expression in rat<br />
hippocampus<br />
Z.-W. Zhu, Z.-Y. Zhao, G.-J. Dong<br />
The Affiliated Children’s Hospital of Zhejiang <strong>University</strong><br />
School of Medicine, Hangzhou, China<br />
Objective: To investigate the effect of developmental<br />
lead exposure on NMDA receptor mRNA expression in<br />
rat hippocampus. Methods: We established a series of<br />
developing rat models exposed to low level lead (drinking<br />
water containing 0.025, 0.05 or 0.075% lead acetate), and<br />
examined mRNA expression levels of the subunit NR2A<br />
and NR2B in rat hippocampus with RT-PCR method.<br />
Results: There were no differences in body weight of rat<br />
pups between any two groups at any age (P . 0:05). The<br />
blood lead level of Pb-exposed rats changed regularly: at<br />
age of 14 days, it was lower than that of 7 days, and<br />
increased to a highest level at 21 days, then returned to<br />
lower level at 28 days. There was difference between 21<br />
days and any other age groups (P , 0:05). The expression<br />
levels of NR2A mRNA of 0.05 and 0.075% groups at age<br />
of 7 and 14 days were higher than those of control group<br />
(P , 0:05), but in 0.025% group, the expression level of<br />
NR2A mRNA was higher than that of control group at 7<br />
days (P , 0:05). There were no significant differences in<br />
expression level of NR2B mRNA between any two groups<br />
at any age (P . 0:05). Conclusions: Developmental low<br />
level lead exposure of rats can raise the expression level<br />
of NR2A mRNA in hippocampus. Developmental low<br />
level lead exposure of rats does not affect the expression<br />
level of NR2B mRNA in hippocampus.<br />
FP-A-020<br />
Development of the prefrontal layer IIIc pyramidal<br />
neurons in fetuses and infants with Down’s syndrome<br />
M. Vukšić, J. Bošnjak, A. Cepika, Z. Petanjek, I. Kostović<br />
Croatian Institute for Brain Research, Salata 12, School of<br />
Medicine, <strong>University</strong> of Zagreb, Zagreb, Croatia<br />
In this study we have analysed the development of associative<br />
layer IIIc pyramidal neurons of the prefrontal cortex<br />
in children with DS during the late fetal and early postnatal<br />
period. Basal dendritic tree of rapid Golgi impregnated<br />
pyramidal neurons was quantitatively analysed (dendritic<br />
length; number and morphology of dendritic spines) in the<br />
postmortal brains from 3 subjects with DS (fetus 36 weeks<br />
of gestation, infants aged 2.5 and 4.5 months) and in 5 age<br />
matched controls. During the perinatal period there is the<br />
most intensive dendritic growth and spinogenesis. No differ-
418<br />
Abstracts<br />
ences were present between DS infants and control subjects<br />
concerning the pattern of the dendritic elongation and<br />
segment outgrowth. Increase in spine number followed in<br />
DS the normal curve up to third postnatal month. At 4<br />
months decreased spine density was observed only on the<br />
most distal terminal branches. Some morphological alterations<br />
of the dendritic spines are present in DS subjects from<br />
the beginning of their occurrence. It was proposed that the<br />
basis of cognitive dysfunction in DS lies in the disordered<br />
development of their associative cortex. These data suggest<br />
that children with DS begin their life with morphologically<br />
normal layer IIIc prefrontal pyramids, which are the key<br />
cellular elements of the corticocortical connectivity. Since<br />
the first regressive changes are not present before the fourth<br />
postnatal month, it seems reasonable to conclude that the<br />
application of some therapeutic procedures in the early<br />
period of life could mitigate a cognitive decline present<br />
later in these patients.<br />
FP-A-021<br />
Reelin and calretinin immunohistochemistry in<br />
ibotenate-induced cortical dysplasia in newborn hamster<br />
T. Takano, Y. Takeuchi<br />
Department of Pediatrics, Shiga <strong>University</strong> of Medical<br />
Science, Otsu, Japan<br />
Reelin is an extracellular matrix protein synthesized and<br />
secreted by Cajar-Retzius (CR) cells in the marginal zone,<br />
and plays a pivotal role in cortical lamination. Calretinin, a<br />
calcium-binding protein, has been postulated to have a<br />
correlation with calcium-dependent events such as synaptogenesis,<br />
neurite elongation or neuroprotective process. The<br />
present experiment reported the model of cortical dysplasia<br />
induced by intracerebral inoculation of ibotenate in<br />
newborn hamsters. In order to investigate the role of reelin<br />
and calretinin in the development of cortical dysplasia,<br />
immunohistochemical localization of these proteins was<br />
analyzed. Main types of cortical dysplasia detected were<br />
microgyria (Mg), leptomeningeal glioneuronal heterotopia<br />
(LGH) and subcortical nodular heterotopia (SNH). Reelin<br />
immunohistochemistry showed evenly spaced CR-like<br />
cells, mainly in the more superficial aspects of the marginal<br />
zone. Focal increases of reelin immunoreactive CR-like<br />
cells were observed in the lesions of Mg and LGH. In the<br />
area of SNH, reelin immunoreactivity was not detected.<br />
Calretinin immunoreactivity was mainly observed in the<br />
following areas; small number of horizontally oriented<br />
cells in the marginal zone, intensively stained cells and<br />
fibers in the subplate, and large number of neurons in the<br />
piriform cortex. Focal accumulation of calretinin positive<br />
fibers and cells was observed in the lesions of Mg and LGH.<br />
Small number of calretinin immunoreactive cells were also<br />
detected in SNH. Overexpression of reelin or calretinin in<br />
the areas of MG, LGH and SNH was thought to be related to<br />
the abnormal tangential neuronal migration.<br />
FP-A-022<br />
Study the protection role of TGF-b1 in acute ischaemia<br />
brain damage of mice<br />
B. Xue, F. Li, X.-Z. Fang<br />
Department of Pediatrics, Sheng Li Hospital of Sheng Li<br />
Petroleum Administrative Bureau, Dong Yin, China<br />
Objective: To investigate the protection role of TGF-b1in<br />
acute ischaemia brain damage. Method: One hundred and<br />
eighty mice were randomly divided into control group,<br />
model group, TGF-b1 prevention and treatment group, cytidine<br />
5 0 -diphosphocholine (CDPC) prevention and treatment<br />
group. Mice in the prevention group were injected TGF-b1<br />
25 mg/20 g or CDPC 62.5 mg/20 g into abdominal cavity an<br />
hour before acute ischaemia brain damage model was established,<br />
while mice in the treatment group were injected the<br />
same medicines as the prevention group an hour after model<br />
was established. Ten mice of each group were killed after 24<br />
and 48 h, the brain tissues were collected to observe the<br />
changes of pathology using light microscope and electric<br />
microscope. Nerve cells of hippocampus CA1 area were<br />
counted. Expression of TGF-b1 mRNA in neuron and glial<br />
cells were detected by in situ hybridization. The death condition<br />
of the rest mice was observed. Results: TGF-b1 mRNA<br />
was not expressed in control group. It was completely<br />
expressed and most III degree in model group. Although<br />
there was also expressed in TGF-b1 prevention group and<br />
treatment group, the degree was lower than those in model<br />
group. TGF-b1 mRNA was completely expressed in CDPC<br />
prevention group and treatment group. But the degree was<br />
lower than those in model group and more than those in TGFb1group.<br />
There were more hippocampus CA1 nerve cells in<br />
TGF-b1 prevention group and treatment group than in model<br />
group and CDPC group. The change of morphology was<br />
lower than in model group and CDPC prevention and treatment<br />
group. The survive time of mice was prolonged in TGFb1<br />
prevention group and treatment group. Conclusion: TGFb1<br />
can down-regulation TGF-b1 mRNA expression, lighten<br />
the extent of damage in hippocampus CA1 area, prolong the<br />
survive time of mice, play a protection role in acute ischaemia<br />
brain damage. The effect of TGF-b1 prevention is superior<br />
to the effect of treatment.<br />
FP-A-023<br />
Building a mouse model hallmarking the congenital<br />
human cytomegalovirus infection in central nervous<br />
system<br />
J.-L. Tang a , M.-L. Wang b , J.-J. Qiu a ,D.Wu a ,W.Hu b<br />
a Pediatric Department, The First Affiliated Hospital, Anhui<br />
Medical <strong>University</strong>, Hefei, China;<br />
b The Microbiology<br />
Teaching and Researching Section, Anhui Medical <strong>University</strong>,<br />
Hefei, China<br />
To investigate the mechanisms that human cytomegalo-
Abstracts 419<br />
virus (HCMV) can vertically transmit from the placenta of<br />
mice to infect their offspring in the CNS and cause congenital<br />
anomalies, in addition provide basic research for<br />
preparing HCMV vaccine, we have developed a new type<br />
of mouse model of HCMV congenital CNS infection. Pure<br />
strain mice were propagated after being infected with<br />
HCMV, then we looked for evidences that CNS of their<br />
filial generations were infected by HCMV. The experiment<br />
shows that in the infection groups the mortality of fetal mice<br />
and the fatality of neonatal mice in 1 week are higher than<br />
that of in the control groups (P , 0:01). At the same time<br />
we research the CNS of fetus’s mice whose mother were<br />
infected by HCMV, the results are as fellows: (1) the virus<br />
was successfully isolated from their cerebral cortex. (2) The<br />
signal of HCMV hybridization print was found in their<br />
nervous cell through in situ hybridization. (3) Especially<br />
human herpes virus-like particles and inclusion bodies in<br />
the cytoplasm of nerve cell were found in the tissue of<br />
their brain under the electronic microscopy. This new type<br />
of mouse model of HCMV inherent CNS infection will help<br />
us to prepare HCMV vaccine and research HCMV congenital<br />
infection in CNS.<br />
FP-A-024<br />
Cerebrolysin protects cortical neurons from<br />
extracorporal HSV-1 infection<br />
J.-L. Tang, M.-L. Wang, D. Wu, Y. Hu<br />
Pediatric department, the First hospital affiliated to Anhui<br />
medical <strong>University</strong>, Hefei City, China<br />
The effects of cerebrolysin on isolated mice cortical<br />
neurons in a herpes simplex virus HSV-1 infection model<br />
has been examined. First prepared culture solution of<br />
newborn mouse’s cerebral cortex neurons (CCNs) and<br />
cultured them, then 0.4 ml cerebrolysin for each aperture<br />
(provided by Austrian Ebewe Medicine Factory) was added<br />
to CCNs culture solution respectively on the 2nd, 4th, 6th<br />
and 10th day. At the same time one group of normal culture<br />
solution of newborn mouse’s cerebral cortex neurons was<br />
utilized as control group. On the 12th day, each aperture was<br />
received 3.0 log TCID50 suspension of HSV-1. The results<br />
are as follow: (1) the culture groups that receiving cerebrolysin<br />
on the 4th or 6th day were found to suffer lower CCNs<br />
pathological damages ratio (25–40%) after 24 h later, while<br />
other culture groups receiving cerebrolysin on the 2nd, 8th<br />
or 10th day suffered higher CCN’s pathological damage<br />
ratio (75–90%). (2) In five kinds of culture solution with<br />
different cerebrolysin concentration showed no obviously<br />
pathological damage, which indicated that cerebrolysincan<br />
protect CCNs from the harm of HSV-1. This conformed that<br />
adding cerebrolysin to CCN culture on the 4th or 6th day<br />
could intensify CCN’s HSV-1 resistance. But why the<br />
culture groups that receiving cerebrolysin on the 2nd day<br />
shows no enough protective efficacy is worthy studying in<br />
the future.<br />
FP-A-025<br />
Experimental study in the effect of platelet activating<br />
factor and its antagonist on hypoxic ischemic<br />
encephalopathy<br />
W. Wang, D. Li, S.-Y. Li, Y. Gao<br />
Children Hospital of Changchun, Changchun, China<br />
Objective: To investigate the relationship between platelet<br />
activating factor (PAF) and hypoxic ischemic encephalopathy<br />
(HIE), and new method of therapy. Methods: Serum<br />
PAF in Wistar rats and 20 patients with HIE were assessed<br />
by improved Henson’s method. The PAF antagonist<br />
(BN51021) was used to treat test rats with HIE. Results:<br />
The level of serum PAF in test Wistar rats and patients<br />
with HIE was significantly higher than that of normal<br />
control group P , 0:001). The level of serum PAF in tests<br />
Wistar rats with higher PAF was reduced by ginkgolides<br />
antagonist (BN51021). Conclusion: The PAF is related to<br />
HIE, can be considered as a marker to assess HIE severity<br />
and prognosis. The ginkgolides antagonist (BN51021) can<br />
obviously inhibit the production of PAF in test Wistar rat<br />
with HIE and decrease serum PAF (0.001). This study may<br />
help for future treatment of HIE.<br />
FP-A-026<br />
Stimulation of N-methyl-d-aspartate (NMDA) receptors<br />
inhibits neuronal migration in the embryonic cerebral<br />
cortex<br />
M. Kihara a , H. Yoshioka b , K. Hirai b , M. Murata b ,K.<br />
Hasegawa b , Z. Kizaki b , T. Sawada c<br />
a Kyoto First Red Cross Hospital; b Department of Pediatrics,<br />
Kyoto Prefectural <strong>University</strong> of Medicine, Kyoto,<br />
Japan; c Kyoto Second Red Cross Hospital, Japan<br />
The role of the NMDA receptor in neuronal migration in<br />
the cerebral cortex is still unclear. We performed a tissue<br />
culture study using embryonic rat brain to investigate the<br />
effect of excessive stimulation of NMDA receptors on the<br />
neuronal migration in the cerebral cortex. Four significant<br />
cellular zones were identified in the cultured cerebral wall:<br />
the ventricular zone, the inner intermediate zone, the outer<br />
intermediate zone, and the cortical plate. After we labeled<br />
progenitor cells in the ventricular zone of E16 cerebral<br />
cortex explants by [ 3 H] thymidine, the explants were<br />
cultured for 48 h, and distribution of labelled cells was<br />
autoradiographically evaluated. Stimulation of NMDA<br />
receptors, by adding the NMDA receptor agonist, NMDA<br />
(10 mM) or ibotenate (1 mM), to the culture medium caused<br />
a significant percent decrease of labeled cells in the intermediate<br />
zone and an increase in the ventricular zone. This<br />
suggests that stimulating NMDA receptors by agonists inhibits<br />
neuronal migration in rat cerebral cortex. It is known<br />
that blocking NMDA receptors also inhibits neuronal migration<br />
in the cerebral cortex. These results suggested that acti-
420<br />
Abstracts<br />
vation of NMDA receptors within a relatively narrow<br />
window is essential for a normal rate of neuronal migration.<br />
FP-A-027<br />
The effect of pentylenetetrazol on the activation of NFkB<br />
in cultured primary hippocampal cells<br />
K.-Y. Wang, X.-Z. Ruan, S.-Q. Zhu, W. Wang<br />
Department of Neurology, Tongji Hospital, Tongji Medical<br />
College, Huazhong; <strong>University</strong> of Science and Technology,<br />
Wuhan, China<br />
Objective: To investigate the role of pentylenetetrazol on<br />
the activation of NF-kB in cultured primary hippocampal<br />
cells. Methods: We measured the apoptosis and inhibiting<br />
rate initiated by pentylenetrazol (PTZ) in both PB-treated<br />
and PB-untreated primary cultured hippocampal cells<br />
respectively by a FACScan side scatter analysis and MTT<br />
method. The activation of NF-kB was detected by laser<br />
scanning confocal microscopy with FITC-tagged p65 antibody<br />
and PI-staining DNA. Results: NF-kB/p65 associated<br />
green fluorescence can be seen in the nuclei of PB-untreated<br />
hippocampal cells after PTZ stimulation, but were not seen<br />
in the nuclei of cells without PTZ stimulation and in the<br />
nuclei of PB-treated cells after PTZ stimulation. After PTZ<br />
stimulation, surviving rates of PB-treated hippocampal cells<br />
were not significantly higher than those of PB-untreated<br />
hippocampal cells (P . 0:01). The percentages of apoptosis<br />
in PTZ stimulated PB-untreated cells were not significantly<br />
higher than those without PTZ stimulation and PB-treated<br />
cells after PTZ stimulation (P . 0:01). Conclusion: These<br />
results demonstrated that PTZ can activate NF-kB of hippocampal<br />
cells, and not induced excitotoxicity. PB may interfere<br />
the effect of PTZ through the pathway of the activation<br />
of NF-kB.<br />
FP-A-028<br />
The mechanism and pathway of cytokine-induced<br />
apoptosis in astrocytes of rats<br />
J.-B. Liu, Y.-J. Yang<br />
Department of Pediatric, Xiangya Hospital, Changsha,<br />
Huna Province, China<br />
Objective: To explore the mechanism of LPS, interleukin<br />
1b (IL-1b), and TNF-a-induced apoptosis and the pathway<br />
of the apoptosis in astrocytes of rats. Methods: The astrocytes<br />
were cultured in vitro and treated with sole or combination<br />
of LPS, IL-1b, and TNF-a. Cell viability was<br />
demonstrated by MTT method. Apoptosis was observed<br />
by fluorescence microscope using acridine orange, EB,<br />
and anti-annexinV-cy3 monoclonal antibody and by electron<br />
microscope. Apoptosis rates of astrocytes were evaluated<br />
by flow cytometry; NO 2 2 /NO 2<br />
3 were assayed by<br />
spectrophotometer; cytochrome c in cell plasma was determinated<br />
by Western blot; caspase-3 mRNA was observed<br />
by in situ hybridization. Results: LPS 1 IL-1b 1 TNF-a<br />
can decrease the cell viability to 0.46 ^ 0.15. The amounts<br />
ranking of MTT in cells were LPS 1 IL-1b 1 TNF-a treated<br />
.LPS 1 IL-1b treated .LPS 1 TNF-a treated.<br />
Amount of NO 2 2 /NO 3 2 produced by astrocytes stimulated<br />
by LPS 1 IL-1b 1 TNF-a was the highest at 72 h. Amount<br />
of NO 2 2 /NO 3 2 and MTT of astrocytes had negative relation,<br />
l-NMMA pretreatment can attenuate NO 2 2 /NO 3 2 produced<br />
by astrocytes stimulated by LPS 1 IL-1b 1 TNF-a and<br />
relieve the cell viability. Cytochrome c in cell plasma of<br />
astrocytes stimulated by LPS 1 IL-1b 1 TNF-a and the<br />
expression of caspase-3 mRNA were higher than normal<br />
control. l-NMMA decreased the amount of cytochrome c<br />
in cell plasma of astrocytes and the expression of caspase-3<br />
mRNA. Conclusion: Cytokines decreased the viability of<br />
astrocytes because of autoendocrine of NO. Inhibition of<br />
NO by l-NMMA relieved the viability of astrocytes stimulated<br />
by LPS 1 IL-1b 1 TNF-a. NO can cause astrocytes<br />
apoptosis, this may relate to releasing the cytochrome c<br />
from mitochondria cell plasma, and activating the expression<br />
of caspase-3 mRNA.<br />
FP-A-029<br />
Treatment of Rett syndrome patients with<br />
transplantation of embryonic nervous tissue<br />
V.I. Tsymbaliuk, N.A. Pichkur, L.D Pichkur<br />
Institute of Neurosurgery Named Academician A.P. Romodanov,<br />
Academy of Medical Sciences, Ukrainian Children’s<br />
Specialized Hospital ‘OKhMATDET’, Kyiv, Ukraine<br />
RS is a neurodevelopmental disorder occurring exclusively<br />
in girls. D. Armstrong et al. (1995) found striking<br />
decrease in the dendritic trees of selected cortical areas,<br />
chiefly projection neurons of the motor, association, and<br />
limbic cortices. They suggested that the pathologic changes<br />
were based on the trophic factors deficit. Degenerating<br />
axons in the caudate nucleus were identified, which suggests<br />
dysfunction in the dopaminergic nigrostriatal system. The<br />
authors suggested applying the method of RS treatment with<br />
transplantation of embryonic nervous tissue into the motor<br />
area of cerebral cortex. Treatment and assessment of five<br />
patients with classic RS phenotype aged 3–10 years was<br />
conducted. Chromosomes and metabolic screening results<br />
of these patients were normal. The patients were observed<br />
6–12 months post-operatively. Positive dynamics in clinical<br />
status was identified in five patients: reductions in stereotypic<br />
behaviors (body rocking, hand mannerisms). Purposeful<br />
hand use improved in two patients. They re-acquired<br />
self-service feeding skills and were able to grasp objects<br />
and transferred them from hand to hand. Signs of spasticity<br />
with rigidity in lower extremities and truncal ataxia diminished<br />
and gait improved (in four patients). Bursts of hyperventilation<br />
stopped in two patients. Significant<br />
improvement was noted in the youngest patients (3 and 4<br />
years old). The changes were stable. Embryonic nervous
Abstracts 421<br />
tissue transplantation could be a potential method of RS<br />
treatment.<br />
FP-A-030<br />
Expression of adhesion and extracellular matrix<br />
molecules in the developing human brain<br />
B. Anlar, P. Atilla, A.N. Çakar, M.F. Kose, M.S. Beksaç,A.<br />
Dagdeviren, Z. Akçören<br />
Hacettepe <strong>University</strong> Department of Pediatric Neurology,<br />
Ankara, Turkey<br />
Cell adhesion molecules (CAM) and extracellular matrix<br />
molecules (ECM) have important roles in cell migration and<br />
connection. Their developmental expression has not been<br />
fully described in human brain. In this report, CAM and<br />
ECM immunohistochemistry was examined in frontal tissue<br />
samples from 14 to 28 weeks old fetuses aborted for obstetrical<br />
reasons (n ¼ 22) and four fetuses with nervous system<br />
abnormalities. Neural adhesion molecule (NCAM) and<br />
fibronectin were present at all gestational ages examined<br />
while laminin and tenascin expression started at 17 weeks.<br />
As gestational age progressed, expression of NCAM and<br />
glial fibrillary acidic protein tended to increase while N-<br />
cadherin and laminin decreased. The distribution was predominantly<br />
vascular for laminin and fibronectin, and in the<br />
neuropil for NCAM, tenascin and thrombospondin. The<br />
expression of thrombospondin and fibronectin shifted from<br />
periventricular to outer cortical layers with advancing gestational<br />
age. This time- and site-related expression supports<br />
the role of these molecules in tissue differentiation and<br />
response to injury. The descriptive data obtained in this<br />
study might constitute a basis for further studies investigating<br />
the role of CAM and ECM in developmental abnormalities<br />
of the CNS.<br />
FP-A-031<br />
Transient intrauterine hypotension causes apoptosis in<br />
fetal brain and affects learning<br />
M. Tombakoglu, M. Durakoǧlugil, G. Kale, H. Orer, B.<br />
Anlar<br />
Hacettepe <strong>University</strong> Departments of Pediatric Neurology,<br />
Pediatric Pathology and Pharmacology, Ankara, Turkey<br />
Hypotensive episodes are frequent during pregnancy, and<br />
their functional effect on fetal brain has not been studied.<br />
We produced systemic hypotension for 30 min during midgestation<br />
in pregnant rats and examined their offsprings on<br />
postnatal days 1 and 28. When compared to sham controls,<br />
the brains of the hypotensive group contained more<br />
TUNEL-positive cells in the hippocampal and periventricular<br />
regions on both time points. Spatial learning was<br />
impaired in 28 day-old pups of the hypotensive mothers,<br />
and correlated with the number of apoptotic cells. These<br />
results indicate that transient maternal hypotension induces<br />
apoptotic cell death in fetal brain and affects learning. Similar<br />
mechanisms might be involved in the pathogenesis of<br />
human learning disorders.<br />
FP-A-032<br />
Use of fluorescent proteins expressed in specific neural<br />
cell types to trace differentiation of neural progenitor<br />
cells<br />
M. Maletic-Savatic a,b , J. Mignone a , R. Malinow a ,G.<br />
Enikolopov a<br />
a Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold<br />
Spring Harbor, NY, USA;<br />
b School of Medicine, State<br />
<strong>University</strong> of New York, HSC T12-020, Stony, Brook, NY,<br />
USA<br />
Neurogenesis, a process first thought to be limited to the<br />
prenatal period, occurs throughout life in distinct brain<br />
regions, such as the subventricular zone and the dentate<br />
gyrus subgranular zone. Over the past decade, a considerable<br />
amount of data has been accumulated regarding the identification,<br />
isolation, propagation, and pluripotency of neural<br />
progenitor cells (NPC). However, little is known about the<br />
specific mechanisms that commit differentiation of neural<br />
progenitor cells toward a specific cell lineage, such as the<br />
neuronal or glial lineage. To investigate the in vivo differentiation<br />
of neural progenitor cell, we developed a unique<br />
approach, which enabled us to visualize differentiation of<br />
neural progenitor cells into different neural cell types,<br />
under a variety of experimental conditions. We generated<br />
transgenic mice that express different fluorescent proteins,<br />
specific to a neural cell type, and we observed differentiation<br />
of NPCs into these cell types using two-photon microscopy.<br />
We studied this process in organotypic slice cultures derived<br />
from the mature (.3-week-old) transgenic mice. This<br />
culture model is a very-well studied model that closely<br />
mimics in vivo conditions, with preserved hippocampal<br />
circuitry. The therapeutic potential of adult hippocampal<br />
neurogenesis may be profound. Identification of specific<br />
conditions that promote neurogenesis will increase the<br />
potential use of NPCs as agents for brain tissue reorganization<br />
and repair.<br />
FP-A-033<br />
Changes of calcium calmodulin and phasphodiesterase<br />
in the brain damage of newborn pigs of hypoxic ischemic<br />
encephalopnthy<br />
L.-P. Hu<br />
Beijing Military Medical College, Beijing, China<br />
Objective: The changes of calcium (Ca 21 ), calmodulin<br />
(CaM) and phosphodiesterase (PDE) were tested in the<br />
brain damage model of newborn pigs HIE. Methods: PDE<br />
indirect determine of improvement Thompson CaM, PDE<br />
and CaM were removed in the response solution and atom
422<br />
Abstracts<br />
spectrophotometry. Results: The brain Ca 21 content was not<br />
change at unit volume of fresh cerebral tissue, CaM content<br />
and PDE activity rose significantly at that time and 12 h of<br />
the brain damage. Conclusion: The changes of CaM content<br />
and PDE activity were related to the brain damage of HIE.<br />
FP-A-034<br />
Resistance to brain damage caused by prolonged<br />
seizures in rats with different maturational stages<br />
L. Jiang, F.C. Cai, X.P. Zhang<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: To demonstrate the special ability to resist brain<br />
damage from prolonged seizures and convulsive status<br />
epilepticus (SE) in premature animals. Methods: Megimide<br />
was injected in 80 healthy and adult rats respectively to evoke<br />
prolonged seizures and SE. The incidences of injured<br />
neurons were analyzed at the slices of hippocampus CA3,<br />
dentate gyrus and parietal cortex. Results: (1) Adults rats<br />
(ARs) only had less than 20 min prolonged seizures with<br />
the same dose of megimide. However 71.4% baby rats<br />
(BRs) experienced SE. (2) The average duration from the<br />
onset to death during the period of seizures was 44 ^ 24<br />
min in BRs, and 7 ^ 5 min in ARs. (3) Comparing the incidences<br />
of dead neurons at different cortical areas, a typical<br />
pathologically pattern of selective neuron damage was<br />
shown predominately at the hippocampus and dentate<br />
gyrus. (4) On the 4th day after the seizure in BRs, the number<br />
of necrotic neurons counted in the hippocampus and dentate<br />
gyrus was 60 ^ 21 in the group with seizures lasting #29<br />
min; 167 ^ 51 with seizures lasting 30 ^ 59 min. However<br />
there were 227 ^ 34 min of necrotic neurons in ARs although<br />
the seizures lasted only #20 min. The number of dead<br />
neurons could be equal between ARs and BRs only when<br />
the seizures of BRs was lasting .60 min. Conclusion: (1)<br />
Premature brain was more likely to have prolonged seizures<br />
or SE than adults. (2) There was a big difference of the resistance<br />
to brain damage caused by severe seizures between the<br />
premature and mature brain, the more premature the more<br />
resistant. (3) Brain damage induced by severe seizures was<br />
characteristically observed as selected neuronal loss predominantly<br />
at the hippocampus and dentate gyrus. (4)<br />
Prolonged SE, particularly more than 60 min, could also<br />
induce brain injury in BRs in spite of their much stronger<br />
resistance to the injury.<br />
FP-A-035<br />
Serial observation on the patterns of selective neuron<br />
injury after prolonged seizures in premature and<br />
mature brain<br />
L. Jiang, F.C. Cai, X.P. Zhang, X. Li<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: To explore the difference of the patterns on<br />
selective neuron injury after prolonged seizures or convulsive<br />
SE in the premature and mature brain. Methods: ARs<br />
experienced 15–20 min seizures, and BRs experienced 21–<br />
75 min seizures were sacrificed at six time points during the<br />
period of 4–168 h after the seizure stopped. The necrotic and<br />
apoptotic neurons were counted microscopically. The incidence<br />
of apoptosis was also comparatively studied by FACS,<br />
TUNEAL and electron microscopy. Results: (1) The process<br />
of neuronal death was shown even at 4 h after severe seizures.<br />
The peak of necrotic process reached at 24–48 h after<br />
seizures in ARs (180 ^ 38 cells). It was two times higher<br />
than BRs (90 ^ 5.9 cells). (2) In ARs, apoptotic neurons<br />
had been shown from the early stage after seizures, and the<br />
peak level of apoptosis (28 ^ 3.3%) was reached at 24–72 h<br />
after prolonged seizures, which was 5–8or5–6 times higher<br />
than controls, and 4–7 or 3–4 times higher than BRs<br />
measured by FACS or TUNEAL. (3) However, there was<br />
only a mild increase of apoptotic neurons in BRs at early<br />
stage, but lower than that of control in 24 h. Conclusion:<br />
(1) Selective neuronal death induced by prolonged seizures<br />
and SE resulted from necrosis and apoptosis. (2) Significant<br />
processes of necrosis and apoptosis of neurons could be well<br />
presented from the early stage, and apoptosis became dominant<br />
with time 12 h after seizures in ARs. (3) The severity of<br />
neuronal death in BRs was much lower than ARs, especially<br />
in the process of apoptosis after severe SE. It was indicated<br />
that there could be an internal response physiologically in the<br />
premature brain after SE to protect neuronal death, or even to<br />
inhibit the process of apoptosis.<br />
FP-A-036<br />
A molecular biological study on the resistance to brain<br />
damage induced by prolonged seizures in the premature<br />
brain<br />
L. Jiang, F.C. Cai, X.P. Zhang<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: In a previous study we found that the premature<br />
brain has a stronger resistance to brain damage induced<br />
by prolonged seizures or SE. In this study we tried to<br />
explore the molecular biological basis of internal protective<br />
response in the premature brain which reduces the process<br />
of apoptosis and necrosis of neurons. Methods: Megimide<br />
was injected in healthy ARs and BRs to evoke prolonged<br />
seizures and SE. ARs and BRs rats were sacrificed at 1/2, 2,<br />
8, 24, 48, and 72 h after the prolonged seizure stopped.<br />
Hippocampus, dentate gyrus and parietal cortex were<br />
taken for immunocytochemistry and Western blot studies<br />
for expression of apoptosis associated genes bcl-2 and<br />
p53. Results: (1) There was a much stronger and higher<br />
rate (90%) of p53 expression in ARs’ brain, and such a<br />
state was continually kept even at 72 h after the seizure<br />
stopped; however, bcl-2 expression was weak and low
Abstracts 423<br />
(57%), and no difference was found in bcl-2 expression at<br />
several hours as compared with normal controls. (2) In BRs’<br />
brain there were more than 85% neurons with a strongest<br />
expression of bcl-2; and the strongest bcl-2 expression was<br />
sustained 72 h after SE. However p53 expression lasted less<br />
than 24 h. Conclusion: Significant difference between the<br />
premature and mature brain was shown in genes expression<br />
associated apoptosis after seizures. Anti-apoptosis gene<br />
(bcl-2) expression was much higher and longer than apoptosis<br />
gene (p53) in BRs’ brain, and it was reversed in the<br />
ARs group. The strongest expression of bcl-2 after SE could<br />
be the important molecular biological basis for the special<br />
resistance to neuronal injury in the premature brain.<br />
FP-A-037<br />
A dynamic study of neuronal death after prolonged<br />
seizures in rats<br />
L. Jiang, F.C. Cai, X.P. Zhang<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: To explore the feature of selective neuronal<br />
injury after prolonged seizures in the mature brain, and to<br />
explore the relationship of serum neuron specific enolase<br />
(NSE) with brain damage. Method: Prolonged seizures<br />
were evoked by Megimide in 30 adult Wistar rats. All rats<br />
experienced prolonged seizures with duration of 15–20 min.<br />
Five rats were sacrificed at 4, 12, 24, 48 and 72 h and 7 days<br />
after seizures stopped. The dead neurons were observed<br />
light-microscopically (HE & Thionine staining) and electron-microscopically<br />
at the areas of hippocampus and the<br />
cortices. At the same time, the serum level of NSE was tested<br />
by ELISA. Results: (1) There was a obvious selective neuronal<br />
death after prolonged seizures. The process of neuronal<br />
death was remarkably shown even at the early stage of 4 h<br />
after severe seizures. A peak of necrotic process was counted<br />
at 24 , 48 h after seizures (180 ^ 38 cells); it was five times<br />
higher than that for controls (38 ^ 6 cells). (2) By the ELISA<br />
study, the NSE level was also increased 4 h after seizures, and<br />
reached its peak concentration at 48 h (5.13 ^ 0.77 nmol/l),<br />
much higher than that of controls (3.53 ^ 0.87 nmol/l).<br />
Conclusion: Prolonged seizures in the mature brain will<br />
lead to selective neuronal death mainly in the hippocampus,<br />
which was related with changes of serum NSE. Serum NSE<br />
could be a useful marker for detecting neuronal death.<br />
FP-A-038<br />
The role of heat shock reaction for protection of brain<br />
damage in the premature brain after prolonged seizures<br />
L. Jiang, F.C. Cai, X.P. Zhang<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: In our previous study we found that the premature<br />
brain has a stronger resistance to brain damage induced<br />
by prolonged seizure. In this study we tried, to explore the<br />
role of heat shock reaction (HSR) and its molecular mechanism<br />
for protection of brain damage in the premature brain<br />
after prolonged seizures. Method: Prolonged seizures were<br />
evoked by Megimide in 30 each of BRs and ARs, respectively.<br />
At 1/2, 2, 8, 24, 48 and 72 h after the seizures stopped,<br />
five rats were sacrificed in each group, and the hippocampus,<br />
dentate gyrus and temporal cortex of their brains were taken<br />
for the following studies: (1) expression of HSR associated<br />
protein, heat shock protein70 (HSP70) was tested by immunocytochemistry;<br />
and in thick liquid of brain tissue by<br />
Western blot; and (2) measurement of the NO level in thick<br />
liquid of brain tissue by fluorospectrometry. Results: (1)<br />
There was a big difference in expression of HSP70 between<br />
the premature and mature brain after severe seizures. Positive<br />
rate of the neurons with HSP70 expression was as high as<br />
85% in the premature brain, and 52.5%of them with strongest<br />
or stronger expression. However, in the adults’ brain, the<br />
positive rate was 65% only, particularly with weak expression<br />
in most (77.5%). (2) A similar result was obtained by<br />
Western blotting. The strongest or stronger HSP70 expression<br />
was well shown continually in the premature brain even<br />
3 days after severe seizures. In contrast, the strongest or<br />
stronger HSP70 expression in the adults’ brain was sustained<br />
less than 24 h. (3) The NO level in the brain quickly increased<br />
in both age groups after severe seizures. A peak level<br />
(9.0 ^ 1.2 nmol/l) in the baby brain was reached within 2 h<br />
after SE but decreased rapidly in 8 h and was lower than<br />
control (5.0 ^ 1.4 nmol/l) 24 h later. In contrast, there was<br />
a peak level (6.6 ^ 1.2 nmol/l) in 24 h after seizures but with<br />
the high level continually in the adult brain. Conclusion: (1)<br />
There was also a significant difference between the premature<br />
and mature brain in heat shock response after prolonged<br />
seizures. There was quick and continual HSP70 expression at<br />
a high level to protect the neurons in the premature brain, but<br />
only weak expression temporally in the adult brain. (3) The<br />
strongest expression of HSP70 after SE could be the important<br />
molecular biological basis of special resistance to neuronal<br />
injury in the premature brain. They are not only to inhibit<br />
apoptosis and protect neurons but also to reduce NO in brain.<br />
FP-A-039<br />
An experimental study on rectal administration of a<br />
mixed solution of clonazepam with acetaminophen<br />
L. Jiang, F.C. Cai, P. Qu<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: To study the efficacy of clonazeparm (CNP)<br />
after rectal administration of CNP with acetaminophen<br />
(ACE). Methods: (1) The mixed solution of CNP-ACE (1<br />
mg CNP with 100 mg ACE) and CNP were administered<br />
rectally to Wistar rats in a dose of 1.5 mg/kg, respectively.<br />
(2) The concentration of CNP was measured by HPLC in the
424<br />
Abstracts<br />
blood at different time points, and the parameters of pharmacokinetics<br />
were calculated by a computer program of<br />
3P87. (3) The pharmacology of CNP was detected by the<br />
change of EEG patterns and the efficacy of seizure control.<br />
(4) At the same time the rectal mucosa was studied pathologically.<br />
Results: (1) The pharmacokinetic study demonstrated<br />
that CNP was rapidly absorbed from rectum in both<br />
groups with a peak blood level at 15.3 ^ 6.1 and 15.8 ^ 1.6<br />
min, respectively. (2) Within 5 min after CNP or CNP-ACE<br />
administration, EEG patterns were significantly changed<br />
and the frequency of b band was increased by 7.8 and<br />
7.3%. (3) Compared with the control group, the incidence<br />
of seizures, duration of seizures, and death induced by<br />
seizures were decreased from 100 to 50, 20%; 9.8 ^ 3.2–<br />
0.7 ^ 0.6, 0.3 ^ 0.1 min; 70% to 0, respectively. (4) There<br />
were no obviously pathological changes of rectal mucosa or<br />
any side effect in both groups. Conclusion: ACE had no<br />
obvious interfering effect with CNP when such a mixed<br />
solution was administered rectally in Wistar rats. CNP-<br />
ACE may be a quick and effective way to control febrile<br />
seizures in clinical work, especially for outpatients.<br />
FP-A-040<br />
The expression of caspase-3 mRNA in the hippocampus<br />
of 7-day-old hypoxic-ischemic rats and the mechanism of<br />
neural protection by magnesium sulfate<br />
Y. Tang, F.-L. Zhao<br />
Department of Pediatrics, The Third Hospital of Beijing<br />
<strong>University</strong>, Beijing, China<br />
Objective: There was consanguineous relationship<br />
between caspase-3 and early damage after hypoxia and ischemia.<br />
Caspase-3 played a key role in the process of apoptosis<br />
in the neuron. Magnesium sulfate could protect the neuron<br />
from injury but the mechanism was not clear yet. The<br />
research was to investigate the expression of caspase-3<br />
mRNA in the hippocampus of 7-day-old hypoxic-ischemic<br />
rats and the possible mechanism of neural protection by<br />
magnesium sulfate. Methods: The model of 7-day-old<br />
hypoxia-ischemia rats was performed. The rats were divided<br />
randomly into six groups as follows: (1) normal control<br />
(n ¼ 4); (2) sham surgery control (n ¼ 4); (3) hypoxia-ischemia<br />
(n ¼ 4); (4) sodium chloride injection with hypoxiaischemia<br />
(n ¼ 4); (5) magnesium sulfate pro-injection with<br />
hypoxia-ischemia (n ¼ 4); and (6) magnesium sulfate postinjection<br />
with hypoxia-ischemia (n ¼ 4). The therapy groups<br />
received a bolus injection of 500 mg/kg magnesium sulfate<br />
intraperitoneally 0.5 h before or after hypoxia-ischemia.<br />
Semi-quantitative RT-PCR was used to measure caspase-3<br />
mRNA expression in the hippocampus 24 h after hypoxiaischemia.<br />
The differences were compared among the groups.<br />
Results: The expression of caspase-3 mRNA was significantly<br />
increased in the hippocampus of the hypoxia-ischemia<br />
pups (P , 0:01). Both magnesium sulfate pro-injection and<br />
post-injection significantly decreased the expression of<br />
caspase-3 mRNA (P , 0:05). Conclusion: Caspase-3 is activated<br />
in the hippocampus of the 7-day-old rats 24 h after<br />
hypoxia-ischemia. The suppression of the expression of<br />
caspase-3 mRNA in the hippocampus is probably related to<br />
the protective effect of magnesium sulfate to brain injury<br />
with hypoxia-ischemia.<br />
FP-B<br />
Epidemiology<br />
FP-B-001<br />
A neuroepidemiological study on severe motor and<br />
intellectual disabilities syndrome in Okayama<br />
prefecture<br />
Y. Yamatogi, M. Morooka, M. Murao<br />
Okayama Prefectural <strong>University</strong>, Kuboki Soja-City, Japan<br />
Objective:Toclarifytheinfluencesofmedicalprogressand<br />
social support systems, a neuroepidemiological study was<br />
carriedoutonseverelymentalandmotorhandicappedpersons<br />
with onset before 18 years of age, on the prevalence day of<br />
January 31, 2001, in Okayama Prefecture in Japan. Results:<br />
(1) 681 severely handicapped persons were found in a population<br />
of1 958 403; prevalence rate was 0.348/1000 population<br />
(0.414 for males and 0.287 for females). Prevalence rates in<br />
the age groups were: 0.33 (0–4 years); 0.87 (5–9 years); 0.97<br />
(10–14 years); 0.73 (15–19 years); 0.57 (20–24 years); 0.52<br />
(25–29 years); 0.55 (30–39 years); 0.32 (40–49 years); 0.04<br />
(50–69 years); and (2) cerebral palsy was most frequently<br />
observed in 57.7% of patients, followed by post-encephalitis<br />
orencephalopathicstatesin13.5%.Etiologieswerepresumed<br />
prenatal in 28.8%, perinatal in 42.6%, postnatal in 22.6%, but<br />
undetectable in 6.0%. A total of 72.8% had epilepsy, which<br />
was more prevalent in those with more severe mental retardation.<br />
(3) According to the severity of handicap, 52.3%<br />
belonged in the severest group and 38.2% in the group with<br />
some, but useless, movement and severe mental defect. The<br />
rate of those institutionalized was 43.5%; lowest in the severest<br />
group, but with a rapid increase after the age of 20 years.<br />
Conclusion: No change was observed in the prevalence rate in<br />
school-age during the last 35 years, but was etiologically<br />
different; very-low-weight births, brain malformations, chromosomal<br />
abnormalities and postnatal factors were increased<br />
and hyperbilirubinemia was markedly decreased. Extremely<br />
severe cases are increasing.<br />
FP-B-002<br />
A study on the epidemiology of childhood cerebral palsy<br />
in Zhejiang Province, China<br />
Z.-Y. Zhao, X.-J. Zhou, Q.-X. Shui<br />
The Affiliated Children’s Hospital of Zhejiang <strong>University</strong><br />
School of Medicine, China<br />
Objective: To understand the prevalence and status of CP
Abstracts 425<br />
in children, in order to provide basic data for future prevention<br />
and therapy of CP. Methods: During October and<br />
November 1998, we investigated the status of CP among<br />
children aged 1 , 6 years from 66 townships of 15 cities or<br />
counties in Zhejiang province. The investigators were given<br />
professional training before the study. Physical examinations<br />
were performed on children selected by screening<br />
standard. According to the diagnostic standard, some of<br />
these children were diagnosed with CP. Results: The register<br />
comprised 62–949 children aged 1 , 6 years, 92 of<br />
whom were diagnosed with CP (1.46‰). No statistical<br />
significance was found between sex or age (P . 0:05).<br />
Furthermore, no significant difference was found in prevalence<br />
between children in cities and rural areas. Conclusions:<br />
The prevalence of CP in Zhejiang province was<br />
lower than that of some developing countries, and also<br />
lower than that of Jiangsu province.<br />
FP-B-003<br />
Epidemiology of childhood brain tumor in Croatia – 30<br />
years analysis of a series of hospital patients<br />
I. Prpić, E. Paučić-Kirinčić, M. Smokvina, A. Sasso, Z.<br />
Modrušan-Mozetič, D. Fiket<br />
<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />
From 01.01.1971. to 31.12.2001 in the Pediatric Clinic<br />
‘Kantrida’, 87 children with primary brain tumor were<br />
analysed retrospectively and prospectively. The mean incidence<br />
of brain tumor was three children annually. There<br />
were 48 boys and 39 girls, and the average age was 6.7<br />
years (^4.1 years). In 48 children (55.1%) the tumor was<br />
located infratentorial (IT), and in 39 (44.8%) supratentorial<br />
(ST). The most common pathohistological type was astrocytoma<br />
and medulloblastoma. Before the brain tumor was<br />
confirmed, symptoms lasted an average of 55.9 days<br />
(median 30 days); the IT tumors 73.1 days, and the ST<br />
tumors 31.5 days, which is a statistically significant difference.<br />
In making a diagnosis, based on neuroimaging techniques,<br />
brain CT was used from 1978, and MR<br />
systematically since 1989. With the purpose of early detection<br />
of brain tumor in children, our data indicates the need<br />
for systematic follow-ups and broader medical attention to<br />
children who besides specific tumor symptoms, show nonspecific<br />
EEG changes. During the last 10 years (1991–2001)<br />
from a total of 36 children diagnosed with brain tumor, eight<br />
have died (22%), 16 are still living (44%), while the<br />
outcome for the other 12 children is unknown. This is in<br />
line with a general survival rate of children diagnosed with<br />
brain tumor (40–50%). Results of our research are comparable<br />
to the results of research conducted on a larger number<br />
of patients which point to the fact that analysis of a hospital<br />
series of patients provides reliable data. Moreover, such<br />
research can be used to implement a registry of children<br />
with history of brain tumor with the purpose of following<br />
the progress of the treatment. and analysing the immediate<br />
and long term effects on the children’s quality of life.<br />
FP-B-004<br />
The epidemiological data of febrile seizures in the<br />
northern coastal region of Croatia<br />
E. Paučić-Kirinčić, S. Surijan, I. Prpić, Z. Modrusan-<br />
Mozetič, A. Sasso, D. Fiket<br />
<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />
Clinical and epidemiological investigations of FS have<br />
appeared in the paediatric literature for many years but<br />
accurate data from Croatia are deficient. From 1.1.1996.<br />
till 31.12.2000. at the <strong>University</strong> Children Hospital<br />
‘Kantrida’ 399 children with FS were retrospectively and<br />
prospectively analysed. Children Hospital ‘Kantrida’ is the<br />
only referral specialist child health centre in this region of<br />
Croatia and all children are referred to the Hospital to ensure<br />
accuracy of the presented data. There were 208 boys and<br />
191 girls. The peak age incidence was between 12 and 24<br />
months and 87.9% of the children were between 7 months<br />
and 3 years of age. The FS were frequently connected with<br />
upper respiratory tract infections and most FS occurred in<br />
the month of February. A total of 271 (67.9%) children had<br />
simple FS, 37 (9.3%) children had complex FS and 91<br />
(22.8%) children had repeated FS. The mean days of hospitalization<br />
were 8.9 days, but longer for complex FS (10.8<br />
days). FS represents 18.2%, of total number of hospitalized<br />
children in the Department of Child Neurology, which is<br />
time and money-consuming for conditions with minor<br />
long term consequences. The results of our study are similar<br />
to the results of researches conducted on larger numbers of<br />
patients, which demonstrates that analyses of a hospital<br />
series gives reliable data.<br />
FP-B-005<br />
A clinical-epidemiological study of epilepsy in the first 3<br />
years of life among children who attended the<br />
Alexandria university children hospital for the period of<br />
1 year<br />
F.M. Kamel, M.I. Kamel, T. El-Omar, A.M.M. Maged<br />
Department of Pediatrics, Faculty of Medicine, Alexandria<br />
<strong>University</strong>, El-Shatby, Alexandria, Egypt<br />
There are many methodological difficulties in studying<br />
epidemiological aspects of epilepsy are developing countries.<br />
These include: incomplete and inaccurate medical<br />
records; questionnaires may miss mild, partial and inactive<br />
epilepsy; traditional views of illness; symptoms and etiology<br />
of epilepsy are different in rural areas; and lastly, epileptic<br />
seizures may be misdiagnosed. This study comprised a hospital-based<br />
cross-sectional cohort. The aim was to evaluate the<br />
pattern of epilepsy in children aged 3 years or less at the time
426<br />
Abstracts<br />
of the study, among those children who attended the epilepsy<br />
clinic at the Alexandria <strong>University</strong> Children Hospital for a<br />
period of 1 year (April 1999–April 2000). A total number of<br />
182 children with epilepsy were selected, and an equal<br />
number of age and sex-matched healthy children served as<br />
controls. Records were revised and filed in a special computer<br />
software package. The data included: demographic characteristics,<br />
medical history, family history, seizure<br />
description, neurological signs, investigations, treatments,<br />
compliance and epilepsy classification. High risk factors<br />
found were: parental illiteracy, epilepsy in the family,<br />
parents who were first cousins, lack of antenatal care, obstetric<br />
problems, congenital malformations, home delivery,<br />
admission to neonatal intensive care units, birth asphyxia,<br />
postnatal head trauma, meningitis or encephalitis, non-traumatic<br />
intra-cranial hemorrhage, status epileptics, post-DPT<br />
problems, and febrile convulsions. Partial seizures occurred<br />
in 27.4% of cases, while the generalized were found in<br />
80.2%, and neurological handicaps were found in 52.7%.<br />
Symptomatic epilepsy was diagnosed in 58.2% of cases.<br />
Recognized epileptic syndromes were found in 15.9%.<br />
Monotherapy was the rule in 86.6% of cases. In conclusion:<br />
major determinants of epilepsy in developing countries,<br />
though similar to developed countries, still constitute controversy.<br />
Epilepsy care in developing countries may be in accordance<br />
with international guidelines; however, precise<br />
delineation of the needs should be based on actual characteristics<br />
in each country.<br />
FP-B-006<br />
Clinical epidemiological analysis of seizures in children<br />
for last 5 years<br />
C.-Y. Zhang<br />
Paediatrics of Xi’an No. 1 Hospital, Xi’an, China<br />
Objective: To analyze the characteristics of clinical<br />
epidemiology of seizures in children during the last 5<br />
years. Methods: Collection of data of 169 cases of seizures<br />
in children treated in the Paediatrics Department, Xi’an No.<br />
1 Hospital from January 1997 to December 2001, and analysis<br />
of types of seizure, the illness-age at onset, seasonal and<br />
annual distribution of cases, and related factors. Results:We<br />
treated seizures in 169 children (107 males and 62 females)<br />
over the last 5 years. The annual distribution of cases was<br />
23, 18, 26, 45, 57. With the annual increasing tendency,<br />
60.3% of the cases manifested in the last 2 years. Generalized<br />
tonic clonic seizures occurred in 158 cases (93.5%).<br />
Ninety four patients (55.6%) had a seizure for the first time,<br />
75 patients (44.4%) had a history of previous seizures.<br />
Febrile convulsions occurred in 140 cases (82.8%), the<br />
body temperature was 38 , 398C in 68 cases, 39 , 408C<br />
in 59 cases, and above 408C in 13 cases. The simple type<br />
of febrile convulsion occurred in 105 cases, and the complex<br />
type in 35 cases. The patients with respiratory tract infection<br />
numbered 109 (77.9%). A FS occurred in 29 cases (17.2%),<br />
14 of these patients had a history of complex febrile seizures<br />
(more than three episodes), and 11 of these patients had<br />
partial seizures with abnormal EEG. The peak age at<br />
onset was from 8 months to 3 years; 71.6% (121/169) of<br />
patients belong to this age group. The seizures occurred<br />
most frequently in January (34 cases), December (31<br />
cases), and February (25 cases), a total of 53.3% patients<br />
had seizures in these months. Patients (28.4%) had seizures<br />
in August, September, and October. It seems that the<br />
seizures occurred more frequently in winter and autumn.<br />
Conclusions: Infant seizures are one of the most common<br />
serious and emergent illnesses in the Pediatrics Department,<br />
with an increasing incidence in recent years. There were<br />
obvious features regarding age and season. Respiratory<br />
tract infections were the most common diseases in these<br />
patients. Febrile convulsions, especially the complex febrile<br />
convulsions, are an important danger factor for future development<br />
of epilepsy.<br />
FP-B-007<br />
Incidence patterns of cerebral palsy in Shiga Prefecture,<br />
Japan, 1977–1991<br />
J. Suzuki a , M. Ito b<br />
a Department of Preschool Education, Shiga Women’s<br />
Junior College; b Department of Pediatrics, Shiga Medical<br />
Center for Children, Shiga, Japan<br />
The prevalence of CP in 6-year-old children in Shiga<br />
Prefecture, Japan, born between 1977 and 1991, was<br />
compared in three successive 5-year periods: period I<br />
(1977–1981), period II (1982–1986) and period III<br />
(1987–1991). Data on accumulated age-specific prevalence<br />
of CP was collected and calculated. During the study<br />
period, 242 293 children entered elementary school, and<br />
326 cases (194 boys, 132 girls) of CP were ascertained<br />
in Shiga Prefecture. The overall prevalence of CP per<br />
1000 6-year-old children was 1.35. The prevalence of CP<br />
for 6-year-old children increased from periods II to III,<br />
although it did not vary from periods I to II. The proportion<br />
of low birth weight (LBW) infants and pre-term infants<br />
among those with CP increased during periods I–III. The<br />
prevalence of CP for term and birth weight .2500 g<br />
infants did not vary over the study period. The prevalence<br />
of CP for pre-term and LBW infants, especially gestational<br />
age ,32 weeks and birth weight ,1500 g, increased from<br />
periods II to III, although the prevalence did not increase<br />
from periods I to II. Multiple births and use of mechanical<br />
ventilation increased from periods II to III. The changes in<br />
the prevalence of CP in Shiga Prefecture suggest that the<br />
intact survival among pre-term and LBW infants increased<br />
in period II owing to better obstetric and neonatal care, and<br />
further improvement in survival of very small babies<br />
receiving intensive care increased CP prevalence in period<br />
III.
Abstracts 427<br />
FP-B-008<br />
The prevalence of epilepsy in Turkish children aged 0–<br />
16<br />
A. Serdaroglu, S. Özkan, K. Gücüyener, K. Aydin, S.<br />
Tezcan, S. Aycan<br />
Sebahat Tezcan, Sefer Aycan, Ankara, Turkey<br />
The aim of this cross-sectional study was to determine the<br />
prevalence of epilepsy in Turkey among children aged 0–16.<br />
The study population comprised 24 773 569 children aged 0–<br />
16 living in Turkey. Since the prevalence of epilepsy in childhood<br />
was 1–0.001% in the world literature, the sample size<br />
was determined as 48 260 with 0.05 error type I; 0.10 error<br />
type 2 (power 0.90) and effect size was 2. By cluster sampling<br />
methods, children from city districts, sub-districts and<br />
villages were selected according to their weight. A total of<br />
46 813 (97 %) children were reached. In the study questionnaire,<br />
there were sections regarding personal information,<br />
questions about related factors, and questions about the diagnosis<br />
of epilepsy and physical examination. Epilepsy classification<br />
was made according to the International League<br />
Against Epilepsy (ILAE). The prevalence of epilepsy was<br />
determined as 0.8%. A total of 55.2% of the subjects with<br />
diagnosed epilepsy were grouped as general; 39% partial<br />
and 5.8% were identified. Age, place of residence, mode of<br />
delivery, place of delivery socioeconomic status had no statistically<br />
significant effect on development of epilepsy. The risk<br />
was increased by male sex, and preterm and post term deliveries.<br />
FP-B-009<br />
The prevalence status of fetal alcohol syndrome among<br />
children in the special classes of east Taiwan<br />
H.-T. Kuo a , P.-Z. Tsai b , M.-L. Lee a<br />
a Research Institute and b Faculty of Early Education and<br />
Care, Chaoyang <strong>University</strong> of Technology, Chinese Taipei<br />
Fetal alcohol syndrome (FAS) is a clinical diagnosis characterized<br />
by fetal pre- and postnatal growth delay, dysfunction<br />
of the central nervous system, and facial dysmorphism,<br />
due to maternal alcohol consumption during pregnancy. In<br />
our study, we focused on the prevalence rate of FAS and fetal<br />
alcohol effect (FAE) on wsux RION special classes in the<br />
area of east Taiwan. The results revealed that of the 847<br />
children (from over ten villages and towns), aged between<br />
6–15 years, who were examined, three were diagnosed with<br />
FAS and two with FAE. This result equals a prevalence rate<br />
of 0.35 (FAS) and 0.24% (FAE). Hualien City has the highest<br />
prevalence rate: 0.63 (FAS) and 0.21% (FAE). The prevalence<br />
rate according to sex is 0.70 (male) and 0.48% (female).<br />
All these results are almost the same, but higher than the<br />
average international rate of 0.19%. In this study, we have<br />
proved: (1) alcohol has the same teratogenicity in Taiwan as<br />
in other parts of the world; and (2) in east Taiwan, there is an<br />
even higher prevalence rate than in other parts of the world.<br />
We think this is a significant phenomenon in Taiwan, because<br />
the children will need additional help that will place a high<br />
financial burden on the government in the future. Of special<br />
importance is the fact that these conditions can be prevented,<br />
if the mother does not drink alcohol during pregnancy.<br />
FP-B-010<br />
The epidemiology of subacute sclerosing<br />
panencephalities at the Philippine General Hospital,<br />
1999–2001<br />
A.M. Salonga, M.B. Lukban, B.C. Sanchez, J.R. Pipo-<br />
Deveza, B.C. Chua<br />
Section of Pediatric Neurology, Institute of Neurosciences,<br />
<strong>University</strong> of the Philippines-Philippine General Hospital<br />
and Medical Center, Manila, Philippines<br />
The demographic characteristics and incidence of SSPE<br />
among pediatric patients at the Philippine General Hospital<br />
were determined by review of data from the hospital registry<br />
of confirmed cases of SSPE patients from January 1999 to<br />
December 2001. Sixty-three cases were identified. All<br />
patients are of Filipino descent, with 55% coming from the<br />
national capital region (Metropolitan Manila). Age at presentation<br />
ranged from 1.5 to 17 years, with a mean of 9.8 years.<br />
There was a male predominance, with a male: female ratio of<br />
1.2:0.8. Eighty-nine percent of the patients had measles<br />
infection prior to the development of SSPE. Mean age at<br />
measles infection was 1.4 years. Only 37.7% of the cases,<br />
however, had measles vaccination. Of the 89% of patients<br />
who had measles infection, 30% had previous measles vaccination.<br />
Mean average interval from measles infection to onset<br />
of SSPE was 8.6 years. The majority were in the late stage at<br />
diagnosis; 44.4% were in Stage II, and 42.9% were in Stage<br />
III (Dyken Clinical Staging). Only six patients (9.5%) were in<br />
Stage I. Our patients received the following treatment modalities:<br />
intraventricular interferon (six cases), IVIG (15 cases),<br />
isoprinosine or inosiplex alone (18 cases), interferon 1 IVIG<br />
(one case). Isoprinosine or inosiplex was given together with<br />
IVIG or interferon in 33 cases. Anticonvulsants were used as<br />
needed. Fifty-six patients (88.9 %) are alive and seven<br />
patients (11.1%) succumbed to infection. Three patients are<br />
in remission, and attending school at present.<br />
FP-B-011<br />
Multiple sclerosis in children: the data of a prospective<br />
study in Russia<br />
O.V. Bylova, A.N. Boilo, V.M. Studenikin, O.I. Maslova,<br />
E.I. Gusev<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
In Moscow since 1996, we have performed a prospective
428<br />
Abstracts<br />
study of 67 patients with multiple sclerosis (MS), with onset<br />
before 16 years of age (mean duration of observation<br />
4.91 ^ 0.58 years). Age and symptoms of MS onset, duration<br />
of the first and the second remissions, relapse frequency, time<br />
from onset to secondary progression and to permanent<br />
disability with expanded disability status scale (EDSS) ¼ 3<br />
and EDSS ¼ 6 were analyzed. Mean age at onset of MS in 67<br />
children (38 girls and 29 boys) was 11.72 ^ 0.34 years. There<br />
were more boys with MS onset before age 8, and significantly<br />
more girls with MS onset at ages 12–13. The analyses of<br />
initial symptoms of MS showed that optic neuritis was the<br />
most frequent (32.8%), the second was brainstem symptoms<br />
(25.4%), and third was sensory disturbances (20.9%).<br />
Female sex was associated with optic neuritis and sensory<br />
disorders at MS onset, while male sex was associated with<br />
brainstem lesions, both clinically and on MRI. No cases with<br />
primary progressive MS were found. Annual relapse rate was<br />
1.00 ^ 0.06 per year; 49 patients (73.1%) had two or more<br />
relapses during the first 2 years of MS. At the final observation,<br />
seven patients (11.4%) had secondary progressive MS<br />
course, 17 (25.4%) had confirmed disability with EDSS ¼ 3,<br />
and three (4.5%) EDSS ¼ 6. Annual relapse rate, relapse<br />
frequency during first 2 years of the disease, duration of the<br />
first and the second remission were significantly associated<br />
with time to EDSS ¼ 3. The high percentage of young<br />
disabled patients with active MS course, raises the question<br />
of early disease modifying treatment.<br />
FP-B-012<br />
The prevalence of headache in Swedish schoolchildren<br />
K. Laurell, B. Larsson, O. Eeg-Olofsson<br />
Departments of Neuroscience and Women’s and Children’s<br />
Health, Uppsala <strong>University</strong>, Uppsala, Sweden; Department<br />
of Child and Adolescent Psychiatry, NTNU, Trondheim,<br />
Norway<br />
Headache is one of the most common health problems, the<br />
first symptoms appearing already at school age. During the<br />
last decades the frequency of unspecific headache as well as<br />
migraine has apparently increased in children and adolescents.<br />
The aim of this study, which was performed during<br />
1997/1998, was to report the prevalence of headache in<br />
schoolchildren from the city of Uppsala, and to compare it<br />
with a similar study performed by Bille 1955. The study<br />
group consisted of 1850 schoolchildren, aged 6–17 years<br />
(median:11). In order to limit the sociodemographic differences<br />
and to get a representative population, the material was<br />
stratified with one class in each grade from different schools<br />
in Uppsala. A questionnaire including questions to receive<br />
information about different types of headache was distributed.<br />
The response rate was 74%, equivalent to 1371 children,<br />
686 girls and 685 boys. The IHS criteria were used for classification.<br />
No headache at all during the last year was<br />
reported by 16% compared to 41% in the study by Bille.<br />
Headache of primary type was found in 45%. For both girls<br />
and boys an increased incidence occurred up to 11 years,<br />
whereupon the incidence further increased in girls but not<br />
for boys. The prevalence of migraine was 15.8% and for<br />
tension type headache 13.6%. Besides comparison with<br />
other prevalence studies, the applicability of the IHS criteria<br />
for classifying headache in children will be discussed and an<br />
exclusion of the duration criterion proposed.<br />
FP-B-013<br />
Survey reports of epidemiological studies of Japanese<br />
encephalitis (JE) in Andhra Pradesh, India<br />
P. Nagabhushana Rao a , Z.-Y. Xu b , J. Jacobson c , W. Liu b<br />
a Niloufer Hospital and Department of Neurology, Osmania<br />
Medical College, Hyderabad, Andhra Pradesh, India;<br />
b International Vaccine Institute, Seoul, Korea; c Program<br />
Officer, Bill and Melinda Gates CVP, Seattle, USA<br />
Survey reports of epidemiological studies of Japanese<br />
encephalitis (JE) in Andhra Pradesh, India, from 1980 to<br />
1997 were analyzed retrospectively and cases from the referral<br />
hospital in the state capital were compared to cases from<br />
rural sites to assess the case fatality rate (CFR) and causes of<br />
death. Subsequently, these results were used to outline appropriate<br />
preventative measures for implementation. The CFR<br />
was used to assess the success of the interventions. From 1980<br />
to 1997, there were 9525 suspected cases of JE reported from<br />
rural sites in Andhra Pradesh out of which 3528 died for a<br />
cumulative CFR of 37.04 %. These results were compared<br />
with 189 morbid cases of suspected JE admitted to Niloufer<br />
Hospital (NH) where ventilator facilities were not available<br />
and patients received only symptomatic treatment. Out of<br />
them 23 cases died for a CFR of 12.17%. Causes of mortality<br />
in NH were analyzed and compared with those of rural areas.<br />
The causes of death, mostly preventable in cases treated in the<br />
rural area, significantly differed from those in NH. Case<br />
management differed between the two groups. The care<br />
given in NH could have been given in the rural setting with<br />
the available medical and nursing staff and budget. Therefore,<br />
detailed step-by-step preventive, diagnostic and clinical<br />
management guidelines were prepared and 65 000 copies<br />
were distributed freely and training was provided for implementation.<br />
A dramatic impact was found within 3 years with a<br />
fall in the cumulative case fatality rate to 12.12% in the year<br />
2001.<br />
FP-C<br />
Perinatal/Neonatal Neurology<br />
FP-C-001<br />
Assessment of damage and efficacy of rehabilitation<br />
therapy of posthypoxic encephalopathy<br />
A. Nigin, D.I. Akhmedova, B.G. Gafurov, K.Sh. Salikhova,<br />
Z.K. Mirsaeva<br />
Scientific Research Institute of Pediatrics, Proesd Talant 3,<br />
Tashkent, Uzbekistan
Abstracts 429<br />
Investigations on changes of cerebral circulation in the<br />
circle of Willis performed by transcranial Dopplerography<br />
in young children, showed that in the diagnosis of posthypoxic<br />
states and their complications, in the evaluation of the<br />
efficacy of criteria of the therapeutic effect of neurotropic<br />
drugs such as in acute periods, or stages of dynamic monitoring,<br />
compared to other functional methods, the leading<br />
role may belong to the non-invasive method of ultrasound<br />
investigation, i.e. transcranial Dopplerography. Thus, in our<br />
investigations we determined Dopplerography criteria of<br />
treatment efficacy. Taking into account that hypoxicischemic<br />
and other damages to the CNS have wave character<br />
and pathologic processes not limited by primary focus of<br />
damage, we consider that observation of children should be<br />
carried out gradually during the whole period of the first<br />
year of life, not only in the contingent of children with<br />
severe damage to the CNS, but also in children with clinically<br />
invisible delayed forms. Dynamic Dopplerography of<br />
cerebral hemodynamics enabled us to reliably determine<br />
perinatal damage to the CNS in children with light injuries<br />
of the CNS. This method allowed us to evaluate: (1) efficacy<br />
of therapy administered, and to increase this therapy if<br />
necessary; (2) compensatory capacities of cerebral autoregulatory<br />
mechanisms in selected cases; and (3) to avoid<br />
administration of pathogenically unfounded therapy.<br />
FP-C-002<br />
Neonatal EEG tracing of burst-suppression: etiological<br />
and evolutionary aspects<br />
V. López-Martín, A. Martínez-Bermejo, J. Arcas, C. Roche,<br />
A. Tendero<br />
Service of Neuropediatrics, Hospital La Paz, Madrid, Spain<br />
Introduction: The EEG tracing seen during the neonatal<br />
period which shows so-called discharges of burst-suppression,<br />
is caused by a severe disorder of cerebral electrogenesis<br />
occurring at this time. Objective: To determine the<br />
aetiology, clinical significance and evolution of a group of<br />
newborns with this type of EEG tracing. Patients and methods:<br />
We performed a retrospective study of full term babies<br />
in whom burst-suppression EEG recordings had been<br />
obtained during the neonatal period. Results: We studied<br />
34 patients. In 14 cases the tracing was associated with<br />
hypoxic-ischemic encephalopathy; four with meningitis;<br />
another four with early infantile epileptic encephalopathy<br />
(Ohtahara syndrome); four cases were attributed to drugs<br />
(four with fentanyl associated in one case with phenobarbitone<br />
and in another with midazolam); two cases were due to<br />
early myoclonic epilepsy; three to multiorganic failure; one<br />
to non-ketonic hyperglycinemia and another to leucinosis.<br />
In one patient the aetiology could not be determined. Seven<br />
patients died before the age of 6 months. Severe neurological<br />
sequelae were seen in all the others except for four cases<br />
(three treated with fentanyl and 1 case with hypoxicischemic<br />
encephalopathy). Conclusions: The presence of a<br />
burst-suppression EEG tracing in a term neonate makes it<br />
necessary to perform extensive studies to determine the<br />
aetiology. Although associated with a worse prognosis,<br />
those not treated with piperidine derivatives should be classified<br />
separately. Those treated with piperidine derivatives<br />
have a good prognosis.<br />
FP-C-003<br />
The early intervention treatment of hypoxic-ischemic<br />
brain damage<br />
L. Liu, S.-T. Fu, Z. Liao<br />
Department of pediatrics, The Second People’s Hospital of<br />
Chengdu, China<br />
Objective: For more effective treatment and reduction of<br />
permanent disability of hypoxic-ischemic brain damage<br />
(HIBD) caused of newborn asphyxia. Methods: 60 cases<br />
of mild and serious newborns with HIBD were divided<br />
into the early intervention treatment group and control<br />
group. After HIBD early treatment, for the intervention<br />
group, the training of motion, cognition, language and social<br />
intercourse were given for 2 years. The development quotient<br />
(DQ) and clinical data were used to evaluate treatment<br />
effect. Results: Compared with the score of DQ that was<br />
followed up for 3, 6, 12, 18 and 24 months, the DQ of the<br />
intervention group was obviously higher than that of the<br />
control group (P , 0:05, P , 0:01). The percentage of<br />
unfavorable prognosis of the intervention group was only<br />
5%, obviously lower than that of the control group<br />
(P , 0:05). Conclusion: The ability of compensation and<br />
plasticity of the brain is best in the early infant stage.<br />
Early intervention can promote brain development and the<br />
connective passageways of nerve cells. It is valuable for the<br />
improvement of the patient’s prognosis.<br />
FP-C-004<br />
Correlation between cerebral palsy (CP) and<br />
periventricular leukomalacia (PVL) in premature<br />
infants<br />
K.-Z. Liu, J.-H. Yao, C.-H. Wang<br />
ICU, Shanxi Children’s Hospital, Taiyuan, Shanxi, China<br />
Objective: To study the prevalence of CP in premature<br />
infants with PVL. Methods: 23 premature infants with PVL<br />
comprised the study group; they were divided into two<br />
subgroups according to cranial CT presentations of<br />
whether lesions were symmetrical, 30 full-term infants<br />
with HIE served as the control group. Results: The prevalence<br />
of CP in the PVL group was significantly higher than<br />
that of the control group (P , 0:01). The prevalence of CP<br />
in the PVL group with symmetrical lesion was remarkably<br />
higher than that with unilateral lesion (P , 0:01). Conclusion:<br />
The premature infants with PVL had a higher probability<br />
of developing CP. The severity of the lesions and
430<br />
Abstracts<br />
the symmetry of lesions in cranial CT were good predicting<br />
factors for the neurological outcomes of the patients.<br />
FP-C-005<br />
The changes and clinical significance of determination of<br />
the neuro-specific enolase in serum of neonates with<br />
hypoxic ischemic encephalopathy<br />
Y. Hong a , Y.-M. Liu b , D.-Z. Chen a<br />
Department of Pediatrics, Zhongnan Hospital of Wuhan<br />
<strong>University</strong>, Hubei Province, China; Department of Neurology,<br />
Zhongnan Hospital of Wuhan <strong>University</strong>, Hubei<br />
Province, China<br />
Objective: To observe the changes of the neuro-specific<br />
enolase (NSE) concentration in the serum of a neonate with<br />
HIE and evaluate its clinical significance. Methods: Fortyeight<br />
neonates with HIE were examined. The concentration<br />
of serum NSE was measured at 3 and 7 days of life. The<br />
cranial CT scan was examined in the 1st week of life.<br />
Results: The concentrations of serum NSE of neonates<br />
with HIE (diagnosed clinically or by CT) at 3 days of<br />
life increased, especially in moderate and heavy cases,<br />
and were identical to the clinical and CT manifestations.<br />
Conclusions: NSE is a specific parameter for early diagnosis<br />
of HIE and estimate of hypoxic-ischemic brain<br />
damage and prognosis.<br />
FP-C-006<br />
Clinical analysis on late diagnosis and late or irregular<br />
treatment of neonatal hypoxic-ischemic encephalopathy<br />
(HIE)<br />
H. Yang, L. Zhang<br />
Paediatric Department, First Teaching Hospital Medical<br />
College of ShiHeZi <strong>University</strong>, Xinjian, China<br />
Objective: To emphasize early diagnosis and treatment of<br />
neonatal HIE in order to decrease sequelae. Methods: Retrospective<br />
analysis of perinatal period factors combined with<br />
clinical manifestation and EEG, skull CT data, to sum up the<br />
clinical data and clinical treatment effect of 36 infants with<br />
late diagnosis, and treatment of HIE. Results: A study of the<br />
curative effect and prognosis demonstrated that the early HIE<br />
diagnosed and treated group of infants had better clinical and<br />
EEG results than the later diagnosed group. For infants who<br />
were diagnosed with HIE at age 6–7 months and 1-year-old,<br />
the clinical symptoms were restored more slowly, and no<br />
clear improvement was shown by EEG. In comparison,<br />
those neonates who were admitted to our pediatric department<br />
at the same time and were given the early, regular and<br />
combined treatment, achieved a quite different curative<br />
effect and prognosis. A certain degree sequel of nervous<br />
system have been left, patient’s limb had dyscinesia and<br />
hypophvenia. Conclusion: The curative effect and prognosis<br />
of late diagnosis, and late or irregular treatment given to HIE<br />
patients, are worse than that of early diagnosis and regular<br />
treatment of neonatal HIE.<br />
FP-C-007<br />
The effect of oxygen chamber in the treatment of infant<br />
hypoxic-ischemic encephalopathy (HIE)<br />
Z.-Z. Wei, W.-Q. Geng, M. He<br />
Shenyang Children’s Hospital, Shenyang, Liaoning, China<br />
Objective: To study the clinical response to the oxygen<br />
chamber of 100 infants with HIE. Methods: Control group:<br />
50 cases of infant HIE treated with cerebroprotein hydrolysate<br />
injection. Study group: 50 cases of infant HIE treated<br />
with cerebroprotein hydrolysate injection in the oxygen<br />
chamber. Infant age: 0–5 days after birth. No statistically<br />
significant difference was found between age and sex in the<br />
two groups (P . 0:05). The transparent infant oxygen<br />
chamber was manufactured by 701 Research Institute of<br />
China Boat Industry Company. Observation Index:<br />
NBNA, DQ, response to the treatment and the evaluation<br />
of prognosis. Results: In the control group: 38 cases (76%)<br />
NBNA score $35, 12 cases (24%) NBNA ,35; 36 cases<br />
(72%) DQ $80, 14 cases (28%) DQ ,80. In the treatment<br />
group: 45 cases (90%) NBNA $35, five cases (10%) NBNA<br />
,35 (10%); 46 cases (92%) DQ $80, four cases (8%) DQ<br />
,80. A statistically significant difference was found<br />
between the two groups (P , 0:05). Conclusions: (1) Treatment<br />
of HIE with the aid of an oxygen chamber is satisfactory.<br />
(2) Treatment of HIE with the aid of an oxygen<br />
chamber decreases the treatment-abandoning rate, disability<br />
rate and mortality.<br />
FP-C-008<br />
Early intervention in hyperbilirubinemia and the<br />
abnormalities of brainstem auditory evoked potential<br />
(BAEP)<br />
H.-Q. Li<br />
Woman’s and Children’s Hospital, Baoji, Shanxi Province,<br />
China<br />
Objective: To observe the hyperbilirubinemic damage to<br />
the conducting route of the hearing nerves, and to study the<br />
diagnosis and curative effect of brainstem auditory evoked<br />
potential (BAEP). Methods: Of 62 hyperbilirubinemic cases,<br />
the ratio of abnormal BAEP account for 61%, as the following<br />
increased interval period (PL) of BAEP’s I, III, V waves,<br />
extended and disappeared interval peak length (IPL). Fifty<br />
seven of the 62 cases had abnormal hearing. We divided them<br />
into three groups A–C with different treatment regimens.<br />
Group A: control group; group B: cerebrolysin 1<br />
hyperbaric; and group C: citicoline sodium injection 1<br />
taurine granules. Results: The disappearance ratios of abnormal<br />
hearings of groups A–C after treatment were 40, 70 and<br />
65%, respectively. No notable difference was found in cura-
Abstracts 431<br />
tive effects between the treated groups (t ¼ 5, P . 0:05), but<br />
the control group (group A) was notably different from the<br />
other two groups (t ¼ 15, P , 0:05). Conclusion: As the<br />
ratio of hyperbilirubinemic hearing injuries is 61%, we<br />
should pay attention to it; BAEP has diagnostic value on<br />
hearing nerve conducting route damage caused by hyperbilirubinemia.<br />
It is also a marker for judging the curative effect.<br />
FP-C-009<br />
The therapeutic effect of naloxone plus cerebrolysin in<br />
the treatment of neonatal hypoxic ischemic<br />
encephalopathy<br />
G.-H. Sun<br />
The Second People’s Hospital of Yichang City, Yichang,<br />
Hubei, China<br />
Objective: To observe the therapeutic effect of naloxone<br />
plus cerebrolysin in the treatment of neonatal HIE. Methods:<br />
Sixty one neonates with HIE were randomly divided into<br />
two groups: 31 as the treatment group who were treated by<br />
naloxone plus cerebrolysin, 30 as the control group who<br />
were treated by cerebrolysin only. Results: The clinical therapeutic<br />
effect in the treatment group was 93%, in the control<br />
group it was 83%. There are significant differences between<br />
the clinical therapeutic effects of the two groups, x 2 ¼ 4:69,<br />
P , 0:05. Conclusion: Naloxone plus cerebrolysin can raise<br />
the clinical therapeutic effect of neonatal HIE.<br />
FP-C-010<br />
High-risk infants in Shenyang: netweb screening report<br />
and methods<br />
Q.-F. Yuan, C.-N. Wang, S.-Y. Shang, Y. Jin<br />
Woman and Child Health Center, Shenyang, China<br />
Objective: To conduct overall early screening of high-risk<br />
neonates and initiate early intervention. Methods: On the<br />
basis of second degree netweb, the third degree netweb-<br />
Woman and Child Health Center determined early diagnosis<br />
and treatment according to the following methods: the Vojta<br />
posture reflection, child neurological development method,<br />
muscle tension, joint activity degree, among others and then<br />
made the assessment. Results: 1235 high-risk neonates were<br />
screened, including normal neonates (n ¼ 637), and abnormal<br />
neonates (n ¼ 598); 306 (24.8%) of the abnormal<br />
neonates suffered from breastfeeding jaundice. Among<br />
breastfed babies with jaundice, 65 (21.2%) had hyperbilirubinemia,<br />
183 (14.8%) had central in coordination, 86<br />
(6.9%) had CP, ten (0.8%) suffered from mental retardation,<br />
and 13 (1.1%) from other conditions. All 306 cases of<br />
breastfed babies with jaundice were cured after 1 year of<br />
treatment according to the study protocol. The number of<br />
central in coordination and CP is 115, among which positive<br />
rate is 98%, normalization is 50%. The perinatal period is<br />
one of the main high-risk factors. The objective of early<br />
screening is to identify various adverse factors in the perinatal<br />
period, and initiate early intervention to prevent the<br />
occurrence of CP.<br />
FP-C-011<br />
Effects of tetramethyl pyrazine (TMP), and<br />
prostaglandin E1 on newborn rats with hypoxicischemic<br />
brain damage (HIBD)<br />
Z.-Y. Jin, C.-H. Xu, H.-Z. Li, Z. Jin, C.-J. Jin<br />
Paediatric Department, Yanbian Hospital, Yanji City,<br />
China<br />
Objective: To study the effects of exogenous tetramethylpyrazine<br />
(TMP) and prostaglandin E1 (PGE1) on brain<br />
neuronal apoptosis of hypoxic-ischemic brain damage<br />
(HIBD) in neonatal rats. Methods: We selected 52, 7-dayold<br />
Wistar rats and randomly divided them into six groups:<br />
normal control group (n ¼ 8), HIBD group (n ¼ 7), normal<br />
saline (NS) group (n ¼ 7), TMP treated group (10). After<br />
established HIBD model, intraperitoneally and subcutaneous<br />
injected TMP and PGE1 then the rats were killed<br />
after hypoxia and ischemia for another 48 h alive. The<br />
number of neuronal apoptosis, the apoptotic rate and apoptotic<br />
density of rats was detected after the brain tissue was<br />
stained by HE and TUNEL. Results: The number of neuronal<br />
apoptosis, apoptotic rate and apoptotic density in the<br />
HIBD group was much higher than in the normal controls<br />
(P , 0:01); the value in the TMP, PGE1 and TMP 1 PGE1<br />
groups was much lower (P , 0:01, P , 0:01, P , 0:01,<br />
respectively), and the value in the TMP 1 PGE1 group<br />
was much lower than that in the TMP and PGE1 groups<br />
(P , 0:05). Conclusion: TMP and PGE1 can pass through<br />
the blood–brain barrier and inhibit cerebrocellular apoptosis;<br />
Moreover, a combination treatment of TMP and PGE1<br />
is more effective than if administered separately; they coordinate<br />
and complement each other, and can enhance the<br />
curative effect.<br />
FP-C-012<br />
Experimental research on the hyperbaric oxygen (HBO)<br />
treating mechanism on SD neonate rat model with<br />
hypoxic-ischemic brain damage (HIBD)<br />
L. Liu, Y.-J. Yang, Y.-J. Jia, J.-H. Song<br />
Xiangya Hospital, Central South <strong>University</strong>, Changsha,<br />
China<br />
Objective: To clarify the mechanism of hyperbaric<br />
oxygen (HBO) in the treatment of the SD neonate rat<br />
model with HIBD. Methods: Forty rats were randomly<br />
divided into four groups: normal, sham, HIBD and HBO<br />
groups. The rats in the HBO group were treated with 2.0<br />
atmosphere absolute HBO every day for 7 days. At the end<br />
of the HBO treatment, we investigated the Bcl-2 and Bax,<br />
apoptosis-regulating protein in CA1 sector of hippocampus
432<br />
Abstracts<br />
and cortex of the brain, and IkBa expression by Western<br />
blot. Results: HBO can increase the expression of Bcl-2 and<br />
reduce the expression of IkBa with no obvious change in<br />
Bax expression compared to the other three groups. Conclusion:<br />
HBO can induce NF-kB activation and the expression<br />
of Bcl-2 to protect the neuron from apoptosis.<br />
FP-C-013<br />
Research on improving the mental development of<br />
hypoxic-ischemic encephalopathy (HIE) children by<br />
early intervention<br />
J.-H. Song, R. Huang, Y.-J. Yang, J. Liu, Z. Luo<br />
Xiangya hospital, Central South <strong>University</strong>, Changsha,<br />
Hunan, China<br />
Objective: To understand the influence of early intervention<br />
on the mental development of children with HIE, and to<br />
ascertain the best time for this measure. Methods: 36 children<br />
with HIE, diagnosed by doctors at the outpatient<br />
department, who did not receive early intervention, served<br />
as the control group. Thirty two children who accepted early<br />
intervention comprised the intervention group. Mental<br />
development of the children in both groups was tested by<br />
the CDCC mental developmental test. Results: The Mental<br />
Development Index (MDI) score of one child and the<br />
Psychomotor Development Index (PDI) score of two other<br />
children were in the marginal level. The MDI and PDI<br />
scores of all the other children were all above medium.<br />
All the children in the control group suffered from mental<br />
retardation. The mental development in the two groups was<br />
significantly different (P , 0:01). Conclusion: Early intervention<br />
can improve the mental development of children<br />
with HIE.<br />
FP-C-014<br />
Study of hypoxia inducible factor 1a (HIF-1a) gene in<br />
neonatal rat models with hypoxic ischemia<br />
X.-R. Zheng, Y.-J. Yang, Y.-J. Jia<br />
Xiang Ya Hospital, Central South <strong>University</strong>, Changsha,<br />
China<br />
Objective: To explore the expression of hypoxia inducible<br />
factor 1a (HIF-1a) gene in a neonatal rat model of cerebral<br />
hypoxic ischemia (HI), and to evaluate whether the<br />
expression of the HIF-1a gene could be available as a<br />
marker of hypoxic ischemia. Methods: Using a neonatal<br />
rat model of cerebral hypoxic ischemia, the expression of<br />
HIF-1a was detected by employing a method of quantitative<br />
RT-PCR in cerebral tissue. Results: In the normoxic condition<br />
the expression of HIF-1a mRNA in cerebral tissue of<br />
the neonatal rat was at a very low level. Expression of HIF-<br />
1a mRNA occurred at once after HI in the HI group, reached<br />
its peak at 24 h, and maintained a higher level within 72 h,<br />
decreased at 7 days after HI, but was still at a mild higher<br />
level compared with the normal group. Conclusion: These<br />
results demonstrate the expression of HIF-1a increased<br />
rapidly under hypoxia-ischemia in neonatal rats. It was<br />
confirmed that expression of the HIF-1a gene could be<br />
sensitively induced by HI, and it may be available as a<br />
marker of hypoxic ischemia.<br />
FP-C-015<br />
Twenty-four hour non-invasive monitoring of anterior<br />
fontanel pressure and blood pressure in sick neonates<br />
Y.J. Yang, Q.H. Wang, L. Liu, X. Wang<br />
Division of Neonatology, Xiangya Hospital of Central South<br />
<strong>University</strong>, Changsha, China<br />
Objective: The present study was undertaken to investigate<br />
the method of anterior fontanel pressure (AFP)<br />
measurement to establish the rhythm of AFP and mean<br />
arterial pressure (MAP) over 24 h in sick neonates. Method:<br />
Sixty-seven neonates were divided into four groups: nonintracranial<br />
disease, slight asphyxia (ASP), hyperbilirubinemia<br />
and premature infant. None of the patients received<br />
dehydrated therapy. AFP (intracranial pressure monitor<br />
SP2000) and MAP were monitored continuously over 24<br />
h. Results: (1) The AFP levels in all patients ranged from<br />
1 to 10 mmHg. (2) The AFP was variable over 24 h, the<br />
highest level of AFP was at 09:00–11:00 h, whereas the<br />
lowest was at 01:00–02:00 h. (3) AFP was lower in premature<br />
infants than term infants. (4) There were no correlations<br />
among AFP and weight, size of fontanel, gestational age,<br />
head circumference and MAP. Conclusions: (1) The appreciated<br />
time was at 09:00–11:00 h in 1 day for AFP measurement.<br />
(2) AFP was lower in the premature infants than term<br />
infants. (3) The AFP has increase obviously in neonates<br />
with slight asphyxia, non-intracranial disease or hyperbilirubinema.<br />
FP-C-016<br />
Relationship between hyperbaric oxygen therapy and<br />
apoptosis, caspase-3 in neonatal hypoxic-ischemic brain<br />
damage<br />
Y.-J. Yang, L.-X. Liu, V. Tukei, Y.-J. Jia<br />
Department of pediatrics, XiangYa Hospital, Central South<br />
<strong>University</strong>, Changsha, China<br />
The objective of this experiment was to investigate the<br />
probable mechanisms of HBO therapy by assessing the<br />
expression of apoptosis and caspase-3 mRNA in a neonatal<br />
HIBD model. Healthy 7-day old SD rats were randomly<br />
divided into three groups: control group (n ¼ 8), HIBD<br />
group (n ¼ 8), and HBO group (n ¼ 8). Detection of the<br />
expression of apoptosis and caspase-3 mRNA was<br />
performed by the TUNEL and hybridization in situ techniques.<br />
Using these techniques the results showed that there<br />
was minimal or no expression of apoptosis and caspase-3
Abstracts 433<br />
mRNA in the control group, but there was massive expression<br />
of apoptosis and caspase-3 mRNA in the HIBD group.<br />
HBO therapy (HBO group) significantly decreased apoptosis<br />
in neuronal cells [(252.96 ^ 68.59) versus<br />
(342.24 ^ 74.16), P , 0:05] and weakened the expression<br />
of caspase-3 mRNA in HIBD rats. The expression of apoptosis<br />
and caspase-3 mRNA was obviously increased in the<br />
HIBD group. We conclude that HBO therapy can weaken<br />
the expression of caspase-3 mRNA and decreases apoptosis<br />
in cells, and this is the probable mechanism of neuronal<br />
protective effect of HBO therapy.<br />
FP-C-017<br />
Change of serum sodium in 78 newborn infants with<br />
hypoxic-ischemic encephalopathy<br />
B. Liu<br />
Department of Infant Medicine Jinzhou Children’s Hospital,<br />
Jinzhou, China<br />
Objective: To study the change of serum Na level in<br />
neonate HIE, and explore the relationship between serum<br />
Na level and severity of HIE. Methods: Serum Na levels<br />
were measured by MI-921 K-Na-Cl Analyzer in 78 neonates<br />
with HIE. Results: Serum Na levels of 70 cases were lower<br />
than the normal value. Serum Na levels of moderate and<br />
severe groups were much lower than that of the mild group.<br />
There were significant differences between the moderate<br />
and severe groups. Conclusion: Serum Na reduced in<br />
neonates with HIE, and the changes of serum Na levels<br />
was related to the severity of HIE.<br />
FP-C-018<br />
Changes of local fibrinolysis in premature newborns<br />
with periventricular leucomalacia<br />
K.S. Ormantaev, L. Saulebekova, D. Kachurina, E.<br />
Gromenko<br />
Scientific Center Pediatrics and Children’s Surgery,<br />
Almaty, Kazakhstan<br />
Severe cerebral ischemia is often accompanied by disturbances<br />
of hemostasis. The aim of our investigation was to<br />
study the tromboplastic and fibrinolitic properties of liquor<br />
in 36 premature newborns with PVL. The mean weight of<br />
the premature newborns was 1400–2000 g. The level of 5-<br />
nucleotidase in liquor was high 2486.0 1 35.0 n/cat, which<br />
indicated the presence of tissue and cerebral thromboplastin.<br />
Production of degradation of fibrinogen (<strong>PDF</strong>) in liquor was<br />
determined in concentrations from 3.1 to 3.75 mg.%, Severe<br />
cerebral ischemia in premature newborns is accompanied by<br />
withdrawal activators of plasminogen, high fibrinolytic<br />
activity, and appearance of <strong>PDF</strong> in CSF. This indicates<br />
the development of local fibrinolysis and more severe disorders<br />
of cerebral circulation<br />
FP-C-019<br />
The neurobiology of the normal and brain damaged<br />
infant cry: a comparison of animal, statistical and<br />
neurobiological models<br />
C. Lenti a,b , B.D. Lenti b,c , D. Galbusera a,c , F. Rocca a,c<br />
a Chair of Child Neuropsychiatry, <strong>University</strong> of Milan,<br />
Milano, Italy; b Laboratory of Bioacoustics and Comparative<br />
Analysis of Behaviour and Cognitive Functions,<br />
<strong>University</strong> of Milan, Italy;<br />
c Faculty of Paedagogical<br />
Sciences, <strong>University</strong> of Urbino, Urbino, Italy<br />
The cry of the human infant primate is a differentiated<br />
signal that can be voiceless, partially voiced and voiced<br />
with many different melodic contours. The physioacoustics<br />
of the infant cry, however, is poorly known and we must rely<br />
on animal models, or on statistical elaboration on measured<br />
parameters of recorded and measured infant cries. In this<br />
preliminary work we compare the qualitative and quantitative<br />
parameters of measured on cries produced by six asphyxic<br />
brain-damaged infants with the same parameters obtained<br />
from normal infants, and examine the differences that can<br />
help in understanding the neurobiology of the human cry.<br />
Our preliminary data show alterations of voicing and abnormal<br />
melodic contours: The frequency jump, that is a discontinuity<br />
in the melodic contour is present only in the<br />
asphyxiated subjects and the vibrato is significantly more<br />
frequent in the pathological sample. This indicates a role<br />
for the higher nervous centers in controlling the shape and<br />
continuity of the contours. A surprising fact was that even<br />
with massive lesions, many single cry units appeared similar<br />
to those emitted by normal infants: This could suggest that the<br />
programming of the cry unit’s main characteristics is<br />
controlled by lower centres, possibly related to the respiratory<br />
function, and whose lesions could not be compatible with life.<br />
Results will be compared with animal and statistical models.<br />
FP-C-020<br />
Study of the electroencephalogram in neonatal infants<br />
with fetal distress<br />
C.-J. Yan a , A.-S. Piao a , G.-H. Li b<br />
a Yanbian women-children hospital, Yanji City, Jilin, China;<br />
b New ear children hospital, Yanji city, Jilin, China<br />
Background: Fetal distress is fetal compromise caused by<br />
hypoxia. Fetal distress can cause brain damage, so early<br />
diagnosis and treatment for fetal distress is very important.<br />
The most commonly used tests for fetal distress are the nonstress<br />
test (NST), and the contraction test (CST). Although<br />
the NST and CST have low false-negative rates, both have<br />
high false-positive rates. In this study, we investigated the<br />
value of the electroencephalagraph in fetal distress. Methods:<br />
Twenty-one cases of fetal distress in newborn were<br />
included in this study and 21 normal newborns were<br />
selected for controls. In the study group, the range of gesta-
434<br />
Abstracts<br />
tional age, Apgar score and weight were. A total of 37–42<br />
weeks, 8–10 and 2500–3999 g, respectively. We used the<br />
international 10–20 electrode placement newborn system<br />
and recorded the sleeping EEG by monopolar and bipolar<br />
montage. Results: Index of EEG in fetal distress of<br />
newborns was significantly lower than that of non-fetal<br />
distress newborns (P , 0:05). The results suggested that<br />
pathophysiological changes by hypoxia in fetal distress<br />
could cause brain dysfunction and EEG could detect this<br />
type of disorder. Conclusion: EEG in the newborn is useful<br />
diagnostic method for fetal distress and it is necessary to<br />
check EEGs in newborns at risk to prevent prolonged brain<br />
damage by fetal distress.<br />
FP-C-021<br />
Intracranial hemorrhage in infants after massaging by a<br />
traditional birth attendant<br />
E.S. Herini, Sunartini, S.W. Daniel<br />
Department of Child Health, Medical School, Gadjah Mada<br />
<strong>University</strong>, Sardjito Hospital, Yogyakarta, Indonesia<br />
The overall incidences of birth injuries appear to be<br />
declining as a result of improved obstetrical practices.<br />
However, it is unknown whether or not incidences of head<br />
trauma were caused by massage of traditional birth attendants.<br />
As a culture in Indonesia especially in Yogyakarta<br />
and Central Java, the infants were massaged after delivery in<br />
order that the baby would be. Despite good intentions,<br />
massaging resulted in intracranial bleeding as if it was<br />
caused by abuse. We report four infants with intracranial<br />
hemorrhage after massaging by traditional birth attendants.<br />
All the infants referred to the Sardjito Hospital, Yogyakarta<br />
were in a bad condition and had severe anemia (hemoglobin<br />
was 6.6, 4.4, 8.6 and 3.7 mg/dl), while the clotting bleeding<br />
times were normal in three infants and the rest had<br />
prolonged clotting time. Head CT scan showed a right hemisphere<br />
cerebral infarct due to intracranial hemorrhage in<br />
case 1, epidural hemorrhage and subdural hemorrhage in<br />
case 2, intracranial hemorrhage in the right temporal parietal<br />
lobe in case 3 and the last case had a subdural hematoma in<br />
the parieto-occipital bilateral region. Three underwent<br />
craniotomy and one was under observation only.<br />
FP-C-022<br />
The effect of hyperbaric oxygen treatment on neonatal<br />
hypoxic-ischemic encephalopathy (HIE)<br />
Q.-H. Yu<br />
Department of Pediatrics, Center Hospital, Qilu Petroleum<br />
Chemical Company, Shandong, China<br />
Objective: To analyze the effect of hyperbaric oxygen<br />
treatment on neonatal hypoxic-ischemic encephalopathy.<br />
Method: The 40 patients with HIE were treated with hyperbaric<br />
oxygen combined with other regular therapy, 30<br />
patients with HIE had only regular therapy. The clinical<br />
features, NBNA scores and cranial CT findings were<br />
recorded during following 3 , 6 months. Result: The<br />
patients treated by hyperbaric oxygen combined with regular<br />
therapy had significant better prognosis than those with<br />
only regular therapy. Conclusion: The hyperbaric oxygen<br />
treatment should be applied to neonatal HIE as soon as<br />
possible for its remarkable effect on improving prognosis.<br />
FP-C-023<br />
Brain stem involvement in neonatal neurological<br />
disorders: ultrasonographic findings and clinical<br />
correlates<br />
Y.-F. Tu, C.-C. Huang<br />
Department of Pediatrics, National Cheng Kung <strong>University</strong><br />
Hospital, Tainan City, Taipei, Chinese Taipei<br />
Neurologic disorders with brain stem involvement often<br />
indicate poor prognosis. Conventional cerebral ultrasound<br />
examination through anterior fontanelle is limited in evaluating<br />
the brain stem lesion. There are few reports on other<br />
trans-cranial views that demonstrate the extent of brain stem<br />
lesions. From the year 2000 through 2002, we found 11<br />
newborns with brain stem lesions detected by ultrasound<br />
examinations obtained via squamous portion of temporal<br />
bone and foramen magnum. The etiology included metabolic<br />
encephalopathy (n ¼ 5), hypoxia-ischemia encephalopathy<br />
(n ¼ 4), birth trauma (n ¼ 1) and group B<br />
Streptococcus meningoencephalitis (n ¼ 1). All the<br />
newborns presented with consciousness disturbance, hypotonia,<br />
and respiratory insufficiency that require artificial<br />
ventilation. Trans-axial ultrasound findings showed hyperechogenic<br />
midbrain and/or pons, and the degree of hyperechogenecity<br />
correlated to disease severity. Trans-foramen<br />
magnum examination demonstrated the medulla and cervical<br />
cord lesions, and especially signs of tonsil herniation<br />
(absence of cisterna magna). All patients had a poor<br />
outcome: six died, and the other five have severe neurologic<br />
deficits, including ventilator dependency. We concluded<br />
that cerebral ultrasound examination through temporal<br />
bone and foramen magnum is valuable in defining the<br />
brain stem involvement, which has a prognostic implication<br />
in neonatal neurological disorders.<br />
FP-C-024<br />
The early application of brain-cell metabolism activator<br />
in the newborns with hypoxic-ischemic encephalopathy<br />
(HIE)<br />
B.-J. Liu, P. Zhang, Z.-H. Zhang<br />
Pediatrics department of Laiwu Iron and Steel Group Ltd.<br />
Hospital, Shandong, China<br />
Objective: To explore the effect of the brain-cell metabolism<br />
activator, by the early application of citicoline or
Abstracts 435<br />
cerebrolysin, on the prognosis of the newborns with HIE.<br />
Methods: We selected 108 newborns with HIE who had<br />
been admitted to hospital during the period 1999 , 2001.<br />
We randomly divided them into two groups: the first group<br />
included 51 cases that began to take citicoline or cerebrolysin<br />
from the 7th day after birth. The second group<br />
comprised 57 cases that began to take these drugs before<br />
24 h after birth. These brain-cell metabolism activators<br />
were combined with other routine treatments. There were<br />
no significant differences in the severity of diseases<br />
between the two groups (P . 0:05). The period of treatments<br />
were both 14 , 21 days. The NBNA evaluations and<br />
electroencephalogram examinations were carried out on<br />
the 7th day, 14th day, the 1st month, the 2nd month, the<br />
6th month and the 1st year after birth, respectively. Results:<br />
The rates of unfavorable prognosis were 19.61%, and<br />
5.26% in the first and second groups, respectively. The<br />
differences were significant between the two groups<br />
(P , 0:05). Conclusion: Early application of brain-cell<br />
metabolism activator may decrease the rate of unfavorable<br />
prognosis of newborns with HIE.<br />
FP-C-025<br />
Characteristics of immune status of newborns with<br />
hypoxemic – ischemic encephalopathia<br />
Kh.T. Mukhamedova, F.A. Nazarova<br />
Doctors Advance Training Institute, Tashkent, Uzbekistan<br />
Chronic fetal hypoxia results in thymus involution. At<br />
neonatal asphyxia there accrues blocking of ferments,<br />
responsible for thymosin synthesis, which results in reduction<br />
of activity both of cellular and humoral immunity.<br />
Studies of immune status revealed that specific weight of<br />
lymphocytes in peripheral blood of patients with perinatal<br />
brain injuries ranges within the normal limits with a rising<br />
tendency in children with severe injuries of CNS. In children<br />
with severe brain injures at birth the absolute numbers of<br />
lymphocytes have been increased as well. Conducted studies<br />
of main sub-populations of T- and B-lymphocytes in children<br />
with perinatal brain injures showed redivision of main immunity<br />
cellular factors depending on severity and duration of<br />
hypoxia. Studies of T-lymphocyte content in children who<br />
had had asphyxia revealed much lower readings (indications)<br />
at birth, irrespective of severity and duration of anoxaemia.<br />
Decrease of cellular immunity in newborns who had had<br />
asphyxia indicates an impairment of the main regulating<br />
member of immune reactions and is combined with decrease<br />
of anti-infective resistance of the organism.<br />
FP-C-026<br />
Characteristics of cellular immunity in newborns with<br />
perinatal brain injures<br />
Kh.T. Mukhamedova, F.A. Nazarova<br />
Doctors Advance Training Institute, Tashkent, Uzbekistan<br />
We conducted an immunologic examination of 40<br />
newborns who had had asphyxia and perinatal hypoxia.<br />
The newborns were been divided into two groups: The<br />
first group was composed of newborns whose condition<br />
was mild to severe, who had had chronic hypoxia due to<br />
the mother’s chronic diseases, and complicated pregnancy.<br />
The second group was composed of newborns who had had<br />
acute asphyxia with combined hypoxia. Studies of subpopulations<br />
of T-lymphocytes/T-helpers, T-suppressors/in<br />
children with perinatal brain injures revealed a decrease of<br />
relative and absolute number of T-lymphocytes, suppressors<br />
and helpers. The findings indicate that perinatal brain injury<br />
leads to substantial impairment of the newborns’ organism<br />
immunologic reaction to imbalance of the immunity cellular<br />
basis, which depends on the severity of the patient’s condition,<br />
age, duration of anoxaemia, state of health and course<br />
of mother’s pregnancy. A severe form of combined hypoxia<br />
results in more acute impairment of cellular immunity,<br />
which makes this group potentially threatening regarding<br />
sepsis and development of acute neurology symptoms.<br />
FP-C-027<br />
Hypoxia-ischemia induced upregulation of brain iron<br />
histochemistry in neonatal SD rats<br />
M.-Y. Hei, S.-J. Kuang<br />
Department of Pediatrics, the 3rd Affiliated Xiangya Hospital<br />
of Central South <strong>University</strong>, Changsha, Hunan, China<br />
The developing characters of the neonatal brain make<br />
them vulnerable to multiple types of injury, including<br />
hypoxic/ischemic injury. The over-accumulation of iron in<br />
the brain may lead to free radical-caused cell damage after<br />
HI insult. Objective: To understand the histochemical<br />
change of iron in the brain tissue in both normal and HI<br />
insulted neonatal SD rats. Method: 30 neonatal SD rats<br />
were randomly divided into normal group (n ¼ 15) (including<br />
postnatal days 7, 8, 10, 14 and 21 subgroups) and HIE<br />
group (n ¼ 15) (postnatal day 7 rats treated with right carotid<br />
artery ligation combined with 2.5 h 8% O 2 /92% N 2 exposure).<br />
After 12, 24 h, 3, 7 and 14 days of recovery, the HIinsulted<br />
animals were perfusion fixed. A total of 45 mm<br />
thick free-floating sections were stained in Perl’s solution<br />
and intensified by DAB/H 2 O 2 . Results: In normal P7–P14<br />
SD rats, there were iron-positive cell foci mainly distributed<br />
in cingulum and corpus callosum, periventricular zone,<br />
internal capsule and the tip of the external capsule. The<br />
iron positive cells were morphologically similar to oligodendrocytes<br />
and microglia. The iron staining intensity of<br />
ipsilateral hemisphere in the HI insulted brain was increased<br />
as early as 12 h after HI and progressed in a time-dependent<br />
pattern with the peak at 7 days after HI insult, especially in<br />
the damaged cortex, internal capsule and hippocampus. The<br />
iron-positive material was mainly glia. An intensified<br />
phenomenon of perivascular iron positive foci was particularly<br />
noticeable. Conclusions: Brain iron histochemistry
436<br />
Abstracts<br />
was upregulated after HI-insult and can be used to assess<br />
cerebral damage in moderate to late stages after hypoxic<br />
ischemia insult.<br />
FP-C-028<br />
Effect of early intervention on the brain and<br />
development quotient of newborns with hypoxic<br />
ischemic encephalopathy<br />
D.-Y. Zhou, M. Peng, S.-Y. Jiang<br />
Harbin Children’s Hospital, Daoli District Harbin, Harbin,<br />
China<br />
Objective: To explore the efficacy of early intervention on<br />
newborns suffering from hypoxic ischemic encephalopathy<br />
(HIE), and evaluate their prognosis. Method: One hundred<br />
newborns suffering from neonatal HIE (states of II, II–III,<br />
III) who received early intervention were followed-up for 2<br />
years. CT and DQ were performed in these cases. Results:<br />
(1) An early intervention was carried out for improving the<br />
prognosis of the newborns with HIE (II, II–III) The normal<br />
rate of their brain CT and DQ in the early intervention group<br />
was higher than that of the non-intervention group. This<br />
difference was statistically significant, P , 0:01. There<br />
were significant differences in neonatal HIE (III),<br />
P , 0:05. (2) The follow-up examination showed a high<br />
correlation between the brain CT and DQ in the early intervention<br />
group, r ¼ 0:88. The brain CT in the early intervention<br />
group was improved, accompanied by the improvement<br />
of clinical signs (DQ level). Meanwhile, the low correlation<br />
between the brain CT and DQ in the non-intervention group,<br />
r ¼ 0:55. Conclusion: Clearly early intervention can<br />
improve the prognosis of neonatal HIE. CT integrated<br />
with DQ can improve accuracy and early diagnosis.<br />
FP-C-029<br />
P-selectin expression and neuroprotective effect of<br />
fucoidin on hypoxic-ischemic brain injury in neonatal<br />
rats<br />
B.-L. Eun a , K.-B. Kim b , D.-H. Pee a , Y.-C. Tockgo a<br />
Department of Pediatrics, College of Medicine,<br />
a Korea<br />
<strong>University</strong>, b Kwandong <strong>University</strong>, Seoul, Korea<br />
Objective: Leukocyte-endothelial adhesion is a key step<br />
in the initiation of post-ischemic reperfusion injury in many<br />
organ systems. We hypothesized that P-selectin might<br />
mediate post-HI injury in the immature rat brain. Methods:<br />
To elicit focal hypoxic-ischemic brain injury, 7-day-old<br />
(P7) rats (n ¼ 160) underwent right carotid coagulation,<br />
followed by 2 h hypoxia (F i O 2 ¼ 0.08). We performed<br />
RT-PCR for mRNA (n ¼ 28) and Western blot for protein<br />
of P-selectin (n ¼ 37). To test the efficacy of a pretreatment<br />
regimen, P7 rats (n ¼ 59) received fucoidin immediately<br />
before and again after hypoxia intra-peritoneally with a 26<br />
gauge needle. Results: P-selectin mRNA expression in the<br />
ipsilateral (right) hemisphere reached a peak at 8 h after HI<br />
and then was barely detected after 24 h. P-selectin protein<br />
was detected as early as 15 and 30 min at both hemispheres<br />
in experimental rats and decreased at 1 h, and increased in<br />
the right hemisphere at 4 h post-HI, peaked at 8 h and was no<br />
longer detectable at 24 h. We found a substantial neuroprotective<br />
effect after pretreatment with fucoidin as a dose<br />
dependency. Conclusion: The temporal profiles of post-HI<br />
P-selectin mRNA and protein expression are consistent with<br />
a role in the evolution of subsequent brain injury. Potential<br />
of therapeutic application of P-selectin blockade or similar<br />
anti-adhesion strategies may reduce the brain damage after<br />
perinatal HI.<br />
FP-C-030<br />
Clinical analysis of 86 neonatal hypoxic ischemia<br />
encephalopathy<br />
A.-Q. Li<br />
The department of Pediatrics, Weihai Municipal hospital,<br />
Huancui district Weihai, Shandong, China<br />
Objective: To investigate the relationship between the<br />
clinical degree of severity of HIE with asphyxia and the<br />
cranial image changes. Method: The data of 86 neonates<br />
diagnosed with HIE were analysed retrospectively. Seventy<br />
five cases had at least once undergone cranial CT examinations<br />
between the age of 2 and 19 days. Result: Among 86<br />
subjects, including 54 male cases and 32 females, 58 cases<br />
diagnosed with mild HIE included 20 cases of mild<br />
asphyxia, and 38 cases of severe asphyxia. Among 17<br />
cases of moderate HIE, one case had mild asphyxia and<br />
16 cases were severe. In 11 cases of severe HIE all had<br />
severe asphyxia. In 75 cases with cranial CT, 58 cases<br />
showed abnormal, including 31 cases of mild pathological<br />
changes, 16 had moderate change, and 11 cases of severe<br />
changes. Among the cases with severe changes in CT scan,<br />
there were three with parenchymal hemorrhage and three<br />
with subarachnoid hemorrhage. The positive rate of CT in<br />
mild and moderate HIE were 64.7 and 84%, respectively. In<br />
severe HIE, all patients had apparently abnormal changes.<br />
The patients diagnosed as mild HIE with mild asphyxia<br />
were usually presented 36 h after birth. The clinical symptoms<br />
of patients with the brain lesion mainly in the occipital<br />
lobe were staring, lethargy, etc., usually not affecting eating.<br />
If the lesion in anterior frontal or temporal lobes, the<br />
patients presented irritability, bulge of fontanel, and many<br />
of them had convulsions. Some had apnea or stubborn<br />
hiccups. The common drugs used in HIE, included vitamin<br />
K, sodium bicarbonate, luminal, antibiotics, ATP, citicoline,<br />
and dehydrating agents. The effect of using dehydrating<br />
agents regularly was better than using them provisionally.<br />
Conclusion: This observation showed the more severe the<br />
asphyxia the more the severity of the state of the patients. It<br />
was important to start treatment before the hypoxemia and<br />
ischemia occurred, and after resuscitation of asphyxia.
Abstracts 437<br />
Additionally, the cooperation of pediatricians and obstetricians<br />
in treatment was imperative to improve the prognosis<br />
of the patients with asphyxia or HIE.<br />
FP-C-031<br />
Neonatal choroid plexus cysts (CPC) and early<br />
childhood developmental outcome<br />
K.-L. Hung, H.-T. Liao<br />
Department of Pediatrics, Cathay General Hospital, Taipei,<br />
China<br />
Choroid plexus cysts (CPCs) are incidental findings on<br />
sonograms of the neonatal head. The true incidence is not<br />
yet known. Childhood neurodevelopmental outcome associated<br />
with neonatal CPCs has been rarely reported. The aim<br />
of this study was to determine the incidence of neonatal<br />
CPCs and early childhood developmental outcome. During<br />
the period July 1997 to June 1998, 2111 normal newborns<br />
underwent brain sonographic examinations as a routine<br />
screening. All newborns detected as having CPCs underwent<br />
serial sonograms at 1, 2, 4 and 6 months of age. Developmental<br />
milestones were evaluated subsequently at followup<br />
visits. Developmental assessment was performed with<br />
the Denver II Developmental Screening Test. The results<br />
showed CPCs were identified in 186 neonates (8.8%). Of<br />
these, 14 (7.5%) were bilateral. The mean size of the cysts<br />
was 2.6 mm (range 1.1 , 8.6). Five cysts were larger than 5<br />
mm in size. Physical check-up was normal in all the 186<br />
neonates with CPCs follow-up ultrasonic studies were available<br />
for 155 children. The cysts regressed spontaneously in<br />
the majority of the infants and, by 6 months of age, residual<br />
cysts were visible in 18 infants (11.6%) only. During the<br />
clinical follow-up period from 30 to 42 months, developmental<br />
outcome was normal in all available 179 children.<br />
The existence of isolated CPCs in the newborn is neither<br />
associated with abnormal physical findings nor with any<br />
delay of early childhood development.<br />
FP-C-032<br />
Protective and therapeutic effects of valproic acid<br />
against hypoxic-ischemic brain injury in the newborn<br />
N. Kabakus, I. Ay, S. Aysun, F. Soylemezoglu, A. Ozcan, B.<br />
Celasun<br />
Pharmacology and Neuropathology, Departments of Pediatric<br />
Neurology, Hacettepe <strong>University</strong> Faculty of Medicine,<br />
Ankara, Turkey<br />
HIBD is still an important cause for morbidity and<br />
mortality in the newborn, and new approaches need to be<br />
developed for the treatment of HIBD. The present study<br />
aims to investigate neuroprotective/neurotherapeutic<br />
effects of valproic acid (VPA) which is reported to be a<br />
protective and therapeutic agent in cellular damage. VPA<br />
was administered acutely (first 24 h) and chronically (after<br />
24 h) at both low (200 mg/kg per day) and high (400 mg/kg<br />
per day) therapeutic doses. All experiments were<br />
performed on 7-day-old rat pups which is an immature<br />
rat model. The findings have shown that VPA had no<br />
significant therapeutic effect on cerebral infarcts<br />
(P . 0:05) following both acute and chronic administration.<br />
However, when administered for five consecutive<br />
days, VPA had significant protective and therapeutic<br />
effects on the area of cerebral infarct in a dose-dependent<br />
manner (control: 17.9%; low dose: 11.2%; high dose:<br />
7.9%). High doses of VPA within the first 24 h showed<br />
therapeutic effects on the patchy lesions in the thalamus,<br />
caudate nucleus and putamen (P , 0:05). VPA protected<br />
the brain from possible deterioration of patchy and cortical<br />
(cerebral and hippocampal) damages into more severe<br />
forms (grades 3–4/4). VPA also prevented progression of<br />
pronounced atrophy in the ipsilateral hemisphere (,75%).<br />
In view of the present results it is concluded that therapeutic<br />
properties of VPA in HIBD need to be elucidated in<br />
more comprehensive studies.<br />
FP-C-033<br />
The effect of intravenous immunoglobulin in hypoxicischemic<br />
brain damage in an experimental immature rat<br />
model<br />
G. Haliloglu, P. Atilla, M. Berker, B. Anlar, A.N. Cakar, S.<br />
Aysun<br />
Histology and Embryology and Neurossurgery, Departments<br />
of Pediatric Neurology, Hacettepe <strong>University</strong> Faculty<br />
of Medicine, Ankara, Turkey<br />
Immunoinflammatory system and cytokines activate a<br />
biochemical cascade of events after hypoxia-ischemia.<br />
Effects of intravenous immunoglobulin as cytokine suppression<br />
and remyelination have been reported in human tissue<br />
cultures and demyelinating diseases. The aim was to study<br />
these effects in histopathological findings in hypoxia-ischemia<br />
immature rat model. Hypoxic-ischemia was induced in<br />
7-day-old rats (right common carotid artery occlusion 18%<br />
O 2 for 2.5 h). The animals were then divided into two groups:<br />
first group received 1 g/kg IVIg intraperitoneally, and the<br />
second group received the same amount of serum physiologic<br />
within 1 h after the insult. The animals were decapitated<br />
after 24 h, and a morphologic classification was done using<br />
vacuolization, clumping of nuclear chromatin, disappearance<br />
of nuclear depression and nucleus pyknosis from both<br />
hemispheres and frontal, temporal and occipital regions<br />
separately. It was demonstrated that vacuolization and<br />
nuclear pyknosis were decreased in the inner cortex in the<br />
first group. Pyknotic changes seen in the outer cortex in both<br />
groups represented cells in the process of apoptosis,<br />
supported by TUNEL method. This study demonstrated the<br />
morphologic effects of IVIg on hypoxic-ischemic encephalopathy<br />
in an immature rat model, and forms a base for<br />
further studies.
438<br />
Abstracts<br />
FP-C-034<br />
Brainstem evoked response in term neonates<br />
L.M.F.F. Guilhoto, E.A. Abreu, E. Ornelas, V.S. Quintal,<br />
M.T.Z. da Costa<br />
Hospital Universitário da Universidade de São Paulo, São<br />
Paulo, Brazil<br />
Brainstem evoked response (BSER) in neonates may<br />
evaluate objectively the integrity of the auditory system<br />
up to the brainstem level. It seems to be a reliable test<br />
for auditory and neurological dysfunction at this age and<br />
it permits early diagnosis and rehabilitation. The purpose<br />
of this study is to demonstrate the latencies of BSER in<br />
normal term neonates in order to obtain normative data in a<br />
university hospital. BSER was performed on the 2nd day of<br />
life of 47 normal newborns (25 males, 22 females) ranging<br />
in gestational ages between 37 and 40 weeks that did not<br />
present with familial history of deafness. The examination<br />
was performed during sleep, after feedings, with 80 dBHL<br />
clicks of alternating polarity presented monaurally at a rate<br />
of 10/s. A total of 2.000 stimulus trials was averaged and<br />
duplicated for each ear. The mean latency time of waves I–<br />
V, as well as the inter-peak latencies were measured. The<br />
mean of the latencies in milliseconds was the following:<br />
wave I, 1.79 (SD 0.20); wave II, 2.88 (SD 0.28); wave III,<br />
4.54 (SD 0.31); wave IV, 5.86 (SD 0.36); wave V, 6.75<br />
(SD 0.38); IPL I–III, 2.75 (SD 0.36); IPL III–V, 2.22 (SD<br />
0.22); and finally IPL I–V, 4.97 (SD 0.43). Normative<br />
BSER studies in term neonates undertaken in university<br />
hospitals are necessary to establish reference values for<br />
evaluation of auditory and neurologic prognostic factors,<br />
as well as to early diagnose children with auditory dysfunction.<br />
FP-C-035<br />
Guidelines for intensive care in the delivery room of<br />
extremely premature newborns<br />
G. Verlato, D. Gobber, D. Drago, L. Chiandetti, P. Drigo,<br />
B.M. Amelia and the Working Group<br />
Intensive Care in the Delivery Room of the Bioethic<br />
Committee of the Department of Pediatrics; Department<br />
of Pediatrics, <strong>University</strong> of Padua, Padova, Italy<br />
Ethical problems related to neonatal intensive care of<br />
extremely preterm newborns, #25 weeks gestational age<br />
(GA) and at risk of disability are extensively debated; withholding<br />
intensive care is considered appropriate for<br />
newborns of GA ,23 weeks and of birth weight ,400 g<br />
(International Guidelines for Neonatal Resuscitation,<br />
Pediatrics 2000), but the importance of local and national<br />
guidelines is underlined. The Bioethical Committee of our<br />
Department promoted a multidisciplinary group to release<br />
guidelines to help the staff in charge of neonatal intensive<br />
care facing the medical and ethical problems related to an<br />
extremely premature birth. The group comprised nurses,<br />
physicians, ethicists and lawyers. The vitality limit, survival,<br />
outcome and the ethical and legal aspects were<br />
analysed according to the literature and the local context.<br />
As a result, a document was produced and distributed to all<br />
the health care professionals involved. Summary of guidelines:<br />
we suggest at 222 GA, defined by the anamnesis and<br />
the clinical evaluation of the neonate, to provide compassionate<br />
care only; 223 GA, in the presence of detectable<br />
vital signs, to practice immediate intubation, respiratory<br />
support and to revaluate neonatal conditions; from 24<br />
GA, to provide intubation, ventilatory support and cardiovascular<br />
resuscitation. If clinical and anamnestic GA are<br />
different, we proceed according to the best one. The importance<br />
of correct information to parents, and the role of<br />
compassionate care are outlined. An annual audit of guidelines<br />
is considered mandatory.<br />
FP-C-036<br />
Parasagittal cerebral lesions in full-term newborns<br />
F. Ciardo, E. Della Giustina, G. Cioni, M. Verdecchia, P.<br />
Curatolo<br />
Pediatric Neurology, Tor Vergata <strong>University</strong> of Rome,<br />
Rome, Italy<br />
Parasagittal cerebral injury (PCI) is a specific pathologic<br />
lesion of full-term newborns suffering from hypoxicischemic<br />
encephalopathy. PCI is characterized by necrosis<br />
of the cortex (most vulnerable in the term infant), and close<br />
subadjacent white-matter, especially in the parieto-occipital<br />
areas of the brain; neuronal elements are most severely<br />
affected. The injury is bilateral and although usually<br />
symmetrical, may be more striking in one hemisphere<br />
than the other. The spectrum of PCI is, however, wide,<br />
including frequent symmetric involvement of basal ganglia<br />
and thalami. Because of its unclear pathogenetic mechanism,<br />
we have studied the clinical and neuroradiological<br />
follow-up of four patients suffering from fetal distress, in<br />
whom MRI scans had clearly demonstrated in vivo the<br />
presence of parasagittal lesions due to perinatal hypoxicischemic<br />
insults. We noted that: (1) the pattern of injury<br />
seen on MRI seems to be related to the type and severity of<br />
the insult, and very strongly to the gestational age at which<br />
the insult occurred; (2) severe acute asphyxia is associated<br />
with lesions in the basal ganglia, thalami, brainstem, hippocampus<br />
and the corticospinal tracts around the central<br />
fissure; (3) the infants were affected by severe white<br />
matter, severe basal ganglia and thalamic injury, which<br />
may have been caused by a more severe perinatal insult<br />
occurring in combination with a chronic and repetitive<br />
insult that involves the white matter; and (4) in the absence<br />
of basal ganglia lesions, the motor outcome may be surprisingly<br />
good even with extensive white matter loss.
Abstracts 439<br />
FP-C-037<br />
Early intervention promotes intellectual development in<br />
asphyxiated newborn and premature infants<br />
X.-L. Bao, S.-Y. Sun, R.-J. Yu, J.-T. Sun, S.-Z. Wei<br />
Intervention of Asphyxiated Newborn and Premature<br />
Infants Cooperative Research Group Pediatric department,<br />
Peking Union Medical College Hospital, Chinese Academy<br />
of Medical Sciences, Beijing, China<br />
Objective: To evaluate the effect of early intervention on<br />
the intellectual development in asphyxiated newborn and<br />
premature infants. Methods: 119 cases of full term<br />
asphyxiated newborn infants (Apgar score ,6 at 5 min<br />
after birth) and 104 premature infants (gestational age ,37<br />
weeks) were randomly assigned to early intervention group<br />
and conventional care group. The normal control group<br />
consisted of same number infants. Sex, mother’s educational<br />
background; environmental condition and physical development<br />
were not significantly different in above groups. A total<br />
of 0–2 years early intervention program was compiled on<br />
basis of the national and foreign material about 1 month<br />
ahead of average development of the child. It included<br />
motor, cognitive, speech development and social behavior.<br />
Parents were instructed to carry out early intervention. At the<br />
age of 1.5 and 2 years. All infants received infant development<br />
tests (CDCC). The examiner did not know which infant<br />
had received intervention. Results: At the age of 1.5 years,<br />
average score of MDI in early intervention groups of<br />
asphyxiated and premature infants were 14.6 and 13.8 higher<br />
than that in conventional care groups respectively<br />
(P , 0:01). MDI score in early intervention group caught<br />
up with that in normal control group (P . 0:05). Conventional<br />
care group were 9.7 and 11.5 lower than normal control<br />
group, respectively (P , 0:01). There were 9 and 7.8%<br />
infants in conventional care group mentally retarded while<br />
none were mentally retarded in the early intervention group.<br />
Conclusions: The results showed that the early intervention<br />
could promote intellectual development of asphyxiated and<br />
premature infants and it may be beneficial to the prevention<br />
of mental retardation. Early and intensive intervention can<br />
produce better results. Bringing parent’s initiative into full<br />
play through deepening their understanding of the importance<br />
of early intervention is the key to success.<br />
FP-C-038<br />
Protective effect of ligustrazine on hypoxic-ischemic<br />
encephalopathy by NBNA<br />
R. Zhu, D.-D. Zhuo<br />
Zhong Lan Hospitol, WuHan <strong>University</strong>, WuHan, China<br />
Purpose: To observe the protective effect of ligustrazine<br />
on hypoxic-ischemic encephalopathy (HIE) by NBNA.<br />
Methods: Sixty cases of HIE were enrolled and divided<br />
randomly into two groups. The treatment course was 10<br />
days. The change score of NBNA 20 were observed before<br />
and after treatment. Thirty healthy cases were taken for<br />
control. Results: The score of NBNA 20 in the tested<br />
group was significantly (P , 0:01) higher than in the<br />
control group. Conclusion: Ligustrazine has protection on<br />
HIE, is a good Chinese drug for HIE in clinical practice.<br />
FP-C-039<br />
A study of the protective effect of magnesium sulfate on<br />
the brain injury of hypoxia and ischemia in newborns<br />
with birth asphyxia<br />
F.-L. Zhao, Y. Tang<br />
Department of Pediatrics, The Third Hospital of Beijing<br />
<strong>University</strong>, Beijing, China<br />
Objective: Perinatal cerebral hypoxia-ischemia remains a<br />
frequent cause of disablement and death of newborn. The<br />
aim of this study was to investigate the protective effect and<br />
security of magnesium sulfate on the brain injury of hypoxia<br />
and ischemia in newborn with birth asphyxia. Methods:<br />
Thirty-nine mature newborns with birth asphyxia were<br />
divided randomly into two groups: therapy and control.<br />
The first group received magnesium sulfate infusions<br />
comprising a loading dose of 200 mg/kg, followed by two<br />
doses of 125 mg/kg at 24 and 48 h later. The occurrence<br />
ratio of HIE, the difference of clinical index and the<br />
instances of side effect were compared between the 2 groups<br />
after the intervention. Results: (1) There was no significant<br />
difference in the occurrence ratio of hypoxic ischemic encephalopathy,<br />
EEG, CT and NBNA scores between the two<br />
groups (P . 0:05), whereas the ratio of serious encephalopathy<br />
in the therapy group was lower (P , 0:05). (2) No<br />
serious side effect was found in the therapy group. Conclusion:<br />
(1) Magnesium sulfate protected hypoxic-ischemic<br />
brain injury in the newborn with birth asphyxia to a certain<br />
extent. (2) The infusion doses were not associated with<br />
serious side effects.<br />
FP-C-040<br />
The relationship among umbilical cord serum<br />
interleukin-6, brain damage in the preterm newborn and<br />
the neurologic prognosis<br />
C.-X. Du, F.-L. Zhao<br />
Department of Pediatrics, Third Hospital of Peking <strong>University</strong>,<br />
Beijing, China<br />
Objective: Brain damage in the preterm newborn is a<br />
major risk of neonatal death and is often associated with a<br />
variety of neurologic deficits in survivors, including CP.<br />
Recently, the roles of maternal choriamnionitis and cytokine<br />
produced in response to maternal infection in the<br />
pathogenesis of preterm birth and neonatal brain damage<br />
have become a major focus of attention. The purpose of<br />
this study is to examine the relationship among neonatal
440<br />
Abstracts<br />
brain damage, maternal choriamnionitis and umbilical cord<br />
serum interleukin-6 (IL-6) concentration, to evaluate the<br />
clinical significance of examining umbilical cord serum<br />
IL-6 concentration, and to provide a new method for diagnosing<br />
of brain damage in the preterm neonate and preventing<br />
neurologic deficits. Methods: The objects of this study<br />
were 31 preterms. The procedure was: (1) the umbilical cord<br />
serum IL-6 concentration of neonates was detected by<br />
ELISA; (2) maternal choriamnionitis was determined by<br />
histologic examination; (3) brain damage was diagnosed<br />
by ultrasonography or CT in the first 3 days; and (4) following<br />
up the neurologic development of these preterms within<br />
3 years after their birth. Results: (1) Five preterms failed to<br />
be followed up, and the loss rate was 16%. The incidence of<br />
neurologic deficits was higher in preterms with brain<br />
damage than in those without brain damage; (2) the incidence<br />
of brain damage and the incidence of neurologic deficits<br />
were higher in preterms whose mothers had<br />
choriamnionitis than in those without maternal infection;<br />
(3) umbilical cord serum IL-6 concentrations of preterm<br />
newborns were higher in preterms with brain damage and<br />
those with neurologic deficits; (4) among the preterm<br />
neonates with brain damage, cord serum IL-6 levels were<br />
significantly higher in the presence of choriamnionitis than<br />
in the absence of choriamnionitis; and (5) using the results<br />
of brain imaging examination as the standard, a cord serum<br />
IL-6 level of $1.20 ng/ml was 80.0% sensitive and 75.0%<br />
specific for identification of the brain damage associated<br />
with maternal infection. Conclusions: These results show<br />
that maternal chorioamnionitis associates with an increased<br />
incidence of brain damage in preterm newborns. So it is<br />
very important to prevent and treat maternal intrauterine<br />
infection early in order to prevent the occurrence of brain<br />
damage in preterm neonates and decrease the risk of neurologic<br />
deficits like CP. IL-6 in umibilical cord serum might<br />
be the link between maternal infection and neonatal<br />
damage. These results provide a new practicable method<br />
for preventing and diagnosing of brain damage in preterm<br />
newborns and preventing of neurologic deficits. An increase<br />
in umbilical cord serum level is a good index for brain<br />
damage in preterm newborns. There is a clinical significance<br />
to examine IL-6 concentration in umbilical cord<br />
plasma of neonates.<br />
FP-C-041<br />
Long-term prognosis of convulsions in the newborn<br />
L. Wei, C.-X. Du<br />
The Third Hospital, Peking <strong>University</strong>, Beijing, China<br />
Objective: To evaluate long-term prognosis in neonates<br />
with convulsions and related factors. Methods: Fifty-six<br />
infants with convulsions were studied. All of them were<br />
subjected to systemic physical examination and intelligence<br />
test, and some of them underwent CT and EEG<br />
examinations. The relationship between prognosis, situation<br />
of perinatal stage and convulsions was analyzed.<br />
Results: CP developed in four infants, and five infants<br />
(including two infants with CP) suffered from epilepsy.<br />
Twelve infants had low IQ (three infants with CP and<br />
one infant with epilepsy). In all infants, 15 infants had<br />
nervous system sequelae. The rate of sequelae was 27%.<br />
Neonatal convulsions caused by hypoxic-ischemic encephalopathy<br />
were significantly different from those caused<br />
by other factors. Additionally, prognosis was highly correlated<br />
with convulsion styles, the number of seizure times<br />
and seizure duration. Conclusion: A high correlation exists<br />
between prognosis and etiology of neonatal convulsions.<br />
FP-D<br />
Neurodevelopmental Neurology<br />
FP-D-001<br />
Organising logopedic therapy for babies with unilateral<br />
or bilateral brain lesion in the pre-speech period<br />
V. Gec<br />
Centre for Hearing and Speech, Maribor, Slovenia<br />
Therapy was carried out in an experimental group of 30<br />
babies in the pre-speech period and suffering from perinatal<br />
unilateral or bilateral lesion at the age of 6–24 months.<br />
The control group comprised 60 babies. Therapy is made<br />
possible by early detection of factors of risk in the earliest<br />
period of the child’s life. Important are: (1) function of<br />
sucking, swallowing and later chewing in the course of<br />
the feeding therapy; and it is also important to (2) improve<br />
proprioceptive findings regarding speech musculature by<br />
means of passive-active motor exercises, to develop a<br />
correct breathing function and vocal activities. Simultaneously<br />
with the simulation of articulation, phonation,<br />
breathing in speech and phonematic hearing, attention<br />
should also be given to the stimulation of speech kinaesthetics,<br />
kinaesthetic observation and the kinaesthetic<br />
scheme of speech musculature. After intensive medical<br />
treatment, therapy is continued in the child’s home environment<br />
guided by a speech therapist, but carried out by the<br />
baby’s parents and surrounding. Based on existing knowledge<br />
and personal experience we examined the basic<br />
elements of logopedic diagnostics, therapy and stimulation,<br />
which were classified into categories and applied to individual<br />
patients, depending on their abilities. The data from<br />
the reports and responses in the logopedic dispensary were<br />
inserted into the protocol of the new-born at risk and the<br />
protocol I had formed to meet the demands of this study.<br />
Both protocols are related and include all the basic phases<br />
of logopedic diagnostics and the results of treatment to 24<br />
months of age. The protocols and the rest present a<br />
complete medical-logopedic treatment and development<br />
of the newborn at risk.
Abstracts 441<br />
FP-D-002<br />
An analysis of electroencephalographic characteristics<br />
in 68 young infants and children with cerebral palsy<br />
S.-M. Li, H.-C. Zheng, X.-G. Li<br />
HeBei Children Hospital, Shijiazhuang, China<br />
Objectives: To study the electroencephalographic characteristics<br />
in young infants and children with cerebral palsy.<br />
Methods: A total of 68 patients (45 boys, 23 girls) aged 4<br />
months–6 years (mean 1 year 5 months) with cerebral palsy<br />
was investigated. They all had clinical evaluation and routine<br />
electroencephalographic studies. Results: electroencephalographs<br />
are normal in 29 patients and abnormal in thirty-nine<br />
with an abnormality rate of 57.4%. In those with abnormal<br />
EEG findings 12 showed focal abnormality and 27 showed<br />
widespread abnormality. All focal abnormal electroencephalographsshowedfocalepileptiformdischarges.Inwidespread<br />
abnormal electroencephalographs, diffuse slow wave was<br />
noted in 12 patients (three of them associated with focal<br />
epileptiform discharges). Hypsarrhythmia was noted in ten<br />
patients (one of them associated with extreme spindles),<br />
with mental retardation in all. Depression of normal rhythms<br />
wasnotedinthreepatients,leapingoutofbackgroundrhythms<br />
and suppression burst of a rhythms was noted in two patients.<br />
The abnormality rate of electroencephalographs in patients<br />
with normal mental faculties is 29.4%. The rate of abnormal<br />
EEG in those with delayed mental function is 83.3%. Conclusions:<br />
The abnormality rate of electroencephalographs is high<br />
in patients with mental retardation. Electroencephalography<br />
might have an important role in the clinical predictions and<br />
provide more objective indexes for the evaluation of brain<br />
function in patients with cerebral palsy<br />
FP-D-003<br />
The etiologies analysis of 292 cerebral palsy children<br />
M.-L. Liu, W.-Y. Wang, J.-Y. Yan<br />
Department of Pediatrics, Affiliated Hospital of Medical<br />
College of Chinese People’s Armed Police Force; Center<br />
of Handicapped Children Recuperation, Tianjin, China<br />
We had analyzed the etiologies of 292 cases diagnosed<br />
cerebral palsy. Result: Among many pathogenic factors<br />
related to cerebral palsy, premature delivery and neonatal<br />
asphyxia was the most common. They accounted for about<br />
49.96% cases. Conclusion: To strengthen perinatal period<br />
care, prevent premature delivery and perinatal asphyxia was<br />
the key to decease occurrence of cerebral palsy.<br />
FP-D-004<br />
Cerebral palsy in 1–6 years old children in the Leshan<br />
area of Sichuan province: an epidemiological survey<br />
Y.-Q. Zhong, W. Ju, D.-Z. Peng<br />
Cheng Du Children Hospital, Cheng Du, China<br />
Objective: To describe the epidemiological features of<br />
childhood CP in Leshan area. Method: A cross-sectional<br />
survey on the prevalence of CP in 1–6 years old children<br />
was conducted using cluster sampling from eight Counties<br />
or Districts of Leshan area. Results: The survey was done<br />
among 148 723 children from the sampled locations and a<br />
CP prevalence of 2.07‰ was found. The results showed that<br />
among CP children there ware more male than female. There<br />
were also more premature and post-term infants than term<br />
infants, with the increased prevalence 22.21 and 5.4 times in<br />
the former than the later, respectively. The prevalence of CP<br />
in low birth weight infants was 16.32 times to that in normal<br />
birth weight infants. Twin infants suffered CP 4.2 times more<br />
frequently than single-born infants. Conclusion: CP prevalence<br />
in 1–6 years old children in Leshan area and the epidemiological<br />
features are comparable to those in advanced<br />
countries. Better recognition of and improvement in gestational<br />
and perinatal health care should be a critical way to<br />
reduce the occurrence of CP in children.<br />
FP-D-005<br />
The diagnosis and outcome of cerebral palsy: a clinical<br />
and neuroimaging study<br />
B.-N. Zhan<br />
Department of Pediatrics, Tongji Hospital, Tongji Medical<br />
<strong>University</strong>, Huazhong; <strong>University</strong> of Science and Technology,<br />
Wuhan, China<br />
Objective: To explore the etiology, methods of early diagnosis,<br />
and management of cerebral palsy. Method: clinical<br />
data analysis, EEG and neuroimaging study (CT, MRI).<br />
Results: Complete clinical data of 51 cases of cerebral palsy<br />
were analyzed. Among them 20 cases had birth asphyxia, 20<br />
cases were with positive history of maternal perinatal<br />
diseases, 12 cases were premature/low-birth-weight/smallfor-gestational<br />
infants. All 51 cases manifested different<br />
extent of mental retardation and neuromotor dysfunction in<br />
the follow-up, while the most common type of disability was<br />
spasticdiplegia (40cases, 78.4%).Neuroimaging study for all<br />
the cases (CT and/or MRI) revealed an 84.3% (43/51) of<br />
abnormality, with brain atrophy as the most frequent finding<br />
(34/51, 66.7%). A comprehensive management strategy was<br />
adopted in the clinic. Among the 16 cases with long-term<br />
follow-up, four (25%) had significant psychomotor improvement<br />
and 12 cases (75%) showed moderate improvement.<br />
FP-D-006<br />
Electrophysiological study of deep coma and its outcome<br />
in children<br />
Yutaka Tomita a , Sachiko Fukuda b<br />
a Department of Pathological Science and Technology,<br />
School of Health Science, Yoshihiro Maegaki; b Department<br />
of Pediatric Neurology, Faculty of Medicine, Tottori<br />
<strong>University</strong>, Yonago, Japan
442<br />
Abstracts<br />
One of the major clinical features of brain death is deep<br />
coma. Therefore, we conducted an electrophysiological<br />
study of 31 children who had suffered from deep coma in<br />
order to investigate its pathophysiological characteristics and<br />
outcome. The patient age at coma ranged from 1 month to 10<br />
years (mean 2 years 1 months). We compared results between<br />
fair and poor prognostic groups. Subsequently, lack of P14,<br />
N18 and N20, and amplitude reduction or vagueness of P13<br />
in short-latency SSEPs in these comatose children strongly<br />
suggested high risk in their future prognosis. SSEPs revealed<br />
findings for a deep coma condition more specific than ABR<br />
and blink reflex. In conclusion: SSEPs might be a very sensitive<br />
and specific examination for predicting the long-term<br />
prognosis of deep coma in children.<br />
FP-D-007<br />
Development of children born to drug-dependent<br />
mothers<br />
E. Berger a , Th. Elstner a , S. Fiala-Preinsperger a , B. Schuch b ,<br />
G. Fischer c , M. Weninger d , G. Langer e<br />
a Department for Neuropsychiatry of Children and Adolescents,<br />
Neurological Hospital Rosenhuegel, Vienna; b Clinic<br />
for Neuropsychiatry of Children and Adolescents, <strong>University</strong><br />
of Vienna; c Clinic for Psychiatry, Outpatient Dep. For<br />
Drug Abuser, <strong>University</strong> of Vienna; d Clinic for Paediatric<br />
and Adolescent Medicine, <strong>University</strong> of Vienna; e Clinic for<br />
Gynaecology and Obstetrics, <strong>University</strong> of Vienna, Austria<br />
Since 1995 we observed in a prospective longitudinal study<br />
thedevelopment of130children (between 6weeksand6years<br />
of age) of drug dependent mothers. We must take into account<br />
a combination of different risks: unspecific and drug-specific<br />
biological risk as the root of neurological risk and multiple<br />
psychosocial risks. We designed the follow-up in a biopsycho-social<br />
frame: The combination of comprehensive<br />
care with clinical evaluation – in a ‘network of helpers’<br />
(drug care, obstetric care, neonatologic care, developmental<br />
care and psychosocial care). We define the risk on different<br />
levels by the following test-battery: pre- and perinatal risk:<br />
drug levels in urine, dosis range of drug-substitute, intrauterine<br />
dystrophy, prematurity; postnatal risk: intensity(Finegan-<br />
Score) and duration of symptoms of detoxication; developmental<br />
parameters: neurological investigations (Prechtl,<br />
Beintema), general movements (Prechtl), sensorimotor and<br />
cognitive investigations (KABC-Scale), Parent Infant Global<br />
Assessment Scale (PIRGAS), Zero to three – diagnosis, child<br />
behavior problem lists (CBCL). Preliminary results: 95 children<br />
(born between march 1995 to November 1999) are<br />
included for evaluation. The biological risks (neurological<br />
development) are very low, if the drug substitution is correct;<br />
the risks are increasing by additional use of benzodiazepines<br />
and cocain. The psychosocial risks are increased: 35% of relationship<br />
disorders and 20% of psychopathological disorders<br />
in the first 3 years. Summarising we can say, that the approach<br />
of comprehensive care can minimise the developmental risks.<br />
FP-D-008<br />
Investigation on the pathogenic factors and clinical<br />
features of cerebral palsy in Shenzhen<br />
L. Chen, J.-X. Liao, B. Li, T.-S. Huang<br />
Epilepsy Center and Department of Pediatric Neurology,<br />
Shenzhen Children’s Hospital and Shenzhen Institute of<br />
Pediatrics, Shenzhen, China<br />
Objective: To explore the pathogenic factors and clinical<br />
features of CP in Shenzhen. Methods: To analyze retrospectively<br />
CP patients’ clinical data in the outpatients department<br />
of Shenzhen Children’s Hospital. Results: A total of<br />
110 cases were investigated. Thirty two had premature birth<br />
history, 44 had low birth weight (less than 3000 g) and 12<br />
had congenital brain malformations, and 15 had perinatal<br />
asphyxia history. Most patients with premature birth or low<br />
birth weight history developed spastic CP and had the cerebral<br />
periventricular leukomalacia tested by computerized<br />
scanning in neuropathology. Most patients with congenital<br />
malformations had small head circumference (range 39–<br />
44.5 cm, median 43 cm, n ¼ 9) and mental retardation.<br />
Conclusion: The common pathogenic factors of CP in<br />
Shenzhen are premature birth, low birth weight and congenital<br />
brain malformations. Asphyxia is now less important<br />
as a pathogenic factor than before. Periventricular leukomalacia<br />
is a common neuropathologic lesion.<br />
FP-D-009<br />
Pre-placement neurodevelopmental screening in<br />
international adoption: key to improved outcome<br />
G.W. Diamond a,b , Y. Senecky a , D. Inbar a,b , M. Nas c , H.J.<br />
Cohen b<br />
a Center for Child Development, Schneider Children’s Medical<br />
Center, Petah Tiqva, Israel; b CERC, Albert Einstein<br />
College of Medicine, Bronx, NY, USA; c Fundatie Prima<br />
Generatie, Bucuresti, Romania<br />
Background: Young, institutionalized children, adopted<br />
from abroad, constitute a high risk, special needs population.<br />
Those who underwent pre-adoption comprehensive<br />
medical and neurodevelopmental testing demonstrated<br />
improved adjustment to their new home environment and<br />
were treated earlier for identified medical and neurodevelopmental<br />
impairments. Objective: To determine the character<br />
and extent of medical and neurodevelopmental<br />
impairments most prevalent among a cohort of young children<br />
who were candidates for adoption in East European<br />
orphanages in order to provide improved treatment and<br />
support services for them and their adoptive families<br />
upon arrival in their new homes. Surveyed also were<br />
those disabilities militating against adoption of select children.<br />
Design: Sixty two East European children, age 3<br />
months–4.5 years (median age: 11 months) were screened<br />
by physicians while still in their original residential
Abstracts 443<br />
settings. Evaluations comprised examinations using standardized<br />
assessment tools, and laboratory analysis of<br />
blood samples, including genetic screening. Results:<br />
Eleven children (18%) were not placed in adoptive<br />
homes abroad due to significant medical illness or developmental<br />
delays. These included hepatitis B and C infection,<br />
MR, CP, and positive family psychiatric history.<br />
Parents reported greater satisfaction with the pre-adoption<br />
method of screening.<br />
FP-D-010<br />
Exploration study to find out increased risk of later<br />
developmental delay in neonates who received intensive<br />
care<br />
S. Usman, N. Somani, S. Raltani<br />
The Age Khan <strong>University</strong>, School of Nursing, Karachi, Pakistan<br />
Many of the health care institutions are equipped and<br />
staffed to provide high technical and quality care to the<br />
high-risk neonates to enhance their survival rate, but there<br />
are number of observed factors, i.e. prematurity, low birth<br />
weight, maternal related diseases and nutritional status to<br />
determine the quality of life of a neonate. The Main purpose<br />
of this study is to test the validity and reliability of the tool,<br />
Jerri and Richi (1993) in our setting, what risk of developmental<br />
delay is involved for neonates who receive intensive<br />
care in our Hospital. The data was collected retrospectively<br />
by convenient sampling. The inclusive criteria is based on<br />
neonate with weight ,1000 g, and gestational age more than<br />
34 weeks. Jerri and Richi (1993) used a screening tool to<br />
identify neonates at risk for cognitive, motor and physical<br />
development delay. The same tool was adopted in this study.<br />
The tool is comprises of seven variables. The variables are<br />
further divided to determine the degree of intensity that is<br />
assigned score. Neonates who score more than five are<br />
considered to be at a higher risk of developmental delay<br />
than others. In conclusion, the study did not show a significant<br />
result because of small sample size and selection of<br />
gestational age, i.e. .34 weeks. Based on the findings,<br />
recommendations are suggested to replicate the study on a<br />
larger sample size.<br />
FP-D-011<br />
Developmental coordination disorder in schoolchildren<br />
with extremely low birthweight<br />
H. Hara, T. Takamura<br />
The National Institute of Special Education, Kanagawa,<br />
Japan<br />
As a result of improving outcome of extremely low<br />
birthweight (ELBW; birthweight ,1000 g) infants, it<br />
becomes more important to evaluate their psychomotorbehavioral<br />
outcome up to school ages. In the cohort of<br />
100 ELBW children without severe neurological sequelae,<br />
we found out thirty-two, 25 boys and seven girls, diagnosed<br />
as having developmental coordination disorder<br />
(DCD) by age of 6. The motor development of 86 children<br />
out of the original cohort was assessed on Kobayashi-Frostig<br />
Movement Skills Test Battery (MSTB, 1989) at ages of<br />
6–7 and/or 8–9. Fine and gross motor skills of the DCD<br />
group were significantly inferior to those on the non-DCD<br />
group at both evaluation ages. Although the means of DCD<br />
group in all the MSTB scores were below the normal<br />
ranges, the improving rates between the first and second<br />
evaluations were approximated with those of non-DCD<br />
group. Interestingly, the gross motor scores of ELBW<br />
boys increased more steadily than those of ELBW girls<br />
from 6–7 to8–9 years old. Whereas MSTB scores of the<br />
ELBW girls marked higher than those of the boys, the<br />
differences became smaller at the second evaluation. A<br />
gender factor might affect gross motor development of<br />
the ELBW children during early school age.<br />
FP-D-012<br />
Psychological intervention in habilitation process with<br />
cerebral palsy preschool children<br />
E.S. Julia, M. Velichko, L. Zeldin, A. Bitova<br />
Russian Federation President’s Medical Center, Center for<br />
Curative Pedagogics, Moscow, Russia<br />
CP is the most common and severe neurological disability<br />
in children. Curative factors bordering pathogenic therapy<br />
and correction of neurological defect is still quite actual.<br />
Purpose: To check up the hypothesis of evolution of<br />
motor competence of CP patients in habilitation work<br />
process including sensory stimulation. Material and methods:<br />
We studied 12 children with different type of CP at the<br />
age of 16 months–6 years (I group) and control group of<br />
seven children with CP. Patients of 2nd group got standard<br />
treatment program and patients of 1st group got modified<br />
one. We pointed the level of motor disabilities (1–5 level of<br />
disability) and investigated not only motor disorders but<br />
also sensorial, social, cognitive, perceptual ones as well as<br />
to get more insight in the developmental evolution of the<br />
behavioural phenotype and analysed relations of ‘therapistpatient’<br />
during habilitation process. The follow-up period<br />
was 2 years. Results: As we got disappointed of the existing<br />
relations ‘patient-therapist’ where the patient with CP<br />
played predominantly passive role. The ‘model of action’<br />
was desired and it allows the patient plays the role of<br />
precosiour of motor competence improvement (I group-<br />
66%, II group-43%). Conclusion: We carry out the analysis<br />
of system of the relations ‘patient-therapist’ which shows<br />
the vertical interaction was the dominant form and patient<br />
had passive role. We suggest adding methods of sensorial<br />
stimulation into standard treatment program of CP<br />
preschool children so it is the essential and necessary part<br />
of it.
444<br />
Abstracts<br />
FP-D-013<br />
Intellectual development of premature infants and<br />
effects of early interventions<br />
L.-F. Liao, R.-Y. Huang, C.-W. Yang<br />
The First People’s Hospital of Shunde, Daliang Town,<br />
Shunde City, Guangdong, China<br />
Purposes: To compare intellectual developmental status<br />
between natural delivery and abnormal delivery premature<br />
infants. To study the effect of early interventions on promoting<br />
their intellectual development. Objectives and methods:<br />
One hundred twenty infants, including 54 natural delivery<br />
premature, 39 abnormal delivery premature (terminate gravidity<br />
artificially), 37 normal full term infants, with average<br />
gestation age of 35.3, 35.9 and 40.0 weeks, respectively, were<br />
assigned randomly into intervention or control group. The<br />
intervention group received early intellectual interventions<br />
beginning from newborn period. All parents of these infants<br />
joined regular routine children health care instruction course<br />
at outpatient clinic. Using Gasell infants diagnosis measuring<br />
scale to check intellectual DQ regularly, five observing<br />
indexes are included: gross motor, fine motor, cognitive,<br />
communication and language, social ability. Results:<br />
Among all six factors of infants’ basic situation (monthly<br />
age, body weight at born, mother’s age when giving birth,<br />
gestational complications, type of delivery, complications of<br />
new-born infants), only infants’ monthly age has influence on<br />
their intellectual development. After adjusting monthly age,<br />
premature delivery seems to influence gross motor and<br />
cognitive ability only (that means lower scores of these two<br />
factors in premature infants) but not influence other indexes.<br />
Early interventions strongly influence all five intellectual<br />
indexes. The intervention group got remarkably higher<br />
scores on all indexes than the control group. Conclusions:<br />
Early interventions promoted intellectual development of<br />
premature infants. It was plausible to promote infant’s intellectual<br />
development on their gross motor and cognitive ability<br />
effectively through training.<br />
FP-D-014<br />
A study about the effects of external hydrocephalus on<br />
neurological and psychomotor development in infants<br />
J.-N. Mai<br />
Neurological and Rehabilitating department, Guangzhou<br />
Children’s Hospital, Guangzhou, China<br />
Objective: To study the effects of external hydrocephalus<br />
(EH) on neurological and psychomotor development of<br />
infants. Methods: Four hundred and twenty-two infants<br />
with EH were assessed with head CT scan and divided into<br />
three groups based on the width of the subarachnoid space<br />
(mild, moderate and severe groups). All infants were<br />
assessed with Gesell development scale, TCD, BAEP and<br />
EEG at age of 4, 8, 18 and 24 months. Results: Two hundred<br />
and sixty-five were in mild group; 119 were in moderate<br />
group and 38 were in severe group. One hundred and<br />
twenty-six Infants (47.5%) in mild group appeared slight<br />
abnormal neuropsychological behaviors within 6 months<br />
age periods, transient motor delay within 12 months age<br />
periods; EEG and TCD were normal and enlargement of E<br />
space disappeared over 24 or 30 months age; 57 infants<br />
(21.5%) appeared 1–2 episodes of convulsion with fever<br />
during 10–24 months age and 15 infants (5.6%) were diagnosed<br />
as seizure. At age of 8 months age, 43 infants (36.1%)<br />
in moderate group had abnormal EEG and in TCD, 86<br />
(72.2%) showed abnormal blood flows in cerebral posterior<br />
or/and middle arteries; and 29 infants (76.3%) in severe<br />
group had abnormal EEG and twenty-one (55.2%) showed<br />
abnormal TCD. Among 157 infants in moderate group and in<br />
severe group, 143 infants (91.0%) had motor delay; at 2 years<br />
age 56 infants (35.6%) had motor dyscoordination with some<br />
neurological soft signs, 46 infants (29.2%) diagnosed as CP;<br />
35 infants had (22.2%) speech problems; only 15 infants<br />
(9.5%) encountered convulsion and five (0.02%) were diagnosed<br />
as seizure. Conclusion: Infant in mild group had transient<br />
effects on infants in motor and neuro-psychological<br />
behaviors. Moderate and severe groups had significant<br />
effects in motor functions and neuro-psychological behaviors<br />
which are some functions of frontal lobes. But long<br />
term effects needs further follow-up.<br />
FP-D-015<br />
1:2 case-control study of risk factors for childhood<br />
cerebral palsy<br />
X.-J. Zhou, Z.-Y. Zhao, Q.-X. Shui, K. Chen, K.-H. Zheng<br />
The Children’s Hospital, Zhejiang <strong>University</strong> School of<br />
Medicine, Hang Zhou, China<br />
Objective: To investigate the possible risk factors for CP in<br />
children. Methods: A population-based 1–2 case-control<br />
study was performed within 66 townships of 15 cities or<br />
counties in Zhejiang Province, from October to November<br />
1998. Results: Statistically significant variables associated<br />
with an increased risk for childhood CP were neonatal<br />
diseases, maternal diseases, low birth weight, maternal irregular<br />
menstruation, receiving toxic substances in pregnancy,<br />
malnutrition in pregnancy, paternal ages. It was highly<br />
significant that mothers perinatal health care was a protective<br />
factor for CP in children. Conclusions: The prevention and<br />
elimination of the possible risk factors for CP might be<br />
expected to reduce the morbidity of CP.<br />
FP-D-016<br />
Neuromental development of term non-asphyxiatd small<br />
for gestational age (SGA) children at the age of four<br />
I. Prpić, I. Vlašić-Cicvarić, E. Paučić-Kirinčić, D. Fiket<br />
<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia
Abstracts 445<br />
The aim of the study was to establish whether the intrauterine<br />
growth retardation (IUGR) has direct effect on<br />
neuromental development in children at age of 4. Term<br />
(38–42 weeks of gestation) small for gestational age children<br />
(SGA) without any detectable risk factors for IUGR<br />
were analysed at the age of four. SGA infants were defined<br />
by birth weight less than 10 percentile considering gestational<br />
age, sex and mother parity, using normative data<br />
from proper population. Control group was appropriate<br />
for gestational age infants, without any risk factors for<br />
altered neuromental development. Retrospectively<br />
collected data were compared by parent’s statement, moreover,<br />
all parents filled specially prepared questionnaire to<br />
avoid possible socio-economic influence on child’s neurodevelopment.<br />
There were 40 SGA children and 20 children<br />
in control group which exams and tests were compared<br />
using standard statistical methods. At the age of four of<br />
SGA children still had statistically significant lower height<br />
and weight than control group children, as it was at the<br />
newborn period. There were no statistically significant<br />
differences in other (sex, age, socio-economic environment)<br />
parameters. All children had normal neurological<br />
exam. Psychological tests of showed adequate neuromental<br />
development of SGA children, but statistically significantly<br />
lower than control group children. These results proved<br />
that SGA children have delayed neuromental development<br />
comparing with their mates, which is a direct consequence<br />
of IUGR. SGA infants need long term neuropsychological<br />
follow up and advising. Further researches needed to determine<br />
pathophysiological mechanism of delayed/decreased<br />
CNS maturation caused by IUGR.<br />
FP-D-017<br />
The etiologic spectrum of cerebral palsy: a<br />
contemporary perspective<br />
M.I. Shevell, A. Majnemer, I. Morin<br />
Montreal Children’s Hospital, McGill <strong>University</strong>,<br />
Montreal, Canada<br />
Objective: CP is an established symptom complex which<br />
results from heterogeneous etiologies. Our understanding<br />
of the relative contribution of etiologies to the occurrence<br />
of CP is largely derived from studies lacking systematic<br />
neurological evaluation or the application of contemporary<br />
imaging modalities. Methods: Over a 10 years inclusive<br />
period, the case records of all consecutive patients diagnosed<br />
with CP in a single pediatric neurology practice were<br />
reviewed with reference to clinical features and etiologic<br />
determination. Results: A total of 217 cases of CP were<br />
identified (129 male, 88 female) – 77 (35.5%) spastic quadriplegic<br />
(Q), 68 (31.3%) spastic hemiplegic (H), 39 (18%)<br />
spastic diplegic (D), 5 (2.7%) spastic monoplegic (M), 12<br />
(5.5%) mixed (Mx), 12 (5.5%) ataxic-hypotonic (AH), 2<br />
(0.9%) dyskinetic (Dk), 2 (0.9%) Worster-Drought<br />
syndrome (WD). Overall etiologic yield was 82.0% varying<br />
according to type of CP; 50% Dk, 59% D, 80% M,<br />
80.9% H, 90.9% Q, 91.7% AH and 100% Mx/WD. As an<br />
identified cause, the top five etiologic entities identified<br />
were: periventricular leukomalacia 24.9%, intrapartum<br />
asphyxia 21.7%, cerebral dysgenesis 17.1%, intracranial<br />
hemorrhage 12.9%, vascular 9.7%. While a single etiology<br />
was apparent in 144 (66.4%) of the cases, multiple etiologies<br />
were felt to be contributory in 34 (15.6%) of the cases.<br />
The etiologic profile varied according to such features as<br />
the type of CP, gestational age and the source (high risk<br />
neonatal population or not) of the patients. Features of the<br />
child’s CP such as microcephaly, neonatal difficulties, prior<br />
or co-existing epilepsy and high-risk source were found to<br />
be predictive of eventual etiologic yield. Conclusion: This<br />
contemporary evaluation of CP etiologic yield suggests<br />
that it is much higher than previously reported and varies<br />
depending on key clinical features suggesting strategies for<br />
prevention, identification and treatment of this symptom<br />
complex.<br />
FP-D-018<br />
Predictors of developmental disability following openheart<br />
surgery in infants with congenital heart defects<br />
A. Majnemer, C. Limperopoulos, M.I. Shevell, C. Rohlicek,<br />
B. Rosenblatt, C. Tchervenkov, H.Z. Darwish<br />
Montreal Children’s Hospital, McGill <strong>University</strong>,<br />
Montreal, Canada<br />
Objective: Neurodevelopmental disabilities are increasingly<br />
reported in infants with congenital heart defects<br />
requiring open-heart surgery. This study describes the<br />
prevalence of persistent developmental impairments 1<br />
year following surgical correction, and identifies risk<br />
factors. Methods: In this prospective study, 131 infants<br />
were recruited and assessed in a blind fashion preoperatively,<br />
following surgery before discharge, and 12–18<br />
months later using standardized developmental assessments<br />
and neurological examination. Results: At a mean<br />
age of 19.1 ^ 6.6 months, 41% had abnormal neurologic<br />
examinations. Motor delays were noted in 42%, and 23%<br />
had global developmental concerns. Using the WeeFIM<br />
measure, moderate disability in functional activities was<br />
documented in 37% but only 6% were severely disabled.<br />
Socialization and daily living skills were delayed in .40%.<br />
Factors enhancing risk for long-term developmental<br />
disabilities included: pre and postoperative neurodevelopmental<br />
status, microcephaly, type of heart lesion, length of<br />
circulatory arrest time, age at surgery, and days in the ICU<br />
(univariate and multiple regression analyses: P , 0:05).<br />
Conclusion: Although severe deficits are rare, ongoing<br />
mild to moderate developmental disabilities are common<br />
in infants undergoing open-heart surgery. Risk factors<br />
suggest that etiology is likely multifactorial and includes<br />
brain injury prior to, during and following surgical correction<br />
of the defect.
446<br />
Abstracts<br />
FP-D-019<br />
How early is it possible to predict cerebral palsy and to<br />
differentiate between the spastic and the dyskinetic<br />
forms?<br />
C. Einspieler a , G. Cioni b , A.F. Bos c , F. Ferrari d , H.F.R.<br />
Prechtl a<br />
a Department Physiology, Graz <strong>University</strong>, Graz, Austria;<br />
b Division of Child Neurology and Psychiatry, <strong>University</strong><br />
and Stella Maris Scientific Institute, Pisa, Italy; c Department<br />
of Paediatrics, Division of Neonatology, Groningen<br />
<strong>University</strong>, Groningen, The Netherlands; d Department of<br />
Obstetrical, Gynaecological and Paediatric Sciences, Division<br />
of Neonatology, Modena <strong>University</strong>, Modena, Italy<br />
The fetus and young infant are characterised by a repertoire<br />
of distinct spontaneous movement patterns. One set of<br />
these patterns is the GMs. They emerge at 10 weeks postmenstrual<br />
age and continue in a similar pattern until the end<br />
of the 2nd month post term. Around this time GMs change<br />
into the fidgety pattern. From 3 to about 5 months these<br />
fidgety movements (FMs) are present in normal awake<br />
infants. They are circular movements of small amplitude,<br />
moderate speed, and variable acceleration of neck, trunk,<br />
and limbs in all directions. A number of studies demonstrated<br />
that any impairment of the young nervous system<br />
changes the GM quality. Applying the GM assessment longitudinally<br />
in 259 infants revealed that two age-specific GM<br />
abnormalities reliably predict spastic CP: (a) crampedsynchronised<br />
GMs (all limb and trunk muscles contract<br />
and relax almost simultaneously and GMs appear to be<br />
rigid). If this pattern exists over several weeks during<br />
preterm and term age, spastic CP will develop at later age;<br />
(b) and the absence of FMs. In addition, the absence of FMs<br />
is also predictive for dyskinetic CP. In contrast to spastic<br />
cases, later dyskinetic cases have ‘arm movements in<br />
circles’, finger spreading, and a lack of limb movements<br />
towards the midline. By qualitative assessment of GMs<br />
and concurrent movements we early identified infants at<br />
high risk for spastic or dyskinetic CP, which is of significant<br />
clinical relevance because the two types of cerebral palsy<br />
ask for different management and early intervention.<br />
FP-D-020<br />
The neonatal and early developmental outcome of very<br />
low birth weight infants ventilated at a private hospital<br />
in South Africa<br />
B. Laughton, A. Crafford, R. Alexander, G.F. Kirsten, P.D.<br />
Muller, J. Smith<br />
Tygerberg Children’s Hospital, Tygerberg, Western Cape,<br />
South Africa<br />
Introduction: The only documented outcome for VLBW<br />
infants in South Africa are for those born at tertiary state<br />
hospitals. Private hospitals have better resources, and we<br />
need accurate information on the outcome of infants managed<br />
at these institutions. Objectives: To determine the<br />
morbidity, mortality and developmental outcome of<br />
VLBW infants admitted to the Panorama NICU. Patients<br />
and methods: 99 VLBW infants admitted between 1 January<br />
1999 and 31 December 2000 were followed prospectively.<br />
The infants were followed up at 4.5, 8, 12 and 18 months by<br />
a paediatrician and a physiotherapist. Development was<br />
assessed on the Molteno Scale (before 24 months corrected<br />
age) and the Griffiths Scales at 24 months corrected age.<br />
Results: (Table 2). Conclusion: The mortality rate (9%), and<br />
early motor developmental and cognitive outcome is similar<br />
to that reported for VLBW and extremely low birth weight<br />
infants managed in first world countries. The prevalence of<br />
ROP and IVH is significantly lower.<br />
FP-D-021<br />
The neurodevelopmental outcome at 6 years of infants<br />
,1250 g electively not admitted to the neonatal intensive<br />
care unit<br />
J.I. van Zyl, G.F. Kirsten<br />
Tygerberg Children’s Hospital, <strong>University</strong> of Stellenbosch,<br />
Tygerberg Hospital, Tygerberg, Western Cape, South Africa<br />
Introduction: Infants with birth weights ,1250 g are<br />
selectively admitted to intensive care because of limited<br />
resources. Objective: To compare the neurodevelopmental<br />
and cognitive outcome at 6 years of age of infants ,1250 g<br />
Table 2<br />
Birth weight and no. (%) , 1000 g (40) 1000–1499 g (59)<br />
Mean gestational age (weeks) 7.2 (r: 25–32) a 29.4 (r: 26–36)<br />
Mean birth weight (g) 814.1 (r: 480–880) 1229.0 (r: 1000–1480)<br />
IVH grades 3 and 4 (%) 3 (8) 3 (5)<br />
Survival – total (%) 33 (83) 57 (97)<br />
ROP grades 3 and 4 (%) 2 (6) b 0<br />
Patients followed up (%) 28 (84) 43 (75)<br />
Definite CP (%) 3 (11) 3 (7)<br />
DQ .80 (%) c 24 (86) 43 (100)<br />
a<br />
b<br />
c<br />
r ¼ range.<br />
None blind.<br />
DQ ¼ developmental quotient.
Abstracts 447<br />
who received neonatal intensive care during the first 48 h of<br />
life (NICU group) to those who received high care (neonatal<br />
ward, NW group). Methods: 178 infants were admitted of<br />
whom 60.4% (NW group) and 80.5% (NICU group) survived<br />
(P ¼ 0:0004). Disability was defined as CP, sensori-neural<br />
(SN) deafness and a general developmental quotient (GDQ)<br />
,80. Results: At 6 years of age 20% were disabled; [NW<br />
group 12% versus NICU group 27%, P ¼ 0:08]. The NW<br />
group had significantly less physical disability (CP and SN<br />
deafness) than the NICU group [5 versus 18% P ¼ 0:047].<br />
The mean GDQ of the Griffiths Mental Developmental<br />
Scales did not differ between the NW and NICU groups<br />
while the locomotor subscale quotient was significantly<br />
higher in the NW group [NW: 107.5 NICU: 93.9,<br />
P ¼ 0:007]. The NW group had significantly less children<br />
with a total impairment score #15%. Movement ABC Test,<br />
only physically normal children tested than the NICU group<br />
[NW: 25%, NICU 50%, P ¼ 0:021]. Conclusions: Elective<br />
refusal to the NICU resulted in a higher mortality rate, but did<br />
not impact on the cognitive outcome. NICU admission<br />
however did result in more physical disabilities and worse<br />
scores for the physically normal children on the Movement<br />
ABC Test. The reason is probably multifactorial and could<br />
include compromise on admission and postnatal complications<br />
of ventilation.<br />
FP-D-022<br />
Observation on pre- and postnatal maternal use of<br />
sertraline, causing transient floppy infant syndrome<br />
I. Sos<br />
Department of Developmental Neurology and Neurohabilitation<br />
Pediatric Institute ‘Svábhegy’, Budapest, Hungary<br />
The SSRI treatment of some psychiatric diseases spread<br />
worldwide, because of its effectiveness and few adverse<br />
effects. By former opinions there is not known side effects<br />
of the treatment of the pregnant or nursing women on the<br />
fetuses, and on the breast fed infants. Our patient’s mother<br />
had used sertraline 50 mg/day from the second trimester of<br />
her pregnancy. The pregnancy and labour was uneventful,<br />
but the neonate was floppy infant. This clinical picture<br />
persisted until the sertraline uptake stopped. Some weeks<br />
later the baby was symptom free. We shortly discuss the<br />
possible adverse effects of the early serotoninerg excess<br />
on the developing human brain.<br />
FP-D-023<br />
Elementary sensorimotor functions in clinical practice<br />
F. Katona, M. Berenyi<br />
Department of Developmental Neurology Pediatric Institute<br />
‘Svabhegy’, Budapest, Hungary<br />
Stimulation of the striopallidal system through vestibular<br />
and reticular channels triggers a series of complex automatically<br />
repeated continuous movements. These are: unsupported<br />
sitting up and sitting in the air, unsupported crawldown<br />
and semi supported crawl-up on a slide, supported<br />
rotation, assisted creep and walk, and others. Activation of<br />
these complex movements can be achieved in neonates from<br />
the 27th–30th weeks of gestation, even in seemingly hypotonic<br />
prematures, and in infants during the first two trimesters.<br />
Elementary sitting, crawling, walking imitate later<br />
human-specific movements and are most likely their ontogenetic<br />
precursors and these elementary activities depend upon<br />
the integrity of the basal ganglia. Authors present evidence<br />
by examinations of various anencephalus neonates. In an<br />
anencephalic neonate whose brain developed up to the rostral<br />
part of the pons all primitive reflexes are present, but none of<br />
the complex elementary functions are elicitable. Examination<br />
of elementary forms of sitting, crawling, walking, rotation<br />
in several weeks old infants offers the possibility to<br />
reveal differences in muscular activity, tonus and coordination<br />
during active movements. Authors illustrate the application<br />
of elementary sensorimotor poly-electromyography<br />
(EMG) activities to diagnose young infants, also applying<br />
videotape, and computerised motor analysis. Evaluation of<br />
sensibility-specificity relation is presented by statistics of<br />
2000 brain injured infants compared to normal control<br />
groups.<br />
FP-D-024<br />
Symptomatic epilepsy in brain injured young infants<br />
M. Berenyi, F. Katona, E. Gisztl, I. Sos<br />
Department of Developmental Neurology, Pediatric Institute<br />
‘Svabhegy’, Budapest, Hungary<br />
Out of 2000 brain injured infants 450 produced symptomatic<br />
epilepsy. From this 450 the number of continuous<br />
epileptic activity from birth was 60 and the other 390<br />
presented their first convulsions with positive EEG<br />
between 4 and 8 months of life. In 300 cases the foci of<br />
the convulsive activity change not only from one hemispherical<br />
lobe to another (178 cases) but from one hemisphere<br />
to the other (36 cases). In 230 cases West type<br />
epilepsy was detected, among them 170 with unspecified<br />
movements during convulsions, nevertheless with classic<br />
EEG signs. In 150 cases the development of epilepsy<br />
was followed up from the first signs of sharp waves to<br />
wave depression and finally to hypsarhythmia. All infants<br />
received in our service regular anticonvulsive therapy<br />
(carbamazepine, vigabatrin, ACTH, etc.). Summary: (1)<br />
Occurrence of symptomatic epilepsy in brain injured<br />
infants is a warning sign predicting serious outcome in<br />
sensorimotor and cognitive development despite any<br />
improvement reached by early neurotherapy. (2) In the<br />
majority of cases abnormal precognitive development<br />
preceded the onset of epilepsy and is not a consequence<br />
of epileptic fits. (3) Serial video-EEG and/or polygraphy<br />
are necessary to follow changes in the nature and location<br />
of bioelectric activity in the injured developing brain.
448<br />
Abstracts<br />
FP-D-025<br />
Effect of cerebrolysin and simple training method at<br />
home on children with cerebral palsy<br />
J.-L. Tang, D. Wu<br />
Pediatric department, The first hospital affiliated to Anhui<br />
medical university, Hefei City, China<br />
The purpose of this study was to find a better and<br />
cheaper way to cure children with cerebral palsy. There<br />
are 266 cases of children with cerebral palsy from 3<br />
months to 10 years old. They were divided into four<br />
groups: cerebrolysin group, simple training method<br />
(STM, which designed by ourselves) group, cerebrolysin<br />
plus STM group and control group which were follow-up<br />
in 5 years. Cerebrolysin was transfused through vein to the<br />
patients, 5 ml/day for no more than 1-year-old children, 10<br />
ml/day for kids older than 1-year-old children. We define 3<br />
months as period of treatment. At the same time we regularly<br />
hold short courses of STM method for the children<br />
with Cerebral palsy and their parents from October 1992.<br />
Children with cerebral palsy and their parents attended to<br />
the course. Some simply training methods of STM method<br />
were introduced to the parents-home conductors, and then<br />
the parents began to train the CP children at home. The<br />
results show that STM plus cerebrolysin is most effective<br />
in all groups (P , 0:01). Both cerebrolysin group and STM<br />
group have show more effective than control groups<br />
(P , 0:01): but the cerebrolysin group is more effective<br />
than STM groups in young children group (age ,3 years<br />
old) and they have no difference in old children group (age<br />
3 years old).<br />
FP-D-026<br />
Case-control study on 89 cases of childhood cerebral<br />
palsy<br />
Q.-X. Shui, X.-J. Zhou, Z.-Y. Zhao<br />
The Children’s Hospital, Zhejiang <strong>University</strong> School of<br />
Medicine, Hang Zhou, China<br />
Objective: To investigate the early identification of CP<br />
in children. Methods: One to two case-control study and an<br />
analysis on the symptoms and signs of 89 children with CP<br />
were done. Results: There were 69 (77.6%) cases with<br />
spasticity type, 11 (12.4%) cases with hypotonia type, 5<br />
(5.6%) cases with the mixed type, 2 (2.2%) cases with<br />
athetosis type, and 2 (2.2%) cases with ataxia type. And<br />
there were 74 (83.1%) children with mental retardation, 20<br />
(23.3%) children with psychological behavior disorders<br />
and 13 (14.8%) children with epilepsy. The high-risk<br />
factors included neonatal diseases, maternal malnutrition,<br />
low birth weight, maternal irregular menstruation, older<br />
father, absence of perinatal health-monitoring, and contacting<br />
toxic substances in pregnancy. Conclusion: The four<br />
main points for earlier identification of CP included<br />
detailed medical history, understanding the normal motor<br />
development of infants, grasping four characteristic manifestation<br />
of abnormal motor of CP, and selective accessory<br />
examinations.<br />
FP-D-027<br />
Morbus Little can be successfully treated – case report<br />
K. Boskovic a , N. Naumovic b , D. Filipovic b , S. Tomasevic a ,<br />
N. Mesanovic a<br />
a Clinical Center Novi Sad, Medical Rehabilitation Clinic;<br />
b <strong>University</strong> of Novi Sad, Medical Faculty, Department of<br />
Physiology, Novi Sad, Yugoslavia<br />
The Morbus Little (ML) or spastic infantile diplegia is<br />
very frequent form of children’s cerebral palsy. Treatment<br />
of that disease has multidisciplinary approach and rehabilitation<br />
team with many members. The aim of this article<br />
was case report of one patient with ML whose result of<br />
treatment was very successful. The patient MM, female,<br />
was born in 1974 year with 32-gestation week’s, 1300-mg<br />
weight and with signs of cerebral hemorrhage. During 1st<br />
year of life motor deterioration, without mental backwardness<br />
was noticed. The diagnosis of ML was established.<br />
Immediately the kinesitherapy for management of muscle<br />
spastics was used and also further stimulation of basic<br />
forms of sitting, standing and walking. But strong spastic<br />
changes of plantar flexor muscles of the foot and knee<br />
flexor and adductor muscles independent walk made<br />
impossible. When patient was 4 years old, the surgical<br />
lengthening of Achilles tendon and adductor tendons was<br />
made. By operation the ‘scissors’ walk was moderated. The<br />
further aim of treatment was independent walk, which is<br />
realized in the patient’s age of 6 years. The walks was<br />
spastically paraparetic, with massive mobilization of<br />
whole body and with rely on interior part of the foot.<br />
Despite to the continuous treatment, in age of 10 years,<br />
patient has second surgery with lengthening knee flexor<br />
and also adductor muscles. The rehabilitation treatment<br />
was applied further with different physical procedures<br />
(hydro-, heating-, exercise- therapy) usage. Because of<br />
very late start of standing and walking patient’s articulations<br />
development was insufficient, and arthritic changes of<br />
the hips appeared in age of 16 years. Until now patient was<br />
under rehabilitation treatment with the aim of the muscle<br />
strengthening, preservation of the articulation motion and<br />
improving of all kind of balance. The result of this long<br />
and difficult treatment is person of 27 years, graduated<br />
psychologist, completely independent in activities of<br />
daily living. So, we can conclude that ML is very difficult<br />
and complex disease which demands continuous, persistent<br />
and multidisciplinary therapy with active participation of<br />
patient, its family and wide social community, but it can be<br />
treated successfully.
Abstracts 449<br />
FP-D-028<br />
Combined conductive education and therapeutics of<br />
neurophysiology to improve and evaluate the motor<br />
function in children with cerebral palsy<br />
C.-M. Zhao, Y.-P. Zhang, W. Liao, Y.-P. Ai, M. Xi, L. Yao<br />
The Pediatrics, The Xinqiao Hospital, Third Military Medical<br />
<strong>University</strong>, Chongqing, China<br />
Objective: To observe combined conductive education<br />
and neurophysiology therapies in the improvement of the<br />
gross motor function in CP patients. Methods: Group one in<br />
23 cases of CP children treated with conductive education<br />
and therapeutics of neurophysiology and group two in 25<br />
cases of CP children treated only with Bobath and Vojta<br />
processes all of cases are 1–3 years old. Results: The results<br />
showed that the improvement of patients’ motor function<br />
can be seen in both groups (P , 0:01). The function<br />
improvement in group one after treatment is much better<br />
than group two (P , 0:05). Conclusion: The results show<br />
that the combined conductive education with therapeutics of<br />
neurophysiology in the improvement of the gross motor<br />
function in CP patients is better than Bobath and Vojta<br />
processes.<br />
FP-D-029<br />
Some new approaches to an estimation of a functional<br />
condition of a spinal cord at children with cerebral palsy<br />
syndrome<br />
T.E. Cimbal, A.G. Remnev<br />
Altai Diagnostic Center, Barnaul, Russia<br />
We observed 53 children with an age between 7 and 15<br />
years with cerebral palsy syndrome (CPS). All patients were<br />
divided into two groups: 24 patients with clinical attributes<br />
bottom spastic paraplegia (first group) and 29 patients with<br />
clinical attributes spastic hemiplegia (second group). We<br />
studied a functional condition of the pyramidal ways<br />
(PW) at magnetic stimulation (MS) of cerebrum cortex<br />
and lumbar region of spinal cord and afferent ways of spinal<br />
cord at MS of cervical and lumbar departments of spinal<br />
cord. We used Magstim-200 (Magstim, UK) and Sapphire<br />
2M (Medelec, UK). As a result of research the attributes of<br />
infringement of realization of excitation on PW at 20<br />
patients of the first group (mainly bilateral changes) and<br />
12 patients of the second group (at seven patients bilateral<br />
changes) as increase of time of the central realization till<br />
21–36 ms were registered. At research of a functional condition<br />
AWSC at 22 patients of the first group and 20 patients<br />
of the second group we have registered decrease of speed of<br />
distribution of excitation on AWSC till 34–49 m/s. Thus,<br />
through a method MS the definition of a defeat of various<br />
conducting ways of a back brain is possible. At the patients<br />
with clinical attributes spastic hemiplegia the attributes of a<br />
defeat of the ‘healthy’ party were registered. It means, that<br />
the functional changes not always correspond clinical.<br />
FP-D-030<br />
The study of Chinese children’s vocabulary development<br />
W.-L. Liang a , B. Hao a , S. Wang a , Y.-Q. Jiang a , Z.-X.<br />
Zhang a , Q.-H. Zuo a , T. Tardif b , P. Fletcher c<br />
a Peking <strong>University</strong> Fist Hospital, Beijing, China; b <strong>University</strong><br />
of Michigan, Ann Arbor, MI, USA; c <strong>University</strong> of Hong<br />
Kong, Hong Kong, China<br />
Objective: To conduct a norm study of Chinese communicative<br />
development inventory (CCDI) and to study<br />
Chinese children’s vocabulary development. Method:<br />
Using CCDI – Putonghua version), Parents of 1056 toddlers<br />
were asked to report their children’s language abilities.<br />
Results: Sixteen-month-old children can say an average of<br />
79 words appearing on the CCDI, including 38 nouns and 21<br />
verbs. By 30 months, children can say an average of 709<br />
words on the CCDI, including 334 nouns and 117 verbs. The<br />
speed with which children acquire nouns and verbs is similar.<br />
After 19 months of age, children also began to use<br />
classifiers question words and pronouns. For most types of<br />
the words, the mean production scores tended to be higher<br />
for females than for males of the same age. Conclusions:<br />
From 16 to 30 months, the development of the children’s<br />
words is rapid for content words, including both nouns and<br />
verbs. After 19 months, Chinese-speaking children also<br />
begin to use function words, including classifiers, question<br />
words and pronouns.<br />
FP-D-031<br />
Birth asphyxia: still a major risk factor for cerebral<br />
palsy in Bangladesh<br />
S. Akhter, M.-M. Rahman, K. Akhter, M.N. Islam<br />
Department of Paediatrics, Bangabandhu Sheikh Mujib<br />
Medical <strong>University</strong>, Dhaka, Bangladesh<br />
This study was done to assess some of the identifiable<br />
risk factors for CP. Four hundred and fifty children suffering<br />
from CP attending over 2 years 3 months time period in<br />
the our-patient department of Bangabandhu Sheikh Mujib<br />
Medical <strong>University</strong> in Dhaka, Bangladesh -were studied<br />
retrospectively. Information regarding antenatal, natal and<br />
postnatal period was collected by taking detailed history.<br />
Physical examinations were done to confirm the diagnosis.<br />
In some of the cases relevant laboratory investigations<br />
were done. Mean age was observed to be 2 years 6 months.<br />
Male to female ratio was 2:1. Most common type of CP<br />
was spastic (82.2%). Diskinetic, hypotonic and mixed were<br />
also found. In the spastic group, diplegia comprised the<br />
maximum number of cases (34%). Tetraplegia (27.3%)<br />
and hemiplegia (19%) were also common. Majority of<br />
the risk factors were natal. Birth asphyxia was found in<br />
43.8% of all the cases making it the most common identifiable<br />
risk factor. Other important natal factors were low<br />
birth weight (18.7%) and preterm (15.8%). Postnatal
450<br />
Abstracts<br />
factors like neonatal convulsion (14%), neonatal jaundice<br />
(9%) was responsible in 34% of cases. Prenatal factors<br />
were identified in 23% of cases. In 13% of cases there<br />
was no antenatal check up at all and in 78% of cases<br />
delivery was conducted at home. From the study it can<br />
be concluded that birth asphyxia has still remained as a<br />
major risk factor for CP in a developing country like<br />
Bangladesh. An integrated antenatal and perinatal care<br />
might reduce the rate of CP.<br />
FP-D-032<br />
Effective analysis of part radicotomy in convulsive palsy<br />
Z.-X. Wang<br />
China-Japan friendship Hospital, Beijing, China<br />
Objective: To explore the effect of part radicotomy in<br />
spastic cerebral palsy and the significance of combination<br />
with rehabilitation. Subjects and methods: 43 cases with<br />
spastic cerebral palsy aged from 2 to 14 years old were<br />
enrolled in the study. All underwent selective part radicotomy,<br />
of that 19 cases were combined with rehabilitation<br />
after operation. Effects were compared between the cases<br />
with only surgical group and the group combined surgery<br />
and rehabilitation. Results: Most of them had asphyxia<br />
history (19 cases 44.4%) and premature birth (12 cases<br />
25.96%). Part radicotomy had effect on 51.2% of 44<br />
cases. However, in contrast to the effective rate of the<br />
only operation group, the combined with rehabilitation<br />
group had much better result (P , 0:05). Conclusion: The<br />
part radicotomy was one of effective therapy for spastic<br />
cerebral palsy. Operation combined with rehabilitation<br />
was more effective than only operation.<br />
FP-D-033<br />
Developmental screening in infancy<br />
F. Soleimani<br />
<strong>University</strong> of Social Welfare and Rehabilitation Sciences,<br />
Tehran, Iran<br />
In this study we screened 6000 infants between 4 and 18<br />
months by infanib scoring. In this assessment infants<br />
divided to three groups; Normal, transient and Abnormal<br />
by 20 items that based on French angles, reflexes, tone<br />
and posture. The transient group was visited 1 month later<br />
and the abnormal group was referred to pediatric neurologist<br />
for diagnostic evaluation and to Rehabilitation Center for<br />
treatment. In the beginning the Infanib was selected because<br />
of high validity and reliability in the previous studies, and in<br />
this study we also found out that it is the same in Iran. thus<br />
the Infanib is proposed as an appropriate screening test in<br />
the developing countries because of quantified, reliable<br />
measure of body tone and posture, short time for examination<br />
and the ability of occupational, physical therapist,<br />
nurses and physician to perform it.<br />
FP-D-034<br />
The outcome of the term infants with low-Apgar score<br />
and the predictor to the cerebral palsy<br />
K.-W. Jiang, Q.-X. Shui<br />
Department of Neurology, Affiliated Children’s Hospital of<br />
Medical College, Zhejiang <strong>University</strong>, Hangzhou, China<br />
To study the factors and the predictors correlated with the<br />
long-term prognosis of the term infants with low-Apgar<br />
score. We carried out a dynamic prospective study on a<br />
cohort of 252 cases in a year. The Infant Motor Screen<br />
test and the children’s development milestones evaluation<br />
were applied at 6 months and 1-year-old, respectively. Five<br />
died, and seven lost during follow-up. Of 240 survivors, 19<br />
infants at 6 months were abnormal, and 15 infants at 1 year.<br />
Compared to the control group, the differences were significant<br />
(P ¼ 0:019 and 0.067, respectively). Four factors<br />
(low-Apgar scores #3 at 1 min and #6 at 5 min, cranial<br />
injury, intrauterine distress and cord wrapped around neck)<br />
were correlated with the long-term prognosis. The neonatal<br />
signs were predictors to the prognosis. Discriminant analyse<br />
indicated that combination of convulsion, apnea, staring,<br />
and spontaneous movements may predict 91.3% CP cases<br />
at 1 year. The special neurobehavioral abilities at 6 months,<br />
such as controlling the trunk at sitting, Moro reflex, may<br />
predict 97.9% CP cases. Duration of severe asphyxia and the<br />
encephalon trauma due to asphyxia were correlated to the<br />
long-term prognosis in term neonates with low-Apgar score.<br />
The neonatal abnormal signs had a positive predictive value<br />
to the long-term prognosis, and a serially observation<br />
showed a more precise prediction to the CP.<br />
FP-D-035<br />
The role of positioning and movement therapy for<br />
infants with gross motor delay due to hypoxic-ischemic<br />
encephalopathy<br />
B. Bayasgalantai, P. Otgonbayar<br />
Maternal and Child Health Research Center, Bayangol<br />
Duureg, Ulaanbaatar, Mongolia<br />
The incidence of infant developmental delay are numerous<br />
in our country: this fact is justifiably one of the major issues<br />
that draws the attention of pediatricians, neurologists and<br />
researchers. As some researchers believe the main cause of<br />
infants disabilities are severe hypoxic-ischemic encephalopathy/HIE/and<br />
cerebral palsy. Objectives: (1) To identify<br />
types of gross motor delay in infants due to HIE. (2) To<br />
investigate role of positioning and movement therapy as an<br />
early intervention in infants with HIE. Study design: We<br />
followed 120 neonates with HIE to identify gross motor<br />
delay, with regular neurological examination by a neonatologist<br />
until 12 months of age: at discharge and follow-ups at 3,<br />
6, 9 and 12 months of age. Then developmentally tested the<br />
children using special scales. We provided a case-controlled,
Abstracts 451<br />
quasi-experimental study. Results: Among the 120 children<br />
followed 68 were identified as having a gross motor delay.<br />
There are differences of muscle tone in 40.8–59.2% of the<br />
children; inability to hold a head, and inability to sit and walk<br />
in 24–62% of children. We have used positioning, sensory<br />
stimulation and motor developmental intervention<br />
approaches individually for each infant. Developmental<br />
outcomes after motor developmental intervention<br />
approaches were good: we have observed results after one<br />
to two courses of therapy. Conclusions: HIE is the most<br />
common disease in the neonatal period which causes developmental<br />
delay. Each infant with HIE should be followed<br />
with the Denver test during the 1st year of life. Positioning<br />
and motor developmental intervention approaches are effective<br />
for the therapy of developmental delay. We developed<br />
standards of treatment for gross motor delay due to HIE<br />
among infants.<br />
FP-D-036<br />
Cutaneomuscular reflex in the lower limbs of patients<br />
with cerebral palsy and its clinical significance<br />
Z.-M. Jiang, L.-Y. Shan, X.-H. Li<br />
Prevention, Treatment and Rehabilitation Center for Child<br />
Cerebral Palsy in Heilongjiang, Jiamusi, Heilongjiang,<br />
China<br />
To study the abnormal cutaneomuscular reflex (CMR)<br />
changes recorded in the lower limbs in children with CP,<br />
provide the index for clinical diagnosis. CMR were recoded<br />
in the lower limbs in 80 cerebral palsy children aged 3 , 5<br />
years and 30 normal children with the same age. Compared<br />
with the control group, the latency of I1 and E2 of patients<br />
with spastic cerebral palsy prolonged (P , 0:05). The<br />
amplitude ratio of E2 and E1 reduced (P , 0:05). The<br />
abnormal degree of CMR in spastic hemiplegia children<br />
accorded with degree of clinical hemiplegia. There were<br />
significant differences in the latency of E2 and the amplitude<br />
ratio of E2 and E1 between the mild and the severe sides or<br />
between side of health and hemiplegic side (P , 0:05 and<br />
P , 0:01). Compared with the control group, the amplitude<br />
rate of E2 and E1 increased in the patients with athetoid CP<br />
(P , 0:05), the amplitude of E1 increased significantly<br />
(P , 0:01). These results suggested that the main damage<br />
brain area of spastic cerebral palsy was motor cortex and<br />
pyramidal tract; the main lesion area of athetoid cerebral<br />
palsy was extrapyramidal system. CMR may be used as<br />
objective index for diagnosis of cerebral palsy.<br />
FP-D-037<br />
The evaluation of developmental age in infants in<br />
Tehran city<br />
P. Karimzadeh<br />
<strong>University</strong> of Social Welfare and Rehabilitation Sciences,<br />
Tehran, Iran<br />
The differentiation of human being in life that leads to<br />
somatic, mental, verbal and social promotion is called<br />
development. Development in childhood period (specially<br />
first and second year of life) is more rapid than the other<br />
stages of life. We decided to evaluate the developmental<br />
age in infants because there is no study in Iran. We studied<br />
the developmental age in 611 infants in respect of Grasping<br />
age, Crawling age, sitting age, walking age and social age.<br />
Before study, infants were examined by pediatrician and all<br />
of cases with genetic, congenital and acquired disorders<br />
were excluded. A descriptive-analytic study was carried<br />
out to evaluate the developmental age in infants in Tehran<br />
city. We used Munich functional Diagnostic test. The<br />
information collected using checklists. The results showed<br />
that the level of developmental age in Iranian infants in<br />
comparison of the results in other countries is upper. In our<br />
studies with increase in educational level in mothers, we<br />
had increase in medians of DQ in infants. The median of<br />
DQ was 115.51 The median of grasping age, crawling age,<br />
sitting age walking age, perception age, speech age, speech<br />
comprehension age and social age were 2, 4, 7, 12, 5, 7, 10,<br />
10 month.<br />
FP-D-038<br />
Hyperbaric oxygen therapy in Malaysian children with<br />
cerebral palsy: a pilot study<br />
M. Thambyayah a , C.T. Lee c , K. Thillainathan b ,S.T.<br />
Cheoh b , K.M. Letchumi b<br />
a Paediatrician, Hospital Selayang, Malaysia;<br />
b Occupational<br />
Therapist, Developmental Nurse/Physiotherapist,<br />
Hospital Klang, Malaysia; c Diving Medicine Physician,<br />
Armed Forces Hospital Lumut, Malaysia<br />
Hyperbaric oxygen therapy (HBOT) has been used an<br />
adjunct to treat children with cerebral palsy in several countries.<br />
Numerous anectodal reports and few randomized trials<br />
indicate that it works, despite ongoing controversies. In this<br />
open-label, non-randomized study, 20 children, aged from<br />
3.5 to 14.8 years, (mean 7.5 years) who had varying types of<br />
cerebral palsy,(spastic ¼ 13, dystonic ¼ 3, ataxic ¼ 1,<br />
mixed ¼ 1) were treated at Armed Forces Hospital Lumut<br />
since May 2000, with 1.5 ATA hyperbaric oxygen, for a<br />
total of 100 treatments (40 1 40 1 20), administered for 1<br />
our, twice daily, 5 days a week, with a 12 week break in<br />
between the three sessions. The team consisted of a child<br />
neurologist, diving medicine specialist, occupational therapist,<br />
developmental nurse and physiotherapist. The<br />
outcomes used to measure were modified Ashworth Spasticity<br />
Scale, (MAS) modified tests of gross motor and fine<br />
motor function, parental reporting/satisfaction scale and<br />
video-recording – these were employed before and after<br />
HBOT. Eighteen children completed the entire treatment,<br />
evaluations and assessments in Dec 2001. There were<br />
significant improvements in alertness, overall communication<br />
and cognition, drooling and also in fine motor more
452<br />
Abstracts<br />
than gross motor testing. Spasticity reduction was maintained<br />
for about 12 weeks. The mean pre-HBOT MA in<br />
hamstrings 1.2 and mean post HBOT MAS: 0.7 (42 %<br />
improvement) were minimal (middle ear and sinus barotrauma).<br />
HBOT is well tolerated in children with cerebral<br />
palsy and there were significant improvements in several<br />
areas of neurological functions.<br />
FP-D-039<br />
Evaluation of rehabilitation to children with cerebral<br />
palsy<br />
O. Nitta, M. Aoyama, M. Miyao, Y. Iwasaki, M. Shibata, M.<br />
Yamamoto, K. Miura<br />
Tokyo Metropolitan <strong>University</strong> of Health Sciences, Tokyo,<br />
Japan<br />
Purpose: Various rehabilitation programs have been<br />
provided to children with cerebral palsy. However, there<br />
has been no sufficient evaluation whether these programs<br />
were adequate or not. Main reasons of this insufficient<br />
evaluation may involve very long clinical course of the<br />
disease, i.e. cerebral palsy, and the absence of objective<br />
criteria to evaluate the programs. Thus, we examined the<br />
rehabilitation programs during the life cycle of disabled<br />
children from the birth to the adult. Furthermore, we<br />
inquired whether these programs were appropriate for<br />
their parents. Subjects and methods: We have made an<br />
investigation based on a questionnaires sent out to the<br />
parents of 110 handicapped children with cerebral palsy<br />
(mean age, 12.26 years; range, 6–18 years) enrolled in<br />
schools for physically handicapped or mentally retarded<br />
children in Tokyo Metropolitan area. We inquired what<br />
kind of rehabilitation programs their children received at<br />
each class of age, and on whether they thought the programs<br />
were appropriate or not. Results: In effective responses, 46%<br />
of parents answered that contents of the programs were<br />
‘inappropriate’ or ‘equivocal’. The reasons of the inappropriateness<br />
involved ‘insufficient frequency’ and ‘inconsistent<br />
programs by various therapists’.<br />
FP-D-040<br />
Do pre- and perinatal factors predict a need for special<br />
education?<br />
M. Mannerkoski, T. Autti, L. Åberg, M. Hoikkala, K.<br />
Kuismanen, H. Heiskala<br />
Departments of Child Neurology and Radiology, Helsinki<br />
<strong>University</strong>, Hospital for Children and Adolescents, Helsinki,<br />
Finland<br />
Our purpose was to see whether some pre- or perinatal<br />
factors as recorded in the school health care units could<br />
serve as predictors for a need for special education? We<br />
used a random and representative sample, altogether 900<br />
pupils, of children attending classes for special education<br />
in Uusimaa (population 1.4 million), Finland. This survey<br />
was carried out in 1997–1998 in 19 different schools. The<br />
teaching programs of these children (born between 1980 and<br />
1993, boys 64% and girls 36%) were: (1) education modified<br />
for specific neurological disabilities (23%); (2) adjusted<br />
education (46%); and (3) training education (30%). A<br />
random sample of children (N ¼ 300) in mainstream education<br />
was used as a control. In preliminary analyses the most<br />
important predictors were abnormalities detected after birth.<br />
Also birth weight, birth height and occipitofrontal circumference<br />
and Apgar score correlated with future academic<br />
problems. More thorough regression analyses will be<br />
presented and discussed.<br />
FP-D-041<br />
Treatment of spastic cerebral palsy by local injection<br />
with different doses of Botulinum Toxin-A<br />
B.-Q. Gao, W.-L. Yang, Y.-J. Wang, B.-J. Zhu, Z.-G. Zhao,<br />
X. Deng, G.-F. Wang<br />
Department of pediatrics, Beijing Tiantan Hospital Affiliate<br />
of Capital <strong>University</strong> of Medical Science, Beijing, China<br />
Objective: To evaluate the efficacy of local intramuscular<br />
injections of three different doses of botulinum-A toxin in<br />
the management of the spasm of cerebral palsy. Methods:A<br />
total of 120 children with cerebral palsy were averagely<br />
divided into three groups: group 1, group 2 and group 3.<br />
Three different doses of BTX-A (group 1 1 m/kg, group 2 2<br />
m/kg, group 3 3 m/kg) were administered. The effect of<br />
treatment was evaluated by Physician Rating Scale method.<br />
The difference among these groups was calculated by<br />
‘analysis of variance’. The tolerance to BTX-A and the<br />
side effects were also assessed. Results: Reduction on<br />
spasm of muscle became apparent after injection in all<br />
patients. Large doses of BTX-A (2 and 3 m/kg) were more<br />
effective than small doses. No markedly side effects<br />
occurred. Conclusion BTX-A may be proved as a safe and<br />
effective treatment for the cerebral palsy.<br />
FP-D-042<br />
Neurological complications in child abuse at King<br />
Chulalongkorn Memorial Hospital<br />
S. Phancharoen a , T. Desudchit a , V. Pongpanlert a ,N.<br />
Thadakul a , S. Chittinand a , N. Suwanwela b , S. Kaoropthum c<br />
a Department of Pediatrics,<br />
b Department of Radiology,<br />
c Department of Surgery, Faculty of Medicine Chulalongkorn<br />
<strong>University</strong>, Bangkok, Thailand<br />
We studied neurological complications abused children<br />
in King Chulalongkorn Memorial Hospital between Jan 1,<br />
1997 to December 31, 2001. There were 65 cases in<br />
suspected child abuse and neglected, 37 girls and 28<br />
boys. Neurological problems were seen in 16 cases<br />
(24.61%). The average age was 4.75 months (12 days–10
Abstracts 453<br />
months). There were seven girls and nine boys. The most<br />
common presentations were lethargy (five cases ¼ 31.25%)<br />
and convulsion (five cases ¼ 31.25%). The neurological<br />
examination and imaging revealed subdural hematoma<br />
(ten cases ¼ 62.5%), retinal hemorrhage (four<br />
cases ¼ 25%), and external physical injury only two<br />
cases (12.5%). One serial imaging change revealed nonaccidental<br />
head injured (Shaking Baby syndrome). Two<br />
patients died shortly after hospital admission due to severe<br />
brain edema. During a follow up 2 months–4 years (mean 2<br />
years), nine cases (56.25%) had delayed development, six<br />
cases (37.5%) had epilepsy and two cases (12.5%) had V-P<br />
shunt. Only two cases (12.5%) were normal development.<br />
High degree of clinical suspicious and early recognition of<br />
this condition and team approach may improve outcome<br />
and prevent child abused in the future.<br />
FP-D-043<br />
Differences in developmental trajectories as a function of<br />
age and weight at birth in premature infants<br />
J.M. Gardner a , B.Z. Karmel a , A. Harin b , A. Barone b , E.M.<br />
Lennon a , M.J. Flory a , H. Phan a<br />
a NYS Institute for Basic Research, Staten Island, NY; b St.<br />
Vincents Catholic Medical Centers of NY, St. Vincent’s<br />
Staten Island, Staten Island, NY, USA<br />
Major advances in pre- and postnatal care in the last<br />
decade have produced a cohort shift in the numbers and<br />
types of infants surviving, with a growing number having<br />
shorter gestations, lower birth weight (BW), and the products<br />
of multiple birth. However, long-term outcome in this population<br />
is poorly understood. This presentation will concentrate<br />
on early medical indices used for predicting<br />
developmental outcome over the first 2 years in 287 surviving<br />
infants born ,32 weeks gestational age (GA) weighing<br />
,1500 g, who were part of a follow-up study of neurofunctional<br />
outcome of at-risk infants (28% were ,27 weeks and<br />
20% were ,751 g). Infants with genetic or congenital<br />
abnormalities were excluded. Bayley Scales of Infant Development<br />
(BSID) were administered every 3 months from 4 to<br />
25 months. Multiple regression indicated no significant<br />
differences in GA or BW as a function of gender, ethnicity,<br />
maternal education, exposure to cocaine in utero, or level of<br />
prenatal care. Using hierarchical linear analyses, and modeling<br />
performance as either a constant or a linear function over<br />
age, we found that as GA or BW decreased, the Mental<br />
Development Index (MDI) decreased regardless of age at<br />
test even when corrected for inherent age trends in the<br />
BSID. However, the PDI showed an accelerated decline as<br />
infants got older, with the youngest and smallest infants at<br />
birth declining fastest. Although increased severity of CNS<br />
injury also predicted decreases in MDI and PDI across age, it<br />
did not produce an accelerated decline in PDI. Combining<br />
severity of CNS injury with degree of immaturity predicted<br />
the developmental trajectories of outcomes best.<br />
FP-D-044<br />
Predicting cognitive and motor outcome in the 2nd year:<br />
the role of early measures of attention, and elicited and<br />
spontaneous movements<br />
B.Z. Karmel, J.M. Gardner, E.M. Lennon, M.J. Flory, H.<br />
Phan, I. Miroshnichenko, R.L. Freedland<br />
NYS Institute for Basic Research, Staten Island, NY, USA<br />
Defining the consequences of CNS injury in neonates is<br />
important for predicting both short-term recovery from<br />
acute problems and long-term outcome. We report relations<br />
among three procedures: arousal-modulated attention<br />
(AMA), neurobehavioral exam (NB), and spontaneous<br />
general movements (GM), to each other and to Bayley<br />
Scales of Infant Development over the first two years.<br />
The sample consisted of 70 high-risk infants studied longitudinally<br />
(mean GA ¼ 29.6 weeks; mean BW ¼ 1284 g;<br />
CNS injury: none ¼ 12%, mild ¼ 54%, moderatesevere<br />
¼ 34%). Infants were tested at hospital discharge<br />
and at 1, 3 and 4 months. Both concurrent and predictive<br />
validity of measures were demonstrated for our AMA<br />
visual preference procedure, our neonatal NB emphasizing<br />
elicited motor behaviors, and Prechtl’s assessment of GMs.<br />
Although CNS injury was associated with each measure in<br />
neonates, relations changed over time. Thus, CNS findings<br />
alone were insufficient to predict later outcome. Early<br />
behavioral evaluations were better predictors into the 2nd<br />
year and indicated that: (1) high-risk infants who<br />
performed normally as neonates had normal development;<br />
(2) those with early transient abnormalities appeared to<br />
normalize by 4 months, but started to show deficits by<br />
13–16 months; and (3) increased degree and/or duration<br />
of abnormal early behavior predicted the worst outcome.<br />
Use of multiple measures in the neonatal period, including<br />
attention and autoregulation along with elicited and spontaneous<br />
movements, as well as multiple assessments across<br />
early infancy, provide the most useful approach for evaluating<br />
recovery from CNS injury, and for predicting later<br />
mental and motor performance.<br />
FP-D-045<br />
Transsynaptic degeneration of lateral geniculate bodies<br />
in children affected by cerebral visual impairment<br />
S.M. Bova a , E. Fazzi a , S.G. Signorini a , C. Uggetti b , P.E.<br />
Bianchi c , G. Lanzi a<br />
a Department of Child Neurology and Psychiatry – IRCCS<br />
C. Mondino, Pavia, Italy; b Paediatric Neuroradiology Unit-<br />
IRCCS C. Mondino, Pavia, Italy; c Department of Ophthalmology<br />
– IRCCS <strong>University</strong> of Pavia, Italy<br />
Cerebral visual impairment (CVI) is the leading cause of<br />
bilateral visual impairment in Western countries. It is characterised<br />
by bilateral impairment of visual functions caused<br />
by damage to the CNS. A common cause is PVL following
454<br />
Abstracts<br />
perinatal hypoxic-ischemic brain injury. Diagnosis of CVI<br />
is based mainly on clinical signs but damage to the posterior<br />
visual pathways is frequently documented on brain MR<br />
in children with PVL. Lateral geniculate body (LGB) is the<br />
thalamic relay nucleus of the geniculate visual pathway.<br />
Lesion at this level have frequently been demonstrated<br />
by pathological examinations - following transsynaptic<br />
degeneration of these nuclei secondary to pregeniculate<br />
or postgeniculate interruption of visual pathways - but<br />
seldom documented on brain MR. In this study we investigate<br />
MR alterations of visual pathways and in particular<br />
of LGB in 20 children affected by CVI and cerebral palsy.<br />
The presence of a small, symmetric area of T2 prolongation<br />
in the exact site in which the LGB are located-consistent<br />
with gliosis – was considered indicative of LGB<br />
damage. Neurophthalmological findings are compared<br />
with a control group of 20 children with similar clinical<br />
and neuroradiological picture, except for LGB damage.<br />
Comparison between the two groups shows higher incidence<br />
of optic nerve atrophy, lower visual acuity, and<br />
higher incidence of disorder of ocular motility (saccades,<br />
and smooth pursuit) in children with LGB damage. These<br />
findings suggest that MR signal alterations in the LGB,<br />
probably attributable to transynaptic degeneration, can<br />
also extend to the optic nerve and lead to poorer visual<br />
outcome.<br />
FP-D-046<br />
The correlations of motor functions with speech and<br />
psychosocial functions in the children with cerebral<br />
palsy<br />
C.-L. Chen a , I.-C. Chen b , C.-Y. Wu a , C.-Y. Chung a , C.-H.<br />
Chen a , S.-C. Chen b<br />
a Department of Physical Medicine and Rehabilitation,<br />
Chang Gung Memorial and Children Hospital, Taoyuan,<br />
Chinese Taipei; b Department of Physical Medicine and<br />
Rehabilitation, Taipei Medical <strong>University</strong> Hospital,<br />
Chinese Taipei<br />
CP is characterized by non-progressive motor impairment.<br />
The developmental functions varied in the children<br />
with spastic CP. This study was to investigate the correlations<br />
of motor functions with speech and psychosocial<br />
functions in the children with CP. We collected 179 children<br />
with CP, aged less than 6 years. We used the Chinese<br />
Child Development Inventory to assess the developmental<br />
functions with 8 domains, including GM, fine motor (FM),<br />
expressive language (EL), concept comprehension (CC),<br />
social comprehension (SC), self help (SH), personal social<br />
(PS), and general development (GD). CP children were<br />
divided into two groups: SD and spastic quadriplegia<br />
(SQ). We compared the DQ between the two groups.<br />
The correlations of different developmental functions<br />
were analyzed by Pearson’s correlation. We found eight<br />
DQs in the SD group were higher than SQ group<br />
(P , 0:01). The DQs of GM and FM in the SD group<br />
were 47 and 75%, respectively. While those in the SQ<br />
group were 23 and 38%, respectively. The DQs of the<br />
other functions in the SD group were 62–83%, while<br />
those in the SQ group were 31–57%. The speech functions<br />
(EL, CC, SC) were correlated more with FM function<br />
(r ¼ 0:6–0:8, P , 0:01) than GM function (r ¼ 0:4–0:7,<br />
P , 0:01). The other functions (SH, PS, GD) were also<br />
correlated more with FM function (r ¼ 0:8, P , 0:01)<br />
than GM function (r ¼ 0:68–0:78, P , 0:01). Our findings<br />
suggest the SD group had better motor, speech and psychosocial<br />
functions than SQ group. The fine motor function<br />
may provide us as the predictor for speech and psychosocial<br />
functions in the children with CP.<br />
FP-D-047<br />
Etiologic determination of 1088 children with<br />
developmental delay<br />
C.-L. Chen, I.-C. Chen, A.M.-K. Wong, C.-Y. Chung, S.F.-<br />
T. Tang, C.-H. Chen<br />
Department of Physical Medicine and Rehabilitation,<br />
Chang Gung Memorial and Children Hospital, Kwei-<br />
Shan, Tao-Yuan, Chinese Taipei<br />
Children with developmental delay (DD) had varieties in<br />
developmental function. The purpose of this study was to<br />
analyze the etiologic diagnosis and risk factors in children<br />
with different functional delay. We collected 1088 children,<br />
aged less than 6 years, who underwent assessments<br />
of developmental function, etiologic diagnosis, and risk<br />
factors. All children were classified into five functional<br />
delay groups: speech, motor, pervasive, global, and nonspecific<br />
DD. The etiologic diagnosis was classified into<br />
brain, neuromuscular, genetic, psychomental, and other<br />
disorders. Differences of etiologic diagnosis and risk<br />
factors of five functional delay groups were determined.<br />
Most children had global (45.3%), motor (22.3%) and<br />
speech (17.3%) delay, the other children had non-specific<br />
(10.6%) and pervasive (4.5%) delay. Approximately 61.5%<br />
of children were associated with biological factors (20.0%<br />
of neonatal insults, 19.9% of genetic defect/congenital<br />
anomaly, 13.5% of central nervous system lesions, 3.5%<br />
of prematurity/low birth body weight, and 4.8% of other<br />
factors). Most children with motor delay were brain disorders<br />
and associated with major risks of neonatal insults<br />
(P , 0:05). While most children with global delay were<br />
brain or psychomental disorders and associated with<br />
major risks of genetic defect/congenital anomaly or neonatal<br />
insults (P , 0:05). Our findings suggested there were<br />
heterogeneous risk factors and etiologic diagnosis in children<br />
with different functional delay. These data could<br />
provide us to investigate the underlying diseases for children<br />
with developmental delay.
Abstracts 455<br />
FP-D-048<br />
Glasgow scale relationships in children with traumatic<br />
brain injury<br />
C.-Y. Chung, C.-L. Chen, M.-K. Wong, L.-C. See, F.-T.<br />
Tang<br />
Department of Physical Medicine and Rehabilitation,<br />
Chang Gung Memorial and Children Hospital, Kwei-<br />
Shan, Tao-Yuan, Chinese Taipei<br />
The purpose of this study was trying to find out the<br />
proper cutting point of GCS as a determinant of outcome<br />
for children with traumatic brain injury (TBI). We<br />
followed 319 children, aged 2–10 years old, with TBI.<br />
The outcome of the children was evaluated using modified<br />
Glasgow Outcome Scale (GOS). The GCS and GOS of the<br />
children were studied in relation to clinical associated<br />
injury and computed tomography scan features. Using<br />
statistical analysis, we investigate the correlation of the<br />
GOS with GCS. We found that a cutting point of GCS at<br />
five got the best correlation of the GOS with GCS. Children<br />
with TBI and GCS equal to or below five had worse<br />
outcome while those with GCS above five had better<br />
outcome. In the associated injuries and neuroimage<br />
features, indicators like chest trauma, basal ganglion<br />
lesion, cerebellar lesion, brainstem lesions, subdural<br />
hemorrhage and other intra-cranial hemorrhage were<br />
significantly correlated with lower GCS. Children had<br />
chest trauma, abdominal trauma, frontal lesions, basal<br />
ganglion lesions, cerebellar lesions, brainstem lesions,<br />
subdural hemorrhage and other intra-cranial hemorrhage<br />
also had worse GOS. We conclude that a cutting point of<br />
GCS at five can best predict the outcome of TBI in children.<br />
The best predictors of outcome from TBI are the<br />
GCS score and other indictors of overall severity of brain<br />
injury.<br />
FP-D-049<br />
Antenatal risk factors associated with the unfavorable<br />
neurological status in newborns and at 2 years of age<br />
T. Stelmach, E. Kallas, H. Pisarev, T. Talvik<br />
Tartu <strong>University</strong> Clinics, Children’s Clinic; Department of<br />
Pediatrics, <strong>University</strong> of Tartu, Tartu, Estonia<br />
The aim of this prospective cohort study was to evaluate<br />
the influence of different antenatal and birth factors on the<br />
neurological signs at first days of life and the neurological<br />
outcome at 2 years of age. Patients and methods: the study<br />
group consisted of 390 children drawn from the cohort of<br />
828 consecutive live births between October 1st 1998 and<br />
March 31st 1999 at the Women’s Clinic, Tartu <strong>University</strong><br />
Clinics, Estonia. The data about all potential antenatal risk<br />
factors were abstracted from pregnancy and delivery<br />
records and registered in the database. The data about<br />
any birth complications and the neonatal course for all<br />
children were also collected from the hospital registry.<br />
Crude Odds ratio estimates with 95% confidence intervals<br />
were used to measure the associations between different<br />
antenatal factors and the neurological symptoms, both in<br />
newborn period and at 2 years of age. Significance level<br />
P , 0:05 was considered acceptable. At 2 years of age 49<br />
children from 390 exhibited adverse neurodevelopmental<br />
outcome (CP and other developmental disorders). The<br />
development of remaining 341 children was age-appropriate.<br />
Comparative analysis of risk factors was conducted.<br />
The strongest correlation with further development of HIE<br />
at first days of life was found in such antenatal factors as<br />
trichomoniasis during pregnancy (OR, 4.34; 95% CI, 1.32–<br />
14.23,) and acute respiratory disease (temperature . ¼ 388<br />
C) in II half of pregnancy (OR, 2.86; 95% CI, 1.08–7.58).<br />
From different antenatal factors, only bacterial vaginosis<br />
(diagnosed both clinically and microbiologically)<br />
combined with threatening abortion in 1st half of pregnancy<br />
(OR, 4.96; 95% CI 1.35–18.26) had significant association<br />
with adverse neurodevelopmental outcome at 2<br />
years of age. Arterial hypertension during pregnancy,<br />
acute respiratory disease, intrauterine growth retardation,<br />
edema, proteinuria, hypertension (EPH)-gestosis and preeclampsia<br />
were not associated with adverse outcome at 2<br />
years of age. Presence of at least one complication at delivery<br />
placed the child at risk of adverse neurological<br />
outcome (OR, 2.44; 95% CI, 1.32–4.54) at 2 years of age.<br />
FP-D-050<br />
Premature rupture of membranes and neonatal<br />
neurological outcome in a cohort of preterm births: an<br />
ongoing study<br />
C. Arpino a,b , A. Di Paolo c , C. Ticconi d , S. Brescianini e ,D.<br />
Poveromo b , E. Piccione d , P. Curatolo b<br />
a ‘E. Litta’ Rehabilitation Center for Developmental<br />
Disabilities, Grottaferrata, Rome, Italy; b Pediatric Neurology,<br />
‘Tor Vergata’ <strong>University</strong> of Rome, Italy; c Department<br />
of Pediatrics, Section of Neonatology, ‘Tor Vergata’<br />
<strong>University</strong> of Rome, Italy; d Department of Surgery, Section<br />
of Obstetrics and Gynaecology, ‘Tor Vergata’ <strong>University</strong> of<br />
Rome, Italy; e National Institute of Health, Rome, Italy<br />
Premature rupture of membranes (PROM) is associated<br />
to 30–40% of preterm deliveries and it is complicated by<br />
chorioamnionitis in up to 70% of cases. Data from medical<br />
literature suggest that the risk of adverse neonatal neurological<br />
outcome is higher in preterm births exposed to<br />
PROM compared to non exposed preterm birth. The objective<br />
of this study is to evaluate the effect of premature<br />
rupture of membranes, on neonatal neurological outcome<br />
in preterm births. To this end, we conducted a retrospective<br />
cohort of preterm births, including all consecutive<br />
preterm newborns (n ¼ 600; gestational age ,37 weeks),<br />
referred to the Pediatric Unit, Neonatal Intensive Care and<br />
Nursery, of the ‘Tor Vergata’, <strong>University</strong> of Rome, in the
456<br />
Abstracts<br />
period 1996–2001. The source of information was represented<br />
by clinical records of newborns (all clinical information<br />
relevant to outcome evaluation and control for<br />
confounding) and newborns’ mothers (history of pregnancy<br />
and delivery, in particular onset, duration and<br />
complications of PROM). Up to now, 109 newborn-andmother<br />
pairs have been enrolled into the study. Overall,<br />
32% of preterm births were exposed to PROM. Adverse<br />
neurological and respiratory outcome (adj RR: 1.5; CI:<br />
0.4–5.7; adj RR: 1.5; CI: 0.9–2.5) tended to occur more<br />
frequently in preterm births with PROM. Our preliminary<br />
results suggest that adverse neurological and respiratory<br />
outcome have a higher incidence among preterm newborns<br />
exposed to PROM.<br />
FP-D-051<br />
The early home-based intervention program on children<br />
with fetal alcohol syndrome and fetal alcohol effect in<br />
east Taiwan<br />
H.-T. Kuo<br />
Research Institute and Faculty of Early Education and<br />
Care, Chaoyang <strong>University</strong> of Technology, Chinese Taipei<br />
Fetal alcohol syndrome (FAS) is a clinical diagnosis<br />
characterized by fetal pre-and postnatal growth delay,<br />
dysfunction of central nervous system, and facial<br />
dysmorphism due to maternal alcohol consumption during<br />
pregnancy. Fetal alcohol syndrome was described by<br />
Rouquette (1957), Lemoine (1968), and Jones (1973).<br />
The fetal alcohol effect (FAE) was then proposed as a<br />
mild form of alcohol teratogenesity by Smithells and<br />
Smith (1984), Abel and Sokol (1987), and Streissguth<br />
and Ladue (1987). The study was performed in Hualien<br />
between 1997 and 1998. The subjects of the study included<br />
six children with age under 6 years old, who lived in<br />
Hualien County. There are five FAS and one FAE children<br />
in our study group. We used Bayley’s Scale of Infant<br />
Development (BSID, II), and CCDI for objective and<br />
subjective developmental assessment. For learning status<br />
we use Individualized Education Program Screening<br />
Checklist (IEPSC) as assessment instrument. The Curriculum<br />
base program including active and quiet activities was<br />
arranged. At the end, the result was compared. The result<br />
of BSID, CCDI, and IEPSC all shows no significant difference.<br />
But, the results of CCDI and IEPSC items show<br />
developmental progress in two assessment sessions. Our<br />
conclusions on this study are (1). The FAS/FAE children<br />
all shows subnormal mentality and is high-risk group for<br />
future developmental disability, so they need early intervention<br />
(2). Although the intervention effect is not statistically<br />
significant, but there is qualitative developmental<br />
progress. For the purpose of promoting developmental<br />
potential and reducing load of family and society, we<br />
would still like to suggest early intervention for all those<br />
children.<br />
FP-D-052<br />
The numerical features of syndrome of hypertension<br />
hydrocephaly and syndrome of hydrocephaly among<br />
children with perinatal lesions of nervous system<br />
B.A. Abeuov, Sh.A. Bulekbayeva, G.A. Mukhambetova,<br />
A.S. Karimova, D.R. Purev<br />
Kazakh National Medical <strong>University</strong>, Almaty, Kazakhstan<br />
Quite often many symptoms of perinatal brain lesions are<br />
barely recognizable and clinically not obvious on the early<br />
stage, although they make effect on the neuro-psychological<br />
growth of the child. In the current report we present the<br />
results of clinical observation, diagnosis and treatment of<br />
1087 patients aged from 1 month to 4 years with perinatal<br />
pathology of central nervous system. To determine the aetiology<br />
of the pathological process the anamnesis of the patients<br />
was carefully learned by inquiring parents with the help of<br />
specially developed questionnaire. The results of the<br />
research revealed that different pathogenic factors are<br />
present in perinatal period in 1045 cases, among which the<br />
intranatal hypoxia is on the first place, on the 2nd place is the<br />
combination of the hypoxia in the 2nd half of the pregnancy<br />
with the trauma during travail, on the 3rd place – birth<br />
trauma. In 3.8% of cases the cause of the nervous system’s<br />
pathology was not succeeded. It is not enough to make a<br />
visual qualitative analysis of CT-scans to determine the<br />
pathological substrate. That’s why we used the quantitative<br />
method which has revealed the following: the dilation of the<br />
ventricular system, especially of the index of anterior horns<br />
of the lateral ventricles (IAHLV) on (17.4), took place. The<br />
indices of cerebral coat at the level of anterior horns and<br />
corpuses of lateral ventricles were reduced accordingly.<br />
The reduction at the level of posterior horns was less noticeable.<br />
Also the considerable dilation of all liquor areas was<br />
determined with the high degree of certainty. The considerable<br />
dilation from the direction of subarachnoid interspace<br />
and apertures of Silvii was revealed in the group of patients<br />
with hydrocephaly. Among children with syndrome of<br />
hypertension-hydrocephaly the indices of ventricular system<br />
increased moderately, which caused the reduction of indices<br />
of the cerebral coat. IAHLV most changed – on (14.3), that is<br />
essentially less than in the group of children with syndrome<br />
of hydrocephaly. Thus, syndrome of hydrocephaly in<br />
comparison with syndrome of hypertension-hydrocephaly<br />
in cases with perinatal cerebral lesions characterizes by<br />
more considerable changes of the indices of the ventricular<br />
system, indices of cerebral coat and sizes of liquor areas.<br />
FP-D-053<br />
Congenital pathology of nervous system in children<br />
U.A. Karimov, N.A. Zakirova, D.S. Aripova, M.K.<br />
Saidakhmedov<br />
Scientific Research Institute of Pediarics, Tashkent, Uzbekistan
Abstracts 457<br />
Analysis of congenital pathology of nervous system in<br />
children under conditions of Tashkent region revealed the<br />
level of the most occurring congenital pathologies of<br />
nervous system at the time of birth. Among 346 live-birth<br />
newborns Spina bifida was noted in 6.9%, among 80 stillborns-in<br />
2.5% and among 40 newborn dead during 0 , 6<br />
day after birth-in 6.2% of cases. Microcephaly was found in<br />
3.7, 10 and 2.5% of newborns, respectively. Hydrocephalyin<br />
4.6, 10 and 1.25% of cases, respectively. The Down<br />
disease was determined in 5.8% and disease of peripheral<br />
nervous system-in 3.5% only in livebirth newborns. Thus,<br />
more early diagnosis before school age and prophylaxis of<br />
congenital pathology of nervous system with determination<br />
of risk factors are very important for reduction of abovementioned<br />
indicators of nervous system disease in children.<br />
FP-D-054<br />
Identification of congenital pathology of nervous system<br />
in children in relation to age in the family polyclinics<br />
N.A. Zakirova, U.A. Karimoy<br />
Scientific Research Institute of Pediatrics, Tashkent, Uzbekistan<br />
Long-term observation of 223 340 children aged from 1 to<br />
14 years in the family polyclinics in Tashkent (Uzbekistan)<br />
revealed congenial diseases and malformations of different<br />
organs and systems in 778 (0.35%) children. Among them the<br />
diseases of nervous system have the special place. Among the<br />
children with congenital pathology of nervous system being<br />
under long-term observation of neuropathologist, we carried<br />
out analysis of their incidence in relation to age. It was found<br />
that Down disease was diagnosed more often in children<br />
under 3 years of age, microcephaly was determined in all<br />
the age groups with equal frequency, DYN was noted more<br />
frequently among children aged from 3 to 7 years. Thus, the<br />
data obtained allow to organize rehabilitation of congenital<br />
pathology of nervous system in relation to age and dynamic<br />
observation in all the age groups for determination of congenital<br />
diseases of nervous system.<br />
FP-D-055<br />
Neuropsychological outcome of 9–10 year-old children<br />
with intrauterine growth retardation (IUGR):<br />
preliminary findings<br />
R. Geva a,b , R. Eshel a , Y. Leitner a , A. Fattal-Valevski a ,M.<br />
Varon a , Y. Vila a , O. Bitchuniski a , B. Radiano a ,K.<br />
Goldberg a , S. Harel a<br />
a Institute for Child Development and Pediatric Neurology<br />
Unit, Division of Pediatrics, Dana Children’s Hospital, Tel<br />
Aviv Sourasky Medical Center and Sackler school of Medicine,<br />
Tel-Aviv <strong>University</strong>, Tel Aviv, Israel; b Department of<br />
Psychology, Bar-Ilan <strong>University</strong>, Ramat-Gan, 52900, Israel<br />
The objective of the study was to trace the neuropsychological<br />
profile of 9–10 years-old children with IUGR<br />
(N ¼ 56) compared with children who are matched for<br />
gestational age and socio-economic factors (N ¼ 31).<br />
Fifty-six children with IUGR were followed-up prospectively<br />
to the age of 9–10 years. They underwent comprehensive<br />
neuropsychological evaluation (lasting 4.5–5 h).<br />
The preliminary results show that the cognitive competence<br />
of most children with IUGR are within normal limits,<br />
however their school achievements are significantly low,<br />
evident in general knowledge, reading decoding and<br />
comprehension and arithmetic. The neuropsychological<br />
analysis showed that these difficulties arise from lower<br />
verbal skills (Ps range ¼ 0.001–0.023), a deficit in shortterm<br />
memory span for auditory stimuli (P , 0:026),<br />
visuo-motor perceptual deficits (P , 0:01), graphomotor<br />
difficulties (P , 0:004) and deficits in executive functioning<br />
(P , 0:003). Both risk groups had difficulties in visual<br />
attention and short-term memory for visual abstract material<br />
as well as executive rigidity. Hence, three neuropsychological<br />
domains impede learning in children with IUGR:<br />
short-term memory for verbal material as proposed by<br />
Pennington (1991), deficiency in executive functioningwas<br />
suggested by Barkley (1997) and visuo-motor, primarily<br />
graphomotor deficits-indicated by Denckla.<br />
FP-D-056<br />
Cerebral palsy and twin pregnancy: zygosity, risk<br />
factors, clinical course and MRI findings<br />
D.I. Zafeiriou, E. Vargiami, A. Vardarinos, E. Pavlou, E.<br />
Kontopoulos, I. Tsikoulas<br />
1st Department of Pediatrics, Aristotle <strong>University</strong>, ‘Hippokratio’<br />
Hospital, Thessaloniki, Greece<br />
The prevalence of twinning and other multiple births is<br />
increasing all over the world, due at least in part to fertility<br />
enhancing medical therapies. Twins and multiplets are at a<br />
higher risk for intrauterine and neonatal death than singletons<br />
and are also at increased risk for neurologic morbidity,<br />
including CP. In a partly retrospective, partly prospective<br />
study during the year period 1984–2001, we identified 149<br />
patients with CP who were the product of a twin pregnancy<br />
(80 males, 69 females; age range 3–13 years). The incidence<br />
of CP due to twinning in the whole CP population taking<br />
care of during the same period (N ¼ 1128) was estimated to<br />
be 13.9%. A total of 117 CP twins (78.5%) were of the same<br />
sex as their co-twin, while only 32 (21.5%) were of the<br />
opposite sex. Eight-six patients (57.7%) had caesarean<br />
section; 68 patients (45.6%) were A twins, while the rest<br />
81 patients (54.4%) were B twins. The vast majority of<br />
patients were monozygotic twins (N ¼ 85; 57.0%)<br />
compared to dizygotic (N ¼ 64; 43.0%). Forty-two twins<br />
(28.2%) had a birth weight (BW) , 1500 g, 82 (55.0%)<br />
between 1500 and 2500 g, and only 25 (16.8%) . 2500 g.<br />
A total of 130 twins were preterm (,37 weeks) and 19 were<br />
full-term (.37 weeks). Regarding the fate of the co-twin, it
458<br />
Abstracts<br />
was normal 68 cases (30 monozygotic, 38 dizygotic;<br />
P , 0:05), the co-twin had CP in 40 cases (31 monozygotic,<br />
nine dizygotic; P , 0:05), there was intrauterine death in 18<br />
cases and death in the first 6 months of life in 23 cases.<br />
Monozygotic twins had smaller mean BW compared to<br />
dizygotic ones; the same was true for normal co-twins of<br />
dizygotic twins compared to normal co-twins of monozygotic<br />
ones (P , 0:05, respectively). Sixty-one patients had<br />
spastic diplegia, 54 had tetraplegia, 26 had hemiplegia and<br />
eight had dystonia. Additional impairments and disabilities<br />
included mental retardation (47.7%), speech impairment<br />
(69.1%), visual impairment (31.5%), hearing impairment<br />
(9.4%), epilepsy (26.2%) and orthopedic problems<br />
(81.9%). MRI of the brain demonstrated prenatal type findings<br />
in 51% of the patients (porencephaly, PVL and combination),<br />
perinatal type findings 36.2% (cystic or subcortical<br />
leucomalacia, cortical atrophy, basal ganglia involvement<br />
and combinations) and dysgenesis in 12.8% of the patients.<br />
Monozygotic twins demonstrated more frequent prenatal<br />
findings and less frequent infarcts compared to dizygotic<br />
(P , 0:05, respectively). We conclude: (1) Twins of the<br />
same sex seem to be at increased risk for CP compared to<br />
those of opposite sex; (2) birth order is not associated with<br />
CP; (3) monozygotic and SGA dizygotic twins are at<br />
increased risk for CP; and (4) intrauterine death of a monozygotic<br />
twin increases significantly the risk for CP in the<br />
surviving co-twin.<br />
FP-E<br />
Nutrition<br />
FP-E-001<br />
Dietary intake and blood folate levels in Honduran<br />
women of childbearing age<br />
K.R. Holden, J.S. Collins, J.F. Greene, S. Hinkle, J.M.<br />
Portillo, R.E. Stevenson<br />
Greenwood Genetic Center, Mt Pleasant, USA<br />
Neural tube defects (NTDs) are common birth defects<br />
whose frequency appears to be reduced by maternal supplementation<br />
and/or fortification of folic acid. Latin Americans<br />
have a high incidence of NTDs, with Honduras having an<br />
estimated NTD prevalence of 2.6 per 1000 live births. A<br />
recent Center for Disease Control study demonstrated that<br />
folic acid supplementation and/or fortification appears effective<br />
in the US Hispanics to reduce the risk of NTD recurrence.<br />
We surveyed the dietary intake of 231 Honduran women of<br />
childbearing age using a 24-h dietary recall questionnaire in<br />
inner city, town, and country areas. We also randomly<br />
checked 24 blood folates in the surveyed population to<br />
compare to the normal range for the US population. Normal<br />
US recommended dietary allowance intake of folic acid<br />
equal to 292.1 ^ 152.0 mcg was documented in Honduran<br />
women in association with a low intake of many other essential<br />
nutrients. There were also differences in nutrient intake in<br />
city, town, and country areas. Serum (6.0 ^ 3.3 ng/ml) and<br />
red blood cell (203.3 ^ 61.6 ng/ml) folate levels in all locations<br />
were in the low normal range when compared to the presupplementation/pre-fortification<br />
US population. Even when<br />
considering the multiple socio-economic hurdles presented<br />
by this developing country, our data support using an established<br />
folic acid fortification public health initiative to<br />
decrease the prevalence of NTDs in Honduras.<br />
FP-E-002<br />
Malnutrition increases dentate granule cell neurogenesis<br />
in immature rats after status epilepticus<br />
Y.-L. Wang, R.-P. Sun, G.-F. Lei, J.-W. Wang, B.-M. Li<br />
Department of Pediatrics, Shandong <strong>University</strong> Qilu Hospital,<br />
Jinan, China<br />
Several experimental seizure inductions that produce<br />
epilepsy as a consequence have been shown to be always<br />
associated with the proliferation of dentate granule cells. To<br />
investigate the effects of prolonged seizures on dentate granule<br />
cell proliferation, and to study the associations among<br />
malnutrition, granule cell proliferation and epilepsy, we<br />
examined proliferating cells using bromodeoxyuridine<br />
(BrdU) mitotic labeling combined with immunohistochemistry<br />
for markers of immature granule neurons (TuJ1) and<br />
mature granule neurons (calbindin). We maintained rat pups<br />
on a starvation regimen from P2 to P22. The status epilepticus<br />
was elicited by unilateral microinfusion of kainic acid<br />
(1 mg) into the amygdula at P15. Rat pups were given BrdU<br />
twice daily for 4 days beginning 3 days after status epilepticus<br />
to label newly born cells. At P22, the rat pups were<br />
killed and the brains were processed for dual-labeling<br />
experiments. The results indicated that early malnutrition<br />
did not modify seizure susceptibility and behavioral manifestations.<br />
Although exposure to status epilepticus augumented<br />
the expression of new cells in the dentate gyrus of<br />
the immature rats, this expression was more pronounced in<br />
the malnourished rat pups. Most BrdU-labeled cells coexpressed<br />
neuro-specific markers (TuJ1 or calbindin). The<br />
findings suggest that malnutrition followed by status epilepticus<br />
can further increase granule cell proliferation, furthermore,<br />
the vast majority of these mitotically active cells<br />
differentiated into neurons in the dentate granule cell layer.<br />
FP-E-003<br />
Effect of iron deficiency on brain monoamine<br />
neurotransmitters in rats<br />
R.-M. Hu, M.-W. Wei, R.-P. Sun<br />
Department of Pediatrics, Qilu Hospital of Shandong<br />
<strong>University</strong>, Jinan, China<br />
Objective: To identify the mechanism of iron deficiency on<br />
learning and memory ability in brain. Methods: An iron deficient<br />
diet (11.9 mg/kg) was used to make an animal model of
Abstracts 459<br />
iron deficiency. The contents of iron in brain and liver were<br />
determined by DCP-AES technique. An enzyme histochemical<br />
method was used to test monoamine oxidase (MAO)<br />
activity. Monoamine neurotransmitter and its metabolites<br />
were determined by high performance liquid chromatography<br />
with electrochemical detection (HPLC-ECD). Results:<br />
The brain iron content(11.2 ^ 5.5 versus 20.7 ^ 6.5 mg/g<br />
wet tissue, P , 0:001) and MAO activity were both<br />
decreased in iron deficient non-anemic rats. The levels of<br />
norepinephrine (NE) and 5-HT in cerebral cortex were<br />
significantly higher than those of controls (269.2 ^ 46.9<br />
versus 208.4 ^ 27.3 ng/g wet tissue, P , 0:05,<br />
1568.8 ^ 234.8 versus 1194.1 ^ 163.4 ng/g wet tissue,<br />
P , 0:01), while hydroxyindoleacetic acid (5-HIAA), a<br />
metabolite of 5-HT in the hippocampus, was lower than<br />
that of controls (2753.7 ^ 365.4 versus 3623.4 ^ 754.1 ng/<br />
g wet tissue, P , 0:05). These changes were more significant<br />
in anemic rats. Conclusion: The result suggested that the<br />
abnormal metabolism of monoamine neurotransmitters in<br />
brain may be a biochemical basis for learning and memory<br />
defect caused by iron deficiency.<br />
FP-E-004<br />
Intracranial hemorrhage infarction due to late onset<br />
Vitamin K deficiency-11 case studies<br />
S.-Z. Xu, H.-H. Zhang, X.-X. Liu<br />
Department of Pediatrics, Affiliated Hospital, Binzhou<br />
Medical College, Binzhou, China<br />
Objective: To summarize the clinical manifestations,<br />
etiology, diagnosis and prognosis of 11 cases with intracranial<br />
hemorrhage infarction which were diagnosed in our<br />
hospital in the past 5 years. All cases were breast feeding,<br />
seven cases had infantile hepatitis syndrome. These were<br />
the common causes of the late onset vitamin K deficiency.<br />
Among seven cases of infantile hepatitis syndrome, four<br />
were CMV-IgG antibody positive. Prenatal or perinatal<br />
CMV infection was an important cause of hepatitis<br />
syndrome. The onset of Vitamin K deficiency in these<br />
cases was between 31 and 70 days. The clinical manifestations<br />
included convulsions, drowsiness, anorexia, irritability,<br />
pallor, bulging of the anterior fontanelle, hypertonia and<br />
external bleeding. Laboratory examination: coagulation<br />
time .15 min. Twenty-four hours after vitamin K1 administration,<br />
it became normal in all cases. Thrombocytosis was<br />
found in eight cases (.350 £ 109/l). CT studies showed left<br />
cerebral infarction after hemorrhage in nine cases, multiple<br />
infarction after hemorrhage in two cases. Multiple intracranial<br />
heamorrhage was seen in eight cases, mild hemorrhage<br />
and quickly absorbed in three cases. Large cerebral infarctions<br />
remained. The hemorrhage or hematoma was absorbed<br />
in 2 weeks, but there were still low density areas on CT.<br />
These areas enlarged in three cases 3 months later and encephalomalacia<br />
formed. Typical clinical manifestations,<br />
coagulation time test and CT are simple and reliable diagnostic<br />
methods. The follow-up CT played an important role<br />
in prognosis evaluation. Early administration of Vitamin K1<br />
is effective in prevention this disease.<br />
FP-F<br />
Cytogenetics/Teratology<br />
FP-F-001<br />
Bilateral frontoparietal polymicrogyria<br />
L. Sztriha, M. Nork<br />
Department of Paediatrics, FMHS, UAE <strong>University</strong> and<br />
Department of Radiology, Tawam Hospital, Al Ain, United<br />
Arab Emirates<br />
Polymicrogyria is a form of non-lissencephalic cortical<br />
dysplasia with abnormal gyration characterized by narrow<br />
and crowded gyri. According to a recent classification of the<br />
malformations of cortical development, polymicrogyria is a<br />
result of abnormal cortical organization. It can be either a<br />
generalized or focal unilateral or bilateral lesion. Among the<br />
rare, bilateral symmetrical forms several syndromes, such as<br />
bilateral perisylvian polymicrogyria, bilateral parasagittal<br />
parieto-occipital polymicrogyria and bilateral frontal polymicrogyria<br />
have been recognized and characterized. Bilateral<br />
polymicrogyria in other cortical areas seems to be even<br />
more infrequent; only a few cases of large, bilateral frontoparietal<br />
polymicrogyria have previously been described.<br />
The clinical and radiological findings in three patients<br />
with bilateral frontoparietal polymicrogyria and epilepsy<br />
are presented. The patients had serious delay in mental<br />
and motor development and seizures with epileptiform electroencephalographic<br />
findings. The MRI revealed bilateral<br />
abnormalities in the frontal and parietal lobes. The cortex<br />
was thick with an irregular outer surface and multiple small<br />
gyri and sulci were recognizable. The cortical-subcortical<br />
junction showed a festoon-like appearance. The abnormal<br />
cortex extended bilaterally from the frontal pole to the<br />
parieto-occipital fissure medially and to the level of the<br />
lateral cerebral fissure (fissure of Sylvius). The volume of<br />
the underlying white matter was reduced, and the lateral<br />
ventricles were moderately dilated. Bilateral frontoparietal<br />
polymicrogyria might represent a variety of the congenital<br />
bilateral symmetrical polymicrogyria syndromes in addition<br />
to perisylvian, parasagittal parieto-occipital and frontal<br />
polymicrogyria.<br />
FP-F-002<br />
The study of telomeric microaberrations in<br />
chromosomes of children with undifferentiated forms of<br />
mental retardation<br />
S.G. Vorsanova, Y.B. Yurov, A.D. Kolotii, A.K. Beresheva,<br />
I.V. Soloviev<br />
Institute of Pediatrics and Children Surgery, Russian Ministry<br />
of Health and National Research Center of Mental
460<br />
Abstracts<br />
Health, Russian Academy of Medical Sciences, Moscow,<br />
Russia<br />
Molecular-cytogenetic studies of chromosomal microanomalies<br />
at subtelomeric chromosomal regions have been<br />
conducted by two-step fluorescence in situ hybridization<br />
(FISH) in 407 children with mental retardation and apparently<br />
normal chromosome complements. A large set of<br />
cosmid, BAC and PAC clones, containing telomeric<br />
sequences was identified by FISH studies. Availability of<br />
large-insertion PAC probes, which contain DNA sequences,<br />
common for telomeric and, partially subtelomeric regions of<br />
all human chromosomes allowed us to mark all telomeric<br />
regions in one FISH study. Therefore, first FISH study for<br />
each patient was performed with large-insertion PAC probe,<br />
specifically marking telomeric and subtelomeric regions of<br />
all human chromosomes. If some chromosome arm had<br />
absence of telomeric hybridization signals, or the intensity<br />
of hybridization signal was reduced in comparison to homologous<br />
chromosome arm, we used second DNA probe,<br />
which is strongly specific todefinite telomeric region of<br />
individual chromosome. Microdeletions of chromosomes,<br />
involving telomeric regions were detected in 20 (4.8%)<br />
cases from 420 patients with severe and mild forms of<br />
mental retardation and apparently normal karyotypes<br />
revealed by classical banding techniques. Microdeletions<br />
were detected in the following chromosomal loci: 4q35.2;<br />
5p15.33 (two cases); 9q34.3; 10q26.3 (two cases); 11q25;<br />
13q34; 16q24.3 (two cases); 18p11.32 (four cases); 18q23<br />
(two cases); 21q22.2 (two cases) and 22q13.33 (two cases).<br />
These data demonstrate that undifferentiated forms of<br />
mental retardation could be associated with non-specific<br />
telomeric micro-aberrations of different chromosomes.<br />
FISH studies using specially developed panel of telomeric<br />
DNA probes could be useful for identification of generally<br />
undetermined forms of mental retardation.<br />
FP-F-003<br />
Bilateral perisylvian atrophy – a study of 11 cases from<br />
Oman<br />
R.A. Syed, S.M. Khusaiby<br />
Department of Child Health, Royal Hospital, Muscat, Oman<br />
Recent advances in neuroimaging have helped the clinician<br />
to correlate clinical features with radiological findings<br />
in various neurological disorders. This study describes 11<br />
children with developmental delay with no known etiology<br />
who showed bilateral perisylvian abnormalities in imaging<br />
studies. Most of the patients had spastic weakness of the<br />
limbs, microcephaly, severe developmental retardation<br />
and seizures, as common symptoms. Speech and language<br />
disorders along with masticatory and swallowing problems<br />
were encountered in 85% of the patients. Three patients had<br />
generalized dystonia with choreic movements mostly seen<br />
in the facial and trunk muscles. Further studies are required<br />
to evaluate the definite etiology.<br />
FP-F-004<br />
Pontocerebellar hypoplasia type 1: new leads for an<br />
earlier diagnosis<br />
M.S. Salman, S. Blaser, J.R. Buncic, C.A. Westall, E. Heon,<br />
L. Becker<br />
<strong>University</strong> of Toronto and Hospital for Sick Children,<br />
Toronto, Canada<br />
Background: Pontocerebellar hypoplasia (PCH) type 1 is<br />
a rare disease characterized by PCH and anterior horn cell<br />
degeneration. Death results from respiratory failure. The<br />
oldest reported child died at the age of 26 months. Methods:<br />
Case study of two siblings with PCH. The diagnosis was<br />
made on autopsy after the death of the second sibling at 40<br />
months from respiratory failure and the finding of anterior<br />
horn cell degeneration on autopsy. The older sibling died at<br />
14 months from pneumonia following a clinical course similar<br />
to his sister. Results: Both siblings had significant global<br />
developmental delay with initial axial and peripheral hypotonia.<br />
Peripheral hypertonia with brisk reflexes developed<br />
later. Extensive investigations in the second sibling ruled<br />
out mitochondrial and other metabolic diseases. Genetic<br />
testing for Friedreich’s ataxia, spinal muscular atrophy,<br />
neuropathy/ataxia/retinitis pigmentosa (NARP), spinocerebellar<br />
ataxia 1–3 and 6–8 gene abnormalities were negative.<br />
Sleep study showed mixed central and obstructive sleep<br />
apneas. The electroretinogram (ERG) showed abnormal<br />
rod-cone response that was consistent with retinal dystrophy.<br />
Conclusions: Our cases call for the expansion of the<br />
phenotype for this disease. Survival may be prolonged with<br />
emergent spasticity. The presence of abnormal ERG<br />
response in infants with PCH may aid in the earlier diagnosis<br />
of this disease, and provide new insights into its pathogenesis.<br />
FP-F-005<br />
The brain complications of immunodeficiency in<br />
Nijmegen breakage syndrome<br />
J. Wendorff, E. Hibner, K. Zeman, M. Piotrowicz<br />
Research Institute, Polish Mother’s Memorial Hospital,<br />
Lodz, Poland<br />
Immunodeficiency is one of the most important symptoms<br />
of Nijmegen breakage syndrome (NBS). Since the<br />
description of the first patient approximately 70 cases<br />
have been reported, mainly in Central Europe. The diagnostic<br />
criteria are: characteristic phenotype with mental retardation,<br />
humoral and cellular immunity disorders, increased<br />
predisposition to cancer and chromosomal instability. The<br />
most frequent clinically manifested NBS complications<br />
result from predisposition to infections. The brain compli-
Abstracts 461<br />
cations of immunodeficiency have not been reported up till<br />
now. We present a 13-year-old girl with decreased levels of<br />
immunoglobulins in all classes, and B and T lymphocytes,<br />
in whom NBS was diagnosed on the basis of typical phenotypic<br />
features and genetic examination (deletion 5 nt in gene<br />
NBS 657–666 position). During 2 year follow-up three<br />
different neurological syndromes were diagnosed: chronic<br />
headache due to disturbance of CSF reabsorption, sinus<br />
cavernosus thrombophlebitis and cerebellitis. The occurrence<br />
of neurological symptoms was connected with lack<br />
of proper immunosubstitution due to non-compliance. All<br />
these neurological syndromes were clinically oligosymptomatic<br />
or asymptomatic while the brain MRI showed considerable<br />
involvement. The duration of neurological<br />
complications was short and they disappeared after treatment<br />
with immunoglobulins and steroids. Conclusion: The<br />
occurrence of neurological signs and symptoms in NBS may<br />
be related to immunodeficiency caused by lack of proper<br />
immunosubstitution.<br />
FP-F-006<br />
Observation of some cases of Klippel-Trenaunay<br />
syndrome<br />
S.S. Shomansurov, Z.B. Rafikova, G.T. Hojaeva, S.R.<br />
Rafikova<br />
Department of Pediatric Neurology, Tashkent Institute of<br />
Post-graduate Medical Education, Tashkent, Uzbekistan<br />
Klippel-Trenaunay syndrome was first described in 1900.<br />
Main clinical manifestations are asymmetric limb hypertrophies<br />
and hemangiomas due to congenital malformations of<br />
arteriovenous and lymphatic vessels. We observed 5 children<br />
from age 2 months to 14 years, who underwent clinical and<br />
neurological examination, brain ultrasonography (BUS),<br />
computed axial tomography (CAT), and symptomatic treatment.<br />
Follow-up lasted for 3 years. Clinical findings varied<br />
from minimal to strongly pronounced. In two patients there<br />
were no intracerebral hemangiomas. These patients developed<br />
satisfactorily physically and mentally. Three patients<br />
had cerebral hemangiomas and demonstrated developmental<br />
retardation and secondary hydrocephalus, and required careful<br />
management. BUS let us monitor forming and growth of<br />
hydrocephalus relevant to location of intracerebral angiomas.<br />
CAT showed enlargement of affected brain hemisphere<br />
in two patients without signs of structural anomalies or<br />
progress. The severity of the disease depended on craniocerebral<br />
angiomatosis; therefore we identified clinical<br />
variants of the syndrome with affected extremities only and<br />
with affected extremities plus brain. Follow-up observation<br />
and symptomatic management allowed us to achieve stabilization<br />
of pathologic process and improvement of neurological<br />
status in all children. So, progress of the disease of<br />
Klippel-Trenaunay syndrome is determined first of all by<br />
the severity of cerebral anomalies, and opportune symptomatic<br />
therapy improves patients’ condition and prognosis.<br />
FP-F-007<br />
Neuronal migration anomalies in children: a study of 43<br />
patients<br />
W.-H. Xie, Y.-C. Chen, A.-D. Zheng, X.-J. Hou<br />
Department of Pediatrics, First Affiliated of Fujian Medical<br />
<strong>University</strong>, Fuzhou, China<br />
The aim is to study the clinical and neuroimaging findings<br />
of children with neuronal migration anomalies<br />
(NMA). The medical records of 43 children with NMA<br />
seen in our hospital during the past 12 years were<br />
reviewed. There were 35 boys and 8 girls. Age ranged<br />
from 2 months to 12 years. The major clinical presentations<br />
of these patients were cerebral palsy (51.2%),<br />
seizures (32.5%), and mental retardation (16.3%). To<br />
study the characteristics of craniocerebral CT and MRI<br />
findings in these migration anomalies, CT images of 43<br />
patients with NMA were evaluated. Five patients were<br />
studied by MRI. Twenty had schizencephaly (46.5%), 14<br />
patients had lissencephaly and/or pachygria (32.6%). Five<br />
had polymicrogyria (11.6%), four had heterotopias of gray<br />
matter (9.3%). Twenty-six patients (60.5%) had other associated<br />
brain anomalies, including absence of the septum<br />
pellucidum in 14 cases, absence or agenesis of the corpus<br />
callosum in eight cases, cyst of the septum pellucidum in<br />
three cases, holoprosencephaly in two cases, and arachnoid<br />
cyst in two cases. MRI is a more superior method for<br />
diagnosing NMA than CT. It can clearly delineate the<br />
detailed morphologic changes of the brain caused by<br />
neuronal migration disorders as well as the other associated<br />
anomalies.<br />
FP-F-008<br />
Dubowitz syndrome<br />
B. Jocic-Jakubi, G. Jovanovic, V. Micic<br />
Clinic of Mental Health and Child Neuropsychiatry,<br />
Department of Child Neurology, <strong>University</strong> Hospital, Nis,<br />
Yugoslavia<br />
Dubowitz syndrome is an autosomal recessive disorder<br />
characterized by small stature, peculiar face, infantile<br />
eczema, microcephaly and mild mental retardation, originally<br />
described by Dubowitz (1965). We report a 7-year-old<br />
boy with postnatal growth retardation, characteristic facies,<br />
micrognathia, short palpebral fissures and asymmetric<br />
ptosis. Hypotonia, hyperextensible joints, clinodactyly of<br />
fifth finger were present. Eczema, speech delay, submucous<br />
cleft palate and delayed skeletal maturation were noted in<br />
early childhood. His mother has craniofacial anomalies too,<br />
but no intelligence abnormalities. In their family there<br />
were mentally retarded persons and one sibling died at<br />
birth with congenital malformation. The differential diagnosis<br />
is discussed with respect to this very polymorphous<br />
syndrome.
462<br />
Abstracts<br />
FP-F-009<br />
One case of Xp21 contiguous gene deletion syndrome<br />
H.-W. Ma a , J. Jing a , Z.-C. Wang a , L.-Y. Chen a , M. Matsuo b<br />
a Laboratory of Genetics, The Second Clinical College,<br />
China Medical <strong>University</strong>, Shenyang, China; b Division of<br />
Genetics, International Center for Medical Research, Kobe<br />
<strong>University</strong> School of Medicine, Kobe, Japan<br />
We describe a Chinese boy previously misdiagnosed with<br />
adrenoleukodystrophy who was subsequently diagnosed<br />
with Xp21 contiguous gene deletion syndrome, which<br />
included congenital adrenal hypoplasia (CAH), glycerol<br />
kinase deficiency (GKD) and Duchenne muscular dystrophy<br />
(DMD). His peripheral blood routine karyotyping was without<br />
visible deletions. Molecular mapping in the Xp21 region<br />
revealed that the deletion encompassed nearly the whole<br />
region from a portion of 3 0 end of the DMD gene to a site<br />
telomeric to the locus for X-linked CAH. The centromeric<br />
startpoint of the deletion was localized to the 3 0 end of the<br />
DMD gene, between exons 62 and 63, while the telomeric<br />
deletion breakpoint was not determined in the present study.<br />
However, no evidence for the deletion of the GKD gene<br />
located between the DMD and the CAH was observed,<br />
which might be fortuitously caused by its pseudogene. Interestingly,<br />
the deletion of the marker DXS992 located<br />
between the DMD and the GKD was not detected too,<br />
which could have resulted from either the presence of a<br />
separate double deletion or the mechanism of other complex<br />
deletion within this region. The exact mapping of the deletion<br />
could be confirmed by FISH and this study is underway<br />
in our patient. These findings suggest that Xp21 contiguous<br />
gene deletion syndrome should be further considered in any<br />
patient with adrenal insufficiency in spite of the normal<br />
karyotype. Analysis of molecular genetics will help in determining<br />
the extent of the deletion.<br />
FP-F-010<br />
Kabuki syndrome (Niikawa-Kuroki): study of five<br />
Spanish cases<br />
S.M. Briceño-Cuadros, J. Campos-Castelló, E. Miravet-<br />
Fuster, G. Bueno-Lozano, O. Pérez-Rodriguez<br />
Hospital Clinico San Carlos, Madrid, Spain<br />
Objectives: The Kabuki Syndrome, described by Niikawa<br />
and Kuroki (1981) has an estimated prevalence of 1:32 000<br />
live births. No biological marker is available yet. The diagnosis<br />
is exclusively based on phenotypic features: facial<br />
dysmorphism resembling the make-up used by kabuki<br />
actors, fetal flesh on finger tips, dermatoglyphic abnormalities,<br />
postnatal failure to thrive, and osseous malformations.<br />
It is associated with variable frequency of ophthalmologic,<br />
dental, cardiac, genitourinary, ENT and neurologic abnormalities.<br />
The latter include mental and language delays,<br />
epilepsy, migration defects and hydrocephalus. A hundred<br />
cases have been reported in Japanese, European and North<br />
American patients. We report five Spanish cases and a<br />
review of the literature. Results: We present five children<br />
(four males, one female) with a history of hypotonia, delay<br />
attaining developmental milestones, mild cognitive impairment<br />
and language with mostly phonologic and syntactical<br />
problems and excentric prosody. Facial dysmorphic features<br />
include arched eyebrows, eversion of external third of inferior<br />
eyelid, enlarged ears, high and depressed nasal bridge,<br />
high arched palate and fetal flesh on finger tips. Short height<br />
and skeletal abnormalities are variable in frequency. Chromosomal,<br />
hormonal, hematologic and metabolic tests were<br />
normal. Imaging studies (CT, MRI) only showed a mild<br />
atrophy in deep grey matter and cortex in two patients.<br />
Conclusion: Kabuki syndrome is relatively easy to recognise<br />
because of its dysmorphic features. It is a multiorgan<br />
disorder that involves the central nervous system whose<br />
most frequent clinical manifestations are mental and<br />
language delay.<br />
FP-F-011<br />
The FG syndrome: report of a large Italian series<br />
A. Battaglia<br />
Stella Maris Scientific Research Institute Division of Child<br />
Neurology and Psychiatry, <strong>University</strong> of Pisa, Pisa, Italy<br />
FG syndrome was first described by Opitz and Kaveggia<br />
in 1974, as a rare multiple congenital anomalies/mental<br />
retardation (MCA/MR) syndrome occurring only in boys,<br />
due to a recessive mutation on the X chromosome. Based on<br />
reports of over 50 reported cases, FG syndrome is associated<br />
with developmental delay (especially speech), hypotonia,<br />
postnatal onset relative macrocephaly, prominent forehead,<br />
frontal hair upsweep or whorls, ocular hypertelorism, thin<br />
vermilion border of the upper lip, relatively short fingers<br />
with broad thumbs and halluces, persistent fetal fingertip<br />
pads, anal anomalies, and/or constipation. Major malformations<br />
are rare, and include pyloric stenosis, anal agenesis,<br />
cryptorchidism, hypospadias, inguinal hernias, and congenital<br />
heart defects. Abnormal EEG findings and seizures<br />
have been reported in almost 70% of patients. MRI studies<br />
commonly show abnormalities of the corpus callosum associated<br />
with variable dilatation of the lateral ventricles; while<br />
less frequent are periventricular nodular heterotopias, mild<br />
cerebellar defects, and reduced amounts of periventricular<br />
white matter. Chiari I malformation seems to be a rather<br />
frequent finding. The behavior phenotype appears to be<br />
characterized by attention deficit/hyperactivity disorder,<br />
and relatively less developed language, fine motor and<br />
executive function skills, whereas visual-spatial abilities<br />
seem to be a relative strength. At present, due to an<br />
improved awareness, FG syndrome emerges as a rather<br />
common MCA/MR syndrome, occurring in boys and girls,<br />
presumed to be due to incompletely recessive mutations of<br />
genes on chromosome X. However, in a few instances
Abstracts 463<br />
inheritance from an affected father has been suspected. Two<br />
or three candidate loci on chromosome X are already at<br />
hand, making it possible the cloning of causal gene(s) in<br />
the near future. We describe twenty patients, referred to our<br />
Institute for investigation of developmental delay/mental<br />
retardation, and diagnosed as FG syndrome. In all of them<br />
diagnosis was confirmed by Dr Opitz. This is the first<br />
reported Italian series of FG syndrome cases, with particular<br />
emphasis on physical, neurological and developmental findings,<br />
and natural history. Follow-up on all patients ranged<br />
between 6 months and 7 years.<br />
FP-F-012<br />
Functional and genetic interactions between<br />
doublecortin and lissencephaly-1 (LIS1) in neuronal<br />
migration<br />
T. Tanaka a , C. Paczkowski a,b , F.F. Serneo a , S. Sasaki c , M.J.<br />
Gambello d , S. Hirotsune c , A. Wynshaw-Boris b,d , J.G.<br />
Gleeson a,b<br />
a Department of Neurosciences,<br />
b Graduate Program in<br />
Neurosciences, d Departments of Pediatrics and Medicine,<br />
<strong>University</strong> of California, San Diego, USA; c Center for<br />
Genome Medical Science, Saitama Medical School,<br />
Saitama, Japan<br />
Neurons destined for cerebral cortex must migrate<br />
hundreds of cell-body distances to reach their final destination.<br />
Neuronal migration is dependent upon doublecortin<br />
(DCX) and lissencephaly-1 (LIS1), as humans with mutations<br />
in either gene display defective migration. However,<br />
very little is known about the molecular events underlying<br />
neuronal migration and its disorders. Here we show that<br />
LIS1 and DCX function on a common pathway in neuronal<br />
migration. We adopted a cerebellar granule cell migration<br />
assay system with retroviral transduction of either wild type<br />
proteins or fluorescently-tagged proteins to study the effect<br />
of gene overexpression and to determine the subcellular<br />
localization of these proteins during cell migration in<br />
vitro. To study the effect of loss of function of LIS1, we<br />
utilized neurons from LIS1 deficient mice. LIS1 deficient<br />
neurons displayed a dose dependent decrease in migration<br />
distance. Overexpression of LIS1 or DCX in wild type (WT)<br />
neurons resulted in increased neuronal migration distance.<br />
DCX overexpression rescues the migration defect in LIS1<br />
deficient neurons. These results suggest that LIS1 and DCX<br />
have dosage-sensitive effects on neuronal migration in both<br />
deficiency and overexpression.<br />
FP-F-013<br />
Angelman syndrome: a case report<br />
M.H. Ortiz, E.C. Cutiongco, S.G.P. Perez<br />
Neurodevelopmental Section, Child Neuroscience Division,<br />
Philippine Children’s Medical Center, Quezon City, Philippines<br />
Angelman syndrome (AS) is a neurological disorder associated<br />
with severe developmental delay, speech impairment,<br />
gait ataxia and characteristic behavior of inappropriate<br />
laughing and smiling. It affects approximately 1 in<br />
12 000–20 000 individuals and is caused by the loss of<br />
maternally imprinted contribution in the 15q11–13 region<br />
which can occur by at least five different known genetic<br />
mechanisms. This is a case report of a 4.5-year-old Filipino<br />
boy seen at the Philippine Children’s Medical Center. He<br />
presented with feeding problems (2 months), developmental<br />
delays (4 months), frequent smiling (9 months), seizures<br />
(2.6 years), and sleep disturbance (4 years). Pertinent physical<br />
examination revealed microcephaly (47 cm P , 2 Nellhaus),<br />
wide mouth, wide-spaced teeth and prominent<br />
mandible. Neurological examination showed an inappropriate<br />
happy demeanor, fleeting eye contact, short attention<br />
span, hyperactivity, monosyllabic utterances, drooling,<br />
and mouthing. On gait testing, ataxia was noted with arms<br />
abducted and elbows flexed. Deep tendon reflexes were<br />
hyperactive. Diagnostic investigations revealed gastroesophageal<br />
reflux on barium swallow; generalized and multifocal<br />
epileptiform discharges and focal and generalized<br />
slowing of the background activity on EEG; and normal<br />
cranial MRI. Cytogenetic study revealed a normal karyotype<br />
on routine high resolution G banding which was then<br />
augmented with FISH technique using the probes small<br />
nuclear ribonucleoprotein and D15S10 loci. On FISH analysis,<br />
a deletion was detected on one of his chromosome 15<br />
confirming the diagnosis of Angelman Syndrome. This may<br />
represent the first reported genetically-confirmed AS in the<br />
Philippines.<br />
FP-F-014<br />
Angelman syndrome in Malaysian children<br />
M.-K. Thong<br />
Department of Paediatrics, <strong>University</strong> of Malaya Medical<br />
Centre, Kuala Lumpur, Malaysia<br />
AS is a neurodevelopmental disorder characterized by<br />
severe intellectual disability, movement or balance disorder,<br />
microcephaly, speech impairment with absent or minimal<br />
speech and seizures with characteristic electroencephalogram.<br />
Earlier reports emphasized the typical behavioral<br />
phenotype such as the ‘happy’ disposition, frequent laughter,<br />
hand-flapping movements and hyperactivity. Consensus<br />
for diagnostic criteria for AS included a normal antenatal<br />
and birth history, normal head circumference at birth with<br />
absence of major birth defects, on-going developmental<br />
delay evident by 6–12 months of age with no regression,<br />
normal laboratory investigations and absence of structural<br />
brain abnormalities. Other associated clinical features<br />
present in 20–80% of patients include flat occiput, deepset<br />
eyes, prognathism, wide mouth with widely spaced<br />
teeth, fair skin and hair, hyperreflexia and drooling. Diagnosis<br />
is based on diagnostic criteria and usually difficult in
464<br />
Abstracts<br />
the first 2–3 years of life. Other conditions with similar<br />
presentation include Rett syndrome, autism, Lennox-<br />
Gastaut syndrome and cerebral palsy. Currently, molecular<br />
diagnosis with DNA methylation study has improved the<br />
accuracy of the diagnosis. However, most reports are<br />
centred upon Caucasian children and there are very few<br />
reports of Angelman syndrome in Asian children. We report<br />
our series of Malaysian children of Malay, Chinese and<br />
Indian ethnic background with Angelman syndrome.<br />
FP-F-015<br />
A case of Niikawa-Kuroki syndrome with chromosomal<br />
abnormality 46, XY, add (22)(p11,2)<br />
M. Sakurai a , H. Satoh a , I. Ichihashi a , K. Yamaguchi a ,T.<br />
Takeuchi a , J. Furusho a , Y. Iikura a , K. Kumagai a,b<br />
a Department of Pediatrics, School of Medicine, Showa<br />
<strong>University</strong>, Tokyo; b Chisaki-Hanano-Sono, Institution for<br />
Social Welfare Corporation, Japan<br />
Niikawa-Kuroki syndrome (Kabuki make-up syndrome)<br />
is characterized by unusual face, mental retardation, skeletal<br />
anomalies, dermatoglyphic abnormalities, and postnatal<br />
growth retardation. However no certain causal factor has<br />
been identified in this syndrome. We report 1 year old boy<br />
case of Niikawa-Kuroki syndrome with chromosomal<br />
abnormality (46,XY, add (22)(p11,2)). He was the second<br />
child of healthy parents. Facial anomalies, skeletal anomalies<br />
and pulmonary artery stenosis were found at birth.<br />
Cataract, mild mental retardation, growth retardation,<br />
dermatoglyphic abnormalities, and dilatation of sylvian<br />
fissure on cranial MRI are noted now. His parents have<br />
no chromosomal abnormalities. Thirteen cases of chromosome<br />
abnormalities in associated with Niikawa-Kuroki<br />
syndrome have been reported. In summary, dominant<br />
inheritance, ring (X) chromosomes and a severe phenotype,<br />
Turner syndrome and pseudoautosomal dominant inheritance<br />
are speculated. In our case, it is very interesting<br />
that his chromatin abnormality is localized to the autosomal<br />
chromatin area (p11,2).<br />
FP-F-016<br />
Dandy-Walker malformation, hypertrophic<br />
cardiomyopathy and cranial anomalies in a newborn: a<br />
new case of 3C syndrome<br />
F. Fabbri, C. Galasso, A. Di Paolo, L. Cristina, F.<br />
Silvestrini, P. Curatolo<br />
Department of Pediatric Neurology, Tor Vergata <strong>University</strong>,<br />
Rome, Italy<br />
Ritscher-Schinzel syndrome or 3C (cranio-cerebellocardiac)<br />
syndrome, characterized by congenital heart<br />
malformation, cerebellar anomalies and cranial defects, is<br />
a rare genetic syndrome only recently delineated. Until now<br />
28 cases have been reported. Craniofacial findings include<br />
cleft palate, ocular coloboma, prominent occiput and forehead,<br />
hypertelorism, down-slanting palpebral fissures,<br />
depressed nasal bridge and micrognathia. Cerebellar<br />
anomalies including Dandy-Walker malformations<br />
(DWM) or its variant are responsible for gross motor<br />
delay associated with secondary hypotonia. Speech delays<br />
are reported in surviving patients. We describe a baby born<br />
at 37 weeks by Caesarean section, from healthy and nonconsanguineous<br />
parents. At 24th week of pregnancy a<br />
routine ultrasound scan detected DWM and cardiac defect.<br />
Birth weight was 2980 g, length 48 cm, and head circumference<br />
35 cm. The infant had no asphyxia at birth; Apgar<br />
scores were 8 and 10 at 1 and 5 min, respectively. At birth<br />
the baby was noted to have typical dysmorphic findings of<br />
3C syndrome. Hepatosplenomegaly and bilateral cryptorchidism<br />
were found. Neurological examination revealed<br />
severe generalized hypotonia with poor spontaneous movements<br />
and poor sucking reflex. Grasp reflexes, Moro and<br />
other primitive reflexes were elicitable but weak. Karyotype<br />
was normal (46,XY) and the 22q11.2 microdeletions (FISH)<br />
were excluded. Cerebral MRI showed: a posterior fossa<br />
cystic malformation with vermis hypoplasia and upward<br />
displacement of the tentorium without evidence of hydrocephalus.<br />
Echocardiogram and cardiac MRI revealed a<br />
hypertrophic cardiomyopathy with secondary valvular<br />
defects. This syndrome should be considered in the differential<br />
diagnosis whenever a newborn is found to have the<br />
DWM, or its variant phenotype, and craniofacial<br />
dysmorphic findings.<br />
FP-F-017<br />
Visual and quantitative analysis of EEG in children with<br />
a cavum of the septum pellucidum<br />
M. Kacinski, A. Kubik, M. Dolik-Michno, G. Augustyn, L.<br />
Bednarski<br />
Department of Pediatric Neurology, Collegium Medicum,<br />
Jagiellonian <strong>University</strong>, Krakow, Poland<br />
Purpose: Persistent cavum of the septum pellucidum<br />
(CSP) is an anomaly of the brain midline and is considered<br />
a marker of brain dysgenesis. The aim of the project was to<br />
determine whether the symmetry and synchrony of the<br />
bilateral bioelectric activity of the brain is different in children<br />
with and without CSP. Material: A group of 17 children<br />
with a CSP and a control group matched for age and<br />
sex were examined. The analysis included 136 pairs of<br />
EEG curves from independent leads from above both the<br />
hemispheres. Methods: A PL-EEG-24 Classic Campaign<br />
Video option apparatus was used for recording the data.<br />
Apart from visual analysis performed by a doctor, mathematical<br />
analysis was used to estimate 7-s sections of the<br />
EEG recording, Fourier transformation included. Results:<br />
The results were shown in the form of topographic description,<br />
symmetry, synchrony, character, frequency, amplitude,<br />
shape of the pattern, physiological factors and
Abstracts 465<br />
faulty elements. The results of the quantity estimation<br />
included the correlation analysis of the signal, as well as<br />
the analysis of the statistic factors and a description by<br />
means of time-frequency analysis. The strength of the<br />
signal was proved to be several times higher and the statistic<br />
factors were twice higher in CSP children in comparison<br />
to the controls; in addition the former displayed<br />
bilateral asymmetry of the activity in terms of frequency<br />
and amplitude. The differences frequently escaped the<br />
visual analysis. Conclusions: It is necessary to use the<br />
mathematical analysis of EEG in children with a cavum<br />
of the septum pellucidum. This paper was supported by a<br />
grant No 4 PO5E 124 18 of the State Committee of the<br />
Scientific Research.<br />
FP-F-018<br />
Long-term efficacy of active congenital hydrocephalus<br />
treatment in pediatric patients: results of 10-year followup<br />
L.M. Kuzenlova, O.I. Maslova, V.M. Studenikin, E.I.<br />
Stepakina<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
Background: Therapy for children with active congenital<br />
hydrocephalus remains a challenge both for pediatric<br />
neurologists and neurosurgeons. Benefits of conservative<br />
versus surgical treatment are still widely disputed. Goal:<br />
Our intention was to compare the long-term efficacy of<br />
various treatment strategies for patients with different<br />
disease types. Methods: Forty pediatric patients with various<br />
hydrocephalus types (originally aged 3 months–2 years)<br />
were followed-up for a 10-year period. Every available<br />
diagnostic procedure was incorporated. Conservative treatment<br />
was used in 20% of cases, and neurosurgery was<br />
performed in 80% of children (including ventriculo-atrial,<br />
ventriculo-peritoneal, and lumbo-peritoneal shunting).<br />
Results: Decrease of linear and planometric indices was<br />
registered in all patients (as judged from CT and MRT<br />
results). Symptomatic epilepsy (with focal sites localized<br />
by shunting regions) was evident in 85% of surgical cases,<br />
and decreased brain tissue perfusion present in the areas of<br />
surgical shunting (100%). As for biochemical hydrocephalus<br />
markers (levels of xanthine and hypoxanthine), these<br />
two indices were significantly increased in lumbar and<br />
ventricular liquor of patients with severe forms of hydrocephalus<br />
(after conservative/surgical therapy, concentrations<br />
of these two metabolites tended to decrease, but still<br />
remained elevated, suggesting that metabolic and energetic<br />
processes in brain tissue were only partially restored).<br />
Conclusion: Efficacy of surgical and non-surgical treatment<br />
protocols for hydrocephalus is still debatable and remains to<br />
be established.<br />
FP-F-019<br />
Place of hydrocephalus in cerebral dysgenesis in infants<br />
O.I. Maslova, V.M. Studenikin, S.Y. Ishkhanova, L.M.<br />
Kuzenkova, E.I. Stepakina<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
Background: Most congenital anomalies and malformations<br />
of the central nervous system are known either to be<br />
combined with or to induce formation of hydrocephalus,<br />
which fact supplements heavily to clinical course and prognosis<br />
of the disease. Goal: Aim of our study was to reveal<br />
the incidence of hydrocephalus in cerebral dysgenesis<br />
syndromes among a group of 1st year patients. Method:<br />
Case histories of 112 pediatric patients with verified cerebral<br />
dysgenesis (infants aged from 1 to 12 months, among<br />
them 78 males and 34 females), hospitalized in our clinic in<br />
1999–2001, were analyzed. Additional diagnostic methods<br />
of neurovisualization (CT, MRI, and neurosonography,<br />
SPECT) were utilized. Results: Excessive head circumference<br />
(pathological) accretion was registered in 26.8% of<br />
cases during the first 6 months of life (30 patients), considered<br />
as an active hydrocephalus form in seven cases, and as<br />
residual or passive hydrocephalus in the rest of patients (23<br />
cases). Etiology of verified hydrocephalus cases varied from<br />
various pathological conditions, such as congenital malformations<br />
and intrauterine infections, to intraventricular<br />
hemorrhages, etc. Conclusion: Our data suggest that hydrocephalic<br />
cases should be identified during infancy. Active<br />
forms of the disease require administration of acetazolamide,<br />
while drugs of such kind are not routinely indicated<br />
for patients with static hydrocephalus. No explanation can<br />
be currently offered concerning the predominance of male<br />
hydrocephalic cases over female ones, other than for genetic<br />
mechanisms involved.<br />
FP-F-020<br />
Chinese fragile X syndrome<br />
Y.-Z. Guo, J.-H. Chia, S.-P. Zhang, Y. Dan, S.-M. Zhao, S.-<br />
Z. Wang<br />
Department of Pediatrics PUMC Hospital, CAMS and<br />
PUMC, Beijing, China<br />
Objective: Fragile X syndrome is the most common<br />
inherited mental retardation (MR) with an IQ level less<br />
than 60. Studies have been done how to perform screening<br />
and diagnosis of fragile X syndrome. Study design: Nine<br />
clinical characteristics from special patient records of 190<br />
boys and 18 female pediatrics for fragile X screening testing<br />
were analyzed. The characteristics included mental<br />
retardation, family history of mental retardation, elongated<br />
face, large or prominent ears, attention deficit hyperactivity<br />
disorder, autistic-like behavior, simain crease, macroorch-
466<br />
Abstracts<br />
idism and hyperextensible joints. The disease was screened<br />
with PCR amplified to detect (CGG) n repeat sequence, and<br />
diagnosed with PCR, Southern hybridization. Results:<br />
Seven cases were diagnosed with fragile X syndrome by<br />
Southern analysis on PCR product. Six boys have been<br />
identified to carry fragile X full mutation and one mosaicism<br />
that consists of a premutation (CGG repeat<br />
size ¼ ,100) allele. Among the nine characteristics,<br />
simian crease, macroorchidism, and hyperextensible joints<br />
were eliminated, because of low frequency and statistical<br />
insignificance. Using the remaining six-item criteria for<br />
requesting fragile X testing, about more than 60% of this<br />
test in our cases could have been eliminated clinically<br />
without missing any positive cases. Thereby the proportion<br />
of case with positive result improved from 3.4 to 8.8%.<br />
Conclusion: Our simplified six-item clinical checklist<br />
obviously increased the proportion of cases with positive<br />
FRAXA. The PCR method is fast, simple and useful in<br />
screening FRAXA.<br />
FP-F-021<br />
Place of hydrocephalus in the structure of cerebral<br />
dysgenesis in infants<br />
O.I. Maslova, V.M. Studenikin, S.Yu. Ishkhanova, L.M.<br />
Kuzenkova, E.I. Stepakina<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
Background: Most congenital anomalies and malformations<br />
of the central nervous system are presently known<br />
either to be combined with or to induce formation of<br />
hydrocephalus. This fact supplements heavily clinical<br />
course and prognosis of the disease. Goal: Aim of our<br />
study was to reveal the incidence of hydrocephalus in the<br />
structure of cerebral dysgenesis syndromes among the<br />
group of 1st year patients. Methods: Case histories of<br />
112 pediatric patients with verified cerebral dysgnenesis<br />
(infants aged from 1 to 12 months; 78 males and 34<br />
females), hospitalized in our clinic in 1999–2001, were<br />
analyzed. Additional diagnostic methods of neurovisualization<br />
(CT, MRT and neurosonography, SPET, etc.) were<br />
utilized. Results: Excessive head circumference (pathological)<br />
accretion was registered in 26.8% of cases during the<br />
first 6 months of life (30 patients); active hydrocephalus in<br />
seven cases and residual or passive hydrocephalus in 23<br />
cases. The origin of hydrocephalus varied from various<br />
pathological conditions, such as congenital malformations<br />
and intrauterine infections, to intraventricular hemorrhages,<br />
etc. Conclusion: Our data suggest that hydrocephalic cases<br />
should be properly examined, as infants with active forms<br />
of the disease require administration of acetazolamide,<br />
while drugs of such kind are not routinely indicated for<br />
patients with residual hydrocephalus. No explanation can<br />
be currently offered concerning the predominance of male<br />
hydrocephalic cases over female ones, except for genetic<br />
mechanisms involved.<br />
FP-G<br />
Infection/Immunology<br />
FP-G-001<br />
Elevated cerebrospinal fluid levels of anti-CD 9<br />
antibodies in patients with subacute sclerosing<br />
panencephalitis<br />
T. Shimizu a,b,f , T. Matsuishi b , R. Iwamoto e , K. Nihei h ,H.<br />
Yoshioka c , H. Kato b , S. Ueda d , H. Hara f,g , T. Tabira f,g ,E.<br />
Mekada a,e<br />
a Institute of Life Science, b Department of Pediatrics, School<br />
of Medicine, Kurume <strong>University</strong>, Kurume; c Department of<br />
Pediatrics, Kyoto Prefectural <strong>University</strong> of Medicine,<br />
Kyoto; Departments of d Neurovirology and e Cell Biology,<br />
Research Institute for Microbial Diseases, Osaka <strong>University</strong>,<br />
Osaka; f Division of Demyelinating Disease and Aging,<br />
National Institute of Neuroscience, Kodaira;<br />
g National<br />
Institute of Longevity Sciences, Aichi, Japan; h National<br />
Children’s Hospital<br />
SSPE is a slowly progressive and highly lethal disease of<br />
the central nervous system. Although the primary cause of<br />
SSPE is persistent infection of neuronal and glial cells by<br />
measles virus, the precise mechanism of the progression of<br />
this disease has not yet been elucidated. CD9, a member of<br />
the tetraspanin family, is expressed in myelin and other<br />
nervous tissues, and this study found that significant<br />
amounts of anti-CD9 antibodies were detected in the<br />
CSF of all SSPE patients. Anti-CD9 antibodies were also<br />
detected in the CSF of some cases of other neurological<br />
disorders, but in these patients’ levels were lower than in<br />
patients with SSPE. The level of anti-CD9 antibodies was<br />
elevated and reached a peak that coincided with the<br />
appearance of brain atrophy. Our findings appear to indicate<br />
a new aspect of the etiology and progression of this<br />
disease.<br />
FP-G-002<br />
Long-term follow up of the intelligence development of<br />
Japanese encephalitis (JE) patients<br />
B. Wang, D. Ding, Z. Hong<br />
Institute of Neurology, Fu Dan <strong>University</strong>, Hua Shan Hospital,<br />
Shanghai, China<br />
Objective: To observe the impact of the JEV infection on<br />
the intelligence development of JE patients. Methods:<br />
Forty six Japanese encephalitis virus (JEV) serological<br />
test positive encephalitis patients and 33 JEV serological<br />
test negative encephalitis patients were followed up for 8–<br />
26 years. Mini-mental state examination (MMSE) and<br />
Wechsler’s Intelligence test were used for examination
Abstracts 467<br />
for them as well as 46 healthy people who were 1:1<br />
matched by 46 JE patients. Results: Seven (15.2%) JE<br />
patients were diagnosed as mental retardation (FIQ , 70).<br />
Among them, six patients’ MMSE scores were under 21.<br />
Comparing the FIQ, VIQ, PIQ, and IQ sub-tests within<br />
these three groups, all the scores of JE patients are lower<br />
than those of other two control groups. Conclusion: JEV<br />
infection during the childhood had severe impact to the<br />
intelligence development. The intelligence development<br />
of JE patients was worse than those of patients suffered<br />
other encephalitis and normal controls.<br />
FP-G-003<br />
Long-term sequelae of Japanese encephalitis<br />
D. Ding, Z. Hong, B. Zhou<br />
Institute of Neurology, Fu Dan <strong>University</strong>, Hua Shan Hospital,<br />
Shanghai, China<br />
Objective: To measure the risk of long-term post-JE<br />
illness-associated disability, and give the basis of estimating<br />
the disease burden of JE. Methods: We carried out a<br />
retrospective, controlled cohort study with participation of<br />
neurologists-experts, to follow up patients suffering from<br />
JE from 1973 to 1994. Two control groups, no-JE (JE<br />
serological test negative) patients and healthy people,<br />
were followed up as control groups. Physical and neurologic<br />
examinations, IQ measurement and MMSE were used<br />
for examination. Results: We found 29 [34%, (95% CI: 24–<br />
44%)] JE patients (including the dead) with long-term<br />
sequelae associated with JE among the 85 patients<br />
followed up, six [8%, (95% CI: 2–14%)] no-JE patients<br />
(including the dead) with long-term sequelae associated<br />
with no-JE among the 73 patients followed up, and only<br />
one [1%, (95% CI: 21–3%)] subject with IQ ¼ 82 in<br />
normal control group. The proportion of long-term sequelae<br />
of JE patients is larger than that of no-JE and normal<br />
control group with the relative risk of 4.15 (95% CI: 1.83–<br />
9.44) and 26.61 (95% CI: 3.71–190.76), respectively<br />
(P , 0:00). Conclusion: The long-term post-JE illnessassociated<br />
disability is very severe, and will give heavy<br />
burden to the society and families.<br />
FP-G-004<br />
CSF b 2 -MG value for the diagnosis of convulsive<br />
diseases<br />
J.-K. Wei, H.-Z. Liu, Y. Tian, X.-Y. Li, Y.-C. Wang, X.-M.<br />
Ma, P.-F. Wei<br />
The Affiliated Hospital of Hebei Medical College for Continuing<br />
Education, Baoding, China<br />
Objective: Mild viral meningitis with convulsions is<br />
similar to infectious toxic encephalopathy in general clinical<br />
manifestations. It is difficult to make therapy scheme<br />
and to predict prognosis. The objective of this paper is to<br />
investigate the search differential diagnosis value of CSF<br />
b 2 -microglobulin (b 2 -MG, X ^ S ng/ml) measuring. Methods:<br />
CSF b 2 -MG was detected in cases with mild viral<br />
meningitis with convulsions and in those with infectious<br />
toxic encephalopathy with CSF b 2 -MG of non-infectious<br />
non-hemorrhagic convulsions by radio-immunization using<br />
the wide-range testing box provided by China Atomic<br />
Scientific Research Institute. Each group included 38<br />
cases. Result: CSF b 2 -MG in mild viral meningitis<br />
(2484.01 ^ 357.57) was obviously higher than that in<br />
infectious toxic encephalopathy (1043.78 ^ 140.73)<br />
(P , 0:01) and the non-infectious non-hemorrhagic<br />
convulsion group (972.12 ^ 102.03), but CSF b 2 -MG in<br />
infectious toxic encephalopathy was not significantly<br />
different from that in non-infectious non-hemorrhagic<br />
convulsion group. Conclusions: CSF b 2 -MG testing is of<br />
help to differentiate mild viral meningitis from infectious<br />
toxic encephalopathy when their clinical symptoms are<br />
similar.<br />
FP-G-005<br />
Effects of early compositive treatment with<br />
immunoglobulin (IG) on serious CNS viral infection<br />
J.-K. Wei, H.-Z. Liu, X.-F. Li, Y.-H. Xu, X. Shi, X.-R. Cao<br />
The Affiliated Hospital of Hebei Medical College for Continuing<br />
Education, Baoding, China<br />
To explore the effects of compositive treatment with IG<br />
in different disease stages on serious CNS viral Infection,<br />
retrospective analysis was taken on 84 cases (1–13 years<br />
old) of serious CNS viral infection. Among them seven<br />
cases had herpes simplex, three cases EB, one case pox<br />
viral infection. The treatment included IG (1.5–2 g/kg IV<br />
divided into 3–5 days), combined with Ribavirin (R, 15<br />
mg/kg daily, 10–14 days) and/or Acyclovir (A, 10–15 mg<br />
daily, 10–14 days), Dexamethasone (0.5–1 mg/kg daily, 5–<br />
7 days), Cerebrolysin (1 ml/kg daily, 10–14 days) and<br />
other supportive therapies. Some cases were subjected to<br />
EEG and CT scan tests. To compare the effect on two<br />
groups, 50 cases of early compositive treatment group<br />
(within 3 days of disease stage) and 34 cases of late<br />
(Middle/Late, M/L) treatment group (after 3 days of<br />
disease stage), we found early treatment is more effective<br />
than later treatment, especially the group with compositive<br />
treatment with IG and R 1 A showed the best result (Table<br />
3).<br />
Table 3<br />
The effect on compositive treatment on meningitis with IG in two stages<br />
Dead Low intelligence Epilepsy Cerebral palsy Recovery<br />
Early 1 3 4 0 42<br />
M/L 5 7 7 3 12
468<br />
Abstracts<br />
FP-G-006<br />
Angiostrongyliasis cantonensis in children: 3 years<br />
follow-up of two cases<br />
X.-Y. Ye, H.-W. Hu, Z.-D. Lin, G.-Q. Li, Y.-L. Zhang<br />
Neurology department, the Yu-Ying Children Hospital<br />
affiliated to Wenzhou Medical College, Wenzhou, Zhejiang,<br />
China<br />
Objective: To confirm the prognosis and manifestations,<br />
and the differences from adults, of Angiostrongyliasis<br />
cantonensis in children. Methods: We analyzed the manifestations,<br />
diagnosis and treatment in two children (a 4-<br />
year-old boy and a 2-year-old girl) with Angiostrongyliasis<br />
cantonensis infection. The two cases had been followed up<br />
for 3 years. Results: The disease was characteristically<br />
demonstrated with eosinophilic meningitis (boy) or eosinophilic<br />
meningoradiculitis (girl). Symptoms of elevated<br />
intracranal pressure and abnormal sensation was observed<br />
in the 2nd week after the onset of the disease. Eosinophils of<br />
peripheral blood and cerebrospinal fluid had been increased<br />
for one month, 43 worms (42 larva) were collected from<br />
CSF during the 1st week of hospitalization in the girl. It<br />
was shown that the conduction was delayed in both patients<br />
at upper brain stem on BAEP, meanwhile intracranial/spinal<br />
CT scan or MRI was negative. After two courses (1 week<br />
per month as a procedure) of the treatment with mannitol,<br />
dexamethasone and Zental, the boy recovered, but the girl’s<br />
CFS returned normal 4 months later after the treatment. The<br />
boy was found without any abnormality associated with the<br />
episode. The girl showed neurological bladder, although it<br />
was gradually improved. Conclusion: In the patient with<br />
Angiostrongyliasis cantonensis, eosinophilic meningitis<br />
would result in complete recovery, but eosinophilic meningoradiculitis<br />
may be followed by some sequelae. The<br />
outcome may be associated with the loci of the disease,<br />
but not with the age of patient.<br />
FP-G-007<br />
The influence of dexamethasone on TNF-a and IL-8<br />
contents in brain tissue during edema induced by<br />
lipopolysaccharide in rats<br />
H.-L. Wang, J.-P. Lu<br />
Department of Pediatrics, The First Affiliated Hospital,<br />
Zhengzhou <strong>University</strong>, Zhengzhou, China<br />
Objective: To study the influence of dexamethasone<br />
(DXM) on TNF-a and IL-8 expression and the relation<br />
between them in brain edema induced by lipopolysaccharide<br />
(LPS) in rats. Methods: TIA and ELISA methods were<br />
used to measure the contents of TNF-a and IL-8 in brain<br />
tissue after brain edema induced by LPS in rats. Results:<br />
The water content and Evans blue (EB) were increased<br />
significantly in the brain tissue of rats in LPS group and<br />
DXM group compared with those of the rats in NS group<br />
(P , 0:05). The levels of TNF-a and IL-8 in brain tissue of<br />
the rats in LPS group were higher than those in NS group<br />
(P , 0:01). The levels of TNF-a and IL-8 in brain tissue in<br />
DXM group were higher than those in NS group in earlier<br />
time (P , 0:05). After 24 h, there was no significant difference<br />
(P . 0:05) between them. In the LPS group, the water<br />
content in brain tissue and EB content, TNF-a and water<br />
content in brain tissue, IL-8 and water content in rain<br />
tissue, IL-8 and EB content were all have positive correlation<br />
(r were 0.537, 0.423, 0.437, 0.831, respectively,<br />
P , 0:05). Conclusion: TNF-a and IL-8 could participate<br />
in the onset and development of brain edema induced by<br />
LPS. Glucocorticoid could inhibit the production of inflammatory<br />
cytokines and attenuate inflammatory response and<br />
tissue injury.<br />
FP-G-008<br />
The role of tumor necrosis factor-a and interlerlcukin-8<br />
in the pathogenesis of brain edema induced by LPS in rat<br />
J.-P. Lu, H.-L. Wang<br />
Department of Pediatrics, The First Affiliated Hospital,<br />
Zhengzhou <strong>University</strong>, Zhengzhou, China<br />
Objective: To study the role of TNF-a and IL-8 in the<br />
pathogenesis of brain edema induced by LPS in rats. Methods:<br />
RIA and ELISA methods were used to measure the<br />
contents of TNF-a and IL-8 in brain tissue after infectious<br />
brain edema was induced by LPS in rats. Results: The<br />
levels of TNF-a and IL-8 in brain tissue in the LPS<br />
group were successively increased as compared to the<br />
blank control group and NS group (P , 0:01) They continued<br />
to be high until 48 h. In the LPS group, water content<br />
in brain tissue and EB content, TNF-a and water content in<br />
brain tissue, IL-8 and water content in brain tissue, IL-8<br />
and EB content were all have positive correlation. (r was<br />
0.537, 0.423, 0.437, 0.831, respectively, P , 0:05).<br />
Conclusion: TNF-a and IL-8 could contribute to the<br />
onset and development of inflammatory brain edema<br />
induced by LPS and have closely relationship with brain<br />
injury.<br />
FP-G-009<br />
Levels of insulin-like growth factors in cerebrospinal<br />
fluid of children with meningitis<br />
X.-P. Guo, G.-C. Xue, T.-X. Shi, W.-M. Wang<br />
Department of Pediatrics, the First Affiliated Hospital of<br />
Xinxiang Medical College, Weihui, Henan, China<br />
The insulin-like growth factors, IGF-I and IGF-II, are<br />
potent mitogenic and anabolic peptides. They play prominent<br />
roles in the regulation of immunity and inflammation.<br />
We used an immunoradiometric assay kit for measuring<br />
CSF IGF-I and IGF-II in four groups of patients: bacterial<br />
meningitis (7), tuberculous meningitis (5), viral meningitis<br />
(21), and normal controls (15). Levels of CSF IGF-I in
Abstracts 469<br />
patients with bacterial meningitis and tuberculous meningitis<br />
were elevated in comparison with that in the control<br />
subjects (P , 0:001 and P , 0:001, respectively), but the<br />
levels of IGF-I in CSF of patients with viral meningitis<br />
were not elevated (P ¼ 0:199). The patients with bacterial<br />
meningitis or tuberculous meningitis had significantly<br />
higher levels of CSF IGF-I than those with the viral meningitis<br />
(P , 0:001 and P ¼ 0:001, respectively). CSF levels<br />
of IGF-II in patients with bacterial meningitis were<br />
elevated in comparison with levels in the control subjects<br />
(P , 0:001) but the levels of IGF-II in CSF of patients<br />
with tuberculous meningitis and viral meningitis were not<br />
elevated (P ¼ 0:221 and P ¼ 0:512, respectively). The<br />
patients with bacterial meningitis had significantly higher<br />
levels of CSF IGF-II than those with tuberculous meningitis<br />
and viral meningitis (P ¼ 0:050 and P ¼ 0:001, respectively).<br />
These data suggested that IGF-I and IGF-II might<br />
play an important roles in the pathophysiological process<br />
of meningitis, especially bacterial meningitis.<br />
FP-G-010<br />
Levels of insulin-like growth factor binding protein-3 in<br />
cerebrospinal fluid of children with meningitis of<br />
different etiologies<br />
G.-C. Xue, X.-P. Guo, T.-X. Shi, F.-L. Zhu, F.-Y. Wang, H.-<br />
Y. Qian<br />
Department of Pediatrics, the First Affiliated Hospital of<br />
Xinxiang Medical College, Weihui, Henan, China<br />
Objective: To observe changes of insulin-like growth<br />
factor binding protein-3 (IGFBP-3) in the CSF of children<br />
with viral meningitis, tuberculous meningitis, and partially<br />
treated bacterial meningitis, and the relations between<br />
IGFBP-3 and CSF inflammatory parameters. Methods:<br />
CSF IGFBP-3 levels of these patients with meningitis and<br />
of normal controls were tested by RIA. Results: In comparison<br />
with normal controls, IGFBP-3 levels in CSF of children<br />
with tuberculous meningitis and partially treated<br />
bacterial meningitis were elevated significantly<br />
(P , 0:001 and P , 0:001, respectively), but the levels of<br />
IGFBP-3 in CSF of children with viral meningitis were not<br />
elevated significantly (P ¼ 0:090). The levels of CSF<br />
IGFBP-3 of patients with tuberculous meningitis were<br />
higher than those of patients with partially treated bacterial<br />
meningitis (P , 0:001), and the latter were higher than<br />
those of patients with viral meningitis (P , 0:001). The<br />
CSF IGFBP-3 levels were not significantly correlated with<br />
the CSF leukocyte counts (P ¼ 0:241), CSF protein concentrations<br />
(P ¼ 0:113), and CSF glucose concentrations<br />
(P ¼ 0:320). Conclusion: These data suggested that<br />
IGFBP-3 involved in pathophysiological process of meningitis<br />
and it might be a useful index for differential diagnosis<br />
of viral meningitis, tuberculous meningitis, and partially<br />
treated bacterial meningitis.<br />
FP-G-011<br />
The clinical features and prognostic analysis of acute<br />
myelitis<br />
S.-J. Yu, W. Wang, X. Wang, X. Wu<br />
Department of neurology, Harbin Children’s Hospital,<br />
Harbin, China<br />
We have done an overall analysis of 30 children with<br />
acute myelitis and follow-up of ten cases. The results<br />
showed that clinical features are diverse, and it is easily<br />
misdiagnosed. Children under the age of 6 years were<br />
more likely featured as the transverse lesion than adults,<br />
and may get a relatively long spinal cord shock period and<br />
serious prognosis. The earlier the application of gammaglobulin<br />
and glucocorticoid hormone, the better the prognosis<br />
was observed.<br />
FP-G-012<br />
Diagnosis and treatment of 86 cases with cerebral<br />
malaria<br />
M.-L. Bao, C. Ma, Y. Chen<br />
Inner Mongolia Medical <strong>University</strong>, Hohhot, China<br />
Objective: To investigate the diagnosis and treatment of<br />
cerebral malaria (CM). Materials and methods: Eight six<br />
cerebral malaria children, male 54, female 32, aged 2<br />
months–14 years. Malaria parasites were examined in<br />
blood experimentally. Quinine and other medicine were<br />
given. Results: The rate of malaria parasites was 100%.<br />
After treatment 53 cases were obviously improved on the<br />
1st day and 25 cases on the 2nd day. eight children died.<br />
Conclusion: The early diagnosis of cerebral malaria was<br />
very important. Mortality may be reduced if the medicine<br />
was given timely. The key of the treatment was eliminating<br />
malaria parasites, lowering down intracranial pressure,<br />
controlling high fever, convulsion, and protecting comatose<br />
patients.<br />
FP-G-013<br />
The relationship of neuroimages and clinical status at<br />
different stages of tuberculous meningitis in children<br />
G.-Q. Li, H.-W. Hu, X.-Y. Ye, Z.-D. Lin, J.-W. Zhao, D.-K.<br />
He<br />
Yuying Children Hospital, Wenzhou Medical College,<br />
Wenzhou, Zhejiang, China<br />
Objective: To investigate the relationship of CT and MRI<br />
at different stages of tuberculous meningitis in children and<br />
the clinical status. Methods: Ninety one cases of tuberculous<br />
meningitis at different stages were studied by CT, MRI and<br />
the clinical status. Results: Sixty seven cases were examined<br />
by CT, and 58 cases were abnormal; the abnormality rate<br />
was 86.6%. Thirty eight cases were examined by MRI, and
470<br />
Abstracts<br />
35 cases were abnormal; the abnormality rate was 92.1%.<br />
Changes of CT were similar to those of MRI: changes of<br />
cisterns and sulci or slightly low density of parenchyma in<br />
the early stage; encephaledema and hydrocephalus in the<br />
middle stage; and low, mixed, or high density in parenchyma<br />
and oppressed, occluded, or adhered sulci in the late<br />
stage. Almost recovered patients had slight changes in CT or<br />
MRI. The patients with poor prognosis had obvious changes<br />
in CT or MRI. Conclusion: We thought that CT and MRI<br />
were useful for clinical evaluation of the degree and prognosis<br />
of TM.<br />
FP-G-014<br />
The change of immune function and serial observation<br />
on IL-2R expression of PHA-activated PBL in 20<br />
patients with viral encephalitis<br />
Y.-Y. Liang a , S.-G. Li b , Q.-H. Kong c , X.-J. Yan c<br />
a Children’s Hospital of Shanxi Province, b Department of<br />
Paediatrics, Shanxi Medical <strong>University</strong>, Taiyuan, China<br />
Objective: The aim of study is to evaluate the significance<br />
of T-lymphocyte subsets, IL-2R, NK cells in peripheral<br />
blood, serial observation on IL-2R expression of PHA-activated<br />
(0, 24, 48 and 72 h) PBL in patients with viral encephalitis<br />
in acute and convalescence stages, with a group of<br />
normal children as controls. Methods: The 20 patients with<br />
viral encephalitis and normal controls were recruited into<br />
the study using the immunofluoresent antibody test (IFAT)<br />
method. The results revealed that the percentages of the<br />
CD8, NK, IL-2R, and B cells in patients with viral encephalitis<br />
are obviously increased compared with those of the<br />
control group, but the expression of IL-2R obviously<br />
decreased in patients with viral encephalitis at different<br />
times (0, 24, 48 and 72 h). The percentages of the NK, Il-<br />
2R, CD8, B cells and CD4/CD8 in patients with viral encephalitis<br />
of the convalescence stage were clearly higher than<br />
those in the acute stage. Conclusion: The result suggested<br />
that the measurement of immune function and observation<br />
of IL-2R expression may be regarded as a valuable judge<br />
index in the evaluation of therapy and the prognosis in the<br />
patients with viral encephalitis.<br />
FP-G-015<br />
A study of nitric oxide in serum and cerebrospinal fluid<br />
in children with viral encephalitis<br />
S.-G. Li a , Y.-Y. Liang b , Q.-H. Kong c , X.-J. Yan c<br />
a Department of Paediatrics,<br />
b Shanxi Medical <strong>University</strong>,<br />
and c Children’s Hospital of Shanxi Province, Taiyuan,<br />
China<br />
Objective: The aim of study is to evaluate the significance<br />
of NO in serum and cerebrospinal fluid in children with viral<br />
encephalitis. Methods: Twenty patients with viral encephalitis<br />
and 20 normal controls were recruited into the study.<br />
The levels of NO in serum and cerebrospinal fluid were<br />
determined by spectrophotometry. Result: The result<br />
revealed the level of serum NO in patients with viral encephalitis<br />
was higher than that the normal control (P , 0:01).<br />
The NO level of the serum in patients of acute stage was<br />
clearly higher than that of convalescence stage. The level of<br />
serum NO showed positive relation with the level of cerebrospinal<br />
fluid (r ¼ 0:489, P , 0:01). Conclusion: The<br />
result suggests that the NO level is associated with the<br />
onset, progress and severity in patients with viral encephalitis.<br />
FP-G-016<br />
The change of C-type natriuretic peptide and<br />
neurotensin in rabbit brain injury induced by endotoxin<br />
Y.-C. Zhang, D.-H. Tang, Y.-M. Zhang, L. Xu, L.-Q. Chen<br />
Shanghai Children’s Hospital, Shanghai, China<br />
Objective: To study the change and significance of C-type<br />
natriuretic peptide (CNP) and neurotension (NTin brain<br />
injury induced by endotoxin in rabbits. Methods: One<br />
hundred mg/kg endotoxin was intraventricully injected in<br />
30 New Zealand white rabbits and the same volume of<br />
normal saline was injected in five rabbits as controls. CNP<br />
and NT concentrations were detected by radioimmunoassay<br />
in variable periods in the plasma, CSF and brain tissue<br />
(hippocampus area), and brain water content were measured<br />
by the dry method. Results: The plasma, CSF and brain<br />
tissue CNP concentrations after 3–6 h endotoxin injection<br />
were significantly higher than those of the control group or<br />
before injection (P , 0:05 or P , 0:01). Then, the CNP<br />
altered to decrease in the following periods and the lower<br />
levels emerged at 12–24 h after endotoxin injection. The NT<br />
content were decreased and the lower levels also emerged at<br />
12–24 h after endotoxin injection (P , 0:05 or P , 0:01).<br />
Brain water content was significantly higher (P , 0:05 or<br />
P , 0:01) and reached the peak level at 24 h after injection.<br />
Conclusions: The changes of CNP and NT were related to<br />
brain injury and brain edema induced by endotoxin. The<br />
early high CNP expression may be one of the protective<br />
mechanism.<br />
FP-G-017<br />
The clinical analysis of eight cases in children colti virus<br />
encephalitis<br />
H.-H. Zhu, C.-F. Yan<br />
Guangzhou Children’s Hospital, Guangzhou, China<br />
The study was designed to examine all double serums of 54<br />
children patients, suffering from clinically diagnosed viral<br />
encephalitis from 1999 till 2001. Their serums were checked<br />
to detect pathogens with ELISA provided by Institute of<br />
Virology of Chinese Preventing Medical Academy of<br />
Sciences. Among them, in eight cases IgM anti-colti virus
Abstracts 471<br />
antibodies were positive; males six, females two, the youngest<br />
child 7 months old, and the oldest 10 years old. The<br />
months they got the disease: one in May, one in September,<br />
and in June, July, August, each of them has two cases. All of<br />
them suffered sickness with acuteonset, and all had symptoms<br />
of upper respiratory infection for 1–7 days before they<br />
showed neurological symptoms. All eight cases had fever at<br />
38–39.58C, five of them had consciousness disturbance of<br />
various degrees. Brain CT: showed disseminating low<br />
density foci in one case, and brain atrophy in three cases.<br />
No patient died, five cases recovered; one case developed<br />
secondary epilepsy, one case mild left hemiparesis, one<br />
case disturbance of speech and intelligence. Colti virus is a<br />
new category of Reoviridae, which was denominated by<br />
International Virology Classifying Committee in Berlin in<br />
1990. This virus has been isolated in America, Germany,<br />
France, Indonesia, and also in Beijing, Hainan Province,<br />
Yunnan Province and Gansu Province. In the 54 cases for<br />
this study with double serum testing with ELISA, eight cases<br />
were found to be positive for anti-colti virus IgM antibody.<br />
Today, ELISA is the most widely used examination technique,<br />
which can be applied to checking virus antibodies. This<br />
group of eight cases got the diseases during May–September,<br />
most of them during June–August. Three cases developed<br />
sequelae although there was no fatal case. The colti virus is<br />
one of the pathogens of the summer-autumn children’s viral<br />
encephalitis in the Guangzhou area, and it has severe clinical<br />
symptoms and poor prognosis. It is important for the clinical<br />
staff to pay more attention and confirm the diagnosis.<br />
FP-G-018<br />
Observing evoked potentials of virus encephalitis in 16<br />
children<br />
Y.-L. Zhu, J. Yang, H. Cai, W.-M. Yang, G.-Z. Xu<br />
Capital Institute of Pediatrics, Beijing, China<br />
This paper is discussing whether the evoke potentials<br />
could serve as an evaluation marker of virus encephalitis<br />
causing brain damage. By assaying the evoked potentials at<br />
the acute phase, recovery phase and sequela phase of 16<br />
children the final diagnosis of virus encephalitis, we demonstrated<br />
that in clinically severe virus encephalitis abnormal<br />
evoked potentials were elicited at all clinical stages studied.<br />
We therefore concluded that evoked potential is well correlated<br />
with the prognosis of encephalitis resulting in brain<br />
damage.<br />
FP-G-019<br />
Cerebellar hypoplasia with in utero parvovirus infection<br />
D.L. MacGregor, E.L. Ford-Jones, S. MacPhee, E.N. Kelly,<br />
S. Blaser<br />
The Hospital for Sick Children, Toronto, Ont., Canada<br />
Background: In utero parvovirus infection is associated<br />
with feline cerebellar hypoplasia – kittens so affected<br />
demonstrate dysmetric head movements and abnormal<br />
behavior. In mice and rats, parvovirus has been found to<br />
be teratogenic and similarly to cause cerebellar hypoplasia<br />
with ataxia. Human fetal parvovirus (B19) infection causes<br />
non-immune hydrops and fetal anemia. Autopsy studies<br />
previously reported confirmed hydrops but no other malformations.<br />
However, there are case reports of CNS abnormalities<br />
including ventriculomegaly, periventricular<br />
calcifications, arthrogryposis and neurodevelopmental<br />
disorders. Case report: An 8 month-old girl was referred<br />
for assessment of dysconjugate eye movements and developmental<br />
delay. The pregnancy was complicated by gestational<br />
diabetes mellitus and hypertension. At 28 weeks, fetal<br />
hydrops was diagnosed requiring treatment with in utero<br />
transfusions. A positive culture for parvovirus B19 was<br />
obtained. Delivery was at 30 weeks by Cesarean section<br />
for breech presentation. Neurological examination showed<br />
poor visual responses and wandering eye movements. There<br />
was optic nerve atrophy and underdevelopment of the macular<br />
area. Motor examination demonstrated hypotonia – but<br />
no tremors or ataxia. MRI – showed extensive periventricular<br />
calcification and severe volume loss in the posterior<br />
fossa – including the pons, anterior medulla and cerebellar<br />
hemispheres without sparing of the vermis. Discussion: This<br />
case represents the first human report of cerebellar hypoplasia<br />
with parvovirus infection. P antigens (blood group P<br />
system) – the binding sites for parvovirus, are located on<br />
vascular endothelium and erythroid precursors – suggesting<br />
that vasculitic thrombosis may be a mechanism for brain<br />
injury with in utero parvovirus infection.<br />
FP-G-020<br />
Inborn syphilis – its diagnostics and problems of<br />
treatment<br />
A.A. Ovchinnikova, S.E. Goulyaeva, N.V. Michailichenko,<br />
S.A. Goulyaev<br />
Vladivostok State Medical <strong>University</strong>, Vladivostok, Russia<br />
Peculiarities of the nervous system prenatal pathology of<br />
198 children born from the mothers infected with syphilis<br />
were studied. Ninety seven children took a course of standard<br />
specific therapy and 101 did not take it. The control<br />
group represented children born from 365 mothers infected<br />
through sex relation, of non-syphilitic etiology. It was found<br />
that infant syphilis developed in children born from the<br />
mothers having a second relapse and early latent syphilis.<br />
In the early neonatal period the following triad was<br />
observed: symptoms of generalized infectious intoxication;<br />
intrauterine growth retardation; and signs of central nervous<br />
system irritation. Abnormalities of skin and mucous<br />
membrane were not specific, and they were fragmentary<br />
and transient. Skeletal system abnormalities were revealed<br />
in 15% of the cases. Blood serological tests were not informative.<br />
Among the infants without treatment at full dosage,
472<br />
Abstracts<br />
signs of the central nervous system disturbance were found<br />
in 80% by the end of the 1st month of life. Generalized brain<br />
symptoms were transformed into meningitis and meningoencephalitis.<br />
In cases of treatment according to the traditional<br />
scheme, 30% of the children got delayed meningitis<br />
and meningoencephalitis at 2 or 3 months of life. The diagnosis<br />
was confirmed by serological tests in the cerebrospinal<br />
fluid. The most precise changes were seen by NSG of the<br />
nervous tissue. This study showed that there is no guarantee<br />
for full recovery in children with syphilis by using the traditional<br />
therapy scheme of treatment. Our result points out the<br />
necessity of diagnosing children as ‘inborn syphilis’ at the<br />
very early stages of life in cases with specific clinical<br />
changes (triad) and also the necessity of early treatment in<br />
full dosage, so that the drugs will pass through the blood–<br />
brain barrier in sufficient amount.<br />
FP-G-021<br />
Intercellular adhesion molecule-1 (ICAM-1) mRNA<br />
changes and drug effects in the brain of mice with herpes<br />
simplex encephalitis<br />
L.-Y. Zhu a ,M.Yi b , B. Wei a , B.-M. Wu b<br />
a Pediatric Department, PLA, 202 Hospital, and b Pediatric<br />
Department, The Second Clinical College, China Medical<br />
<strong>University</strong>, Shenyang, China<br />
Objective: To investigate the ICAM-1 mRNA changes in<br />
the brain of mice with herpes simplex encephalitis (HSE),<br />
and in the brain after the treatment with acyclovir (ACV)<br />
or ACV 1 dexamethasone (DEX). Methods: (1) The HSE<br />
mice models were established by HSV-1 injection into the<br />
cerebral ventricle; (2) ICAM-1 mRNA expression was<br />
detected by the half quantitative RT-PCR method; and<br />
(3) The changes in the brain cells of mice were observed<br />
under transmission electron microscopy. Results: (1) In the<br />
control group, the ICAM-1 mRNA expression was very<br />
low but detectable. In the HSE group, the expression<br />
increased gradually, reached the highest point on the day<br />
4, and then decreased gradually. There was no difference in<br />
ICAM-1 mRNA expression between HSE on day 1 and the<br />
control group. ICAM-1 mRNA expression of HSE 2 day<br />
group was slightly higher than that of the control group<br />
(t ¼ 2:46, P , 0:05). (2) ICAM-1 mRNA expression was<br />
decreased significantly after ACV and ACV 1 DEX treatment.<br />
ICAM-1 mRNA expression of HSE 3 day group was<br />
significantly higher than that of ACV 3 day group<br />
(t ¼ 4:02, P , 0:01). No difference was seen in the<br />
ICAM-1 mRNA expression between ACV 3 day group<br />
and ACV 1 DEX 3 day group. (3) The edema of ACV 1<br />
DEX treated mice brain vessels were attenuated. Conclusions:<br />
ICAM-1 was involved in pathological process of<br />
HSE inflammatory reaction. Treating HSE mice with<br />
ACV or ACV 1 DEX could decrease ICAM-1 gene<br />
expression. ACV 1 DEX might be necessary in treating<br />
HSE in the early phase.<br />
FP-G-022<br />
The effect of dexamethasone therapy on the changes of<br />
nitric oxide in children with bacterial meningitis<br />
F. Gao, J.-F. Lu, Q.-X. Shui, Z.-Z. Xia, B.-L. Zhou<br />
Department of Neurology, Children’s Hospital, Zhejiang<br />
<strong>University</strong> Medical College, Hangzhou, China<br />
Objective: To investigate the effect of dexamethasone<br />
therapy on the changes of nitric oxide in children with<br />
bacterial meningitis. Methods: The concentrations of the<br />
end product of nitric oxide (nitrite) and its precursor (larginine)<br />
in CSF of 26 cases of bacterial meningitis were<br />
detected with Griess method and an amino acid analyzer,<br />
and 31 children without any neurologic diseases formed the<br />
control group. Results: (1) The CSF nitrite level of bacterial<br />
meningitis before the treatment of antibiotic drug with or<br />
without dexamethasone was significantly higher than that of<br />
the control group (P , 0:01). The concentrations of l-arginine<br />
were lower in patients than in controls (P , 0:05). (2)<br />
Among the 26 patients, 16 cases were treated with antibiotic<br />
drug only, and the other ten cases were treated with pulsed<br />
dexamethasone. Dexamethasone exerted a significant effect<br />
on the end product of nitric oxide (P , 0:05). CSF nitrite in<br />
children with bacterial meningitis declined to the normal<br />
range after the treatment of antibiotic drug with or without<br />
dexamethasone. (3) CSF levels of l-arginine were significantly<br />
lower in patients with antibiotic drug only than those<br />
with pulsed dexamethasone (P , 0:05). Conclusion: Dexamethasone<br />
therapy might decrease the neuropathologic<br />
damage of patients with bacterial meningitis caused by the<br />
overproduction of nitric oxide partly.<br />
FP-G-023<br />
The protective effect and its mechanism of pretreatment<br />
with curcumin on infectious brain edema in rats<br />
F. Luo, R. Huang, Y.-J. Yang<br />
Department of Pediatrics, XiangYa Hospital, Central South<br />
<strong>University</strong>, Changsha, China<br />
Objectives: To study the protective effect and its mechanism<br />
of pretreatment with curcumin against infectious brain<br />
edema in rats. Methods: SD rats weighing 210 ^ 27 g were<br />
randomly divided into five groups (1) Normal control group<br />
(NS); (2) Infectious brain edema (PB); (3) DMSO control<br />
group; (4) HS pretreatment group; and (5 curcumin pretreatment<br />
group (CUR). The water content (WC), Na 1 and K 1<br />
content in the brain tissue were measured. The content of<br />
MDA and SOD were assessed by chromatometry. The levels<br />
of TNF-a and IL-1b were detected by ELISA. The HSP70<br />
expression was examined by Western blot analysis. Results:<br />
The results were shown: (1) the contents of water and Na 1 ,<br />
MDA, TNF-a and IL-1b were significantly increased in PB<br />
group than in NS group (P , 0:01 or P , 0:05; compared<br />
with PB group, the WC, the content of Na 1 , MDA, TNF-a
Abstracts 473<br />
and IL-1b were significantly decreased in HS and CUR<br />
groups P , 0:01 or P , 0:05; and (2) the content of SOD<br />
was significantly decreased in PB group than in NS group<br />
(P , 0:05). Compared with PB group, the content of SOD<br />
was significantly increased in HS and CUR group<br />
(P , 0:05); (3) Western blot analysis showed that the band<br />
density areas of HS, CUR and PB groups were more<br />
increased than NS and DMSO group, especially in CUR<br />
group. Conclusion: There is a protective effect against infectious<br />
brain edema in rats of pretreatment with curcumin. The<br />
effect might be associated with antioxidant, inhibiting the<br />
activity of cytokines and inducing expression of HSP70.<br />
FP-G-24<br />
Study of enteroviral central nervous system infection by<br />
polymerase chain reaction in China<br />
Z.-B. Chen, Y.-S. Dong, X.-W. Fan<br />
Department of Pediatrics, The Qingdao Haici Hospital of<br />
Qingdao <strong>University</strong>, Qingdao, China<br />
Objective: The aim of the present study was to evaluate the<br />
diagnostic potential of previously published enterovirus<br />
(EV) PCR assay to detect EV in CSF samples from children<br />
with a diagnosis of aseptic meningitis and to investigate the<br />
patient characteristics and epidemic status in China. Methods:<br />
EV RNA was detected in 187 CSF samples and serum<br />
and/or urine samples of partial patients by PCR and developed<br />
viral culture technique. Results: PCR was positive in all<br />
62 CSF specimens with positive viral culture as well (100%).<br />
In addition 93 (74%) of 125 CSF samples with negative viral<br />
cultures had positive PCR. In 21 cases of these 93 patients,<br />
viral culture from other sites (serum and/or urine) was positive.<br />
The positive rate of CSF PCR based on clinical diagnosis<br />
in patients with meningitis of negative bacterial culture<br />
results was 83%, considerably higher than the sensitivity of<br />
CSF virus culture (33%). This PCR results are available<br />
within 4 h, whereas the viral culture of CSF requires 4.6<br />
days for a cytopathic effect to develop. Echovirus 6 and<br />
echovirus 30 in this study caused twice summer outbreak<br />
in different regions of China. The clinical characteristics of<br />
155 patients with EV meningitis are different in different age<br />
groups. Conclusion: EV infection is the most common cause<br />
of aseptic meningitis in China. The PCR assay was rapid,<br />
sensitive and specific for the diagnosis of EV meningitis<br />
and showed the potential for PCR tests to shorten hospitalization<br />
and reduce the use of antibiotics.<br />
FP-G-025<br />
Clinical characteristics and follow-up studies in 22 cases<br />
of herpes simplex encephalitis in children<br />
F. Fang<br />
Beijing Children’s Hospital, Beijing, China<br />
Objective: HSE was one of the severe forms of acute viral<br />
encephalitis in children, with high mortality and morbidity.<br />
We analyzed the clinical characteristics and the prognosis of<br />
herpes simplex encephalitis in children. Method: Twentytwo<br />
patients with HSE, 14 males and eight females, were<br />
included in our study. The ages were between 3 months<br />
and 13 years. Eighteen patients were treated with acyclovir,<br />
15 mg/kg per day for 14 days. Fifteen of 22 patients were<br />
followed up 6 months–6 years, including intellectual ability<br />
assessment, CT examination, etc. Diagnosis of HSE was<br />
based on positive anti-HSV IgM in CSF, or fourfold increase<br />
in anti-HSV IgG titres in the two different CSF samples, or<br />
ratio of serum to CSF anti-HSV antibody titers ,20 by<br />
ELISA; or using PCR to detect HSV-DNA in CSF. Results:<br />
Fever was found in 22 patients (100%), altered consciousness<br />
in 18 patients (81%, coma in 12 patients. The Glasgow Coma<br />
scale scores were ,4 in three cases, 5–7infive cases, 8–9in<br />
four cases. Seizures were found in 16 (72%), vomiting in 13<br />
(59%), headache in ten (45%), personality change in eight<br />
(36%). Cranial nerve paresis in ten (45%), hemiparesis in<br />
seven (31%). Cranial CT and/or MRI showed abnormalities<br />
in 19 of 22 patients. Temporal and frontal lobes were affected<br />
in 12 patients. Cerebral hemorrhages in seven cases. Five of<br />
15 patients recovered during follow-up, three cases were<br />
mildly disabled, five cases moderately disabled, two cases<br />
severely disabled. Conclusions: HSE was classified as mild<br />
and diffuse encephalitis. The early consciousness and<br />
personality changes are clinical characteristics of HSE. Definite<br />
diagnosis of HSE was based on virological diagnostic<br />
tests in CSF. The duration of illness prior to treatment, the<br />
Glasgow Coma scale score and lesions of the brain are important<br />
to prognosis.<br />
FP-G-026<br />
The clinical characteristics and the treatments of brain<br />
abscess in children<br />
J. Xiao<br />
Beijing Children Hospital, Beijing, China<br />
Objective: To summarize the clinical characteristics and<br />
discuss the treatments of brain abscess in children. Methods:<br />
We summarized the clinical characteristics in 37 patients<br />
with brain abscess diagnosed by CT or MRI. Twentythree<br />
of them were followed up from 3 months to 5 years.<br />
Results: The causes of brain abscess in 78% of patients were<br />
obscure. The seizures as the first symptom were presented in<br />
20 patients (54%). Twenty-four patients (65%) were without<br />
fevers, and 18 patients (49%) with headache. Thirty<br />
patients were treated with antibiotics through intravenous<br />
injections for 3–6 weeks. Eleven patients recovered completely,<br />
12 had improvement and one died, and total efficiency<br />
was 77%; seven patients received surgery, one recovered,<br />
three got better. Conclusions: Clinical symptoms of brain<br />
abscess in most children were not specific; we always<br />
needed to do the diagnostic neuroimaging examinations to<br />
make the diagnosis earlier. The conservation treatments
474<br />
Abstracts<br />
with antibiotics under the surveillance of CT or MRI were<br />
the main therapy.<br />
FP-G-027<br />
Clinical research of treatment with ganciclovir on the<br />
virus encephalitis of children<br />
R. Huang, G.-Y. Zhang, Y.-J. Yang, L. Liang, Y. Yu<br />
Department of Pediatrics, Xiangya Hospital of Center South<br />
<strong>University</strong>, Changsha, China<br />
Objective: To observe the clinical therapeutic effect of<br />
ganciclovir in the children with virus encephalitis. Method:<br />
Ninety eight patients with virus encephalitis were<br />
randomly divided into the virazole treatment group (52<br />
cases) and the ganciclovir treatment group (46 cases). Clinical<br />
performance and therapeutic effect were compared.<br />
Results: The mean time of headache, vomiting, seizures<br />
and the recovering of consciousness was shorter than the<br />
virazole treatment group. The duration of fever was<br />
shorter, but there was no statistical difference. Conclusion:<br />
Ganciclovir showed an obvious effect for the treatment of<br />
children with virus encephalitis.<br />
FP-G-028<br />
Clinical analysis in 37 cases of brain abscess in children<br />
X.-H. Yu, Y.-J. Yang, L.-Z. Cao<br />
Department of Pediatrics, Xiangya Hospital, Central South<br />
<strong>University</strong>, Changsha, China<br />
Objective: To clarify the clinical characteristics and<br />
discuss the causes of misdiagnosis and the treatments of<br />
brain abscess in children. Method: The clinical characteristics<br />
were analyzed in 32 patients with brain abscess diagnosed<br />
by CT or MRI. Results: In the 32 patients, the causes<br />
of brain abscess in ten patients (31.2%) were obscure; ten<br />
patients (31.2%) were otogenic; four patients (12.5%) were<br />
traumatic; eight patients (25%) were hematogenous. There<br />
are only ten patients with typical clinical symptoms of<br />
fever, headache and local signs of the nervous system. A<br />
total of 68.8% patients had no significant clinical manifestations,<br />
so that brain abscess was easily misdiagnosed.<br />
Conclusions: The causes of brain abscess were obscure<br />
or otogenic; most clinical symptoms of brain abscess in<br />
children were not specific. The surgical treatment is the<br />
main therapy.<br />
FP-G-029<br />
Twenty one cases of childhood vestibular neuritis<br />
C.-J. Liu, X.-T. Song, G.-F. Zhao, B.-F. Xu<br />
Yishui Central Hospital, Yishui, Shandong, China<br />
We report 21 cases of childhood vestibular neuritis (M/F<br />
13/8, age 9–13 years). Before onset, there were upper<br />
respiratory tract infection (n ¼ 16), nasosinusitis (n ¼ 1),<br />
and cases with unknown cause (n ¼ 4). Major finding:<br />
vertigo of sudden onset and remission after 7 days; five<br />
cases recovered in 10 days. The concomitant symptoms:<br />
nausea, vomiting, and horizontal nystagmus. No headache,<br />
deafness or tinitus. Cold water test: unilaterally positive in<br />
15 cases and bilaterally positive in six cases. Treatment:<br />
dexamethasone was IV dripped first, then prednisolone,<br />
antibiotics and vitamins were used. The water-electrolyte<br />
imbalance was corrected by transfusion. Completely recovery<br />
was achieved in 16 patients, and hearing loss was<br />
recovered in five patients with persistent mild dizziness.<br />
The time of hospitalization was 10–31 days. No recurrence<br />
has been reported after 2 years. This disease is idiopathic,<br />
but the virus infection theory is approved and no specific<br />
treatment is available. The dexamethasone, antibiotics, and<br />
vitamins can be used. It has the tendency of self-remission.<br />
The recovery was correlated to the age. The younger the<br />
child was, the more rapidly recovery was achieved. The<br />
patients in this group were all children who recovered<br />
rapidly with no sequelae.<br />
FP-G-030<br />
Rhythmic fast activity on EEG in a patient with Mollaret<br />
meningitis<br />
J. Arita<br />
Department of Pediatrics, The Jikei <strong>University</strong> School of<br />
Medicine, Tokyo, Japan<br />
Mollaret meningitis is a very rare disease of unknown<br />
etiology, characterized by repeated aseptic meningitis with<br />
transient neurological manifestations and quick recovery.<br />
The patient, a 16-year-old boy, developed acute encephalitis<br />
with complete recovery from age 13 to 16 every year.<br />
The symptoms at the onset were loss of consciousness,<br />
generalized tonic clonic seizure and pyramidal signs.<br />
First admission to our hospital was at age 15. EEG at the<br />
early stage showed diffuse and low voltage rhythmic fast<br />
activity. He recovered his consciousness after a week. A<br />
recent episode of the attack occurred at age 16. He was<br />
admitted to our hospital last year because of high fever of<br />
398C. Right after admission, he developed generalized<br />
tonic clonic seizure and consciousness disturbance with<br />
the alternating pattern of deep coma and delirium. Cerebrospinal<br />
fluid during the early stage revealed mild leukocytic<br />
pleocytosis, elevation of protein and high level of IL-<br />
6, although brain CT and MRI showed no positive findings.<br />
EEG showed intermittent diffuse middle voltage rhythmic<br />
fast activity. After 5 days of admission, his neurological<br />
symptoms completely disappeared, and the EEG changed<br />
into normal. This is the first report of rhythmic fast activity<br />
on EEG in Mollaret meningitis. These clinical pictures<br />
suggest that this illness could cause a brainstem dysfunction.
Abstracts 475<br />
FP-G-031<br />
Laboratory findings in children with bacterial<br />
meningitis<br />
N.-C. Chiu, H. Chi, C.-S. Ho, E.-Y. Shen<br />
Department of Pediatrics, Mackay Memorial Hospital,<br />
Taipei, Chinese Taipei<br />
Laboratory data from 239 episodes of culture-proved<br />
bacterial meningitis were collected during the period from<br />
1984 to 2000. The most common causative agent was group<br />
B streptococcus (GBS, 19.7%), followed by Streptococcus<br />
pneumoniae (15.9%), Escherichia coli (13.8%), Hemophilus<br />
influenzae (7.5%), and Enterobacter cloacae (5.4%).<br />
The major pathogens in patients less than 1-month-old<br />
were GBS and E. coli, in patients aged between 1 month<br />
and 1 year were GBS, S. pneumoniae and E. coli, and in<br />
patients older than 1 year were S. pneumoniae and H. influenzae.<br />
During the study period, cases of S. pneumoniae<br />
meningitis increased strikingly since 1991. More than<br />
1000 leukocytes/mm 3 in CSF was found in 42.4% patients.<br />
Protein level higher than 200 mg/dl in CSF was found in<br />
53.6%. Normal CSF leukocyte counts, protein levels,<br />
glucose levels or CSF to plasma glucose ratio were found<br />
in 9.6, 5.0, 15.9 and 12.2% in the cases examined. However,<br />
only one patient had all four factors within normal range.<br />
Blood cultures yielded the same bacteria as the CSF cultures<br />
were recorded in 61.2% cases. Hyponatremia (serum<br />
sodium ,130 mEq/l) was found in 19.1% patients. High<br />
mortality rates were found in patients with CSF less than<br />
five leukocytes/mm 3 (40.0%), CSF glucose less than 20 mg/<br />
dl (22.1%), CSF protein more than 250 mg/dl (30.2%), and<br />
serum sodium less than 130 mEq/l (34.8%).<br />
FP-G-032<br />
Long-term follow-up of childhood tuberculous<br />
meningitis<br />
J.F. Schoeman a , J. Wait d , M. Burger b , F. van Zyl c ,G.<br />
Fertig a , A.J. van Rensburg a , P. Springer a , P.R. Donald a<br />
Departments of a Paediatrics and Child Health, b Physiotherapy,<br />
and c Audiology, Tygerberg Children’s Hospital and<br />
Faculty of Health Sciences; and d Department of Psychology,<br />
<strong>University</strong> of Stellenbosch, Tygerberg, South Africa<br />
Introduction: The morbidity of tuberculous meningitis<br />
(TBM) remains high in spite of modern antituberculosis<br />
treatment. Methods: The long-term outcome of 76 children<br />
with TBM, who received modern antituberculosis drugs and<br />
active normalization of raised intracranial pressure, was<br />
determined. The median age on admission was 29.5 months<br />
and on follow-up 9 years. Intelligence, motor function, vision<br />
and hearing were assessed by a team of health professionals,<br />
while functionality was also assessed by means of a quality of<br />
life questionnaire. Results: Only 20% of children were functionally<br />
completely normal on follow-up. Main areas of functional<br />
deficit were cognitive impairment (80%), poor<br />
scholastic progress (43%) and emotional disturbance<br />
(40%). Twenty-five per cent of children had evidence of<br />
motor impairment, but all could walk and only five children<br />
(6% of total) were unable to run. One child was blind but no<br />
child had sensori-neural deafness. Conclusions: Older longterm<br />
follow-up studies on TBM found that 21% of survivors<br />
had moderate to severe hearing loss and 12% were deaf. The<br />
improved auditory outcome in our study is most readily<br />
explained by the exclusion of streptomycin from the treatment<br />
regimen. The multiple other handicaps documented in<br />
this study, however, have serious implications for social,<br />
academic and career prospects, especially since most children<br />
come from socially deprived backgrounds. A high index<br />
of suspicion of TBM in communities as ours where tuberculosis<br />
is highly prevalent will help to diminish the morbidity<br />
associated with this devastating disease.<br />
FP-G-033<br />
Clinical features of multiple sclerosis (MS) in children<br />
L.-L. Tian<br />
Xuanwu Hospital of the Capital <strong>University</strong> of the Medical<br />
Sciences, Beijing, China<br />
Objectives: To obtain clinical features for the early diagnosis<br />
of MS among patients with neurological diseases.<br />
Patients and methods: Clinical data of five patients with<br />
MS hospitalized at pediatrics were analyzed and collected<br />
retrospectively. Results: Age at onset of the five patients vary<br />
from 7 to 10 years (mean 9.4 years). Visual symptoms were<br />
reported in the five patients and were the first manifestation in<br />
four of them. Seizure occurred in one patient. A 10-year-old<br />
boy had developed central diabetes insipidus for 3 years<br />
before visual symptom occurred. Some other clinical<br />
features were found in these five patients, such as hypesthesia,<br />
paresthesia, limb weakness and so on. Brain MRI<br />
disclosed subcortical lesions in four of them. Conclusion:<br />
Visual acuity decrease is a clinical characteristic of MS in<br />
children. Some other symptoms and signs may be found<br />
either. They must be emphasized. Brain MRI and visual<br />
evoked potentials (VEPs) should be recorded as soon as<br />
possible in order to obtain more data for early diagnosis.<br />
FP-G-034<br />
Communication problem and neurological aspect of<br />
cytomegalovirus infection in children<br />
Sunartini<br />
Department of Pediatrics, Gadjah Mada <strong>University</strong>, School<br />
of Medicine, Yogyakarta, Indonesia<br />
Cytomegalovirus (CMV) infections or inclusion diseases<br />
in children, can affect many organs, especially the central<br />
nervous system. Clinical manifestations range from slight to<br />
severe and often fatal. Recently, the incidence of CMV
476<br />
Abstracts<br />
infections in infants and children has been increasing. This<br />
research is a case study, with an analytical descriptive<br />
approach. Subjects and methods: Children with abnormal<br />
psychomotor development, speech or communication disorder<br />
were suspected to have toxoplasmosis, other agents,<br />
rubella, cytomegalovirus, herpes simplex (TORCH) infection,<br />
and admitted to Dr Sardjito Hospital. Routine blood<br />
and serological tests were carried out at least once. USG,<br />
brain CT Scan, EEG and other supporting examinations also<br />
were done based on clinical indicators. Results: The serological<br />
tests of almost 50% of cases were positive for CMV. A<br />
majority was diagnosed as active infections of CMV. Some<br />
cases, particularly with acute infections, and latent infections<br />
suggesting the possibility of reactivation were treated<br />
with ganciclovir. Improvement of psychomotor development,<br />
communication, and clinical course of the disease<br />
varied greatly and continues to be observed, along with<br />
drug side effects. Treatment with ganciclovir remains<br />
controversial. The drug is difficult to obtain and is very<br />
expensive.<br />
FP-G-035<br />
Neurologic and neuropsychologic characteristics of<br />
early disseminated Lyme disease in children<br />
A.L. Belman, M. Milazzo, T. Preston, P.K. Coyle, R.<br />
Grimson, L. Hyman<br />
School of Medicine, State <strong>University</strong> of New York, Stony<br />
Brook, Stony Brook, NY, USA<br />
To identify neurologic and neuropsycholgic features of<br />
early disseminated Lyme disease (LD) in children, we<br />
enrolled 37 children (22 boys, eight girls, ages 6–17<br />
years) with CDC defined LD in a prospective study.<br />
Controls were 25 healthy children (14 boys, 11 girls, ages<br />
6–17 years) from the same LD endemic geographic area.<br />
None had evidence of LD or Bb exposure. Protocol: structured<br />
neurologic history, examination; laboratory studies;<br />
standardized neuropsychologic and behavioral assessments.<br />
Presenting LD syndromes: facial nerve palsy (FNP) (17),<br />
lymphocytic meningitis (LM) (9), radiculoneuritis (1),<br />
multifocal EM (MEM) (4), and arthritis (3). The most<br />
frequent self-reported symptoms were fatigue/listlessness<br />
(84%), headache (81%), neck pain (72%), mood disturbance<br />
(70%), and sleep problems (62%). Disrupted/lost school<br />
days were reported for 56% of the cases; 85% reported<br />
missed activities/sports. CSF findings: " wbc/mm 3 (76<br />
%), " protein (52%), and intrathecal anti-Bb production<br />
(37%). Of the 24 children with CSF pleocytosis, 13 had<br />
FNP, seven had LM, three had MEM, one had radiculoneuritis.<br />
Of the 17 children with FNP, 75% had " wbc/mm 3 .<br />
Behavioral problems (mood disturbances) were significantly<br />
more frequent in cases than controls. Psychometric<br />
evaluation showed no difference between the two groups.<br />
Conclusions: Headache, fatigue, and sleep problems are<br />
frequent in early disseminated LD; a high rate of morbidity<br />
results in disrupted school days and activities; CSF abnormalities<br />
are common, even in children without frank meningeal<br />
signs; FNP is often associated with an occult<br />
meningitis; disturbance of mood is common; and cognitive<br />
function is not affected. Supported in part by NINDS (NIH)<br />
P01-NS34092; NGCRC: M01-RR10710-02.<br />
FP-G-036<br />
Diagnosis of acute disseminated encephalomyelitis and<br />
multiple sclerosis in childhood and their differential<br />
diagnosis<br />
W.-C. Zhang, H.-S. Wu, T.-C. Liu<br />
Beijing Children’s Hospital, Beijing, China<br />
Objective: Acute disseminated encephalomyelitis<br />
(ADEM) and MS are both common demyelinating diseases<br />
of the CNS. This paper was to study the clinical and lab test<br />
features of ADEM and MS so as to improve clinical and<br />
differential diagnosis. Methods: The clinical features and<br />
experimental results were analyzed in 34 cases with<br />
ADEM and 17 cases with MS compatible with the established<br />
criteria. Results: ADEM cases included 19 boys and<br />
15 girls, and MS cases seven boys and ten girls. Frequency<br />
of certain clinical features (ADEM%; MS%) were helpful to<br />
differentiate between ADEM and MS, such as fever (64.7<br />
and 29.4%), headache (58.8 and 23.5%), consciousness<br />
change (64.7 and 5.9%) including coma (17.6 and 0%);<br />
and seizures (35.3 and 0%). ADEM often produced widespread<br />
CNS disturbance, but MS usually presented monosymptomatic<br />
syndrome, such as six cases of myelopathy,<br />
five hemiplegia, and 33 optic neuritis, etc, It was impossible<br />
to make a certain distinction on CSF immunological examinations.<br />
Cranial MRI revealed thalamic involvement<br />
(ADEM 32.4%; MS 0%); EMG examination showed<br />
peripheral nerve damage in ADEM whereas not any in<br />
MS. Conclusion: It is suggested that ADEM be considered<br />
in the patients presenting previous history of an infection or<br />
vaccination, widespread CNS disturbance and alteration of<br />
consciousness or seizures in particular, and multifocal white<br />
matter lesion on MRI especially with thalamic involvement,<br />
and that MS be considered with onset of monosymptomatic<br />
syndrome, at least two non-associated lesions in the white<br />
matter, and relapses and remissions.<br />
FP-G-037<br />
Long term outcome of streptococcal movement<br />
disorders<br />
K.G. Walker, J. Wilmshurst<br />
Neurology/Cardiology Units, School of Child and Adolescent<br />
Health, <strong>University</strong> of Cape Town, Red Cross Children’s<br />
Hospital, Cape Town, South Africa<br />
Post streptococcal conditions such as rheumatic carditis,<br />
Sydenhams chorea (SC), PANDAS and other movement
Abstracts 477<br />
disorders remain major public health problems in South<br />
Africa. Whilst the ideal goal is primary prevention, some<br />
measure of secondary prevention has been attained using<br />
prophylactic penicillin but too many children’s lives are<br />
ruined by long term complications and morbidity. A retrospective<br />
study of 40 cases attending the Rheumatic Fever<br />
Clinic and/or neurology clinics over the past 10 years has<br />
been undertaken in order to direct attention to possible<br />
means of preventing complications but also to emphasize<br />
the urgency of addressing primary prevention and penicillin<br />
prophylaxis. We are discharging children to the same<br />
conditions from which they come! Forty patients with<br />
movement disorders and a past infection with b-haemolytic<br />
streptococcus were identified (22 males:18 females). Average<br />
age of presentation was 8 years. Twenty-one children<br />
are severely socio-economically deprived and 19 moderately<br />
deprived. Pharmacological interventions, results and<br />
side effects have been reviewed. The natural history, long<br />
term morbidity and association with penicillin prophylaxis<br />
and compliance have been addressed. Three patients initially<br />
diagnosed with SC have now been diagnosed as<br />
having Tourette’s syndrome. This study emphasized the<br />
high morbidity of neuropsychiatric disorders in post-streptococcal<br />
movement disorders. Possible links between SC,<br />
PANDAS and Tourette’s syndrome will be discussed.<br />
FP-G-038<br />
Misdiagnosis analysis of 38 children with tuberculous<br />
meningitis<br />
Z.-C. Wang, X.-T. Cai<br />
Department of Pediatrics, Longgang Central Hospital,<br />
Shenzhen, China<br />
Object: To analyse the causes of misdiagnosis of tuberculous<br />
meningitis and to explore prevention methods. Methods:<br />
A total of 186 cases of tuberculous meningitis were<br />
treated from January 1, 1996 to December 31, 2000. We<br />
analysed 38 cases which were misdiagnosed as other<br />
diseases initially. Results: The misdiagnosis rate is 20.4%.<br />
Thirty eight cases were misdiagnosed initially as the following<br />
diseases: viral encephalitis (seven cases), purulent<br />
meningitis (six cases), bronchopneumonia (five cases),<br />
epidemic encephalitis B (four cases), acute upper respiratory<br />
infection with febrile convulsion (four cases), acute<br />
toxic encephalopathy (three cases), typhoid (two cases),<br />
septicemia (two cases), and others (five cases). The main<br />
causes of misdiagnosis included atypical early clinical<br />
manifestations, atypical changes in CSF and the appropriate<br />
using drugs, which may disturb the natural course. Conclusion:<br />
Improving the knowledge of tuberculous meningitis,<br />
serially monitoring the radiography of chest and CSF<br />
features of suspected cases and taking a necessary diagnostic<br />
therapy early can effectively decrease the occurrence of<br />
misdiagnosis.<br />
FP-G-039<br />
Recurrent cerebellar ataxia with central nervous system<br />
(CNS) demyelination: a particular multiple sclerosis<br />
(MS) form in children?<br />
C. Triki, F. Kammoun, Z. Mnif, F. Choyakh, I. Feki, M.S.<br />
Kéchaou, C. Mhiri<br />
Department of neurology, CHU H. Bourguiba, Sfax, Tunisia<br />
Demyelinating CNS diseases include MS, optic neuritis,<br />
acute transverse myelitis, acute disseminated encephalomyelitis<br />
and some rare conditions such as Schilder disease.<br />
MS is rare in children under 10 years and uncommon in<br />
adolescents. We report two patients. A 9 years old girl<br />
and a 15 years old boy presented with subacute cerebellar<br />
ataxia following non-specific infections. Clinical examination<br />
showed cerebellar ataxia, vestibular disturbances and a<br />
pyramidal syndrome in the lower limbs. Eye examination<br />
was normal. CSF was normal: pleocytosis was absent and<br />
oligoclonal banding was present only in one case. Lactic<br />
acid was normal. Evoked potential studies showed an<br />
increase in the latency of the P100 potential of the visual<br />
evoked response and increase of latency of somatosensory<br />
and auditory evoked responses in the two patients. Cerebellar<br />
MRI showed several areas of increased signal on T-2<br />
weighted sequences located in the cerebellum, brainstem,<br />
cervical spinal cord and hemispheric white matter. Basal<br />
ganglia were normal. A diagnosis of acute disseminated<br />
encephalomyelitis was made and these patients were treated<br />
by high-dose intravenous corticosteroids followed by oral<br />
therapy. The outcome was good, in fact, the cerebellar<br />
ataxia disappeared. But, when the dose of corticosteroids<br />
was under 20 mg/day, cerebellar ataxia reappeared. The<br />
diagnosis of MS was suspected, but absence of any other<br />
symptoms continues. After 4 years cerebral MRI showed the<br />
same lesions. These cases show the difficulty of MS diagnosis<br />
in children.<br />
FP-G-040<br />
Early cerebral sonographic abnormalities in a case of<br />
vertically transmitted HIV-1<br />
R.O. Jorge<br />
Hospital G Fricke-Facultad de Medicina Universidad de<br />
Valparaíso-Alvarez, Viña del Mar, Chile<br />
Previously Bode and Rudin (1995) reported echogenic<br />
stripes in the basal ganglia identified in a 4 months infant<br />
with human immunodeficiency virus. This was attributed to<br />
a calcifying arteriopathy. These authors postulated that<br />
cerebral sonography performed in early infancy might<br />
allow identification of HIV encephalopathy even before its<br />
clinical manifestation. We had a control patient whose<br />
parents are both affected with AIDS. During a short period<br />
between the second and third month of age, progressive and<br />
severe developmental abnormalities, acquired microce-
478<br />
Abstracts<br />
phaly, hypotonia and finally quadriplegia were observed. In<br />
this period CMV, toxoplasma, varicella zoster, and other<br />
bacterial, fungal and parasitic infections of CNS were<br />
ruled out. A transfontanelle sonographic examination (US)<br />
was performed in the newborn period and described as<br />
normal. At the age of 1 month a second brain US showed<br />
an increase of distance in which the pericallosal branches of<br />
the anterior cerebral artery were easy followed. Its course<br />
was evident in almost all its extension in the parasagittal<br />
views without moving the transducer. This was associated<br />
with an increase of the pulse ratio in the pericallosal and in<br />
the cortical branches of middle cerebral arteries. The hipoechogenicity<br />
surrounding these vessels was increased. A<br />
brain CT at this stage of disease was considered normal.<br />
Progressive symmetric frontal ventriculomegaly was<br />
evidenced by ultrasounds in the period between 2 and 4<br />
months. A second CT at the age of 4 months showed a<br />
severe frontal and cerebellar atrophy, white matter hypodensity<br />
and multiple calcifications. We postulate that the early<br />
vessels sonographic findings express the increase of sulks<br />
space due to initial cortex atrophy. This findings could help<br />
in the early suspicion of HIV encephalopathy, even before<br />
ultrasound calcifications and clinical regression becomes<br />
evident.<br />
FP-G-041<br />
Multiple sclerosis in children<br />
V.N. Yefimenko<br />
Medical university, Donetsk, Ukraine<br />
Twenty five children with the authentic diagnosis of MS<br />
according to C. Poser et al. (1983) are under our observation.<br />
In the study group the number of female persons predominates<br />
(16 girls and nine boys). The age of onset was 4–15<br />
years, the peak age being 12–13 years. The first symptoms<br />
in eight children (32%) appeared prior to the age of 10. The<br />
earliest onset was noted in a 4-year-old girl. A monosymptomatic<br />
onset was present in 16 children (64%), a polysymptomatic<br />
onset in 9 (36%). The initial symptoms were<br />
retrobulbar neuritis of the optic nerve, ataxia, isolated<br />
disturbance of sensation, facial nerve neuropathy, dyskinesia.<br />
A broad picture of MS developed by the age of 2<br />
months–9 years from the onset, 21 within the first 2 years<br />
(84%). At the onset of the disease a remittent course with<br />
frequent exacerbations, twice to four times a year, prevailed.<br />
Follow-up in these children was studied during 2–12 years<br />
(7.1 years the average). A remittent course persisted in 17<br />
children; in seven patients the course had a secondary<br />
progressive character. A primary progressive course was<br />
noted in one case. At the stage of the first MS manifestations,<br />
MRI abnormalities were revealed in 58.3% of cases,<br />
an increase up to 77% was seen at 5 years. Immunologic<br />
studies during exacerbation showed a decrease in the<br />
content of CD3 1 , CD4 1 , CD8 1 – cells of blood and<br />
increase in the level of circulating immune complexes. The<br />
number of CD8 1 – cells increased and the ratio of CD4/<br />
CD8 decreased when reaching the stage of remission.<br />
Immunogenetic studies of class I HLA-antigens demonstrated<br />
an increase in HLA-B12 incidence in patients in<br />
comparison with controls (P , 0:025; RR ¼ 6.29).<br />
FP-G-042<br />
Brainstem encephalitis and acute disseminated<br />
encephalomyelitis following mumps<br />
F.M. Aynaci a , A. Ayvaz a , A. Ahmetoglu b<br />
Karadeniz Technical <strong>University</strong>, Faculty of Medicine,<br />
a Department of Child Neurology and b Radiology, Trabzon,<br />
Turkey<br />
A previously healthy 4 years 3 month old female developed<br />
brainstem encephalitis with clinical manifestations<br />
including fever, decreased level of consciousness, left facial<br />
and abducens paralysis, and midriasis of the left eye 1 week<br />
after bilateral swelling of the parotis and submandibular<br />
regions. Twenty days after remission of encephalitis,<br />
marked ataxia, dysarthria and fever became apparent. MRI<br />
revealed multiple hyperintense lesions which were<br />
increased in size when compared with MRI at admission.<br />
High dose MPZ therapy was started and followed with<br />
decreased MPZ doses for 2 months. Two weeks after beginning<br />
MPZ, ataxic symptoms resolved. Within 48 days, she<br />
was able to walk with support. Today, now in her 8th month<br />
of illness she has no neurological deficit.<br />
FP-G-043<br />
Reverse Shapiro’s syndrome – an unusual cause of fever<br />
of unknown origin<br />
K.-L. Lin, H.-S. Wang<br />
Division of Pediatric Neurology, Chang-Gung Children’s<br />
Hospital, Taoyuan, Chinese Taipei<br />
Shapiro et al. first described two cases of recurrent spontaneous<br />
hypothermia associated with agenesis of the corpus<br />
callosum (Shapiro’s syndrome). Here we report a girl<br />
presenting with fever of unknown of origin who had<br />
complete agenesis of the corpus callosum. The same condition<br />
had been reported by Hirayama et al. called ‘reverse<br />
Shapiro’s syndrome’. This 9-month-old girl had had the<br />
symptom of periodic hyperthermia since the age of 7<br />
months. On examination, she had mild hypotonia with<br />
delayed developmental milestones. No other neurological<br />
or physical abnormalities were noted besides the callosal<br />
agenesis. Investigations for her prolonged fever including<br />
complete blood cell counts, peripheral blood smear, serum<br />
electrolyte levels, urinalysis, renal function, liver enzyme<br />
levels, thyroid function, immunologic work-up (C-reactive<br />
protein, rheumatoid factor), as well as radiology were<br />
normal. Thus, hidden infections, collagen vascular disease,<br />
hematologic diseases, malignancy, and thyroid dysfunction
Abstracts 479<br />
were carefully excluded as the cause of her periodic<br />
hyperthermia. Whole body Gallium-67 scan revealed no<br />
active inflammatory focus. Hormonal studies were normal.<br />
Her electroencephalogram was normal. According to the<br />
observation of previous literature, we suggest that periodic<br />
hyperthermia in this girl is caused by the dopaminergic<br />
denervation of the hypothalamic thermoregulatory center.<br />
We tried a dopamine agonist (levodopa with carbidopa) in<br />
this girl but failed to control the hyperthermia.<br />
FP-G-044<br />
Neonatal bacterial meningitis in southern Taiwan:<br />
epidemiologic trends and prognostic factors<br />
C.-J. Chang<br />
Department of Pediatric Neurology, Chang Gung Memorial<br />
Hospital (Kaohsiung), Kaohsiung Hsien, Chinese Taipei<br />
In two investigative phases over a 16-year study period<br />
(1986–2001), 60 neonatal patients (under 28 days) were<br />
studied. Normal and mildly abnormal were considered<br />
good outcome. Group B streptococci were the most<br />
common causative pathogens, accounting for about 32%<br />
of the episodes. Escherichia (E) coli, the second common<br />
pathogen, was more frequently noted in the second time<br />
period. Moreover, 73% of E. coli strains and 10% of<br />
Group B streptococci isolates were resistant to ampicillin.<br />
The overall mortality rate was 10%. However, if those with<br />
poor outcomes were considered, 38% would be considered<br />
treatment failures. Significant prognostic factors included<br />
the presence of seizures, thrombocytopenia, high CSF<br />
protein concentration, and low CSF glucose concentration.<br />
Initial empirical antibiotics with third-generation cephalosporins<br />
should be considered for the majority of meningitis<br />
cases resulting from infection with Gram-negative bacilli<br />
and streptococcal species. Despite the availability of<br />
newer and more potent antibiotics, the outcome of neonatal<br />
bacterial meningitis remains unsatisfactory. There has been<br />
increasing incidence for the emergence of resistant strains<br />
presenting a therapeutic challenge in resent years. Early<br />
diagnosis and choice of appropriate antibiotics according<br />
to in vitro antimicrobial susceptibility and epidemiologic<br />
trends are essential to maximize the potential for survival.<br />
FP-G-045<br />
The use of intravenous immunoglobulin in subacute<br />
sclerosing panencephalitis: a retrospective cohort study<br />
M.B. Lukban, B.C. Chua, A.M. Salonga, M.L. Bolanos,<br />
B.C. Sanchez<br />
Section of Pediatric Neurology, Departments of Neurosciences<br />
and Pediatrics, <strong>University</strong> of the Philippines-Philippine<br />
General Hospital, Manila, Philippines<br />
In the search for a treatment for SSPE, Gurer et al. in 1996<br />
reported the successful use of IVIg in SSPE. A retrospective<br />
cohort study was done to compare the clinical outcome of<br />
SSPE patients who received IVIg to those who did not<br />
(control group). The clinical stages before the initiation of<br />
IVIg treatment and serially after from 1 to 36 months were<br />
noted. For patients in the control group, their clinical<br />
outcome was followed from the approximate time of treatment<br />
in the IVIg group (mean ¼ 7 months of illness). Clinical<br />
outcome parameters noted were improvement in the<br />
clinical staging, stabilization of the illness, and deterioration<br />
in staging. There were 33 patients in the IVIg group with a<br />
mean age of 9.8 years. The control group had 26 patients<br />
with a mean age of 10.1 years. Among patients in stages 1<br />
and 2 of the disease, 31% (5/16) improved within 1 until 6<br />
months of the treatment as compared to 0% (0/12) in the<br />
control group. Among patients in stages 3 and 4 of the<br />
disease, 12% (2/17) in the IVIg group improved within 1<br />
month of the treatment however, this decreased to 6% (1/17)<br />
by 6 months from treatment whereas none improved in the<br />
control group. The use of IVIg in SSPE may produce a<br />
transient improvement in the clinical staging of the disease<br />
for up to 6 months among patients in the earlier stages of the<br />
disease.<br />
FP-G-046<br />
Risk factors for the development of subacute sclerosing<br />
panencephalitis among pediatric patients in the<br />
Philippine General Hospital<br />
B.C. Chua, A.M. Salonga, M.B. Lukban, B.C. Sanchez<br />
Section of Pediatric Neurology, Departments of Neurosciences<br />
and Pediatrics, <strong>University</strong> of the Philippines-Philippine<br />
General Hospital, Manila, Philippines<br />
SSPE is a late complication of measles infection the incidenceofwhichappearstobeincreasinginthePhilippines.The<br />
risk factors for the development of SSPE still remain undetermined.<br />
The medical records of the pediatric patients diagnosed<br />
with SSPE in the Philippine General Hospital from<br />
July 1998 to June 2001 were reviewed to determine the risk<br />
factors for the development of SSPE. The subjects for the<br />
control group are children without SSPE seen in the outpatient<br />
follow-up clinic unrelated to the SSPE subjects. Information<br />
on sex, race, family size, birth order, socio-economic status,<br />
residence, educational attainment of parents, medical history,<br />
nutritional status and circumstances surrounding the initial<br />
measles infection of the patients were obtained. The Chisquare<br />
test was used to analyze the relationship between<br />
these factors and the development of SSPE. Thirty-four<br />
patients were included in the SSPE group and 29 patients in<br />
the control group, with a male to female ration of 1.43:1 in the<br />
SSPE group and 1:1.6 in the control group. Among the factors<br />
analyzed, children who contracted measles at less than 24<br />
months of age have a statistically significant increased risk<br />
of developing SSPE ( £ 2 value-8.94, P ¼ 0.001). Male sex, a<br />
history of a sibling who contracted measles at the same time as<br />
the patient did, and the absence of measles immunization can
480<br />
Abstracts<br />
beconsideredasriskfactors,however,thevaluesarrivedatdid<br />
not reach statistical significance. This may be due to the small<br />
sample size.<br />
FP-G-047<br />
Levels of IL1, IL6, and IL8 in serum in viral encephalitis<br />
in children<br />
J. Zhang<br />
Department of Neurology Hunan Children’s Hospital,<br />
Hunan, China<br />
Objectives: Viral encephalitis (VE) is one of the most<br />
frequent infectious diseases of the central nervous system<br />
in children. The prognosis is closely associated with the<br />
severity of the infection. In order to identify the related pathogens<br />
of the infection, we tested the levels of cytokines IL1,<br />
IL6, and IL8 in serum of the patients with viral encephalitis.<br />
Methods: Twenty three patients admitted to the neurology<br />
department of our hospital were randomly selected, as well as<br />
30 normal healthy children. We took blood samples from all<br />
participants early in the morning before they took any food.<br />
ELISA was used to test the levels of IL2, IL6, and IL 8 in<br />
serum. Results: IL1, IL6, and IL8 in the VE patients were<br />
significantly higher than those in the normal controls<br />
(P , 0:001). Conclusion: The higher levels of IL1, IL6,<br />
and IL8 in serum from children with VE indicated that<br />
viral infection and following brain injury may activate<br />
microglial cells to produce IL1. IL1 may stimulate microglial<br />
cells or astrocytes to express IL6 and IL8. All this cytokine<br />
activation may induce secondary neural cell injury and make<br />
more severe functional defects of the central nervous system.<br />
FP-G-048<br />
Effect of heat shock response on brain tissue in rats with<br />
infectious brain edema<br />
D.-A. Mao<br />
The Second Xiang-Ya Hospital of Central South <strong>University</strong>,<br />
Changsha, China<br />
Objective: To explore the effect of heat shock response on<br />
brain tissue in rats with infectious brain edema. Methods:<br />
Sprague–Dawley (SD) rats were randomly divided into<br />
three groups: control group, normal saline treated rats (NS)<br />
and infectious brain edema (PB) group. The rats were administered<br />
pertussis bacilli (PB, 0.2 ml/kg) injected into left<br />
ICA without pretreatment. In the pretreatment with heat<br />
shock (HS 1 PB) group, the rats were pretreated with heat<br />
shock before being injected with PB into left ICA. The rats<br />
were killed at 8, 24 h after injected PB or NS, respectively.<br />
The WC, cations of Na 1 and K 1 in the brain tissue were<br />
measured and the morphological changes were studied by<br />
electron microscopy. Results: The WC and Na 1 content<br />
were significantly decreased in the HS 1 PB group<br />
compared to the PB group (P , 0:01). The K 1 content in<br />
HS 1 PB group was significantly higher than those in the<br />
PB group at all time points except for 24 h (P , 0:01). The<br />
electron microscope revealed that neurons were severely<br />
swollen and the nuclei were slight pyknotic in PB group at<br />
8 h, the processes of astroglial cells were moderately swollen,<br />
mitochondria of neurons were enlarged in HS 1 PB group at<br />
8 h. Dark cells and broken astroglial cells characterized cells<br />
of PB group at 24 h. Dark cells and light cells, processes of<br />
astroglial cells of perivascular region were severely swollen<br />
and neuronal cells widened in HS 1 PB group at 24 h.<br />
Conclusions: Heat stress response had a neuroprotective<br />
effect on the infectious brain edema in rats, the effect may<br />
be associated with the reduction of WC, Na 1 content and<br />
enhancement of K 1 content.<br />
FP-G-049<br />
Clinical evaluation of high dosage intravenous<br />
immunoglobulin on treatment of acute paralysis in<br />
children<br />
S.-H. Guo, R.-M. Hu, R.-P. Sun<br />
Department of Pediatrics, Qilu Hospital of Shandong<br />
<strong>University</strong>, Jinan, China<br />
Objective: To evaluate the clinical effects of high dosage<br />
intravenous immunoglobulin on treatment of acute paralysis<br />
in children. Methods: 72 cases of admitted acutely paralyzed<br />
children were randomly divided into two groups. There were<br />
42 cases in the experimental group, which were given high<br />
dosage intravenous immunoglobulin (400 mg/kg per day for<br />
5 days). There were 30 cases in the control group, which were<br />
given regular treatment. We compared the recovery period of<br />
muscle force and the duration of hospitalization in the two<br />
groups. Result: The recovery period of muscle force of the<br />
experimental group was shorter than the control group<br />
(3.18 ^ 1.38 versus 12.94 ^ 5.19 days P , 0:01). The average<br />
duration of hospitalization of the experimental group was<br />
shorter than that of the control group (14.45 ^ 4.18 versus<br />
21.49 ^ 5.83 days; P , 0:01). The experimental group had<br />
excellent results during an average of 3 months follow-up.<br />
The validity rate in the experimental group was higher than<br />
that of the control group (95.2 versus 86.6%). Conclusion:<br />
Application of high dosage intravenous immunoglobulin in<br />
acutely paralyzed children can increase cure rate and shorten<br />
the average duration of hospitalization. IVIG should be<br />
broadly used in acute paralyzed children.<br />
FP-G-050<br />
Clinical evaluation of the role of ancillary investigations<br />
in the diagnosis of cerebral cysticercosis in 51 patients<br />
G.-L. Li a , D.-Y. Zhou a , X. Yan b<br />
a Harbin Children’s Hospital, Harbin, and b No. 203 Hospital<br />
of P.L.A, Qiqiha’er, China<br />
Objective: To evaluate ancillary investigations in the
Abstracts 481<br />
diagnosis of patients with cerebral cysticercosis. Method:<br />
We reviewed and analyzed ancillary investigations including<br />
cysticercosis skin test (N: 38), cranial MRI (N: 13),<br />
cranial CT scan (N: 45) and strengthened cranial CT scan<br />
(N: 42) in 51 patients diagnosed with cerebral cysticercosis.<br />
Results: Thirty eight cases had the cysticercosis test and 20<br />
of them were positive, with the sensitivity rate 52.6% and<br />
specificity rate 100%. The sensitivity and specificity of<br />
cranial MRI/CT scan and strengthened cranial CT scan to<br />
the low density areas in the brain were 84.6, 44.4 and 100%,<br />
respectively. Our data showed that cranial CT scan had<br />
poorer specificity in the diagnosis of cerebral cysticercosis<br />
but strengthened cranial CT scan was much better in showing<br />
low-density areas of cerebral cysticercosis. Conclusion:<br />
Strengthened cranial CT scan may be used as a good method<br />
in the diagnosis of cerebral cysticercosis.<br />
FP-G-051<br />
Study on the damage to peripheral nerves induced by<br />
Campylobacter jejuni exotoxin<br />
L.-S. Xie, F.-C. Cai<br />
Department of Neurology, Children’s Hospital, Chongqing<br />
<strong>University</strong> of Medical Sciences, Chongqing, China<br />
To explore the pathogenesis of the damage to peripheral<br />
nerves induced by C. jejuni exotoxin (CJT), the CJT was<br />
extracted from Penner’s serotype 19 of the bacterium and<br />
injected perineurally and intravenously in Wistar rats,<br />
respectively. The animals were sacrificed and their sciatic<br />
nerves were examined for teased fibers, transverse section<br />
with toluidine blue stain and electron microscopy; sections<br />
of sciatic nerves in either normal rats or humans were preincubated<br />
with CJT and the pathological sciatic nerves<br />
induced by CJT were obtained for observation of the binding<br />
capability of CJT with peripheral nerves by streptavidinbiotin-peroxidase<br />
complex (SABC) and FITC-immunofluorescent<br />
methods, and nucleic acid hybridization techniques<br />
for detection of TNF-a mRNA expression in<br />
pathological sciatic nerves samples. The results showed:<br />
(1) pathological changes were identified in 76.8% of teased<br />
fibers after perineural injection, but only 9.6% fibers were<br />
damaged in the control group (P , 0:01). The fiber damage<br />
(19.5%) was found on the 3rd day after CJT intravenous<br />
injection, and abnormalities still in 15.5% on the 14th<br />
day. However, no abnormal changes were demonstrated in<br />
the control group, and in the groups with the injection of<br />
anti-CJT sera and the supernatants of peripheral blood<br />
mononuclear cells (PBMCs) (P . 0:05). (2) Positive<br />
combination of CJT was found predominantly in the sciatic<br />
nerves of normal rats or humans incubated with CJT and<br />
also in the pathological sciatic nerves induced by CJT.<br />
Conclusion: CJT could remarkably damage the peripheral<br />
nerves in rats, but the immunological pathogenicity of CJT<br />
could not be demonstrated in the nerves of rats after immunization<br />
with CJT.<br />
FP-G-052<br />
Levels of b-EP in serum and cerebrospinal fluid and<br />
changes in erythrocytes immunological function in<br />
children with nervous system infectious diseases<br />
Y. Chen, X.-H. Wang, Q.-Y. Meng<br />
Department of Pediatrics. The First Affiliated Hospital of<br />
Jiamusi <strong>University</strong>, Jiamusi, China<br />
Objective: To study the levels of b-EP in serum and<br />
cerebrospinal fluid and the changes in erythrocytes immunological<br />
function in children with nervous system infectious<br />
diseases. Methods: Fifty-six children with nervous<br />
system infectious diseases (observation group) and 44<br />
aged-matched children with no nervous diseases (control<br />
group) were selected. Their levels of b-EP in serum and<br />
cerebrospinal fluid, ECR1 and their nitrate reductase<br />
(NtrR) were assayed. Results: The levels of b-EP in serum<br />
in the observation group were higher than in the control<br />
group (P , 0:001). The levels of b-EP in cerebrospinal<br />
fluid in the observation group were higher than that in the<br />
control group too. Compared with the control group, the<br />
quantity of ECR1 showed no obvious changes (P . 0:05)<br />
and NTRR decreased in the observation group (P , 0:001).<br />
The more severe the disease condition was, the higher the<br />
levels of b-EP in serum and cerebrospinal fluid were, and<br />
the lower the NTRR was. Conclusion: b-EP had dual regulation<br />
of erythrocytes immunological function, and both of<br />
them related to the disease condition. Because the levels of<br />
b-EP in serum and cerebrospinal fluid rose in children with<br />
nervous system infectious diseases, their erythrocyte immunological<br />
function was suppressed.<br />
FP-G-053<br />
A case of streptococcus acidominimus meningitis<br />
Q. Zhen<br />
Department of Pediatrics, Anhui Provincial Corps Hospital,<br />
Hefei, China<br />
A 2-year-old boy had chopsticks poked into his pharynx,<br />
which left a small hole in his pharynx. Next day, he had a<br />
fever, cough and whoop with a convulsion. White blood cells<br />
were increased. Chest X-ray showed bronchopneumonia.<br />
Fever, cough and whoop disappeared after treatment by penicillin<br />
and ampicillin for 20 days. Chest X-ray was normal.<br />
However, the child became agitated and irritable. Hypertonia<br />
was found in his right limbs. He was unable to stand and hold.<br />
Five days later, fever relapsed. The patient received penicillin,<br />
ampicillin and chloromycetin intravenous infusion for 10<br />
days. Symptoms had not remitted. Therefore, he was transferred<br />
to our hospital. Temperature was 39.18C. No neck<br />
stiffness was found. Right Babinski sign was positive.<br />
Peripheral WBC was 23.5 £ 10 9 /l, with neutrophils (N)<br />
87%, lymphocytes (L) 10%, eosinophils (E) 1%, monocytes<br />
(M) 2%. CSF was turbid, with the WBC 4050 £ 10 6 /l, includ-
482<br />
Abstracts<br />
ing N 95%, L 5%. In CSF, the protein was 540 mg/l, glucose<br />
0.8 mmol/l, chloride 120 mmol/l. Streptococcus acidominimus<br />
were found in the CSF culture. The child was treated<br />
with ceftriaxone 1.0/day, dexamethasone 2.5 mg/day intravenously.<br />
He was better from 2 days after treatment. The<br />
temperature declined to 37.48C after 4 days treatment. But<br />
2 days later, the temperature was up to 398C. He was irritable<br />
again. The parents of child gave up treatment. Streptococcus<br />
acidominimus belongs to the group of Streptococcus viridans.<br />
It is a Gram 1ve coccus. It resides in respiratory tract<br />
and enteric tract of human being. Streptococcus acidominimus<br />
is a low-virulent pathogen. It is seldom that Streptococcus<br />
acidominimus causes meningitis.<br />
FP-G-054<br />
A case of cryptococcosis accompanying ascariasis of the<br />
biliary tract<br />
X.-D. Wang<br />
Department of Pediatrics, The Chinese People’s Armed<br />
Police Forces Hospital, China<br />
We treated a patient with cryptococcosis accompanying<br />
ascariasis of the biliary tract in June, 1996. A boy, 6 years<br />
old, came from the countryside of Henan province. His chief<br />
complaints were abdominal pain and jaundice for 70 days,<br />
and headache, vomiting, cough and fever for 40 days. Physical<br />
examination found a large head circumference, about 58<br />
cm, a 1 cm long skin lesion on the top of his head and a<br />
setting-sun eye sign. The left eye had strabismus. His neck<br />
was stiff. The liver was palpable at 4 cm below the costal<br />
margin. Deep tenderness was found in the right upper quadrant<br />
of the abdomen. The muscle strength of limbs was<br />
grade IV. Knee and ankle reflexes were weak, Kernig’s<br />
and Brudzinski’s sign were positive. Laboratory examination:<br />
cryptococcus was found in CSF and secretion of skin<br />
lesion. Cranial CT showed a low density lesion. Ultrasonogram<br />
showed ascariasis of the biliary tract. Treatment:<br />
amphotericin B associated with 5-flucytocin was used to<br />
treat cryptococcosis. One month later, his general condition<br />
was obviously better. The setting-sun sign disappeared. The<br />
skin lesion and cough were cured. His neck was flexible.<br />
Cryptococcus had not been found in CSF for three consecutive<br />
examinations. Cranial CT demonstrated that the low<br />
density lesion disappeared completely.<br />
FP-G-055<br />
Outbreak of Coxsackie virus B meningitis in Xuzhou<br />
district of China<br />
B.-Q. Yuan, H. Cheng, A.-H. Guo, M. Lu, T.-Y. Xie, L.<br />
Pang, S.-G. Lu<br />
Department of Pediatrics, The Affiliated Hospital of Xuzhou<br />
Medical College, Xuzhou, China<br />
An outbreak of aseptic meningitis due to Coxsackie virus<br />
B occurred in the Xuzhou district, north of Jiangsu in China,<br />
during May–August 2001, with 262 cases fitting the clinical<br />
case definition. Medical files were reviewed and a standard<br />
questionnaire administered. Viral PCR including Coxsackie<br />
virus B, echovirus, encephalitis B virus and adenoviruses<br />
were performed on cerebrospinal fluid. Meanwhile indirect<br />
immunofluorescence assays were made on serum. Coxsackie<br />
virus B was isolated in 39 of 75 (52%) cerebrospinal fluid<br />
specimens with RT-PCR and 69.8% of 254 cases in serum.<br />
The clinical presentation and laboratory findings were typical<br />
of viral meningitis. Cases were aged 28 days to 49 years;<br />
90% of patients were aged around 3 years. Headache was<br />
present in 20%, photophobia in 10%, vomiting in 40%,<br />
fever in 80%, and neck stiffness in 36.8%. A total of 10%<br />
of cases had seizures, and 84.5% of cases had abnormal EEG.<br />
One case died and other patients got well. In spite of temporal<br />
clustering, the mode of transmission in this outbreak<br />
remained speculative. Respiratory transmission was possibly<br />
responsible for this outbreak of Coxsackie virus B meningitis.<br />
FP-G-056<br />
A clinical values of NSE, NO/NOS changes in<br />
cerebrospinal fluid in patients with various nervous<br />
system diseases<br />
Z. Huang, Q. Chen, C.-F. Zai<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences Chongqing, China<br />
Objective: To determine both NSE and NO/NOS in CSF.<br />
We also investigated their regular changing pattern, their<br />
relationship, their influence on the originating, developing<br />
and recovering of various nervous system diseases. Their<br />
clinical values were illustrated. Methods: A total of 115<br />
cases with nervous system diseases including 18 GBS, 30<br />
epilepsy, 28 bacterial meningitis and 40 acute viral encephalitis<br />
were studied. Twenty age-matched children with<br />
normal neurologic development were taken as the control<br />
group. NSE and NO/NOS levels in CSF were studied by<br />
ELISA enzymo-immunoassay and Griess chemical colorimetric<br />
methods, respctively. Results: (1) NSE, NO/NOS<br />
levels in CSF were significantly higher in all disease groups<br />
(5.309 ^ 0.59 , 11.91 ^ 4.28 ng/ml, 2.45 ^ 0.58 , 6.89<br />
^ 0.89 mmol/ml, 4.44 ^ 0.89 , 12.60 ^ 2.10 mmol/ml<br />
per min, respectively) than those of the control group<br />
(4.11 ^ 0.431 ng/ml, 1.90 ^ 0.41 mmol/ml, 2.82 ^ 0.65<br />
mmol/ml per min). (2) The CSF-NSE levels were at highest<br />
level in the bacterial meningitis group (11.91 ^ 4.28 ng/ml),<br />
and NO/NOS levels in CSF were at highest level in the<br />
epilepsy group (6.89 ^ 0.89 mmol/ml, 12.6 ^ 2.10 mmol/<br />
ml per min). (3) NSE to NO, NSE to NOS and NO to<br />
NOS in CSF changes were markedly correlated<br />
(r ¼ 0:57 , 0:78, P , 0:05 , 0:01) in all groups of<br />
subject. Conclusion: (1) NSE, NO/NOS levels in CSF<br />
were elevated to varying degrees in patients with nervous
Abstracts 483<br />
system diseases. These illustrated the definite neuronal and<br />
glial cell damage in these diseases, including GBS, epilepsy,<br />
bacterial meningitis and acute viral encephalitis. (2) As the<br />
biological marker of living neurons, NSE and NO/NOS CSF<br />
changes correlated (r ¼ 0:57 , 0:78, P , 0:05 , 0:01).<br />
That indicated that they all play an important role in<br />
diseases’ originating and developing course. (3) NSE levels<br />
in bacterial meningitis and epilepsy were highest, associated<br />
with the highest levels of NO/NOS. This implied the most<br />
serious neuronal and glial cell damage, NO/NOS might<br />
make this damage more serious by their cytotoxic effects.<br />
In GBS, mainly due to immunological damage of axon and<br />
myelin of peripheral nerves, the neuronal damage was not<br />
serious, so NSE levels were elevated mildly, as were NO/<br />
NOS levels.<br />
FP-G-057<br />
A child with acute pandysautonomia: recovery after two<br />
courses of intravenous high-dose immunoglobulin<br />
therapy<br />
M. Ishitobi, K. Haginoya, T. Kitamura, M. Munakata, H.<br />
Yokoyama, K. Iinuma<br />
Department of Pediatrics, Tohoku <strong>University</strong> School of<br />
Medicine, Miyagi, Japan<br />
Acute pandysautonomia is a rare disorder, characterized<br />
by acute dysfunction of the autonomic nervous system with<br />
history of preceding infection. It is recently recognized as a<br />
neuroimmunologic disorder like Guillain-Barre syndrome,<br />
and is occasionally treated with IVIG. Here we report a<br />
previously healthy 11 year-old boy, who suffered from<br />
severe orthostatic hypotension after a febrile episode.<br />
Serial examination of the orthostatic test and coefficient<br />
of variation in the R-R intervals showed complete recovery<br />
after two courses of IVIG, which were given 3 months<br />
from the onset. One or more courses of IVIG should be<br />
considered to treat this disorder without spontaneous<br />
remission.<br />
FP-G-058<br />
Availability of cerebrospinal fluid ferritin for early<br />
diagnosis of bacterial meningitis in children<br />
Y.-O. Kim, Y.-J. Woo, M.-H. Youm, E.-Y. Kim<br />
Department of Pediatrics, Chonnam <strong>University</strong> Hospital,<br />
Kwangju, Korea<br />
Purpose: To determine the normal CSF ferritin level<br />
according to age and the cut-off value for early diagnosis<br />
of bacterial meningitis. Methods: 203 children (27 weeks<br />
gestation to 16 years old) were classified into four groups:<br />
non-meningitis (73), aseptic meningitis (76), bacterial<br />
meningitis (26), and bacterial meningitis suspected group<br />
(28). WBC, protein, glucose and ferritin in CSF were<br />
analyzed in each group. Results: CSF ferritin level in the<br />
bacterial meningitis group was significantly higher than in<br />
the non-meningitis group or the aseptic meningitis group.<br />
The CSF ferritin had positive correlation with WBC and<br />
protein in CSF, but negative with CSF glucose<br />
(P , 0:01). The CSF ferritin decreased up to 1 year old<br />
but was not related to age over 1 year in the non-meningitis<br />
group. For early diagnosis of bacterial meningitis, 15.58 ng/<br />
ml was considered as the appropriate cut-off value of CSF<br />
ferritin with a sensitivity of 96.2% and a specificity of<br />
96.6% in this study. Conclusion: The normal CSF ferritin<br />
level according to age was determined and it showed<br />
decreasing levels up to 1 year old including the premature.<br />
CSF ferritin level of 15.58 ng/ml was considered as an<br />
appropriate cut-off value for discriminating bacterial meningitis.<br />
FP-G-059<br />
Enterovirus 71 infection with severe neurological<br />
complications<br />
M.A. Nolan, M. Lahra, M. Craig, P.C. Prager, W.D.<br />
Rawlinson, G.D. Williams, P.I. Andrews<br />
Sydney Children’s Hospital, Sydney, Australia<br />
Enterovirus 71 (EV71) is a picornavirus. It is usually<br />
associated with hand, foot and mouth disease, a mild,<br />
self-limiting febrile illness. Neurologic complications are<br />
infrequent but include aseptic meningitis, acute flaccid<br />
paralysis (AFP) and brainstem encephalitis (BSE). A<br />
distinctive syndrome due to invasive EV71 infection in<br />
infants and young children has emerged. It is characterised<br />
by acute neurogenic pulmonary edema (PE), acute respiratory<br />
failure, BSE, AFP and characteristic MRI signal<br />
abnormalities in pons, medulla and spinal cord, and is<br />
almost universally fatal. We describe seven patients with<br />
this distinctive syndrome who survived the acute illness.<br />
The acute cardiopulmonary crisis was managed with<br />
mechanical ventilation, aggressive after load reduction<br />
and moderate inotrope support. Other acute therapies<br />
included pleconaril (anti-enteroviral agent, unproven activity<br />
against EV71; n ¼ 4), high-dose intravenous steroids<br />
(n ¼ 4) and IVIG (n ¼ 3). Variable neurological improvement<br />
occurred within the first 2 months. The six patients,<br />
who have survived at least 18 months, have severe, residual,<br />
motor dysfunction, including flaccid paresis of one or<br />
more limbs, cranial nerve palsies and ventilatory failure,<br />
with preserved cognition and sensation. Residual motor<br />
deficits are consistent with persistent MRI signal abnormalities<br />
in the respiratory centre and other regions of the<br />
brainstem, phrenic nerve nuclei, and anterior grey matter<br />
of the spinal cord. Clinical improvement after the first 12<br />
months has been limited, and four require ongoing ventilatory<br />
support. At least three epidemics of EV71 infection<br />
associated with this syndrome have occurred in the last 5<br />
years, and there is great need for effective immunisation<br />
and specific therapy.
484<br />
Abstracts<br />
FP-G-060<br />
Spastic paraparesis and encephalpathy associated with<br />
HTLV-1 infection in Argentinian seronegative children<br />
L. Czornyj, A. Mangano, L. Sen, N. Fejerman<br />
Hospital de Pediatria ‘J.P. Garrahan’, Buenos Aires,<br />
Argentina<br />
Human T-cell leukemia virus-1 (HTLV)-1 has been associated<br />
with T cell-leukemia and myelopathy/tropical spastic<br />
paraparesis. There have been some reports of adult patients<br />
with spastic paraparesis (SP) and asymptomatic individuals<br />
carrying detectable tax sequences in PBMC but were<br />
HTLV-1 seronegative. We studied ten children (six girls<br />
and four boys) three with SP and seven with encephalopathy<br />
(E), who were referred for diagnosis of HTLV-1 infection<br />
by serologic and molecular assays. They had an average age<br />
of 43.9 months (ranging from 3 months to 16 years). Detection<br />
of antibodies to gag and env HTLV-1/2 was accomplished<br />
by gelatine particle agglutination and Western<br />
blotting test. HTLV tax and pol sequences were investigated<br />
by nested PCR amplification from PBMC, and then<br />
subtyped by RFLP for HTLV-1 and HTLV-2.All children<br />
were HTLV-1/2 seronegative. HTLV-1 tax sequence was<br />
present in the ten patients studied while the pol fragment<br />
was absent in the seven cases checked. Although preliminary,<br />
the presence of tax sequences in the absence of pol<br />
sequences and without detectable antibodies to HTLV-1<br />
gag and env in children with neurological disorders, may<br />
suggest an HTLV-1 infection with a defective provirus.<br />
FP-G-061<br />
Multiple sclerosis in children: a case series<br />
M.A.M. Prudencio, M.H. Ortiz, E.L. Avendaño<br />
Child Neuroscience Division, Philippine Children’s Medical<br />
Center, Quezon City, Philippines<br />
MS is a chronic relapsing, remitting disease characterized<br />
by neurologic symptoms referable to lesions disseminated<br />
throughout the neuraxis with a propensity for spontaneous<br />
improvement. This disease is rare among infants and children<br />
with an incidence of 2.7%. It is even rare in children<br />
less than 10 years of age. Three boys aged 4–9 years and one<br />
girl aged 15 years were diagnosed as having MS at the<br />
Philippine Children’s Medical Center (PCMC) within a 3<br />
year period (1996–1999). All presented with multiple<br />
neurologic deficits occurring with a relapsing and remitting<br />
course. Neurodiagnostic evaluations included the following:<br />
CSF IgG was elevated in two/four cases (50%) and abnormal<br />
evoked responses (visual evoked response, somatosensory<br />
evoked response, brainstem auditory evoked response)<br />
were noted in three/four cases (75%). Cranial MRI done in<br />
all patients showed presence of nodular lesions with<br />
increased T2 signals involving different areas of the white<br />
matter. Improvements were observed with steroid administration.<br />
FP-G-062<br />
Recurrent purulent meningitis in Thai children<br />
S. Chiemchanya, A. Visudtibhan, J. Patrungsri,<br />
P. Visudhiphan<br />
Division of Neurology, Department of Pediatrics, Faculty of<br />
Medicine, Ramathibodi Hospital, <strong>Mahidol</strong> <strong>University</strong>,<br />
Bangkok, Thailand<br />
Background: Recurrent purulent meningitis in children<br />
was rare and the diagnosis for the causes remained problematic.<br />
There were few reports concerning this illness in<br />
children. Objective: To study the causes of recurrent purulent<br />
meningitis in children. Method: A retrospective study<br />
was conducted by reviewing medical records of all pediatric<br />
patients who had purulent meningitis admitted at the<br />
Department of Pediatrics, Ramathibodi Hospital between<br />
January 1, 1977 and December 31, 1997. Result: Nineteen<br />
children were included in this study. There were 13 patients<br />
who had more than two episodes of purulent meningitis<br />
before presenting for evaluation. Seventeen children had<br />
anatomical defects, which were congenital CSF fistula (11<br />
children) and acquired diseases causing leakage of CSF (six<br />
children). Those with congenital fistula comprised five children<br />
with inner ear anomaly, five children with meningoceles,<br />
and one child with cribriform plate defect. Among<br />
those with acquired diseases, five had traumatic CSF fistula<br />
and the other had chronic otitis media. There were two<br />
children who did not have either demonstrable anatomical<br />
defect or immune deficiency disease. Streptococcus pneumoniae<br />
was the most common causative microorganism.<br />
During follow up evaluation ranging from 1 to 10 years,<br />
one child with temporal bone defect had recurrent meningitis.<br />
However, after second surgical treatment, there was no<br />
recurrence. Conclusion: Anatomical defect was the most<br />
common cause of recurrent purulent meningitis observed<br />
in this study. Complete investigation to exclude any congenital<br />
defect is recommended in children with recurrent purulent<br />
meningitis.<br />
FP-G-063<br />
Herpes simplex encephalitis in pediatrics diagnosed by<br />
CSF polymerase chain reaction: a report of three cases<br />
and review of literature<br />
A.L.F. Luat<br />
Child Neuroscience Division, Philippine Children’s Medical<br />
Center, Quezon City, Philippines<br />
HSE is an acute, devastating infection of the central<br />
nervous system that causes significant morbidity and<br />
mortality. The clinical presentation of HSE includes a<br />
syndrome of acute onset characterized by fever, headache,
Abstracts 485<br />
seizures, focal neurological signs and impaired consciousness,<br />
however, cases of atypical HSE have also been<br />
reported. Early diagnosis of HSE is important because it<br />
is the only viral infection of the central nervous system for<br />
which treatment has been proven effective in rigorous clinical<br />
trials. The diagnosis, however, is difficult because of<br />
the protean clinical manifestations and the inability to<br />
isolate virus from the cerebrospinal fluid. Both the detection<br />
of intrathecal HSV antibody and HSV antigen are<br />
retrospective means of establishing the diagnosis. Brain<br />
biopsy used to be the only means of making a definitive<br />
diagnosis of HSE. The development of PCR as a diagnostic<br />
procedure may contribute to the early diagnosis of HSE<br />
and, therefore, early initiation of treatment and better therapeutic<br />
outcome. We report three cases of pediatric HSE<br />
diagnosed by CSF PCR and treated with Acyclovir. The<br />
use of PCR may uncover a wider clinical spectrum of HSE<br />
than has been previously recognized.<br />
FP-G-064<br />
Acute severe pediatric central demyelination<br />
E. Shahar<br />
Child Neurology Unit, Rambam Medical Center, Haifa,<br />
Israel<br />
The different clinical presentations, medical therapy and<br />
current outcome are reported in a series of thirteen children<br />
diagnosed with acute severe central demyelination<br />
(ASCDM), namely acute disseminated encephalomyelitis<br />
(ADEM) or spinal cord multi-focal myelopathy (SMM):<br />
seven males and six females presenting at age of 2.5–14<br />
years (mean: 6.6). Four children developed ADEM,<br />
presenting with deteriorating alertness and developing<br />
coma along with cranial nerves and brainstem involvement,<br />
brisk tendon reflexes and extensor plantar responses.<br />
Seven children developed SMM with flaccid pyramidal<br />
weakness of limbs, mainly the lower limbs, of whom<br />
seven became bed-ridden, along with bladder and bowel<br />
incontinence, without apparent change in alertness. All<br />
ADEM patients were treated with high-dose methylprednisolone<br />
(HDMP), of whom three completely recovered<br />
within 5–7 days. An additional child, with combined<br />
myelo-radiculoneuropathy (MRN), also treated with<br />
IVIG, failed both therapies and remains handicapped. Of<br />
the seven bed-ridden SMM patients, six were initially treated<br />
with HDMP of whom five completely recovered within<br />
2–9 days (range: 5.83). The seventh patient with West Nyle<br />
Fever MRN, was also given IVIG but remains handicapped.<br />
Another patient with SMM initially failed oral<br />
steroids and subsequently fully recovered with IVIG. Overall,<br />
eight of eleven children with ASCDM, given HDMP<br />
completely recovered. Therefore, HDMP or IVIG, either<br />
given separately or even combined in protracted cases,<br />
seems to be efficacious in severe debilitating pediatriconset<br />
ASCDM with negligible adverse-effects.<br />
FP-G-065<br />
Bacterial meningitis during the season of flu epidemic<br />
Z. Milenkovic, K. Karovski, N. Pop-Jordanova, V.<br />
Markovski, P. Stojovska, R. Naumovski<br />
Clinic of infectious diseases, Faculty of medicine, Skopje,<br />
Macedonia<br />
In an open, randomized, controlled study on 118 patients<br />
with purulent meningitis (PM) treated at Clinic of infectious<br />
diseases in Skopje during the season of flu epidemic (test<br />
group, tg) in the last 5-year (1997–2002) period, some<br />
biochemical, clinical and microbiological characteristics<br />
have been analysed. The results obtained were compared<br />
with the findings of 186 patients with PM treated outside<br />
that period (control group, cg). The etiology of disease was<br />
confirmed by bacterial isolation from CSF in 55.6% of<br />
cases. The most frequent etiological agent in both groups<br />
was Str. pneumoniae. Biochemical and microbiological<br />
findings: lower initial CSF WBC count (898 ^ 788<br />
(87.7%) versus 1.699 ^ 1.008 (59.3%) £ 10 6 /l) with relatively<br />
higher CSF protein level (1.86 ^ 1.36 (73.1%) versus<br />
2.06 ^ 1.46 (70.9%) g/l) and higher percentage of presence<br />
of parameters of bacteriaemia (19.5 versus 16.7%), sepsis<br />
and septic shock (37.3 versus 32.8%), in tg were found.<br />
Clinical parameters: higher frequency of initially disturbed<br />
state of consciousness (32.2 versus 30.6%) and transitory<br />
neurological deficit (11.9 versus 8.6%), in the tg were found.<br />
Contrary to our expectations based on the biochemical, clinical<br />
and microbiological findings cited, the mortality rate<br />
was lower in tg (10.2 versus 13.4%).<br />
FP-G-066<br />
Subacute sclerosing panencephalitis (SSPE): summary<br />
of the California experience<br />
M. Philippart<br />
Brain Research Institute, UCLA, Los Angeles, USA<br />
Measles vaccination almost eliminated SSPE, which still<br />
presents challenges of diagnosis, treatment and pathophysiology.<br />
The natural course has been distorted towards the<br />
most severe cases, leading to early death. SSPE was<br />
confirmed in 26/29 cases evaluated since 1979. Six cases<br />
were born in California, two of them among four born in<br />
1989 during the 400-case Riverside epidemic; two in other<br />
States; 14 in Central America; one each in Belgium, Brazil,<br />
Canada, and the Philippines. Two died within 6 months.<br />
Fourteen with onset from 1965 to 2000 are still alive. One<br />
survives 25 years after onset without treatment. One with a<br />
Rasmussen presentation seems cured after a left hemispherectomy<br />
in 1989. Five received Inosiplex only: one, in stage 4,<br />
did not benefit but survived 8 years; one lived 20 years after a<br />
recovery to stage 1, lasting 10 years; one was lost to followup<br />
(F/U); one, who recovered to stage 2 for 8 years, is still<br />
alive 15 years after onset. One with no benefit from recom-
486<br />
Abstracts<br />
binant interferon has been 15 years in stage 4. Fifteen were<br />
treated with partially purified human interferon: four (stage<br />
4) did not benefit, two of them were lost to F/U; three died<br />
within 2 years of onset; three stabilized (9–15 years); five<br />
improved: two from stage 2 (6 months, 4 years); two from<br />
stage 3 (2 and 6 years), the last, who 6 months after onset sank<br />
to stage 4, had the quickest biological response, IgG synthesis<br />
rate/day falling from 59.6 to 6.8 mg (normal ,3.3).<br />
FP-G-067<br />
Atypical form of subacute sclerosing panencephalitis<br />
related to vaccine measles virus<br />
F.N. Arita, S. Rosemberg<br />
Santa Casa of Sao Paulo School of Medicine, Department of<br />
Pediatrics, Neuropediatrics Division, Sao Paulo, Brazil<br />
SSPE is a rare progressive inflammatory disease of the<br />
CNS caused by persistent mutant measles virus infection<br />
whose onset occurs several years after the primary infection<br />
in early life. Its occurrence fell dramatically after introduction<br />
of measles vaccine. However, a few vaccinal cases have<br />
been reported. It is estimated that this occurs at a rate of 0.5–1<br />
cases per million of applied doses of vaccin. We report three<br />
patients who had been vaccinated after the measles<br />
epidemics of 1997 in Sao Paulo State and presented an<br />
unusually early onset and rapid progressive course of the<br />
disease. At onset, the ages of the patients were 2 years, 2<br />
years 2 months, and 3 years, and all had been vaccinated,<br />
respectively, at 14 months, 16 months, and 2 years 2 months<br />
prior the onset. This third patient, however, had had measles<br />
infection at age of 9 months, 1 month before immunization.<br />
In all cases, the first symptoms consisted of frequent falls and<br />
periodic myoclonic jerks occurring every 5 or 10 s. The EEG<br />
showed typical periodic complexes. CSF protein electrophoresis<br />
showed levels of g-globulins above 30 mg.% and<br />
measles virus-specific antibodies were detected. The clinical<br />
course was characterized by a dramatically rapid progressive<br />
psycho-motor deterioration. In a few weeks all patients were<br />
bedridden and unresponsive to external stimuli. One patient<br />
died at 4 years 8 months of age and the others, aged 4 years 7<br />
months and 5 years 3 months, are alive in a vegetative state.<br />
These cases demonstrate that measles vaccine virus may<br />
provoke a special clinical form of SSPE in which the incubation<br />
period is short and the clinical course acute.<br />
FP-G-068<br />
Subacute sclerosing panencephalitis presenting with<br />
hemiparesis: a case report<br />
H. Ozyurek, A. Degerliyurt, G. Turanl<br />
Hacettepe <strong>University</strong>, Department of Pediatric Neurology,<br />
Ankara, Turkey<br />
Subacute sclerosing panencephalitis (SSPE) is a slow<br />
virus infection of the central nervous system characterized<br />
by myoclonic seizures, involuntary movements, and mental<br />
deterioration. SSPE is diagnosed with strikingly elevated<br />
levels of measles antibodies in the serum and CSF in addition<br />
to the clinical picture. Epidemiologic studies revealed<br />
that the age at onset of SSPE (7.6–5 years) decreased especially<br />
after 1995 in Turkey. In childhood, SSPE rarely<br />
present with focal neurologic signs. A 14-month-old girl<br />
was admitted because of intermittent fever and lethargy of<br />
2 months duration, followed by left-sided hemiparesis. Her<br />
past medical and family histories were unremarkable. Her<br />
motor and mental development was normal. There was no<br />
history of measles. During follow-up, firstly partial than<br />
generalized seizures developed in the patient. In cranial<br />
magnetic resonance, on T2-weighted images there was<br />
hyperintensity of frontoparietal cortex bilaterally and<br />
white matter especially in the right hemisphere. Electroencephalogram<br />
showed periodic paroxysmal activity characterized<br />
by suppression burst that did not disappear with<br />
diazepam. There was delay in the latencies of visual evoked<br />
potentials. Electroretinogram was normal. Urine sample for<br />
organic acids and lysosomal screening was negative. The<br />
lactic and pyruvic acid concentrations were normal in CSF.<br />
Serology for rubella and herpes type I was negative.<br />
Elevated measles antibody titers were detected in both<br />
serum and CSF by complement fixation (1/512 and 1/16,<br />
respectively). The patient was diagnosed with SSPE on<br />
laboratory findings. In summary, symptoms of SSPE may<br />
present as early as infancy like in Sour patient. Although<br />
focal neurological signs are mostly seen in adults with<br />
SSPE, they rarely may be a component of SSPE in childhood.<br />
Thus one should also consider SSPE in infants with<br />
focal neurological signs.<br />
FP-G-069<br />
Long-term follow-up of a patient with subacute<br />
sclerosing panencephalitis successfully treated with<br />
intrathecal interferon alpha<br />
M. Miyazaki a,b , M. Nishimura a , Y. Toda a , T. Saijo a ,K.<br />
Mori a , Y. Kuroda a<br />
a Department of Pediatrics, Tokushima <strong>University</strong> School of<br />
Medicine, Tokushima; b Miyoshi Medical Clinic, Kagawa,<br />
Japan<br />
We previously reported that a patient with SSPE was<br />
successfully treated with intrathecal interferon alpha (IFNa)<br />
and his pronounced improvement was observed in a<br />
dose-dependent manner (Ann Neurol 1991). To clarify<br />
long-term effects of IFN-a in SSPE, we followed up the<br />
patient for 17 years with neuroradiological and physiological<br />
examinations. He was diagnosed with SSPE at age 8<br />
years and treated weekly or fortnightly with 1.0 to<br />
3.0 £ 106 IU IFN-a by intrathecal route. IFN-a therapy<br />
induced remission of SSPE and he maintained a higher<br />
quality of life for approximately 8 years compared with<br />
other SSPE patients. At age 16 years, he gradually devel-
Abstracts 487<br />
oped muscle rigidity, gait disturbance and difficulty in<br />
speech. Increasing the dose of IFN-a to 5 £ 106 IU and<br />
changing to IFN-a brought no remarkable benefit. Currently<br />
he is a malnourished 25-year-old male with akinetic mutism<br />
who barely responds to loud sounds and strong painful<br />
stimulation. The electroencephalogram shows diffused low<br />
voltage fast activity without a-rhythm, and brain CT scan<br />
discloses severe brain atrophy in the cerebellum and brainstem,<br />
as well as linear high density along the circle of Willis.<br />
These results may indicate that IFN-a-induced remission is<br />
most likely to be temporary, even if an SSPE patient shows<br />
an excellent initial response to the treatment. To improve<br />
the long-term prognosis of SSPE patients, more effective<br />
therapy, such as a combination of IFN-a with novel agents,<br />
still needs to be developed.<br />
FP-G-070<br />
CXCL10 production from cytomegalovirus-stimulated<br />
human microglia: regulation by interleukin-10<br />
S. Hu, M.C.-J. Cheeran, S.L. Yager, P.K. Peterson, J.R.<br />
Lokensgard<br />
Neuroimmunology Laboratory, Minneapolis Medical<br />
Research Foundation; and the <strong>University</strong> of Minnesota<br />
Medical School, Minneapolis, USA<br />
Microglial cells orchestrate multi-cellular immune<br />
responses to viral infections of the central nervous system<br />
and synchronize various immune functions through a regulated<br />
network of cytokines and chemokines. Recruitment of<br />
T lymphocytes to local sites of infection is critical for resolution<br />
of cytomegalovirus disease. In the present study, we<br />
investigated the production of an alpha-chemokine<br />
CXCL10 (interferon-gamma inducible protein-10, IP-10)<br />
in response to CMV infection of glial cells and the regulation<br />
of its production by IL-10. We found that human microglial<br />
cells, but not astrocytes, produced CXCL10 in<br />
response to CMV, reaching maximal levels at 48–72 postinfection.<br />
Expression of CXCL10 mRNA in CMV-stimulated<br />
microglia was not dependent on secondary protein<br />
synthesis but did require replication competent virus. Activation<br />
of NF-kappa B and p38 MAP kinase in microglial<br />
cells was observed in response to stimulation with CMV and<br />
inhibitors of this activation decreased viral-induced<br />
CXCL10 production. Exogenous CXCL10 itself had no<br />
effect on CMV replication in permissive astrocytes,<br />
however, supernatants from CMV stimulated microglial<br />
cells increased chemotaxis of activated T-cells, which<br />
could be partially suppressed by anti-CXCL10 antibodies.<br />
Anti-inflammatory cytokines appear to play a critical role in<br />
preventing excessive CNS inflammation including T-cell<br />
accumulation. Treatment of microglial cells with IL-10<br />
was found to inhibit CXCL10 production at the level of<br />
mRNA transcription and was associated with decreased<br />
CMV-induced NF-kappa B activation. These studies<br />
suggest that microglial cell production of CXCL10 plays a<br />
major role in recruitment of T-cells to foci of CMV infection<br />
and that IL-10 functions to prevent excess inflammation.<br />
FP-G-071<br />
Reactivation of HHV-6 infection in chronic<br />
encephalopathy<br />
C. Arpino a,c , L. Lopez a , G. Anzidei b , M.P. Camporiondo b ,<br />
D. Poveromo c , P. Curatolo c<br />
a Eugenio Litta Rehabilitation Center for Developmental<br />
Disabilities; b IRCCS Infectious Diseases L. Spallanzani;<br />
and c Pediatric Neurology Unit, Tor Vergata <strong>University</strong>,<br />
Rome, Italy<br />
We present a case of a 13 year-old girl with chronic<br />
encephalopathy, whose recrudescence of symptoms was<br />
associated with the reactivation of HHV-6 infection both<br />
at the systemic level and at the level of the CNS. Since<br />
the age of 3 years, she had suffered from frequent epileptic<br />
seizures resistant to treatment, and at the age of 8 years she<br />
began to present cognitive deterioration. At the time of our<br />
evaluation, the girl showed intermittent episodes of delirium<br />
and epileptic seizures. Her karyotype, blood and urine<br />
screening for metabolic diseases, optic fundi, motor and<br />
sensory conduction velocity studies, immunoglobulins and<br />
T lymphocyte subsets, were normal. Interictal EEG showed<br />
absence of normal background activity, and a prominent<br />
slow delta activity bilaterally in the anterior leads. MRI<br />
imaging showed mild, non-specific, diffuse cortical atrophy<br />
prevailing in the frontal regions. CSF examination for DNA<br />
sequences of several viral agents (i.e. Cytomegalovirus,<br />
HHV-6, herpes simplex 1 and 2, Epstein-Barr virus, varicella<br />
zoster virus) by nested polymerase chain reaction<br />
revealed HHV-6 sequences, which were also detected in<br />
peripheral blood mononuclear cells. HHV-6 is a neurotropic<br />
virus; up to now, demyelination and seizures or status<br />
epilepticus have been observed in primary disease (i.e.<br />
exanthema subitum) or in immunocompromized children.<br />
Our report suggests that human Herpesvirus-6 (HHV-6)<br />
reactivation, at the CNS level, may occur also in immunocompetent<br />
hosts with severe neurological disease. It remains<br />
to be defined whether, in our patient, viral reactivation was<br />
the mere consequence of illness-related stress or a factor<br />
contributing to the recrudescence of CNS disease.<br />
FP-G-072<br />
Experimental study of endotoxic brain edema in infant<br />
rats and its treatment<br />
M. Li, F.-C. Cai<br />
Department of Neurology, College of Pediatrics, Chongqing<br />
Medical <strong>University</strong>, Chongqing, China<br />
Glucocorticoids are considered as effective drugs in reducing<br />
blood–brain barrier (BBB) permeability. IVIG is
488<br />
Abstracts<br />
frequently used to cure neurological disease, but its role and<br />
potential mechanism in brain edema has not been reported.<br />
In this study, the infant rat endotoxic brain edema was<br />
produced by intraperitoneal administration of 10 mg/kg of<br />
LPS, and the brain water and EB content, intracellular free<br />
Ca 21 and CaM expression were observed. The results<br />
showed that brain water and EB content were remarkably<br />
increased in endotoxemic rats compared with controls. Electron<br />
microscopy studies revealed that brain microvesicular<br />
endothelial cells had more endocytotic vesicles, degeneration<br />
and basal membrane disrupted and the space around<br />
brain capillaries was enlarged. The increase of brain intracellular<br />
free Ca 21 and up-regulation of cellular CaM expression<br />
were coincident with increase of EB and water content<br />
caused by LPS. Administration of DEX and IVIG could<br />
markedly decrease brain water and EB content. These<br />
results suggested that LPS increases the intracellular free<br />
Ca 21 and active CaM-dependent function via the Ca 21 /<br />
CaM pathway, which might relate to the increased BBB<br />
permeability and brain edema formation. The two drugs<br />
have the ability to reduce the BBB permeability and alleviate<br />
brain edema via reducing the intracellular free Ca 21 ,<br />
inhibiting the expression of CaM, and blocking the Ca 21 /<br />
CaM signal pathway. But IVIG failed to reduce the intracellular<br />
free Ca 21 , which suggests that other factors may be<br />
involved in regulating the intracellular free Ca 21 .<br />
FP-G-073<br />
Neurological outcome of children born to<br />
antiphospholipid antibody-positive mothers<br />
B.M. Tabarki, S. Boudhir, N. Salem, T. Mahjoub, A.<br />
Trabelsi, M. Yacoub, H. Selmi, A.S. Essoussi<br />
Farhat Hached Hospital, Sousse, Tunisia<br />
Objective: To evaluate the neurological features and<br />
outcome of children born to antiphospholipid antibodypositive<br />
mothers treated with calcium heparin and/or aspirin<br />
during pregnancy. Design: Retrospective data collection<br />
and prospective pediatric review of patients seen at Farhat<br />
Hached hospital between 1997 and 2001. Results: Seventythree<br />
children, with ages ranging from 10 months to 5 years,<br />
born to mothers with antiphospholipid antibodies were<br />
reviewed. Four patients (5%) died because of prematurity<br />
and/or nosocomial infection. Sixty-one (84%) patients were<br />
normal on neurodevelopmental and physical examination at<br />
pediatric review. Eight patients (11%) showed neurological<br />
abnormalities: severe intellectual and motor dysfunctions<br />
associated with epilepsy (four patients), mild mental retardation<br />
(two patients), hemiplegia (one patient), and epilepsy<br />
(one patient). Neuroradiological findings were: diffuse cerebral<br />
ischemia (four patients), middle cerebral artery infarction<br />
(one patient), sinovenous thrombosis (one patient),<br />
CNS malformation (one patient), and normal MRI in one<br />
patient. Four of the eight patients had positive antiphospholipid<br />
antibodies. Neurologic complications were not related<br />
to prematurity, growth restriction or other diseases. Conclusion:<br />
These data indicate that children born to antiphospholipid<br />
antibody positive mothers are at increased of CNS<br />
diseases, especially cerebrovascular disorders.<br />
FP-G-074<br />
Epidemiological and clinical features of 63 cases with<br />
subacute sclerosing panencephalitis diagnosed in 4 years<br />
Ö.F. Aydin, N. Şenbil, M. Kara, Y.K.Y. Gürer<br />
Department of Pediatric Neurology, Dr. Sami Ulus Children’s<br />
Hospital, Ankara, Turkey<br />
SSPE is an inflammatory neurodegenerative disease<br />
caused by persistence of measles virus. Although its<br />
frequency is declining because of widespread measles vaccination,<br />
it is still prevalent in areas where measles is endemic.<br />
We reviewed 63 patients diagnosed with SSPE over a period<br />
of 4 years (1998–2001). The diagnosis is based on the characteristic<br />
clinical and electroencephalographic findings and<br />
demonstration of an elevated antibody titer against measles in<br />
the plasma and the cerebrospinal fluid. Fifty-one of the<br />
patients were males (81%) and 12 were females (19%);<br />
male/female ratio was 4.25. The mean age of onset of SSPE<br />
was 68.29 ^ 29.87 months and follow-up duration was<br />
9.85 ^ 7.49 months. The initial symptoms noticed by<br />
families were unsteady gait/stumbling (26.9%), head drops<br />
(20.6%), frequently falling (15.8%) and jerks (11.1%). Head<br />
trauma was the precipitating factor in 14 cases (25.9%). Fiftythree<br />
patients had had measles and 20 of 43 patients questioned,<br />
hadreceivedimmunization. Themeanage ofinfection<br />
was 15.68 ^ 11.6 months, mean latent period was<br />
51.8 ^ 28.34 months. Mean time between first symptoms<br />
and admission was 11.4 ^ 14.87 weeks. Major complaints<br />
on admission were slurred speech (41%), frequent falling<br />
(38%) and unsteady gait/stumbling (34%). Examination on<br />
admission revealed myoclonic jerks in 53% of patients and<br />
they were mostly at clinical stage 3 A (24.5%) and 3B<br />
(33.3%). Thirteen of the 49 patients (26.5%) that could be<br />
followed up died. Conclusion: it is necessary to re-evaluate<br />
the immunization programme in preventing in SSPE, which is<br />
a complication of an infection preventable by immunization.<br />
FP-G-075<br />
Evaluation of the treatment results of 63 cases with<br />
SSPE diagnosed between the years 1998–2001<br />
Ö.F. Aydin, N. Şenbil, Ö. Eǧritas¨, Y.K.Y. Gürer<br />
Department of Pediatric Neurology, Dr. Sami Ulus Children’s<br />
Hospital, Ankara, Turkey<br />
Sixty three patients diagnosed as SSPE between the<br />
years 1998–2001 were treated with oral isoprinosine (100<br />
mg/kg per day), subcutaneous a-interferon 2a (Roferon-A,<br />
Roche) 10 million U/m 2 /three times a week and oral lamivudin<br />
(10 mg/kg per day). Patients that received treatment
Abstracts 489<br />
according to this protocol for at least 6 months (19<br />
patients) have been compared with 13 patients controls<br />
that did not or could not take the treatment. On the basis<br />
of neurological deficit index, clinical stage and the average<br />
of ages, there was no statistical difference between the<br />
treatment and control groups. There was no difference<br />
between the groups on their final evaluation for neurological<br />
deficit index and clinical stages. There was no statistical<br />
difference between the exitus ratios of treatment and<br />
control groups, 3 and 6, respectively. Remission ratios<br />
between the treatment and control groups were 7/19 and<br />
0/13, respectively and were statistically significant<br />
(P ¼ 0:036). Survival time was significant in the treatment<br />
group (P ¼ 0:01). The findings that remission ratios were<br />
different in the treatment group compared with the control<br />
group and also different from the 5% spontaneous remission<br />
rate reported in previous studies, and that the survival<br />
periods were remarkably different, has made us think this<br />
treatment protocol is effective.<br />
FP-G-076<br />
Enteroviral meningitis in Northern Jordan: prevalence,<br />
association of clinical presentation, laboratory findings,<br />
and serotypes involved<br />
A. Abdallah, M. Meqdam, M. Kbaloussi<br />
Princess Rahma Teaching Hospital, Irbid, Jordan<br />
During the summer-autumn of 1999,a total of 390 CSF<br />
specimens from infants and children less than 15 years of<br />
age, suspected of having meningitis, and admitted to Princess<br />
Rahma Hospital. Northern Jordan, were studied to determine:<br />
the incidence of enteroviral meningitis, serotypes<br />
involved, clinical presentation, and laboratory data (shell<br />
vial culture assay and fluorescent assay (FA) were used).<br />
Most cases occurred in children of 1 year of age (46.9%),<br />
and males represented 71.9% of the total of diagnosed enteroviral<br />
meningitis. The dominant symptoms were fever,<br />
vomiting, and headache. Clinical presentation did not distinguish<br />
between children with and without enteroviral meningitis.<br />
Enteroviruses were isolated from 32 (8.2%) cases.<br />
Coxsackie virus B types 2, 4 and 5 were isolated from 15<br />
(46.9%) cases, and ECHO virus 9 was the most commonly<br />
identified serotype (31.3%). The analysis of bacterial and<br />
viral CSF cultures revealed 2 (6.2%) out of 32 patients<br />
with mixed viral/bacterial meningitis. The virus isolation<br />
rate was directly proportional to the number of leukocytes<br />
in CSF. However, enteroviral isolation was directly achieved<br />
in four (12.5%) out of 32 CSF specimens without pleocytosis.<br />
Leukocyte differential count revealed that 71.4% of the cases<br />
showed polymorphonuclear cell predominance. Duration of<br />
hospitalization ranged from 1 to 25 days with a mean of 7<br />
days. The majority (88.9%) of enterovirus-infected patients<br />
were treated with at least one type of antibiotic. According to<br />
these data, we conclude that enteroviruses are frequent in our<br />
area and this indicates the importance of enteroviruses as<br />
common and important pathogens. Moreover, clinical<br />
presentation and CSF cytochemical findings in patients<br />
with enteroviral meningitis, closely resemble other bacterial<br />
and viral infections, and viral culture is a leading tool,<br />
together with promising advanced molecular techniques<br />
such as the PCR, for the diagnosis of enteroviral meningitis.<br />
FP-G-077<br />
Host defenses in children with low birth weight against<br />
pertussis, diphtheria and tetanus<br />
N.G. Kim, D.I. Makhmudova, L.D. Mullaeva<br />
Scientific Research Institute of Pediatrics, Tashkent, Uzbekistan<br />
From 5 to 10% of infants with low birth weight, on the<br />
basis of adequate weight increase and achievement of body<br />
mass 2500 g, received the same vaccines at the same terms<br />
as the full-term infants. However, the degree of physiological<br />
maturation of newborn at the moment of birth is the<br />
factor influencing the adequate immune response to<br />
diphtheria and tetanus toxoids and pertussis vaccine<br />
(DTTPV). The purpose of the investigation was to determine<br />
degree of postvaccine immunity against diphtheria,<br />
pertussis and tetanus in children with low-birth-weight.<br />
Investigation was carried out on 40 healthy children and<br />
51 infants with birth weight ,/ ¼ 2500 g and receiving<br />
the scheme of PTTP vaccination. The children with lowbirth-weight<br />
were divided into three groups: (1) premature<br />
newborns with body weight correlated to age of gestation<br />
(31–34 weeks, body weight 1600–2400 g) N ¼ 18; (2)<br />
premature newborns with body mass lower than expected<br />
for gestational age (30–35 weeks, body mass 1300–1500 g)<br />
N ¼ 18. It was established that postvaccine response in<br />
premature infants against diphtheria, pertussis and tetanus<br />
was characterized by low level of immune production.<br />
Premature infants with birth weight lower than expected<br />
for gestational age failed to induce immunity against pertussis<br />
in 60% of cases. Full-term infants with hypotrophic type<br />
of intrauterine growth and development retardation failed to<br />
produce defensive titres of antibodies against tetanus and<br />
diphtheria in every 3-d case and against tetanus in 66.6% of<br />
cases. Thus, efficacy of DTTP vaccination in children with<br />
low birth weight was correlated to the degree of physiological<br />
development of infant at the moment of its birth.<br />
FP-G-078<br />
Factors influencing the formation of postvaccine<br />
immunity in children with damage of the central nervous<br />
system<br />
Z.A. Kushnaeva, D.I. Makhmudova, G.K. Salimova<br />
Scientific Research Institute of Pediatrics, Tashkent, Uzbekistan<br />
Objective: to study the effect of degree of severity and
490<br />
Abstracts<br />
type of clinical syndrome on the formation of postvaccine<br />
antibodies in children with damage to the CNS. Investigation<br />
was undertaken of 45 children with perinatal damage<br />
of the CNS. Studied children were divided into the following<br />
groups: group I with mild degree of disease (n ¼ 16);<br />
group II moderate degree (n ¼ 20) and group III severe<br />
degree (n ¼ 9); and according to clinical syndrome: ICH<br />
(n ¼ 15) and vegetative visceral dysfunction (VVDF)<br />
(n ¼ 10). Analysis of serological data in children with<br />
mild degree of lesion were found 1.9 times more frequently<br />
as compared to control group (P , 0:05). In children with<br />
moderate degree of damage, negative results were registered<br />
in 40% of cases. Frequency of low titres in children<br />
from this group was 1.9 times more frequent (P , 0:05).<br />
The frequency of moderate and high titres in children of<br />
group II was 3.5 and 2.2, respectively (P , 0:05). In the<br />
third group of children seronegative results against<br />
diphtheria were 6.7 times more frequent than in children<br />
of the control group (P , 0:05). The frequency of moderate<br />
titres was 4.7 times higher in healthy children than in<br />
children with severe degree of damage. The titres of antibodies<br />
against diphtheria in the studied groups were as<br />
follows: group I, 62.4%, group 2, 25%, group 3, 11.2%.<br />
In children with ICH seronegative results with vaccination<br />
were eight times more frequent. The frequency of moderate<br />
antibody titres in this group was four times lower than in<br />
control group (P , 0:01). In VVDF seronegative results<br />
against diphtheria were 7.5 times more frequent<br />
(P , 0:01). The frequency of moderate titres in children<br />
of the main group was higher than 5.3 times (P , 0:01).<br />
The high titres in children against diphtheria were 2.2<br />
times lower in children of the main group (P , 0:05).<br />
Host defenses against diphtheria in ICH were 13.3% and<br />
VVDF 20%. Thus, severity and type of clinical syndrome<br />
of children with damage of the CNS influence the results of<br />
immunization against diphtheria. This category of children<br />
should undergo study of the presence of protective<br />
diphtheria antibodies after vaccination. It is necessary to<br />
develop a scheme to prepare this category of children for<br />
vaccination.<br />
FP-G-079<br />
Clinical analysis of 23 children with cryptococcal<br />
meningitis<br />
L.-Z. Zhang<br />
Department of Pediatrics, Heze Municipal Hospital, Heze,<br />
China<br />
The mean age of 23 children with cryptococcal meningitis<br />
was 4.3, 16 of them were misdiagnosed. The rate of<br />
misdiagnosis was 69.6%. A total of 30.4% were diagnosed<br />
correctly initially. Symptoms included fever, headache,<br />
vomiting, visual loss, convulsions and swelling of the spleen<br />
and liver. The principal changes in CSF were as in tuberculous<br />
meningitis. The level of CSF glucose and chloride<br />
decreased. Cryptococcus neoformans can be found by ink<br />
stain technique. Low density changes were found in head<br />
CT. It is suggested that in order to prevent misdiagnosis an<br />
attempt is made to detect the pathogen. The prognosis is<br />
related to the intracranial pressure, delay in correct diagnosis<br />
and severity of inflammation.<br />
FP-G-080<br />
Clinical features of 25 cases of children with viral<br />
encephalitis<br />
B.-Z. Jia<br />
General Hospital of Yangquan Coalmine Group Yangquan,<br />
China<br />
Objective: To explore the clinical feature of pediatric<br />
viral encephalitis to enable earlier diagnosis. Methods:<br />
The complete data of 25 cases of children with viral encephalitis<br />
in the last 2 years were analyzed. Results: The rate<br />
of common symptoms is: fever (96%), convulsions (64%),<br />
vomiting (52%), disturbance of consciousness (44%), headache<br />
(36%). The rate of rarer symptoms is: thrill (16%),<br />
paralysis (12%), supranuclear paralysis (8%), dizziness<br />
(8%), salivation (4%). Before admission into the hospital,<br />
the median of common symptoms is: headache (2.25),<br />
vomiting (2.1), fever (1.96), convulsions (1.57), disturbance<br />
of consciousness (1). The rate of positive pathological signs<br />
is: Babinski’s sign (28%), stiff neck (20%), Kernig’s sign<br />
(4%). Conclusion: In clinical work, special attention should<br />
be paid to the common symptoms of viral encephalitis and<br />
high vigilance over a few symptoms. In the case of headache<br />
and vomiting, with or without fever in the sick children,<br />
viral encephalitis is possible.<br />
FP-G-081<br />
The study of nitric oxide tumor necrosis factor and<br />
interleukin-8 in serum and cerebrospinal fluid in<br />
children patients with infection of central nervous<br />
system<br />
H.-Y. Wang, Y. Yuan, B.-L. Sun<br />
Department of Pediatrics, the First Affiliated Hospital of<br />
Jiamusi <strong>University</strong>, Jiamusi, China<br />
In this study we evaluated the levels of serum and CSF<br />
NO, NOS, TNF and IL-8. The NO, NOS, TNF, IL-8 in 18<br />
cases of viral meningitis (VM), 14 cases of tuberculous<br />
meningitis (TM), 16 cases of purulent meningitis (PM)<br />
and 20 control cases (CG) were determined by colorimetric<br />
method and radioimmunoassay. Results: (1) The levels of<br />
NO, NOS, TNF in serum and CSF with VM, TM and PM<br />
were significantly higher than those in CG (P , 0:01).<br />
Moreover, the concentrations of NO, NOS, TNF with PM<br />
were significantly higher in CSF than those in patients with<br />
VM and TM (P , 0:01). (2) The levels of IL-8 in serum and<br />
CSF with TM and PM were significantly higher than those
Abstracts 491<br />
in CG. While the concentration of IL-8 with PM was significantly<br />
higher than those with TM, there was no obvious<br />
difference between VM and CG (P , 0:01). All of these<br />
suggested that: (1) NO, NOS, TNF, IL-8 all participated<br />
in the pathogenesis of central nervous system infection.<br />
(2) The determination of NO, TNF and IL-8 of serum and<br />
CSF can be a discriminating index among VM, TM and PM.<br />
FP-G-082<br />
Clinical analysis of 68 cases with mumps encephalitis<br />
W.-Y. Sun, Y.-B. Yan<br />
People’s Hospital of Liaocheng, Liaocheng, China<br />
Objective: The aim of the study was to investigate the<br />
epidemiological characteristics and clinical effects of<br />
mumps encephalitis. Methods: Sixty-eight cases of mumps<br />
encephalitis were studied It is a common complication of<br />
epidemic parotitis and has a high incidence rate. Forty-eight<br />
of the 68 cases occurred from May to September (70.6%).<br />
The patients were aged from 7 to 12 years. All patients were<br />
treated by antivirals and replacement of fluid and electrolyte<br />
losses. Mannitol and corticoid was only used in some<br />
patients who had intracranial hypertension. All patients<br />
were cured. Conclusion: Mumps encephalitis mainly<br />
occurred in non-epidemic seasons and the pediatric age<br />
group. Prognosis is good.<br />
FP-G-083<br />
One versus 2 years of antiepileptic therapy in children<br />
with single small enhancing CT lesions<br />
P.D. Singhi a , J. Dinakaran a , N. Khandelwal b , S.C. Singhi a<br />
a Departments of Pediatrics and b Radiodiagnosis, Post<br />
Graduate Institute of Medical Education and Research,<br />
Chandigarh, India<br />
Objective: The duration of antiepileptic drug (AED) therapy<br />
in children with seizures due to single small enhancing<br />
CT lesions (SSECTL) is controversial. We sought to determine<br />
whether there is any difference in the rate of seizure<br />
recurrence after 1 versus 2 years of AED therapy and to<br />
identify the factors predictive of seizure recurrence. Methods:<br />
A total of 115 consecutive children with seizures and<br />
SSECTL were randomly assigned into two groups. Group A<br />
received AED(s) for 1 year and Group B for 2 years seizure<br />
free interval. CT scan and EEG were done prior to AED<br />
withdrawal and children were followed up for seizure recurrence<br />
for at least 1 year. Association between seizure recurrence<br />
and clinical and CT characteristics was analyzed.<br />
Results: Groups A and B consisted of 55 and 51 children;<br />
(nine lost to follow up). There were 61 boys, 45 girls; mean<br />
age 9.33 years. Most (93%) had focal seizures-36%<br />
complex partial, 22% simple partial, 35% partial with<br />
secondary generalization, 21% had status epilepticus. The<br />
two groups were comparable in clinical, EEG and CT characteristics.<br />
CT scan and EEG prior to AED withdrawal were<br />
abnormal in 44 and 33%, respectively. Six children, three<br />
from each group had seizure recurrence. Significant association<br />
was found between seizure recurrence and abnormal<br />
CT (persistence/calcification of lesion) and abnormal EEG<br />
prior to AED withdrawal (P , 0:01). The relative risk of<br />
seizure recurrence in a child with abnormal CT and EEG<br />
prior to AED withdrawal was 26.2 (95% confidence interval<br />
3.3–210.2, P ¼ 0:0003). No association was found between<br />
seizure recurrence and any of the other variables. Conclusions:<br />
There was no difference in seizure recurrence after 1<br />
versus 2 years of AED therapy. Combination of persistent/<br />
calcified CT lesion and abnormal EEG prior to AED withdrawal<br />
was the best predictor of seizure recurrence.<br />
FP-G-084<br />
Bacteraemia during the purulent meningitis<br />
K. Karovski, Z. Milenkovic, N. Pop-Jordanova, A.<br />
Bogdanovska<br />
Clinic of infectious diseases, Faculty of medicine, Skopje,<br />
Macedonia<br />
In an open, randomized, controlled study of 304 patients<br />
with PM treated at Clinic of infectious diseases in Skopje,<br />
the frequency and the influence of bacteraemia on the<br />
outcome of the disease, were investigated. The etiology of<br />
the disease was confirmed by bacterial isolation from the<br />
CSF in 55.6%, with S. pneumoniae (58%), N. meningitidis<br />
(20.7%) and H. influenzae (7.7%), being the most frequent<br />
agents. Fatal outcome in 12.2% of patients, and audiological<br />
sequelae in 8.7% out of survivors occurred. In 17.8% of<br />
patients, the etiological agent was isolated from the blood,<br />
as well; namely, in 43.2% of patients with fatal outcome,<br />
and in 14.2% of survivors. Clinical and laboratory-biochemical<br />
features for sepsis and septic shock were recognized in<br />
34.5% of patients; 70.3% out of patients with fatal outcome,<br />
and in 29.6% of survivors. Out of the laboratory-biochemical<br />
parameters, the increased levels of: ESR, WBC and<br />
granulocytosis in 72.4, 57.2 and 44.7% of patients; as well<br />
as, the decreased levels of WBC and neutropenia in 16.1 and<br />
9.2%, respectively, were found. Increased levels of bilirubinaemia<br />
and enzim activity of aminotranspherases were<br />
registered in 24.3 and 20.6% of survivors, that is in 48.6<br />
and 45.9% of patients with fatal outcome. It was concluded<br />
that sepsis and septic shock lead to dramatic worseness of<br />
the outcome in patients with PM.<br />
FP-G-085<br />
Neurological and psychological aspects of<br />
encephalopathy due to tick born infections of the CNS<br />
K. Gustaw a , K. Bel⁄towska b , M.M. Studzińska c<br />
a Outpatients Neurological Department, Institute of Agricultural<br />
Medicine, Lublin, Poland; b Department of Public<br />
Health, Institute of Agricultural Medicine, Lublin, Poland;
492<br />
Abstracts<br />
c Department of Medical Sociology, Institute of Sociology,<br />
UMCS, Lublin, Poland<br />
The purpose of this study was to delineate the differences<br />
distant neurological and neuropsychological effects of tickborne<br />
encephalitis in children. The group of 11 patients<br />
(four boys and seven girls in the age from 11–15 years)<br />
was included to the study. Every patient had suffered from<br />
encephalitis due to viral infection after bit of the tick and<br />
was properly treated. Medical history, physical examination<br />
and a series of neuropsychological experimental tests based<br />
on WAIS-R, BDI, BENTON-BENDER, DUM were<br />
performed. In the clinical history 27.3% of patients<br />
complained of headaches, 18.1% of the patients of subjective<br />
memory distortion. The neurological examination<br />
showed that. 36.4% of the patients experienced weakness<br />
of the muscles and irritability. Moreover in 72% of the cases<br />
dysmethria, 45% nystagmus and in 54% positive Romberg<br />
sign were found. A total of 45.4% of the patients showed<br />
asymmetry in deep tendon reflexes (DTR’s) and in 45% of<br />
the cases slight muscular strength abnormalities. Besides, in<br />
18% of the cases disturbances in the sensory responses were<br />
noticed. In 18% abnormalities in the function of the muscles<br />
innervated by cranial nerves were examined. Psychological<br />
tests indicated that 72% of the patients had problems in<br />
thinking process and experienced memory impairment<br />
45% of patients had significant organic damage in the<br />
central nervous system. The results of this study suggested<br />
the existence of long lasting consequences of tick born encephalitis,<br />
which can significantly influence the quality of life<br />
of the young patients.<br />
FP-G-086<br />
Conservatively treated multiple brain abscess<br />
Z. Liptai, Z. Meszner, K. Kalocsai, P. Barsi<br />
Pediatric Neurology, Saint Laszlo Hospital, Budapest,<br />
Hungary<br />
Authors report the case of a 17-year-old girl in whom<br />
severe headache and fever developed 8 days after tonsillectomy.<br />
Two days later slurred speech, adynamia and somnolence<br />
occurred. Cranial CT and MRI revealed a 1.2 cm-large<br />
mass in the right parieto-occipital region, with marked ringshaped<br />
contrast-enhancement and wide perifocal edema. An<br />
enhancement of the ipsi- and contralateral ventricular wall<br />
and meninges could be visualized, too. Routine CSF findings<br />
corresponded to massive purulent meningitis. The size<br />
and localization of the abscess did not allow neurosurgical<br />
approach. According to the susceptibility of the cultured<br />
microaerophilic Streptococcus, meropenem was administered<br />
and symptomatic treatment was added. This resulted<br />
in a rapid clinical improvement. Neuroimaging studies 4<br />
weeks later, however, showed marked progression of the<br />
abscess with spreading both inside the right and toward<br />
the contralateral, left hemisphere. Radiological improvement<br />
started on oral cloramphenicol treatment, but severe<br />
adverse effects (depression, anorexia, malnutrition, dehydration,<br />
bone-marrow hypoplasia) made rehospitalization<br />
and a change in antibiotic therapy (reinstitution of meropenem)<br />
necessary, as well as the administration of antidepressant<br />
medication. The patient has become free of complaints<br />
and MR images have shown a slow but unequivocal<br />
improvement. The CSF has been near-normalized. No<br />
relapse occurred after discontinuation of the 3.5-month lasting<br />
antibiotic therapy. Authors will discuss diagnostic and<br />
therapeutic problems related to this case and run through the<br />
scarce experience on similar cases in the literature.<br />
FP-G-087<br />
Postencephalitic parkinsonism in a 7-year-old boy<br />
K.Y. Chae, J.H. Lee<br />
Department of Pediatrics, College of Medicine, Pochon<br />
CHA <strong>University</strong>, Sungnam, Korea<br />
We experienced a 7-year-old boy who developed an<br />
akinetic-rigid Parkinson syndrome following encephalitis.<br />
On admission, he had convulsive status epilepticus with<br />
prolonged postictal confusion state. EEG showed diffuse<br />
high amplitude of slow wave discharges on the background<br />
consistent with encephalopathy. The initial brain MRI<br />
revealed focal high signal intensities on right hippocampal<br />
area. Viral markers in CSF were all negative. On the fifth<br />
hospital day, he developed lead pipe rigidity in all four<br />
extremities but improved cognition. He progressed to bradykinesia,<br />
blepharospasm, slow tongue movement with dysarthria.<br />
Subsequent brain MRI showed no different findings<br />
with the previous one. Methylprednisolone pulse therapy,<br />
amantidine and levodopa were introduced, and thereafter<br />
symptoms of parkinsonism (hypokinesia, blepharospasm,<br />
dysarthria, and lead pipe rigidity) in all four extremities<br />
partially improved. We suggest that steroid and oral amantidine<br />
with dopaminergic therapy will be worthy in the<br />
management of acute stage of postencephalitic parkinsonism.<br />
FP-G-088<br />
Clinical feature of 25 children with viral encephalitis<br />
B.-Z. Jia<br />
General Hospital of Yangquan Coalmine Group Yangquan,<br />
Shanxi Province, China<br />
Objective: To explore clinical feature of pediatric viral<br />
encephalitis for earlier diagnosis. Methods: The complete<br />
data of 25 children with viral encephalitis in the last 2<br />
years were analyzed. Results: The rate of common symptoms<br />
was: fever (96%), convulsion (64%), vomiting (52%),<br />
disturbance of consciousness (44%), and headache (36%).<br />
The rate of a few symptoms was: thrill (16%), paralysis<br />
(12%), supranuclear paralysis (8%), dizziness (8%), and
Abstracts 493<br />
salivation (4%). Before admission to the hospital, the<br />
median of common symptoms was: headache (2.25), vomiting<br />
(2.1), fever (1.96), convulsion (1.57), disturbance of<br />
consciousness (1). The rate of positive pathologic sign<br />
was: Babinski’s sign (28%), tonic neck (20%), Kernig’s<br />
sign (4%). Conclusion: In clinical work, special care should<br />
be taken to common symptoms of viral encephalitis and<br />
high vigilance be made to a few symptoms. In case of headache,<br />
vomiting and/or no fever, to the sick children perhaps<br />
the viral encephalitis is possible.<br />
FP-G-089<br />
A study on nitric oxide tumor necrosis factor and<br />
interleukin-8 in serum and cerebrospinal fluid in<br />
children with infection of the central nervous system<br />
H.-Y. Wang, Y. Yuan, B.-L Sun<br />
Department of Pediatrics, the First Affiliated Hospital of<br />
Jiamusi <strong>University</strong>, Jiamusi, China<br />
In this study we evaluated the levels of serum and CSF<br />
NO, NOS, TNF and IL-8. The NO, NOS, TNF, IL-8 in 18<br />
cases of viral meningitis (VM), 14 cases of tuberculous<br />
meningitis (TM), 16 cases of purulent meningitis (PM)<br />
and 20 cases of control group (CG) were determined by<br />
colorimetric methods and redioimmunoassay. The results<br />
showed that: (1) the levels of NO, NOS, TNF in serum<br />
and CSF with VM, TM and PM were significantly higher<br />
than those in CG (P , 0:01). Moreover the concentrations<br />
of NO, NOS, TNF in patients with PM were significantly<br />
higher in CSF than those in patients with VM and TM<br />
(P , 0:01). (2) The levels of IL-8 in serum and CSF with<br />
TM and PM were significantly higher than those in CG. The<br />
concentration of IL-8 with PM was significantly higher than<br />
those with TM. There was no obvious difference between<br />
VM and CG (P , 0:01). These results suggested that: (1)<br />
NO, NOS, TNF, IL-8 all participated in the pathogenesis of<br />
the central nervous system infection. (2) Determination of<br />
NO, TNF and IL-8 in serum and CSF can be a discriminating<br />
index among VM, TM and PM.<br />
FP-G-090<br />
Clinical analysis of 23 children with cryptococcal<br />
meningitis<br />
L.-Z. Zhang<br />
Department of Pediatrics, Heze Municipal Hospital, Heze,<br />
Shandong, China<br />
The mean age of 23 children with cryptococcal meningitis<br />
was 4.3; 16 of them were misdiagnosis. The rate of misdiagnosis<br />
was 69.6%; 30.4% was diagnosed with cryptococcal<br />
meningitis at first. Symptoms included fever, headache,<br />
vomiting, visual loss, convulsion and hepatosplenomegaly.<br />
Remarkable changes in the CSF were observed in tuberculous<br />
meningitis. The levels of CSF glucose and chloride<br />
decreased. Cryptococcus neoformans can be found by an<br />
ink stain technique. Low density lesions were found by<br />
head CT. It is suggested that misdiagnosis is prevented by<br />
detecting the pathogenic agent. The prognosis is related to<br />
the intracranial pressure, stage of misdiagnosis and severity<br />
of inflammation.<br />
FP-H-001<br />
Benign infantile seizures<br />
FP-H<br />
Seizure Disorders<br />
H.-Y. Li, S.-J. Ling, Y.-L. Cui<br />
Xi’an Children’s Hospital, Xi’an, China<br />
Objective: To determine the characteristics of benign<br />
infantile seizures. Methods: A prospective study of 13<br />
cases and a retrospective study of 44 cases of benign infantile<br />
seizures were carried out in 1989–2001. Results: Among<br />
the 57 cases of benign infantile seizures that had a normal<br />
development, there were 35 males and 22 females. The age<br />
of onset was from 50 days to 2.5 years. The clinical manifestations<br />
included tonic-clonic seizure (44), motion arrest,<br />
staring with or without smile or lip cyanosis (10), and partial<br />
seizure (3). Fifty-three patients had the pretreatment<br />
seizures frequency of two to 17 times, four had .40 times<br />
and 28 had seizures occurred in clusters. A family history of<br />
epilepsy or Fc was present in three. Interictal EEGs showed<br />
general epileptiform discharge in eight, and focal epileptiform<br />
discharges in five, and the remaining were normal.<br />
Cranial CT scans performed in 44 were normal. Phenobarbital<br />
(PB), carbamazepine (CBZ) and valproate (VPA) were<br />
effective in 25, 18 and eight cases respectively. Five patients<br />
received a drug combination of PB with CBZ or VPA and<br />
one took no AEDs at all. No seizure occurred after adding<br />
AEDs in 37 and seizures recurred because of early withdrawal<br />
of AEDs or insufficient dosage in 20. All patients<br />
were controlled between the age of 8 months and 5.5 years<br />
and remained seizure-free for 8 months to 12 years (.4<br />
years in 23). AEDs were discontinued after seizure-free<br />
period of 1–5 years in 31, among them 14 were AEDsfree<br />
for 3–10 years. Conclusion: The benign infantile<br />
seizures are not uncommon and can be easily controlled<br />
with PB or CBZ or VPA with favorable prognosis.<br />
FP-H-002<br />
P 300 test of benign focal epilepsy with centrotemporal<br />
spike in children<br />
Z.-D. Lin, H.-L. Wang, X.-Y. Ye, G.-Q. Li, H.-W. Hu<br />
Department of Neuropediatrics, Yuying Children’s Hospital<br />
Affiliated to the Wenzhou Medical College, Wenzhou,<br />
Zhejiang, China<br />
Objective:P 300 test was done in benign focal epilepsy with
494<br />
Abstracts<br />
centrotemporal spike to evaluate its cognition function.<br />
Methods: 22 benign focal epileptic patients who had never<br />
been treated with anti-epileptic drugs were studied and<br />
compared with 25 healthy controls. Auditory event related<br />
potential P 300 peak latency and amplitude were regarded as<br />
the indicator. Results: No significant differences of P 300 peak<br />
latency and amplitude were found in epileptic patients from<br />
those in controls (P . 0:05), and no significant differences of<br />
P 300 peak latency and amplitude were found in the subjects of<br />
different age or gender (P . 0:05). Conclusion: It is<br />
suggested that there is no severe cognition function abnormality<br />
in benign focal epilepsy with centrotemporal spike in<br />
children, especially in those without anti-epileptic therapy.<br />
FP-H-003<br />
Diagnostic value of video-EEG in children with<br />
paroxysmal disorders<br />
Z.-D. Lin, H.-W. Hu, G.-Q. Li, X.-Y. Ye, Y.-L. Zhang<br />
The Department of Pediatric Neurology, The Yuying Children’s<br />
Hospital affiliated to the Wenzhou Medical College,<br />
Wenzhou, Zhejiang, China<br />
To evaluate the diagnostic value of video-EEG in children<br />
with non-epileptic seizure, 52 children suspected to<br />
have or weeded out the possibility of epilepsy were examined<br />
with video-EEG. Fifty-two cases were monitored to<br />
have ‘seizure’ attacks, 35 of whom were diagnosed as<br />
non-epileptic seizure including ten children with nocturnal<br />
muscle clonic, six sleeping disorders, five habitual tics, two<br />
hysteria, four non-epileptic paroxysmal tonic, four behavior<br />
abnormality, two headache or stomachache attack, one<br />
pertussoid attack and one infantile Moro reflex respectively.<br />
While 17 of them were diagnosed as epileptic seizure,<br />
consisting of four with generalized tonic-clonic seizures,<br />
four tonic seizures, three clonic seizures, two localized<br />
motor seizures and other three complex partial seizures,<br />
myoclonic seizures and infantile spasms respectively. The<br />
results indicated the video-EEG is not only the most sensitive<br />
way to differentiate the seizure characteristics and<br />
patterns but also the most effective way in differentiation<br />
of epileptic seizures from the non-epileptic seizures, and is<br />
of value in the classification of the epilepsy and epileptic<br />
syndromes. But the major disadvantage is that in the period<br />
of monitoring with the video-EEG, the children’s daily<br />
activities must be restricted in some area, and is the best<br />
choice in the children with frequent seizures.<br />
FP-H-004<br />
Hyponatremia is a predictor for recurrence of febrile<br />
seizure<br />
I. Tan<br />
<strong>University</strong> of Santo Tomas, Manila, Philippines<br />
FS even when recurrent have relatively no adverse<br />
effects. However, witnessing a FS is a very scary event.<br />
Predicting and treating FS recurrences will tremendously<br />
allay family anxiety. Risk factors for a first FS and recurrent<br />
FS in future febrile illnesses have been identified.<br />
However, there is scanty information regarding risk factors<br />
for FS recurrence in the same febrile illness. Thus, the<br />
identification of possible risk factors for FS recurrence<br />
within the same febrile illness is important. Low serum<br />
sodium following a FS was found to be a risk factor for a<br />
FS recurrence within the same febrile illness. To affirm or<br />
negate this, 77 children with febrile seizures were prospectively<br />
studied. Serum sodium determination was<br />
performed on all of them upon presentation in the emergency<br />
room. Forty-one of the children (53.25%) had low<br />
serum sodium levels (,135 mmol/l, with a mean of<br />
131.07 mmol/l). The mean serum sodium for the normonatremic<br />
children was 137.58 mmol/l. Twenty-five children<br />
(32.46%) experienced febrile seizure recurrence in<br />
the same febrile illness. Twenty of these children with<br />
FS recurrence were hyponatremic (mean serum sodium<br />
was 129.75 mmol/l) as compared to only five from the<br />
group with normal serum sodium level (P value ,0.01,<br />
chi-squared test). Relative risk for febrile seizure recurrence<br />
in the same illness was 3.5. Our study showed an<br />
increased risk for febrile seizure recurrence in the same<br />
febrile illness in children with hyponatremia, which was<br />
statistically significant.<br />
FP-H-005<br />
The relationship between benign childhood epilepsy with<br />
centrotemporal spikes and febrile convulsions<br />
L. Yin, L.-H. Cao, J.-H. Wu, B.-D. Pang, Y. Zhang<br />
Department of pediatrics, Maternity and Children Hospital,<br />
Tangshan, Hebei, China<br />
Objective: To explore the relation between benign childhood<br />
epilepsy with centrotemporal spikes (BCECT) and<br />
febrile convulsions. To study the possible etiology of<br />
BCECT. Methods: Twenty-six patients, age 1–6 years<br />
old, with typical BCECTs were investigated about the<br />
family history of epilepsy and febrile convulsions. They<br />
were examined with MRI or CT. A control group consisted<br />
of age-matched randomly selected healthy children.<br />
Results: The CT or MRI of the 26 patients was negative.<br />
No hippocampal abnormality was found in the patients.<br />
Only one patient had a history of febrile convulsions. Positive<br />
history of febrile convulsions in the study group is<br />
higher than that in the control group (0:025 , P , 0:05).<br />
There is no difference in the positive epilepsy family<br />
histories between the two groups (P . 0:05). Conclusion:<br />
BCECTs and febrile convulsions are linked closely,<br />
though BCECTs do not certainly derive from febrile<br />
convulsions. Both disorders may have a related genetic<br />
background.
Abstracts 495<br />
FP-H-006<br />
Lateralizing value of ictal version and limbs posturing in<br />
partial seizure in children<br />
L. Yin, K.-X. Luo, J.-H. Wu<br />
Department of pediatrics, Maternity and Children Hospital,<br />
Tangshan, Hebei, China<br />
Objective: To evaluate the lateralizing value of ictal<br />
dystonic posturing of limbs and version of mouth, head<br />
and eyes in partial seizure in children. Methods: By questioning<br />
the parents who have seen the seizure and review the<br />
data of Video-EEG in 48 patients. Results: In the patients<br />
with partial seizure, version of mouth and eyes occurred in<br />
45.83 and 54.17%, respectively and were generally contralateral<br />
to the ictal focus. The version of head were of no<br />
lateralizing significance, dystonic posturing of limbs were<br />
contralateral to the seizure focus (r ¼ 20:908). Conclusion:<br />
The dystonic posturing and version of mouth and eyes have<br />
lateralizing value in partial seizure.<br />
FP-H-007<br />
The value of video-EEG evaluation in clinical diagnosis<br />
L.-H. Cao, J.-H. Wu, B.-D. Pang, Y. Liu, Y. Zhang<br />
Department of pediatrics, Maternity and Children Hospital,<br />
Tangshan, Hebei, China<br />
Objectives: To evaluate the value of video-EEG in the<br />
differential diagnosis of patients with epilepsy or nonepileptic<br />
paroxysmal disorders. Methods: A total of 726<br />
consecutive cases were investigated by VEEG during the<br />
period from August, 1999 to December, 2001, the EEG<br />
patterns and clinical seizure activities were reviewed by<br />
pediatric neurologists. Results: (1) Among the 726 cases,<br />
VEEG patterns were abnormal in 542 cases (74.66%), of<br />
whom, 425 cases had epileptic discharges (78.41% of<br />
abnormal findings) and non-specific changes in 117 cases<br />
(16.12% of abnormal findings). Of these 726 cases, there<br />
were 505 cases that had had previous routine EEG evaluation,<br />
of whom 91 cases (18.02%) had non-specific abnormalities,<br />
and 42 cases (8.31%) had epileptic discharges. There<br />
were significant differences between the two methods. (2) In<br />
the 425 cases with epileptic discharges, the foci were in<br />
frontal in 12, central in 27, frontal-temporal in 50, parietal<br />
in 24, occipital in 15, centro-temporal in 150, diffused<br />
changes in 85, hypsarrhythmia in 20 cases. The epileptic<br />
discharges were only positive during sleep in 238 cases,<br />
during alert state in 52 cases and during both states in 135<br />
cases. (3) After the VEEG evaluation, the paroxysmal disorders<br />
in 187 cases were diagnosed as non-epileptic and in 493<br />
cases were epileptic. Of the latter group, 150 cases had<br />
BECTs, 143 generalized tonic-clonic seizure, 34 complexpartial<br />
seizures, 44 secondarily developed generalized<br />
seizures from partial epileptic activity, 36 myoclonic<br />
epilepsy, 23 infantile spasms, nine Lennox-Gastaut<br />
syndrome, 12 absences, and 15 atonic attacks. (4) The<br />
epileptic discharges and clinical seizures in 227 cases had<br />
been shown simultaneously in VEEG, but only in two cases<br />
during routine EEG investigation. Conclusions: The video-<br />
EEG investigation of patients with clinical paroxysmal<br />
disorders is much more conclusive than routine EEG.<br />
FP-H-008<br />
Diazepam and aspirin-dl-lysine therapy in febrile<br />
seizures: report of 108 cases<br />
W.-Y. Wang, B.-B. Wu, M.-L. Liu<br />
Department of Pediatrics, Affiliated hospital of Medical<br />
college of Chinese People’s Armed Police Forces, Tianjin,<br />
China<br />
Objective: To explore the best method of treating child<br />
with febrile seizures in a clinic work. Methods: Children<br />
with febrile seizures had their body placed properly, their<br />
respiratory tract kept unobstructed, oxygen inspiration therapy<br />
and suction, vein transfusion pathway established<br />
rapidly, and IV diazepam and IV aspirin-dl-lysine infusion.<br />
After control of seizures, we analyzed their possible etiologies<br />
again. IV diazepam and aspirin-dl-lysine can control<br />
seizures rapidly and provides the best effects.<br />
FP-H-009<br />
New progress of drug treating epilepsy<br />
J. Peng<br />
Beijing Military region Department of Pediatrics General<br />
hospital, Beijing, China<br />
Epilepsy is a common and high morbidity disease of<br />
pediatric neural system. After many years of research, functional<br />
mechanism of drugs treating epilepsy has made<br />
progress. This article expounds two problems: (1) when<br />
valproic acid is combined with carbamazepine, the blood<br />
concentration of valproic acid decreases and the dosage of<br />
the latter drug should be increased. (2) If valproic acid,<br />
phenytoin sodium, ethosuximide and clonazepam are<br />
combined with carbamazepine, their blood levels will<br />
decrease. This report also introduces how to choose new<br />
drugs treating epilepsy and how to treat refractory epilepsy.<br />
FP-H-010<br />
Change of serum prolactin levels following children<br />
seizures<br />
Q.-Y. Guo, S.-G. Ming<br />
JiangMen Central Hospital, JiangMen, GuangDong, China<br />
We studied serum prolactin levels following seizures in<br />
49 children with epilepsy; 24 with pseudoseizures; ten<br />
normal children. The epilepsy group showed significantly<br />
increased serum prolactin concentration than the normal
496<br />
Abstracts<br />
group, when the plasma sample was obtained within 60 min<br />
of an attack; but the pseudoseizures group was not significantly<br />
different from the normal group. Different type of<br />
seizures has different effect on serum prolactin; serum<br />
prolactin concentration increased significantly after generalized<br />
tonic – clonic and complex partial seizures, while<br />
simple partial seizures, myoclonic seizures and absence<br />
seizures were not associated with increased serum prolactin<br />
concentration. Our findings showed that prolactin is useful<br />
in differencing epileptic seizures from pseudoseizures.<br />
FP-H-011<br />
Ictal video-EEG and clinical characteristics of infantile<br />
spasms<br />
X. Zhao, F. Wang<br />
Department of Pediatrics, Tangdu Hospital, Fourth Military<br />
Medical <strong>University</strong>, Xi’an, China<br />
Objective: To analyze the clinical and video-EEG characteristics<br />
of infantile spasms. Methods: 18 children with<br />
infantile spasms were monitored by video-EEG. The EEG<br />
data and behavior recordings were analyzed simultaneously.<br />
Results: (1) The seizure types of infantile spasms included<br />
flexor, extensor and mixed. The spasm seizures occurred in<br />
scatter or cluster that coincided with sleep and wakefulness<br />
onset. On average, there were 16 seizures in one cluster of<br />
seizures. The seizure lasted 1–3 s and the interval of seizures<br />
was 5–20 s. (2) Infantile spasms can occur with partial and<br />
other types seizures. (3) The interictal EEG of infantile<br />
spasms had hypsarrythmia and the ictal EEG had slow<br />
spike-and-wave complexes or suppression-burst. Conclusion:<br />
Infantile spasms have unique type of seizures and<br />
can appear as partial or other type seizures. The frequency<br />
of seizures is high. It is easily found by video-EEG. The<br />
ictal and interictal EEG of infantile have unique manifestations.<br />
FP-H-012<br />
Coincidence of Rolandic and absence features: rare, but<br />
not impossible<br />
P.S. Dimova, D.S. Daskalov<br />
Clinic of Child Neurology, <strong>University</strong> Hospital of Neurology<br />
and Psychiatry ‘St. Naum’, Sofia, Bulgaria<br />
This study’s purpose is to evaluate the incidence of<br />
concomitant clinical and EEG absence and rolandic<br />
discharges. The 1997–2000 medical files and EEG records<br />
of all children with Rolandic epilepsy, childhood, and juvenile<br />
absence epilepsy were retrospectively analyzed. Out of<br />
the 66 patients with Rolandic epilepsy, six children showed<br />
during the antiepileptic treatment clinical and/or EEG<br />
features of absences. Most of them were treated initially<br />
with carbamazepine and had generalized spike-wave<br />
discharges of a secondarily generalized type. Five cases<br />
from the group of 34 children with childhood absence<br />
epilepsy and three cases from the group of 11 patients<br />
with juvenile absence epilepsy were identified with an<br />
EEG focus of rolandic type in the first or in subsequent<br />
EEGs. None of the patients with absences experienced<br />
rolandic seizures during the disease course. All atypical<br />
EEG phenomena were registered while awake, thus precluding<br />
the possibility of sleep activation. The likely relation of<br />
absence features in Rolandic epilepsy to the treatment is<br />
considered as well as the probability of their manifestation<br />
as a sign of atypical, complicated course of Rolandic<br />
epilepsy. On the other hand, the presence of a Rolandic<br />
focus in the course of typical childhood or juvenile absence<br />
epilepsy makes the coincidence of these entirely distinct<br />
phenomena, even if very rare, not exceptional, and suggests<br />
that a genetic link between partial and generalized EEG<br />
discharges could exist. Further studies are required to elucidate<br />
the mechanisms and carriers of inheritance and liability<br />
to the most childhood epilepsies.<br />
FP-H-013<br />
Optimal treatment of Rolandic epilepsy: priority of<br />
valproate over carbamazepine<br />
P.S. Dimova, D.S. Daskalov<br />
Clinic of Child Neurology, <strong>University</strong> Hospital of Neurology<br />
and Psychiatry ‘St. Naum’, Sofia 1113, Bulgaria<br />
It was the aim of this study to evaluate the treatment effects<br />
of the anticonvulsants most often used in BECTS. The medical<br />
charts and EEG records of 66 children with the diagnosis<br />
of BECTS were retrospectively analyzed. Out of these<br />
patients, 48 children were treated initially with CBZ, and<br />
17 – with VPA. In general, CBZ and VPA had similar efficacy<br />
in seizure control and reduction, but differed in terms of<br />
lacking efficacy and seizure aggravation. Main differences<br />
between these drugs were found in their effects on the EEG<br />
abnormality. The epileptic potentials disappeared or<br />
improved significantly more often under VPA, and were<br />
unchanged or activated significantly more often with CBZ.<br />
This EEG-response reflected on the better effects of VPA on<br />
the neuropsychological disturbances in some patients. These<br />
results lead us to suggest that VPA could be a drug of first<br />
choice in BECTS.<br />
FP-H-014<br />
Self-control study of depakine for the treatment of<br />
childhood epilepsy<br />
X.-H. Shao<br />
Department of Pediatrics Neurology, Xinhua Hospital<br />
Affiliated to Shanghai Second Medical <strong>University</strong>, Shanghai,<br />
China<br />
Objective: To verify the curative effect and safety of depakine<br />
for the treatment of childhood epilepsy. Methods: An
Abstracts 497<br />
open-label, add-on, self-control study was undertaken in 26<br />
children with epilepsy. The seizure frequencies in 6 months<br />
before and after therapy were compared in these epileptic<br />
patients. The patients were treated with depakine at the<br />
dose of 15–30 mg/kg per day, and the seizure-rate and<br />
side-effects were noted. Results: The seizure frequency<br />
decreased significantly ($50%) in 24/26 (92.3%) patients<br />
after therapy, depakine was effective for all type of seizures,<br />
in particular for generalized tonic-clonic convulsions.<br />
Patients could tolerate depakine well. Most adverse events<br />
including vomiting and dizziness were mild or moderate in<br />
severity, and occurred occasionally (4/26, 15.4%). Conclusion:<br />
Depakine is an effective, broad-spectrum and had a<br />
favorable safety for the treatment of childhood epilepsy.<br />
FP-H-015<br />
Diagnostic analysis of recurrent seizures in 86 children<br />
beginning with febrile convulsions<br />
J.-X. Liao, L. Chen, Y.-H. Xiao, B. Li, T.-S. Huang, Z. Wei<br />
Epilepsy Center, Shenzhen Children’ s Hospital, Shenzhen,<br />
China<br />
Background and objectives: Childhood onset of multiple<br />
febrile convulsions continued with fever beyond 6 years, or a<br />
febrile seizures occurred. It was not mentioned in the international<br />
classification of epilepsy syndromes about how<br />
these seizures are diagnosed. Based on research of a large<br />
multigenerational family, Scheffer IE and Berkovic SF advocated<br />
a new epilepsy syndrome, the GEFS 1 . The commonest<br />
phenotype is denoted as FS 1 . We analyzed the diagnosis of<br />
recurrent seizures beginning with febrile convulsions in children.<br />
Methods: We investigated children attending the pediatric<br />
neurology service of the out-patient department from<br />
1994 to 2001 in whom detailed clinical records were available.<br />
Results: There were 86 individuals that comprised<br />
about 5.0% of seizure patients of our out-patient department.<br />
Two individuals were diagnosed as having febrile seizures,<br />
64 (74.4%) FS 1 , eight FS 1 and absences, five FS 1 and<br />
myoclonic seizures, three FS 1 and myoclonic-astatic<br />
epilepsy, two FS 1 and temporal lobe epilepsy and two FS 1<br />
as suspected and temporal lobe epilepsy. Conclusions: There<br />
are a few GEFS 1 individuals among small family or sporadic<br />
patients. The recognition of GEFS 1 is helpful for the treatment<br />
of these patients.<br />
FP-H-016<br />
The clinical use of digital ambulatory<br />
electroencephalography<br />
Y.-H. Xiao, J.-X. Liao, Y. Chen, W.-Y. Chen, P. Xia<br />
Epilepsy Center and Department of Pediatric Neurology,<br />
Shenzhen Institute of Pediatrics and Shenzhen Children’s<br />
Hospital, Guangdong, Shenzhen, China<br />
Objectives: To investigate the characteristics of digital<br />
ambulatory electroencephalography (AEEG) and the efficacy<br />
of AEEG in the diagnosis and differential diagnosis<br />
of paroxysmal diseases in children. Methods: With 16-channel<br />
digital AEEG, 88 patients whose diagnosis had not yet<br />
been determined, but clinical features made them suspected<br />
of having epilepsy, although routine electroencephalograms<br />
had been tested, were examined for 24 h. The AEEG monitoring<br />
also included activating tests such as opening- closing<br />
eyes and hyperventilation, etc. The positive results meant<br />
that epileptiform discharges and/or abnormal background<br />
activity appeared. Results: Digital AEEG was very convenient<br />
with its multiple channels up to 16, enabling to change<br />
any montage as needed, and adopt wave amplitude and<br />
scanning velocity, and the quality were as high as that of<br />
routine EEG. Of 88 patients the positive rate was 67% (59/<br />
88), and 44 were diagnosed with epilepsy definitely, their<br />
epleptiform discharges was recognized and well localized,<br />
their epilepsy type was classified. Two patients had no<br />
epileptic seizures but had typical epileptiform discharges.<br />
Referred to clinical manifestations, the diagnosis of epilepsy<br />
was excluded in 19 patients. Conclusion: Digital AEEG<br />
might obtain much more information than traditional<br />
magnetic tape analog AEEG, and the focus might be determined<br />
more precisely, and it is a great progress of electroencephalography.<br />
FP-H-017<br />
Continuous intravenous infusion of midazolam for<br />
treatment of intractable seizures in children<br />
J.-M. Zhong, J.-H. Li, M.-Z. Zhou<br />
Jiangxi Children’s Hospitol, Nanchang, Jiangxi, China<br />
Objective: To determine the efficacy and safety of midazolam<br />
given as a continuous infusion in the treatment of<br />
prolonged seizures and a cluster of seizures in children.<br />
Methods: Thirty-two patients admitted to the neurological<br />
ward in our hospital met the criteria of status epilepticus or a<br />
cluster of seizures with duration of more than 30 min and the<br />
seizures were unresponsive to diazepam, clonazepam,<br />
phenobarbital, and valproic acid. They were 24 boys and<br />
eight girls. Mean age was 2.5 ^ 2.9 years (ranging 37 days–<br />
12 years), and 46.9% (15/32) of cases were under 1 years of<br />
age. The type of seizure was generalized in 25 cases, partial<br />
in seven, myoclonus in two, respectively. Etiologically, 13<br />
children had primary epilepsy, 12 central nervous system<br />
infection, one intracranial hemorrhage, one drowning, and<br />
the remaining five had toxic encephalopathy. All patients<br />
received intravenous midazolam at 0.10–0.26 mg/kg as<br />
bolus, followed by a continuous infusion at 0.10 mg/kg<br />
per h initially; the dose was increased gradually up to 0.35<br />
mg/kg per h or until the complete control of seizures was<br />
achieved. Time to control seizures, infusion rate and sideeffects<br />
were monitored. Results: Among 32 children, 21<br />
cases were brought under complete control, and there was<br />
seizure improvement (more than 50% reduction of seizures)
498<br />
Abstracts<br />
in seven. The remaining four showed no responses. Mean<br />
time to control seizures was 10.1 ^ 14.9 h (ranging 1 min–<br />
43 h) and seizures stopped with 5 min in 47.6% of cases.<br />
Mean infusion rate was 0.18 ^ 0.09 mg/kg per h (ranging<br />
0.10–0.35 mg/kg per h). Mean duration of infusion was<br />
62.0 ^ 38.3 h (ranging 14–152 h). None of the children<br />
had clinically important changes in blood pressure, heart<br />
rate, respiratory status and retention of urine attributable<br />
to the use of midazolam. Conclusions: Midazolam infusion<br />
is an effective and safe therapeutic approach to control<br />
intractable seizures.<br />
FP-H-018<br />
The use of goggles flash visual evoked potential in<br />
disorders of children’s central nervous system (CNS)<br />
S.-H. Li, Y. Chen, Z.-X. Qiao<br />
Harbin Children’s Hospital, Harbin, China<br />
Purpose: To obtain the normal value in group of children<br />
and the abnormal value in group of children having<br />
impaired consciousness in different degree by goggles flash<br />
visual evoked potential (GO-VEP). Methods: To stimulate<br />
the eyes by goggles flash using the drawing instrument<br />
(SEEG) of 16 channels colors EEG and evoked potential<br />
made by DanDe company in Denmark. And the potentials<br />
were recorded with silver plate electrode in Oz point,<br />
stimulating both eyes. Each eye must be examined twice,<br />
which will give better reappearance. Conclusion: GO-VEP<br />
can not be affected by the power and sensitivity of sight,<br />
and can be used to detect baby, infant and child with<br />
impaired consciousness who have disorders of CNS. It is<br />
a new way to find the visual nervous damage and can be<br />
repeated. At the same time, it is foundation to detect the<br />
early damage of visual nerves. It can be an assistant<br />
method for pattern reversal visual evoked potential (PR-<br />
VEP).<br />
FP-H-019<br />
Analysis of brain electrical activity mapping of 100<br />
children with generalised epilepsy<br />
S.-H. Liu, X.-Q. Wu<br />
Shenyang Medical and Health Care Center of Children and<br />
Women, Shenyang, China<br />
Epilepsy is a common emergency in clinical pediatrics;<br />
the diagnosis depends upon the seizures and electroencephalogram.<br />
Brain electrical activity mapping (BEAM) is a<br />
new electrophysiological technique that is recently widely<br />
used clinically, but its value in the diagnosis of childhood<br />
epilepsy is rarely reported. The analysis was done in the<br />
BEAM results of 100 cases of childhood epilepsy with a<br />
confirmed diagnosis of generalised epilepsy. It was found<br />
that 91 cases had abnormal BEAM (91%), and the abnormal<br />
ratio increased with the age, there was 30% local<br />
BEAM abnormality in generalised epilepsy. It was also<br />
found that the local BEAM abnormality is coincident<br />
with the part of brain CT abnormality. BEAM can not<br />
display the epileptic waves such as sharp wave, spike<br />
wave, spike and slow waves and so on, but it can show<br />
different brain electrical activity signals which depend on<br />
different frequency of power pedigrees in corresponding<br />
simulated EEG, and make the brain electrical activities<br />
more quantitative, objective, imaginable, and directive. It<br />
is helpful in making diagnosis and observing the remedy<br />
effect of epileptic children.<br />
FP-H-020<br />
Convulsive disorders in PICU: an etiological analysis of<br />
182 cases<br />
S.-H. Liu, Y. Li<br />
Shen Yang Childrens’ Hospital, Liaoning, China<br />
Objective: To summarize and analyze the commonly<br />
encountered reasons of convulsions in pediatric intensive<br />
care unit (PICU). Methods: According to the age, the 182<br />
children from 1 month to 14 years old were divided into four<br />
groups, then according to the sex subdivided into eight<br />
groups. Results: The percentages of different reasons in<br />
these groups were reported. Febrile convulsions, vitamin<br />
Ddeficient hypocalcemic seizures, epilepsies, and central<br />
nervous system infections are most commonly encountered<br />
etiological factors in this study, whereas hereditary metabolic<br />
disorders may constitute one of the relatively rare<br />
causes.<br />
FP-H-021<br />
Applying topiramate to treatment of infantile epilepsy<br />
Y.-Q. Zhang, J. Zhu, D. Li, P.-Y. Zhang, X.-L. Yu<br />
Department of Neurology, Tianjin Children Hospital, Tianjin,<br />
China<br />
Objective: To evaluate the efficacy and tolerance of topiramate<br />
as monotherapy and adjunctive therapy in infantile<br />
epilepsy. Method: Forty-five patients were included, aged<br />
15 days to 2 years, median 9 months (male 27, female 18),<br />
weighed 2.8–15 Kg (median 9.5 Kg). Age distribution: #3<br />
months 11, 26 months 13, 21 year 12, 22 years nine. The<br />
course ranged from 4 h to 21 months. Secondary epilepsy<br />
38, and cryptogenic epilepsy seven. Twenty-five of 45<br />
received monotherapy and 20 adjunctive therapies. Dosages<br />
of topiramate were adjusted to optimal clinical response.<br />
Results: The frequency of all seizures was reduced $50%<br />
from baseline in 91% of 45 patients, and the rate of seizurefreedom<br />
was 37.8%, when the mean duration of topiramate<br />
therapy was 3 months. The frequency of all seizures was<br />
reduced $50% from baseline in 91% of 34 patients, and the<br />
rate of seizure-freedom was 52.9%, when the mean duration<br />
of therapy was 3 months. The frequency of all seizures was
Abstracts 499<br />
reduced $50% from baseline 100% of 25 patients with<br />
monotherapy and 80% of 20 patients with adjunctive therapy.<br />
The incidence of adverse effects was 20%. Adverse<br />
effects of topiramate were mild. Hypohidrosis was notable.<br />
In 28 patients, blood routine/urine routine and function of<br />
liver and kidney was normal during taking drugs. Conclusion:<br />
The study shows that topiramate is an effective and<br />
well tolerated agent in monotherapy and adjunctive treatment<br />
for infants with epilepsy. Adverse effects were mild.<br />
FP-H-022<br />
Febrile convulsions in children: a clinical analysis of 108<br />
cases<br />
Y.-Z. Zhang, M. Feng<br />
Shanghai Baoshan central Hospital, Shanghai, China<br />
To investigate the characteristics and related factors of<br />
febrile convulsions, 108 cases of young children were<br />
divided into relapse group and non-relapse group to<br />
analyse the high risk recurring factor. They were also estimated<br />
in terms of their convulsion characteristics (including<br />
seizure types, duration time and temperature, etc.) and<br />
white blood cells count (including lymphocyte count and<br />
neutrocyte count), by using of logistic multiple regression.<br />
The result shows that there is a significant difference<br />
between the relapse group and the non-relapse group in<br />
the first attack age, the first occurring temperature, seizure<br />
types and family history. There is no significant correlation<br />
between white blood cells count and the characteristics of<br />
convulsions. The results suggest that white blood cells<br />
count is of no value in diagnosis of febrile convulsions in<br />
children. Febrile convulsions are susceptible to recurrence,<br />
and are closely related with the first occurring age, the first<br />
seizure types and family history. It is necessary to estimate<br />
children with high fever by means of those risk recurrence<br />
factors mentioned above in clinical experience. Take<br />
proper intervention when necessary.<br />
FP-H-023<br />
Magnetoencephalographic study of patients with<br />
continuous spikes and waves during slow sleep (CSWS)<br />
H. Hattori a , A. Yasuhara d , K. Tanaka a , T. Tsutada b ,N.<br />
Tsuyuguchi c , M. Shimogawara e , H. Ishida a , O. Matsuoka a ,<br />
T. Yamano a<br />
Departments of a Pediatrics, b Geriatrics and Neurology, and<br />
c Neurosurgery, Osaka City Univeristy Medical School,<br />
Osaka, Japan; d Department of Pediatrics, Kansai Medical<br />
College Kori Hospital, Neyagawa, Japan; e Applied Electonics<br />
Laboratory, Kanazawa Institute of Technology,<br />
Tokyo Japan<br />
Objective: We analyzed the diffuse spikes and waves in<br />
patients with CSWS using magnetoencephalography<br />
(MEG) in order to know the pathogenesis of CSWS.<br />
Patients: MEGs were measured in seven patients who<br />
were electroclinically diagnosed as CSWS. The patients<br />
were 7–11 years old (one boy and six girls). Methods:<br />
MEGs were measured in a magnetically shielded room,<br />
using the newly developed, whole-cortex MEG that has a<br />
160-channel, first-order gradiometer. Data were filtered<br />
with a band pass of 3–250 Hz and digitized to 1000 Hz.<br />
We estimated the dipoles of the spikes in the simultaneously<br />
recorded EEG. These estimated dipoles were<br />
superimposed on the magnetic resonance images. Results:<br />
We could estimate the dipoles in five patients as mapping<br />
onto the focal cortical area bilaterally, localizing almost<br />
symmetrically. Short time differences were recognized<br />
between sides. These time differences were from 14.2 to<br />
35.3 ms. The impulse will transfer through the corpus<br />
callosum and make miller focus. The dipole was localized<br />
in the Sylvius area in two patients, the parieto-oocipital<br />
area in two patients, and the frontal area in one patient.<br />
We could not estimate the dipoles in the other two patients.<br />
Conclusion: Secondary bilateral synchronization will form<br />
diffuse spikes and waves in majority of CSWS patients,<br />
and MEG can define their focus. However, some patients<br />
with CSWS have primary bilateral synchronization. Pathogenesis<br />
of CSWS was considered heterogeneous.<br />
FP-H-024<br />
The magetoencephalographic findings in infantile<br />
spasms<br />
S. Hanaoka, M. Kawatani, M. Izumi, M. Fukumizu, K.<br />
Sugai<br />
Department of Child Neurology, National Center Hospital<br />
for Mental, Nervous and Muscular Disorder, National<br />
Center of Neurology and Psychiatry, Kodaira, Japan<br />
Infantile spasms is an early onset epilepsy with characteristic<br />
clinical and EEG findings. There are already many<br />
approaches to its electrophysiological mechanism, but it is<br />
yet unclear. The MEG is one of useful instruments to detect<br />
the source of paroxysmal discharges, and there is no report<br />
to analyze them in infantile spasms. We examined the<br />
patients affected to infantile spasms by a whole brain type<br />
MEG in order to approach to its electrophysiological<br />
mechanism from the viewpoint of magnetic field. Subjects.<br />
Method: The subjects are five cases of infantile spasms form<br />
the age of 5 months to 1 year and 4 months, three males and<br />
two females. By using Neuromag 204, we analyzed MEG<br />
findings and the source of paroxysmal discharge in comparing<br />
with simultaneous EEG records. Results: All of five<br />
cases showed multifocal pattern and their dipole sources<br />
were scattered on bilateral hemispheres. By the analysis<br />
about more than 30 points of paroxysmal discharges, the<br />
dipole sources showed a tendency to accumulate in the<br />
parietal and its adjacent lesions. The dipole sources accumulated<br />
around the posterior horns in four of five cases,<br />
which seemed to correspond to watershed areas. Conclu-
500<br />
Abstracts<br />
sions: The results suggest the importance of pathophysiological<br />
changes of the watershed areas as a development of<br />
infantile spasms.<br />
FP-H-025<br />
A comparative clinicoelectrical study on the influences of<br />
influenza infection versus vaccination on the epilepsies in<br />
the severely handicapped patients<br />
Y. Yamatogi, T. Misaki, K. Kawakubo, K. Araki, A. Tsutsui<br />
Okayama Prefectural <strong>University</strong>, Soja, Okayama, Japan<br />
To clarify the influence of influenza vaccination on<br />
epilepsy is important for the clinical management of the<br />
severely handicapped patients who are vulnerable to infection.<br />
Methods: Three clinicoelectrical investigations were<br />
made on those without change in antiepileptic medication<br />
around vaccination or infection; (1) influences of the initial<br />
vaccination on clinical seizures and epileptic discharges in<br />
28 patients; (2) influences of the repeated vaccination in 24<br />
patients; and (3) influences of influenza infection in 12<br />
patients. Results: (1) The initial vaccination transiently<br />
increased epileptic discharges more than 50% in seven<br />
patients (25.0%), with recovery within about 6 months.<br />
Allergic predisposition and age at vaccination may relate<br />
the worsening. (2) By the repeated vaccination, worsening<br />
in epileptic discharges increased from eight patients<br />
(33.3%) by the first vaccination to 14 patients (58.3%)<br />
and that in clinical seizures from none to seven patients<br />
(29.2%). Fortunately, both adverse effects were reversible.<br />
(3) Influenza infection also transiently worsened epileptic<br />
discharges in six (50.0%) and clinical seizures in two<br />
(16.7%). Conclusion: Influences on epilepsy may be the<br />
same in both influenza infection and the initial vaccination,<br />
but repeated vaccination is suggested to have a risk to accelerate<br />
the worsening of EEG and clinical seizures. Influenza<br />
vaccination should be carefully evaluated to perform in<br />
those with intractable epilepsy, particularly due to severe<br />
brain damage.<br />
FP-H-026<br />
Changes of cerebral hemodynamics in children suffering<br />
from epilepsy<br />
S.A. Goulyaev, A.A. Ovchinnikova, S.E. Goulyaeva, I.V.<br />
Archipenko<br />
Vladivostok Medical State <strong>University</strong>, Vladivostok, Russia<br />
Changes of cerebral hemodynamics in 410 children<br />
suffering from epilepsy were studied. It is determined, that<br />
a vascular factor is one of the main causes of development<br />
mechanism of epilepsy. During the period of pre-natal<br />
development the lack of blood provision makes worse<br />
genetically determined imbalance of mediator exchange,<br />
then it turns out to become a regulator of degeneration<br />
process development in nerve tissue. Dynamics of clinical<br />
manifestations of epilepsy and its EEG characteristics<br />
reflect fading of epileptic manifestations of cerebral activity<br />
with age. Computer tomography of cerebrum allows to<br />
visualize morphological defects in cerebrum structures in<br />
83.7% cases of epilepsy. Abnormality of anatomic structure<br />
of cerebrum and its atrophy can be observed in equal<br />
percentage. Transcranial dopplerography capacities in diagnosing<br />
changes of cerebral hemodynamics in epilepsy can<br />
reach 86.3%. During the period between the attacks one can<br />
observe the following: changes of vascular tonus of microcirculatory<br />
mouth; different combinations of local changes<br />
of manifestation of cerebral hemodynamics. Among the<br />
local changes we can differentiate three changes reflecting<br />
abnormality of anatomic structure of cerebral vascular<br />
system: alteration turbulent and normal blood flow; combination<br />
of signs of different degree of manifestation of stenosis;<br />
unexpected alterations of findings of peripheral<br />
resistance. All of those mentioned above could be observed<br />
in the adjacent sections of one and the same vessel. In<br />
epilepsy such changes were observed in 22% of cases.<br />
During the period of epilepsy attack one can observe<br />
synchronous registration of generalization of epileptic activity<br />
on EEG and sonic sound of angiospasm reactions on<br />
Monitor-Dopplerograph that arises later 0.3–1.2 s than<br />
generalization of epileptic patterns on EEG, but it remains<br />
even after their disappearance.<br />
FP-H-027<br />
Case report: progressive neuronal degeneration (Alpers-<br />
Huttenlocher disease)-seizure free on Topamax add-on<br />
therapy<br />
V. Mejaški-Bošnjak, K. Fumić, J. Bošnjak, L. Lujic, Z.<br />
Ardašanić, B.M.-D. Marina<br />
Children’s Hospital Zagreb, <strong>University</strong> Medical School,<br />
Zagreb, Croatia<br />
Progressive cerebral poliodystrophy – Alpers-Huttenlocher<br />
disease (A-H d) is a clinico-pathological syndrome<br />
with no specific biochemical marker. A-H d is usually<br />
presented as an early-onset progressive encephalopathy<br />
with intractable seizures and liver dysfunction. Etiology is<br />
still obscure, though respiratory chain mitochondrial disorders<br />
have been postulated. Valproate treatment of the<br />
seizures may trigger hepatic failure and fatal outcome. We<br />
present the case of a 6-year-old girl who, following a period<br />
of developmental delay and failure to thrive during infancy,<br />
suffered at age of 17 months from myoclonic seizures. After<br />
valproate administration the condition of the child worsened<br />
leading to serial seizures of various type (myoclonic, generalised<br />
clonic, etc.) and mild hepatic dysfunction progressing<br />
into coma. Valproates were immediately withdrawn, and<br />
barbiturate was given intravenously along with support of<br />
vital functions. The girl survived this acute life-threatening<br />
episode, deteriorating in terms of severe mental impairment,<br />
along with autistic traits, and intractable epilepsy of predo-
Abstracts 501<br />
minately partial complex and generalised tonic fits. Paraclinical<br />
investigation: biochemical tests, neurophysiological<br />
and neuroimaging findings, liver and muscle biopsy with<br />
analysis of respiratory chain enzymes supported A-H d.<br />
Further anticonvulsive polytherapy consisted of various<br />
drugs, being modified repeatedly due to inefficiency since<br />
the girl had 10–30 fits/day. At age of 5 years she was put on<br />
Topiramate add-on therapy slowly titrated. Fits were gradually<br />
reduced in number and severity, and at the dosage 8 mg/<br />
kg she became seizure-free for 1 year. There was no adverse<br />
effect of the drug. The mechanism of beneficial effect of<br />
Topiramate in the case of A-H d is discussed.<br />
FP-H-028<br />
Lamotrigine in the treatment of epilepsy in patients with<br />
Rett syndrome<br />
V. Mejaški-Bošnjak, L. Lujić, B.M.-D. Marina, R.<br />
Duplančić, V.D⁄ uranović, T. Gojmerac<br />
Children’s Hospital Zagreb, <strong>University</strong> Medical School,<br />
Zagreb, Croatia<br />
RS is a progressive neurodevelopmental disorder, occurring<br />
almost exclusively in female patients, clinically characterized<br />
by acquired microcephalia, mental retardation,<br />
autistic behavior, ataxia, loss of purposeful use of the<br />
hands. Epilepsy and/or EEG abnormalities are common<br />
problems in patients with RS. We present ten girls (aged<br />
4–12 years), who met diagnostic criteria of typical RS,<br />
followed-up for 1.5–9 years. At last assessment 6 of them<br />
were classified as III stage and 4 as II stage of RS. Seven out<br />
of these ten RS patients have epilepsy (generalized clonic/<br />
tonic and/or myoclonic fits), while three were seizure free,<br />
showing multifocal EEG abnormalmalities. Epilepsy was in<br />
all RS patients intractable, treated with various antiepiletic<br />
drugs, most commonly using valproates. Lamotrigine was<br />
given as add-on therapy in all seven RS patients having<br />
epilepsy, and as monotherapy in three patients with abnormal<br />
EEG. Effect of Lamotrigine therapy was evaluated after<br />
1–1.5 years. One RS girl became seizure free, while six<br />
other have marked stabilization of epilepsy in terms of<br />
severity and frequency of the seizures. Remaining three<br />
seizure free patients, during period of follow up were still<br />
seizure free, with improved EEG abnormalities in two. We<br />
conclude on beneficial effect of Lamotrigine in the treatment<br />
of epilepsy in patients with RS.<br />
FP-H-029<br />
Ketogenic diet in four Chinese children<br />
W.-W. Cheng, P.W.T. Tse<br />
Caritas Medicalcentre Caritas Medical Centre, Hongkong,<br />
China<br />
The ketogenic diet is a special diet that was first used as a<br />
treatment for epilepsy in 1921 with increased popularity<br />
recently. In our Developmental Disability Unit, 118 children<br />
had epilepsy, of which 30 were refractory. In the past 2.5<br />
years, ketogenic diet was started in four of them. All of<br />
them had been tried on at least four anticonvulsants. There<br />
were two failures in terms of no improvement in seizure<br />
frequency despite attaining deep ketosis during a 4-month<br />
and a 6-month trial period respectively. In the third child,<br />
medium-chain triglyceride ketogenic diet was implemented<br />
at the age of 5 years. There was ,50% improvement in<br />
seizure frequency initially. After changing to classical ketogenic<br />
diet, .90% improvement was attained. The general<br />
well being of the patient improved. He has been on the diet<br />
for 30 months and experienced no complications such as<br />
growth failure, hypercholesterolaemia and renal stone<br />
formation. In the fourth child, ketogenic diet was started at<br />
the age of 18 months. She attained 50% improvement in<br />
seizure frequency. Prior to the diet, she suffered catastrophic<br />
seizures and status epilepticus which disappeared after the<br />
diet. At the age of twenty-three months, a renal stone of 6 mm<br />
was revealed. Balancing the risk of withdrawal from the diet,<br />
ketogenic diet was continued with close monitoring of the<br />
complications. Conclusion: Ketogenic diet is worthwhile<br />
trying especially in those children for whom epilepsy surgery<br />
will unlikely be an option to them.<br />
FP-H-030<br />
The application of Topamax w to children with epilepsy<br />
J.-F. Guo, H. Zhao, X. Wang, J.-C. Guo, Y.-L. Guo, T. Chen<br />
Panjin No. 2 People’s Hospital, Panjin City, Liaoning,<br />
China<br />
We reported the results of using Topamax w , a new antiepileptic<br />
drug, to 30 cases of children’s epilepsy in our hospital<br />
since June, 1999. Out of the 30 cases, 17 cases were male,<br />
13 cases were female, and they were at the age of 2–12,<br />
average 5.6. The courses of disease were 3 months–10<br />
years. During the period of treatment, of five cases with<br />
simple partial seizures, three cases were seizure free, one<br />
case was markedly controlled and one case partially<br />
controlled. The total effectiveness is 100%. Of eight cases<br />
with complex partial seizures, three cases were seizure free,<br />
one case was markedly controlled, two cases partially<br />
controlled, and two cases not controlled. The total effectiveness<br />
is 75%. Of six cases with tonic clonic seizures, two cases<br />
were seizure free, one case markedly controlled, two cases<br />
partially controlled and one case not controlled. The total<br />
effectiveness is 83.3%. Of six cases with myoclonic seizures,<br />
two cases markedly controlled, two cases partially controlled<br />
and two cases not controlled. The total effectiveness is<br />
66.7%. Of five cases with atypical absence seizures, two<br />
cases partially controlled, three cases not controlled. The<br />
total effectiveness is 40%. Totally eight cases with seizure<br />
freedom occupied 26.7%. five cases with markedly<br />
controlled seizures occupied 16.7%. Nine cases with<br />
partially controlled seizures occupied 30%. The seizures
502<br />
Abstracts<br />
were not controlled in eight cases. The total effectiveness was<br />
73.3%. The best results were obtained in the patients with<br />
simple partial seizures, tonic clonic seizures and complex<br />
partial seizures, in this order. It was relatively difficult to<br />
control the patients with myoclonic seizures and atypical<br />
absence seizures. Our results indicated that 50% infant<br />
patients had adverse events in 1–3 weeks after initiating<br />
medicine. This showed that these adverse events occurred<br />
during the period of dose-increasing. As the time went on,<br />
the adverse events will get improved.<br />
FP-H-031<br />
Infantile autonomic epilepsy: clinical analysis of 32 of<br />
patients<br />
J.-F. Guo, H. Zhao, X. Wang, J.-C. Guo, Y.-L. Guo, T. Chen<br />
Panjin No. 2 People’s Hospital, Panjin City, Liaoning,<br />
China<br />
The study makes an analysis of 32 children with autonomic<br />
epilepsy diagnosed in our section from 1995 to 2001. Out of<br />
the 32 cases, 19 are male, and 13 female. They are at the age of<br />
3–12.Therearefivecasesattheageof3–5,19attheageof6–8,<br />
eight at the age of 9–12. The criteria for diagnosing autonomic<br />
epilepsy are as follows: (1) no positive symptoms were<br />
checked out for nervous system in all of these cases to eliminateorganicdiseaseswhichbelongtothedepartmentofinternal<br />
medicine and those which belong to the surgical<br />
department. (2) Repeated seizures. (3) Autonomic symptoms<br />
are dominant. (4) Abnormal EEG. (5) Antiepileptic drugs are<br />
effective in patients whose EEGs are normal. All cases had<br />
EEG examinations. Abnormal results appeared in the EEG of<br />
23 cases (71.9%). Spikes or spiky slow waves appeared in the<br />
EEG of 15 cases, scattering spikes and sharp waves appeared<br />
in the EEG of eight cases, and the other nine cases had normal<br />
EEGs. As for the distribution of paroxysmal discharges, they<br />
appeared in different regions; 13 cases had notable paroxysmal<br />
discharges in the central area, six in the frontal areas, and<br />
four infrontalorone sideof thefrontalareas. Theantiepileptic<br />
drugs (carbamazepine, phenobarbital, valproic acid, etc.)<br />
were used for the therapy in all of these cases. We gave the<br />
drugs to the patients according to the routine dosage or individual<br />
difference. Notable clinical outcome has been<br />
achieved.<br />
FP-H-032<br />
Analysis of electroencephalogram in 415 children with<br />
febrile seizures<br />
Y. Chen, Y.-H. Xiao, J.-X. Liao<br />
Epilepsy Center, ShenZhen Children’s Hospital, Shenzhen,<br />
China<br />
Objective: To analysis the relationship between recording<br />
time after FS and abnormal rate of EEGs; And to imply<br />
abnormal EEG of FS can predict further seizures and the<br />
occurrence of later epilepsy. Method: EEGs were recorded<br />
2 , 3 days after FS in 415 FS children at the age 5<br />
months , 6 years old. Some of them were recorded again<br />
15 , 20 days after FS. Result: There was no relationship<br />
between the abnormal rate of EEG and the FS history of<br />
their relatives, but it was related to clinical features of FS<br />
(local seizure and FC lasting .15 min) and ages. The rate of<br />
abnormal EEGs was 80% 2 , 3 days after FS. It contained<br />
61% of slow activity and indefinite spikes and 19% of spikes<br />
or spike-slow wave. In records taken again after 15 days, the<br />
rate of spikes and spike-slow wave discharges was 17%.<br />
There was no significant relation between EEG at different<br />
times. The rate of further seizures was raised in children<br />
with abnormal EEGs, and some of them (four of them)<br />
developed epilepsy. Conclusion: There may be no relationship<br />
between the abnormal rate of EEG and FS history in<br />
relatives. It was related to clinical features of FS. EEGs<br />
recorded 2 , 3 days after FS was as important as those<br />
after 15 days. Further seizures might be related to abnormal<br />
EEGs and abnormal EEGs may lead to epilepsy.<br />
FP-H-033<br />
The clinical analysis of 158 cases of iatrogenic<br />
intractable epilepsy in children<br />
G.-B. Bian, Y.-P. Qiu<br />
Hospital Attached to Ningxia Medical College, Yinchuan,<br />
Ningxia, China<br />
In order to explore the causes of iatrogenic intractable<br />
epilepsy and its solutions, 158 cases have been classified<br />
and analysed intensively. Among these causes are: improper<br />
diagnosis and classification of epilepsy, lack of aim of drug<br />
choices, abuse of multi-drugs, improper drug dosage, lack of<br />
individuality, the drug usage are not in accordance with pharmacokinetics,<br />
improper drug variety and dosage regulation,<br />
too short courses, too early drug termination, no consideration<br />
of sick children’s general status. Here is to ask pediatrician<br />
clinical doctors to master epilepsy diagnosis and its<br />
classification skilfully and fully understand pharmacological<br />
characteristics of pharmacokinetics and pharmacodynamics<br />
on different anti-epileptic drugs. With the combination of<br />
examination measures such as EEG and serum drug concentration,<br />
doctors are able to give a regular and individual treatment<br />
to each case after the detailed analysis of the interaction<br />
among diseases, sick children’s status and drugs.<br />
FP-H-034<br />
Determination of neuropeptide Y (NPY) in the plasma<br />
and its clinical significance in children with epilepsy<br />
D. Liu a , Q.-Y. Zhang b<br />
a Department of Pediatrics, Central Hospital Affiliated to<br />
Shenyang Medical College, Shenyang, China; b Department<br />
of Pediatrics, The First Clinical College, China Medical<br />
<strong>University</strong>, Shenyang, China
Abstracts 503<br />
Objective: To observe the change of NPY in the plasma<br />
in children with epilepsy and thereby to evaluate its possible<br />
application in clinical practice. Methods: In the early<br />
morning, 2 ml venous blood was collected from all<br />
enrolled subjects, including 53 children with epilepsy<br />
(43 cases with primary epilepsy, ten cases with symptomatic<br />
epilepsy). Among the children with primary<br />
epilepsy, 34 cases had not been treated, nine cases had<br />
seizures after being treated. Twenty-one healthy children<br />
were enrolled to serve as normal controls. The levels of<br />
plasma NPY were measured by means of radioimmunoassay.<br />
Results: (1) The levels of NPY in children with<br />
epilepsy (210.57 ^ 71.28 pg/ml) were markedly higher<br />
than those of normal control subjects (159.99 ^ 65.10<br />
pg/ml), the difference was significant, P , 0:01. (2) The<br />
levels of NPY in children with primary epilepsy<br />
(210.57 ^ 71.28 pg/ml) compared with that with symptomatic<br />
epilepsy (219.25 ^ 97.14 pg/ml), the difference was<br />
not significant, P . 0:05. (3) The levels of NPY in children<br />
with primary epilepsy who had not been treated<br />
(205.57 ^ 63.89 pg/ml) compared with that with primary<br />
epilepsy who had seizures after being treated<br />
(229.44 ^ 96.61 pg/ml), the difference was not significant,<br />
P . 0:05. Conclusions: The results indicated that the<br />
levels of NPY in children with epilepsy were markedly<br />
increased and the change of NPY did not correlate to<br />
pathogenesis and treatment.<br />
FP-H-035<br />
A study on epileptic children’s intelligence quotients and<br />
affecting factors<br />
Y.-L. Hu<br />
Department of Pediatrics, First Peoples’ Hospital of<br />
Yunnan Province, Kunming, Yunnan, China<br />
Objective: To study the IQ and affecting factors of epileptic<br />
children. Methods: IQ was assessed in 28 children with<br />
epilepsy and 30 normal children. Thirteen possible affecting<br />
factors of the intellectual development were investigated.<br />
Results: IQ of epileptic children was significantly lower<br />
than normal children. With stepwise regression analysis,<br />
the main risk factors were in proper order: age, type of<br />
disease, frequency of disease, course of disease and time<br />
for controlling symptom. Conclusions: Childhood epilepsy<br />
should be diagnosed early and treated correctly, which helps<br />
to reduce the incidence of mental retardation.<br />
FP-H-036<br />
The clinical and EEG analysis of 120 cases of benign<br />
focal epilepsy of childhood with centrotemporal spikes<br />
Y.-W. Zheng a , Q. Zhang b , C.-G. Fong b<br />
a Children’s Hospital Affiliated to Chongqing Medical<br />
<strong>University</strong>, Chongqing, China; b Kunming Children’s Hospital,<br />
Kunming, China<br />
Objective: To recognize the relationship between the<br />
prognosis of benign focal epilepsy of childhood with centrotemporal<br />
spikes (BFECT) and its clinical seizures as well as<br />
its EEG features. Method: The clinical materials and EEG<br />
features of 120 BFECT cases summarized and analyzed.<br />
Result: Age 6–10 is the high incidence period (70.8%) of<br />
BFECT which has the close relations to sleep, the basic type<br />
of epileptic seizure is general tonic-clonic and partial, its<br />
EEG features are partial spikes or sharp waves, 86.6% of<br />
which are in the central part of centrotemporal region.<br />
Conclusion: The literature indicates that the BFECT occurs<br />
during a particular growing period of childhood, the clinical<br />
prognosis of BFECT and its response to treatment with<br />
antiepileptic medicines are good.<br />
FP-H-037<br />
Clinical and electrophysiologic features of patients with<br />
Cockayne syndrome<br />
H.-S. Wu<br />
Beijing Children Hospital, Beijing, China<br />
Objective: Cockayne syndrome (CS) is a rare autosomal<br />
recessive inherited disorder. We studied the clinical and electrophysiological<br />
features in sixteen patients with CS. Methods:<br />
Data of all patients with classical CS admitted in the<br />
Beijing Children’s Hospital between September 1987 and<br />
April 2001 had been reviewed. Results: There were 14<br />
boys and two girls, ranging from 18 months–13 years.<br />
Sixteen patients showed premature ageing, cachectic dwarfism,<br />
microcephaly and mental retardation; 15 patients had<br />
photosensitivity and ataxia, 13 patients had pigmentary<br />
retinal degeneration, and 13 patients had sensorineural hearing<br />
loss. Age-matched control study showed, results of electromyography<br />
and nerve conduction velocity analysis<br />
(EMG/NCV) were abnormal in ten of 14 patients. Both<br />
motor and sensory nerves conduction velocities of median<br />
nerve reduced in eight cases (26.0 , 34.3 and 26.9 , 40.0 m/<br />
s, respectively), whereas in two cases, only motor nerves<br />
conduction velocities reduced in both median and peroneal<br />
nerves (40 , 42 and 30.7 , 38.8 m/s, respectively). All<br />
patients were abnormal on cranial CT or MRI. CT scan<br />
showed calcifications of the bilateral basal ganglia in 15<br />
patients. In one case, it was normal on CT scan, but MRI<br />
showed long T1 and long T2 signal lesions in left basal ganglia.<br />
Conclusions: Our study showed that the most useful diagnostic<br />
tool in CS is cranial neuroimaging. The findings of<br />
EMG suggested the presence of primary demyelinating<br />
neuropathy in peripheral nerves.<br />
FP-H-038<br />
Topamax as a first-choice drug in the treatment of West<br />
syndrome<br />
L.-P. Zou<br />
Beijing Children Hospital, Beijing, China
504<br />
Abstracts<br />
Objective: To establish the efficacy, tolerability and<br />
related events of using topamax as a first-choice drug in<br />
children with West syndrome. Methods: Fifty-four patients<br />
with West syndrome were given Topamax as monotherapy<br />
or as add-on therapy to nitrazepam. We followed up them<br />
ranged from 6 to 21 months (mean, 13 months). Results:<br />
31cases (57.4%) were seizure-free more than 6 months. A<br />
significant reduction from baseline in seizures frequency<br />
was found in 44 cases (81.4%), poor or null response ten<br />
cases (18.6%). The average, maximal and minimal doses<br />
were 5.2, 26 and 1.56 mg/kg per day, respectively. The<br />
adverse reactions included poor appetite (three cases),<br />
absent sweating (three cases), to difficult falling asleep<br />
(three cases). Conclusion: Topamax was proved to be an<br />
effective and safe drug as a first-choice drug in the treatment<br />
of West syndrome.<br />
FP-H-039<br />
Effects of topiramate on immunological function in<br />
patients with West syndrome<br />
L.-P. Zou<br />
Beijing Children Hospital, Beijing, China<br />
Objective: To explore the effect of topiramate on immunological<br />
function in patients with West syndrome. Methods:<br />
We used flow cytometry to measure the proportion of<br />
lymphocytes subsets in peripheral blood of the patients<br />
with West syndrome, and analysis/rate nephelometry to<br />
measure immunoglobulin level in the serum of the patients<br />
before and after topiramate treatment. Twenty-five normal<br />
health infants were taken as controls. Results: After topiramate<br />
treatment, CD4 1 cells in the patients were markedly<br />
decreased (P , 0:05). Compared to control group, CD19 1<br />
cells and serum IgA levels were significant decreased either<br />
before or after topiramate treatment (P , 0:001 and<br />
P , 0:05, respectively). NK cells in the patients were markedly<br />
increased after topiramate treatment (P , 0:05). Serum<br />
IgG levels were significant increased after topiramate treatment,<br />
and nearly reached normal level. Conclusions: Treatment<br />
with topiramate could affect immunological function of<br />
the patients with West syndrome, and it may play a role on its<br />
control to seizures.<br />
FP-H-040<br />
The relationship between the electroencephalogram<br />
(EEG), head computerized tomography (CT) and the<br />
prognosis of the West Syndrome<br />
S.-X. Yu a , H.-Y. Dong a , Z.-X. Li b<br />
a Jiading distract central hospital, Shanghai, China; b Jilin<br />
city children Hospital, Jilin, China<br />
Objective: To observe the relationship between the<br />
EEG, head CT and the prognosis of the West Syndrome.<br />
Methods: All of the 47 cases had EEG and head CT, and<br />
we had a follow-up study to compare with their prognosis.<br />
Results: Nineteen (60.6%) of 31 cases with abnormal<br />
head-CT, and 14 (87.5%) of 16 cases with normal head-<br />
CT showed progress. Twenty-nine of 34 cases with high<br />
rhythm disorder of EEG demonstrated progress, whereas<br />
only four cases with other kinds of EEG disorder did.<br />
Conclusions: There was no obvious relation between the<br />
prognosis of West Syndrome and the morphology of head<br />
CT (P . 0:05). But there was an obvious correlation<br />
between the prognosis and the change of EEG. The prognosis<br />
of patients with high rhythm disorder of EEG was<br />
better than those with the other kind disorders of EEG<br />
(P , 0:01).<br />
FP-H-041<br />
TPM as adjunctive therapy in the long-term<br />
management of children epilepsy<br />
W. Zhou, H. Li, X.-Q. Liu<br />
Qingdao Municipal Hospital, Qingdao, China<br />
Purpose: A total of 35 children (mean age, 6.6 years; range<br />
6 months , 14 years) with partial and/or generalized<br />
seizures previously resistant to AED therapy (median baseline<br />
seizure rate, six seizures/month) were treated with openlabel<br />
topiramate (TPM) at dosages of 3.2 , 12.5 mg/kg per<br />
day. Methods: The mean duration of TPM treatment was<br />
447 ^ 142 days (range, 14 , 582 days) and the mean TPM<br />
dosage was 6.75 mg/kg per day (range, 3.2 , 14.0 mg/kg per<br />
day). Seizure reduction was calculated from seizure counts<br />
during the last 3 months and last 6 months of TPM therapy<br />
compared with baseline. Results: .70% of patients achieved<br />
$50% seizure reduction. A total of 38% of patients were<br />
seizure free for $33 months at the last visit; 43% of patients<br />
were seizure free for $6 months at the last visit. This robust<br />
therapeutic response was consistent for children patients<br />
receiving TPM dosages ,4, 4 , 8 and .8 mg/kg per day.<br />
The most commonly reported adverse events were related to<br />
the central nervous system. Over the 1.5-year treatment<br />
period, 26% of patients discontinued TPM therapy because<br />
of adverse events and inadequate seizure control. Conclusions:<br />
TPM as adjunctive therapy was well tolerated and<br />
safe. It is a useful AED for long-term seizure control and<br />
resulted in seizure freedom for extended periods despite failing<br />
previous AED therapy.<br />
FP-H-042<br />
Treating children with refractory epilepsy with<br />
additional topiramate<br />
X.-W. Wang, Y. Sun, W.-D. Zi<br />
Department of Pediatrics, People’s Hospital of Xingjiang,<br />
Xingjiang, China<br />
Purpose: This paper is to observe the curative effect and<br />
safety in treating childhood refractory epilepsy with the
Abstracts 505<br />
addition of topiramate. Method: Of the twenty cases we<br />
treated, there were four cases of Lennox-Gastaut; three<br />
cases of West syndrome; seven cases of complex partial<br />
seizures; and six cases of generalized tonic-clonic seizures.<br />
In addition to the primary drug treatment, topiramate was<br />
added on with dosage from 0.5 mg/(kg per day), with an<br />
increase of 0.5–1.0 mg/kg every 7–10 days, to 8.0 mg/(kg<br />
per day) at its maximum, the purpose of which is to<br />
observe the effect and side effect. Result: Of the twenty<br />
treated cases, the drug was fully effective in eleven (55%),<br />
seizures reduced by 75% in three (15%), 50% in three<br />
(15%), and it was ineffective in two (10%). One failed to<br />
return for a checkup. In terms of side effects, two cases had<br />
anorexia so that further treatment became impossible; one<br />
became obviously weak; two had symptoms of adiapneustia<br />
and low fever; and the rest showed no obvious undesirable<br />
symptoms. Conclusion: Topiramate is remarkable in<br />
its effect and safe when it is added on in treating children<br />
with refractory epilepsy. It also has low side effects.<br />
However, the side effects, adiapneustia and low fever,<br />
have not been reported up till now. Whether or not topiramate<br />
has effect on the secretion of sweat gland need<br />
further observation and research.<br />
FP-H-043<br />
K ATP channel subunit Kir6.2 and NMDA receptor<br />
subunit 1 mRNA expression in status epilepticus rat<br />
model<br />
Z.-Z. Xia, K.-W. Jiang, Q.-X. Shui<br />
Department of Neurology, Affiliated Children’s Hospital of<br />
Medical College, Zhejiang <strong>University</strong>, Hangzhou, China<br />
K ATP channels play a key role in the neurons excitability<br />
for coupling the intracellular metabolic state to electrical<br />
activity at the plasma membrane. To understand the role<br />
of the K ATP channels in status epilepticus (SE), in the present<br />
study, we determined the alterations of K ATP channels subunit<br />
Kir6.2, and NMDA receptor subunit 1 mRNA expression.<br />
SE was induced in male adult rats by single i.p.<br />
pilocarpine. The survivals (n ¼ 43) were sacrificed for<br />
mRNA assay at 1, 4, 6, 12, and 24 h after SE by in situ<br />
hybridization. One hour after the seizures Kir6.2 mRNA in<br />
CA1 and CA2 hippocampus increased, reached the highest<br />
points at 4 h, and was still higher than that of normal control<br />
group at 24 h after seizure. The up-regulation of the<br />
NMDAR1 mRNA expression was slower than that of<br />
Kir6.2 mRNA. SE evoked the expression of the Kir6.2<br />
mRNA may activate the K ATP channels of the hippocampus<br />
and the excitability modulation of the neuron itself. There<br />
was no correlation between the expression of Kir6.2 mRNA<br />
and NMDAR1 mRNA. It suggested that SE altered the<br />
excitability by activating the NMDAR1.<br />
FP-H-044<br />
Teachers and children with epilepsy<br />
I. Prpić a , Z. Korotaj a , I. Vlašić-Cicvarić a , E. Paučić-<br />
Kirinčić a , A. Valerjev b , V. Tomac c<br />
a <strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia; b Primary<br />
school ‘Kantrida’, Department of <strong>University</strong> Children<br />
Hospital School, Rijeka, Croatia;<br />
c Institute for Public<br />
Health of Primorsko-Goranska County, Rijeka, Croatia<br />
The purpose of the study was to investigate primary<br />
school teachers’ attitude towards children with epilepsy.<br />
Two hundred and sixteen teachers were investigated regarding<br />
their opinion or knowledge about children with epilepsy.<br />
The results reveal that teachers do not have an accurate<br />
conception of the capabilities of children with epilepsy<br />
and that those attitudes differ from teacher to teacher.<br />
Nearly half of the teachers believe that children with<br />
epilepsy differ from healthy children by their behaviour.<br />
The majority of teachers (60%) do not get information<br />
about child’s disease from the parents, but from other<br />
sources. One third of teachers do not feel confident in<br />
their work with children with epilepsy. Great majority<br />
(91.80%) of teachers feel necessity to get additional information<br />
and education about epilepsy. Primary school<br />
teachers who work with children with epilepsy have inconsistent<br />
approach to the capabilities, behaviour and an inadequate<br />
way of working with children. Therefore they are<br />
eager to get more information on epilepsy. Our results are<br />
concordant with similar studies performed in various countries,<br />
which prove that epilepsy as a disease has a similar<br />
social effect on the affected person with no regard of cultural<br />
or social background. It is the duty of the medical team to<br />
offer teachers the necessary information, so that the<br />
approach, work and life quality of children with epilepsy<br />
can be improved.<br />
FP-H-045<br />
Effects of febrile seizures on peripheral blood leukocyte<br />
count<br />
J. Roganović, I. Prpić, E. Paučić-Kirinčić, I. Klarić<br />
<strong>University</strong> Children Hospital “Kantrida” and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />
In children presenting with febrile seizures, peripheral<br />
leukocyte count is often determined to evaluate the source<br />
of the fever. However, some studies have shown that an<br />
increased leukocyte count, without any other obvious clinical<br />
signs indicating a bacterial infection, might be<br />
explained by the seizure duration itself rather than by the<br />
nature of the infection. We assessed data of 82 patients (38<br />
boys and 44 girls) with the history of 129 febrile seizures,<br />
aged 6 months–5 years, referred to the Department of<br />
Paediatrics, <strong>University</strong> School of Medicine, Rijeka, Croatia,
506<br />
Abstracts<br />
between January 1995 and July 2001. The characteristics<br />
included duration of the fever prior to seizure, duration of<br />
seizure, temperature at seizure and peripheral blood leukocyte<br />
count. The parameters for bacterial infection were<br />
defined as follows: obvious clinical finding, sedimentation<br />
rate .40, and positive C-reactive protein. Our results indicate<br />
that peripheral blood leukocyte count was significantly<br />
higher in children with febrile seizures accompanied by<br />
bacterial infection (16.58 ^ 0.86) compared to viral infection<br />
(10.07 ^ 0.4), due to increased neutrophile count. In<br />
children with bacterial infection no association between<br />
seizure duration and blood leukocyte count was found. In<br />
contrast, in children with febrile seizures and viral infection<br />
the leukocyte count in the peripheral blood was significantly<br />
related to the duration of seizures. We conclude that leukocyte<br />
count should be used only as an additional tool to a<br />
carefully performed patient history and physical examination.<br />
FP-H-046<br />
Mutation analysis of Na v 1.1 and GABRG2 in patients<br />
with severe myoclonic epilepsy in infancy and its<br />
borderland<br />
I. Ohmori a , Y. Ohtsuka a , M. Ouchida b , K. Shimizu b ,J.<br />
Hattori a , H. Ota a , M. Oka a , K. Abiru a , M. Inutsuka a ,F.<br />
Endo a , E. Oka a<br />
a Department of Child Neurology, b Department of Molecular<br />
Genetics, Graduate School of Medicine and Dentistry,<br />
Okayama <strong>University</strong>, Okayama, Japan<br />
Purpose: To investigate genotype-phenotype correlation,<br />
we performed mutation analysis of the voltagegated<br />
sodium channel a1-subunit (Na v 1.1) and GABA A<br />
receptor g2-subunit (GABRG2) in patients with severe<br />
myoclonic epilepsy in infancy (SME) and its borderland<br />
(SMEB) who lack myoclonic seizures. Subjects and methods:<br />
Ten patients with SME and 11 patients with SMEB<br />
were recruited. Genomic DNA was extracted from peripheral<br />
blood leukocytes. All coding exons of the Na v 1.1 and<br />
GABRG2 genes were amplified by PCR and analyzed by<br />
direct sequencing. We also investigated clinical and EEG<br />
findings on these patients. Results: Mutations of the<br />
Na v 1.1 gene were identified in 18 of the 21 patients<br />
(85.7%) with SME and SMEB. There was no difference<br />
of detection rate and mutation type between the two<br />
groups. No mutation was found in the GABRG2 gene.<br />
Eight patients with SME (80%) had photoparoxysmal<br />
response on EEG transiently during the clinical course,<br />
in contrast to none with SMEB. Conclusions: It is thought<br />
that the Na v 1.1 mutations were related to the common<br />
clinical characteristics in the both groups. Other factors<br />
may influence occurrence of myoclonic seizures and<br />
photoparoxysmal response in SME.<br />
FP-H-047<br />
The occurrence of migraine in families of children with<br />
benign rolandic epilepsy<br />
H. Bazigou, M. Savani, A. Papavasiliou<br />
Pendeli Children’s Hospital, Section of Pediatric Neurology,<br />
Athens, Greece<br />
The relationship of benign rolandic epilepsy (BRE) and<br />
migraine has not been universally accepted and this study<br />
intended to examine the occurrence of migraine in their<br />
relatives as compared to healthy controls. Methods: Fiftynine<br />
patients with BRE, 31 males, £ 4.7 years and 82<br />
healthy children, 45 males, £ 8.2 years were included.<br />
Detailed histories regarding migraine in first and second<br />
degree relatives were obtained International diagnostic<br />
criteria for migraine and ILAE classification for BRE<br />
were utilized. Results: One child with BRE had migraine<br />
VS none of the controls. This patient developed migraine at<br />
the time of resolution of the BRE (13 years).Thirty BRE<br />
patients (51%) VS 18 controls (22%) had either first or<br />
second degree relatives or both who met the diagnostic<br />
criteria for migraine. A chi-square test resulted in a<br />
P , 0:05. Eleven were first degree relatives (36.6%) of<br />
BRE patients versus 12 (66.6%) in the controls. Three<br />
members from the first group and six from the second had<br />
both first and second degree relatives with migraine. There<br />
was a maternal prevalence (20 out of 30) in the relatives of<br />
the BRE patients. Conclusions: Our results support observations<br />
of some investigators regarding the increased<br />
frequency migraine among relatives of BRE. The association<br />
of these two entities might be due to a common defect<br />
with variable expression. Further clinical and genetic<br />
studies are needed to further clarify the possible association<br />
between the two disorders.<br />
FP-H-048<br />
The effect of subconvulsant discharges on hippocampal<br />
LTP and learning memory of space changes in rats<br />
L. Gu, X.-Y. Lui<br />
Department of Pediatrics, the affiliated railway hospital of<br />
Shanghai, Tongji <strong>University</strong>, Shanghai, China<br />
In order to study the effect of SED on learning and<br />
memory, we set up a model of subconvulsant cerebral<br />
discharges (SCD) by giving subconvulsant electric stimulation<br />
(SES) on anterior frontal lobe cortex of rats. The results<br />
showed that the SES in anterior frontal lobe could cause<br />
SCD in cortex and hippocampal. The SCD interfered with<br />
obtaining and store information and obstructed the transmission<br />
from short-term memory to long-term memory. In the<br />
rats which have formed the long-term memory, SCD can<br />
inhibit extracting of information. These cognitive impairments<br />
are reversible. Study about effect of SCD on hippocampal<br />
LTP indicated that continuous discharges for 3 min
Abstracts 507<br />
could temporally suppressed LTP built in the dentate gyrus<br />
in hippocampus. The suppression phenomena disappeared<br />
after stopping stimulation for 5 min. This phenomenon<br />
revealed that LTP suppression is one the mechanisms of<br />
SCD resulting in TCI. Presumably under the effect of<br />
SES, EAA was over released, resulting in NMDA receptor<br />
channel continuously opened. This leads to intracellular<br />
excessive Ca 21 accumulation and TIC of neuronal function.<br />
This may be one of the mechanisms of SED infecting learning<br />
memory.<br />
FP-H-049<br />
Reasons for drug treatment failure in patients with<br />
juvenile myoclonic epilepsy<br />
R. Naumovski, M. Demerdziev<br />
Clinic of Neurology, Clinical Centre, Skopje, Macedonia<br />
Fourteen patients were referred to our dispensary for<br />
epilepsy due to seizure pharmacoresistance (generally due<br />
to generalized tonic-clonic seizures, GTCS) in the period of<br />
1995–2000. The group consisted of six men (42.85%) and<br />
eight women (57.14%), aged between 12 and 28 years<br />
(18.78 1 4.33) who had previously been treated in pediatric<br />
dispensary unsuccessfully. The disease onset ranged<br />
between 5 and 14 years (10.7 1 3.17); all had myoclonic<br />
seizures (previously not being diagnosed), 13 (92.85%) of<br />
these patients had GTKS, and six (42.8%) had typical<br />
absences as well. None of them previously was diagnosed<br />
to have JME being treated with phenytoin, primidone,<br />
carbamazepine, and part of them administered valproate;<br />
none of them registered the number and the type of the<br />
seizures and the therapy administered. After revision of<br />
the diagnosis, the previous therapy was gradually interrupted<br />
and valproate was administered as monotherapy in<br />
therapeutic doses. Within a year, all patients achieved<br />
complete control of myoclonic and GTS, and one patient<br />
only reported occasional occurrence of absences. Our<br />
results clearly suggested the superiority of valproate in<br />
control of the mixed seizures in JME and the need of its<br />
early diagnosis.<br />
FP-H-050<br />
Clorazepate for refractory epilepsies: excellent efficacy,<br />
tolerance and adverse effects in 200 cases of personal<br />
experience<br />
K. Sugai, S. Hanaoka, M. Fukumizu, M. Sasaki<br />
Department of Child Neurology, National Center Hospital<br />
for Mental, Nervous and Muscular Disorders, National<br />
Center of Neurology and Psychiatry, Kodaira, Japan<br />
Prolonged efficacy, effective epilepsy classifications and<br />
seizure types of clorazepate (CLZ) are controversial. Its<br />
efficacy for refractory epilepsies, tolerance and adverse<br />
effects were studied. CLZ was added on or replaced with<br />
conventional AEDs in 200 patients with refractory epilepsies<br />
unresponsive to three to ten conventional AEDs (average<br />
5.9 AEDs), and its short-term efficacy was studied after<br />
.4 weeks of CLZ administration. Long-term efficacy was<br />
examined in 110 cases administered CLZ for .6 months.<br />
CLZ was started at 0.3–1.0 mg/kg and increased by 0.2–0.5<br />
mg/kg every 1 or 2 weeks up to 2.5 mg/kg. Seizures reduced<br />
by .50% in 136 of 200 short-term subjects, including 45<br />
seizure-free cases, and in 87 of 110 long-term subjects, with<br />
25 seizure-free cases. Both short-term and long-term efficacies<br />
were more favorable in the patients with localizationrelated<br />
epilepsies or focal epileptiform discharges on EEG.<br />
Short-term efficacy was better for partial seizures. Sixtyseven<br />
episodes of adverse effects occurred in 60 patients<br />
including 42 episodes of drowsiness, and CLZ was withdrawn<br />
in 32 episodes. The frequency of adverse effects<br />
decreased by modifications of initial dosage and increase<br />
rate. Tolerance developed in 60 of 130 effective cases, by<br />
2 months in 29 cases, by 4 months in 17 cases, by 6 months<br />
in seven cases, and later than 6 months in seven cases. CLZ<br />
again became effective in 51% of such cases by maintaining<br />
or increasing the dosage. CLZ has prolonged efficacy for<br />
refractory epilepsies. Frequent tolerance and adverse effects<br />
were major but manageable problems.<br />
FP-H-051<br />
Localization-related idiopathic occipital epilepsy –<br />
difficulties in classification<br />
I.S. Ivanov<br />
Department of Pediatrics, Plovdiv Higher Medical School<br />
Hospital, Plovdiv, Bulgaria<br />
The recognition of the types of childhood epilepsy with<br />
occipital spikes (CEOS) is a widely discussed development,<br />
which should promote prognosis and treatment of the<br />
affected children. Aim: To test the clinical application of<br />
the criteria for early-onset CEOS (Panayiotopoulos type)<br />
and late-onset CEOS (Gastaut type). Methods: Retrospective<br />
analysis of the clinical, electrophysiologic, imaging and<br />
other data of the 126 epileptic children registered at the<br />
epilepsy clinic of the pediatric department in the last 2<br />
years. Results: Clinical and EEG data of occipital lobe<br />
epilepsy were revealed in 11 children: four were diagnosed<br />
as symptomatic or criptogenic, three – as late-onset type of<br />
CEOS, and one – as early-onset type of CEOS. Three other<br />
children disclosed signs of benign partial occipital epilepsy<br />
but did not strictly fit the criteria for the CEOS types: The<br />
first child had symptoms of early-onset CEOS (eye deviation,<br />
vomiting, impaired consciousness, occurrence at night,<br />
bilateral occipital discharges) but starting at the age of 9<br />
years. The second patient was an 8 years old girl with occipital<br />
sharp waves on the EEG which had only three brief<br />
episodes of amaurosis with chaotic eye movements at the<br />
earlier ages of 3, 4 and 5 years that ceased without treatment.<br />
The third patient complained of frequent photopsies
508<br />
Abstracts<br />
induced by TV, rarely followed by secondary generalized<br />
seizures, and focal occipital paroxysmal activity with photosensibility.<br />
All but four patients were easily controlled by<br />
carbamazepine or oxcarbazepine. Conclusion: The clinical<br />
practice exposes a variety of symptoms that do not fit<br />
exactly to the criteria for CEOS. Nevertheless strict adherence<br />
to them is essential for unification purposes.<br />
FP-H-052<br />
Epileptic seizures in the first 5 years after hypoxicischaemic<br />
encephalopathy – results from a prospective<br />
study<br />
I.S. Ivanov<br />
Department of Pediatrics, Plovdiv Higher Medical School<br />
Hospital, Plovdiv, Bulgaria<br />
Epilepsy is a major sequela after HIE but prospective<br />
studies on this topic are not numerous. Aim: To estimate<br />
the frequency and characteristics of epileptic seizures after<br />
HIE. Methods: A prospective study of the first 43 children<br />
from a cohort of HIE patients that were followed-up from<br />
birth though their 1st year and at 5-years age undergoing<br />
neurological, kinesiological, developmental, psychological<br />
and neurophysiological examinations. Results: Ten children<br />
(23.2%, Sp ¼ 4.6%) developed epileptic seizures before<br />
their sixth birthday. They were mostly partial (n ¼ 6),<br />
followed by infantile spasms (n ¼ 2) and complicated<br />
febrile convulsions (n ¼ 2). The age of onset was variable.<br />
Valproates were the most frequently applied treatment.<br />
Only two children continued to have seizures at 5-years of<br />
age and three others were still on continuous medication. CP<br />
was more frequent in the epileptic group (3/10) than among<br />
children without epilepsy (0/33) while the occurrence of<br />
mental retardation (MR) did not differ significantly (2/10<br />
versus 4/33). Even when CP and MR patients were excluded<br />
from analysis the results on the neurodevelopmetal Michelsson-Ylinen<br />
test were worse in the epileptic group (33.6<br />
versus 11.8, P , 0:01) and children with more than 24<br />
points (suspected minor neurological dysfunction, MND)<br />
were more common in that group (3/6 versus 1/27). The<br />
occurrence of epilepsy correlated with worse neurodevelopmental<br />
results at 1-year of age. Conclusions: 23.2%<br />
(Sp ¼ 4.6%) of children that suffered HIE developed epileptic<br />
seizures in their first 5 years. They were most often<br />
partial and frequently associated with CP and MND and<br />
abnormal neurodevelopmetal status at age 1 year.<br />
FP-H-053<br />
The alterations of K ATP subunit Kir6.2, SUR1, and<br />
NMDA receptor subunit 1 mRNA in cerebral cortex and<br />
hippocampus of rats with picrotoxin-induced seizure<br />
Q.-X. Shui, K.-W. Jiang<br />
Department of Neurology, Affiliated Children’s Hospital of<br />
Medical College, Zhejiang <strong>University</strong>, Hangzhou, China<br />
Previous reports showed that the K ATP channels play a<br />
pivotal role in neuroprotection induced by epileptic preconditioning.<br />
To study the role of K ATP channels in chronic<br />
epilepsy, we investigate the alterations of K ATP subunit<br />
Kir6.2, SUR1, and NMDA receptor subunit 1 mRNA in<br />
cerebral cortex and hippocampus of rats with picrotoxin<br />
(PTX) induced seizure. Two weeks after the last continuous<br />
PTX injection (20 times, i.p.), those achieved a completely<br />
kindling state (n ¼ 36) were divided into four groups<br />
randomly. And three groups were injected with PTX once<br />
more to kindle the seizures, which sacrificed at 1 h, 1 and 3<br />
days after the seizures, respectively. Another two groups<br />
were the interictal group and control group. K ATP subunits<br />
Kir6.2, SUR1, and NMDA receptor subunit 1 mRNA<br />
expression were detected by in situ hybridization. The<br />
results showed the levels of Kir6.2 mRNA and SUR1<br />
mRNA of the 1 h, 1 and 3 days after seizures groups were<br />
higher than those of interictal and control groups<br />
(P , 0:05). especially the 1 h group. These mRNA<br />
expressed highest in hippocampus CA1. There was no<br />
significant difference of NMDAR1 mRNA among all<br />
seizure model groups, but with a significant difference<br />
compared with the normal control group. Our results<br />
suggested that model process was also a preconditioning<br />
to activate the excitability modulation of the neuron itself,<br />
and the activation of NMDAR1 may result in kindling of the<br />
chronic epilepsy.<br />
FP-H-054<br />
Malignant migrating partial seizures in infancy<br />
V. Gross-Tsur, B. Ben-Zeev<br />
Neuropediatric Units of Shaare Zedek Medical Center and<br />
Sheba Medical Center, Jerusalem, Israel<br />
We report two cases with malignant migrating partial<br />
seizures in infancy, a disorder described in only 20 other<br />
patients. Patient 1, a 3 year old girl, was born with microcephaly<br />
of unknown origin and at age 4 months intractable,<br />
multifocal seizures appeared with bilateral deviation of the<br />
eyes and head, tonic elevation of the arm and flushing of the<br />
face. Despite vigorous AED therapy, the seizures became<br />
virtually continuous and her development arrested so that at<br />
age 3 years she just smiles and responds to voices. A second<br />
pregnancy was terminated at 32 weeks because of progressive<br />
microcephaly, head circumference three standard<br />
deviations below normal. Patient 2 had normal development<br />
until 3 months of age when multiple episodes of partial<br />
status epilepticus appeared, characterized by decreased<br />
motor activity, head deviation, eye blinking and cyanosis.<br />
Aggressive AED therapy was ineffective and at her death at<br />
18 months she had severe psychomotor delay. Interictal<br />
EEG in both cases showed diffuse slowing of background<br />
activity and multifocal spikes. During seizures, the EEG<br />
was characteristic of the disorder, showing rhythmic theta<br />
activity restricted to one region spreading to adjacent areas
Abstracts 509<br />
or the entire hemisphere. In consecutive attacks the epileptogenic<br />
activity shifted between hemispheres (ping-pong<br />
seizures). MRI showed mild atrophy. MRS (patient 2) was<br />
normal. An extensive biochemical and metabolic workup<br />
was normal; TORCH and karyotype in patient 1 and CSF<br />
neurotransmitters in patient 2 were also normal. In<br />
summary, we present two patients with malignant migrating<br />
partial seizures in infancy. The etiology of this syndrome is<br />
unknown but the familial microcephaly in patient 1 is<br />
suggestive of a genetic basis for at least a subgroup of<br />
patients. Alternatively, neurotransmitter dysfunction with<br />
abnormal excitatory activity may explain the continuous<br />
erratic epileptic activity.<br />
FP-H-055<br />
Topiramate as add-on therapy in children with<br />
refractory partial seizure<br />
J. Wu, Z.-P. Wang, K.-R. Bao, X.-P. Xu<br />
Shanghai Xin Hua Hospital, Shanghai Second Medical<br />
<strong>University</strong>, Shanghai, China<br />
Objective: To evaluate the efficacy and safety of TPM in<br />
children (age 4–14 years) as adjunctive therapy for intractable<br />
partial-onset seizures with or without secondarily<br />
generalized seizures. Methods: Patients with at least six<br />
partial-onset seizures during the 12-week baseline phase<br />
while maintained on therapeutic doses of one or two appropriate<br />
AEDs were treated with TPM. The initial TPM doses<br />
were 0.5–0.7 mg/kg per day and increased by 0.5–1.0 mg/kg<br />
per day increments at 1-week intervals. Top dose was ,8<br />
mg/kg per day. Results: Eight patients (25%) were seizure<br />
free for at least 7 months and more than 50% reduction in<br />
seizure was found in 14 patients (43.75%). Inefficacy was<br />
21.88 and 6.25% of the patients had their seizure frequency<br />
increased during treatment. Two patients (6%) had transient<br />
anorexia, dizziness and somnolent, two (6%) had dizziness,<br />
bluntness and impairment of memory, one (3%) had speech<br />
decreased, and one (3%) had abnormal behavior. The<br />
adverse event developed during increment of TPM and<br />
disappeared gradually within 2–4 weeks. Conclusion:<br />
TPM therapy was effective and well tolerated in most of<br />
the patients.<br />
FP-H-056<br />
Predictors of intractable epilepsy – a case-control study<br />
in a cohort of Chinese epileptic children<br />
L.K. Kwong, W.K. Chak, K.T. So<br />
Department of Paediatrics, Tuen Mun Hospital, Hong<br />
Kong, China<br />
Informationaboutearlypredictorsofintractableepilepsyin<br />
childhood is scarce. We performed a case-control study to<br />
identify early predictors of medically intractable epilepsy in<br />
children. Cases were patients who had an average of at least<br />
one unprovoked seizure per month during an observational<br />
period of at least 2 years. Controls were children having<br />
achieved at least 2 seizure-free years. Strong univariate association<br />
was observed between intractability and the following<br />
factors: onset of seizure in infancy, high initial seizure<br />
frequency, remote symptomatic etiology, infantile spasms<br />
and mixed seizure types, abnormal neurological status,<br />
history of status epilepticus, neonatal seizure and early breakthroughattacks<br />
after treatmentinitiation.Independentpredictors<br />
of intractability with multiple regressions were: age of<br />
seizure onset (OR 0.53, 95% CI 0.35, 0.97), abnormal neurological<br />
status (OR 18.6, 95% CI 5.19, 63.6), .3 attacks in the<br />
second half year of treatment (OR 21.86, 95% CI 7.35, 65.01)<br />
and febrile seizures (OR 25.9, 95% CI 1.41 455.7). Our study<br />
suggested that seizure intractability could be predicted early<br />
in the course of illness in children with abnormal neurological<br />
status, high initial seizure frequency, early presentation of<br />
epilepsy and lack of early response to treatment.<br />
FP-H-057<br />
Seizure recurrence in epileptic children after<br />
withdrawal of anti-epileptic drugs<br />
B. Törer, N. Şenbil, Ö.F. Aydin, Ü. Ertan, Y. Gürer<br />
Dr. Sami Ulus Children’s Hospital, Ankara, Turkey<br />
Aim and method: We investigated the rate and the predictive<br />
factors of seizure recurrence after AED discontinuation<br />
in a retrospective analysis of 76 children with epilepsy who<br />
had not had a seizure for at least 2 years, infantile spasms<br />
were excluded. Prognostic criteria analyzed in the patients<br />
were: sex, age at seizure onset, age at AED discontinuation,<br />
type of seizure, etiology, type of epilepsy, family history of<br />
epilepsy in first-degree relatives, mental retardation, delay<br />
in neuromotor development, motor deficit, EEG abnormalities,<br />
multiple medication, history of neonatal and febrile<br />
seizures, history of status epilepticus, time from first to<br />
second seizures, duration of epilepsy, duration of AED<br />
treatment, number of seizures before medication, number<br />
of seizures during first 6 months of treatment, time required<br />
for seizure control, number of seizures experienced until<br />
seizure control, seizure free interval. Results: The overall<br />
recurrence rate was 32.9%. More than half of the recurrences<br />
occurred within 1 year after discontinuation of therapy<br />
and all within 2 years. The factors indicating a higher<br />
recurrence risk were older age at AED discontinuation,<br />
longer duration of epilepsy, longer duration of treatment,<br />
longer time required for seizure control (P , 0:05, Mann–<br />
Whitney U-test). Conclusion: Although some factors<br />
provide an estimate of an individual’s likelihood of recurrence,<br />
the final decision regarding medication withdrawal<br />
must be individualized and should be made jointly by the<br />
physician and the family. The decision process must take<br />
into account the statistical risk of seizure recurrence, the<br />
potential consequences of such a recurrence, and the potential<br />
adverse effects of continued AED therapy.
510<br />
Abstracts<br />
FP-H-058<br />
Case-control study and transmission/disequilibrium test<br />
of childhood absence epilepsy in Chinese population<br />
J.-J. Lu, H. Pan, Y.-H. Zhang, X.-R. Wu<br />
Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />
Beijing, China<br />
CAE is one of the most frequently recognized syndromes<br />
of the idiopathic generalized epilepsies. The inheritance of<br />
CAE is complex. Genes responsible for susceptibility to<br />
CAE have not been identified. Pharmacological studies of<br />
animal models have implicated the GABAergic system<br />
involved in the mechanism of this disease. Our previous<br />
study suggested that the GABA A receptor subunits genes-<br />
GABRA5 and GABRB3 may be either directly involved in<br />
the etiology of CAE or in linkage disequilibrium with<br />
disease- predisposing sites. To further confirm the results<br />
we used the SNPs found in the coding regions of the<br />
GABA A receptor subunits genes GABRA5 and GABRG2<br />
as genetic markers to detect TDT in 90 Chinese nuclear<br />
families. The TDT results suggested that GABRA5 and<br />
GABRG2 may not be the susceptible genes to CAE. On<br />
the other hand, animal models suggested that the GABA B<br />
receptor plays a critical role in the epileptogenesis of<br />
absence seizures. As a result, we used the SNPs found in<br />
the GABA B receptor subunits gene GABBR2 as genetic<br />
markers to conduct a case-control study in 96 CAE patients<br />
and 96 controls from North China. The frequency of the<br />
alleles and genotypes of SNPs showed significant discrepancy<br />
between CAE patients and normal controls. The<br />
results suggested that GABBR2 may either directly<br />
involved in the etiology of CAE or in linkage disequilibrium<br />
with disease-predisposing sites.<br />
FP-H-059<br />
Therapeutic drug monitoring and the pharmacokinetics<br />
of carbamazepine in children<br />
B.-M. Li, R.-P. Sun, J.-W. Wang, G.-F. Lei, R.-M. Hu, S.-H.<br />
Guo<br />
Pediatric department, Qilu hospital, Shandong <strong>University</strong>,<br />
Jinan Shandong, China<br />
Objective: To investigate the factors affecting CBZ serum<br />
concentration in children with epilepsy. Methods: The minimum<br />
steady-state concentrations of CBZ of 68 specimens of<br />
49 children with epilepsy were measured using HPLC.<br />
Results: The minimum steady-state concentrations of CBZ<br />
increased with dose, but no statistical difference was found<br />
among the groups of the children administrated different<br />
doses (P . 0:05). It was seen that CBZ concentrations<br />
increased with weight and age of children. However, sex<br />
and the time after administrating CBZ did not affect the<br />
CBZ serum concentrations significantly. Conclusions: The<br />
factors affecting concentration of CBZ were mainly body<br />
weight, age and dosage. There was no significant correlation<br />
between the concentration of CBZ and sex or time after<br />
CBZ administration. Therefore, CBZ doses that would be<br />
suitable for pediatric patients of different ages or weights are<br />
proposed. And a small CBZ dose at the beginning is the best<br />
choice for administration to children with epilepsy.<br />
FP-H-060<br />
Clinical analysis of childhood convulsion in 508 cases<br />
S.-Y. Shao<br />
Department of Pediatrics, First Affiliated Hospital, Inner<br />
Mongolia Medical College, Huhhot China<br />
Aim: To study the pathogenesis, the season in which the<br />
disease occurred and the preventive measures of childhood<br />
convulsions. The results are that febrile convulsions are<br />
mainly induced by upper respiratory tract infections with<br />
high fever and non-febrile convulsions of infants are mainly<br />
induced by hypocalcemia and CNS infections. Childhood<br />
convulsions can be seen in four seasons of 1 year, especially<br />
in Winter and Spring. Prevention of childhood upper<br />
respiratory tract infections and CNS infections and good<br />
care of high-risk infants are significant factors in decreasing<br />
the percentages of childhood convulsion.<br />
FP-H-061<br />
Febrile seizures: factors affecting risk of recurrence in<br />
hospital in Pakistani children<br />
S. Akram, Z. Habib, S. Ibrahim, B. Hasan<br />
Department of Pediatrics and Physical Therapy, Aga Khan<br />
<strong>University</strong> Hospital, Karachi, Pakistan<br />
Objectives: This is the first descriptive study that<br />
addresses risk factors for seizure recurrence in the emergency<br />
room (ER) in Pakistani children. Aims of the study<br />
were to: (a) describe the effect of temperature rise on seizure<br />
recurrence in the ER; (b) investigate the effect of age,<br />
gender, family and developmental history, type, duration<br />
and multiple seizures, past history and number of seizures<br />
and treatment given (either late or early) on seizure recurrence<br />
in the ER; and (c) explore prognostic indicators for<br />
seizure recurrence in the ER. Methods: Data from 352 children<br />
[ages 3–84 months; 220 males (62.5%) 131 females<br />
(37.2%)] was gleaned from chart reviews for the years January<br />
1998–August 2000 inclusive, from the Pediatric department<br />
of the Aga Khan <strong>University</strong> Hospital. Descriptive<br />
statistics, chi-square, odds ratios, 95% CI and discriminant<br />
analysis were used. Results and conclusions: Of the 52<br />
(16%) cases that had seizure recurrence in the ER, majority<br />
(36.5%) occurred in .38.5 #39.58C temperature range. The<br />
percentage declined to 15% at higher temperatures. Bivariate<br />
tests showed that age, family and developmental history,<br />
type of seizure and treatment given did not affect seizure<br />
recurrence in the ER. Past history number of seizures
Abstracts 511<br />
(P ¼ 0:008, OR ¼ 2.4) and duration of seizure (.5 min)<br />
(P ¼ 0:000, OR ¼ 2.2) were the two most important factors<br />
affecting seizure recurrence in the ER at the bivariate level<br />
of analysis. Duration of seizure was also the most important<br />
prognostic indicator for FS recurrence in the ER at the<br />
multivariate level with b ¼ 0.79. Early treatment did not<br />
affect recurrence, suggesting timely anti-pyretic versus<br />
anti-epileptic medication use.<br />
FP-H-062<br />
Tuberous sclerosis and epilepsy<br />
D. Plesca, F. Buruiana, D. Dragomir<br />
Department of Pediatric Neurology, Dr. Victor Gomoiu”<br />
Children’s Hospital, Bucharest, Romania<br />
Introduction: Tuberous sclerosis is one of the most<br />
commonly occurring and recognized neurocutaneous<br />
syndromes, with a prevalence of about 1 in 6000 newborns.<br />
It is a multi-system disorder affecting predominantly the<br />
CNS and skin. Neurological manifestations associated<br />
with tuberous sclerosis include: recurrent seizures, retardation,<br />
psychological and behavioral disturbances. Epilepsy,<br />
occurring with an incidence ranging between 80 and 90% in<br />
tuberous sclerosis patients, represents the most important<br />
clinical problem. Method: Fourteen children with tuberous<br />
sclerosis associated seizures were diagnosed and evaluated<br />
between 1995 and 1999 at the Department of Pediatric<br />
Neurology. Their clinical manifestations and evolution<br />
under therapy are evaluated in this study. Results: Different<br />
types of seizures were encountered (infantile spasms, focal<br />
and generalized tonic-clonic seizures). The clinical and<br />
electrical patterns were found to be related to the age of<br />
the patient. The patients benefited from anticonvulsant therapy.<br />
The patients were reassessed at 3, 6, 12 and 24 months<br />
in the order to evaluate their response to the therapy and<br />
neurological and mental stage of their development.<br />
Conclusions: This study confirms the existence of a relationship<br />
between the early onset of seizures and the severity of<br />
mental retardation. Failure to obtain seizure control under<br />
therapy represents an unfavorable predictive factor for<br />
neurological and mental outcome of children with tuberous<br />
sclerosis.<br />
FP-H-063<br />
Difficulties of diagnosis in a case of seizures in infancy –<br />
case report<br />
D. Plesca, M. Moiceanu, F. Buruiana, D. Dragomir<br />
Department of Pediatric Neurology, ‘Dr. Victor Gomoiu’<br />
Children’s Hospital, Bucharest, Romania<br />
Background: Menkes disease is a neurodegenerative<br />
illness with an X-linked inheritance. The degenerative<br />
process affects the grey matter in the central nervous<br />
system. The diseased infant presents with particular features<br />
of the hair and facies. The genetic defect is located on the<br />
long arm of the chromosome X (Xq13.3). The authors report<br />
the case of a 2 months and 3 weeks old, male infant (S.O.)<br />
admitted on 17 September 2000 for intractable myoclonic<br />
seizures. On physical examination the patient exhibited an<br />
expressionless facies with rounded cheeks, sparse, short,<br />
rough hair, dry, pale skin, obvious generalised muscular<br />
hypotonia and absent deep tendon reflexes. There were no<br />
eye movements elicited by a moving object and no sounds<br />
produced. EEG revealed irrigative elements and slow, highvoltage<br />
waves located alternatively on the right and on the<br />
left leads. Eye funduscopy showed bilateral optic atrophy.<br />
Serum copper and ceruloplasmin were extremely low (0 and<br />
5.2 mg/dl, respectively). The presumed diagnoses of<br />
Menkes disease was confirmed by a microscopic examination<br />
of the infant’s hair that featured a twisted, fractured<br />
aspect and multiple knots which are quite typical for<br />
Menkes disease. Enzymatic assays were not feasible.<br />
Conclusions: Based on the aforementioned clinical and<br />
paraclincal data, a diagnosis of Menkes disease was established.<br />
Despite its low incidence this disease, still represents<br />
a cause of seizures in infants.<br />
FP-H-064<br />
Benign rolandic epilepsy in two pairs of identical twins<br />
with mirror image localization of spikes<br />
R. Amit<br />
Division of Neurology, Tod Children’ Hospital, Youngstown,<br />
Ohio, USA<br />
Background: BRE is an age and localization related<br />
epileptic syndrome believed to be genetically determined<br />
by autosomal dominant trait. Objective: In the absence of<br />
reported studies of BRE in identical twins, to report this<br />
epileptic syndrome in two pairs of identical twins with<br />
mirror image of the localization of the spikes. In one pair<br />
of twins a discordant handedness was present. Methods:<br />
Medical history, seizures history, physical and neurological<br />
examinations as well as imaging studies of the brain, routine<br />
and long term video-EEG were used. In one case of doubted<br />
identity a monozygocity test was used. Conclusion: BRE<br />
does exist in identical twins. The transcription of the epileptogenic<br />
area may have a mirror image pattern.<br />
FP-H-065<br />
CSF glucose concentrations in convulsive infants with<br />
and without fever and the role of acetaminophen<br />
M. Mohammadi a , M.R. Mohebbi b , F. Naderi c<br />
a Children’s Medical Centre, Tehran <strong>University</strong> of Medical<br />
Sciences (TUMS) b TUMS,<br />
c Bahrami Children Hospital,<br />
TUMS, Tehran, Iran<br />
Hyperglycaemia is common following FS. This leads to<br />
hyperglycorrhachia within 1–2 h after a convulsion. The
512<br />
Abstracts<br />
aim of the present study was to explore the relationship<br />
between the CSF glucose concentrations, and body temperature,<br />
seizure, and prior use of acetaminophen. The cases<br />
consist of 117 convulsive infants aging 3–18 months.<br />
Patients were divided in to several groups based on body<br />
temperature, duration of fever and convulsion, and prior use<br />
of acetaminophen. There was a linear correlation between<br />
CSF glucose level and body temperature in those who had<br />
not taken acetaminophen before admission (r ¼ 0:515,<br />
n ¼ 83, P , 0:001 Spearman’s correlation analysis). The<br />
CSF glucose levels were significantly higher in the febrile<br />
infants (75.33 mg/dl, n ¼ 70), compared with the nonfebriles<br />
(66.15 mg/dl, n ¼ 13, P ¼ 0:014). There was a<br />
negative correlation between the CSF glucose level and<br />
body temperature in those who had taken acetaminophen<br />
before admission (r ¼ 20:389, n ¼ 34, P ¼ 0:023).<br />
Although the mean CSF glucose concentration was higher<br />
in those who had taken acetaminophen compared to the<br />
controls, the difference was not statistically significant<br />
(P ¼ 0:076). Other factors such as age, type of FS, duration<br />
of fever and convulsion and multiplicity of convulsions<br />
were not significantly correlated with CSF glucose concentration.<br />
Our study shows that both fever and convulsion are<br />
related with increased CSF glucose concentrations. The role<br />
of acetaminophen deserves more investigation.<br />
FP-H-066<br />
Benign infantile convulsions associated with mild<br />
gastroenteritis<br />
J.-H. Wu, L. Yin, L.-H. Cao<br />
Department of Pediatrics, Maternity and Children Hospital,<br />
Tangshan, Hebei, China<br />
Objective: To delineate and study the so-called benign<br />
infantile convulsions associated with mild gastroenteritis<br />
(BICE) in our hospital which is located in northern China.<br />
Methods: A clinical study was conducted between January 1,<br />
1999 and April 30, 2001 in all the patients who were treated<br />
for gastroenteritis (GE) accompanied by seizures, to delineate<br />
the clinical characteristics, then follow up these patients<br />
to clarify the prognosis of this syndrome. Results: There were<br />
898 patients who were admitted to hospital during the study<br />
period. Of them, there were 33 patients with GE accompanied<br />
by seizures during the course of the disease: of these 16<br />
patients had mild GE accompanied by a febrile seizures.<br />
There were nine boys and seven girls, the peak age was<br />
between 1 and 2 years old (12 cases, 75%): the youngest<br />
was 4.5 months, the eldest, 2.2 years. The clinical courses<br />
were mild in all cases, accompanied by a febrile seizures of<br />
generalized tonic-clonic pattern (GTCS). The inter-ictal<br />
EEG study (12 cases) and video-EEG study (four cases)<br />
disclosed 4–5 Hzu activity with a background activity of<br />
normal sleep EEG patterns. Neither spike and wave nor<br />
sharp wave activities were seen. Other laboratory findings<br />
including serum electrolytes, blood sugar, liver enzymes<br />
were within normal limits. In three cases the CSF was also<br />
examined and all specimens were normal. In ten cases a CT<br />
scan of brain was performed, with normal results. The<br />
seizures were easy to control. During follow-up study of 14<br />
cases after discharge from hospital (mean period: 1.2 years),<br />
these children have had no further seizures and have normal<br />
development in terms of physical and mental expectations in<br />
the follow-up period. Conclusion: A febrile convulsions<br />
associated with mild gastroenteritis occur in northern<br />
China, with an occurrence rate about 1.78% in the in-patients<br />
with GE in infants. The seizure patterns were GTCS, with<br />
good out-comes. Therefore this syndrome could be called<br />
BICE.<br />
FP-H-067<br />
Does long-term use of valproate cause weight gain in<br />
prepubertal epileptic children<br />
H. Çaksen, G. Deda, M. Berberoǧlu<br />
Ankara <strong>University</strong> Medical School Departments of Pediatric<br />
Neurology and Endocrinology, Ankara, Turkey<br />
VPA is an effective anticonvulsant in many types of childhood<br />
epilepsies. Use of VPA, however, is associated with an<br />
increase in body weight. The pathophysiology of weight gain<br />
is not fully understood. One theory is that elevated levels of<br />
serum leptin cause the weight gain in patients receiving VPA.<br />
In our study we evaluated 15 prepubertal children before and<br />
after VPA treatment for weight gain by calculating their BMI<br />
and serum leptin levels. Our study included 15 patients with<br />
new diagnosed epilepsy and 16 healthy age matched controls.<br />
The patients’ ages were between 9 months and 12 years. The<br />
BMI before VPA treatment in the study group and the control<br />
group were as follows: 16.25 ^ 1.63, 16.34 ^ 2.31. The<br />
serum leptin levels before VPA treatment in the study<br />
group and the control group were respectively; 3.79 ^ 2.39<br />
and 4.28 ^ 2.43. After VPA treatment the BMI in the study<br />
and control groups were as follows; 16.20 ^ 1.75,<br />
16.62 ^ 2.37. The serum leptin levels after VPA treatment<br />
in the study and control group were, respectively;<br />
4.70 ^ 2.80 and 5.44 ^ 2.79. There was no difference<br />
between the groups for BMI and serum leptin levels. In<br />
conclusion, our findings showed that long-term use of VPA<br />
did not cause weight gain in prepubertal children receiving<br />
VPA therapy, and there was no significant difference between<br />
the serum leptin levels of the study and control group.<br />
FP-H-068<br />
Remarks on clinical efficacy of the treatment of<br />
childhood epilepsy in 2000–2001<br />
N.T. Ung, L.T. Huong<br />
Neurology Department, National Institute Pediatrics,<br />
Hanoi, Vietnam<br />
Objective: To study 464 children with epilepsy aged
Abstracts 513<br />
from 1 month to 15 years and examine the efficacy of the<br />
treatment. Methods: By retrospective methods we studied<br />
464 with childhood epilepsy in 2000–2001. Result: There<br />
are 49.8% under 1 year, 25% from 1 to 3 years, 12.3%<br />
from 3 to 6 years, 8.8% from 6 to 11 years, 4.1% from 11<br />
to 15 years. A total of 59.5% was boys, and 40.5% girls.<br />
The following seizure patterns and frequencies were<br />
observed: 21.3% simple partial, 3.7% partial with secondarily<br />
generalized, 75% generalized seizures (61.6% tonicclonic,<br />
3.7% tonic, 2.2% atonic, 2.8% absence, 4.1% West<br />
syndrome, 0.6% Lennox Gastaut syndrome. A total of<br />
72.4% were on monotherapies, 27.6% were on polytherapies<br />
(9.7% a combination of valproate and phenobarbital,<br />
6.4% valproate with carbamazepine, 2.4% valproate with<br />
vigabatrin, 3.2% valproate, with carbamazepine with<br />
phenolbarbital, 0.8% valproate with phenobarbital with<br />
vigabatrin). The treatment was ineffective in 0.7% cases.<br />
A total of 81.9% became seizure free, 12.7% had at least<br />
80% reduction of seizures, 4.7% had on 50–80% reduction,<br />
0.7% had less than 50% reduction. Side effects were<br />
observed 1% cases.<br />
FP-H-069<br />
Comparative study of epilepsy in cerebral palsy and in<br />
developmentally normal children<br />
M.M. Rahman, S. Akhter, M.N. Islam, M.A. Mannan, K.<br />
Akhter, F.A. Khan, S. Parveen<br />
Department of Paediatrics, Bangabandhu Sheikh Mujib<br />
Medical <strong>University</strong>, Dhaka, Bangladesh<br />
This is a prospective analytical hospital-based study done<br />
from September 2000 through February 2001 to observe the<br />
clinical profiles of epilepsy in CP and in developmentally<br />
normal children. Fifty children with CP and 50 developmentally<br />
normal children, aged 1–15 years, comprised the study<br />
population. In both groups male outnumbered female children.<br />
In both groups most of the cases were under 5 years<br />
old. Before the 5th year of age, onset of seizures was 46<br />
(92%) in the CP group (group A) and 39 (78%) in developmentally<br />
normal children (group B). Family histories of<br />
seizures were present in 10 (20%) cases in group A<br />
compared to 8% cases in group B. Perinatal asphyxia 53<br />
(45%), and LBW, 25 (22%), were the commonest risk<br />
factors in group A. On the other hand, in group B perinatal<br />
asphyxia was observed in 14 (26%) cases, and LBW in six<br />
(11%) cases. Spastic tetraplegia, 34 (65%), was the<br />
commonest motor defect in CP patients. Generalized<br />
tonic-clonic was the commonest type of seizure found in<br />
both group - A 23 (43%) and in group B 30 (57%). In<br />
group A 38 (76%) cases had cryptogenic and symptomatic<br />
generalized epilepsy, 12 (24%) had localization-related<br />
epilepsy. In contrast, in group B 42 (84%) cases had idiopathic<br />
generalized epilepsy and eight (16%) cases had localization<br />
related epilepsy. Response to anticonvulsants was<br />
less good in group A than in group B. The clinical profile of<br />
epilepsy in cerebral palsy patients differs from that of developmentally<br />
normal children.<br />
FP-H-070<br />
Gelastic seizures in children<br />
H.-F. Lee, C.-S. Chi, S.-C. Mak, C.-H. Chen<br />
Department of Pediatrics, Taichung Veterans General<br />
Hospital, Taichung, China<br />
Objectives: To describe the etiology, clinical evolution of<br />
epilepsy, and administration of AEDs in patients with GSs.<br />
Methods: Fourteen patients whose seizures were characterized<br />
by typical laughing attacks were observed between<br />
1990 and 2002. All patients received EEG and MRI study.<br />
Results: One patient’s disorder was related to a HH and four<br />
to abnormal MRI findings without evident hypothalamic<br />
lesions. In nine patients, MRI was negative. EEG in the<br />
HH patient showed 2–2.5 Hz SWC. In the group with abnormal<br />
MRI findings, all four patients had focal epileptic<br />
discharges. In the group with normal MRI findings, EEG<br />
in six patients revealed focal epileptic discharges and three<br />
had normal results. The epileptic syndrome in the HH case<br />
was drug-resistant, with the response rate to AEDs less than<br />
25%. The response rates of AEDs in the group with abnormal<br />
brain MRI findings were less than 25% in one, 25–50%<br />
in one, 75–90% in two cases. In the other nine cases without<br />
abnormal MRI findings, three cases became seizure free and<br />
six cases had drug resistance or partial response to treatment.<br />
Conclusions: GSs are the frequent findings in HHs,<br />
but GSs may also be observed in patients without MRI<br />
lesions and with normal neurological status. In these<br />
patients, clinical evolution and response rate to AEDs<br />
seem to be more benign.<br />
FP-H-071<br />
Study on the quality of life in families of children with<br />
epilepsy<br />
Y.-L. Huang a , X.-Y. Wu a , P. Wang a , K.-Z. Ma b , P.-J. Shen b<br />
a Department of Pediatrics, Union Hospital, b Department of<br />
Medicine, Tongji Medical College, Huazhong <strong>University</strong> of<br />
Science and Technology, Wuhan, China<br />
Objectives: During the 2–4 years needed for standard<br />
antiepileptic therapy in epileptic children, their guardians’<br />
cooperation plays an important role in the administration of<br />
the treatment. The guardians’ quality of life (QoL), attitudes<br />
to therapy, and, their compliance are of special importance,<br />
because these factors affect the success of therapy. The<br />
purpose of the study is to investigate the QoL of the parents<br />
of the epileptic children and to find out their attitudes to<br />
epilepsy and to therapy and lastly, the factors affecting<br />
QoL in the family, so that correct advice may be given to<br />
them, allowing them to retain normal psychological profiles,<br />
and achieve compliance for the standard therapy; and,
514<br />
Abstracts<br />
finally, create good environments for the lives and education<br />
of the sick children and to improve their QoL and get the<br />
best results from their physical and psycho-therapy. The<br />
guardians’ attitudes to the anti-epileptic therapy are closely<br />
related to the success of the treatment, education, psychological<br />
development and QoL of the sick children. This<br />
study is aimed at investigating the QoL of parents of epileptic<br />
children, in order to offer appropriate advice to them and<br />
to ensure the success of the standard anti-epileptic treatment.<br />
Methods: The experimental group includes 100<br />
families with epileptic histories of 4 months ,14 years.<br />
The control group consists of 100 families with children<br />
who suffered acute diseases without seizures. The degrees<br />
of anxiety and depression were assessed in both groups. The<br />
questionnaires, including the epileptic situation, family<br />
profiles, parents’ attitudes to epilepsy, the effects of epilepsy<br />
on their lives, etc were offered simultaneously. Results: (1)<br />
In the experimental group, the total score of anxiety and<br />
depression (AD) was: 20.32 ^ 4.44, the anxiety scoring<br />
(A): 10.71 ^ 2.15 and the depression scoring (D):<br />
9.72 ^ 2.68. In the control group, the total score of anxiety<br />
and depression (AD) was: 5.93 ^ 1.55, the anxiety scoring<br />
(A): 3.34 ^ 1.25, and the depression scoring (D):<br />
2.71 ^ 0.65. There was a significant difference between<br />
two groups. (2) Questionnaire: most parents (80%) were<br />
unwilling to let others know of their children’s disease,<br />
and 55% were unwilling to let their children know of the<br />
disease. A total of 81% worried about the effects of the<br />
disease on growth, education, and QoL. Conclusion: Parents<br />
were commonly in a state of anxiety and depression. The<br />
quality of life in these families was decreased. It is<br />
suggested that the mood changes of the parents will exert<br />
negative influences on epileptic therapy. It is therefore<br />
reasonable to give psychological advice to epileptic<br />
families.<br />
FP-H-072<br />
Subcortical band heterotopia – clinico-radiological<br />
analysis of eight cases<br />
A. Kelemen, P. Barsi, G. Rásonyi, J. Janszky, G. Filicki<br />
National Institute of Neurology and Psychiatry, Budapest,<br />
Hungary<br />
Subcortical band heterotopia is considered to be the mildest<br />
end of the lissencephaly – pachygyria – band heterotopia<br />
spectrum, genetically a heterogeneous group. In this work,<br />
we correlated the clinical characteristics (sex, age of the<br />
onset of epilepsy, seizure type, mental and neurological<br />
deficit) with MRI characteristics (antero-posterior gradient,<br />
distribution, asymmetry, additional findings). The first<br />
seizure appeared around puberty in most patients (6/8).<br />
All the patients had multiple seizure types. In patients<br />
with the frontal dominant form (all females) the seizure<br />
disorder begun with GTCS and these patients have lower<br />
IQ (5/5) regardless of the band width, distance and abnormality<br />
of the overlying cortex and extension of the malformation.<br />
Both the males had the posterior dominant form.<br />
Cerebellar hypoplasia (in the frontal form) and aberrant<br />
corpus callosum (mainly in the posterior dominant form)<br />
were the most frequent additional MRI findings. Subcortical<br />
band heterotopia is clinically heterogeneous, with some<br />
distinct clinicoradiological features. Should the currently<br />
ongoing genetic tests reinforce our observations, the clinical<br />
features would enable targeted genetic analysis and counselling.<br />
FP-H-073<br />
Clinical analysis of 375 cases childhood seizures<br />
W. Hou<br />
Department of Pediatrics, DaGang Oil Field Worker’s<br />
General Hospital, Tianjin, China<br />
A review the data of patients with convulsion admitted in<br />
our hospital from 1989 to 1993. There were 246 males<br />
(66%) and 129 females (34%). Thirty-seven of them<br />
(10%) were newborns, 254 (68%) below 3-year old, 62<br />
(17%) below 6-year old. For the newborns, the major<br />
cause was HIE, which occurred in 20/37 (54%), followed<br />
by hypocalcemia in 14/37 (38%). For the infants, the most<br />
frequent causes were tetany, which occurred in 119/254<br />
(47%), febrile convulsions in 99/254 (39%) and epilepsy<br />
in 13/254 (5%). For the preschoolers, the major cause was<br />
febrile convulsions, occurring in 46/62 (745), followed by<br />
epilepsy in 7/62 (11.2%), viral encephalitis in 3/62 (5%).<br />
For the school-age children, the most common reasons were<br />
viral encephalitis in 10/22 (45%) and epilepsy in 9/22<br />
(41%). Among 375 cases, the commonest causes in order<br />
of frequency were febrile convulsions in 150/375 (40%),<br />
infantile tetany in 133/375 (35.5%), epilepsy in 30/375<br />
(8%), viral encephalitis in 17/375 (4.5%) and toxic bacillary<br />
dysentery in 6/375 (1.6%).<br />
FP-H-074<br />
Evaluation of sleep-deprivation EEG in the diagnosis of<br />
childhood epilepsy<br />
L.-H. Chen, Q.-Z. Pang, L.-Q. Chen, Y.-F. Lu<br />
Shanghai Children’s Hospital, Shanghai, China<br />
Objective: To evaluate the sensitivity of sleep-deprivation<br />
EEG examination in children. Method: Sixteen children<br />
suspected of epilepsy clinically but with normal standard<br />
EEG examinations were selected at random (male 12,<br />
female four, age 3–11 years, mean 6 years). Sleep-deprivation<br />
EEG was performed individually. Periods of sleep<br />
deprivation were 18–20 h for children below 7 years and<br />
24 h for the older ones. Results: All the EEG showed slowing<br />
of background electric activity. In addition, eight cases<br />
(50%) showed spike/sharp-slow wave complexes, three<br />
cases had bursts of high voltage u activity, and five cases
Abstracts 515<br />
had normal recordings. The rate of EEG abnormality was<br />
68.75%. Conclusion: Sleep-deprivation EEG is more sensitive<br />
than standard EEG in showing abnormal electric activity,<br />
and has practical value clinically.<br />
FP-H-075<br />
The follow-up survey on the prognosis of 82 cases with<br />
febrile convulsions<br />
P.-F. Xu, Z.-S. Zhou<br />
Department of Pediatrics, China-Japan Friendship Hospital,<br />
Beijing, China<br />
Objective: To explore the relapse of patients with febrile<br />
convulsion (FC) and the relationship between FC and<br />
epilepsy (EP). Subjects and methods: One hundred eight<br />
cases with FC (66 boys and 42 girls) were admitted to our<br />
hospital from 1998 to 2001. Their ages averaged 4.2 ^ 2.4<br />
years. Questionnaires were taken to survey subsequent<br />
conditions. Results: Amongst 108 in-patient hospital cases<br />
with FC during the survey period, 82 cases (75.9%) actually<br />
took part in this survey. There were 70 cases with simple FC<br />
(85.3%) and 12 cases with complex FC. Of 70 cases with<br />
simple FC, relapses occurred in 28 cases (38.8%), of whom<br />
24 cases (85.7%) relapsed within 1 year of onset. Six cases<br />
converted into EP accounting for 7.3% of all 82 cases. None<br />
died. Conclusions: (1) FC had good prognoses, but nearly<br />
half the cases had recurrences. Most of these relapsed within<br />
1 year of onset. (2) Both the number of recurrences of FC<br />
and the interval between onset and recurrence were risk<br />
factors for secondary EP.<br />
FP-H-076<br />
Effect of immunoglobulin G and phenytoin (PHT) on<br />
NMDA receptor-1 density in the brain of<br />
pentylenetrazol (PTZ) induced convulsion rats<br />
C.-N. Zheng a , Z.-S. Zhou a , M. Ariizumi a,b , M. Jinnai b , K.-D.<br />
Wang a<br />
a Pediatric department, China-Japan Friendship Hospital,<br />
Beijing, Republic of China; b Department of Pathology,<br />
Koshigaya Hospital, Dokkyo <strong>University</strong> School of Medicine,<br />
Japan<br />
Objective: To clarify the anti-epileptic mechanism of<br />
IgG, we studied the effect of IVIG on density of N-<br />
methyl-d-aspartate receptor (NR-1) positive neural cells<br />
in the brain of rats with PTZ induced convulsion,<br />
compared with that of phenytoin (PHT). Subjects and<br />
methods: Wistar rats were divided into four groups:<br />
group A, normal control; group B, PTZ 1 saline; group<br />
C, PTZ 1 IVIG; group D, PTZ 1 PHT. PTZ 50 mg/kg<br />
was intraperitoneally injected every day. IVIG 200 mg/<br />
kg and saline were each intravenously injected twice a<br />
week, while PHT 6–10 mg/kg was given orally every<br />
day 2 h before seizure onset. The brains were removed<br />
on the 15th day and NR-1 detected by immunohistochemical<br />
staining. NR-1 positive and negative neural cells were<br />
counted in the CA1 and CA3 of hippocampus, dentate<br />
gyrus, frontal cortex and cerebellum. Results: In group<br />
B, NR-1 positive neural cells were significantly reduced<br />
in CA1 and cerebellum, and the total number of neural<br />
cells tended to decrease in CA3. Group C showed moderate<br />
reduction of NR-1 positive neural cells in CA1, but<br />
not in the other regions. Group D had only minimal<br />
NR1 neural cell reduction in the cerebellum. Conclusion:<br />
These results suggested that the anti-epileptic action of<br />
IgG is possibly related to NR-1 mRNA expression<br />
or NMDA activation through immunomodulation. IgG<br />
might also possess a protective action against neuron<br />
loss due to severe convulsions, comparable to that of<br />
PHT.<br />
FP-H-077<br />
Study on frequency – amplitude gradient in pediatric<br />
sleep EEGs<br />
Z.-C. Guo, F.-C. Cai<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, China<br />
Objective: To explore the clinical significance of the<br />
frequency-amplitude gradient (FAG) in pediatric sleep<br />
EEGs. Method: The patients and normal children were<br />
divided into corresponding five groups in accordance<br />
with age (,1, ,3, ,5, ,10 and ,14 years as groups I–<br />
V). Simultaneous EEGs and brain electric activity mapping<br />
were performed during waking and sleep states. The<br />
energy ratio of slow waves between parietal-occipital and<br />
frontal prefrontal areas was calculated as FAG. The timeamplitude<br />
of EEG was converted into frequency-energy<br />
relation. Results: Thirty-one normal children and 43<br />
patients with encephalopathy joined the study. The mean<br />
values of FAG in normal children of groups I–III were<br />
higher than 1.0 and were interpreted as normal FAG. The<br />
mean values of FAG in patients of groups I–III were lower<br />
than 1.0 and were interpreted as absence of FAG. significant<br />
differences were found between those of the normal<br />
children groups and the patient groups (Ps , 0:05 , 0:01).<br />
The mean values of FAG in group IV normal children<br />
group were not different from that in the patients’ groups<br />
(Ps . 0:05). The mean values of FAG in group V normal<br />
children were lower than 1.0. No significant difference was<br />
found between the corresponding normal children group<br />
and the patients’ group (P . 0:05). Conclusions: The<br />
EEG pattern of FAG was well-developed in normal children<br />
at 4 months of age, with a progressive decrement till<br />
10 years old and absence of FAG when approaching 14<br />
years. Neurological illness may be associated with loss of<br />
FAG. The FAG examination was a valuable parameter in<br />
distinguishing normal sleep EEG from encephalopathic<br />
illness.
516<br />
Abstracts<br />
FP-H-078<br />
Clinical and experimental study of prophylactic<br />
management for febrile seizures with topiramate<br />
Z. Huang, F.-C. Chai, X.-P. Zhang, W.-Z. Zhou<br />
Department of Neurology, Children’s Hospital, Chongqing<br />
<strong>University</strong> of Medical Sciences, China<br />
Objective: To explore the effect, values and side effects of<br />
TPM in the prevention of complex febrile convulsions<br />
(CFC) in animals and children. Methods: (1) Thirty Wister<br />
rats aged from 10 to 30 days, sensitive to FC were selected<br />
randomly, and observed for changes of liability to FC after<br />
taking TPM. (2) Ninety children diagnosed with CFC were<br />
selected randomly. There were 49 males and 41 females.<br />
The patients were 8.9–110.1 months old (average<br />
52.7 ^ 28.7 months). The durations of disease were 2.7–<br />
69.7 months (average time of 25.3 ^ 22.2 months). The<br />
dosages of TPM were 3–6 mg/kg per day (average<br />
50.7 ^ 19.6 mg per day). Observation time was 6.5–18.9<br />
months (average 50.17 ^ 19.6 months). (3) To observe the<br />
side effects on Wister rats and children after taking TPM.<br />
Results: (1) The duration of CFC seizures was significantly<br />
different (t ¼ 48:15, P , 0:01) after taking TPM (respectively<br />
251.27 ^ 246.98 and 96.43 ^ 92.41 s). The incidence<br />
of the CFC seizures declined by about 80% (24/30,<br />
P , 0:01) and the severity of seizures was noticeably<br />
reduced (x 2 ¼ 24:093, P , 0:01). (2) The seizure frequency<br />
of 90 children’s CFC was reduced from 6.5 ^ 4.8 times/<br />
year to 0.38 ^ 0.82 times/year: the difference was significant<br />
(t ¼ 7:23, P , 0:01). Eighty-two of 90 cases had no<br />
CFC seizure during the observation time (91.11%). (3) A<br />
total of 36.67% (11/30) of Wister rats and 11.1% (10/90) of<br />
CFC children had side effects such as narcolepsy, loss of<br />
appetite, and loss of weight. The difference was very significant<br />
(x 2 ¼ 6:635, P , 0:01). However, their routine blood<br />
tests and liver and kidney function had not changed. Conclusion:<br />
The results suggested that TPM had values such as<br />
high clinical effect and infrequent side effects, as confirmed<br />
by animal experiments. So, TPM had good clinical value. In<br />
one word, we thought TPM, as a single drug, had a promising<br />
future in the prevention of CFC in children.<br />
FP-H-079<br />
Effect of high temperature on electrical seizure-induced<br />
neuronal damage in explant culture of rat hippocampus<br />
S.-A. Chae a , D.-W. Kim b<br />
a Chung-Ang <strong>University</strong>, Seoul, Korea; b Inje <strong>University</strong>,<br />
Koyang, Korea<br />
The immature brain has a greater susceptibility to the<br />
development of prolonged provoked seizures in response<br />
to environmental stimuli such as fever. Therefore, the influences<br />
of high temperature (HT) on normal and epileptic<br />
brain were studied in organotypic explant cultures of rat<br />
hippocampus. Fourteen days-in-vitro cultures from 8 dayold<br />
rat pups were perfused with CSF bubbled with 95/5%<br />
O 2 /CO 2 in a microchamber. At 368C initially, after<br />
discharge (AD) was evoked. In the HT group, the cultures<br />
were subjected to 398C for a period of 8 min before the<br />
second stimulus train was applied. They were then restored<br />
to 368C for 10 min. In the control group, temperature was<br />
maintained at 368C for the second stimulus train. The<br />
cultures were returned to the incubator and observed serially<br />
for neuronal damage. The cultures on the same insert that<br />
were not stimulated served as the unstimulated groups.<br />
There was no significant difference in neuronal damage<br />
between the unstimulated groups. Neuronal damage on<br />
AD induced cultures during the febrile setting (n ¼ 16)<br />
was significantly higher than in the non-febrile setting<br />
(n ¼ 16). In CA1, percentage damage (mean ^ SEM) was<br />
6.63 ^ 2.56; 0.92 ^ 0.45 at 24 h (HT group; control group;<br />
P ¼ 0:036, Student’s t-test); 26.37 ^ 7.44; 4.99 ^ 2.23 at<br />
48 h (P ¼ 0:010); and 38.59 ^ 9.63; 6.48 ^ 2.30 at 72 h<br />
(P ¼ 0:003). In CA3, percentage damage was<br />
27.86 ^ 8.68; 7.54 ^ 3.74 at 72 h (P ¼ 0:04). The results<br />
suggest that at high temperatures, seizures in epileptic brain<br />
may be more injurious than seizures at normal temperatures.<br />
FP-H-080<br />
A genome-wide linkage analysis of febrile seizures in a<br />
Japanese affected sib-pair population<br />
J. Nakayama a,b , N. Yamamoto a , K. Hamano c , N. Iwasaki b ,<br />
S. Nakahara d , M. Ohta e , Y. Horigome b , A. Matsui b ,T.<br />
Arinami a<br />
a Department of Medical Genetics; b Department of Pediatrics,<br />
<strong>University</strong> of Tsukuba,<br />
c Kitaibaraki Municipal<br />
General Hospital,<br />
d Kensei General Hospital,<br />
e Toride<br />
Kyodo General Hospital, Ibaraki, Japan<br />
FS are the most common form of childhood seizures, and<br />
they occur in about 7% of Japanese children. Four putative<br />
FS loci, FEB1 (chromosome 8q13–q21), FEB2(chromosome<br />
19p), FEB3 (chromosome 2q23–q24) and FEB4<br />
(chromosome 5q14–q15), have been mapped. Furthermore,<br />
some mutations in the voltage-gated sodium channel b1<br />
subunit gene (SCN1B), the neuronal voltage-gated sodium<br />
channel gene (SCN1A) and the GABA A receptor b2-subunit<br />
gene (GABRG2) were identified in families with a clinical<br />
subset of seizures termed GEFS 1 . Except for FEB4, these<br />
loci are linked to some large, Caucasian families. In this<br />
study, we conducted a genome-wide linkage screening of<br />
48 Japanese nuclear families (192 members) with FS children<br />
(59 affected sib-pairs) using 400 microsatellite markers<br />
separated by an average distance of 10 cM. We used the<br />
GENEHUNTER program to perform nonparametric multipoint<br />
linkage analysis. In addition to FEB4, which we have<br />
previously reported (Hum Mol Genet 2000;9:87–91),<br />
another peak with a non-parametric linkage score (NPL)<br />
.2.0 was observed on chromosome 1 (NPL score ¼ 2.54).
Abstracts 517<br />
Taken together with the report by Baulac et al. who found<br />
evidence for linkage to the near region on chromosome 1q<br />
in a large family with both FS and temporal lobe epilepsy<br />
(Ann Neurol 2001;49:786–792), our data further support the<br />
existence of FS susceptible gene(s) on chromosome 1q.<br />
FP-H-081<br />
Convulsions in children with different types of<br />
helminthiases<br />
Sh.Sh. Shamansurov, Sh.Kh. Saidasisova<br />
Tashkent Institute of Postgraduate Medical Education,<br />
Uzbekistan<br />
Background: The problem of helminthiases and their<br />
effect on the state of nervous system remain actual and<br />
important for today. Helminths creating a stable focus of<br />
stimulation in the central nervous system may lead to the<br />
appearance of convulsions in children. We have investigated<br />
45 children, aged 1–15, with convulsive paroxysms<br />
and invasions by helminths. Lambliasis, dwarf tapeworm,<br />
broad tapeworm and ascarides were found. Mixed invasions<br />
were noted in 92% of cases. Results: In additional to anticonvulsive<br />
therapy dehelminthization was performed.<br />
Convulsions stopped immediately after dehelminthization<br />
in 39% of cases; stopped gradually during 1–3 months in<br />
43% of cases, and became more frequent and stopped with<br />
time in 11% of cases (6 months after finishing of treatment<br />
and repeated dehelminthization). They did not stop and<br />
required prolonged anticonvulsive therapy in 7%. Conclusion:<br />
Thus, during treatment with anticonvulsants, of<br />
convulsive states in children, it is necessary to take into<br />
account the possibility of invasion of helminths into the<br />
children’s bodies.<br />
FP-H-082<br />
Application of a new method of auto-antibodies<br />
detection in children with convulsive state<br />
Sh.Sh. Shamansurov, D.N Gulyaniova<br />
Tashkent Institute of Postgraduate Medical Education,<br />
Uzbekistan<br />
Aim: Application of a new ‘Epitest’ method of detection<br />
of the level of auto-antibodies to fragments of glutamate<br />
receptors, quisqualate membrane protein in blood serum<br />
of children with paroxysmal states. Methods: Forty-two<br />
children were studied, at ages from 3 months to 3 years.<br />
Fifteen of them had non-febrile fits and 17 of them had<br />
febrile fits: and, for comparison, ten of them were healthy<br />
children of the same age. They were examined with ‘Epitest’,<br />
in order to find out whether there were glutamate receptors<br />
in blood. Results: The level of auto-antibodies to<br />
glutamate receptors in healthy children was low:<br />
1.01 1 0.08 ng/ml. Children with non-febrile epilepsy had<br />
elevated levels of receptors in blood: 2.66 ^ 0.13 ng/ml.<br />
But in children with febrile fits it was 1.855 ^ 0.205 ng/<br />
ml. So, by this method the following was investigated: the<br />
increases in the levels of auto-antibodies to glutamate receptor<br />
of AMPA in children with convulsive states compared<br />
with healthy children. In studies of children with epileptic<br />
syndromes and paroxysmal states of non-epileptic origin<br />
and their outcomes, there is, undoubtedly, confirmation of<br />
a hypothesis of damage to glutamate receptors secondary to<br />
high glutamate concentrations in pathological processes and<br />
also intensive production of auto-antibody receptors which<br />
are initiators of a rise in convulsive reactions. Conclusions:<br />
A new method of detection of auto-antibodies to AMPA<br />
receptors relating to cerebral pathology was found very<br />
effective in the clinical diagnosis of convulsive syndromes<br />
in children. It could be used widely to reveal and prevent<br />
paroxysmal states in their early stages.<br />
FP-H-083<br />
The relation of epilepsy related factors to anxiety and<br />
depression scores in epileptic children<br />
A. Oguz, S. Kurul, E. Dirik<br />
Dokuz Eylül <strong>University</strong> Faculty of Medicine, Izmir, Turkey<br />
Cognitive and behavioral impairments are found more<br />
often among epileptic children than among their peers. In<br />
this study, we aimed to evaluate the anxiety and depression<br />
in epileptic children, to compare their results with that of a<br />
healthy control group and to determine the relation of anxiety<br />
and depression scores to epilepsy-related factors. The<br />
State Trait Anxiety Inventory and the Children Depression<br />
Inventory were applied to 35 epilepsy patients aged 9–18<br />
years (mean age 12.9 ^ 2.52) and to 35 healthy children<br />
served as the control group. Both study and control groups<br />
were divided into two age groups (9–11 and 12–18 years) to<br />
exclude the effect of puberty on anxiety and depression<br />
scores. Significant depression and suicidal ideas were determined<br />
in the study group. The mean trait anxiety score was<br />
significantly higher in the 9–11 age group of epileptic<br />
patients than the corresponding control group<br />
(35.90 ^ 6.90 and 29.33 ^ 2.84, P , 0:05). The mean<br />
state anxiety score (33.90 ^ 3.90 and 30.40 ^ 6.02,<br />
P , 0:05), trait anxiety score (38.20 ^ 6.84 and<br />
32.20 ^ 3.90, P , 0:05) and depression score<br />
(16.65 ^ 8.32 and 8.15 ^ 3.15, P , 0:05) were significantly<br />
higher in the 12–18 age group of epileptic children<br />
than in the control group. Among the epilepsy-related<br />
factors, epilepsy duration, seizure frequency and polytherapy<br />
were found to increase the anxiety and depression; and<br />
age of seizure onset, seizure type and EEG findings were not<br />
related to anxiety and depression. In conclusion, symptoms<br />
of anxiety and depression are common among epileptic<br />
children, especially during puberty. State Trait Anxiety<br />
Inventory (STAI) and Children Depression Inventory<br />
(CDI) may be used as tools to give information to the clinicians.
518<br />
Abstracts<br />
FP-H-084<br />
Magnetoencephalographic statistical parametric<br />
mapping of interictal spikes in epileptic patients<br />
K. Imai a , K. Yanagihara a , N. Kamio a , R. Sakakibara a ,K.<br />
Shimono a , T. Okinaga a , N. Hirabuki b , T. Yoshimine c ,K.<br />
Ozono a<br />
a Department of Pediatrics,<br />
b Radiology,<br />
c Neurosurgery,<br />
Osaka <strong>University</strong> Graduate School of Medicine, Osaka,<br />
Japan<br />
Purpose: To evaluate a new MEG imaging with spatial<br />
filtering and statistical analysis to investigate spatial distribution<br />
of interictal spikes. Method: Ten cases of localization-related<br />
epilepsy were investigated. Thirty interictal<br />
spikes with similar morphology and distribution were<br />
recorded from each subject using 64 channel whole-head<br />
MEG system (CTF; Canada). The following two methods<br />
were used for analysis: (a) single dipole model (SDM); and<br />
(b) statistical-SAM (synthetic aperture magnetometry, CTF;<br />
Canada) (stat-SAM). In stat-SAM, the region of interest was<br />
set to include the entire cerebrum with a 5 mm voxel resolution.<br />
The signal power of each voxel was estimated using<br />
spatial filter (SAM). Changes in the beta band signal power<br />
between the spike phase (200 ms) and the prespike phase<br />
(200 ms) of each voxel were statistically analyzed using<br />
Student’s t-test. The distribution of t-values obtained from<br />
each voxel was superimposed on individual MRI images.<br />
Results: Using the stat-SAM, the position and spatial distribution<br />
of interictal spikes could be superimposed on MRI<br />
images in each case. These results correlated well with<br />
SDM. In subjects with localized cerebral lesions, stat-<br />
SAM revealed the precise information of the spatial relationship<br />
between epileptic foci and brain lesions. Conclusion:<br />
While SDM is useful and reliable for the analysis of<br />
interictal spikes generally, complicated results may lead to<br />
difficulties with interpretation. Stat-SAM can easily demonstrate<br />
the 3-dimensional distribution of interictal spikes,<br />
although poor in temporal resolution. Furthermore, this<br />
new statistical method may enable us to make the automatic<br />
MEG distribution images of interictal spikes.<br />
FP-H-085<br />
The therapeutic effect of topiramate in childhood<br />
epilepsy: a hospital-based study<br />
W.-T. Lee, J.-S. Liang, T.-W. Yu, Y.-Z. Shen<br />
National Taiwan <strong>University</strong> Hospital, Taipei, Taiwan,<br />
Chinese Taipei<br />
Topiramate has been shown to be safe and effective in<br />
refractory epilepsy in adults. Pharmacokinetic studies show<br />
that the clearance of topiramate is greater in children than<br />
in adults; therefore, higher doses may be needed in children<br />
than adults. In the present study, we investigate the<br />
effect of topiramate used adjunctively in Taiwanese children<br />
with refractory partial and generalized epilepsy. A<br />
total of 51 children (F:M ¼ 29:22) with epilepsy were<br />
enrolled in the present study. The mean age was 9.5<br />
years, and the mean seizure history was 5.6 years. Of<br />
these 51 children, 68% of children took two or more anticonvulsants<br />
before topiramate was added. Our result showed<br />
that the average seizure reduction rate was 59% after<br />
adding topiramate, and the mean follow-up duration was<br />
8.2 months. Overall 22% of the children became seizurefree,<br />
and another 42% showed more than 50% of seizure<br />
reduction after adding topiramate. Of ten children with<br />
adverse effects, four of them dropped out finally secondary<br />
to adverse effects. Of five children with infantile spasms,<br />
two became seizure free and two showed seizure reductions<br />
of more than 50%. We conclude that topiramate is an<br />
effective agent for the adjunctive therapy of partial and<br />
generalised epilepsy in children. Treatment-limiting<br />
adverse events may be managed by slow titration.<br />
Although comparative studies with the other newer anticonvulsants<br />
are required, topiramate may be an important<br />
addition to the range of drugs that can be used to treat<br />
refractory epilepsy in children.<br />
FP-H-086<br />
Electroencephalographic-video monitoring in<br />
pediatrics: Philippine Children’s Medical Center<br />
experience<br />
R.G. Valeriano, M.H. Ortiz, A.S. Salonga, M.F.A. Soto<br />
Philippine Children’s Medical Center, Quezon City, Philippines<br />
EEG-video monitoring is a valuable tool in evaluation<br />
and management of children suspected of having seizures<br />
or paroxysmal disorders. The prolonged monitoring of the<br />
brain activity simultaneous with prolonged video monitoring<br />
of patients permits correlation of clinical behavior and<br />
EEG activity. Its primary purpose, especially in pediatrics,<br />
is to address fundamental problems of evaluation and<br />
management of children suspected of having seizures. At<br />
Philippine Children’s Medical Center we present our<br />
experience in video-EEG. Since 1998, we have a total of<br />
70 patients who underwent prolonged EEG monitoring.<br />
The youngest patient was 2 months and the oldest, 19<br />
years old: the average age was 4.61 years. The majority<br />
were males 44/70 (63%), with females 26/70 (37%). The<br />
commonest reason, in 59/70 (82%), for prolonged video-<br />
EEG monitoring was to determine if an abnormal movement<br />
noted in a patient had an EEG correlate. Other<br />
reasons were, to determine if there were multiple seizure<br />
types, 3/70 (4%); to localize the area from which epileptiform<br />
discharges were coming 2/70 (2.8%); to determine<br />
the seizure type 2/70 (2.8%). One out of 70 patients underwent<br />
monitoring to confirm whether the seizures were<br />
infantile spasms, to confirm whether there was frontal<br />
lobe epilepsy, to confirm the findings in routine EEGs in
Abstracts 519<br />
patients who did not have clinical seizures and to confirm<br />
whether other clinical findings such as headaches, flashes<br />
of lights, and sudden generalized weakness are actually<br />
seizures. The abnormal movements requiring confirmation<br />
were mostly myoclonic jerks, stiffening of extremities,<br />
blank stares, head turning, tremors of the hands and<br />
shoulders, cyanosis and sudden transient weakness. In<br />
our experience video-EEG monitoring confirms our diagnosis<br />
of epilepsy and helps clinicians in decisions on<br />
giving antiepileptic drugs and eliminating these drugs if<br />
they are not necessary. We have determined different<br />
seizure types, and we have localized the areas from<br />
which the discharges were coming. Prolonged EEG-video<br />
monitoring, in our experience, has helped us in the diagnosis<br />
and treatment of our patients.<br />
FP-H-087<br />
Improvement in the knowledge, attitude and practice<br />
regarding epilepsy among participants of the Epilepsy<br />
Camp conducted in Philippine Children’s Medical<br />
Center<br />
R.G. Valeriano, M.L. Bolanos, M. Sosa, M.H. Ortiz<br />
Philippine Children’s Medical Center, Quezon City, Philippines<br />
Epilepsy Camp is a yearly activity of the Philippine<br />
Children’s Medical Center which aims to improve the<br />
awareness of patients with epilepsy, their parents and caregivers.<br />
This pilot study aims to evaluate the effectiveness<br />
of the camp in attaining the objective of the annual activity.<br />
We would like also to assess the knowledge, attitude<br />
and practice of participants before the Camp and determine<br />
the areas of weakness and use these to address their needs<br />
in the future epilepsy camp. Methods: We administered<br />
pre-tests and post-tests to the participants of the year<br />
2001 Epilepsy Camp. A 60-item test questionnaire, written<br />
in vernacular language was prepared. Questions about<br />
knowledge on etiology, diagnosis, and treatment, attitude<br />
towards the disease, dealing with people with the disease<br />
and common practice regarding emergency management<br />
during active seizures, importance of clinic follow-up and<br />
compliance in giving of medications. The same set of questions<br />
was prepared for the pre-test and post-test. Results:<br />
Sixty-two respondents were able to answer both pre- and<br />
post-tests. In the pre-test, 98% of the respondents are aware<br />
that epilepsy is caused by sudden changes in brain activity.<br />
More than half still believe in the myths and misconceptions<br />
about epilepsy. Sixty percent are aware that etiology<br />
can be undetermined. Ninety percent know about electroencephalography<br />
as a diagnostic procedure. Eighty two<br />
percent believed that persons with epilepsy can live normal<br />
lives. Less than 50% are aware of the emergency measures<br />
during active seizures. Although 70% believe in the importance<br />
of follow up, the majority has doubts about giving<br />
maintenance medication. There is a statistically significant<br />
difference between the results of the pre- and post-tests<br />
with improvement in the results. Conclusion: The Epilepsy<br />
Camp is effective in improving the knowledge, attitude and<br />
practice among participants.<br />
FP-H-088<br />
Seizure recurrence after antiepileptic drug (AED)<br />
discontinuation in children – the Philippine Children’s<br />
Medical Center experience<br />
J.M.B. Ahorro, M.H. Ortiz, A.M. Salonga<br />
Philippine Children’s Medical Center, Quezon City, Philippines<br />
The last decade has seen striking changes in epilepsy<br />
management in children. Identifying seizure etiology and<br />
semiology has significantly helped in the management of<br />
these cases. In all patients with epilepsy, the estimated probability<br />
of achieving seizure remission is 65%. Reported<br />
relapse rates from foreign studies following AED discontinuation<br />
varied from 6 to 76% in general and 6–40% in<br />
children; risk factors that were shown to have significant<br />
correlation to recurrence were age at onset of seizure,<br />
seizure type, and presence of slowing on EEG. This retrospective<br />
study was conducted to determine the rate of<br />
seizure recurrence following AED discontinuation and identify<br />
risk factors predictive of outcome. A total of 30 records<br />
of patients whose anticonvulsants were discontinued were<br />
available for review. The overall relapse rate of seizures in<br />
those patients whose AEDs were discontinued after a minimum<br />
seizure-free period of 2 years, as well as the risk<br />
factors for seizure relapse in these patients, will be<br />
discussed.<br />
FP-H-089<br />
Anticardiolipin antibody and childhood epilepsy<br />
K. Haginoya, H. Yokoyama, M. Munakata, M. Ishitobi, T.<br />
Kitamura, M. Koda, N. Togashi, C. Nara, K. Iinuma<br />
Tohoku <strong>University</strong> School of Medicine, Sendai, Japan<br />
Background: Anticardiolipin antibody (aCL) is reported<br />
to be positive in patients with antiphospholipid syndrome.<br />
However, aCL has been reported in patients with various<br />
CNS disorders. We examined the frequency of aCL in<br />
patients with various kind of epilepsy in order to clarify<br />
whether aCL is involved in the pathogenesis of childhood<br />
epilepsy. Methods: Serum samples from 175 epileptic<br />
patients and 71 non-epileptic patients were obtained after<br />
informed consent. The aCL IgG was measured using an<br />
ELISA kit purchased from MBL (Nagoya, Japan). The<br />
175 epileptic patients included nine with idiopathic generalized<br />
epilepsy, 46 with symptomatic generalized epilepsy<br />
(SGE) including 21 with West syndrome, 73 with cryptogenic<br />
or symptomatic localization-related epilepsy (C/<br />
SLE), 29 with idiopathic localization-related epilepsy,
520<br />
Abstracts<br />
and 18 with unclassified epilepsy. Results: Twenty-four<br />
percent of epileptic patients and 15% of non-epileptic<br />
patients were positive for aCL. When epileptic patients<br />
were divided into aCL-positive (42 patients) and aCLnegative<br />
(133 patients) groups, there were no significant<br />
differences between the two groups in terms of sex, polypharmacy,<br />
antinuclear antibody, antiDNA antibody, and<br />
drugs used for treatment. However, SGE and age less<br />
than 1 year were significantly more frequent in the aCLpositive<br />
group (P ¼ 0:014 and ,0.0001, respectively).<br />
Patients whose seizure type was epileptic spasm including<br />
West syndrome were significantly more frequent in the<br />
aCL-positive group (P ¼ 0:0001). Conclusions: There<br />
was a significant relationship between aCL and those<br />
who had SGE and whose seizure type was epileptic<br />
spasm, suggesting that aCL was involved in the pathogenesis<br />
of epilepsy in those patients.<br />
FP-H-090<br />
Epilepsy after febrile seizures<br />
M. Kuturec, F. Duma, V. Sabolic-Avramovska, O.<br />
Lekovska<br />
<strong>University</strong> Children’s Hospital, Skopje, Macedonia<br />
Data for subsequent epilepsy after febrile seizures varies<br />
form 2 to 12%, depending on the different possible risk<br />
factors: atypical febrile seizures, positive family history of<br />
epilepsy, presence of neurodevelopmental abnormalities<br />
prior to febrile seizures, etc. During the period of 2<br />
years 706 patients were registered with febrile seizures<br />
(401 with clinical features of simple febrile seizure –<br />
group P, and 305 with clinical features of complex febrile<br />
seizures – group C). The longitudinal follow up was done<br />
during a period of 3–6 years for: 327/401 and 216/305.<br />
The follow up (every 3 months the 1st year, and then every<br />
6 months) contains data for: febrile illness, recurrent<br />
febrile convulsions, development of a febrile seizures,<br />
neurodevelopmental status, EEG, AED, etc. An epilepsy<br />
developed after simple febrile seizures in 17, 5.20%. An<br />
epilepsy developed after complex febrile seizures in 27,<br />
12.5%. In both groups the main transformation occurred<br />
within 36 months of an initial or last febrile convulsion,<br />
accounting for 10 (58.82%) of children in group P, and 14<br />
(51.85%) in group C. The causal relationship between<br />
febrile seizures and the subsequent epilepsy is still controversial,<br />
and depends on many different risk factors. In our<br />
study the connection between the febrile seizures and<br />
subsequent epilepsy was more definite and more robust<br />
for group C, with even one positive factor, such as the<br />
clinical feature of an atypical or complex febrile seizure,<br />
the mental, motor or neurological deficit prior to first<br />
febrile seizure, and the initial febrile seizure after 3rd<br />
year, being of importance.<br />
FP-H-091<br />
EEG biofeedback in the treatment of attention deficit<br />
hyperactivity disorder in children<br />
N. Pop-Jordanova a , S. Markovska b<br />
a Department of Psychophysiology, Pediatric Clinic, Faculty<br />
of Medicine, b Research Center for Energy, Informatics and<br />
Materials, Macedonian Academy of Sciences and Arts,<br />
Skopje, Macedonia<br />
In the school age population, ADHD has been diagnosed<br />
worldwide in from two to even ten percent of children.<br />
Precise evidence for Macedonia is lacking and the only<br />
treatment applied so far has been pharmacotherapy, mainly<br />
with Ritalin, which has to be purchased from abroad. The<br />
subjects consisted of 12 children aged 6–13, categorized<br />
into three types of ADHD: predominantly ADD, hyperactive-impulsive,<br />
and, combined type. The diagnosis is made<br />
clinically (ICD-10) and confirmed by psychometric instruments<br />
such as Conners Questionnaire for parents and<br />
teachers, as well as WISC-R. The children participated in<br />
a 4-month program of EEG biofeedback (neurofeedback)<br />
training, twice a week, with sessions of 50 min, using<br />
Biograph/Procomp version 2.0. The aim of neurofeedback<br />
training was beta (16–20 Hz) enhancement and theta (4–8<br />
Hz) suppression. All patients showed considerable changes<br />
in EEG activity. The mean values of theta amplitudes at the<br />
end of treatment were 20–30% lower compared to the initial<br />
states, whilst the simultaneous increase in beta amplitudes<br />
was over 30%. In the cases of two patients with extremely<br />
low concentrations, where neurofeedback was combined<br />
with Ritalin, the increase of beta amplitudes was the highest,<br />
reaching 100%. However, such a synergetic effect was not<br />
observed in theta amplitudes. The comparison of IQ performances<br />
(by WISC-R) before and after the neurofeedback<br />
training program has indicated higher intelligence test<br />
scores. Also, enhanced behavior and learning, improvement<br />
in school grades and increased self-esteem have been<br />
achieved.<br />
FP-H-092<br />
Staring episodes in generalized and focal epilepsies<br />
P.S. Baxter a , A.K. Chattopadhyay b , R.H Kandler b<br />
a Children’s Hospital, Neurophysiology Department, b Royal<br />
Hallamshire Hospital, Sheffield, UK<br />
Staring or ‘blank’ episodes can be due to epileptic<br />
seizures, attentional difficulties, daydreaming, tiredness or<br />
other causes. This can cause diagnostic confusion. We<br />
examined the clinical features of epileptic staring episodes,<br />
by reviewing videos of children having seizures during EEG<br />
recordings. A total of 185 staring episodes were studied in<br />
74 children aged 7 months–15 years (median 7 years). Eighteen<br />
(10%) were isolated stares. A total of 154 episodes had<br />
additional features such as gaze deviation, eyelid flutter,
Abstracts 521<br />
and/or automatisms. During seven the eyes remained closed<br />
without additional features. Six could not be assessed.<br />
Isolated stares occurred significantly more often in children<br />
whose eyes were open rather than closed at seizure onset<br />
(P , 0:001). The 18 isolated stares were seen in 12 children,<br />
ten of whom had other ictal episodes with additional<br />
features during the same recording and two of whom only<br />
had a single seizure recorded. Seizure types were primary<br />
generalised with 3 Hz spike and wave (37), other primary<br />
generalised (89), 3 Hz spike and wave with a focal onset<br />
(13), other generalised with a focal onset (27), focal (7), and<br />
unclassified (12). Isolated stares were as common in those<br />
with focal or generalized onsets. In conclusion, staring<br />
episodes without additional features are not typical of<br />
epileptic seizures. The likelihood of recording an isolated<br />
stare of the habitual type is improved by performing the<br />
video-EEG with eyes open.<br />
FP-H-093<br />
Correlation of hemiplegic or hemiparetic CP and later<br />
development of partial epilepsy<br />
M. Carignani<br />
Neurology Institute, Universidad Nacional de Rosario,<br />
Rosario, Argentina<br />
The CP, a static, residual, pathology secondary, generally,<br />
to hypoxic-ischemic events, seen most commonly as an<br />
expression of variable patency, previously or more recently,<br />
of the basal branches of the cerebral arteries (anterolaterals<br />
or fluted branches) or of the terminal veins, of the internal<br />
cerebrum and the choroid plexus, with subsequent infarction<br />
of the subependymal germinal matrix, is one of the pathologies<br />
formerly studied in pediatric neurology and defined<br />
according to location, affected vessels, lesional sequence<br />
during its development, etiology, and, more recently by<br />
the presence of dysplasias of the cortical mantle due to<br />
genetic factors and/or disturbances of neuronal migration.<br />
It is the intention of the author to consider the hemiparetic<br />
and hemiplegic forms, and their risks for development of<br />
partial epilepsy, the latter’s evolution and factors that can<br />
indicate refractoriness and consequent indications for<br />
surgery. The study is prospective and includes 11 patients<br />
between 8 months and 14 years of age with static unilateral<br />
neurological deficits, all without previous treatment, who<br />
were taken care of between 1 and 14 days after the first<br />
seizure. The group was divided in an arbitrary way,<br />
randomly. The majority were not treated with AED and<br />
the subsequent risk for recurrence was greater than in the<br />
group treated immediately after the first seizure. The cumulative<br />
risk according to delay in the start of treatment was:<br />
60% had repetition of seizures within 36 months. The treated<br />
population was statistically significantly different for the<br />
recurrence risk, after setting down parameters such as 1 and<br />
2 months free of seizures. Of the patients who received<br />
immediate treatment, 85% had a year free of attacks and<br />
67% had repeated seizures 2 years later. Of the group with<br />
delayed treatment, (percentage in which seizures are<br />
increased based on the duration from 18 to the beginning<br />
of therapy) those 46% free of attacks are divided equally<br />
between the 1st year, and 33% both 1os. years. Only 25% of<br />
the first group of patients had almost complete or complete<br />
remission of the attacks. That number rose to 56% in the<br />
patients treated initially. The rest had little or no response to<br />
drugs, with increases, additions or changes of these, and<br />
continued to have partial seizures, thus presenting themselves<br />
as candidates for the surgery. In hemiparetic or hemiplegic<br />
C.P., therapy with anticonvulsant drugs is<br />
recommended prior to the appearance of seizures.<br />
FP-H-094<br />
Lamotrigine vs levetiracetam in treatment of JME,<br />
newly diagnoses epilepsy<br />
M. Carignani<br />
Neurology Institute, Universidad Nacional de Rosario,<br />
Rosario, Argentina<br />
We tried 19 patients with lamotrigine (200–400 mg/day),<br />
who had a diagnosis of JME, versus another group of 16<br />
patients with same pathology on levetiracetam monotherapy<br />
(1000–2000 mg/day). It is well known that levetiracetam’s<br />
mechanism of action is still unclear, apart from the anticonvulsant<br />
effect on rats treated with PTZ or electroshock<br />
seizures. Adverse effects were most frequently dizziness,<br />
often headaches, asthenia and somnolence; also renal and<br />
hepatic functions must be carefully checked. Some cases<br />
had increases in, or developed myoclonus, with eventual<br />
aggravation of seizures. Lamotrigine is a relatively new<br />
AED, with a structure and a pharmacological profile similar<br />
to that phenytoin and carbamazepine. As a triazine derivative,<br />
it is effective in partial and generalized seizures. The<br />
best-studied mechanism of action of lamotrigine is its inhibitory<br />
effects on voltage-sensitive sodium and calcium<br />
channels, which occur in use and time dependent manners.<br />
The most dangerous effect of the drug is a skin reaction<br />
which can be of variable severity, sometimes with associated<br />
multiorgan failure and death; it can be avoided with<br />
very slow titration, reduction of drug dosage when the rash<br />
appears, followed by further slower increases, or withdrawal.<br />
The groups were between 12 and 19 years old. Both<br />
had normal MRI studies, typical clinical profiles of JME,<br />
and normal evaluated results with interictal HMPAO-<br />
SPECT, interictal EEG and factor analysis of creatine or<br />
creatinine ratios. We also checked the statistical analysis<br />
with the Epilepsy Outcome Scale (EOS). We analyzed<br />
thalamic volume, finding reduced concentration of NAA<br />
in the prefrontal cortex, and low values in the hypothalamus.<br />
We found better results in clinical trials with LTG in terms<br />
of reduced myoclonus in the mornings, abolished GCT<br />
seizure rates, less sleep and psychiatric disorders and better<br />
cognitive, and behavioral performances. We also found
522<br />
Abstracts<br />
better mental condition with this drug. Also migraine,<br />
frequently co-morbid with JME, improved in patients treated<br />
with LTG. Pregnant patients had safe outcomes with<br />
both AEDs. Assays with spectroscopy images and neuropsychological<br />
tests showed improvement: the tests after treatment<br />
started were slightly better with lamotrigine.<br />
Monitoring of drug therapeutic and toxicokinetic effects<br />
on larger number of patients is needed to establish more<br />
reliable conclusions. Meanwhile, there is a lack of wider<br />
statistical data.<br />
FP-H-095<br />
Pyridoxal phosphate should replace pyridoxine for<br />
intractable childhood epilepsy<br />
H.-S. Wang a , S.-C. Huang a , M.-F. Kuo b<br />
a Division of Pediatric Neurology, Chang Gung Children’s<br />
Hospital, and Medical College of Chang Gung <strong>University</strong>,<br />
Taoyuan; b Division of (Pediatric) Neurosurgey, Department<br />
of Surgery, National Taiwan <strong>University</strong> Hospital,<br />
Taipei, Chinese Taipei<br />
We have reported a child whose intractable seizures were<br />
controlled with pyridoxal phosphate (PLP), the active form<br />
of pyridoxine, instead of pyridoxine per se. This study is to<br />
compare the efficacy of PLP with pyridoxine in the treatment<br />
of children with intractable epilepsy. Ninety-four children,<br />
aged from 2 months to 15 years, with idiopathic<br />
intractable epilepsy for more than 6 months were enrolled<br />
in the study. Under EEG monitoring, in addition to the<br />
previous antiepileptic medicine, intravenous PLP of 10<br />
mg/Kg was infused first, then 40 mg/Kg of PLP was<br />
added if there was no significant improvement. For those<br />
patients whose seizures could be controlled by PLP infusion,<br />
PLP was then replaced by oral pyridoxine at the same<br />
dose. If a seizure recurred, parenteral PLP was infused again<br />
to stop it and subsequently oral PLP 50 mg/kg per day was<br />
used. If no seizure recurred in a week, the previous antiepileptic<br />
regimen was gradually tapered. Eleven of the 94<br />
(12%) pediatric patients with idiopathic intractable epilepsy<br />
responded to PLP dramatically. Five of the 11 patients were<br />
free of their previous antiepileptic medicine within 6<br />
months of the treatment and were followed for an average<br />
period of 11 months. Three of them were controlled with<br />
PLP and the remaining two were treated with pyridoxine.<br />
The other six patients responsive to PLP therapy still need<br />
one to three kinds of antiepileptics to control their seizures.<br />
Three of them were treated with PLP and the other three<br />
with pyridoxine. In these 11 patients responsive to the initial<br />
PLP therapy, six of them failed to be treated with pyridoxine<br />
and needed PLP for seizure control. The results show that<br />
PLP is effective in 12% of patients with idiopathic intractable<br />
epilepsy. PLP can replace pyridoxine satisfactorily, but<br />
not vice versa. The value of vitamin B 6 in the treatment of<br />
epilepsy is well known. In this study, it is demonstrated that<br />
the responsive rate to PLP is higher than pyridoxine (12<br />
versus 5%). It seemed that infantile spasms were more<br />
affected by vitamin B 6 than other epilepsy types. The<br />
authors suggest that intravenous infusion of PLP, instead<br />
of pyridoxine, should be tried first when patients with<br />
intractable seizures, especially children with seizure onset<br />
under the age of 15 months, come for treatment. For the<br />
patients who fail to respond to pyridoxine treatment, PLP<br />
should not be abandoned.<br />
FP-H-096<br />
Febrile seizures in a referral hospital<br />
A. Charuvanij, N. Hoonsawad<br />
Department of Pediatrics, Bhumibol Adulyadej Hospital,<br />
Bangkok, Thailand<br />
A prospective study of 149 first episode febrile seizure<br />
patients admitted to the pediatric wards of Bhumibol<br />
Adulyadej hospital between March 1997 and February<br />
1998 was performed to determine the epidemiology and<br />
seizure recurrences. The male to female ratio was 1.22:1.<br />
The mean age was 17.15 months. The average body<br />
temperature when first seen was 39.158C. The mean duration<br />
of fever before arrival at the hospital was 20.45 h. The<br />
cause of fever was mostly upper respiratory tract infection<br />
(71.8%). Fourteen percent and 0.7% of the patients had<br />
histories of febrile seizures and epilepsy, respectively, in<br />
first-degree relatives. Ninety one percent had simple febrile<br />
seizures. The average income of the parents was 8004.61<br />
bath per month. Eighty five percent of the patients were<br />
followed up periodically up to at least 6 months. Seizures<br />
recurred in 15 patients (11.81%) and most (14/15) had the<br />
episodes within 6 months after the first attack. A positive<br />
family history of febrile seizures was the only risk factor<br />
which gave significant differences (P ¼ 0:006).<br />
FP-H-097<br />
Electrical status epilepticus during sleep (ESES): clinical<br />
follow-up and EEG changes during the course of<br />
treatment in 14 cases<br />
M. Topcu, D. Yalnizoglu, G. Turanli, A. Degerliyurt, D.<br />
Genc-Acikgoz, E. Erdogan<br />
Hacettepe <strong>University</strong> Children’s Hospital, Ankara, Turkey<br />
ESES consists of sleep-induced paroxysmal EEG activity,<br />
lasting for months or years, which may appear continuously<br />
or discontinuously during sleep and is usually diffused<br />
bilaterally. The epilepsy is relatively easily controlled.<br />
However the prognosis is complicated by cognitive and<br />
behavioral issues. Fourteen patients, aged between 7 and<br />
18 years of age, were studied. The male/female ratio was<br />
10/4. Age of onset of epilepsy ranged between 11 months<br />
and 14 years. Age of onset of ESES ranged between 3 and<br />
15 years; duration of ESES ranged between 2 months and 7<br />
years. MRI was abnormal in six of 14 patients. All patients
Abstracts 523<br />
showed attention and behaviour problems, one had autistic<br />
features. Three patients had mental retardation, two reported<br />
low school performance. Conventional AEDs including<br />
CBZ, valproate, ethosuximide, clonazepam, phenytoin,<br />
phenobarbital, primidone were tried in different combinations.<br />
Pridoxine was tried in two patients and ACTH in one.<br />
New generation AEDs vigabatrin, lamotrigine, oxcarbazepine,<br />
clobazam and topiramate, were used as add-on medications<br />
in nine patients. EEG showed focal discharges<br />
which were concentrated over the frontal, occipital or<br />
centrotemporal regions in 8/14 patients; 6/8 were on topiramate<br />
or clobazam or both. Behavioral and cognitive<br />
problems improved along with the improvement of the<br />
EEG. New generation AEDs could be promising options<br />
in the treatment of ESES, sparing the patients from the<br />
side effects of steroids. Focal features in EEG might be<br />
transitory findings during the normalization of the EEG.<br />
Topiramate and clobazam may help decrease the duration<br />
of ESES. Therefore further studies are required to determine<br />
the effects of new AEDs in ESES.<br />
FP-H-098<br />
Routine neuroimaging studies in children with complex<br />
febrile seizures<br />
S. Aysun, G. Haliloglu, D. Yalnizoglu<br />
Hacettepe Children’s Hospital, Department of Pediatric<br />
Neurology, Ankara, Turkey<br />
The relations between intractable temporal lobe epilepsy,<br />
a prolonged febrile seizure in childhood and mesial<br />
temporal sclerosis are well known, but do not necessitate<br />
a causal relationship. High-resolution magnetic resonance<br />
imaging provides opportunities to define underlying pathology.<br />
The aim of this study is to demonstrate neuroimaging<br />
findings in children with complex febrile seizures who are<br />
subgrouped according to age of seizure onset and frequency.<br />
Of the 65 children with routine cerebral imaging, we identified<br />
abnormal findings either related or unrelated to<br />
seizures in 40% (26/65), mesial temporal sclerosis being<br />
the most common underlying pathology 42.3% (11/26).<br />
The likelihood of demonstrating an abnormal finding even<br />
with routine neuroimaging studies is 33.3% in patients with<br />
an onset of febrile seizures at more than 6 years of age. We<br />
conclude that children with a febrile seizure onset and recurrence<br />
of seizures after 6 years of age, either as febrile or a<br />
febrile seizures, should be evaluated with magnetic resonance<br />
imaging, even by the care-giving pediatrician.<br />
FP-H-099<br />
Favorable seizure outcome in Kabuki make-up<br />
syndrome associated with epilepsy<br />
A. Ogawa a , S. Yasumoto a , Y. Tomoda a , M. Ohfu a ,A.<br />
Mitsudome a , Y. Kuroki b<br />
a Department of Pediatrics, School of Medicine, Fukuoka<br />
<strong>University</strong>, Fukuoka; b Division of Medical Genetics, Kanagawa<br />
Children’s Medical Center, Yokohama, Kanagawa,<br />
Japan<br />
Purpose: Kabuki make-up syndrome (KS), was first<br />
described in the same year independently by Niikawa et<br />
al. and Kuroki et al. In large previously reported series of<br />
patients with KS, the incidence of seizures was about 10–<br />
40%. However, the appearance of seizures has not been<br />
adequately reported or thoroughly evaluated for this<br />
syndrome. In this study, we analyzed seizure characteristics<br />
and differences in nine patients with KS. Methods: Nine<br />
patients with KS associated with epilepsy were identified<br />
among the patients followed at Fukuoka <strong>University</strong> Hospital<br />
and Kanagawa Children’s Medical Center. The diagnosis of<br />
KS was based on the presence of characteristic findings.<br />
Results: Of the nine patients, five were male and four<br />
were female. Patient ages at the time seizures started ranged<br />
from 7 months to 12 years with a mean of 6 years. Four<br />
patients have generalized seizures and two patients have<br />
complex partial, with secondary generalization. West<br />
syndrome, complex partial seizures and atonic seizures<br />
were seen in one case each, respectively. Electroencephalogram<br />
showed focal spikes in seven cases, frontal dominant<br />
diffuse spike and wave bursts in one and hypsarrhythmia in<br />
one. Seizures were well controlled in eight cases, and<br />
incompletely controlled in only one case. Conclusions: KS<br />
is a mental retardation-malformation syndrome affecting<br />
multiple organ systems, with a broad spectrum of neuromuscular<br />
dysfunction and mental ability. Epilepsy, together<br />
with mental retardation, may be a primary feature of KS.<br />
KS associated with epilepsy is a mainly localization-related<br />
epilepsy with a favorable seizure outcome.<br />
FP-H-100<br />
Severe myoclonic epilepsy of infancy: A drug regimen<br />
for ‘optimal’ treatment?<br />
B. Ceulemans a,b , M. Boel a,b,c , L. Dom d , H. Willekens e ,P.<br />
Thiry f , L. Lagae a,b,c<br />
a Epilepsy Center for Children and Youth, Pulderbos;<br />
b Department of Neurology, <strong>University</strong> Hospital Antwerp,<br />
Edegem;<br />
c Department of Child Neurology, <strong>University</strong><br />
Hospital Gasthuisberg, Leuven; d K. Paola Childrens Hospital,<br />
Antwerp; e A.Z. St.-Lucas, Gent; f St.-Oda Institute, Overpelt,<br />
Belgium<br />
It is well accepted that SMEI or Dravet-syndrome (International<br />
League Against Epilepsy 2001) is a very therapyresistant<br />
epileptic encephalopathy. It is only recently that<br />
the etiological genetic defect, a severe damage of the alfasubunit<br />
of the sodium channel SCN1 of the brain, has been<br />
defined. This gives a new view in the treatment of these<br />
patients. In eleven Belgian patients with SMEI, where the<br />
genetic mutations are known, a strategy for treatment is<br />
proposed. It is clear that anti-epileptic drugs working mainly
524<br />
Abstracts<br />
by blocking sodium channels are not effective in SMEI.<br />
They may even worsen attacks which are mainly myoclonic.<br />
This is certainly the case for carbamazepine, phenylhydantoin<br />
and probably also lamotrigine. Broad-spectrum antiepileptic<br />
drugs such as sodium valproate and topiramate<br />
are more effective. Benzodiazepines are the drugs of choice<br />
for acute seizure treatment. Stiripentol, an inhibitor of cytochrome<br />
P450, is not available in Belgium. An anti-epileptic<br />
drug regimen, mainly based on a combination of broad<br />
spectrum AED’s, and a fairly aggressive seizure-treatment<br />
will be presented. We believe that this regimen is preferable<br />
to a complicated multiple AED regime.<br />
FP-H-101<br />
Interleukin-1 beta and interleukine-1 receptor<br />
antagonist gene polymorphisms in patients with febrile<br />
seizure<br />
Ş. Haspolat, Y. Baysal, M. Coşkun, O. Yeǧin<br />
Akdeniz <strong>University</strong> Medical School, Department of Pediatric<br />
Neurology, Antalya, Turkey<br />
Febrile seizures are the most common type of seizure in<br />
children. There is a strong genetic heterogeneity for febrile<br />
seizures. IL-1b is a major pro-inflammatory cytokine that<br />
plays role in inflammatory responses and fever. The interleukine-1<br />
receptor antagonist (IL-1Ra) is a naturally occurring<br />
anti-inflammatory cytokine which competitively binds<br />
to interleukine-1 receptors, thus modulating the potentially<br />
injurious effects of IL-1. We studied the biallelic polymorphisms<br />
at position 2511 and 13953 of the IL-1b<br />
gene and pentaallelic polymorphism of IL-1Ra genes in<br />
73 patients with febrile seizure (36 simple, 37 complex<br />
febrile seizures) and in 154 controls. The distribution of<br />
the biallelic polymorphism at position 2511 of the IL-1b<br />
gene was significantly different in patients with febrile<br />
seizures (P , 0:05). Allele frequencies for IL-1b 13953<br />
polymorphism were not different in patients and the control<br />
group. IL-1Ra polymorphisms were found to be significantly<br />
different when the patient group was evaluated<br />
together (73 patients). But when the groups were classified<br />
as simple and complex febrile seizure groups no significant<br />
difference was present for IL-1Ra polymorphisms. We also<br />
looked for a relation between family history of febrile<br />
seizures, family history of epilepsy or gender and the polymorphisms.<br />
No relationship could be found. Our data<br />
suggest that, the biallelic polymorphism at position 2511<br />
of the IL-1b gene may play a role in the pathogenesis of<br />
febrile seizures.<br />
FP-H-102<br />
Favourable outcome of epileptic blindness in children<br />
E. Shahar, S. Barak, D. Savitzki, J. Andraus<br />
Child Neurology Unit and Epilepsy Service, Rambam Medical<br />
Center, Rappaport School of Medicine, Haifa, Israel<br />
Blindness is a rare phenomenon of epileptic seizures.<br />
We report on thirteen children with epileptic amaurosis,<br />
investigating the ictal manifestations, EEG findings,<br />
analyzing the response to therapy and elucidating the<br />
outcome in relation to termination of blindness and<br />
seizures. Most experienced single or recurrent episodes<br />
of acute visual obscuration, lasting for 1–30 min, mainly<br />
manifesting in the ictal phase and only a few in the preictal<br />
phase. Seven patients had accompanying generalized<br />
seizures, which could be induced by photic stimulation in<br />
three children. CT of brain performed in five children was<br />
unremarkable. All children in this group, treated with<br />
valproic acid, regained full constant vision and became<br />
seizure free within a period of up to 5 years. Three children<br />
who had the constellation of ictal amaurosis, occipital<br />
EEG paroxysms and migrainous headaches, compatible<br />
with the syndrome of occipital lobe epilepsy, also became<br />
asymptomatic on therapy: two on valproate and one on<br />
carbamazepine. Three children with epileptic blindness<br />
also had either focal motor seizures and/or unilateral<br />
EEG epileptic discharges, with a normal CT. On carbamazepine<br />
therapy they regained full vision and the seizures<br />
abated. Our data suggest a relatively benign course and a<br />
favorable outcome for children with epileptic blindness<br />
and associated seizures. They regain full constant vision<br />
in association with control of seizures and preservation of<br />
cognition.<br />
FP-H-103<br />
Cortical developmental malformations and epilepsy:<br />
review of 62 pediatric patients<br />
R.M. Valério, F.N. Arita, S. Rosemberg<br />
Santa Casa of São Paulo Medical School, São Paulo, Brazil<br />
We studied a series of 62 children with cortical developmental<br />
malformations (CDM) in order to determine the<br />
incidence of the different types, the clinical presentation<br />
and the occurrence of epilepsy in each group. The 62<br />
patients (32 males, 30 females) were divided into different<br />
groups according to the MRI results: 34 (18 males, one<br />
females) had polymicrogyria and/or schizencephaly<br />
(PMG/SCH) (ten bilateral opercular PMG; nine focal<br />
PMG; nine bilateral and six unilateral SCH); ten (seven<br />
males, three females) lissencephaly/pachygyria complex<br />
(LIS); one (female) type II lissencephaly; one (female)<br />
double-cortex; four focal cortical dysplasia of Taylor<br />
(FCDT) (one males, three females); two HMG (2m);<br />
seven nodular heterotopia (NH) (two males, five females)<br />
and three, complex unclassified CDM. Twenty-four<br />
patients (38.7%) did not report epilepsy on the first consultation<br />
or during the follow-up (14 PMG/SCH), six LIS, two<br />
NH and two, complex unclassified CDM). Among the<br />
remaining 38 epileptic patients, the seizures were<br />
controlled with AEDs in 15 (39.4%). All patients with<br />
abnormal cortical proliferation and differentiation disorders
Abstracts 525<br />
(FCDT and HMG), 9 with PMG/SCH (26.5%), five with<br />
LIS/type II LIS (45.4%) and two with NH (28.6%) had<br />
intractable epilepsy. Almost all patients had been referred<br />
for psycho-motor developmental delay or abnormal motor<br />
signs. We conclude from our unselected CDM series that<br />
the occurrence of epilepsy is far from being mandatory and<br />
when present it may be clinically controlled. These data<br />
differ from most reported series of CDM in which the<br />
incidence and severity of epilepsy are more prominent<br />
probably because in these series the patients are referred<br />
to pre-surgical evaluation for intractable epilepsy.<br />
FP-H-104<br />
The study of toleration to achieving the target dose<br />
rapidly in infants with epilepsy treated by Topamax<br />
X.-L. Xie, Y.-Q. Zhong, J. Wu, M. Wu, W.-G. Hu<br />
Chengdu Children Hospital, Chengdu, China<br />
Objective: To explore an appropriate dosage and a speed<br />
of increasing dosage of Topamax through observation of<br />
tolerability in infants, and to increase therapeutic effects<br />
and decrease side effects. Methods: We studied 23 infants<br />
with epilepsy from our hospital in 2001. We increased the<br />
Topamax to the target dosage rapidly at 2 or 3 weeks<br />
intervals, by increasing 0.5 mg/kg per day once every 3<br />
days. The average target dosage was 6.2 mg/kg per day.<br />
Therapeutic evaluation was: excellent, if seizure-free;<br />
better, if the frequencies decreased $75%; good, if<br />
$50%; and, bad or ineffective if ,50%. Results: Therapeutic<br />
effects were excellent in 11 of 23 cases (47.8%);<br />
better in seven (30.4%); and, good in five (21.7%). No case<br />
was defined as ineffective or deteriorated. Conclusion: The<br />
therapeutic effects and side effects of Topamax had individual<br />
differences, so methods of giving the drug are important.<br />
Side effects occurred less frequently in infants than<br />
that in other children over 1 year old. It was reasonable to<br />
reach the target dosage of Topamax rapidly in infants with<br />
epilepsy.<br />
FP-H-105<br />
Comparison of partial and generalised childhood<br />
epilepsies using principal and independent component<br />
analysis<br />
C.P. Unsworth a , J.J. Spowart b , G. Lawson b , J.K. Brown b ,B.<br />
Mulgrew a , R.A. Minns b , M. Clark b<br />
a Department of Electronics and Electrical Engineering;<br />
b Department of Child Life and Health, <strong>University</strong> of Edinburgh,<br />
Edinburgh, Scotland, UK<br />
A typical EEG consists of roughly 20 electrical recordings<br />
which are received from electrodes located at different<br />
regions of the scalp. Each recording represents a<br />
mixture of signals from a variety of brain activities.<br />
Depending upon a patient’s activity such signals can<br />
become very complicated to interpret. This is true in the<br />
case of epilepsy. Independent component analysis (ICA) is<br />
a signal-processing tool that can take data from a multichannel<br />
system, as in the EEG, and statistically de-mix the<br />
real signals from their mixtures. As long as the number of<br />
electrodes is larger than the number of real signals that<br />
exist, ICA is valid. Recently ICA has claimed to be able to<br />
de-mix the real epileptic signal components from the<br />
mixtures of an EEG. This seems quite promising as the<br />
EEG has a large number of channels and the signals<br />
detected during an epileptic attack appear relatively simple<br />
and to have few generating sources. In this paper we<br />
examine a variety of partial and generalised epilepsies,<br />
some of which are evoked and others un-evoked, which<br />
occur in children. By examining the correlation between<br />
the principal components of the epilepsies presented here,<br />
it is possible to compare and contrast the different forms of<br />
epilepsy, thus, gaining an insight into nature of the epilepsies<br />
and their connection to each other. In addition, from<br />
this analysis is possible to draw conclusions on the applicability<br />
of ICA to the EEG for the different forms of<br />
epilepsy.<br />
FP-H-106<br />
A study of supporting school life of children with<br />
epilepsy<br />
H. Nagao a , Y. Suzuki b , T. Morimoto b<br />
a Department of Pathophysiology, Faculty of Education,<br />
b Department of Pediatrics, Faculty of Medicine, Ehime<br />
<strong>University</strong>, Ehime, Japan<br />
In order that children with epilepsy can lead safe and<br />
active lives, and also be encouraged to pursue full school<br />
activities, an activity-based school safety map was made.<br />
Subjects were 27 students who had experienced seizures<br />
within the past 2 years, selected from 51 children with the<br />
diagnosis of epilepsy, in a school for mental disabilities<br />
(with a total population of 236). This activity based school<br />
safety map was planned by the school teachers and the<br />
author. The results showed that the students were divided,<br />
according to the guidance of daily life in children with<br />
epilepsy proposed by author, group A: four, group B:<br />
seven, group C: 11, and group D: five. The degree of aid<br />
required in daily activities was categorized into: (1) hand in<br />
hand; (2) within reach of hand; (3) within reach of<br />
eyesight; and (4) no supervision necessary. The school<br />
environment was categorized into five groups according<br />
to the risk and supervision necessary, as follows: (a) swimming<br />
pool; (b) stairs and edge of stage; (c) corridors; (d)<br />
training classroom; and (e) ordinary classroom. This study<br />
proved that making an activity based school safety map for<br />
individuals with epilepsy according to individual needs,<br />
enabled the children to pursue full school activities as<br />
much as possible.
526<br />
Abstracts<br />
FP-H-107<br />
Language disorders and epilepsy<br />
A. Al-Qudah<br />
Division of Pediatric Neurology, Jordan <strong>University</strong> Hospital,<br />
Amman Jordan<br />
Background: A number of language disorders have been<br />
associated with epilepsy or EEG epileptiform abnormalities.<br />
These include Landau-Kleffner syndrome (LKS), electrical<br />
status epilepticus of sleep, developmental dysphasia and<br />
possibly autism. LKS patients have been treated with antiepileptic<br />
drugs and steroids without apparent success. LKS<br />
aphasic patients have been recently treated with immunoglobulins<br />
with good results. This study reports relatively<br />
successful results after treatment of LKS patients with immunoglobulins.<br />
Patients and methods: Four patients with LKS<br />
have been included in the study since November 1999. They<br />
were all males with age range of 5.5–14 years (Mean ¼ 9.5).<br />
Patients were scheduled to receive five consecutive doses of<br />
immunoglobulins over 5 days and one dose every month for 6<br />
months. MRI was done on all patients. Results: Age of onset<br />
of seizures was 3.5, 5.3, 7.5, and 1.5 years and of aphasia was<br />
3.5, 5.9, 8, and 2 years, respectively. Duration of aphasia was<br />
7, 1, 0.8 and 4 years and follow-up was 2 years, 2 months, 5<br />
months and 1 month, respectively. Onset of response to<br />
immunoglobulins was at day 7, 5, 9 and 7, respectively, for<br />
the four patients. Patients 2 and 3 had complete recovery of<br />
their language. Conclusion: This study has added further<br />
support to the little literature on the beneficial value of immunoglobulins<br />
in aphasic LKS patients.<br />
FP-H-108<br />
Diagnosis, types, management of convulsion disease of<br />
the children<br />
R. Sutar<br />
Bhubaneswar Municpal Corporation Hospital, Bhubaneswar,<br />
India<br />
Convulsive disease of children is the most difficult,<br />
complicated disease because of its causes, different types,<br />
diagnosis and treatment which are not yet clear and definite<br />
like all types of diseases seen in the world. Convulsive<br />
disease is the result of deranged brain cells due to direct<br />
disease of the brain cells or effects of other diseases of the<br />
body affecting the brain cells. As in other diseases of people,<br />
advanced modern miracle treatment, such as treatment by<br />
new exchange of organs etc., an alternative process, can<br />
give better life in chronic disease, as seen in other diseases.<br />
But such a clear cut, easy and definite modern facility for cure<br />
of convulsive disease of children is not yet given, by any<br />
modern medical scientist of the world, as a scientific topic<br />
in publication. The parents are still in a dilemma as to<br />
whether they will get hope of a positive permanent cure of<br />
convulsions, as seen with other diseases of people. These<br />
problems are seen more in developing and poor countries<br />
which have no advanced facility for this disease, and, as a<br />
result, people are forced to believe in the old unscientific<br />
processes of treatment. So a universal, reasonably acceptable,<br />
amicable process of diagnosis, facilities, treatment and<br />
education for the people in relation to the diseases should be<br />
given to all concerned in the world, irrespective of city or<br />
remote, inaccessible area, considering the standard living of<br />
the people and facilities available therein. The modern good<br />
effect of the treatment as seen in other diseases of the world,<br />
will be shown to the people in cases of convulsive disease for<br />
their belief and acceptance; and, guidelines of education will<br />
be given to the people for the prevention of the so called<br />
incurable convulsive disease of children. This topic has<br />
been presented in television for discussion and newspaper<br />
for popular science.<br />
FP-H-109<br />
Clinical and EEG study of seven patients with chronic<br />
progressive epilepsia partialis continua of childhood<br />
A. Muto, H. Oguni, K. Imai, Y. Maeda, M. Funatsuka, M.<br />
Osawa<br />
Department of Pediatrics, Tokyo Women’s Medical <strong>University</strong>,<br />
Tokyo, Japan<br />
Chronic progressive epilepsia partialis continua (EPC) of<br />
childhood is characterized by intractable partial epilepsy<br />
and slowly progressive neurological deficits affecting one<br />
side of the body. Most of the patients with this syndrome<br />
have been regarded as Rasmussen syndrome (RS), because<br />
chronic localized encephalitis has been shown to be<br />
responsible for this epilepsy. We studied the clinical,<br />
neuroimaging and EEG findings of patients with chronic<br />
progressive EPC to reveal it’s long-term evolution.<br />
Subjects: The subjects fulfilling the clinico-electrical<br />
features of chronic progressive EPC were seven patients<br />
including two with pathologically confirmed RS. Methods:<br />
We retrospectively studied their medical records, EEG files<br />
and neuroimaging findings. Results: Two patients had uveitis<br />
and one had impetigo before epilepsy onset. The median<br />
age at onset of epilepsy was 6 years and 3 months. The<br />
period between the onset of epilepsy and that of daily<br />
seizures ranged from 1 month to 9 years. Four children<br />
ran a rapidly progressive clinical course and eventually<br />
developed hemiplegia, while the remaining three had a<br />
slower clinical course and two eventually developed mild<br />
hemiparesis. MRI showed progressive atrophy of one<br />
hemisphere in all cases. As for treatment, five patients<br />
received steroid pulse therapy without significant benefits.<br />
Three cases underwent epilepsy surgery. One child died of<br />
pneumonia. Conclusion: This study suggested the presence<br />
of two subtypes in patients with chronic progressive EPC<br />
or RS, one of which has an early epilepsy onset and rapidly<br />
progressive clinical course, while the other has a later<br />
epilepsy onset and more slowly progressive course.
Abstracts 527<br />
FP-H-110<br />
Lamotrigine pharmacokinetics in children<br />
M.I. Arranz a , M. Manero a , M. Aparicio b , Lorenzo b ,E.<br />
Saenz c , B. Tirapu a , R.J. Del a , J. Mercader a , E. Ripoll a<br />
a Bioquímica, b Pediatría, c Hospital Ramón y Cajal, Neurología,<br />
Hospital Gregorio Marañó, Madrid, Spain<br />
Lamotrigine (LTG) is a new AED approved as adjunctive<br />
therapy or monotherapy. LTG is effective against seizures:<br />
partial, primarily generalized tonic-clonic, absences, and<br />
drop attacks associated with the Lennox-Gastaut syndrome.<br />
Its metabolism is affected by co-medicated AEDs. TDM in<br />
children is useful because of age-related differences in<br />
metabolism. We present LTG pharmacokinetic behavior<br />
in children. Methods: We reviewed LTG data from May<br />
2000 to February 2002. Concentrations were determined<br />
by HPLC. Results: From 137 LTG levels, 58 in patients<br />
on monotherapy; and, in association with: VPA (n ¼ 15);<br />
clobazam (CLB) (n ¼ 15), carbamazepine (CBZ) (n ¼ 10),<br />
ethosuximide (ETX) (n ¼ 4), phenobarbital (PB) (n ¼ 1)<br />
and topiramate (TOP) (n ¼ 1); with: VPA 1 CLB (n ¼ 8),<br />
VPA 1 ETX (n ¼ 6), VPA 1 CBZ (n ¼ 3), VPA 1 TOP<br />
(n ¼ 3), ETX 1 CLB (n ¼ 4), PB 1 primidone (PRIM)<br />
(n ¼ 2), CBZ 1 CLB and CBZ 1 TOP (n ¼ 1); to: PB 1<br />
ETX 1 PRIM (n ¼ 2) and VPA 1 CBZ 1 TOP (n ¼ 1),<br />
and with: VPA 1 PB 1 CLB 1 PRIM (n ¼ 1). Mean LTG<br />
levels (mg/l) were lower on monotherapy (2.5 1 1) than<br />
with VPA alone (3.2 1 1.8), or, plus other AEDs<br />
(3.7 1 1.3) except CBZ, and lower when AEDs other than<br />
VPA were added (1.9 1 0.8). Highest LTG values were<br />
found with: VPA 1 TOP (4.9 1 0.8), VPA 1 CLB<br />
(3.9 1 1.4), VPA (3.2 1 1.8), and VPA 1 ETX<br />
(2.8 1 1.3). Lamotrigine mean doses ranged from 130 to<br />
275 mg/24 h. Conclusions: Lamotrigine efficiency increases<br />
with VPA alone or with others, except CBZ; and is underused<br />
with AEDs other than VPA.<br />
FP-H-111<br />
Topiramate as monotherapy in childhood and<br />
adolescent epilepsy<br />
M. Verdecchia, P. Parisi, M. Montanaro, C. Arpino, P.<br />
Curatolo<br />
Department of Pediatric Neurology, Tor Vergata <strong>University</strong><br />
of Rome, Rome, Italy<br />
TPM has proved to be effective as add-on therapy in children<br />
with partial onset seizures. This study was carried out to<br />
evaluate the effectiveness of TPM as monotherapy in epileptic<br />
children and adolescents with no or limited exposure to<br />
other antiepileptic drugs. Twelve patients aged 3–17 years<br />
with partial or generalised epilepsies were treated with topiramate<br />
for a median period of 10 months (range 6–20 months).<br />
Of the 12 patients enrolled, six were children with newly<br />
diagnosed epilepsy. Five patients had idiopathic tonic-clonic<br />
generalised epilepsies, three had benign rolandic epilepsies<br />
and four had symptomatic partial epilepsies. The starting<br />
dose was 0.5–1.0 mg/Kg per day. TPM was increased slowly<br />
at a mean rate of 25 mg/week up to clinical response or to a<br />
maximum of 2–4 mg/Kg per day. The concomitant AED, if<br />
present, was discontinued as TPM was titrated to target<br />
dosages. Eight patients were seizure-free and two had 50%<br />
or greater reduction in seizure frequency; two patients with<br />
rolandic benign epilepsies discontinued because of inadequate<br />
seizure control. Efficacy was seen against simple and<br />
complex partial seizures and generalised tonic-clonic<br />
seizures. The most common adverse effects were anorexia<br />
and weight loss recorded in three cases; only one patient<br />
experienced paresthesiae. Side effects were mild and transitory,<br />
usually occurring during the first 3 weeks of treatment.<br />
Our experience suggests that TPM is safe and efficacious as<br />
monotherapy in a wide spectrum of childhood epilepsies.<br />
The incidence of adverse events was lower than reported<br />
with TPM polytherapy, suggesting that some side effects<br />
observed with TPM as add-on therapy may result from pharmacodynamic<br />
interactions with other AEDs.<br />
FP-H-112<br />
Liposteroid therapy for refractory seizures in West<br />
syndrome<br />
S. Tanaka, A. Araki, Y. Kobayashi<br />
Department of Pediatrics, Kansai Medical <strong>University</strong>,<br />
Osaka Japan<br />
It was reported recently that liposteroid (LS) was effective<br />
for the treatment of West syndrome (WS), with fewer<br />
side effects than those of ACTH. We report a patient with<br />
WS who was successfully treated with LS after ACTH therapy<br />
was ineffective. A female infant was born at term after<br />
an uneventful pregnancy and delivery. Tonic spasms developed<br />
at 2 months of age. An EEG showed hypsarrythmia,<br />
and she was diagnosed as having WS. Magnetic resonance<br />
imaging of the brain disclosed no abnormality. Vitamin B6<br />
and zonisamide were started without any effect. ACTH therapy<br />
was commenced at 3 months of age (0.01 mg/kg for 2<br />
weeks). The number of seizures decreased, but tonic spasms<br />
were not controlled completely. Intravenous administrations<br />
of gamma-globulin were also not effective. Liposteroid therapy<br />
was begun at 4 months of age. In line with the original<br />
method reported by Yamamoto et al., LS (0.25 mg/kg) was<br />
given intravenously once a week for the first 4 weeks, once<br />
every 2 weeks for the next month, and once a month for the<br />
3rd month. Three weeks after the initiation of LS therapy,<br />
the seizure frequency remarkably decreased. A follow-up<br />
EEG showed the disappearance of hypsarrythmia, but<br />
diffuse polyspikes remained. She had no adverse effects.<br />
The patient is now 1 year old and free from convulsions.<br />
Our experience of this case suggests that LS therapy might<br />
be a new option for the treatment of refractory seizures in<br />
WS.
528<br />
Abstracts<br />
FP-H-113<br />
A clinico-electroencephalographic study of children<br />
suffering from febrile seizures plus<br />
K. Kobayashi a , Y. Ohtsuka a , Y. Nishio b , M. Fujiwara b ,I.<br />
Ohmori a , T. Akiyama a , T. Ogino a , H. Yoshinaga a ,N.<br />
Murakami a , K. Nakano a , Y. Watanabe a , T. Nakahori a ,E.<br />
Oka a<br />
a Department of Child Neurology, Okayama <strong>University</strong><br />
Medical School, Okayama; b Department of Pediatrics, JA<br />
Fuchu General Hospital, Hiroshima, Japan<br />
Purpose: FS 1 are attracting attention because of their<br />
related genetic abnormalities, and are defined as FS continuing<br />
beyond 6 years of age or those associated with afebrile<br />
seizures earlier than 7 years. However, general clinical<br />
pictures of children suffering from FS 1 have not yet been<br />
thoroughly clarified. We tried to elucidate their clinical and<br />
electroencephalographic characteristics as compared with<br />
those of children with only FS. Subjects and methods: By<br />
reviewing the clinical records of the pediatric neurology<br />
clinic in the JA Fuchu General Hospital, we found 27<br />
patients with FS 1 (Group FS 1 ) and 51 with only FS<br />
(Group FS), and studied their family history, clinical<br />
pictures and EEG findings. Results: Family histories of<br />
seizures were noted in ten patients (37.0%) of Group FS 1<br />
and in 23 (45.1%) of Group FS. In Group FS 1 , 14 patients<br />
(51.9%) had FS occurring beyond 6 years of age, 12 (44.4%)<br />
had afebrile seizures, and the remaining one (3.7%) had<br />
both types of seizures. Two also had seizures induced by<br />
TV/video-games, and another suffered from absences. The<br />
observed epileptic EEG abnormalities were diffuse and/or<br />
focal, and were noted in 11 patients (40.7%) of Group FS 1<br />
and 12 (23.5%) of Group FS. There were no statistically<br />
significant differences regarding the above findings within<br />
Group FS 1 or between the two groups. Conclusions: The<br />
clinico-electroencephalographic characteristics of the children<br />
with FS 1 were diverse, and their rate of positive family<br />
history was no higher than that of children with only FS.<br />
FP-H-114<br />
A case of a 15-year-old patient with intractable epilepsy<br />
who frequently showed gelasma after the introduction of<br />
clobazam<br />
T. Iwasaki, H. Miura, W. Sunaoshi, N. Hosoda, K. Takei, F.<br />
Katayama<br />
Department of Pediatrics, Kitasato <strong>University</strong> School of<br />
Medicine, Kanagawa, Japan<br />
This is a case of a 15-year-old boy patient who has severe<br />
mental retardation and spastic paraplegia due to fetal<br />
distress and hypoxic brain damage at the time of birth.<br />
The patient developed West syndrome at the age of 7<br />
months. He was diagnosed with undetermined epilepsy<br />
more recently. His intractable epilepsy had not been<br />
controlled well with the administration of nitrazepam and<br />
zonisamide for 5 years. We added clobazam (CLB) to this<br />
combination therapy. CLB was marketed 2 years ago in our<br />
country for the first time. After the introduction of CLB, his<br />
intractable tonic spasms disappeared. But so-called gelastic<br />
seizures appeared frequently before falling asleep. Sleep<br />
disturbance became troublesome subsequently. The gelastic<br />
seizures manifested as laughing with a stiff face and a wry<br />
mouth. As side effects of CLB, gelastic seizures have not<br />
been reported previously, although irritability or sleep<br />
disturbance have been recognized.<br />
FP-H-115<br />
The electro-clinical features of Landau-Kleffner<br />
syndrome<br />
K.Yu. Mukhin, A.S. Petrukhin, A.A. Kholin, L.Yu.<br />
Glukhova, N.V. Mikhalitchenko<br />
Paediatric Neurology Clinic of Russian State Medical<br />
<strong>University</strong>, Moscow, Russia<br />
Purpose: To summarise the seizure semiology, clinical<br />
and EEG findings in LKS. Methods: Clinical examination,<br />
EEG, sleep EEG, video-EEG monitoring, neuroimaging<br />
were recorded in the investigation of five patients with<br />
LKS. Results: We investigated four boys and one girl<br />
aged 6–10 years (medium – 7.8 years) affected by LKS.<br />
The epileptic seizures, presented in three children, began<br />
between 2.5 and 6 years of age (medium – 4 years) with<br />
atypical absences (two cases) and simple partial pharyngooral<br />
seizures (one case). Two of five patients had no<br />
seizures. We have observed the following types of seizures:<br />
atypical absences (all three patients with seizures) accompanied<br />
by atonic drop attacks – in one patient, simple partial<br />
with secondary generalization before awakening (two<br />
patients). All the children developed sensory and motor<br />
aphasia, and cognitive dysfunction with hyperactivity.<br />
Two presented autistic disorder with aggressive behaviour.<br />
The EEG investigation revealed fronto-temporal (three<br />
patients) or centro-temporal (two) sharp-slow wave and<br />
‘rolandic-like’ spike focuses right (one), left (one) unilateral<br />
and right (two), left (one) unilateral with diffuse sharp-slow<br />
wave patterns. Both regional and diffuse sharp-slow wave<br />
patterns increased in non-REM sleep. Secondary bilateral<br />
synchrony mechanism were evident in all cases: continuous<br />
diffuse spikes and waves during slow sleep but less than in<br />
ESES – two patients and ESES in three patients. MRI was<br />
normal in four cases. Antiepileptic drugs used in our group<br />
were valproic acid (Depakin), carbamazepine (Finlepsin),<br />
suxilep, lamotrigine, clobazam, and sulthiame. The seizures<br />
have a favourable outcome, but the aphasia is usually resistant<br />
to therapy. Conclusion: We think that the LKS is a form<br />
of partial epilepsy of cryptogenic origin with a large spectrum<br />
of clinical features. EEG findings often show secondary<br />
bilateral synchrony and continuous spikes and waves<br />
during slow sleep progressing to ESES.
Abstracts 529<br />
FP-H-116<br />
Health-related quality of life in children with epilepsy:<br />
development and validation of a self-report- and a<br />
parent proxy respondent measure<br />
G.M. Ronen, D.L. Steiner, P. Rosenbaum<br />
Canadian Pediatric Epilepsy Network, McMaster <strong>University</strong>,<br />
Hamilton, Ontario, Canada<br />
Health-related quality of life (HRQL) includes the<br />
patient’s own experiences, preferences, values, and their<br />
perceptions of their symptoms and functioning. HRQL<br />
broadens the range of outcomes that are measured and<br />
expands the professional’s awareness of issues that concern<br />
patients. We used qualitative and quantitative research<br />
methodologies sequentially to develop a self-report- and a<br />
parent proxy HRQL measure for pre-adolescent children<br />
with epilepsy. Modified focus groups, run separately with<br />
children with epilepsy and their parents, facilitated exploration<br />
of HRQL issues. Textual analysis helped us understand<br />
the HRQL components and identify 31 domains clustered<br />
into five major themes. Items for the scale were extracted<br />
from the raw data. We created a scale formatted with alternative<br />
paired options of forced responses and used factor<br />
analysis to reduce the number of items. Internal consistency<br />
was measured with Cronbach’s alpha; test-retest reliability<br />
with the Pearson Correlation, and construct validity with<br />
seven hypotheses. A total of 381 children with active<br />
epilepsy, ages 6–15, and their parent(s) completed separately<br />
a 67-item questionnaire. We chose five subscales<br />
from the factor analysis with five items per subscale. Children<br />
and parents could discern differences and report differentially<br />
between the various aspects of their HRQL. Testretest<br />
was only satisfactory for parents and children 8 years<br />
and older. Internal consistency, construct and discriminative<br />
validity were acceptable for all subscales. Our data provide<br />
solid psychometric properties for user-friendly HRQL<br />
measures for parents and children 8 years and older. The<br />
measures subscales encompass HRQL dimensions identified<br />
and judged most important by children with epilepsy<br />
and their parents.<br />
FP-H-117<br />
Evaluation of 76 patients with infantile spasms:<br />
epidemiologic and clinical data<br />
Ş. Uçar a ,Ö.F. Aydin b ,N.Şenbil b ,Ü. Ertan a , Y.K.Y. Gürer 2<br />
Dr. Sami Ulus Children’s Hospital, a Department of Pediatrics<br />
and b Pediatric Neurology, Ankara-Turkey<br />
Infantile spasms (IS) is an epileptic syndrome of early<br />
infancy with poor prognosis which is not controlled by standard<br />
antiepileptic drugs. Medical records of 76 patients<br />
diagnosed with IS between 1995 and 2001 were reviewed.<br />
Forty-two of them were males (55.3%) and 34 were females<br />
(44.7%). The mean onset of infantile spasms was<br />
5.88 ^ 0.53 months. The mean admission age was<br />
8.79 ^ 0.54 months. Spasms were seen mostly at 4–6<br />
months (50%) and 80.3% started before the aged of 1.<br />
Seventy of 76 cases were symptomatic (92.1%) and six<br />
were cryptogenic (7.9%). In the symptomatic group prenatal,<br />
perinatal and postnatal causes were 42.9, 34.3 and<br />
17.1%, respectively. No etiological cause was found in<br />
5.7%. Hypoxic ischemic encephalopathy was the most<br />
common of the prenatal and perinatal causes (48.58%).<br />
Flexor spasms were seen most frequently (59.2%), mixed<br />
spasms were less frequent (31.6%) and extensor spasms<br />
were the least frequently seen (9.2%). A total of 35.5% of<br />
the cases had other kinds of seizures before IS. Spasms<br />
disappeared before the age of 2 in 63.2% of the cases.<br />
EEG findings improved with ACTH treatment. Early treated<br />
patients showed better responses to the treatment. No significant<br />
difference was found in neurodevelopmental and<br />
mental improvement between the pre and posttreatment<br />
states. The patients who were on ACTH or ACTH 1<br />
pyridoxine treatment showed more complete response<br />
compared to the patients on the other alternative treatments.<br />
Patients with tuberous sclerosis showed better response to<br />
vigabatrin. A total of 34% of the 57.9% patients with remission<br />
showed relapse. Relapses were less in the early treated<br />
group. Relapses responded to treatment poorly. Mortality<br />
rate was 2.6%, 25% of the patients developed other kinds<br />
of epilepsies after IS, which were mostly LGS.<br />
FP-H-118<br />
Teaching paediatric and adolescent epilepsy at advanced<br />
level in Slovenia – example of a small country<br />
I.M Ravnik a , P. Wolf b<br />
a Ljubljana, Slovenia, b European Epilepsy Academy, Slovenia<br />
Rationale: In Slovenia (2 million inh), the practice of<br />
child neurology started by studying and treating seizure<br />
disorders (Jeras, 1954), evolving into full-scope child<br />
neurology. General paediatricians have been offered update<br />
courses, and special courses including paediatric and<br />
adolescent epilepsy (PAE) have been organized for paediatricians<br />
interested in neurology. Advanced epilepsy<br />
courses, due to few trained specialists and small audiences,<br />
could not be similarly established. The small team, still<br />
developing, mostly educated abroad, participates with<br />
interested adult neurologists and organizes advanced<br />
courses/workshops for child neurologists, neurophysiologists<br />
and neurologists, with foreign and local experts to<br />
compensate for the lack of formal training in epileptology.<br />
What would be the best way to go in future? Method: (1)<br />
Analysis of post-graduate teaching on epilepsy via<br />
programmes organised by the Slovenian ILAE Chapter,<br />
Slovenian Medical Society’s Epileptology Section, and<br />
local Epi-club in collaboration with European Epilepsy<br />
Academy (Eurepa), and established bilateral (e.g. Slove-
530<br />
Abstracts<br />
nian – French) co-operation. (2) Analysis of questionnaires<br />
on gaps in knowledge in PAE care in Central Eastern<br />
European countries (CEEC). Results: Different answers<br />
could be obtained from students depending on their<br />
previous knowledge. All university post-graduate courses<br />
(paediatrics, child neurology, neurophysiology, child<br />
psychiatry) do offer basic knowledge of PAE. Advanced<br />
students claim more knowledge in neuroradiology, paediatric<br />
EEG and electro-clinical characterisation of PAE<br />
syndromes. Clinical workshops (on classification of epileptic<br />
syndromes, drug treatment, assessment of drug trials,<br />
epilepsy management, EEG, neuropsychology of epilepsy,<br />
severe epilepsies, comprehensive epilepsy care, epilepsy<br />
and handicap) in collaboration with foreign centres and<br />
Eurepa’s trainers have been well attended. Assessment:<br />
clinical work with case-studies and real-life ‘know-how’<br />
added to theoretical work is favoured by the students.<br />
The CEEC questionnaire (Ravnik et al., Epilepsia 1999)<br />
on comprehensive PAE care disclosed domains in which<br />
‘knowledge and expertise were felt to be missing’: presurgical<br />
assessment, surgery (6/7 countries); social work,<br />
functional imaging (5/7); remedial teaching (4/7); neuroradiology,<br />
neuropsychology, child and adolescent psychiatry,<br />
clinical psychology (3/7); while only 2/7 listed EEG<br />
and 1/7 neuropharmacolgy. Quite a few of the above do not<br />
belong to the domain of child neurology in a narrow sense.<br />
The same study showed that in many CEEC, child neurologist<br />
was in charge of the whole bulk of problems encountered<br />
in comprehensive epilepsy care. The perceived ‘lack<br />
of knowledge’ may indeed correspond to lack of paramedical<br />
staff and/or lack of knowledge enabling effective<br />
communication between child neurologist and other<br />
professionals. This may have to be considered in planning<br />
education of child neurologists on PAE care. Conclusions:<br />
Experience gathered in post-graduate teaching of PAE<br />
through years by the local team networking with international<br />
centres of excellence, and including audience from<br />
the neighbouring countries, has proved very useful. Plans<br />
are underway to formalize some of the already tested<br />
educational projects into a curriculum adapted to the<br />
demands of European Epilepsy Academy offering future<br />
child neurologists in the region high level training opportunities<br />
in spite of non-existing formal epileptological<br />
training in their countries.<br />
FP-H-119<br />
Main side-effects of valproic acid drug treatment for<br />
pediatric patients with epilepsy<br />
V.M. Studenikin, O.I. Maslova, V.I. Shelkovsky, S.V.<br />
Balkanskaya, M.Z. Karkashadze<br />
Division of Psychoneurology, Scientific Center of Child<br />
Health (Russian Academy of Medical Sciences), Moscow,<br />
Russia<br />
Background: Valproic acid (VA) drugs are currently used<br />
world-wide as the most popular medicines for seizure<br />
control in the management of partial and generalized<br />
seizures in pediatric and adult patients, but unfortunately<br />
valproates are also known to induce some undesirable<br />
side-effects. Goal: Therefore, the aim of our study was to<br />
find out the incidence of various undesirable effects in<br />
pediatric patients with epilepsy, undergoing therapy with<br />
VA. Method: For this purpose we have analyzed case<br />
histories of 383 epileptic infants and children (aged 2<br />
months–15 years) hospitalized in the neurological clinic in<br />
1995–1999, and receiving VA as mono-or polytherapy.<br />
Results: Most side-effects observed can be divided into<br />
two main categories: hepatotoxic in 26.9% of cases (varying<br />
from raised hepatic enzymes to biliary dyskinesia, mild<br />
reactive pancreatitis, etc.) and hematological changes<br />
(leukopenia with accompanying platelet decrease) 6% of<br />
patients. The latter led to bleeding diathesis in three pts.<br />
Such various side-effects as excessive weight-gain, alopecia,<br />
decreased calcium in serum, and cognitive deficit were<br />
registered, as well, but less frequently. Only rarely VA sideeffects<br />
could be clearly categorized as dose-related, resulting<br />
from idiosyncratic or hypersensitivity reactions.<br />
Conclusion: Our data support the hypothesis that, aside<br />
from common gastrointestinal tract (GIT) side-effects,<br />
administration of VA drugs may lead to thrombocytopenia<br />
of heteroimmune origin, and another possibility is that liver<br />
dysfunction or medicinal hepatic damage develops with<br />
resulting platelets depression. These immunological considerations<br />
remain to be debated.<br />
FP-H-120<br />
Neurovisualisation techniques in diagnostics of central<br />
nervous system dysgenesis with symptomatic epilepsy in<br />
pediatric patients<br />
O.I. Maslova, L.M. Kuzenkova, V.M. Studenikin, S.Y.<br />
Ishkhanova, E.I. Stepakina<br />
Division of Psychoneurology, Scientific Center of Child<br />
Health (Russian Academy of Medical Sciences), Moscow,<br />
Russia<br />
Background: Progress in modern radiology substantially<br />
improves the arsenal of diagnostic methods in neurology.<br />
Seemingly, the diagnoses of CNS dysgenesis and seizure<br />
disorders benefit from the new investigational techniques<br />
most of all. Goal: Combined utilization of neurovisualisation<br />
methods in the determination of brain dysgenesis,<br />
extent and specificity, in children, was the aim of our<br />
study. Method: CT, MRT and SPET scans were used in a<br />
group of 35 patients, hospitalized with cerebral dysgenesis<br />
originally postulated on the basis of typical EEG-verified<br />
epileptic activity (all children aged 1–15 years). Results:<br />
The described group of patients showed the following most<br />
important findings: (1) hypoplasia of cerebral hemispheres<br />
(42.8%); (2) intracranial hemorrhages (37.1%); (3) destruction<br />
of cortical lamina (31.4%); and (4) false porencephalic
Abstracts 531<br />
cysts in white matter of the brain (28.5%). Pathological<br />
vascularisation of brain structures (varying from mild to<br />
profound) was only evident with SPET scans (in 68.5%<br />
of cases observed). Conclusion: CT and MRT scans<br />
allow the demonstration of structural and morphological<br />
cerebral problems, but establishment of adequate clinical<br />
long-term prognoses can only be expected, when the<br />
above-mentioned diagnostic routines are combined with<br />
SPET. The latter method not only objectively (quantitatively)<br />
verifies topographic vascularisation of cerebral<br />
structures, which is of critical interest in pediatric patients<br />
with congenital brain anomalies, but its prognostic value<br />
seems to be second to none, when investigating the cases<br />
of cerebral dysgenesis in pediatric patients.<br />
FP-H-121<br />
Experience in management of Rasmussen syndrome in<br />
pediatric patients<br />
V.I. Shelkovsky, V.M. Studenikin, O.I. Maslova, O.V.<br />
Globa<br />
Division of Psychoneurology, Scientific Center of Child<br />
Health (Russian Academy of Medical Sciences), Moscow,<br />
Russia<br />
Background: Rasmussen syndrome (chronic progressive<br />
focal encephalitis) is a rare neurological form of epilepsy,<br />
described over 40 years ago, with only about 50 verified<br />
pediatric cases reported worldwide. Goal: Our aim is to<br />
describe and to share our own experience in therapeutic<br />
approach and management of Rasmussen syndrome in<br />
pediatric patients. Method: We have analyzed case<br />
histories of four pediatric patients, hospitalized and receiving<br />
treatment in our clinic since 1996. Results: The ages of<br />
patients with Rasmussen syndrome (three females and one<br />
male) varied from 18 months to 14 years and 9 months.<br />
The earliest onset of the described condition was registered<br />
at the age of 9 months, and the latest took place at<br />
the age of 11 years and 8 months. In two cases (both of<br />
them young children) myoclonic paroxysms were evident<br />
with secondary generalization (tonic propulsive paroxysms<br />
with absences), while in two other cases classic partial<br />
paroxysms were seen with myoclonic seizures development<br />
after the period of 2–3 months. Anticonvulsant<br />
drugs such as valproic acid, carbamazepine and phenobarbital<br />
were used, but Rasmussen syndrome proved to be<br />
refractory (the number of paroxysms varied from 5 to 30<br />
daily). In one case complete remission (presently 3 years)<br />
was achieved in a 25-months old female patient after<br />
acyclovir intravenous administration (for herpes type I<br />
generalized infection). Conclusion: Our hypothesis is that<br />
Rasmussen syndrome results from an autoimmune pathological<br />
pathway, which can possibly be altered by using<br />
immunosuppressive drugs, but we lack evidence for this<br />
concept.<br />
FP-H-122<br />
Dynamics of EEG data in pediatric patients with various<br />
epilepsy types under valproic acid treatment and<br />
monitoring in blood<br />
A.V. Anikin, N.Y. Semenova, V.I. Shelkovsky, O.I.<br />
Maslova, V.I. Shelkovsky, S.V. Balkanskaya<br />
Scientific Center of China Health, Russian Academy of<br />
Medical Sciences, Moscow, Russia<br />
Background: Monitoring of VA blood concentration is<br />
currently viewed as disputable, compared with EEG<br />
dynamics in patients with epilepsy under treatment with<br />
this anticonvulsant class. Goal: The aim of our study was<br />
to register correlations between EEG patterns and VA blood<br />
concentrations in children with epilepsy under valproate<br />
treatment for optimization of the therapy. Methods: Ninety<br />
patients (aged 2 months–16 years) with various types of<br />
epilepsy were observed. Digital EEG (‘DG Examiner’,<br />
‘10–20’ system, standard technique) and VA blood monitoring<br />
(until 80–120 mcg concentration achievement) were<br />
incorporated. Positive clinical effect was judged by<br />
complete seizure control or decrease in attacks, with EEG<br />
evidence of reduction or abatement of epileptiform signs.<br />
Results: Typical epileptic seizures and spikes, spike-andslow<br />
wave EEG patterns were evident in 83% of cases,<br />
generalized paroxysms in 32% and focal abnormalities in<br />
42% of cases (in 9% of the latter secondary generalization<br />
was present). Patients with idiopathic epilepsy had better<br />
clinical results and EEG patterns as compared with cases<br />
of symptomatic epilepsy. Correlation was registered<br />
between the VA concentration in blood and EEG specific<br />
activity. In addition, repetitive studies revealed increases in<br />
voltage and discharges in 19% of patients with localized<br />
epileptic activity. Conclusion: Our data seemingly show<br />
that the use of valproic acid blood concentration monitoring<br />
in combination with adequate EEG control is considerably<br />
more reliable in pediatric patients with generalized epileptic<br />
activity, than in cases of epileptic partial seizures. Treatment<br />
effectiveness was considerably higher when increased<br />
VA blood concentrations were seen.<br />
FP-H-123<br />
The clinical characteristics of febrile seizures and<br />
outcomes in children<br />
T. Galia<br />
Almaty ‘480063, Aksai-4’ –101, app. 18, Kazakhstan<br />
The purpose of this research was the study of clinical signs<br />
and outcomes of febrile seizures in children. We observed<br />
179 (75.8%) children with simple and 57 (24.5%) with<br />
complex febrile seizures. Simple febrile seizures were characterized<br />
as generalized tonic-clonic in 43.6% (78), clonic in<br />
25.7% (46), atonic in 19% (34), tonic in 11.7% (21) of children.<br />
Relapses offebrile seizures in this group, were observed
532<br />
Abstracts<br />
in 46.4 (83) children. Simple febrile seizures remitted favorably<br />
in 78.2% of cases. In 21.8% the development of epilepsy<br />
was observed: absence (15), grand mal (19), Lennox-Gastaut<br />
syndrome (four), infantile spasms (one). The spasms of<br />
complex febrile seizures began with a turn of the head and<br />
eyes to the side in 10.5% (six); with nystagmus followed by a<br />
turn of the head and eyes to the side in 7% (four); with focal<br />
motor paroxysms, in 36.8% of children, followed by generalization.<br />
Other seizures observed were myoclonic-12.3%<br />
(seven), tonic-clonic 59.6% (34), tonic 10.3% (23). In 3.5%<br />
(two) children a visual and epigastric aura was observed<br />
before the beginning of an attack. In 64.9% (37) cases there<br />
was evolution to epilepsy: symptomatic partial 22.8% (13),<br />
grand mal 21.1% (12), temporal lobe 7% (four), myoclonic<br />
epilepsy-5.3% (three), infantile spasm-8.8% (five). In 35.1%<br />
(20) cases remission of disease was observed. Therefore the<br />
features of the clinical signs of the febrile seizures were<br />
reflected in the outcomes of the disease.<br />
FP-H-124<br />
Recurrent febrile seizures induced brain damage in<br />
developing rats<br />
Z.-X. Yang a , J.-M. Wang b , G.-P. Zhou a , X.-Z. Chang a ,J.<br />
Qin a<br />
a Department of Pediatrics, Beijing <strong>University</strong> First Hospital,<br />
Beijing, China; b Department of Pediatrics, Shangqiu<br />
First People’s Hospital, Shangqiu, Henan, China<br />
The present study is to establish a FS model and to<br />
explore the FS induced brain damage in developing rats.<br />
FS in Wistar rats was induced ten times, once every 2<br />
days, through a warm (44.58C) water bath. The rats were<br />
randomly divided into two groups: 37.08C water bath group<br />
(n ¼ 10), and 44.58C water bath group (n ¼ 40), The latter<br />
was subdivided into non-FS (FS ¼ 0, n ¼ 10) and FS (FS<br />
$6, n ¼ 22) groups. On HE stain, the disarrangement of<br />
hippocampal CA1 and CA2 neurons in FS group was<br />
observed. The cellular polarity was not clear, and vacuolization<br />
appeared. No obvious loss of hippocampal neurons in<br />
FS group was observed on thionine stain. Whereas neuronal<br />
numerical density (Nv, counted by means of a stereological<br />
method, the dissector system) in hippocampal CA1 in FS<br />
group was significantly decreased (P , 0:01) compared<br />
with that in normal and non-FS groups. The ultrastructural<br />
abnormalities of the hippocampal neurons were observed<br />
under the electron microscope. In FS rats, the mitochondrial<br />
volume was markedly decreased, the matrix condensed, the<br />
ridge obscured or disappeared, and vacuoles formed in some<br />
mitochondrias. Mild to moderate dilation of Golgi apparatus<br />
was also demonstrated. The results indicated that there were<br />
many similarities between warm water-induced FS in developing<br />
rats and febrile seizures in children. This model is<br />
suitable for the research on the pathogenetic mechanisms<br />
and brain damage in FS. Recurrent FS may cause damage<br />
and loss of hippocampal neurons in the developing rats.<br />
(This work was partly supported by a key clinical project,<br />
2001-03, from the Ministry of Public Health of China).<br />
FP-H-125<br />
The syndrome of facial hemangioma – cerebral cortical<br />
and vascular dysplasia: a rare neurocutaneous<br />
syndrome associated with epilepsy<br />
H.B. Szliwowski, A. Aeby, P. David, G. Rodesch, P. Van<br />
Bogaert<br />
ULB-Hôpital Erasme, Brussels, Belgium<br />
Patients with extensive facial hemangioma may present<br />
abnormalities of the cerebral arteries ranging from minor<br />
vascular dysplasia to agenesis of major arteries. Some of<br />
them present associated brain malformations which affect<br />
mainly the cerebellum (Dandy-Walker malformation, cerebellar<br />
hypoplasia or atrophy). We report a patient in whom<br />
facial hemangioma was associated with vascular cerebral<br />
dysplasia and frontal polymicrogyria. This 13-year-old girl<br />
had a history of congenital facial hemangioma which<br />
progressively extended over her nose and forehead during<br />
the first year of life, and then spontaneously regressed.<br />
Neurological examination showed mild mental retardation<br />
and a discrete congenital left hemiplegia predominating in<br />
the upper limb. Seizures were present from the age of 11<br />
years and were refractory to valproate and carbamazepine.<br />
EEG showed interictal right rolandic spikes and generalized<br />
seizures (atypical absences and tonic seizures). Cerebral<br />
MRI showed polymicrogyric-like changes affecting the<br />
right frontal lateral cortex and the parasagittal frontal<br />
cortices, and hypoplasia of the corpus callosum. At cerebral<br />
angiography, the pericallosal arteries appeared tortuous and<br />
presented focal dilatations. This is, to our knowledge, the<br />
second reported case of supra-tentorial cortical dysplasia<br />
associated with facial hemangioma and vascular cerebral<br />
malformation. The fact that the polymicrogyria extended<br />
beyond the vascular territories supplied by the dysplasic<br />
arteries suggests that polymicrogyria and vascular dysplasia<br />
are expressions of the same pathogenic process at different<br />
stages of gestation. This case illustrates that the neurocutaneous<br />
syndrome of hemangioma-cerebral dysplasia must be<br />
suspected in children presenting with epilepsy and facial<br />
hemangioma.<br />
FP-H-126<br />
Benign infantile familial convulsions and paroxysmal<br />
choreoathetosis: report of first cast with homozygous<br />
linkage to chromosome 16p12–q12<br />
V. Humbertclaude, A. Poubertie, F. Rivier, J. Rochette, P.<br />
Szepetowski, B. Echenne<br />
Service de Neuropediatrie, Chu Saint Eloi, Montpellier,<br />
France<br />
We report the first case of homozygous linkage to chro-
Abstracts 533<br />
mosome 16p12–q12 associated with benign infantile familial<br />
convulsions and paroxysmal choreoathetosis. A boy<br />
presented two clusters of seizures at 3 and 4 months of<br />
age. Seizure was characterized by left or right head and<br />
eye deviation, hypertonia of one upper limb and tonicclonic<br />
generalization. Ictal EEG showed right temporoparietal<br />
rhythmic spikes followed by generalization. Cerebral<br />
MRI was normal. Six isolated seizures recurred<br />
between 6 and 9 months. At 25 months of age. Paroxysmal<br />
choreoathetosis (PC) appeared, characterized by unilateral<br />
choreic movements, followed by generalized athetosis.<br />
Attacks occurred spontaneously or after repeated movements.<br />
Ictal and inter-ictal video-EEG were normal. Ictal<br />
ECD SPECT showed bilateral basal ganglia and mild left<br />
temporal hyper perfusion. Daily attacks of PC persisted<br />
despite multiple therapy. The grand-aunt of the boy and<br />
her daughter had presented benign infantile convulsions.<br />
No other case of PC was noted. The parents of the boy<br />
were consanguineous. Genetic analysis showed homozygous<br />
linkage to the chromosome 16p12–q12. This homozygous<br />
status may explain the unusual phenotype, with<br />
repeated seizure and severe early-onset PC.<br />
FP-H-127<br />
Quality of life in children with epilepsy – Indian scenario<br />
S. Aneja, N. Prakash, V.R. Nigam<br />
Department of Pediatrics, Lady Hardinge Medical College,<br />
New Delhi, India<br />
Objective: To study the QoL profile in children with<br />
epilepsy. Methods: A prospective (nested control) study<br />
was done among children (age 6–15 years) attending<br />
epilepsy clinic who were on AED for minimum of 6 months.<br />
Children with associated motor/cognitive deficits were<br />
excluded. Evaluation was done by interviewing parents<br />
with part open ended and part structured pretested questionnaire.<br />
It included responses to measure effect of epilepsy on<br />
physical, psychological, social and school domains. Each<br />
item was rated on a five point likert scale. Results: Ninety<br />
five children (males 56; females 39) were studied. Complex<br />
partial seizures (37%) were the commonest type followed by<br />
generalized seizures (25%). Sixty one percent had infrequent<br />
seizures. The structured questionnaire showed good testretest<br />
reliability (r ¼ 0:9), internal consistency (a ¼ 0.9)<br />
and interparental agreement (r ¼ 0:9) QoL was most<br />
affected in the school domain with 71.5% parents perceiving<br />
problems in school. Behavioural and psychological problems<br />
were felt to be affected by 65.2% of parents. Social limitations<br />
were perceived by fewer parents (40%) and physical<br />
domain was least affected (10%). The effect of Seizure severity<br />
and seizure frequency on QoL was studied after adjusting<br />
for age, sex, socioeconomic status and IQ. It was seen that<br />
patients with frequent seizures and severe seizures had lower<br />
scores on QoL. Conclusion: Epilepsy had significant effect<br />
on schooling and behaviour of children with epilepsy.<br />
Management protocol of epilepsy should include complete<br />
assessment of behaviour and psychological functions.<br />
FP-H-128<br />
The risk factors and outcome of children with<br />
intractable status epilepticus<br />
P.A.M. Kunju<br />
Division of Pediatric Neurology, Medical College Trivandrum,<br />
Kerala, India<br />
Objectives: (1) To identify the risk factors; (2) the<br />
immediate outcome; and (3) to assess the neurological<br />
and mental outcome at the end of 1 year in children<br />
with intractable SE. Setting: Paediatric Intensive Care<br />
Unit, medical college. Design: Prospective Study. Methodology:<br />
160 children with intractable generalized SE<br />
during 1998–2001 were studied. The subjects were classified<br />
into 1. those with previous history of epilepsy and 2.<br />
those with no prior history of epilepsy. Children who<br />
recovered were followed up at 6 monthly intervals had<br />
cognitive assessment by a clinical psychologist and were<br />
grouped under two categories: (1) those with neurological<br />
impairment, (i.e. IQ , 80) and or having neurological<br />
sequelae; and (2) those who were normal. A total of 160<br />
cases (56 were infants, 40 between age 1–6 years and 64<br />
belonged to 6–12 years, 86 males and 74 females) were<br />
studied. Sixty-two (38.75%) belonged to the first group<br />
and 98 (61.25%) to the second group. The causes of<br />
previous epilepsy in the 62 were cerebral palsy, meningitic<br />
sequelae, cerebral malformations, metabolic and idiopathic.<br />
Twenty-eight (45.16%) fell in the idiopathic<br />
group and 21 were having non-progressive encephalopathy<br />
(33.87%). Two had heterotopias, one lissencephaly, one<br />
agenesis of corpus callosum, one tuberous sclerosis, one<br />
Sturge-Weber syndrome and one metabolic disorder,<br />
(1.61%), Gauchers disease. Among the patients with<br />
previous epilepsy, problems with anti-epileptic drugs<br />
were the most prevalent, i.e. 36 out of 62 patients<br />
(58.06%). Twelve out of 62 were precipitated by systemic<br />
infections. In the remaining 14, no precipitating factor<br />
(22.58%) was noticed. There were 98 SE with no previous<br />
epilepsy. Of these 65 were having intracranial infections<br />
(66.32%). Twenty-two had prolonged febrile seizures<br />
(22.44%) two had metabolic problems (2.04%) One was<br />
subdural hematoma in a hemophiliac patient (1.02%).<br />
Immediate outcome of SE: Out of the 160 SE 18 died<br />
(11.4%), 14 out of 18 deaths (77.77%) were due to infections<br />
of the CNS. Two (11.11%) were due to metabolic<br />
causes, one was a case of intractable hypoglycemia, and<br />
the other a case of Gaucher’s disease. The remaining two<br />
were children with previous history of epilepsy. They had<br />
more than two episodes of SE. There was history of abrupt<br />
withdrawal of antiepileptic drugs. Sixteen out of the 18<br />
had seizures lasting for .2 h (88% of cases), five had<br />
raised intracranial tension (27%), three had hypotension,
534<br />
Abstracts<br />
(16.6), two had respiratory insufficiency (11.1%), one had<br />
hypoglycemia and one, uraemia (5.5%). Outcome at the<br />
end of 1 year: Out of the 60 children with previous<br />
epilepsy, 56 had neurological impairment (93.6%).<br />
Among the 82 with no history of prior epilepsy, six developed<br />
neurological impairment (6.25%) and 76 (93.75%)<br />
were normal. Relative risk 14.75%. Conclusions: (1)<br />
Most common cause of SE were acute symptomatic<br />
cases with the previous epilepsy. (2) Important contributing<br />
factors for mortality in SE were seizure duration .2 h<br />
and underlying cause. (3) High association was noted<br />
between children with previous epilepsy and mental retardation.<br />
FP-H-129<br />
Clinical analysis of antiepileptic therapy with<br />
individuated-dose valproate in children<br />
J. Wu, Y.-Q. Zhong, X.-L. Xie, W.-G. Hu, M. Wu<br />
Children’s Hospital of Chengdu, Chengdu, Sichuan, China<br />
Objective: The valproate is a kind of wide AEDs, which is<br />
used widely. To evaluate the efficacy of individual dose<br />
VPA in treatment of 61 epilepsy children, 29 were boys,<br />
as well as 32 girls. Method: Nine months ,14 years of age<br />
children with epilepsy in outpatient treated by single-drug<br />
VPA from August 1999 to October 2001 were retrospectively<br />
analysed. Results: The children with general seizure<br />
or partial were 42 and 19, respectively. Their therapeutic<br />
dosage was from 11.25 , 48.49 mg/kg per day, and average<br />
dosage was 22.92 ^ 7.83 mg/kg day. After 5 , 9 days<br />
taking VPA, the valley blood-drug-concentration of VPA<br />
were from 24.5 , 163 mg/l, Its average blood-drug-concentration<br />
was 69.75 ^ 20.75 mg/l. Conclusion: VPA has good<br />
therapeutic effect on epilepsy, which does better for general<br />
seizure than partial seizure. The target dosage in different<br />
children change greatly, and there are a lot of individual<br />
variations. Meanwhile we should select anti epileptic<br />
drugs according to the epilepsy type. In treatment epilepsy,<br />
it is necessary to monitor the constant concentration of VPA<br />
after five half eliminate time.<br />
FP-H-130<br />
Effects of recurrent audiogenic seizures on hippocampal<br />
structure and seizure behavior of P77PMC rats<br />
S.-G. Zhao, X.-R. Wu<br />
Pediatric Neurology, Department of Pediatrics, Peking<br />
<strong>University</strong>, First Hospital, Beijing, China<br />
To investigate the functional role of hippocampal mossy<br />
fiber (MF) sprouting in the pathophysiological mechanisms<br />
of initiation and propagation of epilepsy, we examined<br />
hippocampal MF synaptic reorganization and changes in<br />
the hippocampal neurons of AGS-prone P77PMC rats at<br />
various stages in the course of recurrent seizures using<br />
Timm’s method of sulfide silver staining and Nissl staining.<br />
Also, we observed the effects of recurrent audiogenic<br />
seizures (AGSs) on the changes of seizure behavior of<br />
P77PMC rats. Our results showed that frequent recurrent<br />
AGSs not only can cause neuronal loss in the CA1 region<br />
of the hippocampus and hippocampal MF sprouting into<br />
the inner molecular layer of dentate gyrus in P77PMC rats,<br />
but can also decrease the latency of IV/V grade AGSs, and<br />
increase the duration of AGSs. Our findings suggest that<br />
hippocampal MF sprouting and neuronal loss are not only<br />
present in limbic seizure, but are also seen in AGS, which<br />
are initiated in brainstem and rapidly generalize. In AGSprone<br />
rats, recurrent AGSs can cause MF synaptic reorganization<br />
and neuronal loss in the hippocampus, and<br />
enhance seizure susceptibility of P77PMC rats. During<br />
the course of recurrent AGSs, enhanced seizure susceptibility<br />
was observed before hippocampal MF sprouting.<br />
This finding may indicate that anatomical changes may<br />
be preceded by functional changes characterized by<br />
elevated excitability in the epileptic brain.<br />
FP-H-131<br />
Clinical and neuro-psychological analysis of epilepsy<br />
patients caused by Japanese encephalitis<br />
D. Ding, Z. Hong, B. Zhou<br />
Institute of Neurology, Fu Dan <strong>University</strong>, Hua Shan Hospital,<br />
Shanghai, China<br />
Objective: To investigate the morbidity, clinical symptoms,<br />
and brain functions of epilepsy patients caused by<br />
Japanese encephalitis. Methods: Eighty-five patients who<br />
suffered from Japanese encephalitis during 1973–1994<br />
were followed and evaluated using neurological examination,<br />
MMSE, intelligence and memory measurements, and<br />
activity of daily life (ADL). Results: Ten patients were<br />
found to have epilepsy with diverse types, including nine<br />
cases of GTCS and one case of absence petit mal seizures.<br />
Another two cases died of GTCS before evaluation. Totally<br />
12 cases (14.4%) were evaluated as epilepsy, among which<br />
nine cases had seizures beyond 1 year and within 17 years.<br />
Therefore the morbidity of lately occurring epilepsy is<br />
10.6%. The cumulative morbidity of epilepsy occurring<br />
within 17 years after discharge was 16.1% calculated by<br />
survival analysis. Among ten epilepsy patients evaluated,<br />
two cases, six cases and eight cases were confirmed as<br />
MMSE abnormal, mental retardation, and memory defect,<br />
respectively. Four cases were considered as disability<br />
because of the abnormal ADL scores. Conclusion: Epilepsy<br />
with higher morbidity and worse prognosis is one of the<br />
sequelae caused by JE virus infectious during the childhood.<br />
The prevention and control of JE should have certain impact<br />
to decrease the morbidity of epilepsy.
Abstracts 535<br />
FP-H-132<br />
The clinical and EEG characteristics of infancy epilepsy<br />
from temporal lobe origin<br />
J.-P. Liang, F.-C. Cai<br />
Department of Neurology, Children’s Hospital, Chongqing,<br />
China<br />
Introduction: The clinico-pathological data indicated<br />
Temporal lobe epilepsy may manifest differently in infants<br />
and older children. The concept of complex partial<br />
seizures, which may be useful in older children, is difficult<br />
to apply to infants, since it is often not possible to assess<br />
impairment of consciousness in this age group. The aim of<br />
study was to analyze the clinical manifestations, EEG, CT<br />
scan and MRI in a cohort of 32 infancy epilepsy from<br />
temporal lobe origin (IETLO). Materials and methods:<br />
Thirty-two cases with IETLO including 19 males and 13<br />
females were subjected to the study. The onset of IETLO<br />
was between 2 and 34 months with an average of 20<br />
months, and 25 cases were followed up for 1–6 years<br />
with the examinations of EEG, Videotapes, CT and MRI.<br />
Results: IETLO was an age-related epileptic syndrome<br />
characterized by the clinico-electrical features in infants<br />
aged less than 2 years different from those in elder children.<br />
The seizure semiology shown atypical presentations<br />
including initial motionless stare, behavioral arrest or<br />
reduction with possible impairment of consciousness in<br />
27 cases, presenting not react to visual threat or loud<br />
noise during seizures, and that all spontaneous purposeful<br />
activities were interrupted; autonomic features and oroalimentary<br />
or simple manual automatisms in 16 cases;<br />
tonic, versive or myoclonic seizures were observed in 13<br />
cases, which may not indicated a localized origin of the<br />
seizures. Most of seizures lasted for more than 1 min. The<br />
interictal EEG indicated that the epileptogenic discharges<br />
found in infants were less often than in elder children with<br />
single or multiple foci. The ictal EEG discharges were less<br />
focal and variable, even falsely lateralized, and the patterns<br />
were not very distinct, including focal attenuation of beta<br />
activity or sleep spindles, focal slowing and unilateral electrodecremental<br />
events, etc. Video-EEG monitoring was<br />
important in identifying the seizure patterns and impairment<br />
of consciousness. CT scans shown structural cerebral<br />
lesions in 5/6 cases and MRI gave more information of<br />
brain lesions in 11/14 cases, which were more valuable<br />
in localization of lesions than EEG. Conclusion: IETLO<br />
is an age-related epileptic syndrome characterized by the<br />
clinico-electrical features as follows: motionless stare,<br />
behavioral arrest or reduction with possible impairment<br />
of consciousness, autonomic features and oro-alimentary<br />
automatisms; convulsive seizures were prominent; duration<br />
of seizures was more than 1 min. The intericatal discharges<br />
were less found while ictal discharges were less focal and<br />
distinct. Video-EEG monitoring was critical to identify the<br />
seizure patterns and impairment of consciousness. Neuroimagings<br />
are more important in finding the structural cerebral<br />
lesions.<br />
FP-H-134<br />
Efficacy and safety of topiramate for pediatric epilepsy<br />
in clinical practice: data from a postmarketing<br />
surveillance study<br />
Y. Roh a , Y.S. Hwang b<br />
a Department of Pediatrics, Chosun <strong>University</strong> Hospital,<br />
KwangJu, Seoul; b Department of Pediatrics, Seoul National<br />
<strong>University</strong> Hospital, Seoul, Korea<br />
Objectives: To evaluate the efficacy and safety of topiramate<br />
in pediatric patients with epilepsy. Methods: TPM<br />
was treated in 561 patients who were taking one or more<br />
antiepileptic drugs or no medication. Topiramate dose was<br />
increased gradually from 0.5 to 1 mg/kg per day weekly or<br />
biweekly. After 16 weeks since the patients started having<br />
TPM, the antiepileptic efficacy was measured. All adverse<br />
events reported during this study period were gathered.<br />
Results: Their mean age was 8 years old (range 3 , 13<br />
years old). A total of 62% of the patients were boys. The<br />
median number of monthly seizures at baseline was 4.5<br />
(mean ¼ 41). The mean duration of epilepsy was 5 years<br />
(^4). Fifty-seven percent of patients were diagnosed idiopathic<br />
or cryptogenic epilepsy and 43% symptomatic<br />
epilepsy. Forty-seven percent of patients had other neurological<br />
disorders like as mental retardation or hemiparesis.<br />
Carbamazepine (52%), vigabatrin (52%), and valproate<br />
(50%) were the most common concomitant drugs. The overall<br />
seizure free rate in 16 weeks from topiramate treatment<br />
was 35%. The .50% seizure reduction rate was 70%.<br />
Seizure free rate in Lennox-Gastaut syndrome (LGS) or<br />
infantile spasm was 18%. Seizure free rate in patients<br />
with topiramate monotherapy was 67%, which was much<br />
higher in patients with combination therapy. Seizure free<br />
rate by monthly baseline seizure frequency was 58% in<br />
less than two times, 27% in three to nine times, 14% in<br />
10–30 times, and 17% in more than 31 times. Seizure free<br />
rate by duration of epilepsy was higher in shorter duration;<br />
70% in less than 1 year and 20% in 11–13 years. A total of<br />
69% of parents with the pediatric patients rated the efficacy<br />
of topiramate good or very good. Seventy percent of medical<br />
doctors rated the efficacy of topiramate good or very<br />
good, 20% fair and 10% poor. The adverse events of TPM<br />
were somnolence (6.0%), weight loss (5.0%), anorexia<br />
(3.7%), and lethargy (3.0%). Conclusions: Topiramate had<br />
high .50% seizure reduction rate (70%) and seizure free<br />
rate (35%) in various seizure types and showed remarkable<br />
seizure free rate (18%) in LGS and Infantile Spasm. The<br />
shorter history of seizure duration was, the higher seizure<br />
free rate of topiramate showed. Drop out due to adverse<br />
effects was 2.8%. This study suggests that topiramate is<br />
the first rank antiepileptic drug in its efficacy and is very<br />
effective for pediatric epilepsy regardless of seizure types.
536<br />
Abstracts<br />
FP-H-135<br />
Efficacy of topiramate monotherapy in pediatric patients<br />
with newly diagnosed epilepsy<br />
K.S. Lee<br />
Department of Pediatrics, ChungNam National <strong>University</strong><br />
Hospital, DaeJun, Korea<br />
Objectives: To investigate efficacy and safety of topiramate<br />
as initial therapy in pediatric patients with newly diagnosed<br />
epilepsy. Methods: Among pediatric patients were<br />
brought to the hospital emergency room due to seizure, 36<br />
patients with newly diagnosed epilepsy were recruited for<br />
this study. Topiramate was given to them for 16 weeks and<br />
CBZ and/or VPA was added if seizure was not controlled<br />
with topiramate within 6–8 weeks. Seizure reduction rate<br />
was evaluated as well as adverse events at end point of<br />
16th week. Results: Among 36 patients there were 19 patients<br />
with secondarily generalized seizure (GS), nine with<br />
complex partial seizure (CPS), six with generalized tonic<br />
clonic seizure (GTCS), one with myoclonic seizure, and<br />
one with tonic seizure. Mean age of the patients was 4.6<br />
years and mean duration of epilepsy was 0.7 year (8.4<br />
months). Mean seizure frequency was 35 times per month<br />
and mean weight was 18 kg. Eight patients had other neurological<br />
conditions such as CP or developmental delay. Five<br />
out of 36 patients were added on CBZ and/or VPA in 6–8<br />
weeks since topiramate treatment. Twenty-six patients<br />
(72%) were seizure free and all of them were on topiramate<br />
monotherapy and no seizure free patients were in CBZ and/or<br />
VPA added group. Seizure free rate by seizure type was<br />
100% in GTCS, 78% in CPS, and 63% in secondarily GS.<br />
Three out of 36 patients withdrew due to adverse events or<br />
lost follow-up. Conclusion: Topiramate was highly effective<br />
in controlling seizures of pediatric patients with newly diagnosed<br />
epilepsy, showing 72% of seizure free rate. Topiramate<br />
was effective in various seizure types and considered<br />
‘good or very good’ by more than 80% of parents and investigator.<br />
There were few serious adverse events and basically<br />
all adverse events were mild.<br />
FP-H-136<br />
Efficacy of topiramate for pediatric patients as<br />
replacement therapy of vigabatrin<br />
S.J. Chung<br />
Department of Pediatrics, KyungHee <strong>University</strong> Hospital,<br />
Seoul, Korea<br />
Objectives: Although many clinical studies of topiramate<br />
(TPM) have been reported, its effect on Asian children was<br />
not evaluated yet. Clinical efficacy of TPM was assessed on<br />
Korean epileptic children whose seizures were not controlled<br />
with more than two kinds of AEDs even at maximum doses.<br />
Methods: A total of 104 patients received add-on therapy of<br />
TPM and 96 patients completed the study. Eight patients<br />
were dropped out at 4th week due to adverse reactions of<br />
TPM. The trial consisted of 8 week baseline phase, 10–16<br />
weeks of titration phase, and 8 week stabilization phase.<br />
Seizure history, adverse events, and drug compliance were<br />
observed at patients visit every 2 weeks. TPM dose was<br />
increased by 1 mg/kg every 2 weeks up to 6 mg/kg, or in<br />
some cases, up to 9 mg/kg. Mean age of the patients was 11<br />
years old (range 2–16 years old) and male patients were 62<br />
(64.5%). A total of 61 (64.0%) patients were on vigabatrin<br />
(VGB) and 65 (68.0%) on carbamazepine. Concomitant<br />
AEDs including VGB were reduced gradually after stabilization<br />
period. Clinical efficacy was evaluated by change in<br />
seizure frequency, i.e. disappearance of seizure (seizure<br />
free), significant improvement (more than 75% of reduction<br />
of seizure), improvement (more than 50% of reduction of<br />
seizure) and no improvement (less than 50% of reduction<br />
of seizure). Results: Out of 96 patients, 65 patients (67.7%)<br />
became seizure free, 22 patients (22.9%) showed more than<br />
50% seizure reduction, nine patients (9.4%) showed less than<br />
50% seizure reduction. When the efficacy was evaluated by<br />
seizure type; 15 (83.3%) showed seizure free and one (5.6%)<br />
showed significant improvement out of 18 patients with<br />
generalized seizure. Three (25.0%) showed seizure free<br />
and 5(41.7%) showed significant improvement or improvement,<br />
while four (33.3%) showed no improvement out of 12<br />
patients with LGS. Forty-seven (71.2%) showed seizure free<br />
and 16 (24.2%) showed significant improvement or improvement<br />
out of 66 patients with partial seizure. TPM showed<br />
higher seizure free rate in less number of concomitant<br />
AEDs: 85.7% (12/14) in one AED, 70.8% (17/24) in two<br />
AEDs, 65.5% (19/29) in three AEDs, 57.1% (13/21) in four<br />
AEDs, and 50.0% (4/8) in five AEDs. Seizure free rate by<br />
duration of epilepsy was 81.8% (9/11) in less than a year,<br />
80.0% (28/35) in 2–4 years, 65.4% (17/26) in 5–7 years, and<br />
45.8% (11/24) in more than 8 years. In the efficacy by baseline<br />
monthly seizure frequency, TPM showed higher seizure<br />
free rate in lower seizure frequency: 41 (93.2%) out of 44<br />
patients whose frequency of seizure was less than once a<br />
month. Fourteen (58.3%) out of 24 patients with one to<br />
three seizures/month, four (50.0%) out of eight patients<br />
with four to five seizures/month, and six (30.0%) out of 20<br />
patients with more than six seizures/month. Seizure free rate<br />
by seizure type was highest in generalized seizure and lowest<br />
in LGS. Global assessment was excellent from 66 (69%) of<br />
patients or physicians, good from 15 (16%), fair from eight<br />
(8%), and poor from seven (7%). Conclusion: It is concluded<br />
that TPM can replace VGB and/or other AEDs without<br />
seizure aggravation or serious side effects.<br />
FP-H-137<br />
Topiramate in pediatric subjects with inadequately<br />
controlled epilepsy: multicenter trial<br />
Y.J. Woo, M.H. Lee<br />
Department of Pediatrics, ChonNam <strong>University</strong> Hospital,<br />
KwangJu, Korea
Abstracts 537<br />
In order to evaluate the efficacy and safety of topiramate<br />
as adjunctive therapy for uncontrolled pediatric seizures,<br />
multicenter add-on topiramate trial was conducted in<br />
Korea. Methods: Twenty study sites in Korea enrolled<br />
patients. Pediatric epilepsy patients, aged 2–16 years old,<br />
with uncontrolled seizures with conventional antiepileptic<br />
medications were included in this study. After receiving<br />
written informed consent, patients were enrolled in a 4-<br />
week baseline phase, followed by a 24 week trial phase<br />
which consisted of a 12 week titration and a 12 week<br />
stabilization period. Topiramate was added to each<br />
patient’s background antiepileptic drugs at an initial dosage<br />
of 1 mg/kg and titrated to target dosage of 9 mg/kg per day.<br />
Study visits were scheduled at 4-week interval. Results:<br />
Data consisted of 184 patients showed that 152 of 184<br />
patients completed this study. Among 184 patients there<br />
were 24 patients with simple partial seizure, 71 with<br />
complex partial seizure, 53 with secondarily generalized<br />
seizure, and 36 with LGS. During the entire period, the<br />
proportion of patients with 50% or higher reductions in<br />
seizure frequency was 59.2%. Among them 12 patients<br />
(6.5%) were seizure free. During the 12-week stabilization<br />
period alone, the proportion of patients with 50% or higher<br />
reductions in seizure frequency increased to 60.9% and 30<br />
of those patients were seizure free, indicating an increase<br />
of seizure free proportion (16.3%) during the stabilization<br />
period. The median percent seizure reduction was 62.2%<br />
during the entire period and 67.1% during the stabilization<br />
period. There were no significant differences in median<br />
percent seizure reduction among patients with different<br />
epilepsy duration, seizure type, and number of concomitant<br />
antiepileptic drugs. Eighteen patients withdrew from the<br />
study due to lack of efficacy, loss of follow-up, poor cooperation<br />
of parents, and adverse reactions. The most<br />
common reported adverse events were anorexia, somnolence,<br />
mental slowing, gastrointestinal disturbances, and<br />
difficulty with concentration or attention. Most reported<br />
adverse events were mild or moderate in severity. In fact,<br />
there were only eight patients who withdrew from this<br />
study due to adverse reactions. Conclusions: TPM was<br />
safe and effective as adjunctive therapy in the treatment<br />
of uncontrolled pediatric epilepsy patients with simple or<br />
complex partial seizures with or without secondary generalization<br />
and LGS.<br />
FP-H-138<br />
Clinical review of severe myoclonic epilepsy in infancy<br />
H.C. Kang, O. Dambajamts, H.D. Kim<br />
Department of Pediatrics, Inje <strong>University</strong>, Sang-gye Paik<br />
Hospital, Seoul, Korea<br />
Rationle: Severe myoclonic epilepsy in infancy (SMEI)<br />
seems to be probably more common than realized, because<br />
it is often overlooked. In addition, the etiology is unknown<br />
and the prognosis is very grave despite of newly developed<br />
anticonvulsants. This study is intended to give a help to<br />
suspect and management with reviewing our experiences<br />
about SMEI. Methods: From April 1995 to April 2002,<br />
subjects were selected by as following criteria; frequent<br />
generalized or focal febrile clonic seizures before the 1st<br />
year of life, subsequent or previous afebrile seizures of<br />
various types including myoclonic seizures, progressive<br />
delayed development from a certain period. We reviewed<br />
retrospectively clinical features such as etiology, change of<br />
seizure types, treatment, prognosis, electrophysiologic<br />
features and MRI findings. Results: Among eighteen<br />
patients enrolled to this study, ten patients were male and<br />
eight were female. The mean age of seizure onset and<br />
duration of seizure were respectively 5.1 months (SD ^ ,<br />
2.8) old and 69.9 months (SD ^ , 32.6). Five patients<br />
(27.8%) had familial tendency of seizure and four<br />
(22.2%) had photosensitivity. With related disease, mitochondrial<br />
cytochrome complex IV deficiency was<br />
confirmed in one patient. In seven patients (38.9%), seizure<br />
had been started with febrile illness and the others with<br />
afebrile seizure. Onset of febrile seizure was from 2 to<br />
11 months old (mean ^ SD, 7.8 ^ 3.0). Those features of<br />
beginning seizures were focal clonic in nine patients<br />
(50.0%), generalized clonic in five (27.8%) and focal<br />
with generalized clonic in four (22.2%), as well subsequent<br />
seizures were atonic in one (1.9%), atypical absence in<br />
6(33.3%), complex partial in 16 (88.9%), partial with<br />
secondary generalization in six (33.3%), generalized clonic<br />
in one (5.6%), generalized tonic clonic in ten (55.6%) and<br />
myoclonic in 18 (100.0%). Myoclonic seizure had been<br />
started from 7 to 48 months old (mean ^ SD,<br />
26.5 ^ 12.1) and persisted in 14 (77.8%) patients. There<br />
were afebrile or febrile status epilepticuses in nine patients<br />
(50.0%). Initial neuroimaging studies were normal in all<br />
patients but subsequently diffuse atrophy and encephalomalatic<br />
change could be seen each in one patient. EEG<br />
features of 14 patients who could have been serially<br />
followed, were initially normal, but diverse abnormal findings<br />
including background abnormalities and epileptiform<br />
discharges have been founded with followed. Duration of<br />
follow up to appearance of EEG abnormalities was from 6<br />
to 86 months (mean ^ SD, 28.2 ^ 21.0). All patients were<br />
intractable to anticonvulsants. Ketogenic diet was introduced<br />
in 13 patients, one patient has been seizure-free<br />
for 7 months, one patient has been reduced seizure<br />
frequency about more than 90%, and six patients about<br />
more than 50%. Among seventeen patients who could be<br />
observed for more over 12 months, 15 (88.2%) had<br />
progressive delayed development, mildly in four (22.2%)<br />
patients, moderately in seven (38.8%), and severely in four<br />
(22.2%). Conclusion: SMEI has progressive and diverse<br />
clinical appearances with grave prognosis. Mitochondrial<br />
cytopathy has to be considered with mechanism of SMEI<br />
and ketogenic diet could be effective to SMEI intractable<br />
to antiepileptic drugs.
538<br />
Abstracts<br />
FP-H-139<br />
Behavioral and psychological problems in pediatric<br />
epilepsy: HOPE study<br />
I.J. Seol a , H.D. Kim b<br />
a Department of Pediatrics, HanYang <strong>University</strong> College of<br />
Medicine; b Department of Pediatrics, InJe <strong>University</strong> Sanggye<br />
Paik Hospital, Seoul, Korea<br />
Purposes: Health outcome of pediatric epilepsy (HOPE)<br />
study aimed to reveal the incidence of various behavioral<br />
and psycho-social disturbances in pediatric epilepsy patients<br />
and to identify the factors related to various behavioral and<br />
psycho-social disturbances. Method: A total of 827 patients<br />
were enrolled from 37 centers during the 6-month study<br />
period. Five questionnaires were given to patients and<br />
their parents who visited epilepsy clinic during the study<br />
period; Korean version of child behavior check list (K-<br />
CBCL), Yale children’s inventory (YCI), family environmental<br />
scale (FES), children’s depression inventory (CDI),<br />
and Piers-Harris children’s self-concept scale. A set of five<br />
questionnaires was filled out by each patient or its parent.<br />
Parents checked out K-CBCL, YCI, and FES and patients<br />
checked YCI and Piers-Harris scale. In case which patients<br />
were too young to understand the questions, YCI and Piers-<br />
Harris scale were excluded but other three scales were<br />
checked by their parents. All scales were analyzed based<br />
on etiology, duration of epilepsy, seizure frequency, number<br />
of AEDs, and presence of complications. Results: Male<br />
patients was 56% and the enrolled patients were 18 years<br />
old and under. Children aged between 6 and 12 years old<br />
was the most with 59%. Based on etiology idiopathic<br />
epilepsy was 78%, crytogenic was 8% and symptomatic<br />
was 14%. Ratio of partial and generalized epilepsy was<br />
65% versus 35%. In terms of number of antiepileptic<br />
drugs (AEDs) 2% of patients did not take any AEDs and<br />
66% of patients had been taking one AED. A total of 32% of<br />
patients had been taking two AEDs and more. Duration,<br />
seizure frequency and number of AEDs were related to<br />
poor results in K-CBCL and YCI. FES showed no significant<br />
difference in all categories. The longer the duration was<br />
the higher CDI score was. In comparison with normal children,<br />
Piers-Harris scale was lower in children with epilepsy.<br />
Conclusions: Various kinds of psycho-social and behavioral<br />
problems are frequently associated with pediatric epilepsy<br />
especially in cases of older age, more frequent seizures,<br />
prolonged duration of treatment and/or using multiple<br />
AEDs.<br />
FP-H-140<br />
Comparative analysis of handedness and footedness in<br />
children with epilepsy<br />
S.R. Ahn, S.O. Nam<br />
Department of Pediatrics, College of Medicine, Pusan<br />
National <strong>University</strong>, Busan, Korea<br />
Purpose: Study for handedness and footedness of patient<br />
with epilepsy is rare. A few studies suggest that left handedness<br />
is more in children with epilepsy. We analyzed correlation<br />
of handedness and footedness of children with epilepsy<br />
according to the cause of epilepsy and site of brain lesion.<br />
Methods: Subjects were 130 epileptic patients who visited<br />
pediatric ambulatory clinic of Pusan National <strong>University</strong><br />
Hospital from June 2001 to August 2001. Controls were<br />
130 children with no history of convulsion or neurologic<br />
problem. We let check them by carrying out and inquiring<br />
ten items about use of hand and foot. We defined as left or<br />
right handedness and footedness by carrying out more than<br />
five items dominantly. We analyzed age, type of seizure,<br />
cause of epilepsy and site of brain lesion in symptomatic<br />
group. Results: In 130 epileptic patients, left handedness<br />
and left footedness were 20.0 and 15.7% which are significantly<br />
higher than 4.0 and 5.6% in control group (P , 0:05).<br />
But there was no significant difference between idiopathic<br />
epilepsy group and control group as 8.9 and 9.3%. However<br />
left handedness in symptomatic epilepsy group was 45.0%<br />
and left footedness was 31.4%, which were significantly<br />
higher than those of control group (P , 0:05). According<br />
to the site of brain lesion in symptomatic group, all patients<br />
with abnormality in left hemisphere showed left handedness,<br />
but only 57% of the patients showed left footedness. In the<br />
patients who have abnormality in both hemisphere or diffuse<br />
brain lesion, left handedness was 25.9% and left footedness<br />
was 36.8%. Concordance rate of left handedness and left<br />
footedness was 80.0% in control group, 87.5% in idiopathic<br />
epilepsy group and 76.9% in symptomatic epilepsy group.<br />
Conclusion: Left handedness and footedness are more<br />
common in epileptic patients than normal control group.<br />
This is mainly due to high proportion of left handedness<br />
and left footedness in symptomatic epileptic patients.<br />
FP-I<br />
Neuromuscular Disorders<br />
FP-I-001<br />
Assessment of the respiratory function in Duchenne<br />
muscular dystrophy patients<br />
A. Lissoni<br />
Valduce Hospital, Como, Italy<br />
Objective: The study is aimed at defining the diagnostic<br />
value and the prognostic reliability of several methods of<br />
respiratory assessment in relation with the progression of the<br />
ventilatory failure in DMD patients. The timely diagnosis and<br />
definition of respiratory insufficiency level arethe basic stepto<br />
start the non-invasive ventilatory support treatment. Methods:<br />
The results of respiratory functional tests carried out on more<br />
than200DMDpatientsina16yearsperiodhavebeenanalysed<br />
and grouped on the basis of the subjects’ age, in a continuum<br />
between the ages of 11 and 31. Mean values and standard<br />
deviations of VC, VC%, MVV, MVV%, Pimax, Pemax,
Abstracts 539<br />
PaO 2 and PaCO 2 were calculated for each age group and<br />
graphs were plotted to show the respective trends. Results:<br />
The diagnostic- prognostic significance of the different tests<br />
changes at different ages: the most appropriate tests as well as<br />
those less significant are identifiable on the basis of the disease<br />
progression. Conclusions: The respiratory assessmentof these<br />
patients is particularly justified from age of 11–12 years on;<br />
between 11 and 20 years VC, VC% and Pimax values are<br />
useful to determine the residual possibilities of the ventilatory<br />
pump. The blood gas analysis, already known to be useful<br />
after the age of 17–18, becomes a guiding criterion in respiratory<br />
function testing after the age of 20. The study of sleep<br />
patterns by oxymetry and transcutaneous capnometry is advisable<br />
after the age of 13 and compulsory after the age of 15.<br />
FP-I-002<br />
Follow up of children with corticospinal tract<br />
involvement in Guillain-Barre syndrome (GBS)<br />
N. Barisic, L. Brcic, R. Likic<br />
Department of Pediatrics, Zagreb Medical School, Clinical<br />
Medical Center Zagreb, Zagreb, Croatia<br />
GBS is characterized by areflexia.Hyperreflexia is<br />
reported in AMAN. We present 13 children with GBS at<br />
the age 14 months–12 years with hyperreflexia or positive<br />
Babinski sign in initial (5/13) or in early recovery period (10/<br />
13) and 2/13 in both periods. The children were examined<br />
clinically and electromyoneurographically 2–5 times successively<br />
during 1–7 years of follow up. Cerebrospinal fluid<br />
protein content was increased initially in seven patients without<br />
pleocytosis. Meningitic syndrome was present in 7/13<br />
children. Compound muscle action potentials (CMAP) in<br />
range 0.1–1 mV (mean 0.39 mV) and motor conduction<br />
(CMNV) ranging 15–33.6 m/s (mean 26.07 m/s) were<br />
decreased in nine children in the initial phase. Neural potentials<br />
and F waves were absent initially in 11 patients. Distal<br />
latency was prolonged in nine patients. On follow up<br />
improvement of CMAP occurred in six children. Improvement<br />
of CMNV was registered in four children. Outcome was<br />
excellent in 7/13 in the period 1 month–7 years. In 1/13<br />
remained spastic monoparesis, while five patients manifested<br />
slight peroneal gait. Hyperreflexia appeared usually in the<br />
recovery period suggesting involvement of upper motor<br />
neurons or spinal interneurons occurring both in GBS of<br />
demyelinating and axonal type in children.<br />
FP-I-003<br />
Motor neuron disease (MND) in a girl associated with<br />
neuropathy, mitochondrial abnormalities and<br />
centromeric deletion of survival motor neuron (SMN)<br />
gene on chromosome 5q13<br />
N. Barisic, J. Sertic, L. Pazanin<br />
Department of Pediatrics, Zagreb Medical School, Clinical<br />
Medical Center Zagreb, Zagreb, Croatia<br />
Childhood SMA is the most common MND. Homozygous<br />
centromeric survival motor neuron (SMNc) gene deletions<br />
are rarely described in SMA but are present in 36% of<br />
lower MND cases. We present a 12-year-old girl of normal<br />
psychomotor development. At the age of 8, she developed<br />
progressive walking difficulties. On examination, peroneal<br />
gait, left leg hypotrophy, radicular pain, absent triceps sure<br />
jerks and bilateral Babinski sign were registered associated<br />
with extensive right leg angiokeratoma. Brain CT and MRI<br />
spinal scan were normal. Clinical and electromyographical<br />
progression of neurogenic lesion and decreasing of motor<br />
nerve conduction occurred during 4 years, followed by<br />
involvement of left upper extremity and development of<br />
cavus foot on the right. Cerebrospinal fluid, immunologic<br />
tests and alpha-galactosidases activity (Fabry disease) were<br />
normal. Increased vascular resistance without stenotic<br />
abnormalities was recorded on both legs by Doppler ultrasonography.<br />
DNA analysis revealed SMNc deletion. Muscle<br />
biopsy showed neurogenic atrophy and accumulation of<br />
abnormal mitochondria. Sural nerve biopsy showed<br />
decreased number of myelinated axons with scarce onion<br />
bulbs. SMNc deletion probably acts as factor of increased<br />
susceptibility for MND. Although SMN gene deletion<br />
detection is useful in atypical SMA it might be coincidental<br />
finding in MND associated with clinical features of other<br />
pathogenetic origin.<br />
FP-I-004<br />
Early onset progressive chronic inflammatory<br />
demyelinating polyneuropathy (CIDP) associated with<br />
CNS demyelination and inflammatory myopathy<br />
N. Barisic, L. Pazanin, Z. Hutinec, L. Sojat-Cvitanovic, M.<br />
Trbojevic-Cepe<br />
Department of Pediatrics, Zagreb Medical School, Clinical<br />
Medical Center Zagreb, Zagreb, Croatia<br />
Chronic inflammatory demyelinating polyneuropathy<br />
(CIDP) is a chronic disorder, which manifests usually<br />
with monophasic or relapsing course. We present a boy,<br />
now at the age of 6, with progressive generalized muscle<br />
weakness since the age of 2, developing after viral infection.<br />
On examination, generalized hypotonia and hypotrophy of<br />
small muscles, peroneal gait, positive Gowers’ sign,<br />
areflexia, and right abducens palsy were registered. Electromyoneurography<br />
showed severe neurogenic lesion, low<br />
compound muscle action potentials, slowed motor nerve<br />
conduction and myopathic pattern in proximal muscles.<br />
Increased protein content was obtained in the cerebrospinal<br />
fluid. Muscle biopsy showed neurogenic atrophy. Sural<br />
nerve biopsy revealed demyelination and onion bulbs.<br />
Inflammatory perivascular CD 3 positive infiltrates were<br />
present in both biopsies. Brain MRI showed cortical atrophy<br />
with hyper intensities of the white matter and gray matter<br />
hypo intensities. Increased serum anti-G M1 (IgM) and anti<br />
G D1b (IgG) antibodies were registered. Very long chain fatty
540<br />
Abstracts<br />
acids, B 12 , folic acid, lactate, and immunologic test were<br />
normal. He rapidly improved on IVIG and methylprednisolone<br />
treatment, while upon tapering off the steroids<br />
complete deterioration occurred. Demyelination might<br />
develop in the central and peripheral nervous system associated<br />
with inflammatory myopathy in patients with<br />
progressive course of CIDP.<br />
FP-I-005<br />
Acute inflammatory polyradiculoneuropathy in<br />
childhood: clinical features, electrophysiological studies<br />
and treatment<br />
S.B. Yahmed, I. Turki, N. Gouider-Khouja, N. Miladi, F.<br />
Hentati<br />
National Institute of Neurology, Tunis, Tunisia<br />
Acute inflammatory polyradiculoneuropathy (AIP) is the<br />
most common form of acute polyneuropathy in Tunisia<br />
since 1992 when acute anterior poliomyelitis was eradicated.<br />
Thirty-six children with acute inflammatory polyradiculoneuropathy<br />
were analysed from 1974 to 2001. The<br />
mean age of onset was 6 years. There was a predominance<br />
of male 2:1. One half had a prodromal illness within a 4-<br />
week period before the onset of AIP. The illness affected the<br />
upper respiratory tract in 27% of patients and gastro-enteritic<br />
infection in 3% of them. Immunization was implicated in<br />
10% of patients. Weakness, particularly of the lower limbs,<br />
was the initial complaint in 89% of patients. In three patients<br />
paresthesias were present without detectable weakness. A<br />
rise in the level of cerebrospinal fluid protein in the absence<br />
of a pleiocytosis was found in 98% of patients. Electrophysiological<br />
studies showed marked slowing of motor conduction<br />
velocities along with prolonged distal latencies<br />
consistent with demyelination in 54% of patients. Axonal<br />
involvement was identified in 17% of patients. Supportive,<br />
symptomatic treatment was the mainstay of therapy until<br />
1995. The last 6 years, a high-dose gammaglobulin (0.4 g/<br />
kg per day for 5 days) was given for the first days of the<br />
disease and has been shown to reduce the duration of the<br />
hospitalization, to avoid respiratory insufficiency and to<br />
limit the extension of the paralysis<br />
FP-I-006<br />
Genetic diagnosis in childhood Duchenne muscular<br />
dystrophy<br />
H. Cai, L.-W. Wang, G.-Z. Xu, J.-X. Wu, Y.-Y. Li, Y.-L.<br />
Zhu<br />
Capital Institute of pediatrics, Beijing, China<br />
Objectives: DMD is the most common hereditary neuromuscular<br />
disease in children. Its incidence is 1:3000 live<br />
born boys whose abnormal gene is on the X chromosome<br />
at the Xq21 locus and is one of the largest gene identified.<br />
Because the genealogical research of childhood DMD have<br />
not been widely reported in our country, our study aimed at<br />
exploring the genealogical gene of the disease as well as the<br />
relationship between the gene deletion and the level of lysosomal<br />
enzymes, establishing the pediatric gene laboratory in<br />
the north area. Methods: By using the method of the PCR,<br />
blood samples from 30 DMD patients and their parents were<br />
screened for the genes deleted. Serum lysosomal enzymes<br />
were detected with biochemical auto analyzer. Results:<br />
There were significant differences in the levels of lysosomal<br />
enzymes between DMD and normal children (P , 0:01).<br />
The positive rate of the gene deletion was 56.7% (17),<br />
among which the positivity rate of No. 55 was 64.7%<br />
(11), the No. 48 was 52.9% (nine), No. 45 was 35.2%<br />
(six), No. 44 was 17.6 (30), No. 12 was 11.8% (two), and<br />
each of Nos. 8, 17, 19 was 5.9% (one). The positivity rate of<br />
monogenic deletion was 47% (eight), multigenic deletion<br />
was 52.9% (nine), and the genes deleted in parents was 0.<br />
Conclusion: (1) Levels of lysosomal enzymes in DMD are<br />
obviously higher than that in healthy children, and<br />
decreased with the severity of DMD. (2) PCR assay was a<br />
convenient and sensitive method for detecting the genes<br />
deleted in DMD. Our result corresponds to the literature<br />
that the rate of multigenic deletion among these patients<br />
are 47%. (3) The result of our research is important for<br />
studying antenatal diagnosis further.<br />
FP-I-007<br />
Mutations in the skeletal muscle a-actin gene in patients<br />
with nemaline myopathy<br />
Y.-J. Jong a , C.-Y. Yuo b , B.S.-C. Mak c , M.-Y. Chung d , S.-P.<br />
Lin e , C.-C. Huang f<br />
a Department of Pediatrics and Clinical Laboratory,<br />
b Department of Biology, Kaohsiung Medical <strong>University</strong>,<br />
Kaohsiung; c Department of Pediatrics, Taichung Veterans<br />
General Hospital, Taichung; d Department of Pediatrics,<br />
Chang Gung Memorial Hospital, Kaohsiung; e Department<br />
of Pediatrics, Mackay Memorial Hospital, Taipei; f Department<br />
of Pediatrics, National Cheng Kung <strong>University</strong> Hospital,<br />
Tainan, Chinese Taipei<br />
Namaline myopathy (NM) is a clinically heterogeneous<br />
condition characterized by the presence of abnormal rodlike<br />
structures in the muscle and ranging in severity from<br />
neonatal onset with early death to adult onset with slow<br />
progression. Recently mutations in the skeletal muscle a-<br />
actin (ACTA1) gene have been found in up to 30% of the<br />
patients with NM. In order to compare the frequency and<br />
position of mutations in the ACTA1 gene in Taiwanese<br />
patients with NM with those in Western countries, we<br />
analyzed the ACTA1 gene for mutations in the six Taiwanese<br />
patients with NM by sequencing PCR products of<br />
genomic DNA containing the coding exons 2–7. We identified<br />
two different heterozygous missense mutations in two<br />
out of the six patients. Both mutations, Tyr69Asn and<br />
Gly197Ser, have not been reported before in patients with
Abstracts 541<br />
NM. In addition, these two mutations gave rise to restriction<br />
digestion variants that were not found in DNA from all<br />
controlled individuals analyzed. We also demonstrated by<br />
DNA sequencing or restriction endonuclease digestion that<br />
the two ACTA1 mutations identified in the patients were de<br />
novo mutations. In conclusion, our results show that the<br />
frequency of the ACTA1 mutation in Taiwanese patients<br />
with NM is similar to that in patients of Western countries.<br />
The identification of two novel mutations in the ACTA1<br />
gene also reflects the genetically heterogeneous nature of<br />
NM.<br />
FP-I-008<br />
Long-term corticoid treatment in Duchenne muscular<br />
dystrophy<br />
B.F. Reitter a , R. Korinthenberg b , M. Stötter c , U. Schara d ,R.<br />
Lindemuth e<br />
Departments of Pediatrics, Universities of Mainz a , Freiburg<br />
b ,Tübingen c , Bochum d , and Homburg/Saar e , Germany<br />
A total of 125 boys with Duchenne muscular dystrophy<br />
have been treated openly and daily with Deflazacort, 0.75<br />
mg/kg resp. Prednisone, 0.9 mg/kg (N ¼ 5). Checks at 3<br />
months intervals: internal and neurological status, timed<br />
motor function tests, blood: cell count, CRP, ALAT,<br />
ASAT, CK, Gluc, Ca, P, bAP, triglycerides, electrolytes;<br />
additionally after 6 months: osteocalcin in urine, ophthalmolog.<br />
control; add. after 12 months: manual muscle test<br />
(twice), joint mobility, bone densitometry, X-ray hand,<br />
ultrasound abdomen, muscles, heart, ECG, spirometry.<br />
Treatment started above age 5 years, has lasted 2 months<br />
to 8:3 years, and was stopped at loss of ambulation (la)<br />
(N ¼ 22, age 7–14 years). Seven boys older than 14 years<br />
are still walking, some still able to hop on one foot. There<br />
was no obvious relation between age at start, duration of<br />
med and la. Effects and side effects varied considerably. In<br />
more than 75% of patients the decline of motor abilities<br />
diminished. Apart from la, medication was stopped only<br />
due to unaccepted weight gain (N ¼ 14), progressing cataract<br />
(N ¼ 1, cataracts total, N ¼ 27), bone fractures (N ¼ 3,<br />
total, N ¼ 7) due to osteopenia. Those who gained weight<br />
above two SD, did so in the 1st year and remained at<br />
approximately the same percentile (PC). Growth fell<br />
below the 3rd PC in all. No increased frequency or severity<br />
of infections were noted. In no case dilative cardiomyopathy<br />
developed. Summarizing, the positive effects outweigh<br />
negative ones in part of the patients; a strict protocol<br />
allows judging the individual balance within 1 year of<br />
treatment.<br />
FP-I-009<br />
Study of the pathgenesis of 31 GBS cases<br />
B. Li, Y.-P. Yang<br />
Shen Zhen Shi Children’s Hospital, Shen Zhen, China<br />
Objective: We measured the serum antibodies IgG and<br />
IgM to ganglioside G M1 in 31 patients with Guillain-Barre<br />
syndrome, in order to study the pathogenesis of GBS. Methods:<br />
We measured the serum antibodies IgG and IgM to<br />
ganglioside G M1 by enzyme-linked immunosorbent assay,<br />
in 31 acute-phase and recovery patients with Guillain-<br />
Barre syndrome (AIDP 23, AMAN eight), with two control<br />
groups (non-GBS neurological diseases and normal<br />
subjects). Results: The results revealed that the serum levels<br />
of anti-G M1 IgG and IgM with GBS were much higher than<br />
those of the other control groups (P , 0:05). Their cerebrospinal<br />
fluid levels also were higher than those of normal<br />
groups (P , 0:05). Conclusion: The finding indicates the<br />
immunological damage caused by gangliosides is an important<br />
factor in GBS, especially in AMAN.<br />
FP-I-010<br />
Genetic heterogeneity of the axonal form of autosomal<br />
recessive Charcot-Marie-Tooth disease (ARCMT2)<br />
Group 1: M.A.M. Salih a , M. Kabiraj b , M. Al-Rayess c ,T.<br />
Maisonobe d , M.H.S. Al-Turaiki e , F.J. Al-Shammary f , J.A.<br />
Urtizberea g , D. Grid h . Group 2: H. Azzedine, A. Brice, E.<br />
LeGuern<br />
Group 1: a Division of Pediatric Neurology, Department of<br />
Pediatrics; b Clinical Neurophysiology Unit; c Department of<br />
Pathology, College of Medicine, Department of Clinical<br />
Laboratory Sciences, College of Applied Medical Sciences,<br />
King Saud <strong>University</strong>, Riyadh; e The JCRPO, Riyadh, Saudi<br />
Arabia, d Service de Neuropathologie, Hopital de La Salpetriere,<br />
Paris; g AFM, Evry and Genethon, Evry, France.<br />
Group 2: INSERM U289, Federation de Neurologie, Hopital<br />
de La Salpetriere, Paris, France<br />
The axonal autosomal recessive phenotype of Charcot-<br />
Marie-Tooth disease (ARCMT2) is relatively frequent in<br />
the Arabian Peninsula and North Africa because of the<br />
high rate of consanguinity. The first locus for ARCMT2<br />
was recently mapped to chromosome Iq21–q21.3 in a<br />
Moroccan family and a mutation in Lamin A/C gene was<br />
reported in Two Algerian families, whereas another locus<br />
was mapped to chromosome 8q21.3 in a Tunisian family<br />
who had an associated pyramidal tract involvement. The<br />
corresponding gene, GDAP1 was identified in three<br />
families from Spain. We describe three consanguineous<br />
families who have eight children (four males and four<br />
females; aged 16 months–13 years) affected with<br />
ARCMT2. Onset was at birth (with foot deformities) in<br />
the first two families (six males and two females) and 6–<br />
7 months in the third family (two females). All patients had<br />
delayed motor development. Cognitive development was<br />
normal in six children belonging to the first two families<br />
who had distal muscle weakness associated with scoliosis<br />
in three of them. The two girls in the third family were<br />
mentally retarded, had epilepsy, showed distal and proximal<br />
muscle weakness and were bed-ridden. In seven exam-
542<br />
Abstracts<br />
ined children, the peroneal motor nerve conduction velocity<br />
ranged between 40.4 and 59.5 m/s and muscle<br />
compound action potential (CAP) was reduced (0.35–<br />
0.56 mV) in five of them. The peroneal CMAPs could<br />
not be recorded in another two patients. The sural sensory<br />
CAP was absent in five cases and abnormal in another two.<br />
The two already known loci for axonal ARCMT were<br />
tested in these three families. These loci were excluded<br />
except the 8q13 locus for the first family. The sequencing<br />
of the coding region of GDAP1 is in progress for this<br />
family. These data further demonstrate the genetic and<br />
phenotypic heterogeneity of the ARCMT2.<br />
FP-I-011<br />
Infantile neuroaxonal dystrophy (INAD). Clinical<br />
spectrum of eleven Brazilian cases, diagnosed through<br />
conjunctival biopsy<br />
S. Rosemberg, D. Fujiwara<br />
Santa Casa of São Paulo Medical School, Department of<br />
Pediatrics, Neuropediatrics Division, São Paulo, Brazil<br />
INAD is a rare neurodegenerative disease whose metabolic<br />
defect is unknown. A recent review disclosed only 44<br />
reported cases between years 1990 and 2000. The diagnosis<br />
is based on the finding of spheroid bodies of peripheral<br />
axons on ultrastructural level. We studied 11 patients diagnosed<br />
through conjunctival biopsies. There were six females<br />
and five males. All came from unrelated families. Consanguinity<br />
was present in six cases. The age of onset varied<br />
between 6 and 24 months (mean: 15 m). The ages at the time<br />
of the diagnosis varied between 20 months and 6.5 years.<br />
The time elapsed between onset and diagnosis varied from 4<br />
months and 6.5 years (mean: 2 years 8 months). The disease<br />
started insidiously, with initial arrest followed by loss of the<br />
psychomotor development. Only one patient achieved independent<br />
walk. At admission, all patients were profoundly<br />
demented. Only a few had some visual contact. The major<br />
neurological sign concerned a severe global hypotonia particularly<br />
prominent in the inferior limbs. In five cases, the<br />
patients presented a ‘frog position’ being almost paraplegic.<br />
Tendon reflexes were hypoactive or absent in seven cases<br />
and brisk in four. Babinski sign was found in all patients. All<br />
patients but one presented brisk, rapid, irregular movements<br />
of the eyeballs. Head circumference was normal even in<br />
older patients. CSF was always normal. Funduscopic<br />
exam disclosed optic atrophy in ten patients. EMG<br />
(n ¼ 6) showed denervation in five. Cranial TC or MRI<br />
revealed cerebellar atrophy in all cases. Two patients died<br />
at ages 6 and 8 years. In summary, a child presenting with<br />
slowing of psycho-motor development beginning under 2<br />
years, severe hypotonia mainly of the lower limbs, abnormal<br />
ocular movements, optic atrophy, denervation and cerebellar<br />
atrophy is highly suspected of having INAD and an<br />
ultrastructural exam of the nerve terminals should be<br />
performed.<br />
FP-I-012<br />
Peripheral neurophysiological and neuropathological<br />
studies in Charcot-Marie-Tooth atrophy disease in<br />
children<br />
J.-L. Lu<br />
Department of Neurology, Beijing Children Hospital, Beijing,<br />
China<br />
Objective: Charcot-Marie-Tooth atrophy disease (CMT)<br />
is one of the most common hereditary neuropathies in children.<br />
The diagnosis will be difficult because of lacking the<br />
available and specific genetic tests. In this study, the authors<br />
characterized the clinical features of CMT in children and<br />
analyzed the value of the neurophysiology test and the sural<br />
nerve biopsy in the diagnosis and classification of different<br />
subtypes of CMT. Methods: Fifteen patients with CMT were<br />
investigated during the years 1991–1999. Their clinical and<br />
experimental data, including nerve conduction studies,<br />
somatosensory and brainstem auditory evoked potentials<br />
and nerve pathology study were analyzed. Results: All 15<br />
patients (eight males and seven females) were characterized<br />
by progressive weakness of four or two extremities, the<br />
course of the disease varying from 1 to 11 years; three of<br />
15 patients had a family history of CMT. The patients were<br />
classified into CMT type I (hypertrophic type) and CMT<br />
type II (neuronal type) according to the neurophysiological<br />
and pathological criteria. The following features were found<br />
in CMT type I patients: the average age of onset at 2.2 years<br />
of age, all extremities involvement in seven, pes cavus in<br />
eight, the appearance of stork leg in five, sensory abnormalities<br />
in three. Five patients showed a decreased nerve<br />
conduction velocity (12–38 m/s); six patients showed<br />
demyelination in their sural nerves (moderate changes in<br />
five and severe in one), onion bulb formations were found<br />
in two patients. CMT type II was found in seven patients<br />
with the following features; average age of onset at 7 years,<br />
all extremities involvement and reduced amplitudes of<br />
compound muscle active potential without conduction slowing.<br />
The sural nerve biopsy in three patients demonstrated a<br />
chronic axonal neuropathy. Conclusion CMT can be classified<br />
into two subtypes. The peripheral neurophysiology test<br />
is a reliable method to diagnose and classify CMT, while the<br />
sural nerve biopsy may further support the diagnosis and<br />
confirm the subtype classification.<br />
FP-I-013<br />
Clinical and genetic profile of spinal muscular atrophy in<br />
Oman<br />
R. Koul<br />
<strong>University</strong> Hospital, BW-1, Children ward one, Alkhod,<br />
Oman<br />
Oman is one of the Gulf countries with a population of<br />
about 1.5 million. In last 10 years about 60 patients of spinal
Abstracts 543<br />
muscular atrophy in children were seen, majority being<br />
Werdnig-Hoffmann disease. There was positive family<br />
history in large number of cases. The genetic work up was<br />
started in last few years. A detailed clinical and genetic<br />
work up will be presented.<br />
FP-I-014<br />
Outcome of Guillain-Barre syndrome in children: Pre<br />
and post intravenous immunoglobulins (IVIG) era<br />
R. Koul<br />
<strong>University</strong> Hospital, BW-1, Children ward one, Alkhod,<br />
Oman<br />
Oman is one of the Gulf countries with a population of<br />
about 1.5 million. Forty-one children were prospectively<br />
followed from 1992 till December 2001. All received<br />
IVIG 400 mg per kg per day for 5 days. Eight children<br />
before 1992 did not receive IVIG and were picked up retrospectively<br />
from medical records. There was not much difference<br />
in age group, sex distribution and onset of weakness in<br />
both the groups. There was a significant difference in other<br />
parameters. The hospital stay was prolonged in preIVIG<br />
group (mean of 45.4 days) as compared to post IVIG<br />
group (20.4 days). Three out of eight (37.5%) required<br />
ventilation in preIVIG group while 19.5% in post IVIG.<br />
Residual neurologic deficit was 43 % in preIVIG as<br />
compared to 5% in post IVIG group. One child died in<br />
preIVIG group (12.5%) and there was no mortality in the<br />
post IVIG group though the number of patients was five<br />
times larger. IVIG has definitely improved the outcome in<br />
Guillain-Barre syndrome.<br />
FP-I-015<br />
Juvenile onset dentatorubral pallidoluysian atrophy:<br />
follow-up MPI findings<br />
T. Nakayama, H. Oguni, M. Funatsuka, M. Osawa<br />
Department of Pediatrics, Tokyo Women’s Medical <strong>University</strong>,<br />
Tokyo, Japan<br />
Purpose: Dentatorubral pallidoluysian atrophy (DRPLA)<br />
is a rare autosomal dominant neurodegenerative disorder<br />
that is mostly prevalent in Japan. Although the clinical,<br />
neouropathological and neuroradiologic findings of adult<br />
onset DRPLA have been well described, they are poorly<br />
understood in childhood onset DRPLA. In this study, we<br />
analyzed the MRI findings, including sequential MRI<br />
changes with age, to reveal the relationship between clinical<br />
symptoms and neuroradiologic findings in childhood onset<br />
DRPLA. Subjects: The subjects were four patients with<br />
childhood onset DRPLA diagnosed by molecular biological<br />
method. The expansion number of CAG repeats ranged<br />
from 68 to 71. The age of onset of clinical symptoms ranged<br />
from 6 to 11 years, with intellectual deterioration in two and<br />
seizures in two. The follow-up period was from 22 to 24<br />
months with a mean of 18.5 months. Method: MRI scan was<br />
performed with T1, T2, FLARE method with 7-mm slices.<br />
The axial, coronal and sagittal planed were recorded.<br />
Results: A total of 16 MRI imaging studies were performed,<br />
ranging from 3 to 9 in each patient. Progressive atrophy of<br />
the cerebrum and cerebellum, and enlargement of the<br />
lateral, third, and fourth ventricles were observed, which<br />
correlated with the progression of dementia and ataxia.<br />
Restoration of the red nucleus was not observed. Conclusion:<br />
The degree of progressive cortical atrophy and enlargement<br />
of the ventricles roughly corresponded to the degree<br />
of dementia and ataxia. None of our patients showed involvement<br />
of the basal ganglia, which may be related to the<br />
lack of involuntary movement in our cases.<br />
FP-I-016<br />
Myasthenia gravis in Chinese children: Hong Kong<br />
perspective<br />
C.-W. Fung, B.H.-Y. Chung, V.C-N. Wong<br />
Department of Paediatrics, The <strong>University</strong> of Hong Kong,<br />
Queen Mary Hospital, Hong Kong, China<br />
This study aims to analyze the clinical features, investigations,<br />
treatment strategies and outcome of Chinese children<br />
with myasthenia gravis (MG) in Hong Kong. A<br />
comparison was made between Chinese and Caucasians.<br />
Fifty-seven children with MG were identified in our unit<br />
from 1992 to 2002. The records were reviewed. Out of the<br />
57 children, the female to male ratio was 6 to 4. Fifty<br />
patients (88%) had ocular MG while the remaining ones<br />
had generalized MG. The mean age of onset of the disease<br />
was 4.1 years old. Only four patients (7%) had identifiable<br />
precipitating factors such as respiratory tract infections.<br />
Majority of the patients presented with unilateral or bilateral<br />
ptosis. Anti-acetylcholine receptor antibodies were positive<br />
in 29 patients (52%). All the 57 children received anticholinesterase<br />
initially. Only 13 of them (23%) required addition<br />
of steroid therapy. Four patients (7%) required<br />
intravenous immunoglobulin therapy and thymectomy was<br />
performed in six patients (10%). Thirty-one children<br />
(54.4%) entered into remission. Among this group, nine<br />
(29%) had relapse. In conclusion, considerable differences<br />
were observed among Chinese and Caucasians in the clinical<br />
presentations and outcome of this disease.<br />
FP-I-017<br />
Nerve conduction studies in Guillain-Barre syndrome of<br />
children<br />
Q. Zhang, L. Wang<br />
Children’s Hospital, Chonqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: To investigate the nerve conduction changes in<br />
GBS patients, the nerve conduction records of 162 children
544<br />
Abstracts<br />
with GBS from 1994 to 2001 were retrospectively studied.<br />
All patients came from rural area or suburbs of southwest<br />
China, including 110 males and 52 females. The onset of<br />
disease was from 9 months to 16 years (43 cases were less<br />
than 3 years; 119 cases were older than 3 years). Results:<br />
The nerve conduction studies suggested that 44 patients<br />
(27.1%, group A) were categorized as acute inflammatory<br />
demyelinating polyneuropathy (AIDP); 77 patients (47.6%,<br />
group B) were recognized as acute motor axonal neuropathy<br />
(AMAN); 41 patients (25.3%, group C) were classified as<br />
AMSAN. The electrophysiologic abnormalities were<br />
detected within the 1st week in 88 of 162 cases (54.3%).<br />
Among them, 22 cases (25%) were less than 3 years, 66<br />
cases (75%) were older than 3 years. Three nerve conduction<br />
patterns detected in two different age groups were similar.<br />
Thirty-four patients were followed up for a period from<br />
1 month to 2 years. Five of 34 (14.7%) still had the nerve<br />
electrophysiologic abnormalities, among them four cases<br />
(11.8%) were in group A, 17 cases (50%) in group B, and<br />
eight cases (23.5%) in group C. Conclusions: This study<br />
suggested that AMAN was the most common type in children<br />
with GBS, it is also not easy to recover; nerve conduction<br />
detection was valuable for GBS early diagnosis, even to<br />
infant and child patients.<br />
FP-I-018<br />
Secondary merosin deficiency CMD linked to<br />
chromosome 19 in two Tunisian families<br />
C. Triki, N. Louhichi, S. Rouissi, M. Méziou, C. Mhiri, H.<br />
Ayadi, F. Fakhfakh<br />
Department of Neurology and Laboratory of Human Biological<br />
Molecular, Sfax, Tunisia<br />
Congenital muscular dystrophy (CMD) is a heterogeneous<br />
group of muscular disorder characterized by autosomal<br />
recessive mode of inheritance. The CMD have been classified<br />
according to the involvement of the brain and the eyes. It<br />
is apparent that defects in different genes are responsible for<br />
each type. We have studied two cases affected with CMD and<br />
belonging to two Tunisian families. These patients have<br />
benefited from complete clinical investigation. Immunohistochemical<br />
and Western blot analyses on muscles biopsies<br />
was performed using antibodies against human merosin 80<br />
and 300 fragments. Linkage analysis was undertaken for<br />
members of two consanguineous families using microsatellite<br />
markers spanning LAMA2 (6q22), FCMD (9q31), MEB<br />
(1p32), CMD 1B (1q42) and FKRP (19q13.3) loci. Clinical<br />
investigation of the two patients showed severe motor delay,<br />
mental retardation and calf hypertrophy. Cranial MRI<br />
showed white matter abnormalities in two patients associated<br />
with cerebellar cysts and vermis hypoplasia in one case.<br />
Immunohistochemical and Western blot analyses revealed<br />
a partial deficiency of merosin in the two cases. DNA analysis<br />
excludes linkage to chromosomes 6, 9 and 1 and showed a<br />
linkage to chromosome 19q13.3.<br />
FP-I-019<br />
Genetic and immunohistochemical studies of congenital<br />
muscular dystrophy<br />
M. Yoshioka a , T. Toda b , I. Nishino c<br />
a Section of Pediatric Neurology, Kobe City Pediatric and<br />
General Rehabilitation Center for the Challenged, Kobe;<br />
b Division of Functional Genomics, Osaka <strong>University</strong> Graduate<br />
School of Medicine, Osaka; and c National Institute of<br />
Neuroscience, National Center of Neurology and Psychiatry,<br />
Tokyo, Japan<br />
The CMD are a heterogeneous group of autosomal<br />
recessive disorders presenting in infancy with muscle<br />
weakness, contractures, and dystrophic changes on skeletal-muscle<br />
biopsy. Recently, a selective deficiency of<br />
highly glycosylated alpha-dystroglycan (a-DG) became<br />
apparent in several forms of CMD, including FCMD,<br />
muscle-eye-brain disease, CMD with mutations in the<br />
fukutin-related protein gene and myd mouse. A-DG is a<br />
peripheral membrane protein linking the extracellular<br />
basal lamina to the cytoskeletal proteins. In Japan, most<br />
CMD patients have FCMD, characterized by severe CMD<br />
associated with brain and eye malformations. Here, we<br />
analyzed three Japanese patients from two families with<br />
FCMD-phenotype. Full mutational analysis of the fukutin<br />
gene, however, revealed neither 3 kb insertion (Japanese<br />
founder mutation) nor point mutation. RT-PCR analysis of<br />
RNA isolated from lymphoblasts of a patient revealed a<br />
normal expression of the FCMD transcript. As classification<br />
of CMD should be based on the genetic background,<br />
our present cases might be a new variant of CMD. Immunohistochemical<br />
analysis of dystrophic muscle in one<br />
patient revealed a selective deficiency of a-DG, but not<br />
beta-DG, merosin, sarcoglycan or dystrophin. These findings<br />
raise the possibility that the abnormality of a-DG is<br />
integral to the pathology in this variant of CMD.<br />
FP-I-020<br />
Benign acute childhood myositis<br />
F.M. Aynacı, M.Çakır, Ş. Yayla<br />
Karadeniz Technical <strong>University</strong>, Faculty of Medicine, Dept<br />
of Child Neurology, Trabzon, Turkey<br />
Six children, one girl and five boys, aged 3–9 years,<br />
were admitted with benign acute childhood myositis during<br />
January–February 2002. They presented with an acute<br />
onset of symmetrical calf muscle pain and tenderness,<br />
weakness and inability to walk a few days after upper<br />
respiratory tract infection. Serum creatine kinase and<br />
aspartate aminotransferase were increased all cases. Viral<br />
studies included throat swab for nasopharyngeal aspirate<br />
was done in one case and found to be negative for influenza<br />
A and B. Full clinical recovery was achieved within<br />
12 h–3 days.
Abstracts 545<br />
FP-I-021<br />
Persistent toe-walking, pain and stiffness as leading<br />
symptoms of hereditary neuropathy with liability to<br />
pressure palsies (HNPP)<br />
T. Lönnqvist, H. Pihko<br />
Hospital for Children and Adolescents, <strong>University</strong> of<br />
Helsinki, Finland<br />
Although molecular determination of the chromosome<br />
17p11.2 deletion in conjunction with electrophysiology are<br />
powerful tools in the diagnosis of hereditary neuropathy with<br />
liability to pressure palsies (HNPP), this neuropathy is underdiagnosed,<br />
especially in children. Most patients present with<br />
mononeuropathies related to mild pressure trauma, but some<br />
present with chronic generalized neuropathy. Clinically<br />
atypical forms of HNPP have been described including<br />
CMT-like polyneuropathy, chronic recurrent inflammatory<br />
demyelinating polyneuropathy, and respiratory failure with<br />
proximal muscle weakness. We present an atypical HNPP<br />
case with very persistent, asymmetric secondary toe-walking<br />
together with pain and stiffness especially in the legs. Our<br />
patient is a previously healthy boy, the only child of healthy<br />
parents, who came to our hospital because of secondary toewalking<br />
at the age of 3.5 years. He had walked normally<br />
without support since 12 months of age, but after an episode<br />
of limping of his left leg for a week at the age of 3 years, he<br />
started to walk on his toes. The clinical examination revealed<br />
an alert boy, whose psychomotor development was normal,<br />
but who persisted to walk on toes. His calves were thick, the<br />
ankles were rigid, and the deep tendon reflexes were exaggerated<br />
in the lower extremities with positive Babinski sign<br />
in the left. A central nervous system process was excluded by<br />
normal brain and spinal MR image, peripheral neuropathy<br />
with normal EMG and muscle dystrophy with EMG and<br />
normal serum concentrations of creatine kinase and transaminases.<br />
Physiotherapy was started with plaster cast treatment<br />
in both legs. In spite of the treatment, and especially<br />
when physiotherapy was discontinued, our patient preferred<br />
toe-walking and suffered from muscle pain and stiffness in<br />
the mornings. Hard exercise in the previous day worsened the<br />
pain. During the follow-up the symptoms and findings were<br />
asymmetric being more severe in the left. At the age of 7<br />
years, when the boy started to go to school, a new symptom<br />
appeared: his hands became weak, when he exercised writing.<br />
At the same time his father complained of numbness in<br />
his hands after hard work. He also told that his sister had had a<br />
brachial plexus nerve entrapment, which was cured without<br />
any treatment in a couple of months. This information after 5<br />
years follow-up made us to perform DNA tests, which<br />
revealed 17p11.2 deletion in the patient, his father and his<br />
paternal aunt and grandmother. To conclude it is important to<br />
remember possibility of HNPP in young patients with persistent,<br />
asymmetric toe-walking added with muscle pain and<br />
stiffness.<br />
FP-I-022<br />
Study of radial nerve conduction in children recording<br />
with surface electrode<br />
L. Wang, F.-C. Cai<br />
Children’s Hospital, Chongqing <strong>University</strong> of Medical<br />
Sciences, Chongqing, China<br />
Objective: To explore the reliability recording radial<br />
nerve conduction with surface electrode in children and to<br />
investigate the norms and the maturation course of radial<br />
conduction in children. Methods: (1) A comparative study in<br />
40 children with different ages at same radial nerve for the<br />
reliability to record radial motor nerve conduction with<br />
surface and also needle electrodes; and (2) maturation<br />
course and norms of motor and sensory conduction of radial<br />
nerve recorded by surface electrode on the basis of data of<br />
128 children aged 0–14 years old. Results: (1) A clear<br />
pattern of complex motor active potential (CMAP) was<br />
recorded by surface electrodes as by the needle electrodes<br />
in all of the tested children regardless their age. The value of<br />
motor conduction velocity (MCVs) and latencies were<br />
highly consistent by both methods. (2) With surface recording,<br />
CMAPs were well presented in all age groups including<br />
neonate. F waves could be obtained also in all subjects if<br />
moving recording electrode to the proximity of upper extremity.<br />
However it was hard to record a sensory nerve potential<br />
(SNP) of radial nerve in infants younger than 6 months<br />
of age, but the incidence of SNPs were increased to 50%<br />
with age before 3 years old and still less than 90% in older<br />
children; (3) a series of norms of radial nerve conduction<br />
tested with surface electrode in children, including MCV,<br />
SCV, distal latencies, amplitudes and duration of CMAPs<br />
and SNAPs were obtained. A two-thirds level of MCV as<br />
the young adult had been reached at birth, there were no<br />
significant difference between the levels of MCV in 3 years<br />
old group and in the older age groups. As MCVs, a similar<br />
maturational course for SCV was demonstrated. Conclusion:<br />
Motor nerve conduction of radial nerve could be satisfyingly<br />
recorded with surface electrodes, instead of needle<br />
electrodes, in children at any age. It could be the most<br />
advantage to promote its clinical use in pediatric population<br />
due to their non-injury operation.<br />
FP-I-023<br />
Physiological and pathological studies in Charcot-<br />
Marie-Tooth disease in children<br />
J.-L. Lu, H.-S. Wu, Z.-Q. Lang<br />
Department of Neurology, Beijing Children’s Hospital,<br />
Beijing, China<br />
Objective: Charcot-Marie-Tooth disease is one of the<br />
most common hereditary neuropathies in children. The<br />
diagnosis can be difficult due to the lack of availability of<br />
specific genetic tests. In this study, we characterized the
546<br />
Abstracts<br />
clinical features of this illness in children and analyzed the<br />
value of neurophysiology and sural nerve biopsy in the<br />
diagnosis and classification of different subtypes. Method:<br />
Fifteen patients with CMT were investigated between 1991<br />
and 1999. Their clinical and experimental data, including<br />
nerve conduction studies, somatosensory and brainstem<br />
auditory evoked potentials and nerve pathology study<br />
were analyzed. Results: All 15 patients (eight male, seven<br />
female) were characterized by progressive weakness of four<br />
or two extremities, the course of disease varying from 1<br />
through 11 years; three of the patients had a family history<br />
of CMT. The patients were classified into CMT type I<br />
(hypertrophic type) and CMT type II (neuronal type)<br />
according to neurophysiological and pathological criteria.<br />
The following features were found in CMT type I patients:<br />
average age of onset at 2.2 years of age, all extremities<br />
involved in 7, pes cavus in eight, the appearance of stork<br />
leg in five, sensory abnormalities in three. Five patients<br />
showed a decreased nerve conduction velocity (12–38 m/<br />
s); six patients showed demyelination in their sural nerves<br />
(moderate changes in five and severe in one), onion bulb<br />
formations were found in two patients. CMT type II was<br />
found in seven patients with the following features: average<br />
age of onset at 7 years, involvement of all extremities in<br />
three, pes cavus in five and stork leg in three patients; all<br />
patients showed reduced amplitudes of compound muscle<br />
active potentials without conduction slowing. Sural nerve<br />
biopsy in three patients demonstrated a chronic axonal<br />
neuropathy. Conclusion: CMT is characterized by chronic<br />
progressive weakness and atrophy in all or lower extremities<br />
and it can be classified into two subtypes. The neurophysiological<br />
and pathological features were corresponded with<br />
chronic demyelinating neuropathy in type I and axonal<br />
neuropathy in type II. Electrophysiological test is a reliable<br />
method for diagnosing and classifying different subtypes.<br />
Sural nerve biopsy provides objective evidence in making<br />
adefinitive diagnosis.<br />
FP-I-024<br />
The study of the value of SEP for diagnosis in pediatric<br />
paralysis<br />
N. Xiao, X.-H. Lan, C.-G. Feng, L. Wang<br />
Department Neurology, Children’s Hospital, <strong>University</strong> of<br />
Medical Sciences, Chongqing, China<br />
Objective: To explore the diagnostic value of somatosensory<br />
evoked potentials (SEP) for children with paralysis.<br />
Method: Comparing the normal data of SEP along median<br />
and posterior tibial nerves in 180 healthy children aged 0–14<br />
years old, the SEP of 335 patients aged from 2 months to 14<br />
years old with extremity paralysis were analyzed and<br />
compared. Results: Among the 266 subjects with spastic<br />
paralysis, abnormal SEP was present in 230/266 cases<br />
(86.5%). The latent period records of spinal and/or scalp<br />
SEP peak were showed delay or complete absence, but<br />
their peripheral potentials were still within normal range.<br />
The SEP abnormalities were higher in 92.6% (25/27) of<br />
spinal diseases cases and 86.3% (139/161) of cerebral<br />
palsy cases. Both were more than those in other CNS<br />
diseases. In the cases with intracranial lesions, the abnormal<br />
SEP in supratentorial lesions were more common than that in<br />
postfovea lesion. In the 69 children with flaccid paralysis,<br />
20.3% (14/69 patients) presented abnormal peripheral potentials<br />
of SEP. Comparing the abnormalities rate of SEP, there<br />
was no significant difference between the two age groups,<br />
older and younger than 3 years old. Conclusion: The results<br />
of the study indicate that SEP was very important to determine<br />
the possible site of lesions pathologically particularly<br />
for spinal and cortical lesions. It was suggested that SEP was<br />
also a valuable diagnostic test for the paralysis in infants.<br />
FP-I-025<br />
Evaluation of the reasons of delayed diagnosis in<br />
Duchenne muscular dystrophy patients<br />
S. Kurul, E. Dirik<br />
Dokuz Eylül <strong>University</strong> Faculty of Medicine, Department of<br />
Pediatric Neurology, Izmir, Turkey<br />
Duchenne muscular dystrophy is a severe X-linked recessive<br />
neuromuscular disease that causes death in the second or<br />
third decade. The clinical manifestations are not recognized<br />
until 3–4 years of age. The early diagnosis of this incurable<br />
disease allows potential benefits including the avoidance of<br />
distressing diagnostic delays, enabling the family to plan for<br />
future pregnancies and prenatal diagnosis, and the offer of<br />
physiotherapy at an early stage. This study has shown that the<br />
diagnosis continues to be delayed. The failure to recognize<br />
the walking problems by families and doctors in affected<br />
boys has been found to contribute to the late diagnosis of<br />
this disorder. We conclude that all clinicians involved in<br />
the assessment of children including general practitioners,<br />
orthopedists and pediatricians should recognize the common<br />
patterns of presentation of children with Duchenne muscular<br />
dystrophy and either refer to a paediatric neuromuscular<br />
diseases center or measure creatine kinase level.<br />
FP-I-026<br />
A clinical description of cases of acute flaccid paralysis<br />
reported in Malaysia over a 5 year period of surveillance<br />
from 1997 to 2001<br />
T.G.S. Thomas c , M.T. Arif a , H. Ihmi b , S. Ali b , T.B. Khoo c ,<br />
D. Kurup b , M. Sinniah b<br />
a Chairman and b Members, Poliomyelitis eradication expert<br />
review committee, Ministry of Health, Malaysia; c Paediatric<br />
Neurology Clinic, Paediatric Department, Penang<br />
Hospital, Penang, Malaysia<br />
Objective: The nation-wide surveillance for acute flaccid<br />
paralysis (AFP) was implemented in Malaysia in 1995 and
Abstracts 547<br />
further intensified in 1996 as part of the World Health<br />
Organisation (WHO) certification process for polio eradication<br />
in the Western Pacific region. Clinical data on AFP<br />
cases during a 5-year surveillance period from 1997 to<br />
2001 were collected and analysed. Results: 517 cases of<br />
AFP were reported during the surveillance period; the<br />
overall rate of AFP was 1.38 per 100 000 children below<br />
15 years old. The major clinical diagnoses associated with<br />
AFP were Guillain-Barre syndrome (29.4%), central<br />
nervous system infection (16.2%), transverse myelitis<br />
(10.6%), non-polio enterovirus infection (6.2%), and hypokalaemic<br />
paralysis (5.2%). There was an excess of CNS<br />
infections and non-polio enterovirus infection due to enterovirus<br />
71 infections occurring in 1997 and in the year<br />
2000. There were no cases of poliomyelitis due to wild<br />
poliovirus, based on the WHO virological classification.<br />
Three cases were ‘polio compatible’ and 61 cases<br />
(11.8%) remained unclassifiable as ‘non-polio AFP’.<br />
There were no cases attributed to vaccine-associated<br />
paralytic polio. Conclusion: These data suggest the absence<br />
of circulation of wild poliovirus in Malaysia from 1997 to<br />
2001. The Malaysian AFP surveillance mechanism has<br />
improved over the years though there was still a need to<br />
improve on the adequacy of stool specimens collected and<br />
post-paralytic clinical follow-up.<br />
FP-I-027<br />
A case of opsoclonus-myoclonus syndrome: a molecular<br />
observation on pre-and-post treatment of high dose<br />
steroid therapy<br />
K. Oishi a , H.J. Okano b , T. Tokoro a , M. Kurauchi c ,H.Ota a,c<br />
a Department of Pediatrics, Jikei <strong>University</strong> School of Medicine,<br />
Tokyo; b Department of Physiology, Keio <strong>University</strong><br />
School of Medicine, Tokyo; c Department of Pediatrics,<br />
Kanagawa Prefectural Atsugi Hospital, Atsugi, Japan<br />
Introduction: Opsoclonus-myoclonus syndrome (OMS)<br />
is a rare disorder with abnormal eye movement, cerebellar<br />
ataxia and myoclonus. The onset is acute and the outcome<br />
is variable depending on the severity of the disease and the<br />
response to therapies. The pathogenesis is still unknown.<br />
However, the clinical response to immunotherapy and the<br />
expression of autoantibodies suggest that dysregulation of<br />
the immune system is involved. Objective: To investigate<br />
the pathogenesis and the efficiency of the treatment, we<br />
analyzed the expression level of autoantibodies in our<br />
patient. Methods: A 2 year-old female of OMS was treated<br />
with high dose steroid (30 mg/kg of intravenous methylprednisolone)<br />
for 3 days. Sera were obtained before and<br />
after the therapy, and were used for Western analysis.<br />
Mouse tissue lysates were used for this assay. Results:<br />
The treatment was successful, and all of the symptoms<br />
disappeared in 2 months. She has been well with several<br />
episodes of minor recurrence on a low dose of steroid.<br />
Autoantibodies were detected in serum from the patient<br />
before therapy. Their targets were 75 and 85 kD proteins<br />
in the cortex, cerebellum, and midbrain. The expression<br />
level was dramatically decreased by the therapy. Conclusion:<br />
Autoantibody was detected in our patient and their<br />
expression levels were decreased with high dose steroid<br />
therapy. This coincided with an improvement in clinical<br />
symptoms. This suggested that high dose steroid therapy<br />
was effective in reducing the expression of autoantibodies<br />
and monitoring<br />
FP-I-028<br />
Focal critical illness neuropathy in children<br />
M.J. Tan, R.H. Kandler, P.S. Baxter<br />
Sheffield Children’s Hospital, Western Bank, Sheffield,<br />
United Kingdom<br />
We describe a hitherto unrecognised association of focal<br />
neuropathy with critical illness. Four children requiring<br />
intensive care for critical illness developed clinical and electrophysiological<br />
features of focal neuropathy. Signs have<br />
persisted with some partial recovery in three. Two had a<br />
generalised polyneuropathy as well, which recovered.<br />
None had deletions in the CMT1a region on chromosome<br />
17. Patient 1 (girl 2 years) had right peroneal nerve palsy<br />
diagnosed 6 months after culture positive meningococcal<br />
septicaemia which required ventilation for 10 days, complicated<br />
by focal skin necrosis, encephalopathy, a generalised<br />
movement disorder and a right hemiparesis. She had a deep<br />
necrotic lesion over the head of the right fibula. Patient 2<br />
(boy 6 years) had right peroneal nerve palsy diagnosed 5<br />
months after type C meningococcal septicaemia, requiring<br />
ventilation for 15 days and complicated by DIC, renal failure,<br />
focal skin necrosis, and central motor signs. Patient 3<br />
(girl 14 years) had right peroneal nerve palsy diagnosed<br />
after resolution of right calf compartment syndrome requiring<br />
fasciotomy, complicating type C meningococcal septicaemia.<br />
She also developed adult respiratory distress<br />
syndrome and polyneuropathy, requiring ventilation for 2<br />
months. Patient 4 (girl 13 years) had left peroneal and tibial<br />
nerve palsies following acute focal myositis associated with<br />
influenza A infection, which also caused severe asthma<br />
requiring ventilation for 5 days. She had electrophysiological<br />
evidence of a generalised axonal polyneuropathy which<br />
recovered. We suggest that peripheral nerves already at risk<br />
from critical illness neuropathy are more susceptible to<br />
damage from local pressure.<br />
FP-I-029<br />
Spinal muscular atrophy type I, hypertension and<br />
neuropathy: a case report<br />
M. Sahin, D. Dayangac, G. Haliloglu, H. Erdem, H.<br />
Topaloglu<br />
Hacettepe Children’s Hospital, Department of Pediatric<br />
Neurology, Ankara, Turkey
548<br />
Abstracts<br />
Spinal muscular atrophy (SMA) is an autosomal recessive<br />
disorder characterized by progressive loss of motor neurons<br />
of the spinal cord. There are three types defined according to<br />
age of onset of symptoms, clinical course and different clinical<br />
severity. Homozygous mutations or deletions in telomeric<br />
copy of survival motor neuron gene located on<br />
chromosome 5q are found in more than 90% of the patients<br />
in the classical form. SMA type I begins in the first few<br />
months of life, muscle weaakness is predominantly proximal<br />
and the facial muscles are spared. The criteria for differentiating<br />
SMA type I from non-5q-linked diseases include<br />
involvement of extraocular muscles and diaphragm and<br />
pronounced facial weakness. A 2-month-old male infant<br />
was admitted to our hospital with respiratory insufficiency<br />
and hypotonia. There was first degree consanguinity. He had<br />
signs of congestive heart failure, bilateral metacarpophalangeal<br />
contractures, tongue fasciculations, abdominal breathing,<br />
hypotonic posture, and absent deep tendon reflexes. His<br />
blood pressure was 160/85 mmHg. Congenital hypomyelinating<br />
neuropathy, hereditary sensorymotor/autonomic<br />
neuropathies were included in the differential diagnosis<br />
besides SMA type I. Molecular analysis revealed that SMA<br />
gene deletion was positive and EMG showed severe and<br />
diffuse motor demyelinating neuropathy with secondary<br />
axon loss, mild sensory polyneuropathic involvement and<br />
active neurogenic process. SMA gene deletion, axonal<br />
neuropathy and hypertension were reported in two families<br />
before. In our patient, presence of severe demyelinating<br />
neuropathy, SMA, contractures and hypertension can be a<br />
different clinical entity.<br />
FP-I-030<br />
Merosin-positive congenital muscular dystrophy:<br />
characteristics of 59 patients. Hacettepe experience<br />
G. Haliloglu, B. Talim, E. Demir, M. Yetuk, G. Kale, H.<br />
Topaloglu<br />
Hacettepe Children’s Hospital, Department of Pediatric<br />
Neurology, Ankara, Turkey<br />
CMD are a heterogenous group of autosomal recessive<br />
disorders characterized by early-onset muscle weaakness,<br />
hypotonia, joint contractures and a myopathic and/or a<br />
dystrophic pattern at musscle biopsy. We present a total<br />
of 59 patients (29 girls, 30 boys) diagnosed with merosinpositive<br />
CMD with an age range of 7 months–21 years.<br />
These patients are subgrouped in four according to clinical<br />
course; severe (n ¼ 18) and mild (n ¼ 14) and presence of<br />
distal laxity (n ¼ 15) and rigid spine syndrome (n ¼ 12).<br />
Clinical presentation, physical examination findings, creatine<br />
kinase (CK) levels, muscle ultrasonography (US), electrophysiologic,<br />
muscle biopsy, cardiac evaluation and<br />
neuroimaging findings are all documented taaking defined<br />
subgroups into consideration. Clinical findings included<br />
decreased intrauterine movements (10/59), neonatal hypotonia<br />
(21/59), consanguinity (40/59), delay in motor milestones<br />
(49/59), contractures (26/59), mental retardation (6/<br />
59), and increased CK levels (17/59). Muscle US showed<br />
grades 3–4 echogenicity in 90–95% of the patients. EMG<br />
was performed in about 50% of the patients and only two<br />
were neuropathic. Cardiac evaluation showed diastolic<br />
dysfunction in some of the patients. However, none of<br />
these patients were symptomatic. Neuroimaging findings<br />
were normal in 21/23 and showed cortical atrophy in 2/23.<br />
CMD represents clinically and genetically heterogeneous<br />
group of disorders. Defining subgroups based on clinical<br />
presentation and physical examination findings will help<br />
further to classify and define molecular aspects of the<br />
disease.<br />
FP-I-031<br />
A novel variant of spinal muscular atrophy with<br />
progressive myoclonic epilepsy<br />
G. Haliloglu, H. Erdem, Z. Akcören, Y. Renda, H.<br />
Topaloglu<br />
Hacettepe Children’s Hospital, Department of Pediatric<br />
Neurology, Ankara, Turkey<br />
SMA is a clinically and genetically heterogeneous<br />
disease characterized by loss of motor function and muscle<br />
atrophy due to anterior horn cell degeneration. The most<br />
common variant is chromosome 5 linked proximal SMA,<br />
ranging in severity from congenital onset and infantile death<br />
to onset in adult life. Genetically separate variants with<br />
different distribution of weakness and/or additional features<br />
such as central nervous system involvement have been<br />
described. A rare variant with associated myoclonic<br />
epilepsy and lower motor neuron disease has been<br />
previously described in three families. We report four<br />
patients from two additional families affected by a<br />
syndrome characterized by severe and progressive myoclonic<br />
epilepsy and proximal weakness, tremor and lower<br />
motor neuron disease proven by electrophysiologic and<br />
muscle biopsy findings. Extensive metabolic investigations<br />
including tests for neuronal ceroid lipofuscinosis, lysosomal<br />
storage diseases and mitochondrial disorders were negative.<br />
Genetic analysis excluded the SMN gene. This study<br />
presents two families who differ from the patients defined<br />
in the literature before and confirms that the association of<br />
myoclonic epilepsy and motor neuron disease represents an<br />
entity genetically separate from chromosome 5 linked SMA.<br />
Metabolic and genetic defect remains unknown.<br />
FP-I-032<br />
Respiratory capacity course in patients with infantile<br />
spinal muscular atrophy<br />
C. Ioos, B. Estournet-Mathiaud, A. Barois, S. Mrad, D.<br />
Leclerc-Richard<br />
Department of Pediatric Neurology, Hôpital Raymond<br />
Poincaré, Garches, France
Abstracts 549<br />
We present the retrospective study of respiratory course<br />
in patients with infantile SMA. We report 36 patients with<br />
SMA type I for onset of symptoms before age 3 months (I<br />
pure form); 43 patients with SMA type I for onset of symptoms<br />
between 3 and 6 months (I bis form); 135 patients with<br />
SMA type II for onset of symptoms between 6 and 18<br />
months; 12 patients with SMA type III for onset of symptoms<br />
after age 18 months. In patients with SMA type I pure,<br />
75% of patients are dead. One third of patients had tracheotomy,<br />
42% of them are dead. Death is due to ventilatory<br />
insufficiency and bulbar symptoms. In patients with SMA<br />
type I bis, 52% of patients needed nasal nocturnal ventilation<br />
(NNV). Fifty-nine % of patients had tracheotomy.<br />
Twenty-three % of patients are dead. In patients with<br />
SMA type II, 39% of patients needed NNV, 16% of patients<br />
needed tracheotomy. Four % of patients are dead. In patients<br />
with SMA type II, we compared three groups: patients born<br />
before 1975, between 1975 and 1985, between 1985 and<br />
1995. This shows that earlier respiratory management<br />
allows to protect the lung function for more a long time,<br />
and reduces the need for tracheotomy. In patients SMA type<br />
III, respiratory impairment is moderate, and begins during<br />
second decade of life.<br />
FP-I-033<br />
Congenital myasthenic syndromes: a clinical study of 23<br />
children<br />
C. Ioos, L. Viollet, A. Barois, B. Estournet-Mathiaud<br />
Department of Pediatric Neurology, Hôpital Raymond<br />
Poincaré, Garches, France<br />
Congenital myasthenic syndromes (CMS) constitute a<br />
heterogeneous group of disorders in which the safety margin<br />
of neuromuscular transmission is compromised. CMS are<br />
classified as presynaptic, synaptic or post-synaptic according<br />
to the site of the primary defect. We report the clinical<br />
findings of 23 children with CMS. Age of onset vary from<br />
1st day of life to the age of 9. The first clinical features are<br />
more frequently swallowing difficulties (48% of cases) and<br />
respiratory distress (44% of cases), then ptosis (26% of<br />
cases) and fatigability of limb muscles (22% of cases).<br />
Ptosis is a frequent clinical symptom (83% of cases), as<br />
well as swallowing difficulties (61% of cases). Ophthalmoparesis<br />
is present in 52% of cases, and occurs during the<br />
course of the pathology. The muscle weakness predominates<br />
on cervical muscles and limb-girdle muscles in 78%<br />
of patients. In 55% of them, pelvic-girdle muscles are more<br />
severely affected than scapular-girdle muscles. There is an<br />
improvement of weakness and fatigability during childhood<br />
in 74% of patients, stability in 17% of them, and worsening<br />
in 9% of patients. There is a restrictive respiratory insufficiency<br />
in 87% of patients, with stability or improvement in<br />
90% of them. Twenty-two patients are treated. Seventyseven<br />
% of them respond favorably to cholinesterase inhibitors.<br />
This response to treatment is incomplete and needs<br />
high doses reaching 4 mg/kg per dose £ 4/day for pyridostigmine,<br />
and 2 mg/kg per day in four or five divided doses<br />
for ambenomium. Morphologic studies in routine histochemical<br />
studies show no abnormality or type 1 fiber<br />
preponderance isolated or combined type 2 fibers atrophy.<br />
FP-I-034<br />
Merosin-deficient congenital muscular dystrophy: lack<br />
of specificity of proton magnetic resonance spectroscopy<br />
associated to MRI in eight patients<br />
C.C. Leite a , M.T.C. Lacerda a , M.O.R. Costa a , M.G.<br />
Otaduya a , L.G. Ferreira b , M.B.D. Resende b , M.S.<br />
Carvalho b , S.K.N. Marie b , U.C. Reed b<br />
Departments of<br />
a Radiology and b Neurology, School of<br />
Medicine, São Paulo <strong>University</strong>, São Paulo, Brazil<br />
To evaluate the extensive brain white matter changes in<br />
merosin-deficient CMD we performed proton magnetic resonance<br />
spectroscopy (1h-MRS) associated to MRI in eight<br />
patients (seven with total and one with partial merosin deficiency).<br />
MRI included axial T1, T2, Flair and diffusion<br />
weighted images (DWI). Enhanced T1-weighted images<br />
were obtained in axial, coronal and sagittal planes. The 1 H-<br />
MRS consisted of STEAM (stimulated echo acquisition<br />
mode) sequence in frontal and parieto-occipital white matter<br />
and parieto-occipital gray matter. Metabolite ratios (N-acetylaspartate,<br />
choline and myo-inositol) were studied relatively<br />
to creatine and water. The apparent diffusion<br />
coefficient (ADC) was measured for the same regions.<br />
ADC and 1 H-MRS results were compared to a control. All<br />
patients presented involvement of supratentorial white<br />
matter that predominated in frontal lobes; one patient had<br />
diffuse involvement, and the external capsules were involved<br />
in all, while internal capsules, corpus callosum, optic radiation,<br />
cerebellum and brain stem were not affected. Lesions<br />
were hypointense on T1, hyperintense on T2 and Flair and<br />
did not enhance after gadolinium. No characteristic pattern in<br />
the metabolite ratios relatively to creatine was seen, but by<br />
measuring metabolite ratios relatively to water, important<br />
dilution of metabolites was observed for the white matter,<br />
compared to normal. ADC was increased only in the white<br />
matter. It was a non specific finding consistent with the metabolite<br />
dilution observed by 1 H-MRS, and correlated with the<br />
demyelination observed on MRI.<br />
FP-I-035<br />
Congenital muscular dystrophy: report of two atypical<br />
cases<br />
H.V. Linden Jr., M.B.D. Resende, L.G. Ferreira, M.S.<br />
Carvalho, S.K.N. Marie, U.C. Reed<br />
Department of Neurology, School of Medicine, São Paulo<br />
<strong>University</strong>, São Paulo, Brazil<br />
We report two atypical cases of CMD. Case 1, a 9-month-
550<br />
Abstracts<br />
old boy, presented from 7 months of age a progressive flaccid<br />
paralysis and loss of head control. The child acquired<br />
head control and was able to sit unsupported at respectively<br />
2 and 6 months of age. A 5-fold increased creatine kinase<br />
serum level and abnormal myogenic pattern on electromyography<br />
were detected. Muscle biopsy revealed marked<br />
dystrophic pattern with no signs of inflammatory changes.<br />
Merosin, sarcoglycan and dystrophin immunostaining were<br />
normal. After 12 months any improvement was observed.<br />
Case 2, a 4 year-old girl, manifested from birth severe<br />
muscle hypotonia, muscular weakness and elongated face.<br />
Her maximal motor ability was walking with support from 3<br />
years of age. MRI revealed diffuse leucodystrophic pattern<br />
and creatine kinase level was 2.5-fold increased. Muscle<br />
biopsy showed marked dystrophic pattern and total absence<br />
of merosin immunostaining. The girl became able to walk<br />
independently at 5 years and 9 months. At 6 years and 5<br />
months she gradually developed worsening of muscle weakness<br />
and of walking again needing support. Deflazacort 0.75<br />
mg/kg per day was started and strong improvement with<br />
return to the anterior walking ability was noted. After 9<br />
months walking persists stable and no side effects developed<br />
except mild weight gain. Subacutely severe course as in<br />
merosin-positive Case 1 and benign course plus additional<br />
improvement under steroid therapy in totally merosin-deficient<br />
Case 2 represent unusual clinical phenotypes to our<br />
knowledge not yet described for the correspondent subtypes<br />
of CMD.<br />
FP-I-036<br />
Juvenile myasthenia: clinical findings, treatment and<br />
prognosis<br />
B. Anlar, A. Deǧerliyurt, S. Aysun, H. Topaloglu, M.<br />
Topçu, G. Turanlı, D. Yalnizoǧlu, E. Özdirim<br />
Hacettepe <strong>University</strong>, Department of Pediatric Neurology,<br />
Ankara, Turkey<br />
Clinical and laboratory data of 27 patients being followedup<br />
with juvenile (autoimmune) myasthenia are presented.<br />
Mean age of onset is 10.1 (1.5–15) years. The F:M ratio is<br />
7:1 in disease starting after age 9, and 2.7:1 before age 8.<br />
Ocular weakness is the most common initial complaint: it<br />
was present in 85.2% of patients, and as the only symptom<br />
in 62.9%. Among the 17 patients who presented with ocular<br />
weakness only, 3 developed systemic or bulbar weakness in 4<br />
months–2 years, but 14 remained restricted to ocular muscles<br />
in average 6.5 years’ follow-up. Myasthenic crisis was seen<br />
only in six female patients with pubertal onset. In general,<br />
33% of patients had mild, 44%, moderate, and 22%, severe<br />
disease. Acetylcholine receptor antibodies were present in<br />
82% of all cases, and in 71% of those with ocular symptoms<br />
only. The rate of seropositivity did not differ between patients<br />
in remission or those with moderate to severe symptoms.<br />
Treatment was done with acetylcholineterase inhibitors in<br />
all patients. In addition, 18 patients received glucocorticoids.<br />
Those who experienced myasthenic crisis were treated with<br />
intravenous immunoglobulin or plasmapheresis. Thynectomy<br />
was performed in ten patients: five of them have been<br />
in remission for 3–11 years, and four had severe symptoms<br />
and myasthenic crisis within 4 months–8 years after surgery.<br />
These results illustrate the clinical profile of juvenile<br />
myasthenia with predominantly ocular disorder and good<br />
response to treatment in the majority of cases.<br />
FP-I-037<br />
Immunoreactivities of GDNF and its receptors in<br />
various neuromuscular disorders<br />
N. Murakami a , R. Sakuta a , T. Murai a , T. Nagai a , I. Nonaka b<br />
a Dokkyo <strong>University</strong> School of Medicine, Koshigaya Hospital,<br />
Koshigaya;<br />
b National Center of Neurology and<br />
Psychiatry, Kodaira, Japan<br />
Objective: Glial cell-line derived neurotrophic factor<br />
(GDNF) belongs to multifunctional cytokines and is a<br />
member of motor neuron survival factors. It has been<br />
reported that it is expressed in diseased muscles including<br />
amyotrophic lateral sclerosis (ALS) and DMD. However, its<br />
function in muscle remains unknown. To clarify how GDNF<br />
functions in muscle, we investigated immunoreactivities of<br />
GDNF and its receptors, GDNF receptor alfa-1 (GFR alfa-1)<br />
and receptor re-arranged during transfection (Ret) in various<br />
neuromuscular disorders. Methods: We examined muscle<br />
biopsies from ten patients with, five with Werdnig-Hoffmann<br />
disease (WHD), five with ALS, five with myotonic dystrophy,<br />
five with myotubular myopathy (MM) and five normal<br />
controls. We stained these frozen sections with anti-GDNF,<br />
GFR alfa-1 and Ret antibodies. Results: GDNF-positive<br />
immunoreactivity was observed on subsarcolemma or sarcolemma<br />
of atrophic fibers in WHD and ALS. On the other<br />
hand, GDNF-positive reactivity was found in cytoplasm of<br />
regenerating fibers in DMD. GFR alfa-1 and Ret-positive<br />
immunoreactivities were observed in regenerating fibers<br />
but not in atrophic ones. Conclusion: (1) GDNF may be<br />
expressed in atrophic fibers as a target-derived trophic factor,<br />
resulting in inducing reinnervation in motor neuron diseases.<br />
(2) GDNF could be related with the process of muscle regeneration<br />
because GDNF-Ret system is described to be<br />
concerned with cell signaling of cell proliferation.<br />
FP-I-038<br />
Autonomic function in spinal muscular atrophy<br />
H. Arai a , Y. Tanabe b , Y. Kohno c<br />
a Department of Pediatrics, National Chiba Hospital;<br />
b Department of Neurology, Chiba Children’s Hospital;<br />
and c Department of Pediatrics, Graduate School of Medicine,<br />
Chiba <strong>University</strong>, Chiba, Japan<br />
Purpose: SMA is a degeneration disease of the anterior<br />
horn cells of the spinal cord, classified into three types based
Abstracts 551<br />
on the age of onset. Scoliosis, joint contracture, pneumonia<br />
and metabolic acidosis have been known as complications<br />
of the disease. However, to our knowledge, there is no<br />
extensive study regarding autonomic function in SMA.<br />
The purpose of this study is to investigate autonomic function<br />
for improving care in SMA. Patients and methods: Six<br />
patients (three males and three females) with SMA aged 2–<br />
24 years old (three in type 1, two in type 2, one in type 3)<br />
and nine healthy age-matched controls were studied by<br />
sympathetic skin response (SSR), hunting reaction, heart<br />
rate variability (RRIV) and oral glucose tolerance test<br />
(OGTT). SSR was performed by electrical and auditory<br />
stimulation, and recorded from the both palm. Hunting reaction<br />
was performed that right index finger into iced water<br />
examined skin temperature. RRIV at rest was examined.<br />
OGTT was checked blood pressure and pulse rate for 2 h<br />
after oral glucose intake. Results: In two patients the difference<br />
of SSR amplitude between right and left palm was<br />
higher than in controls. RRIV in a patient was higher than<br />
in controls. One/6 case had hypotension after glucose intake<br />
with OGTT. Three/6 cases were abnormal in hunting reaction.<br />
Conclusion: It was suggested that there was autonomic<br />
dysfunction in some patients. Careful repeated evaluation of<br />
the autonomic function should be required in SMA.<br />
FP-I-039<br />
Schwartz-Jampel syndrome: clinical documentation of<br />
six families<br />
H. Özyürek a , S. Nicole b , E. Demir a , B. Fontaine b ,H.<br />
Topaloǧlu a<br />
a Hacettepe <strong>University</strong> Faculty of Medicine, Department of<br />
Pediatric Neurology, Ankara, Turkey; b INSERM U546,<br />
Faculte de Medecine, Pitie-Salpetriere, France<br />
Schwartz-Jampel syndrome (SJS; chondrodystrophic<br />
myotonia) is a rare autosomal recessive disorder characterized<br />
by atypical facies with blepharospasm, dwarfism, bone<br />
and joint abnormalities, and myotonia with an EMG<br />
pattern of continuous muscle fibre activity. According to<br />
the age of onset, two different types are distinguished.<br />
Type 1 (SJS1) is the most frequent form, and usually<br />
accompanied with moderate bone dysplasia. Type 2<br />
(SJS2) is more severe, and manifested by severe skeletal<br />
abnormalities and feeding difficulties. Several other<br />
features, such as mental retardation or immunodeficiency,<br />
have been sporadically associated with SJS. A positional<br />
cloning approach allowed identifying the gene responsible<br />
for SJS1. The SJS1 locus was localized on chromosome<br />
1p34–p36.1 and was found to be genetically homogeneous.<br />
Thereafter, some of us demonstrated that loss of function<br />
mutations in the gene encoding perlecan were responsible<br />
for SJS1. Perlecan is the major heparan sulfate proteoglycan<br />
of basement membrane. Recent data suggest that perlecan<br />
is necessary for the clustering of acetylcholinesterase<br />
at neuromuscular junction, suggesting that the SJS1 myotonia<br />
results from a deficiency in acetylcholinesterase. By<br />
contrast, there is no linkage between SJS2 and the SJS1<br />
locus, and the genetic basis of SJS2 is still unknown. We<br />
present seven patients diagnosed with SJS1 from six unrelated<br />
families. Our follow-up period is 5–15 years. Consanguinity<br />
was present in all. First complaints were noticed<br />
between 1 and 2 years of age in all of our cases. The main<br />
clinical findings in our series included characteristic<br />
appearance of facies; blepharospasm, ptosis, and orospasm,<br />
shortness in stature, contactures of joints, and severe<br />
myotonia. The mental status of the children was normal.<br />
EMGs consistently revealed continuous myotonic activity<br />
without any cessation in sleep. There were bone changes in<br />
the plain films (especially acetabular dysplasia). In one<br />
case coxa valga and in the other coxa vara deformity had<br />
been corrected by surgery. We used carbamazepine as an<br />
antimyotonic agent, and a mild relief was observed in the<br />
myotonic component. Genetic linkage analysis showed that<br />
all our patients were linked to the original SJS1 locus.<br />
Subsequently, mutations were detected in two of the<br />
families. The results of the others are pending. In conclusion,<br />
we analysed the natural history, clinical, radiological<br />
and genetic aspects in seven children with SJS. As far as<br />
we know this is one of the largest series reported.<br />
FP-I-040<br />
Critical illness myopathy associated with prolonged<br />
neuromuscular blockade in a 22-month-old female<br />
P. Drigo a , L. Rigon a , A.M. Laverda a , E. Pegoraro b<br />
b Department of Paediatrics and a Department of Neurological<br />
and Psychiatric Sciences, <strong>University</strong> of Padua, Padua,<br />
Italy<br />
Clinical conditions characterized by quadriplegia developing<br />
after prolonged stays in the Intensive Care Unit (ICU)<br />
are reported with increasing frequency in pediatric age as<br />
well as in adults. Their etiology may be neurogenic,<br />
myogenic or correlated with neuromuscular transmission<br />
blockade; forms with a combination of these factors have<br />
also been described. We report on a 22-month-old girl<br />
hospitalized at the ICU for sepsis and respiratory deficiency,<br />
with no prior neuromuscular pathologies, intubated for 14<br />
days and treated with high-dose methylprednisolone,<br />
pancuronium for 48 h and vecuronium for 8 days. On<br />
suspending the curarization, the child revealed quadriplegia<br />
with positive deep tendon reflexes. Serum creatine kinase<br />
levels were normal; the electromyogram showed signs of<br />
myogenic damage. Testing with neostigmine showed a valid<br />
return to spontaneous mobility of the four limbs. Muscle<br />
biopsy 18 days after extubation revealed modest, non-specific<br />
signs of myopathy, with a prevalence of type I fibers and<br />
no alteration of the myofibrillary structure or selective loss<br />
of the thick myosin filaments. A progressive improvement<br />
was observed, with complete resolution of the weakness<br />
within 7 weeks of extubation. We conclude that the patient’s
552<br />
Abstracts<br />
quadriplegia was due to a myopathic component (critical<br />
illness myopathy) overlapping the pharmacologicallyinduced<br />
neuromuscular transmission blockade, exacerbated<br />
by the use of corticosteroids and the concomitant renal deficiency<br />
and plasma acidosis. This blockade lasted longer,<br />
however, than is usually reported in the literature.<br />
FP-I-041<br />
Role of genetic analysis in definition of nosological<br />
diagnosis in pathology of peripheral motoneuron in<br />
pediatric patients<br />
L.G. Khachatrian, V.M. Studenikin<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
Background: Clinical features of spinal cord anterior horn<br />
cell lesions Include palsy, hypotonia, reduced or absent<br />
reflexes, muscular weakness and delay in motor milestones.<br />
Aim: To determine the role of molecular genetic analyses in<br />
nosological diagnostics of neuron pathology. Methods: Case<br />
histories of 28 pediatric patients (aged 3–18 months) with<br />
clinical Signs of spinal cord anterior horn lesions were<br />
analysed. Diagnostic algorithm included electroneuromyography<br />
(ENMG), CT and MRT scan of brain, molecular<br />
genetic analysis. Results: All patients were divided into<br />
two groups. There were 19 patients with SMA: 13 cases<br />
with type 1 SMA (Werdnig-Hoffman disease), six cases<br />
with intermediate type 2 (Fried-Emery disease). Group 2<br />
consisted of nine patients with myelodysplasia. All patients<br />
had the same clinical features and similar ENMG pattern, as<br />
well (poor interference pattern, fibrillation potentials, F-<br />
wave fall-out, and reduced M-reply amplitude). Twentyfour<br />
percent of Group 2 patients had ventriculomegaly<br />
according to MRT scan results. Typical deletion in chromosome<br />
5 (locus 11.2–13.3 in survival motor neuron) were<br />
revealed by molecular genetic method. Besides, in six most<br />
acute cases with type 1 SMA defect of neuronal apoptosis<br />
inhibitory protein was detected. Conclusion: Molecular<br />
genetic analysis is indicated as necessary investigational<br />
method in pathology of motoneuron. This technique allows<br />
to establish the diagnosis reliably and also to determine the<br />
prognosis and the extent of required treatment.<br />
FP-J<br />
Neuro-Oncology<br />
FP-J-001<br />
A rare case of primary diffuse leptomeningeal<br />
gliomatosis in a child: presentation, imaging, and results<br />
of temozolomide therapy<br />
L. Dom a , E. Duval b , D. De Surgeloose c , I. Neetens d ,E.<br />
Michiels b , P.P. De Deyn a<br />
Departments of a Neurology and Child Neurology, b Paediatrics,<br />
c Neuroradiology and d Pathology, Algemeen Ziekenhuis<br />
Middelheim and Koningin Paola Kinderziekenhuis,<br />
Antwerp, Belgium<br />
We report the case of a 12-year old girl with diffuse leptomeningeal<br />
gliomatosis. One year prior to admission she was<br />
diagnosed elsewhere with communicating hydrocephalus<br />
treated by ventriculo-peritoneal shunting. In the course of<br />
the next year school results deteriorated and she presented<br />
multiple episodes of headache, confusion and infantile behaviour<br />
once associated with convulsions. She was admitted to<br />
our hospital due to another of these episodes. Except for her<br />
behaviour her neurological examination was normal. Urgent<br />
CT scan of the brain showed stabilised hydrocephalus.<br />
Cranial MRI showed multiple nodular hyper intensities on<br />
the cerebellar and cerebral surface with minimal meningeal<br />
contrast enhancement. Spinal MRI disclosed leptomeningeal<br />
thickening and gadolinium enhancement from C1 to the<br />
cauda. In addition there was a non-enhancing hypointense<br />
lesion at C7. Analysis of CSF disclosed mononuclear pleocytosis<br />
(13/mm 3 ), raised protein value (447 mg/dl), normal<br />
glucose concentration and no oligoclonal bands. Cultures<br />
and serological tests were negative. Biopsy of the cerebellar<br />
arachnoidea and surface showed a grade 2 mixed astrocytic<br />
and oligodendrocytic leptomeningeal gliomatosis compatible<br />
with a diagnosis of diffuse leptomeningeal gliomatosis.<br />
Diffuse leptomeningeal gliomatosis (DLG) is a rare condition<br />
characterized by diffuse infiltration of the leptomeninges<br />
by glioma. In primary DLG, there is no parenchymal tumour<br />
of the brain or spinal cord. It is considered to arise from<br />
heterotopic glial cells. About 25 cases have been reported<br />
so far. It has to be differentiated from diffuse leptomeningeal<br />
seeding from a parenchymal tumour. This may require postmortem<br />
examination. In our case we considered the possibility<br />
of a primary intraparenchymal spinal tumour at C7.<br />
However the lesion is non-enhancing on spinal MRI which<br />
is a strong argument against an intramedullary neoplasm.<br />
Neuroimaging features in this case are furthermore remarkable<br />
for the absence of intracranial gadolinium enhancement<br />
and the nodular lesions on the cerebellar surface. These characteristics<br />
have only been described once by S. Kastenbauer<br />
et al. Therapy was initiated with vincristine and carboplatin.<br />
Despite this, her condition deteriorated and repeat cranial and<br />
spinal MRI disclosed progression of the disease. Her therapy<br />
was switched to temozolomide in November 2001. Results of<br />
this therapeutic follow-up will be presented. To my knowledge<br />
it is the first case of primary diffuse leptomeningeal<br />
gliomatosis in childhood treated with temozolomide.<br />
FP-J-002<br />
EEG in diagnosing childhood brain tumor – do we still<br />
need it?<br />
I. Prpić, E. Paučić-Kirinčić, A. Sasso<br />
<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia
Abstracts 553<br />
EEG as a technique is simple, painless and can be easily<br />
repeated, but it is not conclusive in diagnosing brain tumor.<br />
With brain CT and/or MR, there is no doubt; the diagnosis<br />
of brain tumor is conclusive. But, these relatively advanced<br />
neuroimaging techniques are still not widely accessible for<br />
every patient. In order to estimate role of EEG in diagnosing<br />
childhood brain tumor we retrospectively analyzed<br />
EEG findings of 39 children with brain tumor, treated at<br />
the Department of Pediatrics ‘Kantrida’ of <strong>University</strong><br />
Hospital Center Rijeka. Group consisted of 18 boys and<br />
21 girls; medium age was 6.8 years. Brain tumor was<br />
confirmed by CT or MR. In 22 children tumor was located<br />
infratentorial and in 17 children supratentorial. The average<br />
days from the first symptoms to final diagnosis were 73<br />
for infratentorial tumors and 32 days for supratentorial<br />
tumors. EEG, performed immediately after admission,<br />
was pathological (delta focus/spikes/spike-wave) in 18<br />
children (46.1%), non-specific (diffusely dysrhythmic) in<br />
15 children (38.6%), and normal in six children (15.3%).<br />
Normal EEG was found only in children with infratentorial<br />
located tumor. Pathological EEG was found in all children<br />
with supratentorial tumor location except two. Almost all<br />
children (13 from 15) with non-specific EEG had infratentorial<br />
tumor. Our results lead to a conclusion that EEG is<br />
suitable for the assessment of ‘tumor suspects’. If there is a<br />
doubt in the mind of the clinician, and CT or MR are not<br />
quite accessible, follow-ups EEGs on regular monthly<br />
intervals can assist in timing appropriate further neuroimaging<br />
procedures. The EEG usually might show an increasing<br />
abnormality as the pathological process advances and<br />
still has a role in diagnosing childhood brain tumor.<br />
FP-J-003<br />
A case of spinocerebellar degeneration as a late<br />
manifestation after Langerhans cell histiocytosis<br />
Y. Nakamura a , M. Ito a , M. Miyao a , K. Nihei a ,Y.<br />
Tsunematu b<br />
Departments of<br />
a Neurology and b Hematology/Oncology,<br />
National Center for Child Health and Development, Japan<br />
Central nervous system complications associated with<br />
neoplasm are well known; paraneoplastic syndrome with<br />
cerebellar degeneration and encephalomyeloneuritis caused<br />
by autoantibodies to neural tissue, as have been described in<br />
neuroblastoma and other malignancies. Langerhans cell<br />
histiocytosis (LCH) is the cryptogenic disease characterized<br />
by proliferation of the monoclonal histiocyte which is the<br />
same as the Langerhans cell in the epidermis. Diabetes insipidus<br />
and anterior pituitary dysfunction are familiar CNS<br />
complications because of proliferation and invasion of<br />
LCH into the CNS. We report a case of spinocerebellar<br />
degeneration as a late manifestation after LCH. In this<br />
case, there was no family history of spinocerebellar degeneration.<br />
Routine laboratory tests and cerebrospinal fluid were<br />
normal. Neuroimaging studies included brain CT, MRI and<br />
SPECT. Brain CT and MRI showed a global cerebellar atrophy<br />
but no evidence of direct invasion into the CNS. He<br />
received treatment with thyrotropin-releasing hormone<br />
(TRH) (2 mg/day, 14 days), g-globulin (400 mg/kg per<br />
day, 5 days) and high dose corticosteroid. Treatment with<br />
TRH was effective but g-globulin and corticosteroid were<br />
not effective. Recently, there are some reports of spinocerebellar<br />
degeneration affected with LCH and we attempt to<br />
hypothesize about the occurrence mechanisms and the treatment.<br />
FP-J-004<br />
Intracranial tumours in infants<br />
H.K. Young, H.M. Johnston<br />
Department of Neurology, Sydney Children’s Hospital,<br />
Randwick, Sydney, Australia<br />
Prognosis in infants with brain tumours has historically<br />
been very poor. This study reviews 16 infants under the<br />
age of 12 months with brain tumours, presenting to our<br />
institution between 1988 and 1999. The aim was to<br />
describe the clinical presentation, diagnosis and management<br />
of these patients, and to establish if newer diagnostic<br />
and treatment modalities have improved prognosis in terms<br />
of survival and neurocognitive outcome. Methods: Charts<br />
were reviewed retrospectively for age at diagnosis, time to<br />
diagnosis, presenting features, location, histology, surgical<br />
and adjuvant treatment, survival and neurocognitive<br />
outcome. Results: Survival has improved. Three quarters<br />
of the patients remain alive. Five year survival is 81%.<br />
Five year progression free survival was 51% with a median<br />
follow up time of 70 months. Five year survival for benign<br />
tumours was 100%. None of those with malignant tumours<br />
survived. Morbidity remains high. Eight/13 of survivors<br />
had focal neurological deficits, 7/13 had epilepsy. Seven/<br />
12 had significant cognitive disability. Conclusions: Future<br />
treatment protocols should include formal analysis of<br />
neurocognitive morbidity, functional outcome and quality<br />
of life measures to provide accurate prognostic information<br />
and to prepare families for early interventional programs.<br />
FP-J-005<br />
A clinical study on intracranial relapsing germinomas<br />
by combined chemotherapy<br />
G. Jia, S.-Q. Luo<br />
Department of Neurosurgery, Beijing Tiantan Hospital,<br />
Beijing, China<br />
Objective: To study the clinical effects of intracranial<br />
relapsing germinomas by combined chemotherapy. Methods:<br />
From August 1993 to December 2000, we conducted<br />
combined chemotherapy to ten patients with intracranial<br />
relapsing germinomas. Pathological examination of the<br />
specimens resected during operation was made in seven
554<br />
Abstracts<br />
out of ten patients. The diagnosis of the others was<br />
confirmed by the result of radiotherapy and examination<br />
of HCG in blood. Metastasis of intracranial relapsing germinomas<br />
was found in seven patients. The drugs we used are<br />
vincristine (VCR), methotrexate (MTX), Pinyangmycin and<br />
pervasive developmental disorder (PDD). Four days are<br />
considered as one course of treatment. A repeat course<br />
was taken after 4 weeks. CT and/or MRI are repeated 1<br />
month after the second course. Local radiotherapy (2500–<br />
3500 Gy) was taken with low or middle dosage 1–2 month<br />
after chemotherapy. Results: All patient were followed up<br />
for 1.5–7 years. They have resumed normal life or back to<br />
school. Conclusion: The authors suggest that combined<br />
chemotherapy should be conducted first once the diagnosis<br />
of intracranial relapsing germinomas has been confirmed.<br />
Local radiotherapy with low or middle dosage was<br />
followed. Thus, it could eliminate the tumors and avoid<br />
affecting the development of the children caused by large<br />
dosage of whole brain and spinal axis irradiation<br />
FP-J-006<br />
Clinical significance of cerebrospinal fluid b2-<br />
microglobulin in central nervous system leukaemia<br />
R.-X. Zhang<br />
Department of Pediatrics, Central Hospital of Yichang, Hu<br />
Bei, China<br />
Objective: To investigate the clinical significance of CSF<br />
b2-microglobulin in the patients with central nervous<br />
system leukemia (CNSL). Methods: We investigated 45<br />
leukemia patients, including 31 patients without CNSL, 14<br />
patients with CNSL. Thirty-one patients without CNS<br />
disease and leukemia were taken as the controls. CSF b2-<br />
microglobulin was detected with RIA. Results: b2-Microglobulin<br />
levels in patients with CNSL (2.63 ^ 0.38 mg/l)<br />
were significantly higher than either those without CNSL<br />
leukemia (1.32 ^ 0.47 mg/l) or controls (1.32 ^ 0.13 mg/l)<br />
(P , 0:01). There was no difference between CSF b2-<br />
microglobulin levels in the patients without CNSL and<br />
those in controls. Conclusion: b2-microglobulin can be<br />
considered as an important index for diagnosis of CNSL.<br />
FP-J-007<br />
Primary non-Hodgkin lymphoma of the vertebral body<br />
with spinal epidural invasion – case report<br />
D. Plesca a , D. Dragomir a , D. Teleanu b , G. Iacob b<br />
Department of Pediatric Neurology, ‘Dr. Victor Gomoiu’<br />
Children’s Hospital; and b Department of Neurosurgery,<br />
<strong>University</strong> Hospital, Bucharest, Romania<br />
A rare case of primary non-Hodgkin lymphoma of the T6<br />
vertebral body with spinal epidural invasion is reported.<br />
Primary non-Hodgkin lymphoma is a rare malignant hematological<br />
tumor. The tumor produced predominantly osteolytic<br />
lesions, usually in the femur and pelvic bones, and very<br />
occasionally presents with vertebral and spinal epidural<br />
involvement. The case now reported was a 12-year-old<br />
boy with primary non-Hodgkin lymphoma involving the<br />
T6 vertebral body and with epidural invasion, who underwent<br />
surgical treatment (laminectomy T6, T7 resection of<br />
the epidural mass), radiotherapy and chemotherapy. The<br />
patient was in complete remission at the follow-up (1 year<br />
after diagnosis). Surgical treatment is only palliative, but<br />
has several goals, e.g. obtaining a biopsy or improving the<br />
neurological symptoms through decompression. Because of<br />
its aggressive behavior, this type of lymphoma should be<br />
treated by combined modality approach (surgery,<br />
chemotherapy and radiotherapy).<br />
FP-J-008<br />
Analysis of clinical and histological characters of 33<br />
cases brain tumours in children<br />
T.N. Minh, N.T. Ung<br />
Neurology Department, National Institute Pediatrics,<br />
Hanoi, VietNam<br />
Objective: Study of 33 children with brain tumours from<br />
January 1998 to December 2001 at National Institute Pediatrics.<br />
Methods: Diagnoses were based on clinical findings of<br />
focal neurological signs and computer tomography. Results:<br />
There were 52% boys, 48% girls. Patients (39%) aged from<br />
3 to 5 years, 27% from 6 to 10 years, 34% from 11 to 15<br />
years. The clinical findings were headache in 70% patients,<br />
vomiting 36%, ataxia 18%, hemiplegia 9%; 24/28 patients<br />
had papilloedema, 4/28 normal optic disk. Histological findings:<br />
astrocytomas comprised 15%, medulloblastomas 48%,<br />
choroid plexus papillomas 6%, oligodendrogliomas 6%,<br />
teratomas 3%, and primitive neuroectodermal tumours<br />
12%. Craniotomy was performed in 33 patients with radical<br />
resection. The results of treatment showed high mortality<br />
and morbidity rates.<br />
FP-J-009<br />
The changes of sICAM-1 and soluble L-selectin in blood<br />
of children with acute lymphoblastic leukemia (ALL)<br />
during high-dose methotrexate (HD-MTX)<br />
chemotherapy<br />
W.-Q. Geng, F.-H. Guan, Y. Hu, K. Tan<br />
Shenya ng Women and Children’s Medical Health Care<br />
Center, Shenyang, China<br />
Objective: To study the mechanism that high-dose methotrexate<br />
(HD-MTX) therapy prevents and treats CNSL.<br />
Method: The serum intercellular adhesion molecule-1<br />
(sICAM-1) and soluble L-selectin (sL-selectin) levels<br />
were measured 1 h before and 24, 28, 32, 44, and 68 h<br />
after the HD-MTX therapy by dual-antibody sandwich<br />
ELISA in 30 children with ALL. The blood MTX levels
Abstracts 555<br />
were monitored 24, 28, 32, 44, and 68 h after HDMTX<br />
therapy in 12 of these cases. Results: There was no difference<br />
between the serum sICAM-1 and sL-selectin levels at<br />
24 h after HDMTX chemotherapy and those before the<br />
HDMTX treatment (P . 0:05). After chemotherapy, the<br />
serum sICAM-1 and sL-selectin levels decreased gradually.<br />
The levels at 28 and 32 h after chemotherapy were significantly<br />
decreased compared with that before chemotherapy<br />
(P , 0:05), so did the levels at 44 and 68 h after chemotherapy<br />
(P , 0:01). Conclusion: The decrease of the serum<br />
sICAM-1 and sL-selectin levels could be another major<br />
mechanism that HDMTX prevented and treated CNSL.<br />
FP-J-010<br />
High level of soluble L-selectin and prealbumin in the<br />
cerebrospinal fluid of children with central nervous<br />
system leukemia (CNSL)<br />
W.-Q. Geng, F.-H. Guan, Z.-Y. Li<br />
Shenyang Women and Children’s Medical Health Care<br />
Center, Shenyang, China<br />
Objective: To observe the changes of the levels of sLselectin<br />
and prealbumin (PA) in CSF of children with<br />
CNSL. Method: The levels of sL-selectin and PA were<br />
determined in the CSF samples of 28 ALL children with<br />
CNSL. CSF samples were obtained from 24 patients at 4–12<br />
weeks before the diagnosis of CNSL, and from 20 of these<br />
patients after treatment of CNSL. In addition, the levels of<br />
sL-selectin and PA were also assayed in 18 ALL children<br />
with complete remission at least a year. There were 12<br />
children without malignant or meningeal disorders selected<br />
as controls. Results: There was no significant difference in<br />
CSF sL-selectin levels between the children with ALL without<br />
evidence of CNSL and the controls. However, the CSF<br />
levels of sL-selectin and PA in patients with CNSL were<br />
significantly higher than those in controls at the time CNSL<br />
diagnosed and 4–12 weeks before the diagnosis of CNSL.<br />
After treatment and disappearance of the lymphoblasts in<br />
CSF, the levels of sL-selectin and PA were decreased in the<br />
majority of children who had CNSL. The levels of sL-selectin<br />
in CSF remained high in six patients after the disappearance<br />
of lymphoblasts in CSF, four of them recurred CNSL<br />
within 12 weeks. Conclusions: Detection of sL-selectin and<br />
PA in CSF may be helpful for the diagnosis of CNSL. The<br />
levels of sL-selectin in CSF may be used as a predictor of<br />
CNSL in children with acute leukemia.<br />
FP-J-011<br />
The clinical profile of pediatric leukemic patients with<br />
neurologic complications in a tertiary hospital: a 5-year<br />
retrospective study<br />
D.M. Dionson-Gigataras<br />
Philippine Children’s Medical Center, Quezon City, Philippines<br />
The leukemias are the most common form of childhood<br />
cancer. Due to advances in treatment and prolonged survival,<br />
an increased incidence of leukemic neurologic complications<br />
has been observed. Objectives: This study was<br />
undertaken to document the spectrum of problems that<br />
prompt neurologic referral in leukemic patients, to determine<br />
the diagnosis associated with the common presenting<br />
neurological symptoms, and to describe the population of<br />
leukemic children who developed such problems. Methodology:<br />
This paper reviewed the clinical profile of 48 leukemic<br />
patients referred to the Neurology service of a pediatric<br />
tertiary hospital from June 1996 to June 2001. Results: The<br />
population was composed of 26 males and 22 females. Forty<br />
percent of the study population belonged to the 4–6 year old<br />
age group. Majority (91.7%) had ALL. The average time<br />
interval from diagnosis of leukemia to the time of developing<br />
neurologic symptoms was 24 months. The most<br />
common symptoms that prompted referral to the neurology<br />
service were headache (39.6%), altered mental status,<br />
seizures and lower extremity weakness. Of the 19 patients<br />
who presented with headache, 14 were diagnosed to have<br />
CNS leukemia while three patients had intracranial hemorrhage.<br />
For those with altered mental status 42.8% had intracranial<br />
hemorrhage, 28.57% had infarction and 28.57% had<br />
CNS leukemia. Among those with seizures, 46.15% had<br />
intracranial hemorrhage, and 10% had CNS leukemia. Of<br />
the 13 patients with lower extremity weakness, 53.84% had<br />
radiculitis and 15.4% had GBS. Mortality in this study<br />
population was 26.22%, majority of which was secondary<br />
to intracerebral hemorrhage (16.4%).<br />
FP-J-012<br />
Epilepsia partialis continua associated with widespread<br />
gliomatosis cerebri<br />
E. Shahar a , U. Kramer b , D. Nass c , D. Savitzki a<br />
a Child Neurology Unit and Epilepsy Service, Rambam<br />
Medical Center, Haifa, b Epilepsy Service, Dana Children<br />
Hospital, Tel-Aviv, c Department of Pathology, Sheba Medical<br />
Center, Tel-Hashomer, Israel<br />
We present herein an uncommon association of intractable<br />
epilepsia partialis continua which was the main presentation<br />
of widespread gliomatosis cerebri in two girls. Both<br />
children had a preceding prolonged secondary generalized<br />
seizure 2–4 months prior to the evolution of epilepsia partialis<br />
continua (EPC). Patient 1 had a 6 month period of up to<br />
80–100 daily clusters of left-sided twitching but remained<br />
fully alert, accompanied with increasing left-sided pyramidal<br />
weakness and sensory impairment. Surface and video-<br />
EEG demonstrated prolonged right fronto-central epileptic<br />
spike/wave discharges, corroborating with the left focal<br />
myoclonic jerks. MRI demonstrated a wide demarcated<br />
area of increasing signals over the right fronto-central<br />
regions, with diffuse cortical-subcortical infiltration,<br />
impinging on the left hemisphere. Patient 2 had recurrent
556<br />
Abstracts<br />
focal sensory seizures followed by focal motor events, along<br />
with progressive hemiparesis, but remained alert, along with<br />
focal epileptic activity. A streotactic brain biopsy in both<br />
revealed gliomatosis cerebri (GC): diffuse widespread infiltration<br />
of glioma cells with no constitution of a circumscribed<br />
tumor mass. The first child is surviving after 2<br />
years on combined treatment, the second perished.<br />
Although very rare, GC should be taken into account in<br />
the differential diagnosis of EPC, of which Rassmussen’s<br />
encephalitis and focal cortical dysplasia are more common<br />
etiologies in children, in order to facilitate a rapid diagnosis<br />
and prompt current combined effective therapy for GC.<br />
FP-J-013<br />
Giant cell tumor in a child: Unusual location, rare<br />
presentation but favorable outcome<br />
H. Bibas-Bonet, R. Fauze, G. Lavado, R. Páez, J. Nieman<br />
Hospital del Niño Jesús, San Miguel de Tucumán, Argentina<br />
An 8-year-old female presented with a 3-month gradually<br />
worsening right (R) otalgia, tinnitus, hearing loss, R facial<br />
numbness, and diplopia. She was admitted with a 2-week<br />
swallowing difficulties, voice change, and R shoulder pain.<br />
Neurological examination revealed R abducens paralysis, R<br />
facial palsy, R sensorineural deafness, R trigeminal hyperesthesia,<br />
R shoulder weakness, right-sided tongue fasciculation,<br />
and normal motor-sensory functions of limbs. Skull X-<br />
ray revealed lytic lesions in R temporal petrous portion. CT<br />
scan showed a destructive mass involving R greater wing of<br />
sphenoid bone and temporal petrous apex. MRI demonstrated<br />
a tumor arising from temporosphenoidal region,<br />
infiltrating neither the brain nor the brainstem. No hydrocephalus<br />
was seen. Biopsy revealed giant cell tumor osteoclastoma.<br />
Posterior treatment consisted of radiotherapy.<br />
Clinical improvement was noticed by second week. After<br />
8-year follow-up, patient is well but with functional sequelae.<br />
There was no MRI evidence of tumor growing. Giant<br />
cell tumor is a primary bone tumor affecting rarely the skull<br />
base. It is considered benign, but could show local aggressiveness.<br />
Progressive involvement of cranial nerves culminating<br />
in paralysis of all unilaterally, without sensory or<br />
motor long tract disturbance, no intracranial hypertension,<br />
and osteoclastic lesion in skull base on X-ray is described as<br />
Garcin syndrome. It is usually resulting from malignant<br />
tumor, sarcoma or nasopharynx fibrosarcoma invading<br />
skull base. To our knowledge, a giant cell tumor presenting<br />
as Garcin syndrome has not yet been reported.<br />
FP-J-014<br />
Gelastic seizures and hypothalamic hamartoma: do not<br />
forget the Pallister-Hall syndrome<br />
C. Arpino a,b , C. Galasso b , M. Marzio b , M. Verdecchia b ,P.<br />
Curatolo b<br />
a ‘E. Litta’ Rehabilitation Center for Developmental<br />
Disabilities; b Pediatric Neurology, Tor Vergata <strong>University</strong><br />
of Rome, Rome, Italy<br />
Gelastic seizures are often associated with hypothalamic<br />
hamartoma. A detailed evaluation, through MRI, in patients<br />
presenting gelastic seizures is recommended. In order to<br />
exclude an autosomal dominant disorder known as Pallister-Hall<br />
Syndrome (PHS), a thorough physical examination<br />
in the presence of gelastic seizures and hypothalamic hamartoma<br />
should be also recommended. We observed a 3-yearold<br />
boy and a 21-year-old girl presenting with mental retardation,<br />
behavioral disorders, and symptomatic localization<br />
related epilepsy characterized by gelastic, partial motor,<br />
autonomic seizures accompanied by staring and impaired<br />
responsiveness, and drop attacks. Interictal EEG showed<br />
bilateral and asynchronous sequences of slow spike and<br />
wave complex (2.5–3 Hz) on fronto-temporal regions with<br />
a secondary bilateral synchrony. MRI showed a non-enhancing,<br />
midline hypothalamic mass with a diameter of 2 cm.<br />
The girl had undergone surgery for central polysyndactyly<br />
and a callosotomy to control seizures. The clinical picture<br />
presented by these patients was suggestive of PHS, for which<br />
the described phenotypic features include hypothalamic<br />
hamartoma, central polydactyly, pituitary dysfunction and<br />
visceral malformations. Seizures are occasionally reported<br />
in PHS and are not currently included in the clinical spectrum<br />
of the syndrome. Whether gelastic seizures in PHS are underdiagnosed<br />
or their occasional occurrence is dependent on the<br />
topographic localization of the hypothalamic hamartoma, as<br />
suggested by a previous study, remains an open question. The<br />
association between gelastic seizures, hypothalamic hamartoma<br />
and malformations suggestive of PHS needs to be carefully<br />
investigated in order to better define the clinical<br />
spectrum of PHS and to plan genetic counseling in apparently<br />
unaffected relatives.<br />
FP-J-015<br />
Spontaneous recovery of medulloblastoma in a girl with<br />
Gorlin-Goltz syndrome<br />
C.-W. Su a , K.-L. Lin a , J.-W. Hou b , S.-M. Jung c , E.-C. Zen d<br />
a Division of Pediatric Neurology; b Division of Pediatric<br />
Genetics; Department of Pediatrics, Chang Gung Children’s<br />
Hospital; c Department of Pathology; d Division of<br />
Oral Surgery, Department of Dentistry, Chang Gung<br />
Memorial Hospital, Taoyuan, Chinese Taipei<br />
The Gorlin-Goltz syndrome is characterized by nevoid<br />
basal cell carcinomas, odontogenic keratocysts of jaws,<br />
palmar and plantar pits, falx calcifications, and various<br />
cancer susceptibilities attributed to a mutation in a tumor<br />
suppressor gene. We presented an 11-year-old female with<br />
Gorlin-Goltz syndrome. Medulloblastoma was diagnosed<br />
when she was 4 years old. She received total excision of<br />
the tumor and adjuvant therapy of chemotherapy and radiotherapy.<br />
One year later, the tumor relapsed with CSF seeding.
Abstracts 557<br />
She recovered spontaneously without any treatment, and she<br />
did not develop basal cell carcinoma within 6 years followup.<br />
It suggests that patients with Gorlin-Goltz syndrome tend<br />
to have a better prognosis with regard to medulloblastoma,<br />
and to diagnose the syndrome as early as possible will make<br />
the management optimal.<br />
FP-K<br />
Genetics/Degenerative Diseases<br />
FP-K-001<br />
Cerebral dysgenesis associated with L1CAM mutations<br />
L. Sztriha, R.M.W. Hofstra, Y.J. Vos, J. Johansen<br />
Departments of Paediatrics and Radiology, FMHS, UAE<br />
<strong>University</strong>, United Arab Emirates; and Department of<br />
Medical Genetics, Faculty of Medical Sciences, <strong>University</strong><br />
of Groningen, The Netherlands<br />
L1 neuronal cell adhesion molecule belongs to the immunoglobulin<br />
superfamily. It plays a key role in axon outgrowth,<br />
guidance and pathfinding during development of the nervous<br />
system. The encoding gene, L1CAM is located near the telomereofthelongarmoftheXchromosome,intheXq28region.<br />
Mutations in the L1CAM gene are responsible for an X-linked<br />
recessive disorder with features of corpus callosum hypoplasia<br />
or agenesis, mental retardation, adducted thumbs, spastic<br />
paraplegia and hydrocephalus (CRASH syndrome). The clinical,<br />
MRI and molecular genetic findings of two boys with<br />
missense mutation in the L1CAM gene are presented. Patient<br />
1 had delayed development, mental retardation, adducted<br />
thumbs and spastic diplegia. Brain MRI revealed simplified<br />
pattern of gyri with reduced volume of gray and white matter,<br />
agenesis of the corpus callosum, dilated lateral ventricles and<br />
hypoplasia of the cerebellar vermis. Transition of a G<br />
(guanine) to T (thymine) was found at position 604<br />
(604G ! T) in the L1CAM gene. This mutation results in<br />
conversion of aspartic acid to tyrosine at position 202<br />
(D202Y) of the L1 protein. Patient 2 presented with congenital<br />
hydrocephalus. Three of his brothers with congenital<br />
hydrocephalus died after birth. The proband showed delayed<br />
development and mental retardation after shunt implantation.<br />
Adducted thumbs and severe spastic diplegia were observed.<br />
MRI revealed parietal-occipital hypoplasia with multiple<br />
small gyri (polymicrogyria), agenesis of the corpus callosum<br />
and fused thalami. Transition of a G (guanine) to C (cytosine)<br />
at position 1243 (1243G ! C) was found in the L1CAM gene,<br />
which led to conversion of alanine to proline at position 415<br />
(A415P) in the L1 protein.<br />
FP-K-002<br />
The Fahr disease in a family<br />
Q.-K. Huang, F.-J. Yang, J.-R. Wang<br />
Department of Pediatrics, Shanxian Central Hospital,<br />
Shanxian County, Shandong, China<br />
Fahr disease is a hereditary disease that rarely occurs in<br />
childhood characterized by calcium deposition in basal<br />
ganglia. It has been considered an autosomal dominant/<br />
recessive inheritance or chromosome disorder. We present<br />
the clinical features and the inheritance pattern of six cases<br />
of Fahr disease in a family. The proband was a 12 yeas old<br />
Chinese girl, normally delivered from unrelated parents.<br />
The initial onset of seizures occurred when she was 2<br />
months old. The head CT showed small local calcification<br />
in bilateral basal ganglia when she was 2 years old. Now she<br />
is 12 years old and still has recurrent seizures, learning<br />
disability and irritability, and CT scan shows diffuse<br />
calcium deposition in bilateral basal ganglia, chromosome<br />
analysis shows normal pattern. Proband’s sister developed<br />
seizures when she was 2 months old. The head CT have<br />
shown small local calcification in her bilateral basal ganglia<br />
when she was 10 months old. Now she is 10 years and 10<br />
months old and still have recurrent seizures, mental retardation,<br />
and CT scan showed diffuse calcium deposition in<br />
bilateral basal ganglia and hemicerebrum. Head CT scan<br />
of the prodand’s father, uncle, aunt and grandfather all<br />
have shown small local calcification in bilateral basal ganglia<br />
10 years ago, but no significant change now. They have<br />
no any clinical symptom and sign. Conclusion: (1) the mode<br />
of transmission of the Fahr disease in this family is autosomal<br />
dominant inheritance; (2) this pedigree shows a<br />
hereditary disease of early onset, and the earlier the onset,<br />
the faster the progression; and (3) the clinical features are<br />
heterogeneous and head CT is an important examination in<br />
the clinical diagnosis of Fahr disease.<br />
FP-K-003<br />
Angelman’s syndrome: Evaluation of clinical features,<br />
EEG and therapeutic approach<br />
J. Arcas, M. Cabrera, A. Martínez-Bermejo, D. López-<br />
Pajares, V. López-Martín<br />
Paediatric Neurology and Genetics, ‘La Paz’ <strong>University</strong><br />
Hospital, Madrid, Spain<br />
Angelman’s syndrome (AS) is a severe neurobehavioural<br />
disorder with a heterogeneous genetic aetiology. Epilepsy<br />
develops in 90% and it is intractable in about 50% in children.<br />
The aim of this study was to evaluate the early clinical<br />
and EEG finding in a group of patients with AS to determine<br />
whether there are any clinical or EEG features sufficiently<br />
distinctive to be of value in early diagnosis, as well as the<br />
best therapeutic approach. The charts of 13 patients with<br />
clinical/genetic diagnosis of AS were reviewed. All patients<br />
had been clinically, neurophysiologically (EEG data) and<br />
genetically investigated. There were five males and eight<br />
females, aged 13 month–19 years. Range age at diagnosis<br />
13 months–15 years. All patients had severe speech impairment<br />
and motor development was delayed in all patients but<br />
one. Seizures were reported in 11 out of 13 cases. The onset<br />
seizures age ranged 12 months–5 years. The most frequent
558<br />
Abstracts<br />
ictal patterns were atypical absences and myoclonic<br />
seizures. EEG studies showed characteristic AS EEG<br />
patterns in 12 out of 13 cases. The most effective antiepileptic<br />
drugs were Benzodiazepines and VPA regardless of<br />
seizure type. We conclude that motor and mental development<br />
delay with severe speech impairment, associated to<br />
characteristic EEG patterns, should help to identify patients<br />
with AS at an early age. Moreover, the effects of GABAergic<br />
drugs for epilepsy in AS may suggest that defective<br />
genes of the g-aminobutyrate-A receptor subunit, are implicated<br />
in the mechanism of epilepsy in this syndrome.<br />
FP-K-004<br />
A case report of mitochondrial myopathy<br />
S.-P. Ying, S.-J. Wang<br />
Department of Pediatrics, No. 3 Affiliated Hospital of<br />
Baotou Medical College, Qingshan District, Baotou, Inner<br />
Mongolia, China<br />
Mitochondrial myopathies are rare hereditary diseases in<br />
children. The prognosis in most cases is very poor. We<br />
report one case of carnitine deficiency syndrome, which is<br />
one type of mitochondrial myopathies. The patient was a 12<br />
year-old girl. The main clinical features were chronic<br />
progressive generalized weakness without muscle atrophy.<br />
The weakness got worse after exercise such as chewing and<br />
walking and improves following rest. The nervous system<br />
examination is normal, without muscle pain or symptoms of<br />
encephalopathy. The case had no positive family history.<br />
Laboratory investigations showed lactate level increased<br />
after exercise. EMG demonstrated a myopathy-type<br />
abnormality. Muscle biopsy showed that fat drops could<br />
be seen in many muscle fibers. After diagnosis, the case<br />
was treated with carnitine 0.5 g three times daily. The<br />
short-term curative effect is very good. After 2 weeks of<br />
treatment, the muscle strength returned to normal. Up to<br />
now, the case had been treated for one and a half years.<br />
The weakness did not appear again.<br />
FP-K-005<br />
Cytogenetic and molecular-cytogenetic studies of Rett<br />
syndrome (RTT): the investigation of 81 girls and four<br />
boys<br />
S.G. Vorsanova, Y.B. Yurov, V.Y. Ulas, I.A. Demidova,<br />
V.O. Sharonin, A.D. Kolotii, A.K. Beresheva, V.S. Kravets,<br />
I.V. Soloviev<br />
Institute of Pediatrics and Children Surgery, Russian Ministry<br />
of Health and National Research Center of Mental<br />
Health, Russian Academy of Medical Sciences, Moscow,<br />
Russia<br />
Rett syndrome (RTT) is a severe neurodevelopmental<br />
disorder with the incidence of 2.5% in mentally retarded<br />
girls in Russia. We have performed cytogenetic studies of<br />
85 patients (81 girls and four boys) with clinical picture of<br />
RTT. Collections of DNA samples and fixed cell suspensions<br />
of RTT patients and their parents were established for<br />
extended molecular studies. MeCP2 testing in randomly<br />
selected group of 30 RTT girls show that 84% of them<br />
have different mutations in the MeCP2 gene. Among 85<br />
patients: 81 girls with clinical picture of RTT had normal<br />
female karyotype, two boys had normal male karyotype in<br />
cells of blood (46, XY) and two boys had mosaic form of<br />
Klinefelter syndrome (47, XXY/46, XY) in blood and<br />
muscle cells. Eighty-one mothers and parents of RTT<br />
girls had normal karyotype, three mothers of RTT patients<br />
– with mosaic forms of Turner syndrome (45, X/46, XX)<br />
and of trisomy X (47, XXX/46, XX), one mother – mosaic<br />
karyotype (47, XX, 1mar/48, XXX, 1mar). We analyzed<br />
chromosome X staining after incorporation of BrdU in<br />
lymphocytes of 81 affected girls with clinical picture of<br />
RTT. Specific types of inactive chromosome X with<br />
unusual conformation of chromatin in long arm of the<br />
chromosome X were found in 93% of RTT girls. This<br />
cytogenetic technique was used for presymptomatic diagnosis<br />
of RTT in five girls in affected families. We believe<br />
that the phenomenon of altered chromatin conformation in<br />
the inactive chromosome X could be used as laboratory test<br />
for diagnosis of RTT. Supported by INTAS and COPER-<br />
NICUS grants.<br />
FP-K-006<br />
FISH analysis of DNA replication of chromosome X loci<br />
in Rett syndrome using interphase fluorescence in situ<br />
hybridization<br />
Y.B. Yurov, S.G. Vorsanova, A.D. Kolotii, I.Y. Iourov, P.<br />
Sheinson, V.V. Monachov<br />
Institute of Pediatrics and Children Surgery, Russian Ministry<br />
of Health and National Research Center of Mental<br />
Health, Russian Academy of Medical Sciences, Moscow,<br />
Russia<br />
RTT is a developmental disorder, affecting girls. It was<br />
shown recently that RTT is caused by mutations in the<br />
MeCP2 gene on chromosome Xq28, whose function is to<br />
silence other genes. In RTT patients the defective MECP2<br />
might fail to keep other genes ‘silent’. The targeting genes<br />
directly involved in the pathogenesis of RTT are still<br />
unknown. To identify the potential regions and loci with<br />
altered transcription and replication status in active and<br />
inactive chromosomes X at RTT we used molecular cytogenetic<br />
approaches. We used interphase FISH with DNA<br />
probes to determine the loci with altered replication pattern<br />
in X-chromosomes at RTT. Large-insertion PAC clones for<br />
Xptel and Xqtel, pseudoautosomal locus at Xq28 and<br />
centromeric alphoid DNA were used. PAC clones 671D9<br />
(MeCP2 gene) and 24.23.0 at telomeric region of the q-arm<br />
(Xq28) escape inactivation in inactive chromosome X only<br />
in some of the RTT patients. Therefore, this region could
Abstracts 559<br />
contain the gene(s), abnormally transcriptionally active in<br />
both chromosomes X. Our results indicate that interphase<br />
FISH analysis of DNA replication patterns allows detecting<br />
the targeting loci with altered order of replication and transcription<br />
in RTT patients. These results support the hypothesis<br />
that the disturbances in dosage compensation effect due<br />
to aberrant activation of genes in inactive chromosome X at<br />
RTT genes (bi-allelic expression instead of mono-allelic).<br />
Our results indicate that MeCP2 itself could escape X-inactivation<br />
and reduce the pathogenic effect of mutated allele at<br />
RTT. Supported in parts by INTAS and COPERNICUS<br />
grants.<br />
FP-K-007<br />
Differences in clinical picture of tuberous sclerosis<br />
complex in patients with TSC1 and TSC2 mutations<br />
S. Jóźwiak a , D. Domańska-Pakiel⁄a a , J. Kasprzyk-Obara a ,<br />
D.J. Kwiatkowski b , S. Dabora b<br />
a Department of Child Neurology, The Children’s Memorial<br />
Health Institute, Warsaw, Poland; b Division of Experimental<br />
Medicine and Medical Oncology, Brigham and Women’s<br />
Hospital, Boston MA, USA<br />
Tuberous sclerosis (TSC) is a relatively common neurocutaneous<br />
syndrome caused by mutations in either of two<br />
genes TSC1 and TSC2. We carried out a comprehensive<br />
mutational analysis in large group of patients treated in The<br />
Children’s Memorial Health Institute in Warsaw and correlated<br />
mutation findings with clinical features. Eighty-six<br />
patients were identified with mutations: 18 within TSC1<br />
gene and 68 within TSC2 gene. Age of patients ranged<br />
from 4 months to 51 years. Epilepsy was reported at an<br />
earlier age (median age 0.5 versus 1.83 years) and occurred<br />
more frequently (86.8 versus 55.6%) in TSC2 group. Incidence<br />
of infantile spasms was much higher in TSC2<br />
patients (64.4 versus 20%). In contrast, mental status of<br />
patients with TSC1 mutations was normal in 64.8% of<br />
those examined and only in 27.7% of patients with TSC2<br />
mutations. Despite of younger age of examined in TSC2<br />
group, skin lesions were more frequently reported in these<br />
patients. Only periungal fibromas were more common in<br />
TSC1 subjects. The incidence of calcified periventricular<br />
calcifications on brain CT was similar in both groups.<br />
There was a slight preponderance of TSC2 patients<br />
among those with subependymal giant cell astrocytoma<br />
(1/16 versus 7/64). Renal and liver angiomyolipomas and<br />
cardiac rhabdomyomas were more frequent in TSC2<br />
patients. None of examined TSC1 patients had retinal<br />
hamartomas or pulmonary lymphangiomatosis. The more<br />
severe clinical presentation of tuberous sclerosis in the<br />
TSC2 group demonstrates the need for more frequent<br />
inner organ screening in these patients than in those with<br />
TSC1 mutations.<br />
FP-K-008<br />
Initial manifestations and follow-up studies of optic<br />
pathway gliomas in children with neurofibromatosis<br />
type 1 (NF-1) and without NF-1<br />
S. Jóźzwiak a , E. Czyzyk b , J. Kasprzyk-Obara a<br />
a Department of Child Neurology, The Children’s Memorial<br />
Health Institute, Warsaw, Poland; b Provincial Hospital No.<br />
2, Rzeszów, Poland<br />
Optic pathway gliomas (OPGs) are frequent central<br />
nervous tumors in patients with neurofibromatosis type 1<br />
(NF-1). The main aim of our study was to compare initial<br />
clinical manifestations and natural history of OPGs associated<br />
with NF-1 from isolated OPGs. There have been 83<br />
children with OPGs identified retrospectively by a review<br />
of medical records: 51 children with N-1 and 32 children<br />
with isolated gliomas. There was a slight preponderance of<br />
female patients in NF-1 group (32/51 versus 19/51,<br />
P ¼ 0:013), while isolated OPGs occurred equally in<br />
boys and girls (16/32 versus 16/32). The median age of<br />
children was 4.6 years for OPGs with NF-1 and 4.8 years<br />
for isolated OPGs. OPGs commonly occurred at an early<br />
age in children with NF-1, but there were no significant<br />
differences. Decreased visual acuity at the time of diagnosis<br />
was more common in children without than with NF-1<br />
(18/19 versus 29/42, respectively, P , 0; 05), similar to<br />
ophthalmoscopic abnormalities (optic atrophy and oedema)<br />
(25/27 versus 30/49, respectively, P , 0:01). Children<br />
without NF-1 had more often proptosis and nystagmus<br />
(11/32 versus 10/51 and 7/32 versus 4/51, respectively).<br />
Multicentric location was more common in NF-1 (34/51,<br />
P ¼ 0:0001), whereas isolated chiasmal involvement<br />
occurred more often in those without NF-1 (15/32). Radiological<br />
signs of progression and deterioration of visual<br />
function at later follow-up were more commonly noted in<br />
children with isolated OPGs than with NF-1. The clinical<br />
presentation of OPGs at the time of diagnosis and during<br />
follow-up was more severe in children without than with<br />
NF-1.<br />
FP-K-009<br />
Three novel SURF1 mutations in Japanese patients with<br />
Leigh syndrome associated with cytochrome c oxidase<br />
deficiency<br />
E. Naito, Y. Ogawa, M. Ito, l. Yokota, T. Saijo, J. Matsuda,<br />
S. Kitamura, Y. Kuroda<br />
Department of Pediatrics, School of Medicine, <strong>University</strong> of<br />
Tokushima, Tokushima, Japan<br />
Leigh syndrome, a severe neurodegenerative disorder,<br />
commonly is associated with cytochrome c oxidase deficiency.<br />
Recent studies in Caucasian patients indicate that<br />
SURF1 gene mutations can cause Leigh syndrome associated<br />
with cytochrome c oxidase deficiency. When we
560<br />
Abstracts<br />
measured cytochrome c oxidase activity in cultured<br />
lymphoblastoid cells from Japanese patients with typical<br />
Leigh syndrome, six proved to have cytochrome c oxidase<br />
deficiency. Three novel mutations of the SURF1 gene were<br />
identified in three of these six patients with cytochrome c<br />
oxidase deficiency. We found one homozygous mutation in<br />
exon 5 of patient 1 (367AG del), and one heterozygous<br />
mutation in each of exon 7 (C640T) and exon 8 (802del<br />
26 bp insGG) of patient 2. We performed subcloning<br />
analysis of exons 7–8 in patient 2 and determined that<br />
each mutation was confined to one allele. Patient 3 showed<br />
the same mutation as patient 1 (367AG del). Parents of<br />
patients 1 and 3 are not consanguineous. Therefore, the<br />
367AG del mutation might have a high incidence in<br />
SURF1 mutations of Japanese patients with Leigh<br />
syndrome. All mutations predicted loss of function of the<br />
SURF1 protein: cytochrome c oxidase activity was<br />
decreased to less than 20% of the control mean in all of<br />
the patients. These results indicate that cultured lymphoblastoid<br />
cells are useful for elucidating the etiology of<br />
Leigh syndrome, and that loss of function of the SURF1<br />
gene product can be responsible for Leigh syndrome associated<br />
with severe cytochrome c oxidase deficiency in<br />
Japanese patients.<br />
FP-K-010<br />
Mutation analysis of phenylalanine hydroxylase gene in<br />
Northern Chinese<br />
F. Song, L.-X. Liu, Y.-L. Yang, Y.-W. Jin, H. Wang<br />
Capital Institute of Pediatrics, Beijing, China<br />
Objective: To detect the mutation of phenylalanine<br />
hydroxylase (PAH) gene in Northern Chinese. Methods:<br />
By using PCR/SSCP and DNA sequencing, we studied the<br />
mutation in exons 3, 5, 7, 10, 11 and 12 of PAH gene. A total<br />
of 108 unrelated children with phenylketonuria from the<br />
northern region of China were included in the analysis.<br />
Result: Twenty-two mutations were identified in the above<br />
exons. Eight mutations were detected in exon 7 and four in<br />
exon 5. Among them there were twelve missense, two<br />
nonsense, three splice and three silent, one insertion and<br />
one deletion mutation. The mutations: I65T, G239D,<br />
722delG, L255s, G346R, 1089-1099insC, IVS 1 2t . c,<br />
Q160Q, L385L have not been previously described in the<br />
China population. Conclusion: Because there are more<br />
mutations in exons 7 and 5 than others, it is suggested that<br />
the exons 7 and 5 is a mutant hot spot of PAH gene in<br />
Chinese. The results obtained confirm the high heterogeneity<br />
of the PAH gene and provide information about the<br />
distribution of PKU mutations in the Northern Chinese<br />
population.<br />
FP-K-011<br />
Polymorphism analysis of ATP7B related microsatellite<br />
DNA haplotype in Wilson disease<br />
X.Q. Liu, Y.F. Zhang, L. Wang, X.F. Gu, K.R. Bao<br />
Department of Pediatrics, Xin Hua Hospital, Shanghai<br />
Second Medical <strong>University</strong> and Shanghai Institute for<br />
Pediatric Research, Shanghai, China<br />
Objective: To explore the distribution and significance of<br />
haplotype of microsatellite DNA (D13S314, D13S301 and<br />
D13S316) closely related to ATP7B in normal population,<br />
WD patients and heterozygotes. Methods: Using three well<br />
characterized short tandem repeat markers of fluorescence<br />
labeling (D13S301–D13S314–D13S316), localization and<br />
sequence were analyzed with Genotype e software in 71<br />
WD patients and 123 parents. Results: Based on the analysis<br />
of haplotypes of D13 S314, D13S301 and D13S316, 19,<br />
20, and 15 alleles were obtained in 71 patients with WD,<br />
123 carriers and 54 normal persons respectively, size of<br />
segments was 134–157, 128–156 and 136–154 bp. Heterozygosity<br />
was 0.79, 0.82, and 0.23. There was a significant<br />
difference in the distribution of alleles of D13S314,<br />
D13S301 and D13S316 markers between WD patients<br />
and normal subjects (P , 0:01); four alleles in D13 S314<br />
marker, six alleles in D13 S316 marker. There were 81<br />
haplotypes. 12-6-5, 15-10-5, 6-10-5 and 6-15-5; the<br />
commonest haplotypes accounted for 5.22, 4.48, 4.48 and<br />
3.37%, respectively, 12-8-5, 12-7-5 and 6-16-5 separately<br />
accounted for 2.99%, 13-10-8,6-13-5,6-14-13, and 6-9-5<br />
separately accounted for 2.24%. Conclusion: The complexity<br />
of haplotype may be related to the complexity of mutation<br />
spectrum of ATP7B. The haplotype analysis of<br />
D13S314-D13S301-D13S316 may be an effective and<br />
feasible method with important clinical significance for<br />
the presymptomatic and prenatal diagnosis of Wilson<br />
disease.<br />
FP-K-012<br />
Gas chromatography-mass spectrometry (GC/MS)<br />
screening for inborn error of metabolism (IEM) in<br />
patients with mental retardation of unknown cause<br />
K.-M. Xu a , L.-W. Wang a , H. Cai a , T. Zhang a , C.-H. Zhang b ,<br />
I. Matsumoto b<br />
a Capital Institute of pediatrics Beijing of China; b MILS:<br />
Matsumoto Institute of Life Science of Japan<br />
Objective: To conduct screening of IEM by GC/MS in<br />
950 infants with mental-motor retardation of unknown<br />
cause. Method: All of the 950 patients’ urines were<br />
collected on filter paper and sent to MILS in Japan<br />
where the urinary compounds were analyzed using GC/<br />
MS, and the chemical diagnosis for IEM was determined.<br />
Results: Among 950 patients analyzed, 85 cases (9.0%) had<br />
abnormal urinary profiles. There were 18 cases of phenylk-
Abstracts 561<br />
etonuria (PKU), 16 cases of methylmalonic acidemia, 13<br />
cases of galactosemia, four cases of lysinuria, two cases<br />
each of glutaric aciduria, homoserinuria, and fructose-1,6-<br />
diphosphatase deficiency, one case each of pyro-glutaminuria,<br />
neuroblastoma, long-chain fatty acetyl CoA dehydrogenase<br />
deficiency, multiple carboxylase deficiency,<br />
maple syrup urine disease, propionic acidemia, ornithine<br />
transcarbamylase deficiency and Lesch-Nyhan syndrome,<br />
six cases of Fanconi syndrome and 14 cases of ketonuria.<br />
Good outcomes were obtained in most of the abovementioned<br />
patients after treatment with appropriate therapy.<br />
Conclusion: (1) Screening for IEM should be<br />
performed in infants with mental retardation of unknown<br />
cause. (2) The GC/MS analysis method is an accurate,<br />
sensitive and specific method. It is very important to<br />
extend the range and type of screening of IEM.<br />
FP-K-013<br />
The clinical analysis of PKU: report of five cases with<br />
atypical manifestations<br />
G.-Z. Xu a , C. Hong a , L.-W. Wang a , Y.-L. Zhu a , C.-H.<br />
Zhang b , I. Matsumoto b<br />
a Capital Institute of pediatrics Beijing of China; b MILS:<br />
Matsumoto Institute of Life Science of Japan<br />
Objective: Classic PKU is caused by the complete or<br />
near-complete deficiency of phenylalanine hydroxylase.<br />
The excess phenylalanine and subsequent metabolites<br />
disrupt normal metabolism and cause brain damage. Sometimes<br />
the mental retardation is misdiagnosed as an atypical<br />
syndrome and neglected by pediatricians, so that older<br />
untreated children become hyperactive with purposeless<br />
movements, rhythmic rocking and athetosis. This study<br />
aimed to explore the clinical characteristics and prognosis<br />
of the disease and diagnostic values of the urinary gas chromatography-mass<br />
spectrometric (GC/MS) analysis. Methods:<br />
All of the five patients’ clinical manifestations were<br />
non-specific. Samples of urine were collected and sent to<br />
MILS in Japan where the chemical compounds was<br />
analyzed using GC/MS. Results: Among five cases, two<br />
are diagnosed as autism, one spinal muscular atrophy, one<br />
dwarfism, and one language barrier with albinism before<br />
urinary analysis. The levels of phenylalanine, phenyllactate<br />
and phenylpyruvate in urine were obviously elevated. The<br />
diet and medical therapy was followed in four cases. One<br />
case have had a relatively satisfactory outcome, one case<br />
refused treatment, another 3 cases were recently diagnosed<br />
and still on the follow-up. Conclusion: Much attention<br />
should be paid to PKU with atypical signs such as autism,<br />
cerebral palsy especially weakness of muscle strength,<br />
dwarfism, language barrier with albinism. Early diagnosis<br />
and immediately treatment contribute to the improvement of<br />
the prognosis of PKU.<br />
FP-K-014<br />
Diagnoses and treatment of methylmalonic aciduria<br />
(MMA)<br />
L.-W. Wang a , K.-M. Xu a ,H.Cai a , C. Qian a , J.-X. Wu a , C.-<br />
H. Zhang b , I. Matsumoto b<br />
a Capital Institute of pediatrics Beijing of China; b MILS:<br />
Matsumoto Institute of Life Science of Japan<br />
Objective: Chemical diagnosis of inherited metabolic<br />
diseases in patients with mental-motor retardation, poor<br />
feeding, hypotonia, lethargy, convulsion and so on. Method:<br />
All of the 950 patients’ clinical manifestations were nonspecific.<br />
Urines were collected and sent to MILS in Japan<br />
where the chemical compounds in the urine were analyzed<br />
using GC/MS. Results: Among 950 patients analyzed, 85<br />
cases (9.0%) with abnormal urinary profiles were found.<br />
In these patients, 16 cases of MMA and one case of propionic<br />
acidemia were found. They accounted for 22.4% of all<br />
patients with abnormal urinary profiles (16/85). Good<br />
effects were obtained in eight cases after treating with suitable<br />
therapy, five did not improve, three died of late onset<br />
lethal complications (one died of intracranial hemorrhage<br />
owing to disorder of the platelet, and two died with coma<br />
and convulsion associated with ketoacidosis, and hyperammomemia).<br />
Conclusion: (1) Some patients with MMA could<br />
be treated by medication and low-protein diet. (2) Clinical<br />
manifestations of patients with MMA are non-specific, and<br />
the diagnoses cannot be achieved by clinical findings only.<br />
The GC/MS analysis method is accurate, sensitive and<br />
specific. It is important to extend the range and type of<br />
IEM screening.<br />
FP-K-015<br />
244insL, a novel mutation in methylmalonic aciduria in<br />
Chinese patients<br />
J.-X. Wu, H.-B. Chang, Z.-W. Liu, Y.-Y. Li, L.-W. Wang,<br />
H. Cai, K.-M. Xu<br />
Capital of Paediatrics Institute, Yabao Road 2, Beijing,<br />
China<br />
MMA is an autosomal-recessive disorder that results<br />
from inadequate function of methylmalonyl-coA mutase<br />
(MCM E.C. 5,4,99,2) nuclear-encoded, mitochondrial<br />
enzyme that uses the vitamin B12 derivative, adenosylcobalamin<br />
as a cofactor. It can be associated with fulminant<br />
metabolic acidosis, widespread secondary aberrations in<br />
systemic metabolic homeostasis, mental retardation, or<br />
even neonatal death. To date, 49 different mutations have<br />
been identified at the methylmalonyl-coAmutase (MUT)<br />
locus on the short arm of chromosome 6, but there have<br />
been no reports on MCM mutations in the Chinese population.<br />
Genomic DNA was extracted from leukocytes of<br />
MMA patients and normal children. DNA was amplified<br />
by PCR for exons III, XII of the MCM gene using oligonu-
562<br />
Abstracts<br />
cleotide primers recognizing flanking intronic sequences<br />
and cloned into pGEMT-easy vector. By sequencing the<br />
PCR product and cloning, we demonstrated that a two<br />
base pair insert in exon of the MCM patient in cDNA805<br />
resulted in a frame shift mutation. 244insL(c805insTT) is a<br />
novel mutation found in a compound homozygote. We also<br />
detected several SNP sites in MCM exons III and XII of the<br />
patient and controls. The positions in relation to different<br />
MCM domains allow for an interpretation of the identified<br />
mutations. This new mutation is the first reported in the<br />
Chinese population.<br />
FP-K-016<br />
Proteomics: a new strategy to identify mitochondrial<br />
diseases<br />
J. Xie a , S, Techritz a , J. Klose b , M. Schuelke a<br />
a Department of Neuropediatrics,<br />
b Institute of Human<br />
Genetics, Charité, Humboldt-<strong>University</strong> Berlin, Berlin,<br />
Germany<br />
Mitochondrial diseases can be caused by any defects in<br />
the metabolic pathways located in the mitochondria.<br />
However, there are several obstacles to the molecular diagnosis<br />
in this disease group. These are: (1) the variety of<br />
inheritance patterns (maternal, autosomal recessive, X-<br />
recessive); (2) the large number of genes involved in mitochondrial<br />
biogenesis; and (3) the similarity of the clinical<br />
features. Based on current diagnostic methods, less than<br />
20% suspected cases can be diagnosed at the molecular<br />
level. We have therefore presently developed a new screening<br />
method by which we hope to increase the identification<br />
rate. We studied the mitochondrial proteins in healthy individuals<br />
and in patients with mitochondrial diseases by twodimensional<br />
protein-electrophoresis (2DE). Differences in<br />
protein patterns between healthy and diseased individuals<br />
direct the attention to disease-specific proteins and genes.<br />
Mitochondria were purified from Epstein Barr Virus-transformed<br />
lymphocytes by density gradient centrifugation. We<br />
obtained a satisfactory yield of mitochondria from a small<br />
cell volume of ca. 10 8 lymphocytes. In order to establish a<br />
reference map of mitochondrial proteins we identified ca.<br />
100 proteins by matrix-assisted laser desorption/ionisationtime<br />
of flight (MALDI-TOF) mass spectrometry. The ensuing<br />
reference map was compared to mitochondrial 2DE<br />
maps of patients with mitochondrial diseases. Three of the<br />
patients had mutations in their mitochondrial DNA<br />
(7472inC; 3243A . G ¼ mitochondrial encephalopathy,<br />
lactic acid stroke (MELAS)-syndrome; 8344A . G ¼<br />
myoclonic epilepsy and red ragged muscle fibers<br />
(MERRF)-syndrome) three others had biochemically<br />
proven deficiencies of complex I, III and IV. We have identified<br />
numerous deviating protein spots, which can provide<br />
novel insights into the pathophysiology of mitochondrial<br />
diseases.<br />
FP-K-017<br />
A family case of spongiform leukoencephalopathy<br />
S. Yamashita, H. Iwamoto<br />
Division of Child Neurology, Kanagawa Children’s Medical<br />
Center, Yokohama Japan<br />
Three members including an 11-year-old girl, 6-year-old<br />
girl and 2-year-old boy among four siblings suffered from a<br />
similar disorder. Their parents were cousins. Their clinical<br />
courses included uneventful neonatal history, psychomotor<br />
retardation and developmental arrest. The neurological<br />
examination revealed that the elder two patients had muscle<br />
hypotonia caused by peripheral neuropathy, and the younger<br />
brother had the increased tendon reflexes and positive<br />
Babinski sign. All had cerebellar ataxia, nystagmus and<br />
slurred speech. Biochemical studies showed no evidence<br />
of mitochondrial encephalopathy, leukodytrophy, amino<br />
acid, or organic acid disorders. MRI showed similar<br />
abnormalities in both the T1 and T2 sequences in the<br />
white matter. The lesions involved cerebral white matter<br />
sparing subcortical U-fibers, corpus callosum, internal<br />
capsule, cerebellar white matter and brain stem longitudinal<br />
fibers. Two patients were autopsied and the neuropathological<br />
findings were similar. Vacuolar changes in the white<br />
matter started immediately below the cortex. The deeper,<br />
the white matter showed the more spongy alterations and the<br />
larger number of vacuoles and astrocytes. The matrix tissue<br />
was sparse and destroyed in the deep white matter with<br />
infiltration by many macrophages. The electron microscopic<br />
examination showed intralamellar splitting in the central<br />
myelin sheaths. The cerebral cortical layers showed normal<br />
structures without abnormal storage materials in the neuronal<br />
cells. A genetic disorder is suspected. We discuss this<br />
disorder in the relation to encephalopathy with vanishing<br />
white matter.<br />
FP-K-018<br />
The neurochemical peculiarity in children with<br />
neurocutaneous syndromes<br />
O.V. Globa, E.G. Sorokina, O.I. Maslova, V.M. Studenikin,<br />
V.I. Shelkovsky, V.G. Pinelis<br />
Divisions of Psychoneurology and Membranology,<br />
Research Institute of Pediatrics Scientific Center of Child<br />
Health Russian Academy of Medical Sciences, Moscow,<br />
Russia<br />
The investigations in neurochemical processes – the<br />
determination on autoantibodies (aAB) to glutamate<br />
AMPA GluR1 receptors, cyclic GMP (cGMP) (ELISA)<br />
and sialic acid (SA) (spectrophotometry) in blood serum<br />
were performed in children with different neurological<br />
diseases. To evaluate the changes in content of aAB the<br />
ELISA, elaborated by Institute of the Human Brain, RAS,<br />
was used. We examined 151 patients from 2 months to 16
Abstracts 563<br />
years of ages: 101 with epilepsy (Epi), 15 with neurocutaneous<br />
syndromes (NCS) (seven – tuberous sclerosis, five –<br />
neurofibromatosis type 1, 2-Sturge-Weber syndrome, 1-<br />
Bloch-Sulzberger syndrome) and 35 healthy children. The<br />
content of aAB was significantly increased by 1.5 times in<br />
patients with Epi in comparison with control group (CG) in<br />
all age groups (P , 0; 05). In patients with NCS the aAB<br />
level was by 2–2.5 times higher versus CG. A tendency for<br />
the increased level of SA in children with Epi was revealed.<br />
In patients with NCS the level of SA was significantly<br />
increased to 1.2 times versus CG. These data indicated the<br />
damage of neurons induced by glutamate receptors overstimulation<br />
in children with seizures. In all age groups the<br />
cGMP concentration, an indirect index of NO, was 5–7<br />
times higher than in CG (P , 0:001). In patients with<br />
NCS the cGMP level was higher by not more than three<br />
times versus CG. The results show more expressed injury<br />
of brain neuronal membranes in children with NCS than in<br />
patients with Epi and damage of the cGMP synthesis in<br />
patients with NCS compared to children suffering by Epi.<br />
FP-K-019<br />
Newly described multiple congenital anomalies in<br />
methylenetetrahydrofolate reductase deficiency in an<br />
Arab child<br />
A.A. Al Tawari, N.A. Al Torki, L.C. Heberle, M.A. Al<br />
Ajmi, J.E. Abdullah, N.A. Al Othman, M.M. Al Ajmi<br />
Child Neurology Unit, Children Department, AL Sabah<br />
Hospital, Kuwait<br />
Methylenetetrahydrofolate reductase deficiency<br />
(MTHFR) is a rare metabolic autosomal recessive inherited<br />
disorder. The principal clinical features are neurologic<br />
rather than metabolic such as hypotonia, developmental<br />
delay, seizures, microcephaly, apnea and coma. There are<br />
reports of association of MTHFR with neural tube birth<br />
defects or with congenital cardiac malformations. We report<br />
on an Arab child who is now 1 year old, presenting with two<br />
different disorders caused by two different gene mutations.<br />
Homocystinuria type III caused by methylenetetrahydrofolate<br />
reductase deficiency and spondylocostal dystosis as<br />
well as urogenital anomalies. The child showed improvement<br />
after he was commenced on betaine therapy.<br />
FP-K-020<br />
Canavan disease in Kuwait<br />
A.A. Al Tawari, Y. Habib, L.C. Heberele, M.A. Al Ajmi,<br />
J.K. Abdullah, M. Boloshi, A. Moosa<br />
AL Sabah Hospital, Children Department, Child Neurology<br />
Unit, State of Kuwait<br />
Canavan disease is a neurodegenerative autosomal recessive<br />
disease associated with disorders in the synthesis or<br />
catabolism of myelin due to deficiency of aspartoacyclase<br />
caused by mutations in the gene for this enzyme. The gene<br />
has been mapped to the short arm of chromosome 17. It is a<br />
panethnic disease more prominent among Ashkanazi Jews.<br />
We report nine children with Canavan disease from eight<br />
families. The diagnosis was confirmed by the elevated N-<br />
acetylaspartic acid in urine and brain imaging abnormalities.<br />
The eldest one is 8 years and the youngest is 6 months,<br />
one died at 3 years. We describe the clinical features, diagnostic<br />
procedures and note the need to elucidate the gene<br />
mutation among Arab Ethnic group.<br />
FP-K-021<br />
A family of episodic ataxia type 2: no evidence of genetic<br />
linkage to the CACNA1A gene on chromosome 19p13<br />
H. Hirose a , T. Arayama b , J. Takita a , T. Igarashi a ,Y.<br />
Hayashi a , Y. Nagao a,c<br />
a Department of Pediatrics, The <strong>University</strong> of Tokyo Tokyo,<br />
Japan; b Kikkoman General Hospital and c Social Health<br />
Insurance Medical Center, Japan<br />
Episodic ataxia type 2 (EA2) is an uncommon autosomaldominant<br />
disorder, which is characterized by bouts of vestibulo-cerebellar<br />
ataxia, lasting from 15 min to days, and<br />
interictal gaze-evoked nystagmus. EA2 has been reported<br />
to be caused by mutations in the CACNA1A gene, located<br />
on chromosome 19p13, which codes the pore-forming<br />
Ca v 2.1 (formerly known as a1A) subunit of a P/Q-type<br />
voltage-dependent calcium channel. In this report we<br />
describe a family with episodic ataxia, clinically indistinguishable<br />
from EA2, which was not caused by CACNA1A<br />
gene mutation. The proband is a 10 year-old boy, who has<br />
had six cerebellar ataxic attacks since 8 years. His attacks<br />
occurred almost monthly, lasting for 2–3 days. He was treated<br />
successfully with acetazolamide. His maternal grandmother,<br />
mother and identical twin had similar attacks<br />
manifesting at 50, 34 and 10 years, respectively. The symptoms<br />
in his grandmother improved gradually without medication.<br />
His mother and identical twin took acetazolamide<br />
with a good response. We examined the CACNA1A gene on<br />
this family but did not detect any mutations. Furthermore,<br />
linkage analysis, using the SNP in exon 46 and the variable<br />
number of tandem repeats of GT repeats in intron 40,<br />
showed that there was no evidence of genetic linkage<br />
between the CACNA1A gene and the symptomatic patients<br />
in this family. This suggests that the cause of EA2 can be<br />
heterogeneous, that is, defects of genes other than<br />
CACNA1A might be the cause of EA2.<br />
FP-K-022<br />
Clinical research of X-linked adrenoleukodystrophy<br />
H. Xiong, Y.-H. Zhang, J. Qin, J.-X. Xiao, C.-Y. Shi, S.-M.<br />
Zhou, X.-R. Wu<br />
Department of Pediatrics, First Hospital, Peking <strong>University</strong>,<br />
Beijing, China
564<br />
Abstracts<br />
Objective: The clinical manifestations, biochemical<br />
changes and genetic counseling aspects of X-linked adrenoleukodystrophy<br />
(ALD) were analyzed. Methods: Clinical<br />
features of 29 cases with ALD were summarized and<br />
analyzed. Results: Among these 29 cases, the clinical<br />
phenotypes include childhood cerebral type (22 cases),<br />
adolescent cerebral type (four cases), adrenomyeloneuropathy<br />
type (one case), Addison disease only (one case), and<br />
asymptomatic or presymptomatic (one case). Nine had positive<br />
family history. Pedigree investigation was consistence<br />
with typical sex-linked recessive inheritance. There were 45<br />
ALD patients in these 29 pedigrees. The neurological manifestations<br />
varied among members of the same family. Nine<br />
cases died during follow-up. The causes of death were<br />
central respiratory failure or other complications associated<br />
with ALD. Laboratory tests demonstrated abnormally high<br />
plasma levels of very long chain fatty acids (VLCFA) in<br />
ALD patients; MRI demonstrated symmetric butterfly-like<br />
T1 low T2 high signals in the parieto-occipital white matter.<br />
The involvement in the splenium of corpus callosum led to<br />
the convergence of bilateral lesions. It can progress forward<br />
and involves the posterior limb of internal capsule bilaterally<br />
and the temporal lobe, and the brainstem inferiorly.<br />
Conclusions: Atypical initial symptoms of ALD were<br />
seizures. The MRI showed abnormal signal in the cerebellar<br />
white matter. The disease can impair the normal development<br />
of children; this was more pronounced in the childhood<br />
cerebral ALD type. It tended to progress rapidly with<br />
dementia, vegetative state or death. We can now do antenatal<br />
examinations. Emphasis should be placed on antenatal<br />
examination, in order to achieve early diagnosis and to abort<br />
pregnancy if indicated.<br />
FP-K-023<br />
Detection of mutations in ALD protein (ALDP) gene by<br />
PCR-DNA sequence analysis in Chinese<br />
adrenoleukodystrophy patients<br />
H. Xiong, H. Pan, Y.-H. Zhang, X.-R. Wu<br />
Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />
Beijing, China<br />
Objective: X-linked ALD is a peroxisomal disorder characterized<br />
by impaired peroxisomal beta-oxidation of<br />
VLCFAs. The ALD gene is localized on Xq28, has ten<br />
exons and encodes a protein of 745 amino acids. The mutations<br />
in ALD gene encoding adrenoleukodystrophy protein<br />
in Chinese ALD patients were identified. Methods: Genomic<br />
DNA from 14 unrelated patients (and two patients’<br />
parent) with X-linked ALD was extracted using standard<br />
procedures from the peripheral blood leukocytes. So far,<br />
exon 6 at the 3 0 end portion of ALDP gene were amplified<br />
with the primers synthesized according to the published<br />
flanking intronic sequences. The PCR products were further<br />
analyzed by agarose gel electrophoresis and directly<br />
sequenced. Results: By DNA sequencing analyses, four<br />
PCR products were identified. One was deleted with one<br />
C nucleotide in the intronic sequences before the exon 6,<br />
maybe induce cut disorder. The missense-type mutations:<br />
T1559A was found in one patient and his mother. One other<br />
had a silent mutation: G1548A. Conclusion: Mutations in<br />
ALDP gene were identified in Chinese ALD patients in the<br />
mainland of China for the first time. No major gene deletion<br />
or rearrangement was detected. Despite many mutations<br />
having been identified in patients with these clinical phenotypes,<br />
the genotype-phenotype correlations have not been<br />
clarified. Furthermore, there were no phenotypic expression<br />
changes caused by the subtle amino acid changes. These<br />
data indicated that no obvious correlations exist between<br />
the phenotypes of ALD patients and their genotypes,<br />
suggesting that other genetic or environmental factors may<br />
also be involved in determining phenotypic expression in<br />
ALD.<br />
FP-K-024<br />
Clinical, biochemical and genetic diagnosis in a family<br />
with atypical Fabry disease<br />
Th. Kroepfl a ,K.Paul a , B. Plecko a , P. Kotanko b , E. Paschke a<br />
a <strong>University</strong> of Graz, Department of Pediatrics, Graz,<br />
Austria; b Krankenhaus der Barmherzigen Brueder Graz,<br />
Department of Internal Medicine, Graz, Austria<br />
Fabry disease (McKusick 301500) is an x-linked deficiency<br />
of lysosomal a-galactosidase A (EC 3.2.1.22) leading<br />
to the accumulation of glycosphingolipids in the<br />
lysosomes. As it mainly affects the skin, eyes, kidneys,<br />
heart and the nervous system, the patients usually suffer<br />
from severe pain attacks in childhood, later followed by<br />
angiokeratoma, renal dysfunction and severe cardiomyopathy.<br />
In a 42 year-old male mild proteinuria was noticed at<br />
the age of 29, leading to end stage renal disease and kidney<br />
transplantation within few years. At the age of 40 a marked<br />
non-obstructive cardiomyopathy became obvious.<br />
Although the majority of typical symptoms like paresthesia,<br />
hypohydrosis or lesions of the skin and the cornea were<br />
lacking, Fabry disease was histologically suspected due to<br />
the result of a kidney biopsy and was biochemical<br />
confirmed when leucocyte a-galactosidase was shown to<br />
be reduced to 1.5% of controls. A novel insertion of 6<br />
bases in exon 7 of the a-galactosidase gene on chromosome<br />
Xq22.11 was found in the DNA of the patient but not<br />
in 40 DNA controls. The mutation was also present in a<br />
sister with cardiomyopathy and her asymptomatic daughter<br />
but not in a second sister without symptoms. Surprisingly<br />
the enzyme level was normal in all relatives examined.<br />
These results illustrate importance of a complete genotype-specific<br />
diagnosis in suspected Fabry patients in<br />
order to provide the benefit of novel therapies to all male<br />
and female patients of this probably highly underdiagnosed<br />
condition. Thus, our patient will be the first to undergo<br />
ERT in Austria.
Abstracts 565<br />
FP-K-025<br />
Eighteen years follow-up of a boy with congenital<br />
disorders of glycosylation (CDG) type IIa syndrome:<br />
clinical aspects<br />
P. De Cock, J. Jaeken<br />
Department of Paediatrics, <strong>University</strong> Hospital Gasthuisberg,<br />
Leuven, Belgium<br />
Because of a cardiac murmur (VSD) and dysmorphic<br />
features J. was transferred soon after birth to our department.<br />
In the following years several diagnoses have been<br />
put forward to explain his congenital anomalies and severe<br />
psychomotor retardation. They all proved wrong when at<br />
the age of 9 years a striking pattern of haemostatic abnormalities<br />
led to the discovery of a new type of congenital<br />
disorders of glycosylation (CDG), namely CDG type IIa,<br />
due to a deficiency in Golgi localised N-acetyl-glucosaminyltransferase<br />
II (ref.). Surprisingly brain imaging showed<br />
no cerebral or cerebellar anomalies. At 18 years J. is a very<br />
dystrophic adolescent with short stature, profoundly<br />
retarded, suffering from a refractory epilepsy, progressive<br />
kyphoscoliosis and muscle wasting in more than one aspect<br />
resembling a progressive myopathy (elevated GOT, normal<br />
GPT). He learned to put a few steps unsupported but now he<br />
is no more able to do so. Communication always remained<br />
very limited. Moreover he has GE-reflux disease with recurrent<br />
GI haemorrhages, gingival hypertrophy, sleep apnea<br />
and an impressive osteoporosis. The coagulopathy almost<br />
impedes any surgical intervention and furthermore several<br />
drugs had to be discontinued because of side effects. His<br />
clinical course will be presented and illustrated and therapeutic<br />
dilemmas will be discussed.<br />
FP-K-026<br />
Familial moyamoya disease in two European children<br />
H. Bazigou a , J. Tolmie b , K. Muir c , C. Fotopoulou d ,A.<br />
Papavasiliou a<br />
a Pendeli Children Hospital, Section of Pediatric Neurology,<br />
Athens, Greece; b Medical Genetics Department, Yorkhill<br />
Hospitals, Glasgow, UK;<br />
c Institute of Neurological<br />
Sciences, Southern General Hospital, Glasgow, UK; d Humboldt<br />
<strong>University</strong>, Berlin, Germany<br />
MMD is characterized by a cerebral angiographic picture<br />
of stenosis or occlusion of the main cerebral arteries.<br />
Although the etiology is still unknown, we present two<br />
cases of familial MMD in order to stress the importance<br />
of familial factors in the pathogenesis of the disease. The<br />
first case refers to a 14-month old Greek girl with a right<br />
hemiparesis after two brief right focal motor seizures. MRI<br />
of the brain showed diffuse infarcts at the left tempo-parietal<br />
and the right temporo-occipital regions. A digital cerebral<br />
arteriography showed stenosis of the supraclinoid right and<br />
left internal carotid artery and hypertrophy of the lenticulostriate<br />
arteries. Her mother, suffering also from MMD, is<br />
heterozygous for FV Leiden, for mutant FII (20210A) and<br />
MTHFR factors, done by PCR and the patient is positive for<br />
two of these factors. A revascularization procedure had been<br />
performed in the mother at nine years of age and in the<br />
patient recently. The second patient is a 5-year old boy,<br />
coming from Scotland with a three-generation history of<br />
MMD (maternal grandmother and sister and a sibling of<br />
the patient), who during his summer holidays in Greece<br />
developed fever, headache and left-sided motor seizures,<br />
followed by left hemiplegia. MRI and bilateral carotid arteriography<br />
confirmed the diagnosis of MMD (subtotal stenosis<br />
of the initial sections of the right mainly and the left<br />
middle cerebral arteries). Coagulation factors were normal.<br />
Further studies are required to determine etiological factors<br />
in familial MMD and to elucidate the role of hemostatic<br />
abnormalities in its pathogenesis.<br />
FP-K-027<br />
CLN2 – Classic late infantile neuronal ceroid<br />
lipofuscinosis (LINCL). Report on 13 Brazilian cases<br />
S. Rosemberg, D. Fujiwara<br />
Santa Casa of São Paulo Medical School, Department of<br />
Pediatrics, Neuropediatrics Division, São Paulo, Brazil<br />
LINCL is by far the most frequent neuronal ceroid lipofuscinosis<br />
(NCL) encountered in Brazil and, perhaps in<br />
Latin America comprising all but one NCL cases diagnosed<br />
in our Service. We studied 13 unrelated patients (nine<br />
males, four females). Consanguinity was present in eight<br />
cases. Clinical phenotype was very uniform. The onset of<br />
symptoms occurred between 2 years 7 months and 4 years 6<br />
months (mean: 3 years 4 months). In three cases there was a<br />
previous delay of speech and psychomotor development<br />
was somewhat slow. Generalized tonic-clonic or astaticakinetic<br />
seizures were the first symptoms which were<br />
concomitant with or followed in a short period by arrest<br />
and decline of the psychomotor skills. Global ataxia, pyramidal<br />
signs and polymyoclonus were prominent and most<br />
patients could not walk within 18 months after the onset.<br />
Visual decline was difficult to assess due to the mental<br />
regression. Funduscopy disclosed isolated optic atrophy in<br />
three patients and macular degeneration associated with<br />
optic atrophy in six. Three patients died at age 10 years,<br />
five patients aged between 6 and 11 years are alive and<br />
five were not followed up. EEG was abnormal in all<br />
cases. Occipital photosensitive response was found whenever<br />
searched (n ¼ 4). ERG performed in four patients was<br />
extinguished. Cranial CT showed diffuse atrophy in all<br />
patients whose severity increased with the patients’ age.<br />
Vacuolated lymphocytes were never encountered. The<br />
final diagnosis was done through the ultrastructural exam<br />
of conjunctival biopsies performed in all patients, which<br />
showed pure curvilinear storage bodies in fibroblasts,<br />
endothelial or perithelial cells. Brazilian LINCL patients
566<br />
Abstracts<br />
form a very uniform clinicopathological population. Future<br />
genetic studies will show whether there is a corresponding<br />
genetic background.<br />
FP-K-028<br />
Renal lesions in tuberous sclerosis<br />
T. Yamano, K. Tanaka, H. Hattori, T. Seto, O. Matsuoka<br />
Department of Pediatrics, Osaka City <strong>University</strong> Graduate<br />
School of Medicine, Osaka, Japan<br />
In tuberous sclerosis (TS), the major causes of death<br />
include status epilepticus, renal disease, brain tumors and<br />
lymphangiomyomatosis of the lung. Child neurologists pay<br />
special attention to treatment of intractable epilepsy, but<br />
rarely to for renal involvement. This study was undertaken<br />
to elucidate renal lesions in 14 patients with tuberous sclerosis.<br />
They included six males and eight females between 3<br />
and 37 years of age (mean: 14 years of age) who were<br />
treated in our hospital. They were repeatedly examined by<br />
abdominal echography, CT and/or MRI. Abnormalities<br />
were found in ten patients. Multiple cysts were detected in<br />
one kidney of a patient and in both kidneys of two, one of<br />
whom developed renal failure at 13 years of age and then<br />
received CAPD therapy. Other three female patients had<br />
angiomyolipoma in both kidneys, which increased gradually<br />
in volume year by year. In the remaining four patients,<br />
kidneys revealed rugged surface and heterogeneous echodensity.<br />
Our study indicated that prominent renal lesions<br />
such as multiple cysts and angiomyolipoma occurred in<br />
six of 16 patients (43%) with TS. Furthermore, these lesions<br />
were progressive, occasionally resulting in renal failure.<br />
Periodical evaluations of kidney structure and function are<br />
required in TS patients.<br />
FP-K-029<br />
Infantile dentatorubral pallidoluysian atrophy: distinct<br />
phenotype from juvenile form<br />
T. Fujii a , M. Ito a , K. Ishikawa b , H. Mizusawa b ,T.<br />
Miyajima a , Toshiyuki Kito a , T. Okuno a<br />
a Department of Pediatrics, Shiga Medical Center for Children,<br />
Moriyama, Japan; b Department of Neurology, Tokyo<br />
Medical and Dental <strong>University</strong>, Tokyo, Japan<br />
Dentatorubral pallidoluysian atrophy (DRPLA) is an<br />
autosomal dominant neurodegenerative disorder associated<br />
with the expansion of an unstable (CAG)n repeat in the<br />
DRPLA gene. There are two clinical forms of DRPLA:<br />
juvenile-onset DRPLA is characterized by progressive<br />
myoclonic epilepsy and dementia; and adult-onset patients<br />
commonly have choreoathetosis, cerebellar ataxia and<br />
dementia. Shimojo et al. reported two infants with<br />
DRPLA. Both had rapid regression and severe involuntary<br />
movements without myoclonus, and an extremely<br />
expanded CAG repeat ($90 repeats). We report an<br />
infant-girl with regression, severe choreoathetosis followed<br />
by dystonia, and the extreme expansion of the CAG repeat<br />
(18/87); similar to two reported patients. Patient: A 5-yearold<br />
girl had psychomotor developmental delay with the<br />
maximum motor ability achieved being sitting and creeping.<br />
The regression started at the age of 3, and she became<br />
unable to sit or creep in 6 months. At age 4, she developed<br />
severe choreoathetosis and oral dyskinesia. CT scan<br />
showed cerebral and cerebellar atrophy. A few months<br />
later, the choreoathetosis diminished, but dystonia became<br />
apparent. Currently, she has severe dystonia and bulbar<br />
symptoms. Discussion: The phenotype of our patient is<br />
similar to that of Shimojo et al.’s two patients. All showed<br />
the infantile-onset regression, involuntary movements<br />
without myoclonus, cerebral and cerebellar atrophy, and<br />
the very long CAG repeats (87 , 93 repeats). Thus, our<br />
patient confirms the existence of another clinical form;<br />
infantile DRPLA.<br />
FP-K-030<br />
Mutation of dystrophin gene of muscular dystrophy in<br />
Javanese children in Yogyakarta Indonesia<br />
Sunartini a , E.S. Herini a , P. Soeryantoro a , Harsono b<br />
a Department of Pediatrics;<br />
b Department of Neurology,<br />
School of Medicine, Gadjah Mada <strong>University</strong>, Indonesia<br />
Both Duchenne and Becker muscular dystrophies are<br />
caused by dystrophin gene mutations. Due to the large<br />
size of the dystrophin gene, the gene mutation occurs<br />
frequently. This mutation was also found in Javanese Children<br />
in Yogyakarta, Indonesia. Materials and methods: All<br />
patients with DMD/BMD admitted to Dr. Sardjito Hospital<br />
were included in this study. The diagnosis was confirmed by<br />
clinical, laboratory and histopathological examination.<br />
Multiplex PCR for DNA analysis was used to detect the<br />
mutation of dystrophy gene. Results: Sixteen DMD/BMD<br />
patients were included in this study. The mutations were<br />
detected in eight cases (50%). Deletions occurred on the<br />
hot spot exon of 6, 7–21, 12–19, 18–49, 45, 46 and 51. In<br />
the other eight cases the mutations have not yet been<br />
detected. Search for the mutation continues in the other<br />
siblings and family members and will include carriers and<br />
cases with normal clinical appearance.<br />
FP-K-031<br />
The clinical and experimental studies of metachromatic<br />
leukodystrophy<br />
W.-C. Zhang, H.-S. Wu, T.-C. Liu<br />
Department of Neurology, Beijing Children Hospital, Beijing,<br />
China<br />
Objectives: To evaluate the clinical features of metachromatic<br />
leukodystrophy (MLD) and diagnostic value of<br />
measuring ASA activity in peripheral leukocytes. Methods:<br />
The analysis was done in 6 patients with MLD according to
Abstracts 567<br />
the clinical and experimental data. Results: There were five<br />
cases of the late infantile form with onset of symptoms<br />
ranging from 1 to 2.5 years of age and one case of the<br />
juvenile form at 6 years. All had a gait disorder at onset<br />
with a progressive course that resulted in spastic paraplegia<br />
or tetraplegia in both legs or limbs. Speech disturbance<br />
occurred in three cases and mental regression in three.<br />
Cranial CT scan revealed symmetric low density area in<br />
the cerebral hemisphere in three cases. Cranial MRI<br />
showed bilateral symmetric T2-high signal intensity<br />
white matter lesions on bilateral white matter in five<br />
cases. Six cases had low or deficient ASA activity. Conclusion:<br />
The clinical features of MLD are progressive motor<br />
deterioration, speech disturbance and mental regression.<br />
The white matter abnormalities on cranial CT and MRI<br />
are useful for the diagnosis of MLD. The diagnosis is<br />
based on the deficiency of ASA activity in peripheral<br />
leukocytes.<br />
FP-K-032<br />
Leigh syndrome with mitochondrial DNA mutation at<br />
14597 T-C<br />
G.T Riordan a , P.M. Leary b , E.P. Owen a<br />
a Department of Neurology and b Chemical Pathology, Red<br />
Cross Children’s Hospital, <strong>University</strong> of Cape Town, Cape<br />
Town, South Africa<br />
A 16 month-old female presented with dystonia of<br />
gradual onset over a month. Prior development was<br />
normal. MRI of her brain aged 3 years demonstrated<br />
symmetrical T1-WI hypointense abnormalities in bilateral<br />
basal ganglia. At 10 years clinical deterioration accelerated.<br />
Dystonia prevented ambulation and reflexes were<br />
increased with extensor plantars. Virtually complete external<br />
ophthalmoplegia was present. Irregular respiratory<br />
pattern and severe hypertension suggested autonomic<br />
disturbances. Repeat MRI showed symmetrical extension<br />
of brainstem lesions. Pyruvate dehydrogenase activity was<br />
normal. No mitochondrial (mt) mutations were found at<br />
base pairs 3271, 3243, 8344, 8993 or sites associated<br />
with Leber’s optic atrophy. A point mutation was encountered<br />
at nt T14597C altering amino acid 26, isoleucine, to<br />
threonine. Degree of heteroplasmy in fibroblasts was over<br />
95% with no normal sequence being seen. The mutation<br />
occurred in a highly conserved region of the ND6 gene and<br />
changed a non-polar to a polar amino acid. Normal<br />
sequence was present in her mother. This amino acid<br />
change could potentially cause an unstable subunit of<br />
complex 1. A mutation at ntT14596A changing isoleucine<br />
to methionine was described in a Dutch family with hereditary<br />
spastic dystonia and optic atrophy. (Am J Hum Genet<br />
1996;58:703–711). It is likely that a T14597 C mutation in<br />
mtDNA was responsible for causing Leigh Syndrome in<br />
this patient.<br />
FP-K-033<br />
Evaluation of the floppy infant: contribution of genetic<br />
and neurological disorders<br />
A.N. Prasad a , K. Birdi a , C. Prasad b , M. Cheang c ,B.<br />
Chodirker b , A.E. Chudley b<br />
Sections of<br />
a Pediatric Neuroscience, and b Genetics and<br />
Metabolism; Department of Pediatrics and Child Health,<br />
Biostatistical Consulting Unit; c Department of Community<br />
Medicine, <strong>University</strong> of Manitoba, Winnipeg, Canada<br />
This study examines in particular the impact of advances<br />
in DNA based diagnostic testing, and neuroimaging on the<br />
laboratory work up in the floppy infant. We present a retrospective<br />
analysis of 89 infants referred for evaluation to the<br />
genetics and neurology services over 11 years (1990–2000).<br />
Cases were ascertained through a systematic search of<br />
genetics/neurology clinic databases, and EMG records.<br />
There were 47 males, 42 females. The majority (83.7%)<br />
presented below the age of 1 mo. The aboriginal population<br />
is over represented in this patient group (37.5 versus 15%),<br />
in comparison to the expected proportion of the aboriginal<br />
population. Operative delivery was necessary in 26.4%<br />
(16.2–36.6, 95% CI), persistently low Apgar scores (,3 at<br />
5 min) were noted in 6% (0.3–11.6, 95% CI). The majority<br />
(56.5%) of infants were delivered at term (45.9–75.1, 95%<br />
CI), and with birth weights between 2500 and 3000 g 61%<br />
(46–75.9, 95% CI). These infants were followed up for a<br />
mean duration of 29 months (24.4–33.5, 95% CI). Genetic<br />
disorders 29% (17.7–40.3, 95% CI), structural brain malformations<br />
35.5% (23.6–47.4, 95% CI) and disorders of the<br />
motor unit 17.7% (8.2–27.3 95%CI) were most frequently<br />
encountered. DNA based diagnostic tests and neuroimaging<br />
studies (CT) were more likely to lead to the final diagnosis<br />
than other tests (P , 0:05). There is significant mortality<br />
(11.6%), and considerable morbidity; 60% showing global<br />
developmental delay, nearly half (56.6%) remaining non<br />
ambulatory, and a small proportion (2.6%) requiring home<br />
ventilation. A diagnostic algorithm for appropriate utilization<br />
of laboratory services based on the findings of the study<br />
is presented.<br />
FP-K-034<br />
Clinical survey of 138 patients with organic aciduria<br />
Y.-L. Yang, Y.-H. Zhang, Y.-W. Jiang, X.-H. Bao, Y. Qi, J.<br />
Qin, X.-R. Wu, S. Yamaguchi, X. Fu, M. Kimura T. Yasiko,<br />
H. Jun, F. Minoru<br />
Department of Pediatrics, The First Hospital of Peking<br />
<strong>University</strong>, China; Department of Pediatrics, Shimane<br />
Medical <strong>University</strong>, Japan, and Sapporo Health Institute,<br />
Japan<br />
Objective: To investigate the incidences, clinical features<br />
of organic aciduria in children with mental retardation and<br />
other neurological defects. Subjects and methods: In the past
568<br />
Abstracts<br />
4 years, 1372 patients with mental retardation, seizures,<br />
motor deficit, vomiting, growth disorders, and metabolic<br />
acidosis or lethargy were screened by urine organic acid<br />
analysis (gas chromatography/mass spectrometry). Results:<br />
Seventy-one (5.14%) patients aged from 5 days to 18 years<br />
with typical organic aciduria were confirmed. Among them,<br />
32 were methylmalonic aciduria, 13 were propionic aciduria,<br />
six were multiple carboxylase deficiency, five were<br />
glutaric aciduria, four were hyperoxalic aciduria, three<br />
were oxoprolinemia, two were methylcrotonyl CoA carboxylase<br />
deficiency, one patient with maple syrup urine disease,<br />
one ketothiolase deficiency, one isovaleric aciduria, one<br />
alcaptonuria, one carnitine palmitoyl transferase deficiency<br />
type II, one glyceric aciduria, respectively. In addition, 67<br />
cases (4.88%) of atypical organic aciduria (such as dicarboxylic<br />
aciduria) were detected. Among the above 138<br />
patients, mental retardation, seizures, metabolic acidosis,<br />
vomiting, and SIDS like strike were in 115 (83.3%), 92<br />
(66.7%), 68 (49.3%), 83 (60.1%) and 14 (10.1%) patients,<br />
respectively. A total of 105 (76.1%) patients were treated.<br />
Nineteen (13.8%) died. Clinical improvement was observed<br />
in 94 (68.1%) patients. Twenty-six (18.8%) showed normal<br />
mental development. Conclusion: Most of organic aciduria<br />
involved nervous system intensively. Early diagnosis and<br />
adequate treatment contributed to the improvement of the<br />
mental prognosis of the patients, and screening is critical.<br />
GC/MS was a very important method to the diagnosis for<br />
organic aciduria.<br />
FP-K-035<br />
Autosomal recessive centronuclear myopathy and<br />
cataract: report of a large pedigree<br />
N. Şenbil, Z. Akçören, G. Tuncer, A. Özön, H. Topaloǧlu<br />
Hacettepe Children’s Hospital, Ankara, Turkey<br />
There are three basic inheritance patterns of centronuclear<br />
myopathy (CM). The gene of the X-linked form maps<br />
to Xq28 and codes for a protein called myotubularin. The<br />
autosomal recessive and dominant forms are rare, and their<br />
genetic loci are unknown. Here, we present a large family<br />
in which three out of seven siblings were affected with<br />
autosomal recessive CM. Interestingly, cataracts were<br />
also segregating within the members. All patients showed<br />
hypotonia from infancy, delay in motor milestones and<br />
weakness. There was generalized muscle weakness, facial<br />
involvement, waddling gait, lordotic posture, and absent<br />
deep tendon reflexes. Serum CK was normal. There were<br />
myopathic alterations in the EMG. The evolution was relatively<br />
non-progressive. The eldest affected sib is an 18<br />
year-old boy with bilateral cataracts (removed), ptosis,<br />
ophthalmoplegia, and long and thin face. The second one<br />
was a 15 year-old girl. She had all the findings of the<br />
brother except the cataracts. A 4 year-old-girl was the<br />
third affected sib and her complaints have just begun.<br />
There was also a 22 year-old girl only with cataracts. We<br />
have no detailed information for the nature of the cataracts<br />
as they were removed many years before our evaluation of<br />
the family. There was no known consanguinity, but both<br />
parents were from the same village. Muscle biopsy was<br />
obtained from two of the affected patients. The pathological<br />
studies revealed a prominent variety in fiber size,<br />
centrally placed nuclei in most of the fibers and adiposis<br />
with ATPase type I fiber predominance and with succinic<br />
dehydrogenase myofibrillar disruption and many motheaten<br />
fibers were present. These findings were compatible<br />
with CM. This family may be a candidate for further<br />
genetic analysis to help to search a genetic locus of autosomal<br />
recessive CM.<br />
FP-K-036<br />
Profile of clinical and biochemical characteristics of 41<br />
pediatric patients with cerebral lipidosis<br />
A. Nalini, R. Christopher, D.K. Subbakrishna<br />
Department of Neurology, Neurochemistry and Biostatistics;<br />
National Institute of Mental Health and Neuro<br />
Sciences, (NIMHANS), Bangalore, Karnataka, India<br />
A retrospective study of 41 patients seen between 1993<br />
and 2001 was done. The clinical features and biochemical<br />
parameters were studied. Results: There were 20 cases of<br />
metachromatic leukodystrophy (MLD) (infantile-14, juvenile-6);<br />
Tay-Sachs disease (TSD)-12 (infantile-9, lateG M2 -<br />
3); Sandoff disease (SD)-8; and one of multiple sulfatase<br />
deficiency. 2 0 consanguinity seen in nine of MLD, six of<br />
TSD, three of SD, 3 0 in one from each group. The M:F ratio<br />
was: MLD (13:7); TSD (4:8); SD (6:2). There were 38<br />
Hindus and three Muslims. The mean age at onset was<br />
39.5 ^ 44.2 months in MLD; 10.0 ^ 8.9 months in TSD;<br />
7.7 ^ 5.5 months in SD. Delayed milestones seen in 80% of<br />
MLD; 75% of TSD and 88% of SD. Macrocephaly seen in<br />
one of SD and one of MLD. Seizures seen in 45% of MLD;<br />
50% of TSD; and 75% of SD. Startle myoclonus was seen in<br />
100% of TSD, 75% of SD, 10% of MLD. Visual loss was<br />
present in 42% of TSD, 50% of SD, 10% of MLD. Cherry<br />
red spot was seen in 75% of TSD and 86% of SD. Optic<br />
atrophy in 30% of MLD, 42% of TSD and 25% of SD.<br />
Deafness in one case of TSD and SD. Spasticity with<br />
brisk DTRs in 32 and absent DTRs in eight. Babinski positive<br />
in 33, cerebellar ataxia in three of MLD and two of<br />
TSD, dystonia of limbs in three of MLD. Family history<br />
of similar illness in eight of MLD, one of SD and TSD.<br />
The mean serum arylsulfatase-A level in 20 of MLD was<br />
20.7 ^ 7.1 (10–36) nmol/h. The mean serum b hexosaminidase-A<br />
level in 12 of TSD was 7 ^ 6.9 (3–23) nmol/ml<br />
per h. The mean total serum b hexosaminidase level in eight<br />
cases of SD was 37.3 ^ 32.8 (0–62) nmol/ml per h. The<br />
MSD case had low level of arylsulfatases A and B in<br />
serum and in leucocytes. NCV showed motor sensory<br />
demyelination in eight of MLD. Sural nerve biopsy was<br />
positive for metachromatic material in six of MLD. Conclu-
Abstracts 569<br />
sion: This is the largest series of biochemically confirmed<br />
cases from India.<br />
FP-K-037<br />
MECP2 gene mutation analysis in patients with Rett<br />
syndrome in China<br />
H. Pan a , Y.-P. Wang b , X.-H. Bao a , H.-D. Meng a , Y. Shen b ,<br />
X.-R. Wu a<br />
a Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />
Beijing, China; b Chinese National Human Genome<br />
Center, Beijing, China<br />
RTT is a progressive neurodevelopmental disorder that<br />
almost exclusively affects girls. Mutations in the X-linked<br />
methyl-CpG-binding protein 2 (MeCP2) gene have been<br />
found to be a cause of RTT. Methylation of CpG in the<br />
mammalian genome is important for transcriptional silence.<br />
Decreased MeCP2’s activity will lead to derepression of<br />
transcription at multiple central nervous system loci and<br />
overexpression of some genes that may be detrimental<br />
during brain development. The developing brain may be<br />
more dependent on MeCP2 than any other tissues. A lot<br />
of mutations have been reported in different races recently.<br />
In order to study the spectrum of mutations in China, we<br />
employed PCR and direct sequencing to analyze the<br />
MECP2 coding region in 31 classical sporadic RTT Chinese<br />
cases. Twelve different mutations in exon three were identified<br />
in 17 of these 31 patients, including four missense<br />
mutations (R133C, T158M, P225R, R306C), three nonsense<br />
mutations (R168X, R255X, R294X), five frameshift<br />
mutations (806delG, 875insA, 1158–1167/1171–<br />
1186del24, 1164del44, and 1152del44 bp). And there was<br />
1 bp variant at the intron (G21830A). All of missense and<br />
nonsense mutations except R168X were located either in the<br />
methyl-CpG binding domain or in the transcriptional repression<br />
domain. The three large deletion mutations were<br />
located in a hot spot for deletion that has been reported. A<br />
missense variant (P381G) was detected in a patient and her<br />
father. Mutations in MECP2 gene were considered to be a<br />
cause for Rett syndrome, and can be found in about 55%<br />
cases in our study.<br />
FP-K-038<br />
Citrullinuria: report of one case<br />
Q. Chen, K.-M. Xu, L.-W. Wang<br />
Capital Institute of Pediatrics, Beijing, China<br />
Citrullinuria is a genetic disease caused by deficiency of<br />
argininosuccinate synthetase (ASS). ASS is a urea cycle<br />
enzyme that catalyzes the synthesization of argininosuccinate<br />
from citrulline and aspartate. The deficiency of ASS<br />
results in hyperammonemia and increased citrulline in urine<br />
as well as a variety of symptoms. A 5-year-old girl was<br />
admitted to our department because of sleeplessness at<br />
night. She was born after a full-term pregnancy by normal<br />
natural delivery and was breast-fed. Her mother was in good<br />
health and had no illness during her pregnancy. Physical<br />
examination revealed normal vital signs, length, body<br />
weight and head circumference. The patient had a massively<br />
enlarged liver, 4 cm below the costal margins. She had no<br />
splenomegaly. There was no lymphadenopathy or skin rash.<br />
She had mild mental retardation (IQ ¼ 65). Her laboratory<br />
findings were mild hyperammonemia (142 mg/dl, normal<br />
,100 mg/dl). Citrulline in her urine determined by GC-<br />
MS was high (14882.3 nmol/mg, normal ,80 nmol/mg).<br />
Complete blood counts were normal; electrolytes and<br />
blood biochemistry test and blood gas analysis were within<br />
normal limit. She was started on a low protein diet after<br />
diagnosis.<br />
FP-K-039<br />
Analysis of clinical manifestations and follow-up in 130<br />
patients with Wilson’s disease<br />
J.-F. Lu, Q.-X. Shui<br />
Department of Neurology, Children’s Hospital, College of<br />
Medicine, Zhejiang <strong>University</strong>, Hangzhou, China<br />
Objective: To investigate the clinical and laboratory<br />
manifestations, and to improve diagnosis accuracy and the<br />
quality of patient’s life. Methods: A total of 130 cases with<br />
Wilson’s disease during 1974–2001 were analyzed and 53<br />
of them were followed up for 1.5–16 years. Results: Seventy<br />
patients presented with liver manifestations (about 53.8%),<br />
45 cases were found neurological damage (36.3%). Fiftyone<br />
cases were CT scanned, with 33 to be found abnormal.<br />
A total of 105 of 130 patients (80.8%) were misdiagnosed at<br />
the beginning. Fifty-three patients were followed up, and 12<br />
of them died from this disease. It was found that early diagnosis<br />
and treatment could lead to good outcome. Conclusion:<br />
Patients with Wilson’s disease are usually<br />
misdiagnosed, therefore it was essential to do laboratory<br />
examination and CT scan to the patients with unknown<br />
liver damage and neurological symptoms. Early diagnosis<br />
and long-term supervised treatment are very important for<br />
good outcome.<br />
FP-K-040<br />
Neurological assessments of phenylketonuria (PKU)<br />
patients<br />
Z.-S. Zhou, W.-M. Yu, C.-N. Zheng, P.-F. Xu<br />
Pediatric department, China-Japan Friendship Hospital,<br />
Beijing, China<br />
Objective: To explore the influence of PKU on neurological<br />
system (NS), 563 PKU patients were assessed for<br />
neurology in this study. Subjects and method: A total of<br />
563 PKU patients (aged 2 days–7 years old) were divided<br />
into two groups. One hundred nine early-treated cases (,3
570<br />
Abstracts<br />
months old) including 82 screened neonates, and 454 latetreated<br />
cases (.3 months old). All underwent clinic neurological<br />
assessments. DQ and IQ were used to evaluate<br />
mental retardation. Morphological changes of brain were<br />
evaluated with Staudt’s staging system about brain myelination<br />
and MRI grading method proposed by Thompson et<br />
al. Results: Among the early-treated group, there was no<br />
NS abnormality in 82 screened cases and mild neurological<br />
abnormality in 27 cases. Among the late-treated cases, a<br />
few patients displayed mental retardation, epilepsy, disturbance<br />
of speech, behavior disorders, affective disorder and<br />
motor retardation. Fine motor defect was prominent among<br />
the movement dysfunction. The later treatments started, the<br />
severe damage of NS occurred. Abnormal EEG records<br />
were found in 68% of 360 cases. MRI scans in 73 cases<br />
before treatment revealed abnormal high T 2 -signal intensity<br />
in the deep white matter and delayed myelination.<br />
Follow-up of 210 cases showed that after specific dietary<br />
and anti-epileptic treatments, except mental retardation,<br />
most NS symptoms had different degrees of recovery.<br />
The neuroimage abnormalities were also improved partly.<br />
Conclusion: Late-treated PKU cases had obvious NS<br />
damage, and the mental retardation was more prominent<br />
than motor retardation. The later treatment started, the<br />
severer damage of NS occurred. It is very important to<br />
carry out nationwide early neonatal screening program of<br />
PKU.<br />
FP-K-041<br />
MECP2 mutations in Swedish Rett syndrome clusters<br />
F.-Q. Xiang, Y. Stenbom, M. Anvret<br />
Department of Clinical Neuroscience, Karolinska Institute<br />
CMM-L8-02, Karonlinska Hospital Stockholm, Sweden<br />
Previous genealogic studies on Swedish females with<br />
RTT documented an increased rate of common ancestry,<br />
with a high percentage originating generations back in the<br />
same small area, ‘Rett area’ (homested). These data indicate<br />
that the disease transmission starting with a premutation<br />
that over generations can result in a full mutation<br />
giving rise to RTT, such as trinucleotide repeat expansion<br />
disease. The discovery of the RTT gene, MECP2 made it<br />
interesting to investigate the MECP2 gene in the RTT<br />
clusters to clarify the hypothesis of genetic transmission.<br />
In this study, RTT patients from three so-called RTT clusters<br />
were investigated for MECP2 mutation. Our data indicate<br />
that not all patients belonging to the same cluster had<br />
mutations and those who were positive harbored different<br />
mutations. This suggests that the Swedish RTT girls<br />
belonging to the same clusters may not be genetically<br />
related to each other and theMECP2 is not the only explanation<br />
to RTT.<br />
FP-K-042<br />
Pathogenetic significance of the CLN2 protein in lateinfantile<br />
neuronal ceroid lipofuscinosis<br />
Y.K. Hanafusa b,c , A. Oka d , M. Itoh b , M. Mizuguchi e ,M.<br />
Hayashi f , Y.-I. Goto b , S. Takashima a<br />
a National Institute of Neuroscience, National Center of<br />
Neurology and Psychiatry (NCNP); b Department of Mental<br />
Retardation and Birth Defect Research, National Institute of<br />
Neuroscience, NCNP; c Department of Pediatrics, Faculty<br />
of Medicine, <strong>University</strong> of Tokyo;<br />
d Division of Child<br />
Neurology, Institute of Neurological Sciences, Faculty of<br />
Medicine, Tottori <strong>University</strong>; e Department of Pediatrics,<br />
Jichi Medical School; f Department of Child Neuropathology,<br />
Tokyo Metropolitan Institute of Neuroscience,<br />
Kodaira, Tokyo 187-8502, Japan<br />
NCLs are hereditary progressive neurodegenerative<br />
diseases during childhood. The LINCL is caused by a mutation<br />
of the CLN2 gene, which encodes a lysosomal protein<br />
of 46–49 kDa. We previously raised polyclonal antibodies<br />
against the CLN2 gene product, and confirmed that they<br />
recognize the CLN2 protein on Western blots. To clarify<br />
when and where the CLN2 protein is expressed in human<br />
organs, we examined tissue specimens (brain and visceral<br />
organs) and cultured cells (fibroblasts) of both NCL patients<br />
and normal controls, by immunohistochemistry and<br />
Western blotting. Immunostaining of control tissues showed<br />
that the CLN2 immunoreactivity was ubiquitous in extracerebral<br />
organs as well as in the central nervous system.<br />
Intense immunoreactivity was seen in cells with phagocytic<br />
function, such as the Kupffer cells and pericytes. In pericytes,<br />
immunoreactivity was seen from the neonatal period.<br />
In the brainstem, CLN2 expression was already seen in the<br />
perinatal period. In the cerebral cortex and brainstem,<br />
neurons express the CLN2 protein, which increased with<br />
development, and reached the adult level at the age of<br />
around 2–3 years. In tissues and cells of LINCL patients,<br />
CLN2 expression was absent. The developmental profile of<br />
CLN2 expression in cortical neurons may be related to the<br />
clinical onset of LINCL.<br />
FP-K-043<br />
A novel mitochondrial mutation T3386C presenting with<br />
mental retardation, hypoparathyroidism, distal renal<br />
tubular acidosis and lactic acidosis<br />
S.K.H. Tay, K.S. Poh, K.Y. Loke<br />
Department of paediatrics, National university of Singapore,<br />
Singapore<br />
We report a novel mitochondrial mutation in a child with<br />
an unusual presentation of mitochondrial disorder. The child<br />
was 16 years old and was the fourth child of non-consanguineous<br />
parents, with a significant family history of two<br />
maternal aunts with recurrent pathological fractures and
Abstracts 571<br />
acidosis. He presented with mental retardation, recurrent<br />
bone fractures and short stature. He had distal renal tubular<br />
acidosis and hypoparathyroidism and was found to have<br />
mild lactic acidosis once only despite repeated testing. He<br />
was found on direct PCR sequencing of the ND1 gene to<br />
have a novel point mutation of the ND1 gene T3386C. This<br />
was a missense mutation that coded for a change in amino<br />
acid isoleucine to threonine at codon 27. This case illustrates<br />
the diversity of presentation of mitochondrial disorders<br />
and the need to consider mitochondrial disease as a<br />
diagnosis in a patient with multi-organ pathology even in<br />
the absence of persistent lactic acidosis.<br />
FP-K-044<br />
Rett syndrome brain neuromorphology: peculiar<br />
adaptive and protective properties of neurons in<br />
entorhinal cortex and thalamic motor nuclei<br />
L.A. Bereshnaya a , J.K. Mukhina a , P.V. Belichenko b<br />
a Brain Research Institute RAMS, Moscow, Russia; b Department<br />
of Neurology and Neurological Sciences, Stanford<br />
<strong>University</strong>, Stanford, USA<br />
RS is a neurodevelopmental disorder affecting young girls<br />
with most cases of this disease associated with mutation in<br />
the X-linked MeCP2 gene. RS patients have severe motor<br />
and cognitive dysfunction. Detailed morphological analysis<br />
demonstrated cell loss, increase in neuronal and glial density,<br />
reduced white matter volume and changes in the dendritic<br />
geometry of neurons. It is practically important to study<br />
morphological changes in single neurons related to both<br />
degenerative and compensatory events. The aim of the<br />
present work was to study the peculiarities of adaptation<br />
reactions in neurons of thalamic nuclei (ventral anterior<br />
and ventral lateralis) and in entorhinal cortex, the areas<br />
which were most affected in RS. Six cases of RS brains (8–<br />
12 years old) were studied by classical Nissl and Kluver-<br />
Barrera methods. Destructive changes included swelling of<br />
neuronal soma and dendrites, diffuse or peripheral chromatolysis<br />
of neurons, neuronal hyperchromia, vacuolization<br />
and presence of ‘ghost’ cells. Also, compensatory adaptation<br />
in neurons could be seen on the RS brains: juxtaposition of<br />
two neurons with joint cytoplasm and/or with common<br />
surface contact, formation of neuronal clusters from similar<br />
cells. These adaptive changes could be directed to maintain<br />
survival functions for these modified neurons.<br />
FP-K-045<br />
Leber’s congenital amaurosis: neurological and systemic<br />
findings<br />
E. Fazzi a , S.M. Bova a , S.G. Signorini a , J. Lanners b ,G.<br />
Lanzi a<br />
a Department of Child Neurology and Psychiatry - IRCCS C.<br />
Mondino, Pavia, Italy; b R. Holmann Foundation, Cannero<br />
Riviera (VB), Italy<br />
Leber’s congenital amaurosis (LCA) is the earliest and<br />
most severe form of inherited retinal dystrophies. It is an<br />
autosomal recessive disease, which accounts for 10–18% of<br />
congenital blindness. Its incidence is 2–3 per 100 000<br />
births. Currently accepted diagnostic criteria refer to ocular<br />
findings, but neurodevelopmental delay, mental retardation,<br />
and systemic anomalies have been frequently reported. We<br />
studied a sample of 35 children affected by LCA (mean age<br />
at first observation: 19 months, range: 6–50 months) in order<br />
to clarify the clinical aspects of this disorder, and to contribute<br />
to a new classification, correlating genotype with<br />
phenotype. All subjects underwent neurological and<br />
neurophthalmological examination, neurophysiological<br />
examinations (ERG, VEPs), EEG, BAEP, brain MRI,<br />
screening for metabolic disease (mitochondrial and peroxisomal<br />
disorders) and systemic involvement (abdomenpelvis<br />
US, hand X-ray). A developmental assessment<br />
using specific Scales for visually impaired children, and<br />
videotape (for stereotypic behaviours-SB) were also<br />
performed. Neurological examination was normal except<br />
for mild muscular hypotonia, mental retardation was documented<br />
in 20%, SB were very frequent (18–93% depending<br />
on the kind of SB), EEG showed floating alpha (21%) or<br />
slow activity (21%), pathological findings on brain MRI<br />
were detected in the 53% (ventricular enlargement, mild<br />
cerebral atrophy, white matter abnormalities, median line<br />
cysts). Systemic abnormalities were detected in a small<br />
but significant percentage of subjects. Our data confirm<br />
that LCA is a heterogeneous entity which can present itself<br />
as an isolate ocular pattern, or associated to neurological<br />
and systemic abnormalities, and support the need for a<br />
multidisciplinary approach and for genotypic-phenotypic<br />
studies.<br />
FP-K-046<br />
Rett syndrome cases at the Philippine Children’s<br />
Medical Center (1989–2001)<br />
M.H. Ortiz, L.V. Lee, E.L. Avendaño<br />
Child Neuroscience Division Philippine Children’s Medical<br />
Center Quezon Avenue, Quezon City Philippines<br />
Rett syndrome is an X-linked neurodevelopmental disorder<br />
affecting mainly females characterized by an apparently<br />
normal psychomotor development for the first 6<br />
months of life. After this age, developmental progress<br />
slows. Eighteen cases of Filipino girls with Rett syndrome<br />
diagnosed over a 12-year period will be presented. Their<br />
clinical manifestations as well as temporal profile will be<br />
described in detail. Age at onset ranged from 6 to 24<br />
months and age at initial consult was 1.1–5.10 years. Thirteen/18<br />
had an initial diagnosis of Rett syndrome, three<br />
were initially diagnosed to have autism and two were diagnosed<br />
to have psychomotor retardation of unknown etiology.<br />
All had a history of an apparently normal prenatal and<br />
perinatal period with 15/18 presenting with regression of
572<br />
Abstracts<br />
previously learned skills. Of the 11 patients with head<br />
circumference measurements noted at birth, ten (90%)<br />
had normal head circumference while one (10%) had a<br />
head circumference below the 2nd percentile. Hand<br />
apraxia, repetitive stereotypic hand movements, impaired<br />
receptive and expressive language with psychomotor retardation<br />
as well as truncal and gait ataxia was seen in all<br />
patients. Nine/18 children had breathing dysfunction.<br />
Seventeen presented with an abnormal EEG and 13 were<br />
diagnosed to have seizure disorder.<br />
FP-K-047<br />
Mutation analysis of methyl-CpG binding protein gene<br />
family in autistic patients<br />
H. Li, T. Yamagata, M. Mori, M.Y. Momoi<br />
Department of Pediatrics, Jichi Medical School, Minamikawachi,<br />
Tochigi, Japan<br />
Autism is a complex neurodevelopmental disorder with<br />
multigenic etiology. Methyl-CpG binding protein 2 gene<br />
(MeCP2) mutation was reported to be the cause of Rett<br />
syndrome, and was also involved in X-linked mental retardation<br />
and autistic disorder. Methyl-CpG binding protein<br />
family consists of MeCP2, MBD1, MBD2, MBD3 and<br />
MBD4, sharing the common methyl-CpG binding domain<br />
(MBD). All MBDs except for MBD4 form complexes with<br />
histone deacetylases and are involved in recruiting histone<br />
deacetylases to methyl-CpG enriched regions in the genome<br />
to repress transcription. Gene silencing is suspected to be<br />
involved in etiology of autism. Thus, we screened these<br />
genes as candidate genes for disease-causative mutations<br />
in autism patients using denaturing high-performance liquid<br />
chromatography (DHPLC) followed by sequencing. We<br />
detected several polymorphisms and found some interesting<br />
base changes. In MBD1, one novel missense mutation,<br />
R269C, in the exon 9 was detected in one patient. It was<br />
also detected in his father, who also has some autism-like<br />
symptom and his normal sister, but not in 100 normal<br />
controls. This mutation may relate to the genesis of autism<br />
although normal sister had same mutation, relating to sex<br />
bias or some other gene’s combination. In MBD2, two<br />
repeat variants (GGC and GGGGCC) in exon1 were<br />
detected in five patients. Although these were also detected<br />
in normal control, it looks interesting to screen more<br />
patients because more expansion out of the range of PCR<br />
may exist and relate to the disease. Autism is thought to be<br />
polygenic disease and methyl-CpG binding proteins family<br />
genes’ high-polymorphic nucleotide changes may have<br />
some effect on the etiology of autism. Further analysis on<br />
more samples is required to clarify their contribution to<br />
autism.<br />
FP-K-048<br />
Down syndrome: a link between development and aging<br />
I.T. Lott, E. Head, L. Nelson, K. Osann, E. Doran<br />
<strong>University</strong> of California, Irvine Departments of Pediatrics<br />
and Neurology; Institute on Brain Aging and Dementia UCI<br />
Medical Center, Orange, CA, USA<br />
The brains from individuals with Down syndrome (DS)<br />
show the changes of Alzheimer’s disease (AD) by age 40<br />
years. We have shown that b amyloid (Ab) is deposited in<br />
DS beginning in childhood (Exp Neurol 2000;163:111) and<br />
is associated with inflammatory and oxidative changes in<br />
the course of brain maturation (Neurbiol Dis 2001;8:792).<br />
The topography of cell loss secondary to AD in DS involves<br />
cholinergic neurons and recent reviews have suggested that<br />
a pathological cascade may involve both Ab and cholinergic<br />
dysfunction in the disorder. Based upon these observations,<br />
we undertook a pilot investigation of an<br />
acetycholinesterase inhibitor (donepezil) in 15 patients<br />
with trisomy 21 for a 5-month period. Treated (n ¼ 9) and<br />
control subjects (n ¼ 6) were comparable with respect to<br />
initial level of dementia, length of follow-up, and age.<br />
Utilizing the Down Syndrome Dementia Scale (Gedye,<br />
1995), the subjects treated with donepezil showed an<br />
improvement in test scores (mean ¼ 24.3, SEM ¼ 4.0)<br />
after 5 months compared to the control group<br />
(mean ¼ 30.7, SEM ¼ 3.0) with the results statistically<br />
significant at P ¼ 0:03. No serious side effects of the drug<br />
were encountered. The results of this pilot study suggest that<br />
further placebo-controlled trials of acetycholinesterase inhibitors<br />
are indicated for treatment of dementia in DS<br />
(supported in part by AG 05142).<br />
FP-K-049<br />
Describing the phenotype in Rett syndrome<br />
H. Leonard a , L. Colvin a , S. Fyfe b , J. Christodoulou c,d ,L.<br />
Raffaele c,d , S. Leonard a , T. Schiavello a , C. Ellaway c,d ,M.<br />
Davis e , N. De Klerk a<br />
a TVW Telethon Institute for Child Health Research, Western<br />
Australia; b Curtin <strong>University</strong> of Technology, Perth, Western<br />
Australia; c Children’s Hospital at Westmead, Sydney New<br />
South Wales; d Department of Paediatrics and Child Health,<br />
<strong>University</strong> of Sydney, Sydney, New South Wales; e Royal<br />
Perth Hospital, Perth, Western Australia<br />
The Australian Rett syndrome epidemiological research<br />
program is internationally unique with ongoing case ascertainment<br />
on a population basis since 1993. By July 2000,<br />
199 verified cases had been reported to the database and<br />
comprehensive phenotype data were collected on 152 of<br />
these. By end of 2001 there were 227 verified cases, fourteen<br />
of whom had died. Molecular testing has now been<br />
undertaken on 77% (174/227) cases and X inactivation<br />
status is complete on one third of the cohort. Of the 152
Abstracts 573<br />
cases surveyed in the 2000 follow up 84 (55.2%) were categorised<br />
as classical, 40 (26.3%) as early onset atypical and<br />
28 (18.5%) as mild atypical. Using the scoring system<br />
suggested by Kerr et al. (2001) we were able to show<br />
considerable variation in clinical severity with a mean of<br />
22.9, and a range from 9.3 to 32.0. Similar variation was<br />
seen using the scale adapted by Percy from Amir et al.<br />
(2000) and the scale designed by Monros et al. (2001) and<br />
modified by Pineda. Age-related changes were seen with the<br />
Kerr (20.5–24.2) and Percy scores (34.4–39.4) but not with<br />
the Pineda score. By including a questionnaire version of the<br />
WeeFIM (the Functional Independence Measure for Children)<br />
(Msall et al., 1994) we were also able to calculate a<br />
WeeFIM score. The mean WeeFIM score was 29 (range 18–<br />
75). Mutations have been identified in 73% (68/93) of classical<br />
and 65% (53/81) of atypical cases. The mean phenotype<br />
scores for the three scales and the mean WeeFIM score<br />
were calculated for each of nine common mutations. The<br />
R133C mutation had a significantly lower Pineda score<br />
(11.8) and a higher WeeFIM score (36) than the others<br />
indicating better functioning. This was followed by the<br />
R294 X with scores of 12.9 and 34.9. The poorest functioning<br />
was for the R270 X and P152R mutations with Pineda<br />
scores of 19.2 and 19.8 respectively. Overall the mean<br />
WeeFIM score was higher in those cases with skewed<br />
(31.9) than in those with random (25.6) X inactivation<br />
(P ¼ 0:03). In the 27 atypical cases in which X inactivation<br />
studies were complete, 10 of the 13 mild atypical cases had<br />
skewing compared with four of 14 with early onset atypical<br />
(P ¼ 0:01). In Australia ongoing case ascertainment<br />
combined with active follow up of existing cases provides<br />
a unique longitudinal profile of a genetically characterised<br />
Rett syndrome cohort over a period of 10 years.<br />
FP-K-050<br />
Neurobehavioral findings in early and late treated<br />
children with phenylketonuria<br />
K. Yalaz, L. Vanlı, I. Ozalp, T. Coşkun, A. Tokatlı, M.<br />
Özgüç<br />
Hacettepe <strong>University</strong> Departments of Pediatric Neurology,<br />
Metabolism, and Medical Biology, Ankara, Turkey<br />
We evaluated 47 children with PKU treated before they<br />
were 45 days old and 99 children treated after this age.<br />
Neurological and neurobehavioral findings including head<br />
circumference, motor performance, behavioral pattern,<br />
intellectual capacity as well as phenylalanine level and<br />
molecular analysis for phenotype-genotype correlation<br />
were examined. Microcephaly, depressed or absent deep<br />
tendon reflexes, tremor of the hands, mental retardation,<br />
hyperactivity were present in both groups but were less<br />
severe in early-treated children. Autistic signs were present<br />
only in late-treated patients. Children whose clinical<br />
response to diet restriction was unsatisfactory or less than<br />
expected had additional medical problems: maternal PKU in<br />
addition to the child’s encephalopathic episode, or other<br />
metabolic disorder. The degree of impairment could differ<br />
between siblings with the same genotype; in addition, earlytreated<br />
siblings could have lower function than later-treated<br />
ones. Further studies are needed to confirm the effect of<br />
other genes modulating the phenotype in PKU.<br />
FP-K-051<br />
Preserved speech variants of classic Rett syndrome:<br />
beneficial effects of long term l-carnitine therapy<br />
M. Topcu, C. Akyerli, R.S. Kocoglu, A. Sayi, G. Haliloglu,<br />
D. Yalnizoglu, T. Ozcelik<br />
Hacettepe <strong>University</strong> Faculty of Medicine Department of<br />
Pediatric Neurology, Bilkent <strong>University</strong> Department of<br />
Molecular Biology and Genetics, Ankara, Turkey<br />
RTT is a neurodevelopmental disorder of early childhood<br />
that is primarily seen in girls. The gene responsible for this<br />
disorder has been identified as MECP2. Although the type of<br />
mutations in MECP2 have been found to be correlated with<br />
the phenotypic manifestations of RTT to some degree, the<br />
pattern of X inactivation appears to be the major determinant<br />
in different studies including our own series. The disease is<br />
incurable as yet, and treatment strategies are essentially<br />
symptomatic and supportive including l-carnitine for<br />
improvement in patient well-being and hand function. We<br />
performed a detailed phenotype-genotype correlation in our<br />
MECP2 mutation positive RTT patients (n ¼ 20) including<br />
three girls who can be classified as preserved speech variants<br />
of the disorder. Two of these girls, an 11-year-old who carries<br />
the T158M mutation and a 4-year-old who carries the P152R<br />
mutation, associated with the classic form of the disease. The<br />
well established androgen receptor assay revealed that X-<br />
inactivation patterns are random. Both of these girls have<br />
been on 500 mg/day l-carnitine treatment since 18 months<br />
of age. The third preserved speech variant carries a 44 bp<br />
deletion at the 3 0 -end of the MECP2 gene, and mild phenotype<br />
associated with these mutations has been reported in the<br />
literature. These results may suggest that beneficial effects of<br />
l-carnitine may go beyond an improvement in patient wellbeing<br />
and hand function when administered at the early<br />
stages of the disorder.<br />
FP-K-052<br />
Rett syndrome in Hungary: clinical and mutation<br />
analysis of the Hungarian Rett syndrome girls<br />
K. Hollódy a ,J.Kárteszi b , J. Bene b , M. Czakó b , B. Melegh b ,<br />
G. Kosztolányi b<br />
a Department of Pediatrics, b Department of Medical Genetics<br />
and Child Development, <strong>University</strong> of Pécs, Pécs,<br />
Hungary<br />
Rett syndrome is a neurodevelopmental disorder. In a<br />
high proportion of sporadic patients it is caused by muta-
574<br />
Abstracts<br />
tions in the X-linked MECP2 gene. Aim: To characterize the<br />
spectrum of the clinical forms and the mutations in Hungarian<br />
girls with Rett syndrome and to relate the genetic results<br />
to the clinical features of the disease. Methods: So far we<br />
have examined 22 patients registered in the Hungarian Rett<br />
Syndrome Association. Two girls were twin with classical<br />
features. Twenty patients had no relationships at all. Fifteen<br />
suffer in the classical, seven girls in the atypical form of the<br />
syndrome. One patient has preserved speech, another one<br />
has tuberous sclerosis. A very thorough history was taken<br />
from the parents of the girls and a detailed clinical examination<br />
was performed by a pediatric neurologist, a clinical<br />
geneticist, an orthopedist, a radiologist, a gastroenterologist<br />
and a psychologist. Mutation analysis of MECP2 coding<br />
region was done by direct sequencing. Results: Mutations<br />
in the MeCP2 gene were found in 12/22 patients (54%).<br />
Among them, all but four have the clinical signs of the<br />
classical form, four have the atypical form. Eight already<br />
described mutations were detected in ten patients (R294X in<br />
three patients, R106W in two patients, in one each patient<br />
R133C, R168X, R270X, P152R, T158M). Among the three<br />
patients with the R294X mutation two have the classical and<br />
one the preserved speech variant form of Rett syndrome. In<br />
our oldest, atypical Rett syndrome patient (22 years of age)<br />
a novel single base insertion in exon 3 (276insG) was<br />
detected. A large deletion in exon 4 was found in a patient<br />
with classical form. Similarly to the published Swedish data<br />
no mutations of MECP2 gene were identified in the twin<br />
Rett syndrome patients. According to the prevalence of the<br />
disease there must be ca. 40–45 girls with Rett syndrome<br />
aged 0–18 years in Hungary. Thirty different mutations<br />
were found in 97 patients with RS. In 81% of the patients<br />
we detected nonsense and missense mutations in the coding<br />
parts of MECP2. Twelve different mutations and one polymorphism<br />
were found. MECP2 may be involved in a<br />
broader phenotype than classical RT including preserved<br />
speech variants. Mutations were identified in 72% of<br />
patients with classical RS.<br />
FP-K-053<br />
Pyruvate dehydrogenase deficiency: Clinical and<br />
molecular analysis<br />
A.M. Garcia, D. Wang, P. Kranz-Eble, D.C. De Vivo<br />
Colleen Giblin Laboratories for Pediatric Neurology<br />
Research, Columbia <strong>University</strong>, New York, USA<br />
Defects in the pyruvate dehydrogenase complex are an<br />
important cause of primary lactic acidosis, a frequent manifestation<br />
of metabolic disease in young children. Clinical<br />
manifestations are heterogeneous ranging from episodic<br />
ataxia and weakness to chronic encephalopathy and congenital<br />
lactic acidosis. The great majority of cases result from<br />
mutations in the E1a subunit gene, located on the X chromosome<br />
(Xp22.1). We present 19 patients (12 males) with pyruvate<br />
dehydrogenase deficiency caused by mutations in the<br />
E1a gene. Eleven patients (two females) showed early onset<br />
with severe lactic acidosis, six of them associated with abnormal<br />
neuroimages. Six patients (one male) developed a<br />
chronic encephalopathy with diverse CNS malformations<br />
in the five females. Two boys had a benign syndrome characterized<br />
by recurrent limb weakness, muscular cramps and<br />
exercise intolerance. Eight patients had genomic rearrangements;<br />
all located in exons 10 and 11. Six patients had a<br />
tandem repeat insertion (S370ins, Q382fs, S388ins,<br />
G365ins, K387fs, N326ins) and two had a microdeletion<br />
(S312fs, R310del). Four missense mutations were located<br />
in the upstream region of the gene involving exons 4–6,<br />
respectively. A number of previously recognized gender<br />
specific hot spots for mutations were detected. Those associated<br />
with females (S312fs, R302C, Q382fs) suggest that<br />
these mutations are severe and probably lethal in male<br />
fetuses, whereas those associated with males (K387fs,<br />
R263Q, N164S, R127W, R310del) are presumably female<br />
asymptomatic.<br />
FP-K-054<br />
Gene transfer to CNS by intrauterine administration of<br />
adenovirus.<br />
J.-S. Shen a , X.-L. Meng a , T. Ohashi a,b , Y. Eto a,b<br />
a Department of Gene Therapy, Institute of DNA Medicine;<br />
b Department of Pediatrics, The Jikei <strong>University</strong> School of<br />
Medicine, Tokyo, Japan<br />
Early and severe CNS involvement occurs in some lysosomal<br />
storage disorders such as Tay-Sachs disease, type II<br />
Gaucher disease and infantile form of Krabbe disease. In<br />
these diseases, lysosomal storage and considerable neuropathology<br />
was observed even prior to birth. Postnatal therapies,<br />
including bone marrow transplantation, enzyme<br />
replacement therapy and gene therapy are often insufficient<br />
in the treatment of these diseases. Therefore prenatal gene<br />
therapy to the CNS may be necessary. In order to investigate<br />
gene transfer to the CNS prenatally, we administered<br />
recombinant adenovirus encoding E. coli -galactosidase (-<br />
Gal) to the lateral ventricles of the brain of mouse embryos<br />
at mid-gestational period, and studied expression pattern of<br />
the transgene at various time points. Results showed that<br />
most of -Gal positive cells are distributed in the cerebral<br />
cortex and some in the brainstem and cerebellar cortex.<br />
Immunohistochemical observations using cell type specific<br />
antibodies indicated that the most of them are neurons and<br />
some are astrocytes. Histochemical and biochemical analysis<br />
showed the expression of -Gal started as early as 2 days<br />
after administration and persisted at least 2 months after<br />
birth without significant decrement of expression level.<br />
The results indicate that intrauterine administration of<br />
adenoviral vector may be useful as a gene therapy strategy<br />
for some lysosomal storage diseases with early CNS involvements.
Abstracts 575<br />
FP-K-055<br />
Frequency of major mutations in Ukrainian patients<br />
with metachromatic leucodystrophy<br />
N.V. Olkhovich, N.A. Pichkur, A.N. Nedoboy<br />
Ukrainian Specialized Children’s Hospital ‘OKhMATDET’,<br />
Kyiv, Ukraine<br />
Nine patients with MLD from eight families were examined<br />
using clinical, biochemical and molecular-genetic<br />
methods. Three patients were diagnosed with late-infantile<br />
form and the illness debut at the age of 12–24 months. Four<br />
patients were diagnosed with juvenile form, the illness<br />
began at the age of 3–7 years. Two patients were the siblings<br />
and had adult MLD form. Arylsulfatase A (ASA) activity<br />
was determined by the standard method of Baum A. et al.<br />
All the examined patients had decreased ASA activity.<br />
Mutations causing MLD were detected in the ASA gene<br />
by polymerase chain reaction amplification of fragments<br />
of the ASA gene and digestion by the appropriate endonuclease.<br />
All patients were screened for ASA-pd mutation.<br />
One homozygote for the splice mutation in intron 2<br />
(459 1 1G ! A) and one compound heterozygosity with<br />
splice mutation 459 1 1G ! A and missence mutation P<br />
426L were detected. Compound heterozygosity with<br />
P426L mutation and unknown mutation were detected in<br />
two patients. The overall frequency of the 459 1 1G ! A<br />
change was three of all 18 MLD alleles and of the P426<br />
change was three of all 18 MLD alleles. Thus, these two<br />
common alleles together accounted for 33% of all MLD<br />
alleles.<br />
FP-K-056<br />
Disease progression in X-linked adrenoleukodystrophy<br />
based on magnetic resonance imaging<br />
D.J. Loes, A. Fatemi, E.R. Melhem, N. Gupte, L. Bezman,<br />
H.W. Moser, G.V. Raymond<br />
Suburban Radiology Consultant Ltd., Minneapolis, MN;<br />
Department of Radiology, <strong>University</strong> of Pennsylvania,<br />
Philadelphia, PA and the Kennedy Krieger Institute and<br />
School of Public Health, Johns Hopkins Medical Institutions,<br />
Baltimore, MD, USA<br />
Introduction: X-linked adrenoleukodystrophy (X-ALD)<br />
has many variants with outcomes that range from no deficits<br />
to death. The purpose of this study was to evaluate the<br />
degree to which MRI findings can predict MRI disease<br />
progression in male X-ALD patients. Methods: Follow-up<br />
MR Imaging studies were performed in 140 X-ALD patients<br />
with cerebral involvement (median age: 12.3, range 1.7–<br />
73.8). Data after bone marrow transplant was excluded.<br />
Gadolinium enhanced axial T1W imaging was performed<br />
in 40 of these patients. Depending on the anatomical location<br />
of the primary involved area three patterns were defined<br />
(pattern 1: parieto-occipital; pattern 2: frontal lobe; and<br />
pattern 3: frontal-pontine/cortical-spinal projection fibers).<br />
Regression analyses were performed to determine the<br />
effects of multiple MRI factors on disease progression.<br />
Results: Average follow-up time was 3.51 years (59 days–<br />
11.1 years). The mean progression of the MRI score per year<br />
was 2.2 ^ 0.55 for pattern 1 and 2.3 ^ 0.75 for pattern 2,<br />
but was much lower, 0.4 ^ 0.16, in patients with pattern 3<br />
(P ¼ 0:001). In patients with pattern 1, age (P ¼ 0:006) and<br />
MRI severity score (P , 0:0001) at initial exam and<br />
presence or absence of perilesional contrast enhancement<br />
(P , 0:0001) accounted for 96% of the variability of MRI<br />
progression after 1 year, while in patients with pattern 2 age<br />
(P ¼ 0:05) and the initial MRI severity score (P , 0:0001)<br />
accounted for 79% of the variability. Conclusions: Our<br />
results demonstrate that differences in anatomical patterns<br />
and perilesional contrast enhancement play a significant role<br />
in prediction of disease progression and can serve as additional<br />
disease markers in the evaluation and management of<br />
X-ALD patients.<br />
FP-K-057<br />
Brain magnetic resonance imaging abnormalities in<br />
females heterozygous for X-linked<br />
adrenoleukodystrophy and association with X<br />
inactivation in fibroblasts<br />
A. Fatemi, P.A. Watkins, A.B. Moser, P.B. Barker, G.V.<br />
Raymond, H.W. Moser, S. Naidu<br />
The Kennedy Krieger Institute, Johns Hopkins Medical<br />
Institutions, Baltimore, MD, USA<br />
Objective: Although the degree of cerebral involvement<br />
has been investigated extensively in affected males with X-<br />
ALD, there is limited data for heterozygote females. The<br />
purpose of this study was to determine the degree of brain<br />
involvement in this group and to investigate the possible<br />
association between MRI abnormalities and the degree of<br />
X inactivation in fibroblasts. Methods: Conventional MRI<br />
studies were performed in 75 X-ALD heterozygotes (mean<br />
age: 42.2, median: 41.3, range: 13–75). Indirect immunofluorescence<br />
analysis of cultured skin fibroblasts using an<br />
antibody raised against the C-terminal 18 amino acids of the<br />
human peroxisomal ALDP revealed a punctate, peroxisomal<br />
immunostaining pattern and average percentages of<br />
immunopositive cells were calculated. Results: Prominent<br />
bilateral white matter T2 signal hyperintensities were<br />
observed in two girls (13, and 14 years old) and a 42<br />
years old women heterozygous for X-ALD. While in heterozygotes<br />
with normal MRI a mixed population of normal and<br />
abnormal cells was demonstrated, typically ranging from 20<br />
to 80% normal ALDP positive cells, the three patients with<br />
MRI abnormalities had 0, 1 and 7% (in the 14, 13 and 43<br />
year old, respectively) immunopositive cells suggesting<br />
skewed X inactivation. Conclusion: MRI changes similar<br />
to cerebral childhood X-ALD in males were detected in<br />
heterozygote females who showed an absence or a very
576<br />
Abstracts<br />
low ALDP expression in fibroblasts. These results suggest<br />
that assessment of X inactivation in fibroblasts correlates<br />
with the degree of brain involvement.<br />
FP-K-058<br />
Contiguous deletion of the X-linked<br />
adrenoleukodystrophy gene and DXS1357E cause a<br />
neonatal phenotype similar to peroxisomal biogenesis<br />
disorders<br />
S.J. Steinberg a,b , K. Johnson a , G.R. Cutting a,c ,P.A.<br />
Watkins a,b , A.B. Moser a,b , H.W. Moser a,b<br />
a The Kennedy Krieger Institute and b Department of Neurology,<br />
c Institute of Genetic Medicine, Johns Hopkins <strong>University</strong><br />
School of Medicine, Baltimore, MD, USA<br />
Plasma VLCFA analysis is a reliable screening tool for<br />
the identification of patients with a perturbation of peroxisomal<br />
fatty acid metabolism, including the disorders X-<br />
ALD, peroxisomal biogenesis disorders (PBD) and other<br />
single enzyme deficiencies (SED) such as D-bifunctional<br />
protein deficiency. The spectrum of X-ALD clinical phenotypes<br />
is readily distinguishable from PBD and SED.<br />
Whereas PBD and SED patients have congenital malformations<br />
and are ill from birth, patients with mutations in the X-<br />
ALD gene, ABCD1, thrive postnatally. We recently identified<br />
three male neonates presenting with severe hypotonia,<br />
cholestatic liver disease and a failure to thrive. All three<br />
died at less than 1 year of age and had increased plasma<br />
VLCFA. Other peroxisomal pathways were normal and<br />
ruled out a PBD. Immunocytochemistry indicated that<br />
their cells lacked ALD protein, but otherwise had normal<br />
peroxisomal structure. Mutation analysis showed that all<br />
three patients had large deletions of ABCD1 that extended<br />
beyond the promoter region and into the neighboring gene<br />
DXS1357. We recommend naming this new disorder<br />
‘Contiguous ABCD1 DXS1357E Deletion Syndrome,’ or<br />
CADDS. Failure to identify X-linked CADDS may lead to<br />
misdiagnosis as autosomal recessive PBD or SED and cause<br />
serious errors in genetic counseling.<br />
FP-K-059<br />
Leukoencefalopathy with vanishing white matter: report<br />
of five Brazilian cases<br />
M.S.T. Souza a ,F.Kok a , C.C. Leite b , M.T.C. Lacerda b ,<br />
M.O.R. Costa b , M.G. Otaduy b , A. Diament a , U.C. Reed a<br />
a Departments of Neurology,<br />
b Radiology of the School of<br />
Medicine of São Paulo <strong>University</strong>, São Paulo, Brazil<br />
In 1993 Hanefeld et al. reported an autosomal recessive<br />
brain white matter abnormality clinically characterized by<br />
early and slowly progressive developmental regression with<br />
episodes of acute deterioration, cerebellar and pyramidal<br />
signs but no remarkable mental deterioration. Brain MRI<br />
showed a widespread leukodystrophy with subcortical cyst<br />
formation. In the last 3 years, we evaluated five patients<br />
from four families who developed such clinical and imaging<br />
changes. All had widespread symmetrical cerebral white<br />
matter involvement, characterized by MRI signal intensity<br />
similar to CSF on all sequences, particularly on T2-<br />
weighted intense signal. No gadolinium enhancement was<br />
detected. In two patients, it was noted a partial preservation<br />
of subcortical U-fibers, and in four individuals, the central<br />
pontine tegmental tract and cerebellar white matter were<br />
also involved. All patients had cavum septi pellucidi and<br />
marked vermis cerebellar abnormality. Spectroscopic analysis<br />
of frontal and parietal white matter revealed decrease but<br />
not complete disappearance of N-acetyl aspartate signal and<br />
height, and marked? slight? increase of choline and myoinositol<br />
peaks. Lactate and glucose spectroscopic peaks<br />
were normal in all patients. Very long chain fatty acids<br />
level, arylsulfatase A and beta galactocerebrosidase activity<br />
were in the normal range. Electroneuromyography was<br />
normal in all patients. We conclude that leukoencefalopathy<br />
with vanishing white matter can be a relatively common<br />
condition in Brazilian children and that this diagnosis<br />
should be considered in the presence of striking MRI<br />
brain white matter changes associated with a chronic clinical<br />
course with acute episodes of motor deterioration and<br />
relatively preserved mental function.<br />
FP-K-060<br />
The participation of microglia in experimentally<br />
induced phenylketonuria<br />
G.G. Skibo a , J.A. McKanna b , O.V. Girnyk a<br />
a Department of Cytology, Bogomoletz Institute of Physiology,<br />
Kiev, Ukraine; b Department of Cell Biology, Vanderbilt<br />
<strong>University</strong>, Nashville, TN, USA<br />
PKU, the neurogenetic disease, is an inherited deficiency<br />
of the enzyme phenylalanine hydroxylase which lead to<br />
increase serum and brain phenylalanine and, as a consequence,<br />
to mental retardation. The primary pathologic findings<br />
during PKU are the loss of number of neurons,<br />
hypomyelination and astrocytosis of central nervous system.<br />
But participation of microglia in this pathological condition<br />
remains unknown. The aim of the present investigation was<br />
to follow the state of microglia in the rat brain with experimentally<br />
produced PKU. The model of PKU was the next:<br />
the rat pups were injected with l-phenylalanine and dl-?-<br />
methylphenylalanine during 3–14th postnatal days. The<br />
tissue of cerebellum and hippocampus was studied at<br />
the14th postnatal day. Lipocortin 1 immunoreactivity<br />
(LC1-ir) was used as a marker for microglia. The area and<br />
the shape factor of microglial cells and density of microglia<br />
in PKU brain were compared with control by computer<br />
system BioQuant OS/2. The area of microglial somata<br />
was larger and processes of microglial cells were shorter<br />
and thicker in cerebellum and hippocampus of treated rats.<br />
The density of LC1-ir microglia was higher in all layer of
Abstracts 577<br />
hippocampus and cerebellum of the PKU brain as compared<br />
with control pups, but the greatest increase in the number<br />
was noted within white matter of cerebellum and in stratum<br />
orients, stratum radiatum and stratum moleculare of hippocampus.<br />
The revealed reaction may suggest the mysterious<br />
functional role of micriglia in the current of PKU: or microglia<br />
may play definite role in repairing of abnormal brain or<br />
its reaction is the response to pathological condition.<br />
FP-K-061<br />
Increase of disaturated phosphatidylcholine in brains of<br />
Pex5 knockout mice, a mouse model of Zellweger<br />
syndrome<br />
M. Nagura a , M. Baes b , M. Saito a , I. Kimura a , H. Hirose a ,M.<br />
Kubota a , Y. Sakakihara a<br />
a Department of Pediatrics, Faculty of Medicine, the <strong>University</strong><br />
of Tokyo, Tokyo, Japan; b Laboratory of Clinical Chemistry,<br />
Katholieke Universiteit Leuven, Belgium<br />
Zellweger syndrome is a familial lethal disease presenting<br />
neuronal migration arrest in cerebral cortex and<br />
dysmorphism in liver and kidney. Its cause was proved to<br />
be the failure of peroxisome biogenesis, but the relation<br />
between disturbance of neural differentiation and peroxisomal<br />
dysfunction still remains unknown. Previously we<br />
reported that fibroblasts of patients with mutation of Pex2<br />
gene, one of the responsible genes for peroxysomal<br />
biosynthesis, contain significantly higher level of glycolipids.<br />
In this report, we aim to demonstrate changes in lipid<br />
compositions such as the increase of glycolipids in brains of<br />
Pex5 knockout mice. The result showed that the amount of<br />
disaturated phosphatidylcholine (disat-PC) was five-times<br />
higher in the brains of knockout mice than those in the<br />
control. The amount of glycosphingolipid was scarce both<br />
in the brains of knockout and control mice. The amounts of<br />
other types of lipids such as cholesterol, sphingomyelin and<br />
total glycerophospholipids did not differ between knockout<br />
and control mice. Disat-PC is involved in pulmonary surfactant<br />
and contributes to the surface tension of alveolus. The<br />
role of disat-PC in the CNS has not been reported, but<br />
increase of disat-PC may be related to peroxisome function<br />
and derangement of neuronal development.<br />
FP-K-062<br />
MECP2 mutation analysis in Rett syndrome<br />
M. Li a , V. Wong b<br />
a Department of pediatrics, First hospital, Peking <strong>University</strong>,<br />
b Department of pediatrics, The <strong>University</strong> of Hong<br />
Kong, China<br />
MECP2 gene, encoding methyl-CpG binding protein 2<br />
(MECP2), is the responsible gene for Rett syndrome. As<br />
RTT is a clinical syndrome without any diagnostic biologic<br />
markers, mutation analysis of MECP2 gene is the only diagnostic<br />
golden standard. It has been obvious that the phenotypes<br />
of Rett syndrome have shown a wide range of<br />
variability. The aims of this project is to identify the<br />
MECP2 mutation in RTT patients using direct sequencing<br />
so as to explore the spectrum of phenotypes resulting from<br />
MECP2 mutations. We identified three mutations of<br />
MECP2 gene among the six RTT patients. The mutations<br />
of P322A and R106W were found in two patients classified<br />
as fruste type. A patient with R306C mutation had the classic<br />
type of Rett syndrome. The patient with P322A mutation<br />
had no deceleration of head growth. Our report is the first<br />
that confirms the normal head growth can occur in RTT with<br />
MECP2 mutation. We think that the head growth deceleration<br />
should not be a necessary criterion for RTT, especially<br />
in the milder form of RTT.<br />
FP-K-063<br />
Progressive cerebello-cerebral atrophy - a new<br />
syndrome with microcephaly, mental retardation and<br />
spastic quadriplegia<br />
B. Ben-Zeev a , C. Hoffman b , D. Lev c , N. Watemberg c ,N.<br />
Brand a , T. Lerman-Sagie c<br />
a Pediatric Neurology Unit,<br />
b Neuroradiology Unit, Sheba<br />
Medical Center, Ramat-Gan, Metabolic-Neurogenetic<br />
Clinic; c Pediatric Neurology Unit, Wolfson Medical Center<br />
Holon, Sackler School of Medicine, Tel-Aviv <strong>University</strong>,<br />
Israel<br />
Progressive cerebellar atrophy in infancy can be seen in<br />
several genetic and metabolic diseases. Occasionally, it is<br />
accompanied by cerebral atrophy. Mental retardation is<br />
commonly seen. Hypotonia is more common than spasticity<br />
in these cases. We describe seven (five females, two males)<br />
children from six families with similar clinical and radiological<br />
features. Clinically, all suffer from profound mental<br />
retardation, and progressive spastic quadriplegia with joint<br />
contractures. Other common characteristics include: generalized<br />
seizures (5) and irritability (5). The children are nondysmorphic.<br />
Head circumference is normal at birth with<br />
progressive microcephaly evident from the 1st year of life.<br />
Radiologically, early magnetic resonance imaging can be<br />
normal but repeat studies show progressive cerebellar atrophy<br />
followed by cerebral atrophy involving both white and<br />
gray matter. All families are non-consanguineous Sepharadi<br />
Jews from Moroccan or Iraqi origin. An extensive metabolic<br />
evaluation was normal, including: blood amino acids,<br />
lactate, very long chain fatty acids, carnitine, lysosomal<br />
enzymes, isoelectric focusing of transferrin, urine organic<br />
acids and purines, CSF lactate, amino acids and biogenic<br />
amines, and muscle skin and nerve biopsies. The clinical<br />
and radiological presentation of this group of patients bears<br />
the closest resemblance to pontocerebellar atrophy type 2.<br />
However, this disorder can be ruled out because in our<br />
group of patients the cerebellar changes are progressive<br />
and are not recognized at birth, there is no pontine involve-
578<br />
Abstracts<br />
ment and clinically the patients develop severe spasticity<br />
but no chorea. We suggest that this is a new syndrome<br />
with profound mental retardation, spasticity and microcephaly.<br />
FP-K-064<br />
Abnormal movements in Leigh syndrome with<br />
cytochrome c oxidase deficiency due to SURF 1<br />
mutations<br />
B. Echenne a , A. Roubertie a , F. Rivier a , V. Humbertclaude a ,<br />
A. Dubot b , M.T. Zabot c , C. Godinot b<br />
a Neuropédiatric Department C.H.U. Montpellier. France;<br />
b U.M.R. 5534 C.N.R.S. Lyon. France; c Debrouse Hospital<br />
Lyon, France<br />
Two unrelated children with an up to now normal<br />
psychomotor development presented abnormal movements<br />
when they were respectively 14 and 16 months old. The<br />
first patient had tremor on hands and arms, occurring in<br />
clusters, lasting a few minutes, without triggering factor,<br />
many times a day. The second patient also had hands and<br />
arms tremor on awakening, occurring in clusters on brief<br />
duration, associated with myoclonic jerks of high amplitude,<br />
affecting arms and legs, triggered by noises,<br />
emotions, or voluntary movements. These abnormal movements<br />
lasted 6–8 months, and were during this period the<br />
main clinical abnormal sign, associated with deafness and a<br />
slight ataxia. Then, the neurological status of both children<br />
worsened, with progressive mental deficiency, pyramidal<br />
signs and motor regression. Death occurred at 7 years 10<br />
months and 3 years of age, respectively. In both cases, a<br />
marked complex IV deficiency was found on muscle<br />
samples, with a SURF 1 gene mutation. These observations<br />
are interesting for two reasons: (1) the early onset and long<br />
lasting abnormal movements, which were during several<br />
months the most striking clinical abnormalities; and (2)<br />
biological aspects, concerning the physiopathology of<br />
mitochondrial diseases.<br />
FP-K-065<br />
Van der Knaap syndrome<br />
K.S. Rana<br />
Army Command Hospital (Central Command), Lucknow –<br />
2, India<br />
Progressive neurological diseases of white matter origin<br />
may be due to failure of myelination or progressive demyelination.<br />
Clinical features of leucodystrophy are spastisity,<br />
gait abnormalities, special sensory deficits. Leucodystrophies<br />
with macrocephaly progress rapidly with early<br />
death. Van der Knaap et al. reported such leucodystrophy<br />
with slow progression. We present eight such children.<br />
Material and method: Case records of patients diagnosed<br />
as leucodystrophy over 10 years time. Patients compatible<br />
with Van der Knaap descriptions were included in the study.<br />
The comprehensive workup included history, neurological<br />
examination, metabolic workup included; arterial blood gas,<br />
aminoacidogram, Cerebrospinal fluid and serum lactate<br />
pyruvate, assays for mucopolysaccharidosis/glycogen<br />
storage diseases, arylsulfatase A. Electroencephalogram,<br />
visual and auditory evoked responses, nerve conduction<br />
studies and Magnetic Resonance imaging in all patients.<br />
Results: Of the eight, four were females and four males,<br />
aged between 2 and 20 years. Onset was within 1st year<br />
of life. Head circumference ranged from 54 to 60 cm.<br />
Motor symptoms progressed up to 5–6 years of age in all.<br />
All children had seizures and were well under control. Six<br />
children were attending normal school. All had increased<br />
tone in all limbs, brisk reflexes. Neuroimaging revealed<br />
diffused involvement of white matter with cysts mainly in<br />
temporal region. Other investigations were non-contributory.<br />
Discussions: Combination of megalencephaly with<br />
leucodystrophy is seen in Canavan’s and Alexander’s<br />
disease. Both have rapidly progressive course. Slow course,<br />
macrocephaly, striking neuroimaging abnormalities is quite<br />
unique in Van der Knaap syndrome into which our eight<br />
patients qualify.<br />
FP-K-066<br />
Effectiveness of creatine monohydrate in mitochondrial<br />
encephalomyopathies<br />
K. Komura a , E. Hobbiebrunken b , E. Wilichowski b ,F.<br />
Hanefeld b<br />
a Department of Pediatrics, Tokyo Women’s Medical<br />
<strong>University</strong>, Tokyo, Japan;<br />
b Abteilung Kinderheilkunde,<br />
Schwerpunkt Neuropädiatrie Georg-August-Universität,<br />
Göttingen, Germany<br />
The mitochondrial encephalomyopathies are chronic<br />
progressive disorders affecting predominantly the neuromuscular<br />
system. Symptoms are induced by insufficient<br />
energy supply resulting from a deficiency of oxidative phosphorylation.<br />
We studied one male and four females with<br />
genetically proven mitochondrial encephalomyopathies.<br />
Their ages ranged from 7 to 19 years (two Kearns–Sayre<br />
syndrome (KSS); one neuropathy, ataxia, and retinitis<br />
pigmentosa, NARP; two MELAS), using retrospective<br />
study method. We studied the effect of creatine supplementation<br />
(0.08 g–0.35 mg/kg body weight/day; 9 months–4<br />
years and 10 months) and measured skeletal muscle power<br />
analysis (bicycle ergometer). After creatine supplementation<br />
all patients showed an increase in their maximum<br />
performance (W) (14– 1 30%; mean: 112.1%).These<br />
results indicate an improved aerobic oxidative function of<br />
mitochondria following creatine administration in the<br />
patient with mitochondrial encephalomyopathies. Continuous<br />
physical exercise was improved to a greater extent than<br />
instantaneous activity.
Abstracts 579<br />
FP-K-067<br />
Early onset spastic paraplegia in purine nucleoside<br />
phosphorylase deficiency<br />
B.M. Tabarki, M. Yacoub, H. Selmi, A. Trabelsi, M. Dogui,<br />
A.S. Essoussi<br />
Pediatric department, Farhat Hached Hospital, Sousse,<br />
Tunisia<br />
Deficiency of purine nucleoside phosphorylase causes<br />
recurrent infections, usually beginning in the 1st year of<br />
life, and neurologic abnormalities. Neurologic findings<br />
range from spasticity to developmental delay, to mental<br />
retardation. We report two siblings with progressive spastic<br />
paraplegia noted from the first few months of life. MRI of<br />
the brain and spine were normal. EMG showed peripheral<br />
neuropathy. Three years later, they developed T cell immunodeficency.<br />
Enzyme study showed complete deficiency of<br />
purine nucleoside phosphorylase. Spastic paraplegia at early<br />
onset can be a prominent clinical feature of purine nucleoside<br />
phosphorylase deficiency. Proposed mechanisms for<br />
neurologic dysfunction in this disease are discussed.<br />
FP-K-068<br />
Mitochondrial encephalomyopathies: cases presentation<br />
L.A. Selim<br />
Street 86 Maadi, Cairo Egypt, Egypt<br />
Mitochondrial disorders, once thought to be relatively<br />
rare, are now thought to be the most prevalent metabolic<br />
disease. They form a heterogeneous group of disease with<br />
multi system presentation that affect mitochondrial ATP<br />
production. The most severely affected organs in mitochondrial<br />
disorders are those Depending on high rate of<br />
aerobic metabolism, such as the brain, the skeletal muscles<br />
and cardiac muscles, the sensory organs, and the kidneys.<br />
Defects in mitochondrial metabolism result in a wide variety<br />
of human disorders, which can present at any time from<br />
infancy to late adulthood and involve any tissue either<br />
alone or in combination. Neurologic presentations of mitochondrial<br />
disorders are protean, they may be highly<br />
suggestive of a specific syndrome such as: MELAS,<br />
NARP, MERRF, Lebers hereditary optic neuropathy, and<br />
more commonly may be non specific as intractable<br />
seizures, global developmental delay and severe hypotonia.<br />
The clinical presentation of five cases diagnosed as mitochondrial<br />
myopathy and encephalomyopathy will be<br />
discussed.<br />
FP-K-069<br />
Electromyographic, clinical and genetic features of<br />
Prader-Willi syndrome in infants and children<br />
L.G. Khachatrian, O.I. Masva, V.M. Studenikin<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of China Health (Russian Academy<br />
of Medical Sciences), Moscow, Russia<br />
Background: Prader-Willi syndrome is usually presented<br />
by such features as muscular hypomentia, hypogonadism<br />
and obesity. Electroneuromyographic (ENMG) investigation<br />
is an essential method in differential diagnostics<br />
between this pathological condition and various diseases<br />
accompanied with hypotonia. Aim: Complex diagnostics<br />
of pediatric patients with Prader-Willi syndrome and<br />
evaluation of ENMG in establishment of this diagnosis.<br />
Method: Case histories of 14 infants and children (aged 6<br />
months–5 years) with Prader-Willi syndrome were<br />
analyzed, ENMG, CT, and MRT can of brain and genetic<br />
analysis were incorporated. Results: Muscular hypotonia<br />
was presented in all cases, motor milestones were delayed<br />
(walking achieved after 26 months of age). In 79% of<br />
patients combination of micropenia, cryptorchidism and<br />
hypoplastic labia. Gross obesity developed after children<br />
learned to walk. Mental retardation was evident (IQ<br />
between 40 and 80). CY and MRT scans were performed,<br />
revealing ventriculomegaly (64% of patients), frontal and<br />
temporal lobes atrophy (14% of cases). Chromosome 15<br />
anomalies have been registered in 71% of pediatric patients:<br />
chromosome 15/15 transformation (57%), deletion in chromosome<br />
15 (14%). In 29% of cases the karyotype was<br />
normal. ENMG disorders were discovered in all patients,<br />
and included increased M-reply amplitude, H-reflex, F-<br />
wave (30%) and raised motor-neural conduction (40%).<br />
Conclusion: In spite of clinical symptoms characterizing<br />
Prader-Willi syndrome, ENMG plays an important role in<br />
verification of this diagnosis, especially when dealing with<br />
chromosome-negative versions of Prader-Willi syndrome.<br />
FP-K-070<br />
Tuberous sclerosis in children: a clinical and<br />
neuropathological study<br />
J. Qin a , J.-M. Wang b , M. Itoh c , X.-H. Bao a , Y.-H. Zhang a ,S.<br />
Takashima c<br />
a Department of Pediatrics, Peking <strong>University</strong> First Hospital,<br />
Beijing, China; b Department of Pediatrics, Shangqiu<br />
First People’s Hospital, Shangqiu, Henan, China; c Department<br />
of Mental Retardation and Birth Defect Research,<br />
National Institute of Neuroscience, NCNP, Kodaira,<br />
Tokyo, Japan<br />
Tuberous sclerosis complex (TSC) is a rare hereditary<br />
multiorgan disease. The present study is to summarize the<br />
clinical and neuropathological features of TSC. The clinical<br />
data from 25 children, aged 6 months–13 years, and the<br />
postmortem brain samples from four cases with TSC were<br />
investigated retrospectively. The main clinical findings in<br />
25 TSC children included seizures (23), mental retardation<br />
(16), skin lesions (25, with hypomelanotic macules in 23<br />
cases, angiofibromas in 15, shagreen patch in five, and fore-
580<br />
Abstracts<br />
head plaque in two), cardiac rhabodamyoma (three) or<br />
rhabodamyosarcoma (one), and multiple renal cysts (four).<br />
In two cases positive familial history of TSC was demonstrated.<br />
The mother of one case had severe seizures and<br />
mental retardation with typical dermatological TSC<br />
features, whereas the father of another case manifested<br />
only as typical dermatological TSC features and intracranial<br />
calcifications with no neurological symptoms. Cranial CT/<br />
MRI scan showed calcifications (22) in subependymal or<br />
other area, and cortical or subcortical tubers (nine). Neuropathological<br />
findings in all the four cases were cortical or<br />
subcortical tubers, subependymal giant cell astrocytomas,<br />
and heterotopic nodules in cerebrum or in cerebellum.<br />
Histologically, these hamartomas contain abnormal giant<br />
cells that show evidence of abnormal differentiation of<br />
immature neural cells. (*This work was partly supported<br />
by a key clinical project, 2001-03, from the Ministry of<br />
Public Health of China).<br />
FP-K-071<br />
Myopathy with Allgrove syndrome<br />
S.H. Ibrahim a , J. Vajsar b , V. Jay b<br />
a Aga Khan <strong>University</strong>, Karachi, Pakistan; b The Hospital for<br />
Sick Children, Toronto, Canada<br />
‘3A’ Syndrome or Allgrove syndrome was first described<br />
by Allgrove et al. in 1978. This syndrome typically consists<br />
of adrenal insufficiency, achalasia and alachrima. Since its<br />
first description more than 100 cases have been described.<br />
We report a 9 years old boy with the typical manifestations<br />
of achalasia, adrenal insufficiency, alachrima, and neurological<br />
manifestations of generalized muscle weakness, developmental<br />
and cognitive delay, who underwent muscle<br />
biopsy, which showed evidence of myopathy. Although<br />
various neurological manifestations including neuropathy,<br />
ataxia, impaired intelligence have been described, as yet no<br />
report has been made of myopathy in children with Allgrove<br />
syndrome. This is the first report of association of Allgrove<br />
syndrome with myopathy.<br />
FP-K-072<br />
Megalencepahlic leukodystrohy in children in a distinct<br />
aslan ethnic group – the agarwlas in India<br />
U.P. Bhat<br />
Department Of Neurosciences, Apollo Hospital Chennal,<br />
India<br />
We are presenting six cases of megalencephalic leukodystrophy<br />
who presented with a very large head in early<br />
infancy from a distinct ethnic community of Agrawals –<br />
head circumference was above the 95th centile in all with<br />
almost normal range of functioning. History of seizures<br />
was present in two cases and minimal neurological deficit<br />
in the form of pyramidal and cerebellar signs was documented<br />
in one case. Neuromaging studies revealed<br />
evidence of severe bilateral white matter changes in the<br />
cerebrum, with characteristic cystic changes in the<br />
temporal lobes. Screening for known metabolic and degenerative<br />
disorders was negative. The striking feature in these<br />
was the extensive white matter changes in the brain as<br />
contrasted with almost near normal intellectual functioning<br />
and minimal neurological deficit.<br />
FP-K-073<br />
Novel TSC2 mutations in Japanese patients with<br />
tuberous sclerosis complex<br />
J.-H. Feng, T. Yamamoto, E. Nanba, H. Ninomiya<br />
Gene Research Center, Tottori <strong>University</strong>, Yonago, Japan<br />
TSC is an autosomal dominant disorder characterized by<br />
hamartomas in many organs. Here we report mutation<br />
analysis of TSC2 in ten unrelated patients, using singlestrand<br />
conformational polymorphism analysis of all coding<br />
exons. We detected six novel mutations in addition to three<br />
mutations that had been previously reported, including two<br />
frameshifts, one in-frame deletion, two nonsense point<br />
mutations, three missense mutations and one splice site<br />
mutation. We also found five new polymorphisms. Mutations<br />
found in this study were distributed on various exons<br />
and there was no clustering of the mutations. In accordance<br />
with the previous findings, there was no obvious relationship<br />
between the location of the mutation and the clinical<br />
symptoms.<br />
FP-K-074<br />
Brain MRI findings in PKU patients<br />
E.S. Suh a , Y.H. Kim a , D.W. Lee a , H.S. Hong b<br />
a Department of Pediatrics, b Radiology, College of Medicine,<br />
Soon Chun Hyang <strong>University</strong>, Seoul, Korea<br />
Purpose: Abnormalities of MRI of the brain occur in<br />
some patients with phenylketonuria (PKU). The purpose<br />
of this study was to evaluate relation between MR findings,<br />
age and serum phenylalanine level. Methods: We investigated<br />
16 patients with biochemically documented PKU<br />
who also underwent MRI. Typical classic form was in 13<br />
patients, atypical in other two patients and malignant<br />
hyperphenylalaninemia in the other two patients. We evaluated<br />
signal intensity, the distribution of abnormal signal<br />
intensity, and the extent of the brain atrophy in MRI, and<br />
possible clinical correlation between age and serum phenylalanine<br />
level and abnormal signal intensity. Results: MRI<br />
scans revealed areas of abnormally increased signal intensity<br />
on T2-weighted images in ten (62%) patients, preferably<br />
involving the parieto-occipital lobes. In one advanced<br />
case, the high signal intensity of both the parietal and<br />
frontal lobes was seen on T2-weighted images, and brain<br />
atrophy and gyriform enhancement on contrast enhanced
Abstracts 581<br />
T1-weighted images. In six (38%) patients, the findings<br />
were normal. No abnormalities were found in the basal<br />
ganglia, brain stem and cerebellum. Nine patients were<br />
under age of 5 years old. There were no remarkable difference<br />
in the average serum phenylalanine levels for the<br />
various groups having different degree of MRI abnormalities<br />
(normal, mild, moderate, and severe – 26.4, 27.6, 28.2<br />
and 20.8 mg/dl, respectively). Conclusion: Although MR<br />
findings were not specific, PKU patients showed symmetrical<br />
high signal intensity, predominantly in the peritrigonal<br />
region. In the advanced case, on T2-weighted images,<br />
high signal intensity extended to the periventricular and<br />
subcortical white matter. There was no correlation between<br />
age, serum phenylalanine level and severity of high signal<br />
intensity.<br />
FP-K-075<br />
Influence of MECP2 gene mutation type and X<br />
chromosome inactivation on the phenotype of Rett<br />
syndrome<br />
J. Chae, H. Hwang, K.-J. Kim, Y.-S. Hwang<br />
Department of Pediatrics, Seoul National <strong>University</strong> Children’s<br />
Hospital, 28 Yongondong, Jongnogu, Seoul 110-744,<br />
Korea<br />
Rett syndrome is a progressive neurodevelopmental<br />
disorder occurring predominantly in females. Recently,<br />
Amir et al. identified mutations in the MECP2 gene on<br />
Xq28, which encodes methyl-CpG binding protein 2, as<br />
responsible for some cases of Rett syndrome. In this<br />
study, we analyzed the entire coding sequence of the<br />
MECP2 gene and their X chromosome inactivation pattern<br />
in 42 sporadic cases of Rett syndrome. Of the 42 patients, 30<br />
(71.4%) had pathogenic mutations, which included 14<br />
different mutations. Altogether, there were nine missense<br />
mutations (D97Y, L100V, R133C, S134P, P152R,<br />
T158M, A279V, R306C, P322L), four nonsense mutations<br />
(R168X, R255X, R270X, R294X), and one frameshift<br />
mutation (a 41-bp deletion at 1157–1197). Three of these<br />
were novel mutations (D97Y, L100V, S134P). Most of the<br />
nucleotide substitutions involved C to T transitions at CpG<br />
hotspots. There was a tendency for patients having nonsense<br />
mutations in TRD region to show earlier onset of regression<br />
and severer language retardation than patients having mutations<br />
in MBD region. However, the clinical severities were<br />
variable among patients with same type of mutation,<br />
depending on the pattern of X chromosome inactivation.<br />
This study suggests that the X chromosome inactivation<br />
pattern can modify the phenotype of Rett syndrome that is<br />
initially determined by type and site of MECP2 gene mutation.<br />
FP-K-076<br />
Preliminary study on linkage mapping of a Chinese<br />
benign familial infantile convulsions pedigree<br />
B. Xiao, X.-S. Yang, J.-C. Ning, Z.-G. Wu, G. Xiong<br />
Department of Neurology, Xiangya Hospital, Central South<br />
<strong>University</strong>, Changsha, 410078, China<br />
Objective: Genetic linkage analysis were performed to<br />
map the disease gene locus of a Chinese benign familial<br />
infantile convulsions pedigree on chromosome 19q12–<br />
13.1 or 2q24. Methods: Seven polymorphic microsatellite<br />
DNA markers (five markers on 19q, and two on 2q) have<br />
been typed, and parametric linkage analysis has been<br />
performed to analyze the segregation of the gene locus<br />
within our BFIC family. Results: There was not a differential<br />
haplotype that co-segregated with BFIC in this family.<br />
When the recombinant rate u was zero, the linkage between<br />
the investigated family and the mapped genes of BFIC was<br />
excluded because the two-point LOD scores were less than<br />
22. When the LOD scores were in the range of 22 and 0,<br />
there was no evidence of linkage as well. So the analysis<br />
showed no evidence of linkage between chromosome<br />
19q12–13.1 or 2q24 and the BFIC phenotype. Conclusions:<br />
There was no evidence that the BFIC gene of the investigated<br />
family was mapped on chromosome 19q12–13.1 or<br />
2q24. We suggest that BFIC shows genetic heterogeneity<br />
and maybe another gene locus is responsible for the Chinese<br />
BFIC family.<br />
FP-L<br />
Metabolism<br />
FP-L-001<br />
A possible new disorder of catecholamine metabolism; a<br />
patient with recurrent serotonin syndrome like-episode<br />
T. Ohtsuka, A. Kobayashi, M. Ito, H. Kakinuma<br />
Department of Pediatrics, Kanazawa Medical <strong>University</strong>,<br />
Uchinada, Japan<br />
Serotonin syndrome is characterized by various combinations<br />
of myoclonus, rigidity, hyperreflexia, confusion<br />
and diaphoresis, caused by the use of serotomimetic agents.<br />
Rhabdomyolysis and death are rare effects. We describe a<br />
7-year-old girl with a 5-year history of recurring serotonin<br />
syndrome-like episodes. Her elder brother died of renal<br />
failure caused by rhabdomyolysis, which was due to overwhelming<br />
involuntary movement persisting several days at<br />
age 5 years and were similar to those in the patient<br />
presented here. No relatives in the family showed any<br />
movement abnormalities. This suggests an autosomal<br />
recessive hereditary disease. She was born after an<br />
uneventful pregnancy and delivery with an Apgar score<br />
of 9. At age 2 years and half she presented with trunk<br />
hypotonia and involuntary dystonic movements. After a
582<br />
Abstracts<br />
Table 4<br />
Changes in ALT/AST during antiepileptic treatment a<br />
Pretreatment<br />
During treatment 2.6 ^ 1 year<br />
AST ALT AST ALT<br />
VPA (N:124) 25.06 ^ 3.12 16.36 ^ 7.06* 30.01 ^ 2.22 4.2 ^ 2.6* / **<br />
CB2 (N:101) 26.08 ^ 6.5 16.28 ^ 8.12 28.01 ^ 7.1 18.32 ^ 6.88**<br />
VGB (N:5) 28.07 ^ 9.3 17.16 ^ 7.45 29.11 ^ 6.4 3.0 ^ 1.31<br />
VPA 1 CB2 (N:31) 31.04 ^ 2.0 18.13 ^ 5.56 33.61 ^ 3.1 16.26 ^ 3.26<br />
VPA 1 LTG (N:24) 29.9 ^ 1.43 12.86 ^ 7.43 32.18 ^ 3.4 17.01 ^ 4.0<br />
VPA 1 VGB (N:4) 33.18 ^ 6.1 18.20 ^ 6.2 34.25 ^ 7.1 3.8 ^ 1.76<br />
Total 289<br />
a<br />
*P , 0.05; and **P , 0.05 (the difference between VPA and CBZ).<br />
viral illness, her movement worsened rapidly and eventually<br />
she became unable to control herself. She also<br />
showed agitation, restlessness, and diaphoresis. This attack<br />
persisted over a month and repeated itself every 2 or 3<br />
months. Normal laboratory findings included plasma<br />
amino acids, organic acids, serum lactic, uric acids, copper<br />
and ceruloplasmin. Five-hydroxyindole acetic acid, homovanillic<br />
acid, neopterin, teterahydroxybiopterin, and 5-<br />
methyltetrahydroforate in the cerebrospinal fluid were<br />
normal. Brain MRI showed mildly enlarged ventricles.<br />
She has slowly developed motor skills, sitting at age 2<br />
years, crawling at 4 years, and standing with support at 5<br />
years. At present her language comprehension is at the 3–4<br />
year-old level. She was treated with antiepleptic drugs and<br />
muscle relaxants, but frequency of the attacks did not show<br />
any change. We propose that this patient has a defect in the<br />
CNS catecholamine metabolism.<br />
FP-L-002<br />
Alanine aminotransferase levels during chronic use of<br />
anticonvulsant drugs<br />
D. Içaǧasioǧlu, Ö. Ünal, G. Deda<br />
Department of Pediatric Neurology, Ankara <strong>University</strong><br />
Medical School, Ankara, Turkey<br />
We aimed to determine the effect of antieplectic drugs on<br />
the serum alanine amino transferase levels in 289 epileptic<br />
children. This study, before and after 2.6 ^ 1.06 years,<br />
compared ALT and gamma-glutamly transferase activities<br />
in sera of children who were under either VPA (42.9%),<br />
CBZ (34.9%) or vigabatrin (VGB) (1.7%) monotherapy,<br />
or VPA 1 CBZ (10.7%), VPA 1 LTG (8.3%), and VPA 1<br />
VGB (%1,41) combined therapy (Table 4). Previous studies<br />
have reported reductions in plasma ALT activity due to<br />
VGB and it is not known whether this can mask early elevations<br />
in transaminases in patients with hepatocellular<br />
damage. Our data indicate that in 28% of patients serum<br />
ALT levels reduced during VPA medication and careful<br />
monitoring of hepatic function is mandatory in patients<br />
under VPA therapy.<br />
FP-L-003<br />
The effect of valproic acid on bone mineral metabolism<br />
and bone density<br />
D. Içaǧasioǧlu, G. Deda, Ö. Ünal, M. Berberoǧlu<br />
Departments of Pediatric Neurology and Endocrinology,<br />
Ankara <strong>University</strong> Medical School, Ankara, Turkey<br />
Many reports of altered calcium, vitamin D and bone<br />
metabolism associated with anticonvulsant therapy have<br />
been published. The purpose of this study was to determine<br />
whether bone mineral density is decreased by VPA treatment<br />
in epileptic children. We studied 18 children with new<br />
onset of epilepsy. Their ages ranged between 9 and 12 years.<br />
Children who had mental and motor retardation, had used<br />
medication known to alter bone metabolism, or had had<br />
neurologic deficit and abnormal cerebral imaging findings<br />
were excluded from the study. Before and after 11 ^ 2.1<br />
months of VPA therapy we measured biochemical parameters<br />
of bone mineral metabolism and dual energy X-ray<br />
absorptiometry was used to assess lumbar spine (L2–4)<br />
bone mineral density (BMD). Comparison of the mean<br />
biochemical parameters and BMD values of the before<br />
and after VPA treatment are shown in Table 5. Our data<br />
indicate that VPA therapy in epileptic children does not<br />
Table 5<br />
Laboratory parameters of patients a Before therapy<br />
After therapy<br />
Male/female 11/7 11/7<br />
Height 30.8 ^ 0.7 31.9 ^ 2.3<br />
Serum drug level (mg/ml) – 60.1 ^ 1.3<br />
Ca (mg/dl) 9.32 ^ 0.1 8.27 ^ 0.5<br />
P (mg/dl) 5.8 ^ 0.7 5.0 ^ 0.2<br />
Alkalin phosphatase (IU/l) 189 ^ 85.40* 237 ^ 97.86*<br />
PTH (pg/ml) 21.48 ^ 19.18 27.31 ^ 16.02<br />
Calcitonin 11.16 ^ 8.91 10.2 ^ 9.18<br />
Osteocalcin 12.66 ^ 7.44 14.12 ^ 6.98<br />
BMD 0.558 ^ 0.084 0.506 ^ 0.046<br />
a *P , 0.05.
Abstracts 583<br />
seem to have an adverse effect on bone mineral metabolism<br />
and BMD.<br />
FP-L-004<br />
Neonatal hypoglycemic brain injury – a specific clinical<br />
and imaging syndrome in 51 children<br />
V. Udani, M. Bawdekar, S. Karia, S. Mandasar<br />
P.D. Hinduja National Hospital and Medical Research<br />
Centre, Mumbai, India<br />
Brain injury attributed to neonatal hypoglycemia<br />
remains a significant problem in developing countries<br />
and is responsible for multiple disabilities. We describe<br />
51 children seen at a mean age of 39 months with a spectrum<br />
of disabilities and characteristic imaging findings.<br />
Forty-five/51 were males. Twenty-two were ,2.5 kg<br />
(LBW) and 22 were FT-AGA though only eight were #<br />
kg and above. A total of 79% had a neonatal encephalopathy<br />
on D2-3; 84% had microcrania; 59% were visually<br />
impaired; 57% had oromotor apraxia; and 75% had<br />
delayed language. Cerebral palsy was uncommon and<br />
was seen in only 10%. Apraxia of hand use was seen in<br />
57%. Epilepsy was seen in 88% and was partial (55%) or<br />
spasms (45%) or both. Spasms were refractory in 55% and<br />
partial seizures in 35%. Outcome in 35 children .5 years<br />
age revealed normal school performance in three, LD in<br />
seven, mild MR in six, severe MR in 11 and frank autism<br />
in eight. Cerebral palsy was noted in only five. Statistically<br />
significant association was noted between presence of<br />
epileptic spasms and autism, apraxia of hand use and<br />
oromotor apraxia. Generalised seizures were more<br />
common following spasms. Imaging revealed mostly bilateral<br />
occipital lesions in 84%, parietal lesions in 35% while<br />
only 7% had temporal lesions. No frontal lesions were<br />
noted. Conclusions: Neonatal hypoglycemic brain injury<br />
damages posterior regions with resultant visual deficits,<br />
apraxia of hand use and oromotor skills, cognitive impairment<br />
and autism, microcephaly, and often refractory<br />
epilepsy. Tone alterations are relatively less common.<br />
This preventable perinatal insult needs top priority in<br />
developing countries.<br />
FP-L-005<br />
Acute intermittent porphyria: case presentation<br />
L.A. Selim<br />
street 86 Maadi, Cairo, Egypt<br />
Acute intermittent porphyria is an autosomal dominant<br />
disorder of heme biosynthesis. The basic biochemical<br />
defect is reduced activity of the enzyme porphobilinogen<br />
deaminase caused by a genetic defect the deaminase gene<br />
located on the 11chromosome. Due to this defect only 50%<br />
of the normal enzyme quantity is produced. The disease<br />
becomes manifested only in the case of increased demands<br />
on a given metabolic pathway resulting in porphobilinogen<br />
accumulation and storage in the organs. Clinical evolution<br />
is characterized by acute attacks of abdominal pain, neurologic<br />
and psychiatric symptomatology, induced by drug<br />
intake, infection, alcohol intake or unknown factors.<br />
Laboratory diagnosis is based on the detection of deltaaminolevulinic<br />
acid, porphobilinogen, uroporphyrin and<br />
coproporphyrin in the urine. The therapy is based on infusions<br />
of 20% glucose solution and hydromineral imbalance<br />
correction. When neurologic symptoms occur it is necessary<br />
to administer hem-arginate intravenously. We report a<br />
case of a female child suffering from the disease with<br />
discussion of the treatment.<br />
FP-M<br />
Neuroimaging<br />
FP-M-001<br />
MRI study on brain in patients with tetrahydrobiopterin<br />
(BH 4 )deficiency<br />
Z.-X. Zhang, W.-M. Yu, Z.-S. Zhou, X.-Z. Zhang<br />
Department of Pediatrics, China-Japan Friendship Hospital,<br />
Beijing, China<br />
Objective: To observe the brain abnormalities of the<br />
white matter in BH 4 deficiency children in order to investigate<br />
the effect on the brain myelination. Methods: Eight<br />
patients with BH 4 deficiency were observed. In six cases,<br />
the level of blood Phe was between 480 and 1500 mmol/l<br />
on newborn screening. A low-Phe-diet was given early<br />
within 1 month after birth. Although the blood Phe had<br />
been controlled in an ideal range (120–240 mmol/l),<br />
there were the progressive myodystonia, the abynamia,<br />
and difficulty in raising their head in these patients.<br />
Among them, four patients had convulsion and the other<br />
two also had the oligophrenia accompanied by high blood<br />
Phe (.1200 mmol/l). All eight patients were diagnosed as<br />
BH 4 deficiency by using the analysis of the urine pterin,<br />
BH 4 loading test and the analysis of dihydropteridine<br />
reductase in RBC. The eight cases were subjected to<br />
0.5T superconductive MRI examination before the treatment<br />
with BH 4 and pro-neurotransmitter. Results: Delayed<br />
myelination was detected in all cases, mainly in the frontal<br />
lobe (eight cases, 100%), in the occipidfol lobe (five cases,<br />
62.5%), and in the temporal lobe (four cases 50%). There<br />
existed abnormal hyperintense foci in white matter shown<br />
by T 2 WI in all cases. Conclusions: (1) Children with BH 4<br />
deficiency have a high occurrence of brain abnormalities in<br />
the white matter. (2) These abnormalities may be related<br />
not only to HPA, but also to the decreased synthesis of<br />
neurotransmitters, such as 5-HT and DA, which could<br />
affect the development of the white matter.
584<br />
Abstracts<br />
FP-M-002<br />
3-D MRI volume of frontal lobe in autistic children<br />
Y. Toda, K. Mori, K. Tao, K. Inoue, M. Miyazaki, T. Saijo,<br />
T. Hashimoto, Y. Kuroda<br />
Department of Pediatrics, School of Medicine, <strong>University</strong> of<br />
Tokushima, Tokushima, Japan<br />
Purpose: We measured volume of the whole brain and<br />
frontal lobe using 3-D MR image and coherence with laterality<br />
and DQ examined volume of frontal lobe. Object/<br />
method: Object is totaled 35 examples of 19 autistic children<br />
(3–5 years old, DQ 50–100) and 16 healthy contrasts (3–5<br />
years old) visiting our hospital. We got informed consent<br />
from family with both group about MRI examination and<br />
measured horizontal image with 3-D SPGR method. We did<br />
reconstitution using image analysis software ‘Scion Image’<br />
and got the volume of the whole brain and frontal lobe and<br />
surveyed volume of right and left each about frontal lobe.<br />
We used Enjyoujishiki developmental test about DQ.<br />
Result: We did not recognize significant difference between<br />
autism group and healthy control group about the volume of<br />
the whole brain and frontal lobe. We compared even rate for<br />
volume of the whole brain (%) about frontal lobe, but did<br />
not still recognize significant difference. The right side was<br />
big in significance compared with the left with autism group<br />
in comparison of right and left frontal lobe volume. We did<br />
not recognize correlation during brain and frontal lobe<br />
volume about DQ. Conclusion: In volume of frontal lobe,<br />
the right side is big in significance compared with the left<br />
with autism group and coherence with frontal lobe dysfunction<br />
was suggested.<br />
FP-M-003<br />
Clinical and magnetic resonance image analysis of 36<br />
cases of periventricular leukomalacia in children<br />
X.-D. Yuan<br />
First People’s Hospital of Shangqiu City, Shangqiu, Henan,<br />
China<br />
Objective: To investigate the clinical and MRI characteristics<br />
of PVL in children. Method: To analysis the clinical<br />
data of PVL in 36 children. Result: (1) Gestational age:<br />
between 30 , 37 weeks in 22 cases, 38 , 42 weeks in 14<br />
cases. (2) Clinical manifestation: (a) paralysis in 36 cases;<br />
(b) cortical blindness in two cases; (c) mental retardation in<br />
nine cases; and (d) epilepsy in ten cases. (3) MRI manifestation:<br />
(a) foci form: patchy areas in 16 cases, punctate areas<br />
in 13 cases, streaks in seven cases; (b) section: symmetric<br />
signal abnormalities were observed in the periventricular<br />
and the subcortical white matter; (c) the signal of the<br />
focus: hyperintense/intense on T1 weighted and hyperintense<br />
on T2 weighted; and (d) other: bilateral ventricular<br />
bodies dilatation in eight cases. Trigon dilatation in five<br />
cases. Conclusion: PVL is a main cause of cerebral palsy,<br />
especially of spastic paralysis, MRI is a main way to diagnose<br />
PVL in early infants.<br />
FP-M-004<br />
Automated histogram-based brain segmentation and<br />
volume measurement in T1-weighted 3-D MR head<br />
images<br />
J.Z. Liu, Z.Y. Shan, G.H. Yue<br />
Department of Biomedical Engineering, Cleveland Clinic<br />
Foundation, Cleveland, OH, USA<br />
Information on human brain volume changes may help<br />
better understand structural and functional development and<br />
adaptations of the brain. Current semi-/automated MRbased<br />
brain segmentation and volume measurement methods<br />
are complex and not sufficiently accurate. We have<br />
developed a simpler, more accurate automated algorithm<br />
for whole-brain segmentation and volume measurement in<br />
T 1 -weighted 3-D MR images. This histogram-based brain<br />
segmentation (HBRS) algorithm is based on histogram<br />
analysis and simple morphological operations. It includes<br />
three major steps: (1) foreground/background thresholding;<br />
(2) disconnection of brain from skull and other head tissues;<br />
and (3) removal of residual fragments (cerebrospinal fluid,<br />
sinus, dura and marrow). Brain volume was measured by<br />
counting the number of brain voxels. Accuracy was determined<br />
by comparing brain volume rendered by applying the<br />
algorithm to computer-simulated MR data with the volume<br />
on which the simulation was based; average error was<br />
1.48%. Reproducibility of brain volume measurements<br />
was assessed by comparing data from two sessions (two<br />
trials in each session) with human volunteers. Intra-session<br />
variability of brain volumes for sessions 1 and 2 was<br />
0.55 ^ 0.56 and 0.74 ^ 0.56%, respectively; mean difference<br />
between the two sessions was 0.60 ^ 0.46%. These<br />
results show that the HBRS algorithm is a simple, fast,<br />
and accurate method for human brain volume assessment<br />
with high reproducibility. This algorithm may find various<br />
applications in research and clinical investigations regarding<br />
cortical development and child neurology.<br />
FP-M-005<br />
Diffusion weighted MRI for early diagnosis of acute<br />
neurological disease in the neonate<br />
W. Brussel, I.M. van Beynum, M.C. Molenschot, V.A. Bok<br />
Rijnstate Hospital, TA Arnhem, Netherlands<br />
Diffusion weighted-MRI (DW-MRI) uses water movement<br />
and transport of water in biological tissues as a source<br />
of contrast. Therefore DW-MRI can be used to obtain information<br />
about molecular displacement over distances<br />
comparable to cell’s dimensions and, consequently, about<br />
geometry and spatial organization of tissue compartments.<br />
Functional insight concerning exchanges between these<br />
compartments in various disease states can be gathered. In<br />
the presence of magnetic field gradients, protons carried by<br />
free moving water molecules, undergo a phase shift of their
Abstracts 585<br />
transverse magnetization. As diffusion is characterized by<br />
the random Brownian displacements of molecules, these<br />
phase shifts are widely dispersed. Interfering with each<br />
other finally results in attenuation of the MRI signal. The<br />
attenuation depends on the amplitude of molecular displacement<br />
and intensity of the magnetic field gradient. In<br />
conventional MRI diffusion effects are extremely small<br />
and invisible. By using strong magnetic field, gradient diffusion<br />
becomes visible and measurable. Especially in intracellular<br />
cytotoxic edema diffusion is strongly limited and<br />
the involved areas will show with high signal on the images.<br />
DW-MRI can detect pathological changes within minutes of<br />
the onset of injury, which is well before conventional MRI<br />
shows changes. Although recent publications reveal the<br />
importance of DW-MRI for early diagnosis of hypoxic<br />
ischemic injury and focal infarction in the neonatal brain,<br />
the information on clinical diagnostic significance in other<br />
neonatal neurological disease is sparse. From examples of<br />
several acute neurological diseases in the neonate, such as<br />
bacterial and viral meningoencephalitis, hypoglycemia and<br />
cerebrovascular accident, the diagnostic value of DW-MRI<br />
in an early stage of these diseases is shown.<br />
FP-M-006<br />
Predictive value of neonatal MRI with respect to late<br />
MRI findings and clinical outcome-a study in infants<br />
with periventricular densities on neonatal ultrasound<br />
L.T.L. Sie, M.S. van der Knaap, A.A.M Hart, J. van Hof, L.<br />
de Groot, W. Lems, H.N. Lafeber, J. Valk<br />
Vrije Universiteit Medical Center, Amsterdam, The Netherlands<br />
Objectives: To correlate hypoxic-ischemic white matter<br />
damage on neonatal MRI with late MRI and neurologic<br />
outcome at 1.5 years. Methods: MR images of 46 infants<br />
(mean gestational age of 31 weeks) with periventricular<br />
densities on ultrasound were obtained at a mean age of 20<br />
days after birth and at 1.5 years. To establish agreement<br />
between the neonatal and follow-up MRI (general, motor<br />
and visual scores), the weighted Cohen’s kappa was used.<br />
Predictive values of neonatal MRI with respect to the neurologic<br />
indices at 1.5 years were calculated. Results: There<br />
was a moderately good to good agreement between the<br />
general, motor and visual neonatal and follow-up MRI<br />
scores: weighted kappa ¼ 0.59 (95% CI: 0.44–0.74), 0.82<br />
(95% CI: 0.72–0.93), and 0.70 (95% CI: 0.56–0.84), respectively.<br />
Neonatal MRI scores provided a good prediction of<br />
the three neurologic outcome measures (developmental<br />
delay, cerebral palsy and cerebral visual impairment): sensitivity,<br />
specificity and predictive values were high, with little<br />
difference between the three MRI scores. The 32 patients<br />
with (nearly) normal neonatal MRI scores were neurologically<br />
(nearly) normal at 1.5 years on all three outcome<br />
measures, whereas eight patients with seriously abnormal<br />
neonatal MRI scores were neurologically abnormal at 1.5<br />
years on all three outcomes measures. Conclusions: Neonatal<br />
MRI is able to predict the precise localization and size of<br />
perinatal leukomalacia on follow-up MRI and provides a<br />
good prediction of neurologic outcome at 1.5 years.<br />
FP-M-007<br />
Ultrasonographic assessment of the fetal frontal lobe<br />
Y.-L. Zhang, Y. Wu, Z.-R. Zhang<br />
Department of Pediatrics, Daqing Medical College,<br />
Daqing, China<br />
Objective: To study the characters of normal growth of<br />
the fetal frontal lobe, and to obtain a nomogram of frontal<br />
lobe measurements in fetuses with different gestational<br />
weeks. Methods: A prospective ultrasound evaluation was<br />
conducted in 338 normal pregnant women with gestational<br />
ages ranging from 15 , 40 weeks. Several biometric<br />
measurements were obtained throughout pregnancy, including<br />
the frontal lobe distance (FLD), the thalamic frontal lobe<br />
distance (TFLD), the biparietal diameter (BPD). A nomogram<br />
of frontal lobe measurements from different gestational<br />
age (GA) and BPD were generated and included the<br />
x ^ s. The linear analysis and the parabolical curve fitting<br />
analysis were made between FLD, TFLD and the GA, the<br />
BPD. Results: The analysis of these data revealed a high<br />
degree of linear correlations between FLD, TFLD and the<br />
GA, the BPD (R. between 0.9562 , 0.9708 P , 0:0001).<br />
The second order polynomes for these two measurements<br />
versus GA and BPD were produced with the parabolical<br />
curve fitting analysis (P , 0:0001), and the growth curves<br />
were plotted by computer. FLD was almost linearly<br />
increased with the gestational age. TFLD was increased<br />
curvely with the gestational age. Conclusion: The results<br />
of this study demonstrated the pattern of normal growth of<br />
the frontal lobe. They offer a method by which early prenatal<br />
diagnosis of developmental anomalies of the fetal brain<br />
(especially microcephaly) can be made.<br />
FP-M-008<br />
Evaluation of 3D-TOF MRA in children ischemic<br />
strokes<br />
X.-L. Yu, Y.-Q. Zhang, L.-M. Ye<br />
Department of Neurology, Tianjin Children Hospital, Tianjin,<br />
China<br />
Objective: To evaluate the applying of 3D-TOF Magnetic<br />
resonance angiography (MRA) in children ischemic strokes.<br />
Methods: Between December 1999 and June 2001, 15<br />
patients (eight males, seven females) were studied. Their<br />
ages ranged from 11 month to 12 years old (mean 3<br />
years). With diagnosis of MRI, ECLIPSE 1.5-T of Marconi<br />
Company, all patients do the examination within 1 week.<br />
All ischemic foci were found on one side (nine left, six<br />
right). Frontal lobe one case, parietal lobe one case, multi-
586<br />
Abstracts<br />
focus eight cases, basal ganglia lacuna infarction five cases.<br />
Result: MRA (2) four cases, single/accompany implicated<br />
cerebral media artery (MCA) eight cases, single implicated<br />
cerebral anterior artery one case and basilar artery two<br />
cases. The initial position of artery and the first branch<br />
stricture/infarction four cases, periphery artery tenuous/<br />
branch decreasing five cases, basilar artery tortuous two<br />
cases. Through therapy, the beginning time of recovery of<br />
muscle strength are 4 , 7 days to MRA (2) and artery<br />
stricture/infarction patients, 7 , 18 days to periphery artery<br />
tenuous/branch decreasing patients, 3 , 10 days to basilar<br />
artery tortuous patients. Conclusion: Most of the ischemic<br />
strokes patients have the corresponding artery changes in<br />
MRA, the majority changed position is MCA system, the<br />
variability was related with prognosis. The patients with<br />
polyartery implicated need followed up for a long time, in<br />
order to exclude moyamoya, polyarteritis, etc.<br />
FP-M-009<br />
Potential epileptogenecity of calcified neurocysticercosis<br />
V. Kalra a , K.S. Rana a , S. Gulati a , B. Ekka a , A.K. Gupta b ,<br />
R.M. Pandey c<br />
a Departments of Pediatrics, b Radiodiagnosis, c Biostatistics,<br />
All India Institute of Medical Sciences, New Delhi, India<br />
Background: Epileptogenecity of calcified neurocysticercosis<br />
being unknown, the AED duration remains a dilemma.<br />
Objectives: To study calcification in neurocysticercosis as a<br />
risk factor for epilepsy. Materials and methods: Retrospective<br />
analysis of 296 patients with CT imaging compatible<br />
with neurocysticercosis- single/multiple parenchymal or<br />
calcified lesions after exclusion of tuberculosis. Follow up<br />
period was 3–6 years for seizure recurrences: breakthroughseizures<br />
recurring on adequate AED and relapse-recurrence<br />
of $2 seizures 3 months after AED discontinuation.<br />
Results: A total of 296 children, mean age 7.9 ^ 2.8 years<br />
of either sex. The initial CT showed calcification in 18.5%.<br />
AED were administered for 1.9 ^ 1.4 years. Albendazole<br />
was given to 33/296 and follow up scans in albendazole<br />
treated group revealed calcification in 52%. On follow up<br />
CT scans (170), 6/31 with normal scans had breakthrough<br />
seizures and similar figure for persisting lesions was 8/50<br />
and calcified 33/89 (P-0:04). Similar figures for relapse<br />
were 1/31 with normal CT scan, 3/50 persisting lesions<br />
and 12/89 calcified (P-0:39). The follow up duration after<br />
AED discontinuation was 2.2 ^ 1.8 years. A total of 130<br />
children had calcification in the initial and/or follow-up CT<br />
scans. Breakthrough seizures were seen in 50/130 (38.4%)<br />
children with calcified lesions versus 32/166 (19.2%) in the<br />
rest (P , 0:001). Similar figures for relapse were 16/130<br />
(12.3%) and 10/166 (6.0%), respectively (P ¼ 0:09).<br />
Conclusions: Calcification in neurocysticercosis, though<br />
an inactive healed lesion, is associated with increased risk<br />
of seizures as compared to persisting lesions or normal scan<br />
on long term follow-up.<br />
FP-M-010<br />
Face perception of Asperger syndrome child<br />
I. Kimura, M. Kubota, H. Hirose, M. Yumoto, Y.<br />
Sakakihara<br />
Department of Pediatrics, Department of Laboratory Medicine,<br />
The <strong>University</strong> of Tokyo, Tokyo Japan<br />
Asperger syndrome (AS) is one group of the pervasive<br />
developmental disorders and accepted as autistic spectrum<br />
entity. Although they have almost normal or superior intelligence,<br />
no significant speech delay, AS adults and children<br />
have problem in social communication skills and are<br />
supposed to have specific deficit in understanding others’<br />
mind. Considerable number of studies has shown that AS<br />
or high-function autism adults are inferior to IQ-matched<br />
controls in understanding emotions from others’ facial<br />
expression, or even if they could detect rightly, some<br />
studies revealed that they might use different pathway in<br />
the brain. As it has not been clearly understood the way AS<br />
child percepts face, we examined an 8-year-old AS girl by<br />
magnetoencephalography (MEG) with the task of selecting<br />
‘laughing faces’ among a series of projected face photographs.<br />
The task was also done with inverted faces. It is<br />
known that basal occipitotemporal cortex is mainly participated<br />
in face processing, especially at early stage, within<br />
latency of about 200 , 300 ms, and all of the controls<br />
except one showed such pattern of MEG activity waveforms<br />
and dipole locations. But the AS girl showed distinct<br />
pattern from this, with larger activation of bilateral parietal<br />
than occipitotemporal cortex. This distinct pattern was not<br />
observed when the faces were inverted. It was suggested<br />
that AS child might use special dorsal way of parietal<br />
cortex in face processing.<br />
FP-M-011<br />
Diagnostic value of magnetic resonance imaging in West<br />
syndrome<br />
F. Fang<br />
Beijing Children Hospital Beijing, China<br />
Objective: To study the value of MRI in West syndrome<br />
(WS) diagnosis. Methods: MRI results of thirty-one patients<br />
with WS were reviewed retrospectively. Results: Twentyfive<br />
patients were diagnosed symptomatic WS, three<br />
patients were cryptogenic and three patients were primary.<br />
Thirty-one patients were classified into four groups on the<br />
basis of their MRI findings: Periventricular leukomalacia,<br />
myelination delay, the other groups and normal. Conclusion:<br />
MRI was helpful in finding etiology and assessing<br />
prognosis in WS.
Abstracts 587<br />
FP-M-012<br />
Using MRI analysis the relationship between the<br />
disorder in basal ganglia in children and the reason and<br />
symptom of it<br />
T.-L. Han<br />
Beijing Children Hospital Beijing, China<br />
Objective: To study the relationship between the causes,<br />
symptoms and the disorders of basal ganglia by MRI in<br />
children. Method: Forty-one patients were studied by MRI,<br />
using CSF, EEG, lactic acid, etc., as the combined diagnostic<br />
method. Results: Forty-one cases all had disorders<br />
on basal ganglia. The number of cerebrovascular disease<br />
was 12 (29.3%), and it was the leading cause, it included<br />
eight cases of idiopathic cerebral vasculitis, and four cases<br />
of moyamoya disease. The number of the immunologic<br />
disorders on nervous system (NS) was eight (19.5%), it<br />
included four cases of acute disseminated encephalomyelitis<br />
(ADEM), two cases of Acute hemorrhagenic leukencephalitis,<br />
a case of multiple selerosis (MS) and a case of<br />
systemic lupus erythematosis (SLE). The number of metabolic<br />
diseases and heredodegenerative diseases of the NS<br />
was 10 (24.4%). The number of other causes or causes of<br />
unknown was 11. Conclusion: (1) Acquired disease was the<br />
leading cause of the disorders of basal ganglia in childhood.<br />
(2) Clinical manifestation of disorders of basal ganglia<br />
was widespread, and was not limited to dystonia and<br />
involuntary movements, and also was not limited to the<br />
nervous system.<br />
FP-M-013<br />
CT analysis of mental retardation children caused by<br />
perinatal cerebral lesion<br />
Z.-H. Song<br />
Woman and Infant Healthcare Hospital, Yangquan City,<br />
Shanxi, China Purpose: Research of the pathological<br />
changes of mental retardation children resulting from perinatal<br />
cerebral lesion and exploration of the early remedial<br />
ways. Way: Selecting 144 patient pupils equal to or under 7<br />
years old without ablepsia and deafness, who have the<br />
history of perinatal cerebral lesion without inherited metabolic<br />
diseases and mental test IQ/DQ is under 69 with head<br />
CT scan. Result: CT abnormal rate is 71.52% and with<br />
significant difference between severe and moderate mental<br />
retardation children. CT showed mainly the atrophy and<br />
hypogenesis, mostly in the frontal lobe. Conclusion: (1)<br />
Perinatal brain injury may be one of the factors to cause<br />
future mental retardation (MR). (2) Head CT scan of the<br />
children with MR showed mainly atrophy and hypogenesis,<br />
mostly in the frontal lobe.<br />
FP-M-014<br />
Abnormal cerebral glucose metabolism in patients with<br />
alternating hemiplegia of childhood<br />
M. Sasaki a , A. Fukushima a , H. Sakuma a , N. Shiroma a , K.-I.<br />
Yamada a , T. Ohnishi b , H. Matsuda b , N. Sakuragawa c<br />
a Department of Child Neurology,<br />
b Radiology, National<br />
Center Hospital for Mental, Nervous and Muscular Disorders,<br />
National Center of Neurology and Psychiatry (NCNP),<br />
c Department of Inherited Metabolic Disease, National Institute<br />
of Neuroscience, NCNP, Kodaira, Japan<br />
Alternating hemiplegia of childhood (AHC) is a rare and<br />
intractable disorder, the cause of which remains unknown.<br />
To determine the extent and degree of neuronal damage, the<br />
brain glucose metabolism in three children and two adult<br />
patients with AHC was studied by PET using 2-deoxy-[18F]<br />
FDG. FDG-PET was performed between hemiplegia attacks<br />
in all patients. All the patients met the criteria of Aicardi.<br />
Hemiplegic attacks occur 2–8 times a month in all patients.<br />
The child patients consisted of 1–3-year-old boys. They all<br />
showed psychomotor retardation and hypotonia. The adult<br />
patients consisted of 22 and 30-year-old women, whose<br />
brain MRI revealed mild cerebellar atrophy. Interictal<br />
FDG-PET revealed abnormal cerebral glucose metabolism<br />
in all patients. Low glucose metabolism in the frontal lobes<br />
with some laterality was demonstrated in all patients, and<br />
low glucose metabolism in the ipsilateral putamen was seen<br />
in three patients. The brainstem and cerebellum were<br />
normal as to glucose metabolism except for an adult patient.<br />
Areas of low glucose metabolism indicate local or regional<br />
neuronal damage, and could be related to neurological<br />
symptoms, for example, hypotonia, mental retardation,<br />
involuntary movement, etc. The unknown cause of AHC<br />
might induce focal abnormal glucose metabolism progressively<br />
or permanently in the brain.<br />
FP-M-015<br />
Neuroimaging methods for diagnosis of behavior<br />
deviations in the early life<br />
A. Jaxybayeva<br />
Institute of Medical Doctor’s improvement, Child Neurology<br />
Department, Almaty, Kazakhstan<br />
The purpose of our study was to investigate MRI-changes<br />
of the brains structure. We analyzed 50 MRI-scans of children<br />
with attention deficit hyperactivity disorder, aged 4–5<br />
years. On the MRI-scans at all of that children were detected<br />
a structure abnormalities as insignificant atrophy of the frontal<br />
lobe, insignificant dilatation of the third ventricle of the<br />
brain, decreased volume of the left caudate nucleus and<br />
increase of the right caudate nucleus. Therefore a neurobehavioral<br />
deviation as ADHD has been associated with thin<br />
brain structure abnormalities as insignificant atrophy of the<br />
frontal lobe, insignificant dilatation of the third ventricle of
588<br />
Abstracts<br />
the brain, asymmetry of basal ganglia (decrease volume of<br />
the left nucleus caudate and increase of the right nucleus<br />
caudate).<br />
FP-M-016<br />
Neuroradiological changes in infants with cysta cisterna<br />
ambiens<br />
K.S. Ormantaev, D.R. Kachurina, L.O. Saulebekova<br />
Scientific Center of Pediarics and Children’s Surgery,<br />
Almaty, Kazakhstan<br />
The purpose is study the character of changes in infants<br />
with some kinds of arachnoid cysts. During the period from<br />
1999 till 2001 years 1000 infants, aged from 0 to 3 months<br />
were examined at ultrasound diagnostic system ‘Aloka-<br />
2000’ (the transducer with frequency 7.5 MHz) was used.<br />
In seven children (0.7%) a small anechoic zone situated on<br />
the midline behind and below the dorsal end of the choroid<br />
plexus of the third ventricle, and above the vermis of the<br />
cerebellum was found. Its diameter was 7–10 mm. These<br />
changes were confirmed by computer tomography. Doppler<br />
investigations of cerebral arteries have not found any<br />
changes in cerebral blood flow. A total of 42.8% infants<br />
had convulsions, and 57.2% infants had not got severe<br />
neurological disturbances, their development was according<br />
their age. Cysta cisterna ambiens is very rare pathology. It<br />
has not specific neurological symptoms. It was found occasionally<br />
only during neurosonography and computer tomography.<br />
FP-M-017<br />
The features of image examination in children with acute<br />
hemiplegia<br />
Y.-F. Lu, L.-Q. Chen, Y.-C. Zhang, Q. Lu<br />
Shanghai children’s hospital, Shangha, China<br />
Objective: To observe the image features of acute central<br />
hemiplegia in children. Methods: Thirty-one cases with<br />
acute hemiplegia were hospitalized in neurological department<br />
of Shanghai children’s hospital from 1992 to 2001.<br />
We analyze the image features of cranial CT, MRI or<br />
MRA. Results: Thirty-one children were aged from 4<br />
months to 11 years (median 3.6 years), with the course<br />
from 6 h to 20 days. All cases were abruptly, 16 cases<br />
with preceding viral upper respiratory infection, two<br />
cases with similar history, two cases with convulsion,<br />
and two cases with fever and coma. Nineteen cases were<br />
abnormal in 23 cases by CT, and nine cases were abnormal<br />
in 11 cases by MRI. Three cases were abnormal by MRI in<br />
CT negative, and two cases were diagnosed with moyamoya<br />
disease by MRA but MRI negative. Twelve cases<br />
were shown with lateral basal ganglia embolus (38.71%);<br />
three cases were represent with bilateral basal ganglia<br />
embolus (9.68%); two cases were revealed with by nucleus<br />
lentiformis embolus; three cases were found with lateral<br />
temporo-parital lobes embolus. Two with lateral parietooccipital<br />
lobes embolus, two with lateral cerebral peduncles<br />
embolus, two with lateral internal capsula embolus,<br />
two with subdural hemorrhage, and two with moyamoya<br />
diseases. Conclusion: CT and MRI are the important diagnostic<br />
methods in acute hemiplegia, and MRI is superior to<br />
CT. It is necessary to do MRA when CT or MRI finding is<br />
negative.<br />
FP-M-018<br />
Attention deficit hyperactivity disorder (ADHD): frontal<br />
aMRI and motor inhibitory deficits<br />
M.B. Denckla<br />
Kennedy Krieger Institute, Baltimore, MD, USA<br />
On volumetric MRI, children with ADHD showed<br />
decreased volume in multiple frontal lobe regions.<br />
Comparing 12 boys with ADHD with 12 age-matched<br />
male controls using semi-automated Talairach-based<br />
parcellation methods (Kaplan, 1997; Kates, 1999), total<br />
cerebral volume was significantly smaller (8.3%) with<br />
ADHD. Frontal lobe volumes both gray and white matter<br />
accounted for most of this decrease; total non-frontal and<br />
other lobar volumes were not significantly smaller. The<br />
ratio of frontal lobe to non-frontal tissue volume in the<br />
ADHD group was smaller than that of the control group<br />
but only as a trend. Frontal lobes were subparcellated into<br />
motor, premotor (includes supplementary motor area<br />
(SMA), ventral premotor cortex (PMv), frontal eye field<br />
(FEF), and supplementary eye field (SEF)), prefrontal<br />
(includes dorsolateral-prefrontal (DLPF) and OF cortices,<br />
amongst other regions), and anterior cingulate, and deep<br />
white matter; reductions were observed in both prefrontal<br />
and premotor functional modules (as well as deep white<br />
matter). Forty-two children with ADHD were impaired on<br />
tests of skeletomotor response inhibition compared with 30<br />
age and gender-matched controls; most significant was the<br />
conflicting motor response test. Physical and neurological<br />
examination of soft signs (PANESS) in a slightly smaller<br />
subsample of children (37 ADHD, 27 controls) revealed<br />
significantly more overflow (including mirror movements)<br />
in children with ADHD. Conflicting motor response test<br />
scores significantly predicted overflow movements for all<br />
children, both ADHD and controls implicating shared inhibitory<br />
function. Oculomotor response inhibition was implicated<br />
in ADHD; unmedicated children with ADHD made<br />
significantly excessive directional errors on an antisaccade<br />
task and anticipatory errors (premature eye movements) on<br />
a memory-guided saccade task.
Abstracts 589<br />
FP-M-019<br />
The clinical significance of evaluation of glucose<br />
metabolism of brain with FDG-PET brain image during<br />
the phase and interphase of refractory epilepsy in<br />
children<br />
Q.-X. Zhai, X.-Y. Lin, X.-H. Zhou, Z.-X. Qiao, Y.-X.<br />
Zhang, H.-X. Qiao<br />
Department of Pediatrics, Guangdong Provincial People’s<br />
Hospital, Guangzhou, China<br />
Objective: To assess the diagnostic value of 18F-FDG<br />
imaging for interictal and ictal epileptic foci. Methods:<br />
Twenty-three patients with refractory epilepsy were examined<br />
in the interictal and ictal periods by 18F-FDG PET, the<br />
results of examination have been compared with MRI and<br />
EEG. The patients are ten cases in male, 13 cases in female.<br />
The youngest is a 1 year old, the oldest is 14 years old.<br />
Result: There are some abnormal metabolism focuses on<br />
PET imaging in 21 (91.3%) patients with epilepsy. Lower<br />
metabolism focus is in 19 cases, higher metabolism focus is<br />
in two cases; and two cases is in normal. One case of two<br />
with higher metabolism focus had seizures during the examination.<br />
Before examination in 3 h there is an epileptic<br />
attack in other one case. The epileptic focus had been<br />
moved by operation in another two cases. It has been<br />
found that the location of focus is the same with the abnormal<br />
metabolism focus from PET. Younger children with<br />
epilepsy, their abnormal metabolism focus is much more<br />
than elder children. MRI is abnormal in 69%, EEG is abnormal<br />
in 86%. Conclusions: The diagnostic value of 18F-FDG<br />
PET imaging foci was higher than that of MRI and EEG in<br />
sensitivity. The specificity and accuracy of 18F-FDG PET<br />
imaging for the diagnosis of epilepsy during epilepsy ictal<br />
period will be the best.<br />
FP-M-020<br />
Diagnostic value of MRA on acute hemiplegia syndrome<br />
in childhood<br />
W.-C. Zhang, H.-H. Wu, T.-C. Liou<br />
Department of Neurology, Beijing Children Hospital, Beijing,<br />
China<br />
Objective: To study the diagnostic value of MRA on<br />
acute hemiplegia syndrome. Methods: Thirty-four AHS<br />
children were studied by 3D TOF MRA, using MRI as the<br />
combined diagnostic method. Results: Twenty-four patients<br />
had cerebrovascular abnormalities including nine stenoses<br />
and 15 severe narrowing or occlusions, which were respectively<br />
located in ICA of 11 patients, MCA of 24 patients,<br />
and ACA of six patients. MRA showed vascular compensation<br />
of 20 patients. Conclusion: The results indicate that<br />
MRA showed good ability of deterting intracranial vascular<br />
disorders in AHS study as a non-invasive, quick and efficient<br />
tool with no need of radiographic agent. MRA will<br />
probably become an important and commonly used diagnostic<br />
technique for CVD in children.<br />
FP-M-021<br />
Functional MRI study in school children with attention<br />
deficit hyperactivity disorder<br />
Z. Jin a , L. Zhang a , Y.-F. Zang b , Y.-W. Zeng a , Y. Wang a , Y.-<br />
F. Wang b<br />
a fMRI Center, Hospital 306, Beijing, China; b Mental Institute,<br />
Peking <strong>University</strong>, Beijing, China<br />
Background: ADHD is a major developmental disorder<br />
affecting 3–7% of school children, which is associated with<br />
a low educational outcome and increased risk for antisocial<br />
disorders and/or drug abuse in adulthood. The pathogenic<br />
mechanisms of ADHD remain unknown. Method: Brain<br />
activation maps had been observed pre and post one dose<br />
of Ritalin (10 mg) in nine schoolboys with ADHD (aged 10–<br />
14 years) and nine matched healthy controls using blood<br />
oxygenation level dependent (BOLD) functional MRI technique.<br />
Event-related Simon tasks contained neutral and<br />
interference tasks were served as the stimuli. Results:<br />
Comparing with healthy controls, ADHD children showed<br />
significantly reduced activity in the prefrontal lobe, anterior<br />
cingulate cortex, basal ganglia, cerebellum, and inferior<br />
parietal lobulus during interference (difficult) task. During<br />
neutral (easy) task, reduced activities in ADHD children<br />
were mainly found in the prefrontal lobe, whereas more<br />
activation was found in basal ganglia, cerebellum, and inferior<br />
parietal lobules in patients compared with those in<br />
healthy controls. After one dose of Retalin, reduced brain<br />
activation were recovered in ADHD group. Conclusion: In<br />
ADHD children, there seems to be some dysfunctional brain<br />
areas, including prefrontal lobe, basal ganglia, cerebellum,<br />
and inferior parietal lobulus. Retalin may help to reverse the<br />
dysfunction partially.<br />
FP-M-022<br />
Early detection of hypoxic injury of the fetal human<br />
brain by using MRI and 1 H MRS<br />
V.A. Rogozhyn a , Z.Z. Rozhkova a , L.G. Kirillova b , E.M.<br />
Lukjanova b , A.P. Perfilov b<br />
a Radiological Center, Academy of Medical Sciences of<br />
Ukraine, Kyiv, Ukraine; b Institute for Pediatrics, Obstetrics<br />
and Gynecology, Academy of Medical Sciences of Ukraine,<br />
Kyiv, Ukraine<br />
Our goal is evaluating the brain anomalies in human<br />
fetus by MRI, for measurement of fetal brain structures,<br />
and 1 H MRS, for determination of cerebral metabolite<br />
concentrations. Two groups of 17 women with (G1) and<br />
15 women without (G2) complicated pregnancies are<br />
studied by 1.5 T Magnetom Vision System (SIEMENS).<br />
MR-images of fetal brain in utero (from 25 to 39 weeks of
590<br />
Abstracts<br />
gestational age) were obtained with HASTE sequence (TR/<br />
TE ¼ 80/8, 16, 24, 32 ms; FA ¼ 30; FOV ¼ 360, slice<br />
thickness ¼ 4 mm, matrix ¼ 256 £ 256) in sagittal, axial,<br />
and coronal planes. Fetal brain structures including lateral<br />
ventricles, corpus collosum, and cerebellar vermis are<br />
measured.<br />
1 H spectra are recorded with the STEAM<br />
sequence (TR/TE ¼ 1365/135, 20; 1500/270 ms) combined<br />
with PRESS sequence (TR/TE ¼ 1500/10 ms) for more<br />
effective suppression of water signal, VOI ¼ 15 £ 15 £ 15<br />
mm, NS ¼ 128. Integral intensity of signals of NAA, Cr,<br />
Cho, Lac, and Glu-Gln complex are determined. The metabolite<br />
ratios NAA/Cr, Cho/Cr, NAA/Cho and NAA/<br />
(Cho 1 Cr) are calculated from spectra. From MR-images<br />
of fetal brain in G2 it is found that the ratio ventricle/brain<br />
decreases, and the length of corpus collosum, and also the<br />
length, height, and area of cerebellar vermis increase with<br />
gestational age. The growth and development of the fetal<br />
brain in G1 are different from ones in G2. The normal brain<br />
demonstrate rapid changes during the fetal period, and in<br />
the case of hypoxic ischemic injury the growth retardation<br />
of fetal brain is observed. The ratios NAA/(Cho 1 Cr),<br />
NAA/Cr and NAA/Cho for G1 and G2 are not significantly<br />
distinguishable. The ratio Cho/Cr decreases significantly in<br />
G1 compared to G2. Lac signal present in nine cases in G1<br />
and in two cases in G2. In seven cases in G1 the decrease<br />
of the intensities of Glu-Gln signals in comparison with G2<br />
is observed. This occurs together with reducing the ratio<br />
Cho/Cr and appearing Lac. MRI and 1 H MRS are very<br />
sensitive and effective methods for early detection of<br />
fetal hypoxic ischemic injury. Both the methods can be<br />
applied in obstetric diagnostics for assessment and understanding<br />
of intrauterine growth retardation.<br />
FP-M-023<br />
Using digital subtracted angiography to detect children<br />
intracranial vascular malformation<br />
Z.-P. Wang, J.-M. Yu, W.-X. Zhong<br />
Shanghai Children’s Medical Center, Shanghai Xin Hua<br />
Hospital, Shanghai Second Medical <strong>University</strong>, China<br />
Objective: To report various types of intracranial vascular<br />
malformations in children; and to determine the clinical<br />
value and safety of angiography. Methods: Review of the<br />
data of 42 patients who had been suspected to have vascular<br />
diseases by CT scan or MRI examination. Digital subtracted<br />
angiographies (DSA) were conducted through the femoral<br />
artery by inserting the catheter into the brachiocephalic<br />
artery. Results: Thirty patients were found to have anomalous<br />
vessels in their brains. Among them, 15 had arteriovenous<br />
malformations, three had intracranial aneurysms, six<br />
had arteriovenous fistulas, five had moyamoya syndrome,<br />
and one had Yasuda syndrome. There were no abnormal<br />
findings in the remaining 12 patients. MRI showed two<br />
patients with cryptic intracranial vascular anomalies.<br />
Conclusion: DSA played an important role in diagnosis<br />
and treatment of vascular diseases, indicating a promising<br />
future for its use in child neurology diseases.<br />
FP-M-024<br />
Bilateral hypodensity of the basal ganglia. Clinicoevolutionary<br />
correlation in children<br />
A. Martínez-Bermejo, J. Arcas, V. López-Martín, A.<br />
Tendero, C. Roche<br />
Service of Neuropediatrics, Hospital La Paz, Madrid, Spain<br />
Introduction: The presence in neuroimaging of areas of<br />
symmetrical bilateral hypodensity in the basal ganglia<br />
(SBHBG) is a striking and unusual finding. Objective: To<br />
determine the aetiology, clinical significance and evolution<br />
of a group of paediatric patients with SBHBG. Patients and<br />
methods: We made a study of 21 patients with neuroimaging<br />
studies (CT or MR) showing SBHBG. The affected area was<br />
related to the aetiology, clinical features and evolution.<br />
Results: The ages varied between 4 months and 16 years.<br />
In seven cases Leigh’s disease was diagnosed, five had had<br />
acute hypoxia, four glutaric aciduria type I, and one case<br />
each of methylmalonic aciduria, Ia glycogenosis, CO intoxication,<br />
acute striatal necrosis and bacterial meningitis. The<br />
putamen was affected in six cases, globus pallidus in four<br />
cases and the lenticular nucleus was damaged in the rest.<br />
Three cases also had lesions in the caudate nucleus. MR was<br />
better than CT for localization of the precise area involved.<br />
Clinically, 13 cases had extrapyramidal signs. We found no<br />
relation between the size, localization of the lesion and the<br />
prognosis, which was more dependent on the aetiology, only<br />
one patient (CO intoxication) recovered and eight died<br />
(Leigh’s disease and one case of hypoxia). Conclusions:<br />
The presence of SBHBG in a patient makes extensive<br />
study necessary to find the aetiology. It is a non-specific<br />
finding, usually of metabolic origin and with little correlation<br />
with the clinical condition. Its presence implies a poor<br />
prognosis and raises suspicion of the presence of certain<br />
neurological disorders.<br />
FP-M-025<br />
Cranial ultrasonograpic characteristics and clinical<br />
correlates in young infants with Sturge-Weber<br />
syndrome (SWS)<br />
Y.-C. Chang a , C.-C. Huang b , L.-T. Huang a<br />
a Department of Pediatrics, Chang Gung Children’s Hospital,<br />
Kaohsiung, Chinese Taipei; b National Chung Kung<br />
<strong>University</strong> Hospital, Tainan, Chinese Taipei<br />
SWS is a rare congenital disorder that is marked by angiomatosis<br />
involving face, eyes, and leptomeninges. Early identification<br />
of the extent of pial angioma, cortical atrophy and<br />
calcification is critical in determining the prognosis. Ultrasonographic<br />
(US) studies are scarce in infants with SWS. In<br />
this study, cerebral US findings of SWS were characterized in
Abstracts 591<br />
four infants, including two infants presented with hemiparesis<br />
or seizures, and two newborns without neurological<br />
signs. Increased echogenicity of the pia-arachnoid was seen<br />
in all four patients, with extensive temporo- parieto- occipital<br />
involvement in three, and temporo-parietal in one. A thin<br />
ribbon of hyperechogenicity subjacent to the affected cerebral<br />
cortex was found in all four patients. Subcortical white<br />
matter hyperechogenicity was shown in three and two evolving<br />
to cortical calcification during follow-up. Contrastenhanced<br />
MR imagines performed in three patients revealed<br />
enlarged choroid plexus in three, white matter abnormalities<br />
in two and cerebral atrophy in one. One newborn developed<br />
intractable epilepsy at age 6 months, along with rapidly<br />
progressive cortical and subcortical hyperechogenicity and<br />
cortical atrophy demonstrated by US. The other newborn<br />
with stable subcortical white matter hyperechogenicity<br />
remained seizure-free, and had mild hemiparesis and normal<br />
cognitive development at age 1 year. Our study demonstrated<br />
that US is useful in early detecting the pial and parechymal<br />
involvement of SWS in newborn infants who have facial<br />
nevus flammeus, and is also of prognostic values. Moreover,<br />
it can detect more extensive cerebral abnormalities associated<br />
with SWS than contrast-enhanced MR images in<br />
young infants.<br />
FP-M-026<br />
SPET imaging of striatal dopamine transporters and D 2<br />
receptors in patients with autosomal recessive l-DOPA<br />
responsive infantile Parkinsonism due to tyrosine<br />
hydroxylase deficiency<br />
J.F. de Rijk-van Andel a , J. Booij b , P.J. van Noorden c , R.A.<br />
Wevers d , E.A. van Royen b<br />
a Department of Neurology, Amphia Hospital Breda, The<br />
Netherlands; b Graduate School of Neurosciences Amsterdam,<br />
Department of Nuclear Medicine, <strong>University</strong> of<br />
Amsterdam, Academic Medical Centre, The Netherlands;<br />
c Department of Nuclear Medicine, Amphia Hospital<br />
Breda, The Netherlands; d Laboratories of Pediatrics and<br />
Neurology, <strong>University</strong> of Nijmegen, The Netherlands<br />
The enzyme tyrosine hydroxylase (TH) catalyzes the<br />
conversion of l-tyrosine to l-dihydroxyphenylalanine (l-<br />
DOPA), the rate-limiting step in the biosynthesis of dopamine.<br />
TH deficiency (THD) has recently been found in the<br />
recessive form of dopa-responsive dystonia (DRD), which is<br />
characterized by extrapyramidal symptoms in infancy and a<br />
good clinical response on low-dose l-DOPA. In the present<br />
study, striatal dopamine transporters and D 2 receptors were<br />
studied by means of single photon emission tomography in<br />
two drug-naive children with THD. Striatal dopamine transporters<br />
were also studied in a third child with THD, already<br />
treated with a low dose of l-DOPA on the moment of<br />
imaging. The results of the study suggest normal integrity<br />
of striatal dopaminergic nerve terminals and striatal D 2<br />
receptors in recessive DRD with THD. These findings<br />
give hope for a sustained response to low-dose l-DOPA,<br />
without the development of unfavourable side-effects, in<br />
patients with THD.<br />
FP-M-027<br />
Congenital mirror movement: investigation of<br />
functional magnetic resonance imaging and transcranial<br />
magnetic stimulation<br />
Y. Maegaki a , T. Koeda b , A. Seki a , I. Suzaki a , S. Sugihara c ,<br />
T. Ogawa c , T. Amisaki d , C. Fukuda e<br />
a Division of Child Neurology, Institute of Neurological<br />
Sciences, Faculty of Medicine; b Department of Humanity<br />
Education, Faculty of Education and Regional Sciences;<br />
c Department of Radiology, Faculty of Medicine; d Department<br />
of Biological Regulation, School of Health Science,<br />
Faculty of Medicine; e Department of Pathological Science<br />
and Technology, School of Health Science, Faculty of Medicine,<br />
Tottori <strong>University</strong>, Japan<br />
Two patients with congenital mirror movement, one a<br />
child and the other an adult, were studied using fMRI and<br />
TMS. Bilateral primary sensorimotor cortices were activated<br />
during unilateral hand gripping on fMRI. Bilateral<br />
motor evoked potentials were induced from the hand and<br />
forearm muscles after TMS of each hemisphere. Bilateral<br />
motor responses were also induced from the arm muscles in<br />
the adult patient. The contralateral motor responses to TMS<br />
were smaller than the ipsilateral ones in the hand muscles,<br />
while the former were larger than the latter in the arm<br />
muscles. The contralateral motor responses reduced in<br />
amplitude or disappeared in the hand muscles and increased<br />
in the forearm muscles with increasing age while his mirror<br />
movements decreased gradually. Our results suggest that an<br />
unusual cortical motor organization develops in patients<br />
with congenital mirror movement. Bilateral activation of<br />
the primary sensorimotor cortices during intended unilateral<br />
hand movement and ipsilateral motor evoked potentials are<br />
responsible, at least in part, for the pathophysiology of<br />
congenital mirror movement. Reduction of the contralateral<br />
hand motor responses and increase of the contralateral forearm<br />
motor responses may be related to the decrease in<br />
mirror movements during development.<br />
FP-M-028<br />
Correlation of apparent diffusion coefficient of water<br />
changes with expression of a water channel protein,<br />
aquaporin 4, in developing rat brain following hypoxiaischemia<br />
S. Meng a,b , M. Qiao a , P. Latta a , M.R. Del Bigio, B.<br />
Tomanek a , U.I. Tuor a<br />
a Institute for Biodiagnostics (West), National Research<br />
Council; b Department of Pediatrics, The Second Clinical<br />
College, China Medical <strong>University</strong>, NW, Calgary, Alta,<br />
Canada
592<br />
Abstracts<br />
Introduction: Decreases in the ADC of water measured<br />
using magnetic resonance imaging techniques have been<br />
well documented to occur in cerebral ischemia. Cellular<br />
edema is considered an underlying cause of these changes.<br />
Recent studies have demonstrated a key role of water channel<br />
protein, aquaporin 4 (AQP4) in the development of brain<br />
edema, however, few studies have examined whether<br />
ischemic ADC changes in developing brain are related to<br />
changes in the expression of AQP4. Methods: One or 4<br />
weeks old rats were subjected to an episode of cerebral<br />
hypoxia-ischemia (HI) (unilateral carotid artery occlusion<br />
plus exposure to 8% oxygen 1 h). ADC images were<br />
acquired before, during, and 1 or 24 h after HI. AQP4<br />
expression was assessed immnuohistochemically in<br />
subgroups of animals at each time point. The correspondence<br />
between hypoxic-ischemic changes in AQP4 expression<br />
and ADC changes were assessed. Results: In the brain<br />
of sham control rats, there were no left-right differences in<br />
ADC values or AQP4 staining although ADC values were<br />
greater in 1-week than 4-week old animals. In both age<br />
groups, ADC values in the ipsilateral hemisphere decreased<br />
during HI, partially recovered at 1 h after HI and decreased<br />
again at 24 h after HI. The areas of ADC decreases were<br />
distributed throughout much of the ipsilateral hemisphere<br />
during HI, with some recovery at 1 h after HI, and further<br />
recovery at 24 h after HI. AQP4 expression was decreased<br />
during, and at 1 and 24 h after HI in both age groups, with<br />
the changes corresponding well to the distribution and<br />
values of altered ADC at the different times. Conclusion:<br />
The diffusibility of water in brain as detected with magnetic<br />
resonance Imaging is dependent on the stage of postnatal<br />
development. The correspondence between AQP4 and ADC<br />
changes during or following hypoxia-ischemia suggests an<br />
important role for this water channel protein in the cell<br />
swelling, however, other tissue changes should also be<br />
considered to account for the hypoxic-ischemic changes in<br />
the ADC of water.<br />
FP-M-029<br />
A quantitative MRI study of the corpus callosum in<br />
autistic children<br />
K. Tao, K. Mori, T. Hashimoto, K. Inoue, Y. Toda, M.<br />
Miyazaki, T. Saijyo, Y. Kuroda<br />
Department of Pediatrics, School of Medicine, <strong>University</strong> of<br />
Tokushima, Tokushima, Japan<br />
The corpus callosum (CC) is the main interhemispheric<br />
commisure of the brain and connects homologous cortical<br />
areas. We measured the total midsagittal area and seven<br />
subregions of the CC, which denote cortical regions according<br />
to Witelson, on MRI scans from 30 autistic and 17<br />
normal young children (age, 3–5 years). Area of the anterior<br />
subregions (Region 1: the rostrum 1 Region 2: the genu)<br />
was smaller in the autistic group (autistic group;<br />
118.5 ^ 14.6 mm 2 versus control group; 134.6 ^ 21.3<br />
mm 2 , P ¼ 0:048). There were no significant differences<br />
between groups in the total midsagittal area and the other<br />
areas. This observation suggests decreased functional<br />
connections between cerebral cortex and delayed maturation<br />
in the frontal lobe of autistic children.<br />
FP-M-030<br />
Magnetic resonance imaging (MRI) changes in<br />
childhood Wilson’s disease after treatment<br />
J.-M. Zhang, M.-X. Wang, K.-R. Bao<br />
Xinhua Hospital, Shanghai Second Medical <strong>University</strong>,<br />
Shanghai, China<br />
Objectives: To observe the changes of MRI during the<br />
course of treatment in Wilson’s disease and evaluate its<br />
clinical significance. Methods: Fifty-seven patients with<br />
Wilson’s disease received routine SE sequence MRI of<br />
brain and liver. Nineteen patients with abnormal MRI (ten<br />
pretreated or newly-treated and nine follow-up patients) and<br />
each of them had 2 , 4 times of serial MRI examinations at<br />
interval of 1 , 1.5 years. Clinical data with MRI were<br />
analysed. Results: In nineteen patients with abnormal MRI<br />
findings, nine patients had lesions in both brain and liver<br />
(46.37%), seven patients in brain (36.84%), three patients in<br />
liver (15.79%). Most of the patients with abnormal MRI<br />
showed a pattern of bilateral, symmetrical T2W high signal<br />
or/and T1W low signal. Abnormal MRI of the liver showed<br />
multiple rounded T1W high signal lesion and T2W low<br />
signal lesion. The major lesions disappeared or decreased<br />
after rational treatments. The rates of improvement in<br />
patients with adequate treatment were markedly higher<br />
than patients with inadequate treatment (x 2 ¼ 19.36,<br />
P , 0:01). Conclusions: Hepatic and brain lesion as<br />
shown in MRI may disappear after adequate treatment.<br />
There were only mild or no change in MRI abnormalities<br />
in patients with inadequate treatments comparable with poor<br />
clinical improvement. MRI was helpful in understanding<br />
therapeutic effect and prognosis of Wilson’s disease.<br />
FP-M-031<br />
Brain SPECT and MR imaging in postinfectious acute<br />
cerebellar ataxia: A case report<br />
T. Isagai, Y. Yamashita, S. Yatsuga, R. Fukui, A. Kusaga,<br />
C. Fujimoto, T. Matsuishi<br />
Department of Pediatrics and Child Health, Kurume<br />
<strong>University</strong> School of Medicine, Fukuoka, Japan<br />
Purpose: There have been few reports on SPECT findings<br />
in patients with acute cerebellar ataxia in children. We have<br />
previously reported on five patients with postinfectious<br />
acute cerebellar ataxia with decreased cerebellar blood<br />
flow using 123 I-IMP SPECT (J Neurol Neurosurg Psychiatry<br />
1999;67:109–112). No abnormal MRI findings were found<br />
in these five patients and they all recovered in 2 weeks. We
Abstracts 593<br />
here report a patient with acute cerebellitis who showed<br />
prolonged symptoms and abnormal MRI/SPECT findings.<br />
Case report: A 7-year-old girl was admitted to Kurume<br />
<strong>University</strong> Hospital with headache, ataxia and slurred<br />
speech, 2 days after upper respiratory infection. Neurological<br />
examination was unremarkable except cerebellar signs.<br />
Laboratory data showed elevated WBC of 13600 and CRP.<br />
Cerebrospinal fluid studies demonstrated 91 lymphocytes/<br />
mm 3 , total protein content of 135 mg/dl. The myelin basic<br />
protein was normal. Epstein-Barr and varicella-zoster viral<br />
titers in serum were negative. Mild consciousness disturbance<br />
and dysphagia were observed for a few weeks, but<br />
she gradually recovered in 2 months. Her initial MRI<br />
demonstrated diffuse cerebellar edema in T1-weighted<br />
image and increased cerebellar intensity in T2-weighted<br />
image, however SPECT image was normal. One month<br />
later her SPECT showed decreased cerebellar and pontiine<br />
blood flow with normal MRI images. Conclusion: The<br />
combined use of MRI and SPECT was useful in evaluating<br />
pathophysiology of patients with acute cerebellar ataxia and<br />
cerebellitis<br />
FP-M-032<br />
Quantitative ultrasonic tissue characterization of the<br />
neonatal brain<br />
C. Fujimoto a , Y. Yamashita a , H. Kanda a,b , E. Harada a,b ,Y.<br />
Maeno a,b , T. Hori b , T. Matsuishi a<br />
a Department of Pediatrics and Child Health; b Maternal and<br />
Perinatal Medical Center, Kurume <strong>University</strong> School of<br />
Medicine, Fukuoka, Japan<br />
Purpose: Increased echogenecity of periventricular white<br />
matter in the acute phase and later development of cysts is<br />
the classic sonographic picture of cystic PVL, however<br />
evaluation of periventricular echodensities (PVE) is rather<br />
subjective and normal periventricular ehogenic halo may<br />
mimic PVL in some patients. To clarify the significance<br />
of ultrasonic integrated backscatter (IBS) as a quantitative<br />
method of evaluating PVE, we investigated sequential<br />
change of IBS levels in neonatal brain by birthweight.<br />
Patients and method: Cranial sonography were routinely<br />
performed by neonatologists using SONOS 5500 (Philips)<br />
with a 12.5 MHz probe in 43 newborn neonates admitted to<br />
Maternal and Perinatal Medical Center, Kurume <strong>University</strong><br />
Hospital. The neonates were divided into four groups: group<br />
A, nine extremely low birthweight infants; group B, 14 very<br />
low birthweight infants; group C, 15 infants with birthweight<br />
1500–2499; and group D, 15 infants with birthweight<br />
more than 2500 g. The first scan was performed<br />
within 24 h after birth, then weekly follow-up scans until<br />
1 month were performed. The IBS levels were measured at<br />
five region of interests (ROIs) bilaterally; periventricular<br />
white matter (WM), choroid plexus (CP), TH, lateral ventricle<br />
(LV), and occipital skull bone (SB). Results: The IBS<br />
levels varied by individuals, however there were no differences<br />
in IBS values of five ROIs between right and left<br />
parasagittal view in each patient. The IBS levels were<br />
higher in the order of SB . CP . WM . TH . LV in all<br />
groups. The IBS levels were sequentially decreased in perivenrtricular<br />
WM in all groups. Conclusion: A real-time IBS<br />
imaging system may be useful in characterizing brain tissue<br />
in the neonate.<br />
FP-M-033<br />
Juvenile neuronal ceroid lipofuscinosis: progressive<br />
brain atrophy on serial MRI<br />
R. Fauze, H.B. Bonet, M.C. Boente, M. Winik<br />
Neurology, Dermatology, Pathology, Children Hospital,<br />
Tucumán, Argentina<br />
A 13-year-old girl, daughter of unrelated healthy parents.<br />
Pregnancy and delivery were normal. Psychomotor development<br />
was normal until 7 years when her teacher noticed a<br />
progressive decrease in her attention level in addition to<br />
communication dysfunction and social withdrawal. A<br />
psychiatric condition was suggested. At the age of 8 she<br />
developed myoclonic jerks. Neurological examination<br />
revealed an inattentive girl with poor fine motor skills. CT<br />
scan showed mild atrophy. EEG showed pseudoperiodic<br />
burst of high amplitude slow waves with posterior spikes<br />
to low frequency photic stimulation. Valproic acid was<br />
prescribed. Two months later, however, myoclonic epilepsies<br />
became more frequent and clonazepam was added to<br />
the regimen. At that time, she was completely mute. By the<br />
age of 11, fell due to ataxia. MRI showed moderate atrophy.<br />
ERG and VEP were decreased. Vacuolated lymphocytes<br />
were present. Skin ultrastructural examination showed<br />
predominance of fingerprint profiles. Ophthalmological<br />
examination not revealed macular degeneration. By the<br />
age of 13 she had myoclonias and a motor disturbance<br />
with ataxia. Myoclonic epilepsies, mental deterioration,<br />
ataxia and progressive brain atrophy suggests NCL,<br />
however a definitive diagnosis is based on skin or conjunctival<br />
biopsy that reveal storage of specific lipopigments.<br />
NCL are a group of progressive, autosomal-recessive and<br />
finally fatal neurodegenerative diseases in children marked<br />
by lysosomal accumulation of disease-specific lipopigments<br />
in cerebral and extra-cerebral tissues and neuronal loss in<br />
brain and retina.<br />
FP-M-034<br />
Magic angle spinning 1 H MR spectroscopy of autopsy<br />
samples from patients with neuronal ceroid<br />
lipofuscinoses reveals decreased neuronal metabolites<br />
T.H. Autti a , A.-M. Häkkinen b , B. Sitter c , J. Tyynelä d ,T.<br />
Bathen c , U. Sonnewald c , I.S. Gribbestad c<br />
Departments of<br />
a Radiology and b Oncology, Helsinki<br />
<strong>University</strong> Central Hospital, Finland, Helsinki, Finland,<br />
c MR Center, SINTEF Unimed and Department of Clinical
594<br />
Abstracts<br />
Fig. 1. HR MAS spin-echo spectra of autopsy samples from a control (top)<br />
and an INCL patient (bottom).<br />
Neurosciences NTNU, Trondheim, Norway; d Department of<br />
Biochemistry, Helsinki <strong>University</strong>, Finland<br />
NCLs are among the most common progressive childhood<br />
encephalopathies. We have applied MAS 1 H MRS to<br />
brain autopsy samples of infantile and juvenile NCL<br />
patients, along with samples of controls without neurological<br />
deficits. Material and methods: The autopsy samples<br />
of frontal cortices from patients with INCL (n ¼ 10), JNCL<br />
(n ¼ 6) and controls (n ¼ 9) were kept at 2808C until MR<br />
analysis. HR proton MAS spectra were recorded using a<br />
BRUKER AVANCE DRX600 spectrometer equipped with<br />
a 1 H/ 13 C MAS probe with gradient. Principal component<br />
analysis (PCA) of mean normalised spectra was performed<br />
on the spectral region 4.6–0.6 ppm. The lactate doublet<br />
was excluded from PCA due to high intensity compared<br />
to other metabolites. Score and loading plots were examined<br />
in detail. Results: Fig. 1.<br />
FP-M-035<br />
Acute disseminated encephalomyelitis and multiple<br />
sclerosis: is there any association?<br />
W.-T. Lee, T.-W. Yu, J.-S. Liang, Y.-Z. Shen<br />
Department of Pediatrics, National Taiwan <strong>University</strong><br />
Hospital, Taipei, Chinese Taipei<br />
Both MS and ADEM are rare inflammatory demyelinating<br />
diseases of the CNS in children. Compared with<br />
western countries, the incidence of MS is much lower in<br />
Taiwan. In the past 7 years, only 12 patients below 18<br />
years of age were diagnosed to have ADEM in our hospital.<br />
Of these, two (17%) turned out to have MS 6 and 2<br />
years later, respectively. The first was an 18-year-old girl.<br />
She was diagnosed to have ADEM at 12 years old, with<br />
initial manifestations of acute onset of psychiatric symptoms<br />
followed by focal neurological signs. The MRI<br />
showed multiple lesions over gray and white matters and<br />
spinal cord, compatible with ADEM. She developed<br />
sudden onset of bilateral optic neuritis followed by right<br />
hand weakness 6 years later, when MS was diagnosed. She<br />
experienced another relapse one month later. Another<br />
patient was an 8-year-old boy, who was diagnosed to<br />
have ADEM at 6 years old, when he had preceding infection<br />
followed by limb weakness. However, one episode of<br />
optic neuritis, followed by another episode of optic neuritis<br />
and limb weakness occurred 2 years later. MRI showed<br />
multiple lesions compatible with MS. Judging from the<br />
low incidence of MS and ADEM in Taiwan, we conclude<br />
that there may be some correlations between the pathogenesis<br />
of MS and ADEM. Longer follow-up of the children<br />
with ADEM may be helpful to clarify the relationship of<br />
MS and ADEM.<br />
FP-M-036<br />
Lactate quantification by means of proton magnetic<br />
resonance spectroscopy in patients with congenital lactic<br />
acidosis<br />
N. Iwasaki a , R. Tanaka a , T. Isobe b , A. Matsumura b ,I.<br />
Anno c , T. Ohto a , A. Matsui a<br />
a Department of Pediatrics, b Neurosurgery and c Radiology,<br />
Institute of Clinical Medicine, <strong>University</strong> of Tsukuba, Ibaraki,<br />
Japan<br />
Proton MRS provides a useful approach for monitoring<br />
children with disorders of lactate metabolism. However,<br />
most studies have evaluated lactate only by its existence<br />
or by relative ratio. In the present study, we have a developed<br />
method for lactate quantification and applied it to three<br />
clinical cases with congenital lactic acidosis. Two of them<br />
had pyruvate dehydrogenase complex deficiency and one<br />
had Leigh syndrome. All patients were examined on a clinical<br />
1.5 T super-conducting MR whole body system; two of<br />
them twice. Data were acquired by using point resolved<br />
spectroscopy (PRESS) sequence. We used a coupling<br />
constant of J ¼ 7.35 Hz (2/J ¼ 272 ms). T2 relaxation<br />
correction was performed for water and lactate in each<br />
case. For lactate, in-phase signals were used to calculate<br />
the T2 relaxation time. The volume of interest was placed<br />
in the ventricular space. The tissue water signal was used as<br />
an internal standard using a water concentration of 100%<br />
(55 mmol/l). The calculated lactate concentration from<br />
proton MRS was compared to the CSF lactate level. The<br />
calculated lactate concentration and CSF level were<br />
3.21 ^ 1.73 and 3.53 ^ 1.52 mmol/kg, respectively. The<br />
correlation coefficient was 0.91. To our knowledge, this is<br />
the first study to estimate the reliability of lactate quantification<br />
using proton MRS in vivo and has allowed us to<br />
examine the precise lactate metabolism of the brain noninvasively.
Abstracts 595<br />
FP-M-037<br />
Use of transcranial ultrasound in the diagnosis of<br />
intracranial bleed in critically-ill children 2 months–2<br />
years old. A pediatric intensive case unit experience<br />
J.A. Comuelo, J.A. Robles, M. Sancho, H. Cifra, L.<br />
Tolentino<br />
Child Neuroscience Division Philippine Children’s Medical<br />
Center Quezon Avenue, Quezon City, Philippines<br />
A retrospective cross-sectional validation study was<br />
conducted to determine the accuracy of transcranial ultrasound<br />
(CUTZ) in the immediate detection of intracranial<br />
(IC) bleed in critically-ill children at a pediatric ICU of a<br />
tertiary hospital over a 30-month period. Inclusion criteria:<br />
2 months–2 years, patent anterior fontanelle, suspected<br />
intracranial bleed, with initial CUTZ and confirmatory CT<br />
scan. Exclusion criteria: clinical deterioration in-between<br />
procedures, .24 H-interval between procedures. Age, sex,<br />
and initial impression were recorded, and CUTZ findings<br />
were compared with CT scan results as to presence of IC<br />
bleed, location, and associated findings. From 239 cases<br />
enrolled, 41% had IC bleed. Male comprised 61%, with<br />
70% less than 1 year old. Significant correlation was<br />
noted with 19–24 months old group-82% had IC bleed<br />
(0.131). Non-traumatic causes (61%), with 70% less than<br />
1 year old. Significant correlation was noted with 19–24<br />
months old group-82% had IC bleed (0.131). Non-traumatic<br />
causes (61%) include seizure disorders, CNS infections,<br />
sepsis, and APCD. Only sepsis showed a significant correlation<br />
(0.175)-73% had IC bleed. IC bleeds were detected at<br />
the ff. areas: intraparenchymal (47.5%) intraventicular<br />
(28%), subdural (13%), subarachnoid (9%), and cerebellar<br />
(3%). Associated findings were cerebral edema (20%),<br />
meningitis (5%), and hydrocephalus (1%), CUTZ had a<br />
sensitivity of 94% and specificity of 99%; 1PV-98.9%;<br />
PV ¼ 95.8%; accuracy ¼ 95%. Using correlation and<br />
regression analysis, CUTZ had a very high correlation<br />
(0.895; sig value ¼ 0.126) with CT scan with no significant<br />
difference. Conclusion: Transcranial ultrasound can be used<br />
as an accurate diagnosis tool for the immediate detection of<br />
intracranial bleed in critically-ill children 2 months–2 years<br />
old.<br />
FP-M-038<br />
Occipital MRI abnormalities following neonatal<br />
hypoglycemia<br />
D. Yalnizoglu, M. Topcu, G. Turanli, A. Cila<br />
Hacettepe <strong>University</strong> Department of Pediatric Neurology<br />
and Department of Radiology, Ankara, Turkey<br />
Imaging features of infants who suffered brain damage as<br />
a result of neonatal hypoglycemia were shown to have similar<br />
patterns, and to affect the parietal and occipital lobes<br />
most severely. A variety of disorders may underlie similar<br />
neuroimaging features in childhood. We report ten patients<br />
with predominately occipital lesions on MRI, and attempt to<br />
relate the neuroimaging findings with underlying neonatal<br />
and early infantile insults. The medical records of ten<br />
patients with predominately occipital lesions on MRI were<br />
reviewed retrospectively. CT was available in three patients.<br />
Imaging studies were obtained between 40 days and 11<br />
years of age. The ages at final follow up ranged between<br />
5.5 months and 11 years; age at admission ranged between 2<br />
days and 11 years. Four/10 patients had well documented<br />
hypoglycemia. Seven patients had sepsis and/or hyperbilirubinemia,<br />
associated with hypoglycemia in two. Seven<br />
patients had perinatal hypoxia. All patients have suffered<br />
mild to moderate global developmental delays. Nine<br />
patients had refractory epilepsy, and two had cortical blindness.<br />
MRI showed severe parietooccipital/occipital volume<br />
loss with some asymmetries in all patients. CT showed<br />
occipital calcification compatible with laminar cortical<br />
necrosis in one patient. Our patients who suffered merely<br />
from neonatal hypoglycemia showed occipital predominance<br />
of MRI abnormalities similar to the previous reports<br />
on neonatal hypoglycemia. Early insults such as hypoxiaischemia,<br />
neonatal sepsis may result with similar lesions.<br />
Prompt recognition and treatment of symptomatic neonatal<br />
hypoglycemia is essential to minimize future neurological<br />
sequelae such as cortical blindness, mental retardation and<br />
refractory seizure disorder.<br />
FP-M-039<br />
PET in Landau-Kleffner syndrome<br />
I. György, I. Velkey, B. Gulyás, L. Trón<br />
Pediatric Department of <strong>University</strong> of Debrecen, Country<br />
Hospital of Miskolc, Karolinska Institute, Stockholm, PET<br />
Center of <strong>University</strong> of Debrecen Pediatric Department of<br />
<strong>University</strong> Debrecen, Debrecen, Hungary<br />
LKS is a rare disorder with a variable course characterized<br />
by gradual or rapid onset of aphasia in a previously<br />
normal child. Children with LKS syndrome have abnormal<br />
EEG: focal spikes or spikes and waves in the temporal or<br />
central area of the brain and electrical status epilepticus in<br />
slow sleep. Epileptic seizures are not frequently in this<br />
syndrome and they are easy to treat. We observed three<br />
children with LKS. Two of them suffered from difficulty<br />
of comprehension of the speech and the other one from<br />
expressive aphasia. All three children had only few epileptic<br />
seizures, but their EEG showed massive paroxysmal signs:<br />
focal spikes awake and electrical status epilepticus in slow<br />
sleep. MRI was negative in all three cases. The cause of<br />
disorder remained unknown. All three children were righthanded.<br />
FDG PET was made in our patients. We found<br />
decrease in glucose utilization in all patients in the left<br />
auditory speech cortex. PET of the boy with difficulty of<br />
expressive speech showed decrease in the glucose utilisation<br />
in the left Broca area, too. All patients were treated with
596<br />
Abstracts<br />
antiepileptic drugs. Prednisolone was done plus to the two<br />
girls with disturbance of receptive speech and intravenous<br />
gammaglobulin to the boy with expressive aphasia. One girl<br />
treated with prednisolone cured. In the other, aphasia<br />
remained and a severe regression of mental function was<br />
observed. The boy with expressive aphasia cured, too. The<br />
PET investigation after healing showed marked improvement<br />
but not normalisation in glucose utilization of the<br />
speech-areas of the brain.<br />
FP-M-040<br />
The spectrum of MRI findings in subacute sclerosing<br />
panencephalitis<br />
Ö.F. Aydin, N. Şenbil, Y.K.Y. Gürer<br />
Departments of Pediatric Neurology, Dr. Sami Ulus Children’s<br />
Hospital, Ankara, Turkey<br />
Purpose: Evaluation of patients diagnosed as SSPE with<br />
MRI and investigation of the relation between MRI findings<br />
and the stage of the disease. Material and methods: Fortytwo<br />
patients with SSPE were evaluated by MRI on T1, T2,<br />
FLAIR and PD series, and the findings were compared with<br />
the stages of the disease. Results: Pathological findings were<br />
found in 33 patients and nine patients had normal findings.<br />
Inflammatory demyelinating lesions were seen mostly with<br />
hypointense appearance on T1 series and with hyperintense<br />
appearance on T2, FLAIR and PD series. Lesions were<br />
asymmetrically located, patchy and multifocal. Pial and<br />
parenchymal contrast enhancement, or local mass effect of<br />
parenchymal lesions was not found. Lesions tended to be<br />
more common in the subcortical white matter (87.8%).<br />
Cerebral atrophy was found in four patients, but this was<br />
not found to be related with the age of the disease. There<br />
was deep gray matter involvement in six patients and brainstem<br />
involvement in three patients, and cortical involvement<br />
was found in two patients. One of the two patients<br />
with cerebellar involvement, showed evident cerebellar<br />
folia and the other one showed hyperintense lesions on<br />
middle cerebellar pedincules. Conclusions: Brainstem,<br />
deep gray matter and cortical involvements observed on<br />
MRI were found at further stages of the disease. Cerebellar<br />
atrophy and cerebellar involvement were not related with<br />
the clinical stages of the disease.<br />
FP-M-041<br />
Clinical and MRI findings in children with transverse<br />
myelitis<br />
Y.-H. Huang<br />
Shantou Central Hospital, Shantou, China<br />
Objective: To explore the clinical and MRI features in<br />
children with transverse myelitis. Methods: Provide spinal<br />
cord MRI examination with the machine of SMT-100XX<br />
from Japan Daojing to four patients, who have been onset of<br />
illness within 3 months. Results: (1) The T2WI in all four<br />
patients shows high intensity, with focal border showing<br />
unclear, little patch, dot shape or reinforcement on the<br />
border. In these four patients, two cases did not have any<br />
change on the T1WI, two did not have augmentation on<br />
spinal cord and I have little augmentation on it. (2) On<br />
neck lesion patients, MRI shows obviously on clinical<br />
dysarthria, not obviously on malfunction of respiratory<br />
muscle and sphincter, slight sensory disturbance and quick<br />
recovery. Conclusion: In children with transverse myelitis,<br />
MRI shows the T2WI is the most sensitive one and the focus<br />
shows little local reinforcement. It seems that children<br />
patients have different features comparing to adults. For<br />
children patients, they have slight sensory disturbance and<br />
most of them have dysarthria, not obviously on malfunction<br />
of respiratory muscle and sphincter. Not all patients show<br />
augmentation on spinal cord.<br />
FP-N<br />
Autism/Learning/Behavior<br />
FP-N-001<br />
Usefulness and limitation of ‘draw-a person’ test to<br />
determine intellectual level<br />
C. Zix<br />
Hospitalor rue Ambroise Pare Saint-Avold Lorraine,<br />
France<br />
The draw-a-man (or draw-a-person) test has been<br />
proposed since 1926 by Goodenough for the rapid evaluation<br />
of intellectual efficiency. We made a prospective study,<br />
comparing the draw-a-man test to conventional IQ studies,<br />
in order to assess the usefulness of this method. Methods:<br />
We studied 81 children (22 girls, 59 boys) who had been<br />
refused to a specialised paediatrician for learning disorders.<br />
All children performed the draw-a-person test, which was<br />
evaluated according to the Goodenough/Harris rating<br />
system. IQ was evaluated with WISC or WPPSI, depending<br />
on age. Six children were tested twice. A total of 87 cases of<br />
combined draw-a-person/IQ tests were analysed. For each<br />
child, we established a ‘main’ diagnosis, after through<br />
analysis of the learning difficulties, including a neurological,<br />
psychological and orthophonic examination. Patients<br />
were assigned to the following categories: MR, instrumental<br />
disorders (dyslexia, dysphasia, dyspraxia: ID), hyperactivity<br />
with attention disorder (ADD), neurotic problems, epilepsy,<br />
and others (psychosis, prematurity). Correlation between<br />
the draw-a-person test and IQ was calculated with correlation<br />
coefficient and regression line. Results: Twenty-two<br />
girls and 59 boys have been examined. The average age<br />
was 9.47 ^ 2.57 years. Diagnosis distribution was as<br />
follows: 21 MR, 19 ID, nine ADD, ten neuroses, 15<br />
epilepsy, seven others. There was a low correlation<br />
(r ¼ 0:42) between the draw-a-person test and global IQ.<br />
Results were most divergent between children with instru-
Abstracts 597<br />
mental disorders and ADD children. When ID and ADD<br />
children were excluded, the correlation coefficient between<br />
draw-a-person tests and IQ tests improved to 0.67. Discussion:<br />
Literature shows an overall good correlation between<br />
draw-a-person tests and global IQ tests. Our study showed<br />
that draw-a-person test must be interpreted with caution,<br />
taking into account instrumental as well as attention disorders,<br />
which may lower the results. The draw-a-person test is<br />
still valid for a rapid initial diagnosis.<br />
FP-N-002<br />
Analysis of topography of spike wave in children with<br />
autism<br />
A. Yasuhara, Y. Yoshida, A. Hori<br />
Department of Pediatrics, Kansai Medical <strong>University</strong> Kohri<br />
Hospital, Neyagawa, Osaka, Japan<br />
We analyzed the EEG spike in order to clarify the critical<br />
age and expression site of the seizure wave in children with<br />
autism. Fifty autistic children with spike detected and<br />
followed up for over 2 years in our Hospital were included.<br />
Informed consent was obtained from a family member.<br />
Recorded spike was analyzed by the topography and the<br />
dipole analysis (GE Marquette: SynaPoint). Of 50 subjects,<br />
39 showed a spike in the frontal region, 29 in the central, 13<br />
in the parietal, and four in the occipital. The average age of<br />
onset was 3.6 ^ 1.3 in the frontal, 3.5 ^ 0.9 in the central,<br />
4.7 ^ 1.4 in the parietal, and 3.0 ^ 0.17 in the occipital<br />
region. In older patients, the spike appears in the parietal<br />
region further than the front-central region (P , 0:05).<br />
Analysis of patients (n ¼ 8) with the spike in the frontal<br />
region showed a map with the highest potential existing in<br />
Fz. Dipole analysis revealed a focus in the position which<br />
agreed with the deep direction of the frontal region, especially<br />
the cingulate gyrus, the Cz and Pz division showed the<br />
highest potential respectively in the EEG potential map with<br />
the spike in the central and the parietal area. The dipole<br />
accumulated on the spike in the frontal region, especially<br />
in the cingulate gyrus. Dysfunction of the cingulate gyrus<br />
appears to be related to the pathophysiology of autism.<br />
FP-N-003<br />
Clinical study on intelligence and behavioral<br />
characteristics in epileptic children with sub-clinical<br />
seizures<br />
Y.-C. Chen, S.-S. Ren, H.-T. Huang<br />
Department of Pediatrics, Daqing Oilfield General Hospital,<br />
Daqing City, Heilongjiang Province, China<br />
To study the intellectual level and behavior in children of<br />
sub-clinical attack of epilepsy. Methods: Forty-eight cases<br />
of epilepsy with sub-clinical outbreak were studied by<br />
WISC, Eysenck personality questionnaire (EPQ) and<br />
CBCL. Results: There were no significant differences in<br />
VIQ, PIQ and FIQ in the two groups but the code and<br />
number of WISC in the epilepsy group were obviously<br />
lower than those in the control group (P , 0:05). The<br />
total marks on CBCL were significantly higher in the<br />
epilepsy group than the control group, including depression,<br />
restlessness, attack and association. Conclusion: Behavioral<br />
characteristic of children with epilepsy should also be paid<br />
attention though no clinic attacks are observed. Overall<br />
comprehensive treatment should be given to control<br />
outbreak, clear up psychology hindrance and increase quality<br />
of life in children with epilepsy.<br />
FP-N-004<br />
The effect of secretin multidose treatment on the<br />
behaviour of autistic children<br />
W. Brussel, S. van Daalen, M.E. de Richemont<br />
Rijnstate Hospital, Arnhem, Netherlands<br />
In 1998 Horvath et al. reported three children with autistic<br />
spectrum disorders who underwent upper gastrointestinal<br />
endoscopy and intravenous administration of secretin to<br />
stimulate pancreaticobiliary secretion. Not only amelioration<br />
of the diarrhoea and increased pancreaticobiliary secretion<br />
were observed, but also a dramatic improvement in the<br />
behaviour, manifested by improved eye contact, alertness<br />
and expansion of expressive language. After this publication<br />
several anecdotal reports of behavioural improvement were<br />
done by parents on internet. Until now, four randomized,<br />
placebo controlled studies are published, which showed no<br />
effect on the behavioural status after one or two doses secretin.<br />
Secretin is a polypeptide hormone secreted by the<br />
pancreas; secretin has a function in the gastrointestinal<br />
tract, but animal experiments have shown effects on the<br />
central nervous system and behaviour in rat. We want to<br />
know whether secretin multidose treatment should give any<br />
effect on the behaviour of autistic children. Pilot prospective<br />
study was done on four autistic children (age 4–6 years/<br />
DSM-IV criteria); during half a year monthly intravenous<br />
administration of secretin (2 IU/kg bodyweight) was given.<br />
Behavioural status was reviewed by weekly parent rating<br />
scales and Childhood Autism Rating Scale (CARS) tests<br />
before the first dose and 4 weeks after the last (sixth) dose<br />
of secretin. CARS test was done by a blinded child psychologist.<br />
Results showed significant improvement in two of the<br />
four children. Conclusion: One or two doses of secretin have<br />
no effect on the behavioural status in autistic children, but<br />
multidose treatment may be effective.<br />
FP-N-005<br />
Study of behavioral problems of children in Fujian<br />
Coastal area<br />
R.-N. Ren, X.-M. Chen, M.-Y. Ling, L.-Y. Ye, H.-Q. Cao<br />
Pediatric Centre of PLA, Department of Pediatrics, Fuzhou<br />
Dongfong Hospital, Fuzhou, China
598<br />
Abstracts<br />
Objective: To explore behavioral problems of children in<br />
coastal area of Fujian. Methods: Achenbach Child Behavior<br />
Checklist was applied to investigate behavioral problems of<br />
children in Fujian coastal area. Children who live in the city<br />
were compared with those in the country. Results: The<br />
prevalence of childhood behavioral problem is 13.5% in<br />
the city group and 12.4% in the non-city group. There is<br />
no significant difference between the groups. Factors affecting<br />
childhood behavioral problems in the city included<br />
physical disease, relationship between parents and children,<br />
correct nursery method, administration attitude, schooling,<br />
achievement; whereas the country included low birth<br />
weight, physical disease, relationship between parents and<br />
children, correct nursery method, administration attitude.<br />
Conclusion: Physical attribute and family relationship<br />
were the main factors affecting behavioural problems.<br />
Medical care and familial education should be introduced<br />
to treat behavioral problems.<br />
FP-N-006<br />
Reactus in patients with diabetes mellitus and Turner<br />
syndrome<br />
N. Nakamoto, S. Kaneko, F. Inouchi, Y. Fujii, Y. Fujita, H.<br />
Kodama, Y. Yanagawa, M. Miyao<br />
Department of Pediatrics, Teikyo <strong>University</strong> School of<br />
Medicine, Tokyo, Japan<br />
Aim: Cognitive function is disturbed in adults with<br />
diabetes mellitus (DM) and Turner syndrome (TS).<br />
WISC-R (or WAIS) and event related potential (ERP)<br />
can be used for evaluating cognitive function. Recently,<br />
‘Reactus’ was developed as a test for evaluating cognitive<br />
function. We examined cognitive function in young<br />
patients with DM and TS using ERP, WISC-R and Reactus.<br />
Patient and methods: Eight patients with DM aged 13–<br />
24 years old, and six with Turner syndrome aged 7–19<br />
years were tested. Four patients had IDDM, and four<br />
patients had non-insulin-dependent diabetes (NIDDM),<br />
including two patients with mutation in mitochondria<br />
gene and two patients with maturity onset diabetes of<br />
youth-Dorland (MODY). A patient with IDDM suffered<br />
from hypoglycemic attack, and cognitive function was<br />
examined before and after the attack. Results and discussion:<br />
Visual motor performance was disturbed two patients<br />
with NIDDM and mutation in mitochondria gene. In the<br />
DM patient with hypoglycemia, visual motor performance<br />
was disturbed after the attack. This disturbance continued<br />
for 1 month. In the two patients with TS, visual reaction,<br />
acoustic reaction and visual motor performance were<br />
markedly disturbed. These results suggest that cognitive<br />
function is disturbed in some DM and TS patients.<br />
FP-N-007<br />
The investigation of related causes of abnormal behavior<br />
and emotion in school age children<br />
L.-Q. Chen, Y.-F. Lu, Y.-C. Zhang, Q. Lu<br />
Shanghai Children’s Hospital, Shanghai, China<br />
Objective: To investigate the causation of abnormal behavior<br />
and emotion in school age children. Methods: Thirtyfive<br />
cases (male 17 and female 18) were analysed on school<br />
age children with problem of behavior and emotion in<br />
Shanghai Children’s Hospital. Results: The first age range<br />
of abnormal behavior and emotion was 7–13 years (mean<br />
age was 9.1). The possible causes were related with family<br />
condition, educational model, social living environment and<br />
heredity. Conclusions: Mental problem were susceptible to<br />
outside environment. The morbidity may be increasing in<br />
school children. The behavior and emotional disorders<br />
could lead to organic dysfunction. In order to reduce incidence<br />
of psychiatric problem in childhood, the health educational<br />
model should be put to practice.<br />
FP-N-008<br />
A controlled study of behavioral problems in children<br />
with tension headache<br />
B. Wei, L.-Y. Zhu, M.-L. Liu, Y.-M. Teng<br />
Pediatric Department, PLA 202 Hospital, Shenyang, China<br />
To investigate the characters of behavioral problems in<br />
children with tension headache, 38 patients and 38 healthy<br />
children were assessed using the Achenbach Child Behavior<br />
Checklist. Behavior problems were showed in 17 patients<br />
(44.74%) and in six healthy children (15.79%). There were<br />
significant differences between two groups (x 2 ¼ 6.12,<br />
P , 0:05). Behavior problems in boys were more than in<br />
girls. The major behavior problems in boys with tension<br />
headache were depression, interpersonal difficult, obsession,<br />
social recession, aggressive behavior and violating<br />
discipline, while girls had higher scores on depression,<br />
social recession, physical complains and schizoid-obsession.<br />
We suggest that the children with tension headache<br />
had more behavior problems than healthy children, especially<br />
being in depression and social intercourse. Behavior<br />
problems of the patients should be considered in the treatment,<br />
to get rid of the source of tension headache.<br />
FP-N-009<br />
Selected neuropsychological data in children with a<br />
cavum of the septum pellucidum<br />
A. Kubik, B. Prajsner, M. Kacinski, A. Gergont, S. Kroczka<br />
Department of Pediatric Neurology, Collegium Medicum,<br />
Jagiellonian <strong>University</strong>, Krakow, Poland<br />
Purpose: This paper presents the effect of a cavum of the
Abstracts 599<br />
septum pellucidum (CSP) on cognitive functions and<br />
emotional-social functioning in children at various stages<br />
of development. Material: We examined 27 children with<br />
CSP (13 boys, 14 girls), aged 4 months–14 years, divided in<br />
three groups (,2, 2–6, .6 years), and 27 as the control<br />
group. Results: IQ of 17 of children with CSP (63%) was<br />
normal, including four patients with IQ above the average.<br />
Four children had IQ below the normal range and six had<br />
overt mental retardation. The intellectual development of<br />
17/27 children was dysharmonic. In the younger group<br />
(five children) poorer results were obtained mostly in active<br />
speech, manual skills and visual perception. In all nine children<br />
from Group 2 visuo-motor coordination development<br />
was delayed. Eight children from this group showed delayed<br />
development of active speech, in three of them passive<br />
speech development was also retarded. Of 13 children in<br />
Group 3, ten achieved higher IQ scores in the verbal than<br />
in nonverbal scale. All children from this group had linguistic<br />
function and logical thinking in the normal range.<br />
Decreased scores were most often observed in the rate of<br />
visuo-motor education, immediate memory and hand motor<br />
functioning. Four children with mental retardation (Groups<br />
2–3) had attention deficits, psychomotor hyperactivity and<br />
lower level of emotional and social maturity. Four children<br />
from Group 3 presented neurotic disturbances. Conclusions:<br />
Development of intellectual functions in more than half<br />
children with CSP was disharmonic.<br />
FP-N-010<br />
Clinical localization in children with attention deficit<br />
hyperactivity disorder (ADHD)<br />
R.J. Konkol, P.F. Carey<br />
Kaiser Permanente NW, Portland, OR, USA; Oregon<br />
Health Science <strong>University</strong>, Portland, OR, USA<br />
The neurological examination in children diagnosed with<br />
ADHD is usually to rule-out treatable conditions including<br />
epilepsy and tumors. However, functional imaging studies<br />
suggest right frontal abnormalities in ADHD. Our goal was<br />
to determine if there is a relationship between a motor<br />
examination and cognitive impairment in 74 unselected<br />
ADHD children, diagnosed by DSM IV criteria and<br />
completing a neuropsychological exam. The neurological<br />
exam sought lateralized upper motor neuron signs. The<br />
ADHD group consisted of 51 boys and 23 girls (mean<br />
age: 11.7 ^ 3.7 SD). A control group contained 61 consecutive<br />
migraine patients with 19 boys and 42 girls (mean<br />
age: 12.9 years ^ 3.9 SD). Age differences were non-significant<br />
(P , 0:05). Lateralized upper motor pattern of weakness<br />
was found in 41/74 (55%). Only three children had<br />
right-sided weakness with a language-based learning<br />
disability, while 54% (37/74) had left sided weakness. Of<br />
those with left weakness, 46% (17/37) also had verbal learning<br />
difficulty. No weakness plus verbal learning disability<br />
occurred in 36% (13/35). In contrast, only 3% (2/61) of<br />
migraine subjects had left weakness and ADHD. Half of<br />
the children with ADHD had a weakness pattern implicating<br />
the right hemisphere. The few with left hemisphere weakness<br />
had a language problem. Verbal learning problems<br />
were common in those with right hemisphere motor localization<br />
(54%), compared to those with no localization (36%).<br />
These results point to dysfunction in several regional brain<br />
networks, with a significant component in the right hemisphere,<br />
as supported by the neurological examination and<br />
emerging imaging studies.<br />
FP-N-011<br />
Early diagnosis of autism at child development centers in<br />
Israel<br />
Y. Senecky a , G.W. Diamond a , D. Inbar a , A. Apter b ,R.<br />
Weitz c<br />
a Center for Child Development, b Child Psychiatry Department,<br />
c Child Neurology Department, Schneider Children’s<br />
Medical Center, Sackler Tel Aviv <strong>University</strong> School of<br />
Medicine, Petah-Tiqva, Israel<br />
Background: Children with a variety of cognitive, physical<br />
language related handicaps are being diagnosed at a<br />
younger age. Earlier diagnosis of neurologically based<br />
debilitating conditions, such as Autistic spectrum disorders,<br />
including PDD, provide more effective intervention strategies<br />
aimed at rehabilitation during the critical developmental<br />
period of a child’s language and social skills. Objective:<br />
To determine the median age of diagnosis of a cohort of<br />
subjects with autistic spectrum disorder, and to compare<br />
the age at diagnosis by three groups of physicians involved<br />
in the diagnostic process: (1) pediatricians and neurologists<br />
at child development centers; (2) neurologists working<br />
solo; and (3) psychiatrists. Design: The charts from the<br />
National Social Security office between 1982 and 1997<br />
on 1159 children with a diagnosis of autistic spectrum<br />
disorders were subjected to a retrospective survey. Of the<br />
total, 1127 were Jews, and 32 Arabs. A total of 652 charts<br />
yielded information pertaining to age at diagnosis and<br />
identified the professional making the diagnosis. Data<br />
was subjected to chi square analysis for significance.<br />
Results: The regional distribution of diagnosed cases of<br />
autistic spectrum disorders varied widely, with statistics<br />
from the central metropolitan area reflecting incidence<br />
figures common in other countries, i.e. 2:1000. Peripheral<br />
areas and the Arab sector were significantly underrepresented.<br />
The median age at diagnosis was 35 months<br />
(^12 months), reflecting a relatively young age as<br />
compared to the literature. Developmentally based physicians<br />
diagnosed autism at 33.4 months, Independent<br />
neurologists at 37.9 months, and psychiatrists at 42.5<br />
months. Conclusions: Early diagnosis of neurological<br />
disabilities by professionals at child developmental centers<br />
will enable more efficient management and better intervention<br />
services.
600<br />
Abstracts<br />
FP-N-012<br />
Cognitive processing in paediatric epilepsy: a study of<br />
long latency auditory evoked potentials<br />
M. Zgorzalewicz, B. Zgorzalewicz<br />
Chair and Department of Developmental Neurology<br />
<strong>University</strong> of Medical Sciences, Poznań, Poland<br />
ERP reflect cognitive process such as memory, attention<br />
or speech processing. The most useful ERP for clinical<br />
evaluation of mental processing is P300 complex. The<br />
purpose of this study is to estimate treatment of epilepsy<br />
in children and adolescents. We assessed ERP in newly<br />
diagnosed patients aged 8 to 18 years before antiepileptic<br />
therapy and in those with CBZ or VPA administered as<br />
monotherapy. They were diagnosed as having generalized<br />
tonic-clonic seizures and partial seizures (simple or<br />
complex), both with and without secondary generalization.<br />
Neuropediatric status and neuroimaging were unremarkable.<br />
All had normal mentality measured by battery of<br />
psychological tests. According to the IFCN recommendation<br />
standards, the ERP was elicited with auditory discrimination<br />
paradigm by presenting a series of binaural 1000<br />
Hz frequent (standard) versus 2000 Hz rare (target) tones.<br />
Statistical analysis showed differences in P300 latencies in<br />
Fz and Cz derivations did not change in amplitudes before<br />
and after CBZ therapy. Based on ERP results, impairment<br />
of cognitive processes in these epileptic children was<br />
detected. ERP recordings after VPA treatment did not<br />
indicate any influence on cognitive function.<br />
FP-N-013<br />
Non-linear dynamic analyses of inter-words time<br />
intervals in children’s speech as a measure of<br />
developmental stage<br />
S. Avissar, D. Todder, G. Schreiber<br />
Faculty of Health Sciences, Ben Gurion <strong>University</strong> of the<br />
Negev, Beer Sheva, Israel<br />
Speech analyses are usually focused on words as signifiers<br />
ignoring inter-words time intervals (ITIs), which are<br />
related to the ‘form’ of speech, rather to its ‘content’.<br />
Speech of healthy children aged 5–15 was recorded, and it<br />
was analyzed by non linear dynamical-mathematical methods<br />
of correlation dimension, symbolic dynamics and bispectral<br />
analysis. The results of all three methods have<br />
shown age dependency. A significant correlation was<br />
detected between the combined ranks of findings based on<br />
these methods and children’s age (Spearman’s r ¼ 0:850;<br />
P , 0:0001). The results of both symbolic dynamics<br />
entropy calculations, correlation dimension analysis (i.e.<br />
presence or absence of saturation) and the bi-spectral analysis<br />
indicated that there was a transition from one type of<br />
thought processes (primary process, psychotic-like thinking)<br />
to normative adult-type thought processes (secondary<br />
process) at approximately the age of 78. The transition age<br />
obtained by ITIs is thus in agreement with the age generally<br />
accepted for transition, between Piaget’s pre-operational to<br />
concrete operational periods, in the field of developmental<br />
psychology. The analytical techniques of the present study<br />
may therefore become highly suitable for use in the assessment<br />
of child development and the detection of learning and<br />
developmental problems in children at the early years of<br />
school.<br />
FP-N-014<br />
Cognitive sequelae of closed brain injury in children:<br />
efficacy of nootropics<br />
N.N. Zavadenko a , A.I. Kemalov b , A.S. Petrukhin a<br />
a Child Neurology Department, Russian State Medical<br />
<strong>University</strong>, Moscow, Russia; b MEDEX Medical Center,<br />
Almaty, Kazakhstan<br />
Many children suffered closed brain injury (CBI) have<br />
persistent neurobehavioural sequelae due to the combination<br />
of cortical damage and diffuse involvement of axial<br />
and subcortical structures. A total of 110 children (aged 7–<br />
12 years) with cognitive problems suffered moderate or<br />
severe CBI (contusion) in the period from 6 months–4<br />
years prior to this study. They were divided into four<br />
groups to enter open-label controlled study of efficacy of<br />
Nootropics. The length of treatment was 20 days. Examination<br />
procedure before and after the treatment included<br />
structured questionnaire, scored physical and neurological<br />
examination of subtle signs, testing of working memory<br />
(ten words retention) and sustained attention, EEG. In addition<br />
to symptomatic therapy 1st group (n ¼ 30) was administered<br />
Cerebrolysin (EBEWE, Austria), containing<br />
biologically active neuropeptides (2 ml i.m. daily), 2nd<br />
(n ¼ 20) – Instenon (1 ml i.m. daily, containing etamivan<br />
25 mg, hexobendine 5 mg, ethophylline 50 mg) and 3rd<br />
(n ¼ 30) – Semax, synthetic analogous of ACTH fragment,<br />
devoid of hormonal activity (12.5 mg/kg nasally daily).<br />
Control group (n ¼ 30) received symptomatic therapy<br />
(acetazolamide, vitamines). A total of 80% of patients in<br />
the 1st group (Cerebrolysin), 70% in the 2nd (Instenon)<br />
and 67% in the 3rd (Semax) responded to the treatment<br />
in contrast to 10% of controls. Relief of complaints for<br />
headaches, tiredness, emotional instability, restlessness,<br />
poor concentration and memory, sleep disturbances was<br />
evident after the treatment with Noortopics. Significant<br />
improvement of attention and memory measures was<br />
revealed in the 1st, 2nd and 3rd groups: decrease of executive<br />
time and omissions in attention testing, improvement<br />
of acoustic-verbal memory. These changes corresponded to<br />
positive dynamics on the EEG in responders. Nootropics<br />
are effective for the treatment of cognitive sequelae in CBI<br />
children.
Abstracts 601<br />
FP-N-015<br />
Association of single nucleotide polymorphisms in<br />
serotonin and dopamine receptor genes in autism<br />
Y.-H. Ma a , E. Nanba b , K. Takeshita b<br />
a Institute of Child and Adolescent Health, Peking <strong>University</strong>,<br />
China; b Division of Child Neurology, Institute of<br />
Neurological Science, Faculty of Medicine, Tottori <strong>University</strong>,<br />
Yonago, Japan<br />
Family and adoption studies indicate that genetic factors<br />
play a role in the development of many psychiatric disorders<br />
including autistic disorder, a severe neuro-developmental<br />
disorder that affects approximately 2–10/10 000 individuals.<br />
Although many studies have been attempted to elucidate<br />
the genetic background of autism, the genetic factors<br />
associated with its pathogenesis are still not well understood.<br />
In order to evaluate the role of SNPs in serotonin<br />
and dopamine receptor genes in autism, we performed association<br />
studies using 57 autism and 100 normal controls for<br />
SNPs with PCR-SSCP. The results showed that among 20<br />
SNPs in serotonin gene tested, 18 revealed no positive association<br />
with autism, but two SNPs in HTR1A showed significant<br />
association (P , 0:05); among ten SNPs in dopamine<br />
gene tested, seven revealed no positive association with<br />
autism but three SNPs in DRD2 showed significant association<br />
(P , 0:00001). The results indicated that difference in<br />
allele and genotype frequency of HTR1A and DRD2 may<br />
play an important role in the pathogenesis of autism.<br />
FP-N-016<br />
Phencyclidine treatment in newborn rats: behavioral<br />
and neurochemical effects<br />
X.-M. Gao, A. White, C.A. Tamminga<br />
Maryland Psychiatric Research Center, <strong>University</strong> of Maryland<br />
school of Medicine, Baltimore, MD, USA<br />
Perinatal accidents contribute to the risk for schizophrenia.<br />
Moreover, the illness may involve some abnormality of<br />
the glutamatergic system, especially of NMDA-sensitive<br />
receptor, possibly of neurodevelopmental origins. Whereas,<br />
low doses of phencyclidine (PCP) can mimic the symptoms<br />
of schizophrenia in normal humans and exacerbate symptoms<br />
in those with the illness, high doses can cause cell<br />
death, possibly due to failure of downstream GABAergic<br />
inhibition. We hypothesized that perinatal treatment with a<br />
lesioning agent, especially one directed toward the NMDAsensitive<br />
glutamate system, might result in long lasting<br />
changes in cerebral systems and abnormalities in behavior<br />
in an experimental animal and produce an informative<br />
animal preparation for schizophrenia. We treated newborn<br />
rat pups with high doses of PCP (10 mg/kg) and evaluated<br />
behavioral and neurochemical measures of CNS response in<br />
the grown rat. The rat pups were treated with a single dose<br />
of the PCP or saline on days, PN7, PN9 and PN11 (three<br />
treatments). All subjects were raised to PN42 without<br />
further treatment, sacrificed at that time, and their brains<br />
harvested for study. We used in situ hybridization to quantify<br />
gene expression for zif268, arc, GAD67, and glutamate<br />
receptor subunits (NR1, NR2A and NR2B) in this tissue.<br />
Half of the animals were assessed on PN42 their locomotor<br />
response to PCP (3 mg/kg) and for PCP disruption of<br />
prepulse inhibition.<br />
FP-N-017<br />
Sleep-disordered-breathing and child behavior<br />
J. Kohyama, W. Furushima, J.S. Ohinata, T. Hasegawa<br />
Department of Pediatrics, Faculty of Medicine, Tokyo<br />
Medical and Dental <strong>University</strong>, Tokyo, Japan<br />
Aim: To assess behavioral problems in children with sleep<br />
disordered breathing (SDB). Methods: Twenty-four children<br />
with suspected SDB (M/F 19/5, age: 4–9 years<br />
(mean, 5.5)) were studied. Their care-takers filled the Japanese<br />
version of the child behavior check-list/4–18 (CBCL<br />
(by Achenbach TM)). One-night polysomnography was<br />
done for each child. The correlation coefficients (r) between<br />
the three items on SDB (1. incidence of obstructive apnea of<br />
more than 10 s per hour of total sleep time; obstructive<br />
apnea index (OAI), 2. percentage of time with<br />
SaO 2 , 90% against the total sleep time, 3. SaO 2 nadir)<br />
and scores of ten scales on CBCL were calculated. CBCL<br />
has 113 questions that were classified into eight categories<br />
(I. Withdrawn, II. Somatic complaints, III. Anxious/<br />
depressed, IV. Social problems, V. Thought problems, VI.<br />
Attention problems, VII. Delinquent behavior, VIII.<br />
Aggressive behavior), and caretakers selected one of the<br />
three answers (0 ¼ not true, 1 ¼ somewhat or sometimes<br />
true, 2 ¼ very true or often true). Internalizing<br />
(I 1 II 1 III) and externalizing (VII 1 VIII) scales were<br />
also scored. Results: Among thirty pairs of correlations<br />
examined, five pairs showed a high r; OAI and I<br />
(r ¼ 20:39, 0:05 , P , 0:1), VIII (r ¼ 0:36,<br />
0:05 , P , 0:1), and externalizing (r ¼ 0:35,<br />
0:05 , P , 0:1), and SaO 2 nadir and I (r ¼ 0:46,<br />
P , 0:05), and internalizing (r ¼ 0:35, 0:05 , P , 0:1)).<br />
Conclusion: The severity of SDB (elevation of OAI and<br />
decrease of SaO 2 nadir) tend to correlate with decrease of<br />
internalization and the increase of externalization in children<br />
with SDB.<br />
FP-N-018<br />
Survey on the prevalence of autism in Japan<br />
H. Shimoizumi, N. Iizuka, S.I. Saitou, M.Y. Momoi<br />
International <strong>University</strong> of Health and Welfare, Otawara,<br />
Japan<br />
Objective: According to recent Japanese reports, including<br />
one study documenting the prevalence of autism in
602<br />
Abstracts<br />
Yokohama at 21.1 per 10 000, the prevalence of autism in<br />
Japan has increased. A survey was conducted to ascertain if<br />
similar results would be obtained from a rural area of Japan.<br />
The Nasu area is a region dependent on agriculture and<br />
forestry, with a population of 214 323. Methods: Subjects<br />
were 6–7-year-old children in the Nasu of Tochigi Prefecture.<br />
Autism was diagnosed based on ICD-10 diagnostic<br />
criteria. Results: A total of 4533 6- and 7-year-old children<br />
(2287 boys, 2246 girls) were identified in the Nasu area in<br />
1998. This population included ten autistic 6-year-old children<br />
(six boys, four girls) and seven autistic 7-year-old children<br />
(seven boys). The prevalence of autism was thus 37.5<br />
per 10 000 (boys, 25.8; girls 17.8). Conclusions: Like the<br />
recent Japanese reports, the results of the present survey of a<br />
rural area demonstrated a high prevalence of autism. The<br />
reasons could be two-fold: (1) The current diagnostic<br />
criteria differ substantially from those used in the past;<br />
and (2) As is the case of Nasu area, the number of falsenegative<br />
cases is decreased in areas where early detection<br />
and intervention systems are available for autism. The<br />
prevalence of autism in Japan is higher than previously<br />
reported, and improvement in prognosis for autistic children<br />
through early detection and intervention are imperative.<br />
FP-N-019<br />
Relationship of social function and motor and speech<br />
functions in children with autism<br />
H.-C. Hsu, C.-L. Chen, C.-Y. Wu, C.-Y. Chung, M.-K.<br />
Wong<br />
Department of Physical Medicine and Rehabilitation,<br />
Chang Gung Memorial and Children Hospital, Kweishan,<br />
Taoyuan, Chinese Taipei<br />
Autism is a pervasive developmental disorder of early<br />
childhood characterized by severe impairment in reciprocal<br />
social interaction, communication, and restricted repertoire<br />
of activities and interests. This study investigated the relationship<br />
of social function with motor and speech function<br />
in children with autism. We collected 32 children with PDD<br />
with the mean age 3.7 years. We used the Chinese Child<br />
Development Inventory to assess the developmental functions<br />
in 8 domains, including gross motor (GM), fine motor<br />
(FM), expressive language (EL), concept comprehension<br />
(CC), social comprehension (SC), self help (SH), personal<br />
social (PS), and general development (GD). Children with<br />
PDD were divided into 2 groups: group A (DQ of PS<br />
.50%), and group B (DQ of PS ,50%) according to the<br />
DQ of PS function. We compared the DQ between the two<br />
groups. The correlations of different developmental functions<br />
were analyzed by Pearson’s correlation. The PS function<br />
was correlated with all the other seven functional<br />
domains (r ¼ 0:6–0:9, P , 0:05), with the SC function<br />
most highly correlated. While the PS function was not correlated<br />
with the age, sex, and educational and economic status<br />
of parents. Children in the group A had better developmental<br />
functions than those in group B in all the eight domains.<br />
Our findings suggest that autism is a multifacted developmental<br />
disorder with impaired motor, speech and psychosocial<br />
function. Therefore, a more comprehensive assessment<br />
and transdisciplinary therapy are more appropriate in the<br />
approach of children with pervasive developmental disorder.<br />
FP-N-020<br />
Evaluation of maturity in drawing in childhood in<br />
neuropediatric consultation. A new test graphomotor<br />
S.I. Pascual-Pascual<br />
Service of Pediatric Neurology, Hospital infantile ‘LA<br />
PAZ’, Madrid, Spain<br />
Introduction: Tests used for measuring the ability of a<br />
child to copy a drawing take more than 15 min and require<br />
direct attention to the patient. This makes them almost<br />
impossible to use in the neurological or pediatric consultation.<br />
Objective: To present a new test of drawing copy, the<br />
graphomotor test (GT). It consists of eight easy figures:<br />
diamond, stair, cross, flower, clock, house, cube and<br />
bicycle. The scoring method is simple. The maturation of<br />
drawing in childhood and the reliability and validity of the<br />
test are studied. Patients and methods: (A) Two studies<br />
were done in order to assess the validity and reliability<br />
of this test in normal childhood population of different<br />
social (n ¼ 210) and economic (n ¼ 133) levels from 5<br />
to 12 years of age, without selection. Drawings were<br />
scored blindly by a neurologist and a clinical psychologist.<br />
(B) A prospective study was made in children with varied<br />
neurologic, mental and/or psychiatric diseases. All patients<br />
of a neurology and psychiatric department completed the<br />
test (n ¼ 349, aged 5–40), and repeated after 15–30 min. A<br />
total of 276 were also studied with Wechsler test (WPPSI-<br />
R, WISC-R or WAIS-R) and in other 53 cases the mental<br />
level was known. The tests were scored blindly by a neuropediatrician<br />
and a clinical psychologist. Results: (A)<br />
Normal school children: The score system proposed is<br />
easy to do and takes less than 1 min. The perfect test get<br />
a score of 0, and the worst possible score is 20; Results<br />
showed high reliability: interobserver Pearson’s correlation<br />
coefficient r . 0:92, and reliability Cronbach alpha<br />
coefficient ¼ 0.97; test-retest reliability r . 0:91 and<br />
alpha ¼ 0.95.It is a valid tool to measure visuomotor<br />
maturation in childhood. Average scores are different at<br />
every age until 11 years. There is no difference in scores<br />
between children of the two socioeconomic levels studied.<br />
Results depend on mental or drawing level, not on the<br />
socioeconomic status. (B) In children with neurologic,<br />
mental or psychiatric diseases. The GT is a reliable tool<br />
for measuring the visuomotor level of children with mental<br />
levels above IQ 50: Cronbach’s alpha ¼ 0.98 (test-retest)<br />
and alpha ¼ 0.98 (between different observers), and Pearson’s<br />
‘r’ correlations .0.92 (P , 0:001). The repetition of
Abstracts 603<br />
the test does not change the score. The GT is a valid tool<br />
for measuring drawing maturation and the non-verbal intelligence<br />
in childhood. Pearson’s correlations with verbal,<br />
performance and total Wechsler test IQ (VIQ, PIQ and<br />
TIQ) were significant (P , 0:01), the best of them were<br />
with the PIQ and with the spatial capability factor of<br />
Wechsler test (r ¼ 20:58 to 20.72, P , 0:001). GT is a<br />
very sensitive screening test of the cognitive non-verbal<br />
level of patients, with a high negative predictive value<br />
(0.97). This allows selection of cases for further study<br />
with neuropsychological tests. Conclusions: Graphomotor<br />
test is a very useful tool to assess the drawing and performance<br />
level of school children. It is simple, fast reliable<br />
and valid in normal children and those with neuropsychiatric<br />
pathology. It can be assessed in the same neurological<br />
or pediatric consultation, while talking with the parents.<br />
The results are related to the mental level and with age.<br />
FP-N-021<br />
Early identification of children with developmental<br />
delay: an appraisal of 24 years’ experience in Hong<br />
Kong<br />
C.-W. Chan<br />
Department of Paediatrics, The <strong>University</strong> of Hong Kong,<br />
Hong Kong, China<br />
Universal Developmental Screening of children below 5<br />
years of age was first introduced in Hong Kong in April,<br />
1978 as part of the White Paper on Comprehensive Observation<br />
Scheme adopting the ‘Hong Kong Developmental<br />
Screening System’ designed by the Department of Paediatrics,<br />
The <strong>University</strong> of Hong Kong with data derived from<br />
a cohort study on Growth and Development of 782 normal<br />
Chinese children follow-up from birth to 8 years. Screening<br />
Tests are provided free of charge at all Maternal and<br />
Child Centres in Hong Kong to all preschool children and<br />
to children at-risk, and at private paediatricians’ clinics.<br />
Before 1987, tests were given at five key-ages from birth<br />
to 5 years old but tests were re-scheduled to three stages: at<br />
10 weeks, 9 and 36 months since 1987 for better compliance<br />
and for more effective utilization of local resources.<br />
At each key-age, each child is tested in major fields of<br />
development: namely, gross motor, coordination, social<br />
skills and language as well as hearing, vision, anthropometric<br />
studies and physical examination. The average<br />
coverage rate for local children is 84% per annum while<br />
detection rate is about 10%. Children with abnormalities<br />
identified were referred to paediatricians, relevant specialists<br />
or to child assessment centres for confirmation of<br />
abnormalities. All children with abnormalities were<br />
comprehensively assessed and provided with appropriate<br />
management and placement as arranged by the multidisciplinary<br />
and interdisciplinary teams at Comprehensive<br />
Child Assessment Centres.<br />
FP-N-022<br />
Evaluation of the crawling of disorders in brainstem<br />
aminergic dysfunction; infantile autism, Rett syndrome,<br />
and Down syndrome<br />
K. Hoshino, J. Uchino, K. Hachimori, Y. Nomura, M.<br />
Segawa<br />
Segawa Neurological Clinic for Children, Tokyo, Japan<br />
The brainstem aminergic neurons are known to have<br />
important roles in functional development of the brain.<br />
Ability and pattern of crawling reflect the development of<br />
locomotion system modulated by the specific brainstem<br />
aminergic neurons. To assess these neurons in infancy we<br />
evaluated locomotion in correlating with the sleep wake<br />
cycle (SWC), another biological phenomenon modulated<br />
by these neurons in disorders of the aminergic neurons.<br />
Method: Thirty-eight patients of infantile autism (IA), 42<br />
RTT, ten Down syndrome (DS) were analyzed for crawling<br />
and the development of SWC cycle in infancy and DQ/IQ<br />
levels in childhood. Result: Crawling with normal pattern<br />
was observed in 34.2% in IA, 17.5% in RTT, and none in<br />
DS, and crawling with abnormal pattern (creeping, shuffling,<br />
backward, etc.) were observed in 55.2, 30 and 70%,<br />
respectively. A total of 10.5% of IA, 52.5% of RTT, 30% of<br />
DS never crawled by the age of 12 months. IA showed delay<br />
in development of circadian SWC in early infancy, whereas<br />
RTT and DS showed delay in physiological decrease of day<br />
time sleep after late infancy. The DQ/IQ were low (moderate<br />
to severe delay) in most cases. Psychobehavioral disorders<br />
were predominant in IA. Discussion: We previously<br />
showed that locomotion during developmental period correlates<br />
with the development of functional specialization of<br />
the cerebral cortex and IQ level. The present study<br />
confirmed the results and suggested that aminergic neurons<br />
involved in locomotion are not those modulating circadian<br />
SWC but are involved in reduction of day time sleep after<br />
late infancy.<br />
FP-N-023<br />
Preschool screening and school performance: how<br />
predictive is Denver II test?<br />
B. Anlar, B.U. Bayoglu, F. Elibol, K. Yalaz<br />
Hacettepe <strong>University</strong> Department of Pediatric Neurology,<br />
Ankara, Turkey<br />
The relationship between preschool developmental<br />
screening and academic performance in the first school<br />
year was assessed in a prospective design. Six year-old children<br />
from two socioeconomically different areas of Ankara<br />
were screened in the beginning of first grade with Denver II<br />
developmental test standardized for Turkey. The results were<br />
compared with school performance in the first grade. All<br />
children with normal or questionable Denver II had satisfactory<br />
school performance while 27% of those with abnormal
604<br />
Abstracts<br />
Denver II had low scores. Denver II results improved after 1<br />
year at school, especially in children from low socioecenomical<br />
status. Denver II appeared to have a good predictive<br />
value in detecting potential school problems. These results<br />
support screening children with disadvantaged backgrounds<br />
at the beginning primary education, and providing supportive<br />
programs in the 1st year at school.<br />
FP-N-024<br />
Using mismatch negativity (MMN) to assess auditory<br />
discrimination and sensory memory in children with<br />
dyslexia<br />
R. Bombardieri, M. Terribili, L. Lopez, P. Curatolo<br />
Department of Pediatric Neurology, Tor Vergata <strong>University</strong><br />
of Rome, Rome, Italy<br />
Developmental dyslexia is a specific learning disorder,<br />
characterized by a difficulty of decoding single letters,<br />
generally due to insufficient phonological ability. Deficits<br />
in phonological skills seem to be present in children with<br />
reading disability but a topographic localization along the<br />
auditory pathways is not yet identified. Using MMN, which<br />
is an auditory event-related evoked potential, we want to<br />
test the hypothesis that children with dyslexia have impairment<br />
in auditory frequency discrimination. Twelve dyslexic<br />
children (nine males, three female) and ten normal subjects,<br />
matched for age and sex, were recruited. Mean age was 13.4<br />
and 10.4 years, respectively. Children were submitted to<br />
neurophysiological evaluation using EEG, BAEP, PEV<br />
and ERPs (MMN). MMN responses were elicited using<br />
two different tones (standard and deviant) and two different<br />
conditions (‘ignore’ and ‘count’). EEG traces and evoked<br />
potentials were normal in both groups. Data found an overlap<br />
in 200 ms latency between the two traces (one obtained<br />
using standard tones and the other using deviant tones) in<br />
children with dyslexia. This could be due to attention is<br />
activated in dyslexic children, even during ‘ignore condition’,<br />
from both tones, as if standard tones were considered<br />
‘new’ and worthy of attention. This result could be related to<br />
an excessive discrimination of auditory stimuli, in dyslexic<br />
children, and could be connected with an alteration in an<br />
early station of the auditory pathway. Thus, MMN can be<br />
used as a marker for the phonologic and mnemonic alteration<br />
and can be a valuable tool for early diagnosis.<br />
FP-N-025<br />
A profile of pervasive developmental disorders in<br />
Filipino children seen at the Philippine Children’s<br />
Medical Center<br />
E.L. Avendaño, M.A.G. Berroya, M.H. Ortiz, L.V. Lee<br />
Child Neuroscience Division, Philippine Children’s Medical<br />
Center, Quezon City Philippines<br />
A total of 187 patients evaluated at the Neurodevelopmental<br />
Section of the PCMC with a diagnosis of pervasive<br />
developmental disorder using the diagnostics and statistical<br />
manual (DSM III R and IV) criteria over a 10 year period<br />
were included in the study. All but five were diagnosed to<br />
have autistic disorder. There were more males than females<br />
with as ratio of 5:1. Majority of the children were between 3<br />
and 4 years old with a mean age of recognition at 1.86 years.<br />
Mean interval between onset of symptoms and age of referral<br />
was 2.67 years. Language delay was the most common<br />
initial manifestation and reason for referral. In majority of<br />
the patients, no definite underlying medical nor neurological<br />
disorder was established. Autistic children displayed significant<br />
impairment in the use of nonverbal behaviors, delay in<br />
or lack of development in verbal language and preoccupation<br />
with stereotyped and restricted patterns of interest.<br />
Neurodevelopmental evaluation revealed marked delays in<br />
expressive and receptive language as well as social adaptive<br />
skills. Work-ups included EEG, BAER, cranial CT scan,<br />
cranial MRI and urine metabolic screen which had low<br />
positive results. Interventions included enrollment in a<br />
special education (SPED) program, speech therapy, occupational<br />
therapy and family counseling. The profile of Filipino<br />
children with PDD in this study is comparable to that of<br />
foreign data.<br />
FP-N-026<br />
Evaluation of cognitive functions in school-age children<br />
with attention deficient with hyperactivity syndrome<br />
M.B. Guryeva, O.I. Maslova, S.V. Balkanskaya, V.M.<br />
Studenikin, M.A. Kirdyashkina<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
Background: Attention deficit with hyperactivity<br />
syndrome (ADHS) is nowadays one the main concerns in<br />
pediatric neurology and psychiatry, since this condition had<br />
been recognized to affect cognitive functions in children by<br />
the time of school education. Aim: Our goal was to evaluate<br />
the basic parameters of cognitive sphere in ADHS patients<br />
of school-age. Method: Objective quantitative evaluation of<br />
cognitive functions was performed in 45 patients (aged 6–10<br />
year) with ADHS, utilizing the testing computer systems<br />
(TCS ‘Ritmotest’, ‘Mnemotest’, and ‘Binatest’ of Russian<br />
Manufacture). Forty-three normal children of identical age<br />
were evaluated, as well, using the same diagnostic protocols.<br />
Results: Evaluation of cognitive parameters in ADHS<br />
patients mainly showed significantly compromised or<br />
impaired functions in children under our observation in<br />
comparison with their healthy compeers. The distribution<br />
of deficient parameters was following: (1) attention<br />
(86.6%); (2) short-term and/or long-term memory<br />
(73.3%); (3) psychomotor activities (82.2%); and (4) analytic/synthetic<br />
processes (80%). The results were expressed as<br />
percentage for normal indices. The important finding is that
Abstracts 605<br />
cognitive functions’ deficiency was more pronounced in<br />
cases with hereditary (genetic) predisposition (ADHS in<br />
families). Conclusion: The obtained results imply that<br />
medicinal correction should be applied for cognitive deficit<br />
correction in management of this condition. Hereditary<br />
predisposition to ADHS seems to be as important as perinatal<br />
damage, even though the precise genetic mechanisms<br />
involved still are not completely understood.<br />
FP-O<br />
Psychology/Psychiatry<br />
FP-O-001<br />
Clinical characteristics of psychogenic diseases in<br />
childhood<br />
Z.-Y. Pei<br />
The Yuncheng Central Hospital, China<br />
Objective: To discuss the clinical characteristics and<br />
diagnosis of psychogenic disease in childhood. Methods:<br />
The clinical features of psychogenic diseases in 86 children<br />
were analyzed. CT, MRI, EEG, ECG, CSF, CPK were<br />
carried out. Results: Total 86 cases, 44 males, 42 females.<br />
Among them, 62 cases lived in the cities, 24 cases lived in<br />
the countryside. The onset of the disease was between 4.7<br />
and 14 years old, and 81 cases (94.2%) were at the age of 7–<br />
12 years old. Fifty-nine cases (68.7%) had known factors<br />
which induced the diseases. Among them, 24 cases (27.9%)<br />
were due to the heavy load of school work, 18 cases (20.8%)<br />
due to the physical disease and six cases (7%) due to the bad<br />
relation between their parents. The patients manifested as<br />
paralysis in 23 cases (26.7%), convulsion in 13 cases, and<br />
headache, syncope, sense disturbance, dizziness, visual<br />
hallucination, etc., in the other cases. All the examinations<br />
were negative, which-helped us to exclude other organic<br />
diseases. Conclusion: The psychogenic diseases in childhood<br />
were not rare. The heavy load of schoolwork is the<br />
most important inducing factors, then the physical diseases<br />
and the bad family relations. The clinical manifestation was<br />
various, and it was likely misdiagnosed. So the pediatricians<br />
should pay more attention to the psychogenic diseases in<br />
children.<br />
FP-O-002<br />
Evaluation of visual perception and adaptive behavior in<br />
children with Tourette’s syndrome<br />
Z.-S. Liu, L.-Z. Yang, F.-L. Wang, J. Lin<br />
Department of Child Neurology, Wuhan Children’s Hospital,<br />
Wuhan, China<br />
Objective: To explore the visual perception and adaptive<br />
behavior of children with TS. Methods: The visual perception<br />
and adaptive behavior of 38 children aged 8–12 years<br />
(M 27, F 11) with TS were measured by means of Benton<br />
Visual Retention Test (VRT) and Scale of Adaptive Behavior<br />
for Children (SAB). Thirty healthy children were<br />
selected as the control group. Results: All correct and erroneous<br />
scores of VRT in the TS group showed no significant<br />
difference compared to the control group (P . 0:05). Adaptive<br />
behavior quotient and T score of cognitive function<br />
factor of SAB in the TS group also showed no significant<br />
difference compared to the control group (P . 0:05). T<br />
scores of independent function factor and social/self-direction<br />
factor of SAB in the TS group were significantly lower<br />
than those in the control group (P , 0:01). Conclusion:<br />
Children with TS had no visual perception deficit, and<br />
possessed lower social adaptive ability.<br />
FP-O-003<br />
A diagnostic study and classification of attention-deficit/<br />
hyperactivity disorder in children<br />
H.-J. Zhu, X.-X. Wang, Q. Zhang<br />
Department of Pediatrics, Zhejiang Provincial People’s<br />
Hospital, Hangzhou, China<br />
Objective: To evaluate the usage of the Children’s Attention<br />
Tester and scales of ADHD in the diagnosis and classification<br />
of ADHD in children. Methods: The authors tested<br />
the attention of 380 ADHD cases aged 6.5 , 11 years with<br />
NJ22 Children’s Attention Tester, and compared positive<br />
rates of attention deficit test with the Children’s Attention<br />
Tester and the DSM-IV criteria scales. The sensitivity and<br />
the specificity of the instrument were analyzed. Results: The<br />
ratios of the different types indicated that the predominately<br />
attention deficit type was 57.1%, the predominately hyperactive-impulsive<br />
type was 7.1%, and the combined type was<br />
35.8%. The general positive rates of attention deficit in these<br />
cases using Children’s Attention Tester was 78.4%. The<br />
sensitivity and specificity of this instrument was 78.4 and<br />
88.3%. The positive rates were not significantly different in<br />
the children of different clinical types x 2 ¼ 0.78, P . 0:05,<br />
but were significantly different in the children in whom<br />
severity degrees was different x 2 ¼ 22.37, P , 0:01.<br />
Conclusions: Conner’s questionnaire is a good screening<br />
tool. The scale of ADHD by DSM-IV criteria is useful for<br />
the diagnosis of the clinical type. The Children’s Attention<br />
Tester can be the index for diagnosis of ADHD, and cannot<br />
substitute of the scales.<br />
FP-O-004<br />
Anxiety of asthmatic children and salivary SIgA assay<br />
L.-H. Wang, R.-P. Sun, H.-J. Zhang, M.-H. Zhang<br />
Pediatric Department of the Second Hospital, Shangdong<br />
<strong>University</strong>, Jinan, China<br />
Objective: Assessment of anxiety in asthmatic children<br />
and observation of the relationship between anxiety and<br />
level of salivary serum immunoglobin A (SIgA), research-
606<br />
Abstracts<br />
ing the new method of improving asthmatic children’s<br />
immune condition and relieving asthmatic attacks. Method:<br />
Forty asthmatic children (asthmatic group) were tested with<br />
Hamilton Anxiety scale (HAMA), and were tested by<br />
measurement of skin resistance, salivary SIgA immunoradiometry<br />
assay, and compared with 26 healthy children<br />
(control group). Result: HAMA score was 12.03 ^ 6.01 in<br />
the asthma group and 4.96 ^ 3.89 in the control group, the<br />
asthmatic children had HAMA scores that were higher than<br />
those of the normal controls (P , 0:01); Salivary SIgA level<br />
in the asthma group was lower than that of in control group<br />
(P , 0:01); skin resistance in the asthma group was higher<br />
than that of the controls (P , 0:01). Salivary SIgA was<br />
121.37 ^ 63.10 mg/ml in the asthma group with anxiety<br />
and 208.23 ^ 166.33 mg/ml in the asthma group with no<br />
anxiety, a significant difference being found (P , 0:05).<br />
Skin resistance in the asthma group with anxiety was higher<br />
than that of the asthma group with no anxiety (P , 0:05).<br />
HAMA score in attack groups was much higher than in the<br />
remission group (P , 0:01). Salivary SIgA and skin resistance<br />
in the two groups were not significantly different<br />
(P . 0:05). Conclusion: Compared with healthy children,<br />
the asthmatics had more obvious anxiety disorders,<br />
decreased humoral immune function, and increased function<br />
of the parasympathetic nervous system. Humoral<br />
immune function was lower in anxious asthmatic children.<br />
Parasympathetic nervous excitement in asthmatic children<br />
with anxiety was higher than in asthmatic children with no<br />
anxiety. Anxiety in asthmatic children during an attack was<br />
greater than that of asthmatic children in remission.<br />
FP-O-005<br />
Emotional disorders and related factors in in-patient<br />
pediatrics<br />
L.-H. Wang, R.-Q. Zhang<br />
Pediatric Department of the Second Hospital, Shangdong<br />
<strong>University</strong>, Jinan, China<br />
Objective: To investigate the state of mental health of<br />
pediatric inpatients. Methods: Thirty-four pediatric inpatients<br />
were assessed with HAMA and Depression Status<br />
Inventory (DSI), compared to 28 healthy children. Results:<br />
HAMA scores were 14.91 ^ 6.10 in the inpatient group and<br />
5.50 ^ 4.06 in the control group. The inpatients had a<br />
HAMA score that was higher than that of the controls<br />
(P , 0:01). The percent of the pediatric inpatients with<br />
anxiety was 52.9%, higher than that of the controls<br />
(P , 0:01). DSI scores were 53.01 ^ 6.75 in the inpatient<br />
group and 47.14 ^ 6.07 in the control group. The DSI score<br />
in the inpatient group was higher than the score of the<br />
controls (P , 0:01). The percent of children with depression<br />
in the two groups was not significantly different<br />
(P . 0:05). HAMA score in female inpatients was higher<br />
(P , 0:05); HAMA score in rural inpatients was higher than<br />
that of urban inpatients (P , 0:05); HAMA score in inpatients<br />
with a longer course was higher than in those with the<br />
shorter course (P , 0:01). No significant difference was<br />
found in the scores of depression in the pediatric inpatients<br />
of different sexes, residence and courses (P . 0:05).<br />
Conclusions: More obvious emotional disorders existed in<br />
hospitalized patients than in the healthy children. The<br />
degrees of anxiety were different in pediatric inpatients of<br />
different sexes, residence and courses.<br />
FP-O-006<br />
Effects of INF on immune function in children with tic<br />
disorder<br />
Y.-H. Chen, W.-X. Chen, S. Chen, Y. Wang<br />
Department of Pediatrics, Union Hospital of Fujian Medical<br />
<strong>University</strong>, Fuzhou, China<br />
Objective: To explore the efficacy and change in cell<br />
immune function with complementary treating tic disorder<br />
(TD) with IFN. Methods: An open-controlled study was<br />
carried out. Forty children with TD were involved in the<br />
study. Twenty of the total number of patients were treated<br />
with routine medication (Haloperidol, Tiapiride, and clonazepam)<br />
(routine group), the others were treated with Haloperidol<br />
and IFN (1 £ 10 6 U/dose, i.m., qod) (IFN group).<br />
The course of treatment was 8 weeks. There were 20 healthy<br />
children (control group). The cell immune function was<br />
measured by flow cytometry. Results: The cell immunological<br />
function in children with TD was significantly<br />
depressed, compared to that in healthy controls. At the<br />
end of the research, the levels of lymphocytic subsets,<br />
NKC in peripheral blood were improved in the IFN group.<br />
The efficacy of the IFN group was 90%, which was significantly<br />
better than the routine group (60%, x 2 ¼ 4.8,<br />
P , 0:01). Conclusions: The present study demonstrates<br />
that children with TD were at low cell immune functional<br />
state, which may underlie the disease. IFN may be a new<br />
effective and safe method for complementary treatment of<br />
tic disorder.<br />
FP-O-007<br />
Consultation of parents of new cases with childhood<br />
epilepsy<br />
K.R. Bao, Z.P. Wang<br />
Department of pediatric Neurology, Xin-Hua Hospital,<br />
Shanghai, China<br />
Objective: To find and resolve the psychological<br />
problems in parents of childhood epilepsy who were<br />
newly diagnosed. Methods: Eighty-two children (aged<br />
from 6 months to 13 years) with a recent diagnosis of<br />
epilepsy (within the previous 18 months) in our clinic<br />
were followed up from January 1999 to December<br />
2000.Their parents had consulted a child neurologist about<br />
diagnosis, medical condition and prognosis for their
Abstracts 607<br />
families. The ways of consulting a doctor were by appointment<br />
interview, communication by letter, telephone and<br />
giving parents a lecture. Results: (1) Parents’ attitude to<br />
diagnosis: acceptant 75 cases, suspicious five cases, refused<br />
two cases. (2) Parents’ attitude towards starting treatment:<br />
acceptant 79 cases, postponed three cases. (3) Seizure<br />
control after 1 year , 72 cases; 13 , 18 months six cases;<br />
.18 months four cases. A significant relationship was found<br />
between effective therapies and complying with doctor’s<br />
orders. (4) The main psychological problems of parents<br />
were fear of use of antiepileptic drugs and seizures which<br />
would influence intelligence and other organ functions for<br />
children. Conclusion: This investigation demonstrated that<br />
psychological problems of parents of new cases with childhood<br />
epilepsy were closely related to being submissive to<br />
medical advice. Resolving these problems would help to<br />
obtain efficacy of treatment. We took various steps to<br />
cover many aspects for children with epilepsy. For example,<br />
nutrition, movement, hobby out of class, nursing, learning<br />
disability, etc. The purpose of our work was to open a road<br />
to keep in touch on a regular basis with the parents of<br />
children with epilepsy.<br />
FP-O-008<br />
Effects of dolphin assisted therapy (DAT) on children<br />
who have some problems of communication<br />
M. Ito a , M. Miyao a , K. Nihei a , K. Shirakawa b , Y. Sato b ,Y.<br />
Sakai b , K. Fukusima c , S. Tomita c , S. Deguchi c , K. Kobari c<br />
a Department of Neurology, National Center for Child<br />
Health and Development, Tokyo, Japan; b Department of<br />
Neuropsychology, National Children Hospital;<br />
c Ocean<br />
Wellness Foundation<br />
Dolphin assisted therapy (DAT) is classed as one of the<br />
animal assisted therapies. The treatment is for people who<br />
have physical or mental problems which can be improved<br />
by interaction with dolphins due to their charm and intelligence.<br />
DAT is reported effective in improving patients<br />
affected by depression, PTSD, Down syndrome (Bs<br />
syndrome, and autism. We applied DAT to three children<br />
(3–12 years old) who have some problems of their communication<br />
at the Dolphin lagoon and in the playroom of the<br />
Okinawa Marine Research Center in Okinawa Pref in Japan.<br />
One boy, 12 years old, had physical and mental handicaps<br />
due to sequelae of encephalitis. One boy, 8 years old, could<br />
not take communications well with the schoolmate because<br />
of ADHD. The other boy, 4 years old, had been treated<br />
cruelly by the mother. Their families also participated. We<br />
prepared clinically based DAT programs in conjunction<br />
with the Department of Neurology of National Children<br />
(Bs Hospital, and made comparative studies of the medical<br />
and psychological condition of each case before and after<br />
DAT. Consequently, DAT is effective in the improvement<br />
of their communication through the interaction with<br />
dolphins. Additionally the climate and natural environment<br />
are important factors for reducing their stress.<br />
FP-O-009<br />
A contrasting model for deficit symptoms of<br />
schizophrenia in leadership, with ‘sex-hormonal<br />
dysgenesis’ in its pathogenesis?<br />
A.G. Alias<br />
Chester Mental Health Center, Chester, IL, USA<br />
Associational loosening, impaired information processing,<br />
poor gating of irrelevant stimuli, poor ability to shift<br />
attention, poor working memory, passivity, ambivalence,<br />
anhedonia, as well as impaired motor coordination are cardinal<br />
features of schizophrenia but, unlike delusions and hallucinations,<br />
they are related more to deficit symptoms. The<br />
results of hundreds of studies during the past decades point<br />
to a striking contrast between leadership and, say, schizotypy,<br />
with the average human in between. Example: As<br />
summarized by Bass (… Handbook of Leadership, NY,<br />
Free Press, 1990), leadership correlated with ‘speed and<br />
accuracy of thought’, ‘finality of decision’, ‘ambition, initiative<br />
and persistence’, ‘mood control, and sense of humor’,<br />
etc. A relationship between cognitive processes and cerebellar<br />
and basal ganglia functions, and a role of neocerebellum<br />
in rapidly shifting attention, have been demonstrated. The<br />
cognitive styles, including a proficiency to quickly shift<br />
attention, of history’s famous leaders can be telling examples:<br />
Julius Caesar and Napoleon could dictate to up to six<br />
secretaries simultaneously, using their exceptional working<br />
memories, and proficiency in smoothly shifting attention<br />
while flawlessly gating irrelevant external and internal<br />
stimuli. I would suggest that specific brain imaging and a<br />
variety of neuropsychological studies of accomplished,<br />
younger, political and business leaders could illustrate this<br />
contrast. Neurosteroids have profound effects on brain development<br />
and functions. Though not scientifically rigorous, I<br />
had noted positive correlations (P ¼ 0:0162) between the<br />
self-rated ratings of voice depth (promoted by testosterone)<br />
and of leadership, but none between those of body hair (dihydrotestosterone<br />
dependent) and leader-ship in 47 male US<br />
National Academy of Sciences members (Alias AG. Med<br />
Hypotheses 2000;54:537–552), which was similar to what<br />
Gray et al. (Psychosom Med 1991;53:375–385) found in<br />
1709 older men.<br />
FP-O-010<br />
Clinical analysis and long-term follow-up survey for<br />
Tourette syndrome<br />
Q.-Y. Zhang<br />
Department of Pediatrics, The 1stClinical College, China<br />
Medical <strong>University</strong>, Nanjing Shenyang, China<br />
Objective: To study the treatment and prognosis of Tour-
608<br />
Abstracts<br />
ette syndrome. Methods: Forty-three cases of Tourette<br />
syndrome were followed up for 12–15 years. Results and<br />
conclusions: (1) The symptoms were self limited and<br />
abated or remitted greatly for most cases in late stage of<br />
adolescence, and their study period and social adaptability<br />
were normal. (2) The younger the patients, the more<br />
serious the symptoms and prognosis. (3) Introverted<br />
personality and relatively higher level of psychological<br />
defense are the main characteristics of their personality.<br />
(4) Mentality of most cases was normal. The intelligence<br />
quotient for some cases was low. (5) The cases with<br />
distractibility, hyperactivity, emotional disorders, obsessive-compulsive<br />
neurosis, anxiety disorder, self-injury<br />
behavior, mental confusion and abnormality of EEG had<br />
a poor prognosis. (6) Severe cases should be treated by<br />
drugs such as dopaminergic receptor blocking agent, the<br />
mild cases or cases in remission stage can be treated by<br />
main therapy with relaxation.<br />
FP-O-011<br />
The study of characteristics of sensitive children<br />
W. Yu<br />
Guangzhou Railway Central Hospital, Guangdong, China<br />
Objective: To study the personality characteristics of both<br />
inpatients and outpatients who were sensitive to infection.<br />
Methods: Both the study group (120 cases) and the normal<br />
control group (100 cases) were assessed with Jacson personality<br />
questionnaire scale. Results: The E score was lower in<br />
the study group than that in the control group (P , 0:01),<br />
but the N score was higher in the study group (P , 0:05).<br />
There were no significant differences in P and L scores in<br />
both groups (P , 0:05). Sensitive patients showed introverted<br />
and unstable characteristics of personality. Conclusion:<br />
Frequently going to hospital would strongly influence<br />
a sensitive child psychologically. It is necessary to carry out<br />
early psychological intervention in sensitive children.<br />
FP-O-012<br />
RC Schumacher and society<br />
N.C. Schumacher<br />
Epilepsy Foundation, New Haven, CT, USA<br />
Many of the problems faced by us are not understood.<br />
Something as simple as why our dog may die, or as complex<br />
as why our family is genetically inclined towards epilepsy<br />
may be shrouded in mystery. One method of removing this<br />
cloud is through education. This cannot be fully accomplished<br />
until we tap the resources of those who suffer<br />
from epilepsy and truly listen to what they themselves<br />
have to tell us. As a society, we need to understand the<br />
emotional problems they face by non-acceptance. Unless<br />
society as a whole accepts the fact that being different is<br />
not wrong, but an individual trait that we are blessed with,<br />
they will fail to accept persons who have epilepsy as the<br />
unique individuals that they are.<br />
FP-O-013<br />
Methylphenidate in children with attention deficit<br />
hyperactivity disorder: evidence from a Sri Lankan<br />
tertiary children’s hospital<br />
S.H. Kariyawasam, H. Perera, A. Koralagama, P.<br />
Jayawardane<br />
<strong>University</strong> of Colombo/Lady Ridgeway Hospital, Sri Lanka<br />
The response to methylphenidate (MPD) was assessed in<br />
children diagnosed as having ADHD during the year 2000,<br />
at the Lady Ridgeway Tertiary Hospital for Children in Sri<br />
Lanka. They were managed in outpatient child psychiatry<br />
clinics. ADHD was diagnosed according to DSM-IV<br />
criteria and severity of the symptoms was determined<br />
with a validated Sinhala assessment form based on the<br />
DSM-IV criteria. The data on problems experienced by<br />
the diagnosed children and their families was obtained<br />
using an interviewer-administered questionnaire. The<br />
severity of the symptoms, problems experienced by the<br />
children and their families were reassessed at 6 weeks<br />
and 6 months of MPD therapy. Thirty-seven new subjects<br />
were diagnosed as having ADHD in year the 2000 and 36<br />
of these were treated with MPD. Severity of symptoms and<br />
the number of subjects receiving frequent complaints from<br />
school was significantly lower 6 weeks after MPD treatment,<br />
while frequency of other social problems was not<br />
significantly reduced. At 6 months of treatment severity<br />
of symptoms was not significantly reduced when compared<br />
with the severity assessed initially and 6 weeks after. There<br />
was no improvement in social problems at the end of 6<br />
months of therapy. MPD did help with school-related<br />
problems short-term, but the long-term effects of MPD<br />
was not convincing in this group of subjects and showed<br />
poor long-term compliance, probably due to inadequate<br />
improvement seen in symptoms.<br />
FP-O-014<br />
Reassessing the efficacy of Adderall w after prolonged<br />
treatment for attention-deficit/hyperactivity disorder<br />
(ADHD)<br />
P.A. Ahmann, L.R. Campbell, F.W. Theye, R.L. Berg, A.J.<br />
Linquist<br />
Marshfield Medical Research Foundation, Marshfield, WI,<br />
USA<br />
Objectives: (1) Assess response to Adderall w over time<br />
in children 5–18 newly diagnosed for ADHD. (2) Describe<br />
long-term behavioral efficacy of Adderall w by measuring<br />
psychodynamic behavior in subjects in medicated and<br />
unmedicated conditions. (3) Assess long-term safety of<br />
Adderall w , especially growth effects. Method: Reassess
Abstracts 609<br />
Adderall w responders after a median of 24 months of treatment.<br />
Assess Adderall w response with Connors’ Parent and<br />
Teacher Rating Scales; ADD-H Comprehensive Teacher’s<br />
Rating Scale; plus parent, teacher, and child narratives.<br />
Evaluate behavioral efficacy with Strengths and Weakness<br />
of ADHD-symptoms and Normal-behaviors (SWAN) scale<br />
completed on and off Adderall w . Assess height, weight at<br />
routine visits. Results: Of 314 children completing initial<br />
assessment, 271 (86%) showed positive response to Adderall<br />
w . Of these, 133 enrolled in the reassessment study.<br />
Seventy-three have currently completed reassessment,<br />
with 47 (64%) demonstrating continuing response to<br />
Adderall w . Thirty-six of 44 (82%) SWAN scores indicate<br />
ADHD behaviors that worsened off medication<br />
(P , 0:001). After a median follow-up of 2 years, the<br />
first 44 children enrolled demonstrated highly significant<br />
(P , 0:001) declines in growth relative to national percentiles:<br />
Median height decreased 1.4 cm/year from the 65th<br />
to 42nd percentile, median weight declined from 81st to<br />
49th percentile, and median body mass index declined<br />
from 77th to 59th percentile. Highly significant negative<br />
correlation appeared between total dose/kg and rate of<br />
change in height. No significant growth trend appeared<br />
prior to therapy. Impact on growth was not significantly<br />
related to dosing schedule. Conclusion: Adderall w response<br />
and behavioral efficacy continue after prolonged treatment.<br />
Clinicians should monitor growth carefully.<br />
FP-O-015<br />
Psychostimulants, amphetamine and<br />
methamphetamine, are toxic to rat cortical neurons and<br />
induce both apoptosis and necrosis<br />
W.-T. Lee, Y.-Z. Shen<br />
Department of Pediatrics, National Taiwan <strong>University</strong><br />
Hospital, Chinese Taipei<br />
Psychostimulants, amphetamine and methamphetamine,<br />
are both popular recreational drugs of abuse in many countries,<br />
including Taiwan. Studies of amphetamine and<br />
methamphetamine neurotoxicity showed the decreased<br />
neurotransmitter levels and neurite degeneration, rather<br />
than neuronal death. However, other studies also showed<br />
that methamphetamine can lead to neuronal apoptosis.<br />
Therefore, in the present study, we investigated the pathogenic<br />
mechanisms of amphetamine and methamphetamine<br />
neurotoxicity using primary rat cortical neuronal culture.<br />
We found that both amphetamine and methamphetamine<br />
induced dose- and time-dependent neuronal necrosis and<br />
apoptosis. There was also time-dependent increase of free<br />
radical production and decrease of ATP content in<br />
neurons. Compared with amphetamine, methamphetamine<br />
led to higher free radical production and ATP depletion,<br />
and induced more necrosis and apoptosis in neurons. There<br />
was also gradual increase of caspase-3 activity and<br />
decrease of Bcl-2 expression following the application of<br />
both amphetamine and methamphetamine. We conclude<br />
that both amphetamine and methamphetamine can lead<br />
to neuronal apoptosis and necrosis by a mechanism related<br />
to mitochondrial dysfunction and free radical overproduction.<br />
FP-O-016<br />
Increased urine phenylethylamine after<br />
methylphenidate treatment in children with attention<br />
deficit hyperactivity disorder<br />
Y. Yamashita a , A. Kusaga a , M. Keneko a , T. Koeda b ,M.<br />
Hiratani1 c , S. Yamada d , T. Matsuishi a<br />
a Department of Pediatrics and Child Health, Kurume<br />
<strong>University</strong> School of Medicine, Fukuoka, Japan; b Faculty<br />
of Education and Regional Sciences, Tottori <strong>University</strong>;<br />
Tottori, Japan; c Hiratani Clinic for Developmental Disorders<br />
of Children, Fukui, Japan; d Department of Psychiatry,<br />
Saga Medical College, Saga, Japan<br />
Objective: We measured urinary monoamines to clarify<br />
the neurochemical metabolism, the pharmacological<br />
mechanism of methylphenidate (MPH), and the correlation<br />
between monoamine levels and clinical symptoms in children<br />
with ADHD. Methods: After informed consent had<br />
been obtained from the children with and without ADHD<br />
and their parents, urine samples were collected over a 24 h<br />
period. The urine levels of b-phenylethylamine (PEA),<br />
MHPG, HVA, and 5-HIAA were measured; PEA by<br />
GCMS and the others by HPLC. We investigated the correlation<br />
between severity and the concentration of monoamines,<br />
their difference between responders and nonresponders<br />
of MPH, and their changes before and after<br />
MPH treatment. Results: The urinary levels of monoamines<br />
in 37 children with ADHD, 21 age-matched controls, 12<br />
children with high function autistic disorder were<br />
measured. The 22 children with ADHD were treated with<br />
MPH, then divided into responders (n ¼ 18) and nonresponders<br />
(n ¼ 4). The mean urinary levels of MHPG,<br />
HVA, and 5-HIAA in children with ADHD were not<br />
significantly different from those of controls. The PEA<br />
levels were significantly lower in children with ADHD<br />
(n ¼ 37, 21.7 ^ 20.5 mg/g creatinine) than in the agematched<br />
controls (n ¼ 21, 46.6 ^ 46.6 mg/g creatinine).<br />
No difference in urinary monoamines was found between<br />
autistic disorder and controls or children with ADHD. PEA<br />
levels in the responders to MPH significantly increased<br />
after MPH therapy, however PEA levels in the 4 nonresponders<br />
did not increase. No changes were found in<br />
other monoamines after MPH therapy. No correlation<br />
between the levels of PEA and ADHD severity was<br />
observed.
610<br />
Abstracts<br />
FP-O-017<br />
Clinical profile of attention/deficit hyperactivity<br />
disorder among Filipino children in a tertiary referral<br />
center 1987–2000<br />
C.L.M. Cruz-Conducto, E.L. Avendano, A.L. Reyes, M.H.<br />
Ortiz, A.L. Tanega, L.K. Ledesma<br />
Neurodevelopmental Section, Child Neuroscience Division,<br />
Philippine Children’s Medical Center, Quezon City, Philippines<br />
Attention-deficit/hyperactivity disorder (AD/HD) is a<br />
developmental disorder characterized by developmentally<br />
inappropriate degrees of inattention, hyperactivity, and<br />
impulsivity affecting 3–5% of school-age children. Charts<br />
of 1355 patients seen over a 13-year period were reviewed.<br />
Of these, 64 were diagnosed as having primary AD/HD. The<br />
majority were in the early childhood age group with more<br />
males affected (6:1). Language delay with heightened activity<br />
level was the most frequent symptom in the combined<br />
type while short attention span with language delay was o<br />
the Inattentive type. AD/HD of the combined type was the<br />
most common subtype (90%) across all age groups, while<br />
AD/HD of the inattentive type was more frequent in adolescents.<br />
The least common across all age groups was the<br />
hyperactive-impulsive type. Diagnostic work-ups (EEG,<br />
neuroimaging, thyroid function test, BAER) were normal.<br />
Apart from the mental status examination, there were no<br />
significant physical and neurological examination findings.<br />
On neurodevelopmental examination, significant delay in<br />
language domains (70%), fine motor (23%), and self-help<br />
skills (7%) were noted. Neuropsycholoical evaluation<br />
revealed cognitive functioning in the average range, delays<br />
in the achievement test were noted in 44%. Co-morbidities<br />
noted were developmental language disorder (95%), oppositional<br />
defiant disorder (33%) and learning disability<br />
(20%).<br />
FP-O-018<br />
A comparative study of the psychological characteristic<br />
of epileptic and normal children<br />
A. Aghaei<br />
Islamic Azad <strong>University</strong> Khorasgan Branch, Iran<br />
Objective: The purpose of this study was to compare the<br />
psychological characteristics of epileptic and normal children.<br />
Method: Fifty elementary school children (34 boys<br />
and 16 girls) were diagnosed as epileptic on the basis of<br />
neurological experimentation. These children constituted<br />
the experimental group and were matched for sex, age,<br />
and grade with 50 normal children (control group). A<br />
demographic questionnaire, Child Symptom Inventory<br />
(CSI-4), and Raven’s matrices were administered to both<br />
groups. Both groups and their mothers were also interviewed<br />
and all the necessary information was obtained.<br />
Results: The results of multivariate of variance using<br />
SPSS showed that a difference between the two groups<br />
exists in the following characteristics: the history of family<br />
epilepsy, gestation illness, type of birth (difficulty of delivery),<br />
cyanosis, late talking, late urine control, enuresis,<br />
fever and convulsion, attention weakness, hypomnesis,<br />
sleep depth, social relations with peers, relation with<br />
teacher, school interest, neglect of appearance, neglect of<br />
personal affairs, jealousy, school GPA, school failure,<br />
hallucination, ADHD, oppositional defiant disorder,<br />
conduct disorder, generalized anxiety, voice tic, PTSD,<br />
depression, autism and Asperger symptoms, nail-biting,<br />
self-abuse and withdrawal at home.<br />
FP-O-019<br />
Psychological distress of families with children having<br />
tics – 3 years experience of a community hospital<br />
K.-W. Tsui, W.-C. Wong, M. Tse, K.-W. Li, K.-C. Chan<br />
Department of Paediatrics, North District Hospital, Hong<br />
Kong, China<br />
Introduction: Tics are not uncommon and can be distressing.<br />
Method: We retrospectively reviewed all patients<br />
referred for tics from 1 July 1998 to 28 February 2002.<br />
Data was retrieved from records, supplemented by telephone<br />
interviews of parents with emphasis on psychological<br />
distress at presentation and at the time of interview.<br />
Results: Thirty patients (25 males, five females) with<br />
median age at presentation ¼ 8 years (range: 4.5–14.5<br />
years) and median follow up ¼ 20 months (range: 3–42<br />
months) were recruited. Twenty-nine were successfully<br />
interviewed. Median symptom duration was 3 months<br />
(range: 1 month–8 years). Eleven (37.9%) had sought<br />
two or more doctors’ advice before the first interview.<br />
Nine patients (30%) had chronic motor tics and four<br />
patients (13.3%) presented with vocal tics, one of which<br />
had TS. Commonly affected muscle groups were eye blinking<br />
(43.3%), head jerk/movement (40%), facial grimace<br />
(23.3%) and shoulder shrug (20%). At presentation,<br />
96.6% of parents were distressed (86.2% worried about<br />
underlying physical illness, 31% felt embarrassed and<br />
31% used negative comments towards children). After<br />
consultations, their distress was alleviated (P , 0:01).<br />
The patients with an urge to control tics also decreased<br />
from 46.4 to 7.1% (P , 0:01). On follow up, parents<br />
perceived a decrease in tic frequency, children being<br />
happier and more confident in 86.2, 41.4 and 17.2% of<br />
cases, respectively. Conclusion: Psychological distress<br />
was not uncommon in these families. Reassurance and<br />
counseling could reduce their distress and the potential<br />
tension build-up between the parents and child.
Abstracts 611<br />
FP-O-020<br />
Clinical study of administration of fluvoxamine for<br />
epilepsy patients with obsessive symptoms<br />
J. Furusho a ,H.Sato a , K. Yamaguchi a , H. Ozawa b ,M.<br />
Fukumizu c , T. Miyajima d , J. Kohyama e , Y. Iikura a<br />
a School of Medicine, Showa <strong>University</strong> (at the present;<br />
College of Literature, Department of Education Aoyamagakuin<br />
<strong>University</strong>); b Tokyo Metropolitan Hachioji Children’s<br />
Hospital, c Division of Child Neurology, National Center of<br />
Neurology and Psychiatry; d Tokyo Medical <strong>University</strong>;<br />
e Tokyo medical and Dental <strong>University</strong>, Japan<br />
We performed a clinical study of administration of<br />
fluvoxamine for epilepsy patients with obsessive symptoms.<br />
Recently, the effectiveness of a selective serotonin reuptake<br />
inhibitor (SSRI) has been reported in patients with<br />
obsessive symptoms. Fluvoxamine is one of the SSRIs.<br />
However, it has no indication for use in children under 20<br />
years of age and patients with epilepsy in Japan because<br />
there has been no report about their usefulness in children<br />
and epilepsy. Therefore, we have established our own ethical<br />
standards by referring to overseas reports, and we have<br />
also performed a clinical study of administration of fluvoxamine<br />
for epilepsy patients with obsessive symptoms at six<br />
different institutions. We selected six patients in accordance<br />
with our criteria: (1) more than two seizures per month; (2)<br />
treated with antiepileptic drugs for at least 2 years; and (3)<br />
having obsessive symptoms. A daily dosage of 25–100 mg<br />
of fluvoxamine was administrated for at least 4 weeks under<br />
their informed consent. Usefulness of fluvoxamine for<br />
obsessive symptoms was defined using CBCL at 4 and 16<br />
weeks after administration. Alleviation of psychiatry symptoms<br />
was observed in two cases and clinical seizures were<br />
decreased in two cases. No adverse effects (including<br />
increase of seizure frequency) were observed. In view of<br />
these results, fluvoxamine may be useful for psychiatric<br />
symptoms even in pediatric patients with epilepsy.<br />
FP-O-021<br />
The importance of psychological testing in differential<br />
diagnosis of childhood headache<br />
I. Franula, I. Prpi, I. Vlaši-Cicvari, Z. Korotaj, E. Paui-<br />
Kirini<br />
<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />
The aim of the study was to establish whether neuropsychological<br />
tests may be helpful in the differential diagnosis<br />
of childhood headache. The retrospective results of<br />
neuro-psychological testing of 54 school age children with<br />
headache were analyzed. There were 18 boys and 36 girls<br />
with a mean age 11.4 years (SD ¼ 2.6). No statistical difference<br />
between the boys and the girls regarding age and social<br />
background were detected. All tests were performed as soon<br />
as a child was able to cooperate – on average 2 days following<br />
the headache (minimum 0 days and maximum 9 days).<br />
General IQ was average in 28 children, higher in 24 children<br />
and lower in two children. The Bender-Gestalt visual-motor<br />
perception test (Bender test) was normal in 28 children,<br />
pathological (cerebral organic dysfunction) in 14 and inconclusive<br />
in seven children. When applying IHS criteria for<br />
headache differentiation we found that the majority of children<br />
with migraine had a higher IQ (higher IQ in 15; average<br />
in nine children) while children with other types of<br />
headache were in the majority with an average general intelligence<br />
(average IQ 19; higher IQ nine children). These<br />
results were statistically significant (Hi2 ¼ 4.89,<br />
P ¼ 0:02). Bender test was pathological in 14 children<br />
with migraine and in one child with other types of headache.<br />
Normal Bender test was found in four children with<br />
migraine and 24 children with different types of headache.<br />
These differences were statistically significant (Hi2 ¼ 21.9,<br />
P , 0:01). Only children with migraine (six) had an inconclusive<br />
Bender test. The results clearly show the importance<br />
and reliability of neuro-psychological tests in differential<br />
diagnoses of migraine and ’ordinary’ headache. In any<br />
child with a characteristic headache attack who has a high<br />
IQ and cerebral dysfunction on the visual-motor perception<br />
test, migraine should immediately be suspected.<br />
FP-O-022<br />
Role of perinatal pathology in formation of attention<br />
deficit with hyperactivity syndrome in children of<br />
school-age<br />
M.B. Guryeva, O.I. Maslova, V.M. Studenikin<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific Center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Russia<br />
Background: Brain damage during prenatal and perinatal<br />
periods of human development is believed to be one of the<br />
principal factors in the formation of attention deficit with<br />
hyperactivity syndrome (ADHS), as well as some genetic<br />
mechanisms. Objective: The goal of our study was to determine<br />
the role of pre-/perinatal pathology as a risk factor for<br />
ADHS formation in school-age children. Method: Case<br />
histories of 45 ADHS patients aged 6–10 years were thoroughly<br />
analyzed (the cohort consisted of three groups in<br />
accordance with DSM-IV classification: (1) ADHS<br />
combined form; (2) ADHS with prevailing attention deficit;<br />
and (3) ADHS with prevailing hyperactivity and impulsivity).<br />
Results: Disturbances of physiological gestation course<br />
took place in 32 cases (17.1%): severe toxemia, threatened<br />
miscarriage, acute somatic conditions, potentially toxic<br />
substances in the domestic environment etc. Pathology of<br />
intranatal period was evident in 34 cases (75.5%): early<br />
rupture of membranes (17.7%), inadequate labour activities<br />
(20%), precipitated deliveries (24.4%). Seventeen neonates<br />
(37.7%) were delivered preterm (gestational age ,36
612<br />
Abstracts<br />
weeks), and four babies post-term (GA .42 weeks). Among<br />
term infants’ morpho-functional immaturity was present in<br />
four cases, with intrauterine hypotrophy in 6.6% of patients,<br />
and severe intranatal asphyxia in 12 pts (26.6%). Conclusion:<br />
Our data provides evidence of high risk for ADHS<br />
formation in children who experienced the influence of<br />
pre- and perinatal pathology. The establishment of social<br />
prognosis for pediatric patients with ADHS requires taking<br />
into account the peculiarities of individual perinatal history.<br />
FP-O-023<br />
Nootropic drugs in therapy of the attention deficit<br />
hyperactivity disorder (ADHD)<br />
M.M. Lepessova, A.Kh. Jaxybayeva<br />
Municipal hospital 7, Almaty, Kazakhstan<br />
The purpose of our study was comparative analysis of<br />
therapeutic effects from therapy by Instenon, a combination<br />
of Instenon and Actovegin and routine form of therapy of<br />
ADHD by Piracetam and Cavinton. During our investigation<br />
we observed three groups of children with behavioural<br />
problems such as ADHD. One group (20 children) had therapy<br />
by Instenon, the second group had therapy by combination<br />
Instenon and Actovegin, and the third group had<br />
therapy by piracetam and cavinton. For assessment of effectiveness<br />
of therapy we used neuropsyhological tests and<br />
electroencephalography. During our investigation in all<br />
the children we detected behavioural deviations such as<br />
attention deficit, hyperactivity, impassivity, different speech<br />
and motors delays. On electroencephalography we detected<br />
slow posterior rhythm. After therapy by nootropic drugs we<br />
obtained positive dynamics such as improvement in neuropsyhological<br />
tests (cognitive and speech skills, visio-kinesthetic<br />
perception, motor activity). In the first group we<br />
observed positive dynamics in 12 (60%) children, in the<br />
second group 15 (75%), and in ten of the third group<br />
(50%). Therefore, for treatment of behavioral deviation<br />
we recommended nootropic drugs, such as Instenon, or<br />
Actovegin. However, treatment by combination of Instenon<br />
and Actovegin is more effective.<br />
FP-O-024<br />
The investigation of social action characteristics in<br />
hyperkinetic syndrome of childhood<br />
D.-M. Wang, S.-M. Jia, S.-Y. Liu<br />
No. 4 Hospital of Baotou, Baotou, Inner Mongolia, China<br />
During the period 1998–1999, in order to understand the<br />
characteristic of social adaptability of hyperkinetic<br />
syndrome of childhood, we investigated the differences<br />
between 46 children diagnosed as having hyperkinetic<br />
syndrome of childhood and 50 normal children. Everyone<br />
examines EEG which expresses normal EEG and critical<br />
EEG. Their examinations of nerval system are normal.<br />
Adopting ‘Wei’s measuring chart of child intelligence’<br />
revised by Yao-Xian Gong and ‘The measuring chart of<br />
child adaptable action’ compiled by Shu-Qiao Yao, two<br />
groups of children were estimated by the intelligence quotient<br />
(FIQ) and adaptation quotient (ADQ). Result: (1) There<br />
is no significant difference in FIQ between the two groups<br />
(100; 102, P . 0:05). (2) There is no significant difference<br />
in ADQ between the two groups (105.4; 105.8, P . 0:05).<br />
But the social/self control factor of the normal children is far<br />
higher than one of sick children (57.6; 40.3, P , 0:05). The<br />
independent factor and cognition factor of the normal children<br />
is far lower than ones of the sick children (that is 52.4;<br />
60.5, P , 0:05:49:3; 57.8, P , 0:05). Analysis: the sick<br />
children is normal in FIQ and ADQ although independent<br />
and cognition Factors maintain certain levels, they are low<br />
value in social/self control Factor, which lead to pay no<br />
attention to what you are doing. Likely, their studies and<br />
lives are irregular. Their social action is unusual.<br />
FP-O-025<br />
A study on the effects of EEG biofeedback on the<br />
cognitive function of ADHD children<br />
R.-H. Jiang, Y.-F. Wang<br />
Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective: To study the effect of different sessions of<br />
EEG biofeedback training on the cognitive function, especially<br />
executive function of ADHD children. Methods:<br />
Thirty-eight cases diagnosed as ADHD according to the<br />
criteria of DSM-IV, aged 7–16 years, and 38 normal<br />
controls well matched by gender and age with ADHD children<br />
were involved in the study. Conner’s behavior rating<br />
scale-parent questionnaire, Chinese-Wechsler intelligence<br />
scale for children (C-WISC), Wechsler memory scale,<br />
number cancellation test, Stroop test, CPT and Raven’s<br />
standard progressive Matrices were administered pre and<br />
post-EEG biofeedback treatment (20 and 40 sessions) and<br />
after 6 months of treatment. No other interventions were<br />
used to the ADHD children during the treatment. Results:<br />
(1) Before treatment, ADHD children performed worse than<br />
normal controls on all psychometric tests except picture<br />
recollection, association memory in Wechsler memory<br />
scale (WMS) and Stroop color-word test. (2) After 20<br />
sessions of treatment, the scores of hyperactivity factor<br />
and index of Conner’s behavior rating scale decreased<br />
significantly. Number cancellation test, rate of omission<br />
errors in CPT, visual reproduction, tactile memory, logical<br />
memory, short-term memory in WMS improved significantly,<br />
and were similar to normal children. Memory quotient,<br />
digit span and Stroop word interference effect improved<br />
significantly, but were not as well as normal children. (3)<br />
After 40 sessions treatment, the scores of behavior and<br />
learning factors and hyperactivity index of Conner’s behavior<br />
rating scale decreased significantly. Memory quotient,
Abstracts 613<br />
number cancellation test, Stroop word-interference effect<br />
improved significantly, and was similar to normal children.<br />
Instantaneous-memory and Stroop word test improved<br />
significantly but was not as well as normal children. Performance<br />
IQ, total IQ and B factor improved significantly.<br />
There is no improvement on the Raven’s standard progressive<br />
matrices. (4) Compared the ADHD children who<br />
finished 20 sessions treatment only (20 session group)<br />
with whom finished 40 sessions of treatment (40 session<br />
group), 20 session group was better on clinical symptoms<br />
before treatment, and improved more significantly than 40<br />
session group. Before treatment, 20 session group<br />
performed better than 40 session group on number cancellation<br />
test, CPT. After 20 sessions treatment, 20 session group<br />
performed still better on number cancellation test, CPT, and<br />
worse on association memory. (5) On follow-up, reaction<br />
time of CPT improved continuously, the others were similar<br />
with post-treatment. Discussion: (1) Vigilance and sustained<br />
attention, response inhibition, working memory, EF and<br />
psychomotor speed of ADHD children started to improve<br />
after 20 sessions of EEG biofeedback treatment. Vigilance<br />
and sustained attention, response inhibition, non-verbal<br />
working memory were as well as normal children. (2) All<br />
of the cognitive functions improved continuously after 40<br />
sessions treatment and were similar with normal children<br />
except verbal working memory, planning and psychomotor<br />
speed. (3) The effect was maintained when the treatment<br />
stopped. Conclusion: (1) The EEG biofeedback was effective<br />
both on clinical symptoms and cognitive function of<br />
ADHD. (2) Cognitive functions began to improve after 20<br />
sessions EEG biofeedback treatment, and improved<br />
continuously after 40 sessions, but there is still some difference<br />
on cognitive function between ADHD children and<br />
normal controls, especially on executive function. The<br />
effect was maintained and psychomotor speed improved<br />
continuously when the treatment was stopped.<br />
FP-O-026<br />
Association of 5-HT 2A receptor T102C polymorphism<br />
and attention deficit hyperactivity disorder in children<br />
J. Li, Y.-F. Wang, Q.-J. Qian, B. Wang<br />
Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective: To detect the genetic association between<br />
attention deficit hyperactivity disorder and a T-C polymorphism<br />
at nucleotide 102 of the serotonin receptor<br />
2A(5-HT 2A ) gene. Methods: A case-control study which is<br />
based on 182 normal control and 323 children diagnosed<br />
with ADHD according to DSM-IV criteria, along with a<br />
transmit/disequilibrium test (TDT) which is based on 195<br />
nuclear families is used to analyze the association of 5-HT 2A<br />
receptor T102C polymorphism with the whole and all kinds<br />
of phenotypes of ADHD in children. Results: As for the<br />
patients of ADHD combined subtype, the genotype of<br />
T102T is sparse (22.3 versus 33.5%, odds ratio,<br />
OR ¼ 0.569, P ¼ 0:028, 95% CI 0.344 , 0.943) and the<br />
genotype of T102C is excessive (64.0 versus 47.3%,<br />
OR ¼ 1.987, P ¼ 0:003, 95% CI 1.264 , 3.124), when<br />
compared with normal control, moreover, for the patients<br />
of girl ADHD combined subtype, there is biased transmission<br />
of the alleles of T102C polymorphism gene locus to the<br />
probands. Conclusion: To ADHD combined subtype, the<br />
genotype of T102T is a protective factor and the genotype<br />
of T102C is a risk factor, besides, to the girl ADHD<br />
combined subtype, the allele C102 is the disease-predisposing<br />
gene.<br />
FP-O-027<br />
Study on developmental and circumstantial<br />
characteristics of ADHD children with and without ODD<br />
J. Liu, Y.-F. Wang<br />
Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective: To compare developmental and circumstantial<br />
characteristics among ADHD children, ADHD/ODD children<br />
and normal controls. Method: Based on DSM-IV<br />
criteria, matched by age, sex and ADHD subtypes, we<br />
sampled 34 pure ADHD cases, 34 ADHD with comorbid<br />
ODD cases and 34 normal controls, and collected information<br />
about their developmental and circumstantial features.<br />
Results: (1) General information: compared with normal<br />
controls, two case groups had significantly higher rate of<br />
self-medical expense, but lower percentages of partial<br />
state reimbursement, father with graduate education, father<br />
being professional, mother with Han nationality and mother<br />
being official. (2) Perinatal stage: two case groups had fewer<br />
mothers with satisfactory mood during pregnancy, the new<br />
born babies cried shorter immediately after their birth, but<br />
more mothers got pregnant complications, mental stress in<br />
late stage of pregnancy and work frustration than control<br />
group; more mothers in ADHD group got too much weight<br />
(more than 15 kg) than normal group; more pregnant<br />
mothers in ADHD/ODD group got medication, drank and<br />
had mental stress in early stage of pregnancy than control<br />
group; ADHD/ODD group had more neonates with intracranial<br />
bleeding than other two groups. (3) Development in<br />
infancy and early childhood: two case groups had lower<br />
rates of good physical development, and higher rates of<br />
hyperactivity after 1 year of age; more children in ADHD<br />
group had poor physical development than normal children.<br />
(4) School life: two case groups had fewer children with<br />
intimate peer relationship, or could maintain friendship for<br />
more than 1 year, or could get helps from peers when having<br />
difficulty, but more children had just a so-so peer relationship<br />
or could last friendship for less than half a year. (5)<br />
Relative factor for current behavior: the teachers or parents<br />
had less efficacy for children’s behavior by way of oral<br />
criticism in two case groups; additionally, they adopted
614<br />
Abstracts<br />
more measures of physical punishment, privilege abolishment,<br />
ignorance, connivance or avoidance. (6) Health<br />
history: more ADHD/ODD children had awkward in bold<br />
movement than normal controls. (7) Living circumstances:<br />
two case groups had worse parental relationship, and more<br />
children were afraid of their fathers; there was higher rate of<br />
harmonious parent-child relationship in normal group than<br />
ADHD group, and that of the latter group was higher than<br />
ADHD/ODD group; when meeting difficulty, families in<br />
ADHD/ODD group had worse social support than the<br />
other two groups. (8) Family history: the rate of positive<br />
family history of mental disorder was higher in ADHD/<br />
ODD group than ADHD and normal group. Conclusion:<br />
Children with ADHD had disadvantaged developmental<br />
and circumstantial features than normal children, particularly<br />
ADHD children with comorbid ODD had many even<br />
worse situations than pure ADHD children.<br />
FP-O-028<br />
A study on the cognitive function of attention deficit<br />
hyperactivity disorder<br />
Y.-X. Liu, Y.-F. Wang<br />
Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective: Our goal was to explore cognitive impairments<br />
of ADHD children. Methods: Participants were children<br />
referred for symptoms of over activity, inattention, and<br />
impulsivity, and 94 children as normal control. Using<br />
DSM-IV diagnostic criteria, we classified the 317 ADHD<br />
children into three subtypes, and assessed comorbidities. All<br />
participants received a series of neuropsychological tests<br />
which consisted of C-WISC, WMS, the number cancellation<br />
test, the Stroop test and the Raven’s standard progressive<br />
matrices. Results: (1) Although children with ADHD have<br />
normal intelligence, their C-WISC, WMS, the reverse digit<br />
span scores were all less than their counterparts. In the<br />
number cancellation test and the Raven’s standard progressive<br />
matrices, ADHD children displayed worse than the<br />
control. ADHD children spent more time on each part of<br />
the Stroop test and made more effort to eliminate the interference<br />
of word meaning; at the same time, they made more<br />
errors on C part (P all ,0.05). ADHD girls had lower scores<br />
on information subtest of C-WISC than ADHD boys<br />
(P , 0:05). However, ADHD girls displayed a tendency<br />
to be superior to that of their counterparts in the Stroop<br />
test (P all ,0.1). There were no significant differences<br />
between each subtype of ADHD children in neuropsychological<br />
tests, though they were well matched by age and sex.<br />
ADHD children combined with learning disability<br />
(ADHD 1 LD) were significantly older than children<br />
suffered from ADHD only (ADHD group). ADHD 1 LD<br />
were significantly more impaired on the Freedom From<br />
Distractibility factor (C factor) and comprehension subtest<br />
of the C-WISC, the comprehension and reverse digit span<br />
subtest of WMS, the number cancellation test (P all ,0.05).<br />
(2) Logistic regression analysis showed that age and<br />
decreased C factor were risk factors for combining with<br />
LD. Gender, subtype and executive functions had little<br />
effect on the onset of LD among ADHD children. C factor<br />
significantly related to WMS, the number cancellation test,<br />
the Stroop test and the Raven’s standard progressive<br />
matrices. The highest relationships were found between C<br />
factor and short term memory and memory quotient. The<br />
middle relationship was found between C factor and the<br />
number cancellation test. We did not find the discrepancy<br />
of C factor with other factors in C-WISC. (3) The Stroop test<br />
had little relationship with the C-WISC<br />
(r ¼ 20:107 , 0:200). It suggested that the traditional<br />
intelligence test did not assess the selective inhibition of<br />
irrelevant stimulus or the control of impulse which were<br />
assessed by the Stroop test appropriately. Full scale intelligence<br />
quotient had little effect on variables standing for<br />
executive functions. Conclusion: ADHD children have<br />
impairments in tests of intelligence, memory, attention<br />
and executive functions such as selective inhibition, working<br />
memory and plan. Compared with ADHD boys, girls<br />
with ADHD displayed a tendency of greater intellectual<br />
impairment; however, their selective inhibition probably<br />
maintained better than that documented in boys with<br />
ADHD. Three subtypes of ADHD have the similar cognitive<br />
model. When ADHD children grow up, maybe they would<br />
combine with LD more easily. ADHD 1 LD children have<br />
poorer C factor, working memory and attention level.<br />
FP-O-029<br />
A study of dopamine candidate genes and attention<br />
deficit hyperactivity disorder<br />
Q.-J. Qian, Y.-F. Wang, R.-L. Zhou<br />
Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective: To investigate the relationships between<br />
ADHD and some candidate genes of dopamine system,<br />
such as dopamine D4 receptor (DRD4) gene, dopamine<br />
transporter (DAT) gene and catechol-O-methyltransferase<br />
(COMT) gene in Han Chinese population. The distribution<br />
of gene polymorphisms in ADHD phenotypes and different<br />
genders, and potential gene-gene interactions were also<br />
analyzed. Methods: The samples were comprised of 340<br />
ADHD children, 224 unrelated controls and 202 integrated<br />
ADHD trios (included proband and biological parents). The<br />
diagnoses and subtypes were ascertained according to<br />
American clinical diagnostic interviewing scales (CDIS), a<br />
structured, interviewer-administered interview based on<br />
DSM-IV criteria. The polymorphisms consisted of 48 bp<br />
VNTR in exon 3 of DRD4 gene, 40 bp VNTR in the 3 0<br />
untranslated region of DAT gene, the restriction fragment<br />
length polymorphisms of Val158Met of COMT gene. Associations<br />
of polymorphisms with ADHD and its subtypes
Abstracts 615<br />
were examined by: (i) comparing cases and controls; and (ii)<br />
using family-based association study in an extension of<br />
TDT and haplotype-based haplotype relative risk (HHRR).<br />
Results: (1) For the association analysis of 48 bp VNTR of<br />
DRD4 gene with ADHD, the frequencies of alleles and<br />
genotypes of long repeat tandem (4 , 6 repeats) in ADHD<br />
boys were significantly higher than in the male controls. The<br />
similar results were also obtained in ADHD-C subtype and<br />
ADHD fulfilling ICD-10 criteria. But the frequency of long<br />
repeat alleles was significantly lower in ADHD girls than in<br />
female controls. The repeat numbers of 48 bp are 2 , 6, we<br />
found no 7 or more repeat alleles among our samples. TDT<br />
and HHRR revealed no preferential transmission of either<br />
allele to ADHD probands. (2) For the 40 bp VNTR of DAT<br />
gene, TDT analysis revealed preferential transmission of 11<br />
repeat allele to ADHD-C probands and nine-repeat to<br />
ADHD-I children. The frequencies of alleles and genotypes<br />
of long repeat (11 , 12 repeats) in ADHD probands were<br />
significantly higher than in the controls. The similar results<br />
were also obtained in ADHD-C, pure ADHD subtype, and<br />
ADHD fulfilling ICD-10 criteria. (3) In the family-based<br />
association of COMT gene in ADHD, TDT and HHRR<br />
suggested the association of COMT gene and ADHD<br />
boys. The low enzyme activity Met158 allele preferentially<br />
transmitted to ADHD boys. This association was particularly<br />
marked among pure ADHD boys, especially the<br />
ADHD-I subtype. The case-control study revealed that<br />
high enzyme activity Val158 allele were more frequently<br />
in ADHD girls fulfilling ICD-10 and DSM-IV criteria than<br />
in the female controls. (4) Binary logistic regression analysis<br />
with the sample of refined phenotype showed that long<br />
repeat genotypes of DRD4 gene, DAT gene, and male<br />
gender were risk factors to ADHD. There was gene-gene<br />
interactions between DAT and DRD4 genes. In the sample<br />
of pure ADHD, there was gene-gene interaction between<br />
COMT and DAT genes. Conclusions: (1) The molecular<br />
genetic mechanisms of ADHD display gender difference.<br />
(2) The length polymorphisms of genes influence ADHD<br />
liability. (3) There are gene-gene interactions which are<br />
associated vulnerability to ADHD.<br />
FP-O-030<br />
The difference of attention-deficit disorder with or<br />
without hyperactivity: a 1 H-magnetic resonance<br />
spectroscopy study<br />
L. Sun a , Z. Jin b , Y.-F. Zang a , Y.-W. Zeng b , G. Liu b , Y.-F.<br />
Wang a<br />
a Institute of Mental Health, Peking <strong>University</strong>, China;<br />
b Center of fMRI, Hospital 306, Beijng, China<br />
Objective: Using proton magnetic resonance spectroscopy<br />
( 1 H-MRS) to investigate the possible neurometabolic<br />
difference among the predominantly inattentive subtype<br />
(ADHD-I subtype), the hyperactivity-impulsive subtype<br />
(ADHD-C subtype) and normal controls. Method: Proton<br />
spectra were acquired bilaterally on the globus pallidus in<br />
20 schoolboys having ADHD and ten matched controls. The<br />
boys having ADHD were divided into ADHD-C subtype<br />
group (n ¼ 10) and ADHD-I subtype group (n ¼ 10)<br />
according to DSM-IV criteria. The peaks of N-acetylaspartate<br />
(NAA), choline moieties, myo-inositol, creatine (Cr)<br />
and a-Glx were measured and their ratios to Cr were calculated<br />
and compared. Results: (1) Though the NAA/Cr ratios<br />
in both ADHD groups were lower than the value in normal<br />
controls, however only the ADHD-C subtype group showed<br />
a significant difference, not the ADHD-I subtype group. (2)<br />
In the right globus pallidus, the NAA/Cr ratios in the<br />
ADHD-C group was significantly lower than the ADHD-I<br />
group. In the left globus pallidus, the NAA/Cr ratios in the<br />
ADHD-C group also showed a decreased tendency<br />
compared to the ADHD-I group. Conclusion: Since NAA<br />
is a useful marker of neuronal function, these findings<br />
suggest that the basal ganglia neuronal dysfunction exist<br />
in ADHD children, the neuronal dysfunction of the<br />
ADHD-C group was more severe than that of the ADHD-I<br />
group.<br />
FP-O-031<br />
Response inhibition in two subtypes of children with<br />
ADHD in a stop signal task<br />
Y.-H. Wang a , X.-L. Zhou a , Y.-F. Wang b , Y.-X. Zhang a<br />
a Department of Psychology, Peking <strong>University</strong>, Beijing,<br />
China; b Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective and method: A stop signal task was used to<br />
investigate two kinds of response inhibition, response<br />
conflict and response stopping. Subjects were two subtypes<br />
of children with ADHD (predominantly inattentive and<br />
combined) and normal controls. Results: The results<br />
showed that ADHD children were deficient in both kinds<br />
of response inhibition compared with normal controls. In<br />
response stopping, it was more difficult for ADHD children<br />
to withhold response when responding with left hand,<br />
which means that they have significant deficit in the right<br />
hemisphere. No significant differences were observed<br />
between the combined and inattentive ADHD group. In<br />
response conflict, normal children did not show significant<br />
conflict effect, suggesting that their strong conflict control<br />
ability can overcome the mild conflict manipulation. The<br />
inattentive ADHD group showed a significant conflict<br />
effect when responding with left hand, suggesting the<br />
impairment in control functions of the right hemisphere<br />
and the anterior cingulated. The combined ADHD group<br />
were more impaired than the inattentive ADHD children,<br />
showing a larger conflict effect when responding by either<br />
left or right hands. Conclusion: This suggested that the two<br />
types of ADHD children were impaired to the different<br />
extent in neurocognitive functions.
616<br />
Abstracts<br />
FP-O-032<br />
Effects of distractors on sustained attention in children<br />
with attention-deficit hyperactive disorder (ADHD)<br />
Y. Xu a , X.-L. Zhou a , Y.-F. Wang b<br />
a Department of Psychology, Peking <strong>University</strong>, Beijing,<br />
China; b Institute of Mental Health, Peking <strong>University</strong>, Beijing,<br />
China<br />
Objective and method: Using an experimental design<br />
combining the sustained attention task (CPT, SART) and<br />
the flanker task, we investigated: (1) whether children<br />
with ADHD have deficits in their sustained attention; (2)<br />
whether distractors have different effects on the response to<br />
targets at different sustained attention levels; and (3)<br />
whether different subtypes of ADHD children show different<br />
patterns in sustained attention. Results: The results<br />
support the view that ADHD children have deficits in<br />
their sustained attention, reflecting the deficits in brain<br />
development. More importantly, this study found that the<br />
effects of distractors in sustained attention can be dissociated<br />
according to the level of demand on sustained attention:<br />
distractors interfered with responses to targets when<br />
the demand on sustained attention was low while they facilitated<br />
responses to targets when the demand on sustained<br />
attention was high. There were no significant differences<br />
between ADHD-inattentive type and ADHD-combined<br />
type in their deficits in sustained attention. Conclusion:<br />
ADHD children have deficits in their sustained attention,<br />
reflecting the deficits in brain development.<br />
FP-O-033<br />
Investigation of ADHD comorbidities in a Chinese<br />
clinical sample<br />
L. Yang, Y.-F. Wang<br />
Institute of Mental Health, Peking <strong>University</strong>, China<br />
Objective: To investigate the comorbid rate between<br />
ADHD and other childhood psychiatric disorders and<br />
analyze the influence of gender and age in a Chinese clinical<br />
sample. Method: The study included 423 ADHD children<br />
consecutively diagnosed by specialists at the Institute of<br />
Mental Health, Peking <strong>University</strong>. All subjects were<br />
assessed by structured diagnostic interviews with parents<br />
for comorbidities based on DSM-IV. Results: The comorbidity<br />
of recruited ADHD children with disruptive behavior<br />
disorder is 35.1% (ODD 28.2%, CD 6.9%), with multiple<br />
anxiety disorder 8.3%, mood disorder 10.1%, Tics disorder<br />
(including Tourette syndrome, TS) 14.4%, and learning<br />
disorder 37.9%. Girls with ADHD were more likely than<br />
boys to have the anxiety disorders (P , 0:001), especially<br />
the special phobia (P , 0:05) and the general anxiety disorder<br />
(P , 0:01). In addition, adolescents with ADHD (12–16<br />
years) were more likely than children (6–11 years) to meet<br />
the criteria for mania (P , 0:05), and less likely to have<br />
chronic tics disorder (P , 0:05) and learning disorder<br />
(P , 0:001). Conclusions: The high likelihood for ADHD<br />
children to comorbid other psychiatric disorder makes it a<br />
clinical problem that should not be neglected. It is necessary<br />
to routinely evaluate, diagnose and manage the comorbidities<br />
in clinical work. The sex and age differences of comorbidity<br />
implicated different pathogenisis.<br />
FP-O-34<br />
The investigation of social action characteristics about<br />
hyperkinetic syndrome of childhood<br />
D.-M. Wang, S.-M. Jia, S.-Y. Liu<br />
No. 4 Hospital of Baotou, Aogan Str., Qingshan District,<br />
Baotou 014030, Inner Mongolia, China<br />
To understand the characteristic of social adaptability of<br />
hyperkinetic syndrome of childhood, we had carried out the<br />
investigation between diagnosed hyperkinetic syndrome of<br />
childhood 46 and normal child 50 in 1998–1999. Everyone<br />
examines EEG which expresses normal EEG and critical<br />
EEG. Their examinations of nerval system are normal.<br />
Adopting (Wei’s measuring chart of child intelligence)<br />
revised by Yao-Xian Gong and (The measuring chart of<br />
child adaptable action) compiled by Shu-Qiao Yao. Two<br />
groups of children were estimated intelligence quotient<br />
(FIQ) and adaptation quotient (ADQ). Result: (1) There is<br />
no significant difference in FIQ between the two groups<br />
(100; 102, P . 0:05). (2) There is no significant difference<br />
in ADQ between the two groups (105.4; 105.8, P . 0:05).<br />
But the social/self control Factor of the normal children is<br />
far higher than one of sick children (57.6; 40.3, P , 0:05).<br />
The independent factor and cognition factor of the normal<br />
children is far lower than ones of the sick children (that is<br />
52.4; 60.5, P , 0:05:49:3; 57.8, P , 0:05). Analysis: the<br />
sick children is normal in FIQ and ADQ although independent<br />
and cognition Factors maintain certain levels, they are<br />
low value in social/self control Factor, which lead to pay no<br />
attention to what you are doing. Likely, their studies and<br />
lives are irregular. Their social action is unusual.<br />
FP-O-035<br />
Multidisciplinary Tourette syndrome clinic<br />
V. Gross-Tsur, A. Zohar, M. Sadeh, F. Benarrouche<br />
Neuropediatric Unit, Shaare Zedek Medical Center, POB<br />
3235, Jerusalem 91031 Israel<br />
Tourette’s syndrome (TS) is a multifaceted disorder characterized<br />
by waxing and waning tics, both motor and vocal.<br />
ADHD, learning disabilities, OCD and other psychiatric<br />
phenomena are strongly associated with the syndrome. In<br />
order to address the multiple handicaps of children with TS,<br />
our patients are treated by a multidisciplinary team of pediatric<br />
neurologists, psychiatrists, clinical and experimental<br />
psychologists and a social worker. In this presentation we
Abstracts 617<br />
report the clinical characteristics and presenting signs in 60<br />
children (49 boys and 11 girls, ages 9.5 ^ 3.0 (mean ^ SD).<br />
Age of presentation was 5.3 ^ 1.5 years, the full syndrome<br />
(vocal and motor tics for 1 year) became apparent at the age<br />
8.7 ^ 2.3 while the diagnosis was made about 1 year later.<br />
Tics were the presenting sign in 57% of children: 30% had<br />
motor tics, 10% vocal tics and a combination of motor and<br />
vocal tics were seen in the rest. ADHD was the presenting<br />
problems in 30% while OCD was rarer, the presenting sign<br />
in only 3% of children. The first motor tics were eye blinking<br />
(38%) or other facial tics (37%) and the first vocal tics<br />
were throat clearing (53%). During their illness, complicated<br />
motor tics were found in 53% and copralalia in 5%.<br />
Although learning disabilities, interpersonal problems and<br />
behavioral disorders were not presenting symptoms in TS,<br />
they were very prevalent appearing in 65 and 58% respectively.<br />
OCD and ADHD were also very common, occurring<br />
in three quarters of the children. Therapy was multimodal,<br />
58% of TS children received medication and 72% psychological<br />
therapy sometime during their illness. The familialgenetic<br />
element was evident in that family history of TS was<br />
found in 10%, tics in 20% and OCD 6.6%. In conclusion, we<br />
found that the data of our TS patients as a group is very<br />
similar to that of TS worldwide despite the differences in<br />
cultural background and the known heterogeneity in the<br />
characteristics of individuals with TS.<br />
FP-O-036<br />
Clinical features in adult attention-deficit/hyperactivity<br />
disorder among substance abusers<br />
Y. Ding, Y.-F. Wang<br />
Institute of Mental Health, Peking <strong>University</strong>, China<br />
Objective: The present study is conducted to explore the<br />
clinical presentations, psychiatric comorbidities and<br />
psychosocial functioning in adults with ADHD among<br />
non-alcohol substance use disorder population. The authors<br />
reason that if the adult diagnosis of the disorder is a valid<br />
clinical entity, it should be similar to the childhood ADHD<br />
with regard to patterns of psychiatric findings. Methods:<br />
Thirty adults with ADHD and thirty non-ADHD controls<br />
were selected from Beijing Compulsory Detoxification<br />
Center, matched with sex, age, and education. Data collection<br />
included the following: (1) self-report measures of<br />
developmental history, employment history, social history<br />
and ADHD clinical symptoms. (2) Psychiatric interview<br />
using structured assessments included the CDIS for DSM-<br />
IV. (3) C-WAIS for adult used to evaluate the cognitive<br />
function. Results: (1) The mean age of ADHD group was<br />
28.97 (SD ¼ 5.90), and the mean age of control group was<br />
29.33 (SD ¼ 6.18). There was no significant difference in<br />
age (P ¼ 0:815). (2) The clinical core symptoms (such as<br />
attention deficit, restlessness, and impulsive symptoms)<br />
among adulthood ADHD were similar the childhood<br />
ADHD except for some hyperactivity symptoms. (3) The<br />
ADHD subjects were more likely to be with current or past<br />
(childhood) DSM-IV symptoms of ADHD (attention deficit,<br />
restlessness, and impulsiveness) than control subjects<br />
(P , 0.05). (4) ADHD subjects were more likely to diagnosed<br />
with comorbid ODD (60 versus 20%, P ¼ 0:008), CD<br />
(76.7 versus 23.3%, P , 0:001) and APD (60.0 versus<br />
3.3%, P , 0:001) than that in non-ADHD controls. There<br />
was no excess risk for anxiety and affective disorder in<br />
ADHD subjects than control. Furthermore, adult ADHD<br />
group was more likely to having an early onset of age of<br />
non-alcohol substance use disorder (23.53 versus 25.48,<br />
P ¼ 0:069). (5) There was no differences of marital status<br />
and occupation between the two groups. There was no<br />
significant differences in speeding violation, licenses<br />
suspended, crashes between the ADHD group and the<br />
control group. The frequency of drunk driving in ADHD<br />
subjects was significantly higher than that in the control.<br />
Conclusions: (1) The similarities and persistence of<br />
ADHD symptoms from childhood to adulthood collaborate<br />
the validity of the ADHD diagnosis for adults. (2) Adult<br />
ADHD prefer to have more antisocial behaviors including<br />
ODD, CD, and ASPD. (3) It is difficult to distinguish the<br />
psychosocial functioning impairment between ADHD and<br />
substance use disorder.<br />
FP-P<br />
Medical Informatics<br />
FP-P-001<br />
Neurologic: a web-based tutorial for teaching an<br />
anatomical approach to the neurological examination<br />
P.D. Larsen a , S.S. Stensaas b<br />
a <strong>University</strong> of Nebraska School of Medicine, Nebraska<br />
Medical Center, Omaha, Nebraska, USA; b <strong>University</strong> of<br />
Utah School of Medicine, Salt Lake City, UT, USA<br />
The first principle of neurological diagnosis is regional or<br />
anatomical localization. A physician must learn the<br />
elements of the neurological examination and how to logically<br />
and systematically interpret the findings in order to<br />
localize the site of neurological disease. In order to teach<br />
these skills we have developed a web-based tutorial that is<br />
available on the Internet for medical schools and neurology<br />
training programs. The tutorial has seven modules: an introductory<br />
module and six modules based on the components<br />
of the exam (mental status, cranial nerves, coordination,<br />
sensory, motor, and gait). Each module is divided into<br />
four sections. (1) Review of anatomical pathway(s) and<br />
structures being examined; (2) video demonstration of that<br />
portion of the exam; (3) Videos of patients showing corresponding<br />
abnormalities of that portion of the exam; and (4)<br />
self-evaluation: At the end of the tutorial there are unknown<br />
cases for the student to practice on. The tutorial is designed<br />
for use on a fast (T1) Internet connection, not a modem. It is<br />
highly interactive and uses progressively downloaded
618<br />
Abstracts<br />
QuickTime movies. Written text is kept to a minimum and<br />
ease of navigation within the site is a priority. Movies come<br />
with a £ 2 option so that they can be projected in the classroom.<br />
The site lends itself to being adapted to the teaching<br />
needs of classroom instruction as well as self-study. The<br />
tutorial will be demonstrated and discussed at the meeting.<br />
FP-P-002<br />
Can a distance learning programme provide effective<br />
training in paediatric neurodisability?<br />
V.A. Harpin, C.R. Pullen, H.A. Davies, S.M. Gentle, D.M.<br />
Hall<br />
Sheffield Childrens Hospital, Sheffield, UK<br />
Training in paediatric neurodisability in the UK was felt<br />
to be patchy and difficult to obtain for many trainees. This is<br />
incompatible with an increasing clinical need. In Sheffield<br />
we have developed a 2 year distance learning programme to<br />
provide core training in a co-ordinated way. Twenty<br />
Students began the Course in September 2000, supported<br />
by 14 tutors. The Course consists of 12 written modules (one<br />
every 2 months) and four residential courses with local<br />
practical visits. Trainees are evaluated by a written assessment<br />
per module and three further assessments. Trainees<br />
evaluated each module for usefulness and level of teaching<br />
(1–6) and each residential session for relevance and enjoyment<br />
(1–5 scale). Tutors are also providing feedback. Overall<br />
feedback has been very positive. The course is felt to be<br />
demanding and thorough. Most students consistently feel<br />
material is at the right level and useful/very useful. Individual<br />
students find different modules most useful/hardest<br />
depending on experience and their own needs. Residential<br />
sessions scored consistently highly. Teaching content<br />
scored very good to excellent throughout and the chance<br />
to meet other trainees and tutors was highly valued. Eighteen<br />
of 20 students remain on the course. One is retraining in<br />
child psychiatry. One has deferred to the next group because<br />
of personal reasons. We will present details of course development<br />
and evaluation. A distance learning course can<br />
provide a good core training in neurodisability and we<br />
feel this kind of format could be used by other specialties<br />
and in other countries.<br />
FP-Q<br />
Oriental Medicine<br />
FP-Q-001<br />
Acupuncture and facilitation technique in the treatment<br />
of cerebral palsy in children<br />
J.-G. Cao, X.-Z. Guo, H.-Y. Lu<br />
Faculty of Pediatrics, Shanxi Medical <strong>University</strong>, Taiyuan,<br />
China<br />
Objective: To explore the effect and influential factors of<br />
acupuncture and facilitation technique in CP children.<br />
Methods: A total of 246 CP were treated by acupuncture<br />
and facilitation technique. Movement function was evaluated<br />
before and after treatment. Results: Ninety-five cases<br />
had significant effect, and 127 cases had effect. Among<br />
them, 34 cases were normalized. The effective rate was<br />
90.2%. Curative effect is related to the age of starting treatment,<br />
sustained course, type, severity of diseases, and<br />
complications. Conclusion: Combined acupuncture with<br />
facilitation technique can promote rehabilitation in CP.<br />
The earlier and the longer the treatment, the better will be<br />
the effect.<br />
FP-Q-002<br />
Successful prevention of relapse in a child with multiple<br />
sclerosis using oriented herbal medicine (Sairei-to)<br />
S. Yamazaki, H. Yoshikawa, T. Abe<br />
Department of Pediatrics, Niigata City General Hospital,<br />
Niigata Japan<br />
Since the age of 3, a 9-year-old Japanese girl developed<br />
recurrent aseptic meningitis, optic neuritis, brainstem<br />
dysfunction and convulsions. At the age of 4, she suffered<br />
from aseptic meningitis and optic neuritis, and brain MRI<br />
revealed high intensity lesions in the white matter on T-2<br />
weighted images. The titers of anticardiolipin antibody was<br />
also elevated. She was diagnosed as having MS associated<br />
with positive anticardiolipin antibodies. In each episode of<br />
MS relapse, the administration of corticosteroids was effective<br />
in stopping the symptoms. However, corticosteroids<br />
had no preventive effects for MS relapse. At age 6, with<br />
the informed consent of her parent, we tried using the oriental<br />
medicine, Sairei-to to prevent MS relapse. Following<br />
this, over a period of two years she experienced no relapse<br />
of MS. Some oriental herbal medicines have been reported<br />
as being effective for MS therapy. Seirei-to has anti-inflammatory,<br />
immunoregulatory, anti-allergic, diuretic, and steroid-like<br />
effects, it has also been reported that Sairei-to is<br />
also effective against antiphospholipid antibody syndrome.<br />
These pharmacological properties could work in the prevention<br />
of MS relapse of this patient, who had a positive anticardiolipin<br />
antibody. Sairei-to is considered to be a<br />
worthwhile trial in the prevention of MS relapse.<br />
FP-Q-003<br />
Study on antiepileptic action and immunological<br />
mechanisms of CaoGuo ZhiMu Tang<br />
H. Zhang, L. Wang<br />
Department of Neurology, Baotou Central Hospital,<br />
Baotou, China<br />
Objective: On the basis of ‘fu zheng gu ben’ of Chinese<br />
traditional medicine, the related immunological mechanisms<br />
of the antiepileptic effect of CaoGuo ZhiMu Tang
Abstracts 619<br />
(CGZMT) were studied from gross, cellular and molecular<br />
levels with audiogenic seizure (AGS) rat model. Method:<br />
First, ten Wister rats and 30 AGS rats were randomly<br />
divided into four groups and were peritoneally injected<br />
NS10 ml/kg, CGZMT 10 g/kg, phenobarbital (PB) 50 mg/<br />
kg, respectively. Rats were treated continually for 7–14<br />
days. We measured the antiepileptic effect. Second, the<br />
immunological mechanisms of the rats were studied by<br />
the colorimetry, QHS, 3H-TdR incorporation, MTT analysis<br />
colorimetry. Results: Comparing with model control,<br />
CGZMT could enhance activity of macrophage (MF)<br />
(P , 0:05); accelerate biological activity of IL-2<br />
(P , 0:05). It could enhance proliferation of T lymphocyte<br />
stimulated by concanavalin-A (ConA) (P , 0:05), but its<br />
proliferation of T lymphocyte to ConA was lower than<br />
that for normal control rats (P , 0:05). It could increase<br />
RBC-C3bRR and RBC-ICR and lower proliferation of B<br />
lymphocyte stimulated by LPS. It could also decrease the<br />
levels of antibody forming cell and hemolysin antibody.<br />
Conclusion: CGZMT had antiepileptic effect. It could accelerate<br />
the activity of MF, cell immune function and RBC<br />
adhesion function. This suggested that one of its antiepileptic<br />
mechanisms is improving immune state of the body, i.e.<br />
‘fu zheng gu ben’.<br />
FP-Q-004<br />
Clinical study on efficacy of traditional Chinese medicine<br />
bushen combined with special training program on<br />
mental retardation (MR)<br />
F.-Z. Du, Y.-J. Dou, J.-F. Ding<br />
Rehabilitation Center, Gansu Traditional Chinese Medical<br />
College, Lanzhou, Gansu Province, China<br />
Objective: To observe the effect of traditional Chinese<br />
medicine (Bushen) combined with special training program<br />
on MR. Method: Patients of MR were divided into two<br />
groups (A and B) according to age. Group A (N ¼ 105)<br />
received special education in the assistant study school.<br />
Group B (N ¼ 42) were treated with western medicine,<br />
such as Vitamin B1 and lysine. Group A was randomly<br />
divided into two subgroups (A1 and A2). The 55 cases of<br />
group A1 were treated with Bushen medicine-Xingnaoyizhi<br />
granule (XNYZG) 10 g per dose, which consisting of herbs<br />
including lujiaoshuang, roucongrong, and tianzhuhuang,<br />
etc. This drug was taken orally three and two times a day<br />
in patients above and below 12 years, respectively for 3<br />
months. The 25 cases of group B1 were treated with<br />
XNYZG 5 g per dose, three times a day for 3 months.<br />
Groups A2 and B2 were control groups. IQ and clinical<br />
data were collected before and 3 months after treatment.<br />
Results: The rate of improvement was 21.8% in group A1<br />
and 12.0% in group B1.The rate of improvement was 87.3%<br />
in group A1 and 60.0% in group B1. Both were significantly<br />
higher than in the groups A2 and B2 (P , 0:01). The rate of<br />
improvement in group A1 was significantly higher than that<br />
in the group B1 (P , 0:01). Conclusion: Although there is<br />
no effective method to treat MR, traditional Chinese medicine<br />
Bushen combined with special training program may<br />
be regarded as an acceptable method for treating MR.<br />
FP-Q-005<br />
Effect of ‘Xi Feng Jing Ning Decoction’ on blood<br />
dopamine and immunological function in Gilles de la<br />
Tourette syndrome<br />
Z.-Y. Yu, J. Wang<br />
Department of Pediatrics, China-Japan Friendship Hospital,<br />
Beijing, China<br />
Objective: To study the mechanism of ‘Xi Feng Jing Ning<br />
Decoction’, a traditional Chinese medicine decoction<br />
consisting of 12 kinds of herbs, in treating Gilles de la TS.<br />
Methods: Forty TS were divided into two groups, Xi Feng<br />
Jing Ning Decoction treatment group (XF group, 30<br />
patients) and control group (C group, ten patients). A clinical<br />
observation table was set up to compare the changes<br />
before and after 60 days of treatment. A comparison was<br />
made in the change of blood DA level and IgA, IgG before<br />
and after 60 days of treatment. Results: The response rate in<br />
the XF group was 93.3%. There was no significant difference<br />
between the two groups (P , 0:01). The blood DA<br />
content in both groups was lower after treatment<br />
(P , 0:01). IgG and IgA of the XF group were increased<br />
(P , 0:01) after treatment, but those of the C group had no<br />
increase (P . 0:05). Conclusion: Xi Feng Jing Ning Decoction<br />
can relieve the symptoms and adjust the DA systems<br />
and immunological status of patients with TS. The Decoction<br />
can also decrease attacks of upper respiratory tract<br />
infection and reduce the possibility of TS relapse. This<br />
showed that the traditional Chinese medicine had a promising<br />
future in treating TS.<br />
FP-R<br />
Neurosurgery<br />
FP-R-001<br />
A case report about melanotic neuroectodermal tumor<br />
of infancy in skull<br />
N. Wang<br />
The children’s hospital of Zhejiang, Hangzhou Zhejiang,<br />
China<br />
This article reports a rare tumor named ‘melanotic<br />
neuroectodermal tumor of infancy (MNTI)’. MNTI is<br />
found more than 200 cases in the world from 1918. Our<br />
case is a male 4 months child. There is a growing mass on<br />
his left temple. After CT and MRI examining, it is diagnosed<br />
‘meningioma’. But it is MNTI in pathology. We<br />
check this tumor with immunohistology, and review it in<br />
literature. This case is the fifth in China, and is the first
620<br />
Abstracts<br />
occurred in frontal bone. Generally, MNTI is low grade<br />
malignity. Our case has not recurred about 13 months<br />
after operation. Our conclusion is that thorough operation<br />
is the most important thing in MNTI’s therapy.<br />
FP-R-002<br />
Children’s tuberous sclerosis associated with brain<br />
tumor<br />
H.-M. Jin, L.-P. Sun, N. Bao, J.-M. Zhu<br />
Department of Pediatric Surgery, Xin Hua Hospital, Shanghai<br />
Second Medical <strong>University</strong>, Shanghai, China<br />
Objectives: To explore the diagnosis and treatment of<br />
TSC associated with brain tumor in children. Clinical materials:<br />
Six tuberous sclerosis complexes, four male, two<br />
female, 4–12 years old, have been confronted during last<br />
10 years. CT and MRI scans showed brain tumors located in<br />
lateral ventricle near foramen of Monro. Four were in left<br />
and two in right. Tumors were excised completely in three<br />
cases, partially in two patients. The pathologic findings were<br />
subependymal giant cell astrocytoma. One child who had<br />
concomitant renal tumor accepted gamma radiotherapy.<br />
Results: All cases were followed 1–7 years. Three children<br />
are disease-free after complete tumor removes. One of two<br />
patients with partial resection died of recurrence, and<br />
other’s residual tumor size does not increase. One tumor<br />
has not changed after gamma radiation. Conclusions: TSC<br />
associated with brain tumor can be well diagnosed by CT<br />
and MRI. Craniotomy is the only effective treatment. The<br />
patients with TSC should be followed in order to detect and<br />
intervene brain tumor earlier.<br />
FP-R-003<br />
Microsurgical treatment for hypothalamic hamartoma<br />
causing epilepsy in children<br />
C.-D. Li, S.-Q. Luo, Z.-Y. Ma, Y.-Q. Zhang, Q. Bai<br />
Department of Neurosurgery, Tiantan Hospital, Beijing,<br />
China<br />
Object: To discuss the surgical treatment for hypothalamic<br />
hamartoma causing epilepsy in children. Methods: Six<br />
boys and five girls with epilepsy and hypothalamic hamartoma,<br />
age ranged from 2 to 15-years-old, were reported. The<br />
onset ages were 2 months–14 years. Ten patients presented<br />
with gelastic seizure, six of them also with generalized<br />
tonic-clonic seizures and three with drop attacks. All<br />
patients were treated by microsurgery via a pterional<br />
approach except one via a laminaterminalis approach and<br />
four patients underwent depth electrode encephalography<br />
with electrodes implanted into the hypothalamic hamartoma.<br />
Result: Two hamartomas were totally removed without<br />
any complications, eight hamartomas were gross<br />
partially removed and one was partially removed. All<br />
patients were followed by 16–87 months after operation,<br />
two were completely seizure-free, nine were significantly<br />
reduced the frequency of seizures. Conclusion: With<br />
removement of hamartoma we can effectively treat epilepsy<br />
caused by hypothalamic hamartoma in children.<br />
FP-R-004<br />
Pediatric craniopharyngiomas: surgical treatment and<br />
protection of the hypothalamus<br />
Y.-Q. Zang, C.-C. Wang, Z.-Y. Ma, S.-Q. Luo<br />
Department of Neurosurgery, Beijing Tiantan Hospital,<br />
Beijing, China<br />
Object: With the protection of the hypothalamus,<br />
craniopharyngiomas can be in children safely removed,<br />
total or subtotal. Methods: A total of 142 pediatric cases<br />
were operated with the transcallosal-interseptal-interforniceal<br />
approach, the transfrontal-longitudinal fissure<br />
approach, and other approaches. The methods of protection<br />
and treatment of hypothalamic functions were used<br />
before and after the operations. Results: A total of 133 out<br />
of 142 tumors (93.7%) were removed totally and subtotally.<br />
The complications were diabetes insipidus 129<br />
(90.8%), hypernatremia or hyponatremia 127 (89.4%),<br />
and seizures 4 (2.8%). However, the seizures were fatal<br />
complication. One patient (0.7%) died postoperatively due<br />
to seizures. Conclusion: For total or subtotal removal of<br />
the pediatric craniopharyngiomas, it is important to protect<br />
the hypothalamic functions before, during and after the<br />
operations. The tumors should be operated directly under<br />
a microscope.<br />
FP-R-005<br />
Evaluation of mild closed traumatic brain injury in<br />
children with CT scan: prospective international study<br />
A. Murgio a , D. Fong b , E.J. Herrera a , G. Hotz c , F. Romeo d ,<br />
D. Rocco d , S. Mutluer e , A.F. de Andrade f<br />
a Quintana 1256 – Mar del Plata (7600), Argentina; b China;<br />
c United States; d Italy, e Turkey, f Brazil<br />
Introduction: Traumatic brain injury (TBI) is the leading<br />
cause of death and disability in pediatric trauma. Although<br />
the incidence and mechanism for TBI in children 0–15<br />
years of age varies through the developmental levels,<br />
early diagnosis and treatment may ameliorate the morbidity<br />
and mortality associated with significant intracranial<br />
injury. Objectives: The principal idea was to evaluate,<br />
using an international and multicenter population, the relationships<br />
between severity of injury, risk factor and<br />
imaging findings by attending physicians. Methods: The<br />
present study was a multicenter prospective, randomized,<br />
study of children who serially presented to emergency<br />
departments with head injury. The organizing group and<br />
administrator study is the International Study of Head<br />
Injury Project, which was created in 1996. A total of
Abstracts 621<br />
9460 children were seen between 1996 and 2000, and it<br />
sample was divided in two groups: Phase I (1996–1998)<br />
with 4690 patients and Phase II (1999–2000) with 4770<br />
patients. Each child was seen by medical staff and evaluated<br />
during acute care. A standardized data base sheet was<br />
completed to include general demographics, medical<br />
status, Glasgow Coma Scale score and Pediatrics Score,<br />
neuroradiologic study. Indicators consisted in frequency<br />
counts and tabulations. On follow-up each subject was<br />
given a Glasgow Outcome Score and asked set standardized<br />
questions considered detect functional level and<br />
quality of life. The baseline information and subsequent<br />
outcome score were compared and evaluated. Results: A<br />
total 9460 children, we observed not statistical difference<br />
between two phases, by number and sex. Boys made up<br />
60% (Phase I) and 61.8% (Phase II) of the sample. The<br />
distribution by age was: birth to 2 years (77.1%: first phase<br />
and 40.8% at the second phase); 3–9 years (18.7 and 46%,<br />
respectively) and 10–15 years (4.1 and 13.2%). Use of the<br />
GCS-PGCS score to rate severity of the injuries indicated<br />
that 79.1% were milds TBI (Phase I) and 96.4% (Phase II).<br />
P ¼ ns. The most frequent mechanism of injury was a fall,<br />
which reported in approximately 70% in a two Phases, road<br />
accidents accounted for 20% (Phase I) and 16.8% (Phase<br />
II), the mechanisms in the remaining 10% hit by object,<br />
crush injury, and others. By comparison, head X-rays were<br />
performed in 89 and 88.6% of the children, 89% of the first<br />
group giving normal and 85.1% with 453 (10% ¼ Phase I)<br />
and 629 (14.9% ¼ Phase II) pathologic results. With<br />
respect the CT scan that was ordered, we found difference<br />
between the two groups: 14.3% in Phase I and 53% Phase<br />
II, were 65% of which were normal with 35% labeled<br />
‘abnormal’ and the second phase 71.4% were normal and<br />
the remaining 28.5% labeled ‘abnormal’. Seven children<br />
died (0.15%) at the first phase and three (0.06%) of the<br />
second phase, and 81 underwent some neurosurgical intervention<br />
(1.7% Phase I) and 130 (2.7% Phase II). Most of<br />
the children 91% of the Phase I and 99.8% (Phase II) were<br />
re-evaluated at the follow-up after 3 months. The vast<br />
majority 99 and 99.7% had scores of 5, i.e. good recovery.<br />
Each center participating demonstrated the same tendency<br />
for the vast majority of children to get good recovery<br />
ratings at the local follow-up assessment. Conclusion:<br />
The advantage of the multicenter study is that allows us<br />
a glimpse of practice in varied settings and makes it possible<br />
to compare these experiences with our own. The<br />
present study seems to suggest that some of the beliefs<br />
that govern us in decision-making need review, for example:<br />
the use of ‘older and familiar’ technologies (X-rays) to<br />
determine the need for a more complex evaluation, including<br />
CT. Until more definitive information is available, clinicians<br />
should be liberal in their use of CT so that early<br />
identification of significant intracranial pathology can be<br />
obtained and appropriate management of the injuries<br />
initiated.<br />
FP-R-006<br />
Is a separate cerebrospinal fluid access device useful in<br />
the management of childhood hydrocephalus?<br />
T.-Y.M. Lo, L.M. Myles, R.A. Minns<br />
Department of Child Life and Health, <strong>University</strong> of Edinburgh,<br />
Edinburgh, UK<br />
A retrospective study was undertaken to determine the<br />
long-term risks and benefits of a separate CSF access device<br />
in the management of 52 patients with shunted childhood<br />
hydrocephalus. We compared the usage and complication<br />
after separate reservoir insertion with a pre-reservoir period.<br />
The risks were assessed in terms of the frequency of: (1)<br />
ventriculoperitoneal (VP) shunt infection and ventriculitis;<br />
(2) shunt blockage; (3) access device failure; and (4) other<br />
potential complications such as porencephaly, epilepsy,<br />
hemiplegia, visual and cognitive deficits. The benefits of a<br />
separate CSF reservoir were gauged from the attendances<br />
where the reservoir was accessed to diagnose, treat or<br />
exclude, raised intracranial pressure (ICP) or shunt infections<br />
and ventriculitis. There was no mortality from raised<br />
ICP or CNS infection over a median follow-up period of<br />
19.05 years. Significantly fewer episodes of ventriculitis<br />
(P ¼ 0:0091) and shunt blockage (P , 0:0001) were<br />
found in the post-reservoir study period. There was no hemiplegia,<br />
epilepsy, visual or cognitive loss from the additional<br />
cortical puncture. The reservoir was used for access in 344<br />
attendances for diagnosis or treatment of raised pressure or<br />
CNS infection. We conclude that a separate CSF access<br />
device is very useful in the long-term management of<br />
patients with shunted hydrocephalus and is without mortality<br />
or significant morbidity.<br />
FP-S<br />
Diagnosis/Treatment<br />
FP-S-001<br />
Different dosage regime of penicillamine and urine<br />
copper for hepatolenticular degeneration<br />
Z.-C. Wen, R.-M. Wang, W.-X. Sun, X.-Y. Wang<br />
Shandong Provincial Hospital, Jing Wu Road 324, Jinan,<br />
China<br />
Objective: To determine the dosage of penicillamine in<br />
treating patients of hepatolenticular degeneration. Methods:<br />
Penicillamine with different dosages are administrated to<br />
patients with hepatolenticular degeneration, group 1<br />
(N ¼ 17) small dose (5 , 10 mg/kg per day); group 2<br />
(N ¼ 17) using moderate dose (11 , 16 mg/kg per day).<br />
The followings are monitored: extrapyramidal symptoms,<br />
liver function, hypersplenism, average amount of daily<br />
urine copper of 8 weeks; and observe side effects (including<br />
fever, white blood cell, skin rash, nausea). Results: (1)<br />
Copper excretion in the moderate dose group was better
622<br />
Abstracts<br />
than the small dose during the first 6 weeks of treatment<br />
(P , 0:01). (2) After 6 weeks, the copper excretion effects<br />
of the two groups were the same (P . 0:05). (3) The side<br />
effects of the two groups were not different. (4) The clinical<br />
symptoms were identical with above three conclusions.<br />
Conclusions: We recommend using moderate dose of penicillamine<br />
in treating patients with hepatolenticular degeneration<br />
in the acute stage (the first 6 weeks) and small dose<br />
after acute stage (after 6 weeks).<br />
FP-S-002<br />
Comparison of topamax with valpronic acid,<br />
carbamazepine and phenobarbital in the treatment of<br />
childhood epilepsy<br />
Y.-Q. Zhong, J. Wu, M. Wu, X.-L. Xie, W.-G. Hu, W.-Z.<br />
Zhou<br />
Chengdu Children’s Hospital, Sichang, China<br />
Objective: To compare the efficacy of adverse reactions<br />
of TPM, VPA, CBZ and PB in children. Method: Single<br />
drug regimens were used to treat 194 newly diagnosed<br />
cases of epilepsy in a prospectively designed non-randomized<br />
parallel control trial (TPM 63, VPA 61,CBZ 34 and<br />
PB 36 cases). The dosage of TPM was 0.5 , 1 mg/kg per<br />
day initially, increased gradually to 2 , 8.5 mg/kg per day<br />
later. The median follow-up duration was 12.2 months.<br />
Therapeutic efficacy and adverse reactions of the drugs<br />
were closely observed during follow-up period. Result:<br />
Complete control of epileptic attack was observed in 58.7,<br />
57.4, 50 and 52.8% of cases in TPM, VPA, CBZ and PB<br />
groups, while unfavorable results were seen in 6.3, 4.9, 2.9<br />
and 8.3%, respectively. The original regimens had to be<br />
discontinued in 19.1% cases owing to unsatisfied efficacy,<br />
untoward reaction or economic reason. The untoward drug<br />
reaction incidence of TPM was similar to CBZ and PB, but<br />
slightly higher than VPA, whereas the severity of which<br />
seemed to be the least among the four drugs. Conclusion:<br />
The use of TPM alone in the treatment of childhood<br />
epilepsy showed similar efficacy to other commonly used<br />
drugs, while its untoward reaction was relatively mild.<br />
FP-S-003<br />
Family rehabilitation on 15 children with cerebral palsy<br />
Chun-Xiang Li, Xue-Mei Liu, Ning-Bo Tang, Qing Chu, Li-<br />
Xia Li<br />
Department of pediatrics, Yantai Yuhuangding Hospital,<br />
Sandong Province, Yantai China<br />
Objective: To study the effect of family rehabilitation on<br />
children with cerebral palsy. Methods: The destination and<br />
scheme of rehabilitation were drawn up after 15 children<br />
with cerebral palsy had been evaluated systematically.<br />
Rehabilitation education and operation training were carried<br />
on to family trainers. Training contents included proper<br />
posture of holding in the arms and lying and training of<br />
exercise and speech. The patients were followed up once<br />
a month, whereas for those outside this city were followed<br />
up once every 2 months. When the patients were seen again<br />
they were evaluated again, their treatment effects were<br />
observed and the training scheme corrected if necessary.<br />
All cases were followed-up 1 year. Results: Three cases<br />
were nearly normal, ten cases were effective and two<br />
cases ineffective. Conclusions: Family rehabilitation is an<br />
effective, economic, and easy method for children with<br />
cerebral palsy.<br />
FP-S-004<br />
An open trial of flunarizine on therapy in children with<br />
migraine<br />
C.-Y. Zeng<br />
First Hospital, Guangzhou Medical College, Guangzhou,<br />
China<br />
Objective: To assess the efficacy and safety of flunarizine<br />
(sibelium) in children with migraine. Methods: Flunarizine<br />
was administered to 30 children with migraine, 5 mg every<br />
night for 2 months–1 year. Results: The effectiveness was<br />
20% after 1 week, 50% after 4 weeks, 80% after 12 weeks,<br />
TCD abnormalities were improved in 18 cases after 3<br />
months of therapy. Conclusion: Flunarizine is an effective<br />
therapeutic drug in children with migraine.<br />
FP-S-005<br />
Efficacy of topiramate (TPM) in refractory childhood<br />
epilepsies<br />
L. Cvitanovic-Sojat a , B. Mucic-Pucic a , S. Miskov b ,Z.<br />
Sabol c , T.F. Hajnžić a , M. Mataija a , T. Sojat a<br />
a Departments of Pediatrics and b Neurology, UH ‘Sestre<br />
milosrdnice’, c Outpatient Clinic ‘Dr. Sabol’, Zagreb, Croatia<br />
Objective: To analyse the efficacy and tolerability of<br />
TPM in children with refractory epilepsies. All patients<br />
treated with TPM had first failed trials of conventional antiepileptic<br />
drugs, some of them were treated with LTG, VGB,<br />
GPB, corticosteroids and IV globulins. Subjects and methods:<br />
We performed a retrospective study of 35 PTS patients<br />
(14 girls and 21 boys). The age range was 3, 5–17 years in<br />
32/35 and 8–10 months in 3/35. In 22 patients, epilepsy was<br />
complex partial, in two myoclonic, five had Lennox-Gastaut<br />
syndrome, multiple seizure types in three children and three<br />
had infantile spasms (IS). Epilepsy was symptomatic in 17/<br />
35 and idiopathic/cryptogenic in 18/35. TPM was administrated<br />
as add-on therapy, it was titrated to target dose of 6–<br />
9 mg/kg per day. The duration of follow-up was 6 months–3<br />
years. During the titration and maintenance phase we evaluated<br />
the seizure frequency, side effects and EEG in all<br />
patients, and visual evoked potentials in 20/35. Results:
Abstracts 623<br />
Seventeen/35 patients became seizure-free, among them<br />
one had IS. A seizure reduction .75% was observed in 6/<br />
35 patients, between 50 and 75% in 4/35, less than 50% in 4/<br />
35. Two/35 patients had seizures only during febrile illness<br />
and two patients with IS had their seizures unchanged.<br />
Twelve/35 patients were switched to monotherapy from<br />
add/on therapy. Side effects noted were transient change<br />
in appetite in 2/35, hyperactivity in 1/35, and hypochidrosis<br />
in 2/35. Conclusion: This report indicates that TPM was<br />
well tolerated, no serious side effects were noted. TPM<br />
was effective as add-on and monotherapy in refractory<br />
childhood epilepsies.<br />
FP-S-006<br />
Treatment of self-induced photosensitive epilepsy with<br />
dopamine agonist<br />
M. Horikawa a , R. Iwanaga b , E. Ohtaki c , T. Yamada a ,K.<br />
Tominaga a<br />
a National Higashi-Saga Hospital, Saga, Japan;<br />
b Asou<br />
Iizuka Hospital, Iizuka, Japan; c Koguma Gakuen, Ogouri,<br />
Japan<br />
We report a 9-year-old girl with self-induced photosensitive<br />
epilepsy in which bilaterally synchronous 3–4 Hz<br />
spike and wave discharges (SWDs) were induced by twirling<br />
of her hands in front of her face while facing the sun.<br />
She drooled in an absent-minded manner after turning her<br />
hands round and round, and on a few occasions she showed<br />
a transition to generalized tonic-clonic spasms. Selfinduced<br />
photosensitive epilepsy is notoriously resistant to<br />
therapy. We used dopamine agonist. A total of 5 mg<br />
bromocriptine mesilate, three times/day, was added to the<br />
previous medication (valproate 1 carbamazepine). After<br />
that, she lost consciousness less frequently and became<br />
unable to develop generalized convulsions although the<br />
hand movements persisted. However, the SWDs induced<br />
by the hand movements were still observed on EEG. It has<br />
been reported that high-frequency photic stimulation in<br />
cats significantly reduces the cortical release of dopamine<br />
and that this is not a phenomenon restricted to the visual<br />
cortex. It is thought that decrease in cortical release of<br />
dopamine during photic stimulation, as observed in cats,<br />
is probably a crucial physiopathological step in epileptic<br />
photosensitivity in man.<br />
FP-S-007<br />
Topiramate add-on or monotherapy in infantile spasms<br />
D.-C. Jiang<br />
Children’s Hospital, Dalian, China<br />
Objective: To study the effect, dosage, and adverse<br />
events of TPM in treating infantile spasms, either used as<br />
monotherapy or an add-on therapy. Methods: Eleven<br />
patients with infantile spasms were treated with TPM to<br />
a course of 4–13 months. Seven cases were used TPM as<br />
monotherapy. The patients were started at a dose of 12.5<br />
mg per day, which was increased by 12.5 mg every 3 days.<br />
Four cases used TPM as add-on therapy, but they were<br />
substituted by VPA and clonazepam for undesirable<br />
control. The clonazepam was used at a dose of 0.66 mg/<br />
day and increased gradually. Results: (1) Three gave up<br />
treatment due to the side effect and unknown reason. (2)<br />
There were a 50% or greater reduction from baseline in<br />
seizure frequency shown in 91% cases, and seven cases<br />
showed no free seizure including four cases using TPM<br />
and clonazepam. (3) Adverse reactions: one patient had<br />
impairment of verbal language, and another failed to<br />
sweat in hot days. Conclusion: TPM is an effective and<br />
safe drug used as monotherapy or with clonazepam in<br />
infantile spasms.<br />
FP-S-008<br />
Immunoregulation and therapeutic effect of biological<br />
agent in intractable childhood epilepsy<br />
Z. Xu, X. Tian, J.-Y. Lan, D.-F. Sun<br />
Department of pediatrics, the second clinical college of Jilin<br />
<strong>University</strong>, Changchun, China<br />
Objective: We treated intractable childhood epilepsy<br />
(ICE) with biological agents, IL-2 and IV IG, and investigated<br />
their immunoregulatory and therapeutic effects.<br />
Methods: 28 children with ICE were treated with IL-2<br />
and IV IG. Before and after treatment, serum IgA, IgG,<br />
SIL-2R, IL-6, T-cell subsets and anti-brain anti-body<br />
(ABAB) were examined, respectively. According to<br />
frequency of seizures, changes of EEG and improvement<br />
of immunological parameters, the immunoregulatory effect<br />
and therapeutic effect of IL-2 and IV IG were evaluated.<br />
Results: (1) The immune state: the serum IgA levels in<br />
epilepsy group were significantly lower than those in<br />
controls (P , 0:01). SIL-2R and Serum Il-6 levels in<br />
epilepsy group were significantly higher than those in<br />
controls (P , 0:01). The CD 4 /CD 8 ratio in epilepsy group<br />
was significantly lower than those in controls (P , 0:01).<br />
The positive rate of ABAB in epilepsy group was 35.7%<br />
(10/28). The parameters after treatment were statistically<br />
significant difference compared to pretreatment (P , 0:01<br />
or P , 0:05). (2) Therapeutic effect: the patients had been<br />
followed up for 0.5–2 years. The improved rate of EEG<br />
was 82.2%. To assess the parameters together, the markedly<br />
effective rate was 53.5%, effective rate 35.5% and<br />
total effective rate 89.2%. Conclusion: (1) The patients<br />
with ICE may present with disturbance of immune function.<br />
(2) IL-2 and IV IG have immunoregulatory effects on<br />
the immune abnormalities in patients with ICE. (3) Biological<br />
products, IL-2 and IV IG, have therapeutic effect for<br />
ICE.
624<br />
Abstracts<br />
FP-S-009<br />
Study on the diagnosis of childhood paroxysmal<br />
headache<br />
G.-Q. Li, H.-W. Hu, X.-Y. Ye, Z.-D. Lin, J.-W. Zhao, D.-K.<br />
He<br />
Yuying children Hospital, Wenzhou Medical College, Wenzhou,<br />
Zhejiang, China<br />
Objective: To investigate the differential diagnosis of<br />
childhood paroxysmal headache. Methods: Clinical data of<br />
122 patients with paroxysmal headache in our hospital<br />
outpatient service were analyzed. The case history, physical<br />
examination, EEG video electroencephalography (V-EEG),<br />
and transcranial Doppler (TCD) were analyzed. The patients<br />
were followed up. Results: Migraine was found in 85 of the<br />
122 patients, tension headache in 35, headache epilepsy in<br />
one, and intracranial tumor in one. Most EEG and V-EEG<br />
was normal. There was increase of diffuse slow wave, and<br />
only one of above abnormal EEG showing scattered epileptic<br />
waves. In 74 patients, TCD showed significant increase<br />
of cerebral blood flow velocity. Conclusion: Migraine and<br />
tension headache were frequent cause of childhood paroxysmal<br />
headache. The diagnosis should depend on the clinical<br />
manifestation, EEG and TCD findings. Headache<br />
epilepsy is rare. We need to differentiate headache epilepsy<br />
from paroxysmal headache only.<br />
FP-S-010<br />
Choice of anti-epileptic drugs for epilepsy caused by<br />
hypoxic-ischemic encephalopathy<br />
S.-W. Yang, H.-L. Yu<br />
Department of Pediatrics, Xianning Central Hospital, Xianning,<br />
China<br />
Objective: To improve the quality of life in patients with<br />
epileptic caused by HIE, to select suitable AED and to<br />
improve control the epileptic attacks. Methods: Retrospective<br />
analysis was performed on 46 cases to detect the different<br />
effect of different anti-epileptic drugs (AED). Results:<br />
Among 19 cases of partial seizure treated with CBZ,<br />
seizures were completely controlled in two cases, in six<br />
other cases the seizures decreased more than 75%. Of the<br />
27 cases of generalized seizure, only three out of 21 who<br />
were treated with PB alone were completely controlled, and<br />
two cases had decreased seizure frequency more than 75%.<br />
In six cases of infantile spasm, five were treated with CZP,<br />
resulting in none being completely controlled or decreased<br />
his seizure more than 75%. One case was treated with Topamax<br />
had its seizure frequency decreased more than 75%. Six<br />
out of 8 cases of partly seizure treated with the addition of<br />
Topamax were completely controlled and two other cases<br />
were decreased their seizure more than 75%. Similar results<br />
were achieved by adding Topamax in both generalized<br />
seizure and infantile spasm. Conclusion: Topamax is an<br />
ideal anti-epileptic medicine to treat secondary epilepsy<br />
caused by HIE.<br />
FP-S-011<br />
Long-term response to zonisamide monotherapy in West<br />
syndrome<br />
Y. Suzuki a,b , H. Ueda a,b , Y. Toribe a,b ,K.Imai a ,T.<br />
Matsuoka a , T. Mano a , T. Nagai a<br />
a Collaborate Clinical Research Group for Pediatric<br />
Neurology, Osaka <strong>University</strong> Medical School; b Division of<br />
Pediatric Neurology, Osaka Medical Center and Research<br />
Institute for Maternal and Child Health, Izumi City, Osaka,<br />
Japan<br />
Aim: To determine the long-term efficacy and safety of<br />
zonisamide (ZNS) monotherapy in patients with West<br />
syndrome. Methods: In our previous study, ZNS (3–12<br />
mg/kg per day) was administered to 54 newly diagnosed<br />
patients with West syndrome (symptomatic 40). Overall,<br />
11 of 54 infants (20%) had cessation of seizures and disappearance<br />
of hypsarrhythmia. These 11 ZNS responsive<br />
patients (symptomatic seven) were the subjects of this<br />
study and eligible to enter a long-term follow-up period.<br />
Results: During the follow-up period (24–79 months,<br />
mean 53 months), this response was maintained in seven<br />
patients (symptomatic three, relapse rate 36%). Seizures<br />
recurred in the remaining four symptomatic patients; three<br />
patients (patients 8—10) had relapses of spasms within 4–<br />
10 weeks after cessation of seizures, and one developed<br />
complex partial seizure 4 years after the initial suppression.<br />
The seven sustained responders had favorable prognosis;<br />
ZNS was discontinued without relapse in two, and five<br />
had normal psychomotor development or only mild impairment<br />
(DQ .70). No serious adverse reactions were noted.<br />
Conclusion: ZNS may be effective and well tolerated for<br />
patients with West syndrome.<br />
FP-S-012<br />
Clinical diagnosis of tuberous sclerosis in children<br />
J.-X. Liao, L. Chen, B. Li, T.-S. Huang<br />
Epilepsy Center and Department of Pediatric Neurology,<br />
Shenzhen Children’s Hospital and Shenzhen Institute of<br />
Pediatrics, Shenzhen, China<br />
Objective: To guide the practical use and to evaluate the<br />
diagnostic criteria for tuberous sclerosis syndrome made by<br />
the National Tuberous Sclerosis Association, the United<br />
States. Methods: The clinical data of 31 children with<br />
TSC features were studied. Results: The age ranged from<br />
2 months to 12 years (median age 2 years 1 month). The<br />
main clinical features of children with TSC were epilepsy,<br />
psychomotor delay, dermatologic lesions (hypomelanotic<br />
macules and facial angiofibromas), subependymal nodule,<br />
cortical tuber, cardiac rhabdomyoma and renal angiomyoli-
Abstracts 625<br />
poma. Of 31 cases 26 had definite TSC, three had probable<br />
TSC and 2 had possible TSC. Conclusion: The commonly<br />
encountered clinical features related to the diagnostic<br />
criteria are dermatologic lesions (hypomelanotic macules<br />
and facial angiofibromas), subependymal nodule, cortical<br />
tuber, cardiac rhabdomyoma and renal angiomyolipoma.<br />
FP-S-013<br />
Topiramate monotherapy in epilepsy of children<br />
W. Wang, J.-M. Li, Y. Chen<br />
Harbin Children’s Hospital, Harbin, Heilongjiang<br />
Province, China<br />
Objective: To observe the effect, dose and side-effects of<br />
topiramate (TPM) monotherapy in children with epilepsy.<br />
Methods: The study was an open-labeled research in 62<br />
children with epilepsy. TPM was administered as monotherapy.<br />
Result: Sixty-two cases were treated with TPM to an<br />
average course of more than 6 months. A total of 88.7% had<br />
50% reduction in seizure attacks and 50% with no attack<br />
occurred. The curative effect of primary epilepsy was<br />
obviously better than secondary epilepsy. TPM monotherapy<br />
may have satisfactory effects. The adverse reaction was<br />
slight and it decreased the titration of dose. Conclusion:<br />
TPM proves to be effective and safe monotherapy with<br />
few side-effects for all types of seizure in children with<br />
epilepsy.<br />
FP-S-014<br />
An open-labeled trial with topiramate in 46 children<br />
with epilepsy<br />
X.-H. Cheng, C. Zhu, C.-Z. Liu<br />
Department of pediatrics, Xiaogan central hospital, HuBei<br />
province, China<br />
Objective: To investigate the efficacy and side-effect of<br />
topiramate as monotherapy and concomitant therapy in children<br />
with different kinds of epilepsy. Methods: An openlabeled<br />
and self-controlled study was conducted in 46 cases<br />
of pediatric epilepsy treated by topiramate. Monodrug therapy<br />
was used in initiative patients and concomitant therapy<br />
was adopted in refractory epilepsy. Results: (1) The effective<br />
rate was 84.8% of all patients with the treatment of<br />
topiramate, seizure attacks decreased 50–74% in two<br />
cases, 13 cases reduced 75–99% and 24 cases were completely<br />
controlled. (2) Seven cases did not have any effect. In<br />
that seven cases, five cases lost contact, one case quitted<br />
because of aggravating of epilepsy. (3) Thirty-seven cases<br />
were treated by monotherapy of topiramate, 33 cases<br />
(89.1%) had satisfied effect; nine cases were under the treatment<br />
of concomitant therapy, four cases (44.4%) had<br />
evident effect. (4) Adverse reaction: dyspepsia and nausea<br />
occurred in 22 cases (47.8%), summer fever-like syndrome<br />
in 22 cases (47.8%), apathy and hypomnesia in 15 cases<br />
(32.6%), lethargy in 11 cases (23.9%), dizziness and gait<br />
imbalance in four cases (8.7%), weight reduction in four<br />
cases (8.7%), polyuria in two cases (4.4%) and rash in<br />
1case (2.2%). Conclusion: Topiramate is a safe and efficient<br />
new anticonvulsant drug. It produced a good curative effect<br />
to different kinds of pediatric epilepsy, and it can be used as<br />
a first-line anticonvulsant drug in children.<br />
FP-S-015<br />
Pallister-Killian phenotype. Diagnostic difficulties<br />
A. López-Lafuente, J. Campos-Castelló, M.-J. López-<br />
Rodríguez, E. Miravet-Fuster, N. Clusellas-Casals, J.<br />
Antich-Femenías, M.-L. Martínez-Frías<br />
Hospital Clinico San Carlos, Calle Martin Lagos S/N,<br />
Madrid, Spain<br />
Introduction: Pallister-Killian syndrome is a sporadic<br />
disorder with multiple congenital anomalies and a wide<br />
clinical spectrum. These anomalies include coarse face,<br />
hypertelorism, epicanthic folds, wide nasal bridge, prominent<br />
upper lip, dysplastic ears, temporal balding, hypotonia<br />
at birth, pigmentary skin anomalies, epilepsy and severe<br />
mental delay. Lymphocytes show a normal karyotype but<br />
a tissue-specific mosaic distribution of an additional<br />
isochromosome 12p often confined to fibroblast is found.<br />
Objective: We report four cases (three males, two of which<br />
were brothers, one female) with Pallister-Killian phenotype.<br />
Karyotype of lymphocytes was normal in all. Chromosomal<br />
analysis in fibroblasts showed tetrasomy 12p in 84.4% of<br />
them in first case, only in 2% in the second case and was<br />
normal in the other two cases. FISH showed three spots in<br />
75% of nuclei in first case, in 2% of nuclei in second and<br />
third cases and was unremarkable in the fourth. These data<br />
confirmed the diagnosis only in the first case but were not<br />
significant enough in the second and third cases. The fourth<br />
case only had a compatible phenotype. We review the clinical<br />
and cytogenetic characteristics of 50 cases reported in<br />
the literature. Discussion: The high percentage of cytogenetic<br />
abnormalities required to make the diagnosis could<br />
seem too strict. The possibility to decrease the diagnostic<br />
criteria should be considered when a compatible phenotype<br />
coexists.<br />
FP-S-016<br />
Diagnosis of attention deficit hyperactivity disorder with<br />
visual evoked potential<br />
L.-Y. Cai, M.-Z. Zhou, J.-H. Li, L.-L. Huang, S.-Z. Hu<br />
Department of Neurology, Jiangxi Children’s Hospital,<br />
Nanchang, China<br />
Objective: To investigate the clinical value of red flash<br />
visual evoked potential (FVEP) used as an index in diagnosing<br />
ADHD. Methods: In 15 cases of ADHD diagnosed by<br />
clinic (CCMD-3-R), red FVEP was tested. Trigger rate was
626<br />
Abstracts<br />
1.2 Hz. Amplitude was weighted 100 times by computer<br />
automatically. Results: According to FVEP P100 amplitudes,<br />
we divided the 15 cases of ADHD into four grades.<br />
Grades I and II (normal) (N ¼ 2 cases); grade III (mild<br />
disorder) (N ¼ 7 cases) and grade IV (N ¼ 6 cases). Diagnoses<br />
by both Red FVEP and CCMD-3-R can be confirmed<br />
in 86.67% of the cases. Conclusions: Red FVEP is a relatively<br />
objective index in diagnosing ADHD.<br />
FP-S-017<br />
Evaluation of medical treatment of late onset vitamin K<br />
deficiency with intracranial hemorrhage<br />
Y.-K. Zhu, Z.-Y. Ren, Y.-H. Liu, L.-J. Dong, Y. Liu, Q.-Z.<br />
Xu, F.-R. Lu<br />
Hospital of Chinese People’s Armed Police Forces, Harbin,<br />
China<br />
Objective: To summarize the prognosis and factors in<br />
medical treatment to late onset vitamin K deficiency with<br />
intracranial hemorrhage, and explore new treatment methods<br />
to change the prognosis. Methods: We studied 124 patients<br />
who suffered late onset vitamin K deficiency with intracranial<br />
hemorrhage in our hospital from 1996 to 2001. Thirty<br />
patients were followed up. Results: Seventy-two cases<br />
(59.5%) were given up for being worse in 1 of 2 days, 12<br />
(9.6%) cases died. Forty cases (32.2%) recovered. Among<br />
patients recovered, thirty were followed up, ten cases DQ<br />
$70 (33.3%), the rest were with low DQ or with cerebral<br />
paralysis, the prognosis was correlated with the severity of<br />
the lesions found by cranial CT. Conclusion: Patients with<br />
late onset vitamin K deficiency with intracranial hemorrhage<br />
had bad prognosis. The doctors in the primary hospitals were<br />
lack in experience of this disease, it was difficult for them to<br />
diagnose and treat this disease at an earlier stage. Medical<br />
treatment cannot get rid of the factors which were closely<br />
related to the prognosis, such as severe intracranial hypertension,<br />
cerebral hernia, and cerebral embolism. Therefore,<br />
early surgical invention may be more important than medical<br />
treatment for improving the affected infants’ living quality.<br />
FP-S-018<br />
The diagnosis and treatment of childhood moyamoya<br />
disease in 19 cases<br />
J. Hong<br />
Beijing Children Hospital, Beijing, China<br />
Objective: To explore the clinical characteristics and prognosis<br />
of childhood moyamoya disease (MMD) and the diagnostic<br />
value of neuroradiological findings. Methods: We<br />
analyzed the clinical data of 19 inpatients with MMD<br />
admitted to our hospital between December 1989 and January<br />
2000. Patients in this study consisted of 13 males and six<br />
females, aged from 2 years to 13 years and 2 months, of<br />
whom 12 cases were beyond 5 years old (63%). We followed<br />
up them for 9 months to 5 years and 4 months (mean 3 years<br />
and 3 months) in 13 cases in terms of residual neurological<br />
symptoms and activities of daily living, etc. Results: The<br />
main clinical symptoms were motor weakness of extremities<br />
or hemiplegia (17 cases), motor-aphasia (11 cases), and<br />
headache (ten cases). Stenosis or occlusion at the terminus<br />
of the siphon portions of internal carotid arteries (ICA) and<br />
proximal portions of anterior or middle cerebral arteries<br />
(ACA or MCA), and abnormal vascular networks in the<br />
brain were noted by the digital subtraction angiography<br />
(DSA) or magnetic resonance angiography (MRA). The<br />
medical treatments were also given in 18 cases. One case<br />
underwent a surgical treatment. We followed up 12 cases<br />
with medical treatments. Neurological impairment was<br />
found in ten cases, motor impairment in six, transient<br />
ischemic attack (TIA) or headaches in two, epilepsy in two,<br />
motor-aphasia in one and intellectual deterioration in five.<br />
The other two cases had a relatively favorable outcome without<br />
neurological sequelae. Of the 12 cases, nine could live on<br />
themselves. The patients with surgery remained absent of<br />
any neurological sequelae or intellectual impairment during<br />
a 2-year and 5-month follow-up period. Conclusions: Motor<br />
weakness of extremities or hemiplegia, motor-aphasia and<br />
headache were the predominant clinical features of MMD.<br />
The findings of MRA or DSA were crucial to the early diagnosis<br />
of the disease. And early diagnosis and timely treatment<br />
contributed to the improvement of the prognosis of MMD.<br />
FP-S-019<br />
Successful treatment of osteopenia with bisphosphonate<br />
in Duchenne muscular dystrophy. Case report.<br />
S. Christerson<br />
Department of Pediatrics, Örebro <strong>University</strong> Hospital,<br />
Sweden<br />
Introduction: Children with DMD often develop osteopenia<br />
from inactivity which is accentuated with loss of ambulation<br />
and the treatment with cortisone make this effect<br />
stronger. Fractures are reported in several studies. Case<br />
report: A 14 year-old boy with DMD was treated with cortisone<br />
0.35 mg per kilo from age 5:5 years until 10:8 years. At<br />
10 years he stopped walking and at 11:1 years he had a<br />
fracture of his right arm. He fell 5 months later and got a<br />
femur fracture. Dual energy X-ray absorbometry (DXA) at<br />
11:6 and 12:6 years showed a BMD 21.9 SD for age at<br />
lumbar spine. He was treated with dinatrium pamidronate<br />
15 mg i.v. once a month for a year. DXA 1 year later showed<br />
an improvement in BMD at lumbar spine with 40%. Side<br />
effects were, at first dose 30 mg, fever, stomach pain and<br />
diarrhea for 2 days. With half that dose there were no side<br />
effects. Discussion: Larson and Hendersson (2000) found<br />
significant decreased bone density in 41 boys with DMD<br />
with loss of ambulation. A total of 44% of the boys had<br />
sustained a fracture and four of nine boys stopped walking<br />
after fracture. Long-term effects of biphosphonates show
Abstracts 627<br />
normal linear growth and lamellar structure of bone. Side<br />
effects exist but are transient. Conclusion: Osteopenia in<br />
DMD can be treated with bisphosphonates, which might<br />
lessen the risk for fractures.<br />
FP-S-020<br />
Idebenone reduces protoporphyrin IX and improves<br />
cardiac function in Friedreich’s ataxia<br />
G.M. Buyse, I. Matthijs, L. Mertens, B. Eyskens, F.<br />
Weidemann, G. Di Salvo, J.L.K. Van Hove<br />
Department of Paediatrics (Neurology, Cardiology, Metabolic<br />
Diseases), <strong>University</strong> Hospital Gasthuisberg, Leuven,<br />
Belgium<br />
Background: In Friedreich’s ataxia (FRDA) no treatment<br />
is currently available despite causative gene and protein<br />
identification. The pathophysiology includes iron-induced<br />
increase in oxidative stress, with secondary deficiency of<br />
mitochondrial Fe-S cluster-containing enzymes such as<br />
ferrochelatase. A recent pilot study in three patients showed<br />
a reduction of hypertrophic cardiomyopathy with idebenone,<br />
a coenzyme Q10 analogue and a free-radical scavenger.<br />
Methods: We conducted a 1 year prospective<br />
therapeutic study with idebenone (5 mg/kg per day) in<br />
seven FRDA patients (age 8.5–27 years). The purpose was<br />
twofold: first, to investigate whether erythrocyte protoporphyrin<br />
IX (normally metabolized by ferrochelatase) is a<br />
therapeutic marker in FRDA, second, to study prospectively<br />
idebenone treatment in FRDA. Neurological function was<br />
assessed using the Cooperative Ataxia Group Rating Scale,<br />
and cardiac function by standard echocardiography and, for<br />
the first time, strain rate and strain imaging, a new method to<br />
quantify regional myocardial function. Results: Baseline<br />
levels of erythrocyte protoporphyrin IX were elevated in<br />
six out of seven patients, and levels decreased significantly<br />
during treatment in all. Idebenone did not improve neurological<br />
function. Long-term idebenone improved left ventricular<br />
mass index, cardiac ejection fraction, and some<br />
regional myocardial function. Changes in protoporphyrin<br />
IX levels did not correlate with changes in cardiac parameters.<br />
Conclusions: Thisisthefirst report showing that<br />
erythrocyte protoporphyrin IX is a potential therapeutic<br />
marker in FRDA. Our results indicate that long-term idebenone<br />
can improve cardiac function in FRDA. Cardiac strain<br />
rate and strain imaging is a sensitive method for therapeutic<br />
assessment in FRDA.<br />
FP-S-021<br />
Selective serotonin reuptake inhibitor (fluvoxamine)<br />
treatment for post-encephalitic Kuver-Bucy syndrome<br />
T. Usuugi, Y. Saito, S. Yanagaki, O. Mayu, E. Yazaki, H.<br />
Mithizu, H. Katumori, K. Hayashij, M. Osawa<br />
Department of Pediatrics, Tokyo Women’s Medical <strong>University</strong><br />
Tokyo, Japan<br />
Kluver-Bucy syndrome (KBS) is a rare amalgamation of<br />
cognitive, emotional and behavioral symptoms seen<br />
following insult to the bilateral temporal lobes. To date,<br />
effective treatment for KBS has not been established in<br />
children or in adults. We encountered a 3-year-old-girl<br />
suffering from KBS following acute encephalopathy with<br />
prolonged status epilepticus. She demonstrated most<br />
features of KBS, including hyperorality (i.e. a strong<br />
urge to put non-food items into her mouth), visual agnosia,<br />
language disorder with aphasia, placidity and memory<br />
dysfunction. MRI revealed marked bilateral frontotemporal<br />
atrophy. TRH (1 mg/day) injection therapy for<br />
2 weeks or daily carbamazepine (maximum 20 mg/kg per<br />
day) therapy failed to improve these behaviors. We treated<br />
her with a selective serotonin reuptake inhibitor, fluvoxamine,<br />
for the KBS-associated symptoms. After treatment<br />
with fluvoxamine (maximum 2 mg/kg per day) plus carbamazepine,<br />
the hyperoral behavior markedly decreased<br />
within 1 month, and fluvoxamine could be stopped after<br />
3 months without relapse. Although the precise pathophysiological<br />
mechanisms of KBS symptoms have not been<br />
elucidated, it is hypothesized that these neurobehavioral<br />
symptoms result from disturbance of specific temporolimbic<br />
networks, including the medial and lateral limbic<br />
circuits. The temporo-limbic networks interface with multiple<br />
cortical and subcortical circuits that care modulate<br />
emotional and behavioral symptoms. The serotonergic<br />
systems of these networks might play a role in the KBSassociated<br />
neurobehavioral symptoms, particularly in<br />
hyperorality in children.<br />
FP-S-022<br />
The clinical features and treatment of cerebral<br />
cavernous angiomas in children<br />
J. Xie, Z.-Y. Ma, S.-Q. Luo<br />
Department of Neurosurgery, Beijing Tiantan Hospital,<br />
Beijing China<br />
Objective: To discuss the clinical features, diagnosis<br />
and treatment of paediatric cerebral cavernomas. Methods:<br />
Over the past 11 years, 30 children with cerebral cavernous<br />
angiomas were reviewed. Twenty-seven were operated.<br />
Results: There were 25 boys and five girls. The<br />
average age was 9.4 years. Epilepsy and focal neurological<br />
deficits due to repeated hemorrhage of lesion were the<br />
most common symptoms. CT scan did not show the<br />
special characters. MRI appearances were mainly high<br />
or complex abnormal signal, with ‘ring sign’ of low signal<br />
on T1, especially T2 around the lesion. DSA did not<br />
reveal the feeding and drawing vessels. The results of<br />
operation were satisfactory. Conclusions: MRI examination<br />
is the best method for diagnosis and follow-up of<br />
cerebral cavernomas. Operation is the first choice for<br />
paediatric lesions.
628<br />
Abstracts<br />
FP-S-023<br />
Paroxysmal dyskinesias: clinical features and etiologic<br />
studies<br />
X.-H. Bao, Z.-Y. Pei, J. Qin, X.-R. Wu<br />
Department of Pediatrics, First Hospital of Peking <strong>University</strong>,<br />
Beijing, China<br />
In order to disclose the clinical feature and the potential<br />
etiology of each kind of paroxysmal dyskinesias, we<br />
reviewed cases with diagnosis of paroxysmal dyskinesias<br />
in the recent 5 years with respect to characteristics of attack,<br />
etiology and treatment response. We evaluated 12 patients’<br />
clinical manifestation, inducing factors, remission, frequencies,<br />
treatment response, etc. Etiologic studies include<br />
video-EEG monitoring, brain MRI/CT, serum ceruloplasmin<br />
level etc. Six belong to paroxysmal kinesigenic choreoathetosis<br />
(PKC), six paroxysmal dystonic choreoathetosis<br />
(PDC). There are family history in one PKC and one PDC.<br />
All patients with PKC were induced by sudden movement,<br />
had shorter duration and higher frequency than that with<br />
PDC. Video-EEG test found epileptic discharge in three<br />
with PKC, no abnormalities were found in patients with<br />
PDC. Antiepileptic drugs were very effective to PKC, and<br />
not useful in PDC. Brain MRI/CT and serum ceruloplasmin<br />
level were normal in all. In conclusion, PKC is different<br />
from PDC in respect of inducing factors, frequency, remission<br />
and the treatment. For PKC, epileptic discharges and<br />
the dramatic response to antiepileptic drugs indicated it<br />
might probably be associated with epilepsy.<br />
FP-S-024<br />
Allopurinol neurocardiac protection trial in infants<br />
undergoing heart surgery using deep hypothermic<br />
circulatory arrest<br />
R.R. Clancy, S.A. McGaurn, J.E. Goin, D.G. Hirtz, W.I.<br />
Norwood, J.W. Gaynor, M.L. Jacobs, G. Wernovsky, W.T.<br />
Mahle, J.D. Murphy, S.C. Nicolson, J.M. Steven, T.L. Spray<br />
National Institute of Neurological Disorder and Stroke<br />
Bethesda, MD, USA<br />
Objective: We conducted a single center, randomized,<br />
placebo controlled trial of allopurinol, an inhibitor of<br />
oxygen free radical production, in infants who underwent<br />
heart surgery using deep hypothermic circulatory arrest<br />
(DHCA). Methods: Allopurinol was administered before,<br />
during and after surgery. Adverse events, including<br />
seizures, cardiac events and coma were monitored. Results:<br />
A total of 318 infants, of whom 131 had hypoplastic left<br />
heart syndrome (HLHS) and 187 had other cardiac disease<br />
(non-HLHS) underwent heart surgery using DHCA. There<br />
was a non-significant treatment effect for death, seizures,<br />
and coma. When cardiac events were added to the primary<br />
endpoint, the allopurinol treatment group experiencing<br />
fewer events (38 versus 60%) in the HLHS stratum,<br />
compared with the non-HLHS stratum (30 versus 27%). In<br />
HLHS surgical survivors, 40 of 47 (85%) allopurinol-treated<br />
infants did not experience seizures, coma or cardiac<br />
events compared with 27 of 49 (55%) controls. Allopurinol<br />
did not reduce endpoint events in non-HLHS infants.<br />
Conclusions: Allopurinol provided neuro-cardiac protection<br />
in higher-risk HLHS infants who underwent cardiac surgery<br />
using DHCA. No benefits were demonstrated in lower risk,<br />
non-HLHS infants. No significant adverse events were associated<br />
with allopurinol treatment.<br />
FP-S-025<br />
Relationship between effect and serum concentration of<br />
loading dosage of phenobarbital in status epilepticus<br />
R.-F. Shi, J. Tian, K.-L. Wang, S.-Z. Sun<br />
Children’s Hospital of Hebei Shijiazhuang, China<br />
Objective: Tofind out the relationship between curative<br />
effect and serum concentration of PB with loading dosage<br />
PB in status epilepticus. Methods: We treated status epilepticus<br />
with intravenous loading dosage of PB at 15 mg/kg<br />
(total dosage #200 mg). We examined serum concentrations<br />
after 10, 15, 25, 30, 60 and 120 min. Results: Sixtyfour<br />
cases were treated, 51 were seizure free in 30 min.<br />
Among them, seizures stopped within 10 min in three;<br />
within 10–15 min in seven; within 15–20 min in 23; within<br />
25–30 min in 18. In 18 cases, seizure frequencies decreased<br />
in 60 min. Six cases showed no responses. In our study, we<br />
examined 180 blood samples. After treatment, serum PB<br />
concentration reached the therapeutic blood level in 15<br />
min. Seizures were controlled after the serum concentration<br />
was above this level. Conclusion: Loading dosage of iv was<br />
highly effective in treating status epilepticus. After 15 min<br />
serum PB concentrations reached the therapeutic blood<br />
level.<br />
FP-S-026<br />
Effects of computerized ultrasonic wave and medium<br />
frequency therapeutic in peripheral facial neuritis in<br />
children<br />
P. Zhang<br />
Department of neurology, Children’s Hospital, Chongqing<br />
<strong>University</strong> of Medical Sciences, Chongqing, China<br />
To explore a new physical treatment which would be safe<br />
and effective for peripheral facial neuritis in Children. Methods:<br />
Forty-one patients with peripheral facial paralysis were<br />
randomly divided into two groups: 25 patients as experimental<br />
groups, received computerized ultrasonic wave and<br />
medium frequency therapeutic apparatus, and 16 as<br />
controls, received electrical acupuncture treatment. The<br />
course of diseases ranged from 1 to 8 weeks. The cure<br />
rate, general effective rate and side effects were recorded.<br />
We considered 20 times treatment as a treatment course and
Abstracts 629<br />
evaluated three times totally for each patient. Facial nerve<br />
function was evaluated according to revised House Brackmann<br />
(H-B) criteria. Results: (1) The general effective rate<br />
in the control group was 62.5% and among them the cure<br />
rate was 37.5%; whereas in the experimental group, these<br />
were 84 and 76%, respectively. Comparison of cure rate<br />
between the two groups showed the difference was significant<br />
(x 2 ¼ 3.8567 , 11.91, P , 0:05 , 0:01). (2) All<br />
patients in the control groups suffered from pain and the<br />
obedience was poor, while nobody in the experimental<br />
groups were upset and the patients expressed good obedience,<br />
as well as their parents. (3) During the treatment, no<br />
infection occurred in two groups. Conclusion: Computerized<br />
ultrasonic wave and medium frequency therapeutics<br />
was better than electrical acupuncture in peripheral facial<br />
neuritis in children. The patients with the apparatus avoid<br />
secondary infection and the danger of pin breaking. There<br />
was nearly no pain. It is a safety and effective physical<br />
treatment for peripheral facial neuritis in children.<br />
FP-S-027<br />
Management of cerebral palsy in Egyptian children with<br />
botulinum toxin type A (BTX-A)<br />
A. Raouf, R.A. Hakim<br />
Police General Hospital, Agooza, Cairo, Egypt<br />
Background: Cerebral palsy is the commonest cause of<br />
physical handicap in children in Egypt, occurring in 3–4 of<br />
every 1000 live births. The most common form of cerebral<br />
palsy is spastic type (88%). Objective: The safety and dosage<br />
of botulinum toxin type A (BTX-A) in children under 2 years<br />
of age were examined in a 18 month period at Police General<br />
Hospital, Cairo, Egypt. Methods: Twenty-two children with<br />
diplegia, aged between 11 and 24 months, were studied. The<br />
average dose was 4–6 u/kg body weight and the interval<br />
between injections was 3–6 months. Results: Significant<br />
improvement in both Ashworth score (P , 0:001) and<br />
ROM (P , 0:01) was achieved and the safety record for<br />
these treatments was excellent. The most commonly reported<br />
adverse effect, apart from local hematoma, was muscle weakness.<br />
Conclusion: Children who respond to BTX-A treatment<br />
have improved physical functioning and gait, and are able to<br />
sustain these results long term.<br />
FP-S-028<br />
Influence of anticonvulsants on carbamazepine diurnal<br />
fluctuation and plasma protein binding in epileptic<br />
children<br />
B. Steinborn<br />
Chair and Department of Developmental Neurology K.<br />
Marcinkowski <strong>University</strong> of Medical Sciences, Poznań,<br />
Poland<br />
CBZ is one of the most commonly used AED. It is<br />
frequently prescribed in combination with other AEDs,<br />
leading to drug interactions. Aim of study was to estimate<br />
pharmacokinetic parameters of CBZ plasma protein binding;<br />
assess diurnal fluctuations in total and unbound CBZ of<br />
epileptic children treated with VPA, LTG, VGB or TPM.<br />
Eighty children, aged 3–18 years were included to the study.<br />
The doses of CBZ did not differ statistically. Blood samples<br />
were taken in steady state before the morning dose and<br />
subsequently every 3 for 24 h. Diurnal fluctuations of<br />
serum concentrations of total and free CBZ during CBZ 1<br />
VPA, CBZ 1 LTG, CBZ 1 TPM and CBZ 1 VGB were<br />
synchronous and in therapeutic range. The fluctuation<br />
index (FI) of total CBZ for polytherapy CBZ 1 VPA and<br />
CBZ 1 LTG were higher than for combination of CBZ 1<br />
TPM or CBZ 1 VGB. Diurnal fluctuations of total CBZ<br />
were prominent than fluctuations of unbound CBZ in comedication<br />
with VPA, LTG or VGB. FI for free and total CBZ<br />
in bitherapy with TPM did not differ statistically. Mean<br />
CBZ free fraction in bitherapy with LTG was 16.4%, with<br />
VGB 15.9% with VPA was 18.2% and with TPM – 21.5%.<br />
The FI for CBZ was the highest in LTG. The increase of free<br />
CBZ in patients treated with VPA or TPM may be a result of<br />
pharmacokinetic interactions between these AEDs.<br />
FP-S-029<br />
Gene therapy to murine MPS VII by human neural stem<br />
cells transplantation<br />
X.L. Meng a , J.S. Shen a , T. Ohashi a,b , S.U. Kim c , Y. Eto a,b<br />
a Department of Gene Therapy, Institute of DNA Medicine,<br />
The Jikei <strong>University</strong> School of Medicine, Tokyo, Japan;<br />
b Department of Pediatrics, The Jikei <strong>University</strong> School of<br />
Medicine; c Division of Neurology, Department of Medicine,<br />
<strong>University</strong> of British Columbia, Canada<br />
Cell therapy to murine MPS VII, authentic model of<br />
human Sly syndrome, caused by the deficiency of the lysosomal<br />
enzyme, b-glucuronidase, was studied. Immortalized<br />
human neural stem cell line, HB2F3, was labeled with EGFP<br />
and transplanted into the lateral ventricles of newborn normal<br />
mouse brain. At 2 weeks after transplantation, EGFP positive<br />
cells were observed to be lining the surfaces of the ventricles.<br />
At 4–6 weeks, some cells migrated to the olfactory bulb, the<br />
striatum and cortex, differentiated into neurons, astrocytes<br />
and oligodentrocytes in vivo. Further, we studied if the<br />
human neural stem cell transplantation is effective for the<br />
treatment of CNS pathology of MPS VII. Human neural<br />
stem cells over-expressing 80 times more b-glucuronidase<br />
activity in vitro were generated by retroviral transduction<br />
which encoding a human b-glucuronidase cDNA under the<br />
CMV promoter. After neonatal intraventricular transplantation,<br />
transplanted cells expressed biological active b-glucuronidase<br />
in the MPS VII mouse brain, which was elevated to<br />
5% that in the wild type mouse in whole brain homogenize at<br />
3 weeks after transplantation. The distribution pattern of the<br />
transplanted cells was similar to that of EGFP expressing
630<br />
Abstracts<br />
cells. Pathological improvement is currently under investigation.<br />
FP-S-030<br />
Topiramate monotherapy in childhood epilepsy<br />
M. Mazurkiewicz-Bel⁄dzińska a , A. Matheisel a , J. Wendorff b ,<br />
G. Ircha b , R. Chmielewski c<br />
a Department of Developmental Neurology Medical <strong>University</strong><br />
of Gdańsk, Gdańsk, Poland; b Department of Child<br />
Neurology, Institute of Polish Mother Health Centre,<br />
L⁄ ódź, Poland;<br />
c Johnson and Johnson Pharmaceutical,<br />
Warszawa, Poland<br />
Introduction: Topiramate is a new antiepileptic agent<br />
with multiple mechanisms of action. It is a broad spectrum<br />
of antiepileptic effect. It can be used for therapy of partial,<br />
generalized seizures and epileptic syndromes. The efficacy<br />
of TPM on monotherapy was evaluated in several clinical<br />
studies, but there are still limited data according to use of<br />
topiramate in monotherapy in children. Materials and methods:<br />
In order to evaluate the efficacy and tolerability of TPM<br />
monotherapy of childhood epilepsy, we analyzed prospectively<br />
two patients on TPM therapy as a first line antiepileptic,<br />
and 16 in whom previous AED was switched to TPM<br />
monotherapy. There were 12 children with symptomatic and<br />
six with cryptogenic epilepsy. Majority of the patients had<br />
partial evolving to secondarily generalized seizures. We<br />
administered TPM according to the slow-titration schema:<br />
initial dose was 0.5–1 mg/kg per day, the dose increased<br />
0.5–1 mg/kg every 10–14 days. The dosage of TPM at the<br />
steady state was 7–11 mg/kg. The mean time on TPM<br />
monotherapy was 10 months. Results: The mean frequency<br />
of seizures before TPM therapy was 1 per month to 2–3 per<br />
day. Seizure reduction was observed in 17 patients, nine of<br />
them were seizure free during the observation. Observed<br />
adverse events were mostly mild and transient. In one this<br />
led to discontinuation of treatment. Conclusions: The use of<br />
TPM as a first-line monotherapy in children with epilepsy<br />
seemed to be valuable and promising.<br />
FP-S-031<br />
Response to topiramate in children with catastrophic<br />
epilepsy syndromes<br />
R. Chmielewski a , M. Mazurkiewicz-Bel⁄dzińska b ,A.<br />
Matheisel b , B. Mańkowska b<br />
a Johnson and Johnson Pharmaceutical, Warszawa, Poland;<br />
b Department of Developmental Neurology Medical <strong>University</strong><br />
of Gdańsk, Gdańsk, Poland<br />
Aim of the study: Several epileptic syndromes in children<br />
are characterized by treatment resistant seizures, progressive<br />
loss of higher intellectual functions and characteristic electroencephalographic<br />
abnormalities. It is well known that<br />
control of seizure results in better intellectual outcome.<br />
The long-term efficacy and tolerability of medication are<br />
important especially in epilepsy. Materials and methods: In<br />
order to estimate the long-term effectiveness of TPM therapy<br />
in children with drug-resistant epilepsy syndromes, medical<br />
records of children with West syndrome (3), Lennox-Gastaut<br />
syndrome (38), myoclonic-astatic epilepsy (3) and severe<br />
myoclonic epilepsy (Dravet syndrome) (3) treated with<br />
TPM were analyzed. Mean age of the patients was 6.8<br />
years (range 7 months–16 years). TPM was administered as<br />
add on therapy with doses ranging 6–10 mg/kg per day. The<br />
mean age of treatment was 12 months and follow up was 18<br />
months. In order to estimate retention rates and factors<br />
predicting successful treatment with TPM we used<br />
Kapplan–Meyer analysis and Gehan tests. Results: A total<br />
of 50% remained in TPM therapy after 12 months of treatment.<br />
The factors which influenced long-term retention rates<br />
were younger age presence of tonic or absence seizures.<br />
Forty-one percent remained in TPM therapy after 18 months<br />
of treatment and seven (37%) of them were seizure free.<br />
Conclusions: Our results showed valuable and long-term<br />
efficacy of TPM in treating drug resistant epileptic seizures<br />
in childhood.<br />
FP-S-032<br />
New antiepileptic drugs in childhood epilepsy – long<br />
term efficacy, tolerability and quality of life<br />
M. Mazurkiewicz-Beldzińska a , A. Matheisel a , B. Mankowska<br />
a , J. Biclicka-Cymerman b<br />
a Department of Developmental Neurology, Medical <strong>University</strong><br />
of Gdansk, Gdans, Poland; b Department of Neurology,<br />
Children’s Hospital, Warszawa, Poland<br />
The long-term efficacy and tolerability of medication are<br />
important in epilepsy. Since 75% of first epileptic seizures<br />
occur before 18 years of age, it is important to have an idea<br />
which drug might have the greatest chance of success in children.<br />
There are a few methods of assessing quality of life in<br />
children with epilepsy. Considering the available methods of<br />
assessing quality of life in epilepsy, we have constructed and<br />
validated a questionnaire for parents children with epilepsy to<br />
estimate the influence of epilepsy on the main aspects of life in<br />
their children, and subsequently, to assess family dynamism.<br />
A retrospective chart review was conducted for epilepsy<br />
patients from our departments who were on lamotrigine<br />
(LTG) (157), vigabatrin (VGB) (79) and topiramate (TPM)<br />
(101). We calculated the retention rates for each antiepileptic<br />
usingKapplan–Meyeranalysis.Thecorrelationbetweentherapeutic<br />
effect and type of epilepsy, age of onset, etiology and<br />
concomitantantiepileptictreatmentwasanalysed.Thetimeof<br />
follow-up was 21 months. After 1 year 69% stayed on TPM,<br />
68% on LTG and 48% on VGB. After 2 years, the retention<br />
rates were 57, 61 and 30%, respectively. The seizure free rates<br />
after 1st year of treatment were 31% for TPM, 28% for LTG<br />
and22%forVGB.Therewasstrongcorrelation between good<br />
LTG effect and absence of CBZ in concomitant therapy, and
Abstracts 631<br />
the presence of generalized seizures. For VGB, correlation<br />
was good between the presence of psychomotor retardation<br />
and better seizure outcome. For TPM, we noticed better<br />
outcome in patients with symptomatic or cryptogenic epilepsies.<br />
The greatest improvement in quality of life in patients<br />
was when their seizures were controlled. Interestingly, it did<br />
not reduce the fear of the parents about child’s general health.<br />
Improvement in the quality of life was reached earliest with<br />
TPM therapy but it lasted longer on LTG therapy. Our results<br />
showed that new antiepileptic drugs can serve as a good treatment<br />
strategy for many childhood epilepsies. They can<br />
provide seizure remission or significant seizure reduction.<br />
They could be considered (in many cases) as the first-line<br />
antiepileptic medications.<br />
FP-S-033<br />
Use of trihexiphenydyl (THP) in dystonic cerebral palsy<br />
– a study of 14 patients<br />
V. Udani, M. Khadye<br />
P.D. Hinduja National Hospital and Medical Research<br />
Centre V.S. Marg, Mahim, Mumbai, India<br />
Dystonic cerebral palsy is a significant problem. High dose<br />
trihexiphenydyl has been used successfully in dystonia due to<br />
other causes. This study was undertaken to assess the effect of<br />
this drug in dystonic cerebral palsy (DCP). Methods: DCP<br />
were identified from our OPD. Those with progressive<br />
diseases were excluded. Our therapist assessed the dystonia<br />
as being functionally handicapping before inclusion. Video<br />
recording was performed using a predetermined plan and<br />
THP started at a minimum dose which was increased if<br />
needed. After 3 months a repeat video recording was<br />
performed. Both video were undated and reviewed by a<br />
blinded observer using the Barry-Albright scale. Results:<br />
Fifteen children (M:F 8:7), median age 8 months were<br />
recruited. Etiology was prenatal in two, perinatal in nine<br />
and postnatal in three. One child was excluded when follow<br />
up revealed a progressive disorder. THP was started at a<br />
median age of 12 m (range 5–144 m). Mean daily dosage<br />
was 9.9 mg/day (range 3–30 mg). Significant improvement<br />
was noted in scores in 13 children though one stopped treatment<br />
due to fever. One child worsened. The main improvement<br />
was in upper limb and neck dystonia. Functional<br />
improvements were noted in all 12 patients who continued<br />
the drug. Conclusion: High dose THP seemed to be effective<br />
for dystonic CP. It seemed to improve functional status and<br />
was well tolerated.<br />
FP-S-034<br />
Infantile spasms in Down syndrome: good response to<br />
short course of vigabatrin therapy<br />
R. Nabbout a,b , I. Melki a , B. Gerbaka a , O. Dulac b ,C.<br />
Akatcherian a<br />
a Department of Pediatrics, Hôpital Hôtel Dieu de France,<br />
Université St Joseph, Beirut, Lebanon,<br />
2 Department of<br />
Neuropediatrics, Hôpital St Vincent de Paul, Paris, France<br />
Purpose: To evaluate the efficacy of VGB in treating<br />
infantile spasms associated with DS and to assess the feasibility<br />
of early withdrawal in order to reduce the possibility<br />
of retinal toxicity. Patients and methods: Five DS children<br />
presenting with IS were treated with vigabatrin as first line<br />
monotherapy in an open prospective study. The mean age of<br />
VGB treatment was 9.9 months (range ¼ 7–14.6 months).<br />
The short term response was evaluated based on clinical<br />
response of disappearance of spasms and of paroxysmal<br />
interictal activity on EEG. VGB was continued in responders.<br />
The treatment was tapered gradually over 1 month<br />
after 6 months in those who were still spasms free. Results:<br />
Four children became spasms free on VGB (75–100 mg/kg<br />
per day) and three responded within 1 week. This response<br />
was maintained during the 6 months in VGB treatment.<br />
After VGB withdrawal with follow-up ranging from 2 to 4<br />
years, none of the responders experienced spasms recurrence<br />
or other types of seizures. Conclusion: Our study<br />
confirmed the efficacy of VGB in Infantile Spasms associated<br />
with Down Syndrome. Moreover, the duration of<br />
VGB treatment can be reduced to 6 months without relapse<br />
of IS. This short treatment might reduce the risk of developing<br />
visual field constriction.<br />
FP-S-035<br />
Analysis on myelin basic protein level in serum and CSF<br />
of infant with intracranial hemorrhage<br />
Y.-Y. Yang, X. He, S.-D. Yang<br />
Neurological and Rehabilitating Department, Guangzhou<br />
Children’s Hospital, Guangzhou, China<br />
Objective: To investigate myelin basic protein (MBP) in<br />
CSF and serum in intracranial hemorrhage (ICH) infant,<br />
study the relation between ICH and quantitative MBP.<br />
Methods: Thirty-eight cases were studied with easy MBP-<br />
ELISA method; study group I (n ¼ 16) were substantial (or<br />
combined with ventricular) hemorrhage, while group II<br />
(n ¼ 22) were non-substantial. There were ten cases in<br />
control group their quantitative MBP in CSF and serum<br />
were tested, then repeated and compared after treatment<br />
for 4–5 weeks. Results: Quantitative values MBP in CSF<br />
and serum in both study groups were significantly higher<br />
than control group (P , 0:01), while values in substantial<br />
group were also significantly higher than non-substantial<br />
one (P , 0:01). MBP levels did not decrease after treatment<br />
for 4–5 weeks. Conclusion: Quantitative test for MBP in<br />
CSF and serum can be used as a biochemical guideline for<br />
the diagnosis to this disease, and helpful in predicting prognosis.
632<br />
Abstracts<br />
FP-S-036<br />
Significance of serum S-100B and NSE of children with<br />
head injury<br />
L.-L. Jin<br />
The pediatric of Tian tan Hospital, Beijing, China<br />
Objectives: To study the significance of measurement for<br />
S-100B and NSE in serum of children with head injury.<br />
Methods: Blood samples were taken shortly after the trauma<br />
(12–24 h) 18 with severe head injury patients (GCS ,8) and<br />
18 minor head injury (GCS .12). Blood was allowed to clot<br />
and after centrifugation for 30 min (3000 g, 4 min) serum<br />
was stored at 2308C for later analysis. Serum protein S-<br />
100B and NSE were analyzed by use of immunoluminometric<br />
assays. In 16 healthy children these markers were<br />
also measured. S-100B and NSE concentrations in serum<br />
of patients and controls were compared. Results: The differences<br />
of serum S-100B and NSE in each group (group 1,<br />
group 2, and controls) are significant. The values of mean<br />
serum S-100B and NSE are as follows: group 1 S-100B:<br />
1.05 ^ 0.52 mg/l, NSE; 69.13 ^ 37.86 mg/l group 2 S-<br />
100B: 0.47 ^ 0.21 mg/l, NSE: 26.14 ^ 13.46 mg/l, controls,<br />
S-100B: 0.19 ^ 0.09 mg/l, NSE: 14.43 ^ 7.70 mg/l.<br />
Compared between groups 1 and 2 S-100B (t ¼ 4:57,<br />
P , 0:01), NSE (t ¼ 4:54, P , 0:01); group 2 and control<br />
S-100B (P ¼ 4:724, P , 0:01); NSE (P ¼ 3:059,<br />
P , 0:01), group 1 and control S-100B (t ¼ 6:569,<br />
P ¼ 0:00); NSE (t ¼ 5:665, P ¼ 0:00). Conclusion: S-<br />
100B concentration was higher in severe head injury than<br />
minor head injury. Median NSE concentration was higher in<br />
patients than controls and severe head injury higher in<br />
patients than that of minor head injury patients. S-100B<br />
and NSE is a useful marker for brain damage and neuron<br />
damage in severe and minor head injury.<br />
FP-S-037<br />
Evaluation of visual-motor Bender-Gestalt perception<br />
test (Bender test) in diagnosis of childhood migraine<br />
I. Frančula, I. Prpić, I. Vlašić-Cicvarić, Z. Korotaj, E.<br />
Paučić-Kirinčić<br />
<strong>University</strong> Children Hospital ‘Kantrida’ and Medical<br />
Faculty of <strong>University</strong> of Rijeka, Rijeka, Croatia<br />
According to IHS 3–5 attacks of headache is required to<br />
fulfil criteria for migraine, which sometimes means a period<br />
of year or more. In order to speed up the diagnosing of<br />
migraine we have analyzed the results of Bender test. Retrospectively<br />
results of the Bender test were analyzed in 24<br />
children with definite migraine diagnosis (according IHS<br />
criteria). There were nine boys (mean ¼ 9.8 age) and 15<br />
girls (mean ¼ 11.8 age). Boys were statistically significantly<br />
younger than girls. No difference between boys and<br />
girls regarding their general intelligence and social background.<br />
The children performed Bender test at an early<br />
phase of the headache (mean ¼ 2 days, SD 1.5 day) and<br />
repeated in a period without headache (mean ¼ 6 days,<br />
SD 2.5). At an early stage after the headache, suspected or<br />
definite organic cerebral dysfunction was found at 20 children<br />
while four had normal results. Bender test performed in<br />
phase without headache revealed only three children with<br />
organic cerebral dysfunction, and the rest of the children had<br />
normal results. There was statistically significant difference<br />
between the results of first and second Bender test measurement<br />
(Fisher test: 0.00015). Our results revealed that visualmotor<br />
capacity is disturbed at children with migraine in an<br />
early phase of headache and it took at least 6 days to normalize.<br />
These findings demonstrated that Bender test may be<br />
used as a rapid and useful diagnostic tool in migraine diagnosis.<br />
One can make safe conclusion of migraine accompanied<br />
by disturbed visual-motor perception. Furthermore, it<br />
was shown that children with migrainous attack need 4–8<br />
days to regain their visual-motor ability which is important<br />
information considering child’s daily school obligations,<br />
particularly reading and writing skills.<br />
FP-S-038<br />
Pontine/extrapontine myelinolysis due to dysequilibrium<br />
syndrome<br />
Ö. Faruk Aydın a ,Ç.Üner b ,N.Şenbil a ,K.Bek c ,Ö. Erdoǧan c<br />
a Departments of Pediatric Neurology and c Pediatric<br />
Nephrology; b Division of Radiology, Dr. Sami Ulus Children’s<br />
Hospital, Ankara, Turkey<br />
Neurological disorders may be seen in end-stage renal<br />
disease patients due to complications of haemodialysis or<br />
peritoneal dialysis. A dysequilibrium syndrome may be<br />
seen, usually soon after or towards the end of dialysis. We<br />
report a patient with pontine/extrapontine myelinolysis due<br />
to dysequilibrium syndrome. The patient had depressed<br />
consciousness, agitation and tremor towards the end of the<br />
second peritoneal dialysis with stupor and hyperactive deep<br />
tendon reflexes. Brain CT scan showed hypodense lesions in<br />
pontine and extrapontine locations without radiocontrast<br />
medium enhancement. After 2 days, the patient had only<br />
memorial deficits. A follow-up Brain CT scan 1 week<br />
later showed a decrease of the lesions in pontine and extrapontine<br />
locations. Central pontine/extrapontine myelinolysis<br />
should be suspected and investigated in the acute<br />
neurological disorders of dialysis patients.<br />
FP-S-039<br />
Complex metabolic therapy at newborns affected by<br />
central nervous system damage<br />
T.A. Djumabekov, B.D. Zhurkabayeva, C.V. Malinina<br />
Children’s Hospital No. 1, Almaty, Republic of Kazakhstan<br />
Objectives: Determining efficiency of a complex hyperbaric<br />
oxygenation and neurometabolic therapy at newborns
Abstracts 633<br />
with hypoxic and ischemic damage of CNS Methods: Eighty<br />
newborns with clinic damage of CNS and with manifestation<br />
of consciousness disturbance of CNS, spoor-35 children,<br />
coma-25 children. Blood circulation and breathing<br />
disturbance, edema of brain symptoms have been identified<br />
by the most of children. The hyperbaric oxygenation had<br />
been prescribed to the main group of children (50 patients)<br />
during 30 min in combination with neurometabolic medicines:<br />
Instenon 1 ml in 5% of glucose solution together with<br />
Actovegin 1000 mg in 24 h. The therapy has been effecting<br />
about 5–10 days. The control group children had only<br />
hyperbaric oxygenation. Results: During complex hyperbaric<br />
oxygenation and neurometabolic therapy had been determined<br />
improvement of rehabilitation processes: the positive<br />
dynamic in neuroreflection sphere, recovery of consciousness,<br />
stabilization of hymodynamic indexes and spontaneous<br />
breathing. The critical condition recovery of<br />
newborns reduced by 2–3 days, lethality was lowered<br />
(comparing with control group) Conclusion: Carrying out<br />
hyperbaric oxygenation and neurometabolic therapy in<br />
combination with Instenon and Actovegin at newborns<br />
with hypoxic and ischemic damage advanced the date of<br />
rehabilitation and also critical Condition recovery. In the<br />
result of this lethality was lowered, staying patients in clinic<br />
was reduced by 3 days. That approves that this method is<br />
advisable for widely using.<br />
FP-S-040<br />
Treatment of movement disorders introducing<br />
homeopathic medicine of original method<br />
T. Osipenko, O. Osipenko<br />
Scientific medical Center on treatment and prophylaxis of<br />
neurologic disability in children, Moscow, Russia<br />
Six courses of treatment have been done in a half year’s<br />
time during 3 years 20 children with movement disorders<br />
from city Pavlodar in country Kasahstan. There were children’s<br />
cerebral paralyses spastic and spastic-hyperkinetic<br />
forms. Complete course of treatment includes: (1) microinjections<br />
biologically active medicaments – homeopathics<br />
medicines by cerebrum compositum, Traumell, coenzyme<br />
compositum (Heel, Baden-Baden) in the perineural, periganglonal,<br />
miomeres and scleromeres points in the spinal<br />
card segmentes, which permits to correlate differentially the<br />
pathological posotonic and motor functions. (2) Scleromere-point<br />
pharmacomassage by Traumel pointment.<br />
After first injection course the changes were fast. Spastic<br />
syndrome and hyperkinesis are significantly decreased. At 3<br />
years children are independently walking and talking.<br />
FP-S-041<br />
Diagnostic criteria for Rett syndrome in children<br />
N.V. Andreyenko, O.I. Maslova, V.M. Studenikin<br />
Division of Psychoneurology, Research Institute of Pediatrics,<br />
Scientific center of Child Health (Russian Academy of<br />
Medical Sciences), Moscow, Lomonosovsky, Russia<br />
Background: A hereditary disease, known as Rett<br />
syndrome, that affects exclusively girls, remains a point of<br />
interest both for neurologists and psychiatrists since it has<br />
been described in 1966 by A. Rett. Goal: The goal was to<br />
determine clinical and diagnostic criteria for Rett syndrome<br />
in pediatric patients. Method: For that purpose we have<br />
observed 22 female patients (aged 1–7 years), using conventional<br />
neurological diagnostic methods, including EEG, CT<br />
and MRT, ultrasonics, etc. Results: Eighteen patients were<br />
diagnosed as having Rett syndrome in our clinic (81.8%).<br />
The main clinical findings in Rett patients were the following:<br />
(1) motor development delay (100%); (2) mental retardation<br />
(100%); (3) manual stereotypy (100%); (4) mild<br />
respiratory distress: episodes of hyperventilation and/or<br />
apnea (86.4%); (5) muscular hypotonicity (86.45); (6)<br />
seizures (72.7%); (7) microcephaly (72.7%); (8) ataxia<br />
(68.2%); (9) induced screams and/or laughter (68.2%);<br />
(10) hypersalivation (68.2%); (11) autism (autistic features)<br />
(54.5%); and (12) bruxism (50.0%), and autoagression<br />
(18.2%). Other (additional) symptoms were not so frequent<br />
or evident. MRI and CT scans revealed cortical atrophy in<br />
frontal-temporal areas of 12 patients (54.5% of cases). Characteristic<br />
EEG findings in Rett patients included quick<br />
complexes ‘peak-slow wave’ configurations with predominant<br />
localization in central areas of the brain. Conclusion:<br />
Our data allow us to conclude, that combination of manual<br />
strereotypy, respiratory paroxysms (apneic spells) and<br />
seizures against the background of developing microcephaly<br />
and progressing disturbances of psycho-motor sphere<br />
should be considered as pathognomonic diagnostic criteria<br />
for establishing the diagnosis of Rett syndrome in children.<br />
FP-S-042<br />
Thallium-201 SPECT in pediatric brain tumors<br />
V. Humbertclaude, J. Chevalier-Tessier, N. Leboucq, A.<br />
Roubertie, B. Echenne, P. Coubes<br />
Department of Pediatric Neurology and Neruosurgery,<br />
CHU Saint Eloi-Gui de Chauliac, Montpellier, France<br />
We retrospectively studied 59 children (4 months–16<br />
years of age). To determine whether Thallium 201 (T1)<br />
SPECT could detect malignant brain tumors and provide<br />
relevant information during follow-up that could not be<br />
derived from MRI imaging. A total of 209 T1 SPECT<br />
were performed. Histological diagnosis was obtained in<br />
each case. Results of T1 SPECT were compared to clinical,<br />
histological and MRI Results. Thallium uptake was considered<br />
significant when the ratio to a homologous region of<br />
interest was equal or superior to two. Twenty-five patients<br />
were studied at the moment of initial diagnosis. Thallium<br />
uptake was present in 16 cases with high grade malignant<br />
tumor. Nine cases with low grade tumor were Thallium
634<br />
Abstracts<br />
negative. A total of 184 T1 SEPCT were realized postoperatively<br />
and/or during medical therapy. SPECT scans<br />
(147) realized in children with absence of tumor recurrence<br />
or evolution on MRI showed absence of Thallium uptake<br />
(true-negative results). In one of these cases, T1 SPECT<br />
permitted the diagnosis of radionecrosis. Thirty true-positive<br />
results were obtained. Thallium uptake was present in<br />
29 SPECT scans realized in children with MRI in favor of<br />
tumoral activity. In one supplementary case. T1 uptake<br />
revealed tumor recurrence 1 month before MRI. False negative<br />
results were observed in two cases, and false positive<br />
results in five cases. Thallium 201 SPECT provided useful<br />
information for the diagnosis and the follow-up of pediatric<br />
malignant brain tumors, even in posterior fossa location,<br />
technically more difficult to study by SPECT.<br />
FP-S-043<br />
Clinical study of treating cerebral palsy with Chinese<br />
and Western medicine<br />
Z.-H. Liu, P.-G. Pan, M. Ma<br />
Pediatric Neurology, Department of Recovery Hospital for<br />
Women and Children, Nanhai, Guang Dong, China<br />
Objective: To investigate the better effective CP rehabilitation<br />
mode and suit the condition of our country. Methods:<br />
To implement modern rehabilitation (western<br />
medicine 1 physic therapist) 1 tradition rehabilitation<br />
(acupuncture, traditional Chinese medicine) 1<br />
rehabilitation mode of home rehabilitation. A total of 300<br />
CP patients of 1–7 years old were randomly divided into two<br />
grouts for clinical study. Results: In the recent period of<br />
treatment group (3 months) there were obvious effects.<br />
Value of big motion, fine action DQ, MQ, GMFM ascended<br />
more than before treatment (P , 0:01). Cranial CT cerebral<br />
atrophy, cerebromalacia recovery normal tare was 26.5%.<br />
There was significant difference (P , 0:01). Conclusion:<br />
Chinese and western rehabilitation mode is better effect<br />
and suit the condition of our country CP rehabilitation<br />
mode.<br />
FP-S-044<br />
Role of botulinum toxin in cerebral palsy<br />
P.A.M. Kunju<br />
Department of Pediatric Neurology, Medical College<br />
Trivandrum, Kerala, India<br />
We have tried botulinum toxin A (BT) for spasticity<br />
(diplegic, hemiplegic or choreoathetosis) management in<br />
15 children with cerebral palsy. Ten of them had severe<br />
spastic diplegia, three had hemiplegia and two had athetosis.<br />
All children were undergoing physiotherapy with monitoring<br />
of their baseline status for 6–24 months before BT injection.<br />
Six of them were walking with varying disability and<br />
nine were either sitting and standing with support only.<br />
Twelve had calf muscle spasticity leading to equinus deformity,<br />
ten had scissoring due to adductor spasm and nine had<br />
flexed knee posture due to hamstring spasm. Two of them<br />
were having very limited range of movement at ankle and<br />
knee. Target muscles identified by functional spasticity<br />
assessment or by EMG guidance. The mean follow-up<br />
time was 25 months. Post injection, intensive physiotherapy;<br />
splinting orthoses and other appliances were done<br />
either by the advice of physiatrist or by the author himself.<br />
Response parameters included changes in muscle tone<br />
assessed by the modified Tardieu scale, periodic observation<br />
of longitudinal gait parameters as well as parental assessments<br />
of improvement. Gait recording was done on videotape<br />
for eight patients. The effect was evident as early as 3–5<br />
days. The peak effect was noticed by 1–2 weeks in the<br />
majority; the effect lasted for 3–10 months. In five of<br />
these patients a repeat injection was done during a varying<br />
period of 4–9 months by the suggestion of relatives, as they<br />
wanted to consolidate the positive response in spite of the<br />
high cost of the treatment. All children except two with<br />
fixed contractures experienced decreased spasticity scores,<br />
scissoring, equinus deformity and improved mobility. Three<br />
non-ambulatory children became ambulatory with assistance<br />
and five with assisted ambulation became more independently<br />
mobile. Video analysis revealed comparative<br />
improvement. Ability to rise from sitting to standing also<br />
demonstrated improvement. No positive response to choreoathetosis<br />
noticed. Remote effect like improvement in<br />
drooling and swallowing also noticed. None of the children<br />
had any untoward side effects. Botulinum toxin is useful in<br />
treating spasticity of CP. Pretreatment patient observation<br />
and assessment is very important, Post treatment physio and<br />
appliances helps in consolidating the results.<br />
FP-S-045<br />
The efficacy of a newly-developed of a newly-developed<br />
package for the promotion of motor patterns<br />
M.T. Joghataei, G.R.H.P. Nezhad<br />
<strong>University</strong> of Social Welfare and Rehabilitation Sciences,<br />
Tehran, Iran<br />
How to deal with spasticity and flaccidity in the upper and<br />
lower limbs of the cerebral palsy child has always been a<br />
very unquenchably controversial issue in the field of rehabilitation<br />
of the cerebral palsy client. A demanding research<br />
area has been the comparison of various inhibitory and<br />
facilitatory techniques in dealing with tone disorders. The<br />
commonly practiced methodologies such as the Bobath<br />
method are well known to the profession. More recent<br />
attempts have, however, turned toward the promotion of<br />
more active functioning on the part of the child, whose<br />
main premise is that sound rehabilitation depends less on<br />
passive or assistive measures and more on independence<br />
through the implementation of client-controlled selfinitiated<br />
goals. The advent of sensory rooms has been a
Abstracts 635<br />
great revolution in the field. In such rooms, the child is<br />
presented with a multitude of sensory stimuli and feedbacks<br />
in order to receive compact sensory stimuli and provide<br />
proper responses to those various stimuli. However, a<br />
demerit of sensory rooms is that they demand general movement<br />
patterns (combinations of motions in different joints of<br />
the upper limb, for instance), which are not necessarily<br />
remedial to the pathological patterns and movements<br />
made by the child, but detrimental in many cases as the<br />
main goal of the use of sensory rooms is mere mobility<br />
and there is no strict control of the abnormal patterns,<br />
where the child tries to, for instance, touch a certain pad<br />
to have a specific sound heard, and may over try and make<br />
the involved muscles more spastic than they actually are.<br />
The present article is the report of the results of a 2-year<br />
research project conducted at the <strong>University</strong> of Social<br />
Welfare and Rehabilitation Sciences in Iran to develop an<br />
electronic package which aimed to have the merits of a<br />
typical sensory room and dispose of its demerits. As regards<br />
the description of the package, it consists of an attachment<br />
kit, which is a combination of pads and straps attached to the<br />
neighboring levers of the given joint (for example, forearm<br />
and arm in the case of the elbow). The pads contain certain<br />
sensors which will record the initial posture of the joint and<br />
signal the flexion/extension attempts of the client after the<br />
‘game’ starts. The ‘brain of the package’ consists of a<br />
keyboard which gets the orders from the therapist. Orders<br />
might include the assignment of the type of feedback to be<br />
presented when a certain motor attempt was reported. These<br />
include beeps, bells ringing, songs, and recorded messages<br />
such as ‘well-done’ as auditory reinforcers and lights of<br />
different color to be displayed on the light-boards of the<br />
package mounted onto the wall in the child visual field as<br />
visual feedbacks (other accessory parts provide the child<br />
with tactile feedbacks such as a breeze blown out of a<br />
small fan). The keyboard also gets orders as to what movement<br />
patterns to reinforce (flexion or extension). Packs of<br />
different sizes have made the kit versatile for all the joints of<br />
the extremities. Utilizing the above package as the instrument,<br />
a true experimental study was carried out to investigate<br />
the performance of this package compared with that of:<br />
(1) traditional facilitatory/inhibitory techniques; and (2) a<br />
typical sensory room. The study was designed for the<br />
following purposes: (1) to find out the possible challenges<br />
to the use of the package. (2) To compare the efficacy of the<br />
package with that of other measures in diminishing spasticity.<br />
(3) To compare the efficacy of the package with that of<br />
other measures in increasing mobility. (4) To cross-compare<br />
the effect of only auditory/only visual/and auditory and<br />
visual feedbacks combined. Ninety-six spastic CP children<br />
of both sexes aged between three and nine from twelve<br />
clinics located in southern and northern parts of the city<br />
were selected and assigned to the experimental group and<br />
the two control groups. The experimental group received a<br />
treatment of a 3-month period of rehabilitation with the<br />
above package, while one control group received rehabilitation<br />
in a sensory room and the other by facilitatory and<br />
inhibitory techniques. The three groups were matched on<br />
mobility, spasticity/flaccidity, and normal patterns as the<br />
dependent variables of the study. At the end of the treatment<br />
period, different scales of the above variables were then<br />
plotted, cross-compared, and interpreted. A variety of statistical<br />
techniques were employed to tackle the questions of<br />
the study. These ranged from simple correlations and<br />
ANOVAs through factor and regression analyses to structural<br />
equation modeling and path analysis. Results: Showed<br />
that the mentioned package specifically significantly<br />
reduces spasticity, increases mobility, and enhances motor<br />
pattern normality differently from the two other measures of<br />
the study. Also, it was found that a combination of auditory<br />
and visual feedbacks proved more effective than the other<br />
two choices. Implications and applications are expounded.<br />
FP-S-046<br />
Selective tibial neurotomy for relief of spasticity<br />
focalized to the ankle in children with cerebral palsy<br />
Y.-B. Yu, L. Zhang, Z.-S. Zhou<br />
Department of Neurosurgery, China-Japan<br />
Hospital, Beijing, China<br />
Friendship<br />
Objective: To study the effectiveness of selective tibial<br />
neurotomy for relief of spasticity focalized to the ankle in<br />
children with cerebral palsy. Methods: Fifty-three feet of 37<br />
cases of ankle spasticity in children with cerebral palsy were<br />
treated by microsurgical selective tibial neurotomy from<br />
February 2000 to June 2001. Results: At follow up evaluation<br />
(mean duration: 8.6 months), this study showed that<br />
100% cases experienced disappearance or notable regression<br />
of the spasticity right after operation, and the percentage<br />
in follow-up duration was 94.34%. The improved<br />
motor capacities right after operation were found in 100%<br />
cases, while 94.34% in follow-up duration. One hundred<br />
percent cases had better quality of life by follow-up studying.<br />
Postoperative complications were few, including<br />
dysaesthesias of foot in two cases. Muscle weakness was<br />
not found in all the cases. Conclusions: Selective tibial<br />
neurotomy is an effective and safe microsurgical method<br />
for the treatment of ankle spasticity in children with cerebral<br />
palsy.<br />
FP-S-047<br />
Early curative effect for neurophysiological treatment of<br />
cerebral palsy<br />
Y.-X. Ma, X. Wu, J.-J. Zhang<br />
Harbin Children’s Hospital, Harbin, Heilongjiang Province,<br />
China<br />
Objective: To investigate early curative effect for neurophysiological<br />
treatment of cerebral palsy. Methods: Diagnose<br />
and type classification of cerebral palsy depend on the
636<br />
Abstracts<br />
standard of the first national meeting of cerebral palsy.<br />
There are Spastic type 27 cases, athetosis type five cases,<br />
dystonic type 1 case. We use Vojta method to bring out the<br />
rolling reflex and bow crawl, and use Bobath method to<br />
promote establishing normal posture and reflex. We pay<br />
more attention on motor function, operative ability, and<br />
speech functional training. We evaluate the effect of treatment<br />
according to the GMFM every half a month. Comparing<br />
the results of two evaluation, it is obvious effect if the<br />
score increase more than 20 points; effective if the score<br />
increase 10 , 20 points; no effect if the score increase<br />
,10 points. Results: Obvious effects were observed in 3<br />
cases (all ,1 year old, spastic type), effective in 27 cases<br />
(23 cases ,2 years old, including spastic type 23 cases,<br />
athetosis type four cases). No effect were observed in<br />
three cases (all .3 year old, spastic type 1 case, athetosis<br />
type 1 case, dystonic type 1 case). Conclusions: Early curative<br />
effect for neurophysiological treatment of cerebral<br />
palsy is relative good, especially for the spastic type. The<br />
older children with good speech and intelligence have better<br />
effect.<br />
FP-S-048<br />
Efficacy of GPi stimulation on pantothenate kinase<br />
associated neurodegeneration (PKAN) related dystonia<br />
P. Castelnau a , A. Gannau b , L. Cif b , S. Hemm b , P. Evrard c ,P.<br />
Coubes b<br />
a Pediatric Neurology Service and INSERM 316, Clocheville<br />
<strong>University</strong> Hospital, Tours, 37044 France; b Department of<br />
Pediatric Neurosurgery (Research Group on Movement<br />
Disorders in Children), Gui de Chauliac <strong>University</strong> Hospital,<br />
Montpellier, 34295 France;<br />
c Pediatric Neurology<br />
Service and INSERM E-9935, Robert Debre <strong>University</strong><br />
Hospital, Paris, 75019 France<br />
We evaluated the efficacy of GPi stimulation on the<br />
dystonia of three patients presenting pantothenate kinase<br />
associated neurodegeneration (PKAN) (formerly Hallervorden-Spatz<br />
syndrome). PKAN related dystonia usually<br />
worsens dramatically and becomes life-threatening. Pharmaceutical<br />
therapies are poorly efficient. Our group has<br />
shown long-lasting efficacy of GPi stimulation in DYT1<br />
patients. All three patients (two boys and one girl – mean<br />
age 16 years old) had a typical PKAN clinical history with a<br />
characteristic eye-of-the tiger sign in both pallidum on cerebral<br />
MRI and a progressive generalized dystonia. Pallidal<br />
electrodes were implanted using a Leksell stereotactic frame<br />
with MRI guidance and were activated as previously<br />
reported. Functional improvement of the patients was<br />
assessed using the Burke-Marsden-Fahn dystonia rating<br />
scale (BMFDRS). Patient 1, a boy, was implanted at the<br />
age of 20. Pre and postoperative BMFDRS scores were<br />
respectively 55/120 and 27.5/120 after 9 months followup.<br />
Patient 2, a girl, was implanted at the age of 17. Pre<br />
and postoperative BMFDRS scores were respectively 52/<br />
120 and 21.5/120 after 11 months follow-up. Patient 3, a<br />
boy, was implanted at the age of 10. Pre and postoperative<br />
BMFDRS scores were respectively 86/120 and 55.5/120<br />
after 31 months follow-up. No adverse events were<br />
reported. GPi stimulation provides a long lasting efficient<br />
treatment to limit the progression of PKAN related dystonia.<br />
This procedure is reversible (unlike pallidotomy), it<br />
preserves cognition and remains compatible with other<br />
treatments. Thus, GPi stimulation should be early considered<br />
in such drug-resistant progressive dystonia. The identification<br />
of a pantothenate kinase-based pathogenesis might<br />
provide additional therapies.<br />
FP-S-049<br />
A infantile case of completely treated multiple<br />
intracranial tuberculoma<br />
E.Y. La, C.W. Lee, H. Bang<br />
Department of Pediatrics, WonKwang <strong>University</strong> College of<br />
Medicine, Iksan, Korea<br />
Although the incidence of intracranial tuberculosis in<br />
children have decreased with development of antituberculous<br />
therapy, mortality rate is high as formerly, if not early<br />
diagnosed and treated. Authors report a case of a 5 months<br />
old male with multiple intracranial tuberculoma who have<br />
been accompanied generalized miliary tuberculosis and<br />
tuberculous meningitis. He was hospitalized at the pediatric<br />
department of Wonkwang <strong>University</strong> Hospital with mild<br />
fever and persistent cough. The brain MRI was performed<br />
and showed multiple intracranial micronodular densities,<br />
perinodular edema and diffuse leptomeningeal enhancement<br />
which were disappeared completely after antituberculosis<br />
chemotherapy for 12 months and he had completely recovered<br />
without sequale.<br />
FP-T<br />
Others<br />
FP-T-001<br />
Physiological basis and significance of yawning in<br />
clinical practice<br />
K.B. Kulkarni<br />
Sanjivani Nursing Home, Gwalior (M.P), India<br />
Yawning is an index of dopaminergic function. Dopamine,<br />
a precursor of norepinephrine, is converted to norepinephrine.<br />
The hypothalamus, brain stem, reticular<br />
formation are rich with norepinephrine while dopamine is<br />
abundant in nerve terminals of corpus striatum which derive<br />
from cell bodies in the substantia nigra. Corpus striatum is<br />
involved in complex unconditioned reflexes with somatic<br />
and vegetative components; the latter through direct<br />
connections between subcortical nuclei, reticular formation<br />
and hypothalamus. The corpus striatum contains neurons
Abstracts 637<br />
influencing both sympathetic and parasympathetic nuclei of<br />
hypothalamus. Hence, yawning in diverse and opposite<br />
situations like sleepiness and over excitation, hunger and<br />
empty stomach. My decade long observations on yawning<br />
in children from newborn to 12 year age convalescent from<br />
serious illness – shock of any origin, dehydration, convulsive<br />
disorders, meningoencephalopathy and comatose<br />
states, head injury and hyperpyrexia – indicate that yawning<br />
is a favourable sign meaning the worst is over. Yawning is<br />
non-repetitive, once twice maximally thrice, and mother<br />
rarely notices it hence pediatrician’s careful observation is<br />
vital. Tone of their eyeball muscles improves after yawning<br />
and they remain awake taking interest in surroundings.<br />
Those who sleep do so comfortably like normal children.<br />
Yawning should be considered on different lines in normal<br />
healthy children and those convalescent from serious<br />
illness. Is it a conditioned reflex out of internal environment<br />
like temperature and pH changes, changed osmolality and<br />
osmolarity, effect of prostaglandins and hormones? All this<br />
appears to be grey area in the pathophysiology of yawning.<br />
The role of glomus cells of carotid sinus and Herring’s nerve<br />
also is discussed.<br />
FP-T-002<br />
Neurocutaneous melanosis (a case report and literature<br />
review)<br />
Y. Sun, W.-H. Du<br />
Department of Pediaetrics, The People’s Hospital in<br />
Xinjiang, Urumqi, China<br />
Introduction: Neurocutaneous melanosis is an infrequent<br />
condition characterised by the presence of numerous gigantic<br />
cutaneous naevi and melanocytic infiltration of the CNS<br />
and/or the leptomeningeal layers. Different clinical features<br />
may be seen: intracranial hypertension due to hydrocephalus,<br />
cranial nerve paralysis, myelopathy, seizures, etc. The<br />
prognosis is considered to be malignant. Case report: A7-<br />
year-old boy with widespread pigmented nevi, with benign<br />
self-limiting epilepsy in early childhood and ataxia. He was<br />
followed up for 6 years. Cerebral CT and MR scans were<br />
abnormal. Serial magnetic resonance imaging scans demonstrate<br />
T1 shortening and T2 shortening signals in the hippocampus<br />
and pons, with atrophy of pons and cerebellum.<br />
Conclusions: The clinical course of this boy was relatively<br />
benign. MRI should be done periodically.<br />
FP-T-003<br />
Transient parkinsonism following the ingestion of tea in<br />
a child with familial idiopathic cerebral calcification<br />
H. Yoshikawa, S. Yamazaki, T. Abe<br />
Department of Pediatrics, Niigata City General Hospital,<br />
Niigata, Japan<br />
We report here a normally developed 12-year-old girl with<br />
familial idiopathic cerebral calcification (FICC), who exhibited<br />
transient parkinsonism (TP) over a period of 20 days<br />
following the ingestion of tea. The patient drank a cup of<br />
tea during her elementary school graduation party, this was<br />
her first experience of drinking tea. The next morning, symptoms<br />
which suggested the condition known as parkinsonism<br />
developed, these included progressing rigidity, akinesia, a<br />
mask-like face and dysphagia. These symptoms gradually<br />
worsened. Although routine laboratory examination<br />
revealed no abnormal findings, brain CT revealed multiple<br />
calcification. No other specific etiology was proven, but a<br />
brain CT of her older sister with no symptoms revealed similar<br />
multiple calcification. Therefore, she was diagnosed as<br />
having FICC. After the 6th day following the onset of her<br />
symptoms, her extrapyramidal symptoms gradually faded<br />
and by the 20th day they had disappeared completely.<br />
Patients with FICC have been reported as displaying various<br />
movement disorders, such as parkinsonism or paroxysmal<br />
dystonic choreoathetosis (PDC). Although caffeine is<br />
known to have a possible protective effect against parkinson’s<br />
disease, the TP which developed in this patient could<br />
conceivably have been caused by the ingestion of caffeine,<br />
which was compounded by emotional excitement and fatigue.<br />
On the contrary, caffeine induced PDC, which is different<br />
condition to the one reported on here. There have been no<br />
reports of TP induced by caffeine in FICC, and the mechanism<br />
which caused TP in this patient remains unclear.<br />
FP-T-004<br />
The influences of methylprednisolone pulse therapy on<br />
eurological tatus in children with nephrotic syndrome<br />
C.-Y. Chen, D.-K. Chen<br />
Capital Institute of pediatrics, Beijing, China<br />
Objection: To evaluate the impact of pulse methylprednisolone<br />
treatment (PMT) on the mental and neurological<br />
status in the children suffering from NS. Method: Twentytwo<br />
administrated NS patients needed PMT. We recorded<br />
the change of their stiffness, Babinski sign, Kernig sign,<br />
Brudzinski sign, knee jerk, communication and sleepingtime<br />
before and after PMT. The methylprednisolone dose<br />
was 15–20 mg/kg per day and was given through intravenous<br />
infusion within 1.5–2 h daily for 3 days. Results: No<br />
patients had any changes except one complain mild headache.<br />
Conclusion: PMT is safe for NS children if the dose of<br />
methylprednisolone and the duration of PMT are proper.<br />
FP-T-005<br />
The analysis of detecting in children vascular headache<br />
by transcranial Doppler ultrasound (TCD)<br />
Y. Chen, J.-J. Zhang, S.-H. Li<br />
Harbin Children’s Hospital, Harbin, China<br />
Purpose: To explore the clinical significance of TCD in
638<br />
Abstracts<br />
detecting children vascular headache. Methods: TCD,<br />
TC2020 made in EME Company of Germany was carried<br />
out in 132 patients of children with vascular headache.<br />
Recording the Vm of their MCAACAPCAVA BA and<br />
their PI. Results: In 132 patients detected with TCD128 is<br />
abnormal. The abnormal rate is 96%. The mean blood flow<br />
velocity (Vm) of the basal cerebral arteries is abnormal 104<br />
is high (81%) 24 is low (19%). A total of 936 blood vessels<br />
of 104 children whose Vm is high was detected in total.<br />
MCA is abnormal in 176 of them ACA is abnormal in<br />
141 PCA is abnormal in 73 of them VA is abnormal in 60<br />
of them BA is abnormal in 43 of them. The abnormal rate is<br />
MCA (19%) . ACA (15%) . PCA (8%) . VA<br />
(6%) . BA (4.5%)in turn. A total of 1152 blood vessels<br />
of 132 patients was detected by TCD in total. PI is abnormal<br />
in 34 of them including 14 of them is lower and 20 of them<br />
is higher and the changes of them is not regular. Conclusion:<br />
TCD as a method to detect children vascular headache without<br />
damage simple and reliable. It has the great clinical<br />
value for the diagnose classification and observing the effect<br />
of treatment.<br />
FP-T-006<br />
Diagnosis and follow-up of acute high level cervical<br />
myelopathy in children<br />
B.-M. Wu, H. Wang, W. Zhang<br />
Department of Pediatrics, The Second Clinical College,<br />
China Medical <strong>University</strong> Shenyang, China<br />
High level cervical myelopathy is uncommon, which<br />
may be clinically manifested as dyspnea and high fever<br />
in addition to symptoms as caused by lesions of spinal<br />
cord. In present paper, 30 cases diagnosed as high cervical<br />
myelopathy by laboratory tests of CSF and spine MRI and<br />
intervened in our department from April, 1989 to February<br />
were reviewed. Eighteen were male and 12 female with<br />
age ranging from 11 months to 14 years old. Of the<br />
patients, 21 patients were diagnosed as acute myelitis,<br />
five as anterior spinal artery syndrome, two as hemorrhage<br />
of the spinal cord, two as extramedullary arachnoid cyst.<br />
All the patients showed abrupt onset with tetraparesis,<br />
sensory disturbances, bowel and bladder incontinences.<br />
Eighteen patients had dyspnea, and 14 had fever at the<br />
early stage of the conditions, among whom five cases<br />
manifested as persisted high fever with flush countenance<br />
and dry skin. In 24 patients experienced spine MRI, 14<br />
patients exhibited swelling of cervical spinal cord, two<br />
hemorrhage of the spinal cord, and two extramedullary<br />
arachnoid cyst. Six revealed normal images. In 18 patients<br />
received 1-year follow-up spine MRI scan, six retained<br />
normal, 12 showed slight spinal atrophy. Physical examination<br />
in clinical follow-up showed that 16 patients had<br />
muscle atrophy, upper limb dyskinesia of different degrees,<br />
and normal lower limb.<br />
FP-T-007<br />
Long term follow up after acute stroke in childhood, a<br />
retrospective study<br />
M. Steinlin, K. Roellin, G. Schroth<br />
<strong>University</strong> Hospital Inselspital, Bern, Switzerland<br />
There are only few studies concerning long term neurological<br />
and neuropsychological outcome of children after<br />
acute stroke, but revealing significant problems. Methods:<br />
Retrospective chart review followed by a questionnaire and<br />
clinical examination, concerning initial presentation,<br />
aetiology and long term outcome of children suffering a<br />
stroke between 1985 and 1999, retrieved by a computer<br />
search at the <strong>University</strong> Children’s Hospital of Bern.<br />
Results: Twenty-three children (15 boys) suffered 20<br />
acute arterial ischaemic events, two sinuous venous thrombosis<br />
and one combination. Aetiology was detected in 15,<br />
suspected in six and unknown in two. Follow up after 1–15<br />
years (median 7 years) was possible for 18 children, three<br />
had died and two were lost to follow. Only four were<br />
completely healthy, five suffered mild, six moderate and<br />
three severe handicap, 11 children presented combined<br />
neurological and neuropsychological problems. Neurological<br />
problems were mild to moderate hemisyndrome in 11,<br />
dysphasia, epilepsy and others in six each. Mild to severe<br />
neuropsychological problems were detected in 14 children,<br />
school problems in nine, attention deficits in ten and behaviour<br />
problems in seven. Headache and increased fatigue in<br />
six each. Recurrence was observed in three, all due to<br />
progressive underlying disease. Outcome was most<br />
affected by combined cortical/subcortical and best with<br />
only subcortical infarction. Size of infarction showed a<br />
tendency to influence prognosis. Epilepsy affected neuropsychological<br />
outcome. Conclusion: Neurological and especially<br />
neuropsychological problems influence the life of<br />
children after acute stroke significantly. Careful long<br />
term follow up is mandatory and more prospective and<br />
exact data on outcome are necessary.<br />
FP-T-008<br />
Sea blue histiocytosis with progressive neurologic<br />
damnification in three cases<br />
C.-H. Ding<br />
Beijing Children Hospital, Beijing, China<br />
Objectives: The cardinal clinical findings of sea blue<br />
histiocytosis (SBH) patients were hepatosplenomegaly,<br />
anemia and thrombocytopenia. The diagnosis and differential<br />
diagnosis of SBH with chronic progressive neurologic<br />
damnification were discussed. Methods: Clinical and<br />
laboratory examinations were performed in three cases<br />
with chronic progressive neurologic damnification. Results:<br />
The clinical findings of three patients were mental deterioration,<br />
paresis of vertical gaze, speaking slowly and not
Abstracts 639<br />
clear, and unsteady walking. The second and third one had<br />
difficulty in swallowing and torsion dystonia. The second<br />
and third one were sisters. Physical examination for three<br />
patients revealed dysarthria, ataxia, paresis of vertical gaze,<br />
pyramidal and cerebella signs were positive. The second<br />
and third one had mild splenomegaly. The serum ceruloplasmin<br />
level was normal. The antibodies of measles virus<br />
and rubella virus were negative in cerebrospinal fluid.<br />
Examination of bone marrow revealed sea blue histiocytes,<br />
no others specific findings. Liver function studies of the<br />
first patient were slightly abnormal. The serum lactic<br />
acid and pyruvate levels were abnormal in the first one.<br />
Conclusions: The features of SBH with neurologic damage<br />
were progressive psychomotor deterioration with vertical<br />
gaze paresis, liver function abnormal, and splenomegaly.<br />
SBH with neurologic damnification should be distinguished<br />
from Wilson’s disease, demyelinating disease,<br />
mitochondrial encephalomyopathy, and slow virus infection<br />
of central nervous system.<br />
FP-T-009<br />
Magnetic stimulation and new method of study of a blink<br />
reflex arch functional condition at children<br />
A.G. Remnev<br />
Altai Diagnostic Center, Barnaul, Russia<br />
The purpose of research: to estimate a functional condition<br />
of a trigeminal-facial complex (TFC) – blink reflex<br />
arch at children. Research of a functional condition of a<br />
blink reflex arch carried out by electrical stimulation (ES)<br />
of a supraorbital nerve and transcranial magnetic stimulation<br />
(TMS) of a cerebral cortex. The caused answers<br />
registered at a level of the eye circular muscles. At realization<br />
of researches used a complex of the equipment:<br />
Magstim-200 (Magstim, UK), Sapphire 2M (Medelec,<br />
UK). We investigated 45 healthy children with an age<br />
between 5 and 15 years: 16 children with an age between<br />
5 and 9 years (1st group), 29 children with an age between<br />
10 and 15 years (2nd group). The received results testify<br />
that TMS was characterized by steady registration of<br />
components of a blink reflex – early (R1) and late (R2).<br />
Latency of the R2 was similar at ES and TMS; latency of<br />
the R1 at ES and TMS had difference. The latency of the<br />
R1 at TMS was more, than at ES (13 % on the average).<br />
The distinction in latency of the R1 can be explained by<br />
distinction of the reflex channels, on which there is a<br />
realization of excitation at TMS and ES. Thus, the noninvasive<br />
technique of the TMS can be useful at an estimation<br />
of a functional condition of various sites of a TFC<br />
(facial nerve, trigeminal nerve and cerebronuclear tracts of<br />
a facial nerve).<br />
FP-T-010<br />
Auditory early and long latency evoked potentials in<br />
children and adolescents with headache<br />
M. Zgorzalewicz, B. Zgorzalewicz, R. Nowak<br />
Chair and Department of Developmental Neurology,<br />
<strong>University</strong> of Medical Sciences, Poznań, Poland<br />
Auditory evoked potentials were studied in 60 children<br />
and adolescents in 8–18 years old with different types of<br />
headache. The examination was carried out in interictal<br />
phase of the disease. Diagnoses of disease were performed<br />
according to the categorization of IHS. The aim of the study<br />
was to investigate the changes in BAEP and auditory ERP in<br />
migraine and non-migraine headache. The obtained results<br />
were compared with healthy controls at the matched age.<br />
The evoked potentials were recorded by Multiliner (Toennies-<br />
Germany) according to the IFCN standards. For BAEP<br />
latencies of waves I–V and inter-peak I–III, III–V, I–V were<br />
measured. The ERP was recorded with the oddball paradigms.<br />
The following parameters of ERP were measured.<br />
The N1, P2 latencies were evaluated from the responses to<br />
the non-target stimuli. The latencies of N2 and P300 parameters<br />
were estimated to target tasks. The inter-peak amplitudes<br />
were measured too. In majority of migrainous subjects<br />
prolongation of ERP latencies was found. No modifications<br />
of the P300 components were found in the tension-type<br />
headache subjects. There were also no differences in<br />
BAEP parameters between children with headache and the<br />
control group. The results were correlated with the clinical<br />
picture of the disease in the examined patients. An impairment<br />
of memory and attention processes in migrainous<br />
patients based on neurophysiological results was found.<br />
The ERP is a non-invasive diagnosis tool in young patients<br />
with headache when signs or symptoms may not be characteristic.<br />
FP-T-011<br />
Encephalopathy with intracranial calcification,<br />
dwarfism, leucodystrophy and neuropathy: a new<br />
clinical entity?<br />
F.M. Aynacı a , F. Celep b , A. Ahmetoglu c<br />
Karadeniz Technical <strong>University</strong>, Faculty of Medicine,<br />
a Department of Child Neurology, b Genetics and c Radiology,<br />
Trabzon, Turkey<br />
Microcephaly, motor and mental retardation, cataract<br />
(two cases) dwarfism and intracranial calcification occurred<br />
in five cases in large consanguineous families between 3 and<br />
6 months of age. The patients died between 4.5 and 8 years<br />
of age variably. Detailed investigation was done for two<br />
cases. Neither pleocytosis in CSF nor parathormon deficiency<br />
was determined. Peripheral neuropathy was determined<br />
in both. Muscle biopsy was performed in one case<br />
and any mutation for MELAS, MERRF, Leigh diseases was
640<br />
Abstracts<br />
not determined. Photosensitivity and pigmental retinopathy<br />
were not described in all cases. We think that these patients<br />
most resemble the first group of Fahr syndrome. But,<br />
compared with progressive intracranial calcification cases<br />
in the literature, we found in our cases autosomal recessive<br />
inheritance, early onset, severe pectus carinatus and dwarfism<br />
without growth hormone deficiency, cataract, peripheral<br />
neuropathy and progressive calcification without CSF pleocytosis.<br />
FP-T-012<br />
Neurologic complications of cyanotic congenital heart<br />
disease<br />
O.M. Luz<br />
<strong>University</strong> of Santo Tomas Hospital, Quezon City, Philippines<br />
Objective: This paper aims to identify the neurologic<br />
complications associated with cyanotic congenital heart<br />
disease and characterize the lesions in relation to different<br />
variables. Methodolegy: Retrospective study of patients 18<br />
years and younger with cyanotic congenital heart disease<br />
who presented with neurologic complications. Conclusion:<br />
Most patients presented with cerebral abscess and cerebral<br />
infarct (45% each). Infarcts tend to be multiple and<br />
abscesses tend to be solitary with predilection for the parietal<br />
area. Alteration of consciousness and seizures carries a<br />
grim prognosis.<br />
FP-T-013<br />
Selected risk factors in ischaemic strokes on migraine in<br />
children<br />
E. Pilarska a , A. Bakowska b , A. Kubik c , S. Kroczka c<br />
a Department of Developmental Neurology Medical <strong>University</strong><br />
of Gdańsk; b Department of Immunopathology Medical<br />
<strong>University</strong> of Gdańsk; c Department of Pediatric Neurology<br />
Faculty of Medicine, Jagiellonian <strong>University</strong> of Kraków,<br />
Poland<br />
Aim: The investigations were made to pronounce the<br />
value of examination of antiphospholipid antibodies and<br />
thrombomodulin in explanation of the pathogenesis of<br />
ischaemic strokes and migraine. Material and method:<br />
We investigated 30 children, who suffered ischaemic<br />
stroke at the age range between 2 and 15 years and 30<br />
children with migraine aged 8–15 years, 19 had migraine<br />
with aura and 11-without aura. The control group consisted<br />
of 30 healthy children at the some age. Anticardiolipin<br />
antibodies aCl -IgG, IgM, IgA and b2 glycoprotein and<br />
thrombomodulin were evaluated. Results: Both in ischaemic<br />
strokes and migraine there were increased concentrations<br />
of thrombomodulin and antiphospholipid antibodies<br />
compared to control group. The highest values were<br />
observed in children with ischaemic strokes. In none case<br />
there were increased b2-glykoprotein levels. Conclusion:<br />
Anticardiolipin antibodies and thrombomodulin, especially<br />
aCl- IgG, IgM maybe the important causative agents in<br />
childhood strokes and migraine. This paper was supported<br />
by a grant No 4PO5E 150 18 of the State Committee of the<br />
Scientific Research.<br />
FP-T-014<br />
Event-related potential N270 and its distribution in<br />
adults and school-age children<br />
L.-P. Li, Y.-P. Wang, H.-J. Wang, L.-L. Cui, S.-J. Tian<br />
Department of Neurology, Xuanwu Hospital, Capital<br />
<strong>University</strong> of Medical Sciences, Beijing, China<br />
To compare event-related potential N270 and its scalp<br />
potential distribution in adults and in school-age children,<br />
and to explore the development of conflict processing<br />
system in human brain, pairs of colored numbers were<br />
sequentially present on screen to subjects tested. They<br />
were instructed to discriminate whether the color or magnitude<br />
of the pairs of number was identical, and ERPs were<br />
recorded at the same time. In adults, a negative potential<br />
peaking at 270 ms (N270) was elicited when the second<br />
stimulus (S2) conflicted with the first stimulus (S1) of task<br />
relevant and irrelevant attributes. N270 was widely distributed<br />
on the entire scalp in adults. In children, N270 was<br />
only elicited by conflict in task-related attribute, the distribution<br />
of N270 in color conflict was on bilateral sides of<br />
the scalp and N270 elicited by magnitude conflict was on<br />
the left central-frontal site. Conclusion: In school-age children,<br />
event-related potential N270 was elicited under the<br />
control of attention. Its distribution in scalp depends on the<br />
attributes of stimulus pairs.<br />
FP-T-015<br />
Questionnaire study: what is the role of child<br />
neurologists who advise caregivers of disabled students<br />
at special schools?<br />
M. Aoyama a , M. Shibata a , M. Yamamoto a , O. Nitta a ,K.<br />
Miura c , M. Miyao d , Y. Iwasaki e<br />
a School of Nursing, b School of Physical Therapy, c School of<br />
Occupational Therapy Tokyo Metropolitan <strong>University</strong> of<br />
Health Sciences;<br />
d Division of Develop. Psychology,<br />
National Children’s Medical Care Center; e Division of<br />
Child Neurology, Tokyo Metropolitan Yotsugi Rehabilitation<br />
Center, Japan<br />
In 2000, we administered a questionnaire study to<br />
parents of neurologically disabled students. The questionnaire<br />
addressed such issues as medical, co-medical and<br />
social problems, all pertaining to neurologically disabled<br />
students. We found that some caregivers, mainly mothers,<br />
complained about poor explanations from doctors on the<br />
future outcomes of their children. They were also
Abstracts 641<br />
concerned about how to properly raise their children under<br />
the given circumstances. We were interested in what the<br />
doctors thought about these issues in 2001, so we conveyed<br />
a questionnaire study again. We collected 137 responses<br />
out of 202 child neurologists, who are all councilors with<br />
the ‘Japanese Society of Child Neurology’. A total of 81%<br />
of doctors ranged from the ages of 41 , 60 and 78% had<br />
over 20 years experience. Fifty-nine percent were clinical<br />
doctors, 64% of them examined the children between 10<br />
and 20 min (per child) and 82% of the doctors worked over<br />
twice a week at the outpatient clinic. Twenty-five percent<br />
of doctors indicated that their explanations were insufficient<br />
to please the caregivers, and 20% of doctors worried<br />
about the inadequate satisfaction of the parents. A total of<br />
83% of them hoped to ask other staff, chiefly clinical<br />
psychologists, to help them with children’s care.<br />
FP-T-016<br />
Electroencephalogram as a follow-up indicator in<br />
pediatric moyamoya diseases<br />
D.-S. Kim a , T.-S. Ko a , Y.-S. Ra b , C.-G. Choi c<br />
a Department of Pediatrics, b Neurosurgery and c Radiology,<br />
Asan Medical Center, <strong>University</strong> of Ulsan, College of Medicine,<br />
Seoul, Korea<br />
Moyamoya disease is one of the most common cerebrovascular<br />
diseases in childhood. The EEG is known to<br />
show the characteristic ‘rebuild-up phenomenon’. In<br />
order to evaluate the usefulness of EEG as a follow-up<br />
test, we performed the statistical analysis between clinical<br />
improvements and EEGs after indirect anastomosis. Total<br />
31 patients below 15 years old, undergone the surgery<br />
from March 1995 to March 2001, were included. The<br />
ratio of male to female was 1.58:1 (19:12) and the median<br />
age was 6 years. The clinical manifestations were TIA<br />
(n ¼ 27), seizure (n ¼ 8), hemiplegia (n ¼ 4), and headache<br />
(n ¼ 4). The analysis for the total patients did not<br />
show statistical significance between clinical and EEG<br />
improvements (P ¼ 0:142). However, the analysis only<br />
for cases with the initial abnormal EEG (n ¼ 23) did<br />
show significance (P ¼ 0:04). In addition, we performed<br />
the correlation analysis. We divided clinical and EEG data<br />
into three groups: (a) no; (b) mild; and (c) marked<br />
improvements, respectively. For the cases with abnormal<br />
initial EEG findings (n ¼ 23), we found the statistical<br />
significance between the clinical and EEG improvements<br />
(r ¼ 0:466, P ¼ 0:025). Our results suggest the EEG can<br />
be used as a non-invasive follow-up test after the bypass<br />
surgery in Moyamoya disease, when the initial EEG was<br />
abnormal.<br />
FP-T-017<br />
Ischemic stroke in a pediatric population risk factors<br />
and clinical aspects<br />
A. Schteinschnaider, C. Romero, F. Meli, R. Lagos, S.<br />
Ameriso, S. Intruvini, J. Pociecha, M. Szlago, M.G.<br />
Alvarez, M. Segalovich, G. Garate, M. Massaro<br />
Raúl Carrea Institute of Neurological Research, FLENI,<br />
Buenos Aires, Argentina<br />
Objective: Ischemic stroke are relatively uncommon in<br />
children and their etiology may differ from the adult population.<br />
We report the characteristics of all pediatric strokes<br />
seen at our institution in a 6-year period. Background:<br />
Ischemic stroke are being more frequently diagnosed in<br />
childhood in part due to greater physicians awareness and<br />
also due to the development of non-invasive diagnostic<br />
procedures such as magnetic resonance angiography, transcranial<br />
Doppler or molecular genetic techniques. Higher<br />
survival rates of patients with cardiological or oncologic<br />
diseases allows for increased time for exposure to specific<br />
risk factors. Design/methods: This was an observational,<br />
retrospective study of institutional chart reviews of every<br />
patients with a discharge diagnosis of ischemic stroke<br />
between January 1995 and December 2000. Results: During<br />
the time period studied there were 21 patients with a diagnosis<br />
of ischemic stroke. There were four girls and 17 boys<br />
aged 6.5 years (1 month–16 years). Acute hemiparesis (16)<br />
was the most frequent clinical presentation followed by<br />
altered consciousness (6), headache (3), and ataxia and/or<br />
gait disturbances (3). Sixteen patients (76%) had a predisposing<br />
risk factor: congenital heart disease (4), prothrombotic<br />
state (4), vascular abnormalities (3), and traumatic<br />
carotid dissection (3). Four patients had a positive family<br />
history of stroke. There were no stroke related deaths and<br />
only two patients suffered recurrent stroke. Twelve patients<br />
had secuelar neurological deficit. Conclusions: Ischemic<br />
stroke continues to be uncommon in the pediatric population.<br />
Nevertheless the cryptogenetic group has certainly<br />
diminished based on a complete and detailed work-up.<br />
Most patients have at least one predisposing factor. A thorough<br />
investigation of potentially treatable causes of the<br />
stroke is warranted and may have been responsible for the<br />
low recurrence rates observed.<br />
FP-T-018<br />
Auditory induced somatosensory cortex activations<br />
identified by magnetoencephalography (MEG) in<br />
patients with cortical lesion<br />
M. Kubota, Y. Sakakihara, H. Hirose, I. Kimura<br />
Department of Pediatrics, <strong>University</strong> of Tokyo, Tokyo,<br />
Japan<br />
A single kind of stimulus usually activates a single specific<br />
sensory cortex such as the auditory cortex activation by tone
642<br />
Abstracts<br />
stimulation, but it rarely activates multiple sensory cortices<br />
in various conditions. Anatomically, reciprocal connections<br />
between different cortices is known to be involved in various<br />
information processing. We here investigated the pathophysiological<br />
significance of auditory induced somatosensory<br />
cortex (SI) activation in patients with cortical lesions or<br />
dysfunction. Subjects were two patients with regional encephalitis,<br />
one with juvenile myoclonic epilepsy (JME) and<br />
four with focal epilepsy. Using MEG, we analyzed SI activation<br />
in auditory evoked magnetic fields which was induced<br />
by 1 kHz/90 dB pure tone stimuli. At first, all patients showed<br />
bilateral responses of the primary auditory cortex (AI) ,100<br />
ms after the stimuli (N100m). In addition, the SI activation<br />
was found in both hemisphere in patients with regional encephalitis<br />
and JME, and in the same hemisphere as interictal<br />
paroxysm in patients with focal epilepsy. Our findings<br />
suggest that unmasking of normally-inhibited inputs from<br />
AI to SI occurred after encephalitis or epileptogenic dysfunction<br />
(intercortical reorganization). This is the first report of<br />
auditory induced SI activation in human, although the precise<br />
mechanism of the multimodal sensory activations is not<br />
known.<br />
FP-T-019<br />
Regional variations in bone mineral density in children<br />
with cerebral palsy using dual energy X-ray<br />
absorptiometry<br />
J. Shiragaki a , N. Iwasaki b , J. Nakayama b , K. Fujita c ,T.<br />
Ohto b , A. Matsui b<br />
a Kyushu <strong>University</strong> of Health and Welfare, Nobeoka, Miyazaki<br />
Japan; b Department of Pediatrics and c Institute of<br />
Disability Science, <strong>University</strong> of Tsukuba<br />
BMD was studied in 34 children with spastic cerebral<br />
palsy (CP group), 40 children undergoing anticonvulsant<br />
therapy (epilepsy group), and 29 normal children (control<br />
group). The CP group was divided into four groups according<br />
to gross motor function. Dual energy X-ray absorptiometry<br />
was performed to evaluate BMD of the whole body, of the<br />
head, upper limbs, ribs, spine, pelvis, and lower limbs separate<br />
from the whole body scan images, and of the lumber<br />
spine separate from the lumber vertebrae images. In the<br />
control group, BMDs increased with age. There was no<br />
significant difference between the control group and epilepsy<br />
group (P . 0:05). The CP group had BMD lower than the<br />
control group for the whole body, upper limbs, ribs, spine,<br />
pelvis, lower limbs, and lumber spine but not for the head<br />
(P , 0:001). In the CP group, BMD Z scores for the pelvis,<br />
lower limbs and lumber spine were remarkably lower than<br />
for the head, upper limbs, ribs and spine. BMD of the upper<br />
limbs and spine were particularly lower in the bed-ridden<br />
group compared with the standing/walking group, whereas<br />
BMD of the lower limbs were lower in the bed-ridden, rolling,<br />
and crawling groups compared with the standing/walking<br />
group. These results suggest that the high incidence of<br />
femur fractures in CP is related not only to mechanical stress<br />
overload on the lower legs but to the strongly diminished<br />
BMD of the lower limbs and pelvis as well. And that BMD<br />
of the lower limbs and pelvis are also associated with standing<br />
posture and walking.<br />
FP-T-020<br />
The importance of rectal biopsy in the diagnosis of<br />
neuronal intranuclear hyaline inclusion disease (NIHID)<br />
R. Kulikova-Schupak a , K.G. Knupp a , J.M. Pascual a , S.S.<br />
Chin a , R. Kairam b , M.C. Patterson a<br />
a Division of Pediatric Neurology, Columbia <strong>University</strong>,<br />
New York, NY, USA; b Bronx-Lebanon Hospital Center,<br />
Bronx, NY, USA<br />
NIHID is a rare neurodegenerative disorder of childhood<br />
onset characterized by the presence of eosinophilic intranuclear<br />
inclusions and neuronal loss throughout the nervous<br />
system. Familial occurrence has been described. We identified<br />
two patients, an 11-year old boy (P1) with new onset<br />
bulbar weakness and Parkinsonism, and a 15-year old boy<br />
(P2) with severe cognitive and motor deterioration of uncertain<br />
etiology. P1 presented at 10 years of age with progressive<br />
dysarthria, drooling, hand tremor and psychomotor slowing.<br />
Key physical findings included saccadic pursuit, impaired<br />
convergence, dysarthria, hypophonia, atrophy of tongue and<br />
small hand muscles, increased tone, brisk reflexes, and electrophysiologic<br />
evidence of chronic denervation. P2 was initiallyevaluated<br />
at4yearsofage foragaitdisturbance andmotor<br />
slowing. Examination revealed drooling, sparse speech,<br />
dynamic equinus, titubation, hypertonia with hyperreflexia<br />
and extensor plantar responses. Cognitive decline, loss of<br />
head control, development of spasticity and myoclonic jerks<br />
followed. At 15, the patient was unresponsive to voice, visual<br />
or painful stimuli. He had absent gag and corneal reflexes,<br />
diffusemuscleatrophyandspasticquadriplegia.Bothpatients<br />
had a history of behavioral problems marked by frequent<br />
temper tantrums. Both had non-diagnostic MRI imaging of<br />
the head and metabolic panels. Rectal biopsy demonstrating<br />
characteristic findings in the neurons of the myenteric plexus<br />
was diagnostic 1 (P1) and 11 years (P2) after the initial evaluation.<br />
Rectal biopsies should be considered in children with<br />
otherwise unexplained multisystem degeneration, particularly<br />
in the presence of both upper and lower motor neuron<br />
signs accompanied by behavioral problems.<br />
FP-T-021<br />
Correlation between visual function and acuity in<br />
children with severe mental retardation: a double blind<br />
randomized cross-over controlled trial utilizing a visual<br />
function checklist<br />
K.K.T. Leung a , C.H. Ko b , C.Y. Ko c , L. Chia c , C.C.H. Lo b ,<br />
P.W.T. Tse b<br />
Tuen Mun Child Assessment Centre, a Department of Health,
Abstracts 643<br />
Hong Kong; b Developmental Disabilities Unit and c Department<br />
of Ophthalmology, Caritas Medical Centre, Hong<br />
Kong, China<br />
Introduction: Refractive errors is one of the major ocular<br />
defects in children with severe mental retardation. While<br />
their visual acuity may improve significantly after prescription<br />
of corrective lenses, it is not clear whether this is associated<br />
with prompt functional and behavioral improvement.<br />
The latter may be assessed by the visual function checklist<br />
(VFC), which is an innovative behavioral tool to assess the<br />
child’s response to light perception, abilities of visual<br />
exploration, fixation, following, distance viewing, grabbing,<br />
orientation, and the presence of optokinetic nystagmus.<br />
Methods: The subjects included ten children with severe<br />
grade mental retardation and significant refractive errors.<br />
They were randomly allocated to wear corrective and<br />
plano lenses. They were then assessed by a developmental<br />
paediatrician with the VFC. Subsequently, children from the<br />
plano lens group crossed over to wear corrective lenses,<br />
while those originally in the corrective lens group changed<br />
onto plano lenses. The assessor, who was blinded to the<br />
treatment allocation, would perform a second evaluation<br />
with the VFC. The assessment was conducted in standardized<br />
settings. The results were converted into a VQ, with a<br />
range from 0 to 1. The mean VQ from both groups were<br />
compared by paired samples t-test. As it was assumed the<br />
visual function might improve or remain the same after<br />
corrective lenses, the significance level was set at a one<br />
tailed probability of ,0.05. Results: The mean VQ for the<br />
corrective lens group and plano lens group were<br />
0.829 ^ 0.304 and 0.789 ^ 0.313, respectively. There was<br />
significant prompt improvement in the visual function of the<br />
subjects after improvement in visual acuity (one tailed<br />
P ¼ 0:045). Discussion: The correction of ocular defects<br />
in children with severe mental retardation may be associated<br />
with functional improvement. The VFC is complementary<br />
to conventional acuity tests in monitoring the functional<br />
improvement.<br />
FP-T-22<br />
Analysis and evaluation of visual-motor integrated<br />
coordinating motion in children -a preliminary result<br />
C. Chen a , S.-C. Chen a , C.-H. Yu a , J.-H. Yeh a , J.-H. Lai a , C.-<br />
L. Chen b<br />
a Department of Physical Medicine and Rehabilitation,<br />
Taipei Medical <strong>University</strong> Hospital, Taipei, Chinese Taipei;<br />
b Department of Physical Medicine and Rehabilitation,<br />
Chang Gung Memorial and Children Hospital, Taoyuan,<br />
Chinese Taipei<br />
The pathophysiology of clumsy hand function in children<br />
is strongly related with the development of visual-motor<br />
integration. In 1967, Berry developed the Beery-Buktenica<br />
developmental test of visual-motor integration (VMI) as an<br />
assessment tool to evaluate the integration ability of visual<br />
perception and motor coordination. Our study is designed to<br />
analyze the motion of selected functional task during daily<br />
life, e.g. spoon manipulation, which demands desirable eyehand<br />
coordination for the children based on VMI test<br />
results. Meanwhile, the comparison with normal children<br />
will be carried out. We collected three children from 3 to<br />
6 years old. They are examined with VMI test following two<br />
additional tests (visual perception and motor coordination).<br />
Furthermore, they are instructed to perform a selected functional<br />
task in activity of daily living (ADL) by using a spoon<br />
to transport objects in four directions (horizontal, vertical,<br />
right downward oblique and left downward oblique). We<br />
recorded the kinematic values including movement velocity,<br />
trajectory and the displacement corresponding to the<br />
straight line between target and initial positions. We found<br />
the child with poor visual-motor integration made more<br />
errors and the one who had pure motor coordination<br />
performed the task with more slow velocity compared<br />
with the normal child. However their movement trajectory<br />
made no significant differences. This preliminary result<br />
offered the clinical physician and therapists a guideline for<br />
further training program in children with problems of visual<br />
motor integration or motor coordination. Further recruitment<br />
of subjects for more convinced conclusion was<br />
required.<br />
FP-T-023<br />
How are fathers first informed about the disabilities of<br />
their children and how do they accept the facts?<br />
K. Miura a , M. Aoyama b , M. Shibata b , M. Yamamoto b ,O.<br />
Nitta c , M. Miyao d , Y. Iwasaki e<br />
a School of Occupational Therapy,<br />
b School of Nursing,<br />
c School of Physical Therapy Tokyo Metropolitan <strong>University</strong><br />
of Health Sciences;<br />
d Division of Develop. Psychology<br />
National Children’s Medical Care Center,<br />
e Division of<br />
Child Neurology, Tokyo Metropolitan Yotsugi Rehabilitation<br />
Center, Japan<br />
Purpose: This research was to investigate how fathers are<br />
first informed about the disabilities of their children, and<br />
how accept the facts. Subjects: Fifty-four fathers ranging<br />
from 31 to 65 years (mean age: 45.6 years) whose children<br />
have physical disabilities (CP, PMD, etc.) and are from 6 to<br />
18 years old (mean age: 12.6 years) at a special school.<br />
Method: Fathers answered a questionnaire developed from<br />
a research project team at Tokyo Metropolitan <strong>University</strong> of<br />
Health Sciences. Results: Most of the fathers were informed<br />
of the disabilities of their children before the children were 1<br />
year old, and the fathers were in the company of their wives<br />
and doctors. Most of them responded like this: ‘I have no<br />
actual feelings’, ‘it is a great shock’ and ‘I am greatly disappointed’.<br />
One father felt that the ‘doctor did not think about<br />
the parents well-being’. The period of acceptance ranged<br />
from 10 months–11 years (mean period: 15 months). Half
644<br />
Abstracts<br />
of the fathers could accept the facts in a year, and for a<br />
quarter of them, it took over 2 years. Conclusions: According<br />
to another survey made by our project team for mothers<br />
having children with physical disabilities, we found a similar<br />
result concerning the period of acceptance. More social<br />
support systems should be implemented for fathers and<br />
mothers.<br />
FP-T-024<br />
The modified paediatric coma scale as prognostic<br />
indicator for immediate outcome in acute non-traumatic<br />
encephalopathy<br />
C.P. Wong a , J.A. Eyre b<br />
a Department of Paediatrics, UMMC, <strong>University</strong> of Malaya,<br />
Kuala Lumpur, Malaysia b Paediatric Neuroscience Group,<br />
Sir James Spence Institute of Child Health, <strong>University</strong> of<br />
Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom<br />
The study examined the prognostic significance of the<br />
James’ modification of Glasgow Coma Scale in children<br />
with acute non-traumatic encephalopathy. Children aged<br />
below 5 years who were admitted into the non-traumatic<br />
coma study in the North of England were recruited for this<br />
study. The coma score on admission, the minimum coma<br />
score and the duration of significant encephalopathy were<br />
assessed for association with the outcome at 6 weeks after<br />
the illness. Minimum coma score and duration of encephalopathy<br />
correlated well with the outcome. Coma score on<br />
admission was not found to be a significant prognostic<br />
indicator. A low coma score on admission is however<br />
specific but not sensitive in predicting death.<br />
FP-T-025<br />
Ischemic stroke in Thai children<br />
A. Visudtibhan, S. Chiemchanya, D. Kitiviriyakul, A.<br />
Chuansumrit, P. Visudhiphan<br />
Division of Neurology, Department of Pediatrics, Faculty of<br />
Medicine, Ramathibodi Hospital, <strong>Mahidol</strong> <strong>University</strong>,<br />
Bangkok, Thailand<br />
Background: The diagnosis for etiologies of ischemic<br />
stroke in children has been improved with the development<br />
of newer imaging and metabolic screening techniques.<br />
Objective: To evaluate the etiologies, clinical courses and<br />
outcomes of ischemic stroke in children. Method: A retrospective<br />
study was conducted at Ramathibodi hospital.<br />
Medical records of children aged below 15 years with<br />
ischemic stroke during January 1st, 1992–December 31st,<br />
2000 were reviewed. Children with trauma or central<br />
nervous system infection were excluded. Results: Fortyone<br />
children (19 girls, 22 boys) were included. Mean age<br />
was 5.08 years (range 2 months–14 years). The most<br />
common sites of stenosis or occlusion were the middle<br />
cerebral artery or internal capsule area (73%). Stroke<br />
subtypes were as follows: ten with Moyamoya disease,<br />
five with heart disease with embolic phenomenon, 12<br />
with undetermined causes. There were 14 children categorized<br />
into inconclusive group who had abnormal coagulogram<br />
or coagulating factors such as protein C, protein S,<br />
antithrombin III. Among these children, five also had<br />
cardiac anomaly. Owing to the lack of repeated blood<br />
tests and none in this group had recurrent stroke, specific<br />
diagnosis of hypercoagulation as the cause of stroke was<br />
not possible. There were recurrences in three children (two<br />
with Moyamoya disease, one without definite cause).<br />
Conclusion: Ischemic stroke in Thai children was not<br />
different from other studies. Abnormal coagulation might<br />
be one of contributing factors of ischemic stroke in children.<br />
Complete laboratory investigations in those without<br />
definite cause of stroke should be performed to exclude<br />
treatable cause of stroke in children.<br />
FP-T-026<br />
A rare cause of cerebral arterial stroke in childhood:<br />
non-compaction of myocardium<br />
S. Hascelik, D. Yalnizoglu, G. Kafali, A. Celiker, M. Topcu<br />
Hacettepe <strong>University</strong> Children’s Hospital Departments of<br />
Pediatric Neurology and Cardiology, Ankara, Turkey<br />
Non-compaction is a developmental disorder of cardiogenesis<br />
in fetal life characterized by prominent trabeculations<br />
and recesses between them. Patients mostly present<br />
with heart failure, arrythmias or thromboembolic events.<br />
We report an 18 month-old girl with non-compaction of<br />
the left ventricle presenting with thromboembolic stroke.<br />
Her past medical history was remarkable for mild motor<br />
delay and easy fatigue. Her parents were relatives, family<br />
history was non-contributory. She was admitted to our<br />
intensive care unit with right sided motor seizures, right<br />
hemiparesis and altered mental status. CT scans and MR<br />
imaging showed infarction in the territory of the left middle<br />
cerebral artery (MCA). MR angiography showed occlusion<br />
in the distal part of the left MCA. She was worked up<br />
thorougly for the etiology of stroke. Two dimentional echocardiography<br />
revealed trabeculations and deep recesses in<br />
the left ventricle; a large thrombus was swabbing the whole<br />
left atrium. Follow up cranial CT was obtained at 1 week<br />
which showed stable radiologic findings and no hemorrhage.<br />
The patient was then started on anticoagulant therapy,<br />
and she died on the fourth day of treatment. No further<br />
imaging studies were performed. We conclude that noncompaction<br />
of myocardium is a rare disorder yet may<br />
have severe and fatal complications. Echocardiography is<br />
mandatory in all infants and children for evaluation of<br />
stroke. Early initiation of anti-aggregant therapy may be<br />
considered in children with non-compaction to prevent<br />
future cardioembolic stroke.
Abstracts 645<br />
FP-T-027<br />
Simple reaction time in children with migraine<br />
R. Matijevic, D. Filipovic, J. Mihaljev-Martinov, K.<br />
Boskovic, V. Ivetic, I. Tanackov, S. Bogdanovic<br />
Medicinski fakultet – Novi Sad, Katedra za fiziologiju, Novi<br />
Sad, Yugaoslavia<br />
In this study we assessed simple reaction time data in<br />
children. Sample consisted of 90 children, 30 of whom<br />
had migraine with aura, 30 with migraine without aura<br />
and 30 healthy children aged 10–18 years. All children<br />
were right handed. In the first group of children there<br />
were 19 (63%) girls and 11 (37%) boys. In the second<br />
group there were 23 girls (77%) and seven boys (23%). In<br />
control group there were 16 girls (57%) and 14 boys (43%).<br />
We tested reaction times with right and left hand on audio<br />
and visual stimulus. In all three groups responses with right<br />
and left hand where shorter on audio stimulus than on visual<br />
stimulus and reaction of right hand is shorter than reaction<br />
with left hand on same stimulus. Control group had significantly<br />
shorter all four reaction times (visual stimulus – right<br />
hand, visual stimulus – left hand, audio stimulus – right<br />
hand, audio stimulus – left hand) than both groups with<br />
migraine. Differentiation on base of average values of RT<br />
between groups with migraine was possible only with some<br />
of RT.<br />
FP-T-028<br />
Brain tumors in children. A review of 84 Brazilian cases<br />
A.A. Espíndola, H. Matushita, A. Diament, U.C. Reed<br />
Department of Neurology of the School of Medicine of São<br />
Paulo <strong>University</strong>, São Paulo, Brazil<br />
From 1970 the incidence of primary brain tumors among<br />
children has increased and environmental factors as well as<br />
an earlier diagnosis by improvement of detection methods<br />
have been considered for explaining it. Along this period,<br />
continuous therapeutic advances have optimized treatment<br />
planning. For evaluating outcome data, we reviewed histological,<br />
clinical and therapeutic aspects in 84 consecutive<br />
children (0–16 years) with primary central nervous system<br />
tumors, attended and followed-up from January/1997 to<br />
May/2001. Tumor was supratentorial in 63.0%, infratentorial<br />
in 30.9%, spinal intramedullary in 3.5% and spinal extradural<br />
in 2.3%. Astrocytic tumors occurred in 34.5%,<br />
followed by medulloblastoma (11.9%), craniopharygioma<br />
(10.7%) and ependymoma (10.7%). The duration of the<br />
symptoms before diagnosis ranged between 1 day and 8<br />
years (mean 9.3 months). Clinically, increased intracranial<br />
pressure manifested in 41.6%, seizures in 17.8%, focal deficits<br />
in 22.6%, visual abnormalities in 20.2%, ataxia in<br />
13.0% and endocrinological changes in 3.5%. Total removal<br />
was achieved in 54.2%, and partial removal in 39.7%. In<br />
respectively 27.3, 38.0 and 20.2%, chemotherapy, radiotherapy<br />
or both were used. Follow-up ranged between 1<br />
month and 4 years and 4 months (mean: 1 year and 6<br />
months). Tumor recurred in 18 patients. At follow-up,<br />
4.7% have died, 50.0% have no tumor and normal neurological<br />
examination; 8.3% have no tumor but neurological<br />
changes; 23.8% have residual tumor but normal neurological<br />
examination and 13.0% have residual tumor and neurological<br />
changes. We concluded that overall outcome has<br />
improved in several childhood brain tumors and the extent<br />
of removal has demonstrated to influence prognosis.<br />
FP-T-029<br />
Asymptomatic cerebrovascular lesions in children with<br />
sickle cell disease<br />
F.N. Arita, S. Rosemberg<br />
Santa Casa School of Medicine, Department of Pediatrics,<br />
Neuropediatrics Division., São Paulo, Brazil<br />
Symptomatic ischemic cerebrovascular disorder is a<br />
severe complication in children with sickle cell disease<br />
(SCD), affecting 6 to 8% of patients within the first 20<br />
years of life. In order to detect clinically silent ischemic<br />
lesions and to determine their prognostic value, we<br />
submitted 28 children with SCD between 5 and 15 years<br />
of age with normal development and without neurological<br />
disease to a unique transaxial T2-weighted MRI. Ischemic<br />
lesions were found in 14 (50%) of the asymptomatic<br />
patients. These were characterized by hyperintense, isolated<br />
or multiple, uni or bilateral punctate or small plaques<br />
images. Five patients presented isolated punctate lesions,<br />
four presented unilateral multiple punctate or small plaques<br />
and five had multiple bilateral lesions. The topographic<br />
distribution of these lesions corresponded to the deep<br />
watershed vascular territories in cerebral white matter.<br />
Two patients with bilateral extensive lesions presented<br />
strokes in the following few years, which recurred in one<br />
of them despite hypertransfusion therapy. A third patient<br />
with extensive lesions presented migraine-like episodes 3<br />
years after the exam. Albeit the control MRI was similar, the<br />
angio-MRI disclosed arterial stenosis and a ’moyamoya’<br />
pattern, and transcranial doppler detected high velocities.<br />
The remaining two patients with bilateral extensive lesions<br />
and the nine patients with less extensive lesions as well as<br />
the 14 patients without lesions remained well after 6 years<br />
of follow-up. We conclude that bilateral and extensive<br />
lesions seem to be an important predictive risk factor for<br />
the development of ulterior cerebrovascular accident in children<br />
with SCD.<br />
FP-T-030<br />
The retrospective study of early diagnosis and EEG<br />
analysis in 31 migraine children<br />
H. Li, X.-Q. Liu, W. Zhou<br />
Qingdao Municipal Hospital, Qingdao Shandong, China
646<br />
Abstracts<br />
Objective: To study the clinical characteristics and<br />
analyse the EEG in children with migraine. Methods: We<br />
reviewed the clinical manifestations and auxiliary examinations<br />
of 31 cases diagnosed as children migraine and<br />
analyzed the EEG abnormality of them. Results: Thirtyone<br />
children were studied, 19 males, 12 females. Headache<br />
occurred bilaterally in 18 cases, and in one side in five cases.<br />
Three cases had auras (10%). Duration of headache varied<br />
from half an hour to 5 h. Headache accompanied with<br />
nausea in eight cases, vomiting in 11 cases, and abdominal<br />
pain in six cases (totally occurred in 80.6% cases). The EEG<br />
abnormalities during attacks and interictal period mostly<br />
were focal and diffuse slow waves or paroxysmal high<br />
amplitude slow waves. Conclusions: There are many<br />
features in children migraine attacks. Clinical manifestations<br />
were the most important aspects in diagnose of children<br />
migraine. Abnormalities of EEG can only be<br />
considered as reference.<br />
FP-T-031<br />
Alternating hemiplegia in childhood: a study of ten<br />
patients<br />
Y.-H. Zhang, W.-X. Sun, Y.-W. Jiang, J. Qin, X.-R. Wu<br />
Department of Pediatric Neurology, Peking <strong>University</strong> First<br />
Hospital, Beijing, China<br />
Alternating hemiplegia in childhood (AHC) is a rare<br />
disorder of unknown cause. We described the clinical<br />
features of ten patients (nine males and one female). The<br />
age of onset was from 2 days to 55 months (average: 13.2<br />
months). The initial symptoms were abnormal eye movements<br />
or dystonic posturing in eight cases, hemiplegia in<br />
two cases. All patients had recurrent alternating hemiplegic<br />
episodes. The hemiplegia attacks lasted from a few minutes<br />
to 10 days. The occurrence of the attacks ranged from 8<br />
times daily to one time every 2 months. Five patients also<br />
had the episodes of quadriplegia that could be isolated manifestation<br />
or occurred when hemiplegia was shifting from<br />
one side to the other. In eight patients the abnormal eye<br />
movements or dystonia posturing recurred intermittently<br />
during the hemiplegia attack. Sleep could relieve both<br />
weakness and associated paroxysmal symptoms. Mental<br />
retardation was present in seven cases, seizures in two<br />
cases, and dysarthria in three cases. Ataxia and choreoathetosis<br />
presented in one case, respectively. EEG was abnormal<br />
in two patients; other laboratory investigations (such as<br />
brain MRI, cerebral angiography, plasma lactate and pyruvate<br />
levels, et al.) were normal in all patients. Nine patients<br />
received flunarizine therapy. Flunarizine reduced the severity,<br />
duration, or frequency of hemiplegic attacks in six<br />
patients. Our results suggested that AHC was characterized<br />
by frequent episodes of alternating hemiplegia with extrapyramidal<br />
symptoms and mental retardation; flunarizine<br />
was effective in treating some AHC patients.<br />
FP-T-032<br />
The risk of stroke recurrence in childhood<br />
V. Brankvic-Sreckovic, V. Milic-Rasic, N. Jovic, S.<br />
Todorovic<br />
Clinic for Child Neurology and Psychiatry, Belgrade, Yugoslavia<br />
Background: Stroke in children, as an important cause<br />
of morbidity, is challenging for further research. Although<br />
the different aspects of childhood stroke are under investigation,<br />
the recurrence rate is still unknown precisely. It<br />
seems to be lower than previously reported, but highly<br />
correlated with certain etiologies and underlying mechanisms.<br />
Patient and methods: Thirty-five children (21 boys,<br />
16 girls) with diagnosed ischemic infarction, all fulfilling<br />
both clinical and radiographic criteria, were investigated.<br />
Patients with neonatal stroke and SVT were excluded. The<br />
mean follow-up period was 59 months and median age of<br />
stroke onset was 8.4 ^ 4.4 years (1–16 years). Diagnostic<br />
studies were proceeded on a case-by-case analysis to determine<br />
the risk factors associated with stroke. The patients<br />
were analysed according to the etiologic contribution to<br />
initial and recurrent stroke event. Results: Cardioembolic<br />
(12 children-34.3%) and arteriopathic processes (12–<br />
34.3%) were identified as the most probable mechanisms<br />
of arterial ischemic stroke. Prothrombotic abnormalities<br />
were found in four (11.4%) children. Underlying pathology<br />
remained unknown in seven (20%). Cardiac abnormality<br />
prior to first stroke was detected in one child.<br />
Progressive arteriopathies were determined in 3 (8.6%)<br />
and transient cerebral arteriophaty of unknown origin<br />
was found in five (14.3%) children. In four (11.4%) children<br />
recurrent stroke was observed in a period of 4 days–<br />
18 months after the first stroke manifestation. In three of<br />
them (75%), recurrence was due to cardiac or transcardiac<br />
embolism. In the remaining case, the diagnosis of Moyamoya<br />
disease was established (repeated stroke in the same<br />
arterial territory). In one patient (migraine-related stoke)<br />
TIA was noticed before the stroke episode. Clinically<br />
silent cerebral infarcts (multiple lacunar infarcts limited<br />
to one hemisphere) disclosed by MRI preceded the overt<br />
stroke episode in two patients. Antiplatelet agent (aspirin)<br />
has been given in three patients, but no valuable data of<br />
effectiveness could be obtained. Conclusion: The risk<br />
factors of stroke in children appear to be multiple and<br />
overlapping, disabling the precise etiologic diagnosis in<br />
certain circumstances. However, congenital and acquired<br />
heart diseases were the most common cause of repeated<br />
stroke in our study. Better recognition of the underlying<br />
mechanisms and aetiology of childhood stroke is crucial<br />
for both effective therapeutic approach and prevention of<br />
recurrences.
Abstracts 647<br />
FP-T-033<br />
Socioeconomic background of the families with children<br />
in special education<br />
L.E. Åberg a , T. Autti b , M. Mannerkoski a , M. Hoikkala a ,K.<br />
Kuismanen a , H. Heiskala a<br />
a Departments of Child Neurology and b Radiology, Helsinki<br />
<strong>University</strong> Central Hospital, Helsinki, Finland<br />
Our aim was to determine the socioeconomic background<br />
of the families with children in special education. This<br />
epidemiological study was carried out during the years<br />
1997–1998 in southern Finland. The information was gathered<br />
from randomly chosen 19 school health care units,<br />
representing evenly different districts. The study group<br />
included 900 pupils, 64% boys and 36% girls, born in<br />
years 1980–1993. Out of these 900 pupils, 23% participated<br />
in education modified for specific neurological disabilities,<br />
46% in adjusted education and 30% in training education.<br />
Multinomial logistic regression was used to compare the<br />
size of the families, position of the pupil in the sibling series,<br />
the parental age and socioeconomic status in these different<br />
teaching groups. Our preliminary results show that neither<br />
the family size nor the position in the sibling series differed<br />
in the three teaching groups. As regards the age of the<br />
parents, the fathers of children in the training education<br />
were older as compared to the fathers of children in the<br />
other teaching groups. Also the socioeconomic status of<br />
parents differed, the parental socioeconomic status in the<br />
training education being higher and in the adjusted education<br />
lower than expected. These results indicate that aged<br />
fathers and highly educated parents may be in risk of having<br />
children in the training education, whereas parents with low<br />
socioeconomic status may be in risk of having children in<br />
adjusted education. The present information will also be<br />
compared to the socioeconomic background of the families<br />
with children in normal education.<br />
FP-T-034<br />
Characteric of the neurological signs at the children with<br />
obesity<br />
R.A. Abedimova<br />
Institute of Postgraduate Study, Almaty, Kazakstan<br />
The aim of study was an investigation of neurological<br />
signs at the children with obesity. We observed 197 children<br />
with obesity (97 of them with exogenicconstitutional<br />
obesity (ECO), 100 of them with hypothalamic obesity<br />
(HO)). We used different methods: neurological assessment,<br />
electrophysiological and neuroradiological. Results: We<br />
found some neurological symptoms such us motor delay<br />
which were determined of 86% of children with ECO and<br />
90% of children with HO). There were neuroradiological<br />
changes such us dilatation of subarachnoidal spaces, devastation<br />
of ventriculis of the brain and sub atrophy of frontal<br />
lobe (41% children with ECO; 54% with HO). Electrophysiological<br />
sings (bilateral synchronized wares, hyper<br />
synchronization) were observed at 51% of children with<br />
ECO, and 63% of children with HO. Moreover, after clinical<br />
and tools investigation we were detected neurological<br />
syndromes such as: astenoneurotical syndrome (58%<br />
ECO; 69% HO); hypertension-hydrocephalic syndrome<br />
(43% ECO; 51% HO); syndrome with vegetodystonia<br />
(49% ECO; 55% HO). Conclusion: Therefore, despite on<br />
the clinical forms of obesity, all children had neurological<br />
sings which characterized of diffuse affection of the brain<br />
during perinatal period.<br />
FP-T-035<br />
Instenon administration in children with burn disease<br />
encephalopathy<br />
T.A. Djumabekov, B.K. Nurmagambetova, B.D.<br />
Gurkabaeva, A.V. Zikeeva, S.R. Aitmagambetova<br />
Children’s Hospital, No.1 Almaty, Kazakhstan<br />
Burn trauma in children is an important medical and<br />
social problem. It is the most frequent pediatric trauma<br />
and leads to high level of mortality or handicap. Serous<br />
water and electrolytes dysbalance leads to disturbances of<br />
central nervous system functions, encephalopathy of<br />
hypoxic and toxic genesis. Instenon, is a product of<br />
Nicomed, and there are several active parts in it, which<br />
activate reticular formation, preserves the functional abilities<br />
of neuron complexes of cortex and subcorical structures.<br />
There is Improvement in oxygenation and<br />
phosphorilisation in nerve cells, stabilisation of central<br />
and peripheral haemodynamics, stimulate the vessel moving<br />
center, the center of vegetative regulation and active metabolism<br />
of myocard. This drug was used as part of a complex<br />
therapy of 34 children aged from 6 months to 14 years of age<br />
with burn trauma, complicated by shock and encephalopathy.<br />
All children had had trauma by boiling water and were<br />
hospitalized in 2 h from the trauma moment. The burn area<br />
varied from 10 to 62%. The I degree of burn shock was<br />
diagnosed in 16 children, the II degree in 12 ones, III in<br />
six ones. Antishock therapy was induced immediately.<br />
Central vein catheterization and surgical dress of wound<br />
were held. Infusional therapy was calculated according to<br />
area and daily physiological solutional need by Brooke<br />
formula. All patients underwent treatment using special<br />
aerofluid bed with temperature regulation. Signs of encephalopathy<br />
were: somnolence and consciousness disturbances<br />
in 26 children, coma of I–II degrees in four. All<br />
children had wide and narrow range tremor in all extremitiles<br />
and in chicken. Because of increasing cardiovascular<br />
and respiratory insufficiency and brain hypoxia, four children<br />
were put on artificial lunges ventilation. Instenon was<br />
administrated in children younger then 1 year of age 1 ml in<br />
glucosa solution 5% intravenously one time daily. For the<br />
older patients Instenon was administrated in dose 2 ml in
648<br />
Abstracts<br />
glucose solution 5% intravenously. Treatment course varied<br />
from 5 to 7 days. Outcomes showed positive dynamics of<br />
clinical indexes. A day after treatment started there were<br />
rapid restore of central nervous system functions, then<br />
tendency to consciousness restore appeared, even going<br />
out of coma in 2–3 days. Artificial lungs ventilation restore<br />
breathe and blood circulating. These factors supported water<br />
and electrolytes metabolism, biochemical indexes restore<br />
and transporting blood functions improvement, what manifests<br />
in positive changes of acid – alkaline blood status.<br />
Conclusion: Instenon administration in children with burn<br />
shock, complicated by toxemia, leads to rapid restoration of<br />
consciousness, improves gases transport, prevents brain<br />
hypoxia and hypoxia of other organs and tissues. Administration<br />
of this drug promotes the outcome of patients from<br />
critical status and decreased the time of hospital treatment<br />
for 3 days.<br />
FP-T-036<br />
Ischemic stroke in child with hypoplasia of right<br />
common and internal carotid artery<br />
J.K. Abdulla, M.O. Al Ajmi, S. Slakovic<br />
Paediatric Neurology Unit, Paediatric Department, Al<br />
Sabah Hospital, Al Safat, Kuwait<br />
Although cerebrovascular disorders occur less often in<br />
children than in adults, recognition of stroke in children<br />
has increased because of the widespread application of<br />
non-invasive neuroimaging studies such as CT, MRI and<br />
MRA. The recognized causes of cerebrovascular disorders<br />
in children are numerous and the probability of identifying<br />
the cause depends on the thoroughness of evaluation. We<br />
are reporting a case with Hypoplasia of rt. common and<br />
internal cartoid artery which is recognized as a rare cause<br />
of stroke in childhood. A 3 years old female child admitted<br />
with acute left sided weakness. On examination she had left<br />
sided hemiparesis, left facial palsy, other systemic examination<br />
was normal. Urgent CT head showed hypodense lesion<br />
in the right caudate and right lentiform nucleus suggestive<br />
of brain infarction. Investigations were done excluded<br />
congenital and acquired heart disease, haematological disorders<br />
and coagulopathy, inflammatory, autoimmune and<br />
other systemic disorders. MRI of brain and neck showed<br />
ischemic partially haemorrhagic infarction in rt. paraventricular<br />
mostly basal ganglia due to occluded or undeveloped<br />
rt. middle cerebral artery, rt. ant. cerebral artery. MRA<br />
showed hypoplastic rt. common car. artery, in particular<br />
int. car. artery with occlusion of middle and anterior cerebral<br />
arteries. Accentuated both posterior cerebral arteries<br />
with marked collaterals supplying territory of rt. middle<br />
cerebral artery. During hospitalization, she remained<br />
conscious and she started to show slow gradual improvement<br />
with physiotherapy. Currently, she is having mild left<br />
sided spastic hemiparesis with shortening of the left tendon<br />
Achillis and shortening of left leg.<br />
FP-T-037<br />
Therapeutic effect of parenan and cyproheptadine on<br />
childhood migraine<br />
B.-X. Tang<br />
Pediatrics Department of Central Hospital, Jinshan Shanghai,<br />
China<br />
Objective: To evaluate the effect and safety of Perenan in<br />
treating childhood migraine. Methods: Perenan and Cyproheptadine<br />
were given orally in the period of 1–3 months.<br />
Results: There were 25 children in Perenan treatment group<br />
and 27 in Cyproheptidine treatment group. The effective<br />
rate were 92 and 70.3% in Perenan and Cyproheptidine<br />
treatment, respectively. The difference between the two<br />
groups was statistically significant (P , 0:05). The therapeutic<br />
effect of Perenan was better than that of Cyproheptadine,<br />
and no side effect was observed during the treatment.<br />
Conclusion: Perenan was an effective and safe drug in dealing<br />
with childhood migraine.<br />
FP-T-038<br />
Synthesis and properties of chitosan-metal complexes<br />
S.Sh. Rashidova, N.L. Voropaeva, S. Pulatova, I.N. Ruban<br />
Institute of Polymer Chemistry and Physics Uzbekistan<br />
Academy of Sciences, Tashkent, Republic Uzbekistan<br />
Introduction: Investigation of chitosans interaction with<br />
ions of transition metals and obtaining of water-soluble<br />
polymermetal complexes with the controlled content of<br />
metal ions is an actual task. Its deciding will allow to<br />
propose a new preparations for medicine, agriculture etc.<br />
Results and discussion: Chitosan complex formation with<br />
metal ions of a transitional series (Co, Ni, Cu, Mn) have<br />
been investigated. Estimation of changes in the spectra of<br />
chitosan and its metal-complexes testify that all main<br />
changes take place in a region of stretching and deformation<br />
vibrations of amide bond (Amide-I, -II and -III). It is<br />
accounted well, because chitosan metal-complexes synthesis<br />
was carried out in an acid media and chitosan aminogroup<br />
is protonized. Therefore the most preferable interaction<br />
is an amide bond of samples chitin residue. In this case<br />
a sharp change of Amide-I and -II intensity is observed,<br />
depending on metal ions content, that can be used in a future<br />
for metal content estimation in the samples. Potentiometric<br />
estimation of chitosan interaction with metal ions evidences<br />
of significant complex-formation in a region of neutral pH,<br />
when an initial polymer precipitates. It is likely, that at a<br />
transition to neutral and weak-alkaline media (pH < 8) chitosane<br />
amino groups also take part in the process of interaction<br />
with metal ions. It is necessary a more detailed<br />
investigation of this phenomenal. Some experiments on<br />
chitosane carboxymethylation by monochloracetic acid<br />
were carried out. The conditions of chitosane-metalcomplex<br />
synthesis which allow to get a homogeneous
Abstracts 649<br />
complexes with metal ions content from 0.8 to 8.4 were<br />
selected. It was shown, that in the samples synthesized,<br />
metal ions are distributed rather uniformly along a polymeric<br />
chains. The composition, structure of the complexes<br />
formed and the conditions of incliding in a coordination<br />
process of polymer different functional groups, as well as<br />
a dynamic of macromolecular tangle behaviour in the<br />
process of metal ions binding are determined. It eventually<br />
allows to predict the system chitosan metal-ion system<br />
behavior in a real conditions when use. Laboratory and<br />
field testing of regulating and fungicidal properties of chitosan<br />
and its metal-complexes on rice and cotton seeds was<br />
carried out. The data obtained show a high activity of<br />
preparations tested. The conditions for rice and cotton<br />
seeds treatment as a growth stimulator on the base of chitin,<br />
chitosane and their derivatives are selected.<br />
FP-T-039<br />
Daytime sleepiness in children and adolescents as<br />
assessed by the Epworth sleepiness scale<br />
C.V. Harden, G.A. Fenton, C. Vemulapalli, J. Puetz, P.<br />
Codden, T.J. Geller<br />
St Louis <strong>University</strong> Medical Center, USA<br />
Objective: To evaluate the incidence of sleep abnormalities,<br />
including excessive daytime sleepiness and restless leg<br />
symptoms in post chemo/radiation therapy survivors of<br />
leukemia, comparing them to healthy sibling controls.<br />
Method: Patients with a previous diagnosis of Leukemia,<br />
who are disease-free following therapy, and non-affected<br />
siblings were consented, and questioned using the Epworth<br />
Sleepiness Scale (ESS). This questionnaire provides a<br />
measurement of the subject’s general daytime drowsiness.<br />
A target population of 80 subjects has not yet been reached.<br />
Nonetheless, a high incidence of ESS scores .10 has been<br />
noted, (a level which in adult studies has been associated<br />
with moderate daytime sleepiness). Results: Mean age of<br />
evaluated leukemia survivors is 13.7 years, SD 4.5: mean<br />
age of sibling controls is 12.9 years, SD of 5.5. Total group<br />
mean age is 13.4 years; SD of 4.75. Total group mean ESS<br />
score (42 subjects) is 7.42, SD of 3.66, with a 30.9% incidence<br />
of ESS scores .10. Conclusions: Our research<br />
suggests that ESS scores are higher in pediatric and adolescent<br />
populations compared to adult studies. In reviewing the<br />
literature regarding measures of chronic sleepiness, a single<br />
reliable tool has not been established for this age group.<br />
Among adolescent drivers in New Zealand, the distribution<br />
of ESS scores was lower than in older drivers, but our data<br />
may suggest a higher incidence of moderate daytime sleepiness<br />
in an US pediatric and adolescent population. Our<br />
enrollment does not yet permit a comparison between leukemic<br />
survivors and control siblings, regarding the incidence<br />
of excessive daytime sleepiness.